<SEC-DOCUMENT>0001193125-14-195836.txt : 20140513
<SEC-HEADER>0001193125-14-195836.hdr.sgml : 20140513
<ACCEPTANCE-DATETIME>20140513061311
ACCESSION NUMBER:		0001193125-14-195836
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		13
CONFORMED PERIOD OF REPORT:	20140331
FILED AS OF DATE:		20140513
DATE AS OF CHANGE:		20140513

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AQUINOX PHARMACEUTICALS, INC
		CENTRAL INDEX KEY:			0001404644
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36327
		FILM NUMBER:		14835304

	BUSINESS ADDRESS:	
		STREET 1:		887 GREAT NORTHERN WAY
		STREET 2:		SUITE 450
		CITY:			VANCOUVER
		STATE:			A1
		ZIP:			V5T 4T5
		BUSINESS PHONE:		604-629-9223

	MAIL ADDRESS:	
		STREET 1:		887 GREAT NORTHERN WAY
		STREET 2:		SUITE 450
		CITY:			VANCOUVER
		STATE:			A1
		ZIP:			V5T 4T5

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AQUINOX PHARMACEUTICALS (USA) INC
		DATE OF NAME CHANGE:	20070626
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>d704250d10q.htm
<DESCRIPTION>10-Q
<TEXT>
<HTML><HEAD>
<TITLE>10-Q</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>FORM 10-Q
</B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(Mark One) </B></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B></B><FONT STYLE="FONT-FAMILY:WINGDINGS">&#120;</FONT><B></B><B></B></TD>
<TD ALIGN="left" VALIGN="top"><B>QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 </B></TD></TR></TABLE>
 <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>For the quarterly period ended March&nbsp;31, 2014 </B></P>
 <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>OR </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B></B><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT><B></B><B></B></TD>
<TD ALIGN="left" VALIGN="top"><B>TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 </B></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>For the transition period from
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; to &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Commission file number: 001-36327 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>Aquinox
Pharmaceuticals, Inc. </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Exact name of registrant as specified in its charter) </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="50%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"><B>Delaware</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>98-0542593</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(State or other jurisdiction of</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>incorporation or organization)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(I.R.S. Employer</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Identification No.)</B></P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>450-887 Great Northern Way, </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Vancouver, B.C., Canada V5T 4T5 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Address of principal executive offices, including zip code) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Registrant&#146;s telephone number, including area code): (604)&nbsp;629-9223 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant (1)&nbsp;has filed all reports required to be filed by Section&nbsp;13 or 15(d) of the Securities Exchange Act
of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)&nbsp;has been subject to such filing requirements for the past 90 days.&nbsp;&nbsp;&nbsp;&nbsp;Yes&nbsp;&nbsp;<FONT
STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;No&nbsp;&nbsp;<FONT STYLE="FONT-FAMILY:WINGDINGS">&#120;</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark
whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such
shorter period that the registrant was required to submit and post such
files).&nbsp;&nbsp;&nbsp;&nbsp;Yes&nbsp;&nbsp;<FONT STYLE="FONT-FAMILY:WINGDINGS">&#120;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;No&nbsp;&nbsp;<FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See
the definition of &#147;large accelerated filer,&#148; &#147;accelerated filer&#148; and &#147;smaller reporting company&#148; in Rule 12b-2 of the Exchange Act. (Check one): </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="16%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="60%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="20%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="1%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Large&nbsp;accelerated&nbsp;filer</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Accelerated&nbsp;filer</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Non-accelerated filer</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#120;</FONT>&nbsp;&nbsp;(Do not check if a smaller reporting company)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Smaller&nbsp;reporting&nbsp;company</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange
Act).&nbsp;&nbsp;&nbsp;&nbsp;Yes&nbsp;&nbsp;<FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;No&nbsp;&nbsp;<FONT STYLE="FONT-FAMILY:WINGDINGS">&#120;</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of April&nbsp;30, 2014, there were 10,675,260 shares of the registrant&#146;s common stock outstanding. </P>
<P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Aquinox Pharmaceuticals, Inc. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Quarterly Report on Form 10-Q </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>For the Quarter Ended March&nbsp;31, 2014 </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc"></A>INDEX </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="6%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="88%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-size:10pt"><B>PART&nbsp;I. FINANCIAL INFORMATION (Unaudited)</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Item&nbsp;1.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><A HREF="#tx704250_1">Condensed Consolidated and Combined Financial Statements</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">F-1</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><A HREF="#tx704250_2">Condensed Consolidated and Combined Balance Sheets</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">F-1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><A HREF="#tx704250_3">Condensed Consolidated and Combined Statements of Comprehensive Loss</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">F-3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><A HREF="#tx704250_4">Condensed Consolidated and Combined Statements of Cash Flows</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">F-7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><A HREF="#tx704250_5">Notes to Condensed Consolidated and Combined Financial Statements</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">F-8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Item&nbsp;2.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><A HREF="#tx704250_6">Management&#146;s Discussion and Analysis of Financial Condition and Results of Operations</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Item&nbsp;3.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><A HREF="#tx704250_7">Quantitative and Qualitative Disclosures About Market Risk</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Item&nbsp;4.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><A HREF="#tx704250_8">Controls and Procedures</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>PART&nbsp;II.&nbsp;OTHER&nbsp;INFORMATION</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Item&nbsp;1.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><A HREF="#tx704250_9">Legal Proceedings</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Item&nbsp;1A.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><A HREF="#tx704250_10">Risk Factors</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Item&nbsp;2.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><A HREF="#tx704250_11">Unregistered Sale of Equity Securities and Use of Proceeds</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">33</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Item&nbsp;3.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><A HREF="#tx704250_12">Defaults Upon Senior Securities</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">33</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Item&nbsp;4.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><A HREF="#tx704250_13">Mine Safety Disclosures</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">33</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Item&nbsp;5.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><A HREF="#tx704250_14">Other Information</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">34</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Item&nbsp;6.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><A HREF="#tx704250_15">Exhibits</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR>
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B><A HREF="#tx704250_16">SIGNATURES</A></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR>
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B><A HREF="#tx704250_17">EXHIBIT INDEX</A></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">37</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as otherwise indicated herein or as the context otherwise requires, references in this report to
&#147;Aquinox,&#148; &#147;the company,&#148; &#147;we,&#148; &#147;us,&#148; &#147;our&#148; and similar references refer to Aquinox Pharmaceuticals, Inc., a Delaware corporation, which we refer to in this report as Aquinox USA, and Aquinox
Pharmaceuticals Inc., a corporation under the Canada Business Corporations Act and a wholly owned subsidiary of Aquinox USA, which we refer to in this report as AQXP Canada. This report contains registered marks, trademarks and trade names of other
companies. All other trademarks, registered marks and trade names appearing in this report are the property of their respective holders. </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PART I. FINANCIAL INFORMATION </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B><A NAME="tx704250_1"></A>Item&nbsp;&nbsp;1.</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Condensed Consolidated and Combined Financial Statements </B></TD></TR></TABLE> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AQUINOX PHARMACEUTICALS,
INC. </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(a development stage company) </P>
 <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx704250_2"></A>Condensed consolidated and combined balance sheets </B></P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Unaudited) (Expressed in U.S. dollars) </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="78%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>MARCH 31,</B><br><B>2014</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>DECEMBER&nbsp;31,<BR>2013</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Assets</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Current assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash and cash equivalents (Note&nbsp;4)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">52,918,327</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">11,006,392</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Short-term investments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,714,100</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,820,600</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounts and other amounts receivable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">66,526</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27,946</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Prepayments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">547,812</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">63,975</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred offering costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,377,438</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total current assets</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">56,246,765</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15,296,351</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Property and equipment</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">67,379</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">75,465</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">135,344</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">277,290</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total assets</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">56,449,488</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">15,649,106</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Liabilities</B></P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Current liabilities</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounts payable and accrued liabilities</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,220,695</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2,350,660</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Current portion of bank loan (Note 5)</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">250,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,907</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19,445</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total current liabilities</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,237,602</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,620,105</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Warrant liabilities (Note 8)</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">107,597</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">221,320</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Redemption option on preferred stock (Note&nbsp;3)</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">800,206</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accrued tax payable on preferred stock (Note&nbsp;3)</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,797,412</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Bank loan (Note 5)</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,036,489</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,047</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,560</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total liabilities</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,352,246</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">7,484,092</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Redeemable convertible preferred stock (Note&nbsp;3)</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">AQXP Canada, Series A exchangeable preferred shares, no par value&#151;authorized unlimited as of March&nbsp;31, 2014
(December&nbsp;31, 2013&#151;unlimited); issued and outstanding, 0 as of March&nbsp;31, 2014 (December 31, 2013&#151;791,016)</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,329,639</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Aquinox USA, Series A preferred stock, $0.000001 par value&#151;authorized 0 as of March&nbsp;31, 2014 (December&nbsp;31,
2013&#151;27,914,951); issued and outstanding, 0 as of March&nbsp;31, 2014 (December 31, 2013&#151;662,875)</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,157,138</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">AQXP Canada, Series B exchangeable preferred shares, no par value&#151;authorized unlimited as of March&nbsp;31, 2014
(December&nbsp;31, 2013&#151;unlimited); issued and outstanding, 0 as of March&nbsp;31, 2014 (December 31, 2013&#151;793,617)</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,684,093</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">The accompanying notes form an integral part of these unaudited condensed consolidated and combined financial
statements </P>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-1 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="78%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>MARCH 31,</B><br><B>2014</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>DECEMBER&nbsp;31,<BR>2013</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Aquinox USA, Series B preferred stock, $0.000001 par value&#151;authorized 0 as of March&nbsp;31, 2014 (December 31, 2013&#151;
45,454,535); issued and outstanding, 0 as of March&nbsp;31, 2014 (December 31, 2013&#151;1,573,797)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21,091,150</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">AQXP Canada, Series C exchangeable preferred shares, no par value&#151;authorized unlimited as of March&nbsp;31, 2014
(December&nbsp;31, 2013&#151;unlimited); issued and outstanding, 0 as of March&nbsp;31, 2014 (December&nbsp;31, 2013&#151;378,786)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,830,961</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Aquinox USA, Series C preferred stock, $0.000001 par value&#151;authorized 0 as of March&nbsp;31, 2014 (December&nbsp;31,
2013&#151;45,793,738); issued and outstanding, 0 as of March&nbsp;31, 2014 (December 31, 2013&#151;1,343,424)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,765,741</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total redeemable convertible preferred stock</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">73,858,722</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Stockholders&#146; equity (deficit)</B></P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share capital</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Common stock (Note 6)</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Aquinox USA, common stock, $0.000001 par value&#151;authorized, 50,000,000 as of March&nbsp;31, 2014 (December&nbsp;31,
2013&#151;139,266,037); issued and outstanding, 10,675,260 as of March&nbsp;31, 2014 (December 31, 2013&#151;301,745)</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Additional paid-in capital</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">124,713,456</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deficit accumulated in the development stage</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(69,616,225</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(65,693,708</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total stockholders&#146; equity (deficit)</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">55,097,242</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(65,693,708</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total liabilities, redeemable convertible preferred stock, and stockholders&#146; equity (deficit)</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">56,449,488</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">15,649,106</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">The accompanying notes form an integral part of these unaudited condensed consolidated and combined financial
statements </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-2 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AQUINOX PHARMACEUTICALS, INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(a development stage company) </P>
 <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx704250_3"></A>Condensed consolidated and combined statements of operations and comprehensive loss </B></P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Unaudited) (Expressed in U.S. dollars) </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="61%"></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>THREE&nbsp;MONTHS<BR>ENDED</B><br><B>MARCH 31, 2014</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>THREE&nbsp;MONTHS<BR>ENDED</B><br><B>MARCH 31, 2013</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>DECEMBER&nbsp;26,<BR>2003<BR>(INCEPTION)&nbsp;TO<BR>MARCH 31, 2014</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Operating expenses</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and development</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,879,514</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">572,967</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">43,789,126</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">General and administrative</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">734,824</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">423,865</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,241,412</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total operating expenses</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,614,338</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">996,832</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">54,030,538</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Other income (expenses)</B></P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Bank charges and financing costs</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(453,808</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,834</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(590,023</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest income</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,835</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,446</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">365,881</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Sale of equipment</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29,396</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">134,553</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Change in fair value of derivative liabilities (Note 8)</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">913,929</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,102,193</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amortization and extinguishment of remaining discount on preferred shares upon conversion of preferred shares</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,884,233</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(25,438</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,395,575</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Foreign exchange loss</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(192,063</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(17,005</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(239,484</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,613,340</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(13,435</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(622,455</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss before income taxes</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,227,678</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,010,267</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(54,652,993</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Income tax recovery</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,150,406</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Net loss and comprehensive loss incurred in the development stage</B></P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(4,227,678</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(1,010,267</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(51,502,587</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accretion for liquidation preference on preferred stock</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,132,893</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,157,865</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(18,566,008</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accretion for share issuance costs on preferred stock</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(19,550</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(44,307</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,014,667</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tax expense on preferred stock</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(100,291</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(346,091</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,897,702</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Reversal of tax payable on preferred stock due to conversion of preferred stock</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,897,702</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,897,702</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Extinguishment of remaining share issuance costs due to conversion of preferred stock</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(439,227</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(439,227</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total loss attributable to common stockholders</B></P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(4,021,937</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(2,558,530</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(71,522,489</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Basic and diluted loss per common stock (Note 7)</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(1.28</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(8.48</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(179.45</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Basic and diluted weighted average common stock outstanding (Note 7)</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,148,481</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">301,745</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">398,573</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">The accompanying notes form an integral part of these unaudited condensed consolidated and combined financial
statements </P>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-3 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AQUINOX PHARMACEUTICALS, INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(a development stage company) </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Condensed consolidated and combined statements of convertible preferred stock and stockholders&#146; deficit </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Unaudited) (Expressed in U.S. dollars) </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:7pt" ALIGN="center">


<TR>
<TD WIDTH="26%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:7pt">
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>AQXP CANADA<BR>EXCHANGEABLE<BR>PREFERRED&nbsp;SHARES</B></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>AQUINOX USA<BR>PREFERRED&nbsp;STOCK</B></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>AQXP CANADA<BR>NEW COMMON<BR>SHARES</B></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>AQUINOX USA<BR>COMMON STOCK</B></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>ADDITIONAL<BR><FONT STYLE="white-space:nowrap">PAID-IN</FONT></B><br><B>CAPITAL</B></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>ACCUMULATED</B><br><B>DEFICIT</B></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>TOTAL<BR>STOCKHOLDERS&#146;<BR>DEFICIT</B></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:7pt">
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>NUMBER</B></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>AMOUNT</B></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>NUMBER</B></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>AMOUNT</B></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>NUMBER</B></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>AMOUNT</B></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>NUMBER</B></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>AMOUNT</B></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD COLSPAN="2" VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD COLSPAN="2" VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD COLSPAN="2" VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Issued for cash on inception, net of share issue costs</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">416,660</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">800</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">800</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Net loss and comprehensive loss incurred in the development stage for the period from December&nbsp;26, 2003 (inception) to
December&nbsp;31, 2004</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(12,188</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(12,188</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Balances, December&nbsp;31, 2004</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">416,660</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">800</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(12,188</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(11,388</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Repurchase of common stock</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(182,292</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(350</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(350</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Net loss and comprehensive loss incurred in the development stage</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(19,275</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(19,275</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Balances, December&nbsp;31, 2005</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">234,368</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">450</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(31,463</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(31,013</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Issued for cash, net of share issue costs</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">62,169</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">489,451</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">489,451</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Issued for intangible assets</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,208</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">44,834</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">44,834</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Stock-based compensation</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50,488</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50,488</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Net loss and comprehensive loss incurred in the development stage</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(543,052</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(543,052</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Balances, December&nbsp;31, 2006</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">301,745</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">534,735</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50,488</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(574,515</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,708</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Share reorganization</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(301,745</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(534,735</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">301,745</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">534,735</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Issued for cash, net of share issue costs</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">506,927</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,992,710</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">397,726</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,886,892</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Stock-based compensation</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">78,255</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">78,255</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Net loss and comprehensive loss incurred in the development stage</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,008,534</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,008,534</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Accretion for liquidation preference on preferred stock</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">245,162</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">196,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(441,162</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(441,162</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Accretion for share issuance costs on preferred stock</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">34,800</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30,224</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(65,024</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(65,024</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Balances, December&nbsp;31, 2007</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">506,927</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,272,672</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">397,726</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,113,116</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">301,745</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">222,326</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,648,073</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,425,747</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Issued for cash, net of share issue costs</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">142,044</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,482,936</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">132,575</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,384,073</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Stock-based compensation</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">103,518</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">103,518</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Net loss and comprehensive loss incurred in the development stage</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(5,459,460</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(5,459,460</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Accretion for liquidation preference on preferred stock</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">553,808</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">454,346</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(325,847</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(682,306</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,008,153</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Accretion for share issuance costs on preferred stock</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">74,650</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">65,108</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(139,758</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(139,758</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Balances, December&nbsp;31, 2008</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">648,971</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,384,066</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">530,301</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,016,643</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">301,745</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(8,929,597</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(8,929,597</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Issued for cash, net of share issue costs</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">142,045</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,467,508</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">132,574</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,369,675</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Stock-based compensation</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">111,673</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">111,673</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Net loss and comprehensive loss incurred in the development stage</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,752,070</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,752,070</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Accretion for liquidation preference on preferred stock</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">708,037</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">593,363</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(111,673</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,189,724</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,301,400</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Accretion for share issuance costs on preferred stock</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">84,954</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">74,657</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(159,611</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(159,611</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Accrual of tax payable on preferred stock</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(74,743</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(74,743</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Balances, December&nbsp;31, 2009</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">791,016</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,644,565</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">662,875</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,054,338</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">301,745</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(14,105,745</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(14,105,745</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">The accompanying notes form an integral part of these unaudited condensed consolidated and combined financial
statements </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-4 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:7pt" ALIGN="center">


<TR>
<TD WIDTH="22%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:7pt">
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>AQXP CANADA<BR>EXCHANGEABLE</B><br><B>PREFERRED&nbsp;SHARES</B></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>AQUINOX USA</B><br><B>PREFERRED<BR>STOCK</B></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>AQXP CANADA<BR>NEW COMMON<BR>SHARES</B></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>AQUINOX&nbsp;USA<BR>COMMON STOCK</B></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>ADDITIONAL<BR><FONT STYLE="white-space:nowrap">PAID-IN</FONT></B><br><B>CAPITAL</B></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>ACCUMULATED<BR>DEFICIT</B></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>TOTAL<BR>STOCKHOLDERS&#146;<BR>DEFICIT</B></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:7pt">
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>NUMBER</B></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>AMOUNT</B></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>NUMBER</B></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>AMOUNT</B></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>NUMBER</B></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>AMOUNT</B></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>NUMBER</B></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>AMOUNT</B></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD COLSPAN="2" VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD COLSPAN="6" VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Issued for cash, net of share issue costs</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">424,499</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,335,318</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">791,572</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,084,158</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Warrant discount of $226,624 on issuance of preferred shares</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(109,115</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(117,509</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Stock-based compensation</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">109,256</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">109,256</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Net loss and comprehensive loss incurred in the development stage</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(8,529,753</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(8,529,753</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Accretion for liquidation preference on preferred stock</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,053,645</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,113,956</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(109,264</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,058,337</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,167,601</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Accretion for share issuance costs on preferred stock</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">78,179</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">97,288</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(175,467</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(175,467</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Amortization of warrant discount on preferred stock</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,442</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17,706</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Accrual of tax payable on preferred stock</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(244,251</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(244,251</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Balances, December&nbsp;31, 2010</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,215,515</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15,019,034</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,454,447</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17,249,937</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">301,745</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(25,113,553</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(25,113,553</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Issued for cash, net of share issue costs</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">369,118</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,885,636</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">782,225</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,234,333</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Stock-based compensation</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">118,243</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">118,243</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Net loss and comprehensive loss incurred in the development stage</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(10,507,008</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(10,507,008</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Accretion for liquidation preference on preferred stock</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,445,120</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,858,080</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(118,250</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,184,950</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,303,200</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Accretion for share issuance costs on preferred stock</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">70,509</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">92,974</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(163,483</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(163,483</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Amortization of warrant discount on preferred stock</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21,823</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23,502</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Accrual of tax payable on preferred stock</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(345,587</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(345,587</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Balances, December&nbsp;31, 2011</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,584,633</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20,442,122</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,236,672</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27,458,826</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">301,745</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(39,314,581</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(39,314,581</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Stock-based compensation</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">351,322</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">351,322</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Net loss and comprehensive loss incurred in the development stage</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(7,714,198</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(7,714,198</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Accretion for liquidation preference on preferred stock</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,647,432</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,212,708</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(351,322</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,508,818</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,860,140</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Accretion for share issuance costs on preferred stock</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">72,296</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">96,406</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(168,702</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(168,702</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Amortization of warrant discount on preferred stock</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21,882</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23,566</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Accrual of tax payable on preferred stock</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(394,908</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(394,908</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Balances, December&nbsp;31, 2012</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,584,633</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22,183,732</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,236,672</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29,791,506</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">301,745</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(51,101,207</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(51,101,207</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Issued for cash, net of share issue costs</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">378,786</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,950,228</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,325,753</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,825,822</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Warrants exercised</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17,671</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">415,431</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Warrant discount of $68,920 on issuance of Aquinox USA preferred shares</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(68,920</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Redemption discount of $466,673 for AQXP Canada and $1,633,357 for Aquinox USA on issuance of preferred shares</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(466,673</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,633,357</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Stock-based compensation</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">349,321</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">349,321</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Net loss and comprehensive loss incurred in the development stage</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(8,729,371</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(8,729,371</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Accretion for liquidation preference on preferred stock</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,036,438</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,315,021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(349,328</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(5,002,131</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(5,351,459</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Accretion for share issuance costs on preferred stock</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">45,754</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">77,320</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(123,074</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(123,074</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Amortization of warrant discount on preferred stock</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21,825</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">34,343</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Amortization of redemption option on preferred stock</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">73,389</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">256,863</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Accrual of tax payable on preferred stock</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(737,925</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(737,925</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Balances, December&nbsp;31, 2013</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,963,419</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27,844,693</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,580,096</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">46,014,029</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">301,745</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(65,693,708</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(65,693,708</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">The accompanying notes form an integral part of these unaudited condensed consolidated and combined financial
statements </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-5 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:7pt" ALIGN="center">


<TR>
<TD WIDTH="25%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:7pt">
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>AQXP CANADA<BR>EXCHANGEABLE<BR>PREFERRED SHARES</B></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>AQUINOX USA<BR>PREFERRED STOCK</B></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>AQXP CANADA<BR>NEW COMMON<BR>SHARES</B></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>AQUINOX USA<BR>COMMON STOCK</B></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>ADDITIONAL<BR><FONT STYLE="white-space:nowrap">PAID-IN</FONT></B><br><B>CAPITAL</B></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>ACCUMULATED<BR>DEFICIT</B></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>TOTAL<BR>STOCKHOLDERS&#146;<BR>DEFICIT</B></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:7pt">
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>NUMBER</B></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>AMOUNT</B></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>NUMBER</B></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>AMOUNT</B></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>NUMBER</B></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>AMOUNT</B></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>NUMBER</B></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>AMOUNT</B></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD COLSPAN="2" VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD COLSPAN="2" VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD COLSPAN="2" VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Stock-based compensation</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">99,417</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">99,417</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Accretion for liquidation preference on preferred stock</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">401,165</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">731,728</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(99,417</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,033,476</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,132,893</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Accretion for share issuance costs on preferred stock</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,649</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,901</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(19,550</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(19,550</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Amortization of warrant discount on preferred stock</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,187</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,467</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Amortization of redemption option on preferred stock</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,623</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">58,300</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Accrual of tax payable on preferred stock</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(100,291</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(100,291</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Net loss and comprehensive loss</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,389,372</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,389,372</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Extinguishment of remaining share issuance costs, warrant discount, redemption option and related tax payable due to conversion of
preferred stock</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">551,334</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,686,549</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,458,478</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,458,478</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Balances, March&nbsp;12, 2014</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,963,419</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28,824,651</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,580,096</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">48,509,974</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">301,745</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(68,777,919</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(68,777,919</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Conversion of preferred stock into Aquinox USA common stock</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,963,419</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(28,824,651</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,580,096</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(48,509,974</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,543,515</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">77,333,945</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">77,333,952</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Issuance of Aquinox common stock, net of share issuance costs of $5,788,726</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,830,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">47,341,274</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">47,341,278</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Stock-based compensation</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">38,237</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">38,237</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Net loss and comprehensive loss incurred in development stage</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(838,306</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(838,306</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Balances, March&nbsp;31, 2014</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,675,260</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">124,713,456</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(69,616,225</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">55,097,242</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">The accompanying notes form an integral part of these unaudited condensed consolidated and combined financial
statements </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-6 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AQUINOX PHARMACEUTICALS, INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(a development stage company) </P>
 <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx704250_4"></A>Condensed consolidated and combined statements of cash flows </B></P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Unaudited) (Expressed in U.S. dollars) </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="61%"></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>THREE</B><br><B>MONTHS&nbsp;ENDED<BR>MARCH&nbsp;31,&nbsp;2014</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>THREE</B><br><B>MONTHS&nbsp;ENDED<BR>MARCH&nbsp;31,&nbsp;2013</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>DECEMBER 26,<BR>2003<BR>(INCEPTION)&nbsp;TO<BR>MARCH&nbsp;31,&nbsp;2014</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Operating activities</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss and comprehensive loss incurred in the development stage</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(4,227,678</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(1,010,267</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(51,502,587</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Non-cash items and reclassifications:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amortization</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18,238</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,785</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">629,410</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Financing costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">319,635</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">333,877</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fees and penalty on bank loan repayment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gain on sale of equipment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(29,396</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(134,553</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amortization and extinguishment of remaining discount on preferred stock upon conversion of preferred stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,884,233</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,438</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,395,575</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Change in fair value of derivative liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(913,929</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,102,193</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock-based compensation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">137,654</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">54,674</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,409,722</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Foreign exchange loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">106,501</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">106,501</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Change in non-cash working capital:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounts and other amounts receivable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(38,580</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(170</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(66,524</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Prepayments and deposits</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(453,705</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,480</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(626,223</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounts payable and accrued liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(734,537</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">37,835</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">854,211</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash used in operating activities</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,802,168</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(896,621</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(48,602,784</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Investing activities</B></P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Purchase of short-term investments</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,820,600</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Purchase of property and equipment</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,463</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,696</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(549,003</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Sale of property and equipment</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50,810</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">191,817</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Purchase of intangible assets</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(183,629</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash (used in) provided by investing activities</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,463</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">46,114</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,361,415</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Financing activities</B></P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Repayment of bank loan, fees and penalty</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,600,000</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(100,000</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loan costs</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(107,911</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Issuance of promissory notes</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">720,863</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Repayment of promissory notes</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(255,775</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Common stock issued</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">490,176</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Repurchase of common stock</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(350</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Preferred stock (redemption) issued</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(491</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17,999,961</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">57,835,418</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Special voting common stock issued</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">44</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share issue costs</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(132,748</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,431,558</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Initial public offering of common shares</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">53,130,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">53,130,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Initial public offering costs</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,810,943</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(5,398,381</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash provided by financing activities</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">45,718,566</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17,867,220</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">104,882,526</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Increase in cash and cash equivalents during the period</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">41,911,935</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17,016,713</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">52,918,327</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash and cash equivalents, beginning of period</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,006,392</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,000,539</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Cash and cash equivalents, end of period</B> <B></B></P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">52,918,327</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">19,017,252</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">52,918,327</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><I>Supplemental disclosure of cash flow information:</I></B></P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest paid</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">31,719</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">31,719</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><I>Non-cash investing and financing activities:</I></B></P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Investing activities</B></P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Purchase of intangible assets for shares issued</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">44,834</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Financing activities</B></P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accrued offering costs</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">390,345</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">390,345</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
</TABLE>
 <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">The accompanying notes form an integral part of these unaudited condensed consolidated and combined financial statements </P>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-7 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AQUINOX PHARMACEUTICALS, INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(a development stage company) </P>
 <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx704250_5"></A>Notes to the condensed consolidated and combined financial statements </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Unaudited) (Expressed in U.S. dollars) </P>
 <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>1. Nature of operations </B></P>
 <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Aquinox Pharmaceuticals, Inc. and its wholly owned subsidiary, Aquinox Pharmaceuticals Inc., (consolidated and combined the
&#147;Company&#148;&#151;see Note&nbsp;2 Basis of presentation) are a clinical stage pharmaceutical company discovering and developing oral drug candidates to treat inflammation and cancer. The Company&#146;s primary focus is the development of
anti-inflammatory product candidates targeting SHIP1 which is a key regulator of a cellular signaling pathway in immune cells. Aquinox Pharmaceuticals (USA) Inc. was incorporated on May&nbsp;31, 2007 in the State of Delaware, United States. On
January&nbsp;27, 2014, Aquinox Pharmaceuticals (USA) Inc. changed its name to Aquinox Pharmaceuticals, Inc. (&#147;Aquinox USA&#148;). Aquinox Pharmaceuticals Inc. (&#147;AQXP Canada&#148;), formerly 6175813&nbsp;Canada&nbsp;Inc., was incorporated
under the Canada Business Corporations Act on December&nbsp;26, 2003 and operates in Vancouver, British Columbia, Canada. </P>
 <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>2. Condensed summary of significant accounting policies </B></P>
 <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>(a) Basis of presentation </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
accompanying unaudited condensed consolidated and combined financial statements are presented in United States (&#147;U.S.&#148;) dollars and have been prepared in accordance with accounting principles generally accepted in the United States of
America (&#147;U.S. GAAP&#148;) and pursuant to the rules and regulations of the United States Securities and Exchange Commission (&#147;SEC&#148;) for interim financial information. Accordingly, these financial statements do not include all of the
information and footnotes required for complete financial statements and should be read in conjunction with the audited combined financial statements and notes for the year ended December&nbsp;31, 2013 included in the Company&#146;s final prospectus
for its initial public offering (&#147;IPO&#148;) filed with the SEC pursuant to Rule 424(b) on March&nbsp;7, 2014. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In management&#146;s opinion, the
condensed consolidated and combined financial statements reflect all adjustments (including reclassifications and normal recurring adjustments) necessary to present fairly the financial position as of March&nbsp;31, 2014, and results of operations
and cash flows for all periods presented. The interim results presented are not necessarily indicative of results that can be expected for a full year. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Through a reorganization on March&nbsp;12, 2014, AQXP Canada became a wholly owned subsidiary of Aquinox USA (Note 3). Prior to the reorganization, management
determined that AQXP Canada and Aquinox USA were entities under common control as each of AQXP Canada and Aquinox USA were owned beneficially by identical shareholders and as such the basis of presentation of financial results prior to
March&nbsp;12, 2014 was on a combined basis. Subsequent to March&nbsp;12, 2014, the basis of presentation of the financial results is on a consolidated basis. All intercompany transactions have been eliminated. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For the period from inception on December&nbsp;26, 2003 through March&nbsp;31, 2014, the Company is a development stage enterprise, as planned principal
operations have not yet begun to generate revenues. In its development stage, all pre-operating costs are being expensed as incurred. The statements of operations and comprehensive loss, convertible preferred stock and stockholders&#146; deficit,
and cash flows present the cumulative consolidated financial information of the Company for the period from inception on December&nbsp;26, 2003 through March&nbsp;31, 2014. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>(b) Use of estimates </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The preparation of financial
statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements
and the reported amounts of expenses during the reporting period. Significant areas requiring management estimates are the valuation of intangible assets, valuation of stock options and warrants, amortization and depreciation, valuation allowance
for deferred income taxes, and contingencies. Actual results could differ from those estimates. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>(c) Taxes </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company accounts for income taxes using <I>ASC&nbsp;740, Income Taxes</I> which is an asset and liability approach that requires the recognition of
deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in the Company&#146;s financial statements or tax returns. In estimating future tax consequences, ASC 740 generally considers all
expected future events other than enactments of and changes in the tax law or rates. The measurement of deferred tax assets is reduced, if necessary, by the amount of any tax benefits that, based on available evidence, are not expected to be
realized. Valuation allowances are provided if, after considering other available evidence it is more likely than not that deferred tax assets will not be realized. ASC&nbsp;740 clarifies the criteria that must be met prior to recognition of the
financial statement benefit of a position taken in a tax return. ASC&nbsp;740 provides a benefit recognition model with a two-step approach </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-8 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
consisting of a &#147;more-likely-than-not&#148; recognition criteria, and a measurement attribute that measures a given tax position as the largest amount of tax benefits that are more than 50%
likely of being realized upon ultimate settlement. ASC&nbsp;740 also requires the recognition of liabilities created by differences between tax positions taken in a tax return and amounts recognized in the financial statements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Investment tax credits relating to scientific research and experimental development are accounted for in operations. To the extent there is reasonable
assurance the credits will be realized, they are recorded in the period the related expenditure is made as an income tax (provision) recovery. If investment tax credit amounts subsequently received are less or more than originally recorded, the
difference is treated as a change in estimate. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Canadian tax rules impose a tax with respect to Canadian corporation taxable preferred stock and their
liquidation rights. In prior periods, AQXP Canada has recorded this tax on preferred stock as a non-current accrued tax payable on its balance sheet, on the same basis as it recorded the accretion of preferred stock. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>(d) Derivative liabilities and fair value of financial instruments </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company accounts for currently outstanding detachable warrants to purchase preferred stock or common stock as liabilities as they are freestanding
derivative financial instruments. The warrants are recorded as liabilities at fair value, estimated using a Black-Scholes option pricing model, and marked to market at each balance sheet date, with changes in the fair value of the derivative
liabilities recorded in the consolidated and combined statements of operations. The Company allocates the total consideration received for issuing preferred stock and warrants based on the relative fair value of each security at the date of
issuance. This allocation results in a discount to the initial carrying amount of the preferred stock at the date of issuance amortized over the life of the preferred stock and is recorded as &#147;amortization of discount on preferred stock&#148;
in the consolidated and combined statements of operations and comprehensive loss. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company also evaluates and accounts for conversion and redemption
options embedded in convertible instruments as they can be free standing derivative financial instruments depending on certain criteria. If they are determined to be free standing derivative financial instruments, the Company records these as
preferred stock embedded derivatives on their consolidated balance sheets at fair value with changes in the fair values of these derivatives recorded in the consolidated and combined statements of operations and comprehensive loss. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company applies the residual value method to record the fair value of warrants issued with loans as a discount to the initial carrying amount of loans at
the date of issuance. Loans are measured at amortized cost using the effective interest method which is a method of calculating the amortized cost of a financial liability and allocating the effective interest expense over the term of the financial
liability. Interest expense is recorded in bank charges and financing costs in the consolidated and combined statements of operations and comprehensive loss. The interest rate is the rate that exactly discounts estimated future cash payments
throughout the term of the financial instrument to the net carrying amount of the financial liability. Debt issuance costs are capitalized, recorded as deferred financing costs, and are amortized into financing costs in the consolidated and combined
statements of operations and comprehensive loss using the effective interest method. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>ASC 820, Fair Value Measurements</I> requires disclosures about
transfers into and out of Levels&nbsp;1 and 2 and separate disclosures about purchases, sales, issuances, and settlements relating to Level&nbsp;3 measurements. It also clarifies existing fair value disclosures regarding the level of disaggregation
and the inputs and valuation techniques used to measure fair value. ASC&nbsp;820 defines fair value as the amounts that would be received upon sale of an asset or paid to transfer a liability in an orderly transaction between market participants at
the measurement date (exit price). The guidance also established a fair value hierarchy that prioritizes the use of inputs used in valuation techniques into the following three levels: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Level 1&#151;Quoted prices in active markets for identical assets or liabilities. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Level 2&#151;Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or
liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Level 3&#151;Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or
liabilities. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>(e) Redeemable convertible preferred stock </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company classified redeemable convertible preferred stock that was redeemable outside of the Company&#146;s control as mezzanine equity. The Company
recorded such redeemable convertible preferred stock at fair value upon issuance, net of any issuance costs or discounts. The carrying value of the redeemable convertible preferred stock was increased by periodic accretion to its redemption value.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-9 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the absence of retained earnings, the accretion was recorded within additional paid-in capital to the extent
there was a sufficient balance, rather than accumulated deficit. Only after exhausting the balance of accumulated paid-in capital, was the accretion recorded to accumulated deficit. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>(f) Accounting for stock-based compensation </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
Company measures the cost of services received in exchange for an award of equity instruments based on the grant-date fair value of the award. The cost of such award will be recognized over the period during which services are provided in exchange
for the award, generally the vesting period. All share-based payments to employees are recognized in the financial statements based upon their respective grant date fair values. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company estimates the fair value of options granted using the Black-Scholes option pricing model. This approximation uses assumptions regarding a number
of inputs that requires management to make significant estimates and judgments. Since prior to the completion of the IPO, the Company&#146;s common stock was not publicly traded, the expected volatility assumption was based on industry peer
information. Additionally, because the Company has no significant history to calculate the expected term, the simplified method calculation was used. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>(g) Segment reporting </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Management has determined
that the Company&#146;s operation, and how they manage the business, was one segment being the identification and development of therapeutics for inflammatory diseases and cancer. All of the Company&#146;s operations are performed in Canada. Total
assets held in the U.S., comprised primarily of cash and cash equivalents, were $51,116,586 as of March&nbsp;31, 2014 (December 31, 2013 - $6,629,383). </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>(h) Loss per share </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Basic loss per common share is
computed by dividing loss by the weighted-average number of common shares outstanding during the period. Diluted net earnings per common share is determined using the weighted-average number of common shares outstanding during the period, adjusted
for the dilutive effect of common stock equivalents, consisting of shares that might be issued upon exercise of common stock options and warrants. In periods where losses are reported, the weighted-average number of common shares outstanding
excludes common stock equivalents because their inclusion would be anti-dilutive. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>(i) Recent accounting pronouncements </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In April 2014, the FASB issued ASU 2014-08, &#147;Presentation of Financial Statements and Property, Plant, and Equipment&#151;Reporting Discontinued
Operations and Disclosures of Disposals of Components of an Entity.&#148; ASU 2014-08 provides guidance related to the definition of a discontinued operation and requires new disclosures of both discontinued operations and certain other disposals
that do not meet the definition of a discontinued operation. This new guidance is effective for the Company for annual periods beginning on January&nbsp;1, 2015 and interim periods within those years. The Company does not anticipate a material
impact to the Company&#146;s financial position, results of operations or cash flows as a result of this change. </P>
 <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>3. Redeemable convertible preferred stock and stockholders&#146; (deficit) equity </B></P>
 <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On February&nbsp;27, 2014, the Company effected a 1-for-19.2 reverse stock split of Aquinox USA&#146;s common stock and convertible
preferred stock and AQXP Canada&#146;s common exchangeable shares and exchangeable preferred shares. All per share amounts and numbers of shares within the condensed consolidated and combined financial statements and notes are presented on a
post-split basis. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On March&nbsp;12, 2014, immediately prior to the closing of the IPO, the Company underwent a reorganization, which resulted in a
simplification of its capital structure. Each of the 301,745 outstanding common exchangeable shares of AQXP Canada was transferred to Aquinox USA in exchange for one common stock of Aquinox USA. Each of the 791,016 outstanding Series A exchangeable
preferred shares, 793,617 outstanding Series B exchangeable preferred shares and 378,786 outstanding Series C exchangeable preferred share of AQXP Canada was transferred to Aquinox USA in exchange for one share of Series A, B and C convertible
preferred stock of Aquinox USA, respectively. As a result, following such exchange, there were 1,453,891 shares of Series A, 2,367,414 shares of Series B and 1,722,210 shares of Series C convertible preferred stock of Aquinox USA. Following the
completion of the exchange and conversion, all special voting shares of AQXP Canada and all special voting stock of Aquinox USA were redeemed for a nominal amount and all exchangeable preferred shares of AQXP Canada, now held by Aquinox USA, were
converted to common exchangeable shares of AQXP Canada. As a result of the reorganization, AQXP Canada became a 100% owned subsidiary of Aquinox USA. Subsequent to this reorganization, all 5,543,515 of the outstanding shares of redeemable
convertible preferred stock of Aquinox USA converted to an equivalent number of shares of common stock of Aquinox USA. The exchange and conversion resulted in the derecognition of non-cash accrued tax payable of $1,797,412 and the derecognition of
the derivative liability for the redemption option on preferred stock of $800,206. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On March&nbsp;12, 2014, the Company closed its IPO whereby the Company
sold 4,830,000 shares of common stock (inclusive of 630,000 shares of common stock sold by the Company pursuant to the full exercise of an overallotment option granted to the underwriters in connection with the offering) at a price of $11.00 per
share before underwriting discounts. The shares began trading on the NASDAQ Global Market in March 2014, under the symbol &#147;AQXP&#148;. The aggregate net proceeds received by the Company from the offering, net of underwriting discounts and
commissions and offering costs of $5,788,726, were $47,341,274. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-10 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On March&nbsp;12, 2014, the Company adopted an amended and restated certificate of incorporation for Aquinox USA,
which authorized two classes of stock, common and preferred. The total number of shares the Company is authorized to issue is 55,000,000 shares, comprised of 50,000,000 common stock and 5,000,000 of a new category of preferred stock both with a par
value of $0.000001 per share. As of March&nbsp;31, 2014 and December&nbsp;31, 2013, no shares of this new category of preferred stock were issued or outstanding. </P>
 <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>4. Cash and cash equivalents </B></P>
 <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="62%"></TD>
<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>MARCH&nbsp;31,&nbsp;2014</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>DECEMBER&nbsp;31,&nbsp;2013</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">49,538,874</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">7,292,116</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash equivalents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,379,453</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,714,276</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">52,918,327</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">11,006,392</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>5. Loan facility </B></P>
 <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On October&nbsp;23, 2013, AQXP Canada entered into a term loan facility with Silicon Valley Bank (&#147;SVB&#148;) for up to
$4&nbsp;million, of which $2.5 million was received on October&nbsp;30, 2013 and a further $1.5 million is available to AQXP Canada through December&nbsp;31, 2014 upon AQXP Canada receiving certain agreed-upon Phase 2 top-line data results from its
Chronic Obstructive Pulmonary Disorder (&#147;COPD&#148;) or Bladder Pain Syndrome/Interstitial Cystitis (&#147;BPS/IC&#148;) clinical trials. Aquinox USA is a guarantor of AQXP Canada&#146;s obligations under the term loan facility. In addition to
principal, interest and other related payments due to SVB, Aquinox USA and AQXP Canada issued SVB warrants at $10.56 per warrant to purchase 11,363 shares of Series C preferred stock and a corresponding number of Canadian special voting shares of
AQXP Canada. Following the completion of the IPO, the warrants are exercisable for 11,363 shares of common stock. These warrants expire in 2023. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The term
loan has an interest rate of 5.25% and is collateralized by AQXP Canada&#146;s assets, excluding intellectual property, but including all proceeds thereof. The term loan principal is repayable in monthly installments approximately $83,000 commencing
October 2014 and the loan has a maturity date of March 2017. AQXP Canada may voluntarily repay the term loan at any time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On March&nbsp;28, 2014, AQXP
Canada made a cash payment of $2,609,844 to fully repay the amount outstanding under the term loan facility. The repayment was accounted for as an extinguishment of debt and the loss on extinguishment of $213,511 along with the prepayment penalty,
repayment fee and accrued interest were recorded within bank charges and financing costs. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="84%"></TD>
<TD VALIGN="bottom" WIDTH="13%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>AMOUNT</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">BALANCE&#151;January&nbsp;1, 2013</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Bank loan cash received - October&nbsp;30, 2013</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Warrant discount</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(226,255</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Financing costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,744</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">BALANCE&#151;December&nbsp;31, 2013</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,286,489</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accrued interest</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,844</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accretion of warrant discount</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">213,511</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Repayment fee and penalty</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Repayment of bank loan and interest</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,609,844</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">BALANCE&#151;March&nbsp;31, 2014</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="66%"></TD>
<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>MARCH&nbsp;31,&nbsp;2014</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>DECEMBER&nbsp;31,</B><br><B>2013</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Short-term portion of bank loan</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">250,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Long-term portion of bank loan</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,036,489</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2,286,489</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-11 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>6. Common stock </B></P>
 <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>(a) Stock option plan </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On
January&nbsp;27, 2014, the stockholders of Aquinox USA approved a 2014 Equity Incentive Plan (&#147;2014 Plan&#148;). The 2014 Plan became effective on the date of the prospectus for the IPO, March&nbsp;6, 2014. The 2014 Plan is the successor to and
continuation of the 2006 Plan. After the 2014 Plan became effective, no further grants will be made under the 2006 Plan. The 2014 Plan provides for the grant of stock options, stock appreciation rights, restricted stock awards, restricted stock unit
awards, performance stock awards, performance cash awards, and other forms of equity awards to employees, directors, and consultants. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The maximum number
of shares of common stock that may be issued the under the 2014 Plan is 1,423,416, which number includes a number of shares of common stock equal to (i)&nbsp;756,279 new shares, plus (ii)&nbsp;the number of shares reserved for issuance under the
2006 Plan at the time the 2014 Plan becomes effective, plus (iii)&nbsp;any shares subject to stock options or other stock awards granted under the 2006 Plan that would have otherwise returned to the 2006 Plan, such as upon the expiration or
termination of a stock award prior to vesting. Additionally, the number of shares of common stock reserved for issuance under the 2014 Plan will automatically increase on January&nbsp;1 of each year for a period of up to 10 years, beginning on
January&nbsp;1, 2015 and ending on and including January&nbsp;1, 2024, by 4% of the total number of shares of capital outstanding on December&nbsp;31 of the preceding calendar year, or a lesser number of shares determined by the board of directors.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>(b) Stock-based compensation </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On
March&nbsp;6, 2014, four of the non-employee directors were granted options to purchase a total of 33,332 shares of common stock; the exercise price per share for these grants was $11.00, which was the offering price of the common stock in the IPO.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The fair value of stock options granted is estimated using the Black-Scholes option pricing model with the following weighted average assumptions: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="51%"></TD>
<TD VALIGN="bottom" WIDTH="14%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="14%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="14%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>THREE&nbsp;MONTHS<BR>ENDED <BR>MARCH 31, 2014</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>THREE&nbsp;MONTHS<BR>ENDED <BR>MARCH 31, 2013</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>DECEMBER 26,<BR>2003<BR>(INCEPTION)&nbsp;TO<BR>MARCH 31, 2014</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Expected volatility</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">108</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">NA</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">88</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Expected dividends</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">NA</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Expected terms (years)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">NA</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6.24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Risk free rate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.52</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">NA</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2.96</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted average grant-date fair value of stock options</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">9.05</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">NA</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4.23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company amortizes the fair value of the stock options on a straight-line basis over the applicable requisite service
periods of the awards, which is generally the vesting period. The weighted average grant date fair value of stock options granted for the three months ended March&nbsp;31, 2014 and 2013 were $9.05 and $0, respectively. There were no stock options
granted during the three months ended March&nbsp;31, 2013. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Stock-based compensation expense charged to income for the plans was $137,654 and $54,674 for
the three months ended March&nbsp;31, 2014 and 2013, respectively. Total unrecognized compensation cost for all stock-based compensation plans was $1,485,971 as of March&nbsp;31, 2014, which is expected to be recognized over a weighted-average
period of 1.47 years. </P>
 <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>7. Net loss per share </B></P>
 <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with the IPO, the Company&#146;s capital structure was reorganized such that AQXP Canada became a wholly-owned subsidiary of
the Company, and the holders of the preferred shares of AQXP Canada, common shares of AQXP Canada and preferred shares of the Company exchanged their shares for shares of common stock of the Company (see Note 3). In connection with the IPO, the
Company effected a 1-for-19.2 reverse stock split. The common stock, options and warrants outstanding as of the completion of the reorganization were 5,845,260 shares, 628,754 options and 11,363 warrants, respectively. Basic and diluted earnings per
share has been retroactively restated for all periods prior to the reorganization. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Basic and diluted net loss per common share are presented using the
two-class method required for participating securities. If a dividend is paid on common stock, the holders of preferred stock are entitled to a proportionate share of any such dividend as if they were holders of common stock (on an if-converted
basis). The Company considers its preferred stock to be participating securities and, in accordance with the two-class method, earnings allocated to participating securities and the related number of outstanding shares of participating securities
have been excluded from the computation of basic and diluted net loss per common share. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-12 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company considers the Aquinox USA Common Stock to be their participating stock that is subordinate to all
other stock or shares of the Company. These shares are used by the Company when computing its loss per share. Under the two-class method, net loss attributable to common stockholders is determined by allocating undistributed loss between common
stock and participating securities. Undistributed loss is calculated as net loss less distributed loss, accretion of liquidation preference on preferred stock, accretion of share issuance costs on preferred stock, and tax expense on preferred stock.
As holders of preferred stock, holders of stock options and holders of common stock warrants do not have contractual obligations to share in the losses of the Company, the net loss attributable to common stockholders for each period is not allocated
between common stock and participating securities. Accordingly, outstanding stock options, common stock warrants and preferred stock are excluded from the calculation of basic and diluted net loss per share as the effect would have been
anti-dilutive. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The detail of the computation of basic and diluted earnings per share is as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="51%"></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>THREE&nbsp;MONTHS<BR>ENDED <BR>MARCH 31, 2014</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>THREE&nbsp;MONTHS<BR>ENDED <BR>MARCH 31, 2013</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>DECEMBER&nbsp;26,<BR>2003<BR>(INCEPTION)&nbsp;TO<BR>MARCH 31, 2014</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><I>Numerator</I></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss and comprehensive loss incurred in the development stage</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(4,227,678</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(1,010,267</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(51,502,587</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accretion for liquidation preference on preferred stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,132,893</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,157,865</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(18,566,008</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accretion for share issuance costs on preferred stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(19,550</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(44,307</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,014,667</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tax expense on preferred stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(100,291</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(346,091</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,897,702</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Reversal of tax payable on preferred stock due to conversion of preferred stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,897,702</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,897,702</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Extinguishment of remaining share issuance costs due to conversion of preferred stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(439,227</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(439,227</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total loss attributable to common stockholders</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(4,021,937</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(2,558,530</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(71,522,489</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><I>Denominator</I></B></P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted average shares used to compute basic net loss per common share</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,148,481</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">301,745</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">398,573</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Effect of potentially dilutive securities:</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock options</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Common stock warrants</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted average shares used to compute diluted net loss per common share</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,148,481</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">301,745</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">398,573</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss per share attributable to common stockholders&#151;basic</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(1.28</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(8.48</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(179.45</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss per share attributable to common stockholders&#151;diluted</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(1.28</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(8.48</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(179.45</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following have been excluded from the computation of basic and diluted net loss per share as their effect would have been
antidilutive: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="64%"></TD>
<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>THREE&nbsp;MONTHS<BR>ENDED</B><br><B>MARCH 31, 2014</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>THREE&nbsp;MONTHS<BR>ENDED</B><br><B>MARCH 31, 2013</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Convertible preferred stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,525,844</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Outstanding stock options</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">630,159</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">435,141</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Common stock warrants</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,363</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">641,522</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,960,985</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>8. Financial instruments </B></P>
 <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Fair value of financial instruments </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The carrying amounts of certain of the Company&#146;s financial instruments including cash, cash equivalents, accounts and other amounts receivable,
prepayments, accounts payable, and accrued liabilities, approximate their fair values because of their nature and/or short maturities and are categorized as Level 1 in the fair value hierarchy. Short-term investments are categorized as Level 2 in
the fair value hierarchy and as of March&nbsp;31, 2014 had a fair value approximating their carrying amount. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-13 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s preferred stock embedded feature and warrants are accounted for as derivative liabilities. The
Company used Level 3 inputs for the valuation methodology of the derivative liabilities. The estimated fair values were computed using a Black-Scholes option pricing model which incorporates a number of assumptions and judgments to estimate the fair
value of these derivative liabilities including the fair value per share of the underlying stock, remaining contractual term of the warrants and redeemable convertible preferred stock, risk-free interest rate, expected dividend yield, credit spread,
and expected volatility of the underlying stock. The derivative liabilities are adjusted to reflect estimated fair value at each period end, with any decrease or increase in the estimated fair value being recorded in change in fair value of
derivative liabilities: </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Fair value of significant unobservable inputs (Level 3) </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="62%"></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>BANK LOAN<BR>WARRANT<BR>DERIVATIVE<BR>LIABILITIES</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>PREFERRED<BR>STOCK<BR>EMBEDDED<BR>DERIVATIVE<BR>LIABILITIES</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>TOTAL</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">BALANCES&#151;January&nbsp;1, 2014</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">221,320</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">800,206</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,021,526</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Change in fair value of derivative liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(113,723</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(113,723</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Derecognition of liabilities upon preferred stock conversion to common stock conversion</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(800,206</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(800,206</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">BALANCES&#151;March&nbsp;31, 2014</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">107,597</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">107,597</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">There were no transfers between Levels 1, 2, and 3 during the three months ended March&nbsp;31, 2014 and 2013. </P>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-14 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B><A NAME="tx704250_6"></A>Item&nbsp;2.</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Management&#146;s Discussion and Analysis of Financial Condition and Results of Operations </B></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>You should read the following discussion of our financial condition and results of operations in conjunction with the consolidated financial
statements and notes thereto included elsewhere in this report and in our prospectus filed with the Securities and Exchange Commission, or SEC, pursuant to Rule 424(b) under the Securities Act of 1933, as amended, or the Securities Act, on
March&nbsp;7, 2014. </I></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Forward-Looking Statements </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>The following discussion of our financial condition and results of operations contains forward-looking statements within the meaning of
Section&nbsp;27A of the Securities Act of 1933 and Section&nbsp;21E of the Securities Exchange Act of 1934. Forward-looking statements are based on our management&#146;s beliefs and assumptions and on information currently available to our
management. All statements other than statements of historical facts are &#147;forward-looking statements&#148; for purposes of these provisions, including those relating to future events or our future financial performance and financial guidance.
In some cases, you can identify forward-looking statements by terminology such as &#147;may,&#148; &#147;might,&#148; &#147;will,&#148; &#147;should,&#148; &#147;expect,&#148; &#147;plan,&#148; &#147;anticipate,&#148; &#147;project,&#148;
&#147;believe,&#148; &#147;estimate,&#148; &#147;predict,&#148; &#147;potential,&#148; &#147;intend&#148; or &#147;continue,&#148; the negative of terms like these or other comparable terminology, and other words or terms of similar meaning in
connection with any discussion of future operating or financial performance. These statements are only predictions. All forward-looking statements included in this document are based on information available to us on the date hereof, and we assume
no obligation to update any such forward-looking statements. Any or all of our forward-looking statements in this document may turn out to be wrong. Actual events or results may differ materially. Our forward-looking statements can be affected by
inaccurate assumptions we might make or by known or unknown risks, uncertainties and other factors. In evaluating these statements, you should specifically consider various factors, including the risks outlined under the caption &#147;Risk
Factors&#148; set forth in Item&nbsp;1A of Part II of this quarterly report on Form 10-Q, as well as those contained from time to time in our other filings with the SEC. We caution investors that our business and financial performance are subject to
substantial risks and uncertainties. </I></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Overview </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are a clinical-stage pharmaceutical company discovering and developing novel drug candidates to treat inflammation and cancer. Our primary
focus is anti-inflammatory product candidates targeting SHIP1, which is a key regulator of an important cellular signaling pathway in immune cells, known as the PI3K pathway. Our lead product candidate, AQX-1125, is a SHIP1 activator and has
demonstrated broad anti-inflammatory activity. AQX-1125 has successfully completed three clinical trials dosed as a once daily oral product with over 100 subjects having received AQX-1125 to date. We are currently investigating AQX-1125 in two Phase
2 clinical trials, one for Chronic Obstructive Pulmonary Disease, or COPD, and one for Bladder Pain Syndrome/Interstitial Cystitis, or BPS/IC. COPD and BPS/IC are debilitating chronic inflammatory diseases affecting millions of people worldwide. For
AQX-1125, we retain full worldwide rights and hold patents with terms through at least 2024. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We use a proprietary screening approach to
discover new drug candidates that selectively target SHIP1 to modulate activated immune cells while minimizing their toxicity to normal cells. Our intellectual property covers SHIP1 as a target, the C2 binding domain for screening and the
composition of matter for our compounds. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have an extensive chemical library and several candidate lead compounds that target SHIP1.
These compounds have both similar and distinct properties from AQX-1125. We believe AQX-1125 is the only SHIP1 activator currently in clinical trials and that no SHIP1 activator has yet received marketing approval as a treatment for disease in
humans. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We commenced operations as 6175813&nbsp;Canada Inc., a corporation formed in December 2003 under the Canada Business Corporations
Act. We subsequently changed the name of such entity to Aquinox Pharmaceuticals Inc. We incorporated Aquinox Pharmaceuticals (USA) Inc., a corporation under the laws of the State of Delaware, in May 2007. We subsequently changed the name of this
corporation in January 2014 to Aquinox Pharmaceuticals, Inc. Upon the completion of our initial public offering in March 2014, AQXP Canada became a wholly owned subsidiary of Aquinox USA. Our operations to date have included our organization and
staffing, business planning, raising capital, in-licensing technology from research institutions, identifying potential product candidates, developing AQX-1125 and future product candidates, as well as undertaking preclinical studies and clinical
trials of our product candidates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Since commencing operations we have dedicated a significant portion of our resources to development
efforts for our clinical-stage product candidate AQX-1125. We incurred research and development expenses of $1.9&nbsp;million and $0.6&nbsp;million for the three month periods ended March&nbsp;31, 2014 and 2013, respectively. We anticipate that a
significant portion of our operating expenses will continue to be related to research and development as we continue to advance our preclinical programs and our clinical-stage product candidates. We have funded our operations primarily through the
sale of common stock and preferred stock and through debt financing. As of March&nbsp;31, 2014, we had $55.6&nbsp;million in cash, cash equivalents and short-term investments. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Since inception, we have incurred significant operating losses. Our net losses were
$4.2&nbsp;million and $1.0&nbsp;million for the three months ended March&nbsp;31, 2014 and 2013, respectively. As of March&nbsp;31, 2014, we had an accumulated deficit of $69.6&nbsp;million. We expect to incur significant expenses and operating
losses for the foreseeable future as we continue the development and clinical trials of, and seek regulatory approval for, AQX-1125 and any future product candidates we advance to clinical development. If we obtain regulatory approval for any of our
product candidates, we expect to incur significant commercialization expenses. For example, we do not currently have the infrastructure for the sales, marketing, manufacture and distribution of any products. We may enter into licensing and
co-promotion agreements with strategic or collaborative partners for the commercialization of our products in the United States and other territories, but have not currently entered into any such arrangements. To develop a commercial infrastructure,
we would have to invest financial and management resources, some of which would have to be deployed prior to having any certainty of marketing approval. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As a result of the requirements of being a public company, we expect to incur additional costs associated with operating as a public company.
Unless and until we generate sufficient revenue to be profitable, we will seek to fund our operations primarily through public or private equity or debt financings or other sources. Other additional financing may not be available to us on acceptable
terms, or at all. Our failure to raise capital as and when needed could have a material adverse effect on our business, results of operations, financial condition and cash flows and future prospects. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Results of Operations </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Revenue </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To date, we have not generated any revenue. In the future, we may generate revenue from a combination of product sales, license fees, milestone payments and
royalties from the sale of products developed under licenses of our intellectual property. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Operating Expenses </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table summarizes our operating expenses for the three months ended March&nbsp;31, 2014 and 2013: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="74%"></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>THREE&nbsp;MONTHS&nbsp;ENDED&nbsp;MARCH&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2014</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2013</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and development</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,879,514</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">572.967</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">General and administrative</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">734,824</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">423,865</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total operating expenses</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2,614,338</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">996,832</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Research and Development Expenses </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our research and development expenses consist primarily of costs incurred for the development of AQX-1125 and our future product candidates, which include:
</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">costs associated with research, development and regulatory activities; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">employee-related expenses, including salaries, benefits, travel and stock-based compensation expense; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">expenses incurred under agreements with CROs and investigative sites that conduct our clinical trials and preclinical studies; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the cost of acquiring and manufacturing our products, for preclinical studies and clinical trials; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">facilities, and other expenses, which include direct and allocated expenses for rent and maintenance of facilities, amortization of equipment and leasehold improvements, insurance and supplies. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In November 2012, following completion of early-stage lead compound identification and screening, we began to decrease our internal research efforts to focus
our resources on clinical development and on outsourced research activities. In July 2013 we began dosing patients in a Phase 2 clinical trial of AQX-1125 for the treatment of bladder pain syndrome/interstitial cystitis&nbsp;(BPS/IC). The trial,
known as the&nbsp;LEADERSHIP study, is being conducted at community and academic sites across Canada evaluating the safety and efficacy of AQX-1125 in approximately 70 BPS/IC patients. In December 2013, we began dosing patients in a Phase 2 clinical
trial of AQX-1125 for the treatment of exacerbations of&nbsp;chronic obstructive pulmonary disease&nbsp;(COPD). This multinational trial, known as the&nbsp;FLAGSHIP trial, is being conducted at outpatient clinics across Northern and Central Europe
evaluating the safety and efficacy of&nbsp;AQX-1125&nbsp;in approximately 350-400 unstable moderate to severe&nbsp;COPD&nbsp;patients with a history of frequent exacerbations. Product candidates in later stages of clinical development generally have
higher development costs than those in earlier stages of clinical development, primarily due to the increased size and duration of later-stage clinical trials.&nbsp;As a result of these clinical trial activities, research and development expenses
for the three months ended March&nbsp;31, 2014 increased to $1.9 million compared to $0.6 million for the three months ended March&nbsp;31, 2013. We expect our research and development expenses to continually increase for the foreseeable future as
the clinical trials progress. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>General and Administrative Expenses </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">General and administrative expenses consist principally of salaries and related costs for executive and other administrative personnel, including stock-based
compensation and travel expenses. Other general and administrative expenses include facility-related costs, communication expenses and professional fees for legal, patent review, consulting and accounting services. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For the three months ended March&nbsp;31, 2014, our general and administrative expenses totaled approximately $0.7 million compared to $0.4 million for the
three months ended March&nbsp;31, 2013. The increase is the result of additional costs associated with being a public company as we completed an initial public offering in March 2014. This included, among other expenses, increased costs for
insurance, costs related to the hiring of additional personnel and outside consultants and increased travel associated with the IPO. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Bank charges
and financing costs </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Bank charges and financing costs consist of bank loan interest, warrant discount amortization and normal course bank charges.
The increase in bank charge and financing costs is attributed to the term loan with SVB entered into in October 2013 and repaid in March 2014 which resulted in early repayment penalty and fees of $0.1 million and accretion of warrant discount and
deferred costs of $0.3 million. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Interest income </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Interest income consists primarily of interest earned on cash, cash equivalents and short-term investments held by us. Interest income for the three months
ended March&nbsp;31, 2014 increased by an insignificant amount compared to the same period in 2013. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Sale of equipment </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the first quarter of 2013, we sold laboratory equipment for gross proceeds of $50,810, resulting in a gain of $29,396. There was no sale of equipment
for the three months ended March&nbsp;31, 2014. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Change in fair value of derivative liabilities </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Derivative liabilities are re-measured at each balance sheet date with the corresponding change recorded within change in fair value of derivative liabilities.
During the first quarter of 2014, most of the change in fair value was due to the extinguishment of the liabilities associated with the redemption option of our preferred stock as the preferred stock was converted into common stock immediately prior
to our IPO. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Amortization and extinguishment of remaining discount on preferred stock </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Amortization of discount on preferred stock for the three months ended March&nbsp;31, 2014 was $85,577 compared to $25,438 for the three months ended
March&nbsp;31, 2013 due to the longer period of amortization of the discount associated with the Series C preferred stock in 2014 compared to the first quarter of 2013 when the Series C preferred stock was only outstanding for 12 days (being issued
on March&nbsp;19, 2013). Upon the conversion of our preferred stock to common stock in March 2014 immediately prior to our IPO, all remaining discount on preferred stock was extinguished and $1.8 million was recorded as an expense </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Foreign exchange gain (loss) </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Foreign exchange
loss of $0.2 million for the three months ended March&nbsp;31, 2014 was higher compared to loss of $17,005 for the three months ended March&nbsp;31, 2013, primarily due to the greater amount of cash balances held in non-USD currencies as of
March&nbsp;31, 2014, which were more vulnerable to the unfavorable exchange rates for British Pounds, Euros and Canadian dollar relative to USD (our functional currency) as of March&nbsp;31, 2014, and the related effects of period end translation of
cash balances and expenses incurred in these currencies </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Liquidity and Capital Resources </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">From inception through March&nbsp;31, 2014, we have received gross proceeds of $111.5 million from the issuance of common and preferred stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Since our inception, we have incurred net losses and negative cash flows from our operations. Our operating activities used $3.8 million and $0.9 million of
cash flows during the three months ended March&nbsp;31, 2014 and 2013, respectively. As of March&nbsp;31, 2014, we had an accumulated deficit of $69.6&nbsp;million, working capital of $55.0&nbsp;million and cash, cash equivalents and short-term
investments of $55.6 million. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Cash Flows </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table summarizes our cash flows for the three months ended March&nbsp;31, 2014 and 2013: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="68%"></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>THREE MONTHS ENDED<BR>MARCH&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2014</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2013</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net cash (used in) provided by:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(3,802,168</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(896,621</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Investing activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,463</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">46,114</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Financing activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">45,718,566</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17,867,220</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(Decrease) increase in cash and cash equivalents</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">41,911,935</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">17,016,713</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Net cash used in operating activities </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The increase in cash used in operating activities for the three months ended March&nbsp;31, 2014 compared to the three months ended March&nbsp;31, 2013 was
driven by an increase in clinical development expenses as a result of the initiation of two large Phase 2 clinical trials in the second half of 2013, whereas in the first quarter of 2013 we had decreases in activities following completion of
early-stage lead compound identification and screening in November 2012. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Net cash used in investing activities </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Cash from investing activities for the three months ended March&nbsp;31, 2014 and 2013 primarily consisted of acquisitions and dispositions of fixed assets.
During the first quarter of 2013, we received $50,810 in proceeds from the sale of lab equipment. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Net cash provided by financing activities </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Net cash provided by financing activities was $45.7 million for the three months ended March&nbsp;31, 2014 due to $53.1 million in proceeds from our IPO of
common shares, offset by $4.8 million of offering costs paid during the quarter and a repayment of a bank loan with SVB Bank for $2.6 million. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Net cash
provided by financing activities was $17.9 million for the three months ended March&nbsp;31, 2013, which was due to $18.0 million in proceeds from the issuance of Series&nbsp;C convertible preferred stock, offset by $0.1 million in share issue
costs. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Operating and Capital Expenditure Requirements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have not achieved profitability since our inception and we expect to continue to incur net losses for the foreseeable future. We expect our cash
expenditures to increase in the near term as we fund our Phase&nbsp;2 clinical trials of AQX-1125, as well as our continuing preclinical activities. We believe that our existing capital resources will be sufficient to fund our operations for at
least the next 12&nbsp;months. However, we anticipate that we will need to raise substantial financing in the future to fund our operations. In order to meet these additional cash requirements, we may seek to sell additional equity or convertible
debt securities that may result in dilution to our stockholders. If we raise additional funds through the issuance of convertible debt securities, these securities could have rights senior to those of our common stock and could contain covenants
that restrict our operations. There can be no assurance that we will be able to obtain additional equity or debt financing on terms acceptable to us, if at all. Our failure to obtain sufficient funds on acceptable terms when needed could have a
negative impact on our business, results of operations, financial condition and cash flows and future prospects. Our future capital requirements will depend on many factors, including: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the timing, receipt and amount of sales of, or royalties on, future approved products, if any; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the timing to completion and the results of our Phase&nbsp;2 clinical trials; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the number and characteristics of any future product candidates we develop or may acquire; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the scope, progress, results and costs of researching and developing our product candidates or any future product candidates, and conducting preclinical studies and clinical trials; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the timing of, and the costs involved in, obtaining regulatory approvals for AQX-1125 or any future product candidates; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the cost of manufacturing AQX-1125 and our future product candidates and any products that may achieve regulatory approval; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the cost of commercialization activities if AQX-1125 or any future product candidates are approved for sale, including marketing, sales and distribution costs; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our ability to establish and maintain strategic collaborations, licensing or other arrangements and the financial terms of such agreements; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">any product liability or other lawsuits related to our products; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the expenses needed to attract and retain skilled personnel; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the costs associated with being a public company; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the costs involved in preparing, filing, prosecuting, maintaining, defending and enforcing patent claims, including litigation costs and the outcome of such litigation. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Please see Item&nbsp;1A of this Quarterly Report titled &#147;Risk Factors&#148; for additional risks associated
with our substantial capital requirements. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Contractual Obligations and Commitments </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our material contractual obligations as of March&nbsp;31, 2014 comprised an Asset Purchase Agreement dated August&nbsp;19, 2009 between us and Biolipox AB,
under which upon commencement by us of a Phase 3 trial of AQX-1125, a $3 million milestone payment will be due to Biolipox. We cannot predict the likelihood or the timing of any such payment. AQXP Canada has a lease agreement for laboratory and
office space which expires August&nbsp;31, 2015. AQXP Canada entered into an additional lease agreement for office space commencing January&nbsp;1, 2014. This new lease expires March&nbsp;31, 2016. Details of these contractual obligations are
described in the Management Discussion and Analysis of Financial Condition and Results of Operation section of our prospectus filed with the SEC pursuant to Rule 424(b) under the Securities Act on March&nbsp;7, 2014. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Critical Accounting Policies and Significant Judgments and Estimates </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The preparation of these financial statements in accordance with U.S. GAAP requires us to make estimates and judgments that affect the reported amounts of
assets, liabilities, revenue and expenses and the disclosure of contingent assets and liabilities in our combined financial statements. On an ongoing basis, we evaluate our estimates and judgments, including those related to accrued liabilities,
stock-based compensation and derivative liabilities. We base our estimates on historical experience, known trends and events and various other factors that we believe to be reasonable under the circumstances, the results of which form the basis for
making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions. Please refer to our Critical Accounting
Policies and Significant Judgments and Estimates included as part of our prospectus filed with the SEC pursuant to Rule 424(b) under the Securities Act on March&nbsp;7, 2014. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Off-Balance Sheet Arrangements </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We do not have any
off-balance sheet arrangements. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B><A NAME="tx704250_7"></A>Item&nbsp;3.</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Quantitative and Qualitative Disclosures About Market Risk </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Management believes there
have been no material changes to our quantitative and qualitative disclosures about market risks during the three months ended March&nbsp;31, 2014, compared to those discussed in our prospectus filed with the SEC pursuant to Rule&nbsp;424(b) under
the Securities Act on March&nbsp;7, 2014. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B><A NAME="tx704250_8"></A>Item&nbsp;4.</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Controls and Procedures </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Evaluation of disclosure controls and procedures.</I> Under
the supervision and with the participation of our principal executive officer and principal financial officer, our management conducted an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures, as
defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, as of the end of the period covered by this report or the &#147;Evaluation Date&#148;. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In designing and evaluating our disclosure controls and procedures, management recognizes that any disclosure controls and procedures, no
matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives. In addition, the design of disclosure controls and procedures must reflect the fact that there are resource constraints and
that management is required to apply its judgment in evaluating the benefits of possible controls and procedures relative to their costs. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Based on management&#146;s evaluation, our principal executive officer and principal financial officer concluded that our disclosure controls
and procedures are designed to, and are effective to, provide assurance at a reasonable level that the information we are required to disclose in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported
within the time periods specified in SEC rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions
regarding required disclosures. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Changes in internal control over financial reporting.</I> There was no change in our internal control
over financial reporting identified in connection with the evaluation required by Rule 13a-15(d) and 15d-15(d) of the Exchange Act that occurred during the period covered by this report that has materially affected, or is reasonably likely to
materially affect, our internal control over financial reporting. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Part II. Other Information </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B><A NAME="tx704250_9"></A>Item&nbsp;1.</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Legal Proceedings </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are not currently subject to any material legal proceedings. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B><A NAME="tx704250_10"></A>Item&nbsp;1A.</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Risk Factors </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You should carefully consider the following risk factors, in addition to the other
information contained in this Quarterly Report on Form 10-Q, including our condensed consolidated financial statements and related notes. If any of the events described in the following risk factors occurs, our business, operating results and
financial condition could be seriously harmed. This Quarterly Report on Form 10-Q also contains forward-looking statements that involve risks and uncertainties. Our actual results could differ materially from those anticipated in the forward-looking
statements as a result of factors that are described below and elsewhere in this Quarterly Report on Form 10-Q. We have marked with an asterisk (*)&nbsp;those risk factors below that reflect significant changes form the risk factors included in our
Form S-1 (Registration No.&nbsp;333-193615), which was declared effective on March&nbsp;6, 2014. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risks Related to Our Financial Position and Capital
Needs </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We have incurred significant losses in every quarter since our inception and anticipate that we will continue to incur significant losses
in the future.* </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are a clinical-stage pharmaceutical company with a limited operating history. Investment in pharmaceutical
product development is highly speculative because it entails substantial upfront capital expenditures and significant risk that any potential product candidate will fail to demonstrate adequate effect or an acceptable safety profile, gain regulatory
approval or become commercially viable. We do not have any products approved by regulatory authorities for marketing or commercial sale and have not generated any revenue from product sales, or otherwise, to date, and we continue to incur
significant research, development and other expenses related to our ongoing operations. As a result, we are not profitable and have incurred losses in every reporting period since our inception in 2003. For the years ended December&nbsp;31, 2013 and
2012, and for the three months ended March&nbsp;31, 2014, we reported a net loss of $8.7 million, $7.7 million and $4.2 million, respectively. As of March&nbsp;31, 2014, we had an accumulated deficit since inception of $69.6&nbsp;million. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We expect to continue to incur significant expenses and operating losses for the foreseeable future. We anticipate these losses to increase as
we continue the research and development of, and seek regulatory approvals for, AQX-1125 and any of our future product candidates, and potentially begin to commercialize any products that may achieve regulatory approval. We may encounter unforeseen
expenses, difficulties, complications, delays and other unknown factors that may adversely affect our financial condition. The size of our future net losses will depend, in part, on the rate of future growth of our expenses and our ability to
generate revenues. Our prior losses and expected future losses have had and will continue to have an adverse effect on our financial condition. If AQX-1125 or any future product candidate fails in clinical trials or does not gain regulatory
approval, or if approved, fails to achieve market acceptance, we may never become profitable. Even if we achieve profitability in the future, we may not be able to sustain profitability in subsequent periods. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We have a limited operating history, which may make it difficult for you to evaluate the success of our business to date and to assess our future
viability. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our operations to date have been primarily limited to organizing and staffing our company, acquiring product and
technology rights, discovering and developing novel small molecule drug candidates and undertaking preclinical studies and clinical trials of AQX-1125. We have not yet obtained regulatory approval for AQX-1125 or any future product candidate.
Consequently, evaluating our performance, viability or future success will be more difficult than if we had a longer operating history or approved products on the market. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We currently have no source of product revenue and may never become profitable. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To date, we have not generated any revenues from commercial product sales, or otherwise. Our ability to generate revenue from product sales and
achieve profitability will depend upon our ability, alone or with any future collaborators, to successfully commercialize products, including AQX-1125 or any future product candidates that we may develop, in-license or acquire in the future. Even if
we are able to successfully achieve regulatory approval for AQX-1125 or any future product candidates, we do not know when any of these products will generate revenue from product sales for us, if at all. Our ability to generate revenue from product
sales from AQX-1125 or any of our future product candidates also depends on a number of additional factors, including our or any future collaborators&#146; ability to: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">complete development activities, including the necessary clinical trials; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">complete and submit new drug applications, or NDAs, to the U.S. Food and Drug Administration, or FDA, and obtain regulatory approval for indications for which there is a commercial market; </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">complete and submit applications to, and obtain regulatory approval from, foreign regulatory authorities; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">set a commercially viable price for our products; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">establish and maintain supply and manufacturing relationships with third parties, and ensure adequate and legally compliant manufacturing of bulk drug substances and drug products to maintain that supply;
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">develop a commercial organization capable of sales, marketing and distribution for any products for which we obtain marketing approval and intend to sell ourselves in the markets in which we choose to commercialize on
our own; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">find suitable distribution partners to help us market, sell and distribute our approved products in other markets; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">obtain coverage and adequate reimbursement from third-party payors, including government and private payors; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">achieve market acceptance for our products, if any; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">establish, maintain and protect our intellectual property rights; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">attract, hire and retain qualified personnel. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, because of the numerous risks and
uncertainties associated with pharmaceutical product development, including that AQX-1125 or any future product candidates may not advance through development or achieve the endpoints of applicable clinical trials, we are unable to predict the
timing or amount of increased expenses, or when or if we will be able to achieve or maintain profitability. In addition, our expenses could increase beyond expectations if we decide to or are required by the FDA, or foreign regulatory authorities,
to perform studies or trials in addition to those that we currently anticipate. Even if we are able to complete the development and regulatory process for AQX-1125 or any future product candidates, we anticipate incurring significant costs
associated with commercializing these products. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Even if we are able to generate revenues from the sale of AQX-1125 or any future product
candidates that may be approved, we may not become profitable and may need to obtain additional funding to continue operations. If we fail to become profitable or are unable to sustain profitability on a continuing basis, then we may be unable to
continue our operations at planned levels and be forced to reduce our operations. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our operating results may fluctuate significantly on a quarterly
and annual basis, which may make our future operating results difficult to predict and could cause our operating results to fall below expectations or our guidance. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our quarterly and annual operating results have varied significantly in the past and may continue to fluctuate significantly in the future from
quarter-to-quarter or year-to-year due to a variety of factors, many of which are beyond our control, which may make it difficult for us to predict our future operating results. Factors that may contribute to these fluctuations include the
following, as well as other factors described elsewhere in this report: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our ability to obtain additional funding for research and development and manufacturing activities relating to AQX-1125 or any of our future product candidates; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the timing and cost of research and development activities relating to AQX-1125 or any of our future product candidates, which may change from time to time; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the cost of manufacturing AQX-1125 or any of our future product candidates, which may vary depending on the quantity of production and the terms of our agreements with manufacturers; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">expenditures that we will or may incur to acquire or develop additional product candidates and technologies; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the level of demand for AQX-1125 or any of our future product candidates, should they receive approval, which may vary significantly; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our ability to enroll patients in clinical trials; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the success or failure of clinical studies through all phases of clinical development for AQX-1125 or any of our future product candidates or competing product candidates, including our Phase 2 trials of AQX-1125, or
any other change in the competitive landscape of our industry; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">any delays in regulatory review and approval of AQX-1125 or any of our future product candidates; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">potential side effects of AQX-1125 or our future product candidates that could delay or prevent commercialization or cause an approved drug to be taken off the market; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the ability of patients or healthcare providers to obtain coverage of or sufficient reimbursement for AQX-1125 or our future product candidates and our ability to achieve acceptance among patients and physicians;
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">competition from existing and potential future drugs that compete with AQX-1125 or our future product candidates; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our ability to receive approval and commercialize AQX-1125 or our future product candidates outside of the United States; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our dependency on third-party manufacturers to supply or manufacture our AQX-1125 or our future product candidates; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our ability to establish or maintain collaborations, licensing or other arrangements; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our ability and third parties&#146; abilities to protect intellectual property rights; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">costs related to and outcomes of potential intellectual property litigation; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">costs associated with recently enacted healthcare legislation; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our ability to adequately support future growth; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our ability to attract and retain key personnel to manage our business effectively; </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our ability to build our finance infrastructure and improve our accounting systems and controls; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">potential product liability claims; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">potential liabilities associated with hazardous materials; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">fluctuations in foreign currency exchange rates; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our ability to use potential future operating losses and our federal and state net operating loss carryforwards to offset taxable income; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">potential unforeseen business disruptions that increase our costs or expenses; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our ability to maintain adequate insurance policies; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the changing and volatile U.S., European and global economic environments. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Investors should
not rely on our quarterly or annual results as an indication of our future performance. This variability and unpredictability could also result in our failing to meet the expectations of industry or financial analysts or investors for any period. If
our revenue or operating results fall below the expectations of analysts or investors or below any forecasts we may provide to the market, or if the forecasts we provide to the market are below the expectations of analysts or investors, the price of
our common stock could decline substantially. Such a stock price decline could occur even when we have met any previously publicly stated revenue and/or earnings guidance we may provide. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We are likely to require additional capital to finance our operations which may not be available to us on acceptable terms, or at all. If we fail to
obtain necessary financing, we may be unable to complete the development and potential commercialization of AQX-1125 or develop future product candidates. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Developing pharmaceutical products, including conducting preclinical studies and clinical trials, is expensive. Our operations have consumed
substantial amounts of cash since inception. We expect research and clinical development expenses to increase substantially in connection with our ongoing activities, particularly as we advance AQX-1125 or future product candidates in clinical
trials and launch and commercialize any product candidates for which we receive regulatory approval, including potentially building our own commercial organization. We believe that our existing cash and cash equivalents and interest thereon will be
sufficient to fund our operating requirements for at least the next 12&nbsp;months. However, circumstances may cause us to consume capital more rapidly than we anticipate. We will likely require additional capital for the further development and
potential commercialization of AQX-1125 or future product candidates and may also need to raise additional funds sooner to pursue a more accelerated development of AQX-1125 or future product candidates. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If we need to secure additional financing, additional fundraising efforts may divert our management from our day-to-day activities, which may
adversely affect our ability to develop and commercialize AQX-1125 or future product candidates. In addition, we cannot guarantee that future financing will be available in sufficient amounts or on terms acceptable to us, if at all. If we do not
raise additional capital when required or on acceptable terms, we may need to: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">significantly delay, scale back or discontinue clinical trials related to the development or commercialization of AQX-1125 or any of our future product candidates or cease operations altogether; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">seek strategic alliances for research and development programs at an earlier stage than we would otherwise desire or on terms less favorable than might otherwise be available; or </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">relinquish, or license on unfavorable terms, our rights to AQX-1125 or any future product candidates that we otherwise would seek to develop or commercialize ourselves. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If we need to conduct additional fundraising activities and we do not raise additional capital in sufficient amounts or on terms acceptable to
us, we may be prevented from pursuing development and commercialization efforts, which will have a material adverse effect on our business, operating results and prospects. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our forecast of the period of time through which our financial resources will be adequate to support our operations is a forward-looking
statement and involves risks and uncertainties, and actual results could vary as a result of a number of factors, including the factors discussed elsewhere in this &#147;Risk Factors&#148; section. We have based this estimate on assumptions that may
prove to be wrong, and we could spend our available capital resources sooner than we currently expect. Our future funding requirements, both near and long-term, will depend on many factors, including, but not limited to: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the initiation, progress, timing, costs and results of clinical trials for AQX-1125 and any future product candidates; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the clinical development plans we establish for AQX-1125 or any future product candidates; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the achievement of milestones and our obligation to make milestone payments under our present or any future in-licensing agreements; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the number and characteristics of product candidates that we discover or in-license and develop; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the outcome, timing and cost of regulatory review by the FDA and comparable foreign regulatory authorities, including the potential for the FDA or comparable foreign regulatory authorities to require that we perform
more studies than those that we currently expect; </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the cost to establish, maintain, expand and defend the scope of our intellectual property portfolio, including the amount and timing of any payments we may be required to make, or that we may receive, in connection with
licensing, preparing, filing, prosecuting, defending and enforcing any patent claims and maintaining and enforcing other intellectual property rights; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the effect of competing technological and market developments; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the costs and timing of the implementation of commercial-scale outsourced manufacturing activities; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the costs and timing of establishing sales, marketing and distribution capabilities for any product candidates for which we may receive regulatory approval in territories where we choose to commercialize products on our
own. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If we are unable to expand our operations or otherwise capitalize on our business opportunities due to a lack of
capital, our business, results of operations, financial condition and cash flows and future prospects could be materially adversely affected. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Raising additional capital may cause dilution to our existing stockholders, restrict our operations or require us to relinquish rights to our
technologies, AQX-1125 or any future product candidates. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Until we can generate substantial revenue from product sales, if ever, we
expect to finance future cash needs through a combination of private and public equity offerings, debt financings, strategic collaborations and alliances and licensing arrangements. To the extent that we raise additional capital through the sale of
equity or convertible debt securities, the ownership interests of existing stockholders will be diluted, and the terms may include liquidation or other preferences that adversely affect the rights of existing stockholders. Additional capital may not
be available on reasonable terms, if at all. If we raise additional funds through the issuance of additional debt or equity securities, that could result in dilution to our existing stockholders, and/or increased fixed payment obligations.
Furthermore, these securities may have rights senior to those of our common stock and could contain covenants that include restrictive covenants limiting our ability to take important actions and potentially impair our competitiveness, such as
limitations on our ability to incur additional debt, make capital expenditures, acquire, sell or license intellectual property rights or declare dividends. If we raise additional funds through strategic collaborations and alliances or licensing
arrangements with third parties, we may have to relinquish valuable rights to our technologies AQX-1125 or our future product candidates, or grant licenses on terms that are not favorable to us. If we are unable to raise additional funds through
equity or debt financing when needed, we may be required to delay, limit, reduce or terminate our product development or commercialization efforts or grant rights to develop and market product candidates that we would otherwise prefer to develop and
market ourselves. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We plan to use potential future operating losses and our federal and state net operating loss, or NOL, carryforwards to offset
taxable income from revenue generated from operations or corporate collaborations. However, our ability to use NOL carryforwards could be limited as a result of issuance of equity securities. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We plan to use our current year operating losses to offset taxable income from any revenue generated from operations or corporate
collaborations. To the extent that our taxable income exceeds any current year operating losses, we plan to use our NOL carryforwards to offset income that would otherwise be taxable. However, under the Tax Reform Act of 1986, the amount of benefits
from our NOL carryforwards may be impaired or limited if we incur a cumulative ownership change of more than 50%, as interpreted by the U.S. Internal Revenue Service, over a three-year period. As a result, our use of federal NOL carryforwards could
be limited by the provisions of Section&nbsp;382 of the U.S. Internal Revenue Code of 1986, as amended, depending upon the timing and amount of additional equity securities that we issue. State NOL carryforwards may be similarly limited. Any such
disallowances may result in greater tax liabilities than we would incur in the absence of such a limitation and any increased liabilities could adversely affect our business, results of operations, financial condition and cash flow and future
prospects. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>The acquisition of control of AQXP Canada could result in adverse Canadian tax consequences, including limitations on AQXP Canada&#146;s
ability to use non-capital loss carryforwards and other similar tax attributes to offset taxable income for Canadian tax purposes.* </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We underwent a reorganization immediately prior to the closing of our IPO in March 2014 which resulted in AQXP Canada becoming a wholly owned
subsidiary of Aquinox USA through an exchange of shares. Under the Income Tax Act (Canada), referred to herein as the Tax Act, in connection with the exchange of shares of AQXP Canada for shares of Aquinox USA, there may be limitations on AQXP
Canada&#146;s ability to use its non-capital loss carryforwards and other similar tax attributes following the acquisition of control. In general, an acquisition of control would result in AQXP Canada losing its net capital loss carryforwards, if
any, and AQXP Canada&#146;s non-capital loss carryforwards and other similar tax attributes only being &#147;useable&#148; to offset income, excluding capital gains, derived from the business operated by AQXP Canada that generated such tax
attributes or a business &#147;similar&#148; to such business and provided the business that generated the tax attributes continues to be carried on by AQXP Canada for profit or with a reasonable expectation of profit. We expect that we will
continue to carry on the business of AQXP Canada for profit or with a reasonable expectation of profit and that, accordingly, its non-capital loss carryforwards and other similar tax attributes should be available to offset future income for
Canadian tax purposes to the extent of income from that business or &#147;similar&#148; businesses, subject to expiry of such loss carryforwards over time pursuant to the provisions of the Tax Act. If our use of these non-capital loss carryforwards
or other similar tax attributes is restricted as a result of an acquisition of control or otherwise, our Canadian federal income tax liability may be materially increased, which could adversely affect our business, results of operations, financial
condition and cash flow and future prospects. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Fluctuations in foreign currency exchange rates could result in changes in our reported revenues and
earnings.* </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We currently incur significant expenses denominated in foreign currencies, specifically in connection with our
operations in Canada. In addition, we utilize numerous clinical trial sites as part of our clinical trials for AQX-1125 which are located in various countries outside of the United States. These clinical trial sites invoice us in the local currency
of the site. We do not engage in foreign currency hedging arrangements for our accounts payable, and, consequently, foreign currency fluctuations may adversely affect our earnings. We may decide to manage this risk by hedging our foreign currency
exposure, principally through derivative contracts. Even if we decide to enter into such hedging transactions, we cannot be sure that such hedges will be effective or that the costs of such hedges will not exceed their benefits. Fluctuations in the
rate of exchange between the U.S. dollar and foreign currencies, primarily the Canadian dollar, could result in material amounts of cash being required to settle the hedge transactions or could adversely affect our financial results. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risks Related to Our Business and Industry </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our
future success is dependent primarily on the regulatory approval and commercialization of AQX-1125 and any of our future product candidates. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We do not have any products that have gained regulatory approval. Currently, our only clinical-stage product candidate is AQX-1125, which is
currently undergoing Phase 2 clinical trials. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As a result, our near-term prospects, including our ability to finance our operations and
generate revenue, are substantially dependent on our ability to obtain regulatory approval for, and, if approved, to successfully commercialize AQX-1125 in a timely manner. We cannot commercialize AQX-1125 or our future product candidates in the
United States without first obtaining regulatory approval for the product from the FDA; similarly, we cannot commercialize AQX-1125 or our future product candidates outside of the United States without obtaining regulatory approval from comparable
foreign regulatory authorities. The FDA review process typically takes years to complete and approval is never guaranteed. Before obtaining regulatory approvals for the commercial sale of any AQX-1125 or our future product candidates for a target
indication, we must demonstrate with substantial evidence gathered in preclinical and well-controlled clinical studies, generally including two well-controlled Phase&nbsp;3 trials, and, with respect to approval in the United States, to the
satisfaction of the FDA, that the product candidate is safe and effective for use for that target indication and that the manufacturing facilities, processes and controls are adequate. Obtaining regulatory approval for marketing of AQX-1125 or our
future product candidates in one country does not ensure we will be able to obtain regulatory approval in other countries but a failure or delay in obtaining regulatory approval in one country may have a negative effect on the regulatory process in
other countries. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Even if AQX-1125 or any of our future product candidate were to successfully obtain approval from the FDA and comparable
foreign regulatory authorities, any approval might contain significant limitations related to use restrictions for specified age groups, warnings, precautions or contraindications, or may be subject to burdensome post-approval study or risk
management requirements. If we are unable to obtain regulatory approval for AQX-1125 in one or more jurisdictions, or any approval contains significant limitations, we may not be able to obtain sufficient funding or generate sufficient revenue to
continue the development of any of our future product candidate that we may discover, in-license, develop or acquire in the future. Also, any regulatory approval of any of AQX-1125 or our future product candidates, once obtained, may be withdrawn.
Furthermore, even if we obtain regulatory approval for AQX-1125, the commercial success of AQX-1125 will depend on a number of factors, including the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">development of a commercial organization or establishment of a commercial collaboration with a commercial infrastructure, </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">establishment of commercially viable pricing and obtain approval for adequate reimbursement from third-party and government payors; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the ability of our third-party manufacturers to manufacture quantities of AQX-1125 using commercially sufficient processes and at a scale sufficient to meet anticipated demand and enable us to reduce our cost of
manufacturing; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our success in educating physicians and patients about the benefits, administration and use of AQX-1125; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the availability, perceived advantages, relative cost, relative safety and relative efficacy of alternative and competing treatments; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the effectiveness of our own or our potential strategic collaborators&#146; marketing, sales and distribution strategy and operations; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">acceptance of AQX-1125 as safe and effective by patients and the medical community; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">a continued acceptable safety profile of AQX-1125 following approval. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Many of these factors
are beyond our control. If we or our potential commercialization collaborators are unable to successfully commercialize AQX-1125, we may not be able to earn sufficient revenues to continue our business. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Because the results of preclinical testing or earlier clinical trials are not necessarily predictive of
future results, AQX-1125, which is currently in Phase&nbsp;2 clinical trials, or any future product candidate we advance into clinical trials, may not have favorable results in later clinical trials or receive regulatory approval. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Success in preclinical testing and early clinical trials does not ensure that later clinical trials will generate adequate data to demonstrate
the efficacy and safety of an investigational drug. A number of companies in the pharmaceutical and biotechnology industries, including those with greater resources and experience, have suffered significant setbacks in clinical trials, even after
seeing promising results in earlier clinical trials. Despite the results reported in earlier clinical trials for AQX-1125, we do not know whether the clinical trials we are conducting, or may conduct, will demonstrate adequate efficacy and safety to
result in regulatory approval to market AQX-1125 or any of our future product candidates in any particular jurisdiction. Even if we believe that we have adequate data to support an application for regulatory approval to market our product
candidates, FDA or other applicable foreign regulatory authorities may not agree and may require we conduct additional clinical trials. If later-stage clinical trials do not produce favorable results, our ability to achieve regulatory approval for
any of our product candidates may be adversely impacted. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the Phase 2 trial we are conducting to evaluate the effect of AQX-1125 on
COPD patients, we are enrolling only unstable moderate to severe COPD patients following a recent exacerbation. We believe this novel trial design will allow us to measure sufficient clinical events to detect the effects of AQX-1125 on the change in
the severity, duration and reoccurrence of exacerbations in COPD patients as measured by a change in EXACT scores as the primary endpoint in a 12 week trial. The EXACT-PRO is a validated 14-item questionnaire to be completed daily by the patient on
an electronic diary to assess the change in symptoms associated with a COPD exacerbation. Answers are converted into a numerical score between 0-100. By comparing the daily scores over a 12 week period for patients receiving AQX-1125 versus those
receiving placebo we believe we can measure the effects of AQX-1125 on the change in the severity, duration and reoccurrence of exacerbations in COPD patients more sensitively than with traditional endpoints such as lung function measures or numbers
of re-exacerbations. We have not discussed our use of EXACT-PRO with the FDA, and we do not know whether the FDA will accept EXACT-PRO as a primary endpoint for Phase&nbsp;3 studies. In January 2014, the FDA issued draft guidance on the use of
EXACT-PRO for clinical trials. The FDA stated that the EXACT-PRO is qualified as a well-defined and reliable measure of symptoms of exacerbations of COPD, for use in Phase 2 trials. Additional development work is needed to further assess measurement
properties over the course of an exacerbation, including ability to detect meaningful change in response to an acute intervention. We are not aware of any other clinical trial utilizing EXACT scores as a primary endpoint in a Phase 2 or Phase 3
trial. If the FDA does not accept EXACT-PRO as a primary endpoint in Phase 3 trials, it could delay our ability to advance AQX-1125 into clinical trials for marketing approval in COPD, and the FDA may require that we use other clinical COPD
measures, such as Forced Expiratory Volume in one second (FEV<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB>), a measure of lung function that is reduced in COPD, as the primary endpoint, rather than EXACT-PRO. Even if the FDA accepts
EXACT-PRO for our Phase&nbsp;3 trials and our Phase 2 clinical trial in COPD supports advancement of Phase&nbsp;3 clinical trials, the trial duration may need to be longer than the 12 weeks of our current Phase 2 trial. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, we have not yet established the optimal dose for AQX-1125. There can be no guarantee that the 200 mg dose currently being studied
in our Phase 2 clinical trial will be efficacious or, if it is, whether it will be the optimal dose. We believe we will need to conduct additional clinical trials to evaluate additional dose levels of AQX-1125. There can not be any guarantee that
any of these studies will be successful in determining a dose of AQX-1125 suitable for marketing approval. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>SHIP1 has not been validated as a
target. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our primary focus is small molecule anti-inflammatory product candidates targeting SHIP1, which is a key regulator of an
important cellular signaling pathway in immune cells. To date, no drug which specifically targets SHIP1 has been demonstrated to provide clinical benefit or been approved by any regulatory authority for the treatment of disease. Therefore, SHIP1 has
not been validated as a target, as such we are pursuing development of AQX-1125 against a novel and unproven target. We believe AQX-1125 is the only SHIP1 activator currently in clinical trials. SHIP1 activators as a class of drug, including
AQX-1125, may ultimately prove unsuitable for treatment of human diseases, or if approved for treatment of human diseases, may be commercially unsuccessful, either of which could cause our business to fail. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Clinical drug development involves a lengthy and expensive process with an uncertain outcome. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Clinical testing is expensive, can take many years to complete, and its outcome is inherently uncertain. Failure can occur at any time during
the clinical trial process. Product candidates in later stages of clinical trials may fail to show the desired safety and efficacy traits despite having progressed through preclinical studies and early clinical trials. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may experience delays in our ongoing or future clinical trials and we do not know whether
planned clinical trials will begin or enroll subjects on time, need to be redesigned or be completed on schedule, if at all. All of our clinical trials to date have been conducted outside the United States and we do not know whether the FDA will
approve the commencement of future clinical trials. While we do not anticipate any future delays, there can be no assurance that the FDA or other comparable foreign regulatory authority will not put clinical trials of AQX-1125 or any other of our
product candidates on clinical hold in the future. Clinical trials may be delayed, suspended or prematurely terminated for a variety of reasons, such as: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">delay or failure in reaching agreement with the FDA or a comparable foreign regulatory authority on a trial design that we are able to execute; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">delay or failure in obtaining authorization to commence a trial or inability to comply with conditions imposed by a regulatory authority regarding the scope or design of a clinical trial; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">delay or failure in reaching agreement on acceptable terms with prospective contract research organizations, or CROs, and clinical trial sites, the terms of which can be subject to extensive negotiation and may vary
significantly among different CROs and trial sites; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">delay or failure in obtaining institutional review board, or IRB, approval or the approval of other reviewing entities, including comparable foreign regulatory authorities, to conduct a clinical trial at each site;
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">withdrawal of clinical trial sites from our clinical trials as a result of changing standards of care or the ineligibility of a site to participate in our clinical trials; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">delay or failure in recruiting and enrolling suitable subjects to participate in a trial; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">delay or failure in subjects completing a trial or returning for post-treatment follow-up; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">clinical sites and investigators deviating from trial protocol, failing to conduct the trial in accordance with regulatory requirements, or dropping out of a trial; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">inability to identify and maintain a sufficient number of trial sites, many of which may already be engaged in other clinical trial programs, including some that may be for the same indication; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">failure of our third parties, such as CROs, to satisfy their contractual duties or meet expected deadlines; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">delay or failure in adding new clinical trial sites; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">ambiguous or negative interim results or results that are inconsistent with earlier results; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">feedback from the FDA, the IRB, data safety monitoring boards, or a comparable foreign regulatory authority, or results from earlier stage or concurrent preclinical studies and clinical trials, that might require
modification to the protocol for the trial; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">decision by the FDA, the IRB, a comparable foreign regulatory authority, or us, to impose a clinical hold following an inspection of our clinical trial operations or trial sites, or recommendation by a data safety
monitoring board or comparable foreign regulatory authority, to suspend or terminate clinical trials at any time for safety issues or for any other reason; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">unacceptable risk-benefit profile, unforeseen safety issues or adverse side effects; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">failure to demonstrate a benefit from using a drug; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">delays in the testing, validation, manufacturing and delivery of the product candidates to the clinical sites; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">lack of adequate funding to continue the clinical trial, including the incurrence of unforeseen costs due to enrollment delays, requirements to conduct additional clinical trials or increased expenses associated with
the services of our CROs and other third parties; or </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">changes in governmental regulations or administrative actions or lack of adequate funding to continue the clinical trial. </TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>As an organization, we have never conducted a Phase 3 clinical trial or submitted an NDA before, and may be unable to do so for AQX-1125 or any product
candidate we are developing. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are currently conducting Phase 2 clinical trials and we may need to conduct additional Phase 2
clinical trials before initiating our Phase 3 clinical trials. If our additional Phase 2 clinical trials are successful, we intend to conduct Phase 3 trials of AQX-1125, either alone or with a future collaborator. The conduct of Phase 3 clinical
trials and the submission of a successful NDA is a complicated process. As an organization, we have not conducted a Phase 3 clinical trial before, have limited experience in preparing, submitting and prosecuting regulatory filings, and have not
submitted an NDA before. We also have had limited interactions with the FDA and have not discussed our current clinical trial designs or implementation with the FDA. Consequently, even if our Phase 2 clinical trials are successful, we may be unable
to successfully and efficiently execute and complete necessary clinical trials in a way that leads to NDA submission and approval of AQX-1125 or any other product candidate we are developing. We may require more time and incur greater costs than our
competitors and may not succeed in obtaining regulatory approvals of products that we develop. Failure to commence or complete, or delays in, our planned clinical trials, would prevent us from or delay us in commercializing AQX-1125 or any other
product candidate we are developing. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>If we are unable to enroll subjects in clinical trials, we will be unable to complete these trials on a
timely basis. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Patient enrollment, a significant factor in the timing of clinical trials, is affected by many factors including the
size and nature of the patient population, the proximity of subjects to clinical sites, the eligibility criteria for the trial, the design of the clinical trial, ability to obtain and maintain patient consents, risk that enrolled subjects will drop
out before completion, competing clinical trials and clinicians&#146; and patients&#146; perceptions as to the potential advantages of the drug being studied in relation to other available therapies, including any new drugs that may be approved for
the indications we are investigating. Furthermore, we rely on CROs and clinical trial sites to ensure the proper and timely conduct of our clinical trials, and while we have agreements governing their committed activities, we have limited influence
over their actual performance. For example, in our Phase 1b LPS challenge proof-of-concept trial of AQX-1125, a large number of data points were lost for one part of the trial through error, rendering an analysis for efficacy uninterpretable for
that part. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If we experience delays in the completion or termination of, any clinical trial of AQX-1125 or any future product candidates,
the commercial prospects of our product candidates will be harmed, and our ability to generate product revenues from any of these product candidates will be delayed. In addition, any delays in completing our clinical trials will increase our costs,
slow down our product candidate development and approval process and could shorten any periods during which we may have the exclusive right to commercialize our product candidates or allow our competitors to bring products to market before we do,
and jeopardize our ability to commence product sales, which would impair our ability to generate revenues and may harm our business, results of operations, financial condition and cash flows and future prospects. In addition, many of the factors
that could cause a delay in the commencement or completion of clinical trials may also ultimately lead to the denial of regulatory approval of AQX-1125 or our future product candidates. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>The regulatory approval processes of the FDA and comparable foreign regulatory authorities are lengthy, time consuming and inherently unpredictable, and
if we are ultimately unable to obtain regulatory approval for AQX-1125 or our future product candidates, our business will be substantially harmed. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The time required to obtain approval by the FDA and comparable foreign regulatory authorities is unpredictable, but typically takes many years
following the commencement of preclinical studies and clinical trials and depends upon numerous factors, including the substantial discretion of the regulatory authorities. In addition, approval policies, regulations, or the type and amount of
clinical data necessary to gain approval may change during the course of a product candidate&#146;s clinical development and may vary among jurisdictions. We have not obtained regulatory approval for any product candidate, and it is possible that
neither AQX-1125 nor any future product candidates we may discover, in-license or acquire and seek to develop in the future will ever obtain regulatory approval. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our product candidates could fail to receive regulatory approval from the FDA or a comparable foreign regulatory authority for many reasons,
including: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">disagreement over the design or implementation of our clinical trials; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">failure to demonstrate that a product candidate is safe and effective for its proposed indication; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">failure of clinical trials to meet the level of statistical significance required for approval; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">failure to demonstrate that a product candidate&#146;s clinical and other benefits outweigh its safety risks; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">disagreement over our interpretation of data from preclinical studies or clinical trials; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">disagreement over whether to accept efficacy results from clinical trial sites outside the United States where the standard of care is potentially different from that in the United States; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the insufficiency of data collected from clinical trials of AQX-1125 or our future product candidates to support the submission and filing of an NDA or other submission or to obtain regulatory approval;
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">disapproval of the manufacturing processes or facilities of third-party manufacturers with whom we contract for clinical and commercial supplies; or </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">changes in the approval policies or regulations that render our preclinical and clinical data insufficient for approval. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The FDA or a comparable foreign regulatory authority may require more information, including additional preclinical or clinical data to
support approval, which may delay or prevent approval and our commercialization plans, or we may decide to abandon the development program altogether. Even if we do obtain regulatory approval, AQX-1125 or our future product candidates may be
approved for fewer or more limited indications than we request, approval contingent on the performance of costly post-marketing clinical trials, or approval with a label that does not include the labeling claims necessary or desirable for the
successful commercialization of that product candidate. In addition, if AQX-1125 or our future product candidate produce undesirable side effects or safety issues, the FDA may require the establishment of Risk Evaluation Mitigation Strategies, or
REMS, or a comparable foreign regulatory authority may require the establishment of a similar strategy, that may, restrict distribution of our products and impose burdensome implementation requirements on us. Any of the foregoing scenarios could
materially harm the commercial prospects for our product candidates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have had limited interactions with the FDA and have not discussed
our clinical trial designs or implementation or our proposed regulatory approval strategy with the FDA. Even if we believe our current or planned clinical trials are successful, the FDA may not agree that our completed clinical trials provide
adequate data on the safety or efficacy of AQX-1125 or our future product candidates to permit us to proceed to Phase 3 clinical trials. Approval by comparable foreign regulatory authorities does not ensure approval by the FDA and approval by one or
more foreign regulatory authorities does not ensure approval by regulatory authorities in </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
other countries or by the FDA. However, a failure or delay in obtaining regulatory approval in one country may have a negative effect on the regulatory process in others. We may not be able to
file for regulatory approvals and even if we file we may not receive the necessary approvals to commercialize our products in any market. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We are
conducting, and may in the future conduct, clinical trials for AQX-1125 or any future product candidates in sites outside the United States and the FDA may not accept data from trials conducted in such locations. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have conducted, and may in the future choose to conduct, one or more of our clinical trials outside the United States. For example, our
Phase 2 trial for AQX-1125 in BPS/IC patients, known as the LEADERSHIP trial, is being conducted in sites across Canada and our Phase 2 trial for AQX-1125 in COPD patients with frequent exacerbations, known as the FLAGSHIP trial, is being conducted
at sites in Northern and Central Europe. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Although the FDA may accept data from clinical trials conducted outside the United States,
acceptance of this data is subject to certain conditions imposed by the FDA. For example, the clinical trial must be well designed and conducted and performed by qualified investigators in accordance with ethical principles. The study population
must also adequately represent the U.S. population, and the data must be applicable to the U.S. population and U.S. medical practice in ways that the FDA deems clinically meaningful. Generally, the patient population for any clinical studies
conducted outside of the United States must be representative of the population for whom we intend to label the product in the United States. In addition, while these clinical trials are subject to the applicable local laws, FDA acceptance of the
data will be dependent upon its determination that the studies also complied with all applicable U.S. laws and regulations. There can be no assurance the FDA will accept data from trials conducted outside of the United States. If the FDA does not
accept the data from our LEADERSHIP and FLAGSHIP clinical trials, it would likely result in the need for additional trials, which would be costly and time-consuming and delay or permanently halt our development of AQX-1125 or any future product
candidates. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>AQX-1125 or our future product candidates may cause undesirable side effects or have other properties that could delay or prevent their
regulatory approval, limit the commercial profile of an approved label, or result in significant negative consequences following any marketing approval. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Undesirable side effects caused by AQX-1125 or our future product candidates could cause us or regulatory authorities to interrupt, delay or
halt clinical trials and could result in a more restrictive label or the delay or denial of regulatory approval by the FDA or other comparable foreign regulatory authority. For example, even though AQX-1125 administered orally has generally been
well tolerated by patients in our earlier-stage clinical trials, in our animal toxicity studies certain side-effects, including severe ulcerations to the gastrointestinal tract of dogs and adverse effects to the ocular lens of some animals occurred.
There can be no assurance that these toxicities in animals will not occur in humans. If these toxicities do occur in our future clinical trials they could cause delay or even discontinuance of further development of AQX-1125 or future product
candidates, which would impair our ability to generate revenues and would have a material adverse effect our business, results of operations, financial condition and cash flows and future prospects. To date, the most common side-effect of AQX-1125
noted in clinical trials is mild gastrointestinal upset including mild diarrhea, nausea and gastric pain. No severe side effects have been noted to date. There can be no assurance that side-effects from AQX-1125 in future clinical trials will be
continue to be mild or that side-effects in general will not prompt the discontinued development of AQX-1125 or future product candidates. As a result of these side effects or further safety or toxicity issues that we may experience in our clinical
trials in the future, we may not receive approval to market AQX-1125 or any future product candidates, which could prevent us from ever generating revenues or achieving profitability. Results of our trials could reveal an unacceptably high severity
and prevalence of side effects. In such an event, our trials could be suspended or terminated and the FDA or comparable foreign regulatory authorities could order us to cease further development of or deny approval of our product candidates for any
or all targeted indications. The drug-related side effects could affect patient recruitment or the ability of enrolled subjects to complete the trial or result in potential product liability claims. Any of these occurrences may have a material
adverse effect on our business, results of operations, financial condition and cash flows and future prospects. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Additionally, if AQX-1125
or any of our future product candidates receives marketing approval, and we or others later identify undesirable side effects caused by such product, a number of potentially significant negative consequences could result, including: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">we may be forced to suspend marketing of such product; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">regulatory authorities may withdraw their approvals of such product; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">regulatory authorities may require additional warnings on the label that could diminish the usage or otherwise limit the commercial success of such products; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the FDA or other regulatory bodies may issue safety alerts, Dear Healthcare Provider letters, press releases or other communications containing warnings about such product; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the FDA may require the establishment or modification of REMS or a comparable foreign regulatory authority may require the establishment or modification of a similar strategy that may, for instance, restrict
distribution of our products and impose burdensome implementation requirements on us; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">we may be required to change the way the product is administered or conduct additional clinical trials; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">we could be sued and held liable for harm caused to subjects or patients </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">we may be subject to litigation or product liability claims; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our reputation may suffer. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any of these events could prevent us from achieving or maintaining
market acceptance of the particular product candidate, if approved. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Even if AQX-1125 or our future product candidates receive regulatory approval,
they may still face future development and regulatory difficulties. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Even if we obtain regulatory approval for AQX-1125 or a future
product candidate, it would be subject to ongoing requirements by the FDA and comparable foreign regulatory authorities governing the manufacture, quality control, further development, labeling, packaging, storage, distribution, safety surveillance,
import, export, advertising, promotion, recordkeeping and reporting of safety and other post-market information. The safety profile of any product will continue to be closely monitored by the FDA and comparable foreign regulatory authorities after
approval. If the FDA or comparable foreign regulatory authorities become aware of new safety information after approval of AQX-1125 or any future product candidate, they may require labeling changes or establishment of a REMS or similar strategy,
impose significant restrictions on a product&#146;s indicated uses or marketing, or impose ongoing requirements for potentially costly post-approval studies or post-market surveillance. For example, the label ultimately approved for AQX-1125, if it
achieves marketing approval, may include restrictions on use. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, manufacturers of drug products and their facilities are
subject to continual review and periodic inspections by the FDA and other regulatory authorities for compliance with current good manufacturing practices, or cGMP, and other regulations. If we or a regulatory agency discover previously unknown
problems with a product, such as adverse events of unanticipated severity or frequency, or problems with the facility where the product is manufactured, a regulatory agency may impose restrictions on that product, the manufacturing facility or us,
including requiring recall or withdrawal of the product from the market or suspension of manufacturing. If we, our product candidates or the manufacturing facilities for our product candidates fail to comply with applicable regulatory requirements,
a regulatory agency may: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">issue warning letters or untitled letters; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">impose restrictions on the marketing or manufacturing of the product candidates; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">mandate modifications to promotional materials or require us to provide corrective information to healthcare practitioners; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">require us or any future collaborator to enter into a consent decree, which can include imposition of various fines, reimbursements for inspection costs, required due dates for specific actions and penalties for
noncompliance; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">seek an injunction or impose civil or criminal penalties or monetary fines; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">suspend or withdraw regulatory approval; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">suspend any ongoing clinical trials; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">refuse to approve pending applications or supplements to applications filed by us; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">suspend or impose restrictions on operations, including costly new manufacturing requirements; or </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">seize or detain products, refuse to permit the import or export of products, or require us to initiate a product recall. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The occurrence of any event or penalty described above may inhibit our ability to commercialize AQX-1125 or any future product candidates and
generate revenue. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The FDA strictly regulates the advertising and promotion of drug products, and drug products may only be marketed or
promoted for their FDA approved uses, consistent with the product&#146;s approved labeling. Advertising and promotion of any product candidate that obtains approval in the United States will be heavily scrutinized by the FDA, the Department of
Justice, or the DOJ, the Office of Inspector General of the Department of Health and Human Services, or HHS, state attorneys general, members of Congress and the public. Violations, including promotion of our products for unapproved or off-label
uses, are subject to enforcement letters, inquiries and investigations, and civil, criminal and/or administrative sanctions by the FDA. Additionally, advertising and promotion of, any product candidate that obtains approval outside of the United
States will be heavily scrutinized by comparable foreign regulatory authorities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the United States, engaging in impermissible
promotion of our future products for off-label uses can also subject us to false claims litigation under federal and state statutes, which can lead to civil, criminal and/or administrative penalties and fines and agreements that materially restrict
the manner in which we promote or distribute our drug products. These false claims statutes include the federal False Claims Act, which allows any individual to bring a lawsuit against a pharmaceutical company on behalf of the federal government
alleging submission of false or fraudulent claims, or causing to present such false or fraudulent claims, for payment by a federal program such as Medicare or Medicaid. If the government prevails in the lawsuit, the individual may share in any fines
or settlement funds. Since 2004, these False Claims Act lawsuits against pharmaceutical companies have increased significantly in volume and breadth, leading to several substantial civil and criminal settlements based on certain sales practices
promoting off-label drug uses. This growth in litigation has increased the risk that a pharmaceutical company will have to defend a false claim action, pay settlement fines or restitution, agree to comply with burdensome reporting and compliance
obligations, and be </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
excluded from the Medicare, Medicaid and other federal and state healthcare programs. If we do not lawfully promote our approved products, we may become subject to such litigation and, if we are
not successful in defending against such actions, those actions could have a material adverse effect our business, results of operations, financial condition and cash flows and future prospects. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Existing government regulations may change and additional government regulations may be enacted that could prevent, limit or delay regulatory
approval of AQX-1125 or any future product candidates. If we are slow or unable to adapt to changes in existing requirements or the adoption of new requirements or policies, or if we are not able to maintain regulatory compliance, we may lose any
marketing approval that we may have obtained and/or be subject to fines or enhanced government oversight and reporting obligations, which would adversely affect our business, prospects and ability to achieve or sustain profitability. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Failure to obtain regulatory approval in international jurisdictions would prevent AQX-1125 or any future product candidates from being marketed outside
the United States. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In order to market and sell our products in the European Union and many other jurisdictions, we must obtain
separate marketing approvals and comply with numerous and varying regulatory requirements. The approval procedure varies among countries and can involve additional testing. The time required to obtain approval may differ substantially from that
required to obtain FDA approval. The regulatory approval process outside the United States generally includes all of the risks associated with obtaining FDA approval. In addition, in many countries outside the United States, it is required that the
product be approved for reimbursement before the product can be approved for sale in that country. Obtaining foreign regulatory approvals and compliance with foreign regulatory requirements could result in significant delays, difficulties and costs
for us and could delay or prevent the introduction of our products in certain countries. We may not obtain approvals from regulatory authorities outside the United States on a timely basis, if at all. Approval by the FDA does not ensure approval by
regulatory authorities in other countries or jurisdictions, and approval by one regulatory authority outside the United States does not ensure approval by regulatory authorities in other countries or jurisdictions or by the FDA. A failure or delay
in obtaining regulatory approval in one country may have a negative effect on the regulatory approval process in others. We may not be able to file for marketing approvals and may not receive necessary approvals to commercialize our products in any
market. If we are unable to obtain approval of AQX-1125 or any of our future product candidates by regulatory authorities in the European Union or another jurisdiction, the commercial prospects of that product candidate may be significantly
diminished and our business prospects could decline. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Recently enacted and future legislation, including potentially unfavorable pricing regulations
or other healthcare reform initiatives, may increase the difficulty and cost for us to obtain marketing approval of and commercialize AQX-1125 or our future product candidates and affect the prices we may obtain. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The regulations that govern, among other things, marketing approvals, coverage, pricing and reimbursement for new drug products vary from
country to country. In the United States and some foreign jurisdictions, there have been a number of legislative and regulatory changes and proposed changes regarding the healthcare system that could prevent or delay marketing approval of AQX-1125
or our future product candidates, restrict or regulate post-approval activities and affect our ability to successfully sell any product candidates for which we obtain marketing approval. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the United States, the Medicare Prescription Drug, Improvement, and Modernization Act of 2003, or Medicare Modernization Act, changed the
way Medicare covers and pays for certain pharmaceutical products. The legislation expanded Medicare coverage for outpatient prescription drugs prescribed to the elderly and introduced a new reimbursement methodology based on average sales prices for
physician administered drugs. In addition, this legislation provided authority for limiting the number of outpatient prescription drugs that will be covered in any therapeutic class. In recent years, Congress has considered further reductions in
Medicare reimbursement for drugs administered by physicians. The Centers for Medicare&nbsp;&amp; Medicaid Services, the agency that administers the Medicare program, also has the authority to revise reimbursement rates and to implement coverage
restrictions for drugs. Cost reduction initiatives and changes in coverage implemented through legislation or regulation could decrease utilization of and reimbursement for any approved products, which in turn could affect the price we can receive
for those products. While the Medicare Modernization Act and Medicare regulations apply only to drug benefits for Medicare beneficiaries, private payors often follow Medicare coverage policy and payment limitations in establishing their own coverage
polices and reimbursement rates. Therefore, any reduction in reimbursement that results from federal legislation or regulation may result in a similar reduction in payments from private payors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In March 2010, President Obama signed into law the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation
Act of 2010, or the Affordable Care Act, in an effort to, among other things, broaden access to health insurance, reduce or constrain the growth of healthcare spending, enhance remedies against fraud and abuse, add new transparency requirements for
healthcare and health insurance industries, impose new taxes and fees on pharmaceutical and medical device manufacturers and impose additional health policy reforms. The Affordable Care Act, among other things, also expanded manufacturers&#146;
rebate liability to include covered drugs dispensed to individuals who are enrolled in Medicaid managed care organizations increased the minimum rebate due for innovator drugs from 15.1% of average manufacturer price, or AMP, to 23.1% of AMP and
capped the total rebate amount for innovator drugs at 100% of AMP. The Affordable Care Act and subsequent legislation also revised the definition of AMP for calculating and reporting Medicaid drug rebates on outpatient prescription drug prices. This
could increase the amount of Medicaid drug rebates to states. Furthermore, the Affordable Care Act imposes a significant annual, nondeductible fee on companies that manufacture or import certain branded prescription drug products. Substantial new
provisions </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
affecting compliance have also been enacted, which may affect our business practices with healthcare practitioners, and a significant number of provisions are not yet, or have only recently
become, effective. Although it is too early to determine the full effect of the Affordable Care Act, and any of its implementing regulations, the new law has the potential to: substantially change healthcare financing and delivery by both
governmental and private insurers; continue the pressure on pharmaceutical pricing, especially under the Medicare program; and increase our regulatory burdens and operating costs. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, other legislative changes have been proposed and adopted since the Affordable Care Act was enacted. More recently, on
August&nbsp;2, 2011, the President signed into law the Budget Control Act of 2011, which, among other things, created the Joint Select Committee on Deficit Reduction to recommend to Congress proposals in spending reductions. The Joint Select
Committee did not achieve a targeted deficit reduction of at least $1.2 trillion for the years 2013 through 2021, triggering the legislation&#146;s automatic reduction to several government programs. This includes aggregate reductions to Medicare
payments to providers of up to 2%&nbsp;per fiscal year that went into effect on April&nbsp;1, 2013. On January&nbsp;2, 2013, President Obama signed into law the American Taxpayer Relief Act of 2012, which, among other things, further reduced
Medicare payments to several providers and increased the statute of limitations period for the government to recover overpayments to providers from three to five years. These new laws may result in additional reductions in Medicare and other
healthcare funding, which could have a material adverse effect on our customers and accordingly, our financial operations. Legislative and regulatory proposals have been made to expand post-approval requirements and restrict sales and promotional
activities for pharmaceutical products. We cannot be sure whether additional legislative changes will be enacted, or whether existing regulations, guidance or interpretations will be changed, or what the impact of such changes on the marketing
approvals of AQX-1125 or our future product candidates, if any, may be. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the United States, the European Union and other potentially
significant markets for AQX-1125 and our future product candidates, government authorities and third-party payors are increasingly attempting to limit or regulate the price of medical products and services, particularly for new and innovative
products and therapies, which has resulted in lower average selling prices. Furthermore, the increased emphasis on managed healthcare in the United States and on country and regional coverage, pricing and reimbursement controls in the European Union
will put additional pressure on product coverage, pricing, reimbursement and utilization, which may adversely affect our business, results of operations, financial condition and cash flows and future prospects. These pressures can arise from various
sources, including but not limited to, rules and practices of managed care groups, judicial decisions and governmental laws and regulations related to Medicare, Medicaid and healthcare reform, pharmaceutical reimbursement policies and pricing in
general. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Some countries require approval of the sale price of a drug before it can be marketed. In many countries, the pricing review
period begins after marketing or product licensing approval is granted. In some foreign markets, prescription pharmaceutical pricing remains subject to continuing governmental control even after initial approval is granted. As a result, we might
obtain marketing approval for a product candidate in a particular country, but then be subject to price regulations that delay our commercial launch of the product, possibly for lengthy time periods, which could negatively impact the revenues we are
able to generate from the sale of the product in that particular country. Adverse pricing limitations may hinder our ability to recoup our investment in one or more product candidates even if our product candidates obtain marketing approval. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Laws and regulations governing international operations may preclude us from developing, manufacturing and selling certain product candidates outside of
the United States and Canada and require us to develop and implement costly compliance programs. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As we expand our operations
outside of the United States and Canada, we must comply with numerous laws and regulations in each jurisdiction in which we plan to operate. We must also comply with U.S. laws applicable to the foreign operations of U.S. businesses and individuals,
such as the Foreign Corrupt Practices Act, or FCPA, and Canadian laws applicable to the foreign operations of Canadian businesses and individuals, such as the Corruption of Foreign Public Officials Act, or CFPOA. The creation and implementation of
international business practices compliance programs is costly and such programs are difficult to enforce, particularly where reliance on third parties is required. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The FCPA prohibits any U.S. individual or business from paying, offering, authorizing payment or offering of anything of value, directly or
indirectly, to any foreign official, political party or candidate for the purpose of influencing any act or decision of the foreign entity in order to assist the individual or business in obtaining or retaining business. The FCPA also obligates
companies whose securities are listed in the United States to comply with certain accounting provisions requiring us to maintain books and records that accurately and fairly reflect all transactions of the corporation, including international
subsidiaries, and to devise and maintain an adequate system of internal accounting controls for international operations. The anti-bribery provisions of the FCPA are enforced primarily by the DOJ. The SEC is involved with enforcement of the books
and records provisions of the FCPA. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Compliance with the FCPA is expensive and difficult, particularly in countries in which corruption is
a recognized problem. In addition, the FCPA presents particular challenges in the pharmaceutical industry, because, in many countries, hospitals are operated by the government, and doctors and other hospital employees are considered foreign
officials. Certain payments to hospitals in connection with clinical studies and other work have been deemed to be improper payments to government officials and have led to FCPA enforcement actions. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Various laws, regulations and executive orders also restrict the use and dissemination outside of
the United States, or the sharing with certain non-U.S. nationals, of information classified for national security purposes, as well as certain products and technical data relating to those products. Our expanding presence outside of the United
States will require us to dedicate additional resources to comply with these laws, and these laws may preclude us from developing, manufacturing, or selling certain products and product candidates outside of the United States, which could limit our
growth potential and increase our development costs. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The failure to comply with laws governing international business practices may
result in substantial penalties, including suspension or debarment from government contracting. Violation of the FCPA can result in significant civil and criminal penalties. Indictment alone under the FCPA can lead to suspension of the right to do
business with the U.S. government until the pending claims are resolved. Conviction of a violation of the FCPA can result in long-term disqualification as a government contractor. The termination of a government contract or relationship as a result
of our failure to satisfy any of our obligations under laws governing international business practices would have a negative impact on our operations and harm our reputation and ability to procure government contracts. The SEC also may suspend or
bar issuers from trading securities on U.S. exchanges for violations of the FCPA&#146;s accounting provisions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The CFPOA prohibits
Canadian businesses and individuals from giving or offering to give a benefit of any kind to a foreign public official, or any other person for the benefit of the foreign public official, where the ultimate purpose is to obtain or retain a business
advantage. Furthermore, a company may be found liable for violations by not only its employees, but also by its third-party agents. Any failure to comply with the CFPOA, as well as applicable laws and regulations in foreign jurisdictions, could
result in substantial penalties or restrictions on our ability to conduct business in certain foreign jurisdictions, which may have a material adverse impact on us and our share price. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Even if we are able to commercialize AQX-1125 or our future product candidates, the products may not receive coverage and adequate reimbursement from
third-party payors, which could harm our business. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our ability to commercialize any products successfully will depend, in part, on
the extent to which coverage and adequate reimbursement for these products and related treatments will be available from government authorities, private health insurers, health maintenance organizations and third-party payors. Patients who are
prescribed medications for the treatment of their conditions generally rely on third-party payors to reimburse all or part of the costs associated with their prescription drugs. Coverage and adequate reimbursement from government healthcare
programs, such as Medicare and Medicaid, and private health insurers are critical to new product acceptance. Patients are unlikely to use AQX-1125 or our future product candidates unless coverage is provided and reimbursement is adequate to cover a
significant portion of the cost of our product candidates. A primary trend in the U.S. healthcare industry and elsewhere is cost containment. As a result, government authorities and other third-party payors have attempted to control costs by
limiting coverage and the amount of reimbursement for particular medications. Increasingly, third-party payors are requiring that drug companies provide them with predetermined discounts from list prices and are challenging the prices charged for
medical products. Third-party payors may also seek additional clinical evidence, beyond the data required to obtain marketing approval, demonstrating clinical benefits and value in specific patient populations before covering our products for those
patients. We cannot be sure that coverage and adequate reimbursement will be available for any product that we commercialize and, if reimbursement is available, what the level of reimbursement will be. Coverage and reimbursement may impact the
demand for, or the price of, any product candidate for which we obtain marketing approval. If coverage and reimbursement are not available or are available only at limited levels, we may not be able to successfully commercialize any product
candidate for which we obtain marketing approval. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">There may be significant delays in obtaining coverage and reimbursement for newly
approved drugs, and coverage may be more limited than the purposes for which the drug is approved by the FDA or comparable foreign regulatory authorities. Moreover, obtaining coverage does not imply that any drug will be paid for in all cases or at
a rate that covers our costs, including research, development, manufacture, sales and distribution. Interim reimbursement levels for new drugs, if applicable, may also not be sufficient to cover our costs and may only be temporary. Reimbursement
rates may vary according to the use of the drug and the clinical setting in which it is used. Reimbursement rates may also be based in part on existing reimbursement amounts for lower cost drugs or may be bundled into the payments for other
services. Net prices for drugs may be reduced by mandatory discounts or rebates required by government healthcare programs or private payors and by any future relaxation of laws that presently restrict imports of drugs from countries where they may
be sold at lower prices than in the United States. Coverage and reimbursement for drug products can differ significantly from payor to payor. As a result, the coverage and reimbursement determination process is often a time-consuming and costly
process with no assurance that coverage and adequate reimbursement will be obtained or applied consistently. Third-party payors often rely upon Medicare coverage policy and payment limitations in setting their own coverage and reimbursement
policies. Our inability to promptly obtain coverage and profitable reimbursement rates from both government-funded and private payors for any approved products that we develop could have a material adverse effect on our operating results, our
ability to raise capital needed to commercialize products and our overall financial condition. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We have never marketed a drug before, and if we are unable to establish an effective sales force and
marketing infrastructure, or enter into acceptable third-party sales and marketing or licensing arrangements, we may be unable to generate any revenue. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We do not currently have an infrastructure for the sales, marketing and distribution of pharmaceutical drug products and the cost of
establishing and maintaining such an infrastructure may exceed the cost-effectiveness of doing so. In order to market any products that may be approved by the FDA and comparable foreign regulatory authorities, we must build our sales, marketing,
managerial and other non-technical capabilities or make arrangements with third parties to perform these services. If we are unable to establish adequate sales, marketing and distribution capabilities, whether independently or with third parties, we
may not be able to generate product revenue and may not become profitable. We will be competing with many companies that currently have extensive and well-funded sales and marketing operations. Without an internal commercial organization or the
support of a third party to perform sales and marketing functions, we may be unable to compete successfully against these more established companies. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>AQX-1125 and our future product candidates, if approved, may not achieve adequate market acceptance among physicians, patients, and healthcare payors
and others in the medical community necessary for commercial success. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Even if we obtain regulatory approval for AQX-1125 or any of
our product candidates that we may develop or acquire in the future, the product may not gain market acceptance among physicians, healthcare payors, patients or the medical community. Our commercial success also depends on coverage and adequate
reimbursement of our product candidates by third-party payors, including government payors, generally, which may be difficult or time-consuming to obtain, may be limited in scope and may not be obtained in all jurisdictions in which we may seek to
market our products. Market acceptance of any of our product candidates for which we receive approval depends on a number of factors, including: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the efficacy and safety of such product candidates as demonstrated in clinical trials; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the clinical indications for which the product candidate is approved; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">acceptance by physicians and patients of the product candidate as a safe and effective treatment; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the potential and perceived advantages of product candidates over alternative treatments; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the safety of product candidates seen in a broader patient group, including a product candidate&#146;s use outside the approved indications; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the prevalence and severity of any side effects; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">product labeling or product insert requirements of the FDA or other regulatory authorities; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the timing of market introduction of our products as well as competitive products; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the cost of treatment in relation to alternative treatments; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the availability of coverage and adequate reimbursement and pricing by third-party payors and government authorities; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">relative convenience and ease of administration; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the effectiveness of our sales and marketing efforts and those of our collaborators; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">unfavorable publicity relating to the product candidate. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If any of our product candidates are
approved but fail to achieve market acceptance among physicians, patients, or healthcare payors, we will not be able to generate significant revenues, which would compromise our ability to become profitable. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our relationships with healthcare professionals, principal investigators, consultants, customers (actual and potential) and third-party payors are and
will be subject, directly and indirectly, to applicable anti-kickback, fraud and abuse, privacy, transparency and other healthcare laws and regulations, which could expose us to penalties, including without limitation, civil, criminal and
administrative sanctions, civil penalties, damages, fines, disgorgement, possible exclusion from participation in Medicare, Medicaid and other federal healthcare programs, contractual damages, reputational harm, administrative burdens and diminished
profits and future earnings and the curtailment or restructuring of our operations. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As a pharmaceutical company, even though we do
not and will not control referrals of healthcare services or bill directly to Medicare, Medicaid or other third-party payors, federal and state healthcare laws and regulations pertaining to fraud and abuse and patients&#146; rights are and will be
applicable to our future arrangements with third-party payors and customers who are in a position to purchase, recommend and/or prescribe our product candidates for which we obtain marketing approval. These broadly applicable fraud and abuse and
other healthcare laws and regulations may constrain our future business or financial arrangements and relationships with healthcare professionals, principal investigators, consultants, customers, and third-party payors and other entities, including
our marketing practices, educational programs and pricing policies. Restrictions under applicable federal and state healthcare laws and regulations that may affect our ability to operate include, but are not limited to, the following: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the federal Anti-Kickback Statute, among other things, prohibits persons from knowingly and willfully soliciting, offering, receiving or providing paying any remuneration (including any kickback, bribe, or rebate),
directly or indirectly, overtly or covertly, in cash or in kind, to induce or reward, or in return for, either the referral of an individual for, or the purchase, lease, order or recommendation of, any good, facility, item or service, for which
payment may be made, in whole or in part, under a federal healthcare program such as Medicare and Medicaid; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">federal civil and criminal false claims laws and civil monetary penalty laws impose criminal and civil penalties, including through civil whistleblower or qui tam actions, among other things, prohibits individuals or
entities from knowingly presenting, or causing to be presented, to the federal government, including the Medicare and Medicaid programs, claims for payment or approval that are false or fraudulent or from knowingly making a false statement to
improperly avoid, decrease or conceal an obligation to pay money to the federal government; </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the federal Health Insurance Portability and Accountability Act of 1996, or HIPAA, among other things, imposes criminal liability for knowingly and willfully executing, or attempting to execute, a scheme to defraud any
healthcare benefit program or to obtain, by means of false or fraudulent pretenses, representations, or promises, any of the money or property owned by, or under the custody or control of, any healthcare benefit program, regardless of the payor
(e.g. public or private) and knowingly and willfully falsifying, concealing or covering up by any trick or device a material fact or making any materially false statements in connection with the delivery of or payment for healthcare benefits, items
or services relating to healthcare matters; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">HIPAA, as amended by the Health Information Technology for Economic and Clinical Health Act, and its implementing regulations, also imposes certain obligations, including mandatory contractual terms, with respect to
safeguarding the privacy, security and transmission of individually identifiable health information without the appropriate authorization by entities subject to the law, such as health plans, healthcare clearinghouses and healthcare providers;
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the federal Physician Payment Sunshine Act, created under Section&nbsp;6002 of the Affordable Care Act and its implementing regulations, requires manufacturers of drugs, devices, biologics and medical supplies for which
payment is available under Medicare, Medicaid or the Children&#146;s Health Insurance Program (with certain exceptions) to report annually to the Centers for Medicare&nbsp;&amp; Medicaid Services, or CMS, information related to &#147;payments or
other transfers of value&#148; made to physicians (defined to include doctors, dentists, optometrists, podiatrists and chiropractors) and teaching hospitals, and applicable manufacturers and applicable group purchasing organizations to report
annually to CMS ownership and investment interests held by physicians (as defined above) and their immediate family members and payments or other &#147;transfers of value&#148; to such physician owners and their immediate family members; and
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">analogous state and foreign laws and regulations, including: state anti-kickback and false claims laws which may apply to our business practices, including, but not limited to, research, distribution, sales and
marketing arrangements and claims involving healthcare items or services reimbursed by state governmental and non-governmental third-party payors, including private insurers; state laws that require pharmaceutical companies to comply with the
pharmaceutical industry&#146;s voluntary compliance guidelines and the applicable compliance guidance promulgated by the federal government; state laws that require drug manufacturers to track gifts and other remuneration and items of value provided
to healthcare professionals and entities and file reports relating to pricing and marketing information; and state and foreign laws govern the privacy and security of health information in specified circumstances, many of which differ from each
other in significant ways and often are not preempted by HIPAA, thus complicating compliance efforts. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Efforts to ensure
that our business arrangements with third parties will comply with applicable healthcare laws and regulations will involve substantial costs. Recent healthcare reform legislation has also strengthened these laws. For example, the Affordable Care
Act, among other things, amends the intent requirement of the federal anti-kickback statute. A person or entity no longer needs to have actual knowledge of this statute or specific intent to violate it in order to have committed a violation. In
addition, the Affordable Care Act codified case law that a claim that includes items or services resulting from a violation of the federal anti-kickback statute constitutes a false or fraudulent claim for purposes of the False Claims Act. It is
possible that governmental authorities will conclude that our business practices may not comply with current or future statutes, regulations, agency guidance, or case law involving applicable fraud and abuse or other healthcare laws and regulations.
If our operations are found to be in violation of any of these laws or any other governmental regulations that may apply to us, we may be subject to penalties, including without limitation, significant civil, criminal and administrative penalties,
damages, fines, disgorgement, exclusion from government funded healthcare programs, such as Medicare and Medicaid, contractual damages, reputational harm, administrative burdens and diminished profits and future earnings, and the curtailment or
restructuring of our operations. If any physicians or other healthcare providers or entities with whom we expect to do business are found to not be in compliance with applicable laws, they may be subject to criminal, civil or administrative
sanctions, including exclusions from government funded healthcare programs. Moreover, we expect there will continue to be federal and state laws and regulations, proposed and implemented, that could impact our operations and business. The extent to
which future legislation or regulations, if any, relating to healthcare fraud abuse laws or enforcement, may be enacted or what effect such legislation or regulation would have on our business remains uncertain. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We may form strategic alliances in the future, and we may not realize the benefits of such alliances. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may form strategic alliances, create joint ventures or collaborations or enter into licensing arrangements with third parties that we
believe will complement or augment our existing business. These relationships or those like them may require us to incur non-recurring and other charges, increase our near- and long-term expenditures, issue securities that dilute our existing
stockholders or disrupt our management and business. In addition, we face significant competition in seeking appropriate strategic partners and the negotiation process is time-consuming and complex. Moreover, we may not be successful in our efforts
to establish a strategic partnership or other alternative arrangements for AQX-1125 or any future drug candidates and programs because our research and development pipeline may be insufficient, our drug candidates and programs may be deemed to be at
too early of a stage of development for collaborative effort and third parties may not view our drug candidates and programs as having the requisite potential to demonstrate safety and efficacy. If we license products or businesses, we may not be
able to realize the benefit of such transactions if we are unable to successfully integrate them with our existing operations and company culture. We cannot be certain that, following a strategic transaction or license, we will achieve the revenues
or specific net income that justifies such transaction. Any delays in entering into new strategic partnership agreements related to our drug candidates could also delay the development and commercialization of our drug candidates and reduce their
competitiveness even if they reach the market. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our employees may engage in misconduct or other improper activities, including noncompliance with
regulatory standards and requirements, which could cause significant liability for us and harm our reputation. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are exposed to
the risk of employee fraud or other misconduct, including intentional failures to comply with FDA regulations or similar regulations of comparable foreign regulatory authorities, provide accurate information to the FDA or comparable foreign
regulatory authorities, comply with manufacturing standards we have established, comply with federal and state healthcare fraud and abuse laws and regulations and similar laws and regulations established and enforced by comparable foreign regulatory
authorities, report financial information or data accurately or disclose unauthorized activities to us. Employee misconduct could also involve the improper use of information obtained in the course of clinical trials, which could result in
regulatory sanctions and serious harm to our reputation. We have adopted a code of conduct for our directors, officers and employees, or the Code of Business Conduct and Ethics, but it is not always possible to identify and deter employee
misconduct, and the precautions we take to detect and prevent this activity may not be effective in controlling unknown or unmanaged risks or losses or in protecting us from governmental investigations or other actions or lawsuits stemming from a
failure to be in compliance with such laws or regulations. If any such actions are instituted against us, and we are not successful in defending ourselves or asserting our rights, those actions could have a significant impact on our business,
results of operations, financial condition and cash flows from future prospects, including the imposition of significant fines or other sanctions. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We face substantial competition, which may result in others discovering, developing or commercializing products before or more successfully than we do.
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The development and commercialization of new drug products is highly competitive. We face competition with respect to our current
product candidate, AQX-1125, and will face competition with respect to any future product candidates that we may seek to develop or commercialize in the future, from major pharmaceutical companies, specialty pharmaceutical companies and
biotechnology companies worldwide. There are a number of large pharmaceutical and biotechnology companies that currently market and sell products or are pursuing the development of products for the treatment of the disease indications for which we
are developing our future product candidates. Some of these competitive products and therapies are based on scientific approaches that are the same as or similar to our approach, and others are based on entirely different approaches. Potential
competitors also include academic institutions, government agencies and other public and private research organizations that conduct research, seek patent protection and establish collaborative arrangements for research, development, manufacturing
and commercialization. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">More established companies may have a competitive advantage over us due to their greater size, cash flows and
institutional experience. Compared to us, many of our competitors may have significantly greater financial, technical and human resources. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As a result of these factors, our competitors may obtain regulatory approval of their products before we do, which will limit our ability to
develop or commercialize AQX-1125 or any of our future product candidates. Although there are no approved therapies that specifically target SHIP1, there are currently approved therapies for treating the same diseases or indications for which our
product candidates may be useful. In addition, many companies are developing new therapeutics, and we cannot predict what the standard of care will be as our product candidates progress through clinical development. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If AQX-1125, our current product candidate, were approved as treatment of COPD, it could face competition from currently approved and marketed
products, including GlaxoSmithKline (fluticasone/salmeterol&#151;LABA/ICS combination (Advair) and umeclidinium, vilanterol&#151;LAMA (Anoro)), GlaxoSmithKline/Theravance ( LABA/ICS combination fluticasone/vilanterol (Breo Ellipta), Boehringer
Ingelheim/Pfizer (tiotropium&#151;LAMA (Spiriva)), Boehringer Ingelheim (olodaterol&#151;LABA), AstraZeneca (formoterol/budesonide&#151;LABA/ICS (Symbicort)), Almirall SA (AMA aclidinium (Tudorza Pressair), and Novartis AG (LABA indacterol (Onbrez
Breezhaler) and glycopyrrolate/indacaterol&#151;LABA/LAMA (Ultibro Breezhaler)) and Takeda Pharmaceuticals International GmbH (Phosphodiesterase-4 (PDE4) inhibitor, Roflumilast). If AQX-1125, our current product candidate, were approved for the
treatment of BPS/IC, it could face competition from currently approved and marketed products, including Janssen Pharmaceuticals Inc.&#146;s pentosan polysulfate sodium, marketed in the United States as Elmiron, which is now generic. Also, we believe
that Gilead Sciences, Inc., Amgen Inc., and TG Therapeutics, Inc. are developing drugs that target the delta and/or gamma isoforms of PI3K. In addition, many companies are developing product candidates directed to disease targets in the fields of
COPD and BPS/IC, including in the specific diseases for which we are currently developing AQX-1125, or for which we may develop AQX-1125 or other SHIP1 activators in the future. Such companies include Pfizer, AbbVie, Urigen, TARIS, and Afferent.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We believe that our ability to successfully compete will depend on, among other things: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the efficacy and safety profile of AQX-1125, including relative to marketed products and product candidates in development by third parties; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the time it takes for AQX-1125 or any of our future product candidates to complete clinical development and receive marketing approval; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the ability to commercialize AQX-1125 and future product candidates that receive regulatory approval; </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">whether coverage and adequate levels of reimbursement are available under private and governmental health insurance plans, including Medicare; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the ability to establish, maintain and protect intellectual property rights related to our product candidates; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the ability to manufacture commercial quantities of AQX-1125 and future product candidates that receive regulatory approval; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">acceptance of AQX-1125 and future product candidates that receive regulatory approval by physicians and other healthcare providers. </TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our failure to successfully identify, acquire, develop and commercialize additional product candidates or approved products other than AQX-1125 could
impair our ability to grow. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Although a substantial amount of our efforts will focus on the continued clinical testing and
potential approval of our most advanced product candidate, AQX-1125, a key element of our growth strategy is to acquire, develop and/or market additional products and product candidates. All of our other potential product candidates remain in the
discovery and preclinical study stages. Research programs to identify product candidates require substantial technical, financial and human resources, whether or not any product candidates are ultimately identified. Because our internal research
capabilities are limited, we may be dependent upon pharmaceutical and biotechnology companies, academic scientists and other researchers to sell or license products or technology to us. The success of this strategy depends partly upon our ability to
identify, select and acquire promising pharmaceutical product candidates and products. The process of proposing, negotiating and implementing a license or acquisition of a product candidate or approved product is lengthy and complex. Other
companies, including some with substantially greater financial, marketing and sales resources, may compete with us for the license or acquisition of product candidates and approved products. We have limited resources to identify and execute the
acquisition or in-licensing of third-party products, businesses and technologies and integrate them into our current infrastructure. Moreover, we may devote resources to potential acquisitions or in-licensing opportunities that are never completed,
or we may fail to realize the anticipated benefits of such efforts. Any product candidate that we acquire may require additional development efforts prior to commercial sale, including extensive clinical testing and approval by the FDA and
applicable foreign regulatory authorities. All product candidates are prone to risks of failure typical of pharmaceutical product development, including the possibility that a product candidate will not be shown to be sufficiently safe and effective
for approval by regulatory authorities. In addition, we cannot provide assurance that any products that we develop or approved products that we acquire will be manufactured profitably or achieve market acceptance. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Product liability lawsuits against us could cause us to incur substantial liabilities and to limit commercialization of any products that we may
develop. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We face an inherent risk of product liability exposure related to the testing of AQX-1125 and any future product
candidates in human clinical trials and will face an even greater risk if we commercially sell any products that we may develop. Product liability claims may be brought against us by subjects enrolled in our clinical trials, patients, healthcare
providers or others using, administering or selling our products. If we cannot successfully defend ourselves against claims that our product candidates or products caused injuries, we could incur substantial liabilities. Regardless of merit or
eventual outcome, liability claims may result in: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">decreased demand for any product candidates or products that we may develop; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">termination of clinical trial sites or entire trial programs; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">injury to our reputation and significant negative media attention; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">withdrawal of clinical trial participants; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">significant costs to defend the related litigation; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">substantial monetary awards to trial subjects or patients; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">loss of revenue; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">diversion of management and scientific resources from our business operations; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the inability to commercialize our product candidates. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We currently have obtained product
liability insurance coverage, which is limited to $5 million per occurrence and $5 million in the aggregate. This coverage may not be adequate to cover all liabilities that we may incur. Insurance coverage is becoming increasingly expensive and in
the future we may not be able to maintain insurance coverage at a reasonable cost or in an amount adequate to satisfy any liability that may arise. We intend to expand our insurance coverage for products to include the sale of commercial products if
we obtain marketing approval for AQX-1125 or our future product candidates, but we may be unable to obtain commercially reasonable product liability insurance for any products approved for marketing. Large judgments have been awarded in class action
lawsuits based on drugs that had unanticipated side effects. A successful product liability claim or series of claims brought against us, particularly if judgments exceed our insurance coverage, could decrease our cash and adversely affect our
business. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We will need to expand our operations and grow the size of our organization, and we may experience
difficulties in managing this growth. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of March&nbsp;31, 2014, we had 14 employees. As our development and commercialization
plans and strategies develop, or as a result of any future acquisitions, we will need additional managerial, operational, sales, marketing, scientific, and financial headcount and other resources. Our management, personnel and systems currently in
place may not be adequate to support this future growth. Future growth would impose significant added responsibilities on members of management, including: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">managing our clinical trials effectively, which we anticipate being conducted at numerous clinical sites; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">identifying, recruiting, maintaining, motivating and integrating additional employees with the expertise and experience we will require; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">managing our internal development efforts effectively while complying with our contractual obligations to licensors, licensees, contractors and other third parties; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">manage additional relationships with various strategic partners, suppliers and other third parties; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">improving our managerial, development, operational and finance reporting systems and procedures; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">expanding our facilities. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our failure to accomplish any of these tasks could prevent us from
successfully growing our company. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our future success depends on our ability to attract, retain and motivate qualified personnel. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may not be able to attract or retain qualified managerial, operational, sales, marketing, scientific and financial personnel in the future
due to the intense competition for qualified personnel among biotechnology, pharmaceutical and other businesses. If we are not able to attract and retain necessary personnel to accomplish our business objectives, we may experience constraints that
will significantly impede the achievement of our development objectives, our ability to raise additional capital and our ability to implement our business strategy. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our industry has experienced a high rate of turnover of management personnel in recent years. We are highly dependent on the development,
regulatory, commercialization and business development expertise of our executive officers. If we lose one or more of our executive officers or key employees, particularly our President, Chief Executive Officer and Chairman of the Board, David Main,
our Vice President, Technical Operations and Planning, Lloyd Mackenzie, our Chief Financial Officer and Vice President, Finance, Kamran Alam, or our Chief Medical Officer and Senior Vice President, Clinical Development, Stephen Shrewsbury, M.B.,
ChB., our ability to implement our business strategy successfully could be seriously harmed. Replacing executive officers and key employees may be difficult and may take an extended period of time because of the limited number of individuals in our
industry with the breadth of skills and experience required to develop, gain regulatory approval of and commercialize products successfully. Competition to hire from this limited pool is intense, and we may be unable to hire, train, retain or
motivate these additional key personnel. Many of the other pharmaceutical companies that we compete against for qualified personnel have greater financial and other resources, different risk profiles and a longer history in the industry than we do.
They also may provide more diverse opportunities and better chances for career advancement. Some of these characteristics may be more appealing to high-quality candidates than what we have to offer. Further, we do not maintain &#147;key person&#148;
insurance for any of our executives or other employees. Our failure to retain key personnel could impede the achievement of our research, development and commercialization objectives. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We may engage in future acquisitions that could disrupt our business, cause dilution to our stockholders and harm our business, results of operations,
financial condition and cash flows and future prospects. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">While we currently have no specific plans to acquire any other
businesses, we may, in the future, make acquisitions of, or investments in, companies that we believe have products or capabilities that are a strategic or commercial fit with AQX-1125 or our future product candidates and business or otherwise offer
opportunities for our company. In connection with these acquisitions or investments, we may: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">issue stock that would dilute our existing stockholders&#146; percentage of ownership; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">incur debt and assume liabilities; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">incur amortization expenses related to intangible assets or incur large and immediate write-offs. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may not be able to complete acquisitions on favorable terms, if at all. If we do complete an acquisition, we cannot assure you that it will
ultimately strengthen our competitive position or that it will be viewed positively by customers, financial markets or investors. Furthermore, future acquisitions could pose numerous additional risks to our operations, including: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">problems integrating the purchased business, products or technologies; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">increases to our expenses; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the failure to discover undisclosed liabilities of the acquired asset or company; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">diversion of management&#146;s attention from their day-to-day responsibilities; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">harm to our operating results or financial condition; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">entrance into markets in which we have limited or no prior experience; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">potential loss of key employees, particularly those of the acquired entity. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may not be
able to complete any acquisitions or effectively integrate the operations, products or personnel gained through any such acquisition. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our business and operations would suffer in the event of computer system failures. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Despite the implementation of security measures, our internal computer systems, and those of our CROs and other third parties on which we rely,
are vulnerable to damage from computer viruses, unauthorized access, natural disasters, fire, terrorism, war and telecommunication and electrical failures. If such an event were to occur and cause interruptions in our operations, it could result in
a material disruption of our drug development programs. For example, the loss of clinical trial data from completed, ongoing or planned clinical trials could result in delays in our regulatory approval efforts and significantly increase our costs to
recover or reproduce the data. To the extent that any disruption or security breach results in a loss of or damage to our data or applications, or inappropriate disclosure of confidential or proprietary information, we could incur liability and the
further development of AQX-1125 or our future product candidates could be delayed. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>If we fail to comply with environmental, health and safety laws
and regulations, we could become subject to fines or penalties or incur costs that could have a material adverse effect on the success of our business. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are subject to numerous environmental, health and safety laws and regulations in the United States and Canada, including, as a result of our
subleased laboratory space, those governing laboratory procedures and the handling, use, storage, treatment and disposal of hazardous materials and wastes. Our operations involve the use of hazardous and flammable materials, including chemicals and
biological materials. Our operations also produce hazardous waste products. We generally contract with third parties for the disposal of these materials and wastes. We cannot eliminate the risk of contamination or injury from these materials. In the
event of contamination or injury resulting from our use of hazardous materials, we could be held liable for any resulting damages, and any liability could exceed our resources. We also could incur significant costs associated with civil or criminal
fines and penalties. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Although we maintain workers&#146; compensation insurance to cover us for costs and expenses we may incur due to
injuries to our employees resulting from the use of hazardous materials, this insurance may not provide adequate coverage against potential liabilities. We do not maintain insurance for environmental liability or toxic tort claims that may be
asserted against us in connection with our storage or disposal of biological or hazardous materials. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, we may incur
substantial costs in order to comply with current or future environmental, health and safety laws and regulations. These current or future laws and regulations may impair our research, development or production efforts. Failure to comply with these
laws and regulations also may result in substantial fines, penalties or other sanctions. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Business disruptions could seriously harm our future
revenues and financial condition and increase our costs and expenses. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our operations could be subject to earthquakes, power
shortages, telecommunications failures, water shortages, floods, hurricanes, typhoons, fires, extreme weather conditions, medical epidemics and other natural or manmade disasters or business interruptions, for which we are predominantly
self-insured. We do not carry insurance for all categories of risk that our business may encounter. The occurrence of any of these business disruptions could seriously harm our operations and financial condition and increase our costs and expenses.
We rely on third-party manufacturers to produce our product candidates. Our ability to obtain clinical supplies of product candidates could be disrupted, if the operations of these suppliers are affected by a man-made or natural disaster or other
business interruption. The ultimate impact on us, our significant suppliers and our general infrastructure of being consolidated in certain geographical areas is unknown, but our operations and financial condition could suffer in the event of a
major earthquake, fire or other natural disaster. Further, any significant uninsured liability may require us to pay substantial amounts, which would adversely affect our business, results of operations, financial condition and cash flows from
future prospects. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risks Related to Our Dependence on Third Parties </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We rely on third parties to conduct our preclinical studies and clinical trials. If these third parties do not successfully carry out their contractual
duties or meet expected deadlines, this could substantially harm our business because we may not be able to obtain regulatory approval for or commercialize AQX-1125 or our future product candidates in a timely manner or at all. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have extensively relied upon and plan to continue to extensively rely upon third-party CROs to monitor and manage data for our ongoing
preclinical and clinical programs. We rely on these parties for execution of our preclinical studies and clinical trials, and we control only some aspects of their activities. Nevertheless, we are responsible for ensuring that each of our studies is
conducted in accordance with the applicable protocol and legal, regulatory and scientific standards, and our reliance on the CROs does not relieve us of our regulatory responsibilities. We also rely on third parties to assist in conducting our
preclinical studies in accordance with Good Laboratory Practices, or GLP, and the Animal Welfare Act requirements. We and our CROs are required to comply with federal regulations and current Good Clinical Practices, or GCP, which are international
standards meant to protect the rights and health of patients that are enforced by the FDA, the Competent Authorities of the Member States of the European Economic Area, or EEA, and comparable foreign regulatory authorities for all of our products in
clinical development. Regulatory authorities enforce GCP through periodic inspections of trial sponsors, principal investigators and trial sites. If we or any of our CROs fail to comply with applicable GCP, the clinical data generated in our
clinical trials may be deemed unreliable and the FDA or comparable foreign regulatory authorities may require us to perform additional clinical trials before approving our marketing applications. We cannot assure you that upon inspection by a given
regulatory authority, such regulatory authority will determine that any of our clinical trials comply with GCP requirements. In addition, our clinical trials must be conducted with product produced under cGMP requirements. Failure to comply with
these regulations may require us to repeat preclinical studies and clinical trials, which would delay the regulatory approval process. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our CROs are not our employees, and except for remedies available to us under our agreements with
such CROs, we cannot control whether or not they devote sufficient time and resources to our ongoing clinical, nonclinical and preclinical programs. If CROs do not successfully carry out their contractual duties or obligations or meet expected
deadlines or if the quality or accuracy of the clinical data they obtain is compromised due to the failure to adhere to our clinical protocols, regulatory requirements or for other reasons, our clinical trials may be extended, delayed or terminated
and we may not be able to obtain regulatory approval for or successfully commercialize AQX-1125 or our future product candidates. As a result, our results of operations and the commercial prospects for our product candidates would be harmed, our
costs could increase and our ability to generate revenues could be delayed. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Because we have relied on third parties, our internal
capacity to perform these functions is limited. Outsourcing these functions involves risk that third parties may not perform to our standards, may not produce results in a timely manner or may fail to perform at all. In addition, the use of
third-party service providers requires us to disclose our proprietary information to these parties, which could increase the risk that this information will be misappropriated. We currently have a small number of employees, which limits the internal
resources we have available to identify and monitor our third-party providers. To the extent we are unable to identify and successfully manage the performance of third-party service providers in the future, our business may be adversely affected.
Though we carefully manage our relationships with our CROs, there can be no assurance that we will not encounter challenges or delays in the future or that these delays or challenges will not have a material adverse impact on our business, results
of operations, financial condition and cash flows and future prospects. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>If we lose our relationships with CROs, our drug development efforts could
be delayed. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We rely on third-party vendors and CROs for preclinical studies and clinical trials related to our drug development
efforts. Switching or adding additional CROs would involve additional cost and requires management time and focus. Our CROs have the right to terminate their agreements with us in the event of an uncured material breach. In addition, some of our
CROs have an ability to terminate their respective agreements with us if it can be reasonably demonstrated that the safety of the subjects participating in our clinical trials warrants such termination, if we make a general assignment for the
benefit of our creditors or if we are liquidated. If any of our relationships with our third-party CROs terminate, we could experience a significant delay in identifying, qualifying and managing performance of a comparable third-party service
provider, which could adversely affect our development programs. In addition, there is a natural transition period when a new CRO commences work and the new CRO may not provide the same type or level of services as the original provider. We may not
be able to enter into arrangements with alternative CROs or to do so on commercially reasonable terms. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We have no experience manufacturing our
product candidates on a large clinical or commercial scale and have no manufacturing facility. As a result, we are dependent on third-party manufacturers for the manufacture of our most advanced product candidate as well as on third parties for our
supply chain, and if we experience problems with any third parties, the manufacturing of our product candidates or products could be delayed. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We do not own or operate facilities for the manufacture of our product candidates. We currently have no plans to build our own clinical or
commercial scale manufacturing capabilities. We currently rely on a single source contract manufacturing organization, or CMO, for the chemical manufacture of active pharmaceutical ingredient for AQX-1125, and another CMO for the production of
AQX-1125 final product formulation in a gelatin capsule and packaging for Phase&nbsp;2 clinical trials. To meet our projected needs for clinical supplies to support our activities through regulatory approval and commercial manufacturing, the CMOs
with whom we currently work will need to increase the scale of production. We may need to identify additional CMOs for continued production of supply for our product candidates. We have not yet identified alternate suppliers in the event the current
CMOs we utilize are unable to scale production, or if we otherwise experience any problems with them. Although alternative third-party suppliers with the necessary manufacturing and regulatory expertise and facilities exist, it could be expensive
and take a significant amount of time to arrange for alternative suppliers. We may encounter technical difficulties or delays in the transfer of AQX-1125 manufacturing on a commercial scale to additional third-party manufacturers. We may be unable
to enter into agreements for commercial supply with third party manufacturers, or may be unable to do so on acceptable terms. If we are unable to arrange for alternative third-party manufacturing sources, or to do so on commercially reasonable terms
or in a timely manner, we may not be able to complete development of our product candidates, or market or distribute them. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Reliance on
third-party manufacturers entails risks to which we would not be subject if we manufactured product candidates or products ourselves, including reliance on the third party for regulatory compliance and quality assurance, the possibility of breach of
the manufacturing agreement by the third party because of factors beyond our control, including a failure to synthesize and manufacture our product candidates or any products we may eventually commercialize in accordance with our specifications, and
the possibility of termination or nonrenewal of the agreement by the third party, based on its own business priorities, at a time that is costly or damaging to us. In addition, the FDA and other regulatory authorities require that our product
candidates and any products that we may eventually commercialize be manufactured according to cGMP and similar foreign standards. Any failure by our third-party manufacturers to comply with cGMP or failure to scale up manufacturing processes,
including any failure to deliver sufficient quantities of product candidates in a timely manner, could lead to a delay in, or failure to obtain, regulatory approval of any of our </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
product candidates and could cause us to incur higher costs and prevent us from commercializing our product candidates successfully. In addition, such failure could be the basis for the FDA to
issue a warning letter, withdraw approvals for product candidates previously granted to us, or take other regulatory or legal action, including recall or seizure of outside supplies of the product candidate, total or partial suspension of
production, suspension of ongoing clinical trials, refusal to approve pending applications or supplemental applications, detention or product, refusal to permit the import or export of products, injunction, or imposing civil and criminal penalties.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any significant disruption in our supplier relationships could harm our business. Any significant delay in the supply of a product
candidate or its key materials for an ongoing clinical study could considerably delay completion of our clinical trials, product testing and potential regulatory approval of our product candidates. If our manufacturers or we are unable to purchase
these key materials after regulatory approval has been obtained for our product candidates, the commercial launch of our product candidates would be delayed or there would be a shortage in supply, which would impair our ability to generate revenues
from the sale of our product candidates. It may take several years to establish an alternative source of supply for our product candidates and to have any such new source approved by the FDA. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risks Related to Intellectual Property </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>If we are
unable to obtain or protect intellectual property rights, our competitive position could be harmed. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We depend on our ability to
protect our proprietary technology. We rely on trade secret, patent, copyright and trademark laws, and confidentiality, licensing and other agreements with employees and third parties, all of which offer only limited protection. Our commercial
success will depend in large part on our ability to obtain and maintain patent protection in the United States and other countries with respect to our proprietary technology and products. Where we have the right to do so under our license
agreements, we seek to protect our proprietary position by filing patent applications in the United States and abroad related to our novel technologies and products that are important to our business. The patent positions of biotechnology and
pharmaceutical companies generally are highly uncertain, involve complex legal and factual questions and have in recent years been the subject of much litigation. As a result, the issuance, scope, validity, enforceability and commercial value of our
patents, including those patent rights licensed to us by third parties, are highly uncertain. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The steps we have taken to protect our
proprietary rights may not be adequate to preclude misappropriation of our proprietary information or infringement of our intellectual property rights, both inside and outside the United States. The rights already granted under any of our currently
issued patents and those that may be granted under future issued patents may not provide us with the proprietary protection or competitive advantages we are seeking. If we are unable to obtain and maintain patent protection for our technology and
products, or if the scope of the patent protection obtained is not sufficient, our competitors could develop and commercialize technology and products similar or superior to ours, and our ability to successfully commercialize our technology and
products may be adversely affected. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">With respect to patent rights, we do not know whether any of the pending patent applications for any
of our discovered or licensed compounds will result in the issuance of patents that protect our technology or products, or if any of our issued patents will effectively prevent others from commercializing competitive technologies and products. Our
pending applications cannot be enforced against third parties practicing the technology claimed in such applications unless and until a patent issues from such applications. Further, the examination process may require us or our future potential
licensor(s) to narrow the claims for our pending patent applications, which may limit the scope of patent protection that may be obtained if these applications issue. Because the issuance of a patent is not conclusive as to its inventorship, scope,
validity or enforceability, issued patents that we own or have licensed from third parties may be challenged in the courts or patent offices in the United States and abroad. Such challenges may result in the loss of patent protection, the narrowing
of claims in such patents or the invalidity or unenforceability of such patents, which could limit our ability to stop others from using or commercializing similar or identical technology and products, or limit the duration of the patent protection
for our technology and products. Protecting against the unauthorized use of our patented technology, trademarks and other intellectual property rights is expensive, difficult and may in some cases not be possible. In some cases, it may be difficult
or impossible to detect third-party infringement or misappropriation of our intellectual property rights, even in relation to issued patent claims, and proving any such infringement may be even more difficult. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We could be required to incur significant expenses to strengthen our intellectual property rights, and our intellectual property rights may be
inadequate to protect our competitive position. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The patent prosecution process is expensive and time-consuming, and we or our
future potential licensors may not be able to file and prosecute all necessary or desirable patent applications at a reasonable cost or in a timely manner. It is also possible that we or our future potential licensors will fail to identify
patentable aspects of inventions made in the course of our development and commercialization activities before it is too late to obtain patent protection on them. Further, given the amount of time required for the development, testing and regulatory
review of new product candidates, patents protecting such candidates might expire before or shortly after such candidates are commercialized. As a result, our owned and licensed patent portfolio may not provide us with sufficient rights to exclude
others from commercializing products similar or identical to ours. We expect to seek extensions of patent terms in the United States and, if available, in other countries where we are prosecuting patents. In the United States, the Drug Price
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Competition and Patent Term Restoration Act of 1984 permits a patent term extension of up to five years beyond the expiration of the patent. However, the applicable authorities, including the FDA
in the United States, and any equivalent regulatory authority in other countries, may not agree with our assessment of whether such extensions are available, and may refuse to grant extensions to our patents, or may grant more limited extensions
than we request. If this occurs, our competitors may be able to take advantage of our investment in development and clinical trials by referencing our clinical and preclinical data and launch their product earlier than might otherwise be the case.
Changes in either the patent laws or interpretation of the patent laws in the United States and other countries may diminish the value of our patents or narrow the scope of our patent protection. The laws of foreign countries may not protect our
rights to the same extent as the laws of the United States, and these foreign laws may also be subject to change. For example, methods of treatment and manufacturing processes may not be patentable in certain jurisdictions. Publications of
discoveries in the scientific literature often lag behind the actual discoveries, and patent applications in the United States and other jurisdictions are typically not published until 18&nbsp;months after filing or in some cases not at all.
Therefore we cannot be certain that we or our licensors were the first to make the inventions claimed in our owned or licensed patents or pending patent applications, or that we or our licensors were the first to file for patent protection of such
inventions. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Recent patent reform legislation could increase the uncertainties and costs surrounding the prosecution of our patent applications and
the enforcement or defense of our issued patents. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On September&nbsp;16, 2011, the Leahy-Smith America Invents Act, or the
Leahy-Smith Act, was signed into law. The Leahy-Smith Act includes a number of significant changes to U.S. patent law. These include provisions that affect the way patent applications will be prosecuted and may also affect patent litigation. In
particular, under the Leahy-Smith Act, the United States transitioned in March 2013 to a &#147;first to file&#148; system in which the first inventor to file&nbsp;a patent application will be entitled to the patent. Third parties are allowed to
submit prior art before the issuance of a patent by the U.S. Patent and Trademark Office, or the USPTO, and may become involved in opposition, derivation, reexamination, inter-partes review or interference proceedings challenging our patent rights
or the patent rights of others. An adverse determination in any such submission, proceeding or litigation could reduce the scope of, or invalidate, our patent rights, which could adversely affect our competitive position. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The USPTO is currently developing regulations and procedures to govern administration of the Leahy-Smith Act, and many of the substantive
changes to patent law associated with the Leahy-Smith Act, and in particular, the first to file provisions, did not become effective until March&nbsp;16, 2013. Accordingly, it is not clear what, if any, impact the Leahy-Smith Act will have on the
operation of our business. However, the Leahy-Smith Act and its implementation could increase the uncertainties and costs surrounding the prosecution of our patent applications and the enforcement or defense of our issued patents, all of which could
have a material adverse effect on our business, results of operations, financial condition and cash flows and future prospects. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Obtaining and
maintaining our patent protection depends on compliance with various procedural, document submissions, fee payment and other requirements imposed by governmental patent agencies, and our patent protection could be reduced or eliminated for
non-compliance with these requirements. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Periodic maintenance and annuity fees on any issued patent are due to be paid to the USPTO
and foreign patent agencies in several stages over the lifetime of the patent. The USPTO and various foreign governmental patent agencies require compliance with a number of procedural, documentary, fee payment and other similar provisions during
the patent application process. While an inadvertent lapse can in many cases be cured by payment of a late fee or by other means in accordance with the applicable rules, there are situations in which noncompliance can result in abandonment or lapse
of the patent or patent application, resulting in partial or complete loss of patent rights in the relevant jurisdiction. Non-compliance events that could result in abandonment or lapse of a patent or patent application include, but are not limited
to, failure to respond to official actions within prescribed time limits, non-payment of fees and failure to properly legalize and submit formal documents. If we or our future potential licensors fail to maintain the patents and patent applications
covering AQX-1125 or our future product candidates, our competitive position would be adversely affected. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We may be subject to claims by third
parties asserting that our employees or we have misappropriated their intellectual property, or claiming ownership of what we regard as our own intellectual property. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Many of our employees, including our senior management, were previously employed at universities or at other biotechnology or pharmaceutical
companies, including our competitors or potential competitors. Some of these employees, including each member of our senior management, executed proprietary rights, non-disclosure and non-competition agreements, in connection with such previous
employment. Although we try to ensure that our employees do not use the proprietary information or know-how of others in their work for us, we may be subject to claims that we, or these employees, have used or disclosed confidential information or
intellectual property, including trade secrets or other proprietary information, of any such employee&#146;s former employer. We are not aware of any threatened or pending claims related to these matters or concerning the agreements with our senior
management, but in the future litigation may be necessary to defend against such claims. If we fail in prosecuting or defending any such claims, in addition to paying monetary damages, we may lose valuable intellectual property rights or personnel
or sustain damages. Such intellectual property rights could be awarded to a third party, and we could be required to obtain a license from such third party to commercialize our technology or products. Such a license may not be available on
commercially reasonable terms or at all. Even if we are successful in defending against such claims, litigation could result in substantial costs and be a distraction to management. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>If we are unable to protect the confidentiality of our trade secrets, our business and competitive position
would be harmed. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition to seeking patents for some of our technology and products, we also rely on trade secrets, including
unpatented know-how, technology and other proprietary information, to maintain our competitive position. We seek to protect these trade secrets, in part, by entering into non-disclosure and confidentiality agreements with parties who have access to
them, such as our employees, corporate collaborators, outside scientific collaborators, CMOs, consultants, advisors and other third parties. We also generally enter into confidentiality and invention or patent assignment agreements with our
employees and consultants. Despite these efforts, any of these parties may breach the agreements and disclose our proprietary information, including our trade secrets, and we may not be able to obtain adequate remedies for such breaches. Enforcing a
claim that a party illegally disclosed or misappropriated a trade secret is difficult, expensive and time-consuming, and the outcome is unpredictable. In addition, some courts both within and outside the United States may be less willing or
unwilling to protect trade secrets. If any of our trade secrets were to be lawfully obtained or independently developed by a competitor, we would have no right to prevent such competitor from using that technology or information to compete with us,
which could harm our competitive position. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Although we expect all of our employees to assign their inventions to us, and all of our
employees, consultants, advisors and any third parties who have access to our proprietary know-how, information or technology to enter into confidentiality agreements, we cannot provide any assurances that all such agreements have been duly executed
or that our trade secrets and other confidential proprietary information will not be disclosed or that competitors will not otherwise gain access to our trade secrets or independently develop substantially equivalent information and techniques.
Additionally, if the steps taken to maintain our trade secrets are deemed inadequate, we may have insufficient recourse against third parties for misappropriating the trade secret. In addition, others may independently discover our trade secrets and
proprietary information. For example, the FDA, as part of its Transparency Initiative, is currently considering whether to make additional information publicly available on a routine basis, including information that we may consider to be trade
secrets or other proprietary information, and it is not clear at the present time how the FDA&#146;s disclosure policies may change in the future, if at all. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We may not be able to protect our intellectual property rights throughout the world. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Filing, prosecuting and defending patents on AQX-1125 and our future product candidates throughout the world would be prohibitively expensive.
In addition, the laws of some foreign countries do not protect intellectual property rights to the same extent as federal and state laws in the United States. Consequently, we and our licensors or collaborators may not be able to prevent third
parties from practicing our inventions in all countries outside the United States, or from selling or importing products made using our inventions in and into the United States or other jurisdictions. Competitors may use our technologies in
jurisdictions where we have not obtained patent protection to develop their own products, and may export otherwise infringing products to territories where we have patent protection, but where enforcement is not as strong as that in the United
States. These products may compete with our products in jurisdictions where we do not have any issued patents and our patent claims or other intellectual property rights may not be effective or sufficient to prevent them from so competing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Many companies have encountered significant problems in protecting and defending intellectual property rights in foreign jurisdictions. The
legal systems of certain countries, particularly certain developing countries, do not favor the enforcement of patents and other intellectual property protection, particularly those relating to biopharmaceuticals, which could make it difficult for
us to stop the infringement of our patents or marketing of competing products in violation of our proprietary rights generally. Proceedings to enforce our patent rights in foreign jurisdictions could result in substantial cost and divert our efforts
and attention from other aspects of our business. We may not prevail in any lawsuits that we initiate and the damages or other remedies awarded, if any, may not be commercially meaningful. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The requirements for patentability may differ in certain countries, particularly developing countries. For example, unlike other countries,
China has a heightened requirement for patentability, and specifically requires a detailed description of medical uses of a claimed drug. In India, unlike the United States, there is no link between regulatory approval of a drug and its patent
status. Furthermore, generic or biosimilar drug manufacturers or other competitors may challenge the scope, validity or enforceability of our or our licensors&#146; or collaborators&#146; patents, requiring us or our licensors or collaborators to
engage in complex, lengthy and costly litigation or other proceedings. Generic or biosimilar drug manufacturers may develop, seek approval for, and launch biosimilar versions of our products. In addition to India, certain countries in Europe and
developing countries, including China, have compulsory licensing laws under which a patent owner may be compelled to grant licenses to third parties. In those countries, we and our licensors or collaborators may have limited remedies if patents are
infringed or if we or our licensors or collaborators are compelled to grant a license to a third party, which could materially diminish the value of those patents. This could limit our potential revenue opportunities. Accordingly, our and our
licensors&#146; or collaborators&#146; efforts to enforce intellectual property rights around the world may be inadequate to obtain a significant commercial advantage from the intellectual property that we own or license. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Intellectual property rights do not necessarily address all potential threats to any competitive advantage
we may have. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The degree of future protection afforded by our intellectual property rights is uncertain because intellectual
property rights have limitations, and may not adequately protect our business, or permit us to maintain our competitive advantage. The following examples are illustrative: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Others may be able to make compounds that are the same as or similar to AQX-1125 or our future product candidates but that are not covered by the claims of the patents that we own or have exclusively licensed.
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">We or any of our licensors or strategic partners might not have been the first to make the inventions covered by the issued patent or pending patent application that we own or have exclusively licensed.
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">We or any of our licensors or strategic partners might not have been the first to file patent applications covering certain of our inventions. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Others may independently develop similar or alternative technologies or duplicate any of our technologies without infringing our intellectual property rights. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">It is possible that our pending patent applications will not lead to issued patents. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Issued patents that we own or have exclusively licensed may not provide us with any competitive advantages, or may be held invalid or unenforceable, as a result of legal challenges by our competitors. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Our competitors might conduct research and development activities in the United States and other countries that provide a safe harbor from patent infringement claims for certain research and development activities, as
well as in countries where we do not have patent rights and then use the information learned from such activities to develop competitive products for sale in our major commercial markets. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">We may not develop additional proprietary technologies that are patentable. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">The patents of others may have an adverse effect on our business. </TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risks Related to Ownership of Our Common
Stock </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our stock price has been and will likely continue to be volatile and may decline regardless of our operating performance, resulting in
substantial losses for investors.* </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The trading price of our common stock has been, and is likely to continue to be, volatile for
the foreseeable future. The trading price of our common stock could be subject to wide fluctuations in response to various factors, some of which are beyond our control. In addition to the factors discussed in this &#147;Risk Factors&#148; section
and elsewhere in this report, these factors include: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the success of competitive products or technologies; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">regulatory actions with respect to our products or our competitors&#146; products; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">actual or anticipated changes in our growth rate relative to our competitors; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">announcements by us or our competitors of significant acquisitions, strategic partnerships, joint ventures, collaborations or capital commitments; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">results of clinical trials, including both safety and efficacy, of AQX-1125 or any of our future product candidates or those of our competitors; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">regulatory or legal developments in the United States and other countries; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">developments or disputes concerning patent applications, issued patents or other proprietary rights; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the recruitment or departure of key personnel; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the level of expenses related to AQX-1125 or any of our future product candidates or clinical development programs; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the results of our efforts to in-license or acquire additional product candidates or products; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">actual or anticipated changes in estimates as to financial results, development timelines or recommendations by securities analysts; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">variations in our financial results or those of companies that are perceived to be similar to us; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">fluctuations in the valuation of companies perceived by investors to be comparable to us; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">share price and volume fluctuations attributable to inconsistent trading volume levels of our shares; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">announcement or expectation of additional financing efforts; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">sales of our common stock by us, our insiders or our other stockholders; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">changes in the structure of healthcare payment systems; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">market conditions in the pharmaceutical and biotechnology sectors; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">general economic, industry and market conditions. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, the stock market in general,
and pharmaceutical and biotechnology companies in particular, have experienced extreme price and volume fluctuations that have often been unrelated or disproportionate to the operating performance of these companies. Broad market and industry
factors may negatively affect the market price of our common stock, regardless of our actual operating performance. The realization of any of these risks or any of a broad range of other risks, including those described in this &#147;Risk
Factors&#148; section and elsewhere in this report, could have a dramatic and material adverse impact on the market price of our common stock. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We may be subject to securities litigation, which is expensive and could divert management attention.
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The market price of our common stock may be volatile, and in the past companies that have experienced volatility in the market
price of their stock have been subject to securities class action litigation. We may be the target of this type of litigation in the future. Securities litigation against us could result in substantial costs and divert our management&#146;s
attention from other business concerns, which could seriously harm our business. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our principal stockholders and management own a significant
percentage of our stock and will be able to exert significant control over matters subject to stockholder approval.* </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our executive
officers, directors, holders of 5% or more of our capital stock and their respective affiliates together beneficially own 64% of our outstanding voting stock as of March&nbsp;31, 2014. These stockholders may be able to determine the outcome of all
matters requiring stockholder approval. For example, these stockholders may be able to control elections of directors, amendments of our organizational documents, or approval of any merger, sale of assets, or other major corporate transaction. This
may prevent or discourage unsolicited acquisition proposals or offers for our common stock that you may feel are in your best interest as one of our stockholders. The interests of this group of stockholders may not always coincide with your
interests or the interests of other stockholders and they may act in a manner that advances their best interests and not necessarily those of other stockholders, including seeking a premium value for their common stock, and might affect the
prevailing market price for our common stock. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We are an &#147;emerging growth company&#148; as that term is used in the Jumpstart Our Business
Startups Act of 2012, or the JOBS Act, and we intend to take advantage of reduced disclosure and governance requirements applicable to emerging growth companies, which could result in our common stock being less attractive to investors and adversely
affect the market price of our common stock or make it more difficult to raise capital as and when we need it. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are an
&#147;emerging growth company&#148; as that term is used in the JOBS Act, and we intend to take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies
including, but not limited to, not being required to comply with the auditor attestation requirements of Section&nbsp;404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in our periodic reports and proxy
statements, exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved and exemptions from any rules that the Public Company
Accounting Oversight Board may adopt requiring mandatory audit firm rotation or a supplement to the auditor&#146;s report on the financial statements. We currently intend to take advantage of some, but not all, of the reduced regulatory and
reporting requirements that will be available to us under the JOBS Act, so long as we qualify as an &#147;emerging growth company.&#148; For example, so long as we qualify as an &#147;emerging growth company,&#148; we may elect not to provide you
with certain information, including certain financial information and certain information regarding compensation of our executive officers, that we would otherwise have been required to provide in filings we make with the SEC, which may make it more
difficult for investors and securities analysts to evaluate our company. We cannot predict if investors will find our common stock less attractive because we will rely on these exemptions. If some investors find our common stock less attractive as a
result, there may be a less active trading market for our common stock and our stock price may be more volatile. We may take advantage of these reporting exemptions until we are no longer an emerging growth company, which in certain circumstances
could be for up to five years. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Because of the exemptions from various reporting requirements provided to us as an &#147;emerging growth
company&#148; we may be less attractive to investors and it may be difficult for us to raise additional capital as and when we need it. Investors may be unable to compare our business with other companies in our industry if they believe that our
financial accounting is not as transparent as other companies in our industry. If we are unable to raise additional capital as and when we need it, our business, results of operations, financial condition and cash flows and future prospects may be
materially and adversely affected. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>If we fail to maintain an effective system of internal control over financial reporting in the future, we may
not be able to accurately report our business, results of operations, financial condition and cash flows and future prospects, which may adversely affect investor confidence in us and, as a result, the value of our common stock. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Sarbanes-Oxley Act requires, among other things, that we maintain effective internal controls for financial reporting and disclosure
controls and procedures. Commencing with our annual report on Form&nbsp;10-K for the year ending December&nbsp;31, 2015, we will be required, under Section&nbsp;404 of the Sarbanes-Oxley Act, to furnish a report by management on, among other things,
the effectiveness of our internal control over financial reporting. This assessment will need to include disclosure of any material weaknesses identified by our management in our internal control over financial reporting. A material weakness is a
deficiency, or combination of deficiencies, in internal control over financial reporting that results in more than a reasonable possibility that a material misstatement of annual or interim financial statements will not be prevented or detected on a
timely basis. Section&nbsp;404 of the Sarbanes-Oxley Act also generally requires an attestation from our independent registered public accounting firm on the effectiveness of our internal control over financial reporting. However, for as long as we
remain an emerging growth company as defined in the JOBS Act, we intend to take advantage of the exemption permitting us not to comply with the independent registered public accounting firm attestation requirement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">30 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our compliance with Section&nbsp;404 will require that we incur substantial accounting expense
and expend significant management efforts. We currently do not have an internal audit group, and we will need to hire additional accounting and financial staff with appropriate public company experience and technical accounting knowledge, and
compile the system and process documentation necessary to perform the evaluation needed to comply with Section&nbsp;404. We may not be able to complete our evaluation, testing and any required remediation in a timely fashion. In connection with the
audit of the combined financial statements of Aquinox USA and AQXP Canada as of December&nbsp;31, 2013 and December&nbsp;31, 2012, and for the years then ended and for the period from December&nbsp;26, 2003 (inception) to December&nbsp;31, 2013, we
identified certain significant deficiencies in our internal controls over financial reporting. A &#147;significant deficiency&#148; is a deficiency, or a combination of deficiencies, in internal control over financial reporting that is less severe
than a material weakness, yet important enough to merit attention by those responsible for oversight of our financial reporting, including the audit committee of the board of directors. During the evaluation and testing process, if we fail to
remediate the significant deficiencies identified, fail to identify and to remediate any significant deficiencies or material weaknesses that may be identified in the future, or encounter problems or delays in the implementation of internal control
over financial reporting, we will be unable to assert that our internal control over financial reporting is effective. We cannot assure you that there will not be material weaknesses or significant deficiencies in our internal control over financial
reporting in the future. Any failure to maintain internal control over financial reporting could severely inhibit our ability to accurately report our financial condition, results of operations or cash flows. If we are unable to conclude that our
internal control over financial reporting is effective, or if our independent registered public accounting firm determines we have a material weakness or significant deficiency in our internal control over financial reporting once that firm begin
its Section&nbsp;404 reviews, we could lose investor confidence in the accuracy and completeness of our financial reports, the market price of our common stock could decline, and we could be subject to sanctions or investigations by the NASDAQ Stock
Market, the SEC or other regulatory authorities. Failure to remedy any material weakness in our internal control over financial reporting, or to implement or maintain other effective control systems required of public companies, could also restrict
our future access to the capital markets. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our disclosure controls and procedures may not prevent or detect all errors or acts of fraud.
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are become subject to the periodic reporting requirements of the Exchange Act of 1934, as amended, or the Exchange Act. Our
disclosure controls and procedures are designed to reasonably assure that information required to be disclosed by us in reports we file or submit under the Exchange Act is accumulated and communicated to management, recorded, processed, summarized
and reported within the time periods specified in the rules and forms of the SEC. We believe that any disclosure controls and procedures or internal controls and procedures, no matter how well conceived and operated, can provide only reasonable, not
absolute, assurance that the objectives of the control system are met. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">These inherent limitations include the realities that judgments in
decision-making can be faulty, and that breakdowns can occur because of simple error or mistake. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people or by an unauthorized override of
the controls. Accordingly, because of the inherent limitations in our control system, misstatements or insufficient disclosures due to error or fraud may occur and not be detected. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We will incur increased costs as a result of operating as a public company, and our management will be required to devote substantial time to new
compliance initiatives. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As a public company, we will incur significant legal, accounting and other expenses that we did not incur
as a private company, and these expenses may increase even more after we are no longer an &#147;emerging growth company.&#148; We will be subject to the reporting requirements of the Exchange Act, the Sarbanes-Oxley Act, the Dodd-Frank Wall Street
Reform and Protection Act, as well as rules adopted, and to be adopted, by the SEC and NASDAQ Stock Market. Our management and other personnel will need to devote a substantial amount of time to these compliance initiatives. Moreover, we expect
these rules and regulations to substantially increase our legal and financial compliance costs and to make some activities more time-consuming and costly. We estimate that we will incur approximately $2.0 to $3.0&nbsp;million of incremental costs
per year associated with being a publicly traded company, although it is possible that our actual incremental costs will be higher than we currently estimate. The increased costs will increase our combined net loss. For example, we expect these
rules and regulations to make it more difficult and more expensive for us to obtain director and officer liability insurance and we may be required to incur substantial costs to maintain the sufficient coverage. We cannot predict or estimate the
amount or timing of additional costs we may incur to respond to these requirements. The impact of these requirements could also make it more difficult for us to attract and retain qualified persons to serve on our board of directors, our board
committees or as executive officers. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Because we do not anticipate paying any cash dividends on our capital stock in the foreseeable future, capital
appreciation, if any, will be your sole source of gain*. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have never declared or paid cash dividends on our capital stock. We
currently intend to retain all of our future earnings, if any, to finance the growth and development of our business. In addition, the terms of any future debt agreements may preclude us from paying dividends. As a result, capital appreciation, if
any, of our common stock will be your sole source of gain for the foreseeable future. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">31 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Sales of a substantial number of shares of our common stock in the public market could cause our stock
price to fall.* </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Sales of a substantial number of shares of our common stock in the public market could occur at any time. These
sales, or the perception in the market that the holders of a large number of shares intend to sell shares, could reduce the market price of our common stock. As of March&nbsp;31, 2014, approximately 5.8&nbsp;million shares of our common stock are
currently restricted as a result of securities laws or lock-up agreements but will be able to be sold upon expiration of the lockup period in September 2014. Moreover, holders of an aggregate of approximately 5.8&nbsp;million shares of our common
stock will have rights, subject to certain conditions, to require us to file registration statements covering their shares or to include their shares in registration statements that we may file for ourselves or other stockholders. We have registered
all currently reserved shares of common stock that we may issue under our equity compensation plans and intend to register in the future any additional reserved or issued shares of common stock. These registered shares can be freely sold in the
public market upon issuance, subject to volume limitations applicable to affiliates and the lock-up agreements. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Future sales and issuances of our
common stock or rights to purchase common stock, including pursuant to our equity incentive plans, could result in additional dilution of the percentage ownership of our stockholders and could cause our stock price to fall. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We expect that significant additional capital will be needed in the future to continue our planned operations. To raise capital, we may sell
substantial amounts of common stock or securities convertible into or exchangeable for common stock. These future issuances of common stock or common stock-related securities, together with the exercise of outstanding options and any additional
shares issued in connection with acquisitions, if any, may result in material dilution to our investors. Such sales may also result in material dilution to our existing stockholders, and new investors could gain rights, preferences and privileges
senior to those of holders of our common stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to our equity incentive plans, our compensation committee is authorized to grant
equity-based incentive awards to our directors, executive officers and other employees and service providers, including officers, employees and service providers of our subsidiaries and affiliates. Future option grants and issuances of common stock
under our 2014 Equity Incentive Plan may have an adverse effect on the market price of our common stock. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Some provisions of our charter documents
and Delaware law may have anti-takeover effects that could discourage an acquisition of us by others, even if an acquisition would be beneficial to our stockholders and may prevent attempts by our stockholders to replace or remove our current
management. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Provisions in our amended and restated certificate of incorporation, or certificate of incorporation, and amended and
restated bylaws, or bylaws, as well as provisions of Delaware law, could make it more difficult for a third party to acquire us or increase the cost of acquiring us, even if doing so would benefit our stockholders, or remove our current management.
These include provisions that: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">permit our board of directors to issue up to 5,000,000 shares of preferred stock, with any rights, preferences and privileges as they may designate; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">provide that all vacancies on our board of directors, including as a result of newly created directorships, may, except as otherwise required by law, be filled by the affirmative vote of a majority of directors then in
office, even if less than a quorum; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">require that any action to be taken by our stockholders must be effected at a duly called annual or special meeting of stockholders and not be taken by written consent; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">provide that stockholders seeking to present proposals before a meeting of stockholders or to nominate candidates for election as directors at a meeting of stockholders must provide advance notice in writing, and also
specify requirements as to the form and content of a stockholder&#146;s notice; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">not provide for cumulative voting rights, thereby allowing the holders of a majority of the shares of common stock entitled to vote in any election of directors to elect all of the directors standing for election; and
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">provide that special meetings of our stockholders may be called only by the board of directors or by such person or persons requested by a majority of the board of directors to call such meetings. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">These provisions may frustrate or prevent any attempts by our stockholders to replace or remove our current management by making it more
difficult for stockholders to replace members of our board of directors, who are responsible for appointing the members of our management. Because we are incorporated in Delaware, we are governed by the provisions of Section&nbsp;203 of the Delaware
General Corporation Law, which may discourage, delay or prevent someone from acquiring us or merging with us whether or not it is desired by or beneficial to our stockholders. Under Delaware law, a corporation may not, in general, engage in a
business combination with any holder of 15% or more of its capital stock unless the holder has held the stock for three years or, among other things, the board of directors has approved the transaction. Any provision of our certificate of
incorporation or bylaws or Delaware law that has the effect of delaying or deterring a change in control could limit the opportunity for our stockholders to receive a premium for their shares of our common stock, and could also affect the price that
some investors are willing to pay for our common stock. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">32 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>If securities or industry analysts do not publish research or publish inaccurate or unfavorable research
about our business, our stock price and trading volume could decline. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The trading market for our common stock depends in part on
the research and reports that securities or industry analysts publish about us, or our business. Securities and industry analysts do not currently, and may never, publish research on our company. If no securities or industry analysts commence
coverage of our company, the trading price for our stock would likely be negatively impacted. In the event securities or industry analysts initiate coverage, if one or more of the analysts who cover us downgrade our stock or publish inaccurate or
unfavorable research about our business, our stock price would likely decline. If one or more of these analysts cease coverage of our company or fail to publish reports on us regularly, demand for our stock could decrease, which might cause our
stock price and trading volume to decline. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B><A NAME="tx704250_11"></A>Item&nbsp;2.</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Unregistered Sales of Equity Securities and Use of Proceeds </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Recent Sales of Unregistered Equity
Securities </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In March 2014, immediately prior to the closing of our initial public offering, or IPO, we issued (i)&nbsp;an aggregate of
301,745 shares of our common stock issuable upon the exchange of all of the outstanding common exchangeable shares of AQXP Canada and (ii)&nbsp;an aggregate of 1,963,419 shares of our convertible preferred stock issuable upon the exchange of all of
the outstanding exchangeable preferred shares of AQXP Canada. In March 2014, upon the closing of our IPO, all 5,543,515 shares of our then-outstanding convertible preferred stock (including the 1,963,419 shares of our then-outstanding convertible
preferred stock issuable upon the exchange of all of the outstanding exchangeable preferred shares of AQXP Canada) automatically converted into 5,543,515 shares of common stock. None of the foregoing transactions involved any underwriters,
underwriting discounts or commissions, or any public offering, and we believe that each transaction was exempt from the registration requirements of the Securities Act in reliance on (a)&nbsp;Section&nbsp;4(2) of the Securities Act,
(b)&nbsp;Section&nbsp;3(a)(9) of the Securities Act or (c)&nbsp;Regulation S promulgated under the Securities Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">From January&nbsp;1,
2014 through the date of closing of our IPO, we granted stock options under our 2014 Equity Incentive Plan to purchase an aggregate of 33,332 shares of our common stock at an exercise price of $11 per share to a total of four directors. The offers,
sales and issuances of the securities described in this paragraph were exempt from registration under (a)&nbsp;Section&nbsp;4(2) of the Securities Act in that the transactions were by an issuer not involving any public offering;
(b)&nbsp;compensatory benefit plans and contracts relating to compensation as provided under Rule 701 promulgated under the Securities Act; or (c)&nbsp;Regulation S promulgated under the Securities Act. Any shares issuable upon exercise of these
options have been registered on the Form S-8 filed with the SEC on March&nbsp;11, 2014. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Use of Proceeds </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On March&nbsp;12, 2014, we completed our IPO and issued 4,830,000 shares of our common stock at an initial offering price of $11.00 per share.
We received net proceeds from the IPO of approximately $47.3 million, after deducting underwriting discounts and commissions of approximately $3.7 million and expenses of approximately $2.1 million. None of the expenses associated with the IPO were
paid to directors, officers, persons owning 10% or more of any class of equity securities, or to their associates, or to our affiliates. Jefferies LLC and Cowen and Company acted as joint book-running managers and Canaccord Genuity acted as
co-manager for the offering. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Shares of our common stock began trading on the NASDAQ Global Market on March&nbsp;7, 2014. The shares were
registered under the Securities Act on registration statement on Form&nbsp;S-1 (Registration No.&nbsp;333-193615), which was declared effective on March&nbsp;6, 2014. The offering was not terminated before all of the shares in the IPO that were
registered in the registration statement were sold. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We expect to use the proceeds of this offering to conduct additional Phase 2 clinical
trials to evaluate AQX-1125 as a potential treatment in indications beyond Chronic Obstructive Pulmonary Disease and Bladder Pain Syndrome/Interstitial Cystitis, to conduct additional toxicology studies, dose ranging studies, and large batch
manufacturing and process development related for AQX-1125, to advance one or more of our next generation SHIP1 activator compounds through preclinical development, and to fund working capital, capital expenditures and other general corporate
purposes which may include the acquisition or licensing of future product candidates, technologies, other assets or businesses. There has been no material change in the planned use of proceeds from our IPO as described in our prospectus dated
March&nbsp;6, 2014, filed with the SEC pursuant to Rule 424(b)(4) under the Securities Act of 1933, as amended. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of March&nbsp;31,
2014, we have not used significant amounts of the net offering proceeds due to the short duration of time since the close of the offering. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B><A NAME="tx704250_12"></A>Item&nbsp;3.</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Defaults Upon Senior Securities </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">None. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B><A NAME="tx704250_13"></A>Item&nbsp;4.</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Mine Safety Disclosures </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Not applicable. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">33 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B><A NAME="tx704250_14"></A>Item&nbsp;5.</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Other Information </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">None. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">34 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B><A NAME="tx704250_15"></A>Item&nbsp;6.</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Exhibits </B></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD WIDTH="90%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="border-bottom:1.00pt solid #000000; width:28.45pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Number</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="border-bottom:1.00pt solid #000000; width:39.50pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Description</B></P></TD></TR>


<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;&nbsp;&nbsp;3.1(1)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Amended and Restated Certificate of Incorporation of Aquinox Pharmaceuticals, Inc.</TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;&nbsp;&nbsp;3.2(2)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Amended and Restated Bylaws of Aquinox Pharmaceuticals, Inc.</TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;&nbsp;&nbsp;4.1+</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Specimen Common Stock Certificate of the Aquinox Pharmaceuticals, Inc.</TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;&nbsp;&nbsp;4.2(2)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Warrant to Purchase Stock of Aquinox Pharmaceuticals, Inc., issued to Silicon Valley Bank, dated October 23, 2013.</TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;&nbsp;&nbsp;4.3(2)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Amended and Restated Qualification and Registration Rights Agreement of Aquinox Pharmaceuticals, Inc., dated March 19, 2013.</TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;10.1(2)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">2014 Equity Incentive Plan.</TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;10.2(2)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Forms of Option Agreement and Option Grant Notice for 2014 Equity Incentive Plan.</TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;10.3(2)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Form of Indemnity Agreement entered into between Aquinox Pharmaceuticals, Inc. and each of its directors and its executive officers.</TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;31.1+</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Certification of Chief Executive Officer pursuant to Rule 13a-14(a).</TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;31.2+</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Certification of Chief Financial Officer pursuant to Rule 13a-14(a).</TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;32.1+</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350.</TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>101.INS+(3)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">XBRL Instance Document</TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>101.SCH+(3)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">XBRL Taxonomy Extension Schema Document.</TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>101.CAL+(3)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">XBRL Taxonomy Extension Calculation Linkbase Document.</TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>101.DEF+(3)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">XBRL Taxonomy Extension Definition Linkbase Document.</TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>101.LAB+(3)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">XBRL Taxonomy Extension Labels Linkbase Document.</TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>101.PRE+(3)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">XBRL Taxonomy Extension Presentation Linkbase Document.</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">+</TD>
<TD ALIGN="left" VALIGN="top">Filed or furnished herewith. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top">Previously filed as an exhibit to the Registrant&#146;s Current Report on Form 8-K filed with the Securities and Exchange Commission on March&nbsp;12, 2014 (File&nbsp;No. 001-36327) and incorporated herein by reference.
</TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top">Previously filed as an exhibit to the Registrant&#146;s Registration Statement on Form S-1, as amended (File No.&nbsp;333-193615), filed with the Securities and Exchange Commission on January&nbsp;28, 2014 and
incorporated herein by reference. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top">Pursuant to applicable securities laws and regulations, the Registrant is deemed to have complied with the reporting obligation relating to the submission of interactive data files in such exhibits and is not subject to
liability under any anti-fraud provisions of the federal securities laws as long as the Registrant has made a good faith attempt to comply with the submission requirements and promptly amends the interactive data files after becoming aware that the
interactive data files fails to comply with the submission requirements. These interactive data files on Exhibit 101 hereto are deemed not filed or part of a registration statement or prospectus for purposes of sections 11 or 12 of the Securities
Act, are deemed not filed for purposes of section 18 of the Exchange Act and otherwise are not subject to liability under these sections. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">35 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx704250_16"></A>SIGNATURES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned thereunto duly authorized. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="47%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="top"><B>Aquinox Pharmaceuticals, Inc.</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="top">(Registrant)</TD></TR>
<TR>
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date: May 12, 2014</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ David J. Main</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">David J. Main</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">President and Chief Executive
Officer</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">(Principal Executive Officer)</P></TD></TR>
<TR>
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date: May 12, 2014</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Kamran Alam</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Kamran Alam</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Chief Financial Officer</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">(Principal Financial and Accounting Officer)</P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">36 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx704250_17"></A>EXHIBIT INDEX </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD WIDTH="90%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="border-bottom:1.00pt solid #000000; width:28.45pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Number</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="border-bottom:1.00pt solid #000000; width:39.50pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Description</B></P></TD></TR>


<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;&nbsp;&nbsp;3.1(1)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Amended and Restated Certificate of Incorporation of Aquinox Pharmaceuticals, Inc.</TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;&nbsp;&nbsp;3.2(2)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Amended and Restated Bylaws of Aquinox Pharmaceuticals, Inc.</TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;&nbsp;&nbsp;4.1+</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Specimen Common Stock Certificate of the Aquinox Pharmaceuticals, Inc.</TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;&nbsp;&nbsp;4.2(2)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Warrant to Purchase Stock of Aquinox Pharmaceuticals, Inc., issued to Silicon Valley Bank, dated October 23, 2013.</TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;&nbsp;&nbsp;4.3(2)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Amended and Restated Qualification and Registration Rights Agreement of Aquinox Pharmaceuticals, Inc., dated March 19, 2013.</TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;10.1(2)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">2014 Equity Incentive Plan.</TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;10.2(2)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Forms of Option Agreement and Option Grant Notice for 2014 Equity Incentive Plan.</TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;10.3(2)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Form of Indemnity Agreement entered into between Aquinox Pharmaceuticals, Inc. and each of its directors and its executive officers.</TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;31.1+</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Certification of Chief Executive Officer pursuant to Rule 13a-14(a).</TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;31.2+</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Certification of Chief Financial Officer pursuant to Rule 13a-14(a).</TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;32.1+</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350.</TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>101.INS+(3)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">XBRL Instance Document</TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>101.SCH+(3)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">XBRL Taxonomy Extension Schema Document.</TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>101.CAL+(3)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">XBRL Taxonomy Extension Calculation Linkbase Document.</TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>101.DEF+(3)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">XBRL Taxonomy Extension Definition Linkbase Document.</TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>101.LAB+(3)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">XBRL Taxonomy Extension Labels Linkbase Document.</TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>101.PRE+(3)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">XBRL Taxonomy Extension Presentation Linkbase Document.</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">+</TD>
<TD ALIGN="left" VALIGN="top">Filed or furnished herewith. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top">Previously filed as an exhibit to the Registrant&#146;s Current Report on Form 8-K filed with the Securities and Exchange Commission on March&nbsp;12, 2014 (File&nbsp;No. 001-36327) and incorporated herein by reference.
</TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top">Previously filed as an exhibit to the Registrant&#146;s Registration Statement on Form S-1, as amended (File No.&nbsp;333-193615), filed with the Securities and Exchange Commission on January&nbsp;28, 2014 and
incorporated herein by reference. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top">Pursuant to applicable securities laws and regulations, the Registrant is deemed to have complied with the reporting obligation relating to the submission of interactive data files in such exhibits and is not subject to
liability under any anti-fraud provisions of the federal securities laws as long as the Registrant has made a good faith attempt to comply with the submission requirements and promptly amends the interactive data files after becoming aware that the
interactive data files fails to comply with the submission requirements. These interactive data files on Exhibit 101 hereto are deemed not filed or part of a registration statement or prospectus for purposes of sections 11 or 12 of the Securities
Act, are deemed not filed for purposes of section 18 of the Exchange Act and otherwise are not subject to liability under these sections. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">37 </P>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>2
<FILENAME>d704250dex41.htm
<DESCRIPTION>EX-4.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-4.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Exhibit 4.1 Specimen Common Stock Certificate of the Aquinox Pharmaceuticals, Inc. </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g704250graphic-1.jpg" ALT="LOGO">
 </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P>&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g704250graphic-2.jpg" ALT="LOGO">
 </P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>3
<FILENAME>d704250dex311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-31.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 31.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CERTIFICATIONS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I, David J. Main, certify
that: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top">I have reviewed this Quarterly Report on Form 10-Q of Aquinox Pharmaceuticals, Inc.; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such
statements were made, not misleading with respect to the period covered by this report; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the
registrant as of, and for, the periods presented in this report; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">4.</TD>
<TD ALIGN="left" VALIGN="top">The Registrant&#146;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and
have: </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">a)</TD>
<TD ALIGN="left" VALIGN="top">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its
consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">b)</TD>
<TD ALIGN="left" VALIGN="top">evaluated the effectiveness of the registrant&#146;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of
the period covered by this report based on such evaluation; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">c)</TD>
<TD ALIGN="left" VALIGN="top">disclosed in this report any change in the registrant&#146;s internal control over financial reporting that occurred during the registrant&#146;s most recent fiscal quarter that has materially affected, or is reasonably
likely to materially affect, the registrant&#146;s internal control over financial reporting; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">5.</TD>
<TD ALIGN="left" VALIGN="top">The Registrant&#146;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#146;s auditors and the audit committee of the
registrant&#146;s board of directors: </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">a)</TD>
<TD ALIGN="left" VALIGN="top">all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#146;s ability to record,
process, summarize and report financial information; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">b)</TD>
<TD ALIGN="left" VALIGN="top">any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#146;s internal control over financial reporting. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Date: May 12, 2014 </P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="100%"></TD></TR>


<TR>
<TD HEIGHT="16"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000">/s/&nbsp;&nbsp;David J. Main&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" ALIGN="center">David J. Main</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" ALIGN="center"><I>President and Chief Executive Officer</I></TD></TR>
</TABLE>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>4
<FILENAME>d704250dex312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<HTML><HEAD>
<TITLE>EX-31.2</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 31.2 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CERTIFICATIONS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I, Kamran Alam, certify
that: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top">I have reviewed this Quarterly Report on Form 10-Q of Aquinox Pharmaceuticals, Inc.; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such
statements were made, not misleading with respect to the period covered by this report; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the
registrant as of, and for, the periods presented in this report; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">4.</TD>
<TD ALIGN="left" VALIGN="top">The Registrant&#146;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and
have: </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">a)</TD>
<TD ALIGN="left" VALIGN="top">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its
consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">b)</TD>
<TD ALIGN="left" VALIGN="top">evaluated the effectiveness of the registrant&#146;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of
the period covered by this report based on such evaluation; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">c)</TD>
<TD ALIGN="left" VALIGN="top">disclosed in this report any change in the registrant&#146;s internal control over financial reporting that occurred during the registrant&#146;s most recent fiscal quarter that has materially affected, or is reasonably
likely to materially affect, the registrant&#146;s internal control over financial reporting; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">5.</TD>
<TD ALIGN="left" VALIGN="top">The Registrant&#146;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#146;s auditors and the audit committee of the
registrant&#146;s board of directors: </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">a)</TD>
<TD ALIGN="left" VALIGN="top">all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#146;s ability to record,
process, summarize and report financial information; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">b)</TD>
<TD ALIGN="left" VALIGN="top">any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#146;s internal control over financial reporting. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Date: May 12, 2014 </P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="100%"></TD></TR>


<TR>
<TD HEIGHT="16"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000">/s/&nbsp;&nbsp;Kamran Alam&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" ALIGN="center">Kamran Alam</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" ALIGN="center"><I>Chief Financial Officer</I></TD></TR>
</TABLE>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>5
<FILENAME>d704250dex321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-32.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 32.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AQUINOX PHARMACEUTICALS, INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CERTIFICATION PURSUANT TO </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>18 U.S.C. SECTION 1350, </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AS ADOPTED PURSUANT TO </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with the Quarterly Report of Aquinox Pharmaceuticals, Inc. (the &#147;Company&#148;) on Form 10-Q for the quarter ended March&nbsp;31, 2014, as
filed with the Securities and Exchange Commission on the date hereof (the &#147;Report&#148;), David J. Main, President and Chief Executive Officer of the Company, and Kamran Alam, Chief Financial Officer of the Company, each hereby certifies,
pursuant to 18 U.S.C. Section&nbsp;1350, as adopted pursuant to Section&nbsp;906 of the Sarbanes-Oxley Act of 2002, that, to the best of his knowledge: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top">The Report fully complies with the requirements of Section&nbsp;13(a) or 15(d) of the Securities Exchange Act of 1934; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dated: May 12, 2014 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>IN WITNESS WHEREOF,</B> the undersigned
have set their hands hereto as of the 12<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> day of May, 2014. </P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="47%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR>
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; font-size:10pt; font-family:Times New Roman">/s/ David J. Main</P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Kamran Alam</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">David J. Main</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">Kamran Alam</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><I>President and Chief Executive Officer</I></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><I>Chief Financial Officer</I></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This certification accompanies the Form 10-Q to which it relates, is not deemed filed with the Securities and Exchange
Commission and is not to be incorporated by reference into any filing of Aquinox Pharmaceuticals, Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of the
Form 10-Q), irrespective of any general incorporation language contained in such filing. </P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.INS
<SEQUENCE>6
<FILENAME>aqxp-20140331.xml
<DESCRIPTION>XBRL INSTANCE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- RR Donnelley Xcelerate Instance Document, based on XBRL 2.1  http://www.rrdonnelley.com/ -->
<!-- Version:  6.21.0 -->
<!-- Round: 5 -->
<!-- Creation date: 2014-05-12T17:22:30Z -->
<!-- Copyright (c) 2005-2013 R.R. Donnelley & Sons Company All Rights Reserved. -->
<xbrl xmlns="http://www.xbrl.org/2003/instance" xmlns:xbrll="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:us-gaap="http://fasb.org/us-gaap/2013-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2013-01-31" xmlns:aqxp="http://imetrix.edgar-online.com/20140331" xmlns:us-types="http://fasb.org/us-types/2013-01-31" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:stpr="http://xbrl.sec.gov/stpr/2011-01-31" xmlns:country="http://xbrl.sec.gov/country/2013-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2012-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2013-01-31" xmlns:invest="http://xbrl.sec.gov/invest/2013-01-31" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:utr="http://www.xbrl.org/2009/utr">
  <xbrll:schemaRef xlink:type="simple" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xlink:href="aqxp-20140331.xsd" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrll="http://www.xbrl.org/2003/linkbase" />
  <us-gaap:PreferredStockSharesAuthorized contextRef="eol_PE749074--1410-Q0003_STD_0_20140312_0" unitRef="shares" decimals="INF" id="id_3828183_59DF8DE0-8C90-4F39-B893-63E357C8A273_1_3">5000000</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:CommonStockSharesAuthorized contextRef="eol_PE749074--1410-Q0003_STD_0_20140312_0" unitRef="shares" decimals="INF" id="id_3828183_59DF8DE0-8C90-4F39-B893-63E357C8A273_1_1">50000000</us-gaap:CommonStockSharesAuthorized>
  <us-gaap:CommonStockParOrStatedValuePerShare contextRef="eol_PE749074--1410-Q0003_STD_0_20140312_0" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_3828183_59DF8DE0-8C90-4F39-B893-63E357C8A273_1_2">0.000001</us-gaap:CommonStockParOrStatedValuePerShare>
  <us-gaap:SaleOfStockPricePerShare contextRef="eol_PE749074--1410-Q0003_STD_0_20140312_0" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_3828183_3BB72D2D-1402-4B6B-8730-A88FD94766C3_2001_2">11.00</us-gaap:SaleOfStockPricePerShare>
  <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="eol_PE749074--1410-Q0003_STD_0_20140312_0" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_3828183_59DF8DE0-8C90-4F39-B893-63E357C8A273_1_4">0.000001</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:StockholdersEquity contextRef="eol_PE749074--1410-Q0003_STD_0_20140312_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_D8629002-FCA3-41A1-8253-7BBD181ADE71_1011_9">-68777919</us-gaap:StockholdersEquity>
  <aqxp:StockSharesAuthorizedNet contextRef="eol_PE749074--1410-Q0003_STD_0_20140312_0" unitRef="shares" decimals="INF" id="id_3828183_59DF8DE0-8C90-4F39-B893-63E357C8A273_1_0">55000000</aqxp:StockSharesAuthorizedNet>
  <us-gaap:TemporaryEquitySharesOutstanding contextRef="eol_PE749074--1410-Q0003_STD_0_20140312_0_921954x1258858_932980x1031975" unitRef="shares" decimals="INF" id="id_3828183_9506BE28-673E-456E-836B-84E1D2BFBEE2_5002_3">378786</us-gaap:TemporaryEquitySharesOutstanding>
  <us-gaap:TemporaryEquitySharesOutstanding contextRef="eol_PE749074--1410-Q0003_STD_0_20140312_0_921954x1258858_932980x1124615" unitRef="shares" decimals="INF" id="id_3828183_9506BE28-673E-456E-836B-84E1D2BFBEE2_6002_2">793617</us-gaap:TemporaryEquitySharesOutstanding>
  <us-gaap:CommonStockSharesOutstanding contextRef="eol_PE749074--1410-Q0003_STD_0_20140312_0_921954x1258858_932980x932064" unitRef="shares" decimals="INF" id="id_3828183_0707DBD9-7256-4012-8515-B01E43B3304F_2002_1">301745</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:SharesOutstanding contextRef="eol_PE749074--1410-Q0003_STD_0_20140312_0_921954x1258858_932980x932377" unitRef="shares" decimals="INF" id="id_3828183_D8629002-FCA3-41A1-8253-7BBD181ADE71_1001_10">1963419</us-gaap:SharesOutstanding>
  <us-gaap:StockholdersEquity contextRef="eol_PE749074--1410-Q0003_STD_0_20140312_0_921954x1258858_932980x932377" unitRef="iso4217_USD" decimals="0" id="id_3828183_D8629002-FCA3-41A1-8253-7BBD181ADE71_1001_9">28824651</us-gaap:StockholdersEquity>
  <us-gaap:TemporaryEquitySharesOutstanding contextRef="eol_PE749074--1410-Q0003_STD_0_20140312_0_921954x1258858_932980x980486" unitRef="shares" decimals="INF" id="id_3828183_9506BE28-673E-456E-836B-84E1D2BFBEE2_7002_1">791016</us-gaap:TemporaryEquitySharesOutstanding>
  <us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion contextRef="eol_PE749074--1410-Q0003_STD_0_20140312_0_921954x1258870_932980x930400" unitRef="shares" decimals="INF" id="id_3828183_9506BE28-673E-456E-836B-84E1D2BFBEE2_8002_6">378786</us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion>
  <us-gaap:TemporaryEquitySharesIssued contextRef="eol_PE749074--1410-Q0003_STD_0_20140312_0_921954x1258870_932980x930400" unitRef="shares" decimals="INF" id="id_3828183_9506BE28-673E-456E-836B-84E1D2BFBEE2_8002_9">1722210</us-gaap:TemporaryEquitySharesIssued>
  <us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion contextRef="eol_PE749074--1410-Q0003_STD_0_20140312_0_921954x1258870_932980x930435" unitRef="shares" decimals="INF" id="id_3828183_9506BE28-673E-456E-836B-84E1D2BFBEE2_9002_4">791016</us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion>
  <us-gaap:TemporaryEquitySharesIssued contextRef="eol_PE749074--1410-Q0003_STD_0_20140312_0_921954x1258870_932980x930435" unitRef="shares" decimals="INF" id="id_3828183_9506BE28-673E-456E-836B-84E1D2BFBEE2_9002_7">1453891</us-gaap:TemporaryEquitySharesIssued>
  <us-gaap:SharesOutstanding contextRef="eol_PE749074--1410-Q0003_STD_0_20140312_0_921954x1258870_932980x930643" unitRef="shares" decimals="INF" id="id_3828183_D8629002-FCA3-41A1-8253-7BBD181ADE71_1007_10">301745</us-gaap:SharesOutstanding>
  <us-gaap:TemporaryEquitySharesOutstanding contextRef="eol_PE749074--1410-Q0003_STD_0_20140312_0_921954x1258870_932980x932152" unitRef="shares" decimals="INF" id="id_3828183_9506BE28-673E-456E-836B-84E1D2BFBEE2_10002_11">5543515</us-gaap:TemporaryEquitySharesOutstanding>
  <us-gaap:SharesOutstanding contextRef="eol_PE749074--1410-Q0003_STD_0_20140312_0_921954x1258870_932980x932258" unitRef="shares" decimals="INF" id="id_3828183_D8629002-FCA3-41A1-8253-7BBD181ADE71_1003_10">3580096</us-gaap:SharesOutstanding>
  <us-gaap:StockholdersEquity contextRef="eol_PE749074--1410-Q0003_STD_0_20140312_0_921954x1258870_932980x932258" unitRef="iso4217_USD" decimals="0" id="id_3828183_D8629002-FCA3-41A1-8253-7BBD181ADE71_1003_9">48509974</us-gaap:StockholdersEquity>
  <us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion contextRef="eol_PE749074--1410-Q0003_STD_0_20140312_0_921954x1258870_932980x932774" unitRef="shares" decimals="INF" id="id_3828183_9506BE28-673E-456E-836B-84E1D2BFBEE2_11002_5">793617</us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion>
  <us-gaap:TemporaryEquitySharesIssued contextRef="eol_PE749074--1410-Q0003_STD_0_20140312_0_921954x1258870_932980x932774" unitRef="shares" decimals="INF" id="id_3828183_9506BE28-673E-456E-836B-84E1D2BFBEE2_11002_8">2367414</us-gaap:TemporaryEquitySharesIssued>
  <us-gaap:StockholdersEquity contextRef="eol_PE749074--1410-Q0003_STD_0_20140312_0_932980x932209" unitRef="iso4217_USD" decimals="0" id="id_3828183_D8629002-FCA3-41A1-8253-7BBD181ADE71_1010_9">-68777919</us-gaap:StockholdersEquity>
  <dei:EntityCommonStockSharesOutstanding contextRef="eol_PE749074--1410-Q0003_STD_0_20140430_0" unitRef="shares" decimals="INF" id="id_3828183_CBB1FE57-AEF2-4C11-8C94-0CED2965EC95_2_5">10675260</dei:EntityCommonStockSharesOutstanding>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="eol_PE749074--1410-Q0003_STD_0_20130331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_AFF72D6D-AE4F-4009-8AA9-58E6D13FB48C_1002_37">19017252</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="eol_PE749074--1410-Q0003_STD_0_20131023_0_923791x1232250_924808x1094993" unitRef="shares" decimals="INF" id="id_3828183_75B3D74B-CB61-4623-AC7D-BCB98AA4CDDD_3001_1">11363</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights contextRef="eol_PE749074--1410-Q0003_STD_0_20131023_0_923791x1232250_924808x1094993" unitRef="iso4217_USD_per_Warrant" decimals="2" id="id_3828183_75B3D74B-CB61-4623-AC7D-BCB98AA4CDDD_3001_0">10.56</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights>
  <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="eol_PE749074--1410-Q0003_STD_0_20131023_0_924808x1094993" unitRef="iso4217_USD" decimals="-6" id="id_3828183_B2B8E234-ED5C-4917-AAE8-38950FF2B967_1001_0">4000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
  <us-gaap:MinorityInterestOwnershipPercentageByParent contextRef="eol_PE749074--1410-Q0003_STD_0_20140331_0" unitRef="pure" decimals="INF" id="id_3828183_9506BE28-673E-456E-836B-84E1D2BFBEE2_4001_13">1.00</us-gaap:MinorityInterestOwnershipPercentageByParent>
  <us-gaap:PreferredStockSharesOutstanding contextRef="eol_PE749074--1410-Q0003_STD_0_20140331_0" unitRef="shares" decimals="INF" id="id_3828183_59DF8DE0-8C90-4F39-B893-63E357C8A273_2_6">0</us-gaap:PreferredStockSharesOutstanding>
  <us-gaap:PreferredStockSharesIssued contextRef="eol_PE749074--1410-Q0003_STD_0_20140331_0" unitRef="shares" decimals="INF" id="id_3828183_59DF8DE0-8C90-4F39-B893-63E357C8A273_2_5">0</us-gaap:PreferredStockSharesIssued>
  <us-gaap:AdditionalPaidInCapital contextRef="eol_PE749074--1410-Q0003_STD_0_20140331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_320C22B7-2B9C-4492-B469-8F01480B8AB2_1_63">124713456</us-gaap:AdditionalPaidInCapital>
  <us-gaap:LiabilitiesCurrent contextRef="eol_PE749074--1410-Q0003_STD_0_20140331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_320C22B7-2B9C-4492-B469-8F01480B8AB2_1_16">1237602</us-gaap:LiabilitiesCurrent>
  <us-gaap:LongTermLoansFromBank contextRef="eol_PE749074--1410-Q0003_STD_0_20140331_0" unitRef="iso4217_USD" xsi:nil="true" id="id_3828183_5F9CA8B8-3F40-492B-90A7-3D9A2ED4413D_1_1" />
  <us-gaap:OtherLiabilitiesNoncurrent contextRef="eol_PE749074--1410-Q0003_STD_0_20140331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_320C22B7-2B9C-4492-B469-8F01480B8AB2_1_21">7047</us-gaap:OtherLiabilitiesNoncurrent>
  <us-gaap:StockholdersEquity contextRef="eol_PE749074--1410-Q0003_STD_0_20140331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_D8629002-FCA3-41A1-8253-7BBD181ADE71_3011_18">55097242</us-gaap:StockholdersEquity>
  <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="eol_PE749074--1410-Q0003_STD_0_20140331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_320C22B7-2B9C-4492-B469-8F01480B8AB2_1_13">1220695</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
  <us-gaap:LoansPayableToBankCurrent contextRef="eol_PE749074--1410-Q0003_STD_0_20140331_0" unitRef="iso4217_USD" xsi:nil="true" id="id_3828183_5F9CA8B8-3F40-492B-90A7-3D9A2ED4413D_1_0" />
  <us-gaap:DerivativeLiabilitiesNoncurrent contextRef="eol_PE749074--1410-Q0003_STD_0_20140331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_320C22B7-2B9C-4492-B469-8F01480B8AB2_1_17">107597</us-gaap:DerivativeLiabilitiesNoncurrent>
  <us-gaap:LiabilitiesAndStockholdersEquity contextRef="eol_PE749074--1410-Q0003_STD_0_20140331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_320C22B7-2B9C-4492-B469-8F01480B8AB2_1_66">56449488</us-gaap:LiabilitiesAndStockholdersEquity>
  <us-gaap:DeferredTaxLiabilitiesNoncurrent contextRef="eol_PE749074--1410-Q0003_STD_0_20140331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_B21D375E-A414-411D-BC9F-EF594B3E7CA8_1_0">1797412</us-gaap:DeferredTaxLiabilitiesNoncurrent>
  <us-gaap:LineOfCreditFacilityAmountOutstanding contextRef="eol_PE749074--1410-Q0003_STD_0_20140331_0" unitRef="iso4217_USD" xsi:nil="true" id="id_3828183_5F9CA8B8-3F40-492B-90A7-3D9A2ED4413D_1_2" />
  <us-gaap:Liabilities contextRef="eol_PE749074--1410-Q0003_STD_0_20140331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_320C22B7-2B9C-4492-B469-8F01480B8AB2_1_22">1352246</us-gaap:Liabilities>
  <us-gaap:OtherLiabilitiesCurrent contextRef="eol_PE749074--1410-Q0003_STD_0_20140331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_320C22B7-2B9C-4492-B469-8F01480B8AB2_1_15">16907</us-gaap:OtherLiabilitiesCurrent>
  <us-gaap:AssetsCurrent contextRef="eol_PE749074--1410-Q0003_STD_0_20140331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_320C22B7-2B9C-4492-B469-8F01480B8AB2_1_7">56246765</us-gaap:AssetsCurrent>
  <us-gaap:AccountsAndOtherReceivablesNetCurrent contextRef="eol_PE749074--1410-Q0003_STD_0_20140331_0" unitRef="iso4217_USD" decimals="INF" id="id_3828183_320C22B7-2B9C-4492-B469-8F01480B8AB2_1_4">66526</us-gaap:AccountsAndOtherReceivablesNetCurrent>
  <us-gaap:OtherAssetsNoncurrent contextRef="eol_PE749074--1410-Q0003_STD_0_20140331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_320C22B7-2B9C-4492-B469-8F01480B8AB2_1_9">135344</us-gaap:OtherAssetsNoncurrent>
  <us-gaap:PrepaidExpenseCurrent contextRef="eol_PE749074--1410-Q0003_STD_0_20140331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_320C22B7-2B9C-4492-B469-8F01480B8AB2_1_5">547812</us-gaap:PrepaidExpenseCurrent>
  <us-gaap:Assets contextRef="eol_PE749074--1410-Q0003_STD_0_20140331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_320C22B7-2B9C-4492-B469-8F01480B8AB2_1_10">56449488</us-gaap:Assets>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="eol_PE749074--1410-Q0003_STD_0_20140331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_D0D9B892-D792-4EF6-8610-549C9177FDD2_1_2">52918327</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:ShortTermInvestments contextRef="eol_PE749074--1410-Q0003_STD_0_20140331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_320C22B7-2B9C-4492-B469-8F01480B8AB2_1_3">2714100</us-gaap:ShortTermInvestments>
  <us-gaap:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage contextRef="eol_PE749074--1410-Q0003_STD_0_20140331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_320C22B7-2B9C-4492-B469-8F01480B8AB2_1_64">69616225</us-gaap:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage>
  <us-gaap:Cash contextRef="eol_PE749074--1410-Q0003_STD_0_20140331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_D0D9B892-D792-4EF6-8610-549C9177FDD2_1_0">49538874</us-gaap:Cash>
  <us-gaap:CashEquivalentsAtCarryingValue contextRef="eol_PE749074--1410-Q0003_STD_0_20140331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_D0D9B892-D792-4EF6-8610-549C9177FDD2_1_1">3379453</us-gaap:CashEquivalentsAtCarryingValue>
  <us-gaap:PropertyPlantAndEquipmentNet contextRef="eol_PE749074--1410-Q0003_STD_0_20140331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_320C22B7-2B9C-4492-B469-8F01480B8AB2_1_8">67379</us-gaap:PropertyPlantAndEquipmentNet>
  <aqxp:UnrecognizedShareBasedCompensationExpense contextRef="eol_PE749074--1410-Q0003_STD_0_20140331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_D7DB1E75-9691-489E-BBF0-238ED21F4881_1001_1">1485971</aqxp:UnrecognizedShareBasedCompensationExpense>
  <us-gaap:TemporaryEquitySharesOutstanding contextRef="eol_PE749074--1410-Q0003_STD_0_20140331_0_921954x1258858_932980x1031975" unitRef="shares" decimals="INF" id="id_3828183_320C22B7-2B9C-4492-B469-8F01480B8AB2_1001_48">0</us-gaap:TemporaryEquitySharesOutstanding>
  <us-gaap:TemporaryEquityParOrStatedValuePerShare contextRef="eol_PE749074--1410-Q0003_STD_0_20140331_0_921954x1258858_932980x1031975" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_3828183_320C22B7-2B9C-4492-B469-8F01480B8AB2_1001_45">0</us-gaap:TemporaryEquityParOrStatedValuePerShare>
  <us-gaap:TemporaryEquitySharesIssued contextRef="eol_PE749074--1410-Q0003_STD_0_20140331_0_921954x1258858_932980x1031975" unitRef="shares" decimals="INF" id="id_3828183_320C22B7-2B9C-4492-B469-8F01480B8AB2_1001_47">0</us-gaap:TemporaryEquitySharesIssued>
  <aqxp:TemporaryEquitySharesAuthorizedUnlimited contextRef="eol_PE749074--1410-Q0003_STD_0_20140331_0_921954x1258858_932980x1031975" id="id_3828183_320C22B7-2B9C-4492-B469-8F01480B8AB2_1001_46">Unlimited</aqxp:TemporaryEquitySharesAuthorizedUnlimited>
  <us-gaap:TemporaryEquitySharesOutstanding contextRef="eol_PE749074--1410-Q0003_STD_0_20140331_0_921954x1258858_932980x1124615" unitRef="shares" decimals="INF" id="id_3828183_320C22B7-2B9C-4492-B469-8F01480B8AB2_2001_38">0</us-gaap:TemporaryEquitySharesOutstanding>
  <us-gaap:TemporaryEquityParOrStatedValuePerShare contextRef="eol_PE749074--1410-Q0003_STD_0_20140331_0_921954x1258858_932980x1124615" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_3828183_320C22B7-2B9C-4492-B469-8F01480B8AB2_2001_35">0</us-gaap:TemporaryEquityParOrStatedValuePerShare>
  <us-gaap:TemporaryEquitySharesIssued contextRef="eol_PE749074--1410-Q0003_STD_0_20140331_0_921954x1258858_932980x1124615" unitRef="shares" decimals="INF" id="id_3828183_320C22B7-2B9C-4492-B469-8F01480B8AB2_2001_37">0</us-gaap:TemporaryEquitySharesIssued>
  <aqxp:TemporaryEquitySharesAuthorizedUnlimited contextRef="eol_PE749074--1410-Q0003_STD_0_20140331_0_921954x1258858_932980x1124615" id="id_3828183_320C22B7-2B9C-4492-B469-8F01480B8AB2_2001_36">Unlimited</aqxp:TemporaryEquitySharesAuthorizedUnlimited>
  <us-gaap:TemporaryEquitySharesOutstanding contextRef="eol_PE749074--1410-Q0003_STD_0_20140331_0_921954x1258858_932980x980486" unitRef="shares" decimals="INF" id="id_3828183_320C22B7-2B9C-4492-B469-8F01480B8AB2_3001_28">0</us-gaap:TemporaryEquitySharesOutstanding>
  <us-gaap:TemporaryEquityParOrStatedValuePerShare contextRef="eol_PE749074--1410-Q0003_STD_0_20140331_0_921954x1258858_932980x980486" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_3828183_320C22B7-2B9C-4492-B469-8F01480B8AB2_3001_25">0</us-gaap:TemporaryEquityParOrStatedValuePerShare>
  <us-gaap:TemporaryEquitySharesIssued contextRef="eol_PE749074--1410-Q0003_STD_0_20140331_0_921954x1258858_932980x980486" unitRef="shares" decimals="INF" id="id_3828183_320C22B7-2B9C-4492-B469-8F01480B8AB2_3001_27">0</us-gaap:TemporaryEquitySharesIssued>
  <aqxp:TemporaryEquitySharesAuthorizedUnlimited contextRef="eol_PE749074--1410-Q0003_STD_0_20140331_0_921954x1258858_932980x980486" id="id_3828183_320C22B7-2B9C-4492-B469-8F01480B8AB2_3001_26">Unlimited</aqxp:TemporaryEquitySharesAuthorizedUnlimited>
  <us-gaap:TemporaryEquitySharesAuthorized contextRef="eol_PE749074--1410-Q0003_STD_0_20140331_0_921954x1258870_932980x930400" unitRef="shares" decimals="INF" id="id_3828183_320C22B7-2B9C-4492-B469-8F01480B8AB2_4001_51">0</us-gaap:TemporaryEquitySharesAuthorized>
  <us-gaap:TemporaryEquitySharesOutstanding contextRef="eol_PE749074--1410-Q0003_STD_0_20140331_0_921954x1258870_932980x930400" unitRef="shares" decimals="INF" id="id_3828183_320C22B7-2B9C-4492-B469-8F01480B8AB2_4001_53">0</us-gaap:TemporaryEquitySharesOutstanding>
  <us-gaap:TemporaryEquityParOrStatedValuePerShare contextRef="eol_PE749074--1410-Q0003_STD_0_20140331_0_921954x1258870_932980x930400" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_3828183_320C22B7-2B9C-4492-B469-8F01480B8AB2_4001_50">0.000001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
  <us-gaap:TemporaryEquitySharesIssued contextRef="eol_PE749074--1410-Q0003_STD_0_20140331_0_921954x1258870_932980x930400" unitRef="shares" decimals="INF" id="id_3828183_320C22B7-2B9C-4492-B469-8F01480B8AB2_4001_52">0</us-gaap:TemporaryEquitySharesIssued>
  <us-gaap:TemporaryEquitySharesAuthorized contextRef="eol_PE749074--1410-Q0003_STD_0_20140331_0_921954x1258870_932980x930435" unitRef="shares" decimals="INF" id="id_3828183_320C22B7-2B9C-4492-B469-8F01480B8AB2_5001_31">0</us-gaap:TemporaryEquitySharesAuthorized>
  <us-gaap:TemporaryEquitySharesOutstanding contextRef="eol_PE749074--1410-Q0003_STD_0_20140331_0_921954x1258870_932980x930435" unitRef="shares" decimals="INF" id="id_3828183_320C22B7-2B9C-4492-B469-8F01480B8AB2_5001_33">0</us-gaap:TemporaryEquitySharesOutstanding>
  <us-gaap:TemporaryEquityParOrStatedValuePerShare contextRef="eol_PE749074--1410-Q0003_STD_0_20140331_0_921954x1258870_932980x930435" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_3828183_320C22B7-2B9C-4492-B469-8F01480B8AB2_5001_30">0.000001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
  <us-gaap:TemporaryEquitySharesIssued contextRef="eol_PE749074--1410-Q0003_STD_0_20140331_0_921954x1258870_932980x930435" unitRef="shares" decimals="INF" id="id_3828183_320C22B7-2B9C-4492-B469-8F01480B8AB2_5001_32">0</us-gaap:TemporaryEquitySharesIssued>
  <us-gaap:CommonStockSharesOutstanding contextRef="eol_PE749074--1410-Q0003_STD_0_20140331_0_921954x1258870_932980x930643" unitRef="shares" decimals="INF" id="id_3828183_320C22B7-2B9C-4492-B469-8F01480B8AB2_6001_62">10675260</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:SharesOutstanding contextRef="eol_PE749074--1410-Q0003_STD_0_20140331_0_921954x1258870_932980x930643" unitRef="shares" decimals="INF" id="id_3828183_D8629002-FCA3-41A1-8253-7BBD181ADE71_3007_19">10675260</us-gaap:SharesOutstanding>
  <us-gaap:CommonStockSharesIssued contextRef="eol_PE749074--1410-Q0003_STD_0_20140331_0_921954x1258870_932980x930643" unitRef="shares" decimals="INF" id="id_3828183_320C22B7-2B9C-4492-B469-8F01480B8AB2_6001_61">10675260</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockSharesAuthorized contextRef="eol_PE749074--1410-Q0003_STD_0_20140331_0_921954x1258870_932980x930643" unitRef="shares" decimals="INF" id="id_3828183_320C22B7-2B9C-4492-B469-8F01480B8AB2_6001_60">50000000</us-gaap:CommonStockSharesAuthorized>
  <us-gaap:CommonStockParOrStatedValuePerShare contextRef="eol_PE749074--1410-Q0003_STD_0_20140331_0_921954x1258870_932980x930643" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_3828183_320C22B7-2B9C-4492-B469-8F01480B8AB2_6001_59">0.000001</us-gaap:CommonStockParOrStatedValuePerShare>
  <us-gaap:StockholdersEquity contextRef="eol_PE749074--1410-Q0003_STD_0_20140331_0_921954x1258870_932980x930643" unitRef="iso4217_USD" decimals="0" id="id_3828183_D8629002-FCA3-41A1-8253-7BBD181ADE71_3007_18">11</us-gaap:StockholdersEquity>
  <us-gaap:CommonStockValue contextRef="eol_PE749074--1410-Q0003_STD_0_20140331_0_921954x1258870_932980x930643" unitRef="iso4217_USD" decimals="0" id="id_3828183_320C22B7-2B9C-4492-B469-8F01480B8AB2_6001_58">11</us-gaap:CommonStockValue>
  <us-gaap:TemporaryEquitySharesAuthorized contextRef="eol_PE749074--1410-Q0003_STD_0_20140331_0_921954x1258870_932980x932774" unitRef="shares" decimals="INF" id="id_3828183_320C22B7-2B9C-4492-B469-8F01480B8AB2_7001_41">0</us-gaap:TemporaryEquitySharesAuthorized>
  <us-gaap:TemporaryEquitySharesOutstanding contextRef="eol_PE749074--1410-Q0003_STD_0_20140331_0_921954x1258870_932980x932774" unitRef="shares" decimals="INF" id="id_3828183_320C22B7-2B9C-4492-B469-8F01480B8AB2_7001_43">0</us-gaap:TemporaryEquitySharesOutstanding>
  <us-gaap:TemporaryEquityParOrStatedValuePerShare contextRef="eol_PE749074--1410-Q0003_STD_0_20140331_0_921954x1258870_932980x932774" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_3828183_320C22B7-2B9C-4492-B469-8F01480B8AB2_7001_40">0.000001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
  <us-gaap:TemporaryEquitySharesIssued contextRef="eol_PE749074--1410-Q0003_STD_0_20140331_0_921954x1258870_932980x932774" unitRef="shares" decimals="INF" id="id_3828183_320C22B7-2B9C-4492-B469-8F01480B8AB2_7001_42">0</us-gaap:TemporaryEquitySharesIssued>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="eol_PE749074--1410-Q0003_STD_0_20140331_0_923497x921516" unitRef="iso4217_USD" decimals="0" id="id_3828183_508BB1D7-F0E3-45FA-A833-4D4B19A35DDA_1001_0">51116586</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <aqxp:ClassOfWarrantOrRightExercisable contextRef="eol_PE749074--1410-Q0003_STD_0_20140331_0_923791x1022881_924808x1094993" unitRef="shares" decimals="INF" id="id_3828183_75B3D74B-CB61-4623-AC7D-BCB98AA4CDDD_2002_2">11363</aqxp:ClassOfWarrantOrRightExercisable>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="eol_PE749074--1410-Q0003_STD_0_20140331_0_927592x923761_929665x1155513_929790x929831" unitRef="iso4217_USD" decimals="0" id="id_3828183_88C874F4-1774-4B50-83DF-28C30B050A79_4001_4">107597</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="eol_PE749074--1410-Q0003_STD_0_20140331_0_927592x932258_929665x933016_929790x929831" unitRef="iso4217_USD" xsi:nil="true" id="id_3828183_88C874F4-1774-4B50-83DF-28C30B050A79_4002_4" />
  <us-gaap:CommonStockSharesOutstanding contextRef="eol_PE749074--1410-Q0003_STD_0_20140331_0_928373x1060520" unitRef="shares" decimals="INF" id="id_3828183_1197415A-10F7-4DDB-8E53-3BDE88CCE32F_1001_2">5845260</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="eol_PE749074--1410-Q0003_STD_0_20140331_0_928373x1060520" unitRef="shares" decimals="INF" id="id_3828183_1197415A-10F7-4DDB-8E53-3BDE88CCE32F_1001_3">628754</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="eol_PE749074--1410-Q0003_STD_0_20140331_0_928373x1060520" unitRef="shares" decimals="INF" id="id_3828183_1197415A-10F7-4DDB-8E53-3BDE88CCE32F_1001_4">11363</us-gaap:ClassOfWarrantOrRightOutstanding>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="eol_PE749074--1410-Q0003_STD_0_20140331_0_929790x929831" unitRef="iso4217_USD" decimals="0" id="id_3828183_88C874F4-1774-4B50-83DF-28C30B050A79_4003_4">107597</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
  <us-gaap:StockholdersEquity contextRef="eol_PE749074--1410-Q0003_STD_0_20140331_0_932980x932209" unitRef="iso4217_USD" decimals="0" id="id_3828183_D8629002-FCA3-41A1-8253-7BBD181ADE71_3010_18">-69616225</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE749074--1410-Q0003_STD_0_20140331_0_932980x932586" unitRef="iso4217_USD" decimals="0" id="id_3828183_D8629002-FCA3-41A1-8253-7BBD181ADE71_3009_18">124713456</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE749074--1410-Q0003_STD_0_20041231_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_1011_4">-11388</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding contextRef="eol_PE749074--1410-Q0003_STD_0_20041231_0_921954x1258858_932980x1099142" unitRef="shares" decimals="INF" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_1005_5">416660</us-gaap:SharesOutstanding>
  <us-gaap:StockholdersEquity contextRef="eol_PE749074--1410-Q0003_STD_0_20041231_0_921954x1258858_932980x1099142" unitRef="iso4217_USD" decimals="0" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_1005_4">800</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE749074--1410-Q0003_STD_0_20041231_0_932980x932209" unitRef="iso4217_USD" decimals="0" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_1010_4">-12188</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE749074--1410-Q0003_STD_0_20051231_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_3011_9">-31013</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding contextRef="eol_PE749074--1410-Q0003_STD_0_20051231_0_921954x1258858_932980x1099142" unitRef="shares" decimals="INF" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_3005_10">234368</us-gaap:SharesOutstanding>
  <us-gaap:StockholdersEquity contextRef="eol_PE749074--1410-Q0003_STD_0_20051231_0_921954x1258858_932980x1099142" unitRef="iso4217_USD" decimals="0" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_3005_9">450</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE749074--1410-Q0003_STD_0_20051231_0_932980x932209" unitRef="iso4217_USD" decimals="0" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_3010_9">-31463</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE749074--1410-Q0003_STD_0_20061231_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_5011_17">10708</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding contextRef="eol_PE749074--1410-Q0003_STD_0_20061231_0_921954x1258858_932980x1099142" unitRef="shares" decimals="INF" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_5005_18">301745</us-gaap:SharesOutstanding>
  <us-gaap:StockholdersEquity contextRef="eol_PE749074--1410-Q0003_STD_0_20061231_0_921954x1258858_932980x1099142" unitRef="iso4217_USD" decimals="0" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_5005_17">534735</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE749074--1410-Q0003_STD_0_20061231_0_932980x932209" unitRef="iso4217_USD" decimals="0" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_5010_17">-574515</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE749074--1410-Q0003_STD_0_20061231_0_932980x932586" unitRef="iso4217_USD" decimals="0" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_5009_17">50488</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE749074--1410-Q0003_STD_0_20071231_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_7011_27">-2425747</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding contextRef="eol_PE749074--1410-Q0003_STD_0_20071231_0_921954x1258858_932980x932377" unitRef="shares" decimals="INF" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_7001_28">506927</us-gaap:SharesOutstanding>
  <us-gaap:StockholdersEquity contextRef="eol_PE749074--1410-Q0003_STD_0_20071231_0_921954x1258858_932980x932377" unitRef="iso4217_USD" decimals="0" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_7001_27">5272672</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding contextRef="eol_PE749074--1410-Q0003_STD_0_20071231_0_921954x1258870_932980x930643" unitRef="shares" decimals="INF" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_7007_28">301745</us-gaap:SharesOutstanding>
  <us-gaap:SharesOutstanding contextRef="eol_PE749074--1410-Q0003_STD_0_20071231_0_921954x1258870_932980x932258" unitRef="shares" decimals="INF" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_7003_28">397726</us-gaap:SharesOutstanding>
  <us-gaap:StockholdersEquity contextRef="eol_PE749074--1410-Q0003_STD_0_20071231_0_921954x1258870_932980x932258" unitRef="iso4217_USD" decimals="0" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_7003_27">4113116</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE749074--1410-Q0003_STD_0_20071231_0_932980x932209" unitRef="iso4217_USD" decimals="0" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_7010_27">-2648073</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE749074--1410-Q0003_STD_0_20071231_0_932980x932586" unitRef="iso4217_USD" decimals="0" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_7009_27">222326</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE749074--1410-Q0003_STD_0_20081231_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_9011_35">-8929597</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding contextRef="eol_PE749074--1410-Q0003_STD_0_20081231_0_921954x1258858_932980x932377" unitRef="shares" decimals="INF" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_9001_36">648971</us-gaap:SharesOutstanding>
  <us-gaap:StockholdersEquity contextRef="eol_PE749074--1410-Q0003_STD_0_20081231_0_921954x1258858_932980x932377" unitRef="iso4217_USD" decimals="0" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_9001_35">7384066</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding contextRef="eol_PE749074--1410-Q0003_STD_0_20081231_0_921954x1258870_932980x930643" unitRef="shares" decimals="INF" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_9007_36">301745</us-gaap:SharesOutstanding>
  <us-gaap:SharesOutstanding contextRef="eol_PE749074--1410-Q0003_STD_0_20081231_0_921954x1258870_932980x932258" unitRef="shares" decimals="INF" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_9003_36">530301</us-gaap:SharesOutstanding>
  <us-gaap:StockholdersEquity contextRef="eol_PE749074--1410-Q0003_STD_0_20081231_0_921954x1258870_932980x932258" unitRef="iso4217_USD" decimals="0" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_9003_35">6016643</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE749074--1410-Q0003_STD_0_20081231_0_932980x932209" unitRef="iso4217_USD" decimals="0" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_9010_35">-8929597</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE749074--1410-Q0003_STD_0_20091231_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_11011_44">-14105745</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding contextRef="eol_PE749074--1410-Q0003_STD_0_20091231_0_921954x1258858_932980x932377" unitRef="shares" decimals="INF" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_11001_45">791016</us-gaap:SharesOutstanding>
  <us-gaap:StockholdersEquity contextRef="eol_PE749074--1410-Q0003_STD_0_20091231_0_921954x1258858_932980x932377" unitRef="iso4217_USD" decimals="0" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_11001_44">9644565</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding contextRef="eol_PE749074--1410-Q0003_STD_0_20091231_0_921954x1258870_932980x930643" unitRef="shares" decimals="INF" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_11007_45">301745</us-gaap:SharesOutstanding>
  <us-gaap:SharesOutstanding contextRef="eol_PE749074--1410-Q0003_STD_0_20091231_0_921954x1258870_932980x932258" unitRef="shares" decimals="INF" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_11003_45">662875</us-gaap:SharesOutstanding>
  <us-gaap:StockholdersEquity contextRef="eol_PE749074--1410-Q0003_STD_0_20091231_0_921954x1258870_932980x932258" unitRef="iso4217_USD" decimals="0" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_11003_44">8054338</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE749074--1410-Q0003_STD_0_20091231_0_932980x932209" unitRef="iso4217_USD" decimals="0" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_11010_44">-14105745</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE749074--1410-Q0003_STD_0_20101231_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_1011_11">-25113553</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding contextRef="eol_PE749074--1410-Q0003_STD_0_20101231_0_921954x1258858_932980x932377" unitRef="shares" decimals="INF" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_1001_12">1215515</us-gaap:SharesOutstanding>
  <us-gaap:StockholdersEquity contextRef="eol_PE749074--1410-Q0003_STD_0_20101231_0_921954x1258858_932980x932377" unitRef="iso4217_USD" decimals="0" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_1001_11">15019034</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding contextRef="eol_PE749074--1410-Q0003_STD_0_20101231_0_921954x1258870_932980x930643" unitRef="shares" decimals="INF" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_1007_12">301745</us-gaap:SharesOutstanding>
  <us-gaap:SharesOutstanding contextRef="eol_PE749074--1410-Q0003_STD_0_20101231_0_921954x1258870_932980x932258" unitRef="shares" decimals="INF" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_1003_12">1454447</us-gaap:SharesOutstanding>
  <us-gaap:StockholdersEquity contextRef="eol_PE749074--1410-Q0003_STD_0_20101231_0_921954x1258870_932980x932258" unitRef="iso4217_USD" decimals="0" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_1003_11">17249937</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE749074--1410-Q0003_STD_0_20101231_0_932980x932209" unitRef="iso4217_USD" decimals="0" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_1010_11">-25113553</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE749074--1410-Q0003_STD_0_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_3011_21">-39314581</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding contextRef="eol_PE749074--1410-Q0003_STD_0_20111231_0_921954x1258858_932980x932377" unitRef="shares" decimals="INF" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_3001_22">1584633</us-gaap:SharesOutstanding>
  <us-gaap:StockholdersEquity contextRef="eol_PE749074--1410-Q0003_STD_0_20111231_0_921954x1258858_932980x932377" unitRef="iso4217_USD" decimals="0" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_3001_21">20442122</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding contextRef="eol_PE749074--1410-Q0003_STD_0_20111231_0_921954x1258870_932980x930643" unitRef="shares" decimals="INF" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_3007_22">301745</us-gaap:SharesOutstanding>
  <us-gaap:SharesOutstanding contextRef="eol_PE749074--1410-Q0003_STD_0_20111231_0_921954x1258870_932980x932258" unitRef="shares" decimals="INF" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_3003_22">2236672</us-gaap:SharesOutstanding>
  <us-gaap:StockholdersEquity contextRef="eol_PE749074--1410-Q0003_STD_0_20111231_0_921954x1258870_932980x932258" unitRef="iso4217_USD" decimals="0" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_3003_21">27458826</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE749074--1410-Q0003_STD_0_20111231_0_932980x932209" unitRef="iso4217_USD" decimals="0" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_3010_21">-39314581</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE749074--1410-Q0003_STD_0_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_5011_29">-51101207</us-gaap:StockholdersEquity>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="eol_PE749074--1410-Q0003_STD_0_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_AFF72D6D-AE4F-4009-8AA9-58E6D13FB48C_3001_36">2000539</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:SharesOutstanding contextRef="eol_PE749074--1410-Q0003_STD_0_20121231_0_921954x1258858_932980x932377" unitRef="shares" decimals="INF" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_5001_30">1584633</us-gaap:SharesOutstanding>
  <us-gaap:StockholdersEquity contextRef="eol_PE749074--1410-Q0003_STD_0_20121231_0_921954x1258858_932980x932377" unitRef="iso4217_USD" decimals="0" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_5001_29">22183732</us-gaap:StockholdersEquity>
  <us-gaap:SharesOutstanding contextRef="eol_PE749074--1410-Q0003_STD_0_20121231_0_921954x1258870_932980x930643" unitRef="shares" decimals="INF" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_5007_30">301745</us-gaap:SharesOutstanding>
  <us-gaap:SharesOutstanding contextRef="eol_PE749074--1410-Q0003_STD_0_20121231_0_921954x1258870_932980x932258" unitRef="shares" decimals="INF" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_5003_30">2236672</us-gaap:SharesOutstanding>
  <us-gaap:StockholdersEquity contextRef="eol_PE749074--1410-Q0003_STD_0_20121231_0_921954x1258870_932980x932258" unitRef="iso4217_USD" decimals="0" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_5003_29">29791506</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="eol_PE749074--1410-Q0003_STD_0_20121231_0_932980x932209" unitRef="iso4217_USD" decimals="0" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_5010_29">-51101207</us-gaap:StockholdersEquity>
  <us-gaap:PreferredStockSharesOutstanding contextRef="eol_PE749074--1410-Q0003_STD_0_20131231_0" unitRef="shares" decimals="INF" id="id_3828183_59DF8DE0-8C90-4F39-B893-63E357C8A273_3_6">0</us-gaap:PreferredStockSharesOutstanding>
  <us-gaap:PreferredStockSharesIssued contextRef="eol_PE749074--1410-Q0003_STD_0_20131231_0" unitRef="shares" decimals="INF" id="id_3828183_59DF8DE0-8C90-4F39-B893-63E357C8A273_3_5">0</us-gaap:PreferredStockSharesIssued>
  <us-gaap:LiabilitiesCurrent contextRef="eol_PE749074--1410-Q0003_STD_0_20131231_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_320C22B7-2B9C-4492-B469-8F01480B8AB2_2_16">2620105</us-gaap:LiabilitiesCurrent>
  <us-gaap:LongTermLoansFromBank contextRef="eol_PE749074--1410-Q0003_STD_0_20131231_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_5F9CA8B8-3F40-492B-90A7-3D9A2ED4413D_2_1">2036489</us-gaap:LongTermLoansFromBank>
  <us-gaap:OtherLiabilitiesNoncurrent contextRef="eol_PE749074--1410-Q0003_STD_0_20131231_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_320C22B7-2B9C-4492-B469-8F01480B8AB2_2_21">8560</us-gaap:OtherLiabilitiesNoncurrent>
  <us-gaap:StockholdersEquity contextRef="eol_PE749074--1410-Q0003_STD_0_20131231_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_7011_46">-65693708</us-gaap:StockholdersEquity>
  <us-gaap:TemporaryEquityCarryingAmountAttributableToParent contextRef="eol_PE749074--1410-Q0003_STD_0_20131231_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_320C22B7-2B9C-4492-B469-8F01480B8AB2_2_54">73858722</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
  <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="eol_PE749074--1410-Q0003_STD_0_20131231_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_320C22B7-2B9C-4492-B469-8F01480B8AB2_2_13">2350660</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
  <us-gaap:LoansPayableToBankCurrent contextRef="eol_PE749074--1410-Q0003_STD_0_20131231_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_5F9CA8B8-3F40-492B-90A7-3D9A2ED4413D_2_0">250000</us-gaap:LoansPayableToBankCurrent>
  <us-gaap:DerivativeLiabilitiesNoncurrent contextRef="eol_PE749074--1410-Q0003_STD_0_20131231_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_320C22B7-2B9C-4492-B469-8F01480B8AB2_2_17">221320</us-gaap:DerivativeLiabilitiesNoncurrent>
  <us-gaap:LiabilitiesAndStockholdersEquity contextRef="eol_PE749074--1410-Q0003_STD_0_20131231_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_320C22B7-2B9C-4492-B469-8F01480B8AB2_2_66">15649106</us-gaap:LiabilitiesAndStockholdersEquity>
  <us-gaap:DeferredTaxLiabilitiesNoncurrent contextRef="eol_PE749074--1410-Q0003_STD_0_20131231_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_320C22B7-2B9C-4492-B469-8F01480B8AB2_2_19">1797412</us-gaap:DeferredTaxLiabilitiesNoncurrent>
  <us-gaap:LineOfCreditFacilityAmountOutstanding contextRef="eol_PE749074--1410-Q0003_STD_0_20131231_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_11FC9E3C-4A9B-47E5-A970-456EC739AB84_3001_5">2286489</us-gaap:LineOfCreditFacilityAmountOutstanding>
  <us-gaap:Liabilities contextRef="eol_PE749074--1410-Q0003_STD_0_20131231_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_320C22B7-2B9C-4492-B469-8F01480B8AB2_2_22">7484092</us-gaap:Liabilities>
  <us-gaap:OtherLiabilitiesCurrent contextRef="eol_PE749074--1410-Q0003_STD_0_20131231_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_320C22B7-2B9C-4492-B469-8F01480B8AB2_2_15">19445</us-gaap:OtherLiabilitiesCurrent>
  <us-gaap:AssetsCurrent contextRef="eol_PE749074--1410-Q0003_STD_0_20131231_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_320C22B7-2B9C-4492-B469-8F01480B8AB2_2_7">15296351</us-gaap:AssetsCurrent>
  <us-gaap:AccountsAndOtherReceivablesNetCurrent contextRef="eol_PE749074--1410-Q0003_STD_0_20131231_0" unitRef="iso4217_USD" decimals="INF" id="id_3828183_320C22B7-2B9C-4492-B469-8F01480B8AB2_2_4">27946</us-gaap:AccountsAndOtherReceivablesNetCurrent>
  <us-gaap:OtherAssetsNoncurrent contextRef="eol_PE749074--1410-Q0003_STD_0_20131231_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_320C22B7-2B9C-4492-B469-8F01480B8AB2_2_9">277290</us-gaap:OtherAssetsNoncurrent>
  <us-gaap:PrepaidExpenseCurrent contextRef="eol_PE749074--1410-Q0003_STD_0_20131231_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_320C22B7-2B9C-4492-B469-8F01480B8AB2_2_5">63975</us-gaap:PrepaidExpenseCurrent>
  <us-gaap:DeferredOfferingCosts contextRef="eol_PE749074--1410-Q0003_STD_0_20131231_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_320C22B7-2B9C-4492-B469-8F01480B8AB2_2_6">1377438</us-gaap:DeferredOfferingCosts>
  <us-gaap:Assets contextRef="eol_PE749074--1410-Q0003_STD_0_20131231_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_320C22B7-2B9C-4492-B469-8F01480B8AB2_2_10">15649106</us-gaap:Assets>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="eol_PE749074--1410-Q0003_STD_0_20131231_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_D0D9B892-D792-4EF6-8610-549C9177FDD2_2_2">11006392</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:ShortTermInvestments contextRef="eol_PE749074--1410-Q0003_STD_0_20131231_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_320C22B7-2B9C-4492-B469-8F01480B8AB2_2_3">2820600</us-gaap:ShortTermInvestments>
  <us-gaap:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage contextRef="eol_PE749074--1410-Q0003_STD_0_20131231_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_320C22B7-2B9C-4492-B469-8F01480B8AB2_2_64">65693708</us-gaap:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage>
  <us-gaap:Cash contextRef="eol_PE749074--1410-Q0003_STD_0_20131231_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_D0D9B892-D792-4EF6-8610-549C9177FDD2_2_0">7292116</us-gaap:Cash>
  <us-gaap:CashEquivalentsAtCarryingValue contextRef="eol_PE749074--1410-Q0003_STD_0_20131231_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_D0D9B892-D792-4EF6-8610-549C9177FDD2_2_1">3714276</us-gaap:CashEquivalentsAtCarryingValue>
  <us-gaap:PropertyPlantAndEquipmentNet contextRef="eol_PE749074--1410-Q0003_STD_0_20131231_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_320C22B7-2B9C-4492-B469-8F01480B8AB2_2_8">75465</us-gaap:PropertyPlantAndEquipmentNet>
  <aqxp:DerivativeLiabilitiesNoncurrentRedemptionOption contextRef="eol_PE749074--1410-Q0003_STD_0_20131231_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_320C22B7-2B9C-4492-B469-8F01480B8AB2_2_18">800206</aqxp:DerivativeLiabilitiesNoncurrentRedemptionOption>
  <us-gaap:TemporaryEquitySharesOutstanding contextRef="eol_PE749074--1410-Q0003_STD_0_20131231_0_921954x1258858_932980x1031975" unitRef="shares" decimals="INF" id="id_3828183_320C22B7-2B9C-4492-B469-8F01480B8AB2_1002_48">378786</us-gaap:TemporaryEquitySharesOutstanding>
  <us-gaap:TemporaryEquityParOrStatedValuePerShare contextRef="eol_PE749074--1410-Q0003_STD_0_20131231_0_921954x1258858_932980x1031975" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_3828183_320C22B7-2B9C-4492-B469-8F01480B8AB2_1002_45">0</us-gaap:TemporaryEquityParOrStatedValuePerShare>
  <us-gaap:TemporaryEquitySharesIssued contextRef="eol_PE749074--1410-Q0003_STD_0_20131231_0_921954x1258858_932980x1031975" unitRef="shares" decimals="INF" id="id_3828183_320C22B7-2B9C-4492-B469-8F01480B8AB2_1002_47">378786</us-gaap:TemporaryEquitySharesIssued>
  <us-gaap:TemporaryEquityCarryingAmountAttributableToParent contextRef="eol_PE749074--1410-Q0003_STD_0_20131231_0_921954x1258858_932980x1031975" unitRef="iso4217_USD" decimals="0" id="id_3828183_320C22B7-2B9C-4492-B469-8F01480B8AB2_1002_44">3830961</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
  <aqxp:TemporaryEquitySharesAuthorizedUnlimited contextRef="eol_PE749074--1410-Q0003_STD_0_20131231_0_921954x1258858_932980x1031975" id="id_3828183_320C22B7-2B9C-4492-B469-8F01480B8AB2_1002_46">Unlimited</aqxp:TemporaryEquitySharesAuthorizedUnlimited>
  <us-gaap:TemporaryEquitySharesOutstanding contextRef="eol_PE749074--1410-Q0003_STD_0_20131231_0_921954x1258858_932980x1124615" unitRef="shares" decimals="INF" id="id_3828183_320C22B7-2B9C-4492-B469-8F01480B8AB2_2002_38">793617</us-gaap:TemporaryEquitySharesOutstanding>
  <us-gaap:TemporaryEquityParOrStatedValuePerShare contextRef="eol_PE749074--1410-Q0003_STD_0_20131231_0_921954x1258858_932980x1124615" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_3828183_320C22B7-2B9C-4492-B469-8F01480B8AB2_2002_35">0</us-gaap:TemporaryEquityParOrStatedValuePerShare>
  <us-gaap:TemporaryEquitySharesIssued contextRef="eol_PE749074--1410-Q0003_STD_0_20131231_0_921954x1258858_932980x1124615" unitRef="shares" decimals="INF" id="id_3828183_320C22B7-2B9C-4492-B469-8F01480B8AB2_2002_37">793617</us-gaap:TemporaryEquitySharesIssued>
  <us-gaap:TemporaryEquityCarryingAmountAttributableToParent contextRef="eol_PE749074--1410-Q0003_STD_0_20131231_0_921954x1258858_932980x1124615" unitRef="iso4217_USD" decimals="0" id="id_3828183_320C22B7-2B9C-4492-B469-8F01480B8AB2_2002_34">10684093</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
  <aqxp:TemporaryEquitySharesAuthorizedUnlimited contextRef="eol_PE749074--1410-Q0003_STD_0_20131231_0_921954x1258858_932980x1124615" id="id_3828183_320C22B7-2B9C-4492-B469-8F01480B8AB2_2002_36">Unlimited</aqxp:TemporaryEquitySharesAuthorizedUnlimited>
  <us-gaap:SharesOutstanding contextRef="eol_PE749074--1410-Q0003_STD_0_20131231_0_921954x1258858_932980x932377" unitRef="shares" decimals="INF" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_7001_47">1963419</us-gaap:SharesOutstanding>
  <us-gaap:StockholdersEquity contextRef="eol_PE749074--1410-Q0003_STD_0_20131231_0_921954x1258858_932980x932377" unitRef="iso4217_USD" decimals="0" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_7001_46">27844693</us-gaap:StockholdersEquity>
  <us-gaap:TemporaryEquitySharesOutstanding contextRef="eol_PE749074--1410-Q0003_STD_0_20131231_0_921954x1258858_932980x980486" unitRef="shares" decimals="INF" id="id_3828183_320C22B7-2B9C-4492-B469-8F01480B8AB2_3002_28">791016</us-gaap:TemporaryEquitySharesOutstanding>
  <us-gaap:TemporaryEquityParOrStatedValuePerShare contextRef="eol_PE749074--1410-Q0003_STD_0_20131231_0_921954x1258858_932980x980486" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_3828183_320C22B7-2B9C-4492-B469-8F01480B8AB2_3002_25">0</us-gaap:TemporaryEquityParOrStatedValuePerShare>
  <us-gaap:TemporaryEquitySharesIssued contextRef="eol_PE749074--1410-Q0003_STD_0_20131231_0_921954x1258858_932980x980486" unitRef="shares" decimals="INF" id="id_3828183_320C22B7-2B9C-4492-B469-8F01480B8AB2_3002_27">791016</us-gaap:TemporaryEquitySharesIssued>
  <us-gaap:TemporaryEquityCarryingAmountAttributableToParent contextRef="eol_PE749074--1410-Q0003_STD_0_20131231_0_921954x1258858_932980x980486" unitRef="iso4217_USD" decimals="0" id="id_3828183_320C22B7-2B9C-4492-B469-8F01480B8AB2_3002_24">13329639</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
  <aqxp:TemporaryEquitySharesAuthorizedUnlimited contextRef="eol_PE749074--1410-Q0003_STD_0_20131231_0_921954x1258858_932980x980486" id="id_3828183_320C22B7-2B9C-4492-B469-8F01480B8AB2_3002_26">Unlimited</aqxp:TemporaryEquitySharesAuthorizedUnlimited>
  <us-gaap:TemporaryEquitySharesAuthorized contextRef="eol_PE749074--1410-Q0003_STD_0_20131231_0_921954x1258870_932980x930400" unitRef="shares" decimals="INF" id="id_3828183_320C22B7-2B9C-4492-B469-8F01480B8AB2_4002_51">45793738</us-gaap:TemporaryEquitySharesAuthorized>
  <us-gaap:TemporaryEquitySharesOutstanding contextRef="eol_PE749074--1410-Q0003_STD_0_20131231_0_921954x1258870_932980x930400" unitRef="shares" decimals="INF" id="id_3828183_320C22B7-2B9C-4492-B469-8F01480B8AB2_4002_53">1343424</us-gaap:TemporaryEquitySharesOutstanding>
  <us-gaap:TemporaryEquityParOrStatedValuePerShare contextRef="eol_PE749074--1410-Q0003_STD_0_20131231_0_921954x1258870_932980x930400" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_3828183_320C22B7-2B9C-4492-B469-8F01480B8AB2_4002_50">0.000001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
  <us-gaap:TemporaryEquitySharesIssued contextRef="eol_PE749074--1410-Q0003_STD_0_20131231_0_921954x1258870_932980x930400" unitRef="shares" decimals="INF" id="id_3828183_320C22B7-2B9C-4492-B469-8F01480B8AB2_4002_52">1343424</us-gaap:TemporaryEquitySharesIssued>
  <us-gaap:TemporaryEquityCarryingAmountAttributableToParent contextRef="eol_PE749074--1410-Q0003_STD_0_20131231_0_921954x1258870_932980x930400" unitRef="iso4217_USD" decimals="0" id="id_3828183_320C22B7-2B9C-4492-B469-8F01480B8AB2_4002_49">13765741</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
  <us-gaap:TemporaryEquitySharesAuthorized contextRef="eol_PE749074--1410-Q0003_STD_0_20131231_0_921954x1258870_932980x930435" unitRef="shares" decimals="INF" id="id_3828183_320C22B7-2B9C-4492-B469-8F01480B8AB2_5002_31">27914951</us-gaap:TemporaryEquitySharesAuthorized>
  <us-gaap:TemporaryEquitySharesOutstanding contextRef="eol_PE749074--1410-Q0003_STD_0_20131231_0_921954x1258870_932980x930435" unitRef="shares" decimals="INF" id="id_3828183_320C22B7-2B9C-4492-B469-8F01480B8AB2_5002_33">662875</us-gaap:TemporaryEquitySharesOutstanding>
  <us-gaap:TemporaryEquityParOrStatedValuePerShare contextRef="eol_PE749074--1410-Q0003_STD_0_20131231_0_921954x1258870_932980x930435" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_3828183_320C22B7-2B9C-4492-B469-8F01480B8AB2_5002_30">0.000001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
  <us-gaap:TemporaryEquitySharesIssued contextRef="eol_PE749074--1410-Q0003_STD_0_20131231_0_921954x1258870_932980x930435" unitRef="shares" decimals="INF" id="id_3828183_320C22B7-2B9C-4492-B469-8F01480B8AB2_5002_32">662875</us-gaap:TemporaryEquitySharesIssued>
  <us-gaap:TemporaryEquityCarryingAmountAttributableToParent contextRef="eol_PE749074--1410-Q0003_STD_0_20131231_0_921954x1258870_932980x930435" unitRef="iso4217_USD" decimals="0" id="id_3828183_320C22B7-2B9C-4492-B469-8F01480B8AB2_5002_29">11157138</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
  <us-gaap:CommonStockSharesOutstanding contextRef="eol_PE749074--1410-Q0003_STD_0_20131231_0_921954x1258870_932980x930643" unitRef="shares" decimals="INF" id="id_3828183_320C22B7-2B9C-4492-B469-8F01480B8AB2_6002_62">301745</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:SharesOutstanding contextRef="eol_PE749074--1410-Q0003_STD_0_20131231_0_921954x1258870_932980x930643" unitRef="shares" decimals="INF" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_7007_47">301745</us-gaap:SharesOutstanding>
  <us-gaap:CommonStockSharesIssued contextRef="eol_PE749074--1410-Q0003_STD_0_20131231_0_921954x1258870_932980x930643" unitRef="shares" decimals="INF" id="id_3828183_320C22B7-2B9C-4492-B469-8F01480B8AB2_6002_61">301745</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockSharesAuthorized contextRef="eol_PE749074--1410-Q0003_STD_0_20131231_0_921954x1258870_932980x930643" unitRef="shares" decimals="INF" id="id_3828183_320C22B7-2B9C-4492-B469-8F01480B8AB2_6002_60">139266037</us-gaap:CommonStockSharesAuthorized>
  <us-gaap:CommonStockParOrStatedValuePerShare contextRef="eol_PE749074--1410-Q0003_STD_0_20131231_0_921954x1258870_932980x930643" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_3828183_320C22B7-2B9C-4492-B469-8F01480B8AB2_6002_59">0.000001</us-gaap:CommonStockParOrStatedValuePerShare>
  <us-gaap:SharesOutstanding contextRef="eol_PE749074--1410-Q0003_STD_0_20131231_0_921954x1258870_932980x932258" unitRef="shares" decimals="INF" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_7003_47">3580096</us-gaap:SharesOutstanding>
  <us-gaap:StockholdersEquity contextRef="eol_PE749074--1410-Q0003_STD_0_20131231_0_921954x1258870_932980x932258" unitRef="iso4217_USD" decimals="0" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_7003_46">46014029</us-gaap:StockholdersEquity>
  <aqxp:WarrantsExercised contextRef="eol_PE749074--1410-Q0003_STD_0_20131231_0_921954x1258870_932980x932258" unitRef="shares" decimals="INF" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_7003_33">415431</aqxp:WarrantsExercised>
  <us-gaap:TemporaryEquitySharesAuthorized contextRef="eol_PE749074--1410-Q0003_STD_0_20131231_0_921954x1258870_932980x932774" unitRef="shares" decimals="INF" id="id_3828183_320C22B7-2B9C-4492-B469-8F01480B8AB2_7002_41">45454535</us-gaap:TemporaryEquitySharesAuthorized>
  <us-gaap:TemporaryEquitySharesOutstanding contextRef="eol_PE749074--1410-Q0003_STD_0_20131231_0_921954x1258870_932980x932774" unitRef="shares" decimals="INF" id="id_3828183_320C22B7-2B9C-4492-B469-8F01480B8AB2_7002_43">1573797</us-gaap:TemporaryEquitySharesOutstanding>
  <us-gaap:TemporaryEquityParOrStatedValuePerShare contextRef="eol_PE749074--1410-Q0003_STD_0_20131231_0_921954x1258870_932980x932774" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_3828183_320C22B7-2B9C-4492-B469-8F01480B8AB2_7002_40">0.000001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
  <us-gaap:TemporaryEquitySharesIssued contextRef="eol_PE749074--1410-Q0003_STD_0_20131231_0_921954x1258870_932980x932774" unitRef="shares" decimals="INF" id="id_3828183_320C22B7-2B9C-4492-B469-8F01480B8AB2_7002_42">1573797</us-gaap:TemporaryEquitySharesIssued>
  <us-gaap:TemporaryEquityCarryingAmountAttributableToParent contextRef="eol_PE749074--1410-Q0003_STD_0_20131231_0_921954x1258870_932980x932774" unitRef="iso4217_USD" decimals="0" id="id_3828183_320C22B7-2B9C-4492-B469-8F01480B8AB2_7002_39">21091150</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="eol_PE749074--1410-Q0003_STD_0_20131231_0_923497x921516" unitRef="iso4217_USD" decimals="0" id="id_3828183_508BB1D7-F0E3-45FA-A833-4D4B19A35DDA_1002_0">6629383</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity contextRef="eol_PE749074--1410-Q0003_STD_0_20131231_0_924808x1094993" unitRef="iso4217_USD" decimals="-5" id="id_3828183_B2B8E234-ED5C-4917-AAE8-38950FF2B967_1003_2">1500000</us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="eol_PE749074--1410-Q0003_STD_0_20131231_0_927592x923761_929665x1155513_929790x929831" unitRef="iso4217_USD" decimals="0" id="id_3828183_88C874F4-1774-4B50-83DF-28C30B050A79_1001_1">221320</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="eol_PE749074--1410-Q0003_STD_0_20131231_0_927592x932258_929665x933016_929790x929831" unitRef="iso4217_USD" decimals="0" id="id_3828183_88C874F4-1774-4B50-83DF-28C30B050A79_1002_1">800206</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="eol_PE749074--1410-Q0003_STD_0_20131231_0_929790x929831" unitRef="iso4217_USD" decimals="0" id="id_3828183_88C874F4-1774-4B50-83DF-28C30B050A79_1003_1">1021526</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
  <us-gaap:StockholdersEquity contextRef="eol_PE749074--1410-Q0003_STD_0_20131231_0_932980x932209" unitRef="iso4217_USD" decimals="0" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_7010_46">-65693708</us-gaap:StockholdersEquity>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized contextRef="eol_PE749074--1410-Q0003_STD_0_20140127_0_932980x1118518" unitRef="shares" decimals="INF" id="id_3828183_EFF42460-DAC5-4DE7-ADB7-350B1EF44574_2001_0">1423416</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
  <us-gaap:ComprehensiveIncomeNetOfTax contextRef="eol_PE749074--1410-Q0003_STD_19_20140331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_D8629002-FCA3-41A1-8253-7BBD181ADE71_5011_17">-838306</us-gaap:ComprehensiveIncomeNetOfTax>
  <us-gaap:StockIssuedDuringPeriodValueIssuedForCash contextRef="eol_PE749074--1410-Q0003_STD_19_20140331_0" unitRef="iso4217_USD" decimals="INF" id="id_3828183_D8629002-FCA3-41A1-8253-7BBD181ADE71_5011_13">47341278</us-gaap:StockIssuedDuringPeriodValueIssuedForCash>
  <us-gaap:AllocatedShareBasedCompensationExpense contextRef="eol_PE749074--1410-Q0003_STD_19_20140331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_D8629002-FCA3-41A1-8253-7BBD181ADE71_5011_16">38237</us-gaap:AllocatedShareBasedCompensationExpense>
  <aqxp:ConversionOfPreferredStockIntoCommonStock contextRef="eol_PE749074--1410-Q0003_STD_19_20140331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_D8629002-FCA3-41A1-8253-7BBD181ADE71_5011_11">77333952</aqxp:ConversionOfPreferredStockIntoCommonStock>
  <aqxp:ConversionOfPreferredStockIntoCommonStock contextRef="eol_PE749074--1410-Q0003_STD_19_20140331_0_921954x1258858_932980x932377" unitRef="iso4217_USD" decimals="0" id="id_3828183_D8629002-FCA3-41A1-8253-7BBD181ADE71_5001_11">-28824651</aqxp:ConversionOfPreferredStockIntoCommonStock>
  <aqxp:ConversionOfPreferredStockIntoCommonStockShares contextRef="eol_PE749074--1410-Q0003_STD_19_20140331_0_921954x1258858_932980x932377" unitRef="shares" decimals="INF" id="id_3828183_D8629002-FCA3-41A1-8253-7BBD181ADE71_5001_12">-1963419</aqxp:ConversionOfPreferredStockIntoCommonStockShares>
  <us-gaap:StockIssuedDuringPeriodSharesIssuedForCash contextRef="eol_PE749074--1410-Q0003_STD_19_20140331_0_921954x1258870_932980x930643" unitRef="shares" decimals="INF" id="id_3828183_D8629002-FCA3-41A1-8253-7BBD181ADE71_5007_14">4830000</us-gaap:StockIssuedDuringPeriodSharesIssuedForCash>
  <us-gaap:StockIssuedDuringPeriodValueIssuedForCash contextRef="eol_PE749074--1410-Q0003_STD_19_20140331_0_921954x1258870_932980x930643" unitRef="iso4217_USD" decimals="INF" id="id_3828183_D8629002-FCA3-41A1-8253-7BBD181ADE71_5007_13">4</us-gaap:StockIssuedDuringPeriodValueIssuedForCash>
  <us-gaap:PaymentOfFinancingAndStockIssuanceCosts contextRef="eol_PE749074--1410-Q0003_STD_19_20140331_0_921954x1258870_932980x930643" unitRef="iso4217_USD" decimals="0" id="id_3828183_D8629002-FCA3-41A1-8253-7BBD181ADE71_5007_15">5788726</us-gaap:PaymentOfFinancingAndStockIssuanceCosts>
  <aqxp:ConversionOfPreferredStockIntoCommonStock contextRef="eol_PE749074--1410-Q0003_STD_19_20140331_0_921954x1258870_932980x930643" unitRef="iso4217_USD" decimals="0" id="id_3828183_D8629002-FCA3-41A1-8253-7BBD181ADE71_5007_11">7</aqxp:ConversionOfPreferredStockIntoCommonStock>
  <aqxp:ConversionOfPreferredStockIntoCommonStockShares contextRef="eol_PE749074--1410-Q0003_STD_19_20140331_0_921954x1258870_932980x930643" unitRef="shares" decimals="INF" id="id_3828183_D8629002-FCA3-41A1-8253-7BBD181ADE71_5007_12">5543515</aqxp:ConversionOfPreferredStockIntoCommonStockShares>
  <aqxp:ConversionOfPreferredStockIntoCommonStock contextRef="eol_PE749074--1410-Q0003_STD_19_20140331_0_921954x1258870_932980x932258" unitRef="iso4217_USD" decimals="0" id="id_3828183_D8629002-FCA3-41A1-8253-7BBD181ADE71_5003_11">-48509974</aqxp:ConversionOfPreferredStockIntoCommonStock>
  <aqxp:ConversionOfPreferredStockIntoCommonStockShares contextRef="eol_PE749074--1410-Q0003_STD_19_20140331_0_921954x1258870_932980x932258" unitRef="shares" decimals="INF" id="id_3828183_D8629002-FCA3-41A1-8253-7BBD181ADE71_5003_12">-3580096</aqxp:ConversionOfPreferredStockIntoCommonStockShares>
  <us-gaap:ComprehensiveIncomeNetOfTax contextRef="eol_PE749074--1410-Q0003_STD_19_20140331_0_932980x932209" unitRef="iso4217_USD" decimals="0" id="id_3828183_D8629002-FCA3-41A1-8253-7BBD181ADE71_5010_17">-838306</us-gaap:ComprehensiveIncomeNetOfTax>
  <us-gaap:StockIssuedDuringPeriodValueIssuedForCash contextRef="eol_PE749074--1410-Q0003_STD_19_20140331_0_932980x932586" unitRef="iso4217_USD" decimals="INF" id="id_3828183_D8629002-FCA3-41A1-8253-7BBD181ADE71_5009_13">47341274</us-gaap:StockIssuedDuringPeriodValueIssuedForCash>
  <us-gaap:AllocatedShareBasedCompensationExpense contextRef="eol_PE749074--1410-Q0003_STD_19_20140331_0_932980x932586" unitRef="iso4217_USD" decimals="0" id="id_3828183_D8629002-FCA3-41A1-8253-7BBD181ADE71_5009_16">38237</us-gaap:AllocatedShareBasedCompensationExpense>
  <aqxp:ConversionOfPreferredStockIntoCommonStock contextRef="eol_PE749074--1410-Q0003_STD_19_20140331_0_932980x932586" unitRef="iso4217_USD" decimals="0" id="id_3828183_D8629002-FCA3-41A1-8253-7BBD181ADE71_5009_11">77333945</aqxp:ConversionOfPreferredStockIntoCommonStock>
  <us-gaap:StockholdersEquityNoteStockSplitConversionRatio1 contextRef="eol_PE749074--1410-Q0003_STD_2_20140227_0" unitRef="pure" decimals="6" id="id_3828183_3044021B-5375-4FD0-BE16-43D4C411C0D8_2_1">0.052083</us-gaap:StockholdersEquityNoteStockSplitConversionRatio1>
  <aqxp:NumberOfNonEmployeeDirectors contextRef="eol_PE749074--1410-Q0003_STD_2_20140306_0" unitRef="Directors" decimals="INF" id="id_3828183_E9970AEF-3511-415B-84F0-098FF8D50BBC_1_2">4</aqxp:NumberOfNonEmployeeDirectors>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="eol_PE749074--1410-Q0003_STD_2_20140306_0_925175x1032852" unitRef="shares" decimals="INF" id="id_3828183_E9970AEF-3511-415B-84F0-098FF8D50BBC_1001_0">33332</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
  <us-gaap:DeferredCompensationArrangementWithIndividualExercisePrice contextRef="eol_PE749074--1410-Q0003_STD_2_20140306_0_925175x1032852" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_3828183_E9970AEF-3511-415B-84F0-098FF8D50BBC_1001_1">11.00</us-gaap:DeferredCompensationArrangementWithIndividualExercisePrice>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE749074--1410-Q0003_STD_2_20140312_0" unitRef="shares" decimals="INF" id="id_3828183_3BB72D2D-1402-4B6B-8730-A88FD94766C3_1_0">4830000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:PaymentOfFinancingAndStockIssuanceCosts contextRef="eol_PE749074--1410-Q0003_STD_2_20140312_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_3BB72D2D-1402-4B6B-8730-A88FD94766C3_1_4">5788726</us-gaap:PaymentOfFinancingAndStockIssuanceCosts>
  <aqxp:NetProceedsFromIssuanceInitialPublicOffering contextRef="eol_PE749074--1410-Q0003_STD_2_20140312_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_3BB72D2D-1402-4B6B-8730-A88FD94766C3_1_3">47341274</aqxp:NetProceedsFromIssuanceInitialPublicOffering>
  <us-gaap:ConversionOfStockSharesConverted1 contextRef="eol_PE749074--1410-Q0003_STD_2_20140312_0_921954x1258870_924791x1204322_932980x930643" unitRef="shares" decimals="INF" id="id_3828183_9506BE28-673E-456E-836B-84E1D2BFBEE2_2003_12">5543515</us-gaap:ConversionOfStockSharesConverted1>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE749074--1410-Q0003_STD_2_20140312_0_931707x960063" unitRef="shares" decimals="INF" id="id_3828183_3BB72D2D-1402-4B6B-8730-A88FD94766C3_1001_1">630000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:RepaymentsOfLinesOfCredit contextRef="eol_PE749074--1410-Q0003_STD_2_20140328_0_924808x1094993" unitRef="iso4217_USD" decimals="0" id="id_3828183_7FDFB0E4-2636-42D2-B849-0FA46AD2D9DF_1001_0">2609844</us-gaap:RepaymentsOfLinesOfCredit>
  <us-gaap:GainsLossesOnExtinguishmentOfDebt contextRef="eol_PE749074--1410-Q0003_STD_2_20140328_0_924808x1094993" unitRef="iso4217_USD" decimals="0" id="id_3828183_7FDFB0E4-2636-42D2-B849-0FA46AD2D9DF_1001_1">213511</us-gaap:GainsLossesOnExtinguishmentOfDebt>
  <us-gaap:ProceedsFromLinesOfCredit contextRef="eol_PE749074--1410-Q0003_STD_2_20131030_0_924808x1094993" unitRef="iso4217_USD" decimals="-5" id="id_3828183_B2B8E234-ED5C-4917-AAE8-38950FF2B967_1002_1">2500000</us-gaap:ProceedsFromLinesOfCredit>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="eol_PE749074--1410-Q0003_STD_2_20140127_0_930809x992678" unitRef="shares" decimals="INF" id="id_3828183_8DD1BABA-6405-49E7-957C-485756FE1D91_1001_0">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
  <aqxp:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedNew contextRef="eol_PE749074--1410-Q0003_STD_2_20140127_0_932980x1118518" unitRef="shares" decimals="INF" id="id_3828183_EFF42460-DAC5-4DE7-ADB7-350B1EF44574_1001_1">756279</aqxp:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedNew>
  <us-gaap:ComprehensiveIncomeNetOfTax contextRef="eol_PE749074--1410-Q0003_STD_365_20051231_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_4011_8">-19275</us-gaap:ComprehensiveIncomeNetOfTax>
  <us-gaap:StockRepurchasedDuringPeriodValue contextRef="eol_PE749074--1410-Q0003_STD_365_20051231_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_4011_6">350</us-gaap:StockRepurchasedDuringPeriodValue>
  <us-gaap:StockRepurchasedDuringPeriodShares contextRef="eol_PE749074--1410-Q0003_STD_365_20051231_0_921954x1258858_932980x1099142" unitRef="shares" decimals="INF" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_4005_7">182292</us-gaap:StockRepurchasedDuringPeriodShares>
  <us-gaap:StockRepurchasedDuringPeriodValue contextRef="eol_PE749074--1410-Q0003_STD_365_20051231_0_921954x1258858_932980x1099142" unitRef="iso4217_USD" decimals="0" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_4005_6">350</us-gaap:StockRepurchasedDuringPeriodValue>
  <us-gaap:ComprehensiveIncomeNetOfTax contextRef="eol_PE749074--1410-Q0003_STD_365_20051231_0_932980x932209" unitRef="iso4217_USD" decimals="0" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_4010_8">-19275</us-gaap:ComprehensiveIncomeNetOfTax>
  <us-gaap:ComprehensiveIncomeNetOfTax contextRef="eol_PE749074--1410-Q0003_STD_365_20061231_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_6011_16">-543052</us-gaap:ComprehensiveIncomeNetOfTax>
  <us-gaap:StockIssuedDuringPeriodValueIssuedForCash contextRef="eol_PE749074--1410-Q0003_STD_365_20061231_0" unitRef="iso4217_USD" decimals="INF" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_6011_11">489451</us-gaap:StockIssuedDuringPeriodValueIssuedForCash>
  <us-gaap:StockIssuedDuringPeriodValueIssuedForNoncashConsiderations contextRef="eol_PE749074--1410-Q0003_STD_365_20061231_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_6011_13">44834</us-gaap:StockIssuedDuringPeriodValueIssuedForNoncashConsiderations>
  <us-gaap:AllocatedShareBasedCompensationExpense contextRef="eol_PE749074--1410-Q0003_STD_365_20061231_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_6011_15">50488</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:StockIssuedDuringPeriodSharesIssuedForCash contextRef="eol_PE749074--1410-Q0003_STD_365_20061231_0_921954x1258858_932980x1099142" unitRef="shares" decimals="INF" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_6005_12">62169</us-gaap:StockIssuedDuringPeriodSharesIssuedForCash>
  <us-gaap:StockIssuedDuringPeriodSharesIssuedForNoncashConsideration contextRef="eol_PE749074--1410-Q0003_STD_365_20061231_0_921954x1258858_932980x1099142" unitRef="shares" decimals="INF" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_6005_14">5208</us-gaap:StockIssuedDuringPeriodSharesIssuedForNoncashConsideration>
  <us-gaap:StockIssuedDuringPeriodValueIssuedForCash contextRef="eol_PE749074--1410-Q0003_STD_365_20061231_0_921954x1258858_932980x1099142" unitRef="iso4217_USD" decimals="INF" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_6005_11">489451</us-gaap:StockIssuedDuringPeriodValueIssuedForCash>
  <us-gaap:StockIssuedDuringPeriodValueIssuedForNoncashConsiderations contextRef="eol_PE749074--1410-Q0003_STD_365_20061231_0_921954x1258858_932980x1099142" unitRef="iso4217_USD" decimals="0" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_6005_13">44834</us-gaap:StockIssuedDuringPeriodValueIssuedForNoncashConsiderations>
  <us-gaap:ComprehensiveIncomeNetOfTax contextRef="eol_PE749074--1410-Q0003_STD_365_20061231_0_932980x932209" unitRef="iso4217_USD" decimals="0" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_6010_16">-543052</us-gaap:ComprehensiveIncomeNetOfTax>
  <us-gaap:AllocatedShareBasedCompensationExpense contextRef="eol_PE749074--1410-Q0003_STD_365_20061231_0_932980x932586" unitRef="iso4217_USD" decimals="0" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_6009_15">50488</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:ComprehensiveIncomeNetOfTax contextRef="eol_PE749074--1410-Q0003_STD_365_20071231_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_8011_24">-2008534</us-gaap:ComprehensiveIncomeNetOfTax>
  <us-gaap:StockIssuedDuringPeriodValueIssuedForCash contextRef="eol_PE749074--1410-Q0003_STD_365_20071231_0" unitRef="iso4217_USD" decimals="INF" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_8011_21">10</us-gaap:StockIssuedDuringPeriodValueIssuedForCash>
  <us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment contextRef="eol_PE749074--1410-Q0003_STD_365_20071231_0" unitRef="iso4217_USD" decimals="INF" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_8011_26">65024</us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment>
  <us-gaap:AllocatedShareBasedCompensationExpense contextRef="eol_PE749074--1410-Q0003_STD_365_20071231_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_8011_23">78255</us-gaap:AllocatedShareBasedCompensationExpense>
  <aqxp:TemporaryEquityAccretionToRedemptionValueLiquidationPreference contextRef="eol_PE749074--1410-Q0003_STD_365_20071231_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_8011_25">441162</aqxp:TemporaryEquityAccretionToRedemptionValueLiquidationPreference>
  <us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits contextRef="eol_PE749074--1410-Q0003_STD_365_20071231_0_921954x1258858_932980x1099142" unitRef="shares" decimals="INF" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_8005_20">-301745</us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits contextRef="eol_PE749074--1410-Q0003_STD_365_20071231_0_921954x1258858_932980x1099142" unitRef="iso4217_USD" decimals="0" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_8005_19">-534735</us-gaap:StockIssuedDuringPeriodValueConversionOfUnits>
  <us-gaap:StockIssuedDuringPeriodSharesIssuedForCash contextRef="eol_PE749074--1410-Q0003_STD_365_20071231_0_921954x1258858_932980x932377" unitRef="shares" decimals="INF" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_8001_22">506927</us-gaap:StockIssuedDuringPeriodSharesIssuedForCash>
  <us-gaap:StockIssuedDuringPeriodValueIssuedForCash contextRef="eol_PE749074--1410-Q0003_STD_365_20071231_0_921954x1258858_932980x932377" unitRef="iso4217_USD" decimals="INF" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_8001_21">4992710</us-gaap:StockIssuedDuringPeriodValueIssuedForCash>
  <us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment contextRef="eol_PE749074--1410-Q0003_STD_365_20071231_0_921954x1258858_932980x932377" unitRef="iso4217_USD" decimals="INF" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_8001_26">-34800</us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment>
  <aqxp:TemporaryEquityAccretionToRedemptionValueLiquidationPreference contextRef="eol_PE749074--1410-Q0003_STD_365_20071231_0_921954x1258858_932980x932377" unitRef="iso4217_USD" decimals="0" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_8001_25">-245162</aqxp:TemporaryEquityAccretionToRedemptionValueLiquidationPreference>
  <us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits contextRef="eol_PE749074--1410-Q0003_STD_365_20071231_0_921954x1258870_932980x930643" unitRef="shares" decimals="INF" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_8007_20">301745</us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits>
  <us-gaap:StockIssuedDuringPeriodSharesIssuedForCash contextRef="eol_PE749074--1410-Q0003_STD_365_20071231_0_921954x1258870_932980x932258" unitRef="shares" decimals="INF" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_8003_22">397726</us-gaap:StockIssuedDuringPeriodSharesIssuedForCash>
  <us-gaap:StockIssuedDuringPeriodValueIssuedForCash contextRef="eol_PE749074--1410-Q0003_STD_365_20071231_0_921954x1258870_932980x932258" unitRef="iso4217_USD" decimals="INF" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_8003_21">3886892</us-gaap:StockIssuedDuringPeriodValueIssuedForCash>
  <us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment contextRef="eol_PE749074--1410-Q0003_STD_365_20071231_0_921954x1258870_932980x932258" unitRef="iso4217_USD" decimals="INF" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_8003_26">-30224</us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment>
  <aqxp:TemporaryEquityAccretionToRedemptionValueLiquidationPreference contextRef="eol_PE749074--1410-Q0003_STD_365_20071231_0_921954x1258870_932980x932258" unitRef="iso4217_USD" decimals="0" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_8003_25">-196000</aqxp:TemporaryEquityAccretionToRedemptionValueLiquidationPreference>
  <us-gaap:ComprehensiveIncomeNetOfTax contextRef="eol_PE749074--1410-Q0003_STD_365_20071231_0_932980x932209" unitRef="iso4217_USD" decimals="0" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_8010_24">-2008534</us-gaap:ComprehensiveIncomeNetOfTax>
  <us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment contextRef="eol_PE749074--1410-Q0003_STD_365_20071231_0_932980x932209" unitRef="iso4217_USD" decimals="INF" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_8010_26">65024</us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment>
  <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits contextRef="eol_PE749074--1410-Q0003_STD_365_20071231_0_932980x932586" unitRef="iso4217_USD" decimals="0" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_8009_19">534735</us-gaap:StockIssuedDuringPeriodValueConversionOfUnits>
  <us-gaap:StockIssuedDuringPeriodValueIssuedForCash contextRef="eol_PE749074--1410-Q0003_STD_365_20071231_0_932980x932586" unitRef="iso4217_USD" decimals="INF" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_8009_21">10</us-gaap:StockIssuedDuringPeriodValueIssuedForCash>
  <us-gaap:AllocatedShareBasedCompensationExpense contextRef="eol_PE749074--1410-Q0003_STD_365_20071231_0_932980x932586" unitRef="iso4217_USD" decimals="0" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_8009_23">78255</us-gaap:AllocatedShareBasedCompensationExpense>
  <aqxp:TemporaryEquityAccretionToRedemptionValueLiquidationPreference contextRef="eol_PE749074--1410-Q0003_STD_365_20071231_0_932980x932586" unitRef="iso4217_USD" decimals="0" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_8009_25">441162</aqxp:TemporaryEquityAccretionToRedemptionValueLiquidationPreference>
  <us-gaap:ComprehensiveIncomeNetOfTax contextRef="eol_PE749074--1410-Q0003_STD_365_20091231_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_13011_40">-3752070</us-gaap:ComprehensiveIncomeNetOfTax>
  <us-gaap:StockIssuedDuringPeriodValueIssuedForCash contextRef="eol_PE749074--1410-Q0003_STD_365_20091231_0" unitRef="iso4217_USD" decimals="INF" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_13011_37">3</us-gaap:StockIssuedDuringPeriodValueIssuedForCash>
  <us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment contextRef="eol_PE749074--1410-Q0003_STD_365_20091231_0" unitRef="iso4217_USD" decimals="INF" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_13011_42">159611</us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment>
  <us-gaap:AllocatedShareBasedCompensationExpense contextRef="eol_PE749074--1410-Q0003_STD_365_20091231_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_13011_39">111673</us-gaap:AllocatedShareBasedCompensationExpense>
  <aqxp:TemporaryEquityAccretionToRedemptionValueLiquidationPreference contextRef="eol_PE749074--1410-Q0003_STD_365_20091231_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_13011_41">1301400</aqxp:TemporaryEquityAccretionToRedemptionValueLiquidationPreference>
  <aqxp:IncomeTaxExpenseOnPreferredStock contextRef="eol_PE749074--1410-Q0003_STD_365_20091231_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_13011_43">74743</aqxp:IncomeTaxExpenseOnPreferredStock>
  <us-gaap:StockIssuedDuringPeriodSharesIssuedForCash contextRef="eol_PE749074--1410-Q0003_STD_365_20091231_0_921954x1258858_932980x932377" unitRef="shares" decimals="INF" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_13001_38">142045</us-gaap:StockIssuedDuringPeriodSharesIssuedForCash>
  <us-gaap:StockIssuedDuringPeriodValueIssuedForCash contextRef="eol_PE749074--1410-Q0003_STD_365_20091231_0_921954x1258858_932980x932377" unitRef="iso4217_USD" decimals="INF" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_13001_37">1467508</us-gaap:StockIssuedDuringPeriodValueIssuedForCash>
  <us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment contextRef="eol_PE749074--1410-Q0003_STD_365_20091231_0_921954x1258858_932980x932377" unitRef="iso4217_USD" decimals="INF" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_13001_42">-84954</us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment>
  <aqxp:TemporaryEquityAccretionToRedemptionValueLiquidationPreference contextRef="eol_PE749074--1410-Q0003_STD_365_20091231_0_921954x1258858_932980x932377" unitRef="iso4217_USD" decimals="0" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_13001_41">-708037</aqxp:TemporaryEquityAccretionToRedemptionValueLiquidationPreference>
  <us-gaap:StockIssuedDuringPeriodSharesIssuedForCash contextRef="eol_PE749074--1410-Q0003_STD_365_20091231_0_921954x1258870_932980x932258" unitRef="shares" decimals="INF" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_13003_38">132574</us-gaap:StockIssuedDuringPeriodSharesIssuedForCash>
  <us-gaap:StockIssuedDuringPeriodValueIssuedForCash contextRef="eol_PE749074--1410-Q0003_STD_365_20091231_0_921954x1258870_932980x932258" unitRef="iso4217_USD" decimals="INF" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_13003_37">1369675</us-gaap:StockIssuedDuringPeriodValueIssuedForCash>
  <us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment contextRef="eol_PE749074--1410-Q0003_STD_365_20091231_0_921954x1258870_932980x932258" unitRef="iso4217_USD" decimals="INF" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_13003_42">-74657</us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment>
  <aqxp:TemporaryEquityAccretionToRedemptionValueLiquidationPreference contextRef="eol_PE749074--1410-Q0003_STD_365_20091231_0_921954x1258870_932980x932258" unitRef="iso4217_USD" decimals="0" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_13003_41">-593363</aqxp:TemporaryEquityAccretionToRedemptionValueLiquidationPreference>
  <us-gaap:ComprehensiveIncomeNetOfTax contextRef="eol_PE749074--1410-Q0003_STD_365_20091231_0_932980x932209" unitRef="iso4217_USD" decimals="0" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_13010_40">-3752070</us-gaap:ComprehensiveIncomeNetOfTax>
  <us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment contextRef="eol_PE749074--1410-Q0003_STD_365_20091231_0_932980x932209" unitRef="iso4217_USD" decimals="INF" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_13010_42">159611</us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment>
  <aqxp:TemporaryEquityAccretionToRedemptionValueLiquidationPreference contextRef="eol_PE749074--1410-Q0003_STD_365_20091231_0_932980x932209" unitRef="iso4217_USD" decimals="0" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_13010_41">1189724</aqxp:TemporaryEquityAccretionToRedemptionValueLiquidationPreference>
  <aqxp:IncomeTaxExpenseOnPreferredStock contextRef="eol_PE749074--1410-Q0003_STD_365_20091231_0_932980x932209" unitRef="iso4217_USD" decimals="0" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_13010_43">74743</aqxp:IncomeTaxExpenseOnPreferredStock>
  <us-gaap:StockIssuedDuringPeriodValueIssuedForCash contextRef="eol_PE749074--1410-Q0003_STD_365_20091231_0_932980x932586" unitRef="iso4217_USD" decimals="INF" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_13009_37">3</us-gaap:StockIssuedDuringPeriodValueIssuedForCash>
  <us-gaap:AllocatedShareBasedCompensationExpense contextRef="eol_PE749074--1410-Q0003_STD_365_20091231_0_932980x932586" unitRef="iso4217_USD" decimals="0" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_13009_39">111673</us-gaap:AllocatedShareBasedCompensationExpense>
  <aqxp:TemporaryEquityAccretionToRedemptionValueLiquidationPreference contextRef="eol_PE749074--1410-Q0003_STD_365_20091231_0_932980x932586" unitRef="iso4217_USD" decimals="0" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_13009_41">111673</aqxp:TemporaryEquityAccretionToRedemptionValueLiquidationPreference>
  <us-gaap:ComprehensiveIncomeNetOfTax contextRef="eol_PE749074--1410-Q0003_STD_365_20101231_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_2011_6">-8529753</us-gaap:ComprehensiveIncomeNetOfTax>
  <us-gaap:StockIssuedDuringPeriodValueIssuedForCash contextRef="eol_PE749074--1410-Q0003_STD_365_20101231_0" unitRef="iso4217_USD" decimals="INF" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_2011_1">8</us-gaap:StockIssuedDuringPeriodValueIssuedForCash>
  <us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment contextRef="eol_PE749074--1410-Q0003_STD_365_20101231_0" unitRef="iso4217_USD" decimals="INF" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_2011_8">175467</us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment>
  <us-gaap:AllocatedShareBasedCompensationExpense contextRef="eol_PE749074--1410-Q0003_STD_365_20101231_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_2011_5">109256</us-gaap:AllocatedShareBasedCompensationExpense>
  <aqxp:TemporaryEquityAccretionToRedemptionValueLiquidationPreference contextRef="eol_PE749074--1410-Q0003_STD_365_20101231_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_2011_7">2167601</aqxp:TemporaryEquityAccretionToRedemptionValueLiquidationPreference>
  <aqxp:IncomeTaxExpenseOnPreferredStock contextRef="eol_PE749074--1410-Q0003_STD_365_20101231_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_2011_10">244251</aqxp:IncomeTaxExpenseOnPreferredStock>
  <us-gaap:StockIssuedDuringPeriodSharesIssuedForCash contextRef="eol_PE749074--1410-Q0003_STD_365_20101231_0_921954x1258858_932980x932377" unitRef="shares" decimals="INF" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_2001_2">424499</us-gaap:StockIssuedDuringPeriodSharesIssuedForCash>
  <us-gaap:StockIssuedDuringPeriodValueIssuedForCash contextRef="eol_PE749074--1410-Q0003_STD_365_20101231_0_921954x1258858_932980x932377" unitRef="iso4217_USD" decimals="INF" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_2001_1">4335318</us-gaap:StockIssuedDuringPeriodValueIssuedForCash>
  <us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment contextRef="eol_PE749074--1410-Q0003_STD_365_20101231_0_921954x1258858_932980x932377" unitRef="iso4217_USD" decimals="INF" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_2001_8">-78179</us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment>
  <aqxp:WarrantDiscount contextRef="eol_PE749074--1410-Q0003_STD_365_20101231_0_921954x1258858_932980x932377" unitRef="iso4217_USD" decimals="0" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_2001_4">226624</aqxp:WarrantDiscount>
  <aqxp:TemporaryEquityAccretionToRedemptionValueLiquidationPreference contextRef="eol_PE749074--1410-Q0003_STD_365_20101231_0_921954x1258858_932980x932377" unitRef="iso4217_USD" decimals="0" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_2001_7">-1053645</aqxp:TemporaryEquityAccretionToRedemptionValueLiquidationPreference>
  <aqxp:TemporaryEquityAccretionToRedemptionValueWarrantDiscount contextRef="eol_PE749074--1410-Q0003_STD_365_20101231_0_921954x1258858_932980x932377" unitRef="iso4217_USD" decimals="INF" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_2001_9">-16442</aqxp:TemporaryEquityAccretionToRedemptionValueWarrantDiscount>
  <aqxp:TemporaryEquityWarrantDiscount contextRef="eol_PE749074--1410-Q0003_STD_365_20101231_0_921954x1258858_932980x932377" unitRef="iso4217_USD" decimals="0" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_2001_3">109115</aqxp:TemporaryEquityWarrantDiscount>
  <us-gaap:StockIssuedDuringPeriodSharesIssuedForCash contextRef="eol_PE749074--1410-Q0003_STD_365_20101231_0_921954x1258870_932980x932258" unitRef="shares" decimals="INF" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_2003_2">791572</us-gaap:StockIssuedDuringPeriodSharesIssuedForCash>
  <us-gaap:StockIssuedDuringPeriodValueIssuedForCash contextRef="eol_PE749074--1410-Q0003_STD_365_20101231_0_921954x1258870_932980x932258" unitRef="iso4217_USD" decimals="INF" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_2003_1">8084158</us-gaap:StockIssuedDuringPeriodValueIssuedForCash>
  <us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment contextRef="eol_PE749074--1410-Q0003_STD_365_20101231_0_921954x1258870_932980x932258" unitRef="iso4217_USD" decimals="INF" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_2003_8">-97288</us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment>
  <aqxp:WarrantDiscount contextRef="eol_PE749074--1410-Q0003_STD_365_20101231_0_921954x1258870_932980x932258" unitRef="iso4217_USD" decimals="0" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_2003_4">226624</aqxp:WarrantDiscount>
  <aqxp:TemporaryEquityAccretionToRedemptionValueLiquidationPreference contextRef="eol_PE749074--1410-Q0003_STD_365_20101231_0_921954x1258870_932980x932258" unitRef="iso4217_USD" decimals="0" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_2003_7">-1113956</aqxp:TemporaryEquityAccretionToRedemptionValueLiquidationPreference>
  <aqxp:TemporaryEquityAccretionToRedemptionValueWarrantDiscount contextRef="eol_PE749074--1410-Q0003_STD_365_20101231_0_921954x1258870_932980x932258" unitRef="iso4217_USD" decimals="INF" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_2003_9">-17706</aqxp:TemporaryEquityAccretionToRedemptionValueWarrantDiscount>
  <aqxp:TemporaryEquityWarrantDiscount contextRef="eol_PE749074--1410-Q0003_STD_365_20101231_0_921954x1258870_932980x932258" unitRef="iso4217_USD" decimals="0" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_2003_3">117509</aqxp:TemporaryEquityWarrantDiscount>
  <us-gaap:ComprehensiveIncomeNetOfTax contextRef="eol_PE749074--1410-Q0003_STD_365_20101231_0_932980x932209" unitRef="iso4217_USD" decimals="0" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_2010_6">-8529753</us-gaap:ComprehensiveIncomeNetOfTax>
  <us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment contextRef="eol_PE749074--1410-Q0003_STD_365_20101231_0_932980x932209" unitRef="iso4217_USD" decimals="INF" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_2010_8">175467</us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment>
  <aqxp:TemporaryEquityAccretionToRedemptionValueLiquidationPreference contextRef="eol_PE749074--1410-Q0003_STD_365_20101231_0_932980x932209" unitRef="iso4217_USD" decimals="0" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_2010_7">2058337</aqxp:TemporaryEquityAccretionToRedemptionValueLiquidationPreference>
  <aqxp:IncomeTaxExpenseOnPreferredStock contextRef="eol_PE749074--1410-Q0003_STD_365_20101231_0_932980x932209" unitRef="iso4217_USD" decimals="0" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_2010_10">244251</aqxp:IncomeTaxExpenseOnPreferredStock>
  <us-gaap:StockIssuedDuringPeriodValueIssuedForCash contextRef="eol_PE749074--1410-Q0003_STD_365_20101231_0_932980x932586" unitRef="iso4217_USD" decimals="INF" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_2009_1">8</us-gaap:StockIssuedDuringPeriodValueIssuedForCash>
  <us-gaap:AllocatedShareBasedCompensationExpense contextRef="eol_PE749074--1410-Q0003_STD_365_20101231_0_932980x932586" unitRef="iso4217_USD" decimals="0" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_2009_5">109256</us-gaap:AllocatedShareBasedCompensationExpense>
  <aqxp:TemporaryEquityAccretionToRedemptionValueLiquidationPreference contextRef="eol_PE749074--1410-Q0003_STD_365_20101231_0_932980x932586" unitRef="iso4217_USD" decimals="0" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_2009_7">109264</aqxp:TemporaryEquityAccretionToRedemptionValueLiquidationPreference>
  <us-gaap:ComprehensiveIncomeNetOfTax contextRef="eol_PE749074--1410-Q0003_STD_365_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_4011_16">-10507008</us-gaap:ComprehensiveIncomeNetOfTax>
  <us-gaap:StockIssuedDuringPeriodValueIssuedForCash contextRef="eol_PE749074--1410-Q0003_STD_365_20111231_0" unitRef="iso4217_USD" decimals="INF" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_4011_13">7</us-gaap:StockIssuedDuringPeriodValueIssuedForCash>
  <us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment contextRef="eol_PE749074--1410-Q0003_STD_365_20111231_0" unitRef="iso4217_USD" decimals="INF" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_4011_18">163483</us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment>
  <us-gaap:AllocatedShareBasedCompensationExpense contextRef="eol_PE749074--1410-Q0003_STD_365_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_4011_15">118243</us-gaap:AllocatedShareBasedCompensationExpense>
  <aqxp:TemporaryEquityAccretionToRedemptionValueLiquidationPreference contextRef="eol_PE749074--1410-Q0003_STD_365_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_4011_17">3303200</aqxp:TemporaryEquityAccretionToRedemptionValueLiquidationPreference>
  <aqxp:IncomeTaxExpenseOnPreferredStock contextRef="eol_PE749074--1410-Q0003_STD_365_20111231_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_4011_20">345587</aqxp:IncomeTaxExpenseOnPreferredStock>
  <us-gaap:StockIssuedDuringPeriodSharesIssuedForCash contextRef="eol_PE749074--1410-Q0003_STD_365_20111231_0_921954x1258858_932980x932377" unitRef="shares" decimals="INF" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_4001_14">369118</us-gaap:StockIssuedDuringPeriodSharesIssuedForCash>
  <us-gaap:StockIssuedDuringPeriodValueIssuedForCash contextRef="eol_PE749074--1410-Q0003_STD_365_20111231_0_921954x1258858_932980x932377" unitRef="iso4217_USD" decimals="INF" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_4001_13">3885636</us-gaap:StockIssuedDuringPeriodValueIssuedForCash>
  <us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment contextRef="eol_PE749074--1410-Q0003_STD_365_20111231_0_921954x1258858_932980x932377" unitRef="iso4217_USD" decimals="INF" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_4001_18">-70509</us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment>
  <aqxp:TemporaryEquityAccretionToRedemptionValueLiquidationPreference contextRef="eol_PE749074--1410-Q0003_STD_365_20111231_0_921954x1258858_932980x932377" unitRef="iso4217_USD" decimals="0" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_4001_17">-1445120</aqxp:TemporaryEquityAccretionToRedemptionValueLiquidationPreference>
  <aqxp:TemporaryEquityAccretionToRedemptionValueWarrantDiscount contextRef="eol_PE749074--1410-Q0003_STD_365_20111231_0_921954x1258858_932980x932377" unitRef="iso4217_USD" decimals="INF" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_4001_19">-21823</aqxp:TemporaryEquityAccretionToRedemptionValueWarrantDiscount>
  <us-gaap:StockIssuedDuringPeriodSharesIssuedForCash contextRef="eol_PE749074--1410-Q0003_STD_365_20111231_0_921954x1258870_932980x932258" unitRef="shares" decimals="INF" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_4003_14">782225</us-gaap:StockIssuedDuringPeriodSharesIssuedForCash>
  <us-gaap:StockIssuedDuringPeriodValueIssuedForCash contextRef="eol_PE749074--1410-Q0003_STD_365_20111231_0_921954x1258870_932980x932258" unitRef="iso4217_USD" decimals="INF" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_4003_13">8234333</us-gaap:StockIssuedDuringPeriodValueIssuedForCash>
  <us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment contextRef="eol_PE749074--1410-Q0003_STD_365_20111231_0_921954x1258870_932980x932258" unitRef="iso4217_USD" decimals="INF" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_4003_18">-92974</us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment>
  <aqxp:TemporaryEquityAccretionToRedemptionValueLiquidationPreference contextRef="eol_PE749074--1410-Q0003_STD_365_20111231_0_921954x1258870_932980x932258" unitRef="iso4217_USD" decimals="0" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_4003_17">-1858080</aqxp:TemporaryEquityAccretionToRedemptionValueLiquidationPreference>
  <aqxp:TemporaryEquityAccretionToRedemptionValueWarrantDiscount contextRef="eol_PE749074--1410-Q0003_STD_365_20111231_0_921954x1258870_932980x932258" unitRef="iso4217_USD" decimals="INF" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_4003_19">-23502</aqxp:TemporaryEquityAccretionToRedemptionValueWarrantDiscount>
  <us-gaap:ComprehensiveIncomeNetOfTax contextRef="eol_PE749074--1410-Q0003_STD_365_20111231_0_932980x932209" unitRef="iso4217_USD" decimals="0" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_4010_16">-10507008</us-gaap:ComprehensiveIncomeNetOfTax>
  <us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment contextRef="eol_PE749074--1410-Q0003_STD_365_20111231_0_932980x932209" unitRef="iso4217_USD" decimals="INF" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_4010_18">163483</us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment>
  <aqxp:TemporaryEquityAccretionToRedemptionValueLiquidationPreference contextRef="eol_PE749074--1410-Q0003_STD_365_20111231_0_932980x932209" unitRef="iso4217_USD" decimals="0" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_4010_17">3184950</aqxp:TemporaryEquityAccretionToRedemptionValueLiquidationPreference>
  <aqxp:IncomeTaxExpenseOnPreferredStock contextRef="eol_PE749074--1410-Q0003_STD_365_20111231_0_932980x932209" unitRef="iso4217_USD" decimals="0" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_4010_20">345587</aqxp:IncomeTaxExpenseOnPreferredStock>
  <us-gaap:StockIssuedDuringPeriodValueIssuedForCash contextRef="eol_PE749074--1410-Q0003_STD_365_20111231_0_932980x932586" unitRef="iso4217_USD" decimals="INF" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_4009_13">7</us-gaap:StockIssuedDuringPeriodValueIssuedForCash>
  <us-gaap:AllocatedShareBasedCompensationExpense contextRef="eol_PE749074--1410-Q0003_STD_365_20111231_0_932980x932586" unitRef="iso4217_USD" decimals="0" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_4009_15">118243</us-gaap:AllocatedShareBasedCompensationExpense>
  <aqxp:TemporaryEquityAccretionToRedemptionValueLiquidationPreference contextRef="eol_PE749074--1410-Q0003_STD_365_20111231_0_932980x932586" unitRef="iso4217_USD" decimals="0" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_4009_17">118250</aqxp:TemporaryEquityAccretionToRedemptionValueLiquidationPreference>
  <us-gaap:ComprehensiveIncomeNetOfTax contextRef="eol_PE749074--1410-Q0003_STD_365_20131231_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_9011_40">-8729371</us-gaap:ComprehensiveIncomeNetOfTax>
  <us-gaap:StockIssuedDuringPeriodValueIssuedForCash contextRef="eol_PE749074--1410-Q0003_STD_365_20131231_0" unitRef="iso4217_USD" decimals="INF" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_9011_31">7</us-gaap:StockIssuedDuringPeriodValueIssuedForCash>
  <us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment contextRef="eol_PE749074--1410-Q0003_STD_365_20131231_0" unitRef="iso4217_USD" decimals="INF" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_9011_42">123074</us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment>
  <us-gaap:ProceedsFromLinesOfCredit contextRef="eol_PE749074--1410-Q0003_STD_365_20131231_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_11FC9E3C-4A9B-47E5-A970-456EC739AB84_4001_2">2500000</us-gaap:ProceedsFromLinesOfCredit>
  <us-gaap:AllocatedShareBasedCompensationExpense contextRef="eol_PE749074--1410-Q0003_STD_365_20131231_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_9011_39">349321</us-gaap:AllocatedShareBasedCompensationExpense>
  <aqxp:DiscountOnIssuanceOfWarrants contextRef="eol_PE749074--1410-Q0003_STD_365_20131231_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_11FC9E3C-4A9B-47E5-A970-456EC739AB84_4001_3">226255</aqxp:DiscountOnIssuanceOfWarrants>
  <aqxp:TemporaryEquityAccretionToRedemptionValueLiquidationPreference contextRef="eol_PE749074--1410-Q0003_STD_365_20131231_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_9011_41">5351459</aqxp:TemporaryEquityAccretionToRedemptionValueLiquidationPreference>
  <aqxp:IncomeTaxExpenseOnPreferredStock contextRef="eol_PE749074--1410-Q0003_STD_365_20131231_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_9011_45">737925</aqxp:IncomeTaxExpenseOnPreferredStock>
  <aqxp:PaymentsOfFinancingCostsDebt contextRef="eol_PE749074--1410-Q0003_STD_365_20131231_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_11FC9E3C-4A9B-47E5-A970-456EC739AB84_4001_4">12744</aqxp:PaymentsOfFinancingCostsDebt>
  <us-gaap:StockIssuedDuringPeriodSharesIssuedForCash contextRef="eol_PE749074--1410-Q0003_STD_365_20131231_0_921954x1258858_932980x932377" unitRef="shares" decimals="INF" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_9001_32">378786</us-gaap:StockIssuedDuringPeriodSharesIssuedForCash>
  <us-gaap:PreferredStockRedemptionDiscount contextRef="eol_PE749074--1410-Q0003_STD_365_20131231_0_921954x1258858_932980x932377" unitRef="iso4217_USD" decimals="INF" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_9001_38">466673</us-gaap:PreferredStockRedemptionDiscount>
  <us-gaap:StockIssuedDuringPeriodValueIssuedForCash contextRef="eol_PE749074--1410-Q0003_STD_365_20131231_0_921954x1258858_932980x932377" unitRef="iso4217_USD" decimals="INF" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_9001_31">3950228</us-gaap:StockIssuedDuringPeriodValueIssuedForCash>
  <us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment contextRef="eol_PE749074--1410-Q0003_STD_365_20131231_0_921954x1258858_932980x932377" unitRef="iso4217_USD" decimals="INF" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_9001_42">-45754</us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment>
  <aqxp:TemporaryEquityAccretionToRedemptionValueLiquidationPreference contextRef="eol_PE749074--1410-Q0003_STD_365_20131231_0_921954x1258858_932980x932377" unitRef="iso4217_USD" decimals="0" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_9001_41">-2036438</aqxp:TemporaryEquityAccretionToRedemptionValueLiquidationPreference>
  <aqxp:TemporaryEquityAccretionToRedemptionValueWarrantDiscount contextRef="eol_PE749074--1410-Q0003_STD_365_20131231_0_921954x1258858_932980x932377" unitRef="iso4217_USD" decimals="INF" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_9001_43">-21825</aqxp:TemporaryEquityAccretionToRedemptionValueWarrantDiscount>
  <aqxp:TemporaryEquityAccretionToRedemptionValueRedemptionOption contextRef="eol_PE749074--1410-Q0003_STD_365_20131231_0_921954x1258858_932980x932377" unitRef="iso4217_USD" decimals="INF" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_9001_44">73389</aqxp:TemporaryEquityAccretionToRedemptionValueRedemptionOption>
  <aqxp:TemporaryEquityRedemptionDiscount contextRef="eol_PE749074--1410-Q0003_STD_365_20131231_0_921954x1258858_932980x932377" unitRef="iso4217_USD" decimals="INF" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_9001_37">466673</aqxp:TemporaryEquityRedemptionDiscount>
  <us-gaap:StockIssuedDuringPeriodSharesIssuedForCash contextRef="eol_PE749074--1410-Q0003_STD_365_20131231_0_921954x1258870_932980x932258" unitRef="shares" decimals="INF" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_9003_32">1325753</us-gaap:StockIssuedDuringPeriodSharesIssuedForCash>
  <us-gaap:PreferredStockRedemptionDiscount contextRef="eol_PE749074--1410-Q0003_STD_365_20131231_0_921954x1258870_932980x932258" unitRef="iso4217_USD" decimals="INF" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_9003_38">1633357</us-gaap:PreferredStockRedemptionDiscount>
  <us-gaap:StockIssuedDuringPeriodValueIssuedForCash contextRef="eol_PE749074--1410-Q0003_STD_365_20131231_0_921954x1258870_932980x932258" unitRef="iso4217_USD" decimals="INF" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_9003_31">13825822</us-gaap:StockIssuedDuringPeriodValueIssuedForCash>
  <us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment contextRef="eol_PE749074--1410-Q0003_STD_365_20131231_0_921954x1258870_932980x932258" unitRef="iso4217_USD" decimals="INF" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_9003_42">-77320</us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment>
  <aqxp:WarrantsExercisedShares contextRef="eol_PE749074--1410-Q0003_STD_365_20131231_0_921954x1258870_932980x932258" unitRef="shares" decimals="INF" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_9003_34">17671</aqxp:WarrantsExercisedShares>
  <aqxp:WarrantDiscount contextRef="eol_PE749074--1410-Q0003_STD_365_20131231_0_921954x1258870_932980x932258" unitRef="iso4217_USD" decimals="0" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_9003_36">68920</aqxp:WarrantDiscount>
  <aqxp:TemporaryEquityAccretionToRedemptionValueLiquidationPreference contextRef="eol_PE749074--1410-Q0003_STD_365_20131231_0_921954x1258870_932980x932258" unitRef="iso4217_USD" decimals="0" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_9003_41">-3315021</aqxp:TemporaryEquityAccretionToRedemptionValueLiquidationPreference>
  <aqxp:TemporaryEquityAccretionToRedemptionValueWarrantDiscount contextRef="eol_PE749074--1410-Q0003_STD_365_20131231_0_921954x1258870_932980x932258" unitRef="iso4217_USD" decimals="INF" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_9003_43">-34343</aqxp:TemporaryEquityAccretionToRedemptionValueWarrantDiscount>
  <aqxp:TemporaryEquityAccretionToRedemptionValueRedemptionOption contextRef="eol_PE749074--1410-Q0003_STD_365_20131231_0_921954x1258870_932980x932258" unitRef="iso4217_USD" decimals="INF" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_9003_44">256863</aqxp:TemporaryEquityAccretionToRedemptionValueRedemptionOption>
  <aqxp:TemporaryEquityWarrantDiscount contextRef="eol_PE749074--1410-Q0003_STD_365_20131231_0_921954x1258870_932980x932258" unitRef="iso4217_USD" decimals="0" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_9003_35">68920</aqxp:TemporaryEquityWarrantDiscount>
  <aqxp:TemporaryEquityRedemptionDiscount contextRef="eol_PE749074--1410-Q0003_STD_365_20131231_0_921954x1258870_932980x932258" unitRef="iso4217_USD" decimals="INF" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_9003_37">1633357</aqxp:TemporaryEquityRedemptionDiscount>
  <us-gaap:ComprehensiveIncomeNetOfTax contextRef="eol_PE749074--1410-Q0003_STD_365_20131231_0_932980x932209" unitRef="iso4217_USD" decimals="0" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_9010_40">-8729371</us-gaap:ComprehensiveIncomeNetOfTax>
  <us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment contextRef="eol_PE749074--1410-Q0003_STD_365_20131231_0_932980x932209" unitRef="iso4217_USD" decimals="INF" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_9010_42">123074</us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment>
  <aqxp:TemporaryEquityAccretionToRedemptionValueLiquidationPreference contextRef="eol_PE749074--1410-Q0003_STD_365_20131231_0_932980x932209" unitRef="iso4217_USD" decimals="0" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_9010_41">5002131</aqxp:TemporaryEquityAccretionToRedemptionValueLiquidationPreference>
  <aqxp:IncomeTaxExpenseOnPreferredStock contextRef="eol_PE749074--1410-Q0003_STD_365_20131231_0_932980x932209" unitRef="iso4217_USD" decimals="0" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_9010_45">737925</aqxp:IncomeTaxExpenseOnPreferredStock>
  <us-gaap:StockIssuedDuringPeriodValueIssuedForCash contextRef="eol_PE749074--1410-Q0003_STD_365_20131231_0_932980x932586" unitRef="iso4217_USD" decimals="INF" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_9009_31">7</us-gaap:StockIssuedDuringPeriodValueIssuedForCash>
  <us-gaap:AllocatedShareBasedCompensationExpense contextRef="eol_PE749074--1410-Q0003_STD_365_20131231_0_932980x932586" unitRef="iso4217_USD" decimals="0" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_9009_39">349321</us-gaap:AllocatedShareBasedCompensationExpense>
  <aqxp:TemporaryEquityAccretionToRedemptionValueLiquidationPreference contextRef="eol_PE749074--1410-Q0003_STD_365_20131231_0_932980x932586" unitRef="iso4217_USD" decimals="0" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_9009_41">349328</aqxp:TemporaryEquityAccretionToRedemptionValueLiquidationPreference>
  <us-gaap:ComprehensiveIncomeNetOfTax contextRef="eol_PE749074--1410-Q0003_STD_366_20081231_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_10011_32">-5459460</us-gaap:ComprehensiveIncomeNetOfTax>
  <us-gaap:StockIssuedDuringPeriodValueIssuedForCash contextRef="eol_PE749074--1410-Q0003_STD_366_20081231_0" unitRef="iso4217_USD" decimals="INF" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_10011_29">3</us-gaap:StockIssuedDuringPeriodValueIssuedForCash>
  <us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment contextRef="eol_PE749074--1410-Q0003_STD_366_20081231_0" unitRef="iso4217_USD" decimals="INF" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_10011_34">139758</us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment>
  <us-gaap:AllocatedShareBasedCompensationExpense contextRef="eol_PE749074--1410-Q0003_STD_366_20081231_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_10011_31">103518</us-gaap:AllocatedShareBasedCompensationExpense>
  <aqxp:TemporaryEquityAccretionToRedemptionValueLiquidationPreference contextRef="eol_PE749074--1410-Q0003_STD_366_20081231_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_10011_33">1008153</aqxp:TemporaryEquityAccretionToRedemptionValueLiquidationPreference>
  <us-gaap:StockIssuedDuringPeriodSharesIssuedForCash contextRef="eol_PE749074--1410-Q0003_STD_366_20081231_0_921954x1258858_932980x932377" unitRef="shares" decimals="INF" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_10001_30">142044</us-gaap:StockIssuedDuringPeriodSharesIssuedForCash>
  <us-gaap:StockIssuedDuringPeriodValueIssuedForCash contextRef="eol_PE749074--1410-Q0003_STD_366_20081231_0_921954x1258858_932980x932377" unitRef="iso4217_USD" decimals="INF" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_10001_29">1482936</us-gaap:StockIssuedDuringPeriodValueIssuedForCash>
  <us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment contextRef="eol_PE749074--1410-Q0003_STD_366_20081231_0_921954x1258858_932980x932377" unitRef="iso4217_USD" decimals="INF" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_10001_34">-74650</us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment>
  <aqxp:TemporaryEquityAccretionToRedemptionValueLiquidationPreference contextRef="eol_PE749074--1410-Q0003_STD_366_20081231_0_921954x1258858_932980x932377" unitRef="iso4217_USD" decimals="0" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_10001_33">-553808</aqxp:TemporaryEquityAccretionToRedemptionValueLiquidationPreference>
  <us-gaap:StockIssuedDuringPeriodSharesIssuedForCash contextRef="eol_PE749074--1410-Q0003_STD_366_20081231_0_921954x1258870_932980x932258" unitRef="shares" decimals="INF" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_10003_30">132575</us-gaap:StockIssuedDuringPeriodSharesIssuedForCash>
  <us-gaap:StockIssuedDuringPeriodValueIssuedForCash contextRef="eol_PE749074--1410-Q0003_STD_366_20081231_0_921954x1258870_932980x932258" unitRef="iso4217_USD" decimals="INF" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_10003_29">1384073</us-gaap:StockIssuedDuringPeriodValueIssuedForCash>
  <us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment contextRef="eol_PE749074--1410-Q0003_STD_366_20081231_0_921954x1258870_932980x932258" unitRef="iso4217_USD" decimals="INF" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_10003_34">-65108</us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment>
  <aqxp:TemporaryEquityAccretionToRedemptionValueLiquidationPreference contextRef="eol_PE749074--1410-Q0003_STD_366_20081231_0_921954x1258870_932980x932258" unitRef="iso4217_USD" decimals="0" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_10003_33">-454346</aqxp:TemporaryEquityAccretionToRedemptionValueLiquidationPreference>
  <us-gaap:ComprehensiveIncomeNetOfTax contextRef="eol_PE749074--1410-Q0003_STD_366_20081231_0_932980x932209" unitRef="iso4217_USD" decimals="0" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_10010_32">-5459460</us-gaap:ComprehensiveIncomeNetOfTax>
  <us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment contextRef="eol_PE749074--1410-Q0003_STD_366_20081231_0_932980x932209" unitRef="iso4217_USD" decimals="INF" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_10010_34">139758</us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment>
  <aqxp:TemporaryEquityAccretionToRedemptionValueLiquidationPreference contextRef="eol_PE749074--1410-Q0003_STD_366_20081231_0_932980x932209" unitRef="iso4217_USD" decimals="0" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_10010_33">682306</aqxp:TemporaryEquityAccretionToRedemptionValueLiquidationPreference>
  <us-gaap:StockIssuedDuringPeriodValueIssuedForCash contextRef="eol_PE749074--1410-Q0003_STD_366_20081231_0_932980x932586" unitRef="iso4217_USD" decimals="INF" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_10009_29">3</us-gaap:StockIssuedDuringPeriodValueIssuedForCash>
  <us-gaap:AllocatedShareBasedCompensationExpense contextRef="eol_PE749074--1410-Q0003_STD_366_20081231_0_932980x932586" unitRef="iso4217_USD" decimals="0" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_10009_31">103518</us-gaap:AllocatedShareBasedCompensationExpense>
  <aqxp:TemporaryEquityAccretionToRedemptionValueLiquidationPreference contextRef="eol_PE749074--1410-Q0003_STD_366_20081231_0_932980x932586" unitRef="iso4217_USD" decimals="0" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_10009_33">325847</aqxp:TemporaryEquityAccretionToRedemptionValueLiquidationPreference>
  <us-gaap:ComprehensiveIncomeNetOfTax contextRef="eol_PE749074--1410-Q0003_STD_366_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_6011_24">-7714198</us-gaap:ComprehensiveIncomeNetOfTax>
  <us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment contextRef="eol_PE749074--1410-Q0003_STD_366_20121231_0" unitRef="iso4217_USD" decimals="INF" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_6011_26">168702</us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment>
  <us-gaap:AllocatedShareBasedCompensationExpense contextRef="eol_PE749074--1410-Q0003_STD_366_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_6011_23">351322</us-gaap:AllocatedShareBasedCompensationExpense>
  <aqxp:TemporaryEquityAccretionToRedemptionValueLiquidationPreference contextRef="eol_PE749074--1410-Q0003_STD_366_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_6011_25">3860140</aqxp:TemporaryEquityAccretionToRedemptionValueLiquidationPreference>
  <aqxp:IncomeTaxExpenseOnPreferredStock contextRef="eol_PE749074--1410-Q0003_STD_366_20121231_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_6011_28">394908</aqxp:IncomeTaxExpenseOnPreferredStock>
  <us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment contextRef="eol_PE749074--1410-Q0003_STD_366_20121231_0_921954x1258858_932980x932377" unitRef="iso4217_USD" decimals="INF" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_6001_26">-72296</us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment>
  <aqxp:TemporaryEquityAccretionToRedemptionValueLiquidationPreference contextRef="eol_PE749074--1410-Q0003_STD_366_20121231_0_921954x1258858_932980x932377" unitRef="iso4217_USD" decimals="0" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_6001_25">-1647432</aqxp:TemporaryEquityAccretionToRedemptionValueLiquidationPreference>
  <aqxp:TemporaryEquityAccretionToRedemptionValueWarrantDiscount contextRef="eol_PE749074--1410-Q0003_STD_366_20121231_0_921954x1258858_932980x932377" unitRef="iso4217_USD" decimals="INF" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_6001_27">-21882</aqxp:TemporaryEquityAccretionToRedemptionValueWarrantDiscount>
  <us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment contextRef="eol_PE749074--1410-Q0003_STD_366_20121231_0_921954x1258870_932980x932258" unitRef="iso4217_USD" decimals="INF" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_6003_26">-96406</us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment>
  <aqxp:TemporaryEquityAccretionToRedemptionValueLiquidationPreference contextRef="eol_PE749074--1410-Q0003_STD_366_20121231_0_921954x1258870_932980x932258" unitRef="iso4217_USD" decimals="0" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_6003_25">-2212708</aqxp:TemporaryEquityAccretionToRedemptionValueLiquidationPreference>
  <aqxp:TemporaryEquityAccretionToRedemptionValueWarrantDiscount contextRef="eol_PE749074--1410-Q0003_STD_366_20121231_0_921954x1258870_932980x932258" unitRef="iso4217_USD" decimals="INF" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_6003_27">-23566</aqxp:TemporaryEquityAccretionToRedemptionValueWarrantDiscount>
  <us-gaap:ComprehensiveIncomeNetOfTax contextRef="eol_PE749074--1410-Q0003_STD_366_20121231_0_932980x932209" unitRef="iso4217_USD" decimals="0" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_6010_24">-7714198</us-gaap:ComprehensiveIncomeNetOfTax>
  <us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment contextRef="eol_PE749074--1410-Q0003_STD_366_20121231_0_932980x932209" unitRef="iso4217_USD" decimals="INF" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_6010_26">168702</us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment>
  <aqxp:TemporaryEquityAccretionToRedemptionValueLiquidationPreference contextRef="eol_PE749074--1410-Q0003_STD_366_20121231_0_932980x932209" unitRef="iso4217_USD" decimals="0" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_6010_25">3508818</aqxp:TemporaryEquityAccretionToRedemptionValueLiquidationPreference>
  <aqxp:IncomeTaxExpenseOnPreferredStock contextRef="eol_PE749074--1410-Q0003_STD_366_20121231_0_932980x932209" unitRef="iso4217_USD" decimals="0" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_6010_28">394908</aqxp:IncomeTaxExpenseOnPreferredStock>
  <us-gaap:AllocatedShareBasedCompensationExpense contextRef="eol_PE749074--1410-Q0003_STD_366_20121231_0_932980x932586" unitRef="iso4217_USD" decimals="0" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_6009_23">351322</us-gaap:AllocatedShareBasedCompensationExpense>
  <aqxp:TemporaryEquityAccretionToRedemptionValueLiquidationPreference contextRef="eol_PE749074--1410-Q0003_STD_366_20121231_0_932980x932586" unitRef="iso4217_USD" decimals="0" id="id_3828183_D94DE27C-E7C5-400B-AD75-CD9E2CE3657B_6009_25">351322</aqxp:TemporaryEquityAccretionToRedemptionValueLiquidationPreference>
  <us-gaap:ComprehensiveIncomeNetOfTax contextRef="eol_PE749074--1410-Q0003_STD_372_20041231_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_2011_3">-12188</us-gaap:ComprehensiveIncomeNetOfTax>
  <us-gaap:StockIssuedDuringPeriodValueIssuedForCash contextRef="eol_PE749074--1410-Q0003_STD_372_20041231_0" unitRef="iso4217_USD" decimals="INF" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_2011_1">800</us-gaap:StockIssuedDuringPeriodValueIssuedForCash>
  <us-gaap:StockIssuedDuringPeriodSharesIssuedForCash contextRef="eol_PE749074--1410-Q0003_STD_372_20041231_0_921954x1258858_932980x1099142" unitRef="shares" decimals="INF" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_2005_2">416660</us-gaap:StockIssuedDuringPeriodSharesIssuedForCash>
  <us-gaap:StockIssuedDuringPeriodValueIssuedForCash contextRef="eol_PE749074--1410-Q0003_STD_372_20041231_0_921954x1258858_932980x1099142" unitRef="iso4217_USD" decimals="INF" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_2005_1">800</us-gaap:StockIssuedDuringPeriodValueIssuedForCash>
  <us-gaap:ComprehensiveIncomeNetOfTax contextRef="eol_PE749074--1410-Q0003_STD_372_20041231_0_932980x932209" unitRef="iso4217_USD" decimals="0" id="id_3828183_354076D1-9742-4112-B86F-D7475144F23F_2010_3">-12188</us-gaap:ComprehensiveIncomeNetOfTax>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="eol_PE749074--1410-Q0003_STD_3749_20140331_0" unitRef="pure" decimals="4" id="id_3828183_A4174175-A9D9-477C-834E-678B87667A02_3_3">0.0296</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:EarningsPerShareDiluted contextRef="eol_PE749074--1410-Q0003_STD_3749_20140331_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_3828183_B8750CD9-87E8-4022-95EF-0FA4C1AC626B_3_15">-179.45</us-gaap:EarningsPerShareDiluted>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="eol_PE749074--1410-Q0003_STD_3749_20140331_0" unitRef="pure" decimals="2" id="id_3828183_A4174175-A9D9-477C-834E-678B87667A02_3_0">0.88</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment contextRef="eol_PE749074--1410-Q0003_STD_3749_20140331_0" unitRef="shares" decimals="0" id="id_3828183_B8750CD9-87E8-4022-95EF-0FA4C1AC626B_3_13">398573</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
  <us-gaap:EarningsPerShareBasic contextRef="eol_PE749074--1410-Q0003_STD_3749_20140331_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_3828183_B8750CD9-87E8-4022-95EF-0FA4C1AC626B_3_14">-179.45</us-gaap:EarningsPerShareBasic>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="eol_PE749074--1410-Q0003_STD_3749_20140331_0" id="id_3828183_A4174175-A9D9-477C-834E-678B87667A02_3_2">P6Y2M27D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="eol_PE749074--1410-Q0003_STD_3749_20140331_0" unitRef="shares" decimals="0" id="id_3828183_690E7802-F096-42F4-844C-B42D2992B3CF_3_22">398573</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
  <us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations contextRef="eol_PE749074--1410-Q0003_STD_3749_20140331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_AFF72D6D-AE4F-4009-8AA9-58E6D13FB48C_3_15">-48602784</us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="eol_PE749074--1410-Q0003_STD_3749_20140331_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_3828183_A4174175-A9D9-477C-834E-678B87667A02_3_4">4.23</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="eol_PE749074--1410-Q0003_STD_3749_20140331_0" unitRef="pure" decimals="2" id="id_3828183_A4174175-A9D9-477C-834E-678B87667A02_3_1">0.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
  <us-gaap:EarningsPerShareBasicAndDiluted contextRef="eol_PE749074--1410-Q0003_STD_3749_20140331_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_3828183_690E7802-F096-42F4-844C-B42D2992B3CF_3_21">-179.45</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="eol_PE749074--1410-Q0003_STD_3749_20140331_0" unitRef="shares" decimals="0" id="id_3828183_B8750CD9-87E8-4022-95EF-0FA4C1AC626B_3_9">398573</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
  <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax contextRef="eol_PE749074--1410-Q0003_STD_3749_20140331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_690E7802-F096-42F4-844C-B42D2992B3CF_3_10">-239484</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
  <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="eol_PE749074--1410-Q0003_STD_3749_20140331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_AFF72D6D-AE4F-4009-8AA9-58E6D13FB48C_3_13">626223</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
  <us-gaap:ComprehensiveIncomeNetOfTax contextRef="eol_PE749074--1410-Q0003_STD_3749_20140331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_690E7802-F096-42F4-844C-B42D2992B3CF_3_14">-51502587</us-gaap:ComprehensiveIncomeNetOfTax>
  <us-gaap:PaymentsOfFinancingCosts contextRef="eol_PE749074--1410-Q0003_STD_3749_20140331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_AFF72D6D-AE4F-4009-8AA9-58E6D13FB48C_3_33">5398381</us-gaap:PaymentsOfFinancingCosts>
  <us-gaap:PaymentsToAcquireShortTermInvestments contextRef="eol_PE749074--1410-Q0003_STD_3749_20140331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_AFF72D6D-AE4F-4009-8AA9-58E6D13FB48C_3_17">2820600</us-gaap:PaymentsToAcquireShortTermInvestments>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="eol_PE749074--1410-Q0003_STD_3749_20140331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_690E7802-F096-42F4-844C-B42D2992B3CF_3_12">-54652993</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
  <us-gaap:GainLossOnSaleOfPropertyPlantEquipment contextRef="eol_PE749074--1410-Q0003_STD_3749_20140331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_690E7802-F096-42F4-844C-B42D2992B3CF_3_7">134553</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
  <us-gaap:PaymentsOfLoanCosts contextRef="eol_PE749074--1410-Q0003_STD_3749_20140331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_AFF72D6D-AE4F-4009-8AA9-58E6D13FB48C_3_24">107911</us-gaap:PaymentsOfLoanCosts>
  <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="eol_PE749074--1410-Q0003_STD_3749_20140331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_B8750CD9-87E8-4022-95EF-0FA4C1AC626B_3_7">-71522489</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
  <us-gaap:RepaymentsOfNotesPayable contextRef="eol_PE749074--1410-Q0003_STD_3749_20140331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_AFF72D6D-AE4F-4009-8AA9-58E6D13FB48C_3_26">255775</us-gaap:RepaymentsOfNotesPayable>
  <us-gaap:RepaymentsOfDebt contextRef="eol_PE749074--1410-Q0003_STD_3749_20140331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_AFF72D6D-AE4F-4009-8AA9-58E6D13FB48C_3_23">100000</us-gaap:RepaymentsOfDebt>
  <us-gaap:InvestmentIncomeInterest contextRef="eol_PE749074--1410-Q0003_STD_3749_20140331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_690E7802-F096-42F4-844C-B42D2992B3CF_3_6">365881</us-gaap:InvestmentIncomeInterest>
  <us-gaap:PaymentsToAcquireIntangibleAssets contextRef="eol_PE749074--1410-Q0003_STD_3749_20140331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_AFF72D6D-AE4F-4009-8AA9-58E6D13FB48C_3_20">183629</us-gaap:PaymentsToAcquireIntangibleAssets>
  <us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables contextRef="eol_PE749074--1410-Q0003_STD_3749_20140331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_AFF72D6D-AE4F-4009-8AA9-58E6D13FB48C_3_12">66524</us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables>
  <us-gaap:GainLossOnDerivativeInstrumentsNetPretax contextRef="eol_PE749074--1410-Q0003_STD_3749_20140331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_690E7802-F096-42F4-844C-B42D2992B3CF_3_8">2102193</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
  <us-gaap:InterestPaid contextRef="eol_PE749074--1410-Q0003_STD_3749_20140331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_AFF72D6D-AE4F-4009-8AA9-58E6D13FB48C_3_39">31719</us-gaap:InterestPaid>
  <us-gaap:PaymentsOfStockIssuanceCosts contextRef="eol_PE749074--1410-Q0003_STD_3749_20140331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_AFF72D6D-AE4F-4009-8AA9-58E6D13FB48C_3_31">1431558</us-gaap:PaymentsOfStockIssuanceCosts>
  <us-gaap:ForeignCurrencyTransactionGainLossUnrealized contextRef="eol_PE749074--1410-Q0003_STD_3749_20140331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_AFF72D6D-AE4F-4009-8AA9-58E6D13FB48C_3_10">-106501</us-gaap:ForeignCurrencyTransactionGainLossUnrealized>
  <us-gaap:NonoperatingIncomeExpense contextRef="eol_PE749074--1410-Q0003_STD_3749_20140331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_690E7802-F096-42F4-844C-B42D2992B3CF_3_11">-622455</us-gaap:NonoperatingIncomeExpense>
  <us-gaap:NetIncomeLoss contextRef="eol_PE749074--1410-Q0003_STD_3749_20140331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_B8750CD9-87E8-4022-95EF-0FA4C1AC626B_3_1">-51502587</us-gaap:NetIncomeLoss>
  <us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="eol_PE749074--1410-Q0003_STD_3749_20140331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_AFF72D6D-AE4F-4009-8AA9-58E6D13FB48C_3_28">350</us-gaap:PaymentsForRepurchaseOfCommonStock>
  <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="eol_PE749074--1410-Q0003_STD_3749_20140331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_AFF72D6D-AE4F-4009-8AA9-58E6D13FB48C_3_18">549003</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
  <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="eol_PE749074--1410-Q0003_STD_3749_20140331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_AFF72D6D-AE4F-4009-8AA9-58E6D13FB48C_3_14">854211</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
  <us-gaap:GeneralAndAdministrativeExpense contextRef="eol_PE749074--1410-Q0003_STD_3749_20140331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_690E7802-F096-42F4-844C-B42D2992B3CF_3_2">10241412</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations contextRef="eol_PE749074--1410-Q0003_STD_3749_20140331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_AFF72D6D-AE4F-4009-8AA9-58E6D13FB48C_3_34">104882526</us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations>
  <us-gaap:ProceedsFromNotesPayable contextRef="eol_PE749074--1410-Q0003_STD_3749_20140331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_AFF72D6D-AE4F-4009-8AA9-58E6D13FB48C_3_25">720863</us-gaap:ProceedsFromNotesPayable>
  <us-gaap:ProceedsFromRepurchaseOfRedeemablePreferredStock contextRef="eol_PE749074--1410-Q0003_STD_3749_20140331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_AFF72D6D-AE4F-4009-8AA9-58E6D13FB48C_3_29">57835418</us-gaap:ProceedsFromRepurchaseOfRedeemablePreferredStock>
  <us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment contextRef="eol_PE749074--1410-Q0003_STD_3749_20140331_0" unitRef="iso4217_USD" decimals="INF" id="id_3828183_B8750CD9-87E8-4022-95EF-0FA4C1AC626B_3_3">1014667</us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE749074--1410-Q0003_STD_3749_20140331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_AFF72D6D-AE4F-4009-8AA9-58E6D13FB48C_3_9">1409722</us-gaap:ShareBasedCompensation>
  <us-gaap:NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1 contextRef="eol_PE749074--1410-Q0003_STD_3749_20140331_0" unitRef="iso4217_USD" decimals="INF" id="id_3828183_AFF72D6D-AE4F-4009-8AA9-58E6D13FB48C_3_42">44834</us-gaap:NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1>
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="eol_PE749074--1410-Q0003_STD_3749_20140331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_AFF72D6D-AE4F-4009-8AA9-58E6D13FB48C_3_35">52918327</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations contextRef="eol_PE749074--1410-Q0003_STD_3749_20140331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_AFF72D6D-AE4F-4009-8AA9-58E6D13FB48C_3_21">-3361415</us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations>
  <us-gaap:InterestExpense contextRef="eol_PE749074--1410-Q0003_STD_3749_20140331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_690E7802-F096-42F4-844C-B42D2992B3CF_3_5">590023</us-gaap:InterestExpense>
  <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="eol_PE749074--1410-Q0003_STD_3749_20140331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_AFF72D6D-AE4F-4009-8AA9-58E6D13FB48C_3_27">490176</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment contextRef="eol_PE749074--1410-Q0003_STD_3749_20140331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_AFF72D6D-AE4F-4009-8AA9-58E6D13FB48C_3_19">191817</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
  <us-gaap:ProceedsFromIssuanceInitialPublicOffering contextRef="eol_PE749074--1410-Q0003_STD_3749_20140331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_AFF72D6D-AE4F-4009-8AA9-58E6D13FB48C_3_32">53130000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
  <us-gaap:ResearchAndDevelopmentExpense contextRef="eol_PE749074--1410-Q0003_STD_3749_20140331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_690E7802-F096-42F4-844C-B42D2992B3CF_3_1">43789126</us-gaap:ResearchAndDevelopmentExpense>
  <us-gaap:DepreciationDepletionAndAmortization contextRef="eol_PE749074--1410-Q0003_STD_3749_20140331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_AFF72D6D-AE4F-4009-8AA9-58E6D13FB48C_3_3">629410</us-gaap:DepreciationDepletionAndAmortization>
  <us-gaap:AmortizationOfFinancingCosts contextRef="eol_PE749074--1410-Q0003_STD_3749_20140331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_AFF72D6D-AE4F-4009-8AA9-58E6D13FB48C_3_4">333877</us-gaap:AmortizationOfFinancingCosts>
  <us-gaap:OperatingExpenses contextRef="eol_PE749074--1410-Q0003_STD_3749_20140331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_690E7802-F096-42F4-844C-B42D2992B3CF_3_3">54030538</us-gaap:OperatingExpenses>
  <us-gaap:IncomeTaxExpenseBenefit contextRef="eol_PE749074--1410-Q0003_STD_3749_20140331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_690E7802-F096-42F4-844C-B42D2992B3CF_3_13">-3150406</us-gaap:IncomeTaxExpenseBenefit>
  <aqxp:AmortizationOfPreferredStockDiscount contextRef="eol_PE749074--1410-Q0003_STD_3749_20140331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_AFF72D6D-AE4F-4009-8AA9-58E6D13FB48C_3_7">2395575</aqxp:AmortizationOfPreferredStockDiscount>
  <aqxp:IncrementalCommonSharesAttributableToCommonStockWarrants contextRef="eol_PE749074--1410-Q0003_STD_3749_20140331_0" unitRef="shares" xsi:nil="true" id="id_3828183_B8750CD9-87E8-4022-95EF-0FA4C1AC626B_3_12" />
  <aqxp:IncrementalCommonSharesAttributableToStockOptions contextRef="eol_PE749074--1410-Q0003_STD_3749_20140331_0" unitRef="shares" xsi:nil="true" id="id_3828183_B8750CD9-87E8-4022-95EF-0FA4C1AC626B_3_11" />
  <aqxp:AmortizationOfDiscountOnPreferredStock contextRef="eol_PE749074--1410-Q0003_STD_3749_20140331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_690E7802-F096-42F4-844C-B42D2992B3CF_3_9">2395575</aqxp:AmortizationOfDiscountOnPreferredStock>
  <aqxp:SpecialVotingCommonStockIssuedValue contextRef="eol_PE749074--1410-Q0003_STD_3749_20140331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_AFF72D6D-AE4F-4009-8AA9-58E6D13FB48C_3_30">44</aqxp:SpecialVotingCommonStockIssuedValue>
  <aqxp:TemporaryEquityAccretionToRedemptionValueLiquidationPreference contextRef="eol_PE749074--1410-Q0003_STD_3749_20140331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_B8750CD9-87E8-4022-95EF-0FA4C1AC626B_3_2">18566008</aqxp:TemporaryEquityAccretionToRedemptionValueLiquidationPreference>
  <aqxp:IncomeTaxExpenseOnPreferredStock contextRef="eol_PE749074--1410-Q0003_STD_3749_20140331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_B8750CD9-87E8-4022-95EF-0FA4C1AC626B_3_4">1897702</aqxp:IncomeTaxExpenseOnPreferredStock>
  <aqxp:ShareIssuanceExpendituresIncurredButNotYetPaid contextRef="eol_PE749074--1410-Q0003_STD_3749_20140331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_AFF72D6D-AE4F-4009-8AA9-58E6D13FB48C_3_44">390345</aqxp:ShareIssuanceExpendituresIncurredButNotYetPaid>
  <aqxp:ExtinguishmentOfRemainingShareIssuanceCostsDueToConversionOfPreferredStock contextRef="eol_PE749074--1410-Q0003_STD_3749_20140331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_B8750CD9-87E8-4022-95EF-0FA4C1AC626B_3_6">439227</aqxp:ExtinguishmentOfRemainingShareIssuanceCostsDueToConversionOfPreferredStock>
  <aqxp:RepaymentFeeAndPenalty contextRef="eol_PE749074--1410-Q0003_STD_3749_20140331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_AFF72D6D-AE4F-4009-8AA9-58E6D13FB48C_3_5">100000</aqxp:RepaymentFeeAndPenalty>
  <aqxp:ReversalOfIncomeTaxPayableOnPreferredStock contextRef="eol_PE749074--1410-Q0003_STD_3749_20140331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_B8750CD9-87E8-4022-95EF-0FA4C1AC626B_3_5">1897702</aqxp:ReversalOfIncomeTaxPayableOnPreferredStock>
  <us-gaap:ComprehensiveIncomeNetOfTax contextRef="eol_PE749074--1410-Q0003_STD_71_20140312_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_D8629002-FCA3-41A1-8253-7BBD181ADE71_2011_7">-3389372</us-gaap:ComprehensiveIncomeNetOfTax>
  <us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment contextRef="eol_PE749074--1410-Q0003_STD_71_20140312_0" unitRef="iso4217_USD" decimals="INF" id="id_3828183_D8629002-FCA3-41A1-8253-7BBD181ADE71_2011_3">19550</us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment>
  <us-gaap:AllocatedShareBasedCompensationExpense contextRef="eol_PE749074--1410-Q0003_STD_71_20140312_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_D8629002-FCA3-41A1-8253-7BBD181ADE71_2011_1">99417</us-gaap:AllocatedShareBasedCompensationExpense>
  <aqxp:TemporaryEquityAccretionToRedemptionValueLiquidationPreference contextRef="eol_PE749074--1410-Q0003_STD_71_20140312_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_D8629002-FCA3-41A1-8253-7BBD181ADE71_2011_2">1132893</aqxp:TemporaryEquityAccretionToRedemptionValueLiquidationPreference>
  <aqxp:IncomeTaxExpenseOnPreferredStock contextRef="eol_PE749074--1410-Q0003_STD_71_20140312_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_D8629002-FCA3-41A1-8253-7BBD181ADE71_2011_6">100291</aqxp:IncomeTaxExpenseOnPreferredStock>
  <aqxp:ExtinguishmentOfRemainingShareIssuanceCostsDueToConversionOfPreferredStock contextRef="eol_PE749074--1410-Q0003_STD_71_20140312_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_D8629002-FCA3-41A1-8253-7BBD181ADE71_2011_8">1458478</aqxp:ExtinguishmentOfRemainingShareIssuanceCostsDueToConversionOfPreferredStock>
  <us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment contextRef="eol_PE749074--1410-Q0003_STD_71_20140312_0_921954x1258858_932980x932377" unitRef="iso4217_USD" decimals="INF" id="id_3828183_D8629002-FCA3-41A1-8253-7BBD181ADE71_2001_3">-6649</us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment>
  <aqxp:TemporaryEquityAccretionToRedemptionValueLiquidationPreference contextRef="eol_PE749074--1410-Q0003_STD_71_20140312_0_921954x1258858_932980x932377" unitRef="iso4217_USD" decimals="0" id="id_3828183_D8629002-FCA3-41A1-8253-7BBD181ADE71_2001_2">-401165</aqxp:TemporaryEquityAccretionToRedemptionValueLiquidationPreference>
  <aqxp:TemporaryEquityAccretionToRedemptionValueWarrantDiscount contextRef="eol_PE749074--1410-Q0003_STD_71_20140312_0_921954x1258858_932980x932377" unitRef="iso4217_USD" decimals="INF" id="id_3828183_D8629002-FCA3-41A1-8253-7BBD181ADE71_2001_4">-4187</aqxp:TemporaryEquityAccretionToRedemptionValueWarrantDiscount>
  <aqxp:TemporaryEquityAccretionToRedemptionValueRedemptionOption contextRef="eol_PE749074--1410-Q0003_STD_71_20140312_0_921954x1258858_932980x932377" unitRef="iso4217_USD" decimals="INF" id="id_3828183_D8629002-FCA3-41A1-8253-7BBD181ADE71_2001_5">16623</aqxp:TemporaryEquityAccretionToRedemptionValueRedemptionOption>
  <aqxp:ExtinguishmentOfRemainingShareIssuanceCostsDueToConversionOfPreferredStock contextRef="eol_PE749074--1410-Q0003_STD_71_20140312_0_921954x1258858_932980x932377" unitRef="iso4217_USD" decimals="0" id="id_3828183_D8629002-FCA3-41A1-8253-7BBD181ADE71_2001_8">551334</aqxp:ExtinguishmentOfRemainingShareIssuanceCostsDueToConversionOfPreferredStock>
  <us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment contextRef="eol_PE749074--1410-Q0003_STD_71_20140312_0_921954x1258870_932980x932258" unitRef="iso4217_USD" decimals="INF" id="id_3828183_D8629002-FCA3-41A1-8253-7BBD181ADE71_2003_3">-12901</us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment>
  <aqxp:TemporaryEquityAccretionToRedemptionValueLiquidationPreference contextRef="eol_PE749074--1410-Q0003_STD_71_20140312_0_921954x1258870_932980x932258" unitRef="iso4217_USD" decimals="0" id="id_3828183_D8629002-FCA3-41A1-8253-7BBD181ADE71_2003_2">-731728</aqxp:TemporaryEquityAccretionToRedemptionValueLiquidationPreference>
  <aqxp:TemporaryEquityAccretionToRedemptionValueWarrantDiscount contextRef="eol_PE749074--1410-Q0003_STD_71_20140312_0_921954x1258870_932980x932258" unitRef="iso4217_USD" decimals="INF" id="id_3828183_D8629002-FCA3-41A1-8253-7BBD181ADE71_2003_4">-6467</aqxp:TemporaryEquityAccretionToRedemptionValueWarrantDiscount>
  <aqxp:TemporaryEquityAccretionToRedemptionValueRedemptionOption contextRef="eol_PE749074--1410-Q0003_STD_71_20140312_0_921954x1258870_932980x932258" unitRef="iso4217_USD" decimals="INF" id="id_3828183_D8629002-FCA3-41A1-8253-7BBD181ADE71_2003_5">58300</aqxp:TemporaryEquityAccretionToRedemptionValueRedemptionOption>
  <aqxp:ExtinguishmentOfRemainingShareIssuanceCostsDueToConversionOfPreferredStock contextRef="eol_PE749074--1410-Q0003_STD_71_20140312_0_921954x1258870_932980x932258" unitRef="iso4217_USD" decimals="0" id="id_3828183_D8629002-FCA3-41A1-8253-7BBD181ADE71_2003_8">1686549</aqxp:ExtinguishmentOfRemainingShareIssuanceCostsDueToConversionOfPreferredStock>
  <us-gaap:ComprehensiveIncomeNetOfTax contextRef="eol_PE749074--1410-Q0003_STD_71_20140312_0_932980x932209" unitRef="iso4217_USD" decimals="0" id="id_3828183_D8629002-FCA3-41A1-8253-7BBD181ADE71_2010_7">-3389372</us-gaap:ComprehensiveIncomeNetOfTax>
  <us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment contextRef="eol_PE749074--1410-Q0003_STD_71_20140312_0_932980x932209" unitRef="iso4217_USD" decimals="INF" id="id_3828183_D8629002-FCA3-41A1-8253-7BBD181ADE71_2010_3">19550</us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment>
  <aqxp:TemporaryEquityAccretionToRedemptionValueLiquidationPreference contextRef="eol_PE749074--1410-Q0003_STD_71_20140312_0_932980x932209" unitRef="iso4217_USD" decimals="0" id="id_3828183_D8629002-FCA3-41A1-8253-7BBD181ADE71_2010_2">1033476</aqxp:TemporaryEquityAccretionToRedemptionValueLiquidationPreference>
  <aqxp:IncomeTaxExpenseOnPreferredStock contextRef="eol_PE749074--1410-Q0003_STD_71_20140312_0_932980x932209" unitRef="iso4217_USD" decimals="0" id="id_3828183_D8629002-FCA3-41A1-8253-7BBD181ADE71_2010_6">100291</aqxp:IncomeTaxExpenseOnPreferredStock>
  <aqxp:ExtinguishmentOfRemainingShareIssuanceCostsDueToConversionOfPreferredStock contextRef="eol_PE749074--1410-Q0003_STD_71_20140312_0_932980x932209" unitRef="iso4217_USD" decimals="0" id="id_3828183_D8629002-FCA3-41A1-8253-7BBD181ADE71_2010_8">1458478</aqxp:ExtinguishmentOfRemainingShareIssuanceCostsDueToConversionOfPreferredStock>
  <us-gaap:AllocatedShareBasedCompensationExpense contextRef="eol_PE749074--1410-Q0003_STD_71_20140312_0_932980x932586" unitRef="iso4217_USD" decimals="0" id="id_3828183_D8629002-FCA3-41A1-8253-7BBD181ADE71_2009_1">99417</us-gaap:AllocatedShareBasedCompensationExpense>
  <aqxp:TemporaryEquityAccretionToRedemptionValueLiquidationPreference contextRef="eol_PE749074--1410-Q0003_STD_71_20140312_0_932980x932586" unitRef="iso4217_USD" decimals="0" id="id_3828183_D8629002-FCA3-41A1-8253-7BBD181ADE71_2009_2">99417</aqxp:TemporaryEquityAccretionToRedemptionValueLiquidationPreference>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="eol_PE749074--1410-Q0003_STD_90_20130331_0" unitRef="pure" xsi:nil="true" id="id_3828183_A4174175-A9D9-477C-834E-678B87667A02_2_3" />
  <us-gaap:EarningsPerShareDiluted contextRef="eol_PE749074--1410-Q0003_STD_90_20130331_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_3828183_B8750CD9-87E8-4022-95EF-0FA4C1AC626B_2_15">-8.48</us-gaap:EarningsPerShareDiluted>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="eol_PE749074--1410-Q0003_STD_90_20130331_0" unitRef="pure" xsi:nil="true" id="id_3828183_A4174175-A9D9-477C-834E-678B87667A02_2_0" />
  <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment contextRef="eol_PE749074--1410-Q0003_STD_90_20130331_0" unitRef="shares" decimals="0" id="id_3828183_B8750CD9-87E8-4022-95EF-0FA4C1AC626B_2_13">301745</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
  <us-gaap:EarningsPerShareBasic contextRef="eol_PE749074--1410-Q0003_STD_90_20130331_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_3828183_B8750CD9-87E8-4022-95EF-0FA4C1AC626B_2_14">-8.48</us-gaap:EarningsPerShareBasic>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="eol_PE749074--1410-Q0003_STD_90_20130331_0" xsi:nil="true" id="id_3828183_A4174175-A9D9-477C-834E-678B87667A02_2_2" />
  <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="eol_PE749074--1410-Q0003_STD_90_20130331_0" unitRef="shares" decimals="0" id="id_3828183_690E7802-F096-42F4-844C-B42D2992B3CF_2_22">301745</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
  <us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations contextRef="eol_PE749074--1410-Q0003_STD_90_20130331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_AFF72D6D-AE4F-4009-8AA9-58E6D13FB48C_2_15">-896621</us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="eol_PE749074--1410-Q0003_STD_90_20130331_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_3828183_BB3CECEC-1F2D-465E-8AF2-9F15BF5B30A9_2_0">0.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="eol_PE749074--1410-Q0003_STD_90_20130331_0" unitRef="pure" xsi:nil="true" id="id_3828183_A4174175-A9D9-477C-834E-678B87667A02_2_1" />
  <us-gaap:EarningsPerShareBasicAndDiluted contextRef="eol_PE749074--1410-Q0003_STD_90_20130331_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_3828183_690E7802-F096-42F4-844C-B42D2992B3CF_2_21">-8.48</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="eol_PE749074--1410-Q0003_STD_90_20130331_0" unitRef="shares" decimals="0" id="id_3828183_B8750CD9-87E8-4022-95EF-0FA4C1AC626B_2_9">301745</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="eol_PE749074--1410-Q0003_STD_90_20130331_0" unitRef="shares" decimals="INF" id="id_3828183_44F854BC-E685-43F4-84DF-3884495E95B1_2_3">5960985</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax contextRef="eol_PE749074--1410-Q0003_STD_90_20130331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_690E7802-F096-42F4-844C-B42D2992B3CF_2_10">-17005</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
  <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="eol_PE749074--1410-Q0003_STD_90_20130331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_AFF72D6D-AE4F-4009-8AA9-58E6D13FB48C_2_13">-10480</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
  <us-gaap:ComprehensiveIncomeNetOfTax contextRef="eol_PE749074--1410-Q0003_STD_90_20130331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_690E7802-F096-42F4-844C-B42D2992B3CF_2_14">-1010267</us-gaap:ComprehensiveIncomeNetOfTax>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="eol_PE749074--1410-Q0003_STD_90_20130331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_690E7802-F096-42F4-844C-B42D2992B3CF_2_12">-1010267</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
  <us-gaap:GainLossOnSaleOfPropertyPlantEquipment contextRef="eol_PE749074--1410-Q0003_STD_90_20130331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_690E7802-F096-42F4-844C-B42D2992B3CF_2_7">29396</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
  <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="eol_PE749074--1410-Q0003_STD_90_20130331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_B8750CD9-87E8-4022-95EF-0FA4C1AC626B_2_7">-2558530</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
  <us-gaap:InvestmentIncomeInterest contextRef="eol_PE749074--1410-Q0003_STD_90_20130331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_690E7802-F096-42F4-844C-B42D2992B3CF_2_6">1446</us-gaap:InvestmentIncomeInterest>
  <us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables contextRef="eol_PE749074--1410-Q0003_STD_90_20130331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_AFF72D6D-AE4F-4009-8AA9-58E6D13FB48C_2_12">170</us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables>
  <us-gaap:PaymentsOfStockIssuanceCosts contextRef="eol_PE749074--1410-Q0003_STD_90_20130331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_AFF72D6D-AE4F-4009-8AA9-58E6D13FB48C_2_31">132748</us-gaap:PaymentsOfStockIssuanceCosts>
  <us-gaap:NonoperatingIncomeExpense contextRef="eol_PE749074--1410-Q0003_STD_90_20130331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_690E7802-F096-42F4-844C-B42D2992B3CF_2_11">-13435</us-gaap:NonoperatingIncomeExpense>
  <us-gaap:NetIncomeLoss contextRef="eol_PE749074--1410-Q0003_STD_90_20130331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_B8750CD9-87E8-4022-95EF-0FA4C1AC626B_2_1">-1010267</us-gaap:NetIncomeLoss>
  <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="eol_PE749074--1410-Q0003_STD_90_20130331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_AFF72D6D-AE4F-4009-8AA9-58E6D13FB48C_2_18">4696</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
  <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="eol_PE749074--1410-Q0003_STD_90_20130331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_AFF72D6D-AE4F-4009-8AA9-58E6D13FB48C_2_14">37835</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
  <us-gaap:GeneralAndAdministrativeExpense contextRef="eol_PE749074--1410-Q0003_STD_90_20130331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_690E7802-F096-42F4-844C-B42D2992B3CF_2_2">423865</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationTransfersIntoLevel3 contextRef="eol_PE749074--1410-Q0003_STD_90_20130331_0" unitRef="iso4217_USD" decimals="INF" id="id_3828183_C63D787D-B38F-4D60-9BBB-C3B42592E799_2_0">0</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationTransfersIntoLevel3>
  <us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations contextRef="eol_PE749074--1410-Q0003_STD_90_20130331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_AFF72D6D-AE4F-4009-8AA9-58E6D13FB48C_2_34">17867220</us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations>
  <us-gaap:ProceedsFromRepurchaseOfRedeemablePreferredStock contextRef="eol_PE749074--1410-Q0003_STD_90_20130331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_AFF72D6D-AE4F-4009-8AA9-58E6D13FB48C_2_29">17999961</us-gaap:ProceedsFromRepurchaseOfRedeemablePreferredStock>
  <us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment contextRef="eol_PE749074--1410-Q0003_STD_90_20130331_0" unitRef="iso4217_USD" decimals="INF" id="id_3828183_B8750CD9-87E8-4022-95EF-0FA4C1AC626B_2_3">44307</us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE749074--1410-Q0003_STD_90_20130331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_D7DB1E75-9691-489E-BBF0-238ED21F4881_2_0">54674</us-gaap:ShareBasedCompensation>
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="eol_PE749074--1410-Q0003_STD_90_20130331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_AFF72D6D-AE4F-4009-8AA9-58E6D13FB48C_2_35">17016713</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations contextRef="eol_PE749074--1410-Q0003_STD_90_20130331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_AFF72D6D-AE4F-4009-8AA9-58E6D13FB48C_2_21">46114</us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations>
  <us-gaap:InterestExpense contextRef="eol_PE749074--1410-Q0003_STD_90_20130331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_690E7802-F096-42F4-844C-B42D2992B3CF_2_5">1834</us-gaap:InterestExpense>
  <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment contextRef="eol_PE749074--1410-Q0003_STD_90_20130331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_AFF72D6D-AE4F-4009-8AA9-58E6D13FB48C_2_19">50810</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
  <us-gaap:ResearchAndDevelopmentExpense contextRef="eol_PE749074--1410-Q0003_STD_90_20130331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_690E7802-F096-42F4-844C-B42D2992B3CF_2_1">572967</us-gaap:ResearchAndDevelopmentExpense>
  <us-gaap:DepreciationDepletionAndAmortization contextRef="eol_PE749074--1410-Q0003_STD_90_20130331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_AFF72D6D-AE4F-4009-8AA9-58E6D13FB48C_2_3">14785</us-gaap:DepreciationDepletionAndAmortization>
  <us-gaap:OperatingExpenses contextRef="eol_PE749074--1410-Q0003_STD_90_20130331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_690E7802-F096-42F4-844C-B42D2992B3CF_2_3">996832</us-gaap:OperatingExpenses>
  <aqxp:AmortizationOfPreferredStockDiscount contextRef="eol_PE749074--1410-Q0003_STD_90_20130331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_AFF72D6D-AE4F-4009-8AA9-58E6D13FB48C_2_7">25438</aqxp:AmortizationOfPreferredStockDiscount>
  <aqxp:IncrementalCommonSharesAttributableToCommonStockWarrants contextRef="eol_PE749074--1410-Q0003_STD_90_20130331_0" unitRef="shares" xsi:nil="true" id="id_3828183_B8750CD9-87E8-4022-95EF-0FA4C1AC626B_2_12" />
  <aqxp:IncrementalCommonSharesAttributableToStockOptions contextRef="eol_PE749074--1410-Q0003_STD_90_20130331_0" unitRef="shares" xsi:nil="true" id="id_3828183_B8750CD9-87E8-4022-95EF-0FA4C1AC626B_2_11" />
  <aqxp:AmortizationOfDiscountOnPreferredStock contextRef="eol_PE749074--1410-Q0003_STD_90_20130331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_690E7802-F096-42F4-844C-B42D2992B3CF_2_9">25438</aqxp:AmortizationOfDiscountOnPreferredStock>
  <aqxp:SpecialVotingCommonStockIssuedValue contextRef="eol_PE749074--1410-Q0003_STD_90_20130331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_AFF72D6D-AE4F-4009-8AA9-58E6D13FB48C_2_30">7</aqxp:SpecialVotingCommonStockIssuedValue>
  <aqxp:TemporaryEquityAccretionToRedemptionValueLiquidationPreference contextRef="eol_PE749074--1410-Q0003_STD_90_20130331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_B8750CD9-87E8-4022-95EF-0FA4C1AC626B_2_2">1157865</aqxp:TemporaryEquityAccretionToRedemptionValueLiquidationPreference>
  <aqxp:IncomeTaxExpenseOnPreferredStock contextRef="eol_PE749074--1410-Q0003_STD_90_20130331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_B8750CD9-87E8-4022-95EF-0FA4C1AC626B_2_4">346091</aqxp:IncomeTaxExpenseOnPreferredStock>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="eol_PE749074--1410-Q0003_STD_90_20130331_0_928305x1263590" unitRef="shares" decimals="INF" id="id_3828183_44F854BC-E685-43F4-84DF-3884495E95B1_1002_0">5525844</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="eol_PE749074--1410-Q0003_STD_90_20130331_0_928305x924898" unitRef="shares" decimals="INF" id="id_3828183_44F854BC-E685-43F4-84DF-3884495E95B1_2002_1">435141</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <dei:TradingSymbol contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0" id="id_3828183_CBB1FE57-AEF2-4C11-8C94-0CED2965EC95_1_0">AQXP</dei:TradingSymbol>
  <dei:EntityRegistrantName contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0" id="id_3828183_CBB1FE57-AEF2-4C11-8C94-0CED2965EC95_1_1">AQUINOX PHARMACEUTICALS, INC</dei:EntityRegistrantName>
  <dei:AmendmentFlag contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0" id="id_3828183_C0C83C49-9FD8-4148-821B-D90584B9EB01_1_1">false</dei:AmendmentFlag>
  <dei:EntityFilerCategory contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0" id="id_3828183_CBB1FE57-AEF2-4C11-8C94-0CED2965EC95_1_4">Non-accelerated Filer</dei:EntityFilerCategory>
  <dei:DocumentFiscalYearFocus contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0" id="id_3828183_C0C83C49-9FD8-4148-821B-D90584B9EB01_1_3">2014</dei:DocumentFiscalYearFocus>
  <dei:DocumentType contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0" id="id_3828183_C0C83C49-9FD8-4148-821B-D90584B9EB01_1_0">10-Q</dei:DocumentType>
  <dei:DocumentPeriodEndDate contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0" id="id_3828183_C0C83C49-9FD8-4148-821B-D90584B9EB01_1_2">2014-03-31</dei:DocumentPeriodEndDate>
  <dei:EntityIncorporationDateOfIncorporation contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0" id="id_3828183_290AD72B-649E-4CE5-A459-957084D455B2_1_0">2007-05-31</dei:EntityIncorporationDateOfIncorporation>
  <dei:EntityCentralIndexKey contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0" id="id_3828183_CBB1FE57-AEF2-4C11-8C94-0CED2965EC95_1_2">0001404644</dei:EntityCentralIndexKey>
  <dei:CurrentFiscalYearEndDate contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0" id="id_3828183_CBB1FE57-AEF2-4C11-8C94-0CED2965EC95_1_3">--12-31</dei:CurrentFiscalYearEndDate>
  <dei:DocumentFiscalPeriodFocus contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0" id="id_3828183_C0C83C49-9FD8-4148-821B-D90584B9EB01_1_4">Q1</dei:DocumentFiscalPeriodFocus>
  <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0" id="id_3828183_7E0FBB5D-2715-42BE-9170-8C9E8ED38412_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;&lt;i&gt;(i) Recent accounting pronouncements&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 In April 2014, the FASB issued ASU 2014-08, &amp;#x201C;Presentation of
 Financial Statements and Property, Plant, and
 Equipment&amp;#x2014;Reporting Discontinued Operations and Disclosures
 of Disposals of Components of an Entity.&amp;#x201D; ASU 2014-08
 provides guidance related to the definition of a discontinued
 operation and requires new disclosures of both discontinued
 operations and certain other disposals that do not meet the
 definition of a discontinued operation. This new guidance is
 effective for the Company for annual periods beginning on
 January&amp;#xA0;1, 2015 and interim periods within those years. The
 Company does not anticipate a material impact to the
 Company&amp;#x2019;s financial position, results of operations or cash
 flows as a result of this change.&lt;/p&gt;
 &lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
  <us-gaap:NumberOfOperatingSegments contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0" unitRef="Segment" decimals="INF" id="id_3828183_22172ABE-5FD6-45B3-9A72-BAAFD5E22C45_1_0">1</us-gaap:NumberOfOperatingSegments>
  <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0" id="id_3828183_CA4EE28A-EA4A-45E6-8369-44A7F46BB207_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;&lt;i&gt;(f) Accounting for stock-based compensation&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 The Company measures the cost of services received in exchange for
 an award of equity instruments based on the grant-date fair value
 of the award. The cost of such award will be recognized over the
 period during which services are provided in exchange for the
 award, generally the vesting period. All share-based payments to
 employees are recognized in the financial statements based upon
 their respective grant date fair values.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"&gt;
 The Company estimates the fair value of options granted using the
 Black-Scholes option pricing model. This approximation uses
 assumptions regarding a number of inputs that requires management
 to make significant estimates and judgments. Since prior to the
 completion of the IPO, the Company&amp;#x2019;s common stock was not
 publicly traded, the expected volatility assumption was based on
 industry peer information. Additionally, because the Company has no
 significant history to calculate the expected term, the simplified
 method calculation was used.&lt;/p&gt;
 &lt;/div&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0" unitRef="pure" decimals="4" id="id_3828183_A4174175-A9D9-477C-834E-678B87667A02_1_3">0.0152</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:EarningsPerShareDiluted contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_3828183_B8750CD9-87E8-4022-95EF-0FA4C1AC626B_1_15">-1.28</us-gaap:EarningsPerShareDiluted>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0" unitRef="pure" decimals="2" id="id_3828183_A4174175-A9D9-477C-834E-678B87667A02_1_0">1.08</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0" unitRef="shares" decimals="0" id="id_3828183_B8750CD9-87E8-4022-95EF-0FA4C1AC626B_1_13">3148481</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
  <us-gaap:StockholdersEquityReverseStockSplit contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0" id="id_3828183_3044021B-5375-4FD0-BE16-43D4C411C0D8_1_0">The Company effected a 1-for-19.2 reverse stock split</us-gaap:StockholdersEquityReverseStockSplit>
  <us-gaap:EarningsPerShareBasic contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_3828183_B8750CD9-87E8-4022-95EF-0FA4C1AC626B_1_14">-1.28</us-gaap:EarningsPerShareBasic>
  <us-gaap:NatureOfOperations contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0" id="id_3828183_473CB5B1-69FA-4E16-A41A-40A4789AC7E2_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"&gt;
 &lt;b&gt;1. Nature of operations&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 Aquinox Pharmaceuticals, Inc. and its wholly owned subsidiary,
 Aquinox Pharmaceuticals Inc., (consolidated and combined the
 &amp;#x201C;Company&amp;#x201D;&amp;#x2014;see Note&amp;#xA0;2 Basis of presentation)
 are a clinical stage pharmaceutical company discovering and
 developing oral drug candidates to treat inflammation and cancer.
 The Company&amp;#x2019;s primary focus is the development of
 anti-inflammatory product candidates targeting SHIP1 which is a key
 regulator of a cellular signaling pathway in immune cells. Aquinox
 Pharmaceuticals (USA) Inc. was incorporated on May&amp;#xA0;31, 2007 in
 the State of Delaware, United States. On January&amp;#xA0;27, 2014,
 Aquinox Pharmaceuticals (USA) Inc. changed its name to Aquinox
 Pharmaceuticals, Inc. (&amp;#x201C;Aquinox USA&amp;#x201D;). Aquinox
 Pharmaceuticals Inc. (&amp;#x201C;AQXP Canada&amp;#x201D;), formerly
 6175813&amp;#xA0;Canada&amp;#xA0;Inc., was incorporated under the Canada
 Business Corporations Act on December&amp;#xA0;26, 2003 and operates in
 Vancouver, British Columbia, Canada.&lt;/p&gt;
 &lt;/div&gt;</us-gaap:NatureOfOperations>
  <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0" id="id_3828183_3F2A3724-FB2B-40E7-9EF1-FD4F57BFE1E0_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"&gt;
 The following have been excluded from the computation of basic and
 diluted net loss per share as their effect would have been
 antidilutive:&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="76%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="64%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="10%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="10%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;THREE&amp;#xA0;MONTHS&lt;br /&gt;
 ENDED&lt;/b&gt;&lt;br /&gt;
 &lt;b&gt;MARCH 31, 2014&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;THREE&amp;#xA0;MONTHS&lt;br /&gt;
 ENDED&lt;/b&gt;&lt;br /&gt;
 &lt;b&gt;MARCH 31, 2013&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 Convertible preferred stock&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;
 &amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;5,525,844&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 Outstanding stock options&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;630,159&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;435,141&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 Common stock warrants&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;11,363&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;
 &amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 Total&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-SIZE: 8pt"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;641,522&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-SIZE: 8pt"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;5,960,985&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;/div&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
  <us-gaap:DebtDisclosureTextBlock contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0" id="id_3828183_A7CF0A4E-3529-45A3-96C4-89A01DBF25D6_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;5. Loan facility&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 On October&amp;#xA0;23, 2013, AQXP Canada entered into a term loan
 facility with Silicon Valley Bank (&amp;#x201C;SVB&amp;#x201D;) for up to
 $4&amp;#xA0;million, of which $2.5 million was received on
 October&amp;#xA0;30, 2013 and a further $1.5 million is available to
 AQXP Canada through December&amp;#xA0;31, 2014 upon AQXP Canada
 receiving certain agreed-upon Phase 2 top-line data results from
 its Chronic Obstructive Pulmonary Disorder (&amp;#x201C;COPD&amp;#x201D;) or
 Bladder Pain Syndrome/Interstitial Cystitis (&amp;#x201C;BPS/IC&amp;#x201D;)
 clinical trials. Aquinox USA is a guarantor of AQXP Canada&amp;#x2019;s
 obligations under the term loan facility. In addition to principal,
 interest and other related payments due to SVB, Aquinox USA and
 AQXP Canada issued SVB warrants at $10.56 per warrant to purchase
 11,363 shares of Series C preferred stock and a corresponding
 number of Canadian special voting shares of AQXP Canada. Following
 the completion of the IPO, the warrants are exercisable for 11,363
 shares of common stock. These warrants expire in 2023.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"&gt;
 The term loan has an interest rate of 5.25% and is collateralized
 by AQXP Canada&amp;#x2019;s assets, excluding intellectual property, but
 including all proceeds thereof. The term loan principal is
 repayable in monthly installments approximately $83,000 commencing
 October 2014 and the loan has a maturity date of March 2017. AQXP
 Canada may voluntarily repay the term loan at any time.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"&gt;
 On March&amp;#xA0;28, 2014, AQXP Canada made a cash payment of
 $2,609,844 to fully repay the amount outstanding under the term
 loan facility. The repayment was accounted for as an extinguishment
 of debt and the loss on extinguishment of $213,511 along with the
 prepayment penalty, repayment fee and accrued interest were
 recorded within bank charges and financing costs.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="68%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="84%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="13%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;AMOUNT&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 BALANCE&amp;#x2014;January&amp;#xA0;1, 2013&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;
 &amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"&gt;
 Bank loan cash received - October&amp;#xA0;30, 2013&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;2,500,000&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"&gt;
 Warrant discount&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(226,255&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"&gt;
 Financing costs&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;12,744&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 BALANCE&amp;#x2014;December&amp;#xA0;31, 2013&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-SIZE: 8pt"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;2,286,489&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"&gt;
 Accrued interest&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-SIZE: 8pt"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;9,844&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"&gt;
 Accretion of warrant discount&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-SIZE: 8pt"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;213,511&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"&gt;
 Repayment fee and penalty&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-SIZE: 8pt"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;100,000&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"&gt;
 Repayment of bank loan and interest&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-SIZE: 8pt"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(2,609,844&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 BALANCE&amp;#x2014;March&amp;#xA0;31, 2014&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-SIZE: 8pt"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;
 &amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="76%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="66%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="11%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="11%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td height="16"&gt;&lt;/td&gt;
 &lt;td height="16" colspan="4"&gt;&lt;/td&gt;
 &lt;td height="16" colspan="4"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;MARCH&amp;#xA0;31,&amp;#xA0;2014&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;DECEMBER&amp;#xA0;31,&lt;/b&gt;&lt;br /&gt;
 &lt;b&gt;2013&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 Short-term portion of bank loan&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;
 &amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;250,000&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 Long-term portion of bank loan&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;
 &amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;2,036,489&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-SIZE: 8pt"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;
 &amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-SIZE: 8pt"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;2,286,489&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0" id="id_3828183_A4174175-A9D9-477C-834E-678B87667A02_1_2">P6Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0" unitRef="shares" decimals="0" id="id_3828183_690E7802-F096-42F4-844C-B42D2992B3CF_1_22">3148481</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
  <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0" id="id_3828183_1B1837C7-4647-4941-BAB6-FFE3B105A70C_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"&gt;
 The detail of the computation of basic and diluted earnings per
 share is as follows:&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="84%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="51%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="7%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="7%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="7%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;THREE&amp;#xA0;MONTHS&lt;br /&gt;
 ENDED&lt;br /&gt;
 MARCH 31, 2014&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;THREE&amp;#xA0;MONTHS&lt;br /&gt;
 ENDED&lt;br /&gt;
 MARCH 31, 2013&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;DECEMBER&amp;#xA0;26,&lt;br /&gt;
 2003&lt;br /&gt;
 (INCEPTION)&amp;#xA0;TO&lt;br /&gt;
 MARCH 31, 2014&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 &lt;b&gt;&lt;i&gt;Numerator&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 Net loss and comprehensive loss incurred in the development
 stage&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(4,227,678&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(1,010,267&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(51,502,587&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 Accretion for liquidation preference on preferred stock&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(1,132,893&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(1,157,865&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(18,566,008&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 Accretion for share issuance costs on preferred stock&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(19,550&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(44,307&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(1,014,667&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 Tax expense on preferred stock&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(100,291&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(346,091&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(1,897,702&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 Reversal of tax payable on preferred stock due to conversion of
 preferred stock&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;1,897,702&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;
 &amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;1,897,702&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 Extinguishment of remaining share issuance costs due to conversion
 of preferred stock&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(439,227&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;
 &amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(439,227&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 Total loss attributable to common stockholders&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-SIZE: 8pt"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(4,021,937&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-SIZE: 8pt"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(2,558,530&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-SIZE: 8pt"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(71,522,489&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 &lt;b&gt;&lt;i&gt;Denominator&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-SIZE: 8pt"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-SIZE: 8pt"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-SIZE: 8pt"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 Weighted average shares used to compute basic net loss per common
 share&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-SIZE: 8pt"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;3,148,481&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-SIZE: 8pt"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;301,745&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-SIZE: 8pt"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;398,573&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 Effect of potentially dilutive securities:&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-SIZE: 8pt"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-SIZE: 8pt"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-SIZE: 8pt"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"&gt;
 Stock options&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-SIZE: 8pt"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;
 &amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-SIZE: 8pt"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;
 &amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-SIZE: 8pt"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;
 &amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"&gt;
 Common stock warrants&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-SIZE: 8pt"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;
 &amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-SIZE: 8pt"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;
 &amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-SIZE: 8pt"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;
 &amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 Weighted average shares used to compute diluted net loss per common
 share&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-SIZE: 8pt"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;3,148,481&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-SIZE: 8pt"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;301,745&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-SIZE: 8pt"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;398,573&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 Net loss per share attributable to common
 stockholders&amp;#x2014;basic&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-SIZE: 8pt"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(1.28&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-SIZE: 8pt"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(8.48&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-SIZE: 8pt"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(179.45&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 Net loss per share attributable to common
 stockholders&amp;#x2014;diluted&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-SIZE: 8pt"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(1.28&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-SIZE: 8pt"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(8.48&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-SIZE: 8pt"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(179.45&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
  <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0" id="id_3828183_B3BB0DFC-2D10-439A-9ADE-90DCEF0E3D56_1_0">&lt;div&gt;
 &lt;p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;
 &lt;b&gt;3. Redeemable convertible preferred stock and
 stockholders&amp;#x2019; (deficit) equity&lt;/b&gt;&lt;/p&gt;
 &lt;p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;
 On February&amp;#xA0;27, 2014, the Company effected a 1-for-19.2
 reverse stock split of Aquinox USA&amp;#x2019;s common stock and
 convertible preferred stock and AQXP Canada&amp;#x2019;s common
 exchangeable shares and exchangeable preferred shares. All per
 share amounts and numbers of shares within the condensed
 consolidated and combined financial statements and notes are
 presented on a post-split basis.&lt;/p&gt;
 &lt;p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;
 On March&amp;#xA0;12, 2014, immediately prior to the closing of the
 IPO, the Company underwent a reorganization, which resulted in a
 simplification of its capital structure. Each of the 301,745
 outstanding common exchangeable shares of AQXP Canada was
 transferred to Aquinox USA in exchange for one common stock of
 Aquinox USA. Each of the 791,016 outstanding Series A exchangeable
 preferred shares, 793,617 outstanding Series B exchangeable
 preferred shares and 378,786 outstanding Series C exchangeable
 preferred share of AQXP Canada was transferred to Aquinox USA in
 exchange for one share of Series A, B and C convertible preferred
 stock of Aquinox USA, respectively. As a result, following such
 exchange, there were 1,453,891 shares of Series A, 2,367,414 shares
 of Series B and 1,722,210 shares of Series C convertible preferred
 stock of Aquinox USA. Following the completion of the exchange and
 conversion, all special voting shares of AQXP Canada and all
 special voting stock of Aquinox USA were redeemed for a nominal
 amount and all exchangeable preferred shares of AQXP Canada, now
 held by Aquinox USA, were converted to common exchangeable shares
 of AQXP Canada. As a result of the reorganization, AQXP Canada
 became a 100% owned subsidiary of Aquinox USA. Subsequent to this
 reorganization, all 5,543,515 of the outstanding shares of
 redeemable convertible preferred stock of Aquinox USA converted to
 an equivalent number of shares of common stock of Aquinox USA. The
 exchange and conversion resulted in the derecognition of non-cash
 accrued tax payable of $1,797,412 and the derecognition of the
 derivative liability for the redemption option on preferred stock
 of $800,206.&lt;/p&gt;
 &lt;p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;
 On March&amp;#xA0;12, 2014, the Company closed its IPO whereby the
 Company sold 4,830,000 shares of common stock (inclusive of 630,000
 shares of common stock sold by the Company pursuant to the full
 exercise of an overallotment option granted to the underwriters in
 connection with the offering) at a price of $11.00 per share before
 underwriting discounts. The shares began trading on the NASDAQ
 Global Market in March 2014, under the symbol &amp;#x201C;AQXP&amp;#x201D;.
 The aggregate net proceeds received by the Company from the
 offering, net of underwriting discounts and commissions and
 offering costs of $5,788,726, were $47,341,274.&lt;/p&gt;
 &lt;p style="font-size:1px;margin-top:12px;margin-bottom:0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;
 On March&amp;#xA0;12, 2014, the Company adopted an amended and restated
 certificate of incorporation for Aquinox USA, which authorized two
 classes of stock, common and preferred. The total number of shares
 the Company is authorized to issue is 55,000,000 shares, comprised
 of 50,000,000 common stock and 5,000,000 of a new category of
 preferred stock both with a par value of $0.000001 per share. As of
 March&amp;#xA0;31, 2014 and December&amp;#xA0;31, 2013, no shares of this
 new category of preferred stock were issued or outstanding.&lt;/p&gt;
 &lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
  <us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_AFF72D6D-AE4F-4009-8AA9-58E6D13FB48C_1_15">-3802168</us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations>
  <us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0" id="id_3828183_10DB0659-2D2D-48E3-9779-2FF247F7DBF4_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;Fair value of significant unobservable inputs (Level 3)&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="84%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="62%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="6%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="6%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="6%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;BANK LOAN&lt;br /&gt;
 WARRANT&lt;br /&gt;
 DERIVATIVE&lt;br /&gt;
 LIABILITIES&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;PREFERRED&lt;br /&gt;
 STOCK&lt;br /&gt;
 EMBEDDED&lt;br /&gt;
 DERIVATIVE&lt;br /&gt;
 LIABILITIES&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;TOTAL&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 BALANCES&amp;#x2014;January&amp;#xA0;1, 2014&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;221,320&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;800,206&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;1,021,526&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"&gt;
 Change in fair value of derivative liabilities&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(113,723&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;
 &amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(113,723&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"&gt;
 Derecognition of liabilities upon preferred stock conversion to
 common stock conversion&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;
 &amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(800,206&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(800,206&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 BALANCES&amp;#x2014;March&amp;#xA0;31, 2014&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-SIZE: 8pt"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;107,597&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-SIZE: 8pt"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;
 &amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-SIZE: 8pt"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;107,597&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;/div&gt;</us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
  <us-gaap:CashAndCashEquivalentsDisclosureTextBlock contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0" id="id_3828183_F2F3AD27-204E-4230-9E2F-8B9A28FD1C2F_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;4. Cash and cash equivalents&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="76%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="62%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="9%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="9%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;MARCH&amp;#xA0;31,&amp;#xA0;2014&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;DECEMBER&amp;#xA0;31,&amp;#xA0;2013&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 Cash&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;49,538,874&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;7,292,116&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 Cash equivalents&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;3,379,453&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;3,714,276&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-SIZE: 8pt"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;52,918,327&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-SIZE: 8pt"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;11,006,392&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;/div&gt;</us-gaap:CashAndCashEquivalentsDisclosureTextBlock>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_3828183_BB3CECEC-1F2D-465E-8AF2-9F15BF5B30A9_1_0">9.05</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0" unitRef="pure" decimals="2" id="id_3828183_A4174175-A9D9-477C-834E-678B87667A02_1_1">0.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
  <us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0" id="id_3828183_F64505EF-F6FA-4AB0-9E3B-631995B54C4A_1_0">&lt;div&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="68%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="84%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="13%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;AMOUNT&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 BALANCE&amp;#x2014;January&amp;#xA0;1, 2013&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;
 &amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"&gt;
 Bank loan cash received - October&amp;#xA0;30, 2013&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;2,500,000&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"&gt;
 Warrant discount&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(226,255&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"&gt;
 Financing costs&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;12,744&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 BALANCE&amp;#x2014;December&amp;#xA0;31, 2013&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-SIZE: 8pt"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;2,286,489&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"&gt;
 Accrued interest&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-SIZE: 8pt"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;9,844&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"&gt;
 Accretion of warrant discount&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-SIZE: 8pt"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;213,511&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"&gt;
 Repayment fee and penalty&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-SIZE: 8pt"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;100,000&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"&gt;
 Repayment of bank loan and interest&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-SIZE: 8pt"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(2,609,844&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 BALANCE&amp;#x2014;March&amp;#xA0;31, 2014&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-SIZE: 8pt"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;
 &amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;/div&gt;</us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock>
  <us-gaap:EarningsPerShareBasicAndDiluted contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_3828183_690E7802-F096-42F4-844C-B42D2992B3CF_1_21">-1.28</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0" unitRef="shares" decimals="INF" id="id_3828183_BB3CECEC-1F2D-465E-8AF2-9F15BF5B30A9_1_1">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
  <us-gaap:StockholdersEquityNoteRedeemablePreferredStockIssuePolicy contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0" id="id_3828183_D7C5EA4E-EC7B-4288-BEE2-7C38EAF12937_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;&lt;i&gt;(e) Redeemable convertible preferred stock&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 The Company classified redeemable convertible preferred stock that
 was redeemable outside of the Company&amp;#x2019;s control as mezzanine
 equity. The Company recorded such redeemable convertible preferred
 stock at fair value upon issuance, net of any issuance costs or
 discounts. The carrying value of the redeemable convertible
 preferred stock was increased by periodic accretion to its
 redemption value.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 1px; MARGIN-TOP: 12px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt"&gt;
 In the absence of retained earnings, the accretion was recorded
 within additional paid-in capital to the extent there was a
 sufficient balance, rather than accumulated deficit. Only after
 exhausting the balance of accumulated paid-in capital, was the
 accretion recorded to accumulated deficit.&lt;/p&gt;
 &lt;/div&gt;</us-gaap:StockholdersEquityNoteRedeemablePreferredStockIssuePolicy>
  <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0" unitRef="shares" decimals="0" id="id_3828183_B8750CD9-87E8-4022-95EF-0FA4C1AC626B_1_9">3148481</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
  <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0" id="id_3828183_B8F915DA-4826-4344-90F0-BBEB6A55787E_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 &lt;b&gt;&lt;i&gt;(a) Basis of presentation&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 The accompanying unaudited condensed consolidated and combined
 financial statements are presented in United States
 (&amp;#x201C;U.S.&amp;#x201D;) dollars and have been prepared in accordance
 with accounting principles generally accepted in the United States
 of America (&amp;#x201C;U.S. GAAP&amp;#x201D;) and pursuant to the rules and
 regulations of the United States Securities and Exchange Commission
 (&amp;#x201C;SEC&amp;#x201D;) for interim financial information. Accordingly,
 these financial statements do not include all of the information
 and footnotes required for complete financial statements and should
 be read in conjunction with the audited combined financial
 statements and notes for the year ended December&amp;#xA0;31, 2013
 included in the Company&amp;#x2019;s final prospectus for its initial
 public offering (&amp;#x201C;IPO&amp;#x201D;) filed with the SEC pursuant to
 Rule 424(b) on March&amp;#xA0;7, 2014.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"&gt;
 In management&amp;#x2019;s opinion, the condensed consolidated and
 combined financial statements reflect all adjustments (including
 reclassifications and normal recurring adjustments) necessary to
 present fairly the financial position as of March&amp;#xA0;31, 2014,
 and results of operations and cash flows for all periods presented.
 The interim results presented are not necessarily indicative of
 results that can be expected for a full year.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"&gt;
 Through a reorganization on March&amp;#xA0;12, 2014, AQXP Canada became
 a wholly owned subsidiary of Aquinox USA (Note 3). Prior to the
 reorganization, management determined that AQXP Canada and Aquinox
 USA were entities under common control as each of AQXP Canada and
 Aquinox USA were owned beneficially by identical shareholders and
 as such the basis of presentation of financial results prior to
 March&amp;#xA0;12, 2014 was on a combined basis. Subsequent to
 March&amp;#xA0;12, 2014, the basis of presentation of the financial
 results is on a consolidated basis. All intercompany transactions
 have been eliminated.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"&gt;
 For the period from inception on December&amp;#xA0;26, 2003 through
 March&amp;#xA0;31, 2014, the Company is a development stage enterprise,
 as planned principal operations have not yet begun to generate
 revenues. In its development stage, all pre-operating costs are
 being expensed as incurred. The statements of operations and
 comprehensive loss, convertible preferred stock and
 stockholders&amp;#x2019; deficit, and cash flows present the cumulative
 consolidated financial information of the Company for the period
 from inception on December&amp;#xA0;26, 2003 through March&amp;#xA0;31,
 2014.&lt;/p&gt;
 &lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
  <us-gaap:EarningsPerShareTextBlock contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0" id="id_3828183_16F5CEF5-670D-4827-9FF8-6CDE7742A4F3_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;7. Net loss per share&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 In connection with the IPO, the Company&amp;#x2019;s capital structure
 was reorganized such that AQXP Canada became a wholly-owned
 subsidiary of the Company, and the holders of the preferred shares
 of AQXP Canada, common shares of AQXP Canada and preferred shares
 of the Company exchanged their shares for shares of common stock of
 the Company (see Note 3). In connection with the IPO, the Company
 effected a 1-for-19.2 reverse stock split. The common stock,
 options and warrants outstanding as of the completion of the
 reorganization were 5,845,260 shares, 628,754 options and 11,363
 warrants, respectively. Basic and diluted earnings per share has
 been retroactively restated for all periods prior to the
 reorganization.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"&gt;
 Basic and diluted net loss per common share are presented using the
 two-class method required for participating securities. If a
 dividend is paid on common stock, the holders of preferred stock
 are entitled to a proportionate share of any such dividend as if
 they were holders of common stock (on an if-converted basis). The
 Company considers its preferred stock to be participating
 securities and, in accordance with the two-class method, earnings
 allocated to participating securities and the related number of
 outstanding shares of participating securities have been excluded
 from the computation of basic and diluted net loss per common
 share.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 1px; MARGIN-TOP: 12px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt"&gt;
 The Company considers the Aquinox USA Common Stock to be their
 participating stock that is subordinate to all other stock or
 shares of the Company. These shares are used by the Company when
 computing its loss per share. Under the two-class method, net loss
 attributable to common stockholders is determined by allocating
 undistributed loss between common stock and participating
 securities. Undistributed loss is calculated as net loss less
 distributed loss, accretion of liquidation preference on preferred
 stock, accretion of share issuance costs on preferred stock, and
 tax expense on preferred stock. As holders of preferred stock,
 holders of stock options and holders of common stock warrants do
 not have contractual obligations to share in the losses of the
 Company, the net loss attributable to common stockholders for each
 period is not allocated between common stock and participating
 securities. Accordingly, outstanding stock options, common stock
 warrants and preferred stock are excluded from the calculation of
 basic and diluted net loss per share as the effect would have been
 anti-dilutive.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"&gt;
 The detail of the computation of basic and diluted earnings per
 share is as follows:&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="84%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="51%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="7%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="7%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="7%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;THREE&amp;#xA0;MONTHS&lt;br /&gt;
 ENDED&lt;br /&gt;
 MARCH 31, 2014&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;THREE&amp;#xA0;MONTHS&lt;br /&gt;
 ENDED&lt;br /&gt;
 MARCH 31, 2013&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;DECEMBER&amp;#xA0;26,&lt;br /&gt;
 2003&lt;br /&gt;
 (INCEPTION)&amp;#xA0;TO&lt;br /&gt;
 MARCH 31, 2014&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 &lt;b&gt;&lt;i&gt;Numerator&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 Net loss and comprehensive loss incurred in the development
 stage&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(4,227,678&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(1,010,267&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(51,502,587&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 Accretion for liquidation preference on preferred stock&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(1,132,893&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(1,157,865&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(18,566,008&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 Accretion for share issuance costs on preferred stock&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(19,550&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(44,307&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(1,014,667&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 Tax expense on preferred stock&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(100,291&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(346,091&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(1,897,702&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 Reversal of tax payable on preferred stock due to conversion of
 preferred stock&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;1,897,702&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;
 &amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;1,897,702&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 Extinguishment of remaining share issuance costs due to conversion
 of preferred stock&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(439,227&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;
 &amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(439,227&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 Total loss attributable to common stockholders&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-SIZE: 8pt"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(4,021,937&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-SIZE: 8pt"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(2,558,530&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-SIZE: 8pt"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(71,522,489&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 &lt;b&gt;&lt;i&gt;Denominator&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-SIZE: 8pt"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-SIZE: 8pt"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-SIZE: 8pt"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 Weighted average shares used to compute basic net loss per common
 share&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-SIZE: 8pt"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;3,148,481&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-SIZE: 8pt"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;301,745&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-SIZE: 8pt"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;398,573&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 Effect of potentially dilutive securities:&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-SIZE: 8pt"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-SIZE: 8pt"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-SIZE: 8pt"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"&gt;
 Stock options&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-SIZE: 8pt"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;
 &amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-SIZE: 8pt"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;
 &amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-SIZE: 8pt"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;
 &amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"&gt;
 Common stock warrants&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-SIZE: 8pt"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;
 &amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-SIZE: 8pt"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;
 &amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-SIZE: 8pt"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;
 &amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 Weighted average shares used to compute diluted net loss per common
 share&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-SIZE: 8pt"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;3,148,481&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-SIZE: 8pt"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;301,745&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-SIZE: 8pt"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;398,573&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 Net loss per share attributable to common
 stockholders&amp;#x2014;basic&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-SIZE: 8pt"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(1.28&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-SIZE: 8pt"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(8.48&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-SIZE: 8pt"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(179.45&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 Net loss per share attributable to common
 stockholders&amp;#x2014;diluted&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-SIZE: 8pt"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(1.28&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-SIZE: 8pt"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(8.48&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-SIZE: 8pt"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(179.45&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"&gt;
 The following have been excluded from the computation of basic and
 diluted net loss per share as their effect would have been
 antidilutive:&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="76%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="64%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="10%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="10%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;THREE&amp;#xA0;MONTHS&lt;br /&gt;
 ENDED&lt;/b&gt;&lt;br /&gt;
 &lt;b&gt;MARCH 31, 2014&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;THREE&amp;#xA0;MONTHS&lt;br /&gt;
 ENDED&lt;/b&gt;&lt;br /&gt;
 &lt;b&gt;MARCH 31, 2013&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 Convertible preferred stock&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;
 &amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;5,525,844&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 Outstanding stock options&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;630,159&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;435,141&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 Common stock warrants&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;11,363&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;
 &amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 Total&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-SIZE: 8pt"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;641,522&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-SIZE: 8pt"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;5,960,985&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
  <us-gaap:SegmentReportingPolicyPolicyTextBlock contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0" id="id_3828183_790615D8-6151-4A31-B840-0841C61DB230_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;&lt;i&gt;(g) Segment reporting&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 Management has determined that the Company&amp;#x2019;s operation, and
 how they manage the business, was one segment being the
 identification and development of therapeutics for inflammatory
 diseases and cancer. All of the Company&amp;#x2019;s operations are
 performed in Canada. Total assets held in the U.S., comprised
 primarily of cash and cash equivalents, were $51,116,586 as of
 March&amp;#xA0;31, 2014 (December 31, 2013 - $6,629,383).&lt;/p&gt;
 &lt;/div&gt;</us-gaap:SegmentReportingPolicyPolicyTextBlock>
  <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0" id="id_3828183_256422B4-854A-4BCF-B20C-FF2C89F3BE2C_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;2. Condensed summary of significant accounting policies&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 &lt;b&gt;&lt;i&gt;(a) Basis of presentation&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 The accompanying unaudited condensed consolidated and combined
 financial statements are presented in United States
 (&amp;#x201C;U.S.&amp;#x201D;) dollars and have been prepared in accordance
 with accounting principles generally accepted in the United States
 of America (&amp;#x201C;U.S. GAAP&amp;#x201D;) and pursuant to the rules and
 regulations of the United States Securities and Exchange Commission
 (&amp;#x201C;SEC&amp;#x201D;) for interim financial information. Accordingly,
 these financial statements do not include all of the information
 and footnotes required for complete financial statements and should
 be read in conjunction with the audited combined financial
 statements and notes for the year ended December&amp;#xA0;31, 2013
 included in the Company&amp;#x2019;s final prospectus for its initial
 public offering (&amp;#x201C;IPO&amp;#x201D;) filed with the SEC pursuant to
 Rule 424(b) on March&amp;#xA0;7, 2014.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"&gt;
 In management&amp;#x2019;s opinion, the condensed consolidated and
 combined financial statements reflect all adjustments (including
 reclassifications and normal recurring adjustments) necessary to
 present fairly the financial position as of March&amp;#xA0;31, 2014,
 and results of operations and cash flows for all periods presented.
 The interim results presented are not necessarily indicative of
 results that can be expected for a full year.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"&gt;
 Through a reorganization on March&amp;#xA0;12, 2014, AQXP Canada became
 a wholly owned subsidiary of Aquinox USA (Note 3). Prior to the
 reorganization, management determined that AQXP Canada and Aquinox
 USA were entities under common control as each of AQXP Canada and
 Aquinox USA were owned beneficially by identical shareholders and
 as such the basis of presentation of financial results prior to
 March&amp;#xA0;12, 2014 was on a combined basis. Subsequent to
 March&amp;#xA0;12, 2014, the basis of presentation of the financial
 results is on a consolidated basis. All intercompany transactions
 have been eliminated.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"&gt;
 For the period from inception on December&amp;#xA0;26, 2003 through
 March&amp;#xA0;31, 2014, the Company is a development stage enterprise,
 as planned principal operations have not yet begun to generate
 revenues. In its development stage, all pre-operating costs are
 being expensed as incurred. The statements of operations and
 comprehensive loss, convertible preferred stock and
 stockholders&amp;#x2019; deficit, and cash flows present the cumulative
 consolidated financial information of the Company for the period
 from inception on December&amp;#xA0;26, 2003 through March&amp;#xA0;31,
 2014.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;&lt;i&gt;(b) Use of estimates&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 The preparation of financial statements in conformity with U.S.
 GAAP requires management to make estimates and assumptions that
 affect the reported amounts of assets and liabilities and the
 disclosure of contingent assets and liabilities at the date of the
 financial statements and the reported amounts of expenses during
 the reporting period. Significant areas requiring management
 estimates are the valuation of intangible assets, valuation of
 stock options and warrants, amortization and depreciation,
 valuation allowance for deferred income taxes, and contingencies.
 Actual results could differ from those estimates.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;&lt;i&gt;(c) Taxes&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 The Company accounts for income taxes using &lt;i&gt;ASC&amp;#xA0;740, Income
 Taxes&lt;/i&gt; which is an asset and liability approach that requires
 the recognition of deferred tax assets and liabilities for the
 expected future tax consequences of events that have been
 recognized in the Company&amp;#x2019;s financial statements or tax
 returns. In estimating future tax consequences, ASC 740 generally
 considers all expected future events other than enactments of and
 changes in the tax law or rates. The measurement of deferred tax
 assets is reduced, if necessary, by the amount of any tax benefits
 that, based on available evidence, are not expected to be realized.
 Valuation allowances are provided if, after considering other
 available evidence it is more likely than not that deferred tax
 assets will not be realized. ASC&amp;#xA0;740 clarifies the criteria
 that must be met prior to recognition of the financial statement
 benefit of a position taken in a tax return. ASC&amp;#xA0;740 provides
 a benefit recognition model with a two-step approach consisting of
 a &amp;#x201C;more-likely-than-not&amp;#x201D; recognition criteria, and a
 measurement attribute that measures a given tax position as the
 largest amount of tax benefits that are more than 50% likely of
 being realized upon ultimate settlement. ASC&amp;#xA0;740 also requires
 the recognition of liabilities created by differences between tax
 positions taken in a tax return and amounts recognized in the
 financial statements.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"&gt;
 Investment tax credits relating to scientific research and
 experimental development are accounted for in operations. To the
 extent there is reasonable assurance the credits will be realized,
 they are recorded in the period the related expenditure is made as
 an income tax (provision) recovery. If investment tax credit
 amounts subsequently received are less or more than originally
 recorded, the difference is treated as a change in estimate.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"&gt;
 Canadian tax rules impose a tax with respect to Canadian
 corporation taxable preferred stock and their liquidation rights.
 In prior periods, AQXP Canada has recorded this tax on preferred
 stock as a non-current accrued tax payable on its balance sheet, on
 the same basis as it recorded the accretion of preferred stock.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;&lt;i&gt;(d) Derivative liabilities and fair value of financial
 instruments&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 The Company accounts for currently outstanding detachable warrants
 to purchase preferred stock or common stock as liabilities as they
 are freestanding derivative financial instruments. The warrants are
 recorded as liabilities at fair value, estimated using a
 Black-Scholes option pricing model, and marked to market at each
 balance sheet date, with changes in the fair value of the
 derivative liabilities recorded in the consolidated and combined
 statements of operations. The Company allocates the total
 consideration received for issuing preferred stock and warrants
 based on the relative fair value of each security at the date of
 issuance. This allocation results in a discount to the initial
 carrying amount of the preferred stock at the date of issuance
 amortized over the life of the preferred stock and is recorded as
 &amp;#x201C;amortization of discount on preferred stock&amp;#x201D; in the
 consolidated and combined statements of operations and
 comprehensive loss.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"&gt;
 The Company also evaluates and accounts for conversion and
 redemption options embedded in convertible instruments as they can
 be free standing derivative financial instruments depending on
 certain criteria. If they are determined to be free standing
 derivative financial instruments, the Company records these as
 preferred stock embedded derivatives on their consolidated balance
 sheets at fair value with changes in the fair values of these
 derivatives recorded in the consolidated and combined statements of
 operations and comprehensive loss.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"&gt;
 The Company applies the residual value method to record the fair
 value of warrants issued with loans as a discount to the initial
 carrying amount of loans at the date of issuance. Loans are
 measured at amortized cost using the effective interest method
 which is a method of calculating the amortized cost of a financial
 liability and allocating the effective interest expense over the
 term of the financial liability. Interest expense is recorded in
 bank charges and financing costs in the consolidated and combined
 statements of operations and comprehensive loss. The interest rate
 is the rate that exactly discounts estimated future cash payments
 throughout the term of the financial instrument to the net carrying
 amount of the financial liability. Debt issuance costs are
 capitalized, recorded as deferred financing costs, and are
 amortized into financing costs in the consolidated and combined
 statements of operations and comprehensive loss using the effective
 interest method.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"&gt;
 &lt;i&gt;ASC 820, Fair Value Measurements&lt;/i&gt; requires disclosures about
 transfers into and out of Levels&amp;#xA0;1 and 2 and separate
 disclosures about purchases, sales, issuances, and settlements
 relating to Level&amp;#xA0;3 measurements. It also clarifies existing
 fair value disclosures regarding the level of disaggregation and
 the inputs and valuation techniques used to measure fair value.
 ASC&amp;#xA0;820 defines fair value as the amounts that would be
 received upon sale of an asset or paid to transfer a liability in
 an orderly transaction between market participants at the
 measurement date (exit price). The guidance also established a fair
 value hierarchy that prioritizes the use of inputs used in
 valuation techniques into the following three levels:&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 4%; MARGIN-TOP: 6pt"&gt;
 Level 1&amp;#x2014;Quoted prices in active markets for identical assets
 or liabilities.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 4%; MARGIN-TOP: 6pt"&gt;
 Level 2&amp;#x2014;Inputs other than Level 1 that are observable, either
 directly or indirectly, such as quoted prices for similar assets or
 liabilities; quoted prices in markets that are not active; or other
 inputs that are observable or can be corroborated by observable
 market data for substantially the full term of the assets or
 liabilities.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 4%; MARGIN-TOP: 6pt"&gt;
 Level 3&amp;#x2014;Unobservable inputs that are supported by little or
 no market activity and that are significant to the fair value of
 the assets or liabilities.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;&lt;i&gt;(e) Redeemable convertible preferred stock&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 The Company classified redeemable convertible preferred stock that
 was redeemable outside of the Company&amp;#x2019;s control as mezzanine
 equity. The Company recorded such redeemable convertible preferred
 stock at fair value upon issuance, net of any issuance costs or
 discounts. The carrying value of the redeemable convertible
 preferred stock was increased by periodic accretion to its
 redemption value.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 1px; MARGIN-TOP: 12px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt"&gt;
 In the absence of retained earnings, the accretion was recorded
 within additional paid-in capital to the extent there was a
 sufficient balance, rather than accumulated deficit. Only after
 exhausting the balance of accumulated paid-in capital, was the
 accretion recorded to accumulated deficit.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;&lt;i&gt;(f) Accounting for stock-based compensation&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 The Company measures the cost of services received in exchange for
 an award of equity instruments based on the grant-date fair value
 of the award. The cost of such award will be recognized over the
 period during which services are provided in exchange for the
 award, generally the vesting period. All share-based payments to
 employees are recognized in the financial statements based upon
 their respective grant date fair values.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"&gt;
 The Company estimates the fair value of options granted using the
 Black-Scholes option pricing model. This approximation uses
 assumptions regarding a number of inputs that requires management
 to make significant estimates and judgments. Since prior to the
 completion of the IPO, the Company&amp;#x2019;s common stock was not
 publicly traded, the expected volatility assumption was based on
 industry peer information. Additionally, because the Company has no
 significant history to calculate the expected term, the simplified
 method calculation was used.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;&lt;i&gt;(g) Segment reporting&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 Management has determined that the Company&amp;#x2019;s operation, and
 how they manage the business, was one segment being the
 identification and development of therapeutics for inflammatory
 diseases and cancer. All of the Company&amp;#x2019;s operations are
 performed in Canada. Total assets held in the U.S., comprised
 primarily of cash and cash equivalents, were $51,116,586 as of
 March&amp;#xA0;31, 2014 (December 31, 2013 - $6,629,383).&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;&lt;i&gt;(h) Loss per share&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 Basic loss per common share is computed by dividing loss by the
 weighted-average number of common shares outstanding during the
 period. Diluted net earnings per common share is determined using
 the weighted-average number of common shares outstanding during the
 period, adjusted for the dilutive effect of common stock
 equivalents, consisting of shares that might be issued upon
 exercise of common stock options and warrants. In periods where
 losses are reported, the weighted-average number of common shares
 outstanding excludes common stock equivalents because their
 inclusion would be anti-dilutive.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;&lt;i&gt;(i) Recent accounting pronouncements&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 In April 2014, the FASB issued ASU 2014-08, &amp;#x201C;Presentation of
 Financial Statements and Property, Plant, and
 Equipment&amp;#x2014;Reporting Discontinued Operations and Disclosures
 of Disposals of Components of an Entity.&amp;#x201D; ASU 2014-08
 provides guidance related to the definition of a discontinued
 operation and requires new disclosures of both discontinued
 operations and certain other disposals that do not meet the
 definition of a discontinued operation. This new guidance is
 effective for the Company for annual periods beginning on
 January&amp;#xA0;1, 2015 and interim periods within those years. The
 Company does not anticipate a material impact to the
 Company&amp;#x2019;s financial position, results of operations or cash
 flows as a result of this change.&lt;/p&gt;
 &lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0" unitRef="shares" decimals="INF" id="id_3828183_44F854BC-E685-43F4-84DF-3884495E95B1_1_3">641522</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:StockholdersEquityNoteStockSplitConversionRatio1 contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0" unitRef="pure" decimals="6" id="id_3828183_1197415A-10F7-4DDB-8E53-3BDE88CCE32F_1_1">0.052083</us-gaap:StockholdersEquityNoteStockSplitConversionRatio1>
  <us-gaap:UseOfEstimates contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0" id="id_3828183_83141F00-03DA-4E90-9142-5D9F462C18D7_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;&lt;i&gt;(b) Use of estimates&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 The preparation of financial statements in conformity with U.S.
 GAAP requires management to make estimates and assumptions that
 affect the reported amounts of assets and liabilities and the
 disclosure of contingent assets and liabilities at the date of the
 financial statements and the reported amounts of expenses during
 the reporting period. Significant areas requiring management
 estimates are the valuation of intangible assets, valuation of
 stock options and warrants, amortization and depreciation,
 valuation allowance for deferred income taxes, and contingencies.
 Actual results could differ from those estimates.&lt;/p&gt;
 &lt;/div&gt;</us-gaap:UseOfEstimates>
  <us-gaap:EarningsPerSharePolicyTextBlock contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0" id="id_3828183_FEE656B2-D603-43A0-928A-EA3DA9928937_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;&lt;i&gt;(h) Loss per share&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 Basic loss per common share is computed by dividing loss by the
 weighted-average number of common shares outstanding during the
 period. Diluted net earnings per common share is determined using
 the weighted-average number of common shares outstanding during the
 period, adjusted for the dilutive effect of common stock
 equivalents, consisting of shares that might be issued upon
 exercise of common stock options and warrants. In periods where
 losses are reported, the weighted-average number of common shares
 outstanding excludes common stock equivalents because their
 inclusion would be anti-dilutive.&lt;/p&gt;
 &lt;/div&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
  <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0" id="id_3828183_32E98283-75AA-4D22-AF23-7856AA0E8514_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"&gt;
 The fair value of stock options granted is estimated using the
 Black-Scholes option pricing model with the following weighted
 average assumptions:&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="84%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="51%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="14%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="14%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="14%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;THREE&amp;#xA0;MONTHS&lt;br /&gt;
 ENDED&lt;br /&gt;
 MARCH 31, 2014&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;THREE&amp;#xA0;MONTHS&lt;br /&gt;
 ENDED&lt;br /&gt;
 MARCH 31, 2013&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;DECEMBER 26,&lt;br /&gt;
 2003&lt;br /&gt;
 (INCEPTION)&amp;#xA0;TO&lt;br /&gt;
 MARCH 31, 2014&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 Expected volatility&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;108&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;NA&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;88&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 Expected dividends&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;0&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;NA&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;0&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 Expected terms (years)&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;6.00&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;NA&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;6.24&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 Risk free rate&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;1.52&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;NA&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;2.96&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 Weighted average grant-date fair value of stock options&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;9.05&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;NA&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;4.23&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
  <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0" id="id_3828183_B626ED48-E059-4837-88B0-5C943599FCF3_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;&lt;i&gt;(d) Derivative liabilities and fair value of financial
 instruments&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 The Company accounts for currently outstanding detachable warrants
 to purchase preferred stock or common stock as liabilities as they
 are freestanding derivative financial instruments. The warrants are
 recorded as liabilities at fair value, estimated using a
 Black-Scholes option pricing model, and marked to market at each
 balance sheet date, with changes in the fair value of the
 derivative liabilities recorded in the consolidated and combined
 statements of operations. The Company allocates the total
 consideration received for issuing preferred stock and warrants
 based on the relative fair value of each security at the date of
 issuance. This allocation results in a discount to the initial
 carrying amount of the preferred stock at the date of issuance
 amortized over the life of the preferred stock and is recorded as
 &amp;#x201C;amortization of discount on preferred stock&amp;#x201D; in the
 consolidated and combined statements of operations and
 comprehensive loss.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"&gt;
 The Company also evaluates and accounts for conversion and
 redemption options embedded in convertible instruments as they can
 be free standing derivative financial instruments depending on
 certain criteria. If they are determined to be free standing
 derivative financial instruments, the Company records these as
 preferred stock embedded derivatives on their consolidated balance
 sheets at fair value with changes in the fair values of these
 derivatives recorded in the consolidated and combined statements of
 operations and comprehensive loss.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"&gt;
 The Company applies the residual value method to record the fair
 value of warrants issued with loans as a discount to the initial
 carrying amount of loans at the date of issuance. Loans are
 measured at amortized cost using the effective interest method
 which is a method of calculating the amortized cost of a financial
 liability and allocating the effective interest expense over the
 term of the financial liability. Interest expense is recorded in
 bank charges and financing costs in the consolidated and combined
 statements of operations and comprehensive loss. The interest rate
 is the rate that exactly discounts estimated future cash payments
 throughout the term of the financial instrument to the net carrying
 amount of the financial liability. Debt issuance costs are
 capitalized, recorded as deferred financing costs, and are
 amortized into financing costs in the consolidated and combined
 statements of operations and comprehensive loss using the effective
 interest method.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"&gt;
 &lt;i&gt;ASC 820, Fair Value Measurements&lt;/i&gt; requires disclosures about
 transfers into and out of Levels&amp;#xA0;1 and 2 and separate
 disclosures about purchases, sales, issuances, and settlements
 relating to Level&amp;#xA0;3 measurements. It also clarifies existing
 fair value disclosures regarding the level of disaggregation and
 the inputs and valuation techniques used to measure fair value.
 ASC&amp;#xA0;820 defines fair value as the amounts that would be
 received upon sale of an asset or paid to transfer a liability in
 an orderly transaction between market participants at the
 measurement date (exit price). The guidance also established a fair
 value hierarchy that prioritizes the use of inputs used in
 valuation techniques into the following three levels:&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 4%; MARGIN-TOP: 6pt"&gt;
 Level 1&amp;#x2014;Quoted prices in active markets for identical assets
 or liabilities.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 4%; MARGIN-TOP: 6pt"&gt;
 Level 2&amp;#x2014;Inputs other than Level 1 that are observable, either
 directly or indirectly, such as quoted prices for similar assets or
 liabilities; quoted prices in markets that are not active; or other
 inputs that are observable or can be corroborated by observable
 market data for substantially the full term of the assets or
 liabilities.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 4%; MARGIN-TOP: 6pt"&gt;
 Level 3&amp;#x2014;Unobservable inputs that are supported by little or
 no market activity and that are significant to the fair value of
 the assets or liabilities.&lt;/p&gt;
 &lt;/div&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
  <us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0" id="id_3828183_310C27D4-9743-405E-AE63-D4B203A6006E_1_0">&lt;div&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="76%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="62%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="9%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="9%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;MARCH&amp;#xA0;31,&amp;#xA0;2014&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;DECEMBER&amp;#xA0;31,&amp;#xA0;2013&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 Cash&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;49,538,874&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;7,292,116&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 Cash equivalents&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;3,379,453&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;3,714,276&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-SIZE: 8pt"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;52,918,327&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-SIZE: 8pt"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;11,006,392&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;/div&gt;</us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock>
  <us-gaap:IncomeTaxPolicyTextBlock contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0" id="id_3828183_4BD6E0CE-4861-4AAD-B0CB-C845E2FE75BE_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;&lt;i&gt;(c) Taxes&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 The Company accounts for income taxes using &lt;i&gt;ASC&amp;#xA0;740, Income
 Taxes&lt;/i&gt; which is an asset and liability approach that requires
 the recognition of deferred tax assets and liabilities for the
 expected future tax consequences of events that have been
 recognized in the Company&amp;#x2019;s financial statements or tax
 returns. In estimating future tax consequences, ASC 740 generally
 considers all expected future events other than enactments of and
 changes in the tax law or rates. The measurement of deferred tax
 assets is reduced, if necessary, by the amount of any tax benefits
 that, based on available evidence, are not expected to be realized.
 Valuation allowances are provided if, after considering other
 available evidence it is more likely than not that deferred tax
 assets will not be realized. ASC&amp;#xA0;740 clarifies the criteria
 that must be met prior to recognition of the financial statement
 benefit of a position taken in a tax return. ASC&amp;#xA0;740 provides
 a benefit recognition model with a two-step approach consisting of
 a &amp;#x201C;more-likely-than-not&amp;#x201D; recognition criteria, and a
 measurement attribute that measures a given tax position as the
 largest amount of tax benefits that are more than 50% likely of
 being realized upon ultimate settlement. ASC&amp;#xA0;740 also requires
 the recognition of liabilities created by differences between tax
 positions taken in a tax return and amounts recognized in the
 financial statements.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"&gt;
 Investment tax credits relating to scientific research and
 experimental development are accounted for in operations. To the
 extent there is reasonable assurance the credits will be realized,
 they are recorded in the period the related expenditure is made as
 an income tax (provision) recovery. If investment tax credit
 amounts subsequently received are less or more than originally
 recorded, the difference is treated as a change in estimate.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"&gt;
 Canadian tax rules impose a tax with respect to Canadian
 corporation taxable preferred stock and their liquidation rights.
 In prior periods, AQXP Canada has recorded this tax on preferred
 stock as a non-current accrued tax payable on its balance sheet, on
 the same basis as it recorded the accretion of preferred stock.&lt;/p&gt;
 &lt;/div&gt;</us-gaap:IncomeTaxPolicyTextBlock>
  <us-gaap:ScheduleOfDebtTableTextBlock contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0" id="id_3828183_3187D056-B763-4060-9CA7-4E2B0CEA2AF3_1_0">&lt;div&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="76%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="66%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="11%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="11%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td height="16"&gt;&lt;/td&gt;
 &lt;td height="16" colspan="4"&gt;&lt;/td&gt;
 &lt;td height="16" colspan="4"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;MARCH&amp;#xA0;31,&amp;#xA0;2014&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;DECEMBER&amp;#xA0;31,&lt;/b&gt;&lt;br /&gt;
 &lt;b&gt;2013&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 Short-term portion of bank loan&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;
 &amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;250,000&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 Long-term portion of bank loan&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;
 &amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;2,036,489&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-SIZE: 8pt"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;
 &amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-SIZE: 8pt"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;2,286,489&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;/div&gt;</us-gaap:ScheduleOfDebtTableTextBlock>
  <us-gaap:FinancialInstrumentsDisclosureTextBlock contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0" id="id_3828183_2017C037-5AC9-4ED5-B47F-06C8FF5BC311_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;8. Financial instruments&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 &lt;b&gt;&lt;i&gt;Fair value of financial instruments&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 The carrying amounts of certain of the Company&amp;#x2019;s financial
 instruments including cash, cash equivalents, accounts and other
 amounts receivable, prepayments, accounts payable, and accrued
 liabilities, approximate their fair values because of their nature
 and/or short maturities and are categorized as Level 1 in the fair
 value hierarchy. Short-term investments are categorized as Level 2
 in the fair value hierarchy and as of March&amp;#xA0;31, 2014 had a
 fair value approximating their carrying amount.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 1px; MARGIN-TOP: 12px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt"&gt;
 The Company&amp;#x2019;s preferred stock embedded feature and warrants
 are accounted for as derivative liabilities. The Company used Level
 3 inputs for the valuation methodology of the derivative
 liabilities. The estimated fair values were computed using a
 Black-Scholes option pricing model which incorporates a number of
 assumptions and judgments to estimate the fair value of these
 derivative liabilities including the fair value per share of the
 underlying stock, remaining contractual term of the warrants and
 redeemable convertible preferred stock, risk-free interest rate,
 expected dividend yield, credit spread, and expected volatility of
 the underlying stock. The derivative liabilities are adjusted to
 reflect estimated fair value at each period end, with any decrease
 or increase in the estimated fair value being recorded in change in
 fair value of derivative liabilities:&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;Fair value of significant unobservable inputs (Level 3)&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="84%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="62%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="6%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="6%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="6%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;BANK LOAN&lt;br /&gt;
 WARRANT&lt;br /&gt;
 DERIVATIVE&lt;br /&gt;
 LIABILITIES&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;PREFERRED&lt;br /&gt;
 STOCK&lt;br /&gt;
 EMBEDDED&lt;br /&gt;
 DERIVATIVE&lt;br /&gt;
 LIABILITIES&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;TOTAL&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 BALANCES&amp;#x2014;January&amp;#xA0;1, 2014&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;221,320&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;800,206&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;1,021,526&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"&gt;
 Change in fair value of derivative liabilities&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(113,723&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;
 &amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(113,723&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"&gt;
 Derecognition of liabilities upon preferred stock conversion to
 common stock conversion&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;
 &amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(800,206&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(800,206&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 BALANCES&amp;#x2014;March&amp;#xA0;31, 2014&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-SIZE: 8pt"&gt;&amp;#xA0;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;107,597&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-SIZE: 8pt"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;
 &amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;font style="FONT-SIZE: 8pt"&gt;&amp;#xA0;&lt;/font&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;107,597&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: #000000 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"&gt;
 There were no transfers between Levels 1, 2, and 3 during the three
 months ended March&amp;#xA0;31, 2014 and 2013.&lt;/p&gt;
 &lt;/div&gt;</us-gaap:FinancialInstrumentsDisclosureTextBlock>
  <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_690E7802-F096-42F4-844C-B42D2992B3CF_1_10">-192063</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
  <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_AFF72D6D-AE4F-4009-8AA9-58E6D13FB48C_1_13">453705</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
  <us-gaap:ComprehensiveIncomeNetOfTax contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_690E7802-F096-42F4-844C-B42D2992B3CF_1_14">-4227678</us-gaap:ComprehensiveIncomeNetOfTax>
  <us-gaap:PaymentsOfFinancingCosts contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_AFF72D6D-AE4F-4009-8AA9-58E6D13FB48C_1_33">4810943</us-gaap:PaymentsOfFinancingCosts>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_690E7802-F096-42F4-844C-B42D2992B3CF_1_12">-4227678</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
  <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_B8750CD9-87E8-4022-95EF-0FA4C1AC626B_1_7">-4021937</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
  <us-gaap:RepaymentsOfLinesOfCredit contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_11FC9E3C-4A9B-47E5-A970-456EC739AB84_7001_9">2609844</us-gaap:RepaymentsOfLinesOfCredit>
  <us-gaap:RepaymentsOfDebt contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_AFF72D6D-AE4F-4009-8AA9-58E6D13FB48C_1_23">2600000</us-gaap:RepaymentsOfDebt>
  <us-gaap:InvestmentIncomeInterest contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_690E7802-F096-42F4-844C-B42D2992B3CF_1_6">2835</us-gaap:InvestmentIncomeInterest>
  <us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_AFF72D6D-AE4F-4009-8AA9-58E6D13FB48C_1_12">38580</us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables>
  <us-gaap:LineOfCreditFacilityIncreaseAccruedInterest contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_11FC9E3C-4A9B-47E5-A970-456EC739AB84_7001_6">9844</us-gaap:LineOfCreditFacilityIncreaseAccruedInterest>
  <us-gaap:GainLossOnDerivativeInstrumentsNetPretax contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_690E7802-F096-42F4-844C-B42D2992B3CF_1_8">913929</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
  <us-gaap:InterestPaid contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_AFF72D6D-AE4F-4009-8AA9-58E6D13FB48C_1_39">31719</us-gaap:InterestPaid>
  <us-gaap:ForeignCurrencyTransactionGainLossUnrealized contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_AFF72D6D-AE4F-4009-8AA9-58E6D13FB48C_1_10">-106501</us-gaap:ForeignCurrencyTransactionGainLossUnrealized>
  <us-gaap:NonoperatingIncomeExpense contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_690E7802-F096-42F4-844C-B42D2992B3CF_1_11">-1613340</us-gaap:NonoperatingIncomeExpense>
  <us-gaap:NetIncomeLoss contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_B8750CD9-87E8-4022-95EF-0FA4C1AC626B_1_1">-4227678</us-gaap:NetIncomeLoss>
  <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_AFF72D6D-AE4F-4009-8AA9-58E6D13FB48C_1_18">4463</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
  <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_AFF72D6D-AE4F-4009-8AA9-58E6D13FB48C_1_14">-734537</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
  <us-gaap:GeneralAndAdministrativeExpense contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_690E7802-F096-42F4-844C-B42D2992B3CF_1_2">734824</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationTransfersIntoLevel3 contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0" unitRef="iso4217_USD" decimals="INF" id="id_3828183_C63D787D-B38F-4D60-9BBB-C3B42592E799_1_0">0</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationTransfersIntoLevel3>
  <us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_AFF72D6D-AE4F-4009-8AA9-58E6D13FB48C_1_34">45718566</us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations>
  <us-gaap:ProceedsFromRepurchaseOfRedeemablePreferredStock contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_AFF72D6D-AE4F-4009-8AA9-58E6D13FB48C_1_29">-491</us-gaap:ProceedsFromRepurchaseOfRedeemablePreferredStock>
  <us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0" unitRef="iso4217_USD" decimals="INF" id="id_3828183_B8750CD9-87E8-4022-95EF-0FA4C1AC626B_1_3">19550</us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_D7DB1E75-9691-489E-BBF0-238ED21F4881_1_0">137654</us-gaap:ShareBasedCompensation>
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_AFF72D6D-AE4F-4009-8AA9-58E6D13FB48C_1_35">41911935</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_AFF72D6D-AE4F-4009-8AA9-58E6D13FB48C_1_21">-4463</us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations>
  <us-gaap:InterestExpense contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_690E7802-F096-42F4-844C-B42D2992B3CF_1_5">453808</us-gaap:InterestExpense>
  <us-gaap:ProceedsFromIssuanceInitialPublicOffering contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_AFF72D6D-AE4F-4009-8AA9-58E6D13FB48C_1_32">53130000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
  <us-gaap:ResearchAndDevelopmentExpense contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_690E7802-F096-42F4-844C-B42D2992B3CF_1_1">1879514</us-gaap:ResearchAndDevelopmentExpense>
  <us-gaap:DepreciationDepletionAndAmortization contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_AFF72D6D-AE4F-4009-8AA9-58E6D13FB48C_1_3">18238</us-gaap:DepreciationDepletionAndAmortization>
  <us-gaap:AmortizationOfFinancingCosts contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_AFF72D6D-AE4F-4009-8AA9-58E6D13FB48C_1_4">319635</us-gaap:AmortizationOfFinancingCosts>
  <us-gaap:OperatingExpenses contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_690E7802-F096-42F4-844C-B42D2992B3CF_1_3">2614338</us-gaap:OperatingExpenses>
  <aqxp:CommonStockDisclosureTextBlock contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0" id="id_3828183_5ED9DA49-7CF8-4901-ABBA-AC5BEC779F90_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt"&gt;
 &lt;b&gt;6. Common stock&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 &lt;b&gt;&lt;i&gt;(a) Stock option plan&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 On January&amp;#xA0;27, 2014, the stockholders of Aquinox USA approved
 a 2014 Equity Incentive Plan (&amp;#x201C;2014 Plan&amp;#x201D;). The 2014
 Plan became effective on the date of the prospectus for the IPO,
 March&amp;#xA0;6, 2014. The 2014 Plan is the successor to and
 continuation of the 2006 Plan. After the 2014 Plan became
 effective, no further grants will be made under the 2006 Plan. The
 2014 Plan provides for the grant of stock options, stock
 appreciation rights, restricted stock awards, restricted stock unit
 awards, performance stock awards, performance cash awards, and
 other forms of equity awards to employees, directors, and
 consultants.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"&gt;
 The maximum number of shares of common stock that may be issued the
 under the 2014 Plan is 1,423,416, which number includes a number of
 shares of common stock equal to (i)&amp;#xA0;756,279 new shares, plus
 (ii)&amp;#xA0;the number of shares reserved for issuance under the 2006
 Plan at the time the 2014 Plan becomes effective, plus
 (iii)&amp;#xA0;any shares subject to stock options or other stock
 awards granted under the 2006 Plan that would have otherwise
 returned to the 2006 Plan, such as upon the expiration or
 termination of a stock award prior to vesting. Additionally, the
 number of shares of common stock reserved for issuance under the
 2014 Plan will automatically increase on January&amp;#xA0;1 of each
 year for a period of up to 10 years, beginning on January&amp;#xA0;1,
 2015 and ending on and including January&amp;#xA0;1, 2024, by 4% of the
 total number of shares of capital outstanding on December&amp;#xA0;31
 of the preceding calendar year, or a lesser number of shares
 determined by the board of directors.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;&lt;i&gt;(b) Stock-based compensation&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 On March&amp;#xA0;6, 2014, four of the non-employee directors were
 granted options to purchase a total of 33,332 shares of common
 stock; the exercise price per share for these grants was $11.00,
 which was the offering price of the common stock in the IPO.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"&gt;
 The fair value of stock options granted is estimated using the
 Black-Scholes option pricing model with the following weighted
 average assumptions:&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="84%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="51%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="14%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="14%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="14%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;THREE&amp;#xA0;MONTHS&lt;br /&gt;
 ENDED&lt;br /&gt;
 MARCH 31, 2014&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;THREE&amp;#xA0;MONTHS&lt;br /&gt;
 ENDED&lt;br /&gt;
 MARCH 31, 2013&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;DECEMBER 26,&lt;br /&gt;
 2003&lt;br /&gt;
 (INCEPTION)&amp;#xA0;TO&lt;br /&gt;
 MARCH 31, 2014&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 Expected volatility&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;108&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;NA&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;88&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 Expected dividends&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;0&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;NA&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;0&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 Expected terms (years)&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;6.00&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;NA&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;6.24&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 Risk free rate&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;1.52&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;NA&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;2.96&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;%&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 Weighted average grant-date fair value of stock options&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;9.05&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;NA&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;4.23&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"&gt;
 The Company amortizes the fair value of the stock options on a
 straight-line basis over the applicable requisite service periods
 of the awards, which is generally the vesting period. The weighted
 average grant date fair value of stock options granted for the
 three months ended March&amp;#xA0;31, 2014 and 2013 were $9.05 and $0,
 respectively. There were no stock options granted during the three
 months ended March&amp;#xA0;31, 2013.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"&gt;
 Stock-based compensation expense charged to income for the plans
 was $137,654 and $54,674 for the three months ended March&amp;#xA0;31,
 2014 and 2013, respectively. Total unrecognized compensation cost
 for all stock-based compensation plans was $1,485,971 as of
 March&amp;#xA0;31, 2014, which is expected to be recognized over a
 weighted-average period of 1.47 years.&lt;/p&gt;
 &lt;/div&gt;</aqxp:CommonStockDisclosureTextBlock>
  <aqxp:AmortizationOfPreferredStockDiscount contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_AFF72D6D-AE4F-4009-8AA9-58E6D13FB48C_1_7">1884233</aqxp:AmortizationOfPreferredStockDiscount>
  <aqxp:UnrecognizedCompensationExpenseWeightedAveragePeriod contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0" id="id_3828183_D7DB1E75-9691-489E-BBF0-238ED21F4881_1_2">P1Y5M19D</aqxp:UnrecognizedCompensationExpenseWeightedAveragePeriod>
  <aqxp:IncrementalCommonSharesAttributableToCommonStockWarrants contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0" unitRef="shares" xsi:nil="true" id="id_3828183_B8750CD9-87E8-4022-95EF-0FA4C1AC626B_1_12" />
  <aqxp:IncrementalCommonSharesAttributableToStockOptions contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0" unitRef="shares" xsi:nil="true" id="id_3828183_B8750CD9-87E8-4022-95EF-0FA4C1AC626B_1_11" />
  <aqxp:DescriptionOfPercentageOfRealizationOfTaxBenefitUponSettlement contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0" id="id_3828183_05D62DDD-7F78-4330-B2F4-3A9708475F19_1_0">A measurement  attribute that measures a given tax position as the largest amount of tax  benefits that are more than 50% likely of being realized upon ultimate  settlement.</aqxp:DescriptionOfPercentageOfRealizationOfTaxBenefitUponSettlement>
  <aqxp:AmortizationOfDiscountOnPreferredStock contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_690E7802-F096-42F4-844C-B42D2992B3CF_1_9">1884233</aqxp:AmortizationOfDiscountOnPreferredStock>
  <aqxp:CommonStockReservedForIssuanceDescription contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0" id="id_3828183_B2B9796B-09C1-4FFF-8664-E0DED2CCE32F_1_0">Additionally,  the number of shares of common stock reserved for issuance under the 2014 Plan  will automatically increase on January 1 of each year for a period of up to 10  years, beginning on January 1, 2015 and ending on and including January 1, 2024,  by 4% of the total number of shares of capital outstanding on December 31 of the  preceding calendar year, or a lesser number of shares determined by the board of  directors.</aqxp:CommonStockReservedForIssuanceDescription>
  <aqxp:PercentageOfRecognitionOfTaxBenefitUponSettlement contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0" unitRef="pure" decimals="2" id="id_3828183_05D62DDD-7F78-4330-B2F4-3A9708475F19_1_1">0.50</aqxp:PercentageOfRecognitionOfTaxBenefitUponSettlement>
  <aqxp:NumberOfYearsSharesReservedForIssuanceWillIncrease contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0" id="id_3828183_B2B9796B-09C1-4FFF-8664-E0DED2CCE32F_1_2">P10Y</aqxp:NumberOfYearsSharesReservedForIssuanceWillIncrease>
  <aqxp:StockBasedCompensationIncreaseInCommonStockIssuancePercentage contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0" unitRef="pure" decimals="2" id="id_3828183_B2B9796B-09C1-4FFF-8664-E0DED2CCE32F_1_1">0.04</aqxp:StockBasedCompensationIncreaseInCommonStockIssuancePercentage>
  <aqxp:TemporaryEquityAccretionToRedemptionValueLiquidationPreference contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_B8750CD9-87E8-4022-95EF-0FA4C1AC626B_1_2">1132893</aqxp:TemporaryEquityAccretionToRedemptionValueLiquidationPreference>
  <aqxp:AccretionOfWarrantDiscount contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_11FC9E3C-4A9B-47E5-A970-456EC739AB84_7001_7">213511</aqxp:AccretionOfWarrantDiscount>
  <aqxp:ExtinguishmentOfDiscountOnTemporaryEquity contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_B21D375E-A414-411D-BC9F-EF594B3E7CA8_2_1">800206</aqxp:ExtinguishmentOfDiscountOnTemporaryEquity>
  <aqxp:IncomeTaxExpenseOnPreferredStock contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_B8750CD9-87E8-4022-95EF-0FA4C1AC626B_1_4">100291</aqxp:IncomeTaxExpenseOnPreferredStock>
  <aqxp:ShareIssuanceExpendituresIncurredButNotYetPaid contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_AFF72D6D-AE4F-4009-8AA9-58E6D13FB48C_1_44">390345</aqxp:ShareIssuanceExpendituresIncurredButNotYetPaid>
  <aqxp:ExtinguishmentOfRemainingShareIssuanceCostsDueToConversionOfPreferredStock contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_B8750CD9-87E8-4022-95EF-0FA4C1AC626B_1_6">439227</aqxp:ExtinguishmentOfRemainingShareIssuanceCostsDueToConversionOfPreferredStock>
  <aqxp:RepaymentFeeAndPenalty contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_11FC9E3C-4A9B-47E5-A970-456EC739AB84_7001_8">100000</aqxp:RepaymentFeeAndPenalty>
  <aqxp:ReversalOfIncomeTaxPayableOnPreferredStock contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0" unitRef="iso4217_USD" decimals="0" id="id_3828183_B8750CD9-87E8-4022-95EF-0FA4C1AC626B_1_5">1897702</aqxp:ReversalOfIncomeTaxPayableOnPreferredStock>
  <us-gaap:ConvertiblePreferredStockTermsOfConversion contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0_921954x1258870_924791x1204322" id="id_3828183_9506BE28-673E-456E-836B-84E1D2BFBEE2_1001_10">All 5,543,515 of the  outstanding shares of redeemable convertible preferred stock of Aquinox USA  converted to an equivalent number of shares of common stock of Aquinox USA.</us-gaap:ConvertiblePreferredStockTermsOfConversion>
  <us-gaap:ConvertiblePreferredStockTermsOfConversion contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0_924791x1261582" id="id_3828183_9506BE28-673E-456E-836B-84E1D2BFBEE2_3001_0">Each of the 791,016 outstanding Series A exchangeable preferred shares, 793,617 outstanding Series B exchangeable preferred shares and 378,786 outstanding Series C exchangeable preferred share of AQXP Canada was transferred to Aquinox USA in exchange for one share of Series A, B and C convertible preferred stock of Aquinox USA, respectively. As a result, following such exchange, there were 1,453,891 shares of Series A, 2,367,414 shares of Series B and 1,722,210 shares of Series C convertible preferred stock of Aquinox USA.</us-gaap:ConvertiblePreferredStockTermsOfConversion>
  <us-gaap:CommonStockConversionBasis contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0_924791x1261582_932980x930643" id="id_3828183_0707DBD9-7256-4012-8515-B01E43B3304F_1001_0">Each of the 301,745 outstanding common exchangeable shares of AQXP Canada was transferred to Aquinox USA in exchange for one common stock of Aquinox USA.</us-gaap:CommonStockConversionBasis>
  <us-gaap:LineOfCreditFacilityExpirationDate1 contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0_924808x1094993" id="id_3828183_5A741CC7-FCD9-46A7-9BF3-ACCBAB1B02B8_1001_2">2017-03-31</us-gaap:LineOfCreditFacilityExpirationDate1>
  <us-gaap:LineOfCreditFacilityInterestRateDuringPeriod contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0_924808x1094993" unitRef="pure" decimals="4" id="id_3828183_5A741CC7-FCD9-46A7-9BF3-ACCBAB1B02B8_1001_0">0.0525</us-gaap:LineOfCreditFacilityInterestRateDuringPeriod>
  <us-gaap:LineOfCreditFacilityFrequencyOfPaymentAndPaymentTerms contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0_924808x1094993" id="id_3828183_5A741CC7-FCD9-46A7-9BF3-ACCBAB1B02B8_1001_3">The term loan principal is repayable in monthly installments  approximately $83,000 commencing October 2014</us-gaap:LineOfCreditFacilityFrequencyOfPaymentAndPaymentTerms>
  <us-gaap:LineOfCreditFacilityPeriodicPaymentPrincipal contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0_924808x1094993" unitRef="iso4217_USD" decimals="0" id="id_3828183_5A741CC7-FCD9-46A7-9BF3-ACCBAB1B02B8_1001_1">83000</us-gaap:LineOfCreditFacilityPeriodicPaymentPrincipal>
  <aqxp:ClassOfWarrantOrRightExpirationYear contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0_924808x1094993" id="id_3828183_75B3D74B-CB61-4623-AC7D-BCB98AA4CDDD_1003_3">2023</aqxp:ClassOfWarrantOrRightExpirationYear>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0_927592x923761_929665x1155513_929790x929831" unitRef="iso4217_USD" decimals="0" id="id_3828183_88C874F4-1774-4B50-83DF-28C30B050A79_5001_2">-113723</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease>
  <aqxp:DecreaseOfEmbeddedDerivativeLiabilitiesForPreferredSharesConvertedIntoCommonStock contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0_927592x923761_929665x1155513_929790x929831" unitRef="iso4217_USD" xsi:nil="true" id="id_3828183_88C874F4-1774-4B50-83DF-28C30B050A79_5001_3" />
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0_927592x932258_929665x933016_929790x929831" unitRef="iso4217_USD" xsi:nil="true" id="id_3828183_88C874F4-1774-4B50-83DF-28C30B050A79_5002_2" />
  <aqxp:DecreaseOfEmbeddedDerivativeLiabilitiesForPreferredSharesConvertedIntoCommonStock contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0_927592x932258_929665x933016_929790x929831" unitRef="iso4217_USD" decimals="0" id="id_3828183_88C874F4-1774-4B50-83DF-28C30B050A79_5002_3">800206</aqxp:DecreaseOfEmbeddedDerivativeLiabilitiesForPreferredSharesConvertedIntoCommonStock>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0_928305x924898" unitRef="shares" decimals="INF" id="id_3828183_44F854BC-E685-43F4-84DF-3884495E95B1_2001_1">630159</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0_928305x929614" unitRef="shares" decimals="INF" id="id_3828183_44F854BC-E685-43F4-84DF-3884495E95B1_3001_2">11363</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0_929790x929831" unitRef="iso4217_USD" decimals="0" id="id_3828183_88C874F4-1774-4B50-83DF-28C30B050A79_5003_2">-113723</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease>
  <aqxp:DecreaseOfEmbeddedDerivativeLiabilitiesForPreferredSharesConvertedIntoCommonStock contextRef="eol_PE749074--1410-Q0003_STD_90_20140331_0_929790x929831" unitRef="iso4217_USD" decimals="0" id="id_3828183_88C874F4-1774-4B50-83DF-28C30B050A79_5003_3">800206</aqxp:DecreaseOfEmbeddedDerivativeLiabilitiesForPreferredSharesConvertedIntoCommonStock>
  <context id="eol_PE749074--1410-Q0003_STD_90_20140331_0_929790x929831">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_90_20140331_0_928305x929614">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_90_20140331_0_928305x924898">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_90_20140331_0_927592x932258_929665x933016_929790x929831">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:EmbeddedDerivativeFinancialInstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_90_20140331_0_927592x923761_929665x1155513_929790x929831">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">aqxp:WarrantDerivativeLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:BankLoanObligationsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_90_20140331_0_924808x1094993">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">aqxp:SiliconValleyBankMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_90_20140331_0_924791x1261582_932980x930643">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">aqxp:SharesTransferredFromAqxpCanadaToAquinoxUsaMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_90_20140331_0_924791x1261582">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">aqxp:SharesTransferredFromAqxpCanadaToAquinoxUsaMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_90_20140331_0_921954x1258870_924791x1204322">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">aqxp:AquinoxUsaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">aqxp:ConversionOfPreferredStockToCommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_90_20140331_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_90_20130331_0_928305x924898">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_90_20130331_0_928305x1263590">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">aqxp:ConvertiblePreferredStocksMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_90_20130331_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_71_20140312_0_932980x932586">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-03-12</endDate>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_71_20140312_0_932980x932209">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-03-12</endDate>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_71_20140312_0_921954x1258870_932980x932258">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">aqxp:AquinoxUsaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-03-12</endDate>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_71_20140312_0_921954x1258858_932980x932377">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">aqxp:AqxpCanadaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-03-12</endDate>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_71_20140312_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-03-12</endDate>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_3749_20140331_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
    </entity>
    <period>
      <startDate>2003-12-26</startDate>
      <endDate>2014-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_372_20041231_0_932980x932209">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2003-12-26</startDate>
      <endDate>2004-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_372_20041231_0_921954x1258858_932980x1099142">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">aqxp:AqxpCanadaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">aqxp:NewCommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2003-12-26</startDate>
      <endDate>2004-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_372_20041231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
    </entity>
    <period>
      <startDate>2003-12-26</startDate>
      <endDate>2004-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_366_20121231_0_932980x932586">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_366_20121231_0_932980x932209">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_366_20121231_0_921954x1258870_932980x932258">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">aqxp:AquinoxUsaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_366_20121231_0_921954x1258858_932980x932377">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">aqxp:AqxpCanadaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_366_20121231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
    </entity>
    <period>
      <startDate>2012-01-01</startDate>
      <endDate>2012-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_366_20081231_0_932980x932586">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2008-01-01</startDate>
      <endDate>2008-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_366_20081231_0_932980x932209">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2008-01-01</startDate>
      <endDate>2008-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_366_20081231_0_921954x1258870_932980x932258">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">aqxp:AquinoxUsaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2008-01-01</startDate>
      <endDate>2008-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_366_20081231_0_921954x1258858_932980x932377">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">aqxp:AqxpCanadaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2008-01-01</startDate>
      <endDate>2008-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_366_20081231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
    </entity>
    <period>
      <startDate>2008-01-01</startDate>
      <endDate>2008-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_365_20131231_0_932980x932586">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_365_20131231_0_932980x932209">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_365_20131231_0_921954x1258870_932980x932258">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">aqxp:AquinoxUsaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_365_20131231_0_921954x1258858_932980x932377">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">aqxp:AqxpCanadaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_365_20131231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_365_20111231_0_932980x932586">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_365_20111231_0_932980x932209">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_365_20111231_0_921954x1258870_932980x932258">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">aqxp:AquinoxUsaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_365_20111231_0_921954x1258858_932980x932377">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">aqxp:AqxpCanadaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_365_20111231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
    </entity>
    <period>
      <startDate>2011-01-01</startDate>
      <endDate>2011-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_365_20101231_0_932980x932586">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-01-01</startDate>
      <endDate>2010-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_365_20101231_0_932980x932209">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-01-01</startDate>
      <endDate>2010-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_365_20101231_0_921954x1258870_932980x932258">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">aqxp:AquinoxUsaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-01-01</startDate>
      <endDate>2010-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_365_20101231_0_921954x1258858_932980x932377">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">aqxp:AqxpCanadaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-01-01</startDate>
      <endDate>2010-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_365_20101231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
    </entity>
    <period>
      <startDate>2010-01-01</startDate>
      <endDate>2010-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_365_20091231_0_932980x932586">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2009-01-01</startDate>
      <endDate>2009-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_365_20091231_0_932980x932209">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2009-01-01</startDate>
      <endDate>2009-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_365_20091231_0_921954x1258870_932980x932258">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">aqxp:AquinoxUsaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2009-01-01</startDate>
      <endDate>2009-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_365_20091231_0_921954x1258858_932980x932377">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">aqxp:AqxpCanadaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2009-01-01</startDate>
      <endDate>2009-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_365_20091231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
    </entity>
    <period>
      <startDate>2009-01-01</startDate>
      <endDate>2009-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_365_20071231_0_932980x932586">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2007-01-01</startDate>
      <endDate>2007-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_365_20071231_0_932980x932209">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2007-01-01</startDate>
      <endDate>2007-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_365_20071231_0_921954x1258870_932980x932258">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">aqxp:AquinoxUsaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2007-01-01</startDate>
      <endDate>2007-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_365_20071231_0_921954x1258870_932980x930643">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">aqxp:AquinoxUsaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2007-01-01</startDate>
      <endDate>2007-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_365_20071231_0_921954x1258858_932980x932377">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">aqxp:AqxpCanadaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2007-01-01</startDate>
      <endDate>2007-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_365_20071231_0_921954x1258858_932980x1099142">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">aqxp:AqxpCanadaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">aqxp:NewCommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2007-01-01</startDate>
      <endDate>2007-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_365_20071231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
    </entity>
    <period>
      <startDate>2007-01-01</startDate>
      <endDate>2007-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_365_20061231_0_932980x932586">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2006-01-01</startDate>
      <endDate>2006-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_365_20061231_0_932980x932209">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2006-01-01</startDate>
      <endDate>2006-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_365_20061231_0_921954x1258858_932980x1099142">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">aqxp:AqxpCanadaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">aqxp:NewCommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2006-01-01</startDate>
      <endDate>2006-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_365_20061231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
    </entity>
    <period>
      <startDate>2006-01-01</startDate>
      <endDate>2006-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_365_20051231_0_932980x932209">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2005-01-01</startDate>
      <endDate>2005-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_365_20051231_0_921954x1258858_932980x1099142">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">aqxp:AqxpCanadaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">aqxp:NewCommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2005-01-01</startDate>
      <endDate>2005-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_365_20051231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
    </entity>
    <period>
      <startDate>2005-01-01</startDate>
      <endDate>2005-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_2_20140127_0_932980x1118518">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">aqxp:StockIncentivePlanTwoThousandFourteenMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-01-26</startDate>
      <endDate>2014-01-27</endDate>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_2_20140127_0_930809x992678">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">aqxp:EquityIncentivePlanTwoThousandSixMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-01-26</startDate>
      <endDate>2014-01-27</endDate>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_2_20131030_0_924808x1094993">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">aqxp:SiliconValleyBankMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2013-10-29</startDate>
      <endDate>2013-10-30</endDate>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_2_20140328_0_924808x1094993">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">aqxp:SiliconValleyBankMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-03-27</startDate>
      <endDate>2014-03-28</endDate>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_2_20140312_0_931707x960063">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqxp:UnderwritersMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-03-11</startDate>
      <endDate>2014-03-12</endDate>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_2_20140312_0_921954x1258870_924791x1204322_932980x930643">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">aqxp:AquinoxUsaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">aqxp:ConversionOfPreferredStockToCommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-03-11</startDate>
      <endDate>2014-03-12</endDate>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_2_20140312_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
    </entity>
    <period>
      <startDate>2014-03-11</startDate>
      <endDate>2014-03-12</endDate>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_2_20140306_0_925175x1032852">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">aqxp:NonEmployeeDirectorsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-03-05</startDate>
      <endDate>2014-03-06</endDate>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_2_20140306_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
    </entity>
    <period>
      <startDate>2014-03-05</startDate>
      <endDate>2014-03-06</endDate>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_2_20140227_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
    </entity>
    <period>
      <startDate>2014-02-26</startDate>
      <endDate>2014-02-27</endDate>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_19_20140331_0_932980x932586">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-03-13</startDate>
      <endDate>2014-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_19_20140331_0_932980x932209">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-03-13</startDate>
      <endDate>2014-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_19_20140331_0_921954x1258870_932980x932258">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">aqxp:AquinoxUsaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-03-13</startDate>
      <endDate>2014-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_19_20140331_0_921954x1258870_932980x930643">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">aqxp:AquinoxUsaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-03-13</startDate>
      <endDate>2014-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_19_20140331_0_921954x1258858_932980x932377">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">aqxp:AqxpCanadaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-03-13</startDate>
      <endDate>2014-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_19_20140331_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
    </entity>
    <period>
      <startDate>2014-03-13</startDate>
      <endDate>2014-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_0_20140127_0_932980x1118518">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">aqxp:StockIncentivePlanTwoThousandFourteenMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-01-27</instant>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_0_20131231_0_932980x932209">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_0_20131231_0_929790x929831">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_0_20131231_0_927592x932258_929665x933016_929790x929831">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:EmbeddedDerivativeFinancialInstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_0_20131231_0_927592x923761_929665x1155513_929790x929831">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">aqxp:WarrantDerivativeLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:BankLoanObligationsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_0_20131231_0_924808x1094993">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">aqxp:SiliconValleyBankMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_0_20131231_0_923497x921516">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">country:US</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_0_20131231_0_921954x1258870_932980x932774">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">aqxp:AquinoxUsaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_0_20131231_0_921954x1258870_932980x932258">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">aqxp:AquinoxUsaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_0_20131231_0_921954x1258870_932980x930643">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">aqxp:AquinoxUsaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_0_20131231_0_921954x1258870_932980x930435">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">aqxp:AquinoxUsaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_0_20131231_0_921954x1258870_932980x930400">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">aqxp:AquinoxUsaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_0_20131231_0_921954x1258858_932980x980486">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">aqxp:AqxpCanadaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">aqxp:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_0_20131231_0_921954x1258858_932980x932377">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">aqxp:AqxpCanadaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_0_20131231_0_921954x1258858_932980x1124615">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">aqxp:AqxpCanadaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">aqxp:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_0_20131231_0_921954x1258858_932980x1031975">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">aqxp:AqxpCanadaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">aqxp:SeriesCConvertiblePreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_0_20131231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_0_20121231_0_932980x932209">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_0_20121231_0_921954x1258870_932980x932258">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">aqxp:AquinoxUsaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_0_20121231_0_921954x1258870_932980x930643">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">aqxp:AquinoxUsaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_0_20121231_0_921954x1258858_932980x932377">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">aqxp:AqxpCanadaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_0_20121231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
    </entity>
    <period>
      <instant>2012-12-31</instant>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_0_20111231_0_932980x932209">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-12-31</instant>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_0_20111231_0_921954x1258870_932980x932258">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">aqxp:AquinoxUsaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-12-31</instant>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_0_20111231_0_921954x1258870_932980x930643">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">aqxp:AquinoxUsaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-12-31</instant>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_0_20111231_0_921954x1258858_932980x932377">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">aqxp:AqxpCanadaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-12-31</instant>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_0_20111231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
    </entity>
    <period>
      <instant>2011-12-31</instant>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_0_20101231_0_932980x932209">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2010-12-31</instant>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_0_20101231_0_921954x1258870_932980x932258">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">aqxp:AquinoxUsaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2010-12-31</instant>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_0_20101231_0_921954x1258870_932980x930643">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">aqxp:AquinoxUsaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2010-12-31</instant>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_0_20101231_0_921954x1258858_932980x932377">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">aqxp:AqxpCanadaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2010-12-31</instant>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_0_20101231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
    </entity>
    <period>
      <instant>2010-12-31</instant>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_0_20091231_0_932980x932209">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2009-12-31</instant>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_0_20091231_0_921954x1258870_932980x932258">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">aqxp:AquinoxUsaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2009-12-31</instant>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_0_20091231_0_921954x1258870_932980x930643">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">aqxp:AquinoxUsaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2009-12-31</instant>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_0_20091231_0_921954x1258858_932980x932377">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">aqxp:AqxpCanadaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2009-12-31</instant>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_0_20091231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
    </entity>
    <period>
      <instant>2009-12-31</instant>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_0_20081231_0_932980x932209">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2008-12-31</instant>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_0_20081231_0_921954x1258870_932980x932258">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">aqxp:AquinoxUsaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2008-12-31</instant>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_0_20081231_0_921954x1258870_932980x930643">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">aqxp:AquinoxUsaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2008-12-31</instant>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_0_20081231_0_921954x1258858_932980x932377">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">aqxp:AqxpCanadaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2008-12-31</instant>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_0_20081231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
    </entity>
    <period>
      <instant>2008-12-31</instant>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_0_20071231_0_932980x932586">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2007-12-31</instant>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_0_20071231_0_932980x932209">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2007-12-31</instant>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_0_20071231_0_921954x1258870_932980x932258">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">aqxp:AquinoxUsaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2007-12-31</instant>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_0_20071231_0_921954x1258870_932980x930643">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">aqxp:AquinoxUsaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2007-12-31</instant>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_0_20071231_0_921954x1258858_932980x932377">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">aqxp:AqxpCanadaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2007-12-31</instant>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_0_20071231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
    </entity>
    <period>
      <instant>2007-12-31</instant>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_0_20061231_0_932980x932586">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2006-12-31</instant>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_0_20061231_0_932980x932209">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2006-12-31</instant>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_0_20061231_0_921954x1258858_932980x1099142">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">aqxp:AqxpCanadaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">aqxp:NewCommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2006-12-31</instant>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_0_20061231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
    </entity>
    <period>
      <instant>2006-12-31</instant>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_0_20051231_0_932980x932209">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2005-12-31</instant>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_0_20051231_0_921954x1258858_932980x1099142">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">aqxp:AqxpCanadaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">aqxp:NewCommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2005-12-31</instant>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_0_20051231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
    </entity>
    <period>
      <instant>2005-12-31</instant>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_0_20041231_0_932980x932209">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2004-12-31</instant>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_0_20041231_0_921954x1258858_932980x1099142">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">aqxp:AqxpCanadaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">aqxp:NewCommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2004-12-31</instant>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_0_20041231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
    </entity>
    <period>
      <instant>2004-12-31</instant>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_0_20140331_0_932980x932586">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-03-31</instant>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_0_20140331_0_932980x932209">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-03-31</instant>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_0_20140331_0_929790x929831">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-03-31</instant>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_0_20140331_0_928373x1060520">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAxis">aqxp:ReorganizationMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-03-31</instant>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_0_20140331_0_927592x932258_929665x933016_929790x929831">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:EmbeddedDerivativeFinancialInstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-03-31</instant>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_0_20140331_0_927592x923761_929665x1155513_929790x929831">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">aqxp:WarrantDerivativeLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:BankLoanObligationsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-03-31</instant>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_0_20140331_0_923791x1022881_924808x1094993">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">aqxp:WarrantsToPurchaseCommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">aqxp:SiliconValleyBankMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-03-31</instant>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_0_20140331_0_923497x921516">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">country:US</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-03-31</instant>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_0_20140331_0_921954x1258870_932980x932774">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">aqxp:AquinoxUsaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-03-31</instant>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_0_20140331_0_921954x1258870_932980x930643">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">aqxp:AquinoxUsaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-03-31</instant>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_0_20140331_0_921954x1258870_932980x930435">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">aqxp:AquinoxUsaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-03-31</instant>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_0_20140331_0_921954x1258870_932980x930400">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">aqxp:AquinoxUsaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-03-31</instant>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_0_20140331_0_921954x1258858_932980x980486">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">aqxp:AqxpCanadaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">aqxp:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-03-31</instant>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_0_20140331_0_921954x1258858_932980x1124615">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">aqxp:AqxpCanadaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">aqxp:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-03-31</instant>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_0_20140331_0_921954x1258858_932980x1031975">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">aqxp:AqxpCanadaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">aqxp:SeriesCConvertiblePreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-03-31</instant>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_0_20140331_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
    </entity>
    <period>
      <instant>2014-03-31</instant>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_0_20131023_0_924808x1094993">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">aqxp:SiliconValleyBankMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-10-23</instant>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_0_20131023_0_923791x1232250_924808x1094993">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">aqxp:WarrantsToPurchaseSeriescConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">aqxp:SiliconValleyBankMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-10-23</instant>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_0_20130331_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
    </entity>
    <period>
      <instant>2013-03-31</instant>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_0_20140430_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
    </entity>
    <period>
      <instant>2014-04-30</instant>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_0_20140312_0_932980x932209">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:AccumulatedDeficitDuringDevelopmentStageMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-03-12</instant>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_0_20140312_0_921954x1258870_932980x932774">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">aqxp:AquinoxUsaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-03-12</instant>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_0_20140312_0_921954x1258870_932980x932258">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">aqxp:AquinoxUsaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-03-12</instant>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_0_20140312_0_921954x1258870_932980x932152">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">aqxp:AquinoxUsaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-03-12</instant>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_0_20140312_0_921954x1258870_932980x930643">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">aqxp:AquinoxUsaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-03-12</instant>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_0_20140312_0_921954x1258870_932980x930435">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">aqxp:AquinoxUsaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-03-12</instant>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_0_20140312_0_921954x1258870_932980x930400">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">aqxp:AquinoxUsaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-03-12</instant>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_0_20140312_0_921954x1258858_932980x980486">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">aqxp:AqxpCanadaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">aqxp:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-03-12</instant>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_0_20140312_0_921954x1258858_932980x932377">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">aqxp:AqxpCanadaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-03-12</instant>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_0_20140312_0_921954x1258858_932980x932064">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">aqxp:AqxpCanadaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertibleCommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-03-12</instant>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_0_20140312_0_921954x1258858_932980x1124615">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">aqxp:AqxpCanadaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">aqxp:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-03-12</instant>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_0_20140312_0_921954x1258858_932980x1031975">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">aqxp:AqxpCanadaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">aqxp:SeriesCConvertiblePreferredStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-03-12</instant>
    </period>
  </context>
  <context id="eol_PE749074--1410-Q0003_STD_0_20140312_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001404644</identifier>
    </entity>
    <period>
      <instant>2014-03-12</instant>
    </period>
  </context>
  <unit id="shares">
    <measure>shares</measure>
  </unit>
  <unit id="iso4217_USD_per_shares">
    <divide>
      <unitNumerator>
        <measure>iso4217:USD</measure>
      </unitNumerator>
      <unitDenominator>
        <measure>shares</measure>
      </unitDenominator>
    </divide>
  </unit>
  <unit id="iso4217_USD">
    <measure>iso4217:USD</measure>
  </unit>
  <unit id="iso4217_USD_per_Warrant">
    <divide>
      <unitNumerator>
        <measure>iso4217:USD</measure>
      </unitNumerator>
      <unitDenominator>
        <measure>aqxp:Warrant</measure>
      </unitDenominator>
    </divide>
  </unit>
  <unit id="pure">
    <measure>pure</measure>
  </unit>
  <unit id="Directors">
    <measure>aqxp:Directors</measure>
  </unit>
  <unit id="Segment">
    <measure>aqxp:Segment</measure>
  </unit>
</xbrl>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>7
<FILENAME>aqxp-20140331.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- RR Donnelley Xcelerate Taxonomy Schema, based on XBRL 2.1  http://www.rrdonnelley.com/ -->
<!-- Version: 6.21.0 -->
<!-- Round: 5 -->
<!-- Creation date: 2014-05-12T17:22:30Z -->
<!-- Copyright (c) 2005-2013 R.R. Donnelley & Sons Company All Rights Reserved. -->
<schema xmlns="http://www.w3.org/2001/XMLSchema"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:us-gaap="http://fasb.org/us-gaap/2013-01-31"
  xmlns:us-types="http://fasb.org/us-types/2013-01-31"
  xmlns:aqxp="http://imetrix.edgar-online.com/20140331"
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  xmlns:country="http://xbrl.sec.gov/country/2013-01-31"
  xmlns:currency="http://xbrl.sec.gov/currency/2012-01-31"
  xmlns:dei="http://xbrl.sec.gov/dei/2013-01-31"
  xmlns:exch="http://xbrl.sec.gov/exch/2013-01-31"
  xmlns:invest="http://xbrl.sec.gov/invest/2013-01-31"
  xmlns:stpr="http://xbrl.sec.gov/stpr/2011-01-31"
  targetNamespace="http://imetrix.edgar-online.com/20140331"
  elementFormDefault="qualified" attributeFormDefault="unqualified">
  <annotation>
    <appinfo>
      <link:roleType roleURI="http://imetrix.edgar-online.com/taxonomy/role/DocumentandEntityInformation" id="DocumentandEntityInformation">
        <link:definition>101 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://imetrix.edgar-online.com/taxonomy/role/StatementOfFinancialPositionClassified" id="Role_StatementOfFinancialPositionClassified">
        <link:definition>103 - Statement - Condensed Consolidated and Combined Balance Sheets</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://imetrix.edgar-online.com/taxonomy/role/StatementOfFinancialPositionClassifiedParenthetical" id="Role_StatementOfFinancialPositionClassifiedParen">
        <link:definition>104 - Statement - Condensed Consolidated and Combined Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://imetrix.edgar-online.com/taxonomy/role/StatementOfIncomeAlternative" id="Role_StatementOfIncomeAlternative">
        <link:definition>105 - Statement - Condensed consolidated and combined statements of operations and comprehensive loss</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://imetrix.edgar-online.com/taxonomy/role/StatementOfShareholdersEquityAndOtherComprehensiveIncome" id="Role_StatementOfShareholdersEquityAndOtherComprehensiveIncome">
        <link:definition>106 - Statement - Condensed consolidated and combined statements of convertible preferred stock and stockholders' deficit</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://imetrix.edgar-online.com/taxonomy/role/StatementOfShareholdersEquityAndOtherComprehensiveIncomeParenthetical" id="Role_StatementOfShareholdersEquityAndOtherComprehensiveIncomeParen">
        <link:definition>107 - Statement - Condensed consolidated and combined statements of convertible preferred stock and stockholders' deficit (Parenthetical)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://imetrix.edgar-online.com/taxonomy/role/StatementOfCashFlowsIndirect" id="Role_StatementOfCashFlowsIndirect">
        <link:definition>108 - Statement - Condensed consolidated and combined statements of cash flows</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsNatureOfOperations" id="Role_NotesToFinancialStatementsNatureOfOperations">
        <link:definition>109 - Disclosure - Nature of operations</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsSignificantAccountingPoliciesTextBlock" id="Role_NotesToFinancialStatementsSignificantAccountingPoliciesTextBlock">
        <link:definition>110 - Disclosure - Condensed summary of significant accounting policies</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsStockholdersEquityNoteDisclosureTextBlock" id="Role_NotesToFinancialStatementsStockholdersEquityNoteDisclosureTextBlock">
        <link:definition>111 - Disclosure - Redeemable convertible preferred stock and stockholders' (deficit) equity</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsCashAndCashEquivalentsDisclosureTextBlock" id="Role_NotesToFinancialStatementsCashAndCashEquivalentsDisclosureTextBlock">
        <link:definition>112 - Disclosure - Cash and cash equivalents</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsDebtDisclosureTextBlock" id="Role_NotesToFinancialStatementsDebtDisclosureTextBlock">
        <link:definition>113 - Disclosure - Loan facility</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsCommonStockDisclosureTextBlock" id="Role_NotesToFinancialStatementsCommonStockDisclosureTextBlock">
        <link:definition>114 - Disclosure - Common stock</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsEarningsPerShareTextBlock" id="Role_NotesToFinancialStatementsEarningsPerShareTextBlock">
        <link:definition>115 - Disclosure - Net loss per share</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsFinancialInstrumentsDisclosureTextBlock" id="Role_NotesToFinancialStatementsFinancialInstrumentsDisclosureTextBlock">
        <link:definition>116 - Disclosure - Financial instruments</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsSignificantAccountingPoliciesTextBlockPolicies" id="Role_NotesToFinancialStatementsSignificantAccountingPoliciesTextBlockPolicies">
        <link:definition>117 - Disclosure - Condensed summary of significant accounting policies (Policies)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsCashAndCashEquivalentsDisclosureTextBlockTables" id="Role_NotesToFinancialStatementsCashAndCashEquivalentsDisclosureTextBlockTables">
        <link:definition>118 - Disclosure - Cash and cash equivalents (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsDebtDisclosureTextBlockTables" id="Role_NotesToFinancialStatementsDebtDisclosureTextBlockTables">
        <link:definition>119 - Disclosure - Loan facility (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsCommonStockDisclosureTextBlockTables" id="Role_NotesToFinancialStatementsCommonStockDisclosureTextBlockTables">
        <link:definition>120 - Disclosure - Common stock (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsEarningsPerShareTextBlockTables" id="Role_NotesToFinancialStatementsEarningsPerShareTextBlockTables">
        <link:definition>121 - Disclosure - Net loss per share (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsFinancialInstrumentsDisclosureTextBlockTables" id="Role_NotesToFinancialStatementsFinancialInstrumentsDisclosureTextBlockTables">
        <link:definition>122 - Disclosure - Financial instruments (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://imetrix.edgar-online.com/taxonomy/role/DisclosureNatureOfOperationsAdditionalInformation" id="DisclosureNatureOfOperationsAdditionalInformation">
        <link:definition>123 - Disclosure - Nature of operations - Additional Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://imetrix.edgar-online.com/taxonomy/role/DisclosureCondensedSummaryOfSignificantAccountingPoliciesAdditionalInformation" id="DisclosureCondensedSummaryOfSignificantAccountingPoliciesAdditionalInformation">
        <link:definition>124 - Disclosure - Condensed summary of significant accounting policies - Additional Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://imetrix.edgar-online.com/taxonomy/role/DisclosureRedeemableConvertiblePreferredStockAndStockholdersdeficitEquityAdditionalInformation" id="DisclosureRedeemableConvertiblePreferredStockAndStockholdersdeficitEquityAdditionalInformation">
        <link:definition>125 - Disclosure - Redeemable convertible preferred stock and stockholders' (deficit) equity - Additional Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://imetrix.edgar-online.com/taxonomy/role/DisclosureCashAndCashEquivalentsScheduleOfCashAndCashEquivalents" id="DisclosureCashAndCashEquivalentsScheduleOfCashAndCashEquivalents">
        <link:definition>126 - Disclosure - Cash and cash equivalents - Schedule of cash and cash equivalents (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://imetrix.edgar-online.com/taxonomy/role/DisclosureLoanFacilityAdditionalInformation" id="DisclosureLoanFacilityAdditionalInformation">
        <link:definition>127 - Disclosure - Loan facility - Additional Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://imetrix.edgar-online.com/taxonomy/role/DisclosureLoanFacilityScheduleOfLoanFacility" id="DisclosureLoanFacilityScheduleOfLoanFacility">
        <link:definition>128 - Disclosure - Loan facility - Schedule of Loan Facility (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://imetrix.edgar-online.com/taxonomy/role/DisclosureLoanFacilitySummaryOfBankLoanFacility" id="DisclosureLoanFacilitySummaryOfBankLoanFacility">
        <link:definition>129 - Disclosure - Loan facility - Summary of Bank Loan Facility (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://imetrix.edgar-online.com/taxonomy/role/DisclosureCommonStockAdditionalInformation" id="DisclosureCommonStockAdditionalInformation">
        <link:definition>130 - Disclosure - Common stock - Additional Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://imetrix.edgar-online.com/taxonomy/role/DisclosureCommonStockScheduleOfWeightedAverageAssumptions" id="DisclosureCommonStockScheduleOfWeightedAverageAssumptions">
        <link:definition>131 - Disclosure - Common stock - Schedule of Weighted Average Assumptions (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://imetrix.edgar-online.com/taxonomy/role/DisclosureNetLossPerShareAdditionalInformation" id="DisclosureNetLossPerShareAdditionalInformation">
        <link:definition>132 - Disclosure - Net loss per share - Additional Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://imetrix.edgar-online.com/taxonomy/role/DisclosureNetLossPerShareScheduleOfComputationOfBasicAndDilutedEarningsPerShare" id="DisclosureNetLossPerShareScheduleOfComputationOfBasicAndDilutedEarningsPerShare">
        <link:definition>133 - Disclosure - Net loss per share - Schedule of Computation of Basic and Diluted Earnings Per Share (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://imetrix.edgar-online.com/taxonomy/role/DisclosureNetLossPerShareScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfBasicAndDilutedNetLossPerShare" id="DisclosureNetLossPerShareScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfBasicAndDilutedNetLossPerShare">
        <link:definition>134 - Disclosure - Net loss per share - Schedule of Antidilutive Securities Excluded from Computation of Basic and Diluted Net Loss Per Share (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://imetrix.edgar-online.com/taxonomy/role/DisclosureFinancialInstrumentsFairValueOfSignificantUnobservableInputs" id="DisclosureFinancialInstrumentsFairValueOfSignificantUnobservableInputs">
        <link:definition>135 - Disclosure - Financial instruments - Fair Value of Significant Unobservable Inputs (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://imetrix.edgar-online.com/taxonomy/role/DisclosureFinancialInstrumentsAdditionalInformation" id="DisclosureFinancialInstrumentsAdditionalInformation">
        <link:definition>136 - Disclosure - Financial instruments - Additional Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbaseRef xlink:type="simple" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:href="aqxp-20140331_cal.xml" xlink:title="Calculation Links, all"/>
      <link:linkbaseRef xlink:type="simple" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:href="aqxp-20140331_def.xml" xlink:title="Definition Links, all"/>
      <link:linkbaseRef xlink:type="simple" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:href="aqxp-20140331_lab.xml" xlink:title="Label Links, all"/>
      <link:linkbaseRef xlink:type="simple" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:href="aqxp-20140331_pre.xml" xlink:title="Presentation Links, all"/>
    </appinfo>
  </annotation>
  <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <import namespace="http://fasb.org/us-types/2013-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2013/elts/us-types-2013-01-31.xsd"/>
  <import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>
  <import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
  <import namespace="http://fasb.org/us-gaap/2013-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd"/>
  <import namespace="http://xbrl.sec.gov/country/2013-01-31" schemaLocation="http://xbrl.sec.gov/country/2013/country-2013-01-31.xsd"/>
  <import namespace="http://xbrl.sec.gov/currency/2012-01-31" schemaLocation="http://xbrl.sec.gov/currency/2012/currency-2012-01-31.xsd"/>
  <import namespace="http://xbrl.sec.gov/dei/2013-01-31" schemaLocation="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd"/>
  <import namespace="http://xbrl.sec.gov/exch/2013-01-31" schemaLocation="http://xbrl.sec.gov/exch/2013/exch-2013-01-31.xsd"/>
  <import namespace="http://xbrl.sec.gov/invest/2013-01-31" schemaLocation="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd"/>
  <import namespace="http://xbrl.sec.gov/stpr/2011-01-31" schemaLocation="http://xbrl.sec.gov/stpr/2011/stpr-2011-01-31.xsd"/>
  <element name="AccretionOfWarrantDiscount" id="aqxp_AccretionOfWarrantDiscount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="AmortizationOfDiscountOnPreferredStock" id="aqxp_AmortizationOfDiscountOnPreferredStock" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="AmortizationOfPreferredStockDiscount" id="aqxp_AmortizationOfPreferredStockDiscount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="AquinoxUsaMember" id="aqxp_AquinoxUsaMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="AqxpCanadaMember" id="aqxp_AqxpCanadaMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="ClassOfWarrantOrRightExercisable" id="aqxp_ClassOfWarrantOrRightExercisable" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="ClassOfWarrantOrRightExpirationYear" id="aqxp_ClassOfWarrantOrRightExpirationYear" type="xbrli:gYearItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="CommonStockDisclosureTextBlock" id="aqxp_CommonStockDisclosureTextBlock" type="nonnum:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="CommonStockReservedForIssuanceDescription" id="aqxp_CommonStockReservedForIssuanceDescription" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="ConversionOfPreferredStockIntoCommonStock" id="aqxp_ConversionOfPreferredStockIntoCommonStock" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="ConversionOfPreferredStockIntoCommonStockShares" id="aqxp_ConversionOfPreferredStockIntoCommonStockShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="ConversionOfPreferredStockToCommonStockMember" id="aqxp_ConversionOfPreferredStockToCommonStockMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="ConvertiblePreferredStocksMember" id="aqxp_ConvertiblePreferredStocksMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="DecreaseOfEmbeddedDerivativeLiabilitiesForPreferredSharesConvertedIntoCommonStock" id="aqxp_DecreaseOfEmbeddedDerivativeLiabilitiesForPreferredSharesConvertedIntoCommonStock" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="DerivativeLiabilitiesNoncurrentRedemptionOption" id="aqxp_DerivativeLiabilitiesNoncurrentRedemptionOption" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="DescriptionOfPercentageOfRealizationOfTaxBenefitUponSettlement" id="aqxp_DescriptionOfPercentageOfRealizationOfTaxBenefitUponSettlement" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="DiscountOnIssuanceOfWarrants" id="aqxp_DiscountOnIssuanceOfWarrants" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="DocumentAndEntityInformationAbstract" id="aqxp_DocumentAndEntityInformationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="EquityIncentivePlanTwoThousandSixMember" id="aqxp_EquityIncentivePlanTwoThousandSixMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="ExtinguishmentOfDiscountOnTemporaryEquity" id="aqxp_ExtinguishmentOfDiscountOnTemporaryEquity" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="ExtinguishmentOfRemainingShareIssuanceCostsDueToConversionOfPreferredStock" id="aqxp_ExtinguishmentOfRemainingShareIssuanceCostsDueToConversionOfPreferredStock" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="IncomeTaxExpenseOnPreferredStock" id="aqxp_IncomeTaxExpenseOnPreferredStock" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="IncrementalCommonSharesAttributableToCommonStockWarrants" id="aqxp_IncrementalCommonSharesAttributableToCommonStockWarrants" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="IncrementalCommonSharesAttributableToStockOptions" id="aqxp_IncrementalCommonSharesAttributableToStockOptions" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="NetProceedsFromIssuanceInitialPublicOffering" id="aqxp_NetProceedsFromIssuanceInitialPublicOffering" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="NewCommonStockMember" id="aqxp_NewCommonStockMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="NonCashFinancingActivitiesAbstract" id="aqxp_NonCashFinancingActivitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="NoncashInvestingActivitiesAbstract" id="aqxp_NoncashInvestingActivitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="NonEmployeeDirectorsMember" id="aqxp_NonEmployeeDirectorsMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="NumberOfNonEmployeeDirectors" id="aqxp_NumberOfNonEmployeeDirectors" type="xbrli:integerItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="NumberOfYearsSharesReservedForIssuanceWillIncrease" id="aqxp_NumberOfYearsSharesReservedForIssuanceWillIncrease" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="PaymentsOfFinancingCostsDebt" id="aqxp_PaymentsOfFinancingCostsDebt" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="PercentageOfRecognitionOfTaxBenefitUponSettlement" id="aqxp_PercentageOfRecognitionOfTaxBenefitUponSettlement" type="num:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="RegulatoryAssetsAbstract" id="aqxp_RegulatoryAssetsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="ReorganizationMember" id="aqxp_ReorganizationMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="RepaymentFeeAndPenalty" id="aqxp_RepaymentFeeAndPenalty" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="ReversalOfIncomeTaxPayableOnPreferredStock" id="aqxp_ReversalOfIncomeTaxPayableOnPreferredStock" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="ScheduleOfEarningsPerShareLineItems" id="aqxp_ScheduleOfEarningsPerShareLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="ScheduleOfEarningsPerShareTable" id="aqxp_ScheduleOfEarningsPerShareTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem"/>
  <element name="SeriesAConvertiblePreferredStockMember" id="aqxp_SeriesAConvertiblePreferredStockMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="SeriesBConvertiblePreferredStockMember" id="aqxp_SeriesBConvertiblePreferredStockMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="SeriesCConvertiblePreferredStockMember" id="aqxp_SeriesCConvertiblePreferredStockMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedNew" id="aqxp_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedNew" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="ShareIssuanceExpendituresIncurredButNotYetPaid" id="aqxp_ShareIssuanceExpendituresIncurredButNotYetPaid" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="SharesTransferredFromAqxpCanadaToAquinoxUsaMember" id="aqxp_SharesTransferredFromAqxpCanadaToAquinoxUsaMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="SignificantAccountingPoliciesLineItems" id="aqxp_SignificantAccountingPoliciesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="SignificantAccountingPoliciesTable" id="aqxp_SignificantAccountingPoliciesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem"/>
  <element name="SiliconValleyBankMember" id="aqxp_SiliconValleyBankMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="SpecialVotingCommonStockIssuedValue" id="aqxp_SpecialVotingCommonStockIssuedValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="StockBasedCompensationIncreaseInCommonStockIssuancePercentage" id="aqxp_StockBasedCompensationIncreaseInCommonStockIssuancePercentage" type="num:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="StockIncentivePlanTwoThousandFourteenMember" id="aqxp_StockIncentivePlanTwoThousandFourteenMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="StockSharesAuthorizedNet" id="aqxp_StockSharesAuthorizedNet" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="TemporaryEquityAccretionToRedemptionValueLiquidationPreference" id="aqxp_TemporaryEquityAccretionToRedemptionValueLiquidationPreference" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="TemporaryEquityAccretionToRedemptionValueRedemptionOption" id="aqxp_TemporaryEquityAccretionToRedemptionValueRedemptionOption" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="TemporaryEquityAccretionToRedemptionValueWarrantDiscount" id="aqxp_TemporaryEquityAccretionToRedemptionValueWarrantDiscount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="TemporaryEquityRedemptionDiscount" id="aqxp_TemporaryEquityRedemptionDiscount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="TemporaryEquitySharesAuthorizedUnlimited" id="aqxp_TemporaryEquitySharesAuthorizedUnlimited" type="xbrli:stringItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="TemporaryEquityWarrantDiscount" id="aqxp_TemporaryEquityWarrantDiscount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="UncategorizedAbstract" id="aqxp_UncategorizedAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="UnderwritersMember" id="aqxp_UnderwritersMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="UnrecognizedCompensationExpenseWeightedAveragePeriod" id="aqxp_UnrecognizedCompensationExpenseWeightedAveragePeriod" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="UnrecognizedShareBasedCompensationExpense" id="aqxp_UnrecognizedShareBasedCompensationExpense" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="WarrantDerivativeLiabilityMember" id="aqxp_WarrantDerivativeLiabilityMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="WarrantDiscount" id="aqxp_WarrantDiscount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="WarrantsExercised" id="aqxp_WarrantsExercised" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="WarrantsExercisedShares" id="aqxp_WarrantsExercisedShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="WarrantsToPurchaseCommonStockMember" id="aqxp_WarrantsToPurchaseCommonStockMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
  <element name="WarrantsToPurchaseSeriescConvertiblePreferredStockMember" id="aqxp_WarrantsToPurchaseSeriescConvertiblePreferredStockMember" type="nonnum:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"/>
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>8
<FILENAME>aqxp-20140331_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- RR Donnelley Xcelerate Taxonomy Calculation Linkbase, based on XBRL 2.1  http://www.rrdonnelley.com/ -->
<!-- Version: 6.21.0 -->
<!-- Round: 5 -->
<!-- Creation date: 2014-05-12T17:22:31Z -->
<!-- Copyright (c) 2005-2013 R.R. Donnelley & Sons Company All Rights Reserved. -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="aqxp-20140331.xsd#DocumentandEntityInformation" roleURI="http://imetrix.edgar-online.com/taxonomy/role/DocumentandEntityInformation"/>
  <roleRef xlink:type="simple" xlink:href="aqxp-20140331.xsd#Role_StatementOfFinancialPositionClassified" roleURI="http://imetrix.edgar-online.com/taxonomy/role/StatementOfFinancialPositionClassified"/>
  <roleRef xlink:type="simple" xlink:href="aqxp-20140331.xsd#Role_StatementOfFinancialPositionClassifiedParen" roleURI="http://imetrix.edgar-online.com/taxonomy/role/StatementOfFinancialPositionClassifiedParenthetical"/>
  <roleRef xlink:type="simple" xlink:href="aqxp-20140331.xsd#Role_StatementOfIncomeAlternative" roleURI="http://imetrix.edgar-online.com/taxonomy/role/StatementOfIncomeAlternative"/>
  <roleRef xlink:type="simple" xlink:href="aqxp-20140331.xsd#Role_StatementOfShareholdersEquityAndOtherComprehensiveIncome" roleURI="http://imetrix.edgar-online.com/taxonomy/role/StatementOfShareholdersEquityAndOtherComprehensiveIncome"/>
  <roleRef xlink:type="simple" xlink:href="aqxp-20140331.xsd#Role_StatementOfShareholdersEquityAndOtherComprehensiveIncomeParen" roleURI="http://imetrix.edgar-online.com/taxonomy/role/StatementOfShareholdersEquityAndOtherComprehensiveIncomeParenthetical"/>
  <roleRef xlink:type="simple" xlink:href="aqxp-20140331.xsd#Role_StatementOfCashFlowsIndirect" roleURI="http://imetrix.edgar-online.com/taxonomy/role/StatementOfCashFlowsIndirect"/>
  <roleRef xlink:type="simple" xlink:href="aqxp-20140331.xsd#DisclosureNatureOfOperationsAdditionalInformation" roleURI="http://imetrix.edgar-online.com/taxonomy/role/DisclosureNatureOfOperationsAdditionalInformation"/>
  <roleRef xlink:type="simple" xlink:href="aqxp-20140331.xsd#DisclosureCondensedSummaryOfSignificantAccountingPoliciesAdditionalInformation" roleURI="http://imetrix.edgar-online.com/taxonomy/role/DisclosureCondensedSummaryOfSignificantAccountingPoliciesAdditionalInformation"/>
  <roleRef xlink:type="simple" xlink:href="aqxp-20140331.xsd#DisclosureRedeemableConvertiblePreferredStockAndStockholdersdeficitEquityAdditionalInformation" roleURI="http://imetrix.edgar-online.com/taxonomy/role/DisclosureRedeemableConvertiblePreferredStockAndStockholdersdeficitEquityAdditionalInformation"/>
  <roleRef xlink:type="simple" xlink:href="aqxp-20140331.xsd#DisclosureCashAndCashEquivalentsScheduleOfCashAndCashEquivalents" roleURI="http://imetrix.edgar-online.com/taxonomy/role/DisclosureCashAndCashEquivalentsScheduleOfCashAndCashEquivalents"/>
  <roleRef xlink:type="simple" xlink:href="aqxp-20140331.xsd#DisclosureLoanFacilityAdditionalInformation" roleURI="http://imetrix.edgar-online.com/taxonomy/role/DisclosureLoanFacilityAdditionalInformation"/>
  <roleRef xlink:type="simple" xlink:href="aqxp-20140331.xsd#DisclosureLoanFacilityScheduleOfLoanFacility" roleURI="http://imetrix.edgar-online.com/taxonomy/role/DisclosureLoanFacilityScheduleOfLoanFacility"/>
  <roleRef xlink:type="simple" xlink:href="aqxp-20140331.xsd#DisclosureLoanFacilitySummaryOfBankLoanFacility" roleURI="http://imetrix.edgar-online.com/taxonomy/role/DisclosureLoanFacilitySummaryOfBankLoanFacility"/>
  <roleRef xlink:type="simple" xlink:href="aqxp-20140331.xsd#DisclosureCommonStockAdditionalInformation" roleURI="http://imetrix.edgar-online.com/taxonomy/role/DisclosureCommonStockAdditionalInformation"/>
  <roleRef xlink:type="simple" xlink:href="aqxp-20140331.xsd#DisclosureCommonStockScheduleOfWeightedAverageAssumptions" roleURI="http://imetrix.edgar-online.com/taxonomy/role/DisclosureCommonStockScheduleOfWeightedAverageAssumptions"/>
  <roleRef xlink:type="simple" xlink:href="aqxp-20140331.xsd#DisclosureNetLossPerShareAdditionalInformation" roleURI="http://imetrix.edgar-online.com/taxonomy/role/DisclosureNetLossPerShareAdditionalInformation"/>
  <roleRef xlink:type="simple" xlink:href="aqxp-20140331.xsd#DisclosureNetLossPerShareScheduleOfComputationOfBasicAndDilutedEarningsPerShare" roleURI="http://imetrix.edgar-online.com/taxonomy/role/DisclosureNetLossPerShareScheduleOfComputationOfBasicAndDilutedEarningsPerShare"/>
  <roleRef xlink:type="simple" xlink:href="aqxp-20140331.xsd#DisclosureNetLossPerShareScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfBasicAndDilutedNetLossPerShare" roleURI="http://imetrix.edgar-online.com/taxonomy/role/DisclosureNetLossPerShareScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfBasicAndDilutedNetLossPerShare"/>
  <roleRef xlink:type="simple" xlink:href="aqxp-20140331.xsd#DisclosureFinancialInstrumentsFairValueOfSignificantUnobservableInputs" roleURI="http://imetrix.edgar-online.com/taxonomy/role/DisclosureFinancialInstrumentsFairValueOfSignificantUnobservableInputs"/>
  <roleRef xlink:type="simple" xlink:href="aqxp-20140331.xsd#DisclosureFinancialInstrumentsAdditionalInformation" roleURI="http://imetrix.edgar-online.com/taxonomy/role/DisclosureFinancialInstrumentsAdditionalInformation"/>
  <roleRef xlink:type="simple" xlink:href="aqxp-20140331.xsd#Role_NotesToFinancialStatementsNatureOfOperations" roleURI="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsNatureOfOperations"/>
  <roleRef xlink:type="simple" xlink:href="aqxp-20140331.xsd#Role_NotesToFinancialStatementsSignificantAccountingPoliciesTextBlock" roleURI="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsSignificantAccountingPoliciesTextBlock"/>
  <roleRef xlink:type="simple" xlink:href="aqxp-20140331.xsd#Role_NotesToFinancialStatementsSignificantAccountingPoliciesTextBlockPolicies" roleURI="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsSignificantAccountingPoliciesTextBlockPolicies"/>
  <roleRef xlink:type="simple" xlink:href="aqxp-20140331.xsd#Role_NotesToFinancialStatementsStockholdersEquityNoteDisclosureTextBlock" roleURI="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsStockholdersEquityNoteDisclosureTextBlock"/>
  <roleRef xlink:type="simple" xlink:href="aqxp-20140331.xsd#Role_NotesToFinancialStatementsCashAndCashEquivalentsDisclosureTextBlock" roleURI="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsCashAndCashEquivalentsDisclosureTextBlock"/>
  <roleRef xlink:type="simple" xlink:href="aqxp-20140331.xsd#Role_NotesToFinancialStatementsCashAndCashEquivalentsDisclosureTextBlockTables" roleURI="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsCashAndCashEquivalentsDisclosureTextBlockTables"/>
  <roleRef xlink:type="simple" xlink:href="aqxp-20140331.xsd#Role_NotesToFinancialStatementsDebtDisclosureTextBlock" roleURI="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsDebtDisclosureTextBlock"/>
  <roleRef xlink:type="simple" xlink:href="aqxp-20140331.xsd#Role_NotesToFinancialStatementsDebtDisclosureTextBlockTables" roleURI="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsDebtDisclosureTextBlockTables"/>
  <roleRef xlink:type="simple" xlink:href="aqxp-20140331.xsd#Role_NotesToFinancialStatementsCommonStockDisclosureTextBlock" roleURI="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsCommonStockDisclosureTextBlock"/>
  <roleRef xlink:type="simple" xlink:href="aqxp-20140331.xsd#Role_NotesToFinancialStatementsCommonStockDisclosureTextBlockTables" roleURI="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsCommonStockDisclosureTextBlockTables"/>
  <roleRef xlink:type="simple" xlink:href="aqxp-20140331.xsd#Role_NotesToFinancialStatementsEarningsPerShareTextBlock" roleURI="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsEarningsPerShareTextBlock"/>
  <roleRef xlink:type="simple" xlink:href="aqxp-20140331.xsd#Role_NotesToFinancialStatementsEarningsPerShareTextBlockTables" roleURI="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsEarningsPerShareTextBlockTables"/>
  <roleRef xlink:type="simple" xlink:href="aqxp-20140331.xsd#Role_NotesToFinancialStatementsFinancialInstrumentsDisclosureTextBlock" roleURI="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsFinancialInstrumentsDisclosureTextBlock"/>
  <roleRef xlink:type="simple" xlink:href="aqxp-20140331.xsd#Role_NotesToFinancialStatementsFinancialInstrumentsDisclosureTextBlockTables" roleURI="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsFinancialInstrumentsDisclosureTextBlockTables"/>
  <calculationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/DocumentandEntityInformation">
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/StatementOfFinancialPositionClassified">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccountsAndOtherReceivablesNetCurrent" xlink:label="us-gaap_AccountsAndOtherReceivablesNetCurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredOfferingCosts" xlink:label="us-gaap_DeferredOfferingCosts"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxLiabilitiesNoncurrent" xlink:label="us-gaap_DeferredTaxLiabilitiesNoncurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DerivativeLiabilitiesNoncurrent" xlink:label="us-gaap_DerivativeLiabilitiesNoncurrent"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_DerivativeLiabilitiesNoncurrentRedemptionOption" xlink:label="aqxp_DerivativeLiabilitiesNoncurrentRedemptionOption"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LoansPayableToBankCurrent" xlink:label="us-gaap_LoansPayableToBankCurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LongTermLoansFromBank" xlink:label="us-gaap_LongTermLoansFromBank"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="us-gaap_OtherLiabilitiesCurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="us-gaap_OtherLiabilitiesNoncurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="us-gaap_PrepaidExpenseCurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShortTermInvestments" xlink:label="us-gaap_ShortTermInvestments"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_AssetsCurrent" order="1.0700" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="1.0800" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_OtherAssetsNoncurrent" order="1.0900" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="1.0200" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_ShortTermInvestments" order="1.0300" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AccountsAndOtherReceivablesNetCurrent" order="1.0400" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_PrepaidExpenseCurrent" order="1.0500" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_DeferredOfferingCosts" order="1.0600" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_LiabilitiesCurrent" order="1.1300" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_DerivativeLiabilitiesNoncurrent" order="1.1400" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="aqxp_DerivativeLiabilitiesNoncurrentRedemptionOption" order="1.1500" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_DeferredTaxLiabilitiesNoncurrent" order="1.1600" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_LongTermLoansFromBank" order="1.1700" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_OtherLiabilitiesNoncurrent" order="1.1800" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_Liabilities" order="1.1900" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" order="1.2000" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_StockholdersEquity" order="1.2300" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" order="1.1000" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LoansPayableToBankCurrent" order="1.1100" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_OtherLiabilitiesCurrent" order="1.1200" weight="1.00" priority="2" use="optional"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/StatementOfFinancialPositionClassifiedParenthetical">
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/StatementOfIncomeAlternative">
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_AmortizationOfDiscountOnPreferredStock" xlink:label="aqxp_AmortizationOfDiscountOnPreferredStock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_ExtinguishmentOfRemainingShareIssuanceCostsDueToConversionOfPreferredStock" xlink:label="aqxp_ExtinguishmentOfRemainingShareIssuanceCostsDueToConversionOfPreferredStock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:label="us-gaap_GainLossOnDerivativeInstrumentsNetPretax"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_IncomeTaxExpenseOnPreferredStock" xlink:label="aqxp_IncomeTaxExpenseOnPreferredStock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="us-gaap_InvestmentIncomeInterest"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_ReversalOfIncomeTaxPayableOnPreferredStock" xlink:label="aqxp_ReversalOfIncomeTaxPayableOnPreferredStock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" xlink:label="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_TemporaryEquityAccretionToRedemptionValueLiquidationPreference" xlink:label="aqxp_TemporaryEquityAccretionToRedemptionValueLiquidationPreference"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="1.1100" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="1.1200" weight="-1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_OperatingExpenses" order="1.0300" weight="-1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_NonoperatingIncomeExpense" order="1.1000" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax" order="1.1300" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="aqxp_TemporaryEquityAccretionToRedemptionValueLiquidationPreference" order="1.1400" weight="-1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" order="1.1500" weight="-1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="aqxp_IncomeTaxExpenseOnPreferredStock" order="1.1600" weight="-1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="aqxp_ReversalOfIncomeTaxPayableOnPreferredStock" order="1.1700" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="aqxp_ExtinguishmentOfRemainingShareIssuanceCostsDueToConversionOfPreferredStock" order="1.1800" weight="-1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_InterestExpense" order="1.0400" weight="-1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_InvestmentIncomeInterest" order="1.0500" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" order="1.0600" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_GainLossOnDerivativeInstrumentsNetPretax" order="1.0700" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="aqxp_AmortizationOfDiscountOnPreferredStock" order="1.0800" weight="-1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" order="1.0900" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="1.0100" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="1.0200" weight="1.00" priority="2" use="optional"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/StatementOfShareholdersEquityAndOtherComprehensiveIncome">
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/StatementOfShareholdersEquityAndOtherComprehensiveIncomeParenthetical">
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/StatementOfCashFlowsIndirect">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AmortizationOfFinancingCosts" xlink:label="us-gaap_AmortizationOfFinancingCosts"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_AmortizationOfPreferredStockDiscount" xlink:label="aqxp_AmortizationOfPreferredStockDiscount"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossUnrealized"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:label="us-gaap_GainLossOnDerivativeInstrumentsNetPretax"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables" xlink:label="us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:label="us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PaymentsOfFinancingCosts" xlink:label="us-gaap_PaymentsOfFinancingCosts"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PaymentsOfLoanCosts" xlink:label="us-gaap_PaymentsOfLoanCosts"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PaymentsToAcquireShortTermInvestments" xlink:label="us-gaap_PaymentsToAcquireShortTermInvestments"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="us-gaap_ProceedsFromNotesPayable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromRepurchaseOfRedeemablePreferredStock" xlink:label="us-gaap_ProceedsFromRepurchaseOfRedeemablePreferredStock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_RepaymentFeeAndPenalty" xlink:label="aqxp_RepaymentFeeAndPenalty"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RepaymentsOfDebt" xlink:label="us-gaap_RepaymentsOfDebt"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="us-gaap_RepaymentsOfNotesPayable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_SpecialVotingCommonStockIssuedValue" xlink:label="aqxp_SpecialVotingCommonStockIssuedValue"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" order="1.1300" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" order="1.1800" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" order="1.3000" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:to="us-gaap_RepaymentsOfDebt" order="1.1900" weight="-1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:to="us-gaap_PaymentsOfLoanCosts" order="1.2000" weight="-1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:to="us-gaap_ProceedsFromNotesPayable" order="1.2100" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:to="us-gaap_RepaymentsOfNotesPayable" order="1.2200" weight="-1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="1.2300" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:to="us-gaap_PaymentsForRepurchaseOfCommonStock" order="1.2400" weight="-1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:to="us-gaap_ProceedsFromRepurchaseOfRedeemablePreferredStock" order="1.2500" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:to="aqxp_SpecialVotingCommonStockIssuedValue" order="1.2600" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts" order="1.2700" weight="-1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering" order="1.2800" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:to="us-gaap_PaymentsOfFinancingCosts" order="1.2900" weight="-1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:to="us-gaap_PaymentsToAcquireShortTermInvestments" order="1.1400" weight="-1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="1.1500" weight="-1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:to="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" order="1.1600" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:to="us-gaap_PaymentsToAcquireIntangibleAssets" order="1.1700" weight="-1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax" order="1.0100" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_DepreciationDepletionAndAmortization" order="1.0200" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_AmortizationOfFinancingCosts" order="1.0300" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="aqxp_RepaymentFeeAndPenalty" order="1.0400" weight="-1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" order="1.0500" weight="-1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="aqxp_AmortizationOfPreferredStockDiscount" order="1.0600" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_GainLossOnDerivativeInstrumentsNetPretax" order="1.0700" weight="-1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_ShareBasedCompensation" order="1.0800" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_ForeignCurrencyTransactionGainLossUnrealized" order="1.0900" weight="-1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables" order="1.1000" weight="-1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="1.1100" weight="-1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" order="1.1200" weight="1.00" priority="2" use="optional"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/DisclosureNatureOfOperationsAdditionalInformation">
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/DisclosureCondensedSummaryOfSignificantAccountingPoliciesAdditionalInformation">
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/DisclosureRedeemableConvertiblePreferredStockAndStockholdersdeficitEquityAdditionalInformation">
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/DisclosureCashAndCashEquivalentsScheduleOfCashAndCashEquivalents">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_Cash" xlink:label="us-gaap_Cash"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashEquivalentsAtCarryingValue"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_Cash" order="1.0100" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashEquivalentsAtCarryingValue" order="1.0200" weight="1.00" priority="2" use="optional"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/DisclosureLoanFacilityAdditionalInformation">
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/DisclosureLoanFacilityScheduleOfLoanFacility">
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/DisclosureLoanFacilitySummaryOfBankLoanFacility">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LineOfCreditFacilityAmountOutstanding" xlink:label="us-gaap_LineOfCreditFacilityAmountOutstanding"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LoansPayableToBankCurrent" xlink:label="us-gaap_LoansPayableToBankCurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LongTermLoansFromBank" xlink:label="us-gaap_LongTermLoansFromBank"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LineOfCreditFacilityAmountOutstanding" xlink:to="us-gaap_LoansPayableToBankCurrent" order="1.0100" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LineOfCreditFacilityAmountOutstanding" xlink:to="us-gaap_LongTermLoansFromBank" order="1.0200" weight="1.00" priority="2" use="optional"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/DisclosureCommonStockAdditionalInformation">
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/DisclosureCommonStockScheduleOfWeightedAverageAssumptions">
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/DisclosureNetLossPerShareAdditionalInformation">
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/DisclosureNetLossPerShareScheduleOfComputationOfBasicAndDilutedEarningsPerShare">
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_ExtinguishmentOfRemainingShareIssuanceCostsDueToConversionOfPreferredStock" xlink:label="aqxp_ExtinguishmentOfRemainingShareIssuanceCostsDueToConversionOfPreferredStock"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_IncomeTaxExpenseOnPreferredStock" xlink:label="aqxp_IncomeTaxExpenseOnPreferredStock"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_IncrementalCommonSharesAttributableToCommonStockWarrants" xlink:label="aqxp_IncrementalCommonSharesAttributableToCommonStockWarrants"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_IncrementalCommonSharesAttributableToStockOptions" xlink:label="aqxp_IncrementalCommonSharesAttributableToStockOptions"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_ReversalOfIncomeTaxPayableOnPreferredStock" xlink:label="aqxp_ReversalOfIncomeTaxPayableOnPreferredStock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" xlink:label="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_TemporaryEquityAccretionToRedemptionValueLiquidationPreference" xlink:label="aqxp_TemporaryEquityAccretionToRedemptionValueLiquidationPreference"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:label="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_NetIncomeLoss" order="1.0100" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="aqxp_TemporaryEquityAccretionToRedemptionValueLiquidationPreference" order="1.0200" weight="-1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" order="1.0300" weight="-1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="aqxp_IncomeTaxExpenseOnPreferredStock" order="1.0400" weight="-1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="aqxp_ReversalOfIncomeTaxPayableOnPreferredStock" order="1.0500" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="aqxp_ExtinguishmentOfRemainingShareIssuanceCostsDueToConversionOfPreferredStock" order="1.0600" weight="-1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" order="1.0700" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:to="aqxp_IncrementalCommonSharesAttributableToStockOptions" order="1.0800" weight="1.00" priority="2" use="optional"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:to="aqxp_IncrementalCommonSharesAttributableToCommonStockWarrants" order="1.0900" weight="1.00" priority="2" use="optional"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/DisclosureNetLossPerShareScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfBasicAndDilutedNetLossPerShare">
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/DisclosureFinancialInstrumentsFairValueOfSignificantUnobservableInputs">
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/DisclosureFinancialInstrumentsAdditionalInformation">
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsNatureOfOperations">
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsSignificantAccountingPoliciesTextBlock">
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsSignificantAccountingPoliciesTextBlockPolicies">
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsStockholdersEquityNoteDisclosureTextBlock">
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsCashAndCashEquivalentsDisclosureTextBlock">
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsCashAndCashEquivalentsDisclosureTextBlockTables">
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsDebtDisclosureTextBlock">
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsDebtDisclosureTextBlockTables">
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsCommonStockDisclosureTextBlock">
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsCommonStockDisclosureTextBlockTables">
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsEarningsPerShareTextBlock">
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsEarningsPerShareTextBlockTables">
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsFinancialInstrumentsDisclosureTextBlock">
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsFinancialInstrumentsDisclosureTextBlockTables">
  </calculationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>9
<FILENAME>aqxp-20140331_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- RR Donnelley Xcelerate Taxonomy Definition Linkbase, based on XBRL 2.1  http://www.rrdonnelley.com/ -->
<!-- Version: 6.21.0 -->
<!-- Round: 5 -->
<!-- Creation date: 2014-05-12T17:22:31Z -->
<!-- Copyright (c) 2005-2013 R.R. Donnelley & Sons Company All Rights Reserved. -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="aqxp-20140331.xsd#DocumentandEntityInformation" roleURI="http://imetrix.edgar-online.com/taxonomy/role/DocumentandEntityInformation"/>
  <roleRef xlink:type="simple" xlink:href="aqxp-20140331.xsd#Role_StatementOfFinancialPositionClassified" roleURI="http://imetrix.edgar-online.com/taxonomy/role/StatementOfFinancialPositionClassified"/>
  <roleRef xlink:type="simple" xlink:href="aqxp-20140331.xsd#Role_StatementOfFinancialPositionClassifiedParen" roleURI="http://imetrix.edgar-online.com/taxonomy/role/StatementOfFinancialPositionClassifiedParenthetical"/>
  <roleRef xlink:type="simple" xlink:href="aqxp-20140331.xsd#Role_StatementOfIncomeAlternative" roleURI="http://imetrix.edgar-online.com/taxonomy/role/StatementOfIncomeAlternative"/>
  <roleRef xlink:type="simple" xlink:href="aqxp-20140331.xsd#Role_StatementOfShareholdersEquityAndOtherComprehensiveIncome" roleURI="http://imetrix.edgar-online.com/taxonomy/role/StatementOfShareholdersEquityAndOtherComprehensiveIncome"/>
  <roleRef xlink:type="simple" xlink:href="aqxp-20140331.xsd#Role_StatementOfShareholdersEquityAndOtherComprehensiveIncomeParen" roleURI="http://imetrix.edgar-online.com/taxonomy/role/StatementOfShareholdersEquityAndOtherComprehensiveIncomeParenthetical"/>
  <roleRef xlink:type="simple" xlink:href="aqxp-20140331.xsd#Role_StatementOfCashFlowsIndirect" roleURI="http://imetrix.edgar-online.com/taxonomy/role/StatementOfCashFlowsIndirect"/>
  <roleRef xlink:type="simple" xlink:href="aqxp-20140331.xsd#DisclosureNatureOfOperationsAdditionalInformation" roleURI="http://imetrix.edgar-online.com/taxonomy/role/DisclosureNatureOfOperationsAdditionalInformation"/>
  <roleRef xlink:type="simple" xlink:href="aqxp-20140331.xsd#DisclosureCondensedSummaryOfSignificantAccountingPoliciesAdditionalInformation" roleURI="http://imetrix.edgar-online.com/taxonomy/role/DisclosureCondensedSummaryOfSignificantAccountingPoliciesAdditionalInformation"/>
  <roleRef xlink:type="simple" xlink:href="aqxp-20140331.xsd#DisclosureRedeemableConvertiblePreferredStockAndStockholdersdeficitEquityAdditionalInformation" roleURI="http://imetrix.edgar-online.com/taxonomy/role/DisclosureRedeemableConvertiblePreferredStockAndStockholdersdeficitEquityAdditionalInformation"/>
  <roleRef xlink:type="simple" xlink:href="aqxp-20140331.xsd#DisclosureCashAndCashEquivalentsScheduleOfCashAndCashEquivalents" roleURI="http://imetrix.edgar-online.com/taxonomy/role/DisclosureCashAndCashEquivalentsScheduleOfCashAndCashEquivalents"/>
  <roleRef xlink:type="simple" xlink:href="aqxp-20140331.xsd#DisclosureLoanFacilityAdditionalInformation" roleURI="http://imetrix.edgar-online.com/taxonomy/role/DisclosureLoanFacilityAdditionalInformation"/>
  <roleRef xlink:type="simple" xlink:href="aqxp-20140331.xsd#DisclosureLoanFacilityScheduleOfLoanFacility" roleURI="http://imetrix.edgar-online.com/taxonomy/role/DisclosureLoanFacilityScheduleOfLoanFacility"/>
  <roleRef xlink:type="simple" xlink:href="aqxp-20140331.xsd#DisclosureLoanFacilitySummaryOfBankLoanFacility" roleURI="http://imetrix.edgar-online.com/taxonomy/role/DisclosureLoanFacilitySummaryOfBankLoanFacility"/>
  <roleRef xlink:type="simple" xlink:href="aqxp-20140331.xsd#DisclosureCommonStockAdditionalInformation" roleURI="http://imetrix.edgar-online.com/taxonomy/role/DisclosureCommonStockAdditionalInformation"/>
  <roleRef xlink:type="simple" xlink:href="aqxp-20140331.xsd#DisclosureCommonStockScheduleOfWeightedAverageAssumptions" roleURI="http://imetrix.edgar-online.com/taxonomy/role/DisclosureCommonStockScheduleOfWeightedAverageAssumptions"/>
  <roleRef xlink:type="simple" xlink:href="aqxp-20140331.xsd#DisclosureNetLossPerShareAdditionalInformation" roleURI="http://imetrix.edgar-online.com/taxonomy/role/DisclosureNetLossPerShareAdditionalInformation"/>
  <roleRef xlink:type="simple" xlink:href="aqxp-20140331.xsd#DisclosureNetLossPerShareScheduleOfComputationOfBasicAndDilutedEarningsPerShare" roleURI="http://imetrix.edgar-online.com/taxonomy/role/DisclosureNetLossPerShareScheduleOfComputationOfBasicAndDilutedEarningsPerShare"/>
  <roleRef xlink:type="simple" xlink:href="aqxp-20140331.xsd#DisclosureNetLossPerShareScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfBasicAndDilutedNetLossPerShare" roleURI="http://imetrix.edgar-online.com/taxonomy/role/DisclosureNetLossPerShareScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfBasicAndDilutedNetLossPerShare"/>
  <roleRef xlink:type="simple" xlink:href="aqxp-20140331.xsd#DisclosureFinancialInstrumentsFairValueOfSignificantUnobservableInputs" roleURI="http://imetrix.edgar-online.com/taxonomy/role/DisclosureFinancialInstrumentsFairValueOfSignificantUnobservableInputs"/>
  <roleRef xlink:type="simple" xlink:href="aqxp-20140331.xsd#DisclosureFinancialInstrumentsAdditionalInformation" roleURI="http://imetrix.edgar-online.com/taxonomy/role/DisclosureFinancialInstrumentsAdditionalInformation"/>
  <roleRef xlink:type="simple" xlink:href="aqxp-20140331.xsd#Role_NotesToFinancialStatementsNatureOfOperations" roleURI="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsNatureOfOperations"/>
  <roleRef xlink:type="simple" xlink:href="aqxp-20140331.xsd#Role_NotesToFinancialStatementsSignificantAccountingPoliciesTextBlock" roleURI="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsSignificantAccountingPoliciesTextBlock"/>
  <roleRef xlink:type="simple" xlink:href="aqxp-20140331.xsd#Role_NotesToFinancialStatementsSignificantAccountingPoliciesTextBlockPolicies" roleURI="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsSignificantAccountingPoliciesTextBlockPolicies"/>
  <roleRef xlink:type="simple" xlink:href="aqxp-20140331.xsd#Role_NotesToFinancialStatementsStockholdersEquityNoteDisclosureTextBlock" roleURI="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsStockholdersEquityNoteDisclosureTextBlock"/>
  <roleRef xlink:type="simple" xlink:href="aqxp-20140331.xsd#Role_NotesToFinancialStatementsCashAndCashEquivalentsDisclosureTextBlock" roleURI="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsCashAndCashEquivalentsDisclosureTextBlock"/>
  <roleRef xlink:type="simple" xlink:href="aqxp-20140331.xsd#Role_NotesToFinancialStatementsCashAndCashEquivalentsDisclosureTextBlockTables" roleURI="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsCashAndCashEquivalentsDisclosureTextBlockTables"/>
  <roleRef xlink:type="simple" xlink:href="aqxp-20140331.xsd#Role_NotesToFinancialStatementsDebtDisclosureTextBlock" roleURI="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsDebtDisclosureTextBlock"/>
  <roleRef xlink:type="simple" xlink:href="aqxp-20140331.xsd#Role_NotesToFinancialStatementsDebtDisclosureTextBlockTables" roleURI="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsDebtDisclosureTextBlockTables"/>
  <roleRef xlink:type="simple" xlink:href="aqxp-20140331.xsd#Role_NotesToFinancialStatementsCommonStockDisclosureTextBlock" roleURI="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsCommonStockDisclosureTextBlock"/>
  <roleRef xlink:type="simple" xlink:href="aqxp-20140331.xsd#Role_NotesToFinancialStatementsCommonStockDisclosureTextBlockTables" roleURI="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsCommonStockDisclosureTextBlockTables"/>
  <roleRef xlink:type="simple" xlink:href="aqxp-20140331.xsd#Role_NotesToFinancialStatementsEarningsPerShareTextBlock" roleURI="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsEarningsPerShareTextBlock"/>
  <roleRef xlink:type="simple" xlink:href="aqxp-20140331.xsd#Role_NotesToFinancialStatementsEarningsPerShareTextBlockTables" roleURI="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsEarningsPerShareTextBlockTables"/>
  <roleRef xlink:type="simple" xlink:href="aqxp-20140331.xsd#Role_NotesToFinancialStatementsFinancialInstrumentsDisclosureTextBlock" roleURI="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsFinancialInstrumentsDisclosureTextBlock"/>
  <roleRef xlink:type="simple" xlink:href="aqxp-20140331.xsd#Role_NotesToFinancialStatementsFinancialInstrumentsDisclosureTextBlockTables" roleURI="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsFinancialInstrumentsDisclosureTextBlockTables"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension"/>
  <definitionLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/DocumentandEntityInformation">
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/StatementOfFinancialPositionClassified">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccountsAndOtherReceivablesNetCurrent" xlink:label="us-gaap_AccountsAndOtherReceivablesNetCurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_AquinoxUsaMember" xlink:label="aqxp_AquinoxUsaMember"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_AqxpCanadaMember" xlink:label="aqxp_AqxpCanadaMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:label="us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredOfferingCosts" xlink:label="us-gaap_DeferredOfferingCosts"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxLiabilitiesNoncurrent" xlink:label="us-gaap_DeferredTaxLiabilitiesNoncurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DerivativeLiabilitiesNoncurrent" xlink:label="us-gaap_DerivativeLiabilitiesNoncurrent"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_DerivativeLiabilitiesNoncurrentRedemptionOption" xlink:label="aqxp_DerivativeLiabilitiesNoncurrentRedemptionOption"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage" xlink:label="us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LiabilitiesAbstract" xlink:label="us-gaap_LiabilitiesAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LoansPayableToBankCurrent" xlink:label="us-gaap_LoansPayableToBankCurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LongTermLoansFromBank" xlink:label="us-gaap_LongTermLoansFromBank"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="us-gaap_OtherLiabilitiesCurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="us-gaap_OtherLiabilitiesNoncurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="us-gaap_PrepaidExpenseCurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_SeriesAConvertiblePreferredStockMember" xlink:label="aqxp_SeriesAConvertiblePreferredStockMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="us-gaap_SeriesAPreferredStockMember"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_SeriesBConvertiblePreferredStockMember" xlink:label="aqxp_SeriesBConvertiblePreferredStockMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="us-gaap_SeriesBPreferredStockMember"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_SeriesCConvertiblePreferredStockMember" xlink:label="aqxp_SeriesCConvertiblePreferredStockMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SeriesCPreferredStockMember" xlink:label="us-gaap_SeriesCPreferredStockMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShortTermInvestments" xlink:label="us-gaap_ShortTermInvestments"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:label="us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TemporaryEquityAbstract" xlink:label="us-gaap_TemporaryEquityAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsCurrentAbstract" order="1.3900" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="1.4000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_OtherAssetsNoncurrent" order="1.4100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_Assets" order="1.4200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="1.2200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_ShortTermInvestments" order="1.2300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AccountsAndOtherReceivablesNetCurrent" order="1.2400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseCurrent" order="1.2500" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_DeferredOfferingCosts" order="1.2600" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrent" order="1.2700" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="aqxp_SeriesAConvertiblePreferredStockMember" order="1.2800" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesAPreferredStockMember" order="1.2900" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="aqxp_SeriesBConvertiblePreferredStockMember" order="1.3000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesBPreferredStockMember" order="1.3100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="aqxp_SeriesCConvertiblePreferredStockMember" order="1.3200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesCPreferredStockMember" order="1.3300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonStockMember" order="1.3400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:to="us-gaap_CommonStockValue" order="1.3500" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:to="us-gaap_AdditionalPaidInCapital" order="1.3600" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:to="us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage" order="1.3700" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityDomain" xlink:to="aqxp_AqxpCanadaMember" order="1.0100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityDomain" xlink:to="aqxp_AquinoxUsaMember" order="1.0200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract" order="1.1500" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAbstract" xlink:to="us-gaap_DerivativeLiabilitiesNoncurrent" order="1.1600" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAbstract" xlink:to="aqxp_DerivativeLiabilitiesNoncurrentRedemptionOption" order="1.1700" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAbstract" xlink:to="us-gaap_DeferredTaxLiabilitiesNoncurrent" order="1.1800" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAbstract" xlink:to="us-gaap_LongTermLoansFromBank" order="1.1900" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAbstract" xlink:to="us-gaap_OtherLiabilitiesNoncurrent" order="1.2000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAbstract" xlink:to="us-gaap_Liabilities" order="1.2100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" order="1.0300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LoansPayableToBankCurrent" order="1.0400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_OtherLiabilitiesCurrent" order="1.0500" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrent" order="1.0600" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="100.0000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AssetsAbstract" order="1.0700" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LiabilitiesAbstract" order="1.0800" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquityAbstract" order="1.0900" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquityAbstract" order="1.1000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" order="1.1100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="2.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract" order="1.1200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" order="1.1300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquity" order="1.1400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityAbstract" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" order="1.3800" priority="2" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/StatementOfFinancialPositionClassifiedParenthetical">
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_AquinoxUsaMember" xlink:label="aqxp_AquinoxUsaMember"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_AqxpCanadaMember" xlink:label="aqxp_AqxpCanadaMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_SeriesAConvertiblePreferredStockMember" xlink:label="aqxp_SeriesAConvertiblePreferredStockMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="us-gaap_SeriesAPreferredStockMember"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_SeriesBConvertiblePreferredStockMember" xlink:label="aqxp_SeriesBConvertiblePreferredStockMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="us-gaap_SeriesBPreferredStockMember"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_SeriesCConvertiblePreferredStockMember" xlink:label="aqxp_SeriesCConvertiblePreferredStockMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SeriesCPreferredStockMember" xlink:label="us-gaap_SeriesCPreferredStockMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:label="us-gaap_TemporaryEquityParOrStatedValuePerShare"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TemporaryEquitySharesAuthorized" xlink:label="us-gaap_TemporaryEquitySharesAuthorized"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_TemporaryEquitySharesAuthorizedUnlimited" xlink:label="aqxp_TemporaryEquitySharesAuthorizedUnlimited"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TemporaryEquitySharesIssued" xlink:label="us-gaap_TemporaryEquitySharesIssued"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="aqxp_SeriesAConvertiblePreferredStockMember" order="1.1200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesAPreferredStockMember" order="1.1300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="aqxp_SeriesBConvertiblePreferredStockMember" order="1.1400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesBPreferredStockMember" order="1.1500" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="aqxp_SeriesCConvertiblePreferredStockMember" order="1.1600" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesCPreferredStockMember" order="1.1700" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonStockMember" order="1.1800" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityDomain" xlink:to="aqxp_AqxpCanadaMember" order="1.0100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityDomain" xlink:to="aqxp_AquinoxUsaMember" order="1.0200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain_2" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_2" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="100.0000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquityParOrStatedValuePerShare" order="1.0300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="aqxp_TemporaryEquitySharesAuthorizedUnlimited" order="1.0400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesAuthorized" order="1.0500" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesIssued" order="1.0600" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesOutstanding" order="1.0700" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="1.0800" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" order="1.0900" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="1.1000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" order="1.1100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="2.0000" priority="2" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/StatementOfIncomeAlternative">
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/StatementOfShareholdersEquityAndOtherComprehensiveIncome">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccumulatedDeficitDuringDevelopmentStageMember" xlink:label="us-gaap_AccumulatedDeficitDuringDevelopmentStageMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_AquinoxUsaMember" xlink:label="aqxp_AquinoxUsaMember"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_AqxpCanadaMember" xlink:label="aqxp_AqxpCanadaMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_ConversionOfPreferredStockIntoCommonStock" xlink:label="aqxp_ConversionOfPreferredStockIntoCommonStock"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_ConversionOfPreferredStockIntoCommonStockShares" xlink:label="aqxp_ConversionOfPreferredStockIntoCommonStockShares"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConvertiblePreferredStockMember" xlink:label="us-gaap_ConvertiblePreferredStockMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_ExtinguishmentOfRemainingShareIssuanceCostsDueToConversionOfPreferredStock" xlink:label="aqxp_ExtinguishmentOfRemainingShareIssuanceCostsDueToConversionOfPreferredStock"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_IncomeTaxExpenseOnPreferredStock" xlink:label="aqxp_IncomeTaxExpenseOnPreferredStock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_NewCommonStockMember" xlink:label="aqxp_NewCommonStockMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockMember" xlink:label="us-gaap_PreferredStockMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForCash" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForCash"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForNoncashConsideration" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForNoncashConsideration"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForCash" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForCash"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForNoncashConsiderations" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForNoncashConsiderations"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="us-gaap_StockRepurchasedDuringPeriodShares"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue" xlink:label="us-gaap_StockRepurchasedDuringPeriodValue"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" xlink:label="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_TemporaryEquityAccretionToRedemptionValueLiquidationPreference" xlink:label="aqxp_TemporaryEquityAccretionToRedemptionValueLiquidationPreference"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_TemporaryEquityAccretionToRedemptionValueRedemptionOption" xlink:label="aqxp_TemporaryEquityAccretionToRedemptionValueRedemptionOption"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_TemporaryEquityAccretionToRedemptionValueWarrantDiscount" xlink:label="aqxp_TemporaryEquityAccretionToRedemptionValueWarrantDiscount"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_TemporaryEquityRedemptionDiscount" xlink:label="aqxp_TemporaryEquityRedemptionDiscount"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_TemporaryEquityWarrantDiscount" xlink:label="aqxp_TemporaryEquityWarrantDiscount"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_WarrantsExercised" xlink:label="aqxp_WarrantsExercised"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_WarrantsExercisedShares" xlink:label="aqxp_WarrantsExercisedShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ConvertiblePreferredStockMember" order="1.2700" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_PreferredStockMember" order="1.2800" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="aqxp_NewCommonStockMember" order="1.2900" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonStockMember" order="1.3000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" order="1.3100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_AccumulatedDeficitDuringDevelopmentStageMember" order="1.3200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityDomain" xlink:to="aqxp_AqxpCanadaMember" order="1.0100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityDomain" xlink:to="aqxp_AquinoxUsaMember" order="1.0200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="100.0000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" order="1.0300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="aqxp_ConversionOfPreferredStockIntoCommonStock" order="1.0400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockRepurchasedDuringPeriodValue" order="1.0500" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" order="1.0600" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="aqxp_ConversionOfPreferredStockIntoCommonStockShares" order="1.0700" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockRepurchasedDuringPeriodShares" order="1.0800" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueIssuedForCash" order="1.0900" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForCash" order="1.1000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="aqxp_WarrantsExercised" order="1.1100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueIssuedForNoncashConsiderations" order="1.1200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="aqxp_WarrantsExercisedShares" order="1.1300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForNoncashConsideration" order="1.1400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="aqxp_TemporaryEquityWarrantDiscount" order="1.1500" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="aqxp_TemporaryEquityRedemptionDiscount" order="1.1600" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" order="1.1700" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax" order="1.1800" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="aqxp_TemporaryEquityAccretionToRedemptionValueLiquidationPreference" order="1.1900" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" order="1.2000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="aqxp_TemporaryEquityAccretionToRedemptionValueWarrantDiscount" order="1.2100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="aqxp_TemporaryEquityAccretionToRedemptionValueRedemptionOption" order="1.2200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="aqxp_IncomeTaxExpenseOnPreferredStock" order="1.2300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="aqxp_ExtinguishmentOfRemainingShareIssuanceCostsDueToConversionOfPreferredStock" order="1.2400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" order="1.2500" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding" order="1.2600" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="2.0000" priority="2" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/StatementOfShareholdersEquityAndOtherComprehensiveIncomeParenthetical">
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_AquinoxUsaMember" xlink:label="aqxp_AquinoxUsaMember"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_AqxpCanadaMember" xlink:label="aqxp_AqxpCanadaMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConvertiblePreferredStockMember" xlink:label="us-gaap_ConvertiblePreferredStockMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PaymentOfFinancingAndStockIssuanceCosts" xlink:label="us-gaap_PaymentOfFinancingAndStockIssuanceCosts"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockMember" xlink:label="us-gaap_PreferredStockMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockRedemptionDiscount" xlink:label="us-gaap_PreferredStockRedemptionDiscount"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_WarrantDiscount" xlink:label="aqxp_WarrantDiscount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ConvertiblePreferredStockMember" order="1.0600" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_PreferredStockMember" order="1.0700" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonStockMember" order="1.0800" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityDomain" xlink:to="aqxp_AqxpCanadaMember" order="1.0100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityDomain" xlink:to="aqxp_AquinoxUsaMember" order="1.0200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="100.0000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="aqxp_WarrantDiscount" order="1.0300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockRedemptionDiscount" order="1.0400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PaymentOfFinancingAndStockIssuanceCosts" order="1.0500" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="2.0000" priority="2" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/StatementOfCashFlowsIndirect">
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/DisclosureNatureOfOperationsAdditionalInformation">
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/DisclosureCondensedSummaryOfSignificantAccountingPoliciesAdditionalInformation">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_DescriptionOfPercentageOfRealizationOfTaxBenefitUponSettlement" xlink:label="aqxp_DescriptionOfPercentageOfRealizationOfTaxBenefitUponSettlement"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="us-gaap_NumberOfOperatingSegments"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_PercentageOfRecognitionOfTaxBenefitUponSettlement" xlink:label="aqxp_PercentageOfRecognitionOfTaxBenefitUponSettlement"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SegmentGeographicalDomain" xlink:label="us-gaap_SegmentGeographicalDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SegmentGeographicalDomain" xlink:label="us-gaap_SegmentGeographicalDomain_2"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_SignificantAccountingPoliciesLineItems" xlink:label="aqxp_SignificantAccountingPoliciesLineItems"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_SignificantAccountingPoliciesTable" xlink:label="aqxp_SignificantAccountingPoliciesTable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementGeographicalAxis" xlink:label="us-gaap_StatementGeographicalAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/country/2013/country-2013-01-31.xsd#country_US" xlink:label="country_US"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentGeographicalDomain" xlink:to="country_US" order="1.0500" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="aqxp_SignificantAccountingPoliciesLineItems" xlink:to="aqxp_SignificantAccountingPoliciesTable" order="100.0000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aqxp_SignificantAccountingPoliciesLineItems" xlink:to="aqxp_DescriptionOfPercentageOfRealizationOfTaxBenefitUponSettlement" order="1.0100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aqxp_SignificantAccountingPoliciesLineItems" xlink:to="aqxp_PercentageOfRecognitionOfTaxBenefitUponSettlement" order="1.0200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aqxp_SignificantAccountingPoliciesLineItems" xlink:to="us-gaap_NumberOfOperatingSegments" order="1.0300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aqxp_SignificantAccountingPoliciesLineItems" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="1.0400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="aqxp_SignificantAccountingPoliciesTable" xlink:to="us-gaap_StatementGeographicalAxis" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementGeographicalAxis" xlink:to="us-gaap_SegmentGeographicalDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementGeographicalAxis" xlink:to="us-gaap_SegmentGeographicalDomain_2" order="1.0000" priority="2" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/DisclosureRedeemableConvertiblePreferredStockAndStockholdersdeficitEquityAdditionalInformation">
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_AquinoxUsaMember" xlink:label="aqxp_AquinoxUsaMember"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_AqxpCanadaMember" xlink:label="aqxp_AqxpCanadaMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="us-gaap_ClassOfStockLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockConversionBasis" xlink:label="us-gaap_CommonStockConversionBasis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_ConversionOfPreferredStockToCommonStockMember" xlink:label="aqxp_ConversionOfPreferredStockToCommonStockMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConversionOfStockSharesConverted1" xlink:label="us-gaap_ConversionOfStockSharesConverted1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConvertibleCommonStockMember" xlink:label="us-gaap_ConvertibleCommonStockMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:label="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConvertiblePreferredStockTermsOfConversion" xlink:label="us-gaap_ConvertiblePreferredStockTermsOfConversion"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxLiabilitiesNoncurrent" xlink:label="us-gaap_DeferredTaxLiabilitiesNoncurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_ExtinguishmentOfDiscountOnTemporaryEquity" xlink:label="aqxp_ExtinguishmentOfDiscountOnTemporaryEquity"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:label="us-gaap_MinorityInterestOwnershipPercentageByParent"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_NetProceedsFromIssuanceInitialPublicOffering" xlink:label="aqxp_NetProceedsFromIssuanceInitialPublicOffering"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PaymentOfFinancingAndStockIssuanceCosts" xlink:label="us-gaap_PaymentOfFinancingAndStockIssuanceCosts"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RedeemableConvertiblePreferredStockMember" xlink:label="us-gaap_RedeemableConvertiblePreferredStockMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="us-gaap_SaleOfStockPricePerShare"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="us-gaap_ScheduleOfStockByClassTable"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_SeriesAConvertiblePreferredStockMember" xlink:label="aqxp_SeriesAConvertiblePreferredStockMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="us-gaap_SeriesAPreferredStockMember"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_SeriesBConvertiblePreferredStockMember" xlink:label="aqxp_SeriesBConvertiblePreferredStockMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="us-gaap_SeriesBPreferredStockMember"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_SeriesCConvertiblePreferredStockMember" xlink:label="aqxp_SeriesCConvertiblePreferredStockMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SeriesCPreferredStockMember" xlink:label="us-gaap_SeriesCPreferredStockMember"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_SharesTransferredFromAqxpCanadaToAquinoxUsaMember" xlink:label="aqxp_SharesTransferredFromAqxpCanadaToAquinoxUsaMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:label="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquityReverseStockSplit" xlink:label="us-gaap_StockholdersEquityReverseStockSplit"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_StockSharesAuthorizedNet" xlink:label="aqxp_StockSharesAuthorizedNet"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TemporaryEquitySharesIssued" xlink:label="us-gaap_TemporaryEquitySharesIssued"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_UnderwritersMember" xlink:label="aqxp_UnderwritersMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonStockMember" order="1.2500" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ConvertibleCommonStockMember" order="1.2800" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="aqxp_SeriesAConvertiblePreferredStockMember" order="1.3100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="aqxp_SeriesBConvertiblePreferredStockMember" order="1.3200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="aqxp_SeriesCConvertiblePreferredStockMember" order="1.3300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesAPreferredStockMember" order="1.3400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesBPreferredStockMember" order="1.3500" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesCPreferredStockMember" order="1.3600" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_RedeemableConvertiblePreferredStockMember" order="1.3700" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ScheduleOfStockByClassTable" order="100.0000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_StockholdersEquityReverseStockSplit" order="1.0100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" order="1.0200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockConversionBasis" order="1.0300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" order="1.0400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ConvertiblePreferredStockTermsOfConversion" order="1.0500" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_TemporaryEquitySharesOutstanding" order="1.0600" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" order="1.0700" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_TemporaryEquitySharesIssued" order="1.0800" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ConversionOfStockSharesConverted1" order="1.0900" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_MinorityInterestOwnershipPercentageByParent" order="1.1000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_DeferredTaxLiabilitiesNoncurrent" order="1.1100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="aqxp_ExtinguishmentOfDiscountOnTemporaryEquity" order="1.1200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="1.1300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_SaleOfStockPricePerShare" order="1.1400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="aqxp_NetProceedsFromIssuanceInitialPublicOffering" order="1.1500" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PaymentOfFinancingAndStockIssuanceCosts" order="1.1600" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="aqxp_StockSharesAuthorizedNet" order="1.1700" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" order="1.1800" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="1.1900" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="1.2000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="1.2100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockSharesIssued" order="1.2200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" order="1.2300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityDomain" xlink:to="aqxp_AqxpCanadaMember" order="1.2600" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityDomain" xlink:to="aqxp_AquinoxUsaMember" order="1.2900" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="aqxp_UnderwritersMember" order="1.2700" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScenarioUnspecifiedDomain" xlink:to="aqxp_SharesTransferredFromAqxpCanadaToAquinoxUsaMember" order="1.2400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScenarioUnspecifiedDomain" xlink:to="aqxp_ConversionOfPreferredStockToCommonStockMember" order="1.3000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_StatementScenarioAxis" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="2.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="dei_LegalEntityAxis" order="3.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="4.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain_2" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_2" order="1.0000" priority="2" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/DisclosureCashAndCashEquivalentsScheduleOfCashAndCashEquivalents">
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/DisclosureLoanFacilityAdditionalInformation">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_2"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_ClassOfWarrantOrRightExercisable" xlink:label="aqxp_ClassOfWarrantOrRightExercisable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_ClassOfWarrantOrRightExpirationYear" xlink:label="aqxp_ClassOfWarrantOrRightExpirationYear"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LineOfCreditFacilityAxis" xlink:label="us-gaap_LineOfCreditFacilityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LineOfCreditFacilityExpirationDate1" xlink:label="us-gaap_LineOfCreditFacilityExpirationDate1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LineOfCreditFacilityFrequencyOfPaymentAndPaymentTerms" xlink:label="us-gaap_LineOfCreditFacilityFrequencyOfPaymentAndPaymentTerms"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" xlink:label="us-gaap_LineOfCreditFacilityInterestRateDuringPeriod"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain" xlink:label="us-gaap_LineOfCreditFacilityLenderDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain" xlink:label="us-gaap_LineOfCreditFacilityLenderDomain_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems" xlink:label="us-gaap_LineOfCreditFacilityLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LineOfCreditFacilityPeriodicPaymentPrincipal" xlink:label="us-gaap_LineOfCreditFacilityPeriodicPaymentPrincipal"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:label="us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LineOfCreditFacilityTable" xlink:label="us-gaap_LineOfCreditFacilityTable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit" xlink:label="us-gaap_ProceedsFromLinesOfCredit"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit" xlink:label="us-gaap_RepaymentsOfLinesOfCredit"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_SiliconValleyBankMember" xlink:label="aqxp_SiliconValleyBankMember"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_WarrantsToPurchaseCommonStockMember" xlink:label="aqxp_WarrantsToPurchaseCommonStockMember"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_WarrantsToPurchaseSeriescConvertiblePreferredStockMember" xlink:label="aqxp_WarrantsToPurchaseSeriescConvertiblePreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_2" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="aqxp_WarrantsToPurchaseSeriescConvertiblePreferredStockMember" order="1.1500" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="aqxp_WarrantsToPurchaseCommonStockMember" order="1.1600" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="aqxp_ClassOfWarrantOrRightExercisable" order="1.0600" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="aqxp_ClassOfWarrantOrRightExpirationYear" order="1.0700" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" order="1.0800" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="us-gaap_LineOfCreditFacilityPeriodicPaymentPrincipal" order="1.0900" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="us-gaap_LineOfCreditFacilityExpirationDate1" order="1.1000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="us-gaap_LineOfCreditFacilityFrequencyOfPaymentAndPaymentTerms" order="1.1100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="us-gaap_RepaymentsOfLinesOfCredit" order="1.1200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt" order="1.1300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_LineOfCreditFacilityAxis" xlink:to="us-gaap_LineOfCreditFacilityLenderDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_LineOfCreditFacilityAxis" xlink:to="us-gaap_LineOfCreditFacilityLenderDomain_2" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LineOfCreditFacilityLenderDomain" xlink:to="aqxp_SiliconValleyBankMember" order="1.1400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_LineOfCreditFacilityLineItems" xlink:to="us-gaap_LineOfCreditFacilityTable" order="100.0000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LineOfCreditFacilityLineItems" xlink:to="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" order="1.0100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LineOfCreditFacilityLineItems" xlink:to="us-gaap_ProceedsFromLinesOfCredit" order="1.0200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LineOfCreditFacilityLineItems" xlink:to="us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" order="1.0300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LineOfCreditFacilityLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights" order="1.0400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LineOfCreditFacilityLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" order="1.0500" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_LineOfCreditFacilityTable" xlink:to="us-gaap_LineOfCreditFacilityAxis" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_LineOfCreditFacilityTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" order="2.0000" priority="2" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/DisclosureLoanFacilityScheduleOfLoanFacility">
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/DisclosureLoanFacilitySummaryOfBankLoanFacility">
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/DisclosureCommonStockAdditionalInformation">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_CommonStockReservedForIssuanceDescription" xlink:label="aqxp_CommonStockReservedForIssuanceDescription"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualExercisePrice" xlink:label="us-gaap_DeferredCompensationArrangementWithIndividualExercisePrice"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_EquityIncentivePlanTwoThousandSixMember" xlink:label="aqxp_EquityIncentivePlanTwoThousandSixMember"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_NonEmployeeDirectorsMember" xlink:label="aqxp_NonEmployeeDirectorsMember"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_NumberOfNonEmployeeDirectors" xlink:label="aqxp_NumberOfNonEmployeeDirectors"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_NumberOfYearsSharesReservedForIssuanceWillIncrease" xlink:label="aqxp_NumberOfYearsSharesReservedForIssuanceWillIncrease"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedNew" xlink:label="aqxp_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedNew"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_StockBasedCompensationIncreaseInCommonStockIssuancePercentage" xlink:label="aqxp_StockBasedCompensationIncreaseInCommonStockIssuancePercentage"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_StockIncentivePlanTwoThousandFourteenMember" xlink:label="aqxp_StockIncentivePlanTwoThousandFourteenMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TitleOfIndividualAxis" xlink:label="us-gaap_TitleOfIndividualAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="us-gaap_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_2"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_UnrecognizedCompensationExpenseWeightedAveragePeriod" xlink:label="aqxp_UnrecognizedCompensationExpenseWeightedAveragePeriod"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_UnrecognizedShareBasedCompensationExpense" xlink:label="aqxp_UnrecognizedShareBasedCompensationExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="aqxp_StockIncentivePlanTwoThousandFourteenMember" order="1.1400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain_2" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="aqxp_EquityIncentivePlanTwoThousandSixMember" order="1.1300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" order="2.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_TitleOfIndividualAxis" order="3.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="100.0000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="1.0100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" order="1.0200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="aqxp_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedNew" order="1.0300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="aqxp_CommonStockReservedForIssuanceDescription" order="1.0400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="aqxp_StockBasedCompensationIncreaseInCommonStockIssuancePercentage" order="1.0500" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="aqxp_NumberOfYearsSharesReservedForIssuanceWillIncrease" order="1.0600" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_DeferredCompensationArrangementWithIndividualExercisePrice" order="1.0700" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="aqxp_NumberOfNonEmployeeDirectors" order="1.0800" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="1.0900" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensation" order="1.1000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="aqxp_UnrecognizedShareBasedCompensationExpense" order="1.1100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="aqxp_UnrecognizedCompensationExpenseWeightedAveragePeriod" order="1.1200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_TitleOfIndividualAxis" xlink:to="us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TitleOfIndividualAxis" xlink:to="us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_2" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="aqxp_NonEmployeeDirectorsMember" order="1.1500" priority="2" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/DisclosureCommonStockScheduleOfWeightedAverageAssumptions">
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/DisclosureNetLossPerShareAdditionalInformation">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis" xlink:label="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain" xlink:label="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain" xlink:label="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_ReorganizationMember" xlink:label="aqxp_ReorganizationMember"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_ScheduleOfEarningsPerShareLineItems" xlink:label="aqxp_ScheduleOfEarningsPerShareLineItems"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_ScheduleOfEarningsPerShareTable" xlink:label="aqxp_ScheduleOfEarningsPerShareTable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:label="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquityReverseStockSplit" xlink:label="us-gaap_StockholdersEquityReverseStockSplit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis" xlink:to="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis" xlink:to="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_2" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain" xlink:to="aqxp_ReorganizationMember" order="1.0600" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="aqxp_ScheduleOfEarningsPerShareLineItems" xlink:to="aqxp_ScheduleOfEarningsPerShareTable" order="100.0000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aqxp_ScheduleOfEarningsPerShareLineItems" xlink:to="us-gaap_StockholdersEquityReverseStockSplit" order="1.0100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aqxp_ScheduleOfEarningsPerShareLineItems" xlink:to="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" order="1.0200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aqxp_ScheduleOfEarningsPerShareLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" order="1.0300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aqxp_ScheduleOfEarningsPerShareLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="1.0400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="aqxp_ScheduleOfEarningsPerShareLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding" order="1.0500" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="aqxp_ScheduleOfEarningsPerShareTable" xlink:to="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis" order="1.0000" priority="2" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/DisclosureNetLossPerShareScheduleOfComputationOfBasicAndDilutedEarningsPerShare">
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/DisclosureNetLossPerShareScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfBasicAndDilutedNetLossPerShare">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_2"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_ConvertiblePreferredStocksMember" xlink:label="aqxp_ConvertiblePreferredStocksMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain_2" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" order="100.0000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" order="1.0400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="aqxp_ConvertiblePreferredStocksMember" order="1.0100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="1.0200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_WarrantMember" order="1.0300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" order="1.0000" priority="2" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/DisclosureFinancialInstrumentsFairValueOfSignificantUnobservableInputs">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BankLoanObligationsMember" xlink:label="us-gaap_BankLoanObligationsMember"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_DecreaseOfEmbeddedDerivativeLiabilitiesForPreferredSharesConvertedIntoCommonStock" xlink:label="aqxp_DecreaseOfEmbeddedDerivativeLiabilitiesForPreferredSharesConvertedIntoCommonStock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="us-gaap_DerivativeContractTypeDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="us-gaap_DerivativeContractTypeDomain_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="us-gaap_DerivativeInstrumentRiskAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EmbeddedDerivativeFinancialInstrumentsMember" xlink:label="us-gaap_EmbeddedDerivativeFinancialInstrumentsMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockMember" xlink:label="us-gaap_PreferredStockMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_WarrantDerivativeLiabilityMember" xlink:label="aqxp_WarrantDerivativeLiabilityMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DerivativeContractTypeDomain" xlink:to="aqxp_WarrantDerivativeLiabilityMember" order="1.0800" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DerivativeContractTypeDomain" xlink:to="us-gaap_EmbeddedDerivativeFinancialInstrumentsMember" order="1.0900" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_DerivativeInstrumentRiskAxis" xlink:to="us-gaap_DerivativeContractTypeDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DerivativeInstrumentRiskAxis" xlink:to="us-gaap_DerivativeContractTypeDomain_2" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_BankLoanObligationsMember" order="1.0200" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_PreferredStockMember" order="1.0300" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_DerivativeInstrumentRiskAxis" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" order="2.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="3.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" order="100.0000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" order="1.0400" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" order="1.0500" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="aqxp_DecreaseOfEmbeddedDerivativeLiabilitiesForPreferredSharesConvertedIntoCommonStock" order="1.0600" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel3Member" order="1.0100" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="1.0000" priority="2" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_2" order="1.0000" priority="2" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/DisclosureFinancialInstrumentsAdditionalInformation">
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsNatureOfOperations">
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsSignificantAccountingPoliciesTextBlock">
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsSignificantAccountingPoliciesTextBlockPolicies">
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsStockholdersEquityNoteDisclosureTextBlock">
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsCashAndCashEquivalentsDisclosureTextBlock">
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsCashAndCashEquivalentsDisclosureTextBlockTables">
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsDebtDisclosureTextBlock">
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsDebtDisclosureTextBlockTables">
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsCommonStockDisclosureTextBlock">
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsCommonStockDisclosureTextBlockTables">
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsEarningsPerShareTextBlock">
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsEarningsPerShareTextBlockTables">
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsFinancialInstrumentsDisclosureTextBlock">
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsFinancialInstrumentsDisclosureTextBlockTables">
  </definitionLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>10
<FILENAME>aqxp-20140331_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- RR Donnelley Xcelerate Taxonomy Labels Linkbase, based on XBRL 2.1  http://www.rrdonnelley.com/ -->
<!-- Version: 6.21.0 -->
<!-- Round: 5 -->
<!-- Creation date: 2014-05-12T17:22:30Z -->
<!-- Copyright (c) 2005-2013 R.R. Donnelley & Sons Company All Rights Reserved. -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  <labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US" id="id_3828183_928978_1_1">Accounting Policies [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US" id="id_3828183_928978_2_1">Accounting Policies [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccountsAndOtherReceivablesNetCurrent" xlink:label="us-gaap_AccountsAndOtherReceivablesNetCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsAndOtherReceivablesNetCurrent_lbl" xml:lang="en-US" id="id_3828183_937364_1_1">Accounts And Other Receivables Net Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccountsAndOtherReceivablesNetCurrent_lbl" xml:lang="en-US" id="id_3828183_937364_2_1">Accounts and other amounts receivable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsAndOtherReceivablesNetCurrent" xlink:to="us-gaap_AccountsAndOtherReceivablesNetCurrent_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_lbl" xml:lang="en-US" id="id_3828183_935297_1_1">Accounts Payable And Accrued Liabilities Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_lbl" xml:lang="en-US" id="id_3828183_935297_2_1">Accounts payable and accrued liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_AccretionOfWarrantDiscount" xlink:label="aqxp_AccretionOfWarrantDiscount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqxp_AccretionOfWarrantDiscount_lbl" xml:lang="en-US" id="id_3828183_1261606_3_1">Accretion Of Warrant Discount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqxp_AccretionOfWarrantDiscount_lbl" xml:lang="en-US" id="id_3828183_1261606_1_1">Accretion Of Warrant Discount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aqxp_AccretionOfWarrantDiscount_lbl" xml:lang="en-US" id="id_3828183_1261606_2_1">Accretion of warrant discount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqxp_AccretionOfWarrantDiscount" xlink:to="aqxp_AccretionOfWarrantDiscount_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccumulatedDeficitDuringDevelopmentStageMember" xlink:label="us-gaap_AccumulatedDeficitDuringDevelopmentStageMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedDeficitDuringDevelopmentStageMember_lbl" xml:lang="en-US" id="id_3828183_932209_1_1">Accumulated Deficit During Development Stage [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccumulatedDeficitDuringDevelopmentStageMember_lbl" xml:lang="en-US" id="id_3828183_932209_2_1">Accumulated Deficit [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDeficitDuringDevelopmentStageMember" xlink:to="us-gaap_AccumulatedDeficitDuringDevelopmentStageMember_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xml:lang="en-US" id="id_3828183_933723_1_1">Additional Paid In Capital</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xml:lang="en-US" id="id_3828183_933723_2_1">Additional paid-in capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xml:lang="en-US" id="id_3828183_932586_1_1">Additional Paid In Capital [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xml:lang="en-US" id="id_3828183_932586_2_1">Additional Paid-in Capital [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US" id="id_3828183_927352_1_1">Adjustments Noncash Items To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US" id="id_3828183_927352_2_1">Non-cash items and reclassifications:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xml:lang="en-US" id="id_3828183_940280_1_1">Allocated Share Based Compensation Expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xml:lang="en-US" id="id_3828183_940280_2_1">Stock-based compensation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US" id="id_3828183_921947_1_1">Amendment Flag</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US" id="id_3828183_921947_2_1">Amendment Flag</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_AmortizationOfDiscountOnPreferredStock" xlink:label="aqxp_AmortizationOfDiscountOnPreferredStock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqxp_AmortizationOfDiscountOnPreferredStock_lbl" xml:lang="en-US" id="id_3828183_1125851_3_1">Amortization Of Discount On Preferred Stock</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqxp_AmortizationOfDiscountOnPreferredStock_lbl" xml:lang="en-US" id="id_3828183_1125851_1_1">Amortization Of Discount On Preferred Stock</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="aqxp_AmortizationOfDiscountOnPreferredStock_lbl" xml:lang="en-US" id="id_3828183_1125851_14_1">Amortization and extinguishment of remaining discount on preferred shares upon conversion of preferred shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqxp_AmortizationOfDiscountOnPreferredStock" xlink:to="aqxp_AmortizationOfDiscountOnPreferredStock_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AmortizationOfFinancingCosts" xlink:label="us-gaap_AmortizationOfFinancingCosts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfFinancingCosts_lbl" xml:lang="en-US" id="id_3828183_939963_1_1">Amortization Of Financing Costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AmortizationOfFinancingCosts_lbl" xml:lang="en-US" id="id_3828183_939963_2_1">Financing costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfFinancingCosts" xlink:to="us-gaap_AmortizationOfFinancingCosts_lbl"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_AmortizationOfPreferredStockDiscount" xlink:label="aqxp_AmortizationOfPreferredStockDiscount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqxp_AmortizationOfPreferredStockDiscount_lbl" xml:lang="en-US" id="id_3828183_1009534_3_1">Amortization Of Preferred Stock Discount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqxp_AmortizationOfPreferredStockDiscount_lbl" xml:lang="en-US" id="id_3828183_1009534_1_1">Amortization Of Preferred Stock Discount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aqxp_AmortizationOfPreferredStockDiscount_lbl" xml:lang="en-US" id="id_3828183_1009534_2_1">Amortization and extinguishment of remaining discount on preferred stock upon conversion of preferred stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqxp_AmortizationOfPreferredStockDiscount" xlink:to="aqxp_AmortizationOfPreferredStockDiscount_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xml:lang="en-US" id="id_3828183_931668_1_1">Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xml:lang="en-US" id="id_3828183_931668_2_1">Antidilutive securities excluded from the computation of basic and diluted net loss per share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xml:lang="en-US" id="id_3828183_928305_1_1">Antidilutive Securities Excluded From Computation Of Earnings Per Share By Antidilutive Securities [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xml:lang="en-US" id="id_3828183_928305_2_1">Antidilutive Securities [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" xml:lang="en-US" id="id_3828183_923482_1_1">Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" xml:lang="en-US" id="id_3828183_923482_2_1">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_lbl" xml:lang="en-US" id="id_3828183_927484_1_1">Antidilutive Securities Name [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_lbl" xml:lang="en-US" id="id_3828183_927484_2_1">Antidilutive Securities, Name [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain_lbl"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_AquinoxUsaMember" xlink:label="aqxp_AquinoxUsaMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqxp_AquinoxUsaMember_lbl" xml:lang="en-US" id="id_3828183_1258870_3_1">Aquinox USA [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqxp_AquinoxUsaMember_lbl" xml:lang="en-US" id="id_3828183_1258870_1_1">Aquinox Usa [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aqxp_AquinoxUsaMember_lbl" xml:lang="en-US" id="id_3828183_1258870_2_1">Aquinox USA [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqxp_AquinoxUsaMember" xlink:to="aqxp_AquinoxUsaMember_lbl"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_AqxpCanadaMember" xlink:label="aqxp_AqxpCanadaMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqxp_AqxpCanadaMember_lbl" xml:lang="en-US" id="id_3828183_1258858_3_1">AQXP Canada Member</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqxp_AqxpCanadaMember_lbl" xml:lang="en-US" id="id_3828183_1258858_1_1">Aqxp Canada [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aqxp_AqxpCanadaMember_lbl" xml:lang="en-US" id="id_3828183_1258858_2_1">AQXP Canada [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqxp_AqxpCanadaMember" xlink:to="aqxp_AqxpCanadaMember_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US" id="id_3828183_938186_1_1">Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US" id="id_3828183_938186_6_1">Total assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsAbstract_lbl" xml:lang="en-US" id="id_3828183_928450_1_1">Assets [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AssetsAbstract_lbl" xml:lang="en-US" id="id_3828183_928450_2_1">Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US" id="id_3828183_937150_1_1">Assets Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US" id="id_3828183_937150_6_1">Total current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US" id="id_3828183_926145_1_1">Assets Current [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US" id="id_3828183_926145_2_1">Current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BankLoanObligationsMember" xlink:label="us-gaap_BankLoanObligationsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BankLoanObligationsMember_lbl" xml:lang="en-US" id="id_3828183_923761_1_1">Bank Loan Obligations [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_BankLoanObligationsMember_lbl" xml:lang="en-US" id="id_3828183_923761_2_1">Bank Loan [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BankLoanObligationsMember" xlink:to="us-gaap_BankLoanObligationsMember_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xml:lang="en-US" id="id_3828183_930060_1_1">Basis Of Accounting Policy Policy [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xml:lang="en-US" id="id_3828183_930060_2_1">Basis of presentation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis" xlink:label="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis_lbl" xml:lang="en-US" id="id_3828183_928373_1_1">Business Combination Separately Recognized Transactions [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis_lbl" xml:lang="en-US" id="id_3828183_928373_2_1">Business Combination, Separately Recognized Transactions [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis" xlink:to="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain" xlink:label="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_lbl" xml:lang="en-US" id="id_3828183_932435_1_1">Business Combination Separately Recognized Transactions [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_lbl" xml:lang="en-US" id="id_3828183_932435_2_1">Business Combination, Separately Recognized Transactions [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain" xlink:to="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_Cash" xlink:label="us-gaap_Cash"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Cash_lbl" xml:lang="en-US" id="id_3828183_940452_1_1">Cash</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_Cash_lbl" xml:lang="en-US" id="id_3828183_940452_2_1">Cash</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Cash" xlink:to="us-gaap_Cash_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashAndCashEquivalentsAbstract" xlink:label="us-gaap_CashAndCashEquivalentsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAbstract_lbl" xml:lang="en-US" id="id_3828183_932055_1_1">Cash And Cash Equivalents [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CashAndCashEquivalentsAbstract_lbl" xml:lang="en-US" id="id_3828183_932055_2_1">Cash and Cash Equivalents [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US" id="id_3828183_938283_1_1">Cash And Cash Equivalents At Carrying Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US" id="id_3828183_938283_4_1">Cash and cash equivalents, end of period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US" id="id_3828183_938283_5_1">Cash and cash equivalents, beginning of period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US" id="id_3828183_938283_2_1">Cash and cash equivalents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US" id="id_3828183_938283_6_1">Cash and cash equivalents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US" id="id_3828183_938283_12_1">Cash and cash equivalents (Note 4)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashAndCashEquivalentsDisclosureTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsDisclosureTextBlock_lbl" xml:lang="en-US" id="id_3828183_928355_1_1">Cash And Cash Equivalents Disclosure [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CashAndCashEquivalentsDisclosureTextBlock_lbl" xml:lang="en-US" id="id_3828183_928355_2_1">Cash and cash equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsDisclosureTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_lbl" xml:lang="en-US" id="id_3828183_938600_1_1">Cash And Cash Equivalents Period Increase Decrease</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_lbl" xml:lang="en-US" id="id_3828183_938600_6_1">Increase in cash and cash equivalents during the period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashEquivalentsAtCarryingValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashEquivalentsAtCarryingValue_lbl" xml:lang="en-US" id="id_3828183_940698_1_1">Cash Equivalents At Carrying Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CashEquivalentsAtCarryingValue_lbl" xml:lang="en-US" id="id_3828183_940698_2_1">Cash equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashEquivalentsAtCarryingValue_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" xml:lang="en-US" id="id_3828183_925504_1_1">Cash Flow Noncash Investing And Financing Activities Disclosure [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" xml:lang="en-US" id="id_3828183_925504_2_1">Non-cash investing and financing activities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfStockDomain_lbl" xml:lang="en-US" id="id_3828183_932584_1_1">Class Of Stock [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ClassOfStockDomain_lbl" xml:lang="en-US" id="id_3828183_932584_2_1">Class of Stock [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ClassOfStockDomain_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="us-gaap_ClassOfStockLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfStockLineItems_lbl" xml:lang="en-US" id="id_3828183_925604_1_1">Class Of Stock [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ClassOfStockLineItems_lbl" xml:lang="en-US" id="id_3828183_925604_2_1">Class of Stock [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfStockLineItems_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightAxis_lbl" xml:lang="en-US" id="id_3828183_923791_1_1">Class Of Warrant Or Right [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightAxis_lbl" xml:lang="en-US" id="id_3828183_923791_2_1">Class of Warrant or Right [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightAxis_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_lbl" xml:lang="en-US" id="id_3828183_928960_1_1">Class Of Warrant Or Right [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_lbl" xml:lang="en-US" id="id_3828183_928960_2_1">Class of Warrant or Right [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_lbl"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_ClassOfWarrantOrRightExercisable" xlink:label="aqxp_ClassOfWarrantOrRightExercisable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqxp_ClassOfWarrantOrRightExercisable_lbl" xml:lang="en-US" id="id_3828183_1043965_3_1">Class Of Warrant Or Right Exercisable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqxp_ClassOfWarrantOrRightExercisable_lbl" xml:lang="en-US" id="id_3828183_1043965_1_1">Class Of Warrant Or Right Exercisable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aqxp_ClassOfWarrantOrRightExercisable_lbl" xml:lang="en-US" id="id_3828183_1043965_2_1">Warrants exercisable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqxp_ClassOfWarrantOrRightExercisable" xlink:to="aqxp_ClassOfWarrantOrRightExercisable_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights_lbl" xml:lang="en-US" id="id_3828183_932954_1_1">Class Of Warrant Or Right Exercise Price Of Warrants Or Rights</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights_lbl" xml:lang="en-US" id="id_3828183_932954_2_1">Warrants to purchase per share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights_lbl"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_ClassOfWarrantOrRightExpirationYear" xlink:label="aqxp_ClassOfWarrantOrRightExpirationYear"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqxp_ClassOfWarrantOrRightExpirationYear_lbl" xml:lang="en-US" id="id_3828183_964356_3_1">Class Of Warrant Or Right Expiration Year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqxp_ClassOfWarrantOrRightExpirationYear_lbl" xml:lang="en-US" id="id_3828183_964356_1_1">Class Of Warrant Or Right Expiration Year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aqxp_ClassOfWarrantOrRightExpirationYear_lbl" xml:lang="en-US" id="id_3828183_964356_2_1">Warrant expire</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqxp_ClassOfWarrantOrRightExpirationYear" xlink:to="aqxp_ClassOfWarrantOrRightExpirationYear_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xml:lang="en-US" id="id_3828183_925087_1_1">Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xml:lang="en-US" id="id_3828183_925087_2_1">Warrants to purchase shares of stock, shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xml:lang="en-US" id="id_3828183_929417_1_1">Class Of Warrant Or Right Outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xml:lang="en-US" id="id_3828183_929417_2_1">Warrants outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockConversionBasis" xlink:label="us-gaap_CommonStockConversionBasis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockConversionBasis_lbl" xml:lang="en-US" id="id_3828183_924960_1_1">Common Stock Conversion Basis</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockConversionBasis_lbl" xml:lang="en-US" id="id_3828183_924960_2_1">Common stock shares conversion, description</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockConversionBasis" xlink:to="us-gaap_CommonStockConversionBasis_lbl"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_CommonStockDisclosureTextBlock" xlink:label="aqxp_CommonStockDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqxp_CommonStockDisclosureTextBlock_lbl" xml:lang="en-US" id="id_3828183_985995_3_1">Common Stock Disclosure [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqxp_CommonStockDisclosureTextBlock_lbl" xml:lang="en-US" id="id_3828183_985995_1_1">Common Stock Disclosure [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aqxp_CommonStockDisclosureTextBlock_lbl" xml:lang="en-US" id="id_3828183_985995_2_1">Common stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqxp_CommonStockDisclosureTextBlock" xlink:to="aqxp_CommonStockDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US" id="id_3828183_930643_1_1">Common Stock [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US" id="id_3828183_930643_2_1">Common Stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:label="us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_lbl" xml:lang="en-US" id="id_3828183_932770_1_1">Common Stock Number Of Shares Par Value And Other Disclosures [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_lbl" xml:lang="en-US" id="id_3828183_932770_2_1">Common stock (Note 6)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:to="us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US" id="id_3828183_931741_1_1">Common Stock Par Or Stated Value Per Share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US" id="id_3828183_931741_2_1">Common stock, par value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_CommonStockReservedForIssuanceDescription" xlink:label="aqxp_CommonStockReservedForIssuanceDescription"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqxp_CommonStockReservedForIssuanceDescription_lbl" xml:lang="en-US" id="id_3828183_1193058_3_1">Common Stock Reserved For Issuance Description</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqxp_CommonStockReservedForIssuanceDescription_lbl" xml:lang="en-US" id="id_3828183_1193058_1_1">Common Stock Reserved For Issuance Description</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aqxp_CommonStockReservedForIssuanceDescription_lbl" xml:lang="en-US" id="id_3828183_1193058_2_1">Shares of common stock reserved for issuance description</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqxp_CommonStockReservedForIssuanceDescription" xlink:to="aqxp_CommonStockReservedForIssuanceDescription_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US" id="id_3828183_930676_1_1">Common Stock Shares Authorized</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US" id="id_3828183_930676_2_1">Common stock, shares authorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US" id="id_3828183_925763_1_1">Common Stock Shares Issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US" id="id_3828183_925763_2_1">Common stock, shares issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US" id="id_3828183_923588_1_1">Common Stock Shares Outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US" id="id_3828183_923588_2_1">Common stock outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US" id="id_3828183_923588_12_1">Common stock, shares outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US" id="id_3828183_935685_1_1">Common Stock Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US" id="id_3828183_935685_2_1">Common stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xml:lang="en-US" id="id_3828183_933343_1_1">Comprehensive Income Net Of Tax</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xml:lang="en-US" id="id_3828183_933343_2_1">Net loss and comprehensive loss incurred in development stage</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xml:lang="en-US" id="id_3828183_933343_6_1">Net loss and comprehensive loss incurred in the development stage</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xml:lang="en-US" id="id_3828183_933343_12_1">Net loss and comprehensive loss incurred in the development stage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax_lbl"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_ConversionOfPreferredStockIntoCommonStock" xlink:label="aqxp_ConversionOfPreferredStockIntoCommonStock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqxp_ConversionOfPreferredStockIntoCommonStock_lbl" xml:lang="en-US" id="id_3828183_960214_3_1">Conversion Of Preferred Stock Into Common Stock</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqxp_ConversionOfPreferredStockIntoCommonStock_lbl" xml:lang="en-US" id="id_3828183_960214_1_1">Conversion Of Preferred Stock Into Common Stock</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aqxp_ConversionOfPreferredStockIntoCommonStock_lbl" xml:lang="en-US" id="id_3828183_960214_2_1">Conversion of preferred stock into Aquinox USA common stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqxp_ConversionOfPreferredStockIntoCommonStock" xlink:to="aqxp_ConversionOfPreferredStockIntoCommonStock_lbl"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_ConversionOfPreferredStockIntoCommonStockShares" xlink:label="aqxp_ConversionOfPreferredStockIntoCommonStockShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqxp_ConversionOfPreferredStockIntoCommonStockShares_lbl" xml:lang="en-US" id="id_3828183_1056320_3_1">Conversion Of Preferred Stock Into Common Stock Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqxp_ConversionOfPreferredStockIntoCommonStockShares_lbl" xml:lang="en-US" id="id_3828183_1056320_1_1">Conversion Of Preferred Stock Into Common Stock Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aqxp_ConversionOfPreferredStockIntoCommonStockShares_lbl" xml:lang="en-US" id="id_3828183_1056320_2_1">Conversion of preferred stock into Aquinox USA common stock, Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqxp_ConversionOfPreferredStockIntoCommonStockShares" xlink:to="aqxp_ConversionOfPreferredStockIntoCommonStockShares_lbl"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_ConversionOfPreferredStockToCommonStockMember" xlink:label="aqxp_ConversionOfPreferredStockToCommonStockMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqxp_ConversionOfPreferredStockToCommonStockMember_lbl" xml:lang="en-US" id="id_3828183_1204322_3_1">Conversion Of Preferred Stock To Common Stock [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqxp_ConversionOfPreferredStockToCommonStockMember_lbl" xml:lang="en-US" id="id_3828183_1204322_1_1">Conversion Of Preferred Stock To Common Stock [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aqxp_ConversionOfPreferredStockToCommonStockMember_lbl" xml:lang="en-US" id="id_3828183_1204322_2_1">Conversion of Redeemable Convertible Preferred Stock to Common Stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqxp_ConversionOfPreferredStockToCommonStockMember" xlink:to="aqxp_ConversionOfPreferredStockToCommonStockMember_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConversionOfStockSharesConverted1" xlink:label="us-gaap_ConversionOfStockSharesConverted1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConversionOfStockSharesConverted1_lbl" xml:lang="en-US" id="id_3828183_926028_1_1">Conversion Of Stock Shares Converted 1</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ConversionOfStockSharesConverted1_lbl" xml:lang="en-US" id="id_3828183_926028_2_1">Common stock shares converted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockSharesConverted1" xlink:to="us-gaap_ConversionOfStockSharesConverted1_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConvertibleCommonStockMember" xlink:label="us-gaap_ConvertibleCommonStockMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertibleCommonStockMember_lbl" xml:lang="en-US" id="id_3828183_932064_1_1">Convertible Common Stock [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ConvertibleCommonStockMember_lbl" xml:lang="en-US" id="id_3828183_932064_2_1">Exchangeable Common Stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleCommonStockMember" xlink:to="us-gaap_ConvertibleCommonStockMember_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConvertiblePreferredStockMember" xlink:label="us-gaap_ConvertiblePreferredStockMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertiblePreferredStockMember_lbl" xml:lang="en-US" id="id_3828183_932377_1_1">Convertible Preferred Stock [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ConvertiblePreferredStockMember_lbl" xml:lang="en-US" id="id_3828183_932377_2_1">Exchangeable Preferred Shares [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertiblePreferredStockMember" xlink:to="us-gaap_ConvertiblePreferredStockMember_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:label="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_lbl" xml:lang="en-US" id="id_3828183_931255_1_1">Convertible Preferred Stock Shares Issued Upon Conversion</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_lbl" xml:lang="en-US" id="id_3828183_931255_2_1">Convertible preferred stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:to="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_lbl"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_ConvertiblePreferredStocksMember" xlink:label="aqxp_ConvertiblePreferredStocksMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqxp_ConvertiblePreferredStocksMember_lbl" xml:lang="en-US" id="id_3828183_1263590_3_1">Convertible Preferred Stocks [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqxp_ConvertiblePreferredStocksMember_lbl" xml:lang="en-US" id="id_3828183_1263590_1_1">Convertible Preferred Stocks [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aqxp_ConvertiblePreferredStocksMember_lbl" xml:lang="en-US" id="id_3828183_1263590_2_1">Convertible Preferred Stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqxp_ConvertiblePreferredStocksMember" xlink:to="aqxp_ConvertiblePreferredStocksMember_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConvertiblePreferredStockTermsOfConversion" xlink:label="us-gaap_ConvertiblePreferredStockTermsOfConversion"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertiblePreferredStockTermsOfConversion_lbl" xml:lang="en-US" id="id_3828183_923251_1_1">Convertible Preferred Stock Terms Of Conversion</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ConvertiblePreferredStockTermsOfConversion_lbl" xml:lang="en-US" id="id_3828183_923251_2_1">Preferred shares conversion, description</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertiblePreferredStockTermsOfConversion" xlink:to="us-gaap_ConvertiblePreferredStockTermsOfConversion_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US" id="id_3828183_922004_1_1">Current Fiscal Year End Date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US" id="id_3828183_922004_2_1">Current Fiscal Year End Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtDisclosureAbstract_lbl" xml:lang="en-US" id="id_3828183_928741_1_1">Debt Disclosure [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtDisclosureAbstract_lbl" xml:lang="en-US" id="id_3828183_928741_2_1">Debt Disclosure [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtDisclosureAbstract_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="us-gaap_DebtDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtDisclosureTextBlock_lbl" xml:lang="en-US" id="id_3828183_925940_1_1">Debt Disclosure [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtDisclosureTextBlock_lbl" xml:lang="en-US" id="id_3828183_925940_2_1">Loan facility</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureTextBlock" xlink:to="us-gaap_DebtDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_DecreaseOfEmbeddedDerivativeLiabilitiesForPreferredSharesConvertedIntoCommonStock" xlink:label="aqxp_DecreaseOfEmbeddedDerivativeLiabilitiesForPreferredSharesConvertedIntoCommonStock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqxp_DecreaseOfEmbeddedDerivativeLiabilitiesForPreferredSharesConvertedIntoCommonStock_lbl" xml:lang="en-US" id="id_3828183_1235383_3_1">Decrease Of Embedded Derivative Liabilities For Preferred Shares Converted Into Common Stock</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqxp_DecreaseOfEmbeddedDerivativeLiabilitiesForPreferredSharesConvertedIntoCommonStock_lbl" xml:lang="en-US" id="id_3828183_1235383_1_1">Decrease Of Embedded Derivative Liabilities For Preferred Shares Converted Into Common Stock</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="aqxp_DecreaseOfEmbeddedDerivativeLiabilitiesForPreferredSharesConvertedIntoCommonStock_lbl" xml:lang="en-US" id="id_3828183_1235383_14_1">Derecognition of liabilities upon preferred stock conversion to common stock conversion</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqxp_DecreaseOfEmbeddedDerivativeLiabilitiesForPreferredSharesConvertedIntoCommonStock" xlink:to="aqxp_DecreaseOfEmbeddedDerivativeLiabilitiesForPreferredSharesConvertedIntoCommonStock_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualExercisePrice" xlink:label="us-gaap_DeferredCompensationArrangementWithIndividualExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredCompensationArrangementWithIndividualExercisePrice_lbl" xml:lang="en-US" id="id_3828183_931540_1_1">Deferred Compensation Arrangement With Individual Exercise Price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredCompensationArrangementWithIndividualExercisePrice_lbl" xml:lang="en-US" id="id_3828183_931540_2_1">Exercise price per share of options granted to non-employee directors</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredCompensationArrangementWithIndividualExercisePrice" xlink:to="us-gaap_DeferredCompensationArrangementWithIndividualExercisePrice_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredOfferingCosts" xlink:label="us-gaap_DeferredOfferingCosts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredOfferingCosts_lbl" xml:lang="en-US" id="id_3828183_937911_1_1">Deferred Offering Costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredOfferingCosts_lbl" xml:lang="en-US" id="id_3828183_937911_2_1">Deferred offering costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredOfferingCosts" xlink:to="us-gaap_DeferredOfferingCosts_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxLiabilitiesNoncurrent" xlink:label="us-gaap_DeferredTaxLiabilitiesNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxLiabilitiesNoncurrent_lbl" xml:lang="en-US" id="id_3828183_935808_1_1">Deferred Tax Liabilities Noncurrent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxLiabilitiesNoncurrent_lbl" xml:lang="en-US" id="id_3828183_935808_2_1">Accrued tax payable on preferred stock</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DeferredTaxLiabilitiesNoncurrent_lbl" xml:lang="en-US" id="id_3828183_935808_12_1">Accrued tax payable on preferred stock (Note 3)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesNoncurrent" xlink:to="us-gaap_DeferredTaxLiabilitiesNoncurrent_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepreciationDepletionAndAmortization_lbl" xml:lang="en-US" id="id_3828183_939791_1_1">Depreciation Depletion And Amortization</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DepreciationDepletionAndAmortization_lbl" xml:lang="en-US" id="id_3828183_939791_2_1">Amortization</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationDepletionAndAmortization" xlink:to="us-gaap_DepreciationDepletionAndAmortization_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="us-gaap_DerivativeContractTypeDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeContractTypeDomain_lbl" xml:lang="en-US" id="id_3828183_928318_1_1">Derivative Contract Type [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DerivativeContractTypeDomain_lbl" xml:lang="en-US" id="id_3828183_928318_2_1">Derivative Contract [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeContractTypeDomain" xlink:to="us-gaap_DerivativeContractTypeDomain_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="us-gaap_DerivativeInstrumentRiskAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeInstrumentRiskAxis_lbl" xml:lang="en-US" id="id_3828183_929665_1_1">Derivative Instrument Risk [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DerivativeInstrumentRiskAxis_lbl" xml:lang="en-US" id="id_3828183_929665_2_1">Derivative Instrument [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeInstrumentRiskAxis" xlink:to="us-gaap_DerivativeInstrumentRiskAxis_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DerivativeLiabilitiesNoncurrent" xlink:label="us-gaap_DerivativeLiabilitiesNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeLiabilitiesNoncurrent_lbl" xml:lang="en-US" id="id_3828183_935603_1_1">Derivative Liabilities Noncurrent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DerivativeLiabilitiesNoncurrent_lbl" xml:lang="en-US" id="id_3828183_935603_2_1">Warrant liabilities (Note 8)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeLiabilitiesNoncurrent" xlink:to="us-gaap_DerivativeLiabilitiesNoncurrent_lbl"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_DerivativeLiabilitiesNoncurrentRedemptionOption" xlink:label="aqxp_DerivativeLiabilitiesNoncurrentRedemptionOption"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqxp_DerivativeLiabilitiesNoncurrentRedemptionOption_lbl" xml:lang="en-US" id="id_3828183_1262827_3_1">Derivative Liabilities Noncurrent Redemption Option</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqxp_DerivativeLiabilitiesNoncurrentRedemptionOption_lbl" xml:lang="en-US" id="id_3828183_1262827_1_1">Derivative Liabilities Noncurrent Redemption Option</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aqxp_DerivativeLiabilitiesNoncurrentRedemptionOption_lbl" xml:lang="en-US" id="id_3828183_1262827_2_1">Redemption option on preferred stock (Note 3)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqxp_DerivativeLiabilitiesNoncurrentRedemptionOption" xlink:to="aqxp_DerivativeLiabilitiesNoncurrentRedemptionOption_lbl"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_DescriptionOfPercentageOfRealizationOfTaxBenefitUponSettlement" xlink:label="aqxp_DescriptionOfPercentageOfRealizationOfTaxBenefitUponSettlement"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqxp_DescriptionOfPercentageOfRealizationOfTaxBenefitUponSettlement_lbl" xml:lang="en-US" id="id_3828183_1110264_3_1">Description Of Percentage Of Realization Of Tax Benefit Upon Settlement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqxp_DescriptionOfPercentageOfRealizationOfTaxBenefitUponSettlement_lbl" xml:lang="en-US" id="id_3828183_1110264_1_1">Description Of Percentage Of Realization Of Tax Benefit Upon Settlement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aqxp_DescriptionOfPercentageOfRealizationOfTaxBenefitUponSettlement_lbl" xml:lang="en-US" id="id_3828183_1110264_2_1">Tax benefits realized upon ultimate settlement, description</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqxp_DescriptionOfPercentageOfRealizationOfTaxBenefitUponSettlement" xlink:to="aqxp_DescriptionOfPercentageOfRealizationOfTaxBenefitUponSettlement_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage" xlink:label="us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage_lbl" xml:lang="en-US" id="id_3828183_939146_1_1">Development Stage Enterprise Deficit Accumulated During Development Stage</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage_lbl" xml:lang="en-US" id="id_3828183_939146_14_1">Deficit accumulated in the development stage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage" xlink:to="us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xml:lang="en-US" id="id_3828183_930617_1_1">Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xml:lang="en-US" id="id_3828183_930617_2_1">Disclosure of Compensation Related Costs, Share-based Payments [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_DiscountOnIssuanceOfWarrants" xlink:label="aqxp_DiscountOnIssuanceOfWarrants"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqxp_DiscountOnIssuanceOfWarrants_lbl" xml:lang="en-US" id="id_3828183_1247721_3_1">Discount on Issuance of Warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqxp_DiscountOnIssuanceOfWarrants_lbl" xml:lang="en-US" id="id_3828183_1247721_1_1">Discount On Issuance Of Warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="aqxp_DiscountOnIssuanceOfWarrants_lbl" xml:lang="en-US" id="id_3828183_1247721_14_1">Warrant discount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqxp_DiscountOnIssuanceOfWarrants" xlink:to="aqxp_DiscountOnIssuanceOfWarrants_lbl"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_DocumentAndEntityInformationAbstract" xlink:label="aqxp_DocumentAndEntityInformationAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqxp_DocumentAndEntityInformationAbstract_lbl" xml:lang="en-US" id="id_3828183_951207_3_1">Document And Entity Information [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqxp_DocumentAndEntityInformationAbstract_lbl" xml:lang="en-US" id="id_3828183_951207_1_1">Document And Entity Information [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aqxp_DocumentAndEntityInformationAbstract_lbl" xml:lang="en-US" id="id_3828183_951207_2_1">Document And Entity Information [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqxp_DocumentAndEntityInformationAbstract" xlink:to="aqxp_DocumentAndEntityInformationAbstract_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US" id="id_3828183_922019_1_1">Document Fiscal Period Focus</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US" id="id_3828183_922019_2_1">Document Fiscal Period Focus</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US" id="id_3828183_921974_1_1">Document Fiscal Year Focus</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US" id="id_3828183_921974_2_1">Document Fiscal Year Focus</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US" id="id_3828183_921989_1_1">Document Period End Date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US" id="id_3828183_921989_2_1">Document Period End Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US" id="id_3828183_921984_1_1">Document Type</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentType_lbl" xml:lang="en-US" id="id_3828183_921984_2_1">Document Type</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareAbstract_lbl" xml:lang="en-US" id="id_3828183_929815_1_1">Earnings Per Share [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EarningsPerShareAbstract_lbl" xml:lang="en-US" id="id_3828183_929815_2_1">Earnings Per Share [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareAbstract_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xml:lang="en-US" id="id_3828183_925621_1_1">Earnings Per Share Basic</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xml:lang="en-US" id="id_3828183_925621_2_1">Net loss per share attributable to common stockholders-basic</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xml:lang="en-US" id="id_3828183_929231_1_1">Earnings Per Share Basic And Diluted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xml:lang="en-US" id="id_3828183_929231_2_1">Basic and diluted loss per common stock (Note 7)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasicAndDiluted" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xml:lang="en-US" id="id_3828183_924397_1_1">Earnings Per Share Diluted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xml:lang="en-US" id="id_3828183_924397_2_1">Net loss per share attributable to common stockholders-diluted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xml:lang="en-US" id="id_3828183_931897_1_1">Earnings Per Share Policy [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xml:lang="en-US" id="id_3828183_931897_2_1">Loss per share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="us-gaap_EarningsPerShareTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl" xml:lang="en-US" id="id_3828183_930641_1_1">Earnings Per Share [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl" xml:lang="en-US" id="id_3828183_930641_2_1">Net loss per share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareTextBlock" xlink:to="us-gaap_EarningsPerShareTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EmbeddedDerivativeFinancialInstrumentsMember" xlink:label="us-gaap_EmbeddedDerivativeFinancialInstrumentsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmbeddedDerivativeFinancialInstrumentsMember_lbl" xml:lang="en-US" id="id_3828183_933016_1_1">Embedded Derivative Financial Instruments [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EmbeddedDerivativeFinancialInstrumentsMember_lbl" xml:lang="en-US" id="id_3828183_933016_2_1">Embedded Derivative Liabilities [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmbeddedDerivativeFinancialInstrumentsMember" xlink:to="us-gaap_EmbeddedDerivativeFinancialInstrumentsMember_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeStockOptionMember_lbl" xml:lang="en-US" id="id_3828183_924898_1_1">Employee Stock Option [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EmployeeStockOptionMember_lbl" xml:lang="en-US" id="id_3828183_924898_2_1">Outstanding Stock Options [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeStockOptionMember" xlink:to="us-gaap_EmployeeStockOptionMember_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US" id="id_3828183_921997_1_1">Entity Central Index Key</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US" id="id_3828183_921997_2_1">Entity Central Index Key</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US" id="id_3828183_922042_1_1">Entity Common Stock Shares Outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US" id="id_3828183_922042_2_1">Entity Common Stock, Shares Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityDomain_lbl" xml:lang="en-US" id="id_3828183_921970_1_1">Entity [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityDomain_lbl" xml:lang="en-US" id="id_3828183_921970_2_1">Entity [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityDomain" xlink:to="dei_EntityDomain_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US" id="id_3828183_921955_1_1">Entity Filer Category</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US" id="id_3828183_921955_2_1">Entity Filer Category</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityIncorporationDateOfIncorporation" xlink:label="dei_EntityIncorporationDateOfIncorporation"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationDateOfIncorporation_lbl" xml:lang="en-US" id="id_3828183_921996_1_1">Entity Incorporation Date Of Incorporation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityIncorporationDateOfIncorporation_lbl" xml:lang="en-US" id="id_3828183_921996_2_1">Date of incorporation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationDateOfIncorporation" xlink:to="dei_EntityIncorporationDateOfIncorporation_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US" id="id_3828183_921937_1_1">Entity Registrant Name</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US" id="id_3828183_921937_2_1">Entity Registrant Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityAbstract_lbl" xml:lang="en-US" id="id_3828183_932367_1_1">Equity [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EquityAbstract_lbl" xml:lang="en-US" id="id_3828183_932367_2_1">Equity [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_EquityAbstract_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityComponentDomain_lbl" xml:lang="en-US" id="id_3828183_927325_1_1">Equity Component [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EquityComponentDomain_lbl" xml:lang="en-US" id="id_3828183_927325_2_1">Equity Component [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_EquityComponentDomain_lbl"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_EquityIncentivePlanTwoThousandSixMember" xlink:label="aqxp_EquityIncentivePlanTwoThousandSixMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqxp_EquityIncentivePlanTwoThousandSixMember_lbl" xml:lang="en-US" id="id_3828183_992678_3_1">Equity Incentive Plan Two Thousand Six [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqxp_EquityIncentivePlanTwoThousandSixMember_lbl" xml:lang="en-US" id="id_3828183_992678_1_1">Equity Incentive Plan Two Thousand Six [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aqxp_EquityIncentivePlanTwoThousandSixMember_lbl" xml:lang="en-US" id="id_3828183_992678_2_1">Equity Incentive Plan 2006 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqxp_EquityIncentivePlanTwoThousandSixMember" xlink:to="aqxp_EquityIncentivePlanTwoThousandSixMember_lbl"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_ExtinguishmentOfDiscountOnTemporaryEquity" xlink:label="aqxp_ExtinguishmentOfDiscountOnTemporaryEquity"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqxp_ExtinguishmentOfDiscountOnTemporaryEquity_lbl" xml:lang="en-US" id="id_3828183_1262829_3_1">Extinguishment of bifurcated redemption feature of preferred shares.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqxp_ExtinguishmentOfDiscountOnTemporaryEquity_lbl" xml:lang="en-US" id="id_3828183_1262829_1_1">Extinguishment Of Discount On Temporary Equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aqxp_ExtinguishmentOfDiscountOnTemporaryEquity_lbl" xml:lang="en-US" id="id_3828183_1262829_2_1">Derivative liability for redemption option on preferred stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqxp_ExtinguishmentOfDiscountOnTemporaryEquity" xlink:to="aqxp_ExtinguishmentOfDiscountOnTemporaryEquity_lbl"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_ExtinguishmentOfRemainingShareIssuanceCostsDueToConversionOfPreferredStock" xlink:label="aqxp_ExtinguishmentOfRemainingShareIssuanceCostsDueToConversionOfPreferredStock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqxp_ExtinguishmentOfRemainingShareIssuanceCostsDueToConversionOfPreferredStock_lbl" xml:lang="en-US" id="id_3828183_1262939_3_1">Extinguishment Of Remaining Share Issuance Costs Due To Conversion Of Preferred Stock</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqxp_ExtinguishmentOfRemainingShareIssuanceCostsDueToConversionOfPreferredStock_lbl" xml:lang="en-US" id="id_3828183_1262939_1_1">Extinguishment Of Remaining Share Issuance Costs Due To Conversion Of Preferred Stock</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aqxp_ExtinguishmentOfRemainingShareIssuanceCostsDueToConversionOfPreferredStock_lbl" xml:lang="en-US" id="id_3828183_1262939_2_1">Extinguishment of remaining share issuance costs, warrant discount, redemption option and related tax payable due to conversion of preferred stock</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="aqxp_ExtinguishmentOfRemainingShareIssuanceCostsDueToConversionOfPreferredStock_lbl" xml:lang="en-US" id="id_3828183_1262939_14_1">Extinguishment of remaining share issuance costs due to conversion of preferred stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqxp_ExtinguishmentOfRemainingShareIssuanceCostsDueToConversionOfPreferredStock" xlink:to="aqxp_ExtinguishmentOfRemainingShareIssuanceCostsDueToConversionOfPreferredStock_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" xml:lang="en-US" id="id_3828183_932133_1_1">Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" xml:lang="en-US" id="id_3828183_932133_2_1">Fair Value Measurements, Recurring and Nonrecurring [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_lbl" xml:lang="en-US" id="id_3828183_928243_1_1">Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_lbl" xml:lang="en-US" id="id_3828183_928243_2_1">Fair Value of Significant Unobservable Inputs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xml:lang="en-US" id="id_3828183_929790_1_1">Fair Value By Fair Value Hierarchy Level [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xml:lang="en-US" id="id_3828183_929790_2_1">Fair Value, Hierarchy [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueDisclosuresAbstract_lbl" xml:lang="en-US" id="id_3828183_930808_1_1">Fair Value Disclosures [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueDisclosuresAbstract_lbl" xml:lang="en-US" id="id_3828183_930808_2_1">Fair Value Disclosures [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresAbstract_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel3Member_lbl" xml:lang="en-US" id="id_3828183_929831_1_1">Fair Value Inputs Level 3 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueInputsLevel3Member_lbl" xml:lang="en-US" id="id_3828183_929831_2_1">Level 3 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel3Member" xlink:to="us-gaap_FairValueInputsLevel3Member_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_lbl" xml:lang="en-US" id="id_3828183_925195_1_1">Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_lbl" xml:lang="en-US" id="id_3828183_925195_2_1">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl" xml:lang="en-US" id="id_3828183_930398_1_1">Fair Value Measurements Fair Value Hierarchy [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl" xml:lang="en-US" id="id_3828183_930398_2_1">Fair Value Hierarchy [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_lbl" xml:lang="en-US" id="id_3828183_931594_1_1">Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_lbl" xml:lang="en-US" id="id_3828183_931594_2_1">Change in fair value of derivative liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl" xml:lang="en-US" id="id_3828183_934561_1_1">Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl" xml:lang="en-US" id="id_3828183_934561_4_1">Ending balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl" xml:lang="en-US" id="id_3828183_934561_5_1">Beginning balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationTransfersIntoLevel3" xlink:label="us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationTransfersIntoLevel3"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationTransfersIntoLevel3_lbl" xml:lang="en-US" id="id_3828183_937578_1_1">Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Transfers Into Level 3</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationTransfersIntoLevel3_lbl" xml:lang="en-US" id="id_3828183_937578_2_1">Transfers between Levels 1,2 and 3</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationTransfersIntoLevel3" xlink:to="us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationTransfersIntoLevel3_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xml:lang="en-US" id="id_3828183_931938_1_1">Fair Value Of Financial Instruments Policy</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xml:lang="en-US" id="id_3828183_931938_2_1">Derivative liabilities and fair value of financial instruments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:label="us-gaap_FinancialInstrumentsDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinancialInstrumentsDisclosureTextBlock_lbl" xml:lang="en-US" id="id_3828183_932819_1_1">Financial Instruments Disclosure [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FinancialInstrumentsDisclosureTextBlock_lbl" xml:lang="en-US" id="id_3828183_932819_2_1">Financial instruments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:to="us-gaap_FinancialInstrumentsDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_lbl" xml:lang="en-US" id="id_3828183_933074_1_1">Foreign Currency Transaction Gain Loss Before Tax</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_lbl" xml:lang="en-US" id="id_3828183_933074_2_1">Foreign exchange loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:to="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossUnrealized"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossUnrealized_lbl" xml:lang="en-US" id="id_3828183_935350_1_1">Foreign Currency Transaction Gain Loss Unrealized</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossUnrealized_lbl" xml:lang="en-US" id="id_3828183_935350_14_1">Foreign exchange loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:to="us-gaap_ForeignCurrencyTransactionGainLossUnrealized_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:label="us-gaap_GainLossOnDerivativeInstrumentsNetPretax"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainLossOnDerivativeInstrumentsNetPretax_lbl" xml:lang="en-US" id="id_3828183_935162_1_1">Gain Loss On Derivative Instruments Net Pretax</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_GainLossOnDerivativeInstrumentsNetPretax_lbl" xml:lang="en-US" id="id_3828183_935162_2_1">Change in fair value of derivative liabilities (Note 8)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_GainLossOnDerivativeInstrumentsNetPretax_lbl" xml:lang="en-US" id="id_3828183_935162_14_1">Change in fair value of derivative liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:to="us-gaap_GainLossOnDerivativeInstrumentsNetPretax_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment_lbl" xml:lang="en-US" id="id_3828183_933543_1_1">Gain Loss On Sale Of Property Plant Equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment_lbl" xml:lang="en-US" id="id_3828183_933543_2_1">Sale of equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment_lbl" xml:lang="en-US" id="id_3828183_933543_14_1">Gain on sale of equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:to="us-gaap_GainLossOnSaleOfPropertyPlantEquipment_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl" xml:lang="en-US" id="id_3828183_934736_1_1">Gains Losses On Extinguishment Of Debt</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl" xml:lang="en-US" id="id_3828183_934736_2_1">Term loan, loss on extinguishment of debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xml:lang="en-US" id="id_3828183_937408_1_1">General And Administrative Expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xml:lang="en-US" id="id_3828183_937408_2_1">General and administrative</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xml:lang="en-US" id="id_3828183_933538_1_1">Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xml:lang="en-US" id="id_3828183_933538_6_1">Net loss before income taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xml:lang="en-US" id="id_3828183_927850_1_1">Income Statement [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xml:lang="en-US" id="id_3828183_927850_2_1">Income Statement [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xml:lang="en-US" id="id_3828183_940829_1_1">Income Tax Expense Benefit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xml:lang="en-US" id="id_3828183_940829_14_1">Income tax recovery</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_IncomeTaxExpenseOnPreferredStock" xlink:label="aqxp_IncomeTaxExpenseOnPreferredStock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqxp_IncomeTaxExpenseOnPreferredStock_lbl" xml:lang="en-US" id="id_3828183_1262832_3_1">Canadian tax with respect to Canadian corporation taxable preferred shares and their liquidation rights.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqxp_IncomeTaxExpenseOnPreferredStock_lbl" xml:lang="en-US" id="id_3828183_1262832_1_1">Income Tax Expense On Preferred Stock</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="aqxp_IncomeTaxExpenseOnPreferredStock_lbl" xml:lang="en-US" id="id_3828183_1262832_14_1">Accrual of tax payable on preferred stock</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="aqxp_IncomeTaxExpenseOnPreferredStock_lbl" xml:lang="en-US" id="id_3828183_1262832_18_1">Tax expense on preferred stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqxp_IncomeTaxExpenseOnPreferredStock" xlink:to="aqxp_IncomeTaxExpenseOnPreferredStock_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xml:lang="en-US" id="id_3828183_932576_1_1">Income Tax Policy [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xml:lang="en-US" id="id_3828183_932576_2_1">Taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables" xlink:label="us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables_lbl" xml:lang="en-US" id="id_3828183_934873_1_1">Increase Decrease In Accounts And Other Receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables_lbl" xml:lang="en-US" id="id_3828183_934873_14_1">Accounts and other amounts receivable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables" xlink:to="us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xml:lang="en-US" id="id_3828183_936903_1_1">Increase Decrease In Accounts Payable And Accrued Liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xml:lang="en-US" id="id_3828183_936903_2_1">Accounts payable and accrued liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xml:lang="en-US" id="id_3828183_924543_1_1">Increase Decrease In Operating Capital [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xml:lang="en-US" id="id_3828183_924543_2_1">Change in non-cash working capital:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xml:lang="en-US" id="id_3828183_933216_1_1">Increase Decrease In Prepaid Deferred Expense And Other Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xml:lang="en-US" id="id_3828183_933216_14_1">Prepayments and deposits</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_IncrementalCommonSharesAttributableToCommonStockWarrants" xlink:label="aqxp_IncrementalCommonSharesAttributableToCommonStockWarrants"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqxp_IncrementalCommonSharesAttributableToCommonStockWarrants_lbl" xml:lang="en-US" id="id_3828183_1046590_3_1">Incremental Common Shares Attributable To Common Stock Warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqxp_IncrementalCommonSharesAttributableToCommonStockWarrants_lbl" xml:lang="en-US" id="id_3828183_1046590_1_1">Incremental Common Shares Attributable To Common Stock Warrants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aqxp_IncrementalCommonSharesAttributableToCommonStockWarrants_lbl" xml:lang="en-US" id="id_3828183_1046590_2_1">Common stock warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqxp_IncrementalCommonSharesAttributableToCommonStockWarrants" xlink:to="aqxp_IncrementalCommonSharesAttributableToCommonStockWarrants_lbl"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_IncrementalCommonSharesAttributableToStockOptions" xlink:label="aqxp_IncrementalCommonSharesAttributableToStockOptions"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqxp_IncrementalCommonSharesAttributableToStockOptions_lbl" xml:lang="en-US" id="id_3828183_1101613_3_1">Incremental Common Shares Attributable To Stock Options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqxp_IncrementalCommonSharesAttributableToStockOptions_lbl" xml:lang="en-US" id="id_3828183_1101613_1_1">Incremental Common Shares Attributable To Stock Options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aqxp_IncrementalCommonSharesAttributableToStockOptions_lbl" xml:lang="en-US" id="id_3828183_1101613_2_1">Stock options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqxp_IncrementalCommonSharesAttributableToStockOptions" xlink:to="aqxp_IncrementalCommonSharesAttributableToStockOptions_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestExpense_lbl" xml:lang="en-US" id="id_3828183_938923_1_1">Interest Expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_InterestExpense_lbl" xml:lang="en-US" id="id_3828183_938923_14_1">Bank charges and financing costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="us-gaap_InterestExpense_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_InterestPaid" xlink:label="us-gaap_InterestPaid"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPaid_lbl" xml:lang="en-US" id="id_3828183_935259_1_1">Interest Paid</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InterestPaid_lbl" xml:lang="en-US" id="id_3828183_935259_2_1">Interest paid</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaid" xlink:to="us-gaap_InterestPaid_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="us-gaap_InvestmentIncomeInterest"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentIncomeInterest_lbl" xml:lang="en-US" id="id_3828183_934440_1_1">Investment Income Interest</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InvestmentIncomeInterest_lbl" xml:lang="en-US" id="id_3828183_934440_2_1">Interest income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentIncomeInterest" xlink:to="us-gaap_InvestmentIncomeInterest_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_InvestmentsAllOtherInvestmentsAbstract" xlink:label="us-gaap_InvestmentsAllOtherInvestmentsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentsAllOtherInvestmentsAbstract_lbl" xml:lang="en-US" id="id_3828183_928016_1_1">Investments All Other Investments [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InvestmentsAllOtherInvestmentsAbstract_lbl" xml:lang="en-US" id="id_3828183_928016_2_1">Investments, All Other Investments [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentsAllOtherInvestmentsAbstract" xlink:to="us-gaap_InvestmentsAllOtherInvestmentsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LegalEntityAxis_lbl" xml:lang="en-US" id="id_3828183_921954_1_1">Legal Entity [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_LegalEntityAxis_lbl" xml:lang="en-US" id="id_3828183_921954_2_1">Legal Entity [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LegalEntityAxis" xlink:to="dei_LegalEntityAxis_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Liabilities_lbl" xml:lang="en-US" id="id_3828183_936129_1_1">Liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Liabilities_lbl" xml:lang="en-US" id="id_3828183_936129_6_1">Total liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LiabilitiesAbstract" xlink:label="us-gaap_LiabilitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAbstract_lbl" xml:lang="en-US" id="id_3828183_925364_1_1">Liabilities [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LiabilitiesAbstract_lbl" xml:lang="en-US" id="id_3828183_925364_2_1">Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAbstract" xlink:to="us-gaap_LiabilitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US" id="id_3828183_935778_1_1">Liabilities And Stockholders Equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US" id="id_3828183_935778_6_1">Total liabilities, redeemable convertible preferred stock, and stockholders' equity (deficit)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US" id="id_3828183_934201_1_1">Liabilities Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US" id="id_3828183_934201_6_1">Total current liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US" id="id_3828183_929787_1_1">Liabilities Current [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US" id="id_3828183_929787_2_1">Current liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LineOfCreditFacilityAmountOutstanding" xlink:label="us-gaap_LineOfCreditFacilityAmountOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCreditFacilityAmountOutstanding_lbl" xml:lang="en-US" id="id_3828183_935864_1_1">Line Of Credit Facility Amount Outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_LineOfCreditFacilityAmountOutstanding_lbl" xml:lang="en-US" id="id_3828183_935864_4_1">Ending balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_LineOfCreditFacilityAmountOutstanding_lbl" xml:lang="en-US" id="id_3828183_935864_5_1">Beginning balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LineOfCreditFacilityAmountOutstanding_lbl" xml:lang="en-US" id="id_3828183_935864_6_1">Total loans</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityAmountOutstanding" xlink:to="us-gaap_LineOfCreditFacilityAmountOutstanding_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LineOfCreditFacilityAxis" xlink:label="us-gaap_LineOfCreditFacilityAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCreditFacilityAxis_lbl" xml:lang="en-US" id="id_3828183_924808_1_1">Line Of Credit Facility [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LineOfCreditFacilityAxis_lbl" xml:lang="en-US" id="id_3828183_924808_2_1">Lender Name [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityAxis" xlink:to="us-gaap_LineOfCreditFacilityAxis_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LineOfCreditFacilityExpirationDate1" xlink:label="us-gaap_LineOfCreditFacilityExpirationDate1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCreditFacilityExpirationDate1_lbl" xml:lang="en-US" id="id_3828183_925773_1_1">Line Of Credit Facility Expiration Date 1</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LineOfCreditFacilityExpirationDate1_lbl" xml:lang="en-US" id="id_3828183_925773_2_1">Term loan, maturity date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityExpirationDate1" xlink:to="us-gaap_LineOfCreditFacilityExpirationDate1_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LineOfCreditFacilityFrequencyOfPaymentAndPaymentTerms" xlink:label="us-gaap_LineOfCreditFacilityFrequencyOfPaymentAndPaymentTerms"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCreditFacilityFrequencyOfPaymentAndPaymentTerms_lbl" xml:lang="en-US" id="id_3828183_931431_1_1">Line Of Credit Facility Frequency Of Payment And Payment Terms</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LineOfCreditFacilityFrequencyOfPaymentAndPaymentTerms_lbl" xml:lang="en-US" id="id_3828183_931431_2_1">Term loan, payment terms</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityFrequencyOfPaymentAndPaymentTerms" xlink:to="us-gaap_LineOfCreditFacilityFrequencyOfPaymentAndPaymentTerms_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LineOfCreditFacilityIncreaseAccruedInterest" xlink:label="us-gaap_LineOfCreditFacilityIncreaseAccruedInterest"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCreditFacilityIncreaseAccruedInterest_lbl" xml:lang="en-US" id="id_3828183_935112_1_1">Line Of Credit Facility Increase Accrued Interest</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LineOfCreditFacilityIncreaseAccruedInterest_lbl" xml:lang="en-US" id="id_3828183_935112_2_1">Accrued interest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityIncreaseAccruedInterest" xlink:to="us-gaap_LineOfCreditFacilityIncreaseAccruedInterest_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" xlink:label="us-gaap_LineOfCreditFacilityInterestRateDuringPeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_lbl" xml:lang="en-US" id="id_3828183_930419_1_1">Line Of Credit Facility Interest Rate During Period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_lbl" xml:lang="en-US" id="id_3828183_930419_2_1">Term loan interest rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" xlink:to="us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain" xlink:label="us-gaap_LineOfCreditFacilityLenderDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCreditFacilityLenderDomain_lbl" xml:lang="en-US" id="id_3828183_924620_1_1">Line Of Credit Facility Lender [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LineOfCreditFacilityLenderDomain_lbl" xml:lang="en-US" id="id_3828183_924620_2_1">Line of Credit Facility, Lender [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityLenderDomain" xlink:to="us-gaap_LineOfCreditFacilityLenderDomain_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems" xlink:label="us-gaap_LineOfCreditFacilityLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCreditFacilityLineItems_lbl" xml:lang="en-US" id="id_3828183_931932_1_1">Line Of Credit Facility [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LineOfCreditFacilityLineItems_lbl" xml:lang="en-US" id="id_3828183_931932_2_1">Line of Credit Facility [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityLineItems" xlink:to="us-gaap_LineOfCreditFacilityLineItems_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl" xml:lang="en-US" id="id_3828183_935023_1_1">Line Of Credit Facility Maximum Borrowing Capacity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl" xml:lang="en-US" id="id_3828183_935023_2_1">Term loan facility with Silicon Valley Bank</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LineOfCreditFacilityPeriodicPaymentPrincipal" xlink:label="us-gaap_LineOfCreditFacilityPeriodicPaymentPrincipal"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCreditFacilityPeriodicPaymentPrincipal_lbl" xml:lang="en-US" id="id_3828183_938197_1_1">Line Of Credit Facility Periodic Payment Principal</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LineOfCreditFacilityPeriodicPaymentPrincipal_lbl" xml:lang="en-US" id="id_3828183_938197_2_1">Term loan, periodic principal repayments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityPeriodicPaymentPrincipal" xlink:to="us-gaap_LineOfCreditFacilityPeriodicPaymentPrincipal_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:label="us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_lbl" xml:lang="en-US" id="id_3828183_935349_1_1">Line Of Credit Facility Remaining Borrowing Capacity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_lbl" xml:lang="en-US" id="id_3828183_935349_2_1">Term loan borrowing capacity, available upon receiving Phase 2 top-line data results</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:to="us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LineOfCreditFacilityTable" xlink:label="us-gaap_LineOfCreditFacilityTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCreditFacilityTable_lbl" xml:lang="en-US" id="id_3828183_928337_1_1">Line Of Credit Facility [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LineOfCreditFacilityTable_lbl" xml:lang="en-US" id="id_3828183_928337_2_1">Line of Credit Facility [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityTable" xlink:to="us-gaap_LineOfCreditFacilityTable_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LoansPayableToBankCurrent" xlink:label="us-gaap_LoansPayableToBankCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LoansPayableToBankCurrent_lbl" xml:lang="en-US" id="id_3828183_935572_1_1">Loans Payable To Bank Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LoansPayableToBankCurrent_lbl" xml:lang="en-US" id="id_3828183_935572_2_1">Current portion of bank loan (Note 5)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LoansPayableToBankCurrent_lbl" xml:lang="en-US" id="id_3828183_935572_12_1">Short-term portion of bank loan</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LoansPayableToBankCurrent" xlink:to="us-gaap_LoansPayableToBankCurrent_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LongTermLoansFromBank" xlink:label="us-gaap_LongTermLoansFromBank"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermLoansFromBank_lbl" xml:lang="en-US" id="id_3828183_934446_1_1">Long Term Loans From Bank</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LongTermLoansFromBank_lbl" xml:lang="en-US" id="id_3828183_934446_2_1">Bank loan (Note 5)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LongTermLoansFromBank_lbl" xml:lang="en-US" id="id_3828183_934446_12_1">Long-term portion of bank loan</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermLoansFromBank" xlink:to="us-gaap_LongTermLoansFromBank_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:label="us-gaap_MinorityInterestOwnershipPercentageByParent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MinorityInterestOwnershipPercentageByParent_lbl" xml:lang="en-US" id="id_3828183_925475_1_1">Minority Interest Ownership Percentage By Parent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_MinorityInterestOwnershipPercentageByParent_lbl" xml:lang="en-US" id="id_3828183_925475_2_1">Ownership percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:to="us-gaap_MinorityInterestOwnershipPercentageByParent_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NatureOfOperations" xlink:label="us-gaap_NatureOfOperations"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NatureOfOperations_lbl" xml:lang="en-US" id="id_3828183_925631_1_1">Nature Of Operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NatureOfOperations_lbl" xml:lang="en-US" id="id_3828183_925631_2_1">Nature of operations</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NatureOfOperations" xlink:to="us-gaap_NatureOfOperations_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US" id="id_3828183_924600_1_1">Net Cash Provided By Used In Financing Activities [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US" id="id_3828183_924600_2_1">Financing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations_lbl" xml:lang="en-US" id="id_3828183_937867_1_1">Net Cash Provided By Used In Financing Activities Continuing Operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations_lbl" xml:lang="en-US" id="id_3828183_937867_6_1">Cash provided by financing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US" id="id_3828183_924425_1_1">Net Cash Provided By Used In Investing Activities [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US" id="id_3828183_924425_2_1">Investing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations_lbl" xml:lang="en-US" id="id_3828183_938815_1_1">Net Cash Provided By Used In Investing Activities Continuing Operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations_lbl" xml:lang="en-US" id="id_3828183_938815_6_1">Cash (used in) provided by investing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US" id="id_3828183_930909_1_1">Net Cash Provided By Used In Operating Activities [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US" id="id_3828183_930909_2_1">Operating activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_lbl" xml:lang="en-US" id="id_3828183_927292_1_1">Net Cash Provided By Used In Operating Activities Continuing Operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_lbl" xml:lang="en-US" id="id_3828183_927292_6_1">Cash used in operating activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US" id="id_3828183_935636_1_1">Net Income Loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US" id="id_3828183_935636_2_1">Net loss and comprehensive loss incurred in the development stage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetIncomeLossAbstract" xlink:label="us-gaap_NetIncomeLossAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLossAbstract_lbl" xml:lang="en-US" id="id_3828183_928590_1_1">Net Income Loss [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetIncomeLossAbstract_lbl" xml:lang="en-US" id="id_3828183_928590_2_1">Numerator</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAbstract" xlink:to="us-gaap_NetIncomeLossAbstract_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xml:lang="en-US" id="id_3828183_933727_1_1">Net Income Loss Available To Common Stockholders Basic</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xml:lang="en-US" id="id_3828183_933727_6_1">Total loss attributable to common stockholders</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_NetProceedsFromIssuanceInitialPublicOffering" xlink:label="aqxp_NetProceedsFromIssuanceInitialPublicOffering"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqxp_NetProceedsFromIssuanceInitialPublicOffering_lbl" xml:lang="en-US" id="id_3828183_1028291_3_1">Net proceeds from issuance initial public offering.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqxp_NetProceedsFromIssuanceInitialPublicOffering_lbl" xml:lang="en-US" id="id_3828183_1028291_1_1">Net Proceeds From Issuance Initial Public Offering</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aqxp_NetProceedsFromIssuanceInitialPublicOffering_lbl" xml:lang="en-US" id="id_3828183_1028291_2_1">Aggregate net proceeds received from offering</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqxp_NetProceedsFromIssuanceInitialPublicOffering" xlink:to="aqxp_NetProceedsFromIssuanceInitialPublicOffering_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US" id="id_3828183_923522_1_1">New Accounting Pronouncements Policy Policy [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US" id="id_3828183_923522_2_1">Recent accounting pronouncements</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_NewCommonStockMember" xlink:label="aqxp_NewCommonStockMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqxp_NewCommonStockMember_lbl" xml:lang="en-US" id="id_3828183_1099142_3_1">New Common Stock [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqxp_NewCommonStockMember_lbl" xml:lang="en-US" id="id_3828183_1099142_1_1">New Common Stock [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aqxp_NewCommonStockMember_lbl" xml:lang="en-US" id="id_3828183_1099142_2_1">New Common Shares [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqxp_NewCommonStockMember" xlink:to="aqxp_NewCommonStockMember_lbl"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_NonCashFinancingActivitiesAbstract" xlink:label="aqxp_NonCashFinancingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqxp_NonCashFinancingActivitiesAbstract_lbl" xml:lang="en-US" id="id_3828183_1012417_3_1">Non Cash Financing Activities [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqxp_NonCashFinancingActivitiesAbstract_lbl" xml:lang="en-US" id="id_3828183_1012417_1_1">Non Cash Financing Activities [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aqxp_NonCashFinancingActivitiesAbstract_lbl" xml:lang="en-US" id="id_3828183_1012417_2_1">Financing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqxp_NonCashFinancingActivitiesAbstract" xlink:to="aqxp_NonCashFinancingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_NoncashInvestingActivitiesAbstract" xlink:label="aqxp_NoncashInvestingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqxp_NoncashInvestingActivitiesAbstract_lbl" xml:lang="en-US" id="id_3828183_1052220_3_1">Noncash Investing Activities [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqxp_NoncashInvestingActivitiesAbstract_lbl" xml:lang="en-US" id="id_3828183_1052220_1_1">Noncash Investing Activities [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aqxp_NoncashInvestingActivitiesAbstract_lbl" xml:lang="en-US" id="id_3828183_1052220_2_1">Investing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqxp_NoncashInvestingActivitiesAbstract" xlink:to="aqxp_NoncashInvestingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1" xlink:label="us-gaap_NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1_lbl" xml:lang="en-US" id="id_3828183_938549_1_1">Noncash Or Part Noncash Acquisition Intangible Assets Acquired 1</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1_lbl" xml:lang="en-US" id="id_3828183_938549_2_1">Purchase of intangible assets for shares issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1" xlink:to="us-gaap_NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1_lbl"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_NonEmployeeDirectorsMember" xlink:label="aqxp_NonEmployeeDirectorsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqxp_NonEmployeeDirectorsMember_lbl" xml:lang="en-US" id="id_3828183_1032852_3_1">Non Employee Directors [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqxp_NonEmployeeDirectorsMember_lbl" xml:lang="en-US" id="id_3828183_1032852_1_1">Non Employee Directors [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aqxp_NonEmployeeDirectorsMember_lbl" xml:lang="en-US" id="id_3828183_1032852_2_1">Non-employee Directors [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqxp_NonEmployeeDirectorsMember" xlink:to="aqxp_NonEmployeeDirectorsMember_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl" xml:lang="en-US" id="id_3828183_935626_1_1">Nonoperating Income Expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl" xml:lang="en-US" id="id_3828183_935626_6_1">Total other income (expenses)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" xml:lang="en-US" id="id_3828183_927496_1_1">Nonoperating Income Expense [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" xml:lang="en-US" id="id_3828183_927496_2_1">Other income (expenses)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_NonoperatingIncomeExpenseAbstract_lbl"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_NumberOfNonEmployeeDirectors" xlink:label="aqxp_NumberOfNonEmployeeDirectors"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqxp_NumberOfNonEmployeeDirectors_lbl" xml:lang="en-US" id="id_3828183_1163829_3_1">Number Of Non Employee Directors</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqxp_NumberOfNonEmployeeDirectors_lbl" xml:lang="en-US" id="id_3828183_1163829_1_1">Number Of Non Employee Directors</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aqxp_NumberOfNonEmployeeDirectors_lbl" xml:lang="en-US" id="id_3828183_1163829_2_1">Number of non-employee directors</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqxp_NumberOfNonEmployeeDirectors" xlink:to="aqxp_NumberOfNonEmployeeDirectors_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="us-gaap_NumberOfOperatingSegments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NumberOfOperatingSegments_lbl" xml:lang="en-US" id="id_3828183_923679_1_1">Number Of Operating Segments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NumberOfOperatingSegments_lbl" xml:lang="en-US" id="id_3828183_923679_2_1">Operating segment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NumberOfOperatingSegments" xlink:to="us-gaap_NumberOfOperatingSegments_lbl"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_NumberOfYearsSharesReservedForIssuanceWillIncrease" xlink:label="aqxp_NumberOfYearsSharesReservedForIssuanceWillIncrease"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqxp_NumberOfYearsSharesReservedForIssuanceWillIncrease_lbl" xml:lang="en-US" id="id_3828183_1231826_3_1">Number Of Years Shares Reserved For Issuance Will Increase</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqxp_NumberOfYearsSharesReservedForIssuanceWillIncrease_lbl" xml:lang="en-US" id="id_3828183_1231826_1_1">Number Of Years Shares Reserved For Issuance Will Increase</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aqxp_NumberOfYearsSharesReservedForIssuanceWillIncrease_lbl" xml:lang="en-US" id="id_3828183_1231826_2_1">Years of increase in shares of common stock reserved for issuance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqxp_NumberOfYearsSharesReservedForIssuanceWillIncrease" xlink:to="aqxp_NumberOfYearsSharesReservedForIssuanceWillIncrease_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpenses_lbl" xml:lang="en-US" id="id_3828183_940683_1_1">Operating Expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingExpenses_lbl" xml:lang="en-US" id="id_3828183_940683_6_1">Total operating expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xml:lang="en-US" id="id_3828183_927909_1_1">Operating Expenses [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xml:lang="en-US" id="id_3828183_927909_2_1">Operating expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xml:lang="en-US" id="id_3828183_937594_1_1">Other Assets Noncurrent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xml:lang="en-US" id="id_3828183_937594_2_1">Other</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsNoncurrent" xlink:to="us-gaap_OtherAssetsNoncurrent_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="us-gaap_OtherLiabilitiesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilitiesCurrent_lbl" xml:lang="en-US" id="id_3828183_936298_1_1">Other Liabilities Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherLiabilitiesCurrent_lbl" xml:lang="en-US" id="id_3828183_936298_2_1">Other</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesCurrent" xlink:to="us-gaap_OtherLiabilitiesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="us-gaap_OtherLiabilitiesNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilitiesNoncurrent_lbl" xml:lang="en-US" id="id_3828183_934563_1_1">Other Liabilities Noncurrent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherLiabilitiesNoncurrent_lbl" xml:lang="en-US" id="id_3828183_934563_2_1">Other</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesNoncurrent" xlink:to="us-gaap_OtherLiabilitiesNoncurrent_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PaymentOfFinancingAndStockIssuanceCosts" xlink:label="us-gaap_PaymentOfFinancingAndStockIssuanceCosts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentOfFinancingAndStockIssuanceCosts_lbl" xml:lang="en-US" id="id_3828183_935779_1_1">Payment Of Financing And Stock Issuance Costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PaymentOfFinancingAndStockIssuanceCosts_lbl" xml:lang="en-US" id="id_3828183_935779_2_1">Common stock share issuance costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PaymentOfFinancingAndStockIssuanceCosts_lbl" xml:lang="en-US" id="id_3828183_935779_12_1">Underwriting discounts and commissions and offering costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentOfFinancingAndStockIssuanceCosts" xlink:to="us-gaap_PaymentOfFinancingAndStockIssuanceCosts_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:label="us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsForRepurchaseOfCommonStock_lbl" xml:lang="en-US" id="id_3828183_936173_1_1">Payments For Repurchase Of Common Stock</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsForRepurchaseOfCommonStock_lbl" xml:lang="en-US" id="id_3828183_936173_14_1">Repurchase of common stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="us-gaap_PaymentsForRepurchaseOfCommonStock_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PaymentsOfFinancingCosts" xlink:label="us-gaap_PaymentsOfFinancingCosts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsOfFinancingCosts_lbl" xml:lang="en-US" id="id_3828183_933358_1_1">Payments Of Financing Costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsOfFinancingCosts_lbl" xml:lang="en-US" id="id_3828183_933358_14_1">Initial public offering costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfFinancingCosts" xlink:to="us-gaap_PaymentsOfFinancingCosts_lbl"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_PaymentsOfFinancingCostsDebt" xlink:label="aqxp_PaymentsOfFinancingCostsDebt"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqxp_PaymentsOfFinancingCostsDebt_lbl" xml:lang="en-US" id="id_3828183_1262857_3_1">Payments of Financing Costs Debt</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqxp_PaymentsOfFinancingCostsDebt_lbl" xml:lang="en-US" id="id_3828183_1262857_1_1">Payments Of Financing Costs Debt</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aqxp_PaymentsOfFinancingCostsDebt_lbl" xml:lang="en-US" id="id_3828183_1262857_2_1">Financing costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqxp_PaymentsOfFinancingCostsDebt" xlink:to="aqxp_PaymentsOfFinancingCostsDebt_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PaymentsOfLoanCosts" xlink:label="us-gaap_PaymentsOfLoanCosts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsOfLoanCosts_lbl" xml:lang="en-US" id="id_3828183_933570_1_1">Payments Of Loan Costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsOfLoanCosts_lbl" xml:lang="en-US" id="id_3828183_933570_14_1">Loan costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfLoanCosts" xlink:to="us-gaap_PaymentsOfLoanCosts_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xml:lang="en-US" id="id_3828183_935307_1_1">Payments Of Stock Issuance Costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xml:lang="en-US" id="id_3828183_935307_14_1">Share issue costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets_lbl" xml:lang="en-US" id="id_3828183_934868_1_1">Payments To Acquire Intangible Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets_lbl" xml:lang="en-US" id="id_3828183_934868_14_1">Purchase of intangible assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="us-gaap_PaymentsToAcquireIntangibleAssets_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xml:lang="en-US" id="id_3828183_936514_1_1">Payments To Acquire Property Plant And Equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xml:lang="en-US" id="id_3828183_936514_14_1">Purchase of property and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PaymentsToAcquireShortTermInvestments" xlink:label="us-gaap_PaymentsToAcquireShortTermInvestments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireShortTermInvestments_lbl" xml:lang="en-US" id="id_3828183_933480_1_1">Payments To Acquire Short Term Investments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquireShortTermInvestments_lbl" xml:lang="en-US" id="id_3828183_933480_14_1">Purchase of short-term investments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireShortTermInvestments" xlink:to="us-gaap_PaymentsToAcquireShortTermInvestments_lbl"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_PercentageOfRecognitionOfTaxBenefitUponSettlement" xlink:label="aqxp_PercentageOfRecognitionOfTaxBenefitUponSettlement"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqxp_PercentageOfRecognitionOfTaxBenefitUponSettlement_lbl" xml:lang="en-US" id="id_3828183_1195612_3_1">Percentage Of Recognition Of Tax Benefit Upon Settlement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqxp_PercentageOfRecognitionOfTaxBenefitUponSettlement_lbl" xml:lang="en-US" id="id_3828183_1195612_1_1">Percentage Of Recognition Of Tax Benefit Upon Settlement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aqxp_PercentageOfRecognitionOfTaxBenefitUponSettlement_lbl" xml:lang="en-US" id="id_3828183_1195612_2_1">Percentage of tax benefit upon settlement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqxp_PercentageOfRecognitionOfTaxBenefitUponSettlement" xlink:to="aqxp_PercentageOfRecognitionOfTaxBenefitUponSettlement_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PlanNameAxis_lbl" xml:lang="en-US" id="id_3828183_930809_1_1">Plan Name [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PlanNameAxis_lbl" xml:lang="en-US" id="id_3828183_930809_2_1">Plan Name [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameAxis_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PlanNameDomain_lbl" xml:lang="en-US" id="id_3828183_931386_1_1">Plan Name [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PlanNameDomain_lbl" xml:lang="en-US" id="id_3828183_931386_2_1">Plan Name [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameDomain" xlink:to="us-gaap_PlanNameDomain_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockMember" xlink:label="us-gaap_PreferredStockMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockMember_lbl" xml:lang="en-US" id="id_3828183_932258_1_1">Preferred Stock [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockMember_lbl" xml:lang="en-US" id="id_3828183_932258_2_1">Preferred Stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockMember" xlink:to="us-gaap_PreferredStockMember_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xml:lang="en-US" id="id_3828183_932596_1_1">Preferred Stock Par Or Stated Value Per Share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xml:lang="en-US" id="id_3828183_932596_2_1">Preferred stock, par value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockRedemptionDiscount" xlink:label="us-gaap_PreferredStockRedemptionDiscount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockRedemptionDiscount_lbl" xml:lang="en-US" id="id_3828183_933647_1_1">Preferred Stock Redemption Discount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockRedemptionDiscount_lbl" xml:lang="en-US" id="id_3828183_933647_2_1">Redemption discount on issuance of preferred shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockRedemptionDiscount" xlink:to="us-gaap_PreferredStockRedemptionDiscount_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xml:lang="en-US" id="id_3828183_929540_1_1">Preferred Stock Shares Authorized</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xml:lang="en-US" id="id_3828183_929540_2_1">Preferred stock, shares authorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xml:lang="en-US" id="id_3828183_932934_1_1">Preferred Stock Shares Issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xml:lang="en-US" id="id_3828183_932934_2_1">Preferred stock, shares issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xml:lang="en-US" id="id_3828183_926142_1_1">Preferred Stock Shares Outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xml:lang="en-US" id="id_3828183_926142_2_1">Preferred stock, shares outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="us-gaap_PrepaidExpenseCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseCurrent_lbl" xml:lang="en-US" id="id_3828183_937707_1_1">Prepaid Expense Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PrepaidExpenseCurrent_lbl" xml:lang="en-US" id="id_3828183_937707_2_1">Prepayments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseCurrent" xlink:to="us-gaap_PrepaidExpenseCurrent_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl" xml:lang="en-US" id="id_3828183_939370_1_1">Proceeds From Issuance Initial Public Offering</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl" xml:lang="en-US" id="id_3828183_939370_2_1">Initial public offering of common shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xml:lang="en-US" id="id_3828183_938994_1_1">Proceeds From Issuance Of Common Stock</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xml:lang="en-US" id="id_3828183_938994_2_1">Common stock issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit" xlink:label="us-gaap_ProceedsFromLinesOfCredit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromLinesOfCredit_lbl" xml:lang="en-US" id="id_3828183_939713_1_1">Proceeds From Lines Of Credit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromLinesOfCredit_lbl" xml:lang="en-US" id="id_3828183_939713_2_1">Bank loan cash received - October 30, 2013</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromLinesOfCredit_lbl" xml:lang="en-US" id="id_3828183_939713_12_1">Term loan, amount borrowed</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromLinesOfCredit" xlink:to="us-gaap_ProceedsFromLinesOfCredit_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="us-gaap_ProceedsFromNotesPayable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromNotesPayable_lbl" xml:lang="en-US" id="id_3828183_937957_1_1">Proceeds From Notes Payable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromNotesPayable_lbl" xml:lang="en-US" id="id_3828183_937957_2_1">Issuance of promissory notes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromNotesPayable" xlink:to="us-gaap_ProceedsFromNotesPayable_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromRepurchaseOfRedeemablePreferredStock" xlink:label="us-gaap_ProceedsFromRepurchaseOfRedeemablePreferredStock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromRepurchaseOfRedeemablePreferredStock_lbl" xml:lang="en-US" id="id_3828183_938147_1_1">Proceeds From Repurchase Of Redeemable Preferred Stock</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromRepurchaseOfRedeemablePreferredStock_lbl" xml:lang="en-US" id="id_3828183_938147_2_1">Preferred stock (redemption) issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromRepurchaseOfRedeemablePreferredStock" xlink:to="us-gaap_ProceedsFromRepurchaseOfRedeemablePreferredStock_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_lbl" xml:lang="en-US" id="id_3828183_939045_1_1">Proceeds From Sale Of Property Plant And Equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_lbl" xml:lang="en-US" id="id_3828183_939045_2_1">Sale of property and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:to="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US" id="id_3828183_940861_1_1">Property Plant And Equipment Net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US" id="id_3828183_940861_2_1">Property and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RedeemableConvertiblePreferredStockMember" xlink:label="us-gaap_RedeemableConvertiblePreferredStockMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RedeemableConvertiblePreferredStockMember_lbl" xml:lang="en-US" id="id_3828183_932152_1_1">Redeemable Convertible Preferred Stock [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RedeemableConvertiblePreferredStockMember_lbl" xml:lang="en-US" id="id_3828183_932152_2_1">Redeemable Convertible Preferred Stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RedeemableConvertiblePreferredStockMember" xlink:to="us-gaap_RedeemableConvertiblePreferredStockMember_lbl"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_RegulatoryAssetsAbstract" xlink:label="aqxp_RegulatoryAssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqxp_RegulatoryAssetsAbstract_lbl" xml:lang="en-US" id="id_3828183_1166510_3_1">Regulatory Assets [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqxp_RegulatoryAssetsAbstract_lbl" xml:lang="en-US" id="id_3828183_1166510_1_1">Regulatory Assets [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aqxp_RegulatoryAssetsAbstract_lbl" xml:lang="en-US" id="id_3828183_1166510_2_1">Regulatory Assets [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqxp_RegulatoryAssetsAbstract" xlink:to="aqxp_RegulatoryAssetsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_ReorganizationMember" xlink:label="aqxp_ReorganizationMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqxp_ReorganizationMember_lbl" xml:lang="en-US" id="id_3828183_1060520_3_1">Reorganization [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqxp_ReorganizationMember_lbl" xml:lang="en-US" id="id_3828183_1060520_1_1">Reorganization [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aqxp_ReorganizationMember_lbl" xml:lang="en-US" id="id_3828183_1060520_2_1">Reorganization [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqxp_ReorganizationMember" xlink:to="aqxp_ReorganizationMember_lbl"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_RepaymentFeeAndPenalty" xlink:label="aqxp_RepaymentFeeAndPenalty"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqxp_RepaymentFeeAndPenalty_lbl" xml:lang="en-US" id="id_3828183_1263522_3_1">Repayment Fee and Penalty</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqxp_RepaymentFeeAndPenalty_lbl" xml:lang="en-US" id="id_3828183_1263522_1_1">Repayment Fee And Penalty</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aqxp_RepaymentFeeAndPenalty_lbl" xml:lang="en-US" id="id_3828183_1263522_2_1">Fees and penalty on bank loan repayment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="aqxp_RepaymentFeeAndPenalty_lbl" xml:lang="en-US" id="id_3828183_1263522_12_1">Repayment fee and penalty</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqxp_RepaymentFeeAndPenalty" xlink:to="aqxp_RepaymentFeeAndPenalty_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RepaymentsOfDebt" xlink:label="us-gaap_RepaymentsOfDebt"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfDebt_lbl" xml:lang="en-US" id="id_3828183_934270_1_1">Repayments Of Debt</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RepaymentsOfDebt_lbl" xml:lang="en-US" id="id_3828183_934270_14_1">Repayment of bank loan, fees and penalty</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfDebt" xlink:to="us-gaap_RepaymentsOfDebt_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit" xlink:label="us-gaap_RepaymentsOfLinesOfCredit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfLinesOfCredit_lbl" xml:lang="en-US" id="id_3828183_933944_1_1">Repayments Of Lines Of Credit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RepaymentsOfLinesOfCredit_lbl" xml:lang="en-US" id="id_3828183_933944_2_1">Term loan repayment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RepaymentsOfLinesOfCredit_lbl" xml:lang="en-US" id="id_3828183_933944_14_1">Repayment of bank loan and interest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfLinesOfCredit" xlink:to="us-gaap_RepaymentsOfLinesOfCredit_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="us-gaap_RepaymentsOfNotesPayable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfNotesPayable_lbl" xml:lang="en-US" id="id_3828183_933781_1_1">Repayments Of Notes Payable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RepaymentsOfNotesPayable_lbl" xml:lang="en-US" id="id_3828183_933781_14_1">Repayment of promissory notes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfNotesPayable" xlink:to="us-gaap_RepaymentsOfNotesPayable_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xml:lang="en-US" id="id_3828183_939407_1_1">Research And Development Expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xml:lang="en-US" id="id_3828183_939407_2_1">Research and development</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_ReversalOfIncomeTaxPayableOnPreferredStock" xlink:label="aqxp_ReversalOfIncomeTaxPayableOnPreferredStock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqxp_ReversalOfIncomeTaxPayableOnPreferredStock_lbl" xml:lang="en-US" id="id_3828183_1263895_3_1">Reversal of Canadian tax with respect to Canadian corporation taxable preferred shares and their liquidation rights upon conversion of preferred stock.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqxp_ReversalOfIncomeTaxPayableOnPreferredStock_lbl" xml:lang="en-US" id="id_3828183_1263895_1_1">Reversal Of Income Tax Payable On Preferred Stock</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aqxp_ReversalOfIncomeTaxPayableOnPreferredStock_lbl" xml:lang="en-US" id="id_3828183_1263895_2_1">Reversal of tax payable on preferred stock due to conversion of preferred stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqxp_ReversalOfIncomeTaxPayableOnPreferredStock" xlink:to="aqxp_ReversalOfIncomeTaxPayableOnPreferredStock_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_lbl" xml:lang="en-US" id="id_3828183_931590_1_1">Sale Of Stock Name Of Transaction [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_lbl" xml:lang="en-US" id="id_3828183_931590_2_1">Sale of Stock, Name of Transaction [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="us-gaap_SaleOfStockPricePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockPricePerShare_lbl" xml:lang="en-US" id="id_3828183_932019_1_1">Sale Of Stock Price Per Share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SaleOfStockPricePerShare_lbl" xml:lang="en-US" id="id_3828183_932019_2_1">Common stock share price per share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockPricePerShare" xlink:to="us-gaap_SaleOfStockPricePerShare_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScenarioUnspecifiedDomain_lbl" xml:lang="en-US" id="id_3828183_930891_1_1">Scenario Unspecified [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScenarioUnspecifiedDomain_lbl" xml:lang="en-US" id="id_3828183_930891_2_1">Scenario, Unspecified [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScenarioUnspecifiedDomain" xlink:to="us-gaap_ScenarioUnspecifiedDomain_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl" xml:lang="en-US" id="id_3828183_928220_1_1">Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl" xml:lang="en-US" id="id_3828183_928220_2_1">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" xml:lang="en-US" id="id_3828183_925701_1_1">Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" xml:lang="en-US" id="id_3828183_925701_2_1">Schedule of Antidilutive Securities Excluded from Computation of Basic and Diluted Net Loss Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:label="us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_lbl" xml:lang="en-US" id="id_3828183_932295_1_1">Schedule Of Cash And Cash Equivalents Table [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_lbl" xml:lang="en-US" id="id_3828183_932295_2_1">Schedule of Cash and Cash Equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:to="us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock" xlink:label="us-gaap_ScheduleOfDebtTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDebtTableTextBlock_lbl" xml:lang="en-US" id="id_3828183_932813_1_1">Schedule Of Debt Table [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfDebtTableTextBlock_lbl" xml:lang="en-US" id="id_3828183_932813_2_1">Summary of Bank Loan Facility</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDebtTableTextBlock" xlink:to="us-gaap_ScheduleOfDebtTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xml:lang="en-US" id="id_3828183_927124_1_1">Schedule Of Earnings Per Share Basic And Diluted Table [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xml:lang="en-US" id="id_3828183_927124_2_1">Schedule of Computation of Basic and Diluted Earnings Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_ScheduleOfEarningsPerShareLineItems" xlink:label="aqxp_ScheduleOfEarningsPerShareLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqxp_ScheduleOfEarningsPerShareLineItems_lbl" xml:lang="en-US" id="id_3828183_963939_3_1">Schedule Of Earnings Per Share [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqxp_ScheduleOfEarningsPerShareLineItems_lbl" xml:lang="en-US" id="id_3828183_963939_1_1">Schedule Of Earnings Per Share [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aqxp_ScheduleOfEarningsPerShareLineItems_lbl" xml:lang="en-US" id="id_3828183_963939_2_1">Schedule Of Earnings Per Share [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqxp_ScheduleOfEarningsPerShareLineItems" xlink:to="aqxp_ScheduleOfEarningsPerShareLineItems_lbl"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_ScheduleOfEarningsPerShareTable" xlink:label="aqxp_ScheduleOfEarningsPerShareTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqxp_ScheduleOfEarningsPerShareTable_lbl" xml:lang="en-US" id="id_3828183_1092577_3_1">Schedule Of Earnings Per Share [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqxp_ScheduleOfEarningsPerShareTable_lbl" xml:lang="en-US" id="id_3828183_1092577_1_1">Schedule Of Earnings Per Share [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aqxp_ScheduleOfEarningsPerShareTable_lbl" xml:lang="en-US" id="id_3828183_1092577_2_1">Schedule Of Earnings Per Share [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqxp_ScheduleOfEarningsPerShareTable" xlink:to="aqxp_ScheduleOfEarningsPerShareTable_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock" xlink:label="us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock_lbl" xml:lang="en-US" id="id_3828183_929163_1_1">Schedule Of Line Of Credit Facilities [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock_lbl" xml:lang="en-US" id="id_3828183_929163_2_1">Schedule of Loan Facility</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock" xlink:to="us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xml:lang="en-US" id="id_3828183_930578_1_1">Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xml:lang="en-US" id="id_3828183_930578_2_1">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xml:lang="en-US" id="id_3828183_931898_1_1">Schedule Of Share Based Payment Award Stock Options Valuation Assumptions Table [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xml:lang="en-US" id="id_3828183_931898_2_1">Schedule of Weighted Average Assumptions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="us-gaap_ScheduleOfStockByClassTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfStockByClassTable_lbl" xml:lang="en-US" id="id_3828183_929898_1_1">Schedule Of Stock By Class [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfStockByClassTable_lbl" xml:lang="en-US" id="id_3828183_929898_2_1">Schedule of Stock by Class [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_ScheduleOfStockByClassTable_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SegmentGeographicalDomain" xlink:label="us-gaap_SegmentGeographicalDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentGeographicalDomain_lbl" xml:lang="en-US" id="id_3828183_925438_1_1">Segment Geographical [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SegmentGeographicalDomain_lbl" xml:lang="en-US" id="id_3828183_925438_2_1">Geographical [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentGeographicalDomain" xlink:to="us-gaap_SegmentGeographicalDomain_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl" xml:lang="en-US" id="id_3828183_930875_1_1">Segment Reporting Policy Policy [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl" xml:lang="en-US" id="id_3828183_930875_2_1">Segment reporting</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:to="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_SeriesAConvertiblePreferredStockMember" xlink:label="aqxp_SeriesAConvertiblePreferredStockMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqxp_SeriesAConvertiblePreferredStockMember_lbl" xml:lang="en-US" id="id_3828183_980486_3_1">Series A Convertible Preferred Stock [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqxp_SeriesAConvertiblePreferredStockMember_lbl" xml:lang="en-US" id="id_3828183_980486_1_1">Series A Convertible Preferred Stock [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aqxp_SeriesAConvertiblePreferredStockMember_lbl" xml:lang="en-US" id="id_3828183_980486_2_1">Series A Exchangeable Preferred Shares [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqxp_SeriesAConvertiblePreferredStockMember" xlink:to="aqxp_SeriesAConvertiblePreferredStockMember_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="us-gaap_SeriesAPreferredStockMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SeriesAPreferredStockMember_lbl" xml:lang="en-US" id="id_3828183_930435_1_1">Series A Preferred Stock [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SeriesAPreferredStockMember_lbl" xml:lang="en-US" id="id_3828183_930435_2_1">Series A Preferred Stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesAPreferredStockMember" xlink:to="us-gaap_SeriesAPreferredStockMember_lbl"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_SeriesBConvertiblePreferredStockMember" xlink:label="aqxp_SeriesBConvertiblePreferredStockMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqxp_SeriesBConvertiblePreferredStockMember_lbl" xml:lang="en-US" id="id_3828183_1124615_3_1">Series B Convertible Preferred Stock [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqxp_SeriesBConvertiblePreferredStockMember_lbl" xml:lang="en-US" id="id_3828183_1124615_1_1">Series B Convertible Preferred Stock [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aqxp_SeriesBConvertiblePreferredStockMember_lbl" xml:lang="en-US" id="id_3828183_1124615_2_1">AQXP Canada, Series B Exchangeable Preferred Shares [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqxp_SeriesBConvertiblePreferredStockMember" xlink:to="aqxp_SeriesBConvertiblePreferredStockMember_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="us-gaap_SeriesBPreferredStockMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SeriesBPreferredStockMember_lbl" xml:lang="en-US" id="id_3828183_932774_1_1">Series B Preferred Stock [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SeriesBPreferredStockMember_lbl" xml:lang="en-US" id="id_3828183_932774_2_1">Series B Preferred Stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesBPreferredStockMember" xlink:to="us-gaap_SeriesBPreferredStockMember_lbl"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_SeriesCConvertiblePreferredStockMember" xlink:label="aqxp_SeriesCConvertiblePreferredStockMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqxp_SeriesCConvertiblePreferredStockMember_lbl" xml:lang="en-US" id="id_3828183_1031975_3_1">Series C Convertible Preferred Stock [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqxp_SeriesCConvertiblePreferredStockMember_lbl" xml:lang="en-US" id="id_3828183_1031975_1_1">Series C Convertible Preferred Stock [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aqxp_SeriesCConvertiblePreferredStockMember_lbl" xml:lang="en-US" id="id_3828183_1031975_2_1">Series C Exchangeable Preferred Shares [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqxp_SeriesCConvertiblePreferredStockMember" xlink:to="aqxp_SeriesCConvertiblePreferredStockMember_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SeriesCPreferredStockMember" xlink:label="us-gaap_SeriesCPreferredStockMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SeriesCPreferredStockMember_lbl" xml:lang="en-US" id="id_3828183_930400_1_1">Series C Preferred Stock [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SeriesCPreferredStockMember_lbl" xml:lang="en-US" id="id_3828183_930400_2_1">Series C Preferred Stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesCPreferredStockMember" xlink:to="us-gaap_SeriesCPreferredStockMember_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensation_lbl" xml:lang="en-US" id="id_3828183_938471_1_1">Share Based Compensation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensation_lbl" xml:lang="en-US" id="id_3828183_938471_2_1">Stock-based compensation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensation_lbl" xml:lang="en-US" id="id_3828183_938471_12_1">Stock-based compensation expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xml:lang="en-US" id="id_3828183_928648_1_1">Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xml:lang="en-US" id="id_3828183_928648_2_1">Expected dividends</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xml:lang="en-US" id="id_3828183_926378_1_1">Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term 1</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xml:lang="en-US" id="id_3828183_926378_2_1">Expected terms (years)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xml:lang="en-US" id="id_3828183_925061_1_1">Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xml:lang="en-US" id="id_3828183_925061_2_1">Expected volatility</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xml:lang="en-US" id="id_3828183_924177_1_1">Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xml:lang="en-US" id="id_3828183_924177_2_1">Risk free rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xml:lang="en-US" id="id_3828183_926498_1_1">Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xml:lang="en-US" id="id_3828183_926498_2_1">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl" xml:lang="en-US" id="id_3828183_929330_1_1">Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl" xml:lang="en-US" id="id_3828183_929330_2_1">Maximum number of shares of common stock that may be issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedNew" xlink:label="aqxp_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedNew"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqxp_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedNew_lbl" xml:lang="en-US" id="id_3828183_1262854_3_1">Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized New</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqxp_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedNew_lbl" xml:lang="en-US" id="id_3828183_1262854_1_1">Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized New</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aqxp_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedNew_lbl" xml:lang="en-US" id="id_3828183_1262854_2_1">Common stock, shares outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqxp_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedNew" xlink:to="aqxp_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedNew_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xml:lang="en-US" id="id_3828183_929506_1_1">Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xml:lang="en-US" id="id_3828183_929506_2_1">Stock options granted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US" id="id_3828183_928357_1_1">Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US" id="id_3828183_928357_2_1">Weighted average grant date fair value of stock options granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US" id="id_3828183_928357_12_1">Weighted average grant-date fair value of stock options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xml:lang="en-US" id="id_3828183_928127_1_1">Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xml:lang="en-US" id="id_3828183_928127_2_1">Options outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xml:lang="en-US" id="id_3828183_923943_1_1">Share Based Compensation Option And Incentive Plans Policy</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xml:lang="en-US" id="id_3828183_923943_2_1">Accounting for stock-based compensation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_ShareIssuanceExpendituresIncurredButNotYetPaid" xlink:label="aqxp_ShareIssuanceExpendituresIncurredButNotYetPaid"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqxp_ShareIssuanceExpendituresIncurredButNotYetPaid_lbl" xml:lang="en-US" id="id_3828183_1262842_3_1">Share Issuance Expenditures Incurred but Not yet Paid</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqxp_ShareIssuanceExpendituresIncurredButNotYetPaid_lbl" xml:lang="en-US" id="id_3828183_1262842_1_1">Share Issuance Expenditures Incurred But Not Yet Paid</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aqxp_ShareIssuanceExpendituresIncurredButNotYetPaid_lbl" xml:lang="en-US" id="id_3828183_1262842_2_1">Accrued offering costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqxp_ShareIssuanceExpendituresIncurredButNotYetPaid" xlink:to="aqxp_ShareIssuanceExpendituresIncurredButNotYetPaid_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesOutstanding_lbl" xml:lang="en-US" id="id_3828183_923726_1_1">Shares Outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharesOutstanding_lbl" xml:lang="en-US" id="id_3828183_923726_4_1">Ending Balance, Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_SharesTransferredFromAqxpCanadaToAquinoxUsaMember" xlink:label="aqxp_SharesTransferredFromAqxpCanadaToAquinoxUsaMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqxp_SharesTransferredFromAqxpCanadaToAquinoxUsaMember_lbl" xml:lang="en-US" id="id_3828183_1261582_3_1">Shares Transferred From AQXP Canada To Aquinox USA [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqxp_SharesTransferredFromAqxpCanadaToAquinoxUsaMember_lbl" xml:lang="en-US" id="id_3828183_1261582_1_1">Shares Transferred From Aqxp Canada To Aquinox Usa [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aqxp_SharesTransferredFromAqxpCanadaToAquinoxUsaMember_lbl" xml:lang="en-US" id="id_3828183_1261582_2_1">Shares Transferred from AQXP Canada to Aquinox USA [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqxp_SharesTransferredFromAqxpCanadaToAquinoxUsaMember" xlink:to="aqxp_SharesTransferredFromAqxpCanadaToAquinoxUsaMember_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShortTermInvestments" xlink:label="us-gaap_ShortTermInvestments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermInvestments_lbl" xml:lang="en-US" id="id_3828183_938382_1_1">Short Term Investments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShortTermInvestments_lbl" xml:lang="en-US" id="id_3828183_938382_2_1">Short-term investments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermInvestments" xlink:to="us-gaap_ShortTermInvestments_lbl"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_SignificantAccountingPoliciesLineItems" xlink:label="aqxp_SignificantAccountingPoliciesLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqxp_SignificantAccountingPoliciesLineItems_lbl" xml:lang="en-US" id="id_3828183_961708_3_1">Significant Accounting Policies [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqxp_SignificantAccountingPoliciesLineItems_lbl" xml:lang="en-US" id="id_3828183_961708_1_1">Significant Accounting Policies [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aqxp_SignificantAccountingPoliciesLineItems_lbl" xml:lang="en-US" id="id_3828183_961708_2_1">Significant Accounting Policies [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqxp_SignificantAccountingPoliciesLineItems" xlink:to="aqxp_SignificantAccountingPoliciesLineItems_lbl"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_SignificantAccountingPoliciesTable" xlink:label="aqxp_SignificantAccountingPoliciesTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqxp_SignificantAccountingPoliciesTable_lbl" xml:lang="en-US" id="id_3828183_1001815_3_1">Significant Accounting Policies [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqxp_SignificantAccountingPoliciesTable_lbl" xml:lang="en-US" id="id_3828183_1001815_1_1">Significant Accounting Policies [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aqxp_SignificantAccountingPoliciesTable_lbl" xml:lang="en-US" id="id_3828183_1001815_2_1">Significant Accounting Policies [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqxp_SignificantAccountingPoliciesTable" xlink:to="aqxp_SignificantAccountingPoliciesTable_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US" id="id_3828183_931089_1_1">Significant Accounting Policies [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US" id="id_3828183_931089_2_1">Condensed summary of significant accounting policies</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_SiliconValleyBankMember" xlink:label="aqxp_SiliconValleyBankMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqxp_SiliconValleyBankMember_lbl" xml:lang="en-US" id="id_3828183_1094993_3_1">Silicon Valley Bank [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqxp_SiliconValleyBankMember_lbl" xml:lang="en-US" id="id_3828183_1094993_1_1">Silicon Valley Bank [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aqxp_SiliconValleyBankMember_lbl" xml:lang="en-US" id="id_3828183_1094993_2_1">Silicon Valley Bank [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqxp_SiliconValleyBankMember" xlink:to="aqxp_SiliconValleyBankMember_lbl"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_SpecialVotingCommonStockIssuedValue" xlink:label="aqxp_SpecialVotingCommonStockIssuedValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqxp_SpecialVotingCommonStockIssuedValue_lbl" xml:lang="en-US" id="id_3828183_1259172_3_1">Special Voting Common Stock Issued Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqxp_SpecialVotingCommonStockIssuedValue_lbl" xml:lang="en-US" id="id_3828183_1259172_1_1">Special Voting Common Stock Issued Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aqxp_SpecialVotingCommonStockIssuedValue_lbl" xml:lang="en-US" id="id_3828183_1259172_2_1">Special voting common stock issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqxp_SpecialVotingCommonStockIssuedValue" xlink:to="aqxp_SpecialVotingCommonStockIssuedValue_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US" id="id_3828183_932980_1_1">Statement Class Of Stock [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US" id="id_3828183_932980_2_1">Class of Stock [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US" id="id_3828183_927592_1_1">Statement Equity Components [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US" id="id_3828183_927592_2_1">Equity Components [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementGeographicalAxis" xlink:label="us-gaap_StatementGeographicalAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementGeographicalAxis_lbl" xml:lang="en-US" id="id_3828183_923497_1_1">Statement Geographical [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StatementGeographicalAxis_lbl" xml:lang="en-US" id="id_3828183_923497_2_1">Geographical [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementGeographicalAxis" xlink:to="us-gaap_StatementGeographicalAxis_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US" id="id_3828183_926570_1_1">Statement [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US" id="id_3828183_926570_2_1">Statement [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US" id="id_3828183_932756_1_1">Statement Of Cash Flows [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US" id="id_3828183_932756_2_1">Statement of Cash Flows [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xml:lang="en-US" id="id_3828183_924693_1_1">Statement Of Financial Position [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xml:lang="en-US" id="id_3828183_924693_2_1">Statement of Financial Position [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xml:lang="en-US" id="id_3828183_926289_1_1">Statement Of Stockholders Equity [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xml:lang="en-US" id="id_3828183_926289_2_1">Statement of Stockholders' Equity [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementOfStockholdersEquityAbstract_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementScenarioAxis_lbl" xml:lang="en-US" id="id_3828183_924791_1_1">Statement Scenario [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StatementScenarioAxis_lbl" xml:lang="en-US" id="id_3828183_924791_2_1">Scenario [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_StatementScenarioAxis_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US" id="id_3828183_926771_1_1">Statement [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US" id="id_3828183_926771_2_1">Statement [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_StockBasedCompensationIncreaseInCommonStockIssuancePercentage" xlink:label="aqxp_StockBasedCompensationIncreaseInCommonStockIssuancePercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqxp_StockBasedCompensationIncreaseInCommonStockIssuancePercentage_lbl" xml:lang="en-US" id="id_3828183_1251612_3_1">Stock Based Compensation Increase In Common Stock Issuance Percentage</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqxp_StockBasedCompensationIncreaseInCommonStockIssuancePercentage_lbl" xml:lang="en-US" id="id_3828183_1251612_1_1">Stock Based Compensation Increase In Common Stock Issuance Percentage</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aqxp_StockBasedCompensationIncreaseInCommonStockIssuancePercentage_lbl" xml:lang="en-US" id="id_3828183_1251612_2_1">Shares of common stock reserved for issuance percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqxp_StockBasedCompensationIncreaseInCommonStockIssuancePercentage" xlink:to="aqxp_StockBasedCompensationIncreaseInCommonStockIssuancePercentage_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US" id="id_3828183_934682_1_1">Stockholders Equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US" id="id_3828183_934682_4_1">Ending Balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US" id="id_3828183_934682_2_1">Total stockholders' equity (deficit)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US" id="id_3828183_925186_1_1">Stockholders Equity [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US" id="id_3828183_925186_2_1">Stockholders' equity (deficit)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xml:lang="en-US" id="id_3828183_927127_1_1">Stockholders Equity Note Disclosure [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xml:lang="en-US" id="id_3828183_927127_2_1">Redeemable convertible preferred stock and stockholders' (deficit) equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquityNoteRedeemablePreferredStockIssuePolicy" xlink:label="us-gaap_StockholdersEquityNoteRedeemablePreferredStockIssuePolicy"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteRedeemablePreferredStockIssuePolicy_lbl" xml:lang="en-US" id="id_3828183_929566_1_1">Stockholders Equity Note Redeemable Preferred Stock Issue Policy</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockholdersEquityNoteRedeemablePreferredStockIssuePolicy_lbl" xml:lang="en-US" id="id_3828183_929566_2_1">Redeemable convertible preferred stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteRedeemablePreferredStockIssuePolicy" xlink:to="us-gaap_StockholdersEquityNoteRedeemablePreferredStockIssuePolicy_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:label="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_lbl" xml:lang="en-US" id="id_3828183_931725_1_1">Stockholders Equity Note Stock Split Conversion Ratio 1</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_lbl" xml:lang="en-US" id="id_3828183_931725_2_1">Conversion ratio of reverse stock split</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:to="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:label="us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract_lbl" xml:lang="en-US" id="id_3828183_924187_1_1">Stockholders Equity Number Of Shares Par Value And Other Disclosures [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract_lbl" xml:lang="en-US" id="id_3828183_924187_2_1">Share capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:to="us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquityReverseStockSplit" xlink:label="us-gaap_StockholdersEquityReverseStockSplit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityReverseStockSplit_lbl" xml:lang="en-US" id="id_3828183_925324_1_1">Stockholders Equity Reverse Stock Split</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockholdersEquityReverseStockSplit_lbl" xml:lang="en-US" id="id_3828183_925324_2_1">Conversion basis for reverse stock split</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityReverseStockSplit" xlink:to="us-gaap_StockholdersEquityReverseStockSplit_lbl"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_StockIncentivePlanTwoThousandFourteenMember" xlink:label="aqxp_StockIncentivePlanTwoThousandFourteenMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqxp_StockIncentivePlanTwoThousandFourteenMember_lbl" xml:lang="en-US" id="id_3828183_1118518_3_1">Stock Incentive Plan Two Thousand Fourteen [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqxp_StockIncentivePlanTwoThousandFourteenMember_lbl" xml:lang="en-US" id="id_3828183_1118518_1_1">Stock Incentive Plan Two Thousand Fourteen [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aqxp_StockIncentivePlanTwoThousandFourteenMember_lbl" xml:lang="en-US" id="id_3828183_1118518_2_1">Equity Incentive Plan 2014 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqxp_StockIncentivePlanTwoThousandFourteenMember" xlink:to="aqxp_StockIncentivePlanTwoThousandFourteenMember_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_lbl" xml:lang="en-US" id="id_3828183_931845_1_1">Stock Issued During Period Shares Conversion Of Units</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_lbl" xml:lang="en-US" id="id_3828183_931845_2_1">Share reorganization, Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForCash" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForCash"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForCash_lbl" xml:lang="en-US" id="id_3828183_924366_1_1">Stock Issued During Period Shares Issued For Cash</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForCash_lbl" xml:lang="en-US" id="id_3828183_924366_2_1">Issued for cash, net of share issue costs, Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesIssuedForCash" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForCash_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForNoncashConsideration" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForNoncashConsideration"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForNoncashConsideration_lbl" xml:lang="en-US" id="id_3828183_925842_1_1">Stock Issued During Period Shares Issued For Noncash Consideration</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForNoncashConsideration_lbl" xml:lang="en-US" id="id_3828183_925842_2_1">Issued for intangible assets, Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesIssuedForNoncashConsideration" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForNoncashConsideration_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xml:lang="en-US" id="id_3828183_932873_1_1">Stock Issued During Period Shares New Issues</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xml:lang="en-US" id="id_3828183_932873_2_1">Shares of common stock sold in IPO</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits_lbl" xml:lang="en-US" id="id_3828183_934771_1_1">Stock Issued During Period Value Conversion Of Units</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits_lbl" xml:lang="en-US" id="id_3828183_934771_2_1">Share reorganization</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForCash" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForCash"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForCash_lbl" xml:lang="en-US" id="id_3828183_935365_1_1">Stock Issued During Period Value Issued For Cash</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForCash_lbl" xml:lang="en-US" id="id_3828183_935365_2_1">Issued for cash, net of share issue costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueIssuedForCash" xlink:to="us-gaap_StockIssuedDuringPeriodValueIssuedForCash_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForNoncashConsiderations" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForNoncashConsiderations"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForNoncashConsiderations_lbl" xml:lang="en-US" id="id_3828183_935780_1_1">Stock Issued During Period Value Issued For Noncash Considerations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForNoncashConsiderations_lbl" xml:lang="en-US" id="id_3828183_935780_2_1">Issued for intangible assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueIssuedForNoncashConsiderations" xlink:to="us-gaap_StockIssuedDuringPeriodValueIssuedForNoncashConsiderations_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="us-gaap_StockRepurchasedDuringPeriodShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockRepurchasedDuringPeriodShares_lbl" xml:lang="en-US" id="id_3828183_931573_1_1">Stock Repurchased During Period Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_StockRepurchasedDuringPeriodShares_lbl" xml:lang="en-US" id="id_3828183_931573_14_1">Repurchase of common stock, Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchasedDuringPeriodShares" xlink:to="us-gaap_StockRepurchasedDuringPeriodShares_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue" xlink:label="us-gaap_StockRepurchasedDuringPeriodValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockRepurchasedDuringPeriodValue_lbl" xml:lang="en-US" id="id_3828183_938532_1_1">Stock Repurchased During Period Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_StockRepurchasedDuringPeriodValue_lbl" xml:lang="en-US" id="id_3828183_938532_14_1">Repurchase of common stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchasedDuringPeriodValue" xlink:to="us-gaap_StockRepurchasedDuringPeriodValue_lbl"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_StockSharesAuthorizedNet" xlink:label="aqxp_StockSharesAuthorizedNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqxp_StockSharesAuthorizedNet_lbl" xml:lang="en-US" id="id_3828183_1263894_3_1">Stock Shares Authorized Net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqxp_StockSharesAuthorizedNet_lbl" xml:lang="en-US" id="id_3828183_1263894_1_1">Stock Shares Authorized Net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aqxp_StockSharesAuthorizedNet_lbl" xml:lang="en-US" id="id_3828183_1263894_2_1">Total number of shares authorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqxp_StockSharesAuthorizedNet" xlink:to="aqxp_StockSharesAuthorizedNet_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_lbl" xml:lang="en-US" id="id_3828183_931707_1_1">Subsidiary Sale Of Stock [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_lbl" xml:lang="en-US" id="id_3828183_931707_2_1">Subsidiary, Sale of Stock [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SubsidiarySaleOfStockAxis_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xml:lang="en-US" id="id_3828183_930441_1_1">Supplemental Cash Flow Information [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xml:lang="en-US" id="id_3828183_930441_2_1">Supplemental disclosure of cash flow information:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TemporaryEquityAbstract" xlink:label="us-gaap_TemporaryEquityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquityAbstract_lbl" xml:lang="en-US" id="id_3828183_931635_1_1">Temporary Equity [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_TemporaryEquityAbstract_lbl" xml:lang="en-US" id="id_3828183_931635_2_1">Redeemable convertible preferred stock (Note 3)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityAbstract" xlink:to="us-gaap_TemporaryEquityAbstract_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" xlink:label="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment_lbl" xml:lang="en-US" id="id_3828183_938443_1_1">Temporary Equity Accretion To Redemption Value Adjustment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment_lbl" xml:lang="en-US" id="id_3828183_938443_14_1">Accretion for share issuance costs on preferred stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" xlink:to="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment_lbl"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_TemporaryEquityAccretionToRedemptionValueLiquidationPreference" xlink:label="aqxp_TemporaryEquityAccretionToRedemptionValueLiquidationPreference"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqxp_TemporaryEquityAccretionToRedemptionValueLiquidationPreference_lbl" xml:lang="en-US" id="id_3828183_1261135_3_1">Accretion for liquidation preference on temporary equity.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqxp_TemporaryEquityAccretionToRedemptionValueLiquidationPreference_lbl" xml:lang="en-US" id="id_3828183_1261135_1_1">Temporary Equity Accretion To Redemption Value Liquidation Preference</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="aqxp_TemporaryEquityAccretionToRedemptionValueLiquidationPreference_lbl" xml:lang="en-US" id="id_3828183_1261135_14_1">Accretion for liquidation preference on preferred stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqxp_TemporaryEquityAccretionToRedemptionValueLiquidationPreference" xlink:to="aqxp_TemporaryEquityAccretionToRedemptionValueLiquidationPreference_lbl"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_TemporaryEquityAccretionToRedemptionValueRedemptionOption" xlink:label="aqxp_TemporaryEquityAccretionToRedemptionValueRedemptionOption"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqxp_TemporaryEquityAccretionToRedemptionValueRedemptionOption_lbl" xml:lang="en-US" id="id_3828183_1261174_3_1">Temporary Equity Accretion To Redemption Value Redemption Option</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqxp_TemporaryEquityAccretionToRedemptionValueRedemptionOption_lbl" xml:lang="en-US" id="id_3828183_1261174_1_1">Temporary Equity Accretion To Redemption Value Redemption Option</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aqxp_TemporaryEquityAccretionToRedemptionValueRedemptionOption_lbl" xml:lang="en-US" id="id_3828183_1261174_2_1">Amortization of redemption option on preferred stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqxp_TemporaryEquityAccretionToRedemptionValueRedemptionOption" xlink:to="aqxp_TemporaryEquityAccretionToRedemptionValueRedemptionOption_lbl"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_TemporaryEquityAccretionToRedemptionValueWarrantDiscount" xlink:label="aqxp_TemporaryEquityAccretionToRedemptionValueWarrantDiscount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqxp_TemporaryEquityAccretionToRedemptionValueWarrantDiscount_lbl" xml:lang="en-US" id="id_3828183_1261173_3_1">Temporary Equity Accretion To Redemption Value Warrant Discount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqxp_TemporaryEquityAccretionToRedemptionValueWarrantDiscount_lbl" xml:lang="en-US" id="id_3828183_1261173_1_1">Temporary Equity Accretion To Redemption Value Warrant Discount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="aqxp_TemporaryEquityAccretionToRedemptionValueWarrantDiscount_lbl" xml:lang="en-US" id="id_3828183_1261173_14_1">Amortization of warrant discount on preferred stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqxp_TemporaryEquityAccretionToRedemptionValueWarrantDiscount" xlink:to="aqxp_TemporaryEquityAccretionToRedemptionValueWarrantDiscount_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl" xml:lang="en-US" id="id_3828183_934783_1_1">Temporary Equity Carrying Amount Attributable To Parent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl" xml:lang="en-US" id="id_3828183_934783_2_1">Redeemable convertible preferred stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:label="us-gaap_TemporaryEquityParOrStatedValuePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquityParOrStatedValuePerShare_lbl" xml:lang="en-US" id="id_3828183_928253_1_1">Temporary Equity Par Or Stated Value Per Share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_TemporaryEquityParOrStatedValuePerShare_lbl" xml:lang="en-US" id="id_3828183_928253_2_1">Redeemable convertible preferred stock, par value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:to="us-gaap_TemporaryEquityParOrStatedValuePerShare_lbl"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_TemporaryEquityRedemptionDiscount" xlink:label="aqxp_TemporaryEquityRedemptionDiscount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqxp_TemporaryEquityRedemptionDiscount_lbl" xml:lang="en-US" id="id_3828183_1262840_3_1">Discount on issuance of preferred shares for value of bifurcated redemption feature.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqxp_TemporaryEquityRedemptionDiscount_lbl" xml:lang="en-US" id="id_3828183_1262840_1_1">Temporary Equity Redemption Discount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="aqxp_TemporaryEquityRedemptionDiscount_lbl" xml:lang="en-US" id="id_3828183_1262840_14_1">Redemption discount of $466,673 for AQXP Canada and $1,633,357 for Aquinox USA on issuance of preferred shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqxp_TemporaryEquityRedemptionDiscount" xlink:to="aqxp_TemporaryEquityRedemptionDiscount_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TemporaryEquitySharesAuthorized" xlink:label="us-gaap_TemporaryEquitySharesAuthorized"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquitySharesAuthorized_lbl" xml:lang="en-US" id="id_3828183_923969_1_1">Temporary Equity Shares Authorized</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_TemporaryEquitySharesAuthorized_lbl" xml:lang="en-US" id="id_3828183_923969_2_1">Redeemable convertible preferred stock, shares authorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquitySharesAuthorized" xlink:to="us-gaap_TemporaryEquitySharesAuthorized_lbl"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_TemporaryEquitySharesAuthorizedUnlimited" xlink:label="aqxp_TemporaryEquitySharesAuthorizedUnlimited"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqxp_TemporaryEquitySharesAuthorizedUnlimited_lbl" xml:lang="en-US" id="id_3828183_1259106_3_1">Temporary Equity Shares Authorized Unlimited</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqxp_TemporaryEquitySharesAuthorizedUnlimited_lbl" xml:lang="en-US" id="id_3828183_1259106_1_1">Temporary Equity Shares Authorized Unlimited</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aqxp_TemporaryEquitySharesAuthorizedUnlimited_lbl" xml:lang="en-US" id="id_3828183_1259106_2_1">Redeemable convertible preferred stock, shares authorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqxp_TemporaryEquitySharesAuthorizedUnlimited" xlink:to="aqxp_TemporaryEquitySharesAuthorizedUnlimited_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TemporaryEquitySharesIssued" xlink:label="us-gaap_TemporaryEquitySharesIssued"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquitySharesIssued_lbl" xml:lang="en-US" id="id_3828183_931547_1_1">Temporary Equity Shares Issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_TemporaryEquitySharesIssued_lbl" xml:lang="en-US" id="id_3828183_931547_2_1">Redeemable convertible preferred stock, shares issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquitySharesIssued" xlink:to="us-gaap_TemporaryEquitySharesIssued_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquitySharesOutstanding_lbl" xml:lang="en-US" id="id_3828183_925522_1_1">Temporary Equity Shares Outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_TemporaryEquitySharesOutstanding_lbl" xml:lang="en-US" id="id_3828183_925522_2_1">Redeemable convertible preferred stock, shares outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquitySharesOutstanding" xlink:to="us-gaap_TemporaryEquitySharesOutstanding_lbl"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_TemporaryEquityWarrantDiscount" xlink:label="aqxp_TemporaryEquityWarrantDiscount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqxp_TemporaryEquityWarrantDiscount_lbl" xml:lang="en-US" id="id_3828183_1262837_3_1">Discount on issuance of preferred shares for value of warrants.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqxp_TemporaryEquityWarrantDiscount_lbl" xml:lang="en-US" id="id_3828183_1262837_1_1">Temporary Equity Warrant Discount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="aqxp_TemporaryEquityWarrantDiscount_lbl" xml:lang="en-US" id="id_3828183_1262837_14_1">Warrant discount on issuance of preferred shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqxp_TemporaryEquityWarrantDiscount" xlink:to="aqxp_TemporaryEquityWarrantDiscount_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TextBlockAbstract" xlink:label="us-gaap_TextBlockAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TextBlockAbstract_lbl" xml:lang="en-US" id="id_3828183_931202_1_1">Text Block [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_TextBlockAbstract_lbl" xml:lang="en-US" id="id_3828183_931202_2_1">Text Block [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TextBlockAbstract" xlink:to="us-gaap_TextBlockAbstract_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TitleOfIndividualAxis" xlink:label="us-gaap_TitleOfIndividualAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TitleOfIndividualAxis_lbl" xml:lang="en-US" id="id_3828183_925175_1_1">Title Of Individual [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_TitleOfIndividualAxis_lbl" xml:lang="en-US" id="id_3828183_925175_2_1">Title of Individual [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TitleOfIndividualAxis" xlink:to="us-gaap_TitleOfIndividualAxis_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="us-gaap_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_lbl" xml:lang="en-US" id="id_3828183_925395_1_1">Title Of Individual With Relationship To Entity [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_lbl" xml:lang="en-US" id="id_3828183_925395_2_1">Relationship to Entity [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US" id="id_3828183_921927_1_1">Trading Symbol</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US" id="id_3828183_921927_2_1">Trading Symbol</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_UncategorizedAbstract" xlink:label="aqxp_UncategorizedAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqxp_UncategorizedAbstract_lbl" xml:lang="en-US" id="id_3828183_941397_3_1">Uncategorized [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqxp_UncategorizedAbstract_lbl" xml:lang="en-US" id="id_3828183_941397_1_1">Uncategorized [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aqxp_UncategorizedAbstract_lbl" xml:lang="en-US" id="id_3828183_941397_2_1">Uncategorized [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqxp_UncategorizedAbstract" xlink:to="aqxp_UncategorizedAbstract_lbl"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_UnderwritersMember" xlink:label="aqxp_UnderwritersMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqxp_UnderwritersMember_lbl" xml:lang="en-US" id="id_3828183_960063_3_1">Underwriters [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqxp_UnderwritersMember_lbl" xml:lang="en-US" id="id_3828183_960063_1_1">Underwriters [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aqxp_UnderwritersMember_lbl" xml:lang="en-US" id="id_3828183_960063_2_1">Underwriters [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqxp_UnderwritersMember" xlink:to="aqxp_UnderwritersMember_lbl"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_UnrecognizedCompensationExpenseWeightedAveragePeriod" xlink:label="aqxp_UnrecognizedCompensationExpenseWeightedAveragePeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqxp_UnrecognizedCompensationExpenseWeightedAveragePeriod_lbl" xml:lang="en-US" id="id_3828183_1025228_3_1">Unrecognized Compensation Expense Weighted Average Period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqxp_UnrecognizedCompensationExpenseWeightedAveragePeriod_lbl" xml:lang="en-US" id="id_3828183_1025228_1_1">Unrecognized Compensation Expense Weighted Average Period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aqxp_UnrecognizedCompensationExpenseWeightedAveragePeriod_lbl" xml:lang="en-US" id="id_3828183_1025228_2_1">Unrecognized stock-based compensation cost, weighted-average period recognized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqxp_UnrecognizedCompensationExpenseWeightedAveragePeriod" xlink:to="aqxp_UnrecognizedCompensationExpenseWeightedAveragePeriod_lbl"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_UnrecognizedShareBasedCompensationExpense" xlink:label="aqxp_UnrecognizedShareBasedCompensationExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqxp_UnrecognizedShareBasedCompensationExpense_lbl" xml:lang="en-US" id="id_3828183_1034093_3_1">Unrecognized Share Based Compensation Expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqxp_UnrecognizedShareBasedCompensationExpense_lbl" xml:lang="en-US" id="id_3828183_1034093_1_1">Unrecognized Share Based Compensation Expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aqxp_UnrecognizedShareBasedCompensationExpense_lbl" xml:lang="en-US" id="id_3828183_1034093_2_1">Unrecognized stock-based compensation cost</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqxp_UnrecognizedShareBasedCompensationExpense" xlink:to="aqxp_UnrecognizedShareBasedCompensationExpense_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/country/2013/country-2013-01-31.xsd#country_US" xlink:label="country_US"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_US_lbl" xml:lang="en-US" id="id_3828183_921516_1_1">U S</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="country_US_lbl" xml:lang="en-US" id="id_3828183_921516_2_1">United States [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_US" xlink:to="country_US_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UseOfEstimates_lbl" xml:lang="en-US" id="id_3828183_931855_1_1">Use Of Estimates</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_UseOfEstimates_lbl" xml:lang="en-US" id="id_3828183_931855_2_1">Use of estimates</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_WarrantDerivativeLiabilityMember" xlink:label="aqxp_WarrantDerivativeLiabilityMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqxp_WarrantDerivativeLiabilityMember_lbl" xml:lang="en-US" id="id_3828183_1155513_3_1">Warrant Derivative Liability [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqxp_WarrantDerivativeLiabilityMember_lbl" xml:lang="en-US" id="id_3828183_1155513_1_1">Warrant Derivative Liability [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aqxp_WarrantDerivativeLiabilityMember_lbl" xml:lang="en-US" id="id_3828183_1155513_2_1">Warrant Derivative Liabilities [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqxp_WarrantDerivativeLiabilityMember" xlink:to="aqxp_WarrantDerivativeLiabilityMember_lbl"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_WarrantDiscount" xlink:label="aqxp_WarrantDiscount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqxp_WarrantDiscount_lbl" xml:lang="en-US" id="id_3828183_1191924_3_1">Warrant Discount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqxp_WarrantDiscount_lbl" xml:lang="en-US" id="id_3828183_1191924_1_1">Warrant Discount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aqxp_WarrantDiscount_lbl" xml:lang="en-US" id="id_3828183_1191924_2_1">Warrant discount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqxp_WarrantDiscount" xlink:to="aqxp_WarrantDiscount_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantMember_lbl" xml:lang="en-US" id="id_3828183_929614_1_1">Warrant [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WarrantMember_lbl" xml:lang="en-US" id="id_3828183_929614_2_1">Common Stock Warrants [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantMember" xlink:to="us-gaap_WarrantMember_lbl"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_WarrantsExercised" xlink:label="aqxp_WarrantsExercised"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqxp_WarrantsExercised_lbl" xml:lang="en-US" id="id_3828183_1141951_3_1">Warrants Exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqxp_WarrantsExercised_lbl" xml:lang="en-US" id="id_3828183_1141951_1_1">Warrants Exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aqxp_WarrantsExercised_lbl" xml:lang="en-US" id="id_3828183_1141951_2_1">Warrants exercised</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqxp_WarrantsExercised" xlink:to="aqxp_WarrantsExercised_lbl"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_WarrantsExercisedShares" xlink:label="aqxp_WarrantsExercisedShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqxp_WarrantsExercisedShares_lbl" xml:lang="en-US" id="id_3828183_1068179_3_1">Warrants Exercised Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqxp_WarrantsExercisedShares_lbl" xml:lang="en-US" id="id_3828183_1068179_1_1">Warrants Exercised Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aqxp_WarrantsExercisedShares_lbl" xml:lang="en-US" id="id_3828183_1068179_2_1">Warrants exercised, Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqxp_WarrantsExercisedShares" xlink:to="aqxp_WarrantsExercisedShares_lbl"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_WarrantsToPurchaseCommonStockMember" xlink:label="aqxp_WarrantsToPurchaseCommonStockMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqxp_WarrantsToPurchaseCommonStockMember_lbl" xml:lang="en-US" id="id_3828183_1022881_3_1">Warrants To Purchase Common Stock [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqxp_WarrantsToPurchaseCommonStockMember_lbl" xml:lang="en-US" id="id_3828183_1022881_1_1">Warrants To Purchase Common Stock [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aqxp_WarrantsToPurchaseCommonStockMember_lbl" xml:lang="en-US" id="id_3828183_1022881_2_1">Warrants to Purchase Common Stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqxp_WarrantsToPurchaseCommonStockMember" xlink:to="aqxp_WarrantsToPurchaseCommonStockMember_lbl"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_WarrantsToPurchaseSeriescConvertiblePreferredStockMember" xlink:label="aqxp_WarrantsToPurchaseSeriescConvertiblePreferredStockMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="aqxp_WarrantsToPurchaseSeriescConvertiblePreferredStockMember_lbl" xml:lang="en-US" id="id_3828183_1232250_3_1">Warrants To Purchase SeriesC Convertible Preferred Stock [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="aqxp_WarrantsToPurchaseSeriescConvertiblePreferredStockMember_lbl" xml:lang="en-US" id="id_3828183_1232250_1_1">Warrants To Purchase Seriesc Convertible Preferred Stock [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="aqxp_WarrantsToPurchaseSeriescConvertiblePreferredStockMember_lbl" xml:lang="en-US" id="id_3828183_1232250_2_1">Warrants to Purchase Series C Convertible Preferred Stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="aqxp_WarrantsToPurchaseSeriescConvertiblePreferredStockMember" xlink:to="aqxp_WarrantsToPurchaseSeriescConvertiblePreferredStockMember_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:label="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_lbl" xml:lang="en-US" id="id_3828183_925122_1_1">Weighted Average Number Diluted Shares Outstanding Adjustment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_lbl" xml:lang="en-US" id="id_3828183_925122_6_1">Weighted average shares used to compute diluted net loss per common share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:to="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:label="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_lbl" xml:lang="en-US" id="id_3828183_927586_1_1">Weighted Average Number Diluted Shares Outstanding Adjustment [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_lbl" xml:lang="en-US" id="id_3828183_927586_2_1">Effect of potentially dilutive securities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:to="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xml:lang="en-US" id="id_3828183_927104_1_1">Weighted Average Number Of Share Outstanding Basic And Diluted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xml:lang="en-US" id="id_3828183_927104_2_1">Basic and diluted weighted average common stock outstanding (Note 7)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_lbl" xml:lang="en-US" id="id_3828183_926588_1_1">Weighted Average Number Of Shares Outstanding [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_lbl" xml:lang="en-US" id="id_3828183_926588_2_1">Denominator</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_lbl"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xml:lang="en-US" id="id_3828183_929768_1_1">Weighted Average Number Of Shares Outstanding Basic</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xml:lang="en-US" id="id_3828183_929768_2_1">Weighted average shares used to compute basic net loss per common share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl"/>
  </labelLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>11
<FILENAME>aqxp-20140331_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- RR Donnelley Xcelerate Taxonomy Presentation Linkbase, based on XBRL 2.1  http://www.rrdonnelley.com/ -->
<!-- Version: 6.21.0 -->
<!-- Round: 5 -->
<!-- Creation date: 2014-05-12T17:22:31Z -->
<!-- Copyright (c) 2005-2013 R.R. Donnelley & Sons Company All Rights Reserved. -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="aqxp-20140331.xsd#DocumentandEntityInformation" roleURI="http://imetrix.edgar-online.com/taxonomy/role/DocumentandEntityInformation"/>
  <roleRef xlink:type="simple" xlink:href="aqxp-20140331.xsd#Role_StatementOfFinancialPositionClassified" roleURI="http://imetrix.edgar-online.com/taxonomy/role/StatementOfFinancialPositionClassified"/>
  <roleRef xlink:type="simple" xlink:href="aqxp-20140331.xsd#Role_StatementOfFinancialPositionClassifiedParen" roleURI="http://imetrix.edgar-online.com/taxonomy/role/StatementOfFinancialPositionClassifiedParenthetical"/>
  <roleRef xlink:type="simple" xlink:href="aqxp-20140331.xsd#Role_StatementOfIncomeAlternative" roleURI="http://imetrix.edgar-online.com/taxonomy/role/StatementOfIncomeAlternative"/>
  <roleRef xlink:type="simple" xlink:href="aqxp-20140331.xsd#Role_StatementOfShareholdersEquityAndOtherComprehensiveIncome" roleURI="http://imetrix.edgar-online.com/taxonomy/role/StatementOfShareholdersEquityAndOtherComprehensiveIncome"/>
  <roleRef xlink:type="simple" xlink:href="aqxp-20140331.xsd#Role_StatementOfShareholdersEquityAndOtherComprehensiveIncomeParen" roleURI="http://imetrix.edgar-online.com/taxonomy/role/StatementOfShareholdersEquityAndOtherComprehensiveIncomeParenthetical"/>
  <roleRef xlink:type="simple" xlink:href="aqxp-20140331.xsd#Role_StatementOfCashFlowsIndirect" roleURI="http://imetrix.edgar-online.com/taxonomy/role/StatementOfCashFlowsIndirect"/>
  <roleRef xlink:type="simple" xlink:href="aqxp-20140331.xsd#DisclosureNatureOfOperationsAdditionalInformation" roleURI="http://imetrix.edgar-online.com/taxonomy/role/DisclosureNatureOfOperationsAdditionalInformation"/>
  <roleRef xlink:type="simple" xlink:href="aqxp-20140331.xsd#DisclosureCondensedSummaryOfSignificantAccountingPoliciesAdditionalInformation" roleURI="http://imetrix.edgar-online.com/taxonomy/role/DisclosureCondensedSummaryOfSignificantAccountingPoliciesAdditionalInformation"/>
  <roleRef xlink:type="simple" xlink:href="aqxp-20140331.xsd#DisclosureRedeemableConvertiblePreferredStockAndStockholdersdeficitEquityAdditionalInformation" roleURI="http://imetrix.edgar-online.com/taxonomy/role/DisclosureRedeemableConvertiblePreferredStockAndStockholdersdeficitEquityAdditionalInformation"/>
  <roleRef xlink:type="simple" xlink:href="aqxp-20140331.xsd#DisclosureCashAndCashEquivalentsScheduleOfCashAndCashEquivalents" roleURI="http://imetrix.edgar-online.com/taxonomy/role/DisclosureCashAndCashEquivalentsScheduleOfCashAndCashEquivalents"/>
  <roleRef xlink:type="simple" xlink:href="aqxp-20140331.xsd#DisclosureLoanFacilityAdditionalInformation" roleURI="http://imetrix.edgar-online.com/taxonomy/role/DisclosureLoanFacilityAdditionalInformation"/>
  <roleRef xlink:type="simple" xlink:href="aqxp-20140331.xsd#DisclosureLoanFacilityScheduleOfLoanFacility" roleURI="http://imetrix.edgar-online.com/taxonomy/role/DisclosureLoanFacilityScheduleOfLoanFacility"/>
  <roleRef xlink:type="simple" xlink:href="aqxp-20140331.xsd#DisclosureLoanFacilitySummaryOfBankLoanFacility" roleURI="http://imetrix.edgar-online.com/taxonomy/role/DisclosureLoanFacilitySummaryOfBankLoanFacility"/>
  <roleRef xlink:type="simple" xlink:href="aqxp-20140331.xsd#DisclosureCommonStockAdditionalInformation" roleURI="http://imetrix.edgar-online.com/taxonomy/role/DisclosureCommonStockAdditionalInformation"/>
  <roleRef xlink:type="simple" xlink:href="aqxp-20140331.xsd#DisclosureCommonStockScheduleOfWeightedAverageAssumptions" roleURI="http://imetrix.edgar-online.com/taxonomy/role/DisclosureCommonStockScheduleOfWeightedAverageAssumptions"/>
  <roleRef xlink:type="simple" xlink:href="aqxp-20140331.xsd#DisclosureNetLossPerShareAdditionalInformation" roleURI="http://imetrix.edgar-online.com/taxonomy/role/DisclosureNetLossPerShareAdditionalInformation"/>
  <roleRef xlink:type="simple" xlink:href="aqxp-20140331.xsd#DisclosureNetLossPerShareScheduleOfComputationOfBasicAndDilutedEarningsPerShare" roleURI="http://imetrix.edgar-online.com/taxonomy/role/DisclosureNetLossPerShareScheduleOfComputationOfBasicAndDilutedEarningsPerShare"/>
  <roleRef xlink:type="simple" xlink:href="aqxp-20140331.xsd#DisclosureNetLossPerShareScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfBasicAndDilutedNetLossPerShare" roleURI="http://imetrix.edgar-online.com/taxonomy/role/DisclosureNetLossPerShareScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfBasicAndDilutedNetLossPerShare"/>
  <roleRef xlink:type="simple" xlink:href="aqxp-20140331.xsd#DisclosureFinancialInstrumentsFairValueOfSignificantUnobservableInputs" roleURI="http://imetrix.edgar-online.com/taxonomy/role/DisclosureFinancialInstrumentsFairValueOfSignificantUnobservableInputs"/>
  <roleRef xlink:type="simple" xlink:href="aqxp-20140331.xsd#DisclosureFinancialInstrumentsAdditionalInformation" roleURI="http://imetrix.edgar-online.com/taxonomy/role/DisclosureFinancialInstrumentsAdditionalInformation"/>
  <roleRef xlink:type="simple" xlink:href="aqxp-20140331.xsd#Role_NotesToFinancialStatementsNatureOfOperations" roleURI="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsNatureOfOperations"/>
  <roleRef xlink:type="simple" xlink:href="aqxp-20140331.xsd#Role_NotesToFinancialStatementsSignificantAccountingPoliciesTextBlock" roleURI="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsSignificantAccountingPoliciesTextBlock"/>
  <roleRef xlink:type="simple" xlink:href="aqxp-20140331.xsd#Role_NotesToFinancialStatementsSignificantAccountingPoliciesTextBlockPolicies" roleURI="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsSignificantAccountingPoliciesTextBlockPolicies"/>
  <roleRef xlink:type="simple" xlink:href="aqxp-20140331.xsd#Role_NotesToFinancialStatementsStockholdersEquityNoteDisclosureTextBlock" roleURI="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsStockholdersEquityNoteDisclosureTextBlock"/>
  <roleRef xlink:type="simple" xlink:href="aqxp-20140331.xsd#Role_NotesToFinancialStatementsCashAndCashEquivalentsDisclosureTextBlock" roleURI="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsCashAndCashEquivalentsDisclosureTextBlock"/>
  <roleRef xlink:type="simple" xlink:href="aqxp-20140331.xsd#Role_NotesToFinancialStatementsCashAndCashEquivalentsDisclosureTextBlockTables" roleURI="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsCashAndCashEquivalentsDisclosureTextBlockTables"/>
  <roleRef xlink:type="simple" xlink:href="aqxp-20140331.xsd#Role_NotesToFinancialStatementsDebtDisclosureTextBlock" roleURI="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsDebtDisclosureTextBlock"/>
  <roleRef xlink:type="simple" xlink:href="aqxp-20140331.xsd#Role_NotesToFinancialStatementsDebtDisclosureTextBlockTables" roleURI="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsDebtDisclosureTextBlockTables"/>
  <roleRef xlink:type="simple" xlink:href="aqxp-20140331.xsd#Role_NotesToFinancialStatementsCommonStockDisclosureTextBlock" roleURI="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsCommonStockDisclosureTextBlock"/>
  <roleRef xlink:type="simple" xlink:href="aqxp-20140331.xsd#Role_NotesToFinancialStatementsCommonStockDisclosureTextBlockTables" roleURI="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsCommonStockDisclosureTextBlockTables"/>
  <roleRef xlink:type="simple" xlink:href="aqxp-20140331.xsd#Role_NotesToFinancialStatementsEarningsPerShareTextBlock" roleURI="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsEarningsPerShareTextBlock"/>
  <roleRef xlink:type="simple" xlink:href="aqxp-20140331.xsd#Role_NotesToFinancialStatementsEarningsPerShareTextBlockTables" roleURI="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsEarningsPerShareTextBlockTables"/>
  <roleRef xlink:type="simple" xlink:href="aqxp-20140331.xsd#Role_NotesToFinancialStatementsFinancialInstrumentsDisclosureTextBlock" roleURI="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsFinancialInstrumentsDisclosureTextBlock"/>
  <roleRef xlink:type="simple" xlink:href="aqxp-20140331.xsd#Role_NotesToFinancialStatementsFinancialInstrumentsDisclosureTextBlockTables" roleURI="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsFinancialInstrumentsDisclosureTextBlockTables"/>
  <presentationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/DocumentandEntityInformation">
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_DocumentAndEntityInformationAbstract" xlink:label="aqxp_DocumentAndEntityInformationAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aqxp_DocumentAndEntityInformationAbstract" xlink:to="dei_DocumentType" order="1.0100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aqxp_DocumentAndEntityInformationAbstract" xlink:to="dei_AmendmentFlag" order="1.0200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aqxp_DocumentAndEntityInformationAbstract" xlink:to="dei_DocumentPeriodEndDate" order="1.0300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aqxp_DocumentAndEntityInformationAbstract" xlink:to="dei_DocumentFiscalYearFocus" order="1.0400" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aqxp_DocumentAndEntityInformationAbstract" xlink:to="dei_DocumentFiscalPeriodFocus" order="1.0500" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aqxp_DocumentAndEntityInformationAbstract" xlink:to="dei_TradingSymbol" order="1.0600" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aqxp_DocumentAndEntityInformationAbstract" xlink:to="dei_EntityRegistrantName" order="1.0700" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aqxp_DocumentAndEntityInformationAbstract" xlink:to="dei_EntityCentralIndexKey" order="1.0800" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aqxp_DocumentAndEntityInformationAbstract" xlink:to="dei_CurrentFiscalYearEndDate" order="1.0900" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aqxp_DocumentAndEntityInformationAbstract" xlink:to="dei_EntityFilerCategory" order="1.1000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aqxp_DocumentAndEntityInformationAbstract" xlink:to="dei_EntityCommonStockSharesOutstanding" order="1.1100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/StatementOfFinancialPositionClassified">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccountsAndOtherReceivablesNetCurrent" xlink:label="us-gaap_AccountsAndOtherReceivablesNetCurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_AquinoxUsaMember" xlink:label="aqxp_AquinoxUsaMember"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_AqxpCanadaMember" xlink:label="aqxp_AqxpCanadaMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:label="us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredOfferingCosts" xlink:label="us-gaap_DeferredOfferingCosts"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxLiabilitiesNoncurrent" xlink:label="us-gaap_DeferredTaxLiabilitiesNoncurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DerivativeLiabilitiesNoncurrent" xlink:label="us-gaap_DerivativeLiabilitiesNoncurrent"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_DerivativeLiabilitiesNoncurrentRedemptionOption" xlink:label="aqxp_DerivativeLiabilitiesNoncurrentRedemptionOption"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage" xlink:label="us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LiabilitiesAbstract" xlink:label="us-gaap_LiabilitiesAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LoansPayableToBankCurrent" xlink:label="us-gaap_LoansPayableToBankCurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LongTermLoansFromBank" xlink:label="us-gaap_LongTermLoansFromBank"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="us-gaap_OtherLiabilitiesCurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="us-gaap_OtherLiabilitiesNoncurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="us-gaap_PrepaidExpenseCurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_SeriesAConvertiblePreferredStockMember" xlink:label="aqxp_SeriesAConvertiblePreferredStockMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="us-gaap_SeriesAPreferredStockMember"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_SeriesBConvertiblePreferredStockMember" xlink:label="aqxp_SeriesBConvertiblePreferredStockMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="us-gaap_SeriesBPreferredStockMember"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_SeriesCConvertiblePreferredStockMember" xlink:label="aqxp_SeriesCConvertiblePreferredStockMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SeriesCPreferredStockMember" xlink:label="us-gaap_SeriesCPreferredStockMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShortTermInvestments" xlink:label="us-gaap_ShortTermInvestments"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:label="us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TemporaryEquityAbstract" xlink:label="us-gaap_TemporaryEquityAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsCurrentAbstract" order="1.3900" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="1.4000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_OtherAssetsNoncurrent" order="1.4100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_Assets" order="1.4200" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="1.2200" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_ShortTermInvestments" order="1.2300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AccountsAndOtherReceivablesNetCurrent" order="1.2400" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseCurrent" order="1.2500" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_DeferredOfferingCosts" order="1.2600" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrent" order="1.2700" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="aqxp_SeriesAConvertiblePreferredStockMember" order="1.2800" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesAPreferredStockMember" order="1.2900" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="aqxp_SeriesBConvertiblePreferredStockMember" order="1.3000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesBPreferredStockMember" order="1.3100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="aqxp_SeriesCConvertiblePreferredStockMember" order="1.3200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesCPreferredStockMember" order="1.3300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonStockMember" order="1.3400" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:to="us-gaap_CommonStockValue" order="1.3500" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:to="us-gaap_AdditionalPaidInCapital" order="1.3600" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:to="us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage" order="1.3700" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityDomain" xlink:to="aqxp_AqxpCanadaMember" order="1.0100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityDomain" xlink:to="aqxp_AquinoxUsaMember" order="1.0200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract" order="1.1500" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAbstract" xlink:to="us-gaap_DerivativeLiabilitiesNoncurrent" order="1.1600" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAbstract" xlink:to="aqxp_DerivativeLiabilitiesNoncurrentRedemptionOption" order="1.1700" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAbstract" xlink:to="us-gaap_DeferredTaxLiabilitiesNoncurrent" order="1.1800" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAbstract" xlink:to="us-gaap_LongTermLoansFromBank" order="1.1900" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAbstract" xlink:to="us-gaap_OtherLiabilitiesNoncurrent" order="1.2000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAbstract" xlink:to="us-gaap_Liabilities" order="1.2100" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" order="1.0300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LoansPayableToBankCurrent" order="1.0400" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_OtherLiabilitiesCurrent" order="1.0500" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrent" order="1.0600" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AssetsAbstract" order="1.0700" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LiabilitiesAbstract" order="1.0800" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquityAbstract" order="1.0900" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquityAbstract" order="1.1000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" order="1.1100" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementTable" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="10.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="11.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="100.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract" order="1.1200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" order="1.1300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquity" order="1.1400" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityAbstract" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" order="1.3800" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/StatementOfFinancialPositionClassifiedParenthetical">
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_AquinoxUsaMember" xlink:label="aqxp_AquinoxUsaMember"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_AqxpCanadaMember" xlink:label="aqxp_AqxpCanadaMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_SeriesAConvertiblePreferredStockMember" xlink:label="aqxp_SeriesAConvertiblePreferredStockMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="us-gaap_SeriesAPreferredStockMember"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_SeriesBConvertiblePreferredStockMember" xlink:label="aqxp_SeriesBConvertiblePreferredStockMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="us-gaap_SeriesBPreferredStockMember"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_SeriesCConvertiblePreferredStockMember" xlink:label="aqxp_SeriesCConvertiblePreferredStockMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SeriesCPreferredStockMember" xlink:label="us-gaap_SeriesCPreferredStockMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:label="us-gaap_TemporaryEquityParOrStatedValuePerShare"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TemporaryEquitySharesAuthorized" xlink:label="us-gaap_TemporaryEquitySharesAuthorized"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_TemporaryEquitySharesAuthorizedUnlimited" xlink:label="aqxp_TemporaryEquitySharesAuthorizedUnlimited"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TemporaryEquitySharesIssued" xlink:label="us-gaap_TemporaryEquitySharesIssued"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="aqxp_SeriesAConvertiblePreferredStockMember" order="1.1200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesAPreferredStockMember" order="1.1300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="aqxp_SeriesBConvertiblePreferredStockMember" order="1.1400" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesBPreferredStockMember" order="1.1500" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="aqxp_SeriesCConvertiblePreferredStockMember" order="1.1600" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesCPreferredStockMember" order="1.1700" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonStockMember" order="1.1800" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityDomain" xlink:to="aqxp_AqxpCanadaMember" order="1.0100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityDomain" xlink:to="aqxp_AquinoxUsaMember" order="1.0200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquityParOrStatedValuePerShare" order="1.0300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="aqxp_TemporaryEquitySharesAuthorizedUnlimited" order="1.0400" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesAuthorized" order="1.0500" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesIssued" order="1.0600" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesOutstanding" order="1.0700" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="1.0800" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" order="1.0900" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="1.1000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" order="1.1100" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementTable" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="2.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="100.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/StatementOfIncomeAlternative">
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_AmortizationOfDiscountOnPreferredStock" xlink:label="aqxp_AmortizationOfDiscountOnPreferredStock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_ExtinguishmentOfRemainingShareIssuanceCostsDueToConversionOfPreferredStock" xlink:label="aqxp_ExtinguishmentOfRemainingShareIssuanceCostsDueToConversionOfPreferredStock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:label="us-gaap_GainLossOnDerivativeInstrumentsNetPretax"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_IncomeTaxExpenseOnPreferredStock" xlink:label="aqxp_IncomeTaxExpenseOnPreferredStock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="us-gaap_InvestmentIncomeInterest"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_ReversalOfIncomeTaxPayableOnPreferredStock" xlink:label="aqxp_ReversalOfIncomeTaxPayableOnPreferredStock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" xlink:label="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_TemporaryEquityAccretionToRedemptionValueLiquidationPreference" xlink:label="aqxp_TemporaryEquityAccretionToRedemptionValueLiquidationPreference"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OperatingExpensesAbstract" order="1.0800" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_NonoperatingIncomeExpenseAbstract" order="1.0900" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="1.1000" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="1.1100" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax" order="1.1200" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="aqxp_TemporaryEquityAccretionToRedemptionValueLiquidationPreference" order="1.1300" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" order="1.1400" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="aqxp_IncomeTaxExpenseOnPreferredStock" order="1.1500" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="aqxp_ReversalOfIncomeTaxPayableOnPreferredStock" order="1.1600" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="aqxp_ExtinguishmentOfRemainingShareIssuanceCostsDueToConversionOfPreferredStock" order="1.1700" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" order="1.1800" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted" order="1.1900" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" order="1.2000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_InterestExpense" order="1.0100" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_InvestmentIncomeInterest" order="1.0200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" order="1.0300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_GainLossOnDerivativeInstrumentsNetPretax" order="1.0400" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="aqxp_AmortizationOfDiscountOnPreferredStock" order="1.0500" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" order="1.0600" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_NonoperatingIncomeExpense" order="1.0700" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="1.2100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="1.2200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpenses" order="1.2300" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/StatementOfShareholdersEquityAndOtherComprehensiveIncome">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccumulatedDeficitDuringDevelopmentStageMember" xlink:label="us-gaap_AccumulatedDeficitDuringDevelopmentStageMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_AquinoxUsaMember" xlink:label="aqxp_AquinoxUsaMember"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_AqxpCanadaMember" xlink:label="aqxp_AqxpCanadaMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_ConversionOfPreferredStockIntoCommonStock" xlink:label="aqxp_ConversionOfPreferredStockIntoCommonStock"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_ConversionOfPreferredStockIntoCommonStockShares" xlink:label="aqxp_ConversionOfPreferredStockIntoCommonStockShares"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConvertiblePreferredStockMember" xlink:label="us-gaap_ConvertiblePreferredStockMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_ExtinguishmentOfRemainingShareIssuanceCostsDueToConversionOfPreferredStock" xlink:label="aqxp_ExtinguishmentOfRemainingShareIssuanceCostsDueToConversionOfPreferredStock"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_IncomeTaxExpenseOnPreferredStock" xlink:label="aqxp_IncomeTaxExpenseOnPreferredStock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_NewCommonStockMember" xlink:label="aqxp_NewCommonStockMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockMember" xlink:label="us-gaap_PreferredStockMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForCash" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForCash"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForNoncashConsideration" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForNoncashConsideration"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForCash" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForCash"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForNoncashConsiderations" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForNoncashConsiderations"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="us-gaap_StockRepurchasedDuringPeriodShares"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue" xlink:label="us-gaap_StockRepurchasedDuringPeriodValue"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" xlink:label="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_TemporaryEquityAccretionToRedemptionValueLiquidationPreference" xlink:label="aqxp_TemporaryEquityAccretionToRedemptionValueLiquidationPreference"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_TemporaryEquityAccretionToRedemptionValueRedemptionOption" xlink:label="aqxp_TemporaryEquityAccretionToRedemptionValueRedemptionOption"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_TemporaryEquityAccretionToRedemptionValueWarrantDiscount" xlink:label="aqxp_TemporaryEquityAccretionToRedemptionValueWarrantDiscount"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_TemporaryEquityRedemptionDiscount" xlink:label="aqxp_TemporaryEquityRedemptionDiscount"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_TemporaryEquityWarrantDiscount" xlink:label="aqxp_TemporaryEquityWarrantDiscount"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_WarrantsExercised" xlink:label="aqxp_WarrantsExercised"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_WarrantsExercisedShares" xlink:label="aqxp_WarrantsExercisedShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ConvertiblePreferredStockMember" order="1.2700" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_PreferredStockMember" order="1.2800" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="aqxp_NewCommonStockMember" order="1.2900" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonStockMember" order="1.3000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" order="1.3100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_AccumulatedDeficitDuringDevelopmentStageMember" order="1.3200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityDomain" xlink:to="aqxp_AqxpCanadaMember" order="1.0100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityDomain" xlink:to="aqxp_AquinoxUsaMember" order="1.0200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" order="1.0300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="aqxp_ConversionOfPreferredStockIntoCommonStock" order="1.0400" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockRepurchasedDuringPeriodValue" order="1.0500" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" order="1.0600" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="aqxp_ConversionOfPreferredStockIntoCommonStockShares" order="1.0700" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockRepurchasedDuringPeriodShares" order="1.0800" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueIssuedForCash" order="1.0900" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForCash" order="1.1000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="aqxp_WarrantsExercised" order="1.1100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueIssuedForNoncashConsiderations" order="1.1200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="aqxp_WarrantsExercisedShares" order="1.1300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForNoncashConsideration" order="1.1400" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="aqxp_TemporaryEquityWarrantDiscount" order="1.1500" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="aqxp_TemporaryEquityRedemptionDiscount" order="1.1600" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" order="1.1700" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax" order="1.1800" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="aqxp_TemporaryEquityAccretionToRedemptionValueLiquidationPreference" order="1.1900" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" order="1.2000" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="aqxp_TemporaryEquityAccretionToRedemptionValueWarrantDiscount" order="1.2100" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="aqxp_TemporaryEquityAccretionToRedemptionValueRedemptionOption" order="1.2200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="aqxp_IncomeTaxExpenseOnPreferredStock" order="1.2300" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="aqxp_ExtinguishmentOfRemainingShareIssuanceCostsDueToConversionOfPreferredStock" order="1.2400" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" order="1.2500" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding" order="1.2600" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementTable" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="10.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="11.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="100.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/StatementOfShareholdersEquityAndOtherComprehensiveIncomeParenthetical">
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_AquinoxUsaMember" xlink:label="aqxp_AquinoxUsaMember"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_AqxpCanadaMember" xlink:label="aqxp_AqxpCanadaMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConvertiblePreferredStockMember" xlink:label="us-gaap_ConvertiblePreferredStockMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PaymentOfFinancingAndStockIssuanceCosts" xlink:label="us-gaap_PaymentOfFinancingAndStockIssuanceCosts"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockMember" xlink:label="us-gaap_PreferredStockMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockRedemptionDiscount" xlink:label="us-gaap_PreferredStockRedemptionDiscount"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_WarrantDiscount" xlink:label="aqxp_WarrantDiscount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ConvertiblePreferredStockMember" order="1.0600" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_PreferredStockMember" order="1.0700" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonStockMember" order="1.0800" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityDomain" xlink:to="aqxp_AqxpCanadaMember" order="1.0100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityDomain" xlink:to="aqxp_AquinoxUsaMember" order="1.0200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="aqxp_WarrantDiscount" order="1.0300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockRedemptionDiscount" order="1.0400" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PaymentOfFinancingAndStockIssuanceCosts" order="1.0500" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementTable" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="2.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="100.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/StatementOfCashFlowsIndirect">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AmortizationOfFinancingCosts" xlink:label="us-gaap_AmortizationOfFinancingCosts"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_AmortizationOfPreferredStockDiscount" xlink:label="aqxp_AmortizationOfPreferredStockDiscount"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossUnrealized"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:label="us-gaap_GainLossOnDerivativeInstrumentsNetPretax"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables" xlink:label="us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_InterestPaid" xlink:label="us-gaap_InterestPaid"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_NonCashFinancingActivitiesAbstract" xlink:label="aqxp_NonCashFinancingActivitiesAbstract"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_NoncashInvestingActivitiesAbstract" xlink:label="aqxp_NoncashInvestingActivitiesAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1" xlink:label="us-gaap_NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:label="us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PaymentsOfFinancingCosts" xlink:label="us-gaap_PaymentsOfFinancingCosts"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PaymentsOfLoanCosts" xlink:label="us-gaap_PaymentsOfLoanCosts"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PaymentsToAcquireShortTermInvestments" xlink:label="us-gaap_PaymentsToAcquireShortTermInvestments"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="us-gaap_ProceedsFromNotesPayable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromRepurchaseOfRedeemablePreferredStock" xlink:label="us-gaap_ProceedsFromRepurchaseOfRedeemablePreferredStock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_RepaymentFeeAndPenalty" xlink:label="aqxp_RepaymentFeeAndPenalty"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RepaymentsOfDebt" xlink:label="us-gaap_RepaymentsOfDebt"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="us-gaap_RepaymentsOfNotesPayable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_ShareIssuanceExpendituresIncurredButNotYetPaid" xlink:label="aqxp_ShareIssuanceExpendituresIncurredButNotYetPaid"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_SpecialVotingCommonStockIssuedValue" xlink:label="aqxp_SpecialVotingCommonStockIssuedValue"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_DepreciationDepletionAndAmortization" order="1.0300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AmortizationOfFinancingCosts" order="1.0400" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="aqxp_RepaymentFeeAndPenalty" order="1.0500" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" order="1.0600" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="aqxp_AmortizationOfPreferredStockDiscount" order="1.0700" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_GainLossOnDerivativeInstrumentsNetPretax" order="1.0800" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ShareBasedCompensation" order="1.0900" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ForeignCurrencyTransactionGainLossUnrealized" order="1.1000" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables" order="1.1600" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="1.1700" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" order="1.1800" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" order="1.1900" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_RepaymentsOfDebt" order="1.2000" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_PaymentsOfLoanCosts" order="1.2100" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromNotesPayable" order="1.2200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_RepaymentsOfNotesPayable" order="1.2300" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="1.2400" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_PaymentsForRepurchaseOfCommonStock" order="1.2500" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromRepurchaseOfRedeemablePreferredStock" order="1.2600" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="aqxp_SpecialVotingCommonStockIssuedValue" order="1.2700" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts" order="1.2800" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering" order="1.2900" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_PaymentsOfFinancingCosts" order="1.3000" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" order="1.3100" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" order="1.3200" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="1.3300" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_2" order="1.3400" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquireShortTermInvestments" order="1.1100" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="1.1200" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" order="1.1300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquireIntangibleAssets" order="1.1400" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" order="1.1500" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax" order="1.0200" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aqxp_NonCashFinancingActivitiesAbstract" xlink:to="aqxp_ShareIssuanceExpendituresIncurredButNotYetPaid" order="1.4500" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aqxp_NoncashInvestingActivitiesAbstract" xlink:to="us-gaap_NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1" order="1.4400" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" order="1.3500" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" order="1.3600" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" order="1.3700" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" order="1.3800" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" order="1.3900" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract" order="1.4000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" order="1.4100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="aqxp_NoncashInvestingActivitiesAbstract" order="1.4200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="aqxp_NonCashFinancingActivitiesAbstract" order="1.4300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_InterestPaid" order="1.0100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/DisclosureNatureOfOperationsAdditionalInformation">
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityIncorporationDateOfIncorporation" xlink:label="dei_EntityIncorporationDateOfIncorporation"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_UncategorizedAbstract" xlink:label="aqxp_UncategorizedAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aqxp_UncategorizedAbstract" xlink:to="dei_EntityIncorporationDateOfIncorporation" order="1.0100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/DisclosureCondensedSummaryOfSignificantAccountingPoliciesAdditionalInformation">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_DescriptionOfPercentageOfRealizationOfTaxBenefitUponSettlement" xlink:label="aqxp_DescriptionOfPercentageOfRealizationOfTaxBenefitUponSettlement"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="us-gaap_NumberOfOperatingSegments"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_PercentageOfRecognitionOfTaxBenefitUponSettlement" xlink:label="aqxp_PercentageOfRecognitionOfTaxBenefitUponSettlement"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_RegulatoryAssetsAbstract" xlink:label="aqxp_RegulatoryAssetsAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SegmentGeographicalDomain" xlink:label="us-gaap_SegmentGeographicalDomain"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_SignificantAccountingPoliciesLineItems" xlink:label="aqxp_SignificantAccountingPoliciesLineItems"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_SignificantAccountingPoliciesTable" xlink:label="aqxp_SignificantAccountingPoliciesTable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementGeographicalAxis" xlink:label="us-gaap_StatementGeographicalAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/country/2013/country-2013-01-31.xsd#country_US" xlink:label="country_US"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aqxp_RegulatoryAssetsAbstract" xlink:to="aqxp_SignificantAccountingPoliciesTable" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentGeographicalDomain" xlink:to="country_US" order="1.0500" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aqxp_SignificantAccountingPoliciesLineItems" xlink:to="aqxp_DescriptionOfPercentageOfRealizationOfTaxBenefitUponSettlement" order="1.0100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aqxp_SignificantAccountingPoliciesLineItems" xlink:to="aqxp_PercentageOfRecognitionOfTaxBenefitUponSettlement" order="1.0200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aqxp_SignificantAccountingPoliciesLineItems" xlink:to="us-gaap_NumberOfOperatingSegments" order="1.0300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aqxp_SignificantAccountingPoliciesLineItems" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="1.0400" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aqxp_SignificantAccountingPoliciesTable" xlink:to="us-gaap_StatementGeographicalAxis" order="10.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aqxp_SignificantAccountingPoliciesTable" xlink:to="aqxp_SignificantAccountingPoliciesLineItems" order="100.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementGeographicalAxis" xlink:to="us-gaap_SegmentGeographicalDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/DisclosureRedeemableConvertiblePreferredStockAndStockholdersdeficitEquityAdditionalInformation">
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_AquinoxUsaMember" xlink:label="aqxp_AquinoxUsaMember"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_AqxpCanadaMember" xlink:label="aqxp_AqxpCanadaMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="us-gaap_ClassOfStockLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockConversionBasis" xlink:label="us-gaap_CommonStockConversionBasis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_ConversionOfPreferredStockToCommonStockMember" xlink:label="aqxp_ConversionOfPreferredStockToCommonStockMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConversionOfStockSharesConverted1" xlink:label="us-gaap_ConversionOfStockSharesConverted1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConvertibleCommonStockMember" xlink:label="us-gaap_ConvertibleCommonStockMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:label="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConvertiblePreferredStockTermsOfConversion" xlink:label="us-gaap_ConvertiblePreferredStockTermsOfConversion"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredTaxLiabilitiesNoncurrent" xlink:label="us-gaap_DeferredTaxLiabilitiesNoncurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_ExtinguishmentOfDiscountOnTemporaryEquity" xlink:label="aqxp_ExtinguishmentOfDiscountOnTemporaryEquity"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:label="us-gaap_MinorityInterestOwnershipPercentageByParent"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_NetProceedsFromIssuanceInitialPublicOffering" xlink:label="aqxp_NetProceedsFromIssuanceInitialPublicOffering"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PaymentOfFinancingAndStockIssuanceCosts" xlink:label="us-gaap_PaymentOfFinancingAndStockIssuanceCosts"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RedeemableConvertiblePreferredStockMember" xlink:label="us-gaap_RedeemableConvertiblePreferredStockMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="us-gaap_SaleOfStockPricePerShare"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="us-gaap_ScheduleOfStockByClassTable"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_SeriesAConvertiblePreferredStockMember" xlink:label="aqxp_SeriesAConvertiblePreferredStockMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="us-gaap_SeriesAPreferredStockMember"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_SeriesBConvertiblePreferredStockMember" xlink:label="aqxp_SeriesBConvertiblePreferredStockMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="us-gaap_SeriesBPreferredStockMember"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_SeriesCConvertiblePreferredStockMember" xlink:label="aqxp_SeriesCConvertiblePreferredStockMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SeriesCPreferredStockMember" xlink:label="us-gaap_SeriesCPreferredStockMember"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_SharesTransferredFromAqxpCanadaToAquinoxUsaMember" xlink:label="aqxp_SharesTransferredFromAqxpCanadaToAquinoxUsaMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:label="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquityReverseStockSplit" xlink:label="us-gaap_StockholdersEquityReverseStockSplit"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_StockSharesAuthorizedNet" xlink:label="aqxp_StockSharesAuthorizedNet"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TemporaryEquitySharesIssued" xlink:label="us-gaap_TemporaryEquitySharesIssued"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_UnderwritersMember" xlink:label="aqxp_UnderwritersMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonStockMember" order="1.2500" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ConvertibleCommonStockMember" order="1.2800" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="aqxp_SeriesAConvertiblePreferredStockMember" order="1.3100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="aqxp_SeriesBConvertiblePreferredStockMember" order="1.3200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="aqxp_SeriesCConvertiblePreferredStockMember" order="1.3300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesAPreferredStockMember" order="1.3400" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesBPreferredStockMember" order="1.3500" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesCPreferredStockMember" order="1.3600" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_RedeemableConvertiblePreferredStockMember" order="1.3700" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_StockholdersEquityReverseStockSplit" order="1.0100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" order="1.0200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockConversionBasis" order="1.0300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" order="1.0400" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ConvertiblePreferredStockTermsOfConversion" order="1.0500" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_TemporaryEquitySharesOutstanding" order="1.0600" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" order="1.0700" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_TemporaryEquitySharesIssued" order="1.0800" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ConversionOfStockSharesConverted1" order="1.0900" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_MinorityInterestOwnershipPercentageByParent" order="1.1000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_DeferredTaxLiabilitiesNoncurrent" order="1.1100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="aqxp_ExtinguishmentOfDiscountOnTemporaryEquity" order="1.1200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="1.1300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_SaleOfStockPricePerShare" order="1.1400" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="aqxp_NetProceedsFromIssuanceInitialPublicOffering" order="1.1500" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PaymentOfFinancingAndStockIssuanceCosts" order="1.1600" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="aqxp_StockSharesAuthorizedNet" order="1.1700" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" order="1.1800" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="1.1900" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="1.2000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="1.2100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockSharesIssued" order="1.2200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" order="1.2300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityDomain" xlink:to="aqxp_AqxpCanadaMember" order="1.2600" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityDomain" xlink:to="aqxp_AquinoxUsaMember" order="1.2900" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_ScheduleOfStockByClassTable" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="aqxp_UnderwritersMember" order="1.2700" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScenarioUnspecifiedDomain" xlink:to="aqxp_SharesTransferredFromAqxpCanadaToAquinoxUsaMember" order="1.2400" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScenarioUnspecifiedDomain" xlink:to="aqxp_ConversionOfPreferredStockToCommonStockMember" order="1.3000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_StatementScenarioAxis" order="10.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="11.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="dei_LegalEntityAxis" order="12.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="13.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_ClassOfStockLineItems" order="100.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/DisclosureCashAndCashEquivalentsScheduleOfCashAndCashEquivalents">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_Cash" xlink:label="us-gaap_Cash"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashAndCashEquivalentsAbstract" xlink:label="us-gaap_CashAndCashEquivalentsAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashEquivalentsAtCarryingValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashAndCashEquivalentsAbstract" xlink:to="us-gaap_Cash" order="1.0100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashAndCashEquivalentsAbstract" xlink:to="us-gaap_CashEquivalentsAtCarryingValue" order="1.0200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashAndCashEquivalentsAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="1.0300" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/DisclosureLoanFacilityAdditionalInformation">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_ClassOfWarrantOrRightExercisable" xlink:label="aqxp_ClassOfWarrantOrRightExercisable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_ClassOfWarrantOrRightExpirationYear" xlink:label="aqxp_ClassOfWarrantOrRightExpirationYear"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LineOfCreditFacilityAxis" xlink:label="us-gaap_LineOfCreditFacilityAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LineOfCreditFacilityExpirationDate1" xlink:label="us-gaap_LineOfCreditFacilityExpirationDate1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LineOfCreditFacilityFrequencyOfPaymentAndPaymentTerms" xlink:label="us-gaap_LineOfCreditFacilityFrequencyOfPaymentAndPaymentTerms"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" xlink:label="us-gaap_LineOfCreditFacilityInterestRateDuringPeriod"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain" xlink:label="us-gaap_LineOfCreditFacilityLenderDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems" xlink:label="us-gaap_LineOfCreditFacilityLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LineOfCreditFacilityPeriodicPaymentPrincipal" xlink:label="us-gaap_LineOfCreditFacilityPeriodicPaymentPrincipal"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:label="us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LineOfCreditFacilityTable" xlink:label="us-gaap_LineOfCreditFacilityTable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit" xlink:label="us-gaap_ProceedsFromLinesOfCredit"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit" xlink:label="us-gaap_RepaymentsOfLinesOfCredit"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_SiliconValleyBankMember" xlink:label="aqxp_SiliconValleyBankMember"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_WarrantsToPurchaseCommonStockMember" xlink:label="aqxp_WarrantsToPurchaseCommonStockMember"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_WarrantsToPurchaseSeriescConvertiblePreferredStockMember" xlink:label="aqxp_WarrantsToPurchaseSeriescConvertiblePreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="aqxp_WarrantsToPurchaseSeriescConvertiblePreferredStockMember" order="1.1500" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="aqxp_WarrantsToPurchaseCommonStockMember" order="1.1600" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="aqxp_ClassOfWarrantOrRightExercisable" order="1.0600" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="aqxp_ClassOfWarrantOrRightExpirationYear" order="1.0700" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" order="1.0800" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="us-gaap_LineOfCreditFacilityPeriodicPaymentPrincipal" order="1.0900" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="us-gaap_LineOfCreditFacilityExpirationDate1" order="1.1000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="us-gaap_LineOfCreditFacilityFrequencyOfPaymentAndPaymentTerms" order="1.1100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="us-gaap_RepaymentsOfLinesOfCredit" order="1.1200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt" order="1.1300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_LineOfCreditFacilityTable" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LineOfCreditFacilityAxis" xlink:to="us-gaap_LineOfCreditFacilityLenderDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LineOfCreditFacilityLenderDomain" xlink:to="aqxp_SiliconValleyBankMember" order="1.1400" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LineOfCreditFacilityLineItems" xlink:to="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" order="1.0100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LineOfCreditFacilityLineItems" xlink:to="us-gaap_ProceedsFromLinesOfCredit" order="1.0200" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LineOfCreditFacilityLineItems" xlink:to="us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" order="1.0300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LineOfCreditFacilityLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights" order="1.0400" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LineOfCreditFacilityLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" order="1.0500" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LineOfCreditFacilityTable" xlink:to="us-gaap_LineOfCreditFacilityAxis" order="10.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LineOfCreditFacilityTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" order="11.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LineOfCreditFacilityTable" xlink:to="us-gaap_LineOfCreditFacilityLineItems" order="100.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/DisclosureLoanFacilityScheduleOfLoanFacility">
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_AccretionOfWarrantDiscount" xlink:label="aqxp_AccretionOfWarrantDiscount"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_DiscountOnIssuanceOfWarrants" xlink:label="aqxp_DiscountOnIssuanceOfWarrants"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LineOfCreditFacilityAmountOutstanding" xlink:label="us-gaap_LineOfCreditFacilityAmountOutstanding"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LineOfCreditFacilityAmountOutstanding" xlink:label="us-gaap_LineOfCreditFacilityAmountOutstanding_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LineOfCreditFacilityIncreaseAccruedInterest" xlink:label="us-gaap_LineOfCreditFacilityIncreaseAccruedInterest"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_PaymentsOfFinancingCostsDebt" xlink:label="aqxp_PaymentsOfFinancingCostsDebt"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit" xlink:label="us-gaap_ProceedsFromLinesOfCredit"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_RepaymentFeeAndPenalty" xlink:label="aqxp_RepaymentFeeAndPenalty"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit" xlink:label="us-gaap_RepaymentsOfLinesOfCredit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_LineOfCreditFacilityAmountOutstanding" order="1.0100" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_LineOfCreditFacilityIncreaseAccruedInterest" order="1.0200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_ProceedsFromLinesOfCredit" order="1.0300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="aqxp_AccretionOfWarrantDiscount" order="1.0400" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="aqxp_DiscountOnIssuanceOfWarrants" order="1.0500" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="aqxp_RepaymentFeeAndPenalty" order="1.0600" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="aqxp_PaymentsOfFinancingCostsDebt" order="1.0700" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_RepaymentsOfLinesOfCredit" order="1.0800" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_LineOfCreditFacilityAmountOutstanding_2" order="1.0900" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/DisclosureLoanFacilitySummaryOfBankLoanFacility">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LineOfCreditFacilityAmountOutstanding" xlink:label="us-gaap_LineOfCreditFacilityAmountOutstanding"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LoansPayableToBankCurrent" xlink:label="us-gaap_LoansPayableToBankCurrent"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LongTermLoansFromBank" xlink:label="us-gaap_LongTermLoansFromBank"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_LoansPayableToBankCurrent" order="1.0100" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_LongTermLoansFromBank" order="1.0200" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_LineOfCreditFacilityAmountOutstanding" order="1.0300" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/DisclosureCommonStockAdditionalInformation">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_CommonStockReservedForIssuanceDescription" xlink:label="aqxp_CommonStockReservedForIssuanceDescription"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualExercisePrice" xlink:label="us-gaap_DeferredCompensationArrangementWithIndividualExercisePrice"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_EquityIncentivePlanTwoThousandSixMember" xlink:label="aqxp_EquityIncentivePlanTwoThousandSixMember"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_NonEmployeeDirectorsMember" xlink:label="aqxp_NonEmployeeDirectorsMember"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_NumberOfNonEmployeeDirectors" xlink:label="aqxp_NumberOfNonEmployeeDirectors"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_NumberOfYearsSharesReservedForIssuanceWillIncrease" xlink:label="aqxp_NumberOfYearsSharesReservedForIssuanceWillIncrease"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedNew" xlink:label="aqxp_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedNew"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_StockBasedCompensationIncreaseInCommonStockIssuancePercentage" xlink:label="aqxp_StockBasedCompensationIncreaseInCommonStockIssuancePercentage"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_StockIncentivePlanTwoThousandFourteenMember" xlink:label="aqxp_StockIncentivePlanTwoThousandFourteenMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TitleOfIndividualAxis" xlink:label="us-gaap_TitleOfIndividualAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="us-gaap_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_UnrecognizedCompensationExpenseWeightedAveragePeriod" xlink:label="aqxp_UnrecognizedCompensationExpenseWeightedAveragePeriod"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_UnrecognizedShareBasedCompensationExpense" xlink:label="aqxp_UnrecognizedShareBasedCompensationExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="aqxp_StockIncentivePlanTwoThousandFourteenMember" order="1.1400" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="aqxp_EquityIncentivePlanTwoThousandSixMember" order="1.1300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="10.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" order="11.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_TitleOfIndividualAxis" order="12.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="100.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="1.0100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" order="1.0200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="aqxp_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedNew" order="1.0300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="aqxp_CommonStockReservedForIssuanceDescription" order="1.0400" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="aqxp_StockBasedCompensationIncreaseInCommonStockIssuancePercentage" order="1.0500" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="aqxp_NumberOfYearsSharesReservedForIssuanceWillIncrease" order="1.0600" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_DeferredCompensationArrangementWithIndividualExercisePrice" order="1.0700" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="aqxp_NumberOfNonEmployeeDirectors" order="1.0800" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="1.0900" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensation" order="1.1000" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="aqxp_UnrecognizedShareBasedCompensationExpense" order="1.1100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="aqxp_UnrecognizedCompensationExpenseWeightedAveragePeriod" order="1.1200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TitleOfIndividualAxis" xlink:to="us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="aqxp_NonEmployeeDirectorsMember" order="1.1500" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/DisclosureCommonStockScheduleOfWeightedAverageAssumptions">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" order="1.0100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" order="1.0200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" order="1.0300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" order="1.0400" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="1.0500" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/DisclosureNetLossPerShareAdditionalInformation">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis" xlink:label="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain" xlink:label="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_ReorganizationMember" xlink:label="aqxp_ReorganizationMember"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_ScheduleOfEarningsPerShareLineItems" xlink:label="aqxp_ScheduleOfEarningsPerShareLineItems"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_ScheduleOfEarningsPerShareTable" xlink:label="aqxp_ScheduleOfEarningsPerShareTable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:label="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquityReverseStockSplit" xlink:label="us-gaap_StockholdersEquityReverseStockSplit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis" xlink:to="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain" xlink:to="aqxp_ReorganizationMember" order="1.0600" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="aqxp_ScheduleOfEarningsPerShareTable" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aqxp_ScheduleOfEarningsPerShareLineItems" xlink:to="us-gaap_StockholdersEquityReverseStockSplit" order="1.0100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aqxp_ScheduleOfEarningsPerShareLineItems" xlink:to="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" order="1.0200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aqxp_ScheduleOfEarningsPerShareLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" order="1.0300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aqxp_ScheduleOfEarningsPerShareLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="1.0400" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aqxp_ScheduleOfEarningsPerShareLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding" order="1.0500" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aqxp_ScheduleOfEarningsPerShareTable" xlink:to="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis" order="10.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="aqxp_ScheduleOfEarningsPerShareTable" xlink:to="aqxp_ScheduleOfEarningsPerShareLineItems" order="100.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/DisclosureNetLossPerShareScheduleOfComputationOfBasicAndDilutedEarningsPerShare">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_ExtinguishmentOfRemainingShareIssuanceCostsDueToConversionOfPreferredStock" xlink:label="aqxp_ExtinguishmentOfRemainingShareIssuanceCostsDueToConversionOfPreferredStock"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_IncomeTaxExpenseOnPreferredStock" xlink:label="aqxp_IncomeTaxExpenseOnPreferredStock"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_IncrementalCommonSharesAttributableToCommonStockWarrants" xlink:label="aqxp_IncrementalCommonSharesAttributableToCommonStockWarrants"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_IncrementalCommonSharesAttributableToStockOptions" xlink:label="aqxp_IncrementalCommonSharesAttributableToStockOptions"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetIncomeLossAbstract" xlink:label="us-gaap_NetIncomeLossAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_ReversalOfIncomeTaxPayableOnPreferredStock" xlink:label="aqxp_ReversalOfIncomeTaxPayableOnPreferredStock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" xlink:label="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_TemporaryEquityAccretionToRedemptionValueLiquidationPreference" xlink:label="aqxp_TemporaryEquityAccretionToRedemptionValueLiquidationPreference"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:label="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:label="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_NetIncomeLossAbstract" order="1.0100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="aqxp_TemporaryEquityAccretionToRedemptionValueLiquidationPreference" order="1.0200" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" order="1.0300" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="aqxp_IncomeTaxExpenseOnPreferredStock" order="1.0400" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="aqxp_ReversalOfIncomeTaxPayableOnPreferredStock" order="1.0500" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="aqxp_ExtinguishmentOfRemainingShareIssuanceCostsDueToConversionOfPreferredStock" order="1.0600" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" order="1.0700" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" order="1.0800" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" order="1.0900" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareBasic" order="1.1000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareDiluted" order="1.1100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetIncomeLossAbstract" xlink:to="us-gaap_NetIncomeLoss" order="1.1600" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:to="aqxp_IncrementalCommonSharesAttributableToStockOptions" order="1.1300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:to="aqxp_IncrementalCommonSharesAttributableToCommonStockWarrants" order="1.1400" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:to="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" order="1.1500" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" order="1.1200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/DisclosureNetLossPerShareScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfBasicAndDilutedNetLossPerShare">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_ConvertiblePreferredStocksMember" xlink:label="aqxp_ConvertiblePreferredStocksMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" order="1.0400" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="aqxp_ConvertiblePreferredStocksMember" order="1.0100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="1.0200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_WarrantMember" order="1.0300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" order="10.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" order="100.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/DisclosureFinancialInstrumentsFairValueOfSignificantUnobservableInputs">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BankLoanObligationsMember" xlink:label="us-gaap_BankLoanObligationsMember"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_DecreaseOfEmbeddedDerivativeLiabilitiesForPreferredSharesConvertedIntoCommonStock" xlink:label="aqxp_DecreaseOfEmbeddedDerivativeLiabilitiesForPreferredSharesConvertedIntoCommonStock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="us-gaap_DerivativeContractTypeDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="us-gaap_DerivativeInstrumentRiskAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EmbeddedDerivativeFinancialInstrumentsMember" xlink:label="us-gaap_EmbeddedDerivativeFinancialInstrumentsMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_2"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockMember" xlink:label="us-gaap_PreferredStockMember"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_WarrantDerivativeLiabilityMember" xlink:label="aqxp_WarrantDerivativeLiabilityMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DerivativeContractTypeDomain" xlink:to="aqxp_WarrantDerivativeLiabilityMember" order="1.0800" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DerivativeContractTypeDomain" xlink:to="us-gaap_EmbeddedDerivativeFinancialInstrumentsMember" order="1.0900" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DerivativeInstrumentRiskAxis" xlink:to="us-gaap_DerivativeContractTypeDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_BankLoanObligationsMember" order="1.0200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_PreferredStockMember" order="1.0300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_DerivativeInstrumentRiskAxis" order="10.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" order="11.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="12.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" order="100.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" order="1.0400" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" order="1.0500" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="aqxp_DecreaseOfEmbeddedDerivativeLiabilitiesForPreferredSharesConvertedIntoCommonStock" order="1.0600" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_2" order="1.0700" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel3Member" order="1.0100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="1.0000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/DisclosureFinancialInstrumentsAdditionalInformation">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationTransfersIntoLevel3" xlink:label="us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationTransfersIntoLevel3"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationTransfersIntoLevel3" order="1.0100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsNatureOfOperations">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NatureOfOperations" xlink:label="us-gaap_NatureOfOperations"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_NatureOfOperations" order="1.0100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsSignificantAccountingPoliciesTextBlock">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock" order="1.0100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsSignificantAccountingPoliciesTextBlockPolicies">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquityNoteRedeemablePreferredStockIssuePolicy" xlink:label="us-gaap_StockholdersEquityNoteRedeemablePreferredStockIssuePolicy"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" order="1.0100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_UseOfEstimates" order="1.0200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_IncomeTaxPolicyTextBlock" order="1.0300" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy" order="1.0400" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_StockholdersEquityNoteRedeemablePreferredStockIssuePolicy" order="1.0500" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" order="1.0600" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SegmentReportingPolicyPolicyTextBlock" order="1.0700" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock" order="1.0800" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" order="1.0900" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsStockholdersEquityNoteDisclosureTextBlock">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock" order="1.0100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsCashAndCashEquivalentsDisclosureTextBlock">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashAndCashEquivalentsAbstract" xlink:label="us-gaap_CashAndCashEquivalentsAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashAndCashEquivalentsDisclosureTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashAndCashEquivalentsAbstract" xlink:to="us-gaap_CashAndCashEquivalentsDisclosureTextBlock" order="1.0100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsCashAndCashEquivalentsDisclosureTextBlockTables">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashAndCashEquivalentsAbstract" xlink:label="us-gaap_CashAndCashEquivalentsAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:label="us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashAndCashEquivalentsAbstract" xlink:to="us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" order="1.0100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsDebtDisclosureTextBlock">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="us-gaap_DebtDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtDisclosureTextBlock" order="1.0100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsDebtDisclosureTextBlockTables">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock" xlink:label="us-gaap_ScheduleOfDebtTableTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock" xlink:label="us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock" order="1.0100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_ScheduleOfDebtTableTextBlock" order="1.0200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsCommonStockDisclosureTextBlock">
    <loc xlink:type="locator" xlink:href="aqxp-20140331.xsd#aqxp_CommonStockDisclosureTextBlock" xlink:label="aqxp_CommonStockDisclosureTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TextBlockAbstract" xlink:label="us-gaap_TextBlockAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TextBlockAbstract" xlink:to="aqxp_CommonStockDisclosureTextBlock" order="1.0100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsCommonStockDisclosureTextBlockTables">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_TextBlockAbstract" xlink:label="us-gaap_TextBlockAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TextBlockAbstract" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" order="1.0100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsEarningsPerShareTextBlock">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="us-gaap_EarningsPerShareTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareTextBlock" order="1.0100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsEarningsPerShareTextBlockTables">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" order="1.0100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" order="1.0200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsFinancialInstrumentsDisclosureTextBlock">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:label="us-gaap_FinancialInstrumentsDisclosureTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_InvestmentsAllOtherInvestmentsAbstract" xlink:label="us-gaap_InvestmentsAllOtherInvestmentsAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentsAllOtherInvestmentsAbstract" xlink:to="us-gaap_FinancialInstrumentsDisclosureTextBlock" order="1.0100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsFinancialInstrumentsDisclosureTextBlockTables">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_InvestmentsAllOtherInvestmentsAbstract" xlink:label="us-gaap_InvestmentsAllOtherInvestmentsAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentsAllOtherInvestmentsAbstract" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" order="1.0100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" use="optional"/>
  </presentationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>g704250graphic-1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g704250graphic-1.jpg
M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````/```_^X`#D%D
M;V)E`&3``````?_;`(0`!@0$!`4$!@4%!@D&!08)"P@&!@@+#`H*"PH*#!`,
M#`P,#`P0#`X/$`\.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'!P<-#`T8$!`8
M&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?_\``$0@#2`)J`P$1``(1`0,1`?_$`-````("`P$!````````
M```````%!@<"`P0(`0$!``,!`0$```````````````$"!`,%!A```@(!`P,"
M!`(%!@D'"`$5`0(#!!$`$@4A$P8Q(D$R%`=1(V%Q0G05LC,D538(@=%2DK/3
ME!8WD6)R-;5V%Z&Q@M)#4S16&,%S1+0E=9-4U)4FX<+PHF.CXX2D)Q$``@`#
M!`<%!@4#!0$!``,!``$1(0+P,4$#46%QH;$2!(&1P='A\2(R<A,S4J)3%`5"
M8M*"DK+"(^+R0X,D%?_:``P#`0`"$0,1`#\`]4Z`-`&@#0!H`T`:`-`&@#0!
MH`T`:`-`&@#0!H`T`:`-`&@#0!H`T`:`-`&@#0!H`T`:`-`&@#0!H`T`:`-`
M&@#0!H`T`:`-`&@#0!H`T`:`-`&@#0!H`T`:`-`&@#0!H`T`:`-`&@#0!H`T
M`:`-`&@#0!H`T`:`-`&@#0!H`T`:`-`&@#0!H!;XSS0YSQ_CN8$78%^O'8$)
M;?L[B[MN["YQ^K0#+0!H`T`:`-`&@#0!H`T`:`-`&@#0!H`T`:`-`&@#0!H`
MT`:`-`&@#0!H`T`:`-`&@#0!H`T`:`-`&@#0!H`T`:`-`&@#0!H`T`:`-`&@
M#0!H`T`:`-`&@#0!H`T`:`-`&@#0!H!7P'.#EX[SB'L_17;-'&[=N^FD*;_0
M8W>N-`--`&@#0!H`T`:`-`&@#0!H`T`:`-`&@(S]LO\`A[X[_P#>^O\`Z,:`
MDV@#0!H`T`:`-`&@#0!H`T`:`-`&@#0!H`T`:`-`&@#0!H`T`:`-`&@#0!H`
MT`:`-`&@#0!H`T`:`-`&@#0!H`T`:`-`&@#0!H`T`:`-`&@#0!H`T`:`-`&@
M#0!H`T`:`-`&@#0$6^W_`/\`#<Y_]^^2_P!.=`2G0!H`T`:`-`&@#0!H`T`:
M`-`&@#0!H",_;+_A[X[_`/>^O_HQH"3:`-`&@#0!H`T`:`-`&@#0!H`T`:`-
M`&@#0!H`T`:`-`&@#0!H`T`:`-`&@#0!H`T`:`-`&@#0!H`T`:`-`&@#0!H`
MT`:`-`&@#0!H`T`:`-`&@#0!H`T`:`-`&@#0!H`T`:`-`1;[?_\`PW.?_?OD
MO].=`2G0!H`T`:`-`&@#0!H`T`:`-`&@#0!H!+X5Q5OB/$>'XNX%%NE4BAG"
MG<H=%`.#\=`.M`&@#0!H`T`:`-`&@#0!H`T`:`-`&@#0!H`T`:`-`&@#0!H`
MT`:`-`&@#0!H`T`:`-`&@#0!H`T`:`-`&@#0!H`T`:`-`&@#0!H`T`:`-`&@
M#0!H`T`:`-`&@#0!H`T`:`-`&@$?B?$7.,AY-+04&UR=RW#M.[\J>4NA/X''
MPT`\T`:`-`&@#0!H`T`:`-`&@([R'->80W9HJ?C8MU4;$5GZZ&+>,>NQE)70
M&C_>#SO_`.4A_P#G&#_U-`'^\'G?_P`I#_\`.,'_`*F@)'1ELS4X9;4'TMET
M#35]XDV,1U7>N`V/QT`KJ<UR]NM%9@XK,,RAXR;"`E3U&1C6NO(HI;3KFM1Y
M^7U>;72JJ<N3_N1N_B'._P!4C_:$_P`6J_3R_P`>XO\`7S_T_P`R#^(<[_5(
M_P!H3_%I]/+_`![A]?/_`$_S(/XASO\`5(_VA/\`%I]/+_'N'U\_]/\`,@_B
M'._U2/\`:$_Q:?3R_P`>X?7S_P!/\R#^(<[_`%2/]H3_`!:?3R_Q[A]?/_3_
M`#(/XASO]4C_`&A/\6GT\O\`'N'U\_\`3_,@_B'._P!4C_:$_P`6GT\O\>X?
M7S_T_P`R#^(<[_5(_P!H3_%I]/+_`![A]?/_`$_S(/XASO\`5(_VA/\`%I]/
M+_'N'U\_]/\`,@_B'._U2/\`:$_Q:?3R_P`>X?7S_P!/\R#^(<[_`%2/]H3_
M`!:?3R_Q[A]?/_3_`#(/XASO]4C_`&A/\6GT\O\`'N'U\_\`3_,@_B'._P!4
MC_:$_P`6GT\O\>X?7S_T_P`R#^(<[_5(_P!H3_%I]/+_`![A]?/_`$_S(/XA
MSO\`5(_VA/\`%I]/+_'N'U\_]/\`,@_B'._U2/\`:$_Q:?3R_P`>X?7S_P!/
M\R#^(<[_`%2/]H3_`!:?3R_Q[A]?/_3_`#(/XASO]4C_`&A/\6GT\O\`'N'U
M\_\`3_,@_B'._P!4C_:$_P`6GT\O\>X?7S_T_P`R#^(<[_5(_P!H3_%I]/+_
M`![A]?/_`$_S(/XASO\`5(_VA/\`%I]/+_'N'U\_]/\`,@_B'._U2/\`:$_Q
M:?3R_P`>X?7S_P!/\R#^(<[_`%2/]H3_`!:?3R_Q[A]?/_3_`#(/XASO]4C_
M`&A/\6GT\O\`'N'U\_\`3_,@_B'._P!4C_:$_P`6GT\O\>X?7S_T_P`R#^(<
M[_5(_P!H3_%I]/+_`![A]?/_`$_S(/XASO\`5(_VA/\`%I]/+_'N'U\_]/\`
M,@_B'._U2/\`:$_Q:?3R_P`>X?7S_P!/\R#^(<[_`%2/]H3_`!:?3R_Q[A]?
M/_3_`#(/XASO]4C_`&A/\6GT\O\`'N'U\_\`3_,@_B'._P!4C_:$_P`6GT\O
M\>X?7S_T_P`R#^(<[_5(_P!H3_%I]/+_`![A]?/_`$_S(/XASO\`5(_VA/\`
M%I]/+_'N'U\_]/\`,@_B'._U2/\`:$_Q:?3R_P`>X?7S_P!/\R#^(<[_`%2/
M]H3_`!:?3R_Q[A]?/_3_`#(/XASO]4C_`&A/\6GT\O\`'N'U\_\`3_,@_B'.
M_P!4C_:$_P`6GT\O\>X?7S_T_P`R#^(<[_5(_P!H3_%I]/+_`![A]?/_`$_S
M(/XASO\`5(_VA/\`%I]/+_'N'U\_]/\`,@_B'._U2/\`:$_Q:?3R_P`>X?7S
M_P!/\R#^(<[_`%2/]H3_`!:?3R_Q[A]?/_3_`#(/XASO]4C_`&A/\6GT\O\`
M'N'U\_\`3_,@_B'._P!4C_:$_P`6GT\O\>X?7S_T_P`R#^(<[_5(_P!H3_%I
M]/+_`![A]?/_`$_S(/XASO\`5(_VA/\`%I]/+_'N'U\_]/\`,@_B'._U2/\`
M:$_Q:?3R_P`>X?7S_P!/\R#^(<[_`%2/]H3_`!:?3R_Q[A]?/_3_`#(/XASO
M]4C_`&A/\6GT\O\`'N'U\_\`3_,@_B'._P!4C_:$_P`6GT\O\>X?7S_T_P`R
M#^(<[_5(_P!H3_%I]/+_`![A]?/_`$_S(/XASO\`5(_VA/\`%I]/+_'N'U\_
M]/\`,@_B'._U2/\`:$_Q:?3R_P`>X?7S_P!/\R#^(<[_`%2/]H3_`!:?3R_Q
M[A]?/_3_`#(/XASO]4C_`&A/\6GT\O\`'N'U\_\`3_,@_B'._P!4C_:$_P`6
MGT\O\>X?7S_T_P`R#^(<[_5(_P!H3_%I]/+_`![A]?/_`$_S(/XASO\`5(_V
MA/\`%I]/+_'N'U\_]/\`,@_B'._U2/\`:$_Q:?3R_P`>X?7S_P!/\R#^(<[_
M`%2/]H3_`!:?3R_Q[A]?/_3_`#(/XASO]4C_`&A/\6GT\O\`'N'U\_\`3_,@
M_B'._P!4C_:$_P`6GT\O\>X?7S_T_P`R#^(<[_5(_P!H3_%I]/+_`![A]?/_
M`$_S(Z.*Y!KU=Y'A,$D4LD,D18-AHVVG##UUSSLOD<(QE$Z]-G_4I;:@TVNX
M47>;\RAN315?&1:K(Y$-CZZ&/N*/1MC*2N?PUR-!I_W@\[_^4A_^<8/_`%-`
M'^\/G?\`\I#_`/.,'_J:`DM62>2M%)/%V)W16EAW!]C$99=PZ-@],Z`V:`-`
M&@#0!H`T`:`-`&@#0"SQG^SW'?N\?\D:T=7]VK:S'_'_`&*/E0SUG-@:`-`&
M@#0!H`T`:`-`&@#0!H`T`:`-`&@#0!H`T`:`-`&@#0!H`T`:`-`&@#0!H`T`
M:`-`&@#0!H`T`:`-`&@#0!H`T`:`-`&@#0!H`T`:`-`&@#0!H`T`:`-`&@#0
M!H`T`:`5^/\`\W>_?K/^D.M/4WT_+3P,7175_/5Q&FLQM#0!H`T`:`-`&@#0
M!H`T`:`-`1KC_-*+\U;XB]-%'<6TT-*.(.V^,``%V`*!M^5/7UZ>NK06SM7`
MB-H,DNJDBSQG^SW'?N\?\D:T=7]VK:S'_'_8H^5#/6<V!H`T`:`-`&@#0!H`
MT`:`-`&@#0!H`T`:`-`&@#0!H`T`:`-`&@#0!H`T`:`-`&@#0!H`T`:`-`&@
M#0!H`T`:`-`&@#0!H`T`:`-`&@#0!H`T`:`-`&@#0!H`T`:`-`&@#0!H!7X_
M_-WOWZS_`*0ZT]3?3\M/`Q=%=7\]7$::S&T-`5E_>(\FY_QO[<2<GP5UZ%\7
M*T8L1A2VQV(8>\,.OZM"4>7F^^WW?"D_[T6O3_(@_P!7H2>G^=\A\F7POQ*W
M4N2I;OTHI;ME5R'D:O&_OV1RX+.?@!\=2JH:.THZ8XP)!]R^9Y'C.'JOQ]GZ
M>>6QMD8%`QB$3LV-Q'HVWTU-+:P\?!AI.WL))P\TDW$TII&WR25XG=SZDL@)
M.JLDZ]`&@#0!H`T!##1\&'EH]DJ<_P!_N_2*TH)R=YG[0.WM%UW%_3=^G3D<
M(\TK2)YL(3)GH0+/&?[/<=^[Q_R1K1U?W:MK,?\`'_8H^5#/6<V!H`T`:`-`
M&@#0!H`T`:`-`&@#0!H`T`:`-`&@#0!H`T`:`-`&@#0!H`T`:`-`&@#0!H`T
M`:`-`&@#0!H`T`:`-`&@#0!H`T`:`-`&@#0!H`T`:`-`&@#0!H`T`:`-`&@#
M0!H!7X__`#=[]^L_Z0ZT]3?3\M/`Q=%=7\]7$::S&T-`4_\`WJO^$\O[_4_E
M'0E'C5_D;]1T)/87E-L5O`?"&ED1(7XV!5S$9&W?3Q;NI=%7V^A]<^FI42MK
M>1+_`+J+<EXJ*$*D--BV;YG[+QRF*3`_FI/:?U]3@:JTGM[/$M3MX^#1*?'0
M1X_Q@(8$5(`0WS#\M?7].I*L8:`-`&@#0!H",<;#P=OF>0DGJQ5^3IW1LF[N
MZ9P5';;/1E1LD;/33DQ4;8;"%7A*WB2?0D6>,_V>X[]WC_DC6CJ_NU;68_X_
M[%'RH9ZSFP@OW3Y#D*E2K_#[DE>X4F:O`LC0Q3RAHD1)94(9>LF%^&3[B!K9
MTE*;<5(R]54TE!E0U_NWYE!R$M6LKW!8B>"-WGLMMD7`FW!YE[+1D.%?/7;T
MZ'7I/H\MJ+EW>1YRZJM."G;:=?!^>^3\N]Z*GR'>E@C+P1F[<@D`$B#?.LS(
M$38_KNQN(Z[0Q%<SIZ*816Y$T9]=48/>S;4^XG-\C7FKU^1E^OHF55W2V*]=
MX]X[<KV9K$>[>7VA55F]IP",$P^FII<6I.UT"5U%3E&:MI-5[[C^9\?%6BKF
M7D+5_L6^,@C>X[S1'T#GNYCP=P>-AD^SUSTFGILNJ^4+[A5U%=.N-U_F;N'\
MW\SOUDY0WH8$$!Y":*2],52-)MKCMB;+84'\L#<"-K!058Q7D9:<(:KO0FC.
MK<XZ[_4T<O\`<SSN6RI3;'6BIPS1V%ENUUEC*))*VU7?=)")?>/F('09&-6H
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MN`V`20!UU5]+EPT=B++J*XZ>UA%]T?(+TDB<1R1GD#,E6M:M7*\T_;0-(8V$
MDM<X_97O;F^`ZC1])2OB6Y>W<%U-3N?'V;SBI_=CSVY3CN0(6@DL_1Y/(V%9
M92AD]ZM("B[%)W'IT.KU='EIPU1N15=5F-1\?4Z7^Z/F5:ZL%IS(`2E@5^1M
MR&)Q*T&,H9-^Q@KMVPWM(_'5?VF6U%<$3^YK3GQ9T5/NA]QZ\-[OP102Q%(1
M!=O6!/++)T1*\;2;B2'W9'08ZGIJKZ3*</!+>674YJCYFF7[K>2,5[$TJJR#
M:?KK,Z!T!$Q+P2,=@8#:^S'N]V/4V7248\$0^IJPXC2OY]YC)!R"6[4<3<0)
MXW$=VZ)MZ=R1)'1B&DAD$1".O^4OJ?;KF^GRXJ"^+4BZSZX.+NUL6I]Q?/'2
M\1,G<H@,\1Y"X&*'!+N2VV$!2#^:5/P]01J_[;+EKU*W<4_<9D_-V[QM0\U\
MSM\A5IW;\52A]`U\<A':N,PB90ZF2$NDQQ)((R=O3!QD#7.K(RTFTHN,(01T
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MF$[E4[5^;]&>FJK(RW=P4GK19YV8K^+XFCEONGY/-0DYJ@?Z`)&CF[?(VI17
M=(VV02",)NDD[+/W$]F""2.IU-'24)\KOV*WB15U-;7,KMK%U7[M^5R6*<DK
M31<9<DV1V)KUJ$XQU8@/+M4MD*V#NQTUT?1T0>E:D4755RT;6,H?N'Y8SCZE
MYJ08$SPRWK@FI8D$8-A6[:N93G8B'<!U/0:YOIJ,)]BGL+_N*[-R.1ON/YRL
M@4V$`68U[&^]>1X9=C2*)(G(E"NJ]&VXSTSG5OVV7HW(K^XS-.]G1Q_GOFEA
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M#ZC,5_%FB?[H_<&%J\;0RM8M2"."%+EQM^X`JRR!^T=Q)7&[.0<ZE=)E/LU(
MJ^IS%[6;*7W;\F[5F3DA?B>O)VS7KSV)'RC*)!(&G1H_YQ0IVMDZBKHZ,(;O
M(E=75C&W:=[?<CFHYK0L\G+5CA@,T*-->D>>1T,D->)U<0M(4V;LN.I]H;5/
MVM,H+AWE_P!Q5.?$U1?<SR":N)EO3UE57:PUVQ:@CC)V?3#?WF#=[?U"^Y?4
MC'74OI:4[NZ';@0NHJ:OX^9KJ?<SRWD(;)XRTT\U*.26SW;EJ"*18VP36D>7
M\S"^XA@I^`!U+Z6BF]7ZEO(74UNYW:WNF?*7W/\`*I^+LWWN'=6E:+Z:"[9G
MDDPH"F,)+UW2,!^KK^@JNEH32AN7D%U-;48[WYG8?N#Y(O'P]SD5CY>201&F
M.0LN@+@L`\N]4B:/:5=2Q);`'7(%?VU$;O=V(M]>J%\]K,D^Y=^>Q+##?N+)
M'(Q$1GF)^D13_2F9[$0C!.UML@7"MT+8.G[5)7+UT7#]RWB_33><$'W0\MEX
MRK;5[+S6Q(8HHK-AT`C'S/+WP$`)4-GJO7IZ9N^DHBU*6I>15=37",[=IHY3
M[M>5<;L>>68Q2=Y$V6[+.LT!V[)`)=H#'J&5F]I!_1J:.CHJNX+R*U]573>]
M[\S?XW]UO)>2NU8YKO\`#Y)-T\9M6+\D<L<3`%8EB:1I')#^PJ,XQGKJ,WHZ
M*4Y1[BV7U5=3OAWC+D_N5R$-M6CY"S'")9(;L%N>U5F@EC,8`D7N.(TE>0[<
M;MBXW?''.CI4U<MS+U=2XWO>CJE\UY*LAEY+G)N-@PR]V>6W@31R.DD?;$_?
M88C/;=8L.<CVD'55D)W4Q[O*&\GZS5[AW^<2.3?=+S]2NRK<"@`2R3V;<**[
M*\J+N,A'OB3<,X.<C'37==)EZ5W(Y/J<S7O\S*7[G>>17;51R=U205Y9/K;N
M#.<CM(-VYSW%[9*C:#USMZZ+I<N">G4@^IS(P\6,.+\[\SO<;/;:WVV2%IHT
M2]89?RR&D1W,RA6[&Z5-N[.QAT.N=?3Y:<(;EY:2].?6U&.]^9CS/W.\FKI%
M?>\&ISSB`-7LV_<I9EC>%5E*N3%&LCKNR-P_'4T=+0Y0GL0KZFM3C+M`?>:Z
MW/V%3DG[$#1A;DAM14RP0]T/').K(!M.P%=SGX+I^Q7+=PCP(_>/FOXPXC7B
MO*/(GY1Z+>3+%<"S+/5Y">2!$CE?;&ZEYUD+1HN]2%^0ALL<:YUY5$(\LM7L
M.E.;5&'-W^T&\OY"QQPNTO(IOIA)/#>E>2=)*G98H964V6C8=,JN[/5<C!R(
M^BDX.GA/</JMJ*JXRWG'3\\YGC&Y&V_EUV>:.$I!QDM.2Y-`0T:*\J[X8^])
MNR#UA_R6/35ZNGIJ@N1;8PLMY59]2B^9]T;<#E\F^Y'G]6C4Y&/D(Y^-3<8G
M29JDTL*OA&DB$A=NZLB8/S`JP_'-LKI<IMJ$^\KF=1F))QEW$@K?=+S.&J_'
MV6I1<M:!FGK2?4O]()F3I+9,H6)5BD5U"ANI"C)SC@^DRVXJ,%LGV'9=56E"
M4>V6\EOV^^X%SR@,W)S159*O(I6K)260"4O6DD[-@.9<,%!9@K8##&<YUFZG
MIEEW:,=N!HZ?J'7?IPV%D:PFT-`*_'_YN]^_6?\`2'6GJ;Z?EIX&+HKJ_GJX
MC368VAH"G_[U7_">7]_J?RCH2CQJ_P`C?J.A)[&\@$`\(\&[J/)W.+B50)&1
M%(JQ=<!D]Q#8]=()V]&5C"WJB;_<GD.2H\+4EX^>2M*;:*\L8#801R,=V[*X
M]O[0(T;6,.WUAQ'+&WDF/N"DMR\57FLSBP\R+*L@4*=C@,H.WVD@'U&,_AI$
M'?H`T`:`-`&@(:OBT\G-B9JM:O''R+7XY4L/]0P)R<J(\%7(R4+8&H@[U&UI
M$Q5S?9#U\"9:D@6>,_V>X[]WC_DC6CJ_NU;68_X_[%'RH9ZSFPKG[V5H)/'U
MFGCWQQ(ROGW#;)/7#`Q!)3)D#X#_``'6[H7[UM#,76KW;:4>>9&K-02O7Y*6
MS/,0M&002"H;"*T18F213&S]`C=OVE<^WJ=>VHQBUYGD2A!,RM^3UJ7%0<;1
MY+Z[EJ\,</U^QPID:5B8$)(26&-&(WRJQ)/M]O40LIMQ:@K;]A+S$E!.+)9%
MR_CECE9:5>FC)QD]2C$D9FNQ3//E9+*0G$7<C<S"/<0N9/Q49S\E:IBW?%Z.
MSAW'?GI;@E=!:;>I\XWA8CP]V@UF7AXX;,%OF*G(13L:(PRQ6%OK(JJ\ZJC;
M2P'3&[IU59GO)PYI2A"?9J%-$FKISOEVZS*[9EKUO'):)@XZE2Y6>G)8E[7U
M,J1R135C($!V/-!$5#9]ZXRWNU%*BZHS;ICY[R6X<L))/V'-;;R+E.?`XBO'
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MTMM1TXG51JJ23AH.R.?BI:!G=ZS7.7MV:=?LD*@K1O$&V2.F(W6-Y`DVW'1L
M+N?.J0<83A2D^-H%HJ&MORM$YJMHKQ]>C8BKS5I-_)V;2S+7Y6H8),+.UB;>
M2UB+81W$ZYVC;UU9J<5L_M?9J(3:4'MU]YJ?R<UI;'DU&;=Q,?(A)*3=EFM3
MF,SPO-#V81&A:,[FQGT`'MSJ?I1]Q_%#NWE?J0]Y71-QLVI>=XB3R.!UXFQ=
M?=1J1L9;8GB9HI5GC5(Y#)WMJE2/4GXDZB"Y7R7PQP)B^9<UT>\XKW&-9O1\
MA3N1<91[KP)+:8@1UW5"C/!&NV-H5>-&V?@'`PI;5J:X*#47;B5=,7%.",A9
M%3B>1K?PK_X1U@XI[&R2Q&BC=<#YD#QQSA2VZ/<5SM4X.=(1J3C??X=Q,84N
M6SQ[S5)'>I<S5FKO_0IU=OK+>8(W5(N_+(K0,DS*Y8NR[07PJD,=2H.EQO*N
M*:A<=?\`"?XJ]"C2Y226MRLD=/AY$#/9D%%5#2S!P)%A67<L2>U0?<=N.M>?
MEBVKIOM\=)?DYH).^[L&*WTNWDY'E%A2YR%X5:$54Q-8C<0/&MJ2.3MKUG?N
M[C[NI+?LZY\L%!7)3\NZ1?FBXO%VWG'-3IPWH%KQ2R/R-F)JFQE>[-<@=@+2
MR2LIDBSW8V98UC;`PN?2ZJ;4\.Z&CAK*NF#VVM@2>7G8.,@HS<I_]T*?(7%K
M\JEZN:U6L%4`S2QUM@E8ET5)0&5A'Z@]%SK+YFX2:4H7OOX:SOS\J49Q<[*T
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MK96.Q`S6XQ7$LRLM=F2.598">X)&?V],EL:MFU>[&_AW[2N73[T+AQP?(U^3
M\?XI^9X2#DDF:16PCQ6@@1TC:N:P0,L;9<*WN5>JX`W:Y9E+IJ?+5#AVQ.M%
M4:5S*/'<<DEJG9<35WDBY-Z[<A)5M/'6XRI5>#9*98^Y-8DFD_9W-EMV[XZL
MDU?==K;X0*W[;]7G$WU?&Z[\I%15VXQN2@FGBL))-)5:"&JDEDQO,OU1:26,
M(0K_`"@@$="8>:X1OAWWRU!9<X71[KIZS[Q_%CFG2K)+7X]#5:.I1DAEBH-6
MB>0^TV8YIGMNY:8%AD!LY^&HJKY9WS[8]F&!:FGFE=+L]N)T/X_=COWH!]5R
M:5>,%JN:]AK"2UW42J(%F]\BQ%R8W*Y5F.<X4F/J*"<E[V@GZ;BU?(Z>8\AJ
M\PT?*T..6Y7FJ;:UZ,!9DY`IUA6$KV0Z=M"T;EBZJK(VX:K1ENF3<)[N/:37
M7S32PW\`\BXRC?2["T47#3RR8O5@F)!-O*N(AOV['VD1E!MS(4:4?%EUM0_J
MM;NN&92G'"UO,3K/%#Q7.\68X+!NF*(UX@\:QO"RK4M0&-7,TD/<59(\OO\`
M4-T;76$72]%FCG&36FR]@HO'CK0^@:"*N7#++(,6V-A@(Y8XUC8!Y0YW(""?
M>[^W`UUIBI^AS<'([ZWC_/\`;FJSK#,W'R6;\=FFKF7?].L)6)CF)`98HT5]
MI;?G;G#:H\RF_3!3VEEEU=TSL@J4%@XB3R:63ZWF(9N0LV%C,T=:2$@55$2G
MM8F0!25VN"?GQTU1MQ?)=3+;IMN+I*"YL9^0JCDNO9BX.KRLD'%T8Y&[U832
MUI3=BWM@B.:5I)3M"H5;)W%6&NCA#F:F^^1S46^5.2\1I<XZIQM<#A./%BK=
MX^6RBTYY7!!5U9/Z5MD!"8DE4)E=H89!..=-3J?O.:>/IN+NE)>ZI-8"2*[(
M]=*="E#1D^FK-59X$16FA"K-WI``RS/+$Q7>V"#M(!(UV=,XMQF[;#G%M04I
M(;'CC4COW'^ON\?-#FI4DV4'D::1"UA!(\K*))6CEC>//7*E5&N?-&"DGW]G
M@7Y81<VNX5<6]*N];C(*4'(P6N/879I2B0.9!F,D50TDDU>9\#WEV.!M4ZZ5
MQ<7&$':_!E*904(Q5KM!S4.)/\,EI03/'!9<"_7L%(D26,"5(>\%,C_4=AE7
M"JN\+AFVG5JJYQ=O85IHE"UF:+_#T.3AM6>,JF-*J-*J5YI+I"]I&%9`X4B.
MOG+R$GYL#)P-336Z8)OP[>TBJA51:\SOX2G4I\52J6./A,W+2=QGM2D&,+$X
MCE[B;6@??'+L7:QP<G!"'5,RIMMIW6[2V6DDE"\92UGL<9Q<\<45JD[=Z=;L
ML"P%Y8>XOU"P,UAGD1,ON;(;MY)QG7-.#>G5:%F=&I*WK9"VE/2CJ<U-?XP"
MY#`TG%]GO3K'M<"8M89FD"-M<'<Y^8X`SNUTJ3C3!RQ*4M0<5L&ESE;LUSAH
M./NTK-.599^/X]%FCV)'#N;$F]K(9IXY`@D;<6.X='.N=-"2;:<<7:5Q>JIQ
M4&K;S#E*/$2=BO54M#R\JS(+!CB>N4W5I*]@2=U-\K*TJRQL?S/5>HPHJJO>
M'MBO+0*TKEC[+<#HAH5^-L4*$,(:68R".NZF2Q+'!E98S"GYCQV(BW;5YPB[
MG4X.,0ZN9-VLMF@GEA!6L]IRVTX#E8YXJRV.&VQI-83MM)'(BG*()RLDBRGM
MH/;OW,50=%+:LG53?[Q5JFJZ1O2**OX1%RE,"U92U%;Y*U'BQ!7^D5DBBVV/
M9,-DKDC<=S;NN$`:(QS(.2A!=NPF$*(J^,S;=L6;4O`\7:X:@;EFM]/8XL;H
M+H@=&<R267[SP(![U8OM9"/8`"-5I27,TW"-^'=B6J;<%!;+F=L5:P_`M>H+
M66%ZCQ5J#+':F1:S[5KJ&CC9)P$($TBN&W%E_#56US0<;[[NW9J+)/EBH7;>
MS;K.6[QW$T?&F9J%N+DKO9Y/C>*L1B.=8HT*2I+9KRP,M?8A,:,JMTRJ^NK4
MU-UWJ"DWZ/$BJE*FZ;G#UT!4[7.R6(XWH5:_+UA)P_'48UKV9)(1V\`R[\RA
M-Z[6EP?E'S*0?N:7!S;MX$+W]$[H6\1?Q_D`EM\C5KP20<Q4=,&&P*U2.O3$
M==FVV3*3((HE(/JI&?AJ]67)-_"]47.>!2G,BVL=TMI:?V";C[-7F+4L$2H_
M)QO0E3<RO+],?S-Q:0=WML1)AO7.>NO._D8II?VS[S?T,&FWI+FUY9Z0:`5^
M/_S=[]^L_P"D.M/4WT_+3P,7175_/5Q&FLQM#0%/_P!ZK_A/+^_U/Y1T)1XU
M?Y&_4="3VM>3C)/!?"$Y#Z@1MQ]?MR01),%?Z6+'M8C#G]AOAI".*[8^!"JA
M[23?<V7B5\?BBY.O-9@L3]E$@E[+!VAD.XOGX*#_`(<:E;8$1U)[21<*L*\-
M06%2D(KQ"-&.XA0@P"?CTU`.S0!H`T`:`-`1HP\%:\GAYQ.0)L0[^.%<'V&2
M&1XW!_YRO-@ZGEJ["(K1,DNH)%GC/]GN._=X_P"2-:.K^[5M9C_C_L4?*AGK
M.;"%_=>D[^,O?@G>"W3D@6L5PR;IK<`W.A^;;MZ:U]'5[\'<_)F7JZ?<BKUY
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MK'B<:4Z?>5D2FQRM*/E^2;E(LU>.$-MZR1S+>42L9`QD,XCF.Z;>&F9^C8QC
M*ZSJA\JY;WW<.!W=2BXW+OMM%W(^.BQ;L37[)FX6U=666VMB*%G,<3%XJR-L
MB9HH\*[N/;@[4]-UZ<V"DO>A:)2K+C-OW1?R<-9.,BL#C>SQ@@,D89B9MLL3
M0589!+NW%I=TH*8]N64*=7I;C",[1\BE2E=*T#=+QMQN)Y)DAN"X8HTN!E:+
MO+(F^*FC.QD6.%8RS1$;Y`H/X8A5+F5T+3]<"SI<'IM(VWFY;F:T'-5^"@J1
M4)(J%7@XZZ2H>['"L1DAF1F=IE9RDC;O3]&3%/+2^5U1C./?P#YJH5)0A*`Y
MYZ7FI_K:M"Y#%)R"QQ3\?8E[L]05V46([$IB"K4#*Z@OM_`=&PW++5*@VKL=
M.B&LZUQ<8._=Z"RGP_DE>M?%/D*D/<GC[]`I'%#))+&DFR`*`R*[;0I4*.GJ
M#@:Z55T-J*9S5%2C!HU2FUQ[\/%?5K50S13\7]39+)&8O?-+6>L6F$#R;QE@
M-G0G)#:E0JC"_&7&.(::A'L-L/DO\;\FI33O+4EDEJ0-60]N20RIF:X6`;V1
M;G>,8";3^L&'E<E#A._V!9G-4L+O::?)N%OVJ-<05$:*XD<U2S'#%%]0XR(@
MT2@1Q$1Y!96Z[3Z@9$Y5:3F[B,RAM2Q-EBR]:Q2XHM*E@$2&RI:3L3R85^W)
M&K)%`G<[;K&"?E`QZZA*,7;VDMP@C/CX>*GIRV+4TW"<S/`_T-=G18EH._;2
M&&7_`.Q@RN%=V5I'R<+AB2J=2<%[U/CX\":4FHW5>'@<%JCY#RWAEGCZ[4DX
MO@PMR2G")4DWLSUY656R9&WH`Q_2#TZZNJJ:<R+C&J7B4:JJHA*%,R3<5RWF
M`YP15:DW'W9:RQ5^*MB.SO\`J5`04'"!X5;:TC@%579U<'6>NBCEFXJ-]UVF
MW8=Z*J^:2@X7>5NT^4Z-JGR?*\;/Q37:O%)V>1JR-#780H8UGG9I&F5$;NJV
M(B$.WY1ZA54FDTX1NMYD4TM-IJ,+[>1PU^-IM3K0V^$MO#5S8J2!VL,M9IV9
M:C*A_-+JJAHV4-M.0!ZF[J<7"I>L+RM-,IJV@=CD[<E#CJ]5!<CDAL/7NWXH
M38JPPQ/*6AE4J[@1@!$?W`A>JC*ZY<BBVY778G3F<$E/:+&E>_R,-5/R]M]H
M918D$HK"2N+$3QO(K29RKC<Q/7&Q,A1KI""CJ[YPMQ*7OMM;<8PV;?#&6?D9
M+'#W!%+LL3_F101LB)$:L<*V<G$[[G9MQSG<I8Y-*JZ:M?<$W3?)VN$GD?D-
MFG(\M.2::[<G.SE)XU`->8;PD=>0R2H#N5_=U+=>O377*RT[[E@<LRMJZ_2-
M[-N"O+#RTE"?EF^F5*R3PF"I#',7KSLL$;.R",QG\R0]#A=GQ'-*/NQA/MTV
MXG1N$X1X:+<#LX>ARW`QRP<Q7C3B>0!FXAN0I"TTDNR.`?2N9>ZE@1%V6-WV
MX'_)2NJFOX?B5\'#OU%Z*:J+[G=%<-9T15^2Y/RV&6.G+)5XB,<<;=_9)-'5
M:)HCR#,5BVH[8_RP"7*G.H;5-%\W.6G02DZJ]2E/1I.N2'F_X3)XMRM!!Q0B
MAL7^3^LEGJ-7A*=LKW^[)7=X5"JL;'=GX8)6B=/-SIST0GZS+0JARM2TQM`9
M^2P326^/\FJVX>$DYFE4L^/QP+)8E6VBQ+ATC5>G:;MAAT8='R-H%,IR=#7-
MRMQV6]"^8IJM/EBE#:5]S-^9?).1J4Y*B)REEXKEJ#N5H[!$I`V5)2L:3PL#
MZGHQ5NF<ZV44KD3<9+;OT&2NI\S2QM<2FQW^&B6*M87D9+-R:AQEN8#;6:&M
M%.9$E=9'EWD&.4.!TZ877!0JOE*+USM`[.--SC."(_P='B;<`>8K:K5>0L&"
MS9:2..:!0LG8I3E))%?O.JLNYBV<J0"QUVS*JD^RT3E12FNVT#/BIZ-6^.$E
MI=@*D5M[3=PA-Q:>2JD:[5B+K^TK(=Z9&,!=16FUS1U>MHBEI/EA;1:!R</;
MY6#C2]:$\51OS5[`Y#)M!1-,_<9UP6<QA\!%3H,MN]WOM6DW.;497$4-PT)C
M:#CI>"LQT88[4EF<(M6[?>`@V+<S+`WT\1E;8:Z2,B%\^XNNP]=<W5SJ,NS5
MKVG3EY'"T_0U7:W,^/\`'7/'ZW%R132026)K<`LK'%4$I#"))W8]^%G94PP)
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M,375XNW"J&G##5%VQ'*T+0L.Y"*[O`YKL1^P"PB]RLQW/[2FI=:=^'GI\>[$
MA4-78G#;YOBGX-:M"NM&.T3#RUZPDL_89FD,ABC`9HE`G"N#G+-[#[<ZNJ'S
M1<]%NPJZU""EI-WBW`SF/M798N$%CMRI<OUT@W_0,&4UU>-FE.6B9E)7>3UR
M.NHSLQ8>]L>G3O)RLMX^[Z&F"WSU?E&+5[DG(7)&EG2W2(>WAMY;&[MG;*Y8
MRMAD7&&^&I:I:P@M=UM!"=2>O8,K?%4Y^8FX]:T?%U5ABO3Q/+!.\,\JJ.Y3
MLP_(S3#!B;"YQG'[/-5M4QC'#VKQ+NE-PNM@,:'-V8>*7E;D<M^KQMWZF[3F
MA6"#Z_N?T=JJ`0R0*VW,HZIGKACD:I50F^52;6[&.G475;2BYI/?A#1K-4L,
MW>LTN1A,'(Q&S,E.U&MR&*O590S1/&B8VKN56@V=/7Y<ZE-2:NEJOMC$B#FG
M?WV[#16G3@WL0T?_`+J0)LL+%$RBM72P9.^+$<9C67Y0`I*@$;5)'S2USWRX
M]A5/ENF,.3Y&>V(N'Y/D)JTD;0/QO&M39J\MJ4)F811P5S)VE($,)4X^8^WU
MI32E[R6UQP[WVLZ55-^ZW;=V(S\>A>ASEX\=S$/$VI)/I*M_E7CDGGA96W%9
M8XY,O*^X88$)MV]648C,<:5%16H9:A4X.&T[.,JR<;03B(9K#7:'*2K?D)C9
M>1+Q++,G9CVO8GB;:JH9E8!LYZ$"M;YGS2@Z>[R786I4%#%/OMM'\%,TJ'-\
M_P"5<-7O5N6AAIUJ4;S/(26PE5U9F"21Q`;)%C&[UW9.=<75%TTT.$)^IV2@
MG54HQM`A7(UZ]*@WC"RL.$2:6Q6',4WAN\>L<V917E1#[Y%4%7W$'J-N[6NE
MMOG_`*M3D]IFJ4%R_P!.M35K(SCGO5O)N<CHR4^4X:2I%%%8KPBP2+!6:,*`
MJL7'O+"1PJ[OS&P>L-)T4QBJHVMW!153A!TPM;O+$^Q\<_'Q<I''(\D-_DHY
M_P`U"N%GKO(RJI=BNUTVL3^T"/TZP]?[T-2\39T4HZV7!KS#T0T`K\?_`)N]
M^_6?](=:>IOI^6G@8NBNK^>KB--9C:&@*?\`[U7_``GE_?ZG\HZ$H\:O\C?J
M.A)[3Y*U2B\%\)BL5OJ'EXV$H>_].JHE6(R`G#9W#H,=<^FDM+[(>)$]''P]
M@Z^Z]NC)Q]/C''<L/.LQB!*L(^U,-X88;HR_L_J/0ZGEC;T9'-#5;:B8\*`.
M'H`'(^GBP<;<^P?`9QJ`=F@#0!H`T`:`K'CN#YB#G7N6*,_8EYVPU7LR/LCB
M>QN:2:(G!678'#+\?AJO/K?<O*-KRW)JWOSAN+.U8J+/&?[/<=^[Q_R1K1U?
MW:MK,?\`'_8H^5#/6<V$3^Y]B2GXE8OJLT_TDU63Z*``M,1;A(5>A;=T]N#Z
MZT](HUPTQX,S]2X41V<4><;2/Q=KE9+U./;71(F1I^X$>3;`M/=#VU$D6^60
M2[/FW=#ZZ]Q>\E!VT\)'C5>[&*NM`SY+Q;A;4<$M&\R3\9/#7LQSUY143N2*
MG=GF#F9#ND4*O7VC"L=13FU*]7]Y-64G<[AGS?%&*&"Q]*+$7%K])S5&]:[E
M:CR1<J5F15#R1S[E[,C,54^N0,:IEUQE&^Z"O7IB7KHA/1?'!VN.[RQ?&V\6
MCJ&-Z7(\/"T?&\4LB6I)K`='DR(5$ZA,[6E>13^&X9S3)Y^>-ZJO=WIV%\WE
MY(7-8"0VS-P];PSG(3#;AL5X4MJK0QR02QKVB>RP5[#1^Q3+NZ8Z?,==80J^
MI3="W9L.48KDJMZ[3[-RCW/(..KOQ+0M7L14(XHR@CWQ`RO`BRY964D(%5@B
MGK[2=%1"EN.L<T:DH:AC?N<?<-[Q^K!!";\*O4JS2SV#!``LV9'G'?B8F3?A
M9,-TZ*`<TI34*GA;86J:<:5C;:1OF:L_(T)+\5"/^&&6S+)'%-3DR%,8W+,R
MI,BLL389AO9OE!RQUWH?*X1G+2<:U%1P[#?QK6K/CJ32"Q>I.M->7CN7>U&^
M#+V(HPL;S")1'W&;("A3U_"*H*K0YP@B:9TZ5*,SHX#D(X?+X8;ER.M:4TU.
M^9X0J0!1(K-)B/NN6W*PQ@H"IPV=5S*8T24IELMPKFYR.F]S#^13\)42W)-Q
ML4KR<_R)G^DKO$+`154`#M*P@$@1!T8DJ,`G5::.3F<)X*_`EU\\%&6.&(HE
MYSC['"R\'6KFS92U8CAXV:S*P>:60[9$:,J)`%7'O?'P`)8-KJLMJKF>B^!S
MYTURZ](Z\:YGB^)Y*WQ?US4J7(VS-QG+3O*7-6,,CI&V?8[30K"&VJP&?<-<
MLVAU).$6E-:[3.N74J7"-[O,([D?&5DYBQR'\2YY#*\W%S=UNX\L3X1V4),'
MKB,J/F7()Z9SHZ>9\J4*=-I3(3@HMQJT6T$;_AMBU5X^U%7@FXN`N.4DK3RX
M:2+<AEE#R,Y01X/Y8'0[>F5UHYDFUC@<>5P3PQ/M3E/)CQ-O^'2S2499%JP3
MP)&441]M5)>9FGJK(57J<+GI^C454T<RC?;L8554'"ZW<=E&W+#5GNTQ(ZE&
MF269F7CH3%#AH(YG7-B=H1AH\HK,/B!C5:E%P?KZ(NG!17H;_'A_&.447>XO
MTKF.G!"@/]&4"18R\3R&%1'+M?!53D98L-5S/=4K,G+]YS'/*\I5;R3_`'?\
M<KS7(X9+!Y9X=UI4K22+--)79C9(9\LLK*2L@QE=VN5%#Y.:N6C">[LT'2NI
M<W+3/3CYG!RG/4.*K<OXUP[VN/>TCH*3S"P)&?!C>.T64Q*$7,B,5RQZ[OEU
M>C+=35=4';05JS%2G2I!X=Y3_#I?I.>CDIUK?MXI)'9YJEI8EW.!8),<<RV,
MHSJ^#U'IG3/RN:=,X7ZUV:($9.9"54M&HZO)*7'?3\2_#W)*O+WZBV8J4,\M
MB,"25AL<;`CC,6QL^[N.2Y(U7*J<7S+W4[6T7%LRE04'-HSX^_WI*B&Q!R]H
M1;8N/ECA261YY,,@/<$98DLCQ/T9@2H&=Y54PC_3KMQ]A-+C#$T<Q3XN'A2H
M@#<@T)[2W8IX;<,<*%VEE5I)"O;E&!L=1E@0,'W314W5JU7%:Z4J=9CPI\BF
M\PKO)8J6+')5"]2:[8F(AC4*\K0V0$DD1(XFVJLF!G!.0=3F<JHQD\/(4<SK
MVK'S/EOC^0GY@W./XI*U"Q*TC&U8^I>GOBD,T,YD)QW`P<[CM#'#GT`4U)4P
M;GW1M[!52VXI2X##D.3GX:5N-XFM7M77K0S1&LJ!ZT7*(B2;]BQ_F)(8U82]
MSN*W7'N)I33S3J<%'OA;"$"]57+)7PXVUB:+D(^)7D>-X:1K?'<>2UWEA+]0
MLJQG9$7BF22")XY07C:([MF0NXG75T\T'5>\+3.?-RQ2N6(I\DNV:L+5?&^3
MMVZ7-TZYYJ`MG=+(7F2%8R\KX6,>[J?B#ZXUTRJ4YUI)TN1RS*FI4-S4R5-1
M\@O<#5I1SS1P6:%2W#7EF;Z&"M''ODAC8RR29>$$F%2).HQA<ZS\U*J;UM:[
M:[C1RU.F&KLX[CF\.YV2OQE/AI>1D@XSDA'/4Y-D#)7*/+$U*5C\BF;;)$3(
M`A*LPZZG.RXMU0FL/'S(R:X)4QD[0.[DY.*I`TDXZS3XR1NZ!*D^Z6RTDNZ!
M99&>0O(L2KNB;#=S<RY`U6B+G%-]EN_06J@I0D?)+'(<@G#U.$Y1[]OZ<\JX
MM2P122(2?K(>Y&Y4RD*H<3H6P.C8!T25,74H*[RLA-PY7''SLS3R/D%R&G-*
M78\.MT5XC++8K0PL8PQ*Q21RQ;^YEP^WKM;&3[M33EIO^Z&HBJMPU1.NCXU-
M9AM)<L1S6>4HP6E,HD8SB-721A6K"&6)4BE+*\C`$,!AOA6K-A"&#M-DK+C'
M6K7''X]6O\?-RMVZAY%:/'LE:*';VYJH8?EO%#MA;M&NT;(SL"2-H8+JV8TX
M)2B]_'$C+33;<Y&KR*VO*WZ_C_&W3-Y&]AN_R58?2P10KAW:Y%$FQW@6/:'4
M+T7K\-3E+E3J:]W1?W;2,Q\S5*?O:;N_8*+UOD8S#3H\3)_#ZE4FV_(36FJN
M47ZEY.IB,<FV0YVG)R"`IUUI2O;FWA".@Y5-W)2UQVF?)4QXOSH-C-BI']0E
M=VM*Y%](2JM8;:QB1XY,]C)W#H3ZXBFKZE,K]F&KS+5+DJM?;`[.0>G5_B-V
MUWHJ[RIQ?`VED=JNVFH1=C-O=4WCN#;)M51MZX"FM,7!+:],R:H3?8NPYK%7
MD9/'8.,O2O&\-@R15.X0BQ6U.$M6CF(21"LC]LQAMO3UZ:LFN:*M#0NTAINF
M#M'3W&')4;J>2A*$''U;7>:I9J2I$Y@#`L38K6%V-*P!W2QG#?*H`QE34N2<
M86N:(KI?-*%MIGPM+RJ&U:_/6]Q?$SQI=26%6HPR6'$':V.D@"M%*V5C3(`'
M08&%=5#2P;[Q136GI2[C;#]<)[?&B5H[3RI+QE9V5Z4D5SN;8X7R`R3IMV1R
M$80N`-PSJ'""??IEY%IQ:[M$QAY2C<%2K5YK[<OY//.]>G0L-W##%.FV"Q"V
M7&%?V%'9E;H3@@'7/*]]MPY:-/@6S5RI3C4<'C_*VZ_C\M&B4X[DDEKJ_+W6
MEF5F]R.H299(D:.176.1-O7V[OQOF4)U1<UH17+J:I@I/2:N"Y!N#YNG3>9^
M2')HZ<Q!D6G2"`'N+[W[;`RQ.[Q_%5'4Y&IS*>>ENZ%V!&75RU)7QO)=?O7;
MHX^?QJ.CQ-J>:Y,9IQ!"7[<L=40_E11.6LR,)70Y!(`(VZS4TI15<6I>>XT.
MIN'+!.?EO--#F>/GJ3<;R-RK!%W$S;@C22N@F5F43F,021_DLS%8]H#=#U9E
MU:JAIQ29"J34&T:.0O0<;=MW;;O:YQ+==!:L1&.L\T?OQ!(AGBPV>XCLON+;
M?ERIFFGF22^&!%3@VW\0BH0<G#Y-8%@&SQZSB"5Y)S%!#<EG(29&6/'Y;(#V
MU`;'PVYUVJ:=$K_`XTIJJ=WB/YJZ_P"]MF5)OIYX8*"\79B@M&ON4F-P\<A9
M%7?[QN9_DP,]5UQ3]Q=L;K>T[->_W0O-[\Q=\*J33>3\FO)/N>?@^-[LCK9C
MF@W0":/8IBAC+=5Z*Q;KU4#550LU^XH:7H]275]->\XZ%;`QB\?XQ'XCR-IK
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M\K6,<.XR"*"3C[$B1KW&E=#T#$%LY)^!UY_6*/92^*-W2.'>N#+MUY)Z@:`5
M^/\`\W>_?K/^D.M/4WT_+3P,7175_/5Q&FLQM#0%/_WJO^$\O[_4_E'0E'C5
M_D;]1T)/9G,]M_"O`X9!&4;C8WS*R)M*58<,A?"[QGH?A^!TM::(M:3)=]S;
M+T^#ALUZ]6Q>,PBKBW")A[HW8A0<?Y/7]&=0Z:7-J(535S@-?##S#>.U&Y8*
MMIERJH$`$9`*#"`*,#4QCA`B$,8CO0!H`T`:`-`0%O&.;D\J7DVJ11"O?,G>
MC*DSP2.-K'=U7M1`[OQ8]/33ZCN][O<.,-P^FK_=[E'A$GV@%GC/]GN._=X_
MY(UHZO[M6UF/^/\`L4?*AGK.;"(_=@4V\#Y$776.F9*@LR-NVK']7%N)VE6Q
MC\#G6GHX_44+Y\#-U</IN-TN)YKBHF_=N/+'8:>G!-)S5:469X8:0R8(6(9-
M\==5616[GO'R]?7WG5!*Z=UU_J>,E%XROV$@N^7-Q]?C;J<#'62&Q5DX[G;B
M@_5O!`D4S"-#VI&9>V5;'M`/[8SKA3DQ;7-IBE@=:LV"3AH@])]YOCI:W.0\
MG-QM^[%!4^JY'DU>**Q]5,P[5MFC*-)'&"OKC`.X^N2RZHTPBE.2U:!73"J,
M&Y7Z])WP5>(Y"GSG(4K4HXN*E+&>9,IFLTZ]1DD$4,*M$Q=9'4'YLJ=S-DX-
M&ZJ72FIQNP<2]-*JBU="_0+N>CX*UR/#U+$J\5:+Q#EJ=U!)!3EC@3Z=X%7L
MXB:!<MG<&Q@Y.">F6ZDFU/1#'3O*5JEM)RTQP.7C;'CMSP:-([31\VUIJ@D,
MZ+,8$59QF"0Q0/!+<9B>YU53\<:M4JEF7>["VN,"M+I>7?[UO$W>-^0V^(JE
M>2,%>E;G>GS33<@EB1IYHNXMU-@E[:(^!^6A.?VNFHS<M5.5ZFI;BV77RJ>-
M\]XJJ5_&N]PEKDH*B\8HECEL1SSS=SLQ21PGLR`AE:R.YD#U;#*H];MU^\E&
M-O`YI4RC=;Q-5V#A^%7FZ5K<:=5/HZ=&P\$TGU4FXRS*:[*3AX%0$_*KG]1M
M2ZJ^5J]S[.VTB*E33%,Y^0Y;@H['CT/(4JT2QPN;DL/],,5:Q-OBC?<["5H8
M"5"94J3ZCTU--%4*H-\+3*U54QICYC/B.7;D.)AXBK<FLL\AK\9%9-:!%[]@
MG?&D)$H53$&*NR[%SMZ=#SKHA5S-;;]!THJBN5/82/C?!8;M'Z.[YIQ7$4[?
M7DZ]&6.2U9D7<L66:5Y&&T@!-V/P7.N%740<5154U=&Y':G)34'6D06:W'1I
M7:=F"/DXI@G(54@["R1RF-XY))ECCDVQ1J6W1.`5<@].IUL2BTU+"WF98P33
MGB+>/OVK`KT[<]:"E:F`@@9]NPL[%>ZXW3?3K(IW(\@QNW?IUTJI2FHQMO.=
M#C)W#">[9AXGC;J75?ZJQ-5M06;`V_F,CM*T=9^[L+"16=^I7;^C5%2G4U"W
M:7;DG$=\I#PO%<T]*YQU>G1Y"(=GDJTCP2PUFE[,DA59F[BHO14:(.XSN&X,
M=<:'553%.+6%EXG6I4TN#4F:.1A7E^!6GQEWN\1!;FV<9$PSV5")7E$8+3.8
M9+.P*ZC/7J3UU-+Y:HM>]"_CP(J7-3!.4;K;3YS=>7B?#I)J5BO<H-8CI&P+
M@FMQ5FAW=A8XF7MQ_5++)UZ,0OJ!J<M\V9.3ONE:`K7+1*?;;$EOA?D?"Q5*
ML+2<DZPF:O3I_P!#DAFLLL:K%E6"QJ(F0E8\8+L=WS:S9^54V[MYHR<RE)7[
MC'QCQCZNK;KTO).&XV?D++BY%]3W6<$`3K#F3O8=H]^0^#Z$L/1FYL&FZ:G!
M:",O+C&%5*CK%TO!0\2E^Z+='GO%^=ECCAYFXVV5[%:9C&D9=MW:B,8$H;.1
MU&[5UF<T%!TUTX*W<5>7RQ<G35B*N*O4H>,M\LMF$00RT]W&PXC6M+5N0[CT
M+*8YB%)D`]P!.,C72NEMJF&F>F*?`YT-)1M>?+/+_7</S4%#DN)BX[D9DMR<
M-%#,]E;=ARRQTU8?.C,J;X]N<>G3K*HA4HJJ*QU:PZXTN#4'AY$@XSD+_."Q
MRSV:G)F&RLE3A.66"PLL`@9I8N\Y5M\44:*>X<KAG_Z7&NE4>[!K6CK34ZIR
M>IA?2VEF3CN'H5&I312S6.7B,-6"*^$/Y=<SCLK"$EBCD2/VRY^;J<J6H1J;
MCHOEKUW[!4L*4H:;IV[Q?8FXZK>O-RW-06I34CCYBN)>W/);-E:=J2,LKJ#+
M4#!\=?0E21G5TFTH+&6R$5O*MI-Q>WOAP-W"6O'I><@/&U)88K8CO\;4IRQU
M9UKP,C)`;C=':*7N/-W7/15P<@#5<Q5<LW=)QGNX0)HY>:2MM\R>#QK@[U;F
MXN/M0\*;A`Y2K%:KB6:5&D=1&X5(E1]['>RG!7V^F=9/JU)TQ7-"Z3-/TZ6G
M!\NF:(I9XCSCCK,%R]31IT#_`%*/'(65I`L4A[[_`%)9C"J[G[BQJ,,HW*<:
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MRP6J@1+=JI>DL&ZI:D(!`\DI[DC%MSA48(ZXW;01KE1E-*&-TH0OC;$Z5YB;
MCVSON%G.>94)./K3>-UJU"&XR+R]!O9W+1+$JH#`]K:V&)/H=N?FUTR\EQ]]
MMPN>HYYF:H>[*-YNHQ<?9X.YRO)<LM#RN6VBI:K6(H\0R-%7>/L0G8R+$[,"
MNT#)^`U%3:J5*4:(>I-*3IBW"N)(>+N<!#R4,="G#6XFFTOTE:_.M9[*RNI^
MIAD=HUG5NPRY>3:G3;DXSPK534W[ST3AJU':ETQE<M/'6;O_``O\G^HAYJE:
MH3\=:[D5BW+<,$K5S(4[*S(5CEW0)G?@[B23N]=1^[HARM..RV)/[:KXDU#:
M+?X/QO$$>/\`-<6]'EQ)6L_5P+':K&O$XAK3]B-LRQR;-LS*`[;VZ8U?G=7O
M4N-,]3U^A7D5/NU*?>:6M]GRBES%>A'6HW[*]N"(FN+863>TD=>)NW)'`=FU
M248L-K!FSJT(T.EN:7=VZRL85*J$GO\`8;9^6L4JLU*O/3IV8_J.)LP=L2&]
M2WL:WY,>V7>PZ*V,,'W^ONU"HBXN+N>QXVU$NN"@H:-J-'`\EY!P\MFS5YN#
M@PJ"JEFTD90P5E26JDL++,%>5)@V(>O7)]#J<RFFJ3IYO6^S(RZJJ;GRVE9'
M6)?)J-X>3B[Q]FM9Y!)(:UJ1SQ2R392*:-H]D:SJ!(V/6)2"?=JL*&N2#N_U
M>SB6]Y/FBK^RW`Y'_B$W`"M7"<S.E^&[1J5)4LQUVD$[S0RF?N.=XB,CD^P[
M5;'4ZLH*J+]V4-&@JXNF"G/;I)+QO%(+:VGK0R\O!5KVN*G@Y!(YK:6T96LQ
MRMVR\:N#WHWR$"X3H<:X55RA_3&<KH8>6\[4T3CC"4[[8G/?7R*&**YR4<%B
MWV9:;UGVUD^HAD9YZTIC?!K$PR",N0J'J,`])IY7)77^NTBKFO=M6PB'!<GY
M5:YRY6IWJ5;C8GCL6IJRL:%1>F3!"NQ_=M"/VU+'&<]-VM6930J4VG'>S/EU
M5NII-0W([?-;B\/+3FBVQ<I"L7US1.]B&:4UX_JHK(5C&'LR9[@]2$]WS:ID
M4\T='K*&PMG/EVVC':=8K^,<UP];D8TEBVPOQF^I),TT9CWA7$!!&94,<`+-
MUW_*`!JL:Z:FNVW$M"FI)]EN!/?ME:FLR4I)J:TG3E*<014=!)'%Q=F.*7,@
M4R;XE7\S'NUCZI0C./NO_DC5TS;A*$U_Q9=FO)/4#0"OQ_\`F[W[]9_TAUIZ
MF^GY:>!BZ*ZOYZN(TUF-H:`I_P#O5?\`">7]_J?RCH2CQJ_R-^HZ$GM/DGXD
M>#>"IR$=ANY1@2.6M+#$R!J<:R9[_M(*MCH0?PU*I;N;[HE6]2[9#/[FW4M<
M-19H9X8@[2.)U1(NJ2)L8OG$@/5<?#.B@[I]GHR4X7\?)HFO`#'!<<,[L58?
M</0_EKUU!!WZ`-`&@#0!H"M(^6YRKY-5H_4M:X^SRMW-E.X1&HM1_DR;B`-A
M;MKC(]?AJW/@[]OH1R8J[9ZEEZJ2+/&?[/<=^[Q_R1K1U?W:MK,?\?\`8H^5
M#/6<V$2^Y#&SPR<-'(L-CD983%*S[2O8LP,S+\N<9]-P/X9.M/2RJYM'DS/U
M,Z>73YH\^\URG,5N1Y.3FH8N0\CF6D;->R2O=WL5$=2*-5:161$<J^44]<9.
M->UET4M+EE3.S/(KJ:;YIU2,.`Y2*OQ,M&X8JW"O(D@JS6"9^/LS"-^[7A<H
MZ(,D[P'P,C\29S*(U17Q;+UK(HK4(.[@2'C?*.4',O/R,OT3W&BJO2<3NK0/
M7,:($AD*.L;1OE4V(&<,<``:X592Y8*</.W<=J<U\T7B8^0<?#XGSDODG`<5
M>FIVRMCNQ0B&"M^63,ICB7=].Z3)\KKZ'\`=,NKZE/)4U%;_`%%=*RZN:E.%
MMPEY+[C<O6X:WSWCS3\=<O6ZL%RY,BR-:V1V?>HF[^U!M"@`]-NNU/34NI4U
M323[+CE7U#5+JIDW#Q'?A7+_`'QYJ:AS"30<G0D@FGB$L5-G"JYAD5(QV7$A
M*X'7;UZGX:XY]'3T1IN?:=<BO/JA5>NPGMVUYY<ENTY.'@GXF5DP)(X+R[1)
MLFB]BA'/=90`P&Q58G.!G'2LM0<9]QKJ>8XJ$N\^<)6XZQPD<=B>:ER)$DYX
M:M#39DKU;++-'6C$.T1Q63UP6;VAO5M,QM52FM,\5C/010DZ9R>B6G#M$-IQ
M=7AOH>2M\M.ZR3T*\U6HD,)1^VT,=KZ<HC1*C^\##]OVZ[*48I+3-\(VB<G.
M$&WV+C`C$\W/6XJT=RF;U.&L+A66O7$22EJZR=K%==TJJX_+1FR-N<XVZT)4
MJ,'!QA>]>LX-U-**BO9J'7T<YGL1_65Z%29H(:,D-&KV()9%BE5<O`K]AY9E
ME$I]I(&=IP#RYM3;VOSOP@=8;$MBM#6<M\^33\QR-2:2">U5MQ!K=BO"LC35
MQ(D>+#5'AVDDA'9@0RXZ==6IY%2GI6GPB4JYFVM=IP,.4')<)<IW;D!@%JK=
MGL3\?QU-.WVY`R/998IFP2X5MGMZJ0QZZFB%::6#5[>X51I:;T.Y(U<U%?:!
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MVP>&\/Y-!RJ<;7H<5R?$!J<34JU.U3FF*J\4QD:`;I![EDC#=#ZXU#SZLN$8
MM53FVGQ)6337&$$UHA#@?.(XWQ:3AH><-+B[,-&"9;_$3K04]^`K$SM,(Q$!
MDAVZX7/0G.E=5?-RQJG<YBBFCEYH4RPD<MKQKA>-Y&6UR?'-2X.A/*;UT5*5
MFK+7:-7A966NK@`2C/3YATW>FK+-JJ4$XU/6X\2KRJ:7%KW5J7D2/@/&OMUM
ML7Z\='D>(J5UMV[%FI4DD0/'W$QVXHWCQ&-[*R;O37#,S<VYQ53>EG;+RLJ]
M0:V(E];POPN/;/6X+CXRRG#I5A4E9%*MZ+^TC$']&LSS\S&I]YI63EX4KN,3
MX'X05VGQ_CBH]%^DAQ_R;?T:?N,S\3[Q]#+_``KN/A\!\&)R?'>-)]<_20?^
MII^XS/Q5=Y'[?+_"NX^CP+P<>GCW&C'I_1(/C_Z&G[C,_$^\G]OE_A7<9IX3
MX:BR(G!<>JS`+*HJP@.JD,`WMZ@$9U'U\S\3[Q]"C\*[@_W(\-P1_`J&#ZCZ
M:+_U=/KYGXGWCZ%'X5W'S_<;PK(/\!X_(Z`_2PY_DZG]QF?B?>/H4?A7<96?
M"_#[3*]G@Z$[*JHK25H7(5`%51N4]`H`&H6?F*ZI]X>10[Z5W'R7PCPR5BTO
M`\>[$*I+582<(H51U7X*`!HL_,_$^\/(H_"NXP'@/@P((\>XT$>A%2#/\C4_
MN,S\3[R/V^7^%=P?[A^#[=O^[_&[?\GZ2#'3]&W3]QF?B?>3^WR_PKN`^`^#
M'&?'N-..@S4@]/\`,T_<9GXGWD?M\O\`"NX^?[@>"GU\=XS_`&.#_P!33]SF
M?BJ[V/V^7^%=P'P#P4G)\=XPD^I-.`__`+&G[C,_%5WC]OE_A7<'^X'@N0?]
MW>-R/0_209Z>G[&G[C,_%5WC]OE_A7<?6\#\';YO'^-;X]:D!ZGU_9T_<9GX
MGWD_M\O\*[CY_N!X+_\`+O&?['!_ZFG[C,_%5WLC]OE_A7<9P^#>%0RI+#P'
M'1RQL&CD6I`&5@<@@A>AT?49C_J?>2LC+7]*[C$^!>#$Y/CW&D_B:D!/\C3]
MQF?B?>1^WR_PKN/G^X'@O_R[QG^QP?\`J:?N,S\57>/V^7^%=QIY#[=^&V^/
M-).)J5(]W<1Z]6L&5C@,5WQNH+!0#[?34T]3F)QBWVLBKIZ&H02[$+[WVD\0
MM3"00+74*J+#%7I!!M&,@/7<]?4]?772GK*U[7YE*NDH=EY&,?VE\<B5ECFF
M170QLJQ40"C>JD"MZ'\-'UE=H^8724VAY&!^SWBQ.=\FX#`;LT<X_7]-J?WM
M=H^9'[.BT/([!]LO'8Z\M>ONK1SA%G$,--=Z1@>QAV""I<;S_P`[KJG[JJ,7
MX^9;]K3"7AY&V]]M_&+W*3\E:@26Q.\;MO@JMCM`#:&:$OA@,-EOU8U%/55I
M07CYDU=-0W%^'D<]?[5>'Q&/?4BL=O)(EK4SORX;W8@7T"[>G[).K/JZ].]^
M9"Z2C1N7D.7\.\2DIQ4GX6BU.!F>&L:T1B1W^=E3;M!;XD:Y?7KC'F<=IU^C
M1"$%#8<)^W'A?:=$XBG&7D[G<2K6#`9SL'Y>-OP_5J_[K,TOO93]M1H7<A%]
MP/%/'^&\*Y'D^*H5*%_CJKR07X:L(L(R+[71T52K!O=[?7T^.NO3YU568E4V
MTWI.6?E4TT-I)-:BA?)N2Y3GYCQ]/DK/+06:\W(I+;BA@9'4,MPO7C!"91-P
MVJ7S[L^XZ]C*I5$VH8>4SRLVIUR3CCYC7^$Q-QW'_P`1*595C^GGG@JE!!54
M]^M&D-F+8>[*74S[\[<%Q@G7/GFX3[<<;N!?E4%'AY\11:IM)'6N0U)YIX(U
MX]>/K?E11V%F-J=;9D!4Q+O*?%>GN/3KU56$=<=TCFZ<>SQF,.-OI4BNQ7$M
MU$,IN27(A&9.\[1=^N'/?>*)9)?=)^*KGW@:I53&$(/#UPMJ+TU0C$LSP??_
M`!"H)7G>R.1X\6>^\3[9/X1/E8NP3&L0Z;%&.GPU@ZBY['_R1MR+UM7_`!9<
M6O+/2#0"OQ_^;O?OUG_2'6GJ;Z?EIX&+HKJ_GJXC368VAH"G_P"]5_PGE_?Z
MG\HZ$H\:O\C?J.A)[2Y.I)=\`\0CIVJD'(0\77,8M6#`=LE>)3M`/7T/K^&C
MI=\(]WB0FHPC"VH>_=S;+XU259VB6:[&O>BW,VUH9=Q4)[FPN3TT:LUYD)V3
M@2SQ]=O`\:NW9BK`-A^&(UZ==`=^@#0!H`T`:`KBZMH_<2I7:H:7'_6"9W5V
MGBFD[3,DK(I[<#,_M]RY)ZZ12E/MEW:>_L$(N,GL\?9VECZ`6>,_V>X[]WC_
M`)(UHZO[M6UF/^/^Q1\J&>LYL*W^]O(?1<%'(L[U951I8[4:1R&+M6*[;]KC
M)*^H`8`_'6[H*8U6T,Q=;5"FVE%!THJ\?DMFVO'4+O"(TD;V9\]MUF(A#2R)
ME86=F+;@H`Z]OT77LU-\B46JK=]HGDTPYHP7+:W`DDU+P:VM=[<MBH&A6C5L
M.4=Q!(3W-P@:)5^GV]J3=E2&Z_-TX*K,5T\;;;SO"AWRMX&`Y/R^/C;,=.6N
MMAY(9(.18]N-G9!AEA,?:E;MK'&F=Q`903NZZGDHBHQV$.NN#@=%'FI>#6M'
M8@-QXIA0L>2<4S1R]^Y&[SK&T@?<T0C]Y[88XP"H`&JU4<\82QY7J)IKY>$5
MK(=</'7/$[Q5;+,;T3+.L2[K-CLV627:H7$;@^N,C6JF*K5UW=<9ZH.A[?,L
M;[;<=]NK?"\AQT'+\EP5@L;KR=^:G)M5I8H]S]$<)&R,4!]3_P`F'JJLU5)M
M*K#2;.FIRW2U%T[B2T^2^V_(W:7(5O)^7BLR7Q8L12V[$4:%!O:"9)&6*.)B
M0=H^;]G(SKA51FTIITTW:$=U7E-IJJJ_21CAJ'&<+]_J7'<9;MV5GEGM[FD<
M)&MF.9YH'1NI7<J.K'YNA.>AUWKJ=?3-M*T#A12J>H23=HDJ\MX3Z;G+(X>W
M6M4['?Y";QU99*Y[H$8L67G5^T@7"[04^=B?7W#/DYD:5S*#NYN".^=1"KW=
ML#1!XGRE:A3X^PO(JM:2&M%261F:Q8@C%E9EGEFDBV!894`"J/<H(!&1+SDV
MVH>6&C8564TDG&TSDC\)\VBJ4MM&7AXK4E9;=&A(;$<4"_DK49!*F44IW7ER
M>AVG<,ZO]?+BY\T(W\;MQ'T:]$(PNX7F^W]LIJG'3W[RSPQ&66S8JBQ-(9$6
M8+!`W;D1$W!M^40[26_5JJZJ+@B7TT%%FNG]O><IIR7)BK)P1XZO:CXN=I#=
ME+F-3->EVRJYDECC[6-Q_9.U<'4U=32X*/-&$<.P+IVHN'+"/M/C_;Z7F;#0
MT^.F+!(:MCE;EA]\+S53,]E:R2!.ZILA/G;(+Y)/J_<\JF^Q+7='L'[?FDEV
MVVFR+P[GN>Y^TED61%%#4%/Z@]AZ54D-$BMND:1MT6Z1"%;/1F/34/.IHI4(
M8]K"R:JZIZNQ&')>&^3S65KV:B\WRP^JFNQ6'DKPVZSR`+G$TNT;P-@!&`!T
M`SJ:<^A**?*I=C[B*LFIN:BY]N\^\QXGY#9M3\-P-:1Z$GU5*P%>2O7[AR\L
MDTI::1]T<BQ*'5O5V3:=*,ZE+FJ<Y.W$FO*J;Y:5*:&'A_#<QX]Y-Q]'DK4W
M)_11P<;"Y9DC266`S8W,[[Q'#&_RHH8[=V3C;SSJZ:Z&TH1F7RJ'14DYPD?>
M;@$WDG!6.;DD^AXV647>9[Z0M%;EEC6-"D<S.$>.,0OA1C=N)TRW"BI4WO#5
MW=I%:C4G5<L=??V$B\SX.[:?^"T0E7BN2B<7K+;RT"Q(SHM*&+HKY#,SG'5A
M@D]!PR,Q+WG-JTSOG4-^ZKG:1HY3Q.C:\8L\16,_)K5@A#\6JQPIM,6!7@=E
MC[*NO5UW;MO3(SJU&<U6JG*./CK*U92=,%.&%KCK'V[:=*!GY">%>]]7S%6N
M[I#9F[4:*`C-(51&@7"[CCX:K^YA&6I:BW[>,)[23)P].&><UZT"07B[<E'M
MZ2LP(W%1["6R=Y(RWQUGYV[W=<=^1*Y7WG>````,`=`!JA<-`8RB1HG6-MLA
M4A&(R`V.AQH"OCQ'W1K\;''QMF*.WW,V7LSFP)&`CW.NY/8DF)/8/0D?AI]5
MZ(]WAQ)^G3IAW^)PV.+^^K\8)(^1I)R7U/<$73M+#W)1VR=GN_*,9_Z0.GUW
M^&W>1]&G\3MV&7DM'[U*>_QUNO+#'*)I((P`^Q)/YN/*]2R?!M/K0_IMWCZ-
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M(YU+$]L*VT@;>F3^'Z=/K-?TV[[7CZ-/XG;LM<6-16RM.%;)S8"`2DD'W8Z]
M0`/_`":1!OT`:`-`&@#0!H`T`:`-`&@#0!H`T`:`-`&@(O\`<J_#5\,Y<EE[
MT=5K"Q>K%870L=H()`)`_P`.M'2TQS%M.'4U0H>P\T3>?<YY!)5K\N1<CL68
MJ--5BC:P(XY"[$-,9"K/W%5LXW?Y7MU[RZ>FB+IE*)XGUW7*J>`VH=AK/\'L
M-5%/D+=JRMNI;*JKI&KX0NF()%>6,*8X]V5*]<ZYU1AS*,4E>K1.E,+I0;>(
MKJ>-.*=C8+J\9A[?,Q*_;BD@$H[';EM=EG[@*KA%W'>"<_+KI5FSPCA9'-9<
ML88V8_K06PL_'Q4HZLJRE8Y9KG:6-H=LD==S6`[RP;?;'!N.]LGJ2=<6U?&/
M9OG='6=4G=#?;<2O[5BBMUUH<A+R50>01&.S,23[^-L.RJ2SDJ&8XSU_R@&S
MK-U<834'R?\`9&CIH1DX^]X,O/7D'JAH!7X__-WOWZS_`*0ZT]3?3\M/`Q=%
M=7\]7$::S&T-`4__`'JO^$\O[_4_E'0E'C5_D;]1T)/<_%0<\/!>(DXFO45)
M.`JB>S*=DS.*ZA5$GH`BG=ENFJM4QG3%D87P0R^X\]/B_&8)33J35J]A":MF
M'N1;`CEMBA'"D+D[MOIG5DECQAXD.IWQ@.?$>7K\MX]3MP((U[:QLBJ%4,B@
M$(`3[?\`)_1J6H$)Q'&H)#0!H`T`:`K^A0H<;YS)93EV::>:Q'*C53VV:W(D
MPKM:'M+Q]L"-2<@=-3&JY\O>X]T2)?W;H:\"P-02+/&?[/<=^[Q_R1K1U?W:
MMK,?\?\`8H^5#/6<V%:?>N6O#4H2V`#7C65I03M!03U<Y.U\=/\`FG]6M_0I
MMN%I,P]:Y*V@I.K5>A'R%YJB?3\=-)4G#.TR0R'$E:9(Y62/:)FCC/;7!56V
MY!UZS<8*-\_,\U*";T60[Y6W)#,9N6M+9H7X\22PPR*;,#Q200S&>)R\,@>M
MC\S.[YB64=.-%,?A4UNM$Z550ON=O`XHX[*<E#5A,?(6K4LD\/,E9"%KP*$F
MFBDG+1[&53'M"A]R_IU=PA&Y:"JC&%^LY?(^8Y+G:U=4N0EN4MR\26$802H@
MA?ZI4"",^Q\9&&R3MSG5LJA4.ZY1XR*YE;JQO</4D?@56I4EY&C5Y*_+5%NM
M1H\M+7#-5,D4Z0L&$S(D&\`;EZ-G;@>NN'4-N#:48-PTW:KSOD)**3>B.B\E
M<OB'WJN074B\AI2F*P'AKV:[1XDE!F=PRF7MM$TOY>QF'Z1C&LRSNG4/=9W>
M5G./O(3\+0^XM[F[?`6.1X^K<Y)VGY2_Q*D6>U&VR8M;*2)N970K'UQTZ)KK
MF592I523@KD_*W:<Z%F.KEBHN^'F6#!X[XYXY6L<HD1GEG=8Q+<FZP0J,Q*)
M8A)LAEEB5L$X]W_HZQ/,KK<.!K6730HDD\=X^]7C::]M::1(Q'M5$$2;<]A$
M0858R<#WMG7#-J3N.V72U>.-<CJ&@#0!H`T`:`-`&@,7BB=D9T5FC.Z,D`E6
MP1D9]#@D:1$!9RWC/#\EW)9:L*WG`"WNTC3*5^7W$9./P/372C-JIQD<Z\JF
MK"9RKX5Q!Y-.0L&2Y.M<UF:RQD8Y0QEP3C:S1NROMQNZ9Z@:M]>J$%(K]%1C
M>/((8H(8X(E"11*$C0>@51@#_DUR;B=4H&>H)#0!H`T`:`-`&@#0&NR;`K2F
MNJM8",85<X4OCVAB/AG0%/W_``3[UR\/2IQ>0PBW`]E;-L22*9(K)21>FT^Z
M-PRK_P`W3]S7?RS[!]#+NC+M.-OMI]XWIN$Y[LVXV=XW^JD82%V'3H@V`)G\
M=3^YS-'`?M\O3Q&UGPW[O=EDI<K%':$R3R7);,KK,(?='$(@@$2GHCG)SC.H
M_<5:(_[8=@^C1IXQ[9G?QGA_W*B\6YZAR',"QR5Q(%XN=)65HP@S*K.5Z$DD
M;@.HT^M6YPFM@^E0I1D]HIE^W?W&CD2ZW,NSB"-9HOK9DC281C=/U4Y$;+G;
M^UJ?W&9K_*/HY=H^9]K^.?<"YR$-FMY!#8KQR]^ZJ7&*W8FD.W:BKBN"JE?:
M3U75GF9BDZ7NE\OJ55&4\>.^?`[?,O#/)K'(<I/QOD)XXW)HYZ:R6G"I&D.V
M0!/09L,OI\-0LS-5T7#8'1E._':<G/\`C/W;L\S.]3R&K3BMKBG6,S;E>O7,
M>-NWW"0LSOCT.-/JYBNIEV6V#Z>6[ZIG+P?@OW#6W]-ROE"[ZRRE(DM-)+).
MT65[@VIA?VO3H-/K9K48<!]/*6/$[/%/#?N'Q/*\7R?-<XOT5-MEZ!K32K*L
M@9=V2J+\[)@?^73ZV95)ISV$_3RZ9I\3JK>/>;V/#^;K<OS4*S-R/UG'7X+3
MJ(X.[F:-Y`!M55#JHU/U,R,DU5V$<N6L8HX'\%^YJ\AR+\9SZSTK!F@2)K+Y
MKER55L[6RT:;3C57GYBO7`E966[GQ&57P'SE^?DLW^6D?CUY-+,:):D#-6P^
M]"JJH'_L\+^@]=/KUW7=Q/TLN_S\S=:\2^X$D'(K]9W&FMB4`6Y(^_%F0J%P
MG]'V!H_:N=VW].H^M5K_`"[O4?2HU;]\^!&.(^U_WI:>O%S'EF*L9P\\$KM)
MM,G=W;2JAFRQ49^`&I_=9KPAW#]OE+&/>.[?B'W@FJ<@B<Y!%8GMM;I2!WQ&
MC0O%].PV]5^1LCXYU'UZOP\!]&C22+[;4YJ-&\EOG!S,O?"1R=X2]J%%`6,G
M`]P8MD^IZ:N_J/XE;L*)Y:^&W>2Z6W5AB::69(XE^:1F`4?#U.H5+;A`EUJ$
M8GU[%=(VE>15C1=[N2``@&=Q/X:CE9/,@2Q`Z*Z2*R,`RL"""K#((/Z1IRLC
MF6DR2:)V94=69<;E!!(SU&?UZ--$JI,RU!)%_NA*\/V^YZ9"P>*H[J8\;P5P
M1MR"-W3ITUHZ11S:=IPZE_\`FSS<L<MRY#Q<,7T<25YK$O*LZ12107)M\TC&
M4;@%'MWLJL0>NU<8]VY1OU;#Q5-PW[3CK<*EHUJM*LU2/F!%'-%3(PT84=M5
ML2[E+.D,LTJ%P"<8/J-6=<)MQY;7=R1"HC)*\F5R/RF.G=I+%-9NFF@AN((T
M6-&GW)#%%(NR!%-E&[F=P'RXP0N9<D4\(VVW'=\\&L86XD2MWN'JQ0*(I8[-
MRL!-(\@K(ZO$.XT0=E=E*]R)2VZ/V)A6/76BFFI]CVVTZ9G!U)*Z\L3[-T*M
M`BI5DBF@A\@14GAD,H?''V1N8E4PWP(VCTSC!UBZVIN;_!XHV=)2E)?B\&7Y
MKQCU@T`K\?\`YN]^_6?](=:>IOI^6G@8NBNK^>KB--9C:&@*?_O5?\)Y?W^I
M_*.A*/&K_(WZCH2>SN;OSU?MYX=%&S)'<XE8)F#E%*&E&Q5O9(/<%P/C^&I3
M*P)!]XXX)O%8:TR;TL61'G.-I[$I#^J_*1TZ^NHM:3X$JUHKB2CQ>G5I^.\;
M7JQ)#$M:'"1J%&3&,G`^)U"4`W$::D@-`&@#0!H"M./M\,><-426HY7YNTYH
M-*#'WH[(7NX*9VN7WA<ZF<+Y;*8^9$HW3[?867J"19XS_9[COW>/^2-:.K^[
M5M9C_C_L4?*AGK.;"MOOC!R4?C9Y>G")5XR*1Y,A7`9IJY3,9SN'L.>F/QUO
MZ!KGY7CZF+KD^6*P]"F.+8<ZZ<OS+65Y"B@D,SP0R6#4AWJD,:D1QR!X@RL3
M\KK@+[@->I5[GNTP@^)YM+YIN,4-Q!:M?0TW<PP126;`G9CME<0&Q"TT1$4T
MN0[=7=2V\>P+A6YQ2B]GE;9>7@W!;14O+/RDRU>:8QI)*TU.G)!>,8DRFR*%
MVC!1'D2('N!AG<3C/7IR<LZ?"VDIS\TJO$QN4SRO&0TZLYKUX+IG=B4P[M*\
M+M`^8Y#&&D^G&UERL>0IP=JFKE<7HMY]HJ7,DEIMY$T\?H5>7I^2,]R3QC;:
MJ)4EKRO/)&8Y;-=8H0)&_G0N!&`!UZ+^T<N94Z73+GD_!FG+2J54^6[Q.OC/
M$(_&.$1_*[?+\Q84V5K<56#L\BF(2&12NUE9(SDYE90PZ-TQJM6=]2KW%33=
M.WD6IRN2GW^9WR)SQO%P<35K<F.(J<::E':K@`[,JS'9'&&D=]B+O3?[CZ,V
M-VL=5?,VHMQ9JIIY5&"4CCX2KS,_G=2[%%8XGA9:MB6QQ<GM=[",D$;N(VE0
M1;%_+7*_CC5\QTK+:OJC?;>5H3>8G<H7%B:PFP-`&@#0!H`T`:`-`&@#0!H`
MT`:`-`&@#0!H`T`:`-`&@#0!H`T`:`-`<O+4?K^,M4MYC-B-HPX^!8>NFP%<
M6OL)P=FPMG^*7JCM$B68:LG;B9U=I2ZKCVY=_P#]\ZJGF*YP+OD=],23\7]O
M.)H\7Q="2>>Z>*LFY#9LMW)6=B20['U'N]-'S.]Q9":5R@A&GV7X^+DUY6/E
MK9OPR"6K)(5=494=!N4_.&WY?_*(TYLR-]N\>YH&/,?:WC>5Y&QRDMZS7Y"U
M"\,\U<A`=\21;L?BO;Z?H8C2-2<4Q[L(-1,/%_M/Q/`1\A$.0N<A#R%;Z62*
MW)W$53DLR`^A+$G4QK?Q.(]U?#3`TW/L]PMJM9J/=LK5L(L9A4KA0L)B_#K\
MVX9^.HC7"$;=XC3&,"1>*^-?P&&S#]0UA974QLWS!$4*N\_M/_E-\=2F\2'#
M`>:D@-`&@#0%<^7_`&]\7GK21WN:?B3:>R\<JO'$VZS*LC[<XSC&!I117_0*
M\VC^J8BYC[<>#'BEX^QY-9%6G6%B<12*[-$Z0P]UMH;YW16_6<ZETYN+MWA5
MY>%,;;!QP/C_`(1_N_8HQ>0M:BY2O%2DEEE43F*.5]\8!]RF3<R'I^K4\F9B
MROU<N,(0U$57[<>*<A>;N>;.O'-$IX^"&<)*(2X*I*2<'8%"*,9`SJ89]R'/
ME7M;K>A9OA7"<#QYMS\/?%^*79'(59)`AC+%5W+^"OC!U5TU+XB5734O=)1J
M"2-?<J=J_@G,V%&6AKF10!NR48,!M!7/IZ9UHZ51S$CAU+AEL\[4^5O\KY=>
MYR]2V<#R%>?C37:92J_5Q&4--O8$D.QF?_G]!UU[=5"IH5*?O*?=:!X]-;JK
M=37NN5N)T6TALP7HZ*6.0M\,&GGMR,\<CF.`5TCK$!6$FQ5F0HGRCX`X6JE"
M,E5[9\"U\83:MZD;=X/H?I6OJ+#JV^S5EE>.M!%Z5S(^5=WWN,%ER%5<X89[
MPG&'KK.,90B.BE@K)"]YVMM8+<U(NQ5CEAD_HT,3/%-]+F1U"IM``#!L8URE
MHEAX[3I9^&PF_P!HIX+U@<EF`VY.=A@LM`I7<\7&V-\KD%T=I9"S[U;W>O3T
MUDZQ04,.7_LC3TKBXX\W@R^=>.>L&@%?C_\`-WOWZS_I#K3U-]/RT\#%T5U?
MSU<1IK,;0T!3_P#>J_X3R_O]3^4="4>-7^1OU'0D]M7O([O#_;7Q:.M"L@N<
M3"C2DLKQ,M2,I)'A6]RDYQI"G%%9X.W>AO\`<NESMC@XJ=.-YJVW$EF)Y#9$
MG:D56V1QON&2"?T_HU%525_A`M2K6:)5P$,T/`\;#,I2:.K"DB-ZAEC4$'].
M=259WZ`-`&@#0!H"OIKG&+YW4E%56$T\]?O)/(WY\<D:%V0+M78QV8)]3IRK
M7N\XB+U;X\(%@Z`6>,_V>X[]WC_DC6CJ_NU;68_X_P"Q1\J&>LYL(]]PX1+X
M)Y`A+J/X?8;,;%6]L9;&00>N,'KU&N_3.&93M1QZA?\`G5L/.L,O$23L;')-
MQD+,L,UMYQ:2.9R"D;+#"ZK(W;!=G=RI53N++[O;:JP4=WCY'CIK3"VSS)#R
MRO+)6OTZ"O6KQ*T\%UYZCVTBD+*(PFY(W>7WO^9[=B!@N`#QHE)ONG`ZU:4O
M")R+]0]&M?\`I:%RAR!215AN7TD,\`*[(&F>9%'4R';ABHW=#M.K2BU%IK4B
MLX1@H/:<]F+DC0@XKB:L4W(32FWQMJY,M2*GM0[U-6=I`VP,RI-*^X%@`/3-
MDU'FJ<L83CV^!#3A!>4.SQ)U]I?"9HX_(>$\BIPFG*M.Q0CB=&_)=[#K()8G
M<[^X6(;>2/@<8UCZS/\`AJI<Y^!JZ3)^*FI:/$8\GQ/F,4U3CN"GMP<W/*DD
ME^=EM5:-&*1]B3/*6=Y7C8^T$ACGK@+CG370XNJ'+W-LO517)4QYN")7XYXH
ME>,W^2N/S/)22M.MN64O$=LDAKO%%TBB98I-OY:@:SYN=&27*K1-&7E0FW%C
MKBX)Q&UNTG:N6PCSP[E<1$(!V@ZA0P4Y]WQURK:N5R.E"Q=[.W5"X:`-`&@#
M0!H`T`:`-`&@#0!H`T`:`-`&@#0&,CK'&TC?*@+']0&=`13A?N7P7+V(*U:&
MR)K,G:A5H_4X#MU!(&V,ASGX:LU3I*KFT$MU4L&@#0!H`T`:`-`&@#0!H`T`
M:`-`&@#0!H`T`:`-`1WRGP'QORBUQ]GF('FDXR0350KLBAU=7&X`^[W(/75*
MJ6\8%J:H&FM]M?$ZWU(BK/V[4203QF1BI1#&1T)^/93/ZM.5Z2>?4)9OLAX:
M.6AY.@LM&PEGZB?ML660&99VCPV0JET7T^&HY:ECWD_4BIHZ:7V7\"IHZ05)
M`KYW`S.?5&3XGX"1L:<CTO=Y#ZFH?^)>(<'XIQ1XOAHFAJ&5YR'8NQ>0Y8[F
MZ^NK4TM7N)6JJ(ZU8J1;[IC/V\Y\=SM`U''=!QLSCW9)'IZ^NM'2?=IVG#JO
MMO8>=^3AX#G>)IP<9<1KHB>&[-9CF@ACK]8:KM+(TT3^Z..,!`S%^H?7MTNJ
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M5';_`*+%^8I=D0,O[.YO\!T2B5C:R9,?./K;WCM2S52:K8CL"7JYAEC`CD4Y
MVRPY]?\`+QCW?#4JI_T\/"#X!K3X>PDW&"0<;4$O\X(8P_NW^[8,^_)W?KSU
MU`.G0!H`T`:`-`5B:-L?<9X:LU2:O)<2U?AC>-6B"9:/?F//<9CG:K9/J=6@
MTOA>_P#SEW3T%>:F-\_]/^,7W]I9VJEA9XS_`&>X[]WC_DC6CJ_NU;68_P"/
M^Q1\J&>LYL$/GYQX+Y"<[<<;;.[\/R&ZZ[=/]RG:CCU'VZMC/+5"M2XSC[DE
MCD((N3ER:W,)'W8F,I661IFR9%<*/R@$QO!]7ZCZ&INIJ"EHMO\`(\.E))SG
MI&'`<G=M\;;HP<L]RA&D@Y'E.2CD^A[+1MW(8T![K==KC>![NI"^K4S*4FFU
M!X)7ELNIM03EI=Q(I.!YXQU[]22>*MV4NR3QQI,(*<^Z:2%Z\KB*QV^ZF1M&
MV,*!NZZX+,IN>SMVX>9VY*KUM[/$CWEW*\1R0J\55Y%;%.U"7L+QT+U*A^G&
M(U,?;G=\R)G>S!5.?:JX.N^3153%M36F;..;4G)/NDB3?;WD>=\:X/RJUQ59
M^3DDM<7'6KQ(V[Z:=I(W6%860*4&X*RD)GW#VZS]333752G*51HZ>JJBFJ$[
MBPO,ON#"W!QP\;2M\C'R""I)0C2:&ZLLJDA<AHWZ!"LN#E`0W4=#BR.F]Z;2
MA/5;0:\[/]V"48]Y(/MO4YRCXY'Q_,-)+8J.T:V7GBL*X#$;8V148*F,;9!N
M'I\-<.J=+KC3B=>F52IA42K6<T!H`T!C++%%&9)76.->K.Q``_63HE$-D1\J
M\X6GQS6.-626-)>S-.J;")@Z(E=.\`-TK28WD%54,>IP#JR<B+@[:S-FY\%%
M$0XC[P<I=\?:_=0077PT,5=#VI=DS1_3UNZK,9B^$<ME=H+J.A`TU]$E5!76
MF]1GHZMNF+OMO)3XOY!RL-:I#S+P"Y9)E"Q/.YEK@B+N1K983*(R4W>T[MV[
MIDXSYN72V^6ZV@[Y695!<UN\EM7DJ-J26*"4-+"[QR1D%6!C(5L!@"0"<;AT
MUF=+5YH529TZJ6#0!H`T`:`-`&@#0!H`T!\9592K#*D8(/X'0"VGP7C_`!$0
M>M5@IQPL9.X`%"EEV%MQ_P";TU6F@EUZ1GJQ`:`-`&@#0!H`T`:`-`&@#0!H
M`T`:`-`&@#0$:L?<3Q6KS5WA[5OLVZ!B$NX>TF92X"D9SM`]WX:NJ(J\JZM1
MP)]W_!PUA;%MZC5]Q(GB==R1HLDCK@'VH)!NT5"=S1#J:O3-P^ZOA:U5M6;A
MJP.9-CS(R@B*0Q$YQTRR]`=%0G<T3S/0SY+]T/&1Q_\`$(#+9IFR*JS1I[3F
M-9>X-V/9LD!!TY5&#8B]!G7^Z7A4T]2L;W;LW$22.%D;(#[![B`5&TRH#UZ9
M&G)K1',]#-*?=[P!EMO_`!("&DP2:8H^S>2J[5..IS(O_+J?IZT.=Z&/N`\G
MX+GXIY.)M+:6M)VI]N04?&=I!U6JF!9..$!IJI)&/N;.:_@/.6!MS#6:0;P6
M3V$-[@.I'3J!K1TJCF4K6<.I?_FSS-7XNDO)\CRT'+F[P'&1S"U/3B$1G,KF
M7Z=%?N8W=PE'D4@%3^`.O>=;@J80J>GB>(J%%N/NH=1<I5FY.>SQROR0@HQ6
M:@M)6AAJ0PJLR+9BKNJV72)$W]#D=,;P-<G0TH.4]<]D;CHJDW%3EJEMA>1^
M]/R*U)8;`%CA*A5IFBDQ85Y79_K$,NR1764D=EER!T/7W:[TI1E\3M#U.53:
M4[E:)VIW+=F5;#0WJE&<W;4M&;M.LCN$7N02`NH^IR2B.J^_.5&#JERE)N4[
M:"U[G-7RMI)]]FJ5FK!4-AY':UR]6PC2J%;8_%3A1[2ZD#;@$'T_3D:Q];4F
MW#\+_P"2-?1IJ'S+_BR^]>,>L&@%?C_\W>_?K/\`I#K3U-]/RT\#%T5U?SU<
M1IK,;0T!3_\`>J_X3R_O]3^4="4>-7^1OU'0D]I6Z7$OX%XV_*V[1BEX:N:M
M..&&2+?#6C<C>\4A0N=O5FQTU#4917CQ"<,-['7W<!L^*5HBT5>=K$<KI/A]
MB]M\Y`#]<G:#M(S^C5DG>DRD5&#@3#@05X/C@?4580<^O\V/PU!)W:`-`&@#
M0!H"N>)O16_-)%L3-5G%VXJUS6BPPK2K%%F4Q!_SD;>#N^'KJO+3&*Y/^W_+
M_J6YJH0?/X?\?$L;5BHL\9_L]QW[O'_)&M'5_=JVLQ_Q_P!BCY4,]9S8(_.\
M_P"Y//X.T_P^UAO7'Y+=>NNW3_<IVHY9_P!NK8SS'4L<)7\O6:E7N]^X4,UA
M9(X'>4VU2:98`'[:3*S;.U(3U./;D#WVJG1.$O(\-.E5Q49^9C6EY"Q/<7CY
M_P"'TQ)(L4$PDS)8[?8FG;!6/VHDLBRO[NX-IZ#H:2A&;M:&@*+C"1G?GOR5
M*'CL%JXG#589#8M3%^/AE<1]R.)W=5C/<V"5'.YBK`=<#2E*+J@N;O)J;@J9
MP[CGHTKU/QJX*?'[;,$GT_*UF:.)UIVE,IAFGVJ)!(L#?,=RED"=009JJ3K4
M7LVJW&)6FEJF7;L)U9X#B*/'<E#1NE>1YBE0MU:UR2>"!V6=(H9+.\N[/-*[
M+&!M78N#ZG619E3:BI4MW;,#7]-).#FTCCX_QSC+A$\`%J?A97O\E')*BQVY
MI8DPDTL*(U:'\MRB*&3;Z^NK59K7^J2U>;*4Y:?9-Z_(O#P:6W_`8*=M$[]-
M1&TT"*E=\DD"/82I*#VR8Z;P=>3U"7-%8GJ9#?+!X$AUP.P:`-`1CS.WQMKC
M)J8Y".K8KLEE968)$'AE`"/,Q6)3OP,%MWZ-:,A-.,#AG--0B5%QWCW!>3^*
M\WQEB*:UY#Q<SB$\;.2LTE<EXE65Y-EF216=^XR;@I/7VZ].K,JRZZ6OA>FT
MCSJ,NFNEK^I:+3'/A%"E:<<#;X^;BZWC<4G;KR.EI19E:2*>X\^V([0S3(<,
M.G4;#UURSZFO>3CS=DM'`ZY-*?NP@J;1.[Q"&<\7)%?GEOT>%:1N&>K%?IWU
MA=2\D.^;>67LG"[)-WMV@D]=4SFHRDZK[FBV4I0<U3=>F??MQ<#WQS*7]O#7
M+5H(1)+,DAB5E9I6.1$?0_F8+!=[>YM1U-,N6'O)*UM@Z=SYHR;9;@((R.H/
MH=>:>B&@#0!H`T`:`-`(^>6=K]-:R-'9E#0KR!#.D"OC=L3JIE8+A21@?$_`
M]LN$''N.69>H=Y'Z]J'>MA8):M&JLM%QW'>:<S'/93859[+/EG;<0G_2W%>S
M6%[<[:CBGCA=;6=43<A#?KAH,=Q/HXC5;>./##"PH-KH9,!6D=N@`_#&ZK@U
MOVEE%.TC5)/))WY)YWF[SB"]:KY#3R#.VA0'0A5.=\GZ^H.2LI6\60W;P1]F
M>&V@2:$6XV<0\;QL1123&`):LBA25AB9%,C,W4CTVX5BEJTOQVZ`Y^"\-AI,
M\]VQ8IQ6EDL6(W?D.0.Y876+<!#&5.8ZJ-E6?U<Y`.2S+,$E&&Q6Q(C%PCMM
MH,4M5P@@C$MF$@68H&#))?=1@6)<#\NK%V_:H'H!TQM#3!WV6K:1&VG7L.LR
MVRT;SM%9Y1T2U%+*AA6L@5R9[:@@!(S(PBC;KT^;.XK2"PNX[/$M%]O#;X''
M%?CG%JM#=%>I"HL6[-I0\TQ=ES992#M?HO8C`_R21C:INZ80<)VEYE55&*C*
MT_(+]DPUXX3')'+M*\=0W.TD'?W#ZFP5(=[,NYNVF<^IS\S*I47Q?@M0J<%P
M\WK,Z]6#C5>.M.\1KQJMNY)A_HED5=\4>W<LMJ4X&1Z>T`8VJ8;=5_M]"4N6
M[V>I]%B5*\J-'9XWC!M@FK;V:68C+)#!N]PFD!S,ZM@?CNW,J$\&[;M`C+%*
MUF=$5UH9(V"-8Y&W`T/'QTI(VAK*"N((B=ZY``:60K@=/^:-5=,=BOCCK\D2
MJH;7=#"V)).#G>>@))+:W92[B6:-=L8<,0R1].J(?:#US^.N&8H.Z!WRW%7Q
M._5"X:`-`&@#0!H`T`:`4V_$_&;DJRVN,KS2I(TJN\:ENX[!V;/XEE!U1T(N
MJVC5/X/XA8SW^(JR;F=VW1J<F4*KG_T@B@_JT>6GI[V%F,^6/!_$+))GXBK*
M2"IW1@C!8N>G_28G1T+7WL<[,QX;XJ*8I#BZXJ"7OB`(-G<P%W8_Z*@?JTY%
M"$^]CG<8G+6^W?A];EIN4CXZ,VIHUA]PRB1H4(6-#T7K$A./P&G)K<!SLR'V
M\\'$9C'!T^VSB5E[2X+@Y#?KZ#4?36OO8^HQKQW#\5QO?_A]2*K]3(9K':4+
MOD/JS8]3JU-*1#J;O.S5BI&?N9#)/X%S<$959)JQC1G`90SD*"RG.1D]1K1T
MKAF4O6<.I7_FRD?./'O'XK5CA%@CH<O''7AG[NU*1[-?+1UK(Q*&D18RHV-M
M)VD88C7K9&95#FOIWWXH\O.RZ8\MSW=C(+-QO+'D38X>BW$"NU:GR-=FCDC-
MEF8QM"F`94$:B7)R1@L6^.M:JIA"IQO:MN,KI<?=E<:KO*W/K*ZSR5OIXCWY
M%^HEQ8=))$62&9PTBX$:A!N*Y52<G.IIH4+2(=3B:^9Y+\]A)$AJ"..!Y8HI
M:]F58^VK4K##<BR[81NW*P!&1ZZFBF6NTT*ZIZK2+K^V35Y)*TE5$CKCFJ\6
MU(HX"LB\98:6-HX]ONC9^V6*+N(SMUY751G'\+_Y(]+IH2A^+_JR[->2>H&@
M%?C_`/-WOWZS_I#K3U-]/RT\#%T5U?SU<1IK,;0T!3_]ZK_A/+^_U/Y1T)1X
MU?Y&_4="3V-Y0!+]N_":S*>W-QL.Z49]NRM"P]"!U].ND8>V!5JT"=>?W^-X
MOCX+UCC(N1M3RK2KJZKD-(KLN68'"Y7KJ.2EWHGGJ2DX#KQV267@..EE9&>2
MM$Y,:=M/<@(VIEMHP?3.I(&&@#0!H`T`:`6&'G#Y$LR2UCP(K%9(-C&S]7W.
MC!\[=FSIC&<ZC5#M"V]@SU(%GC/]GN._=X_Y(UHZO[M6UF/^/^Q1\J&>LYL$
M/W`W?[B^1;?F_AMO;^OL-C7;ION4[4<>H^W5L9Y;YY;4]#ZRQ>NON:G3FY**
M1[-22"N@,ZRN%1]]>9U]-R]<!CTU]#EP3@DL7#&S/#S$X1;>&PX;7(4..;CD
MLTX.0I16(_K0MAK$K)`6;Z;)*XC99?5<!AT]0=75+JC!P>S>4=2IAC,[KO.W
MQ9@M22,@Y6*&O>DW&S#-&T6Q#%&0S/"'#+VDQC:%.W"ZI3EJ$-%N_67JK<8Z
M3;4NU*_`W>*@,<UKG;,HB:956%9HY65`L#[VBR^P;'Q\JD9P1J'2W4JOPJTR
M54E2U^)EA\[Y!#Y#PSI#QD<7.<;3[?)59&>&V*]'D$3MI,3$I9XTD*CKUSK#
MEY;HJO\`=;EHFC776JU=[R4],F1.SS',V8(^4Y"XTG#U[PCO7Q66,UW[>V%7
MC8Q@NL+*%PF\.N&;;MUI5%*DE[T--YP=53FW*)>OVJM<C+XNL?*JR\K'(WU9
M>"6%R3T3>9!^8P10-ZLV0`<Z\CJTE7[MQZG2M\L[R8ZRFD-`&@*'\O\`&+]K
MS#DY+L$D%.>L$HHU1+=>M%$^Z7;5RYD[[E1W8EW*6.X+D-KV,G-2H4+XZ81[
M=6@\K-RVZW&[9$YS%Q7&\CQ?+5IN;$M6BM43S<=8+"595>`2+*O9BB3=V\Y9
MOTY]VK1=2=+Y9O2BL$FFN:2T!Y":`J?4\/0Y'C>0MVHX.3V<7/&TS]]+4AC@
M3'<ACCK.I4?CU/4G3+C&%3324O>[/$FM*$4FF[Y=O@-?-^7YCG*=OCZ-/D:,
MO(RF*>2S4L)3[<!1G641(SEI!%&BLISU;#8URR**:&FVG#6HE\ZMU)I)J.J1
MR\]!P]KGTY#C:]RK-&SR_P`/ITQ1:1$4+*\LSQQR*LS9_.:08&!^UJ^6ZE3!
MPVMQML*YBI=45'NA;:6GX+%R*<(AO@+:./J556$9L`?G21EL95VZ^U57=DCH
M<Z\[J&N:1OR$^69(M<#L&@.+F^6K</Q-OE+2NU>G&TLBQ+O<A?@J_$G4H3P(
ME3\_YVUYGQ_$MX_9I</?$B+>N(8I!+%"\NW:"RG/;_'3GRW).+MI0Y*U-PAM
MCP)UJ`&@$/E+RJ("TKUZ?N662%V[\K/[5KP1J1EY/\K]D>F/4=LK?:9QS=UI
M"/\`I*V(H88^W;5DJCZ9>Y%QT4G_`+&']DSLGND<]%'_`*(;M*&KCZ'*<=?#
MU!`$1Q)8DEC=EK7;L)9I;#KT6C2).\A>O<DSGU).<E5O5BWH@EBC-F/?%#R,
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MKC!EI0$DBW=<XW2!>D2,<@#J<[F$2]F.I>(G[<-;--.:_5;D8?J3#`DS&[==
M4=HP#A)%<99[,ZGHF/:-N`!M4VJ2<)6\D12VHVLV864B[M:O8WUH(LO%Q4`+
MV$$GR!W!_P#BK)+98G<J[L$>Y]%BUWVP0>A]UL6;IK#1RCO2K6G3%62>)2\-
M!&7VTZVU6W3N%`9\=/3_`"5U"5M.MZB6[:-2UG+Q]5(8"WO6"4"I86N039D5
MF(J42,,(_7N2;NO4DYW,+5.-KM;\"M*A;<B7^+VWM<2KLL:&.22'LQ+L2,1L
M5[:@]?9C&2!G\!K-FTPJ-.4XH;:Y'0-`)O'[]NUR'/Q3R;XZ?(""LN`-D?TE
M>3;T'7WR,>OXZ`U^<6KU/QFW<HVS3LU]CI*%5]WO`[>&##+YVC].I3:NAVD-
M)WQ[!+P,MOF?M@)UDDFM6(YYE[>!,S+,\@CZ%!OZ;3@XS^C1U.,?/V]@5*<O
M+RAN(-R]WF8_"Z`OQ<C0L?Q&Q"(XG:/>`4*;S(VXYP2F#\"/CJ:<R,Z6^Z(J
MRTI-4]Z1=\>>VN<YP/F]?\.JDGW0!H`T`:`-`&@#0!H`T!'?N'+'#X7RLTK;
M(HH@\CGT"JZECT_`#7?IE',1QZA^XSSG]P+=;S/R#F^9X*S$>)<UYKUR=,/4
MBKQB$':4:8=V1<CM]/EW?,,>YTZ>53334IS[3QL]K,J=5+D1KB;?$2-1J\?9
MM0]\V(^9:T#+3KT9R$8KM'<W+&BL7P.N!\-=ZU5-M+"&F)QH=+@E'7H@<W+F
MU5@DK<A39+\(M59[]F$OWM\RM%L<>T2KLD_,Z_$?JM1!S3E(K7*34QA3O0<?
M8^HB)K4J5L*+$ZBPZ(T1AL($1YX@9W!W$J<_,OIC5*J6U#%KV=Q>EI/8RW?M
M9--.M*S(Q<W>8KW-[>]CW>-LC!F;\R7`0`L_[6<`#7F=6H16BF'YD>ATKC#Y
MO!EWZ\D]0-`*_'_YN]^_6?\`2'6GJ;Z?EIX&+HKJ_GJXC368VAH"G_[U7_">
M7]_J?RCH2CQJ_P`C?J.A)[%\H11]O?";#^](.,B+0B/N;MU:%0?ED`P2.N/C
MI&%[@0HQE&.HEGW>CDF\9K5D!(LW(XF4?$&.0XQT)R1CI^O1A$KX`YX+CCNW
M9JPG<.F?RUZZ$'=H`T`:`-`&@*ZXNKR?&>8S44DMV4M<A8O2I#:B[$,,[EP9
MH3'N`^`7?D_#IJW-*;>KW?&)'NX+>_86+JI(L\9_L]QW[O'_`"1K1U?W:MK,
M?\?]BCY4,]9S8(?/MO\`N-Y#N^7^&V]WZNRV==NG^Y3M1QZC[=6QGDF<\-5X
MI(^#L]W^*S_3O%*3&R+7E62.4,6]J/G:\;D9*ALZ^D7,ZO>5QX#Y4O=Q&MF2
MS1YB+C.#E%TWDAY&:<4S&T-UUD2*0LS3,4#3@DY(S^G.N:@Z8U2A*_`NY50I
MG&=V)MX[^&4.5AY.:_L7A*T->MNC:]!4L/`\B%0)/S-TR.H3"C/N/Z8JBZ80
M^)[(S)I:548W"SDZ$?C\D%Z.Z\=:XM>[/PLZ2H9)D=&[;A"B'"2]Z/W9`Z=#
MKI15SRA=*-NXYU+DG'LMWG5XWS4+</Y!9ACF1S7J5I:R;99+,<U_?(V]U(!=
MV"[<-^@_#5<VCWJ5K?9(ME5KEJ>I<2PKG%WA%1Y`UK-E9I9GY]XZ2"U&CQQ[
MX8(WK1K9C5GP3*-S$94=-8J:U-2U3EQD;'1<YZY>A<?A7(R7.$C%IX_XBA9[
M=9"VZ'NNTD2,KDNOY9&-V.GP'H/+SZ852N/2R:HTZQ]KB=0T`:`K?[D/R/&<
MM7_@=2&?D/(T:G.3*D=@",*,PF<]K#@JD@'NP`0&(Z;NFA53[SE3,Q=1&FKW
M;ZB"W?%O.;W&7>;@YF7C:O'B2@.$MK))VE+1Q_E!RKB/V(\?=W$X#?'6RG-R
MTU2U&,XV\#+5E5M.J,(2@-I/$_NWX]2YF>IYA%;MUE?E9X)(5"/W%DW@*=VS
M<8RW0!<C])US^MDUM)T05QT^EFT)PJUBSD?%?N[R]F?A9/-UM2IQJ\DM6.+L
MRR!V(1#L5%'N3VL7Z'X#UU>G.R*5S<F,#G5E9U3Y>?")K\7\PY^>`<7Y`((;
MT\D,?)UYITWW(I+"1K-$$>1UL;G'P"F,`KTP1.;DTIQINPU2X>)&5G5-0JOQ
MU^O@>@(88H(4AA01Q1*$CC485548``_`#7C-Q/72@9Z@D-`?&564A@"I]0?3
M1J(C`^9B8CJK,O4>A(^&CI"J,M`&@$/D@*30SJ!6[<;B7E7]W8C<@%8(^N9Y
M.BK[?^7T/;*T;K8''-L[8D=1<I)%((UXVO.T->:LF;4QWL17@D^=I7R3+(/3
MKUSN9>_'=M\CCPW[/,[J3.EY%[!>XFRL!67?7HJQ4_2QXVC<8P>[)TQT_P":
MNJ57:N.OR+TWZ^&KS-+-&T8!)EC95J6;5<OWKTD><5*I9BPC7_VDF[K@Y/S,
M)MLULK;;J1D52>M`)UBNVG=DI\3".VL31'9)7?*@K7CVHTA.-Q`Z8*J5SE+7
MX[2;UIU6P..U/)9-BM6MPRVK"%[5R9C$ED1YW11']BK$`WQ]^&P?G;5TH3:E
MP]>!1N,D_7T/JQ5EAAD%;N[U,E6O(/SK94*6L6-JAEJQ[5V1A<'"X'RKJ(O3
MZ:EK)@M'KMU&<"NUDW#.9^2=1.\EN,PI4"@AK%A&./9[A!'G&/<,Y9M'=##5
MCJ7B%?''AK?@8325>V8WD>*J"MGMV`ZSVPQVM<E;8PW`X[,1'KM&WY5!)]O#
M5YL.%L=?DCLLO;1JLDX%9P"./6TV8JB(O\_8=SB6T4'M3/MZ_P#..JJ$X=NO
M4M19QENU>IHCBBJJS"0PV8EV\IR08S=EY3[HJYV_F6ILJ&(!QT`'RKJ6X^"\
M]2(2AXORUFTI$88&M4WJUZK25H.+PY>5I4)183N4F8ACW)<].N&QN;4;''7;
M#43M79;'68,]Q9@(#&E\$5?J$]M:J2,I0K-M9`[;0))"/7`]=JB98W;WK9$^
MWAJ1)/%6W<-&3(DC[Y.X8@%A#[SN$.%4%`?0]?UG7#.^([Y7PC;7(Z''R_*U
M>)X^2_:W=B(H&V#<V9'$8P/UL-`1WB.7J<;RW."SNS>YZ.G!M&?S)./K%=WX
M#VGKH#J^X\;2^$\K&LG:9XT4-ZY)D4;,=?G^7_#H$*/%Z-2M]IEJUGL58:]6
MQM,)_/A:-W8JFW'N5AZ?'116/:2X/")`N9I\ERWBG#/R%Z0B2[/N<2=]44%#
MVVD(>3#8]/AHVZKN"\)$)4T^V'&!?````'H.@T`:`-`&@#0!H`T`:`-`&@(Q
M]SY98OM]S\D48EF6G)VHR&.7Q[<;2#G/ICXZT=*O_6G:<.I^V]AYGY&S!?M'
MCTEI_P`9XZ/Z2SR8B9HS5B=FW!6W1_EC:'=R3MZ>HZ^]2FE&?*YPUGB5-.4H
MK$8+5@XE+57A[JKR*K%WZ\$4R23,$'YKPS1LZ))($9&C7/NZ@(W2D75!U*5K
M>I>"IDG,AW*^12F]=!DE:?:E>M(Q1E6/:L<RR9C4RIM0"/<,C&?76JC*DC-7
MF38_XVC1MBS6JVUY#CR7GDEF)6Q8NQ(\<BP"5=CM85UPN2ZI[E&\:XU5-0;4
M'X>AVI2<E->)9GV<_B<X2.P%E?C^7JPM)!WF00Q\7,J-^=[P/>!Z`9]!K!UL
M%=C2_P#DC;TB?=4O^++UUXYZH:`5^/\`\W>_?K/^D.M/4WT_+3P,7175_/5Q
M&FLQM#0%/_WJO^$\O[_4_E'0E'C5_D;]1T)/:W*<%RO(_;3Q6UQLD4$E#BH7
MEGEDDCV1O4CW=8R#C"]?\&HYFKE;M(23O>Z)U>>&])X!Q0Y'=;GEL(9C`IG9
MQVI7C*F),_!?<H'_`":EU8N6[S"IP7O6["9^)MR#>.T#>6))C#'L6`$+V]@V
M9!]#CU'II&.$"&AOH`T`:`-`&@*S$U./S>1]T47,GDTBDXU80<UGR$LM(.NY
MD&X'/3Y<:)8X;7'NC=V0(BKL=,%#A?VQ+,T)%GC/]GN._=X_Y(UHZO[M6UF/
M^/\`L4?*AGK.;!!]P?[">1?_`'LM_P"@?7;ION4_,CCU'VZMC/)E2O4KP4Z%
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MA%81;X#+C!QP2XCN[Y9R[S7Z#\:'D\HL;DLS/&(%B_\`9V(PBR=M=I!8CVL$
MW`Y!URIR:9./P6@=:LUS4/B+\^VG(BQPRQ)2LUH#NGK/-)#)$89'/:6()(\B
M+LPVQE&W.!KQNJIA5>CUNFJC3<3'64TFOZBOB,]Q<3'$1W#WG&?;^/09Z:GE
M9',@M2215Y)(D$DB*65"2H./T@,?_)HE,-R*UH\_Y=R7E]22YQ[TN/FMR0\;
M+#<5DVQ^^:*W``2':&`R(/@>C8R=;ZLNBFAP<7"<N':8J<RNJM14%&4^)*ON
M-,M?PGEK!5G$42R%$&7;8ZG"CXDXZ:S=,HYB1WZAPH8NYJ023^6R;2N_@(&V
ML,,,K<."/QUTH7P?/_B4K?Q?+YGWBJ<C^9$R0;:MK@*\9G%D@N4E8%?IU8,-
MHD_G,?'&=*ZO_/6J]!-"]_\`TE?<F:0^X_+0B_'5NV)N,^N1I4CCF:)ZQ3M`
M++,XZX6/V]?=N..FVB/TE*7O>)CJA]5J,Y>!>NO'/5#0&F2]2CF6&2>-)G(5
M(V=0Q)]``3GKJRI;48%74DX1%_EO&6>5\9Y/CJLRP6+5=XHIG)559A^T5]P'
MZM5BU=>6@L;BNO&^,J4/N#Q51AQ7&WXA-*U6C8M333QM7=0F)?R]HSO_`/1U
M9NJ']7^JN.XB6KLHAO+;U4D-`1?S"'?<H//W?HQO7$+`RO,<;(HH\KB209'<
M'51GY?F&C(<G"\SYRFM`KE:PDC)$T<-R,"MW(^E>B'&(Z==PK*LLAPKRD87(
M_P":NNBAV<=;\BCCV\-7J8UQ`*$2K$T<+*M:RU<;9[DP+,:=;WMA58GNRANI
MR2WS-J7?:6M^"(5UIZEXF,B-/8K-&TDMUEDB@KTW$$<#PLJK77(WI'"1OE<J
M`WM^;*II<GHU\?(7M:=7#S.@[9DL32SBQ%+N^KLAUA:^\*EC6K%V`2M&`=S9
MZ]?TDUNM=K>LF^U^I:@2:U9KU8'7ZB!B6XSCGPO>53D36"JKBK!GV94;^F1D
MA=()-OO?EK8BVEN5L$:8['>GLK!-'=>4+)<Y*U'&U?:@<-/[ODACSB%<^XAO
MAN<V:A",M5L=)$8W3UVPT&4YB@XH/'$G926.S%%<<K+97/;-JS&,,4W%>U&%
M)Z`;?15A3?EAJ7B2Y*T];\#JMR6'M!WG)GB3ZE!:"B+CDD&YIK'4JTHR5B7/
M0#]9U5)0M/9XEG&-I;?`P9GAAF2M:?CZM25XN0E8B6>5Y0N)<JI#V)?1%#':
M"O3J%$WWJ+=UM!%USA"^VDU+):K7:IAI"5J8WIQ*`N:D;XVEBIP]J;<<EC[<
MDDXRS3!-.=^.GT(BTU*[#1ZFYI)[%\M8L]NS*XJV^0CR8JG<]*=5L8[C8`DE
M/QP/F*J(@DI+LTZWY$WN??HU+S,;$8CW5XZ\M7CFVUCQ\4C,;DJ9*QUPP4JA
M4YFEZ9Z_`%B3QO>G1M\$&L,..SQ)5Q$=J.A&MEHC+U]D`VQ1K^S&GXA!TS\=
M9JVHR-%"<)G9JI8C?W%_L?=_Z=;_`.V8]`1N_P#]<2_][ZG_`&;%H"1_<>&.
M7PWD=[2J$57'9)!)W@;6P1[#G#_\W.D88P)2U1./Q2"M7^V44=R7M5%J6#-)
M68MVXB7)[3KU]B_*?711V=WL#[[:R)K_`+C\=XK!0O)R<_&79[5I694#?L]Q
M6(8^T`@CXXU/)S2=4]E7^+*_45,U3+:O"I%NC&!CT^&H)#0!H`T`:`-`&@#0
M!H`T!%?NHXC^W7D$ASA*<C'&,X'7IN!'_+K1TGW:=IPZK[=6P\Q2/R=NAR%M
M^,IU*=JU'7>!T9+#31-OQVQVTGD*.6V`@9'0!MN?H$DFE%MPML/#BVFX2,9J
M4=;CZ_+(_'P-WU'TBCM-*TA[L<;NKR&OVRKA29`1M&[;HJHOEG;B1""YI6X&
M^M7=#QZV^.7^']L6N3L<C+'/',L<2C>98E>8+&+$0B1?_2!ZXAN^#GA"T,&3
M2KHJ6L66ZW(\0Z\78OQQS-4&)!^6M))I1N3<RARWN83B-"_3;DX(UT354TL>
M^V!1ITR;P[K8EJ?9.S)8W2R.)'/D,2O,I8B0IQ<Z]S+*C'N;=WN&>NO.ZY0_
MV?\`9&_HW'_=X,]`Z\4]<-`*_'_YN]^_6?\`2'6GJ;Z?EIX&+HKJ_GJXC368
MVAH"G_[U7_">7]_J?RCH2CQJ_P`C?J.A)[$\J>9_MUX74AM-5W\9`\KQM@A1
M5B`]@>/.<X^/Q_'5DZE=;<RCAC;>2'RU:O$<+0X*>">U#406HKL+/`R2(S[0
M.W%,@Z,>FJJK2X/L\:D6AJEV^")QPAA;A:!A4K":T)C5FW$+VQ@%CC/3XZ$'
M;H`T`:`-`&@*WX#BN+L^:-?BO]RQ#<Y7;6L0QELK9C6;#AL^QL"(GJ%)U+IJ
MODUV^R1',KHO=Y1F61J"19XS_9[COW>/^2-:.K^[5M9C_C_L4?*AGK.;"#?>
MODGH_;3G#!8[%F2`(A7&XHTL:2XS_P`QR#K7T-,<VDR];5#*9YACBIGFY*42
MR6XW*7A')%,6F=82_9M1@N_YKXP0Y"[\YU]`V^6-V'L/#E&':<5F"S4X[CY.
M2A)XVU762.!62,LK&18Y8&W.68-DR84#=T8>FKIIMPO*M-)1N.R*_%!;K\-R
M51HN(LV$M=N%@=ZRQHJA>W[&C9D5FV]3C\1JCIBN9/WB55!\K4AOY0T7-LC<
M'"*2V>42"&I$LD"+9AA"33*@;;MZ(^0FY,G.,C//*]SXI^[N.F;[WPRF;.,I
M4N.J<[(+*W.)@BJ)-S48GBBL[[Y+,K*%FS@,GZ2OKC45U.ITR@YRT2+44\L<
M5*?:2J[QG'UN`XZI+5XR*ASL\9Y97ELQK4+1K,DU^17*QRQ[]J+TZ']/3,JF
MZF_>C3==/8=W2E2E*%6W>7-]MH8Y>$;DY:;5K]N:8RO-62M,8^X3&,A07C*X
M9"6;H<;B1KR^J?O0C):STNF7NQA-ZB6-\I]/3X^FLQH*/\%XF>OYUQW*6>6J
MV^(LV+L'`T]MOM0/&'[PIF0]O+$GYLY7=MU/-4_=>']W&4X;ARTKWE&?]J\Y
M>)=\B+)&T;?*X*G]1&-0@R`4%I5_+>-ITIS<XUK$ERO-&R,JV7AMQS*S*.JJ
MB*,=,,?\&MM470VY.[LD8Z8*M)37M&7GSRS\%Y)2>Y'7K+Q:R-N$>8U=I1*_
MN+$[D3"ADQD>OKCGTZA52X?U'3/?NU*.!RSQQRKY%'7.(W\=J+"TI5/:4MA2
M[$[1^D^FKI_#'\;\"C7Q?(O$ZZ%*O%YK0LJBBS+P+132J<[EBGA*#(Z$`NV/
MUZI54_IM?W>9>E>^OE*7H<G%/Y[9Q&\3W/X')92&:.-F0_3E8U5XV,D:GW.H
MP?B/CKU:J(9:U<WB>937',V\O@>EM>">V1CSCSB'Q6.DTE86#=D[2;ID@53N
M1!EG!^,@_4,GX:M2D]/9[45J<-';[&07R"+ZS[I<4$$9^J^CLVMXD*1CVG$,
MP&UV;MIC;T`'4C.J.K#Q45;:=$G#5L<[:T6IS?$5>8XFWQ=LL*UR-H9MAVMM
M;H<'4SP<"JAC,4T_MYXA0Y6GRG'\='3N4F=HY(1MSW(FB96_$8?_`)=5Y9QB
M^]OB6=4KEW)$CU8J&@$'DP*216!BJJ1LDO*?-)&CD`PUX^I,TIP`=O\`RG`U
MVRM%^KSU''-T[_+6);%:OV8)498Z&&K04JV/KF8X[E(LK-EGD#-,Y;ICX>YM
M=DWV[MOD<FEV;]GF?42U+;$$(8VLK5L3U!F.E$?_`+%K?*%*@9EEZ8]![MJB
M)0U:\=;\$3.-I:EXL*]6N]=:\`5ZQ0P220$0R<B\(9_IJQ9AMA7KO?=[NO7Y
MB3;C%^S6]824(+VZEJ!XS8^G[LD=ZRS.L'$(ABBB>)@K+(6`9:T&Q2P(&]L'
M!]JZ1AJUVQ9$(Z]5L$?#(&AL2F6.S7M!EN6Y62-[NU3W/IPY"K7KKE@,X;'K
MC):8;MVW6Q;;LU()'W10JL33QA1+3J2+M>SV0!]==50"(D"CMIC)Z=,X4%;5
MJ0=M>MF-9ZS&2S!;2]9D*VVY2Q$8TJHJLIL2;\9SENPGRXZC]IB<;FH:M.KS
M"A>G'7HU^0"2*."93(:U9%68U+(86+23OL-N1MK$S,RCLH`2IP"`2`J$[2U;
M-(MMU[=`.;,"9);ZBC$TD,4SK(..@8$AY7=@DEIU.U%9L+^.,EDGV[_0379N
M]3X*]6G-<[$SK%$YBGY/=W95$FW,%?"C=:F?YV&2.@SG:%1;A'N\7J0@E'CY
M:V?0+$,D8LU)H*I66G7XB,`*ZN@(A0[PSNQ.Z6;;M&TX;&69)W.=\;;D)J]:
MH6WLR[1GLJKRB.7N1UYN1B#""NR'='1JE<;1N0"20X!/M^8@*C!>&G6Q"+\?
M!$IX"6&3BH>S(LRKN4S1Q]J-V#'<T:@8V9]"/7\3K-F*9HRW(8:H7(W]Q?['
MW?\`IUO_`+9CT!&[_P#UQ+_WOJ?]FQ:`EWF@JGQ?D1:+B#M9?M,J.<,"`I;V
M]3\#T/IH".<)R/%4_MC.M,7XJ].N\<GU<7;MH)<DOL8;3MWY&,CII%?B56OV
MDP?X8:O9$KCF?IZ_AG%VA6CM1_72Q0P3*.Q'('4H%W=QLG<2#N_']&H@G)SV
M>A,6IVWP/0@.0#C&?@=25#0!H`T`:`-`&@#0!H`T!$_NNT7_`(=>0H^6S1E)
MC0C>RC`.W.>O7\-:>D^[3M,_5?;JV'F/E810K\5PMB2O;XUJ\GT]NPS?2I-+
M8DZQ31HK@JIP=WM#!F'3!U[]#BW4I/?<>'4H)4WHQ-:*HO"7=\AXVD)5I2)$
MLG>"S,KSS-^8(T>8D!`K$(,XR<F8QYEBQ"$'@CDMI!0@^FRU.]8(G:!IWGKP
M5[7RLL<8DZJC!F$H#K^!.,646XWKRM@5<I7,;W.,')<9W)!4?DN,N#OSV64/
M,$1-R20)O>3,2B1U3<P(<NV?;KDJ^5XP:M;8='3%813M;:6#]F)[DX62TB1.
M?($$==&#"&->/LA8?4L.WC:`_N`QK%UR2N_!XHU]&V[_`,7@R_=>,>N&@%?C
M_P#-WOWZS_I#K3U-]/RT\#%T5U?SU<1IK,;0T!3_`/>J_P"$\O[_`%/Y1T)1
MXU?Y&_4="3U_S%*]#XGXG=CE+QW.*J5DB!.Y'6HK+M&>O<?`/H!ZG40CAN(D
ML>!//N=-Q:>/PQ<E1^OALS]E8=[QX9H93NS&DK=%!QA?74]K6RR([$]I(^%$
M0X>@(4[<0KQ"./).U=@PN2`3@?HT!V:`-`&@#0!H!>OCW!)>^O6A`MW>9/J`
M@#[VZLV?Q/QU14*,?%EN=P@,-7*BSQG^SW'?N\?\D:T=7]VK:S'_`!_V*/E0
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MTGJ&&/0C/7+S?Q7<=NLY9F7^$?\`$U:?$^.\S<NQV():4G%5C.\/;=8$MNDO
M<`0QLV^/*_,=@QG/77&MNJI)8\W`[T+EI<<.7B,Y?,X:)M4*G;O3-;2M1(K#
M>U98N_-WIZX>-Y'?"B/W_@RJ-<UD1@W*6G'M+/.A%*<R\/`9*<U*Q8JR]R&5
ME$0="DPCB+0IW,,8R#VSL*(N5QD9UY'4)IP9ZG3PA%$I<@(Q(R`#D?CK.:"A
M/!2/]Z^"O2NDG`WKME>"X%;KRS<=,%E)EDKE0,85@>OLW:F#A/FY<'*?C:8B
MHRASXJ<M\-VPO>W))'`S1H\C=!^7M+*"<%@&(SM]<>IT2(;*[XSA+G'>:TK[
M5$K5^3N.PF`5992*=GYU`#(&5(V,>``W7&=;J\Q59;4;EXHQTT.FM.%[\&._
M*XK,P\BAI2S5KK<3"(K%:MWY@2]C:(P&S*W_`#.F,^O77'):7+&[FT[#KF_U
M0_#YG(_'V)^8YOW.['QVM7-&0B*.1Y#9P9"/D8;=N0V`"=7YDJ:?G?@5Y8U/
MY%XG8*J_[\\(781/7X:R%B!!!)EKJ0"<YVZI'_SJ^9>):'_HOE?@5-X%5G7S
M1^4I\C56.Q0XX./K'@,8@^GAD25(T;>S,=JQL1^GUZ^EU#_\X-.]X;3S^G7O
MQ3P6.P]#:\0]@@/W2K<=8FXB.\:DJNTT<52_O$+22F.)9`T8)#HTBXS^)]-.
M3FPCVP)5?+.,-_BA'+0Y"'RZEQJ'ZR2N>.5^7WE7KB-%W)%'O"LDH'7I\>N[
M4Q:TQU1AVRAO[B(+5#_3'LG'<6-Y3S+\+X[R/+1Q"9Z4#S+$20&*C/4@$X_'
M10Q$'@0CQ3[G\GROED7"SR\9;A>1X>]0,^YMM8V>\HD&WM@CM'K\VK.&B#^9
M/P*JEZX:Z6O$LO5"P:`1^1&O#;H3R*S3N[05GW!NT\@P)8X</W)!\/;T7.2!
MKME1::.69"*$4S[)[EJ>=8YP>WR'(5QD1%L#Z.D,9>>3`#OC/I\=H7LL$NQ>
M+U'%XOO?@M9S5KE+DJ-::&O&G'C=6IQ4FS/;5\-]*DF[J@QNFD]/7K@,S2Z7
M2W.>O#7Y(A-5+5JQU>9LL=R21U"23S1M'';L44+"LD9WK6IJNTA4[?YLGQQM
M'N(52M''6_`.T,-2-UF46XR2386WB!IH5"2\E,@.$C'4)5BS[F]"/7IDM5*'
M9^7U);CV[_0PHKFG6B>RG,W'5ECJRQ[$ADAD`=Y&(!C@A,2^W`W'\20!-5[E
MRJV]BF[\3MN/DL26J=DB_''%95Y&OVO;]?)"I).T?+4B^`'1OTK\Y.#4NS1Z
MVV&HJ_U]#[!'[*T4<'5OZ35I6"?>P^:_R#="$4C\M#CX=`>B&[[=B"5O%F$$
M%&*4VJ<R[S$EHV9CW(J$3I_.2,6D$DV"5A7=@+^C):6VY/V^FDA)7KV6P-_:
MBKUX;4P6&K!(MFOQMG>UBQO;:;$VT%FL.Q';0@X/KU^2L8N&.G1JV%H04=WC
MM/F&CDP.W3EIQY`)!K\7"X]2>JR6Y0?TXS\1\[?'\WI;9&Z'Y?4QQ!!$WYC)
M].@JW^0B=Y6W$Y-2D7.YI9&_G''Q_`_+,WX+Q?@+O/P1G+(3!%2EB:&%E6.+
MB*AW1V5)+1P+*&*@KU^H;IT_YOS0ECO>%L"6\-VFV)*.#D=^/7?8BL2(S(YK
M@"*,J<&),?"/Y<GKK/F*9WHN._5"Y&_N+_8^[_TZW_VS'H"-W_\`KB7_`+WU
M/^S8M`23[BU8K'AW(B1"QB59D*N4*M&X.\$>NWUV_M>GQT'=VBSQVS);^TW>
ML$P-)0L[G7<2![_<`ON!QUQZC1NS$+(AW#<EQ/#^+T8[G"CDDDNVIG6:962"
M9=A+$$,&C56!W=0OZ]'2JI5-VPGRB+I^&"MA#FXET`@C(Z@^AT`:`-`&@#0!
MH`T`:`-`&@(E]TX:P\'Y>\\:-/4JR-%*^["@XW`E/=M..H'_`)\:T](W]1+2
MS/U27TV]1YKI\B\O.3W'F;_=VG"8/S7A+F.S&T,=B*&VL(E53[%8H&"[5+9Z
MZ]ZJGW8?U.T)'BJJ<?Z;:0I#B:/(14[/%_Q.]:CD:*U`0;3M.6$,SB-Q$BR1
M,K(@D/R_@^E46HIP2[@H)P:B::?`37:6VS#=E>+NU+5TJL7;D,B/VYS&9)#N
M;N!6DW*#U(P#MFK,@Y0TE51%3B1BNZ4DO-VFGXZ=7C@:6('<\;XC8LK?E,N<
MY!.?3J#K0YPTG!2CH+U^Q\2S\=7G#+'.>9BFGC<Q(QW<?/U]NW=(Y8MMV@A<
M>HZZ\?KW!P_M\4>KT2BE\W@R^=>.>L&@%?C_`/-WOWZS_I#K3U-]/RT\#%T5
MU?SU<1IK,;0T!3_]ZK_A/+^_U/Y1T)1XU?Y&_4="3VIR?#+R/V\\1;^)IQQK
M<0CN#DR2Q?21&18U&2WH,]/CIRU.Y1\"O,E>QC]P+''P>/\`&\0DLMAWD28?
M4;GE,31S$.S-AB0PZ_'X'IJ9N=]M2?`:DH6VKB3GANO#T2#G^CQ=<;<^P?LC
MT_5J`=F@#0!H`T`:`-`&@%GC/]GN._=X_P"2-:.K^[5M9C_C_L4?*AGK.;"N
M_O=X[?Y7Q&W9JE,4:D[2HS;25+12,RG!'M2%CK=T&:J:TGBS'UN6ZJ&U@BEY
MO$.5Y/\`BW*F2&Y7$3RCDINTD8I*H1IXWA*R/$$4Y[:J<@Y0[SCU%G4TP5VK
M7;VGFO*J<7:!\FCGHU;R<,\$\:_1O88UDADM1O.J1B%K`FDF4R@%>F%1<L,M
MC4J#:YM>-W=<0TTG#480BY4DDH<A3C%99TEJO!;$RQR0L$E>0X[;A7E5O?A0
M4'K\3@YI[B%%2:WARO&3TZ478IQWXII(I)):L+R0V9XT8F6Q:#Q6))%]TG;C
MBV,1G!.=**DW-P\-BN)JI:6FVF\Y_%Y>4(\D@L3)]1"U'_[HVX)2CCZL8[L$
MX4-F-R5[J@A5QD#5LU+W6M<NRUQ&7'WD]7$EK\73%V7CI&LQ/0MS2\+:>M%8
M8V!#E(53ZEDG5XO;O=!Z`;QMUFYW",IJ<_25I'?EG#1=+U+F^WSQGQX11S-.
ME>9X!(TLTQ/:PO0S^Y0<9"AF7'HQUY?4_$>ET_PDD?.QL'!P<'6<[E%_:N;C
MZGDW'1S<Y2EY:W]3WX(^-7O29>7:IY$'W$[-P/[0&G)C"F/S/F[KMI9URA&J
M'9#A$N;FJ5BU7B:O:DJ25IH[&Y#@2+$<M$XRH*.N5.3^G5Z*DG-1.5=+:DR'
MUN+\CB\JXCDN6YC^(KR%KNUN/BB$4-1$H6`VS$DVX,9%!;/KCKUUJ=='(U2H
M05^F:,ZIJYTVXQ?=)G=YC?Y!ZWE%"*(68X.%2Q!6W"(F60V58]SU'2)<?JU3
M(I4:7_=Y%LZIPJ7]OF<50V+OD-WAF@=H.3\9JDWB65=X>:(Q[MK#<1/N^./P
M.KN"I56BM^!51=36FA&3221><^'Q7..6.]+Q=V-Y"_=6N46$LD;A5!9L8W?Y
M/PU$(Y=<'+F7B3%\],5.#*J^W?*)2\@Y1C+7/(1QT:L2-*;7L:>M'O1I<1E9
M%'M6(97X]`#KT>IHC2M$]6D\_IZH5/3+P/2.O"/:(-]T;3UH>.D/%5N4A#N9
M%LB,]O#1DLG<9?V-_I\<:<M+O3>R/@3S-7.'=XD7:_8C\_X.ND%%[5N'CY;Z
M[8M\`$84E'9#CTPBH^3\-):+?[^-/>1/3;_;X]Q:W+O83B[;5D[E@1/VDW*F
M6VG'N<%5_6>FD(ZQ$AGV^X;RI;<_(\WRL[1B4I3X]I*DZ-'V5!9Y((T]W<W$
M!2/TZ0<?A5/^A4O<Q&G!Q_U5-;R?:`-`(_(9?I;%>[M2!(AMEO$"27:S#^C5
MX^I,DQ&,X]/T^G;+45"VU[#EF.#C;8)):[*J1O0,CM%+%6H5RA6G&Z[2JYW+
M)9<R`N3T5<]<=6ZIZ^W3Z')K5Z>IKPD;3R-((V!%>[;J+\K'`%#CU`!+G`#R
M>OZCC9-O5D6]$<Z0F>1)9ZQCKL#2I<77]C3!3EJR-T_*##,\IZ-Z#V_/:,+G
MKCX^2*PCPAX>;-[B[8DFBI[9[38KW+D9[<,2#/\`1H#ZQP1[3W)!U)Z#W'V5
MDK[K3>LM-W7VEL,((*BUHX($-FI98)'&@$;\E)&.B@?^RI1?\A'XCYY;<9W\
M/_JVR$E"T_0WK))8VBQV[UYI#+6@=9(HJ_:]DC3HVW9!$ZC8G4LR[LY/MK"%
MTEQV:R8QOF[;C!#QTX=+EMX:%J.2S)>E7#WFA`S*V056"/<.W'C#?AM^:9JY
M36[U$G>Y<?0^QF"%ZL9K.ZAOJ*G&N?S6ZY:[<.&+2MC\J/&<_#/R'.,^WP7B
MPI0EV>+\#=.B4YK$2VQ--7;ZFQR4Z`_1"1`K.?4/8D'1$`"J,>T#HT*>'9I]
M"7+'MT>IP6)+48^F"24*"JDGT\F[OS+-*/=G#M);E*Y__E_](Y6ZA?>[;N)1
MQNN5M_`Z;=0-4D5TC3L*:TT$8[L?&P2J`555!+SR*WODP0O4^@PU55.WO>A9
MJ5I>IG/!3K1O/'+BNX^GM6H7#S%E]IH5,!#DLOODP#\?7JL)MRMM?D2TE.VQ
M$IX-U;BX%6LM18UV"NG5%`]-C8&Y<?M#H=9\R^^)WHNN@1GE?-.8XORF2C-Q
M=J?B0R$6:U:6;$9KLQPR9&[O;5Q^&N?U*%)M)E_IUN:4>X[ON"X?PRVX!`9J
MQ`(P>MB(]1J01V__`-<2_P#>^I_V;%H"2_<52?"^4Q&9,(C$#.X!9%)9<8]R
M8W#X9'7IH2A)XM2-/[76IJUIHYK-6W86U+*9`KMO(D)R54_M-MZ9SC11(<")
M<-XY+=\4J+9OU*/'07I':A.IJ&*0A,HK@RG!)W;?CGKHN9_"HZ\=\0ZJ5>VK
M?Z2ZQC'3T^&@#0!H`T`:`-`&@#0!H`T!$ONTK-]M?)%4$LU&4*!U))'0#6GH
M_NT[3AU7VZMA1_E_CM*?B^'OW(S52S73AK$<4T4W:[40:I(E2O&L[-N!=X\`
MC!&->MDYK3:6F/G-R/*S<M-)O9Y2(Z]N>MQ_(7+UU9XGC@KPWEAR93'#OCB^
MG:,JJEY=V^0H?U'IKO!-I)6VG&,$VV+Z'+<Y0H6KG(552M`O\.J30;4:I/'*
MTX"1HRJR,SM&_P#S3^C5ZJ*6TD]>THJZDFWL.;@K\=V_7D/\WQZ23Q<6;,<"
M`PLUC*O-%(DB#J!&^YSUZZOF4P6W&'85H<7LPWEL_998U9Q'*LR?[Q1%7C?N
MH,\7.=B/N?<J?*#N]!KS.N_Z?]D>CTB_Y>#+_P!>,>L&@%?C_P#-WOWZS_I#
MK3U-]/RT\#%T5U?SU<1IK,;0T!3_`/>J_P"$\O[_`%/Y1T)1XU?Y&_4="3V+
MSMU%\(\,B>M(>UQU4QS;,H6>M'\I`8G9CW*<*?B=)6]A"55H>:)G]T+-FIPE
M:Q2HU[UY[*UXEL1)+CN(_P`H?H#D#X_KU$*;VA%W)P)-PLK2\/0E9%C:2O$S
M(@`52R`X4#X#4D'9H`T`:`-`&@#0!H!9XS_9[COW>/\`DC6CJ_NU;68_X_[%
M'RH9ZSFP0?<$9\#\C'X\9;'_`/0?7;ION4_,CCU'VZMC/.W&4N=_W?GHU>*[
M/.3_`$QY&>R^V".M"H016))BI'NDCD[()3I[LGIKW*JJ>:+?NSAZ>9Y%--7+
M"$Q?6XE+%B**SY"+-^6T#<I0*E>3;-^7++5GD'1&ARTKJ-N?QP2+NN"E3*%H
M^!14:\1K;X^I#QMFM5,0CGKJLM](NZ\![J+8^I2!9&_91"T;[D]K`*KXUS53
M;3>F[A"W`NZ5"5M,19Y#%RO*<P>'J1A'6P9K4W$0V'$EF*26.-J[32,SA8V>
M1MA4_-G)75\MTTT\SWPNUE*U555!;C=+//R#^4\?<F:+B*\%`.[@"*1:EI8S
M8*HRC\Q]V[8QV[FZ]-0ER\K5\]ZN)C'F3NEN8U,G'O#S=*ZC\EV;D<TE0V[1
M=DF2-X^U^;$[01;F5I']PW`[6]-<X/W6I2T*T2\IISGI9>O@5'E*'$M3O,&6
M$A(3%)')7&,[UA*HDV%;HW>RV?CKR.HJ3JBK6U'J]/2TH.UM9)6`*D$9!'4:
MSG<ISP__`,-H?.:W"T*/,1<Q#/+;CAMQR=F+9&Z1[R20D<:L_:#?%M55*OYX
MVV%HU?@AKCZE@^5A4Y/QZR$WRQVYU49QN4T+#%#\,,47UUIR;JEJ\49\V^EZ
M_!D?X^_XU:\GX8\;*J\REDCF*22O)].9J-F;M')V!=_^3TZ#\!KO536J''X8
M2[T<4Z74H7X]S'/D[)9B\DHS.DD`X8.:Q3#`O]2"QDQU#;!A<],?IUQRI<K_
M`+O(Z9L^9?V^8O\`'YF'GU>$SY$GC=61:XP<%)R&<]=RYW@#`PV#^&NF8O\`
MS_ULIEO_`-/]"-7$LS6?`FBDFDJFK9_,EV`EOIAM+C+/OQGT;;_Y-37=F:8K
MB13?1L?`K*MPEGQ_CAY)VUEX;E[%#+0J[BN:=M4Q[XCN[J1Y[^Y%/PP"-;WF
M*M\G]2CVQ5I3,2RW0N;!PW.TST-3N5KE:.U5D$L$HW(Z^A'I_P`H/0C7B54M
M.#/833445]]XZUF5.':M6>:197#.B/+L4M%[F1/4)_.=?\G'QU5M*^VY^R)9
M)X6WH51TZE7S?B9'6M9IPQ4X8=TCQSJPCKI$RQX/RM)NP3UWC\-3!Z^_V<"+
M7>TL+S2I6N>*<K5LVDI5I:[K-:DZ)&F/<S?HQJ4GA>(I7W$!\;F\;/W`AJ^.
M\E5_@QMO<CI5H)@HL_PXPO$LP_(^3\TKZZ0=,HK_`'1<-FW6&XS@_P#;!6AJ
M+8U`#0$?\F$B30V(8)#+`CLU[:94K1D@.\<74/-CY>G09)Z=#WRM%GZ''-TV
M7J)GK14>X4/:KY,3<I`SR3S*[G%>N&+'ZF1P1,X_#/0_)UC'R\7JT'*$//RU
MZ3LEH6:5*&TU<K<;^B\=0K$?T1)$;`B)5XS+TS)(_MQGX?-15)N&&+TEW2TH
MXX:CA9RL<LDMEY&`%6U?C+/)(P]*-$D[CU'YLN<GJ<@]4OV=GB_!6=+1\$<_
M'=Z3C:\=B".1;.(XZU91$U\Q_(A(Z+5A!]S^C?I'SVJOE[/5VU5ING[?2VWO
MXRRT\DTZ/WYIU^GLV5#0&KVV)S$=RXJIL(Z$%F'J2?;2M0M?ZEZ7&UWH:5$,
MT,CEC9AL!YP)CLEY-X5R9'P/95C_`&5`Z_JZ--UOA]2+[7^AL:::=]\\0>W(
M_P!72AM,=M6`#'?L@;%2)=H,<>,Y&2=VXK$(777;=GF3&.WAM%:(MNQ:<RAZ
M<,D=H\I93;)$ZK_\0V#[FDSB&$C&W:=H&`_2Y+3H\/-G.]O1IMN1UM=K5)X8
MYJ<N(F2:KQ[Y+9F)_I-EL,9+,A!V1]2#_A*UY6\>WP6HMS)8=GB]84ZHI`IW
MNS/5'])M2$2I060`;5.-LEN08'087H`-N`RIQM?Z!*%KO4WRM)"K5U6?C^/K
M,]:2.)RTEF21MP2+H&DGE`R\FX[1Z'=N9:J<[WP]"7*5RX^I]@-,[A8@CLVT
M[G'U^"1?9%E5;MQ-D+@(?SI2#ZXZ``$XX77QMN1*AC?="V]DGX*4R\>K-92T
MX=U>2%0L2LK$&./`&43Y0?CK/F*=T#OEN5Y"O,^&Y>QSEV9N-N\EWH(UX&Q3
ML=F.I,J$,9%WQX/<PV_!Z=/AJGU82C53L5^WU.GTT\*7MPMJ'/FJ6H_`)$N.
M)+:+36Q(/1I!/$&(_6=(Q(@([_\`UQ+_`-[ZG_9L6@);YHM$^+W_`*XS"J$4
MR&MCN]'4KMW`K\V,YZ8]>FG;`=D2/>/4)+?VZ/\`N[8LR)=;NP17C$C",SYG
MA5D38HD4.%.,#.H;A_=V$PG=R]K$'.>.\-Q_"5H_)&CXRJUR>:C2$;6GB25E
MW!I8V3('3\<=/PT2=6K;CW$U5<NO9"'YD6T@4*`ORX&W'X:DJ?=`&@#0!H`T
M`:`-`&@#0$7^Z"AOM]SRDL`U1P2F=PSCY<`G/X8&M'2?=IVG#J?ML\X<C//Q
M-$0717K5XV/+T*=F!X+H8S1M]-%.5A7+KDN`H.UC[>HU[E*53BMFK:>-4W2I
M[=9@LO$\QP$L?%5YZ4O)3%/HZ<DO(2EGF?MU721PD*]L($DP"VW!Z:F#IJ]Z
M<-,NTA0JIE*/;V&E>):O0%&.C#/QYLJHGBDS,9>KP"6/M;91"N[<"OYJD;/A
MJ>>+C&<+6P(Y(*$)6MK,>+H<AR$=Q)+5*]QU2O)&)9.U&[5DD"]AYU!>.150
M2Q*-P`!)]N<S74J82:;XVO%-+>B!8_V9K0UJ]2*O;-VL.9KM!.0H]C\;98(`
MI;Y,X.?VL_#&L/7.+<5#W7_R1LZ-0A!Q][P9?>O&/6#0"OQ_^;O?OUG_`$AU
MIZF^GY:>!BZ*ZOYZN(TUF-H:`I_^]5_PGE_?ZG\HZ$H\:O\`(WZCH2>W;->M
M)]N?%99K5:L(^)AP;.[J&JQY*!?G9<?S9Z-HJ6[N,++25;2OX1]AU_=@P3<#
M1LM/(:MF5$BA';10YBDD6;<T<CA@J[>F/74S"@\(]_@33@55>"XY5&%%6$*!
M^`C7\,:@'=H`T`:`-`&@#0!H!9XS_9[COW>/^2-:.K^[5M9C_C_L4?*AGK.;
M!'YW_8GG_3_J^UZ]1_,MZ@:[=/\`<IVHY9_VZMC/-T<=_C^4%;E+M6Y2O<A!
M'4@L;A2=G;WAJ\SL.Q75B`Q4E6.#@^GNMJI12::7;WZ6>+-.;E'L]B,JDZ_P
MV4\7QT<_%\<EN+F[,:1RLE>=%][PR%HS+$\;2H$54"`)GX:AJ<W-PA;=O)5T
ME)1B+_XC8\=6M8X2U:GHS1"3E-D#H(3`CB.D&D2<Q.T/N=B2-K=1A=7Y57%5
M)1P\RG,Z)J.ORQ%G%\?RE>G5L\3R#&N9Y;/(YD4P5XZ$B2"1)3[V<)-[L)G#
M>A#'72NI-M5+9VE**7+E=D3VGXY2XN;EZM[CVL]WA:O(2BVZ!95EY`N[!(X7
M=/>P95(W#&WT.L=6:ZH-/^IK=M-2RU3%-?TI[]AE+X[1YV2#D8X:G?H6C+RE
ML3%OK3*$"26'6/N5QCWK&$[./T:+,=$IS4M6S3Q'TU5.4K]?EP+J^W<=N+Q>
MO#9GCLM$[K'-"FQ"A.X`>Y@2"2&P%`;("@#7E=3#GD>GT\>29)'.$8X)P#T'
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MD+;3U+=`N1D9]1CK7]I_.<J/N+Y#'AHRD_@*PRM-46K9`E`"(S?3#:=C#N`X
MSCKC\?AI7=F:8KB*%.C1!\!7X+YAQ=GA;WC\?&*]CQOD?HHZDVU/R.^(XYY=
MQP),,V['0N/TZZ=1DM5*J/Q*.XID9R=+IA\+\2U$1$7:BA5ZG`&!U.3KSC>5
MY]X*',V8N)?AY9?K(I9#]'"F7F4&.3'</LCVM&O5NGPTYW3;@ARIW^$.WT0J
M?Q&^WE/#7DXN:5::\:D5G,#P]N-(Q,TS;MY=-GM*=.@]=5=4X./YO."UR994
MRPW>463_`,UFXZ'Q+EI.2J&]06M)]13!V]U",%,],;M6@G)E4VKBO/#N-XSC
M?-J]9/'[G#!+<D8B%Y9Z:W6X\R;^T,EBU7INST.HIA@ZNU+C>6<<53V1X7%N
MZDJ&@(]Y0]BM/6O0;8#%['L9)DE#NO\`18HAD.\F.A8''P_$=\J#BG;6<<V*
M@[;!+),\4X1$$-JNNWMUU$B\=`<;T@C'\[9*MN=@#M'PQ@/U2CLX^AR;MH]3
MKGY2RU22FT[-Q]>4UVN5RYL6CZ)5@+$L9?A+(#TP<$')6JH48X\-?D6=3A##
MCJ-$U81R5#/%':ED6:K#PE?MM'$-JCZ?)SM`#;II,?`#.,*TIW\?'R1#5W#P
M\S;4CDLV)&^L2'=F.URBGMJYB!?Z2EU4K#%M)D8')P>N<E8J<%=V>+UDI1=_
M;X+48649F6!HA96<JL<2!(WY*2-1^;+VQM2I'G_#\<^C2M-J?4AVU^AA1F-A
M9.0AD%RZ^U9'L1K%!`8RS=_)8L((MI6,+@,P;)).X*E"5RM+:12XSO=MQK%B
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MBE,`9*?\Q9LQ,6DG<9+4Z;':VS=N,DIZGJ2<Y946[[[3?@A)776DO,E7CS3M
MQ<?=BCAVDB**$8B6,?($.3O4+^UTS^&L^9>:,NXA_EWW'DX?E>2XF:(HB0LU
M:98YBQ!IO(K!D4C^?"I_AU554Z5':O$LT^S8,/*$=/ML`[2,YCI%S*S.^3/$
M3N9O<3^O58Q)2%-__KB7_O?4_P"S8M`2+[DP";PSD1@ED$;J,N.HD7UV%3C'
MXG'X]-(P"41)XM?>A]GQ:O[HVAK6@YJD%OYV15,3#(ZY&UO3XZE/LW^8:A:'
MD0/D..Y&3P7C)(;"W9([=EWA>;;&IW(PVHXW?EC/[7M_PZ5.I_%'=Q<12DKH
M+O\`""+]7.!D8/X:@!H`T`:`-`&@#0!H`T`:`C/W,0/X%S:%^V&K%3)MW[02
M!NV_M8_#XZT=+]RG:<.I^VRM?/+EVM):XIKM97G:&>[<:((C.E=8\'>"(/:*
MS8ZX9OVO0;^GI3A5!V>_$PY[:E&WA@51?YOF;7EDG'UJYXZY/8C41K.RPPUX
MAGY(!"<=E5WD^[`/HQZ>C312J(N:,%5=3K@I$BJ<E9N\E;H>)-!QE-/I#(;M
M1>T.1KR.JM^;'*V]F9>V<)L!`(&W7"JE))US<[G@=Z:FW"B2EWBPW$Y.#BN-
M$]6;D+,C31I.Y,<EZ8B*W%((E15:2/`$C#.20#D;M=.7E;<X>&!2/,DHS\2>
M_9N>*81]F>6Q!'SL,<)F979(UXVQVXMR]#VTPI_3G6/K5_Q_[(U=)_V\&7WK
MQCU@T`K\?_F[W[]9_P!(=:>IOI^6G@8NBNK^>KB--9C:&@*?_O5?\)Y?W^I_
M*.A*/&K_`"-^HZ$GLOG5(\&\#F4(SU^/ADC$BJRJPJ18D(=7!"?$>ND(X1(C
M"UIZAY]P([=7PRA%&L-3DX9V>"K"Q>,R=F?"H&1BP.?BO3_!IA&$M=F0VHP;
MG;6B:\`9CP7'&;K,:L/<.,>[MKGI^O0'=H`T`:`-`&@#0!H!9XS_`&>X[]WC
M_DC6CJ_NU;68_P"/^Q1\J&>LYL$/GPSX-Y".O7C;8Z=3UA;T&NW3_<IVHX]1
M]NK8SS#6GFX=:JVV,U=J#U.-N3&,B&U]0=DU;N&66N5?/>]JD'/H=IU]`US1
MAIGLACIU'B1Y81T2[]PVYOD^-VDI=D5)IM\DM=R(;%!B4EJQ5XB2Y[RK'-O9
M_@5RN=<LNEZ/;ICP+UM:?9H-G,V(K/$\77J5K,7CHM2NO'_12R=EI=Z&S9;=
MV]\DCG;$5(5-NT'KF*%"IMM<T+X[EYDUN*27PQT'!P]?B>5\BKV:-2[8%)(@
MER<0R1KN]PGEEAB>(L%3VF<$DD;^BZO6ZJ:8-J=K0*TI5523E:T23>1^8\?S
MW'CEH>7=K'&UJU?E+3C\I6CY`,I6-0FYIE0AR@V'*^FN&5DNA\L+VX=QVS,U
M5J,;E/O(ESXYWD."FGM<A1CI6N0+\C=2F]:2)HHR8HIRB*JR[78"-5R?1GQC
M6G+Y::I)Q2E,X5\SIFU-Z#T1]MXGCX^SWJ\$5QW1[<L%:6JTLC@L6D$B(K$9
MQ[6;_I'UUXG5.:T;8GK],I/22]NBDYQT]=932>;_`+:^4\E9^\JUDY.:]4LR
M65FGL5(J<C[(W(0A8V,@!7UWCTT@M%$?[5YB,OZH:ZHE\>5WN1J<6/H:+76L
M/V;!5U000LK&2=LGJ$`]!UR==<FE-S<#GFU-*2B0'Q/B/%ZG.\%R'%RN>5Y)
MX'Y>$LQ021<993>H(Z%FSNP=;<ZNMTU)W*[_`'(QY5-*JI:O=_\`M9)_)&L3
M6/**HGDCC'!1L@3!VLQMAF4,&7)"@>FL^5!*E_W>1WS(MU+^WS/G'0S_`.]G
M`2K.5C_@,HDKE05Z25L%3T93D]<Y]/AI4UR5?-YBE>_3\OD<O"S/-%X'*X4.
M\,S,$547)J'T50%'^`:M6H?4MB5H<>2V!47@]BO_`+T\UY!]#'=X^YS$$,,T
M\"W98Y6M*'F[NR!8]Y?*LO13^SZ'7IYZ?(J8P:IV8'GY#7,ZH1][;B>F->`>
MV5I]ZFG2+AF@>2*3O,O<3.T9DA(+823HK*&/_-!TY^7&'=XM$JF.''P3([?6
M.O\`<KQ>EL2Z*\/'QQ1P!^X"L?\`/S,I4[5525#X'Z#JW.TKVEM<_#=VE>5-
MW3V*7?!VN+3\ULSUO$^5L5ZR6YXJSO'6DC,J.0,@-&O5A^@:HX8W%E&,KR'>
M/>5<IR'E7%U9+M?EH7DF:5DXRU4>#;7?$PEFRHR<1_J;3FI?X(ZJH[B>2I?C
MA_=2D67J2H:`0>292>&PH%<Q1OW.4D.Y:\;$!A#'U#3R?*OM_P"7Y3VRM&[3
MZ''-T[[8D:J,S(9&C-2G`\E:*6`,+DHE<L:JD,W<GD89E?\`8.<$-N*Z'WO=
MMV:#@NY;]FW2=\$%V2RL5>/98@"5Y6K!6CXZ!R!V*^?:TY7!D?\`9'P]%-&U
M"?MVZBZ3C+V;-9K9./A1XZ@(IY^DFM5]PGN.&8BK5RS$=23-*#U.3G.669N^
M_AK?@B)*Z[CJ7B:VJI8-::;M6I'#5ZO"P954,3`-`V0-D,6U3,V/><#Y=JE&
M$<-?CMT"$8<+8:3Y9EFD#,&-F.TYAO\`(1E$[PC5F>&N'9-M:$`[MIRW7KU+
M:E+=<O/6R&_;Y:@@$*\5`K0M8DF+2BJ%*B\8E7;8E`&]*L6/:FWJ-H`]%)_%
M:6K:%=:>O8=4E:03&TDD-ZYTDLV[*M$*LL>\":2-BOY"*&[2D?,,[LDMJL<+
MEQ]=):&-[X>F@TEU2I+(E]N/21)+%::96:>W(`$-FP`,A#D+%'C\/;\J:G&Z
M/AJ7B1A?#QUOP-KOR$LD2I`SW:\8EIT7/=-5`NT6;)8_F67`Q&A;_#ZG42[.
M.I:B9]O#6]9A+6K4;5DU[;LT)(N<I(`S5^Z!O2(`'N6YC@9Q[1@`8VJ2;:45
MV:?1$-)-P?;;$P9INRD3UY^.X^'=7%*-SW;#RG>(8QT+3/ZRR[CMZ[3G<XG>
M^'IH0W*UFS9!?DJ\E#''4CN<F%:O'6B.*]50H_HT&!CV^TSR8P!T]=JZATQ5
M\%QU^1*J@[HOAJ\R3\#,9>.5VM"X^]P\R+LCW!B"L70913[5/7]>L^8H.Z!W
MRW%7Q*H^YU.NOF7U%AZ/(R2=@0</(UA[3IL9!!VH0PV22MO&[H3JL6E.*I^:
M'KW%U",K_ECON)]YT,>"SC9VNE3\O_)_I$7M_P`&H`@O_P#7$O\`WOJ?]FQ:
M`<?=:'DY/$F?CIWKS16('=HRHS&6V,K;BHVG?UZZE-JZW<&D[[=YJJ5.43[7
M&O,L+78ZTA>.:/ZJ)E21FVF-6._<@P`&U5ZUWQ7FR:?[7W0]A77/W:G*5>(%
MATX^J#84T*";$D=9%#LCQM[U*,!(OH?\&B22A3[JV^9+3;]Z-3UHOKTU)4-`
M&@#0!H`!!]#G0!H`T`:`-`1W[AJC>%\JLB&6-H@'B`!+J77*X/3KZ:[]-]Q'
M'J/@9YE\@\SY#F[]V[R-4W:M:T8VAF@,=:J6(AB29T+((T&_M@J2#GXG.O?R
M\A4)).$N\\/,SG4VW.9O\6X;F:-T0/2B5*\*";R"')B,?U+.!)O$<A:1D>)\
M>_`!QA<ZKFUTM7]G99ELNAIW=O:=G/<APM*\>,YVJW#V42&Q,M5XU=Y988U9
M7B`E@[<DH[LO49"J2I)U7+IJ:C2^96[=1:MTIPJDSEFLU).'@Y>P9Z%M(X*.
MTK/'_P#<Z'>98%<E!,TJR1;CN'L.0H`U9)\W*IJ_M\,2K:Y8N6'86']I/K3V
MZ_)0K1:CS$$%"*./V2P1T+/9974(KAD8L)<8?&?CK#UD+U.-/BK0-G21QE"K
MP9>&O)/4#0"OQ_\`F[W[]9_TAUIZF^GY:>!BZ*ZOYZN(TUF-H:`I_P#O5?\`
M">7]_J?RCH2CQJ_R-^HZ$GM^"D.1\&\;B>"RL-/B*LDUQ#"L822LF_:TV?>`
MOJ,;=0X.6.R/BO$*-G#P<AEY9>X`7(['-\>C0246^BDL4GL2?4%F_*W*&VX'
M[/QSZZ/E>.^%N(55:NCV6]"7<1G^%4MT8A/8BS"HVA#L'M`ZXQZ:DJ=>@#0!
MH`T`:`-`&@%GC/\`9[COW>/^2-:.K^[5M9C_`(_[%'RH9ZSFP0?<`$^">1!>
MK'C;8`_28'UVZ;[E.U''J/MU;&>6X.0>U9XGC^#JRIR7T,U7DL!^Y'-'(LTD
MWTZ[5#QB'<%CQO(!.3D'Z%TP3=3E&7M/#546E2IPM(V<IXM/R'#5N1XZM!2O
MF.:*2QQ\DCU[T[%4%:!%!;OS+(S;4&S'MZ8.(HS>6IIS6O#7L%65%)J3U8ZA
M@[4EY&;CHQ9/(\C5[5Y1NAKQ5HH(VCC<J6]@9'>2.+)Z*H/S9I.$<$]]M)>4
M88M'P>1R<>JSU:,S\`]R)HFC,C15>3AB8/7@3;M4R";,@:/#'.`?@^E&]^]#
MO6D?4A<O=CW,X/'N4G1^:AG@C[''255AX]1W8`9.25BG;<SQX8L%8*/3X9U?
M-H4M<9_Z2F75?J\R8U.1DOO)=A$_U7?DB\AXP<7%++#Z#M1K])FSOD'7N.GH
M1^&LKIA+#!\WK(TJJ,^]<OH7-]O+JV>%EWV5GLBQ(\T?<9Y8@Y]B3*[-VVVC
MY5"K^"KZ:\OJ:857'I=/5&DD[#*D8ST]-9SN>9OM?Q<4?WJ62O7I4(HI;6ZM
M7L_4[FV.I*23+N+9/N6-NFD'HJ[6H[GQ19N48J>A-1[_`$/1G-5Y9^-F2.<P
M8&YV`!W(O5T.0V`Z@J2!D?#5\MP9SK4403A?(9;W+>,<=_"K%*G2E5:-^3<8
MK2#C)LF,LJ,-N1\X!/X>NME>7"FIQBWN]Y&2C,BZ5"7_`,LD-R*.?R;G('C>
M8/Q%7\B*1H9'Q-:]JR*R,A/IN!&N%+A13\S\#JU&NKY5XFA*,B?<?CKZ(L9G
MX.:&S&^6D58K$+*`X)#$-+_^LZMS?^37]W@R.7_U3_M-5*>E/+X3-1@-6G(E
MAJ]<G<40U&PN3G.-34FN>-_J0FGR0N]"B/!*_(Q<ER=-::10T.6K_41RQ5K#
M0,;\2XCL;DG!`&"R[E_0,YUZ_4-03C?3KT:+CRLA.+4+JM6D]5Z^=/?(3]RO
M*N:X!N,_AD:2_5,RS(Y4=!+"@P6^)$A4?I(U*ABHD-/!P$E/F8N2\CX?^)0T
M)+[1<?8K3,LJW0TD"O+L:%2-H9_1FVX/7IJ(4QC"#^9+=B63JA",5\K>^Y%G
MR21Q1M)(P2-`6=V(``'J23HE$JW`U4K]&]#WZ5B*S#DCNPNKKD?#*DC4U4.E
MS4!34G<S?J"0T!'O)Y*\5JG-(TW?BW-518N]%W2-J84E`9F)PG4X&3T&6UWR
MDX.UD<<V$5:S%4]BTUB6S:G6&U".W:M)[XZ*28_HU88/<M2Y&X@?AT]`>B2A
M!>W6]1S;<8OV:EK-31QBO`O;[5-`\$;UCMMV5E;=]$`KM^8&4]Z1FZ')!&68
M3&>O<M?D1"6K>]7F921=Z:.INA:[.WT4L$""1*=<!2T$",O;/3'>D/IZ8SM7
M1.$\+]ML$(1EC=LMB?)'$@FEED:RMI^U:L0^V2](N<4ZG7V5TZ[WSUZ]?F;3
MPW:WK%MNI:C4W%V!R+27JD37)L1U.,BPL<BPA0N\J/95APNXGJY`R,;4U/.H
M2<M-L>&\CD<9J>BV%M1M`Y"86IJTXGBL;/J>99A"F^!B[LI#;OI(U]H5<;F_
M:ZLQB2A'NMB3-QAWVP/CO52NTDK?D'=;KP6RPDO2J1_2K6U25B!QVH\=?:`/
ME72<;2U+Q8E"T];\`0(+$DT#E9=\ET16U,<5`R9[MFPC87?N#")1T(]V3EGT
MPW;=2\1COV:WX''"9))WEBL/6X^G*TK7V7%G?.@1FD(]TEB7]B+'M!7<OR)J
M[NUO##V:RJW*W>=E>U'!R56K)4[;P/&M.A(=T5=9\DO*5+M+:D&<Y'MR6SC<
MQHU%-Q[;8%DX-*%O,^".:O'*8F"2U5[,TT;,T5-'88I4V(<M,Y(#-@[>@`Z*
MH1CV[];U"$+7:EK"*4&@L!ACCI*SU%DJ=)[RB1BE6%S[MO4F:3.,[NOS-HU.
M.-\\-?D@G+5QU>9+>#:4\>JRO`TD;,C1U<=J':<=D8_]W\OP_4-9LR\T47%:
M?=&>D/**%9QPL-J<XAY"Q9EJW:S0Q-,LCO%@A,KA,],G550XQ2JCJ=_8TT6=
M<H-R^6.^/`F/G>?]QI\L'/\`1,N#D,?J(NH/QSJ"4(+_`/UQ+_WOJ?\`9L6@
M)7YU2%WQ/DJIKO:$L8!@B`+-AU/RG.X#&67XCIJ'"$R5>*_$*DO"?;6.&E&T
M$E.M9:LME=F"&D9&9#LVJWS;3C`TI?:*NXK[D.=Y'R'PKB.7ENUQ;%RR\,PC
M>+9#'MW@%1U"C(;'S],'4P2<DNRW>0G*;?:EX[B\5SM&3DX]1H#[H`T`:`-`
M1OPYC];Y/"#^5#S#K%'^R@>I6E8*/09>1F/Z23\=`230!H`T`JY3RK@>+O04
M+UH17+(!@@"2.S;B0,!%;UVM_P`A_#4PE&*[TB(ZGW,4?=@X^VWD1VA\4I3L
M.<'`]#C!ZZT=']VG:<.J^W5L/,]..CY1RO)\C.Z<1';0M?XI&L3-(R$.TRH%
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M21IO"5D=W(<=<=%]?B-2HX.6R/@RCY<5'M:\4-O++0CM&/\`B-ZH6JL1!6JM
M8B;JPW,RQ2X;X8_#4<T,:>WVHGECA5V,?<*".&H`YR*\0.1M/R#X8&/^30,[
M-`&@#0!H`T`:`-`+/&?[/<=^[Q_R1K1U?W:MK,?\?]BCY4,]9S8(?/QGP7R(
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MC8SQB4#O6%8N596D[?M&['NU"IG_`$QTP<7X>9+:OG/"*@NR_P`BX+JEZ<Z!
MS&6C<!QDE<J>HQUZ:M3>5JN(!PHL<;SW"\1(R7HYYCR"<@RN'+6*EI3C<>C?
MD=<]?<=;:X54U5780[48Z/=J5-^.YC#G^Q_'O)<QYL?[NKLEV$X3?:W+W,8&
M3M.W/7'Z-4RX\M/S^1?,^*KY/,PXJ&PGG'"SJA:&;QUHY':8[5[<L+>V';C)
M+@$YZ_\`HZ5M?3J7]_F*4_J+Y?(T^/?_``G@'_UB;_[4.K9E^9;$C+NHM@4W
M]M[5>;S'G8+=9FXVM;^H^F:2.0I/)R$20M$5VQQNC?,T2'>O3H->GU2:HI@Y
MP\&>;TS3K<;H^*/46OGSW2%?<OQ[E>:BH1T:,%Q(FD,QE5&>/.T@H'(&2%;_
M`-+&JU-:'O\`!HM3MMW,BL_`<[#YSP]D=J!X%HPSF*VL03*0"2(09ZAU@D&/
MVAC\-63>"J[E#S*M4XM;X^1/_N!'4D\*YJ.Y8^EJM5D$UG;W!&N.K%,C<!\1
MHHX",+R)>$S5^+\E^E@\CXJ[%S4[R-QG&UT3$D-7&Y=DC!%VP9/3J?UZMR54
MJ=*I6UD.NFIRJJJ?86;JI(:`1^22S0E9(W-2(QE;/(EBVR,L/RX8@3OG<]$.
MWI^GTUVRE'7JM@<LQPU:[8B0+7@16?=!9IF(\;Q,8,CQ]Q\_F,-RM:G0-G<?
M:"3G&YM=9OMO=L$<I+LN5L6?'[G?MVW<03@D<A<KKN6MW"!]+5`'YEF3VAY,
M9]/^:`P2[M>MZAI??JU+6%B.L\5;MUA!0[9KUDJM_2;:R'<:@*NWHRDS2%OQ
MP1[FT3<YSW+7Y$-+LXZO,R:%I6S]+#R=L.*TU="ZUZHC`>.O&0`G:5ES,Y]=
MNW:3M4(ZX+CK\B8:HOA;$Y)G=JEJ6S8$T=IW66W'[&O,@.V&+<<1U81GN-G:
M>OPR397J&&[U95W./M]#MM?3W&I2QU4>66(-7HF,0F5HR%^HLL/<*R!$*J0,
M].GH-545&=M"UEG!PE;2]1K,<<M:>:O:@O\`U&R:[R%@=OZ>2%F9+(.Y3V0J
MGM*O0^N[#,2C!S4-7AMTB$I..OQ\CGMR0Q50&[BQR$SU8921//*3CZ^YT+`!
ML=J+;DG:`N<*MJ;[=R\65=UN]^!O)LK(7D98K%<26$2;;VN/CF+.T]C:`KV'
MW'8OP_3U9HE;'4M1,[8;=9\BNTHJHJ5Y>TZ#OWK[+NLQ&P%#P1,5#R6)']I.
MWV]!MSA0=+;B^[#V!5*$%Z^T^K!>4R1/4DAK00HE?C(MSJ\$S;98=T;#,Y]K
M/(S>P_\`-RY16GMMAJ$'H[+8F4]*>=,/VF^H"TK5B(QF&K&SB,4JR$C!W8[C
MXSCT!.T+"JAQVZV2Z8\-FI$B\7C@CX:&."<68T+*)539'D,01$,=4!Z*<G/K
MDZX9L>:9VROA(;YOXCY1RW.6I((UDXYX5:)DDCBDW11-LA&Y&(+6"K,^?D&-
M<*H1^'M@GQ[CO3MWM<.\=^:1V8O`)([3![*+36=U&%+B>(,1_AU<H([_`/UQ
M+_WOJ?\`9L6@)+]P[(K^)W7:9JZML4S1N8Y`2XV["`V26P,?AG4J.!#AB+>$
M5J7VM(8S[A4G&9`]F52[.`2(SO<+G/0YQJ&\6^_V>!*6A=T/.!!.#YP\=X/2
MAH1<7RH>_-)&)U5%B7<.VVQ@OO.&R3USHZ$OBIMV^PMS5-RJ:[/*)=Z[MHW#
M#8Z@?CH5/N@,9HDFB>)\[)%*-@E3AA@X*D$?X-`$:+'&L:YVH`JY))P!CU/4
MZ`RT`B\,JV(.)G-F)H[,U^_+*9`0[@W)1$S$]3^2$"G_`"<?#0#W0!H`T!5O
MW-F[/EE":.C-/9BAA:"U%,T8B9FGC!<!U'SR(G4>CG4IPQ?=_P#+$(Z+=J)7
M]SI7B\!YR6/'<CK,Z98*-RD$>X]%Z_$^FN_2K_TIVG#J?ML\VWSYZ'K3#FS/
MS=@36%X>P(7(K&`1RS.\I>"3^:[(5_><9`ZZ]VGZ<_=]W3V]^L\6KZE\9Z.P
MW\[9O1VH/KK\,T/(O-_$[%6U"%68&)EEA>1`H>)=JLT:!LA@>OK&6E"2NND3
M6VG-WZQ<]"M>G$TLW(5*-A9;,L,AQ$T;S!XHO<:T;;HV!VQC+%QC\-7YFM#=
MMI2">F%M@^X=^6H<DD$\$$<=BW)!R%<S]F-A-&6EJ"2`."B9(2.,-M9Q^T<Z
MXU\K4=4O,ZT13[;(G7VLLV4E^EM=FU)%SD<2VC(\\NTT+#@/(\CMOCZQ^X*=
MOJH.L?5I7J7N^*-?2O#^[P9=>O*/3#0"OQ_^;O?OUG_2'6GJ;Z?EIX&+HKJ_
MGJXC368VAH"G_P"]5_PGE_?ZG\HZ$H\:O\C?J.A)[*N<=R_*^)>(5HN*-N"O
MQE66O.G:?W&K&#[9&4[E(Z`=#\=0ZDM._P`"$MA,ON+Y8G`\7&(N0@I6YF(+
M3(TI$7;?+A$]V=RC!],ZO2G?"/;`JYR'OCF[^`<<6D>5FK1,TDIW.Q9`26/X
M]=5;)A`8Z`-`&@#0!H`T`:`6>,_V>X[]WC_DC6CJ_NU;68_X_P"Q1\J&>LYL
M$'W`Q_N)Y%G./X;;SCUQV&UVZ;[E.U''J/MU;&>0ZE,0+09Q8%"2TB\==7H8
MI697E2.Q$9$W1KM)`C^9B2!C7TS<8Z83]A\\E"&B(V7RAX^2^B5AQZ&4=N_)
M7$@$:'!9=C>Q4<N^Y,J#\H4$C7+Z4HW]IT^K.%QLX2W2XPR034WI32325U#L
M[K!'+MVPP2K)W9E+E'8(/<K-\,DLREU3C$FBI+`[^6H7;L53A)>+''F-T;BN
M%)5)I;,JPQRF>(NJR?3JA`^5F]#TW$4HJ2C5&.EZI\2]:;A3#8A_XWQOT_@7
MD;<A?J25Y9N/EL_4V7$<L+S3.(V1':6+N)(NU&V^[U^+:X9M4<RF">.&PZY5
M,,NJ+6'B</!\A6L\94DLN2(['T%>Q-=*H9+4"NYKM&9)(&0)L_)R%8CV]2-7
MS*6FX;;M&G3VE,NN*3[+R^_`*JT^'EII0^BCAGD`8=HQRL&*O(K1L7)9E+-W
M%#`G'PUX_4N-48Q/6Z=0IA"!)M9SN1CC/MMXCQG-_P`9J5&6VK/)#&TLC0PO
M+G>T,))1"V3\HU54NZ+@L,"[K6A1TPF2<@$$$9!Z$'5BA39\:I^%>?\`$%9)
MYJ_+W''&UIKS"*J#(J,M:OLVDMWQD9Z1[@->I]5YN6]2G*_:^SO/.^FLO,6M
MZ;B9\T\T?/>1R`1O`G`1%XW4DLX>V5^(&W&=PUEH^&GY_(T5_%5\OF<_&7[3
M_<'B:QKO]-_NYW5E0((E9YXMPZD-^PHZ9]1^G5JZ5])O^\K34_J)?V&7%P1U
M_P#<:".03)'%.JRC;A@*AZ^UG7_D8ZBMQY[8DTJ');`HG[<V^%BY+D0])^4Y
M<\K58W+D*,(4^N1%DZR"97;<Q;Y@#C.=>QU--32G"GE=VP\KIZDFY1?,N)ZM
MU\X>^&@([?\`#*]OF&O_`%DT4$TL%BW279LEEJX[3;B-ZXVC(!ZZJXZNZ?>6
MBK/P-WG-BC6\0Y>Q?K"Y3BK.T]4ML$B@=5+=<#\3JT$Y,A-JXC7'^0>/W?*>
M$2CP<:PR23K5YF,)$AG2M(9>PNU7FBV;E,G1<D8SJJR\M.5ZT<&].PEUYC4[
MM<8[88=I8.K%0T`C\BEEC>-HO8RHSO;L`&K553UGPP]TPSA%!_7TUVRE;%^A
MRS';!")5:F+#UY):E">.+N<DQD:=P_S"-&`W6YI#@X4E,#XX4=K[YO1;!'&Z
MZ2TVQ9]COOQ]J&..N6L*!#!Q,;;DKQ.=Y1\'$MJ8#+9.$&68X&6AT\R\;8(E
M50?A;$UQQ)`DN).SV_Z/8L5LL(`S9''\>/5I6/SL!T_Y`LQC;>R(0MN1K1?J
M$0R51!4)-2I1K>V:PH()J*^?=$K+NFE/3.X`[<LTW8SX:_)$7X2M+S.J.&>Q
M+,4JP<E8BVI9=FV58=C#MUX!D?E0LNZ5L>[&,$]$JVEC#CM?@62CA'AL\SEG
MGB[8>0R7JUUV,]@;4>^\2EMO4_ETH_3(R/\`T<EK)=D-W_T5;[8[_0*D%EQ`
MUA%GMRJLL%9P8UE$6=ENZ.FV&$'$88;FP,^[`54UA=:2UL)/&^TV==:2A-5G
M976S&7[W(<O8VHZ.@WPVERQ(B&"(DVC/_1.6JTT^"\/,LFFO'Q\CELQU15$<
M\LE2+I8JUFR;4S,ZAK=CVO\`G2?^Q0C.['[0PMDW'3PV+5I*N$-'':]>@[3`
MB2R1U-RV*4`:E55$9:7<`R'W2;'MR[FVDL?^0DM2.G'?Z%X:,-WJ:%^BKP31
MTK$PJ;\6;[K_`$A7E"[JM;IO:S*P_,;U4]/7HMIN^^TWJ*R5UUI+69221*HJ
M/7:"U"J5H^&CW/%+7G!<PJRL!WMN#)(3[<9ZKU:$L<--L-!+>&XE'!R2/QZ]
MR:&:1&9'%8`11E3CM)CU$?RYUGS%,[Y=Q6/G=;DK'F5F7<+-&L(N[6'(2TSV
M4JO-)$41"#G'<R.N!J.>I27,MG+XLMR4N?N]J?@B9>;R1R>!2R1?S;K49.I;
MVF>(CJ?7524(K_\`UQ+_`-[ZG_9L6@'OW/["^)326*$O(UXYH&FKP2K!*!W`
M`R,P(Z,1TZ=/CJ'#&*V*/$E1PAVQ\#5PTGU7VW"\#`*;R0S0UX+TO2-VD9&[
MDL>[.&)/MU9:HU;F0W&^%.]>I":?@G/Q7JE4T([%6O$TQEJ21=MI&FV@3R2(
MHFD5%R#MR,^NJ1A)IT]G_P!*'86@G.*JVN'=*HN;5BH:`-`&@#0"CQ7DK7)<
M2UFT5,HMW8`5&T;*]R6&/I_T(QG0#?0!H#":>"%0TTBQJ2%!=@H)/H.NI5+=
MQ#:5Y6/W#D#>:4^-2[%2CY6O!#>$S86>,232*N[!V8[3#</BP&D'@HVPD3%8
M^.^9)ON7#2?P_E$M2R+'-4E@%9&`[F[#$`,5&["8#$]`2=:.E;YU#29^IAR.
M.@\[<]X+/8YNAXV+(DL1Q-)*\04[JE5V6,F1OVXX-T:8)#E1T_;/MY?4)4NN
M'M9X^9D1J5)A<\?K\C<I\=R=*;BH$[]MXJ\('T\:@GZ4/(Q$;+%$99/FS(V,
M*<G4TYCI3:<;7^&PBJA5-)J%KC3Y&ECBE7A.1L1K;K/WGGAM0D5D8D1Q1IL:
M5%"=MRJY<=`/P$Y4*O>5VR\C-]WW7?M#DZ5.>]W*]UI:5N,-1@EAD16(P>V^
M\1!8(&C>-^[,V!@@-CHHJ:4U-6[WL%249.^UIEA?:&S2:\]6O+6D-?GH$WU&
M+12)'QMB)95]L>=VS!(4`D$_'6+K$X1<?A_[(V=(U&']W@R^]>,>L&@%?C_\
MW>_?K/\`I#K3U-]/RT\#%T5U?SU<1IK,;0T!3_\`>J_X3R_O]3^4="4>-7^1
MOU'0D]C\M<K_`.Z7A,0C%B6IQ=>=HS(8PI:M$(V8JZ/Z@G;D9U916GLCY,HX
M/1VP?%HDWW-K5Z'B]'^E2U^Q;54NF1>ZH:.4`&20A=ONQ[CZ?IQJG+%SFRW-
M!:NWU)EQ"LG%4D<@LL$08J=PR$&<-\?UZD@Z]`&@#0!H`T`:`-`+/&?[/<=^
M[Q_R1K1U?W:MK,?\?]BCY4,]9S81[[@30CPSG8&;\R;C;I1/0L%@;=C]6==^
MF7_I2]:./4/W*MC/+Z5[7#P<?F*O'VIS+2@4-8C5PAB6S-)`KEIBI#IM`3\L
MGU]NOH(JINW9L\SPX.F!WU[]*RTT,\5BE+%]5*7L,W(.JRJT4L<Q8UX8E]SF
M1>XH+*0R]1JCI:NG=J\RW,G?*_7Y&ORQN%L4.#J01I6K<=5B?CN1G4*UXQB/
MN+-)"9-Q5%`1$'J<!B1[F3S)U-XN:T#.@TEHWG)R/D?)6?)X9>9>;AN:CF.;
M448LP)+,`IDBB)&)%@[2J58]5Z^N1>G*2H]WWJ>ZTXE:LU\\Y.WH.N/DX.SX
MAS?%/<S4Y._QA"B"'B_S$$C64BWM+%O"Q>I;#."%UQJ52KI<)I5:]AUI:=#4
M;VM6TVMXCX@E,6%7CKPKVI=O:F2**R=NU8S.K.()%"B40N#'U(W=0`^M7&$U
M+N\]$;Q]*B&#GW^6G0>B?$!R<?!5J_)(L=FLB0E%4J,+&N.N65B?CL.T?*"<
M9UX>=#F;1[&3'E@QSKD=0T`:`KK[A5Z1Y"M?@F>WR?"):L148Y0+'=G-?`C;
M;+(A56!55C.<X)&>N[IFX-.2JAXF+J$HQQICX'%1\RJ\G'/--4L6I.7HI1-V
MO+3B@>%>^5F"V)H9(G;N-N211@XZ==7JR'3C#E<<=6A%5G)WJ]0PUZS#CO._
M%UY:CR]?C;9M_00<;&[3<>IDAGE)AW_TG((>!OU9Z^HTJZ>OE=+:A&./D*<^
MF*<'=##S,*7EO#OQ?'KQL-J%^#HF6G:GGXT`)9@>*.256LKG;L+%1_A]=35D
MU1<8>\_[O(BG-4%"/NK^WS$/`^,1<[R7'WX12BGB>)^6L';.JRQVVGD*V'*2
MO9,Z-M*%DV-@]-I;MF9O(FIZN[1H@<J,KF:<M??Q+U1T=0Z,&1AE6!R"#\0=
M>.>J?=`&@%_D!(X.]AF0]A\,D/U+#V_"#![G_1QUU#AC#MN[25'"/9>0/Q;E
M.>G\FXR$V;7(U%$R3FUP_P!`M>(0L5:.8JN,R*B;1Z@Z<]#DN35RQ)=%2F^=
M?,Z9]Q9FI*AH!)SBT9+U9;,Y#QHTM>NZ%JXF#*L<LVW&=KL`H+>OIUUURXP<
M#EF0C,47D@@OV)(FCKVH=TMF?.^K1[A(:<`A=UB9<;5/I^KYNM,U:+U;$<ZI
M.T%ZLTVZU6*"JQ,E2FK-)3N0B22Q*90$F1VR'%J5C@`KTZX]P]LIN+Q=MQ#2
MEHMO,)38@CF>"(1V./@8K%%M:/CH2N=B$^R2W*/4GH/U?/*@[\=_H0XKLW>I
MDMR:2F>]9E="1':M(&,NYPH%"EN`<N=H$K^N<_M?(Y9W6TOP'-*W<O$W7:"1
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M7D&U:E38=QE9E#2'/0]#[L[8=+CA'=M9*:AJM)$GX-)(^-CC>*&OV\HM6`[E
MB4'VQEOBZCYB/CK/F7G>BXJCSN3@#]QI*_)VIZ%6=8X;<L5B2-B9:KIW0H4I
ML$9[;'.>NJ)-W.'^WQ.FMJ/^[P)YYS%!#X'-%`<P1BHL1]?8L\07_P`FA`AO
M_P#7$O\`WOJ?]FQ:`F/EU^3C_'+UR-4D>)`1'*I='!<*48#X,#C]'KI+$3P$
MT7*<;S/VQGY"2DD=&2C.[44/;11$&]JG`QU3H0-(*Y;K(F+QF]=F5WQ7FUSC
M/`:J\%.AL\C:M+-/)#)"T;(4&$C8*H;X?KZ_CJRJ2U]L>,&5=+>KL_\`T7FN
M[:-V-V.N/3.JDGW0!H`T`:`6\,@K2WJ(2O"D4[300U]V>U8_,+R[NF]YC*?;
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M52"S-V`>\FPA)6F@FDD,L4GL)6/J>KD9.E#@Y.3=L+8$5IM34TK6[S5R,-^W
M&B(\?\4A@S8L=^`_42S$N0\L8[4Q/=9E5P)!N`5FU-+2V6MH(JB]MK:2T_M1
M#21*LE:17-CG(II!&%,8+\?9/MD4YDS_`,]58?*1D:\_K&YQ_#XHW=+"4/Q>
M#+QUY!ZH:`5^/_S=[]^L_P"D.M/4WT_+3P,7175_/5Q&FLQM#0%/_P!ZK_A/
M+^_U/Y1T)1XU?Y&_4="3UYY$[5_#/$K3@UJZ\35#SB10)S]/'B-D"LV%)]?7
MKTU$HW</-#WL/'R:)?\`>4\;)XY5@NRP(GU2RF.PZHA"0RGW;BO3.K*ENY-V
MVHJG"WHR8\%(TO!\=(V-SUH6.W.W)C!Z9^&H!W:`-`&@#0!H`T`:`6>,_P!G
MN._=X_Y(UHZO[M6UF/\`C_L4?*AGK.;!!YU/57Q>_3L65J'DH)Z<%APVQ)'@
MD8,Q4$@*J$YUVZ=/G32C">\XY[7(UI*'Y2%6L1^.R\^D?(\,7N\L(H;,-B5T
M.Y!&L<(5GD6<&0-O=26VY]->Q0Y<W+*J2N\_(\JI3Y>::FSOJ>-1<>YH\CR3
MUTYJHEF7O\;9M5I2L@E19HYXR?D3HO=5@_7&6U1YO--+X7I2=NPNLN$FX16B
MW$57:?A\TDU>EYAQ->9"C2"Q`\"@,LQ)61EDW'=/[X,>S`7>,:Z4U5J;HJM"
MT=Q1T4N2J5K7;S+R#PM/X?4EAY"GR/$(3+QEVBEJ5WM1Q)))),(H9]JNB%C$
MC9^&[VC3+SYN356,87=^\C,R9*::POO[CJX'AZ/`<=:XGR"Q;J/R+P689X>/
MM3#<7G`"&5>Y"5,R%779UZ=?<=5S*W6U53!PUK46RZ%2FJI1U;3.7QVWPO$0
MU(;<YAK6?KKT5;B+3&(F`PLD9DE7>&V%92,/N]Q]-%FJJJ,,(?$M-H$_3=*A
M'7\++J\"_C2\&L/)U#66-C])))(7FGC<E^[*A&Z(G=\C.S?Y1SKR>HY>:3/2
MZ?FY9HDFN!W#0&,I98G*_,%)'0MUQ^`QG1!E/W;'(<YY;;J7K@X;CVCD62_`
MQH]QAVNU(V^17EW1QE?:Y"]`5RI.O4I2HH32YGHO/-J;JK@W!=Q'Y.#Y^PEF
M27D(YQ4F%&MR%!FLK>MR[6(:&*%Y/R$WENH+'`+G!;799E*A*^<'*"[\;(X\
ME3C/5+%FCR"AR7&W/&:/%/:Y@6[E@\G:*2*STXY8T&55(PFQ9O>RCYAC/KJV
M74JE4ZH4P2AM%=+3I2G%SV#?F/%^3AY>/C1R*V+4PL"I(DL$$4MB-LI`1'7Q
M&Y#'*,2RG;[F4,-<J,U.F,)2]MY>O*<81G;48>-3UY/&H;TG/R\7R,DLTT=>
MTRO'79-D#030D,F>^&**4+NNWW`]1.:GSPY8JW@,M^['F@RU_")9W\<JK8:+
MO0HD<E>&/M+78(I:OM!8?E$[?U=#UR=>;GI<[A;6>AD-\LQ]KB=0T`O\AXR?
ME.#N\?7L&I/9B:.*RN28V(]K8!4]#^G2+4U>()WW"6A0\YN<S0L\W)1JT^-:
M1^U2:9VM2/$\09MX41H.YNV^XY^.GU(R5,-,7PMV#D2O<>R'?,E6@#0"3R;D
M^5JQ".@D<2M'))9Y*PQ6*NJCVD`*^]V8X5?AZ]?0]LJFEW]VDY9M35W>(XY:
MB25*_P!',DJ)+:K5W*S8D(+)9M1YCD>=RI*)DG\,,#MZM.;C;0M1R34E"VEZ
MS+N+6$_:8TI?_B.1D=A-%1:5BQ*=,/:E#X"]=OZ1@,A'7HU^@C#5IU>IKMHL
M4=1`'K<22\E:>LTC6)&=0C0MUR;4K,V6(RHW8.<E94X_BMN(>&BV\^I:CKVD
MA6`/RB+V*="#!BJJV-U>-PRXF:,[I)NH3X],!HA%:M.G7LT(1@]?#5MUFV)Y
MIX7BGMM+70LE^\A)9RH&^I3)]^Q0GYLGJ<']K)6'*Y;/-^!*GC;0O$U8I3UH
M(S!]6N37XQ8E6!KT"L6"2(H]M>,[2S]`V/EP0&M-/1IU>I$FM.C7Z&R[7599
M*D\:7.9E"2S67+Q10"$K)&ZC&%JQ=?VLLPQU.2(I>*E3;>34L+ZK;CE:Q362
ML;1,G%7)6EM6)CLDM]M=QL2J`2*RG"QI@*>GHN-UH.<+UNU;2L5C<]^O8=EN
MQ-;N+(84BE/])ITI1MC@4#'UU[&/=@?EQYS_`(<E*)05NY%VXNW>S#N)4>U'
M4M>U<2\GR%J)>Y6F!*&4-CW2RJ<1QXPHP1[<*TPC"*V+3;$B,(P>UG%9A<25
MX;->Q0XJ/\RO'M9IGD?T&[U>W-NSD_(,X]^2MT]$W;<MY5K3)6WLZXK$E6Y#
MVH(6O0$00U=P%:H&7<M2)LJK6I5'N;/3]6U6HU%:M[U["R<'KX:MI*N'-#Z$
M"D(EC5G$@A.Y!+N/=PQ`W>_/76>N,9G>B$)$*\J\L\BXWG;U2+C)[5<1EJ<T
M5-YQDU'91O4')^I"C!^&N3>5_5RQUG1<^#>X;>:/8?[?R/97;89:;3+C&',\
M188_7JQ`CO\`_7$O_>^I_P!FQ:`D/W+K&?PKD@HS)&JR)[BHRKC.[!&Y=N<K
M\1TTB\!!8G-X0Z5?MK6ED"\A''7GE,4"%5==[MVHXY"QQCV@,=1"7O>8C^$@
M/F?/<5'XKPO*<?0BJ1R79F6M`PF1F8HKL5VC))/5\>W_``ZGEI6F%MH=53OA
M&WREVJVY0WXC/3KZZ`^Z`-`&@#0"SF*W())%R/&JLEJN"LM5L#OPGJT:N?D?
M(RI],]#T.0!T\9R=3DJBVJK$H25=&!5T=>C(ZGJK*>A!T!U:`AOW)\7\?\DJ
MU*'+<B*$@[LE579.U(5"ANXDGM<+D=,C3Z=57PV\25F4TN=O#O%GF')TZ7)\
M;3;Q^/F+$5:%ZMF*%F1/YT=%0-A`\28!/3=^C4-4)>]+MW$IUOX9C_[FUWL>
M`<]"D;3%Z<@[2C+,,=5`RN21^D:T]*X9M.TS=2HY;V%*^2F9N93B^%YFN9E>
M*&7AI8+?U2/#`&[<<3K9585QOCE8G:WQ(&O5ROAC4NV4/">H\W,C&%+[)Q\1
M`/("]J7F;U`_37:\50PV2\LIAC.V%AV.SNB!0F41JF5QU;<<]OIRY4[K>R\X
M_4G%JUMACP//V+')RI#X]&*44ZTY!`_YE0"13#,I4*7,4<6/=E2P4XSG=.9E
MI+XIW[2,O,;=TN!NEO<#1Y"?EZ=66-=FU(;=N*N:_P!6VQC"S":.<*^4=60&
M,*/8I&[5534URM[KX</$LVDXI;R1?9RG"/(Y;U.R;%!^4KQ1K&`M9'-.W,R0
M+W)&V(),+D`X]<'IKCUM7N0:GROBCKT:]Z*NCX,]$Z\,]D-`*_'_`.;O?OUG
M_2'6GJ;Z?EIX&+HKJ_GJXC368VAH"G_[U7_">7]_J?RCH2CQJ_R-^HZ$GL.\
MT$GBOCL=VS)%6BX2H8XQ4L21L/IXVD)D26.-B,+\.FE\HKO]"LKVO^/B2O[E
M4KU\05:'&&>Z`LT-TQAX0$+;XIR5/LQ[L`Y)QTU2KEQ[K/>6I3)APL;Q\-0C
M<,'2O$K!QA@0@!W#IUU=%3LT`:`-`&@#0!H`T`L\9_L]QW[O'_)&M'5_=JVL
MQ_Q_V*/E0SUG-A7_`-X.0KP4N%J3[&CNW6B:#N&.>0-6E0K!['4N>Y@;NF<:
MV]%2VV]"\3)U;DEI?@0SDN8X'CN<M7N-J3<WSG+Q"_/+4':JR21KAD6WAY5B
MB@?=N1<;E&2&.W6JFBJJE)OEIIE._NVF:JNE514VYV8PX3S+CN4JV"%@HQU*
M*2UEAL(L$U(,SNR;B>S/$X.WNY&%S[<DBF9D.EZ8O?Y;"U&<JEH@MWGM.+C.
M(Y^GY#+5XZEQU:'C8/JI&MRRS36!R7=$"22(LZ,L+^X`E^O7?U.KUUTNF+;G
MHU>=D4IHJ54$E+Q.Z]S7!<7XI4K\79DGL1UH((N5>/936&]-'%9:*937@[G=
M!R&<%>H^7(U2FBJJMMK&[&5VEG2JNFFA0[]M^@U<3)R?-<1QTSS-)<,`E[D`
M6.G,T+%[*6JS[XV8+(=K1+C/56ZX$UI45/1OU096B-25EKBB0)P5OE>8J\=8
M[MKBN-LK8K6I&;<,1E6[<V38B]^\;)-V=HVNOIKA]14TMJ]VV6N.RH=54,%;
M:6,HVJ!U.!C)ZG6$VGW0!H`T!'O)?&^/L4+%F*`+9CVV"$WCNFNK%8V$;)D'
M<1_A]#KOE9K3@<<W*342O?'O(:?%^'I+S$MFC?O37&:W#3F:FDUW+*L\$16-
MF1![58G'XYUMS,MU5^[!I0QG(QY>8J:/>DW'"4S@H<B\GC=ZE:DAKV.0[4'!
M6>)%BM7E,T1L0V,NT>]F6!6?;(0N,%1\;U4^^FL+XP>J!5-\K3QN@:N#\TY2
M!K0F@^MY3EUD;E*D?&.17EIQ,LFV2/M?4NVW;L9@RYSO(]9S,A.&"IN][3P*
MT9S4<6[Y:.)(?"^-X.#R.K1X^&S8XR!YY*,\P:(*743R!U9`\XBD;:LDC'&[
M;U*YUPSZJG0VX1MW';)II522NMWEI5JU>K72O7C6*"(;8XT&`!^C7GMMN+-Z
M22@C9J"0T`:`-`&@#0"#R7#6JH0&6Q&K2Q+-TIP;<9M3GIGMCY5SZ_A\P[95
MSL]AQS;U9;197EJ+QTUNI,]<[BUOE[?N++T!G6,97O-N"Q*P&%(P,84]&G&#
M[E:[2434(KOMCH%]V6>F*JK6EK'<LW&0LHEV,9/=-84Y::U-UVIZC/S*=S+>
ME)QGM]-12IPA+9ZZQC/))/8>4`UK56(_6S1XFCH(V6>.NJKA[,H(W=#M_2,!
MJ)05I[=1=N+M+U.&G;=J,L.QJ_%"=XXA&`;<IDQ_0XI!U>1V4M*^?;Z;B066
M]5,]>[;Y%$Y:M^SS-]>PR3SQ&D[\A&HJ4HZW;:M6+J&^FC+!E!"Y[SLOP_#:
M-5:UROUO7Y$IZI\-7F'U5=4LSV6%J*96KVK46Y#8D`.*E'#+LABP=[DX]<_M
M,$')*7AK>L15[MJ6HP6N5C2+_P".CO,)JL`($E]B`R-8(R$KUU*KZ8..BXPK
M3'LANV:V(=L=^W4CZ)X9I'^FE%WD)`S6>19GB@C6)@>X5&%^ECPW;&[W,#Z^
MY](0ODM%L1&-TWIM@?+$]2.JY67NT;"QR7C*H%J7O,5%R3NH5VH8U,2`8/I_
MDJ23CKW;/,-J&K?M\CH_IEJU#%'$3;0"2E3F]_TR8VBY=.??.P'L0G_]IA62
M6KCJ6HF;>OAK>LU2,$D>9Y#!=@0?Q*Z2LB4S(`&$(1%5[<_M!P#CX=,*TK=A
MK]$...KU9E-.U>E#QL\1HTY\RK3B1WMNA($<1DZKWYWW,QSN4`_I<$HN-[W>
MQ!N"A<M_M9)^"$J\;''*L$31DI]/6ZI"%.!%D'JR#HQZ=?AK/F7G?+N(=]P?
M'K=I[W(1\/1ECCJLQY6:S/'/%VT)+K'&C9,?JN&ZZJJX7<_8X+CX'3EBKZ8:
MZ8L8>6DG[<Y,QL$Q4B9V&&D_.B]Y'XMZZ@A">_\`]<2_][ZG_9L6@)3YZ)CX
MCR/9A2Q($0B&3.T@2*3Z8.0.HQ\=&2A+7LTJ7VGEL4J@^CBISL]6%Y">V&83
M;7/OW8W'/XZ)0MZ>`<7[/"/B5I:YJ&?[=T;=99$`Y&T)4FK!WW)VUR,HJQ>H
M7&T9SGX:A\O]N\FF.'-V>/O/B>@X_D7KGH.N,9_P:DJ?=`&@-%V_1H0&Q>LQ
M5:X(!FG=8T!/0#<Q`ZZ`7?[Y>(?UYQ_^U0_^MH#G_P!]N+G@,G%0VN5</VNW
M6@?HY!*[VD"*JG_+/30'=Q-6RMBW=L5H:KW#$PBC&91MC`/?D!VLX)(]O0`>
MIT`RT!7OW<6[MXEJ$(>YNF03/'!/'%&_;#NT4_S'.T*%^/QU#2Q4>Q^#4-Y*
M;TP[O%>0K\P>"SY!P*&PL:PTJMA)HW^CG??(P`$D:2$(=O5%(&K)M72V0_[5
M+@R()WS6N/\`UI\4M1+/NH5'VZ\@+$!13D+$[L`#&2=ON_Y.OX:[])]VG:<.
MJ^W5L//%^URO'\@O*!89)&HRM1L\;]1!/$LCRDP%+&\X8/M(=2P4ICKKW*53
M4H:\8>!XS=2<=6`^Y"KOEF\AXSBY8>01UKO!'8^L2-2&,\A20JT>6$86((I9
MP5Z+G/"E_P!+<NZVT[5+^I*?>1+R#C./H\?8MU%0TZO(!!#+$\,DL4>U_P`P
ME-G<E[AW!MRM^R```=.74VTG>T9\RE)-K!D@K>1\SR,]KF_XC6L\)QT<<TE*
MBQ^KM3R%8(H9`W9L+O8G'ZLX8DD\7ETTPIA[STW+P.RKJ?O1DM&/B2_[:\;!
M1YJ;Z=K"PS<]!*8+';)$DG'67D8%"[8+'IN;./49ZG-U54:9_A_[(T=-3"J7
MXO!EXZ\@]0-`*_'_`.;O?OUG_2'6GJ;Z?EIX&+HKJ_GJXC368VAH"G_[U7_"
M>7]_J?RCH2CQJ_R-^HZ$GLWR"G8G^V_ATD5>>VL'&UW:O!&S@DUH50MMDB(P
M3^G]6JU5)7VW,4INY1[O$??=,W(:\%FK#;:7!C22M,0C$JY,9A66$L0N7W?#
M&KJMK%V[RCI3O5/;["4\?R%.AXS0M7)]D"UJZM-(<DED55SC=DL3HDVQ<=G%
M\A#R-"&]"&6*==R!A@XSC4,DZM`&@#0!H`T`:`6>,_V>X[]WC_DC6CJ_NU;6
M8_X_[%'RH9ZSFP2<]XS7YCDN*M6(X73C'EFC,B;W65E"QM'G*C:?=GUZ#!'7
M7;+S72FEB<LS+YFGH*VYKQY_&/*J];C'W_Q*@C7V%5RKQTO;/W)%D6-%L/+N
ME]K$9+>NW6[+S/J41>#TZ?+`Q5Y?)5+%</,3<WXC%Q?)V9>&I1QU^6CEI\G'
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MG**UD1YV]S:`=H8M@``*!Z`#`Z:\[-KYJHF_*HY:8#37,Z!H`T`:`U6JM:W6
MDK68UFKS*4EB<95E/J"-2FTXHAI-09'/*_!^+Y;A+5*-/IXY0TTB0AO?,BAH
MGV@A2RO&GS*<KE?CKOD]0Z:DSCFY"JI:(5QGVPY4\/7I\I4J6N1IQ1UJ_)P)
M].8(8PC1R0I*'#SACU)PNU2@QDYUU=73S13:3PM@9:>F<(-**QMB=?C/V\L7
M>4L\WRX-?D[!DCL2UJYHQ%2Z]S$)D8N]A![I6'H67_)Q7-ZE)*FF[;&T-!;*
MZ=MNIW]UHEB<9P7#<69#QU*&H9<=PQ(%W8],XUAKS*JKW$V4Y=--R.[5"X:`
M-`&@#0!H`T`A\J>LBPO=E)J+N852K=EY4&Y'L.N3VU(^7'5B/4X&NV3'"^UQ
MQS88W6O$L:,D5.-56.W!%]0T,XVPU"2QDOVLLQ:1QU17;(Z_I8=7CHXZD<M&
MGAK9C%8I?3K+6=HI8!(U_F)=S/$)GZ%$<=;4Z[<`+[00,8VJ9:<9]BM@@FH2
M[[8L#)7KJ$D:2G9A7=QG'1)WVC:0]/J`3^98LJ6R"<A=W4=6T@WKTORU(26K
M0K8LWD%G)AC-:2E`([LM?\U*,8&36IJJC,[C&YL';_FC5?'?K>HGPW:EK-&:
M0$XI(\?$S&.`)'N%BS(JG^APL6;IOW--(,>K=?F;5IX_%PU^1$L+N.KS-DT5
M*U'4L&)+=F=%AI\7!(>TK1966%@479!&P5I#ZD^TY&U=0FU%7:[8DM)P=^JV
M!@RS6$FF#-9J2';R7)@%$L",^Z&(C^:JQC/4?-^/S-J;MN"T>I%^S%VP-<TH
MDCADFB%J-$9>.@,0BDM0Q-N6:RJ#VUHA@A0OO/7;U5=$NS3JV:PWZ:]NHVM7
MDBL[[!6;F@7GDL2MNKP0KD);F7H$V@-V8MW3_I;FU$92^&TO-B$Y_%:?DC36
M:M,9;`_+XRL7^IN2X^K,DJJRV6W(Q[KNJ=J,#H,9'RKJSBI8[MGF0H.>&_;Y
M';7$):K5AB6KR4(:2C1G;N1Q%VR)9_3=:DCWL`6)]?TG5'B[U:[476"QMO/B
M3-;GD[(^EE,C-:M,D:O3:8*K58#UWV)2HRV3ZYQZ+I"%K]>P1C:[5M)%P$3Q
M<7"C5!149,=8-N94)RO</_O#ZMZ]?B=<,QQ=\3MEJ5T"M/NCQG(<AY`88>-B
MEX\I$G(WZ[-9NQQ/TD)J!UVA4]#M;/X:KSNE?U):8U<N[T+JE-_TMZ(4\W>R
M8^<1QQ^!S1QY[:"HJ9&#M$\0&1TQJ"1#?_ZXE_[WU/\`LV+0@E_F,#3^,WXE
MNKQQ:,?TR3(5,,#UP0?=\O3KUU*C@)8W"CQGC3QGVU^DKVFY(QUK+1V8AEY6
M=I'R.YC+%C^U\=1MAQ]I,L/+V$,I>;W.*\<X^\O\./'6)["6`L(CCEDC96,T
M;;D4G!(V8W,PZ:E4TW.FV\K54[^9[GY%Q@@@$>AZZ@D-`1SS#QR?EA6GC1+B
MU=XDXBT[K4L*^TY<+D=Q-OY98$#KZ9R`./A3XAQE62*QP\?C[3[FMP6(D6$_
M3@$NTPS"47N85BPS\-`2"OQO`6((YZ]6K-!*H>*6..-D92,AE8`@@Z`[)YHJ
M\$DTAVQ1*7<@%B%49.`H)/\`@T!F""`1Z'J-`&@*B^\GD'B5D\="_-UH9*QL
MEY(9A(Z21&)UA=(G4KNDC'4^A74.J&,+?+465+>$;;4;>5Y:.9:W\',U>?C>
M/I)>M)-,B559AV]\>S;.JAB<]>F=(K;_`+=\5'N(@\?^VZ#AWDQ^Y:++X!S4
M;N%62J5:3;O`#$`MLZ[O^C\=:>E^Y3M,_4_;94?W1XZW]*.&NV*DO*3/(]*S
M%5%5[`DCRJ@##!H%CAWN'QM."&VZ]+I*E'F48;8P]LSS^II<(._9;407QJW6
MY#RRFE'BC8O5;<+SVZ;$4^TDI226?M]M"$APT<RB,ANI!]=;,U.FAQ<FL;[:
MIF7*<:X)7.UI$UY:ER?+<S<H^,\2UW@)K<57DHK+Q+58=PK$L)7\]2M=06VR
M;U&WICV#)14J:4ZW"J$M/E>::Z74VJ%&F-M=PA2C!%XYPD/$+'2FCGM5K]L=
MJ(V[--3,L,LCDC&9)(58!L^W/0XUVYFZZN:=T-4;1./+"E)2O[86@37[15+G
MY2S3&S9@Y6F]QY&B[B-_"Y@8W*GW-'N"]?>/0^FLO6-?E?\`R1JZ1/'2O^++
MQUY!Z@:`5^/_`,W>_?K/^D.M/4WT_+3P,7175_/5Q&FLQM#0%/\`]ZK_`(3R
M_O\`4_E'0E'C5_D;]1T)/:%^_/7\/\'^G-HO%Q<,SK4E:`G^C1!.XZJWLSZ@
M==2JH8PMW;F4:3<X6[4QU]P.[])4X>?E*J0X[\KW`QGEV[\`=N)U`'KG&>FD
MWHCM2W,LH+\78F]Z.SRX"7P&I"B/;,XI+&:X!+$,C*R,P]N[;[6*^I'346M`
MBT_&T1QX.K+XEQ:L"&6``JW4@@GH?TZ`>:`-`&@#0!H`T`L\9_L]QW[O'_)&
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MN*NQU?X>E='E:6TW?BDB94$%=WD[>\MN38K`_`!QTSU5<U<6K]G$[TKEI@G=
MM,_#.)Y#E>6H1\A%-#0\:!>&.:,1=R=_YN1E1$3>ON^0G:N`Q;>=1GUJFEPO
MJ&30ZFHW4EHZ\\WAH`T`:`-`&@#0!H`T`:`-`&@#0!H`T`:`-`(/(I;J7:QJ
M2E&6*4S=T8J11]";$Q]H+1X]JD]?T>NNV4E!Q]=AQS&XR]-HICAB2O'>MJR\
M(LZRO]0"9;+D$BU8`&3EU411X_#I\H'5N<%\7#4O%G-*47\/'6_`SLVKEF[W
MI0E>S&.]%%-CL\?"01]59ZA6L,OR+GV_YQU"22M/4M1+;;M+6]86!4H26H:-
MN9(DVCE.2=NX4D/0I"H'OM3%NIP=O0#]E=%%PBMBM@@X*,'M=L3FFJR1=@7Z
M<E>B\3+QM&O)^:)&8#LG!)::="QD<GHN[!'N8V3C<YXVT+`JU"]2PMI9NAJ\
MC9ED2JJ_50IV;,L!"15(^G]"IL1M[F/YR3'3_-`AM*^[CK9*3=WLU(UVJR"U
M).SFS!95(%EKL1)R!*`BM%^9(!$"I:23]+?\XF4Y6EK(:G:>HZLV46G))ML\
MC.N_CZ4`,"(A&&CD]JN*T6$)S\S?#Y5U64]&-M):<M-MQRQ69G:<T[<#O(`;
M7)V).TTNS+=V%5966M7"G:!T?KUQN8V:TKLMBRJ>A]ML$<]NRM>"*01AZSR"
MPE>T6$ML@@&[;VC(4-M[4>.O0`9VJ)2C:[4O$AN%K];.B3>W(37#&E:](?JF
M28[HZ,83:+5HDX:8H/RX\X7K_P`XZA70PXZEJ)=\<>&MZS;))2;C=M.7M4%=
M7Y&S8CS;6QN#JZ[@=UB7*[!C*=.F<+J$G&=^&CV$RA*['3[3ED>U#/5CJPK'
M<KDO6XL@2+6C9&;W$LO<N3#W?,2!GX98VDXQNTZ?_DK-0A?HT>I+N"[XX]5L
M21R3*[B1(W,HC.XGM%V+,S)Z$G_D&LN9",C3EW$/\XX+A>2YD-R_.T^&CAC6
M2-XC'!R.T'!;ZEVW(F>@VKJ*:,R^A=L^%W?$M5F4*53CJPMW#GSX(/"+(1S(
MF:NV0G<6'U$6#GXYU4E$>O\`_7$O_>^I_P!FQ:`D_P!P0A\.Y,.4"F-?G!()
M[BX"X_;)Z(?0-C.@$_`3"[]JITEE<.*=N*8K^;/&1W!M;&=TBCUQZGTU+BID
M)K"?=["N#'P3>)4;7)L]^O-?E%F..PA1601@R1,B%-I]N_'^#XZJ\N,GP4NR
M!95PFO&>_P!I?ZXVC;\N.GZM20?=`&@(]:\U\><M7I%^;EZAH..C^J7H<,K2
M#\D,OQ5GW?HT`@_@W)V;QM<7XPG#O))W_JGO255E(.X&S7I%2[G\'W`=1H2;
MT\*\V-Y;5KSBZE$@-8XZ*M3(!V>]4L-#NV[^H)3..FA!UU/#.*Y'AH63FN4L
MU9ZZ_P`/LQ6FJ&*%T&PQ+56LAZ8([B-C_P`F@.=/M%XK+7>'EY+7.EHXXEL<
MC(KV4$3;UVVHDAL9S^+GITT!&ONMXKX?!_!_J^U`RQRP)+84S22(98?8\[MW
M3EY!NRQ]I8Z<CJD2J^6?D:?*^_G@Q6K06H5XRF6GL3)"^TB0+OC++W%[AB(!
M##U^)U*QE5V7=LR'A-=M_9)[B>_<*M5D\2Y22P_;05F1BPDDCVLRD[HD^;.T
M#H,XSCUUVZ9OG4-)PZA+D<=!3OE_(?Q+GK27^3DEC5#%Q$<:.U&.>2,PLAK+
MEV6>")W0%@HV[LX;7J9-/+2H+;I[]3/.S7S5.+V:+,@0FEXR2S'X]"8K5&&(
M3VH[(6*W``D@>S&5AC*;$]H4[BYR"QP=;(<T.:YZKMAEC"/+AO.KRFU<XZ>O
M>FY99&Y**2U+$T(>":2S&R-+$L00J)$6.5MW4,RD@D9U7*2JE"[PM`G-;IG&
M_P`3&]S<]#C(H>.Y&.^]A<<94@=;<T=M[22S.QV1;Y)&50&9&;`'XX"G+BXM
M0TX2@*J^503]L2V?M18@OY-:"+^A<E525-LB]C9QTBM&!LC)ECD9A([C#,6_
M1KSNL4+\4_\`D>ATKC=I7`N+7EGHAH!7X_\`S=[]^L_Z0ZT]3?3\M/`Q=%=7
M\]7$::S&T-`4_P#WJO\`A/+^_P!3^4="4>-7^1OU'0D];\X.._W=\3#5F%AN
M%J&:7$869%@CV*K'+Y4D@G]G2.L3M'P)Y]W-B^+QRM*8$2?=+(A99-BPRE@C
M(&*_I_1G4$)-GWR2>JOVZHLT:29BHO!!*`ZL5:)EW)^TH_:&K)$<T'?!C?P%
M@WAO$L%V@P`[<`8ZGH`O0#\-0(C_`$`:`-`&@#0!H!9XS_9[COW>/^2-:.K^
M[5M9C_C_`+%'RH9ZSFPY.8Y!>.XFYR#QF9:D,DS1+ZL(U+;1G\<:M13S5):2
MM=4$V4OXJ9>8XOGH:J137N+Y>\(4F6,SR3&9I4KQ-(0&62OO4+D`$=<KD:]7
M-]UTQN=*]O>>;E>\G"]5,X&YM>9OW.,Y;D;?].N-#9KQ.Z+5*F-4K23P1R]X
M9G]\0.W>?@,:O]/E2=*4EWZ]6TIS\S@VYLF-3CI5K2$/9H4:$\E&2.`PQA(F
MRS3/E*K()=L>\J5Z_+D8.LM54\&W.UYH5,L4E*UQMH<#2X:S%83@(H[,E?OT
M;%EA/;CDA+3&&(2"0[U$FU%[F<#ID>BK,=2AS>1-.6J7\/F2WPR@L'$I;WAG
MO*DQ"D%47;[4RH16VYQNV@XP#G:-9<^J-4-!HR:8*.D?ZXG8-`&@#0!H`T`:
M`-`&@#0!H`T`:`-`&@#0!H!!Y))4-JK%9GW`Y>*FP'9[@($<UELK^4CD#'Q8
MCU.-=LI.#A;8<<R$5&VTX+7Y$S`=K^,;1-R-R7:]>L(P52TV[Y7*`]N,-@9/
MPR3=3^7#7J*.7S8ZM9IEABCI*S3RU>*GC,K/)%OLO,)$/>E#*^9I.G9'0KTP
MN0%%DYZ7N]FDAJ6JUD?*]:X\\5>K"L%N!=U:NV'BX^.0'\R4DD26YLG&2<9/
MPR6-J$7=Q]`DXP5_#U/JBC0G,L&\"N%3DK<C&9A+)@R5:Q7:7L3/\[#KZ?H"
MIM3[/-ZD)+Q\EK,KU6M#%%6MTG,!!'$5JS!'RV`]5QN8[W7)DD_R2_N`SNBE
MMS3V^9-22DUL\CE>Q?6\D-/9-RS'LO+",0P)&035KY!"QQ].])C\%^;"K:"A
M/X;3?@5BXROM)>(3S0=B6>:4V:UAB+%C(C?D9$!)BB).(Z<0SN;T(SZC)8DX
MPLO_`*#=M/H9/#-8LU;%B.O;MS0H:-:(,D31@]Q99PP!CKP%@`N/>P!/7`",
M$TI*V]B$6F[[;D9P<C*LCGCK"R/*C2\GRUJ,;=J_)9!)PL*X80Q_M>ORY9H=
M.E;%X;=)*JT=K\?(T3JA@C@PR+8;?1K3/LFDD=@OU]UV]#NQVD(^;`QG`2RO
MC;8O$J]%MK\#<18$['(@M1#O*EB0R1<;&R[1+.[LP:S(ORC.%Z_#):LH:N/H
M6G;#U-A^E3AS'&SUH%G!Y-IMLUF.RH4[("%/<L2N?G!)4^@!P`GS<-GD)<O&
MVDDO!121<7#&]9*87/;JQG=VTSE5=OB^/F_3^.L^8YWQ.^6I70*H^XYIP>=Q
M_1W/J.=L/6DK<4U..51)VV@BW33,BA&W$X&<'7-TQFU2UVM[O$ZJIJ[F6N21
M/O/1(/![`D`$G]%W@>@;ZB+.,:DJ1^__`-<2_P#>^I_V;%H"9>6QUI/&^02R
M`:YB/=RI<;0022J]3_@TA$1A;V$6\?;QNI]LKC<;8K<C7,,XFF@4QK))*6V(
MX0=P'WJF2,Z<KIOXKC<2ZN:Z/:GPO(I5XVC+XGQ3<CRD-2B+LTLL=N%D>6QE
M0K#M_*(P,9P!^.JTTQ4*>6&U;KUV$MP<W5'8]]S+J!!&1Z:L5#0$2\YBCFGX
M^#F8P_A\HE',N9#$B2#:U<V",$P$A@W4#.W=[<Z`;\ES_`\)2KRRR*J6W6"A
M7KKO>>5A[(X43YB0/U`>I`T!PCB?*.4_.Y'DWXF(]8:7&[-Z@]1WIY5D#-@X
M(50.F0=`*N=K<WQ:BAQ_+6^6FO(RV*$YC%A:_P`LL\-B)8>RR*3LW##/@=-`
M32I+!-5AEKN)8)$5HI%(8,A&5(8=#D:`VZ`KG[O4WNS^/U%E2,SV3'MD,B*V
M^2%<%T#;=^>WG\7!U#4<(]WBF2G#&'?X-'-YWXCY!>Y?BIN/XU;*TZL,<%GO
M[34E0R%FBW$'=N[66QU4$:JZDL'W+>65+>*MWDG^Z)0?;[GC(%:,5'+JY(4K
MTR&*^X#\<==:^D^[3M,O5?;JV'F+D+\\UZ]'Q$4=.XZK4KTN/G:01+V`&C6S
M(>Z5V1DL,[1C9Z-KWZ:8)<TUKVZ+:3PZG%N$M@SH<CPU7BZ%F\9KN2(^.(`:
MS/8=U,TN$WC:8[`C9';>R].C(-4JIJ;:4M.BTK1.E-5*2;$G'T%KRV>4NK"H
M:&RW&ID0FQ9*1O+`>W*#$L,;D?*`W5/4X'6JJ,$M4;6TG&FF$V,.":Q_">4I
M0UZ-SCK*0;9DCB@41)@B03RL&2Q'ECL9AACEB5V@TS/B3FG;<=*+FI-6WE@?
M:CFUY#GW-61&XV3EJ\E/H(I0J4+$3*8$RB)O4XZ^XY.-8NKR^6F=_*^*-?2U
MQJE=S>#+]UXQZP:`5^/_`,W>_?K/^D.M/4WT_+3P,7175_/5Q&FLQM#0%/\`
M]ZK_`(3R_O\`4_E'0E'C5_D;]1T)/8_DD<K^`>#A#(J_PZ$N802^!5BP2`#[
M0>I)Z#II&%O81".@EWW%YVW0%.NDTM&&5Q(;\*12D[%?N1&.4J#D;=2E&4NU
M-K<5<O:D]YI\PCAF\'AOWFBGL;Z[4;C0QAXEGECV$(Q*;L8R,[3J.6+NXP[K
M_$LJX8M#_P`'B6+Q'BHU``6!1T*L/CUROMZ_HTA`B,1YH`T`:`-`&@#0"SQG
M^SW'?N\?\D:T=7]VK:S'_'_8H^5#/6<V"?S*>2OXCS5B)VCDAHV)%D0D,I6)
MCE2O7(Q\-=<A1KI6M'/.<*'L*$\0\.Y2WS_-^0\=::Q0-N&\\"]N.&:*>5WD
M69I0QVBK,Y#1@]<C&1KV<[/2III:G"%NT\G)R6ZG4KHQMV%H2>.\76XVS;JA
MN<J6ZD5VJEX;Q++$ROEI8XED$DB"+!=B20.G0Z\]9K;2?NM.$K;3<\M)-KWI
M1F)N-Y3E.81.,A;L,DLT5F.":6TI>*,!8'>19(7[90#WR@R`[OU]:J%3/TMW
M2.5-3JEZV\1JT?)V.<X_Q[DEFO0R*T\JR)722*&.<#?(G<E5D9D7:P(D7=D>
MAQRBE2ZE+OMX'2;J5+G:VLL9$5$5%^50`,DDX'Z3UUA-I]T`:`-`&@#0!H`T
M`:`-`&@%\'.\?-SEKA%9AR%2"*S(A4[3%,6565O3U0YUT>4U0J\&X'-9J=3I
MQ0PUS.@:`-`&@#0!H!)Y%%R'NEAM014^P\=N.R`T81B-TS*W1MB@^WT.>O37
M;*:T3.68GID1XF&)($V!8V834JML[=[LP47^0)Q@;L=J,]<X``/R=K>B\3C;
MU9W6LU+$CI*(.4$6_E;[.36@C^43NIPK2NJ?EQ^B]?A\U%-:L%X%G)Z\3F%Y
M(*7T<E.6#CI9#)+8*2-;!*!HIF)7!L33%=@&64X&,_+;EBXQGN]B(YH*$);_
M`&F4%:X]A:]6-(+E=,0P@AH>.CD'3W'<'MS`^O7&<^GSFU"+NX^@2<8*_AZF
ME8(:L;A2T+1@0<C<B9I9#*YRU2F3[FFE?K+)^/Z1[)C'P\WJT$0AX^2-X*-Q
M\,4]425[2]OC:G'RCMD;ANIN5.&_F]TDGIC<,@?-&,G=?'B3A=LAP-,IM-'9
MDCA2_-E:]FTH_)B974K7K)ACV8&&9F`)./Q'LE0EA:]ZW@0X[;8;,3&O'4+U
MJP22QQUZ3MO)"BJ]YHQZ!,KVZ40^4+[2/T'+FW-XK=_]!0DL'O\`08WDM(T7
M'6"MVS`W<H([80QI_P#9-T*%4)$3A1^TP_'Y:4PO4M/DB]4;G.U[-,-FE_#I
M)*;I):,G?N\U<$>8U"D+:"$EMK*66`8`Q^CYI:<9]RX>9":A+O?'R-,9HP*C
M6T<5H@+5;C7WF>3>ZH;=K"L3.Y;\J,XZ_P#.'MEQ=W?X+5I(4%?W>+UZ#[-+
M8,S232"O8J1@EG/<AXR`K@%F.[NVY%_7C/X?.27?^;T#;[MWJ27Q^%(N+C"5
M7J(Q9U29MTS!CGN2_'N/\S`]1KAF.=\3OEJ5Q!?,U\AL>6K'9X2?F/'(S&OT
M\<->1#&T3&217=TD65)=NW:1TUPJJHC.3TPJCWH[4TUPBNZ*AW,DGGP4>$V0
MJE%!JX1O4#ZB+H?7TU<H1Z__`-<2_P#>^I_V;%H"2_<62%/"^4:9BL9C53@`
MY+2*`#GX$G!/P'IUT`K\>AY6G]L4EJV%'+1UGE^J$8L%C$[$+M!7N>Q=B]<Z
MJH*<%X;B6HRGX[R*>2\Y;Y[QKBI+,$%FY)<GB2)5RA*!2)$<':R)D%E_:/3X
M:LX/#NCX1[0DZ;X]L/&'87$!@`?A^&A`:`YN2O5^/X^Q=LY[%>-I'`P6(49V
MJ#C+'T`^)T!`Z'AEWBX;_DT5^QQM^V3+%Q=2!):]:!L%:\=5E`[A/ND<;<O[
MF]-"1?#]Q//[=HT:%"G;LH[PV($#B1"(V(/>A>[6C?>H&V=D!_'0#&67S?A^
M,DL_1T5Y*[)'%,;,LEJQ<GE(5%4PK"(DC!/M56"KEA\<B"=<3QT'&<73XZN"
M(*<,=>($[B$C4*N2?7H-`=6@%W,>.\'S2PKRM*.X("6A[HSM)P21_FC4.F.G
MO:X$JJ&CNB5W]Q.;YC@_,.,_A=AX84KPA*@BDDBDP+2;6V]`/<H_7M/PU99D
M).':R'EQG/L1+/NB5_\`#[G0SF,&H_O4D,H'4LN`3E1U]-=^D^[3M.'5?;>P
M\Y<AS;RU[:7.+$ECD((*JRBNO])[4JY50W:FEL=Y_<_NP0-P(U[E.7-0=V[T
M/&=<G%7[_4SJ>+6OI+?&8@J5*-@PO%RTN]Y)1'W1`)JA<9@S)*RJF%/S>[2K
M-44[V]'KI"R[U=#3Z'-R<_BU?RF>+:C'-SZZ$6&@_/$3!`EAD+A<(58[B9"W
MH,]+4*MT=V'A:!%3H57><_)3I<XSCH>/AI4Y99UELJ=OTU!0X,4"R2@KU$@>
M4>YC^W\N!-"@W&+\;8;BM;BE"'E;$G_VGYH6/)(:''UDBX(<A!9JF$/'"KFC
M8238K[BSF3(D((7(Z#KK'UF7"B+^*'BC7TM<:H+X8^#/0NO$/8#0"OQ_^;O?
MOUG_`$AUIZF^GY:>!BZ*ZOYZN(TUF-H:`I_^]5_PGE_?ZG\HZ$H\:O\`(WZC
MH2>QO)K,L/@/@@CB,S-Q\12,`'+)3C<%L@^Q5#,R_'&I15[427[EM9/BO'/R
M"(EUK05HX-SIDPRG;NP'VX7/3XZJX.<.^'HB5%7/NCZC'GZM.UX!5AN2-%"8
MZ1(CC,I9E:,K'LR"=[#;ZZ-1T6V>`3:=O&7>,/"*K5_'ZZ+=-VH5!INT7998
ML8V,N2<@Y]=3.Z781&,Q]H`T`:`-`&@#0"SQG^SW'?N\?\D:T=7]VK:S'_'_
M`&*/E0SUG-A%_N;?EX_PCD;<1*RQ&#8P>1"I:Q&H.80TG3/H%.?3!UHZ6GFS
M$K7'#J:N7+;*1EN5^.BGX'D;THO7Z[+8@57GFDH32LQDE>*%0KU41I!&J#IT
M;_(UZRI=7O)27'OQMI/+;@N5X\/2V@91\_=/B]FK9$7.4><FKPI-;A:*/ZF+
M8))TJ1]N6.K$L+$'86=U)(`US>6N=->ZZ>&W2=/J/EA>JK7:#[XE:X&SY%RD
MS21QS`U*E.S8M-6VV828[3TV>.?\SV1;MHQU`!`TSE4J5VX881WD93I=3[,>
M^!<'BP-J[?Y!K%AFCE>FE:;N)B*-]Z.\3D^]MQ*N`,H1TUYF=))06D]'*FV^
MPD>N!W#0!H`T`:`-`&@#0!H`T!%?+ON=X=XM'_\`=&Z)+3#='2KXEF8'X[0<
M*.AZL0-:^GZ+-S?A4M)DZCK<O*^)ST%;?:CR?EO-/NMR?D,@6K5@H]CZ16;^
M:,GY(;'1V!W$D_X->GU^13D].J+W'VGG=#GU9V>Z[E`O/7@GN!H`T`:`-`&@
M$'D52*:Y!(BI8N0INCJR%4B`W@BQ.>CM'$1G:/CCX]1VRJH+5:1QS%%ZS@XR
M.!HYKUBR%XG:TUNU/M#W\J4,CJ1[:R@XC3X_J^:];=R7O</4I3"]W<?0T#OR
M/6KHC$Q+WN/I6F+=I<D_77B3G.>L<?X_@?DM*;[_`"1&A=WFS;9=*L\[Q3"O
MR,<?_P!V.1+[H(%.!W"N`K3R*J[$QA?U?-"FM6"M@2Y;<7;$Y;%?LU89)(IH
M(5??2J&,S-W"0>[<PRLUBP6"HH.Y2V1U!*V3B[;M2*M05M^MFUK$\=DV)G6&
M>BJB1V/=BX^$@8A3U[UJ5<`GKZ_A@-$%"&G?Z$QG'1N]39>M4VDMO2>6&C8D
M6.Y+%D233=?Z+408Q(S$]U_4'/7.2L4IRC?:;\":FIPNM)>)C9KH(Z];D:"2
MRN"G%TJDBA%`(#TV^.Q54&63&"-PZ#"M*>*>V/'R(:P:V>7F8PBX\[7*Y6W/
M"S=^\-JQ,\2MMK5E9XA]/"W\XV[J?TY*G"$'*U[UA1O5M2U&A52:)!MDMQ7V
MWJC';-R<JC^<DQGMTX_@/0CX$$;YNU0_+ZD7ZX[_`$-J&W+%42[&D_*PH)*Q
MG&SMPIU^IO#X*C>Z.,^[/K[LE8E.%UI(F<HWVFSY';6*`6:CF6EO27EKLY6.
M9O>K+:8[U?:4'Y,8`Z?`C"L:G!WX>7F0G**NQ\_(^)'`LM>M+'+&NY9*U'>%
MEB[C8%RW(V<V)7Z1H?VOTY*S&]VV+5I&JVUZR7\;-<FJB2XD<4[,Q,,;;NV,
M]$9O0N!\V.F=9:DDY&FEMJ9#_,/*^4XSGQ4@Y6I3J"N)91)4GM21L6(#2&(A
M4C(!.6_#4<\)-4STU0+<D;N;L41EY[()?![$@=9`_P!*PD3Y6S8B.X?H.H81
M'[__`%Q+_P![ZG_9L6@)!]S;L%3PN^TW59>U"!MW]9)5`_5^AOAZZ)1$;>TX
M_&N0MUOM>EV/N&Q%6L-"%7OR*5=PF0<=PK\?3.ICI\2(:/#V%9>2\YS7(^%\
M>;\TUB7ZJXQL(T(")`8SMDW;&8JC'Y>O7T.CEA#_`$^R`IDI37S>V/>7[7FB
MG@CFBD$L4BADD7J&!^(QHU`)Q-FH)%/DO&<IR%&%.+MI3N5[,-E'D5VC80N&
M:-U1HV*N.AZZ`U#QD6+YN<K<FO;237ID]NM&&&".TF.YT9AF3.0=`-Z]>O6@
MCKUXDA@B4)%%&H1%51@*JC``'X:`X#PS2^0#E;,HE2M%V^.@VX[+/GON3GW%
MQM`_`#].@&>@#0!H"N?N-QD5KR;B)V#%8-AME;,$([3.RI[9/=GO,G7XCIZZ
ME<V$>Q>J(EC#M_\`RQE]WK<U7P?DI88BSK6L'O!"W:Q`YSO!4H&^0GXYQ\=:
MNC4<Q;3/U;A0SSI!:''R1<E6:1?)99%XZ\J5MDE1[$2A.QB+MQ,FUE!52YW=
M/EW-[;49/X;[[SQDX37Q7&[R9*?C20#LW)K4L]D2V^VL*6Z^Y6FD5]F&61EC
M&,>U<]`W4QE1S-&'83F0HT^9QW[DD7&V$DXZE3>^BS\8(_I$$<4B=P,9<LQE
MPP#QX'JOH<:M33.]N%]Y6JJ5RGL-%KQWFK\LU6OQ,U/D^0G*1QN91)NBCC,]
M>=V7:0<B;<[#'4N?35EF4TS;BE;T(JRZG*$V33[$UHZ?F$].=#W*\U..-HPB
MAG->TV]\&0.I#'#*?<-IUD_D'&B*U\4:>A4*X;.#/3&O!/;#0"OQ_P#F[W[]
M9_TAUIZF^GY:>!BZ*ZOYZN(TUF-H:`I_^]5_PGE_?ZG\HZ$H\:O\C?J.A)[4
MY&'B9/!/"6Y*V:L2\;%L_),R,?HXR0Q!7'M7`'[6<:0;NAVQ\"(PT]D/$<?=
MM[9X>NJUT^FBF6?ZN9U$0D5)`(Y$(+;6'3(^.!I%:XVQYD$F[>'*S;Y5,8_M
MM15RJ2R1T%"RA#DYC9@5;:K84$E=2HNZW$AN%H>0\\%8-XAQ1#;P8%]P`4'J
M?0`G&H`]T`:`-`&@#0!H!9XS_9[COW>/^2-:.K^[5M9C_C_L4?*AGK.;!%YQ
M`L_C<\32F#,U4K.K(K(PLQE6'<!4D,![?VO3U.NW3N%??P.6>HT]W$JJ/EJQ
MXVA=HWZZ^>U:\<;O9A+6%KGMPQ3SE>X@7MSJSMM.5Z#W`MKT70XM-?\`G;R,
M"JDFG[YVT.,^@HQ'SGF^.G-)FFDL5Y"1)':>1BDIG!RCDJ$:`!U/3T&J55Q?
M_G2Y^%L9%J:8+_T:E:T!KPT_`4_'MU/CX>/E:!)(N*XXR2S05I'[BMDK&7[D
MS!I$R@V]#U'7G6JG5-QULO0Z53)0U(G?BW&#C.`ITP_<V)N+AS(I+DN2A8*=
MI+>T8Z#IK'FU<U39KRJ>6E(:ZYG0-`&@#0$2^ZWF%_P[P'E?(Z$$5FW06(Q0
MS[NVW<F2,[MA5O1_QT`\\;Y5N7\>XSE&V![U6&PXC.4#2QAF"G)Z`G&@&.@*
M^\[^XT7%>7>)>-\7?A/)<KR:1<E4`$KBEL<-G_W9,FW'Q]=`3Z::*"&2:9Q'
M%$I>1V.`JJ,DD_@!J4HN"(;@HGE_S[[T^4>2\A-0X226CQ#-VX(:_P#\1,!G
MW,Z>[W>NU?37U/2?QN7E4QKG5N/F.J_D<S,JY:)4G)X[]DO+.1BEO<SM\>XF
M`,]BY>Z.%`R66/(/^%B!^G5\[^3RZ94^_5H13*_C<RJ=7NTZ63/[13<'3^ZU
M_C/%B\O!BAVY[;DR=^6%E_.#$#8&9C@#I^&L7\@JWTZJS/BYN[4;>@=*SW3E
M_##O+[U\^>\&@#0!H`T`:`C_`)01))6J,386;)3BH_:;#J1@S/UVP)ZOT_Y?
ME/;*Q>_1ZG'-T;K8"=X'AY!_J9:M_D[*I8@+'\B&*+W?4R$_+%&6_+C'J1N)
MR2R]8Q4HI6D<H0<X-VF8RPQCC_K9R[<1)/&\\TRY>Z2PW6+'5-D*H#VD^)QT
M/M4RG."^+AJ6O2&I1PX^F@W.TTMF(!%CFC`GK5[&-M=<8^NOGINF;'L0G/\`
MAR5BY6GJ6HG&W>S;+9EJ?5HNZA9Z?Q?D"0Z`9PDD8`P\\RXVKCV_A\H:$HPQ
MT*V");A'#2[8LYI(:,,,*WZ]B.NQ9:-"`YFCD<;A).V=S6IMWM'JH)/P9M63
M;N[[8(K!*^WJSX5E5F"-#4GK*(#(K`5^/5\!:M=L$-8DR`[[3M_#T4M_CK>H
M6V:MH21\7$)!01XJ3D59I86+S69!\U2FQP=K/EI9/B<]?4J3>-_#6_!""PNX
MZEXFV6DLT].MR$4+2%9!1JUF'9`0;6IR;5+K%&47?)C#'(.!A3"J@FU;62Z8
MP3MJ-4D%RS4MVH)A(K82]RA#JDN&"F&N%RR58<DNP/NP?=\S"8I-)]WGK9#3
M:;W^6HUN]9(`\BO9JSDV!')[9N0,8RUFR0#VZL8^5<=1CI\JE..OAJ6L2MCK
M>H[[!Y"WR$,)D%JTN)J-=U*I71NJVKBX3\Q<[8X\?#\<L**"6A<=2+.+=N]F
M59:]:&:625HJ4#D\D]C,=J2?.Y+)9=Q.=JB./"]#^I='%[<-&PE06S'3M'?C
M\`AXN)%J&FI+,L+MOE(8YWRG_P!X_P`S=3U^.N68XN^)URU!70*K^[<Z5_)R
MLMN;CS9J(L$=0;A=8%QVKGO39&,[0>G0GKJBBKI=\]D,2S2=\^Z6V)./,49/
MMZR-&D+*E,&&,Y1")XO:I^('H-02:_+.-J4[7$30*0]_R&K9L$DG,GT[19&?
M3V1+H!CYV.+;QFS%R<[U:LK1H;"1F9D8N-OM`;U/MS^G4-1T=I*<-/8)*4W%
M<']IY3);')488)XC//&\:NTLK1[9$^=5#OM;]&I2TP[/`AO0GVE><G%Q0\#H
M=^-^+KR<E9FBC9$?+@(QZ%B!(Y!"`';CUU$-&^V[$LVXSGL?IO+[@ABAA2*%
M!'$@`1%`4`?H`P!HE`AN)GJ2`T`:`-`&@#0!H`T!'^=\-J\O<>PUN>LMB)*]
MZ&(IMGBC<NJMN5BN"QZJ1JK3LN!9-68F^\C%/!>1Q&DD0K6.ZKF0':('.%*=
M.OH=WP].N-;>B^XNPQ]7\#/.O'78))A44?P^"_)%)R$UL2M$T--3.LDC&..0
MR02A4D9)/=T]I/77N54N^^%W;YGCTU871\!['?XNS)7HO'':Y;D8)FY:TC*[
M6+$L:DHI(C1(K*LKJQ(W.F,_$\72U/!76U'7F3EB[R)/;I-PD0B>I<OR3QP5
M.*-2)&0N2W=9DE+>U]T>QAU!'Z-:8/FQ2TQ,\5RZ]$#NBI6H;Z)`;/U\;O5G
M<L!(TL8D:S&'`B9SA3(()B&S@'?G5'4FL(6A[462<91C:T":_9*C1'ETST75
M$@L5$LPRM'&XF2O;5U2,!"VW(#';U8,1TUEZZI\D]?%&KHZ5SRTK@STAKPCV
M0T`K\?\`YN]^_6?](=:>IOI^6G@8NBNK^>KB--9C:&@*?_O5?\)Y?W^I_*.A
M*/&K_(WZCH2>Q>=XY3X-X=8BBL233\=4600M)C\NM&R,54.NU.K'H,_CJ'5"
M]RM;2*:6[E;O1/\`SS@^1YGC8*]-XHUAE,\SRN4`"QLHZ!)`P]^3G1MX$)+'
MAZH7>2V)H/"N/Y*G?!BJI6![*QR13[VCCR&>.3:/7#!>F>NIJIC)I=T0GBH]
M\!]X9-8F\7XZ6Q*)YGBR\H&`QR>H&U/Y(T(8YT`:`-`&@#0!H!9XS_9[COW>
M/^2-:.K^[5M9C_C_`+%'RH9ZSFP5>446N\-)`L338EKRF-6"'$,Z2$Y(/H$S
MCX^@QZZZ954*H[>!SS:8TE'\UWU\DYL\=2CG>/Q>D]>M.S12Q]NO(RLB;99'
M=-N.UOZYZYQD>OEPY5%_UOC:9YE?Q."_H7`3Q<%5%;PBY1%>5X>2H(R2S.J2
MM;K)*=J@SQQ1HR$-VU^.<9UT>8XUIZ'N9SY94/6MY9_EN9X_'^(I\B)(GMQV
M/JWFFL3+*GYG=CL$+&5@#B3#'WKGTV]<&3+FJ:PM+6;<V?*D\;3U%G:\\W!H
M`T`:`-`1+[K>(<AY?X#RGCO'3107+PB$4MC<(@8YDD.[8&;T3\-`5#=X3S/[
M%T:G,<9S,?+>+D5UYC@;D@$O=/LE:D2JX0,X("C/IN!&3H21S[D_WI>7YNL>
M+\.K2\36F!2>[-L:TX==NR-5W+'U/S!BWIC&@@<WV0^S'GU[RGB_,^1C-"E1
MN1V6/(&06;2[3ED4AF_#K)C0,](?<^*W-]ON>CJ*[6#4DV+'D-@=6QC_`)N=
M:NB:6=3'29>L3>55#04+3\OX'[?4(J?`TJ_)>62PJ>2YB4]R&O(V6[4*@D,T
M8;!92!D=<^FOH*NGKZAQK;67@M.T\"GJ*.GIA2D\S%Z-@AM>0?<KS^ZE%Y[7
M(]Z15%:(=NNK$8&X(`BC"Y.[]>NZR<CIU&"7$X/.S^H<(ME_?:#[9GPSB99;
MKK+S/(!3:*8*Q*ORQ*W[6"<D_CKY_P#D.M^M5+X4>_\`Q_1_1IG\3+!UYQZ!
M"?*?**1X#F_KF%7^'VEBBACLF.Q/VV1EV[=K*TA]J@9SJZI<(J,-)5M1@X-Z
M";:H6#0!H`T`@\GL,I6O6>$7)*\[M%,@`EA1?>C3$CMIELGTS^*^NNV4L7<<
M<UX*\1BO0F:%:]+?7L,9*5$^V2V1@&:9CN,52,8"K\0!T/M![1:O?IZG*"=R
M]?0[I;SLLU*6+=R$%J2RLMU@T-6)/DLR;=BA`O\`-H/7\0=Q%%3CA##'46=6
M&,<<-9A3B2*J>0L.8N$)9[$E@D3W#(A3ORKM.020L46!^/P5=34YP7Q<-7FQ
M2I1?P\;8(UPD-8K5I-\$L2C^'UI`9Q3,F1%8MY8;YY6/M7/M_P`XZ.YOOUZE
MJ(5\++6]9I8116K<Y8UK4+%.0Y#*2"$MA2*P15WV;`Q^SE,XQ\JFV"7<O/4B
M,7O?EK8"9Z<D$,U66"HWMK4("KNC_P`XBLP?=]7(VUF)R`I/7YFTA'&>FV`C
M#"5MYTTYB>6B1US=+&MW:RAH*/3=]-`"K*S;1^<YQ_@]JZK4O=U<=?D6I<]?
M#5YG/:GH$3V00*LY[5NS7RC79%R7@J!F/;@W;FE?=CUZ^K:LD[L>&MZ]!5M7
MV>S5I-]F1K$5:%)X>0HV/S.-XRN!''(%.%68@';7@`&[UW-_@354H1P>+MBR
MSG#%8*V"/C2WVM0WJ-B!I%A+6^48JD4R992Q3/2&`@XZ[F..N-S:04(/NMBR
M(N,5WVP1]HP"3M2!+$E6259E53BW:<Y_IEGJI2)=OY:?JZ?*NE3[]RU(FE6Q
M>MF^[/)-/#7RC6JH$U9IBY2I"R`+8N;RH:;UV)C.?CZMJ*5">#WZEJ)J<966
MMZQ]PU:*OQ\:1]X[BS2/8SW6=B=S/GXL>OX?AKC6XL[4*"*J^ZTTE;R:8);7
MBQ=IQQ.DB-*>2QO'T\.%?MLN[;GU]VJ<L<$]L)?+%,O&&+[([_>187*\+/RG
MAT?%UD%.5XJVV*8D]L1/&Y1B,DD!,:$'1Y%PUCDVXDPNB?0<A#<EWY]R1*X*
MK@'W>_0&CSR`6/$^0KE))#,J1B.'!=BTB@`9*_X>HZ?$:AJ0B1WAN+$7V?>E
M3G>%H:]DQSW$*%7BF=LRHQ)"[E^)/32$OQ$RV*VCP(S%PG/^3>"5/X,8Y[<%
MNPEGZ@]N10Q17A'NQL(SN#>O345.&$=GMOX$TSQA;9X%SKG:,C!QZ#5BH:`-
M`&@#0!H`T`:`-`&@(;]W*<=KP+F$%<SVA4L&JP7/;8PL&;=Z+E-RY/XXUJZ.
MJ&8MIGZI1RWL/,USE(>:X*C8K03Q\E"IBY-.U')QIBC/2185[D_=>1HR[8QG
M]`U[ZHY*FG=AI\CPW4JJ5"_'0=S<39_B%SBN.6K2X]:\%:[R$0,JYJLSM(3M
MC&]RK*[R#!8=,#&J<Z@JG%O1M+<KBTH0-ULS4'J-R$<%]DI]WBX8S!$D9>`F
M:O)^4&_(.&>,9]I"$_M:BF<82G/SOQ)JBH1G*V`FX#EFFFNT[R/3FLP--+-4
MA$J!2&L=]X=Z+W%RJQ,&&,^[T&NN91"#4[0]ISRZXQ3D6/\`:B:?_?859:9J
M)7DX](1*5>=DCIVT#NZEP-^-VP'"_P#EU@ZQ?^<8QOXHV]*_?ALX,]$Z\0]@
M-`*_'_YN]^_6?](=:>IOI^6G@8NBNK^>KB--9C:&@*?_`+U7_">7]_J?RCH2
MCS#Y/]L?+?'/'ZO-\G6$=*X%V8R64NI.)!CVX(V]?CKG3F19T=,,3T_Y!<OU
MOM_X/]);DKE^/AWQ0L4>3%./8<C'MC?:S?HUU3:N.+I3O)']U^/63C*MN"$R
M7VF%9'RY4(\<A(,:9W>[TP,YQIS-8^1,$[+Q-OE,*1?;2I&)>PL,=#;+EE"[
M)(B,E1D#IU.W_!JJ1,9COPB5I?$^,D+;M\((.2W3)Q[FZGI\3J2!YH`T`:`-
M`&@#0"SQG^SW'?N\?\D:T=7]VK:S'_'_`&*/E0SUG-@:`\W_`'#8\S]P^>M\
M9Q\O)]OABZ-&S1M`8HK$1F"B2/++(,#V-^C!QKW>F]W*I3</>\CQNH][,;2C
M(0\''VTX&+?8NSKY/76'EHT)DB4TZY,:PNKH2<@*&'['IUUVS/ZL/<<NUG&B
MZGYU/N+%Y)I;ODW'P3<E6:C!)V$X4=B5N2BI%ORT1%BA2=9WD#A=H`VXR1K#
M3*AN#CIT1\(&RJ=2G+1IAXETZ\H],-`&@#0!H"(_=GRWDO$?`.5\@XV.*6[2
M6+LI.&:/,DR1G(4J>@?IUT"/(%+A_NE]WO()KB++RME2%GMRD15*^5Z*/1(\
MJOHHR="Q;5G^ZWS7CM+CN<\7Y=+WE7%R_5R5[<:BM,T8W)'$O7!##'O.&]?;
MH1$D'%_?SDN;Y/QKA'J/X_Y+)S4-/G.(GCW&2F\,A+Q&100ID5?TC\2#G00+
M/^Y/)R\9X%SUZ(*7AIR_/DKAAM)."/@VM'24IYM,;HF;JJFLJJ%\#R53^V7E
MGE?B0Y_Q.>#DX8G:*YQ4#[+L3*3C>K;0=PP5`/IK=_(?R+S'RY;]SB8N@_CE
MEKFS%[_`5>'_`'+^XWVVNM7JF2O%(>[/Q/(PN(Y,]-^UMD@SM^93\->4ZF[V
M>JJ4KD>O/MA]T.!\_P""%^@>S>@VKR/'.<R02$?_`,2-^RWQ_7I`$RU`*:\I
MY#CKOD_(7;7-<%Q%[B;'T]5+-5;%W"!2)-[2*0S;O;A#C5OI5.:I36NI\+A]
M1*3JJ[%XP+EU4!H`T`:`0^3&"62O4>);L\ONK4.JEF4C+RN#@0+^V"O7IZGI
MKME1ONUVQ..;HOMP.#CVM`-R5603#O#^(<G+LCBFB13O[3-N*5X>NT*ON/[7
MS,;U0N?8K8LK3&]=KM@CC55E[<<<36$M.9Z]:P<27'7UNWCCV0)TV)C\.GR@
M7MLU+64MMUO4;I4N*8)9[1LV`C6XY[&#3JKDAK;%6*/T_F4!]H_])M54-'F]
M7F2XZ?):_(U"RBUE^DDM\?!&6FY#D)AB2;O`+&^W&Z2>4?S:>B9&5R%74PG.
M#T*V!$92BM-M)LCB2`0-,HHJA*4T;;+'1>0#;-:RWOLRF08W'IG_`*1)N.OQ
MV:B80U>&W6835VIV;4L[B&SG-V_$A_*$V,0U!M!DLS]-S[>GP'RJ"<4H=WGJ
M0:@W;NULUPS.8&ALT^QQRLU:GQT883O*008HG!5F8]>_(QV_`>C.9:G)STVW
M$)Z5+1;>;HI(Q9*FL;W)+_1X$@)2E`0/=45O_=HO69L=3TQG""'=?!;]OD2K
M[HO=L\S0.P8W;+6(;;F.:6%=DG(2`DF"LN?RZJ==S9Z]>OS,9GW;M;UD>._9
MJ.SD6KSVXX$B:RSK')QU0XC@>$J&'?`1<00,-WQR3CJ<#5:8I<;:66J@WPMH
M1\J\@84EEHNL]FVC26N<L*RQJD3$-+@^WLJ/YE%;K^K+:.F-^&%L=(54+L<;
M8:#57%,('L+(])/Z:M)^MFT%8!KMH>I`SF.+'P].@59<<+[M2U+S(4,;K];U
MLEO'?5?2J;)+.22K-@.4)RN\!4"MCH0!K-5",C13&$RO_N)QGCK<M+/=YF"I
M;MU1$U2Q`EAPB;MK0,Y'89MQ]QZ9Z_#5>2IZ-46]TU$NJDM/9X^ZRP>-C6+C
MZL:%F5(HU5G8.Q`4#+,.A/Z=-I!P6>>C,U,4I()();C4K,DC,I61`P9(\*0S
M[UQ@]/74P(./[B5XI_#^0[BANVJR(=VPJRN/<#^('[/[7R_'4$BS@X^6Y#[9
M5H^/(%N1,+NQ%W(EL?F+@@]LRQ!AU'M)U#?;W,F$_;[2*\_PWG''<13X_@*=
MCCF-RQ>'T.)6AB8KLK-(&5"9&W9+*P`QHLWENWKP49Z"7E\U[W^<'#86U1BL
M0U(8K,QL3HH$DY`4N1\2%Z?\FIB5-V@#0!H`T`:`-`&@#0!H"*?=50WVY\A4
MHT@:G(#&G1FS^RO1NI^'36GI/NT[3AU7VZMAYCA9N.XQ(HI:2?PHMR5.5H72
M[,K%)5B);M=R/?'LD8#<NTCT.->^_>>,Y:CPZ?=6$IZR6<U>')\:91QDW(6J
M=*"SS2S]MJK3HD4KI`HPD84]99&.YE+!,YR,U%/*[X)N6FV@T5U<RNPF0VUQ
ML5SE(UY:[+5Y*[3ENBS"5->.0ED$$<:>J!8]CLK>WKD$*=:E7!>ZI)P,KIC5
M-SA$V>)WX:-F:Q=X>=8;M4UECK%4JR2QHBQF57CE*A]P8L3AF;/RDZC.IBH)
MW/M)RJH.+5Z)Q]GN,7C?-HZT=KZNJQX^:G(0J.(I:MQPCHI;8RLS`C/Z?0ZR
M=;5S9<80<^*-?24PKOC=P9Z1UX1[(:`5^/\`\W>_?K/^D.M/4WT_+3P,7175
M_/5Q&FLQM#0%/_WJO^$\OP_I]3K_`.D="44_]V^*YJM]L^!FN>2)R==A%VZ@
MVX_FR,JP]SY^;W?#KJSJK=ZMW\"$J,+;BVO*+%>O]O\`P:21-\O\.B6'W,O4
MU8>GM_'_`,FJVM)DP>%MZ'_W>,25Z;M>"E71I:!PSA%$G])B4,C[U+8Z>HU,
M6MEM=Q$M%NYC3GJC7/MQ3CB>*!NS0D3N-VTRC1,$#9QEL;5ZXSJ)X6[Q+&W<
M//$J\M?QNA!*4,D<>UNVP=1@GIN'0X]#H!OH`T`:`-`&@#0"SQG^SW'?N\?\
MD:T=7]VK:S'_`!_V*/E0SUG-@:`\R^27VY3R+RFW-%<L6(>,>(6*)>%89H_J
MXT,X78IAVC#'_P`_77OY5/+32I7X]F\\3,JYG4YW8=IU2QV8O$.]RU2Q)!Q/
MDE!8Z8#68F05(Q+W>T3W@3GW#<<D+\=537/[KOH>K$EKW)JZM<!IXO)O\EJ2
MCAS)8>>R:WF";4I58VA5C)%"24"R!MW;DP`S'86/77/-7N.>CW<7;VG3+^)2
MT^]@B_->,>L&@#0!H`T!"_O)XMS'E/VWYC@>'5'Y*XL0KK*XC0E)TD.6.<>U
M3H$=/$V/&_`_"^+J\O8I\-'3IQK.I=(U:2*->\4'0R'=D]!G0'-QWWH^U?(V
MTJ5/)J3SN"55W,8PHR?=(%4=/TZ"!H\Y\('.^1>(^0<75K26^,Y.&Q<Y#*K*
M:"Q2^U7P2XWNI"YT!+^9XFES'$W.*O)W*=Z%X)UZ$[7&#C((R/4=-2JFG%$-
M)R9XJ\M\)^XGVC\D:[0FM5J:R-_#^9KDF.2(/M19]N45F&,H_KJ"Y)*'W[X_
MRJ*+A_N9XY7YND=JIR%-#':B/16DP&]3ZDQLOX`==6HHJJ<*5%E*ZZ:%%N")
M-_=WI5.+^YW,UO'[$UKQVS79XY9XMLH12IB67I[65F9?ANUZ>=T;RNG]_P")
MU(\W*ZQ9N?[GPJE]IZ`\E3RAJE<>.258[G?4SM<5FB[&QMPPA#9W;<8UY7-#
M"/;`]/ECC`A]_P`7^XTT-EA%XV\]@EY'^EFWLQQD[G9ANP/CKFZ:&XO+G\WH
M=$W=SON]2Q]=#F&@#0!H!)Y'5MV@D$31=MT8R52_;FM!2"80^#MC*_-CUZ#H
M,Z[932G9'+,3<K,56+LEM17^E[T$[+)Q7&S?EG;%@=Z<+M"5D(RJN"Q/^`#H
MJ83CM=L3FZHRAL5L#3.&VS0K8B,ME3+?O6Q&8;5;MX:51D_T>'?A8U/7I[L;
MBTKV)8>K(=M?H:=R+%7@2,O'(XEH4K)VM/(6`%V[Z;4WX[46.IP`,X"S9^2\
M61;U?@=%RYR$D;W[CHMVBBR?3D96E&ZG-EX\D/88`[4W>W./Q)BFE7*Y[]6P
MFIN]WK=KVF]915XM)(#-Q]4MW+,MA%EFLB5_:X4JQ:Q*4`"GY0WR^@%81>E\
M/0M&"T>/J8"&QTE:-:LL$<@J0JT1AX[*@KW-S!38E[@QGHN>G3.Z8JV/H1!V
MP]3E^JMR//9NR-'9C9JMRY$1(8QNPM.CM'NFDP.XX&0?P(`6T%<K:WJ*Q=[M
MJ6LW7*BTH8Z_T;PU^0,:FA`R]V4)%@4\[VPBODR,N!ACGXDQ2XSC=CXDM0E"
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M>G&)[D#9BL11JY=)%P3N]W;4*0?=G7)UTJ^_6N$G`ZJANS_R42T^$5UX>BLE
M?Z-UKQ!JN=W:(0#9N^.WTU8J5_'5Y*UYE7GBKSGQ^OR<QCBFN0)$MI6D62=8
M0O>;\S=M4O\`'.-3A"</E\8W=A$:8WT\VU\+HDD^YO&_7^&W8OJEJ=LQS=YU
MWKF-PP#+NCSG]>HGAX^!,L?#Q$W"<Q:K?9M^1L3&S8CJV@+$)V%CW9$1E)+;
M<=/B<:F,]!$,%;N(-_&><X?P7C5K<M*CS7;,DMM`(8UPR$1`.[L0N3@?*<]=
M33F5N;@WW[W[0\NE2N7=N4"^QG`R<GXG520T`:`-`&@#0!H`T`:`-`(//C5'
MAO+?5LR56KLL[QHLKA&(#%4?VD@'IKMT\?J*%YQZB'(XGFGS;Q"YP[O=Y*U(
MR\38BJ\22PD6&K`VY(ID18I=TBR1R!U`SN.<-KWLC.54DK[]IXN?E.F;PN$5
MSD/*H>3J\F\JW':2*>Q1I1AZT9JHJ1QN`C0%T3IC#;?4YSKM330TU=MOGO.-
M55:<;_0W<SS_`!-WF;/,14)X&D>*7CKPWQPUX6!B13'"L?MAQA=GSNIZX.-1
M1EU*E4QVZ_:6KK3JC`Z[_BQOIQU'AW58;<==7EGZ26&979YA(RCYFCVK&&Z#
M:OS9&JTYL(NK#<6JRHP5)8?V)Y*B_(QT:29%5$$LJN2Q$[6)%$I=HV+QA=C8
M7'H0N.HP_P`A2X1=KC9T-2C!6O+^UXQZP:`5^/\`\W>_?K/^D.M/4WT_+3P,
M7175_/5Q&FLQM#0%/_WJO^$\O[_4Z_\`I'0E%#?<?Q?PCC?`^(O</S,EWD9A
M'WJ[2,XZQGKVR?R^GNP?3TU+IS%\3BK7$*NAN2@R^.>B6]]O/$Z]:[3ANU>+
MJR-#9LI`VUZT2J=IZD>K?X-.6J])L>[CPC;>3;[BBLO#0O)5%F5I@B,'>)U'
M;D)(:(;^JY&!^.JP5]O$<S5O5&CRFI->\+IU*XJT^.EBK_426I@@B13&41&9
M)5+?LACZ'KJ=23=MJ$<6.O#ZPK>,<;`LD,PCA51+6.Z)OTH0%S^O&D\0.-`&
M@#0!H`T`:`6>,_V>X[]WC_DC6CJ_NU;68_X_[%'RH9ZSFP-`>4>?^FBY#RBW
M/6N4G$,U>J]6))%L/)]:'>5]K;8V4C=U#8Z_#(^CRXPI2:=D>!F0C4YJS)GR
M]I5^WG%(DWTK)Y%4#7#OC[!$`E#H^47T&,]0,_CK+0O_`%?R,T5O_P`U\Z,/
M".7JVIZ<T?DRVJMV67M>*"&K&;:&,2=AMP+%HGQ&#+C(4[#UTSZ&D_=@U_5.
M5M7:3DU)P]Z_^F4[>PO[7C'K!H`T`:`-`1[[@^71>(>&\IY%)'WOH(=T4/7#
MRNPCC5B.H4NPR?@-`>5&^TGWK^Y<TGEO(5T#WR)(#>F[&8V&4[,6'V1@=%S@
M_P#GT+'7;_NG?<I*=:2&;C[%B8$V:QE9.R1Z#>5(?/Z`-!$>_;RS]R_M#YAQ
MG#>7]P>)<Q**B2"0V*L<\G5&A;.8VW-[QM]WZ<9`@]2:$%'_`'3^^M:M+9X#
MQZ"O?&UH;EZ=1+`&.59(T/MDP/4GI^O7N=%_$\RYLR6H\3K/Y7E?+ES>DI/Q
M_P`3YSR'D#'PO&F62S-B62"(1P(TA)][(!'&OKTZ#'IKU_\`QZ:G"GCYL\G_
M`-NHJG&K@7/]EJL'B_GM_P`7^JBOV9Z"37)H`I2&S"Y[D'<QN8*''ITS\->5
M_)5/-R5F0@HRUK2>K_'4K*S7EQBX3VZ"]=>">X0SROSFK"LO$\?9EJ<P[NB6
M!6^H6&.`H9YV3<OY:A]NX_M?CJURC+MCX%;Y3[(>)*Z$5R*I''=F6Q908DG1
M.V'_`.=LR<?\NJQB6@=&@#0!H!'Y%]"TM>(5%N<JQW58B2H"QL&WS,/2%&P2
M#ZG'0G&NV5'3!6WG+,AHB[;A#E9E)8O=BNR8=D]LO)RK^PG_`+NG%\?@1^()
MW]KM4/R__5MG&_7'?Z#"1(TM14IXVL0M+WZE&4DO`%<]R:9LA>PGK&C9R<8]
M!MIA%6]2^,+>PT55NFK8Y"K<2O5![L_+6D!-IQT,NT_+!$N>TH]3CKCJTN$8
M-3T:/720HPBG+3I]-!A36+ZFK&U:66'?]3!1;K,_7+7[I;'N)_FD/Q^&1[)J
MN<[:%XD4WJW:S&Q-,]Z:[*(ZEU%$LKL`T7'Q,H422XZ2VW3HHZ[1T]/F)2A>
MN/H&YQN?#U-Z148>'EF22YQBMB">!\O/.7<2*P#?_9,P;YE.1G!ZJ-L1;JP=
MN!,%RXJW$PIR58+D:7$^F:!.Q"D)!AXT3#;$I8AE:Q)GW,?3]1]RJ+4O_P!>
M@I@G/V>ISE1&UAVEZEVAO7:RX)=V)-&@HQ^8[G,L@Z[LGH1[+6]7X6C6WHO$
MUCCS'AYJJQ)=_*3C*[2"2?M':M0ASM6&'9ND<`*<G'M/OGFUW8^.TCEU7X>!
MUK=MM/&(JZ7K:&2,WUS%6C<#W0JR@;J\`)W[S[FQ@9^6G*MBT8^UEN9[;<$?
M,5+,5BR_;7CG0V9V9NTW)-`HW-[RQ2JI_9]#G_)/NF:ECP]1)SPX^AUS69[,
MBUK9@D=5^IXV(HZHBQJS)9MKN&Q,D*J,/F&?7Y:))37;Y(LW&3[/-C?QYXY.
M,21)9K`D9V^IG!!E)8YD1?V8V_8`Z8USS+SKEW$;\P^X:<%R+\,\:?77D"\1
M,)XD3N%3N^H,A_)"?,"00P].NHIIC@^Z_8*GK7D.[@\GK\#57BG@O\J#$)9;
MC;(W0_SC%HE]<>F%U3FA-J.R1?EC).&\B-#PCFX_(Z?*S\!PL<OUQMW+T$L[
MV09-Y=TWJH)W-JO-JK_W2[B\X?%3_MGWDM\VY'BN.\:N6>4CCGJ*HS!+G;(V
MX%5&T,<Y'3IZZM!.^[N*IO"_9$1<%R<,_P!N99O'>/?AUK0O)7JW(C.N`3(^
M%5SW0WN`PWKJ/=2D^9:R?>;G[KU0(5Y7Y8_.<1QE27C(;5V1YR41<1*%955D
ME#;656P753D_X-*N39V^J"5?M7HR[E&%`QC`Q@>FI*AH`T`:`-`&@#0!H`T`
M:`C/W+=8_`^:D:(SJE8LT`&3(`02@'QW>FM'2_<I.'4_;94GED-CR:U=A2U#
M)P_*\A&U*">KL`DJU6C=(IQ(JD)]-AB''RXV^[7I9+^FE+WDM.E^IY^:N>.A
MOP]"O_'>#Y#D&JS>,O*>.J7"O(K(P7Z=1AR59U=$[R1'.W=NRJ'=\=N;F*F*
MKO:E:VDR9>6W!TW1'GDGCB001>0\)RG$TJUH2E*K64DAI22$2.L:F)QW&SE-
MJ1L@`P,@ZXY6;'W:E4X:K[=L3KF9:7O4M+P$U;QZE6\0',Q754TY&AN)9820
M-R'>40Q2QH[AE16DFC<#:?CGTUU>8W7RPOX6D<EEI4<T;N-IEE?W?*EA.6Y&
MX*T866CQ\<S+9^I?=ME/==L;58C:.T#E1C6#^1:@E'%X6[S=_'J;>I%Z:\@]
M0-`*_'_YN]^_6?\`2'6GJ;Z?EIX&+HKJ_GJXC368VAH"H?[TT;R_:MHHQNDD
MY&FJ+^)9R`-"441P/V(\JA@YJ]Y9Q$]+C*/$7K=><2Q8^JABWP@[6<D$@Y&-
M<EF<TE%=AU:5,XTLN_R40Q_;KPVP[)`C<7`MF49$KI]+$!&,>H;T.?\`!KIR
MJ/L\?`Y1T^/@3C[FW'J<!7D2G7N;K<<;"W"9XH@Z..Z5'7V__J^.IECQAO";
MP<#YY/&U[P*MN5:IE6E(V$D"P>^-L[(V1U$?Z#TU$5;U$SO^WZ6D\+XA;;,]
M@5U$KL&!)R>N']V/PSJ4XS#4)$@T(#0!H`T`:`-`+/&?[/<=^[Q_R1K1U?W:
MMK,?\?\`8H^5#/6<V'-R:SMQUI:[R1SF)Q%)"JM(K;3@HK^PL#Z;NFK40BHE
M:KCS-]U:4M/S'FZ`M_32?PM7,%:$LDRD3RLK;A*4`!W,V<9Z_AM][I*HT4N'
M]7D>+U2A6UJ)3!+Q*>,4(+]^Y%4Y:U6Y-WBR'IE(XZRP_3KWI&)?\P[H]GI\
M2-9VJN=M)12:VXWG9-<B3;G/9@9_;N7B^,Y_B>-XS@:M]UD[S<M"%ADAK2QO
M$EE-Q:1D8*7E#OM5G`3X:=2JJJ6W4UJUZ/(GIW2JDDD]?B7MKQSU0T`:`-`&
M@*Q_O'<;:N?:N_-7>8'CIZ]Z6"$$]Z.*4!TDQ^P`V\_AMSH2A_X3]U/"?+>-
MI6..Y*O%;M*?_N7-+&EI'09=#$3N.W'J!@CKH02:URG&U*\EFU;A@K0J7FFD
MD5$11ZLS$@`:`HW[V^<^,>47O%_$O&[-?FN:;FJ=EOISW%BCC.XLLP81;F#8
M]3TSZ'0E%K_<GD;''>!\[<K[>]%4D"[AD>X;3Z$?!M:>CH56=2GI,O5U.G*J
M:T%&<'XCX1X=XK0\J\R7^)\AR`6;BN$C;`*$!E,@.,X'5L^T>G77O9O49N=F
M/+RO=2OJ/#RLC*R<M9F;-NY"OR?[T^0<C!_#/'X8_'>'!(CK40$E8%B>KH%V
MYSZ(!U^.NN1_&T4OFK?/5K..=_(UU+EH7)3J+(_N_P#V^Y'AX+?D/+PO7N71
MV:U:>/;*D:MEI"6]R]P_#IZ:\S^6ZNFMJBF:1Z?\5TCH3KJO9:'D,?D<E!5\
M?GK5[W<7=);1I(^UUW>U"IW>F.NO&YH81[8'L0CC`J#RBZ]?D.0I<ES?`#F+
M(2*ZD/'VC8DVD,J;T=AGJ.A_PZF&/+2O_P"SPM$G5&I_Z%QM`O+4$!H`T`:`
M0>4Y8UX')EAGRHXZ+I-;<=1&S>BP#UD/_+TZ'ME:=^CU..;HW:?0XS3Y&%8[
M]=8KO(,X$EE9-M>()O0P``J5AB]6]2S#J,_+?F3DY*T]I7E:FINVX6N'FC41
M`WDNRJQ63VR<HZD;V.,]NI$F=O[)Z>H/OO=JA^7UMLI?KC^;T.VV+QM)%-+]
M5.K/8J49PL<4`#$?46MA([407\I<Y)Z^OR5IA#1:Y>)9QC;O?@:@5?B9VAD,
M<<C]Z[RUQ05L0LC(9RC(590W2&/(_9/R_-/]7@L+8D8>-MQS3_41QQ"M"XEA
M(M5:,D;3R!2V7NW5&&::3_V:>H/ZB4LH8VU+5I*N.%M;.B1>5B6.?D)V2U%#
MEKTP#1TH6RK%=H"2VY?3VCIZ>GSUDY*[CZ%IXW\/4Z-YI0RP;'J<?!(86A`=
MY+:SKN7MD[)&LR-U9@?;N]=P.VM^M\/0F[4N/J?..BM&VPAKH;U.+;##&0:U
M!<`K64^C32KTD<?*/T8W34U#4^]Z]@I3CK6[5M-)L(WU<]MWG:<?3V;L!*L\
MN[(HT!Z[!@B1_P!9SD';,+DK:V1&^-M2.:)99HHY'6*2IR`3Z3BJF%$_9!1(
M2VU3]/$.LCGVM\/;A6LY;5B[7E5/8\+8'72DE:XTRH+5AUE#<LV]:JRQ(0(X
MPI4?319(.3[FZC)!*TJ4M&K'VEJ;_'#V&A3$R)N62Y6M/W1&1B?DY$^::48]
ME6,?*OH>@^(#6W?]?4C?X^A,..,K0N[[]LDC/%W",]MCE.FU"HQ^R1D?'66H
MTTE6?<>UQE3R+DZW(U$Y"?EJD,7'SK)L^AV@@-.<'MJ9??O/J.GIKFZ*7\5^
M'PS[^XZ4U5+X;L;Y=R+4XQ)H^.JI/(LLZ0QK+*GRLP4`LOZ"=6*D,Y;S#^*<
M_7X+C[5KC9*]HQ6[<2PNIDRZQP-W,_/VRY"]0OZ]6C"Z$=:]2(:5+;#P'WFW
M\2'C%L4*ZV[&%#1,"<KN&Y@J]25'7&J-I7DPB+O&'N\9]N.[)FM:K06IE-E7
MVJ0\CJS(0)-F,$+ZXZ:E51G?;3XATPE<5WSO*\W/P?#\QS%PUR]BQ#)#`G:/
M9W(T;C:=OL+8/Q.=2KY)+OMM(@H3;?\`M+S!!`(]#U&H)#0!H`T`:`-`&@#0
M!H`T!%_N@4'V^YXR!6C%1RZN2%*],ABON`QZXZZT=)]VG:<.J^W5L/,1Y2M9
MY<Q<-'_#X+],Q*M.62:"B"26PT\?<12^V1RI'KC.#KW^1JGWIP>.)X?.G5*4
M5W'=RDYX6O6H\;R,OT+V#:DI]^O]1#+"%E#U[D/M#NLS+(S-G`VC.!JE"YVV
MU/MWHO4^503E;$UT>6X7DN/FGY&+DI>#J6Y+MSA*T<45>65G/:3<NW9M5\NW
M4X_#VG4U454N"AS-0B1372U./+&XU1\M6XM+G%>0\:HXF["PD`<_4J:LY584
ML`3"66/:$5CM"C]'0V=#J@Z7->.HA5JF*J4F6'_=JY'ZN_S<B0-'`BUZ]6O&
MR,L,/YCC<6(E;KZMC&3TQZ##_*4P5)L_C:HME^Z\8]8-`*_'_P";O?OUG_2'
M6GJ;Z?EIX&+HKJ_GJXC368VAH"H_[T,:R?;`1M((5?DJ2M,<X0&0C<<?Y/KI
ML)17G*?;;QWQ_P"W'-\W3GM^8V%HD0WEL9IH9P4=TBB9FS"#N._IJU5>:ON5
MU+5AWXD4K+?VZ:?'NP+%YCD[U+[>^&)56-Q/QD`<211S9V58F4;7/0%OF89P
M/\&JN&*7:2HX-K9[&2+[NR"+QJM8;Y8+B2'`.X;8I,%"#T8'T]?P]3I&&,`E
MVG#<\AO6_MU1O\6Z4:T8B@L;I<-['1%5)L[55O1F;J!^G5L91?'NQ9$-,K=A
M+O#[4UKQCC;$\QL320J7F./<?QZ>OZ]0P.-0`T`:`-`&@#0"SQG^SW'?N\?\
MD:T=7]VK:S'_`!_V*/E0SUG-@L\EY27C.)>W$G<D[M>$+Z?S\Z0DC]($F1KI
ME4<U4#GF5<JB>>_N%>V^0<W]5R4M*Q;\=I!X9`G=M$P2,\,GOB"MNPS$*1T(
M^(!]KIJ?=I@HPK?8>3U%4W.'N]\C+RFER4OV^X;R&\DE#E1'4DXV>%5*32UJ
MH,:S022;/1&VML)].A!TRJE]5TJ:G'M>D9M+^FJG?*'8B0>-A;O*^.M85Z`K
M\I/0GF%I+%:1)JJVFJ.C'#?43Y]NW,;`K_DZX9LJ:H3]V-T[X1[%WG7+FZ8Z
M87ZHP[2]=>0>J&@#0!H`T!JMU*]RK-4LQK+7G1HYHG`961QA@0>A!&@/+WGW
M]T_FZUR:YX58CM4""Z<=9<I80JH]B2GVON.<;MN/QT)B0BK_`'=/O'8L1P2<
M+].DK!6GFM0=M`?VGV2.V!^A3H3$O?[(_P!W^/P>V>>YNQ'<\@*&.ND&X0UE
M=<2;2<&1F]-Q`Z?#0ALMOEZ="[Q=NKR(4T9H72SOP%$94[B2>@P.N=7RZG34
MG3><\RE.EJJX\R\!X;S'W0\FN3Q6FK\+QHCK)9G<SR+!'[(8ER?>Y1=Q;TSU
M^.OJ,WJ:>ERTH1JJGVXGS.5TU759C<?=1>?B/VF\+\9B0UZ*6[HVEKMH"60L
MN""H8;4]PR-HUX/4=?FYM[@M"/=R.ARLM247K)EK$;`T!6WDM.C)QO/\I):L
MTX*%R19`IA#.C",6DCR#TEP,;NN1TU')%RA_MM=I',L>)9.I`:`-`&@$?D,3
MR30)N2"&56CEEC95MS_M"K`6V[>YMR3N^'P]1VRG;#:<LQ6QV&KR0%S4JMF:
M&4'9Q*=)+,@P0)7SA8$]9/Q]#GY3.5B]^CU(S<%NT^AS\/\`5F2[;A:&:7M.
MD_+2Y$)E3Y8:Z@C^CP]=QSU/Z<ZFN$EN\];*T1F]_EJ.*O7%E>BF[!.1-VI&
M6.;DY`RJ9Y`WRU8]PVJ!U'P(P&NW#5_U]2J4=?CZ'7R$]@V7B)668,+56"UC
M92"[@UFPRMMV#_V2?H_65K2E"T]2\2U3<;2UOP..&60(BT[K4.Z6FL7[6%>S
M$X$?U6&7'1O;''GIE6(Q@&S6E1U:-15/0X>.LW/`M*^E<+$R46[T$#N6AKQY
M)>]<D."TS^[8#\>OXL(C%1TV@M1,(.&BT69WN3GFWL\L<$L(S;NI^;'31BVU
M("5R]F6-P"%_1T]`8IHA:_;J%54;7>IH6.:/AX#)))Q]9L5YN+@#&69VS)B%
MS[GDGW+O;<=ON]V<L+1][3KMH(_IT:K:3$,Z-*.D5R-15BE@P*U`OCMTXFVL
MO<?Y7DQ[<C_FJ7#>]8X\-1C6L`1=R6",B3N5;<M8'-R0L^*U,`KM4%BSR#'7
M.3T9A+5M&MD)VTZD?9Z5];")=V3BPJK4X6L_Y+]OTC8`!4KP?^T8CWG]&U"5
M2A+OMB[:0Z7CW6P1MKB\RS7J]M5PP^JYED+)-(IPL42C.RI$Q]S>AZ]?F;57
M"YKLMB2HWI]ML"0^.]L\7&\;SRJ[,WU%GH\Q)R90I/M5_51@=/AKCFWG?+N(
M!Y3R5&'RGG:$?.1<0;D$$7*QV:YG+H\)57KLORGMG:0W3/77.'RO:X0\SHE'
M\4M"C'=(FE[QQ[O$\?2H<K;XV"HJ!9:C*))(UCV*K,ZMT^.D:E<UVJ(A2[UO
M:*_JF]'YIQ]62?E9Z\/(%4L7+57M2F/?$S")$$I]RX]?PSJ+?`EOCX$25RA_
MJJ>ZXGGG\UF/Q2\E6":Q9G"PPI!&\KAG8#=M3W84=2=3S)3;@%2W)>'B)N"K
M\G4^VUIK%BTL[5YLMR+,TD*KN1I,NIDV[5[BJXS\-.9U3O[EZ$\B4KMD_'Q(
MAP_%^-<IX)57G>3KT(8+]@0J@+Q#.U&6,3@.6&<K)ZKNZ:<E55UN`YU3?%V_
MU%TC&!@Y'P.A`:`-`&@#0!H`T`:`-`&@(E]UNY_X?\W\AA^DD[X92Y*;?V5!
M7/7U&>HUIZ3[M.TS]5]MGG:CSO&[>/\`I(;O\9OO'7>^)GCIHTI,8C-5&)B/
MY09=I7:`".@Z^W5EN<8<J[^\\>FM2A>^XX4L<_4J22WN0GL<9`@DEXJ%X_;W
M&6)$1)3.RQ,Y(ZJN4PPSG5VJ6Y*>DHG4E-RT'/3XWEI[5F2[RU00T6D"VG=G
M3N%GDDC#;H2RS)UD<9+(0!D^W5JJJ4E!.96FEQFU(W5I^4FJ6;-9EJV#%1CC
MK-#OA-DR2&&*,2QM%"BP2;]K>H]V[.=5:2:3UV[RR;A%:BR?[OO'W*?F_E56
M4K!8@2J;:(K;68]PN`)$B9,NV[&P8]!TUA_D:D\NE[3;T%+5=2+]UXQZP:`5
M^/\`\W>_?K/^D.M/4WT_+3P,7175_/5Q&FLQM#0%2?WG^Y_X9+VT$DG\3I;(
MSZ,W<.%.?QT)17/E?%>+\1XAR5_EWB\&\JM598TXKAKAGCN%XB.W/64,B!\[
M3UZ:FBFJ'N.JFC17#=B1572W[T*ZM-*:AM=Q/_(.P/`?!=TG;G_AL0C7H`5:
MG&K'=W(NJY#`9ZZ*-H^!-L":_<EN*/"5J_*5Y[-6W9%<K5E6*4,\,FU@79`>
MOPS^GX:B&N!'8GM-O*TZ,_A=-*]*"W72*LU6O=<+'MPJJ78'!(4_X3J.173>
MR0YL9+;,[O#JCU^`JM-4BH6IE$EJI7;?#')C!5.K#`Q\-2NWM'=V#K0!H`T`
M:`-`&@%GC/\`9[COW>/^2-:.K^[5M9C_`(_[%'RH9ZSFP1>:@'@U!&0;W'`C
M_P#SH-=LCXNQ\&<<_P"'M7%%4?<J*YQ_F/D,U"2CQR'@X2M[D8"$C0,83'5<
M+(K,R$J!M]3@`_#T>E:JHIC%^]AXF#J8JNJ$%[N/@):7(\K_`.'7C]F+B1=H
M4J2U8K$L3RPQ[Y-UZ2<I[H4[81$<A@<-TP==733]6I1@V_9#2<U4_IIPBE9F
M'A'(<K_O;X]5NPVKO!W;T_(4H)*_4VZM8PK)%*I$6T-[B%.T?,S=<"<^FGDJ
M:@JDH=C9&34^>E.+3<=QZ1UX1[0:`-`&@#0'!S_/<3P'#VN8Y:PM7CZ:=R>9
MO0#.``!U))(``]3H"B;O]\3@8[<J4_&[5BJIQ#/)/'$[#'J8]K[?\XZ$P-'_
M`-,CC?\`Y5L?[7'_`*O00--?^\)_OYYIX=P]'C;/#[.8BFL2?4AUEC$4B&)E
M14R"7!Z].F@@7;]R[]BAX#SMNN0)HZD@4L,CW#:>GZFUJZ*E59U*>DR]94Z<
MJIK0*_LIP8XC[<\6I5%FNJ;DK(2=W?.Y"V<>X1[0?U:Z_P`EF\^=5JD<OX[+
MY<E:Y]Y.=8#<&@-5SZLU9OHR@M;&[!E!,8?'MWA<'&?7&@*I\EX/F.2Y.[S@
MBX%HN.FV_43_`%9=7@"[FDB#=IG5OERI^&C3NY:H?/+N@$Z;^:?RJ/8RV]`&
M@#0!H!?RS%>SBL\S2%H5FA_GH3*-N]"1A1_E,6&,?'TU>C:4KV$=.;K8:42]
MQ37M78B(I+SQ;G^DJEF&V->H=\]?3/J1WNM=K9POM?J1ML"01QP.GU$=U`L'
MC[+L57A*C&[:FVO$4RS%?=GXY53"TZ,;8EGQPM@?:G)(9[ST1&_(2Q*[\G,7
M^G/;(20Q]#M@B.2N6&YMP!]6T=%T;M%L0JKX7Z;8'"%5T18XWMI.38KP2@]V
M_*OK;M`#*UTZ;$QUZ8'RKJ^[PU+64W^.MZC[4L2&C"JV%M2A1=A>RN$H@[S)
M8GRS?%B(HR<C`_!F"I3T8;=7F$Y;]FOR.ZK2:&;:TJK3!,QAGQ/-?]!)8D"9
MW>JB)!Z=.GHHHZH[>&KS+JF&SCK\A;;G-2-IEK]AJ:&Q7IX[BT8W))LV!G#V
MI,G:I/3XG&YM7I4>W?J6HHW#LW:WK-\QAA"K'8V_0Q"K/R2C/8B)]D-=!N4V
MY5*A]@Z?A\HU"GVX>>HER[,?+6=;QS4^.K]]/I*DN^"/AHLO--'(OLCSNQWF
M8EI'!Z?CZMJM[<)O3;`M<M"T6Q.:OM[[+*YAL>VF;M<9KT2S`)3K^TC)`VR2
M=,''H=JB7=OVZV55M6HY(U$B]V1<I8'TM@5#M_B$J.["&JOMV1>X]Q^F>O7Y
MF-W:.&WP*VV[#H9;\FV&Q+%=1Y,5N*K'^C]V$`,DI``2O6Z;A^TWZU35982U
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M>::),-'M9,1[(R%=BK#<P]>F-5;6SMAQY67I3=RCV1_R6^)Z&````&`/0:L4
M(GQ/EMSDO-KO#K3>*GQR2H]@L"KR!H\';C_)/3K^.I;4)$0<9DLU!(:`-`&@
M#0!H`T`:`C?W'A:;P?EX5.&E@V*<D8+,`#E<$>OPUWZ9PS$<.I^VSSKYEPLM
M6U!6%JM#"8HXOXXF4$]:@'B)6PIGV-*Y6,;NI8>[:O0^YD5Q48/9MU2/'SJ&
MG#?L(W/?Y/C[TEFIPPH6;L*5UF=L+7%I%EJB)EVK&4KJ#[\GU+>G3NJ54H-Q
MAOA?O.+J:<E;#<=G.4(?&^+FAMQ16>2NF18K4S/8D6L<Q1PN>Y&N1V6/6/V$
M#X]!7+J^HY7(M6N13O9HX2F6Y)4K6S5J598Z<%G=MLVI9"RQ"N82B^UV9L]T
M#:?<S:G,<IJ+<]FWV$4*<K6VEH_9CE*4?D?)QUX%$EODXE>-NXDD`:&U(4ER
M,/+&Z%"V\AAUQG7G]=0^11P7D;NCJ7,X:?,OS7C'K!H!7X__`#=[]^L_Z0ZT
M]3?3\M/`Q=%=7\]7$::S&T-`5+_>=,`^VD9L,RUQRE'O,OS!.Y[B,?'&A*(=
MY?!/)Q?DW\7K<0OVU3BW?QNY`838:UVU^F*."9FD9_GW:/+BX<C52_J]<0LV
M"CSQ3_I],($B\@M?_H5X5'VI$DAXN%DE8`1N&HJ7VL)8VS$%WD8P=)6C_BT0
M3'[N+*_C-=5([36T$^2HRG:DQC<T?7?M]&SH2C'S)X1]OZE-I(5L/'3>.*8X
M1EBDAW$E3[57(RR^GKJ8,B,Q_P"$C'B?%^T)^0I*J"!DDDXW$G_EU`'>@#0!
MH`T`:`-`+/&?[/<=^[Q_R1K1U?W:MK,?\?\`8H^5#/6<V$5^X=F]'Q_$UZD'
M?-SF..AGZ$E(EL+,SC'X=KXZT=,E%MX4O@9^H;@DL:D1+[EUS>\HG2/C*G)5
MV\=MK):M,X6N3-M!C>-9#O8Y&``QQT(UIZ5PHO:]]&?J5&IR3]UE<\MRG'0?
M9WB)^/XZWQ?(+%&YOUF=(%E[HA,MM0?S$EC3\LMN)_R1ZZW44-Y[BTU:XR55
MI9*@FG:\G7#>-WI;'C'(5.43CSPQ0W4*"9VL<G$9+++F-4/=B:(J?1`6)&1K
M)7FI*I-1YO"[Q--&6XTM.'+XWEPQ2Q2QK)$ZR1N,HZD%2#\01KRVH'I)F6@#
M0!H`T!57]YT<E_X0<HU.2-(4EKM?609+P=T#:G0X;NE#^K.A*$WB7]VG[6W/
M%N(N7JMJQ<M4X)[$WU,J;GEC#GVH548W8Z#01&W_`-%[[0_U?9_VN?\`];01
M._@?[O/VQX+FJ7,\=2L1WZ$HGK.UJ9U#KZ$JS8/KH(CO[M_\-O(?W1O_`#C6
MSH/OT[3'UWV:MAV?;K^P7CW_`-[ZW^B75.L^]5\S+=']FGY42+68TAH`T!1_
ME'CW&<3RO*6J]+QW9'8-A8K5NPUMF8JQS`&V;B?E75E35"[,=/S^[PN(>8HP
MC3S?)/O+PU4D-`&@#0"+RB601PP22%*4Y*20P$_567/RUXATVJW7>V?3\!DZ
M[92QQW+6<LU]V]ZCB@XI)E?ZB-)[>T0-!5E[9HQJ4*1UQ[.B9#.^03CT/1=7
M=<+KN.THJ(WW\-AS0"*Q]0)&^M%T-%+:#=F2[-%[_IZF64+`@5E8DX.3U]3J
M7+5#=K>LJIZX[]2U&_DE[IJ1;#(9D4Q<"=R1=V'V[Y2P7;6CQGY`&..A]HU%
M,H\;8EJL.%L!9'+'/;F,4HMRD++<Y";"5RJB19)#C#K`H;;$H?W$=.FY]=&H
M+1JMCILCG&+TZ[8:#J5:TC=Q83)5>3ZNO0E?;/;8N!]58W9<HN1VH]I)P.GH
M!6?;IT:EXEI6QULWW+4CROE\3)BY&+@!'&(RMNEF.Y@9#N/;CSTZ?@3JM*\I
M?U$M^<\#CN0M7ALP"P:4$>V55ER\MQ9)`LEEI`KAIFZ=I`"5Z9`)4+>EQ@[_
M``U;-)6I0E=XZ_(^2,T$D444206X<+1IDJ4I"4':\A8[)+D_7:&;`)ZG&68I
M[./_`,H7;>'JS562:NL_U,^QZ[&"QR"2-.T*2$,:M4E06M2.3W&&?\'M59<[
MN[Q>HA2OMJ6LW0)77;.U4UT]U*/C(27^I22/*PH>X5W@-F67&/P;`+&''3KC
MHM@B5#1JAIMBSJBBP1)),$FG_H;<A5(,--@X"TX5`)1?;M>0[>N.N<!:M^<-
M.LLE[=&H*L\331K7D[=*S/U,>[^G6`/<D"8?MU5P2[?']62QK3?P]0GHNX^A
M(>#-L\>OU10RAF`$001!0<*L6PGV*.@W=?Q`]-<,R$9':B,)E8?=/F[E;RJM
MQT5SD^,BL1HSW*EF,!AG&R"N[*`Q^+OT_1HJFE)_EBN$7L+.E.])]L'QDBU6
MJP6>/6O80S1.BATEZEL`'WX^.1UU1DHJKB9^,?S"K#-PG$TN9'*2M+;%R&6Q
M\TAPL2C?W"O_`-74\DHPK[;O^7@.?"-/8I_\?$L#SN"2?Q+DHHU9W:-<!&VG
MHZG/Z<>I7]KT^.HC`6F+O&8[%S[:K##"DD\U2Q%#%_-QR$EU7H,;`_X>HT81
M#:MKSKQ#CJE=J[UJ222(L3)!+W0Q5@0T1;;)ZJJ>C?CJ*<RG%=\?\O4L\MNY
MQV?_`)+A!R`?3/P.I*E;>,P76^[7-6S)NJ/7=0!UZ!X]A+CVL/F`4=5Q[M(N
MZUN(4&HQ+)T`B\R\W\=\.X:3EN=L]BLF`J(I>1V)PJHB]3DD#/H/B1H"I[WW
M5^Y7FR/!X/Q8X3A@N^UY%>ZND1SN*(X14>,)(&SD;EP&],DHB2%=+PG[@<M]
MP.-@\D\[`O<>*MJKQ]'ZF2">O$%+L\GY"!YNUN(.[U/PZ:MRR(YM1S4O!ON%
MX_REKC>"^Y,,HO"1+2W7GCF@D2Q&F^NCF8.ZEA'\RCW8_2)66VB'F(D%7[K?
M=#PYED^XW#K;X4H#_&N*42ID*!MQ%E`^[<7WLHPIV_\`.JTU>633N+8\3\S\
M9\MXS^)>/WX[]0':[)D,C8SMD1@&1L'.&&H`ZT!%ONDTZ_;SGVKDBPM1S`5^
M;N#&S'Z=VM'2?=ICI.'4_;>P\P^0>5\H]+CGY+Z6U8JF>E<RD.^Q!,N])MD@
M[H;$T@5R@4'&!G.OH,O)47".D\/,S7!1&-.]QG$3"_#9;EKM>.,TIE[C&SWV
M*UIF:0';(@=Z\NXC&T!0=4JI=2A""X:?-%U4J7&]V]AP<Y7O6[=B&>:-XZ+U
M$^JNV%>K%&TN(.LB(TO<1C(Q3.4;/ID:MEM);8W7E*TV]D#BN^.26..IWZL,
M?(`1RUZ]>H97CE2#=OE]PCD78Q#E>N=RC`&KTYL&TY%*LJ*34RWOLS-7[+SW
M8T2=^5K/L@3MQQS+QDH($2B(Q;8U*E64G/7KD'7F=:GA^%_\D>ETCTZ?!EV<
M??J<A1KWJ<@EJVHUE@D'[2.,@]=>552Z7!WGITU)J*.C5217X_\`S=[]^L_Z
M0ZT]3?3\M/`Q=%=7\]7$::S&T-`5+_>=A2;[:1PR'$<O*44<^GM:3!T)1$?.
MO`?':OB?-VJ?BU%I.*BGBX<PW4535:ME[DT9<[I8VSM7&2=/IM*#^I!;8-^"
M)^K%WT1>J>PD7)\Q?XWPCQJ2U%6DXP<31:H;$4<I[HKIOP&RWQ4>FDG)JW^Y
M<"(.]-V_TOB3#[M36H?&Z\M81F46E&)6*##0RCYE9"/7KCX9T(A$X_-'XW_<
M+B^\8CR!BJ-QP8+U8&(L%RR;5QZG/0==.7$E/`DW@[!O$N+8;0&A!PHVJ,DG
M`&6Z#T]="!YH`T`:`-`&@#0"SQG^SW'?N\?\D:T=7]VK:S'_`!_V*/E0SUG-
MA$/N5<CK4>#63O%+/.<="5AD$>29MR[\J^Y`R@E>F?Q&M72TQ=7RLS=35!4_
M,B%_=BO4/D,,B\2G+UY>(LPUZJS11Q"86`SRM&P</V1ER=IVGU]>FKHV^6_E
M]Y<#-U4.:Z/ND/XCBN,L?;7@K/DG)'CS!#*\,L%62TR03LU:H\W:<((]Y^5U
MR3D9&3K376UFU*A1[8:V9Z:$\M.IP[.Q&SR7QWR9;%>YPMP<C:CN0\CQ5DO"
M*<T"13;I]IV]CMK&(B@`7&WJ2>C*S:(0J4)0>GUTDYF75&*<9Q6@N?[>,*_!
M_P`'RC'B&2NLD;!T9)(DGCPX)W$)*`Q],^FO*ZF=7-^(]+IY4\N@E&LYW#0!
MH`T!#?O%S''<1]M><N\EQ_\`%*(A6&Q1[G9,B3R+$<2;7VE=^X''J-`CS-]O
M?[R'E'A]).(>HG+\'`[_`$L5F5A:BA(.R)9P-I"G\4_5C0M`FO\`],A__E0?
M[;__`&-"(&NG_>!L^?\`FWAO#Q\4_$+%S,4\LJ6C()4$4B=ME"1Y!WYZGX:"
M!=GW;_X;>0?NC?\`G&MG0??IVF/KOLU;#B^R%V6W]L^(::8S21"6$DG)58Y6
M5$_1M3&/T:O_`"=,,^J!S_C*HY%).]8#>&@#0%0>06%H>7\P#Q0L<S;[+<`B
M<>K`V!(1W&L[2#N7&\LPP/35&LMN+Y9;8OL.B>9"7-#<BW]7.8:`-`&@%/+U
MK4EV"2M4#GMO'/<#!94BD(!2'W(5<_-N^`7XG`UUH:A-G.M.,D)>4MTKDSR0
MQLU.?;5:2'_XCD7CSBO"WPA7KW)/0]>N,G76A-;>&O:<JFGLXZMA]@CEAMP?
M4`/<Y"%ZX@A#Q2U(T8+^1G:%@0#W.=I8X(SE5!N*E<M_J$H.=[W>AR_D3),\
MDWU%>SN,]AF6%^2DB4MV8BQ`CJQX_'!_'&2UKK7>I6^U_H;9?K+$Z02UE,KO
MOI<40$5C'A>_9*JA^FA(_*##<W3X[0(4$K^WRUO$EQ>'9YZD8QO2E[[03@\E
M4D^IM\K<C';("F,R@$-L6/>W90E<[<Y(R2<<;G@K=XEVZ;;C0D]:.>&$UII4
M++:JTI@P>PS,0;EM\'+97\N+&<[>F<!9@]/IJ7F1%6XOR-@$D3]6^GDJAIHT
MG;NQ<7!(2>Y*6)#V&4XC3T4=![02SQ_-Z"WR^H-9[-?Z()-QO'R*9YY9@)+,
MZNZA'4%2YM3./3)V`CINP%0BXWNVX1E"Y6WFNPLL:QBO^1R%1D2KQT*"458Y
M@P[>2&C:U(/<S,P"CKG;G>6NYXZ?0/?HT>IG4JHKF+ZE87.VI=Y)3[8R<**=
M1NA9S@=V7UZ?`XV&]6N'B_!!+V^"\6:H/?`%,:"G-BK'5HET3D&B)V1Q*[';
M$HZRR],CIG:,M+WZ\+8(A;M6-L6,X*^^-Y0TDMV<K6?D*>SLUU1COKQY*F.*
M()[VZ%O@=V`.;?=H>.LZ)=^K@.?&S`>*C,$[64+.?J&7MJ[%CN:)>@$>?DQT
MQ^/KKEFQYCIEW%:_<+FJO%>4\A04HTG.UHX[1LT;$_;58S&#7EC';;HV=A(P
MW77*%+OY6\)P:[(/<=ES)2YDNR#WK>6IQ==*_&U*Z,SI##'&KO\`.0J@`M^G
M4[2I7,?Y_EZSW;,<56'F.W3@CI01RRRMW0I[X9I&4%'#'`)Q^&HY%>J:5KG'
MR)YW<VWJBN$/$EGW%KI8\*Y6)PQ7M*QV>HV2*^X^F%7;EC\!J2!+XSR%*G]H
MTO;'I5UJ3N/I_G!9G`:+)/J2-N=2M3#CBK;B*4O*.:\=\.XNQ!<^JGGO3K+$
M3WE*.R[8QO.\,N?:,_CDZM%N=4^R/C;05Y5<I=O_`,^!=`.0#C&?@=4+%:>`
M\0_#><<Q1V2/&QL2I.Z;3B699,''MVG=["#UP?34*J,HSMK\"SI=\)6U>)-/
M+?*.,\8\?N\UR,BI!3A>4(QP9&520B@`DEL?`:DJ>=H:W)>?VE\W\\A=^,G9
M_P#=?PY1[[$4<9F6;N(8B\<?<.YL>\9!'0:LE*+N#>"O)1S'D,]E."GL/R"3
MHDTE.G0I[9KIGC_.B6`@0_3QD@-+(P#;NASJKK;E3"=]\.-Y/(E.KPCZ'=7\
M"^XL\5>[0H5N/Y&K'%!5M<OR$MBQ&D87JBU$[2KM+1K[LXZGUU"YHQ;W(F-,
M()2,O+_MMS;49;MCB!RO(EWG^HXBP898V)=I"(K3>\/N5A&K9W+C/QU5JJ],
ME5*YHDWVRO>/\OP7(<2X@[CRNO(<(\$E5XMZA7C>I,6(7X94E&]0=63>B';$
MJUKCV0X%=><^(\_]H>=F^X'A(-G@K#L.;X:8R2K']0^YI$1`@6-=JX8MD'I\
MNI!>GC7DG#^2<-7YCB+"V:5D95T(;:P^9&P2-R'HP_'0@4_=,*WV[Y]6`*FH
MX8'<00<9!">[_-Z_AK1TGW:=IPZK[=6P\LUJ5F#EKT')"3COX)0=)[_'1I8/
M99L)W%=@'#I((E)=2!C/77T+J3I34^9XV[3P52XN,H+`YK'=I7:\G*1QK!%/
M,L\D;;W+X7$JN5L1J\CP':44@'/PQJRFI6X%7)SMQ&MWR/ZGD[7(591-=59(
MFXV6'MYCD+R,@B9D&!'(\;GW.FT;#C&.=.5!).[3:SQ.E69%MF5A(J_$27YV
M>*'<UE*A+32PS*RM!.^P102[Y"Z2$A2A]K=0H).-4+>9+4*8EB_9^W]9$EN7
MNM'+S4!^HM/OEFC7B["=V0Y(&X+\H]`,=?4X>MIA+^W_`+(V=)5&?]W@R\N*
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M&U<WRDI.]*/;`V>427N,\$KF$FK<@6G$S1A28\O&C@`%01C(P",_#2"OAWJ(
MOEXP&_B-R6[XUQ]N68SR31!VE("DDD_LJ6`_Y=20-]`&@#0!H`T`:`6>,_V>
MX[]WC_DC6CJ_NU;68_X_[%'RH9ZSFPCOG5:O-PU=Y8U=J_)<=+`6&2D@NQ+N
M7\#AB-=^G;578^#..>HT]JXE8?=BJ.1\SN01\3-<'#\2DJR4+`B>(36-\CS`
M20X4@'V==PR<KC.O0Z-\N6IPYJL=AAZI1K<KD<W&PWT^V'$7#/'_``J/QJS+
M-2WR"2:2I82;.Q612`A(#?`GKD=-34U]9K'G6]$)/Z2>'*]S$G,/P'.=J]:\
MKLTY.1@C'&PU!^=NY&=ENJU79"[1A=N=KD>N/PUVHYJ)*E.%\=5TSE5RU3=5
M_C>7/]O+5*"G/P,<213<6YC[D;!DL*OM[R-N9GP1M<L!ANF/37E=2FWS:=QZ
M73M)<N@EVLQH#0!H`T!"OO-XSS/D_P!MN8X/A8EFY.VL(KQNZQJ2DZ.<LW0>
MU3H$1GA_[M/VN'$41R?#,>2%>+ZXK;L8[^P=W&V3;\^?30F)U_\`T:OL[_4S
M_P"UVO\`6:")W<)]@_M;PG+U.7XWBGAOT9!-6E-FPX5U]#M9RI_PC0B)+O*5
M1O&>75P&4TK&01D?S3:ZY'W*=J.6?\%6QE7_`-V3D8I?%>3X\(PEJVQ,[G&T
MB>,!0/CD=HYUZO\`-T0S$]*X'F?PU<:*EH=N!<FO%/8#0!H"I_,?))N,M<KX
M]%/5$W*6!-_$YKR*U17V8'TY)FWIM]BH.NNB54(PJCAH[\"ONQO4,;X\/$MC
M7,L&@#0!H!#Y*ZHR";=+7LQM7%&)Y!-8D8AEC15*HHP#O<_L]#@9UVRK:CCF
MB98[LU@I`C23;EJW;=0`1UHR>M2HQVA%11F63U^`]VT+UDE:>M^".<&W:6I>
M)]GB1(TK-'WX'2.NO958Y>3*KN2&/!]E6-6]S$]1ZG&=Q/&U/J&L+/T/L*M.
MK6%BK<I:F_H\E>12B57@E]H4'(%6,QG)QEF`]2<*<I32X^H4YW^'H8".6>O/
M8A=+,#$33S3R"NW(F-@&*L<]NM%N]H]&_';U:8P<++U(A%1L_0^R+8:P5DKJ
M)YIGM0<?)A4W`X:[<("'M1D?E*W4],^[Y84(>/@O$F<?#Q?@:Z?)8>[]))O5
MQ'-:YJV$(3:&)L[-HQD$+!'G&!G`7JTU4W1[O#S(IJOAW^/D9*@6)>W$`Z'Z
MBCQU@YE=G;'UUM<[I)6(S'%Z_P"'Y%H^"\Q:'B_(^UH+/?BA#""U`/;W&[D/
M&13'H,N65[,F["KDA!T'M^>&UV?\O0E)VP]3,/)#QKUW#<6M29H;9@DEEEG:
M91[8VVJ)9IFZ[NK*#\&^5>XWQMW"Y0NA;O%ZSO':KTK=(6+4*"!>/KF,5XUD
MB;=613W#W6R&E8GVK^UM^:\)13EI\?(I&<&K:/,[7$C):G,C,(U[-Z]64D#K
MM6A0`QA0V`\G3]8/R4T</%EM-NQ&N&P;/&UHS32*M.J1I0JG;]?-&H&U2?DJ
MQ@>]O1OQ*_/+4&Y]NCU"<5=Z^A+.#E:3CU+68[3J[J[PJ%B5E8@QQX'RI\H)
MUFS%.Z!HRW*\IS[WP>5MY`C26$;QAXD"TWD61.Z/4O32-Y9.OQ&=5=32NEIA
M#\W,H%U2FY/WM%^YR+LHC%*N.G\TGH,#Y1Z#IC4`KU8J\/FM=UX?_P#2*7D)
M?J>0:OLA7CR7V%9C[#(4V_+[B<ZCW=/9/OA<2ZG=OEW:25^=B$^)\@)8Y94*
MI^7`0LA(D4C!(88!ZGH>F=21&S$'&\8]?[9VQ!(+"S12V/I[R_40JH<O)&$B
M2%F5@#@`=#J,)^6]1)QE+9/_`)$'\HMI<\9XNY7XNG7B2Q8K3=INVH9MI,*,
MJS*S3#Y2#Z@]1HZ4KD^_?-8";O?>O*HO1?E'J.GH?74D%=>,16J_W1Y>NL=E
M:`AEDC,A<INDDC+`DDIMZ9C"]0,YTYVY-MVMM'(E-)*VSQ(%]U^<A\U^[/'_
M`&UGC>3QZ@OU?,M!-VY&,<1G?&.XK"-`OMV!\Y`(SH28V/(:5V.6YQZU[%^S
M$M#@^,CWQS276]M2,Y#QPM6[+.9%(W*ON&-35>O/AXX"FTN.G5*)*+]F.CRU
M?Q*Q"O(<IR4,$?,\@66&Q8LD;]T2Y*A(MNXQ_+MZ#H-(*&/81-LL?B7X[B:]
M/@IN2CEOI&%CCED19I!U.5CSNQT.,?`:B+=XE@-&FB1TC9U623/;0D`MCJ<#
MXXU,!$KC[M6_X5-2Y+BZRU/(Y5:"KY&8U988P=[02D@[UEQC80?\H=5&II@Y
M8D.-^!(O&><XGS_P@6I:X6MR44M7D:#E9#%(,Q3PL1E25;(U4DJ;["V#X3YW
MY%]L.3GE,YF:WQ"N%[3Q*@.Y&SO+R188C:%]I/QT)9:7W6B__07EK/U,M<5*
M\DI,3;`?:5]V`Q]N=RX]&`/Z-:>D?_HEI,W5+_S9YHY%83?LBO<L&S8E,U"=
MJHIO/6C(CD20Y]B-(F(\QD@J20N<'WJ;E%;XGB57N?@.K/`<9RU1*_#6JTTL
M\TKI=NTXZ\0VA.\(8858C:(W:667`PN0`6!/)9CI<:D^QV[$=7EJI2>XB?U=
MM..H3VJ]>]1Y(RU3>E+D_50_E)(\DV]5:*-TP5&"OK[AD:8*+2DUP,\6DHXC
M_C^.\@X*E<K"-+%TS2TXMEC%Q[4SQA9X8Y48QE`0KKT,@;]&=<:JJ:VGA?JA
M;N.U--5*:Q)Q]JN'J4PW"21[XFY>)CN'6>)^.M(9&VNZY+JRX5OV?AK)U=;?
MO?V_]D:>EH2]W^[P9=OC*64X&DEF62:9(]K230FO(0"0H:(EBN%P.I)^.O)S
M8<S@>GE1Y5$9ZYG05^/_`,W>_?K/^D.M/4WT_+3P,7175_/5Q&FLQM#0%2_W
MG6A7[9HTXS`O*43*#U]@D]W_`)-($HK?[C<]]NO-_&.3JU_(YKMNDS\AP]>'
MC7Q6BBKD&KO4#$;%02[>FE>3RPGEKMO\V*,R,?=K9/O(HD?P?[>RRV9*D->I
M6FDGA3N/E*D;*@P5([A7;ZZE1PMN(BL>/KX,F_W*Y"U0X.M:KS30!+2B8P,H
MD:)HI%90C)()/7.W'PS\-$X6]40U$T>4E_\`PXK.JJ76.B_;EPRG#QG:W6/.
M?3H1J(DPM9/@,OMU))+X1PTDD0A=ZRLT2KL"Y).-OPQI+`EDBT(#0!H`T`:`
M-`+/&?[/<=^[Q_R1K1U?W:MK,?\`'_8H^5#/6<V"'S?=_`1LQO\`K>/VY],_
M70XSKMD?%V/@SCG_``]JXHI7[D6HZWFGE"\N]]GD\>K).G$F9(I)PK$B8JLB
MK"?</S.@!.O5Z91RZ>6'QXVO/.ZA^_5&/PX#CRSF.3B\,\>X3CZPL<6\->MR
M\![YL2U9:Z;^T5Q(Z*Y._MYQ@9]N=<\FA/,JJ=^&V)?-K?)32KL2,M6H1\+R
M+BU=N-0WU[$7(Q-%++5B@66G#EX9$`2?_P!IE"$.%.WKKO%NI22CHTQGCH.$
M$DYN6G1@6Q]M:%^Q!0YF[PT'"=OCA#!6JA41I+,O=LMVQN*+F./8"?BWKKS>
MJJ2C2GS3X7'H=-2W"IKED3[6,UAH`T!7_P!U/O+P/VZ/'QWZLUZSR&]DKUB@
M=8X\9=MY7VDG&@@?$^\_`2_:V3[APU9I:,&%GH*4[Z2=Y82A.=F1O#>OIH3`
M@/\`],/Q/_Y?Y'_.K_\`KZ"`?_3#\3_^7^1_SJ__`*^@@<$OWZXGS_S+PKB>
M-X^YQ\D'-PV)9)GCV/&(I4V?EL2>K@]>F@@>CB`001D'H0="#SS]@KD_%_<+
MG."MF2"6=)1])^R)J\N3N`Z`JI(&OHOY6E59--:M$^?_`(NITYU5#M`]#:^=
M/H`T`:`IWS!N);EN32E7NVK4=EA+9J\6+"(TRQ]^(SDKE_:I#_L?IU2JFA.+
M=$=<8V6!>EUM254-J5EI+BU<H&@#0!H!!Y.>TT<YQ7B*&*6['UM,'(Q6K`>[
M?*1\P]/AUZCME:/9M9QS;:=B%;\;/'7[7?::GL[?\!A=%DZ%6^E.PA-J]S,K
M_,5P#TSNZ<T]>GQ\CGR]VCP\P@2>>:5%B>P\A6I<Y&JPBC@`8%J]8GY88E4B
M1AABWH=WRRX+R\7K"GY^".<"N]:*"&(6*DH6O#'$BPOR;Q#H,+@)4B!ZGXCU
M)'SS..O_`(^I$H:N/H=4\L4Y1=ILWW?N)1L!DAJO!E'E?Y5%9-H*#;[F`.2?
MEJE#9Q]2S<=O#T%]Q9K-&7Z:Q'_2R72>V=C<A(F-TK_!:T0_FT/M;H#TZ->F
M3GAHP]2CFI8[_0Z$BE0PP=@)*N9X*EAB50CY^0ON3D^X'MJ?_/\`)$<;;$3#
M"VUFMDIM]2JRI:0F.W/R]I$<0(T2GO=1N,SEL1QGHJA<+CYDY=T+8:1*?&V)
MM%6*2%5;$':_I%;B)2QL2+(3NGF=2&^KE]QCR<J?TY*Q'VVPTB'LMB?6>19<
MNZ59*<81Y!AX>,@8`+%'ZB2W(N!GX?JP&;X_F]"?#=ZGTV88Z<E2L)8..AF>
M.:="KV)I7;'TM5U`9Y)"NZ20DL,D9SDJA.+OM-B,H*ZTD?('IUWL5GB,M^P(
MX#PU8*:NU495JLQ!4E%8/*_P&/A@$XN>&G';Y!04L=&&SS-E:.6>664V>VH*
MPW>7B!"E@V%J5,=4AC;YWZ?'KG)6&X8=GB]82CCV^"U$FX>:66A&9419%RK-
M$-L3X_\`:1_\Q_4:X5J#-%#D51]R.&X*WY=?O<G+'QU^G5B/$AH#*]\["2F_
MUZ.-FU,'XZI/!W7QJ:[IKQ.D)348W02WR9;?%O-)QM22:+L3/#&TD'KL8J"5
MZ_@>FD2L(%6)1X8_<2O8K023W!RLWU%T5K+QY!<@"=CVU*$M&WPZ#&CJP=79
MS/A<2E*5,M,%QC$G7GLMF#QR6U`D$IK21R/%9B,R,F[:PP"NT^[YO0>ITECY
M!1PCV')1YB=_M[_$Z"0TY(HI'VJ`((Q%(>X5R2I7:I.<]=)8*VXAIN^W$B*\
MYXMRG!<?S'/7)H?I;5BM#%5B18MP9=[O%M<>W*C=J?IQDFDMWB.>$VG4]K]"
MVP00".H/4:@%;^)/6_\`$KET::X;2BR,-&%I2DR0EV1@Y_,C&U<;1TTYFY1[
M(>(@M';%<(1(!PW`6;_/^>^7<M9EOR)%-4XY*T:O8K0R3'^:B5Y!M=4.X;P=
MI(^/1&&,"7W[N(W^V5Q^;\WXV5C#644[7/34X8E`,D[BA$"?<8^VJ.=NXG).
M<=-1!1DA%PFXDF\9N6>7^YW(R<C6KEN+$\?'6T@*3=L2&,H[EMQ`&,97KU(T
M?*W=O\+:"85)7RMJ\31Y9XUQES[\>&<E((TM5J%^4;"!.[0[%CW],M&HG?X^
MIU)`WYZ[9K<[R/*5[55SQM5BM9YY99(V`1G8U=RHN4)ZC_"=6@Y.'N]D.!2*
MTSV6X&SG>1/._:^SRL=>*W.U5[-:,Q=U.[$3M9(V^8C;D?XM5J2QN+T-X.V\
MCGA'D/$>*<-RW*\U_0!-4J\KRBR,5E:T\!5U2NQ]KNL`.Q?4YP-(IS1$&I$7
MYWSSA[/WR\%Y3B<7N/YRJJUK3B8F)IGDKN8HV>-%WJ`KDJWID=="2VON?#'/
M]O\`G8)',<<M5HWD`W%5<A2P4>N`<XUHZ5PS:=IGZG[;/.'EG$7^/Y+C*=WE
MJ%GE.*K1TJILP.JH\<LDL<9+CM2-L9`[."/>/^EKW,FM5)M)P;B>+FT--)M1
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MZN(TUF-H:`J/^]$\2?:_?,G=A7DJ3219QN42$LN?AD=-"45U:^XG@'+_`&WY
M[A_$K$/B5V2B<<9+"L32B-2TZ+93<93,@V8.K4Y"IG1"K;\6_P`"M6<ZI5Q6
MSX=Q87*PQ?[H^`3M$S;>.B$ACA2>1HUJ1L(]DG3#L`,X./T:HX8[X^'FBZ;P
M\B1?=JA4/%5>2<B*Q!,(UFD+=M4:*7.0K+@]>C#KG`]-62;NCLB5BL86[&;/
M,)HZ_P!MZ@V-,3'2$)<$L&4HRLQ5DP?;Z[L9U&WR&SS.K[62\Q-XC5FY+;MD
M`>GM(8=HJ#T(R<;LXW$G'KI&(Y8$OT`:`-`&@#0!H!9XS_9[COW>/^2-:.K^
M[5M9C_C_`+%'RH9ZSFP2>;6&K>)\I96.21X(&EC6)F1MR>Y3N1HV`4C+8;TU
MVR%&M(Y9[A0V>=>>Y+FN2\P\J-VS/2CY*FT-BU`+(K15(FF5'G""P2GY07]D
M'<?09U[>733313!1@]5^X\>NJJJNJ..WU)=RW$5Y/"([7'7+$$Z+`E6M4BDE
M9#5JQM;/;#CV%0XW*/V@N<'!S45OZD&K-R.]5"^G%.T)BZ#DY7CY3RN3F[J<
M?Y$:\[%X&KA%K-L6.4K*76O,[]B/ML-W4YVJ=7=-U'*HTQW^.)7FOKBX56[L
M"V?".5G5:O%SSFTD]5[-.8RFRRB&41SQ&?:G>5#(FR3'N!/KC)\[/HO:E.TC
M?D57+42_64TAH`T!#_N']J?$//J]:/G89!-38FO<K,(YU5OF3>5;*-ZX(T!'
MON+]MDI_9+DO#O#..,DFR$5JJE>Y*XL1O([NY4,[!222="2.\/\`W4?M]-Q%
M&7D7Y.'D)*\37(ELQ@),R`R*,1MZ-GXZ")U__1,^UW_O^4_VE/\`5:"(R\<_
MNU?;SQ_GJ'.4)>1-WCIEGKB6PC(77TW*(UR.OXZ"):VA!YGL._C/]X5GFG;M
MS\COD:'()2\-RQL/B,RJ&U].E]7HY+^G@?--_3ZR?XN)Z8U\P?2AH`T!3'+4
M>6M\UY#V..YVW']>ZAN.OQ5ZGRIT,(8'/^7D9.GU%3_54ME$=Y/)'^FE[6RY
M]"`T`:`-`(?)(E:5)&HO8C6&5;%E??V89!L?M1'<&E.?\GY0?7T/;*>LXYJU
M"%0D,4C-8=T4+5M\A$6:60CHM"D6._/3\R3.<YR01E.U_EXOP5GRNMN0-%1G
M2'N2+9GZ05^"IG\CMLH=:XE'LV!<-._Q&!\N%9%KS?'R$$_)6[S*8/+#9GD@
M')1J5AO6(P1O8.%2O1P5V1P.=S/D98>N<E2P5UKWM#Q=]KEL-''I(]"NDD`F
M^KQLK(<&_*@Z,QQ[*4*XP,;2/T$!IJOV;O\`Z9%-VW?Z&]K+VN[3$L?)22Y>
M660/'!7DA93]1$X8;:\>W:`,%F7U/N(B$)W6NVDQC*^W`Q>6`PAFS/!:?N1+
M8(C>_*,#ZFT2!VZL?3:F,'H,?*I0W;M2UB-M.MZCKN6;UFVK3Q1Q6D'?KU)2
M.S511@W;A!P6Z?E)GI^O)6M*24O;J7B6;;=I:V8-&]5)RC(L4<K23\U,JO9@
M;:$D)P7WRS`J80``$8#;@!3-_E;1B1=YVW&N)+26:B5ZA+U6^JBXH^\Q0]2T
M]ERWNMS?L9)P<_\`.;1P@XN_'RU$*,5!=GGK".&]-R`"V$@GC+I:E8[XZ0LM
ME8*\CGW679O<V#C('0;5)M)6GK>HE)MVEZG-2B6&HP*LB%C6M30,6DL2;CBE
M1/S;2<F63.2<DG.66U3B[=[\"M*@K=R.OL.CHUA(K%EP].KPT!C>`IL7=!Z$
M1QQ'K,Q&6(7X;5-8Z-L;;BT-.R%MY)N!F,O'*[6A<?>ZR3(NR/<K$,D0P,HA
M]JGK^O6?,4'=`[Y;E?$BGE5'R5N3Y,04K'(17Z\<7%3P6%@6G(@.2P+*03)A
M]ZYR/;KFZEC&5TDSHJ=$-<632@EJ.C72VXDM+$BSR+T#2!0&(_6=3$@K+A.-
MY2;RDW17D:E'S5O-D\I(D0VRRC`HX$9(_#X^NIYG=[W=3#OO(A3_`&1[>;R)
ME]PB_P#N9RFR3ML8U`)S@YD4;.GKO^7'QSJ"11XAR%/COM3!=B<205JDS#ZD
MX3<K.-CX!PN[V]/AI",G.VOQ&R1$9H^=\EX?C#0X>*7CHK5B6>.M&E96F1DV
M.XW'8>I]"<_'5&Z%)+N]XNE6YM]\O(N?5RA6WAK6V^Y7.2<A`([DB3!'R%S!
M')&(PJ#U&#\WK^.B:=UO$EQ5G["J:7"<%PW(?<[QZJR1F22&=:=X2]P-%*S)
M*C(T!E$@F9QMZ+\3C1-J[C`6M$G'VH@J49?%^36.*1KE&WPMNY'*K;)$G%NL
MD@&%#,N_H.NXX.=2TT&XC?P"_<J>?^0<=?E:-;<TLE6`NLJ-('W,0VU7!V$=
M,X_PZF,45<%;U\#5Y;Y34J??OPSB<"6::C>BD554/$;`5HW9R,["*[^T'UZX
MU4L?+?TW(_=7EN"K=J)[/'2&RNR)E+L(E[DC1XE9MO38[#`ZCUU#IM:,NPE-
MZX*W?W]@]YNS7\+^W:T[H%IL&HD4#21F3O2-G85+2*0C>H]#J:%*<H6V%:G.
M4]MID8^V_`\1Y#-Y%%9KM:X,4ZO".9&8K*T:O+859,AF*&QL+KCJ.ON!TBW-
MS)A"0@YB'D8_OOX[XMXJ'XGQWQZ*LU^C7D2.&59"\Y(@WHTF5]KL`<>IT!;?
MW(Q_N-S&5#CL=58%E(W#H0H)(/X#7?I?N(S]3]ME%>9VZ'.>4W*?T<?(M86D
M:?<FN-`7GA[C_3HQB2/:F[8KD;!N.#Z#V,A.BA.,+]&\\O.:JK:A&[20F.#D
MZENFM"[4GHUPTMVV9Y!6+13;E^JD0QS'9^7L'^5\GQUK;33BG&UQE2::@U`Z
MN7C;FJD/-\6EL,T4LW.UEGD-<RE_Z2L#R%YR\P19'SN'Z3C&JT>X^5PU>'<6
MK]Y<RCK\18*L?'42TCUJ\,Z+")8IH[BRRP2K*)9*SAB=T4HV8"_*1ZEAJ\>9
MX\-YSA!%N_916LWWIO"(JU9Z%N&R)(F61GHSPF)54!5Z,7[?S#J3\=>;UTE'
M;Q1Z/13<-G`NO@*D-/B*U2!D>&N#%&T;;UVHQ4=>GICJ!T!Z#IKR<QQJ;/3R
MU"F`PU0N*_'_`.;O?OUG_2'6GJ;Z?EIX&+HKJ_GJXC368VAH"H_[T(0_;`"1
M#(AY*D'C7YF'<.5'Z3H2BGN;^RGC7#>,<EY:YY._QDU>3^#\4M62.S!,8F.Z
MZ6'M2%NN1T(UR3G.JF&G\6K4==E/O;5!>9<'/VGJ?;;PZTM*&Z8N-KEN[6^I
M*`UH1[?<NS<V`3^'ZM=8I7\8'*>%MQ+?N-5FY/C$XZ@(I>4A86HJ\LHB!':E
M13DJX.6Z8_P_#1TRNBNSQ(523OA;L,_(N]6\#JI8@KV9HUI)-6L*)(9&#QAE
MZ$#J?E;T!ZZ=G@Q&$XCCQ2>.QX[0FCBBA22(,(H`1&N2>B@_#2$`-=`&@#0!
MH`T`:`6>,_V>X[]WC_DC6CJ_NU;68_X_[%'RH9ZSFP^,5"DM@+\<^F@/*_,V
MHZ_+^1V*MJPL5[B9A_1P)DF$TMIMKR,DICBVIN]A7./\(^BH452FKJO(\&MP
M=36*?B-_$*U:+[>V.(YAA5LPT9Y@)9$?VRV'`583U?>_9W=MU8^T;A@:Y9S?
MU>:G3X>TZ9*7T^6K1;P.#FG\9:KR4#0]R[P_TM>$">LL<DE"H8NW+$TBQR1=
MY_5(B02W75Z.>*>%4=.+*5\D&M$-&"+J^VGC[5ZK\U;@2&U905Z<$8RD%*)B
M8TC=\RMW"=[LYRQQ^`UY759D7RJ[Q/3Z;+@N9V1-]9#4&@#0!H!-YAY7Q7B?
MCMOR#E1*:%((9A"N^3\QUC&U<KGW./CH"L__`*6'VK_R.2_V4?ZS0F`?_2P^
MU?\`D<E_LH_UF@@*[OW[\<\P\K\-XCQB?D*TS<U"]Y9$,"2UNU*K1OM<[P79
M3M/300+YT(/-/]XOCI>/\ZJ<K70P&Y6CD%E&PS3UV*EA@Y4HO;_#7T_\/7S9
M3I>#W.S/F?Y>ATYJJ6*WV@>AO'N37E>!X[DE4HMVM%.$8Y([B!L$CU(SKYS.
MHY*W3H9]%E5\U"JTH8:YG0-`4OY3'!!SO,)67R,BW/)-,]2Q%!1W1",3'83N
MVIN7<<==2JX2YH:N2.^T`Z8_TKMJ?`NC4`-`&@#0"'R:Q$IBBEEGKH5]KUR_
M<F+D+]-&!A=\@]#G*C)&/F';*5O$XYKMX$?N16FK68X:JS3UX3!-!`%>*E`X
M`-6NI!5YW0_F/M.!\#[5/>EJ*GZZWJ.-2<+O35M-N8A70`EHPJTK-NL7[UMT
MSBE3+,6"C&)),C.#D@@E8QW[-;)PW;=2,XP([2%BL_)Q%8:?%TV:..$H-QK[
M@`O90%&F<>IPIZ80P[M6E\=N@G'7HMO/BI)8[CF9)8IF[5Z\9!7%D1@L]:JQ
MSLKQ*K%B/FP>OJVEUKM;UB^U^I:C*6>.Z(>S1CCKV50T^-0!/JS$H433D`8J
MPC&W(]W3IU"DE#'MT;-;#<<.S3Z'Q%C7E76<BW<0=VW;GC,:P-$#BP-S;?IX
M\D1HPZLI92>KZ?TRDK2VC'2[3V'-8>..L)-Z?3L?JDANEQ)>*$!K5G8K,J`E
M>U&1UZ#'RKJRO\L-2\2KN\\=;\#I@@LO8@KP5U@LQ_G5:3Y>.F)"<W+9))DL
M2'.Q2<_I^9M5;4(OVZEJ+).Y>S6]9E);2-[\<,:TQ!:E:WRC*KRQ"4*I2,@N
M7L3'Y%Z[5V]/E72%V,KK8(1OPG?;$U@-5:&2>NU?Z9XVXWBGC,JR"4L'&\,=
M]M^I9F^3K\"S:7^+M@1=X*V)J6.6M%)VB(Y*B]F66-B8J:R,,4J;$.6G<L%9
MP#CH,?*HF,>W?K>H0A:[4M9IJI'!4F+*%IO+)`TL#?FVU1F*5*[=-L:@$S2`
M]3N.?F;5G-Z^&M^!526KCJ\R9<!(TG&1EI*\A7*A*F.S&!\L2D>NP8&?_)K)
MF*?F:LMR*Q^X?(<AQ_E=N*'DHX%Y",B*O)!>D)9J4D!"F!'1MH;N8'7IJJS8
M8J7]Z7'67^E'!_[8^):W%Q&+C*D1;>8X8U+D$;MJ`9P>O7].HB(%5P\0(?N!
M7M#BZ,,<O+3,D\<%EK1=2^]GE)[2E@P?TQ@]-1SJZ?\`O_ZEFG#_`.5QO)[Y
MY'+)XM=C2TE*-PJV+#QF4+$7`?VKUZCH3\!UU+[.TA+;V7G+0@FH?;SM\"U>
MU-7JRFB<%H'92S`>X@X/IZZB$+U&VH.^]K;ZD"O^6>9<EP'%\E!-#VS9L)+'
M2$\*S;0HA`V_F*"VY<L-N?7X:Z1Y;ERVUHI!.^J/=X5>)<X]-4+$#X>E9'W/
MY&Y)R-.>,5Y(UHJY%F(NT;+F-B3C:G5AT.IA4U&$M(C2I1GHA:)`/O'W/#_N
M;QOG,U-K'!7*\5#F6[9D@,1D[4L4X50@!21)$:0L24*@>F*M14"R<+CHO\28
MN4'"7>8V2\E9CY/@^7CJ_3QU[T>PUHJP4DR(8SMD1=HVEO=G.IHFH0I4-&'?
MX3(KDXS<=,)VUR.GF^>K\Q/,>/BBK_<#B)8H>7XF0]I',.'>U`K@23Q+U*NI
M],9'IJLJ7&W?Q+3J4(EM<8HO5:7(WJ:1<@L>5WJ#)&7&&VL>J[AZC_!JT4[B
MD&KSM6"!9#*L:B1O5P!N/^'_``:KR*,83)BR$?<"[QMJY2X[BX8>5\RJRQV*
M'&]_M]J/NQF2>SM.5A48;J/<0`!ZZ-1)3@2#C.-XSQ/QR2.+I7JB:U9E">Z2
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M'<L<8DBC3N[LG<,.Q4#W9.,L=8OY++Y4L;S7_'U\S<"YO&AC@J8P1[#Z_4`_
M,?\`\:_/_P`_KKR\WXGZ>$CTLKX5;B,]<SH*_'_YN]^_6?\`2'6GJ;Z?EIX&
M+HKJ_GJXC368VAH"I_[S2&3[;Q1ABA?E:"[U]5S+C(_2-"4<'W"J<[#X=Y#.
MG'\C*E"M8J557DB8K-22J=]VRCOU[7N]@]?PU//KJU^ZK^Z2(Y5_;WN7FSHY
M"IQR>$^'W>3DN35CQ=:.*&!89(8G^C0[BCQR$M(0%!/I^C2+NC#L]5V!N$_&
M%M9*_NCQG"VN%@FY&2O7,4P6.>PC-G=&_P"6K(KN,^N!ZXQ\=0DXQ7&!/-"3
M-?EQDI^*<=9B:-Z5:&))[1D>)0CB-`XA"LLB_':R_JTA&4(]T-\2-:=N]#[P
MN_/R'BO&79]G=G@5F[2[4_1M7X#&D$KE`#K0!H`T`:`-`&@%GC/]GN._=X_Y
M(UHZO[M6UF/^/^Q1\J&>LYL(C]Q;%R.E4CAEB6%YX&FB8XF<QVZY0Q#\%ZE]
M:>F2B[8,S]0W!6Q10O)78N(6Y66VT;VO&ZYEM6$4SV1/#,[U=LNUTWNY8R+U
MPOQ)7/LTT\T'#^ONUGDU/E4(WTD@\RG\*XJIPD'TW(2<K?IP6XPLL2)F'#"'
MN6%`8-(V\]"&*+_@X9"S*G4Y03M<=LYT4I7Q:%?D7/>1R>069.+JIVC:FX)N
M),+2M]!7ACGFC[4:"7\EY'DDD60%B0<=-=,O+IY5%X<T=9SS*ZN:2U0U%Z_;
MF(+XO'81(HX+L]BY6C@<21B&Q*TD>&'XJ<G_`!Z\CJ7[\-$CU>F7N1TDGUG.
MX:`-`&@*V_O&!S]F_(0BEVVU\*H))Q:B^`T)17'`_P!TSQWDN#X[D9>?O127
M:L-AXA'#A6EC5RHR,]"V@B=C_P!SOQS8W;\BO;\'9NBAQG'3.!Z:")$_&OL_
M+]O_`+S>+5_(;_=IVY#+P_(UEVI);A&>Q-&V]ESNP"#\0<^N@/6&A!1_]Y[C
M4;CN#Y/<V^*:6MLQ[=LB!]Q/XYCU[O\`"5^]53VGA_S5'NTU$F_N^<D]S[<P
M0NH7Z"S-64@Y++D2Y/\`AE(_P:R_RU$,YO2D:OXFN.2EH996O,/2-%R]2I0]
MZY8CK0Y"]R5@BY/H,L0-6IH=3@E$K54J5%E1^1RP\]:Y=ZMW@J=&*V`3:GE>
M>5XE4&8=N144.#C:`0WQSJSR\Q745/\`U0VX7$+-HQJ7^U.S+CUS+AH`T`:`
M0>39CDBL#%41QLLO*-[FA1R`4KQY.9Y3A5.W_E]-=LK1N\]1QS=.^V(GB@BI
M7:MVU6[`@4KQM!%[LI+DYB8GHUB7=O=B_M&?AN?75N*:3VVT'-*#3?9;2:EL
MK(LMA+$<?8S5GM5</%3&=GT%)5'OL,P"NP'0_#T`F&%GK>HB.-EJ6LU5#(U4
MO.SS1V&$#R1;A8ME1[:-<EVVQQX/=D#=>IW?,VIJOE[-;\"%=/VZD=$I:22*
MIB._;>79-QL3NE6(5T_+@50NPQ1,X,KGXC;CJ%U"TW+3C[=!+T7ZL+:3"::(
MPRV)YC9@L,5LV5(C>_)&"3!`2?RJD0SO;.,9Z^K$E@O9KVAO&S]#:6-E:\:5
M]Z3!7J4I,*UDQ@`6KA54Q7BZ!`5]W3IZ+J+K7:EK)OM?K>H*<YDK-=JSPVI;
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MMK5MV%CI5!T!;=M[C8_1^`6E=UHO6R]%]I:D.O'K<UOC1--)',W<E420@A"J
MN0N"0`W0?,O0_#7+,I@SKEN**^\HK>2<GYQ<^F'*/!PXA?CSQ[U(TCDL5V64
MGZ@98E6(_#7-YD,?R\WBCHLN,VK_`.YK@F33R;R*YP'$075H-=08%IGGBKB%
M0N3)([^WUZ=-33!O'L4?$J^SM?H0O@*G+\IS='G+7"VIA8NM9CY%>5$M:.!M
M_:Q7C;8P1"%^7].E5<X1K6KE27F2J5"*5&V<>!*?N=;>KX9>=2HW[$;)8':6
M!;&T$M@#)7XC(U$86@.5N24>R(F\<MU:GV;2Q.^:B5I@[RJY$D9E=?:GL<=Q
M3A1TQD:)QG'?XD\K4H=D/`KBQ96EXYQ5R1(7XE^2D@D2/<\K3R%3O,YV*8US
MTZJ,Y]=%"ZVR$]T27'7L\=)Z*T*E7>,V>(O_`'2Y&$J+UF!9I5O25WCDBD@D
MC3MK(ZKD`28VH<?B-5BF[_>U,F:5S2UD\\I\9XGR?@;?!\M&9:%U-DH4@..N
M0R-@[6!'0_#5B#S8E67P-SX9]P*%D>.F^5\7\I@2(]A99&+*78MT?YR&;<G5
MOPU5IWIS+IDZY;C!8KNUJK6'`+)6@\8OU[96:(RH3]1%RJ#=$K=K<XZ[BW75
MU5S2@WQ91TPG%+@O$XZ/W"Y]N)B_A_G$<'T@*W_XSQ?U%@$A7#;ZSQ*4&\IN
M*]<:OR)W-%74U>F;K/E_FB].1\GFNQB/>\'"<6*<J*)TBD$\EMY>TV6"IA<]
M?\(K"G&KQ)][!<"8_;=_#N&\%D\E3CTX:)A8FY*U,&DM,L,C[GGE;=+(Y"[F
M'^5G`U#:=UQ,&K[RN^:\DY/[X^0Q^-^.K:K?;^HROS'*;3"\LT3=$1\.N,.K
M"-QEL9Z8U!)>/BOC'$>+\#4X/B(C%0IKLB#$%SDY+.V!N8D]3H0+ON=-+#X!
MSDT.WO156>+?@)O4@KN)P,9'7.M'2J.93M.'4O\`\V>8Q":GD=&63D+$MB^P
MY+DYAN/=BM=!MAA><_EJ7<LS`E#T'IGWXQI<KI+L/#NJ4[YLZ?($M6&EJ6)=
M]Q*_:X^:2=I[EB*Q$LN]]KRLT04*05SUR=HRVVN7!35V.A%LR<L=Y')K''V;
MG&OR)*I*)+5N:662VZ())-D3[O>,L/>GQR#N&3KNDTG#R.+:;40I+%4=;-*K
M+%8GF1:C%U:`&5'.U)\[1M1UWJ^<C*MCKI5.38IE-(M/^[+$U+GO+86RK5HH
MD;O+VB#')*#O7KL].H^&O/\`Y5QIH-W\8H55%_<-9M6>+K3VW@>S)&K3-48M
M!N89_+9NI'Z=>-6DFTCUZ&VIG9JA85^/_P`W>_?K/^D.M/4WT_+3P,7175_/
M5Q&FLQM#0%2_WGHXI?MFD4LG9BDY.BLDO^0K28+?X!UTV$H@GD_C%-J?D_`3
M>,OQ?CO#<5):XSRXS2EYYDB#)ND+;)!.QQM&GU&WRJJOGQBW#N'*DN9JCDPD
MH]]Y,^1X=;/B/ADPY..I-)Q4`CCN2!8%"58BYC5HW&]N@.3^K4I5.242.:E7
MN'?YDE^[?(S5>)JKVI8X5F$CWU>-40]N1=NUV4LW7/I@#KGIJ)64B4G:,=Q]
MO7^&Y;P#CZ\7(0TC,E<5Y+A:$AZIC9NC%6RN!JWTV[ES%>9*^1(/"()H/$N+
MAGM1W9D@426H6WQR'KEE;XC58-7J!,L!YH`T`:`-`&@#0"SQG^SW'?N\?\D:
MT=7]VK:S'_'_`&*/E0SUG-A"?/\`D9N/YKQ^Q''W%9IX)L$`K'.\$18`AMWS
M>G3]>M?34\U-2MB9>HJA53;05+Y.PHV^?K\?)6K5)/&J4:PWED>9D-*RP2$E
MF*28S\QZ>F?@?2RIJEN,>=W;48,V44H0Y<=AV^6>/CF_'Z<IDFXOB?'DX^:X
M8E2>2>>U%$S301)&[AR)!C,@'MZJ/75,G,Y*GBZH[BV;1S4K!4PWG;X6USEO
M)>.6RJ);6<S268*D?T[15P]::8S1/"T$MN5&^#`YP>O05SX4T.%VWM[8%LGW
MJUY=F\O&K5KU*\=:M&L4$2A(XU&``/AKR&VW%GJ))*"-NH)#0!H`T`D\S\MX
MSQ'QJYY#R:2R4:00S)`H>0]R18QM5BH]7'QT!5W_`-+?[9__`(GRO^SP_P"N
MT)@'_P!+?[9__B?*_P"SP_Z[00*\^Y'WJJ?<GG?&?'_'^+L+6@Y>K:2:;'?E
MD4A=BQ(6"A0S$^XY_1H('J_0@@/WTXXW?MKR9$@C^D,5DY&=PC<>WU&,Y]=>
MA_%U\N>M<C!_)4<V2]17O]V'DW6_S?%[5V21Q60V?=N0E,`?AAM>C_-T2IJ[
M#SOX6N=5)Z`U\\?0$+^Z\G'#QZI!?EIUJ]F]%%];?C6:*`['?N"-_:S^S:H/
M3KIR\TH1[8=Y*JAI[+R(\3R?V<IU+4'+V.%Y%JS)V+D=6"*:964'Y(UQN5NG
MMU'[6-Z2V5.'$G]Q4KN;M7H7%J2H:`-`&@$/D<;M9KRPH>]`DD@MS`FK54#W
MSE?1Y0.B#]?H-=LIRM%G',4[01'Z]=8(WNQ6>W#*%6>Z29+,$DBKW:\2D!GL
MSN1[B@('3'10.[<90MIV(XI0G;VLU1V<7:NVN>Q4D"5*5:6)VC<AR8"AW,\\
MF/S9#C:-W7&6:6I/7;NT$1FK6>D[*\Y:Q<*1M9GII]/R#4?_`+#C=1MJT@-N
M748:1Q^'IG"K1J2UW1QULNG-ZKX8:D:XY$EHQ5TB!H,37KQP(L=B\`2ZUE96
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M",/7'3=@(48VAL6K2'"%H[7KT'=:5H&<4E_,H0]R&`A1'Q\;)N9I-S,DEN3)
MP2WZ3TSNHIWX[_0NY78;O4YX88:OU+*[0K&W:M7U?ONI<`M6JMM0O8E?^<?&
M1T_0%LW&'#Q>HJE"VY:S?8B(6M!/!+5C[?:K\35)*68Y3O2%)0VS=[?Z0Y^`
M]=I+-5.]J>O1;`EJ[AIMB2C@I'?CU$DT,TB,R.*P`BC*G'93'PC^7.L^9>:,
MNXAGDOGW*^/>9+2MP-+Q=AD:NJ-7#NA@92J]R2-L_4;?7X:BF#PW/P):>'%$
MD\NXCD>9XBO%0%=;*6:]G9=4R0XC;<0Z(1N_5GUU2JZZ.XO3M@*^*X7[A4[D
M`>[Q:\:UKOW*]:O+&W;92'6,L[J,MAO3\=%7!0Y8=MVX.E.?,V]B&?GJV'\5
MNPUZL]N>8)'%#7!+[BX.3C]@8RP^(Z?'1M*;(2C(Y_'>-Y*MX`E((&Y'Z><)
M%*IB3NN7*KL891<D8'P&D8J9/+"5UNT@4,'E_BW$49.4A@E>2W9D-9X(YMA<
MH4,3@OL<K[50?,<^FH55+7O)0UQ\_4LJ&OA;[/\`\ER@Y`/IG\=6*$$\?Y[B
M;GW&Y2G5XR*.Q#'*)>128.7,;HK?ECVKNR-Q]<CKJSHA^+P(5<<:?$G>JDBW
MG_&^!\AX]N/YNA#R%-_6&=0P!],J?53^D'0%'6O[OGW!X#DVB\`\H%+@+FWZ
MNG;+/L(V;W$3++%(6()]$QT7.HJI34&6534T+%C^XCU.=J>1^`?6\Q#598;-
M6"1(+0$AEP)8'8-([V"V%],'](U3Z:P;1?ZANNVOO#R5:C)4\#BI\Q<LF<3,
MDIBA$BAB9^^\>'1ZX.QLIU'[6K<NME>8DE?[">2>0SPR?<;RNWS%.L3V^,@8
M10NP9L2,46/U!!"[=R]1O(.I2*Q+:X#QK@/'N/7C^$H0\?37_P!E`H7)],L?
M5C^DG4D#+0$7^Z)4?;WGBT@A45'W3%=X0=,ML_:V^N/CK1TGW:=IPZG[;*'I
M^*<DOE$O#\C/6K<;S7'QSU^1KS.QN<?7B`^E@DD"I%WCMW=Q?9^S\->Q5G+D
MYE&-+NT/2SRJ<IJJ#N:W"6&CS?+^02\)R5BP_+0&.W:C79-:C,9$G;,CF!HT
M@5@A"2KM?<<,/3JZJ::>97;K,Y)555<KO/O.7..@I,GO//<:LCU[L@DF6S42
M0Y%F.3)4RR3=Y5<G!^?IM&F72V_[7N>K@*ZDE_<K3XG/`GUT5:.I9M3VIGDF
MAC:M($!@64S545=Q42L-TBQLB+OQ[L=+.48I0V[[:"+X7]VXL?\`N_0U^0\D
M\NM;#)0NPUE$5EA)(58,65\K&7V[MI?;U/Q)ZZP?R+=-%"Q43;T$*JJG@R[N
M)XCC>(I+2XVNM:JA9A&N>K.2S,Q.2S,3DDG.O)KK=3BSTZ*%2H([-5+"OQ_^
M;O?OUG_2'6GJ;Z?EIX&+HKJ_GJXC368VAH"I?[SR,_VS1$C$K/R=%5B8X#DR
M$!2?P/IH2B`_<WQ?AZOVZ+^16[OB]KLL_'^/UKDO(4Y9$3**4VE8U+=/FP-2
MJZVH*II:*X1\V.6E3Y54]-,8>187)KQ)^WWA3<G/)7C''U]DB1]Q0WTB-_E)
MA_;A/7)^&J\L=':%5#3V$G^Y/$KR7%THI+,4,`LXECL3?3QRAHG`7?LD]V[&
M/T9U,*G)*)$4IMPVJ)Q^4<3Q/&^`0111QQ+6>OVVB+.O=D=8V(8,F[<6^)QJ
M.33OLR>?1NA[!U]OEE7PKAQ,09?IUW[?3/7..I_\^I()#H`T`:`-`&@#0"SQ
MG^SW'?N\?\D:T=7]VK:S'_'_`&*/E0SUG-A'/+^/CLM3L25U<5MQ%J20(D3-
M)$5&S:V]G9!M/P(^'KKODU0BCCG4Q@4@Z-RZ\W9N4DM,WBE.0\ER65:O(D$P
M,JF.*<-(5)95R"P&?7T];X>5)P]]R6,SRW[R;:C[E[V#+F>2MGQ7CZ7&\B:5
MB&/;]-``+(K05T0SLYEA[B"9D]KD^T?$!LTHI7.VU'A&)>NI\B2=H"W[<0BW
MR/AT]N-;$?%3+Q9LPO*`0Z&Y40]S8`\4D99TQT4J.IU?J7!5I8S\&4Z>;I;P
MEXH]):\(]H-`&@#0!H"`_?CB.5Y?[4\[Q_$U);W(3+!V*L"EY'*V(V.U1^`!
M.A**XX?^Z1XM:XFC9N\KR=:[/7BDM5_R!VY70,Z8,9/M8D:")U__`$/_``K^
MN^3_`/\`7_U6@B3'P#[`^!>%WXN4JQS7^6@#B*[<8.5WGYDC4+&K`=`P&=!$
MLG0@X/(.-/)\%R''`(S6ZTL*"493<Z$*6Z'H&ZZZ9-?+6JM#.>;1S4.G2CR]
M]C;W\.^YO'Q-'W&LK-4)!QM)4MN].O\`-Z^I_E*>;(;T3/F/XROESTM)ZPU\
MD?5FFS2J6@BV84F6)^Y&)%#!7`(W`'XX8ZK50JI.9:FIJXCG*<_X#4I7I+YJ
MK%2E^EM0O&N\RG&$5"-S%MPQC1=+0YPIAIT!]16I1JCQ)3JQ4-`&@#0$?\DY
M"M!>I13M+$(P]E9XR2`RE45.T`W<:3<54'_!DZ[Y5+:<#CF5)-"RJ#'<C/8C
MB-`=SZ=B6@XZN<L[2%3^9:E7/Q]N?P^>[NV[_0YJ_9N]3F:O5K.YALN%KO+#
M:Y*($R,;#`_2P#W-+9?:-TGJ/^0+:+>'9XO41!+S\-ILAL)!*\!1X[U<PPT>
M)@.Z((["5X-RMM:5E7\YGZ*.O5>K0U&>&FVX)PVZ+;S";ZMEGDA7OS+BM;GK
MG8B1@C=2H],A449ED5=W3H-WR2H6XOP#C;@O$QNO'8@5G;O5@DE6I+$NR:]&
MIW+'U)'T\.,O(>C=?V3[U,K7>I%4[7^AFDO>N2125ZO(76BAC23,JQ(U<*SR
M%6`1*RN>H4]77XDX1""Q2MO)C%X-VW&*Q0VXIS)LGXV3\WD>2M!%>7VMV[(5
MP=L,94B%%'N_0O5D8;<%X;=(A'9B_'9H,YYV/8!A:1P%EHT)5_,D,:A5NW54
M!F;"#M1?,2!\?D)>WP7B[,W;Q?D?9(X8[<MO/8Y$*;%V:PXECH!\XD8^CSF,
MA8X^H3X=/F1E##CZ"$XX\/4^Q3W*5.2HS-0H66^H$C#/(&.0A`F![FL6'ZY(
MR@_YWRPTFXWO=[$2FTH7+?[690)&EF)%:-.1IX%+A5"O%&C(Q>OO8A38=/<[
M[O;_`-$G<=VIX^.P*_6L+8GVO2K-,Z5I/IJRE:MF\K96%68`T:387'O^>3'3
MT]?D.IX]WBPJ5A;4B2<!/4EXJ$TXDAK)NCB2+<8]J$J"C,J;E.,[L==9\Q-5
M3.^6TU(B_D_BG*3\ER=BFW'25^9@CKVGY%6,E<(AC#0D=&!W9VG'N^.N3IB_
MAYM$[MSW'55P7Q<NG7O7B3'CZGT="M4WF7Z>)(NXWS-L4+N/Z3C5IXE=A7-7
MD?(K'FZ4)N37Z&MR4KKQ$4\9N=LE]LDYVC\CKE8E]P&,DZOS50NEIAX8+^[$
MKRTQOGHG#OQ>JXE7W"Y%*'B5Z8S20.X2*%X?GWNX`&?@#^U^C..NJIP):CA$
M4<9#=D^TVR2XT]H5)6:X)7+`H['<LB!G.P#I^K&CKJC'&VT<BNA+O\B#<?YY
MY9P?B5._'/7FCFM6([,<T=B=E>-T7$;EF]N&'JWJ>FI=:?Q0>UO_`!\!]+0Z
MEV+S+S!!`(Z@]0=5)*\\*;CZ_FO*T_X51J<B._OO4T='F42JQ#[B3GWJ6)Z$
M^FH5%*FE![8^'C(M574Y-Q6Q+Q\"P]25#0!H`T`:`-`&@#0$8^YT:R^`<Y$Q
M`62JR$E=X`8@=5Z;OU?'6CI?N4[3AU/VV49>\JL\AY)3M7VI68!7EXKD)((W
MJH:5A@:PC,R]T2QL<CIM!V@G+:]>G)5-#2CI6,\3RWFNJI-P>'8='/UO'*Z2
M48.9:_=G@8SO,K7OJ(6B(CV-&.\`\*#(=O:R#+=>M<MU.;4%W6GQ)S.523GW
MB^W?0<?!Q7)5X[/D-,S6H)I:J"(5SL5C;5)#+"NTLH=TS@AFQC*W5,XI^Z]?
M`HZI0:]Y:N(N?E[\\<TW'V9!'6@A[5QB!%"C(%EDLY27<[JS?-AO<`IDR#KI
MR)7VV6[BCK>%K6B6/]AUN0>0<Q#;D$:15:R5*LDJ/-$DDDLB0E@Q:38F!N(!
M^&.FL/\`(0=*AI9MZ&*J<2[->2>F&@%?C_\`-WOWZS_I#K3U-]/RT\#%T5U?
MSU<1IK,;0T!4O]YR(3?;6.%LE9.4HH0#@X:3'0_#0E%5>?><^6>/\1R_@_#>
M+2U^'CB>"W?MM/R)*-'[GCED`10%;U^&H>;E.53=57]T)=WF663F7J%-/]JM
MP+/Y->.K^$>)6N6OVXZ9XFN*]:"*.2(2+5C)+Y&26_9R<#4P;E(I%+">TEGW
M4=%X;C@\:31O?16CD$;J289=N4E9$;W8Z$Z0C9^$R4X3NML9H\ACX;_<>G0%
MN#CY+XKV:QF]J22(\<K8$88+N/\`DC`ST&G*WK[?.(3G;P@2+PU8U\7XX1S1
MV(Q$-LT18QD9/RE\,0/3)TA`@<Z`-`&@#0!H`T`L\9_L]QW[O'_)&M'5_=JV
MLQ_Q_P!BCY4,]9S8&@/-?(4J]F]Y-43B9.2D@XB66&))$2*!5DM+WEC(#%U.
M%]AZJ3TZ:]ZFJ"I<8>]Y'BU*/,H1EYBE>2')"G<%+<\]=ZRI'VQ/6FEM8JA8
M;$F[:SQIE]X8##!AG!Z<O+%1]93N.7-&#A:,B>T[O&R3\53NU+"V>0YN;DVE
M[';2TR1]F1(\?/V^YM38"2B9.W.L=5+@VFI4PV&M5*2:<ZH[2[=>2>H&@#0!
MH`T`C\W\OH>(>,7?(N0BEGJ40AEB@"F0]R18QM#%1ZO^.@*G_P#I>^`_U3RO
M^97_`-=H3`/_`*7O@/\`5/*_YE?_`%V@@'_TO?`?ZIY7_,K_`.NT$#BYO^]C
MX/=X7D*5?C>4BL6:TT,,A2`!7DC*JV1-D8)^&@@6Q]JY)9/MKXN\SM)*W%U"
M\CDLS,85R2QZDZ$'F_Z27QO[PI6AWT4J<PBQ%S@K7DF&"6;]EHG]3\#K[#F^
MKTT7.-.^'F?(\OT^I@I0JW1\CUSKX\^N#0%2\WPL4WD_)\L:?(6;$$Q2+R,&
M'M<>H`S%!7=MTB+N.]MN>O357",&^SE]W_5KX%E&$E+YO>[-"XEM:L5#0!H`
MT`C\BFEA9'C/9"QLTMZ;K7K(I&9`AZ--UP@_Y>G0]LI1M?Z'+,<+7>HF#?11
MU'GK34J`=K%28$O8>4D#\]#N[D]@,VU2/:/CNZ+UOC!Q=MR.5T)05M[-;"Q'
MO,$2PV*$+$11[6BXZ$KDJF?9);D7U)Z+^KYYEW[_`$(GW;O4^%:E<3Q5R8ZL
M4KUI.0B/<LR]Q@WTM=@%9IG?)D?KC_*SU1-W]WB]0DKN_P`$:'BIV6J!P+&W
MN5H>%J%=L94+MK%R01D9:>3;Z#&0O1IBU'B^/D1!.'#P\SK/U+PWK"1&[B,U
M[UN#*JH'05J0WQ8BA/61L]?U_+64E=:]EIS=]KD<@6`\1EY9)S=>1L!`CW>V
MH[;$EI-M:`9S[=K8Z9!PUOZMF[U97^G;O]$;A%8-H?52-;Y,;9.Q,O;J+VAE
M+;[6*_3QJWY:]"6SGW?+$5"4EOV;=),'&<WNV[#*O9@*2^V"6JS1V[?(WLK-
M($;(MA`5(C]FR!5_7T&-QKON@N'F$_:^/D8R25:Z+W$$13-GC^-F#R.TCM@6
M;@7+//(2>W&3G/Q!^0DWXOP6K2&TO!>+UF$4`IF4JP@L50SR/(YFBXY)0!MW
M-N[MJ1<*!U"CH.GSRW&U_I;9"4+7>H56CAK3+!+)'Q[L@EE4%K"RR*.[3JL=
MK22R/_.2;01\?=U4YO7:;"DM5I(RWQ]R2I)&?JXME2#AH@)*Q@D7<]56!`[@
M&&FE/R]/5>C1KPTX[?)$ZL='AYDMX.5I./4O8BLNKNCM`H6)&5L&*/\`%8_E
MR?76;,4S1EN16?G?'5+WD_*=ZTK1Q0$O5FCD8&6*C+-&H974=M`#+C&=X'75
M8U:=[7AOT2+J%H6M$L[A`HX:AMD:5?IXL2OT9AL'N;])U`*_BY!V\T@XVK!W
M>,CY.65[T-&8O]03(7C>P?RMJ,2I8=?AJON)_P!/-MGW0\2WOM8\O9#CX=I+
M//S37Q._);ACG2)5>.*4!E:4..V-I9,^['3.K0B5YH6]HM\9EY+D_`9(_P"B
M\([121Q6:99X8ADB5MDFQD9&W`ACT/Q.GRKOF'_<^Z1'I_(>*\3\8XZGQ<E'
MEH+$TS9VDJ2A7*K&&<@EFZOZ+^&I^G#XU'M]ML0JXOW'"W86H,D`D8/Q&H!7
M_`\SR,_W4Y;CY9T:M%78QQK`J,0KH!N?&\[=Q`R<'X:2T(F#_N\+=A8&A`:`
M-`&@#0!H`T`:`BGW6C:7[<>0Q+C=)2D1<^F6&!K3TGW:=IPZK[=6PH"MQ]BI
MP*RVN/DJ'A:K-<Y18ZI**Z+`4[;SDV@_P&8_TJW0#V74G5)QYG=/REO/(5+5
M-UV,O.>XVFE?%OZB9ZR/22&66I6>55[)F:9`9&8PN5E9Y<$[-N1N^4:CF4(3
MG;T$'&,I&V'RNO\`4\7!;J1\R\E"KMHO*('?"MW$$NW!AE*]UEVL=V1N"GK#
MR7!P?+-VVX$K-NBHR1FTO,3W+5*Q3>U-+&MB&"B*[4;E.:=I!&IL.?J(PY41
M(JADZ_Y.TQ"E)-/OC%.&[63&J+4.ZYKQU$B^P1>3S'R+^CJABCKAH).ZK5U$
MD^U%63NX*J54*C;`OH?QX?R/P4VT'?H9UU%]Z\<]4-`*_'_YN]^_6?\`2'6G
MJ;Z?EIX&+HKJ_GJXC368VAH"IO[S;R)]MHWB3N2+RE$I'Z;F$O0?X3H2BO/N
M+3^\EBOSE]_*Z=?@5KS+RW&PV08ZC?3Y^B(=59GE!P,?CJ_U:[E1)[+M;*\F
M7>ZI]M^HG',5.3N^#>)5S4CFX_\`A%<H$#O,\@K0MLZ0RB/JHQUZ_HURJJI5
M\K8'2E/"/9XS1+_NQ&)/&Z\3$%'M)NC8X#@12'!;?'C!&[YO48U:!2VDT>1B
M^OVWA6Y.OU3FH*\M:,HV#)&4`1GW!]H]VUOU:)1FE=V^'@'"Y[Y>/B/?`2A\
M.XHH<H8`1T*^I/P)8_\`*=`/]`&@#0!H`T`:`6>,_P!GN._=X_Y(UHZO[M6U
MF/\`C_L4?*AGK.;`T!YDLMQS^8\U-)1DY6Q4XYGJUH)C&@L1VISB?;-%E%7+
M,"&Z?A\??4>13A%^"ND>(X<SE&7B//#^"7DO`*M^)VX6FPBHS-'#W^2LVC9$
M:JTC*#%&P91F/!;)8X'37+.S.7,:^)WZDH'3*R^;+C<KM<3=P7C]Q_N9P=N"
M>"*/CTL\97K3PB+M2TDVNZP[]TZR#=LDRI&,M\N#7,S%]*I/&#[^!.7EOZJ>
MB7=Q+YUXYZP:`-`&@#0$&^]]CC*_VMYZ7DJ1Y&L(HPM,,R"25ID$(9D:-MO=
M*EL-G&@16_@_]U3QOZ2OR7E<LT]NPO>DXB!FAKP"1<]AGRTSF,GYMX]/CH3$
MD?*?W6?M3<@6.K!;XV0,&,]>R[L1@C:1/W5Q\?3.@B5AY/\`8_QG[?\`EW#6
M.9#<[X7S=H<<PD>2"W4GER8FS`1W?E]<#X]!T.@B6W_]&;[/?U1+_M=G_6:"
M)8_#\31XCBJG%4$,=*C"E>M&6+%8XU"J-S$D]!\="#S%]_\`CEI_<FS-W-_U
MT$%DKC&S"]K;ZG/\UG_#KZO^)KYLA+0VCY7^5HY<]O2DST]Q5VO>XRI=KDM7
MM0QS0L002DBAER#Z=#KY?,I=-33O1]114JJ4UB=6J%BJ?)HN6Y'FK[</QG)6
M>+K6.W?A6]#5I3SH%+[HVS(4]-VTC=I]1*4:NRE/\UXY(SA3VM\%+O+6T`:`
M-`&@(_Y+N:U6$,,ERU$KS05BI:O&4Q_2)`,%V3T1,]2>F/F'?*N>"M(XYMZQ
M%S[['(=U`M7DL+]7,Y5X:+387V=`K6I5V+C)V_I'1KW+5Q]"E[U\/4YIZE(<
M6MAEEH._<BXMX-\U@L3AA.5<;YYF+=![ERWN!R19-QA?IMH*M*$;M%M)DK,L
MYC5DJV*D+!NR!(G'5P`6BKH`>[98$;V`]N?PP&C#;OVZA;9LUA%7J.UC^')(
ME`H(I)4W"U,40M)4@9G.79@S3.,=<^K993;QOW;7X!)87;]GF:RB2RO#:B$D
MZ,E6IQ%24=HA5$C5F`7`B3*--)GJ1C&W"F=G?X^0V]WAYG9406!<L3'ZFJ4,
M?)<C%N3>%./IZ>UEV01?MMGKU]3DBM4H+N7B]993B^]^"U'%(U4095)+%2PS
M2Q12=)N0:,9[TV![*D0QM7;U&,#&`UE'MX>I679Q]#Y7BM%JSVMLW(QQ!X!9
M&T10H6*V[ISG"9/:C9MW^4=V2LMJ<+K27B0D\;[3?@<<"17WGOU;SKQM>16M
MVK&`YF0D_5/$5#%R<+#'^HXV[5:SE)J=I>953FG*T_(82V4JU!`,5IT,5CCJ
M+Q]^5'[F1+8.&9K-C+;4R#Z]0<LM$HN/?Z:D7;@H=WKK9LGGF:Q+/-(M>Q74
MB>5`&BXZ.7_V4(`Q+;ESU(_'\,!H2E"S]"6YVEZFB&Q43CG$`L5N-+E9G9@U
MAW;H:=4J?F;;F:3.<YR=V666G&=]IOP(34-5I+Q)?PB3)QD`ECAA&W,4%;K'
M'&?D0-Z-A?5AT/PUFS+S11<5-]R)>)E\VEK6J-",LL,,MVY!:E;:\+,9<PLJ
ME5'Y>W]/KKG+!S^?EW'51[/DYBW!(U;BXVK0_4F.-!'#%A-PP![=Y``Q^)U,
ME?YE;RM:<5^+S.*,'E4@;EII&C>_4^DP[2,<5E8R[<GH,9^.K1JAC#Y)?[BO
MNQ_IC\[C_MN)MYT*H\7N3V*4/(+7"RK6L_S996`#'\2N<@?'TU6"=\>PNJFK
MG`X./E:Q]N-W%T:SO/6E6"BH[%<M(S*0PD/M'7+`G.D%H??'?(AU8M]KLR'T
MWY[P_A..I_0TII;5JR0UEA-+UV-O:5"(\G)R,_AJL*?ZJ9]V[WN);F;^&J6J
MU/`M[5BI7?B_(6I?N=S$,5R:3CS',SU;$2+LE22)08GVB0IU;H3C\-.YZX3V
M1$-O?X%B:`-`&@#0!H`T`:`KSS7F;%+SOB:]>Y9JM/`L9CK&(B8N\C!9!8;M
MA56)SN"[OAGTU>F,)<&^%W?V%:N7'BE[1W]T$#_;[GD+M&'J.ID0%G4'`W*H
MZDCX#77I/NT[3EU/VV>;UN<;%4GXOAUK6(:E=[_U79GJW;)%A6L5H.Z06`[/
MN9M[@`X_R1[L'&-49RTI2O/&BKE!XZ[[AH*GC]2E6XWB>1CEHV[R&^>2[<+Q
MK,1]0:W3=D+#*#*7]J]%]S9/.-3;=2FE*'CY%X4P@G*.)\G?B)>6FJF6YQ+P
MUF-DUS6WXI*XC>&`!>V"%2-TC;'1LD^XZ+FY8R<]>)#A&$U+@,_&*5;B>,47
M>(EEYR=9DY!:]F.*&."9$MQRA)#)63:K^U4*Y8[6&#G7/-J=3D_=PEV;3IET
MJE37O6>PEGVLD)Y23DZ/<E-VS3I3V'B,;/32G/(KO#W)NR9)55_4>OH`=9^K
M4H/!-]L4:.E<XK2NZ#+FUY1Z0:`5^/\`\W>_?K/^D.M/4WT_+3P,7175_/5Q
M&FLQM#0%3?WFS,/MK&8$[DXY2B8H_P#*?N^U?\)T)1%?*9^9;P'R2UYOP_`\
M1W*KV7IPI)8NM;EB,-:9P&VH^[`#'.-0E35\--26NKP@3&JF^J.RGQ\B2<_/
M<A^WGA+07'J*.-B:549T+[:<>S++\%?:Q'QQC5Z:JE=X%*E2_BAVDT^XO%7.
M3XJE7J#,XMJZ[9%B?I#*/879`3UZC\,ZHRRABX6V,X?)HK]C[?QF]7%&Y3DK
M,"SQSA>S(@[O7N*RLN?:>I'32_#O].(4L5V60_\`"V9_%>,9B"Q@4DKM`/Z0
M$"J/\`U)`ZT`:`-`&@#0!H!9XS_9[COW>/\`DC6CJ_NU;68_X_[%'RH9ZSFP
M7^0B<\#R(KSFM.:TO:L`X,;;#AP01\IZZOEPYE'24S/A9YFX/CX3Y!YU9AEY
M&U(D=R26+BNY%+%+]1)M21BK*ZLJGJ,C!/3\/?S*O=H4L+]AXE%/O5N>-VTL
M5^3H4_ME9EFAGDH0<O3!?M*Q*=RNZMMR5/P7\-W36'D;SEIY7XFOF2RM7,O`
MRJU(K?G_`!R^5T$BY!XNTUF2N]<W7CD[E9D,,DJLR!"94.$^)]%&CJAE/D<N
M&GT)2CF+G4^.CU+BUY9Z0:`-`&@#0%>??WQNSS_VNY:"G"T]ZGV[U1$9@V^N
MX9BH7YCV]^%^)_3C0(IWP7^]G=X[C*_'^4\9)R;UHRG\3KR*)Y2"`G<C<*N=
MOS,&Z_AH3`D[_P!\'Q+8VS@>1+X.P,T`&<=,D.>F@@09_N/Y;]Z?.?'>!6@O
M'\12O17YHZP-AXQ#C=--*VSVCJ!T7YOB<:`];Z$!H"@?[T%.?ZK@K@C_`".W
M/"TW3&\E65?Q]`3KZ#^$J4*EL/`_FJ7&EEO?;ZW7M>#<#-7D$D7T,";AZ;HX
MPCC_``,I&O'ZNEK-J3_$SU^DJ3RJ8:$.[<EB.K+)7B[\Z(S10[@F]@.B[CT&
M3\=9S04[Y3P<DG*<O)_!)V>Q-W'G/-BO'N94R16#`;1CT(ZZLN>$GFPU4J'>
M5;HC/Z4=<8ESZJ6#0!H`T`B\E[):,W9YX>.B4R2-$@V"7/Y;R.<YV'JJ;3EL
M9SZ:[96J\XYNNX1VWMRR9KI%4LQGZN"O80&&I&S;I+MT*4!GD7=VUS[?\['9
M0QGAMU+4<G'"7AK>L^Q2U:]=S1LRQ(T<<W)7Y2'%>24;F[:A=KVYB_X';TZ8
MPIAIMS6Q:?1$II*3VVTF=>2K0MP/?HRQ1QPLW$T4'<8/*2A$ASE[4PR3D]!G
M)^8Z--J3VVT(*"<ULMI9JD>2,3.&2M-53LR2P]8J*,`%IU``=]B3H&8#I_FK
MJ5;7K>HAVU:EK,(EH)7/TT<J5)BL,Q0[I[,GK]#5/M/;#;N[)ZGKDYW,)<8S
MOX:WX!0A*ZTEXGQX;#\AV[<*3R;5BI\968&N^T^Z`LO1(:[*.]D99L?#:A14
M)=]L7@1!QGW6P6)G+>B7&".1;D#(G(6COA62*$KO[#@J%K0AFZ`G=@^N6;4*
MGLA=ZZV2ZNV-NXUV;%*"KW&5I*<A,T,-@XDO.N`+5H@92NG38FWKT`7Y5U*3
M;U\-2UD-I+5QUO48TOJMX-E3_$8%#AK:A4AC1<B];.?<P4E8D9LC'4YW,%4,
M+M7!>(ICC?:;\#OK<C2B@=*CR+4$;2<GR4R;;"3."J2!F#;IY,C9'LZ`CT]J
MZHZ7&=^"M@752PNQ=L1;R#<A'&M2)9>-A90(*6R1V=)'!QO4_F6ICDGW93!Z
MC)<=*87WVX*V@YU1NNMQMK.^*"Q-.88VBK68U%9IE(%>@CX"U*Q(VM8DZ!WQ
MT_S5U1M)6GK>HNDV[2U+62/QY*<?%QQ4Y!)7B9HU"'*(5.&2-MJEU5L@,>I^
M)UPS(QF=\N$)%9?=F?F1Y'4AB/(WZ4NS;P,,#I7M=I3++&MF$@LS1J<JXP-<
MG6E>TO\`EPX-'14-W*>MR[H^#+:J8^EAQ&81VU_*/JG0>T_J]-204_<Y/AX/
M,_K+-*K!'4Y2206JG&6Y+<LJ%U[??QVRS$G=MSZ:K[D;TGKK?"!;WX?U-?*N
M,?`F7G]EN3^WDEVJ7ACL)7FV.K+)LD=<*5`W*X+`C_)(S\-6CHMN9"6FV]"W
MQV#CKOV:V6R/IFKV9)9+AD`WI,[AY6!#GW*">N3HE&Z=NP-\M\NSP<2ON2XK
MF$^W%%()8JA3D;4D"N/FW%.QM0R!LDCY@3C/IHZJKTN/'SD1[K<&^'A[2_.*
MEO2\=7DO1""XR`SQ`[@&_7I&(A`KWQ]N)B^[G+22NM:Y)')!!#N)[I+1NS;B
M<;NGR?#4I.S\`W:!9FH`:`-`&@#0!H`T!67W+#V/*.,KK:KQQPI!-8K-#BS*
MC6&'Y=GMR[1[3[?;^O4-+13MBH]B;AQ+)O35OAVPGX$N\^DK1^&\NUI2]8UV
M695QNV,0K%=RR#(!R/:==^G3^HH&?J&N1Q/-?DW@\?BU[DY[EV2ZE`0+P]B1
M]EA6@>*9D""1,CZ:0'H?0GT;IKWLK/\`J))*$;[;3QLS(Y&XNZZVP75[]N3R
M:/Z.I67EVA';:"6L\%:/>TDBO"(HHI9E&/F)&>K9^%W2N2;?+VS.:J?-*_L'
M$TG$\_6DA"\C<Y2'MCE(28ZD<,DT<:RR.S[7:9K,3Y'N!WDA<^O)<U#P2PQL
MH'65:QCC;:+N:E\=@\93B>,F:"]?MU9C7199':&57WC:LDOM4")=AW$E>@UT
MH53KYG<D[<3G6Z>6"O;1:'VQNV[-M9Y[$,\DW,U79ZK97;)Q<\HCDVA%$B;M
MKA5`R/37G]52DH?VO_DC=TS;<?[E_P`67;KR3U`T`K\?_F[W[]9_TAUIZF^G
MY:>!BZ*ZOYZN(TUF-H:`J#^]0S)]J79259>0J%6'0@AS@C0'G*#[U>8-XWR'
MCW-&+G>,NUW@`O*'FB.TB.1)1[LQM[EW9UTJJIJ^)3TJ3*TT.GX7!:+T>CN?
MXZY>^W7AD%?C#R8;C(`P!<&(_30L)`4_#:?U^GQUQJ:5[A;8SI3'"V]$@^[E
MJFW%TJ)'=O"REF&!HC)&52.0$R-C"KC(]<ZO&$XP[8$(R\MHQ2>!<78>60FH
ME%E1'>.-R7B^=49<^G3\-0V]/#Q3(@A[X"^_P[B7[C2Y@!WN,,>I]>IT`_T`
M:`-`&@#0!H!9XS_9[COW>/\`DC6CJ_NU;68_X_[%'RH9ZSFPTWB@ISEW>-!&
MQ:2-=[J,>JKM?)'P&T_JU--Y%5QYEYRA7X#RG[@1'E)J4MRI+)%6H*9(Y#9C
MGD,%GI*$(V!BV01DXQDX]_+J==&7*,'CV7'B5TJBJN<(Z/$D7/6+',^,<9Q4
M;M)VN=X:G%AAT9^.5BON!C7:S?Y/Z\G7#+2IK=7]M3_,=<QNJA+^ZE;B;>.U
M[]+D.,AD7$?YCPW)X15$,;31I8BWY?N2VI%5E#HK;<^[)UES&FG[=G<:LM--
M6M$LC6`VAH`T`:`-`&@*Y\L_N_\`VP\EG>U8XPT+LKAY;7'O].SD9R&3#1^X
MMECLR3\="8D?3^Z=]K5=6,G)N%()1K*X.#G!Q&#@Z")+(Z7A'VT;AN.X3A$J
MKY#R*<:)(,%P[I)*'EDD+2.J[#@9.,]-""=:`-`5+_>3XU9_"JEXR%32N)A,
M9#=Y2G4_#&O7_AJX9K6E'D_S%$<I/0R2_9?_`(8<#_\`6I/]/)K-_)??JM@:
M?X[[%-L2:ZPFTI+S:7QN;R+E*=FGXW5L/.%DY.Y9/UB'"_FM%V_F'[(W:GZ4
M9I51^=)=T?`GZC4FY?(WO+=X3R#AN=JO;XBVEVJDC1--$<IO7Y@#\<9U-5+3
M@RJ<1AJI(:`-`(_(I7$D21*'F"F59;"K])6$9R;4C,/G3]E0W7]`ZZ[92MB]
M1RS';!:Q!NCA:G-:A?\`@<DS32/.&[D[JNX6K(`R=S[5AB_5T^51VOC#XK27
MBSC="/PVF_!&^U<B$T'Y,-"ZC/-##.ZBO463+_43K[5-EU#%4W?CU`W'4*GM
M7'4M1+?8^&O:$TD"`LB+2LP;_P")WXW><P/.^YH*Y;=W+4N54D#IT'7VKHD]
MNA>>H/NT^FLP21(XZ;V*(6B-[<5!7999.Z6"&NP)=7EE4.9'/RC=[OF;2%\'
M/'S&B*EAY'U*O)V&F2DB&]"G9EDB8)#5C&,4:CXP),`=V0#I^O:H12ONXZWX
M"#=U_#4CFKPU8JO:A_/JRGL2R5QM>_(N<5*HS[*R==[YZ]23U9M6;<;2UO65
M24+3U+4;9J]V6W#_`!"G&UQ0T-+C8\JDBQON#R=6"58>G7`[A`)'RKJ$TE)R
MTVQX$M.,U/1;#B9Q3]Y+(J6:UN::-CRMVXGL>/Y1*H)V"M'[]BY]^/UOJ&H0
MBFM$+7VU$IQNGIMH.2=ZZ"O%-OAXNP7F=W/]*E*KA;TZ;23^9M6&,KC..GRJ
M+*,].[9YE7#LW[?(WM9MJU9+<L<=^*-?ITLD"*I^6?Z5:W,V^S(JDHA8X&>O
MS-J(*<+N.I:B8O&_AK>L*TK5H+"QV+$`W`\C9F(9J['H8H@I99;<S-\X]`1T
M'M71J/AK]`G#QMI-#QQS,J68Y:E:J_;K<2B.)'W@X2*0^UYI3N[TF[*+G!ZL
M^INNG'&V&BR(OOEJMCILR9\&9OX>J3&`21LR&&KCMP[3@0Y'J8Q[3Z?JUES+
MS3EW%7?<P6['E4@B%J">E")ZEA9[:1(BP.TTRB$;!N'Y`P=Q9M4^I#'?2N*9
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ML5#0!H`T`:`-`&@*S^XO,>0T_+:-+AY"KWX(HF5$8N3FST#!3_\`7/7]@Z12
MO2'*WIMVDL^X%A:_AG+3NBR)'`6D1U6160,-P*O[3T_'7?IE',2./4.%#*$^
MZ%[F.2\BD^A$5@UK34+E!%A[)CD@CE!=Y%,:;8XMJR.Q(*[O9@#7L=)3333/
M1&UN\\GJ6ZJI;"$U.$O<GRII<<BR332QS0R5MOT*&"-N\3&<]V4A&`0*-_4J
MN"!K75F*E1?J9J:'4X+T.\V.6EK<WS]&O)6\8C>"2".T$M8*N8XTC,WY6X.H
M+1D%E7&/0'5(4QII?Q]Q><'4OA[S`\K=F\=^IXB05./K332U*"8:6&SD2X10
MOO9(W=A*Y9@J@Y4C3D2JA5-VM`CF;IC3=:T2ROLS&\->O#O22`\Y!-6D5(4=
MHY>+F*]SLDC?TPV3G/Z]8>NFW\O_`&1MZ.27S?\`5E]Z\8]8-`*_'_YN]^_6
M?](=:>IOI^6G@8NBNK^>KB--9C:&@*?_`+U6/_">7/I]?4S_`)QT)12?W2Y/
MQFQ]N>#CX_QZ;C;.(C]7(A12#$2`)-H[OMZ9./QU544)^ZYVO]"SJK?Q76UE
MW<Y::KX+X+-$WY_\-C14$DD3%6IQ@G?&\?16VE@<Y'IKI2VKHV['Z'-PQ)E]
MR*!N\)7B6R*KBRI63Z@56),<B[5E/3KNZ@^HS\=52;<E%]Y,L;K:F9>2PTX/
M"(J]ZH;\,:U8I*]<D@D.B@@X<[%/7T]--KY25.Z9W^$14HO$N+BHQM%42!5A
MC=M[*H^!;"9/^#2!#8[T`:`-`&@#0!H!9XS_`&>X[]WC_DC6CJ_NU;68_P"/
M^Q1\J&>LYL--QRE29Q,M8JC$6'`*QX'SL"5&!Z^NIIO(JN/.WFW*PU/*/*[/
M%<E7IR#C!7:&W#"6L+LG,D<3,-AW-GY1UV@$YZ:]S(HC12JE&>&%QX^=5"JJ
M#A+O.Z3E.5N<15"]:O'^0</7[KQR6VK*E"+;)%#&!D%F(93G.['4G5%12JGI
M=%6J,RSJ;I7S4ZX2'_'4*,/*AGXM+U5Y)%DH5TD:Q9[I1N_-N`>.)'5XEK6"
MJC'J<=.-53=-\'IT6OBCK32D[HVM)EOP!1!&$C[2A1MB(`VC'1<#ITUYC/11
MGJ"0T`:`-`#,JC+$`?B=`03RO[W_`&S\8WI>YF*Q;3UITOZ3+D/L8'MY564^
MH9@=!`IORO\`O><C+OA\6X=*X]%N7V[C=']1#'@89/Q;(T)@0KP;[A>:^8?=
MGQ-N>Y2:]%#R4;QUQA8(R=^"(T`7(W$!CUQTSH2>U-"H:`@?WQX^O<^VG+--
MNS4$=B+:<>])`!G]'N.M_P#&5M9],,3#_)4)Y+U&G[#<FEW[;4(U0H:,DM5R
M2#N*OW-PQ\/S-6_E:.7/>N97^+KYLE:BPM><>@5?]PI(>(BNUIKW%5*/*R]R
M:6<%N04R%0ZP1*#W&./:3Z?'4?13FZ$_[G=;83]3!5/Y5:7:69!6K5U98(DB
M5CN8(H4%C\3CXZBFE4R4@ZF[S9JQ`:`-`1_R7\RS5@7^E2D&2'C3[8BZD8L6
M7_\`=1?A\6QZG&N^5<WO\$<<V]</,2P\E+8622'Z<7%D::UR4J;H5BC01Q72
MSGV9`<Q1KT.?PRQZNF&F&CP\SDJH[=/CY&UJ$+<5-;LR&IQ\69*8GSWYK+]$
MMV,!G,C-CM)MR.G3.`L<WO04WX:%XD\LHN2\=+/DPAIRR1//!2GIJWT$;'?!
M34Y)DD9B.Y:FCWN,Y./UDL4]<;]?H'+5#=ZG/76M#7$D+/`RJ$Y&\I:1XWE(
M9JU7<JLUF9B.XV,@_J"BSBWP\WJ1502X^2ULV.],@<?=I,K0J!0HTV]T?=_^
MQ)&!P9944O(WP0MEL=6B=Z>V/$F5S5M!\%3D6$Z\?"CVRW:N6*V(H(`[>ZK6
M;IMQZSR@;O\`TL!7,L;K3?@A!X6U+Q9B[P"LTDLK6JLYVV+`.R3D7C!/:B+'
M\NG$,[FS@C)R02S3.-I>HPM/T-CF&W9CFA2M;[Q+T:\2",2A"/S;A`RL5;:J
M;3ZLOIG`$7+%6PVB]Z;8[#*&[$5D%1H[-EA]3;YJVF$C*9"VAD[1$%+"!!C/
M4_+EC#IT]RX>9*JT=_CY'/9K&2&/?**7&(WU+=X[KLI)P+<D1&YI97]L*D>T
M]<9"J+)]KW;/,JUV+?M\C88[9M5*U4Q4[<;8JTY-KQTTD1CND)/ON2_,/4^O
MPW,8BH-N:X^A,'%)2?#U,*Z1PI(Z//`R$QW;DF'E@:0C?5K;2W<LS/\`.XZ]
M1^"J)<[;WJ1"E;<M9+/'9Z<W$0&G"*\";HQ`IW!&1B&&\=&.?5@3D_$ZS9J:
MJF:<MITR(CY3]P[W"\U?H/4=XHHR]65:\\H/]$>5<M&K*<V%5/\`#KGS47.$
M=;2+\E=ZC#82XT:?-\'##R]2.Q%:AC>Q6E4,FXJ&/0_@?3454JI$TU.FX65/
M&.2XF[&>&Y`KQLMA9;U*T#,VP)LQ#*3N7HJ]&SZ:)M2OW0[KPTGJ,ON%%#8\
M3N4G199+IC@@@8X+R%PRA1^TPV[@/CCKTU.!"O%'C$-:#[7S3)%!`SU;33.\
M2A6*;UW3QH/FP/>OP]-1!6?B6=3TV[2MK+<?/XEQ<DL\S<>ERS%/$8WDF>PK
MQEB9B5PNT8PPS@=#TU+UM6U$):$]WH6]QWEM6YY;/P`)BLTXY'[:LCK)&.WA
MF_;1EW8VG\=6:D45]O+Q(UXA5OM]S^:NVK1;,#I](H]J'N)C<^]LX7T7'34.
MNIRPMAZ%N1*>-M7B65J`&@#0!H#79D:.M+(OS(C,N?Q`SH#A\9OV.1\<XKD+
M.WZBY3KV)MHPN^6)7;`ZX&3H!EH"LON/5B?R))Y8(Y+"5H/X;/OC7L2K+([-
M,'(8H45OESTW:*.O?YH2U6T29)_N5>MT/`><O57*6JU1Y8F7/SI@CT^&N_2T
MIYE*>DX]2X9;:/+%CD^8YF_!QO2[>MLSU[]:-ELI8D_G5!S$KJ^T_,ID9<#.
M>FOHE132HW)886W'@NIU.%[)#](CORD-.U%+`T,D-:E)!/#;9FR"+3EX#++$
MP1Y%8OL9O@H.N/-=%>79>=8*</7M(3_$V>U=K7Y/_N?%+W&X2&8)%8=78!1+
M74QLZ;\J^TY'0'&-:N62:OTZ.\S*J;3NT#*I96C>^C9*U#BYIF$]61N_9B$*
MI-(CF18CE70H-ZY!+!01ZT:BHS;W%TX.%R+5^PW(TKM-I(ZZU8EYB&.O7)DG
M";:,^-C$KLRN>IR,YZ=>GF_R%+3_`-/BCT.AJ37^KP9?>O'/5#0"OQ_^;O?O
MUG_2'6GJ;Z?EIX&+HKJ_GJXC368VAH"G_P"]5G_PGDQZ_7U,?YQT)12?W1Y_
M[@7?MYPU?G.(CI<8!&8;:;"TAV$G<@1>WEOPQ@]-1]2AR2A;`M].I3;CW[R[
M/($A/@7@[/,L+IQL10LP4M_18<KU*]#\<9/X#4PM+Q(4</'PX8DI^[@B'C,$
MLV##!9$TBE2^52&4^FUQT]>JXU#(2>!CS%S@:7A/'PV:<DT?)+7D2G"KC=)(
MT;,69$94&YLGI^H:LH?BAVS[)^PA[(CWP=:*^)<6M!#'36!1#&7,A"C(P7(3
M)_P:B`B/-`&@#0!H`T`:`6>,_P!GN._=X_Y(UHZO[M6UF/\`C_L4?*AGK.;!
M5Y6^SQCEG[[5MM2<_4("6CQ&?>H!4Y7U]==,GXUM.>;\+V'F2?D^WR?W`E@.
MSCY7FI11V)(Y9MY$Z]N,.=RAM\C)M'K@9_9;WU1++C??P/$=<Z]%W$GE&"F_
MAMN]`B/`.?H6:MAIEKR1I$D$!F:8;QE>J%M@"Y/X:QU-_42?X'XFI)<D5^)>
M!)93R\G/<9#3#<>L0VRRU;T=M84:+=!);9T#M#@.41R0[/G<#C7!<O*XS[(=
MVL[N/,H2[8]Y9L081(&?N-M&7QC<<>N!^.O/9N1EH`T`:`IW[V>?_=[QJUL\
M5X`6.'[2ROS*Q-:9&4,9D>)#[%5<'>VA*/+W+^;_`'"\JN_1<ER]Z_/;,<'T
M&]D1VW?EKV$V)G=_S="2P?%?[JWG_*[9N7FK<+6;.0S"S,<,!\L1V>X9(._]
M8T(B3;[,?8/P'E>(L<OS<,O)SP<C>I)!+(4A,=:9JZEDCVY8[=V<^N@;+[X?
MQOQ_A8S'Q'&UJ"L%5_IX4B+!!A=Y4`MC/QT(&.@#0$8^YW&OR7V_YZHCB-C4
M>7>1D8A_-(_P[,:U=%7RYU+UF;K:.;)J6HB_]W6">+[=*TL;1K-<GDB+`@,A
M"#<N?494C.M7\PT\[L1E_B4UD]I/^?XJ?E>)L4(+T_&RS+M6Y5*B5#^*E@PU
MY<6KK^\]."=]Q7G%>,?[E<G;Y6_Q`Y&LU1(6Y"J&M6))%D=FDF68M("RN`=I
M(Z?`:H^6I^_WN:[-%IEUS)0H[E[OM+3U<H&@#0!H"/>6RQHL2V9`U1E=FX]/
M:]ADZXD<]$KH/=(3T_'\#WR5HOTZ/70<<YZ;M%L!(SPQ)$.VJ1%A-2J6FVAW
M9@OU_(,<84-@1(>N<``'&SK?;<O$Y6]6<PK17M]OO]N2L6DNV[A62"6*563Z
MLHR;<;!B%"1T.1[?FM&$N'#S*PC.VWR.JY!56K2[J6ZE%F=U(`>?O;E*6)E*
M[C/.#MC4^Y6((7(]M:6XNYNTMB+5)05Z5M[-L%>X\ZP58T@N0+M@A!!BXZ*0
M=,DY5[<P/KUQG\/GAM0B[N/H2D\+^'J81!:M5X(Y7A3*Q\I9A=Y2TYSFK4SU
M>>1F/<D]<_IZ++F^'F]1"DN/DM9OKS21U:[O%"U6=#'QO&TI`Y?+#-8CK&R!
M8\S2'TR?0#K5J>O%OCY%DY<$N'F<;6[INK!2ECGY63*3V(\+#&D1R:U?/R01
M$?FOZD^T9;Y;\JA.ZTWKT%(N,K[2V:3&S,H@[IS=J6I,V96812<@4!+,,_)2
MA'_HD?B/G)3T/A_].VHWVKCZ&P6K[UJ:\C(DLJJK4JTP[2,=V%MW![=L:,0(
MT/5CCIN^6(*+A;4O$F+@HVULU5Q.EJQ)(56_7:5K7(V0=L`#%1:=6PN]HP1"
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M^[S%:.78Q7<A23*MCU!QZ:`W^:1T?X!-:MI.RT2MF)JKF.9)%]H=7_9P&.XG
MX9T[8$]D19PG+0I]N?XMPU3:BP364KW7R7(=FE,DG[6_W'=I+74B''Y7;M*_
MYODN2\J\;XNUP$5&C-#?LJU1E[<4Q3M[B(I^S[QN.2>OX>NH34/<45M\H6O#
MG\;@[:>8>>)SVF^[W,Q6>/$1$<Y2T.OJT6`"0IPPZZ1I[2850U&SPZ>.+[K\
M]4-DRSR1RRS1=DH$??'G#ER2NTC]GXZF>E;_`&$06O=Y>)9^@#0!H`T!C+&)
M(GC)P'4J2/TC&@([]N:II^&<;1^H6T*0EJK83=AEKS/$N=_7=A/=\,^G30$D
MT!6/W+X3D+_D=2:OP\EQ8X8\6%:78<-*"C"-@,_F;>OP<GT&JNI+%V[':!94
MMZ+=J)']U&Q]N/(&+F+%*0F1>K)T^88QU7UUJZ3[M.TS=5]NK8>>JGF?G-B_
M-2;DNW7LRK,IK&/D+$K(B(H7>TT2`=T2.3MP=WQ&->V\C+2C#P/'ISJVX1\1
M-%QO)>/WK$;1UZ\BLL=F]8F>.&"R@<2J0N[ZA&"ON5%(#9"GVYUU=2K5KO`Y
M*ET-G,>"Y#D>?XR22:O5$N%;E*Y6.LTT#%W6*2NC(DD<8'4J,8W$X]QM]14T
MO'5[2OTW54N/L,ZMJM'/RUVLY[3VRU2>U`EBU+/%&[E&GLYA53N+%6W._0>O
M74-.2>CLW%DU-ZRWOL,(QR//6/H3`EJ_7DB55,:Q]ZJ\PZA5;&'_`)LJ(QGV
MGTUYO\A=2HW+QMK/0Z&]N&)>.O(/4#0"OQ_^;O?OUG_2'6GJ;Z?EIX&+HKJ_
MGJXC368VAH"G_P"]5_PGE_?ZG\HZ$H\P>3_<[RWR+Q^KPG*61)2IA>V!NW,4
M4C,A).[.<]?CJ]5<5<5IRX,]0>0U)[/V\\-$,X@,/%1S,[.(UQ'4B/4D'.#U
MP.N=4GA;>B7#&!.//['-U^'KS</(\=E;"[RL1G4H8I`0\85R03CT'KC4.I*]
M)[252W<+_N'-.GV]2W865IHC4EFK1A5ED?>@,>#@*VX],>ATBE.Y!4MRO=MH
M^\-C2/Q7BU2*2!/IT(AG&)4W#.U_:G49_P`D:*&$[=O$/6.=20&@#0!H`T`:
M`6>,_P!GN._=X_Y(UHZO[M6UF/\`C_L4?*AGK.;!3Y9SO%\#XYR'+<J-U"I$
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M:P5J#9MI<4CIU4L&@#0!H"+>5_:_P/RI7_C7#UYYWW?TM%[4X9E"[^ZFUBP`
M&"<XT!!7^R/EGC1,_P!N_,+="./W1<-R)-JF0G6.$%O<B%BVX]?70F(E\4\E
M^Y?VMH3\;Y5XE+R?#-;L7)><XAN\$$\AFL2-$!D*#)[`VSXZ`96OOSX_Y/SG
MB''>+\A9J7K/-QQ<MQD\)BF-3M2AEDR'3#/L.`V=!`NO0@-`(_.;$%?PSG99
MY%BC^@LKO<@#+Q,JC)_%B`-=^E3>;3#\2.'5-+*JCH8E^RO_``OX#_ZS)_IG
MUW_DOOU6P./\?]FFV)-M83:&@#0!H`T`:`1^0/"MNJ8(^[RJAGKC<4B1!T:6
MPPQ^4F<[<]3Z?B.V7<XW6N.69>M-KQ`?HWC#6;2K0L.)I;%A6+<@8L-)+(%Q
MLJHO2,?*3C]D^[M/!3X>IQEBY<?0W7K9[7U;JL,-9EEH\?.2>T)7.VY:CSW&
M]_\`-1#J#@=#\L4TX;_!>+)J>.[Q?D:8ZDM;?=D[U>T3(UCD[JCMP*K&-K*`
MA=\LP]L:D>Q?AM^>6XRW+@1"$][XF$\UF".*C)6EJ<188/N"B2UN4[EW,3O%
MJRY&/VE&,==Q24DYQC5N]B(;:E<M_M9V4HW^J6&+MU^3@793K`!Z]-<;C75L
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MK1AQ]+;(ITX\/6VW9`\G9M0_FU.'[D8<.N^SW@<A(B1N-J=L,V/YO_IYVP\,
M:MWL6\E8X4VWO<2WQ^"S#0"3)'`H.(:4."M=``!&7'SO\6/XZS9C39HRTTBM
M/NSQ4\O-"U-4H?P@K"+]R(0MR8B9MCX6<@8QT3;UUS5.A/;-KN3\&=>98M;)
M+>UXHFGG*QKX),L6>VHJ!-W0[1/%C.A!Q>2\NM^]Q\`B,9XWR2K4+$YWGZ7O
M;ATZ?SV,?HT!W?<I)9?%I*T=Z&@]F:&(2V).RC`R`F/?AOFQZ?'TU*C@HD.&
M-QLXJ%*'@1CN25WC@JSF:2#W0;!O)Q@'("^O340P:@3%8$"\-X;AK'')R<_.
M)2X]9I:E>#$81I>]W-Q:POO<[L;@N<?'4\E;<$D^R(^I33.+[X<#OXSZX?=R
MU4H6VCAB#RV(WR8WB)3?&J$$AE8_-GKGIZ:CF>JVL<JM`W^(O9M_<_EKL,07
MC>U813MD0B82QJQQ(`=S]OW8Z?AJO-3&"AWIV\"SIJ2B^%D69JQ4-`&@#0!H
M".?;W^RT/[S>_P#MV;0$CT!7/GM[R+_>J&AQO(-4KO5A>9!%8ESO>Q%T,*L%
M^96]V/E&GU.7\/;4EQO"R^:<^Q-CW[I1K)]O/($?.QJ<@<KG(7]HC`;T'Z#K
M1TGW:=IPZK[=6P\KPT..B\?GJ/<%3EN.OBQ7VM@ST[2*@,=K=VQNZ8(3'7+=
M/3Z)U-U1A%-;UJ/`5*5,(S3W;1=9XLU2DE*>I)4:6:+C[KH5>3Z256[AW`HN
M\RA=S>W`ZXQJZKC?&./:4=,+H#/D;=5>43ADXV.K++*BW6>W7V3U0=XB%D@1
MH=JHHD4CJ#ZYUSII<.:.YW[#I54H\L-ZXFR;@.46>/D8&M0VWL071"KPEDDD
MF:-Y(ZQD,CN)$*(OS$*6)QZ%F*YPA=9AY;OG;477]@`I3GJURJE2_6LP.U"0
MR//`1`8QW#/[]^,C/X=->3_(_P!+3BH7GJ=!BG>7!KS#T0T`K\?_`)N]^_6?
M](=:>IOI^6G@8NBNK^>KB--9C:1'R#RVCQ_E/&57YJ*K`',%[C^RTKR2SJ#7
MS(O2(#J>OXZLD]4]<^PJ^V7<0W^]5_PGE_?ZG\HZJ71XU?Y&_4="3V5RO/+7
M\*\.IU+,0O1<;6FE@E2-T5340+(QD*[64G<GXD:-+%)VMM"56'-V1\$_0FGW
M)YGE.*X"*7C9E@GGG$#2NH90C1N3U)`4^WH?QU*J@4=,;>C.;F;UFE]MZ=SC
M[>V>!*3_`%`D23/YD?<&Z4D/GJ,9R?32<9J.WT"@[A_XG?L<AXY0NV',LT\0
M=I&"@MDG!(3VCI^&C9,(#;4`-`&@#0!H`T`L\9_L]QW[O'_)&M'5_=JVLQ_Q
M_P!BCY4,]9S81WS^I#>\8L\?+43D?JFA7^'-*L1G59D=T1F9`6VJ2!GJ>FN_
M3N%:<8:SCGJ-,+RJIHK?=3EZW/VN!L<5!5K?P>?;$IKP=N)EL&5JYCR[A6;V
MJQZQYUZ*:^%TJJ,9^5]KS`XWI\L(2M`TT>/_`(OP=:6".">8<@8>8CDMRUX[
M-N$6)4BA^H3LM'&S#9@/O&`<;=355RU..B4KE+1,K33S4K;.>,SI^WJ\IQ5B
M6#FI'KV*TEZ#C:&(6C>-X83`.\P7MR;)/FP&91[O3!KU,*E[NJ+[RW3QI?O:
MX;BSO$>74V+7!2F-)Z`5Z\:[%+UI`#&Z)'G\H!@H<X+'.57&L&=1)5:>)NR:
M[Z=!)M9SN&@#0!H`T`:`-`0CS+[<UN7\B\9YSCJU2M>XCE%O7K139-+7[;JZ
M!D4[V+[#[OP]=`3?0!H"N_OKR\=7P:7BDC::]SLL=&E"N=S.7#=,`Y^7T^.O
M1_B\N.;S84S9Y_\`)9D,KEQJD3'Q?BVXGQSC.,<()*=6&&7MC"%T0!R.@]6R
M=8\^OGK=6EFO(HY*%3H0SUR.H:`-`&@#0!H"/>5.A:M7E?O1RD[.+4[#8D!&
MWO29]L"9R_3KT]?E/?)Q>_1ZG'-T;K8"J:K!]:LAE%_F<=R7NJ4IQ!0&2PV?
M_80@_E+GW-D_-EEZ)N&BG?LVZ3FU/35NV[#Y#VVAF9WC'%/ML7;5Y6WVT#C-
M@X'1<IMACZ=#G&W"L>_5AJ\PMVO'7Y&,D[*].#&R92O\+HVF+=DN2$M6]QRT
MTC?S4>?7\/<5E*_?Y+5I9$;MWF]9].(Y))Y"E;D8U+<ER`]ZU1(`,`#*/<D3
M"^P87X#&`T:L,%I]!QQU>IRH()5$J12T:,#&`&*1S8G:3/Y`&[:]EV+=Q_V-
MQ7.[++:>UVGL(EL5MYLCM(TE=JL9ENIMCI1T67L5,>Y:L;%2CNZC,[D=%_\`
M14H:;M>.OR$=%^K#5YG3MEM-9F:1[6[*7K=8'?.5/_P-$9RL2GI(^?UG.2M;
MH86O9:^-NQ')4KH*J0+&;$%F0_3UP.U)R!0^PR#J(ZD"8'3VMZ@;2`UFYQLO
M5E4I0L_1#"W!/'92*VE6SRJ'ZB)T7MQ(H&6LV\8&R-AB-3U.T=<Y*TI<I1A:
M2+M3G"-IL7?4+.+-6*55HR1BQR/(VE!>52P*V7!^!*X@B'0CJ1MPK7A"#QP7
MAYLI&,L,7X^2/MP+%66(1R1,H[E*G[FEA,AVB[;Q[GL2,?RH_7<?UE5-]NY:
MM(JNMWO7H.T'D;5P&:;_`.Z42!)9\!HZ".`-B!1LDN2@]<#IG_)P&I)+5Q]"
M\V]?#U'WC)@_A2K!7^E17=>TS;Y<ACDS'_WK>KC)Z_'7'-CS3.N5"!6/W%7C
MSY7?[:2V+?9`-9A7[9F^DDS+F7W;(:VY\'V[\?'7-J-\ULCV7K:=55#5V[[G
ML)CY3]/_`.&J_3%S7[5'LF3Y]G>AV[OTXT(%-_\`ZXE_[WU/^S8M`2OSE*#^
M+7Q?G^FK!5+S[.YM.]<>WUP3T./@?4:ATQT=I*<-/8*_&HX+GVX2&E8[L$T$
MT8FEWU@J.[!\9WNFQ2=N<^G74PT3V6\"(Z9;2N.3XCBN/X+AN&K*EZE-:LVY
M;5%N^,[D#1+@(/<1EQC\,:K4N654GK:\UZ%Z6ZITS['Y5$T\$X9:?E_*V;'+
MT^4NS"15$4KM9BC60>QD)VX7H#^&KNFN^I;_``AXG-54W)[O7P,O%?(><Y/[
MD<S`;BR<'722."N6`?N1R(NY8]O15R1NW=?PU'.[H2TR]O@.3'S]A86A(:`-
M`&@.;D;M>E3DL3S)"JJ=KR,%7=@D#J1H!']M8+,7@G"M:8/9LUQ;G8$$%[;&
MPQ&%0>LOICIZ=?70"'[M\[S/%_PA>-M25A/(_P!1VY4B9T$L$>T,ZOU(E('X
M$Y^&K4U-7+<GQ*M)W\6N`K\TY?D;')^-)Q]NUB[!4EDXQ=J"=6+2XEM*R.#V
MXY,C!7I^)T3:NX/FX-=@@G?Q4.YM=Y+ONG.\'VZ\AF0D%*4I]K%#C'4;E((R
M.G37;I%'-IVG+J7_`.=6P\Z^.^*\%R$5S@6#\;?Y2%)I+2/-]/38L)X:MA),
MEXUCC+]WK[BHS\=>YFYM5,*KTM^M>1XV7ETN--S>[4<M#B/(*DB),4XR1*_T
M3V;CQN\E9^X"168%A"]8Y1>@+KNW9.K55TO7C9[2M--2E=A9;#M;F?KX[5FS
MV^8FX:G&LCXBMU9J[N(XXF0K&R-'+N5</N*L-N=N33DA!+W>9[&7YXSO@A)3
MCFECB6PT7&(*,<<.YI4?M,P+J)G#&-7WC!VF++]2/379M*Z<[6O.23V2M:XM
MK^[LG*0<WY1!>B>HTGT]DTU&^`M)O!F24LV3)MSCTQZ:\W^2@Z:6IWGH?Q\4
MZHEXZ\@]0-`*_'_YN]^_6?\`2'6GJ;Z?EIX&+HKJ_GJXC368VE+>=M$?NM2I
MQ3UE2U)5DY&"22:)"(BO;,I'M:0^B*OKTW:0M%>4N^8M<[/P.G^]5_PGE_?Z
MG\HZ$H\:O\C?J.A)[.FFL0>(^*FW7CN<?)Q%80H)IX'3^BQB7N=E'W1GH26/
M342UK9#Q*M;'M0_^\8E?QNM"K,$GM"+9$KM*TCQN(PNR2+'7/4GIT/PU,;63
M$L35=X*M4^U]:I6>21)#4LHY`!WO+')DA%?VY]<`G&HGBR6T2CPL8\5XP88$
M0*#N]?CZ]%_\VI('6@#0!H`T`:`-`+/&?[/<=^[Q_P`D:T=7]VK:S'_'_8H^
M5#/6<V%<?=;C?XES_AM(PAUGO3#ODLC0-'$)Q)'(H;:_Y.!T_$=/4;NDJY::
MWJ,?54QJI6LB/,6JM)9N`L)%RGE5VK5B_BXJ[Z:TIR'>.7Z@A/;'&0FY\ME?
MEQTTT)OWE*A-RC./89ZW#W;ZI3U#I.2\0JU9?(RXCXZ9*5;CZ]X6>/I1O6D$
M17L/'*(U##=OVYVM@].NN7+6WRXSC"#9TYJ%[V$H8(Y_&YX*H?DK,C7OXM;M
M21VJ)DJ-'!9988YC&X4AA(>TKIA>WAFU;-3<E*"5\[:=I7+<)N<6[I#6KS%*
MIY>EZ&2W8I^V@J3+(S-9`$2M*[O@'&<2O@8R.IZKS=#=$)1O[+8%U6E7&<+B
MSM>>;PT`:`-`&@#0!H`T`:`-`:IZE6P8S/"DIB;?$74-M8?M+D=#J54U<0Z4
M[S;J"0T`:`-`&@#0!H!-Y!5LV"J1Q5YHFC?O5I2HELJ,'L*S*0J_M9_$#T]=
M=<MI6N.68F[7D?,=20+'4J$U+<A>GQ[$J]MD])K!.=E2$8"K\1CI\H/>>+FL
M=&S6SC+!2T:=NH[.5)EY"NYFKV;L5=)4(7;5K``EK<YW$L,_S*%O_JL*47:M
M[U>9>N_7N6OR%U:51)9GKW#3@BC66Q;M*6FD$I8?6`%=HE?&R%!^R?3&U-=&
MKDU&UWF<T[VG"U_D;H?IHI8(I/Z$8QOIPRCN+4:4[8[5W<R[K$KGVJ3T_P`X
MZJX[?'4M190V>&MZS$,(3,&"5)Z+2QV[\7O2%97)Q70>TVK`(SM48S\OHIF_
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ME.4%:2)G+&U[-=.98I+EFERDM:(PJ]Y[48WE)&(%M2`=TDFW$2,!@$=,;5TJ
M5R:MH\Q2[VG;2?9XZ24^W85H=@`I<6I+3Q-.&V3SJ'222S,PP`&RN<_Y3:)N
M,N_PV!I0GW6Q)9PBVQ4)LN@;=A*L1#+750%$.\=79<>XGX^G36;,A&7M-%$8
M3*U^X5[D:7D7)O)1ALUI*W:BL.]162.:L\:(>ZRN`;15O\&J03O3[G;4=(O!
MKOMM);YB)A]O6$Q!F"4A*1C!;O1;L8Z>NA`DO_\`7$O_`'OJ?]FQ:`DGW%_B
M(\.Y%N/F2"PB!C(Z[@$##<<97)`Z@?'T^.G9$2TP%GBTLK_:A9+SBPQI6FEF
M:-L2@F0[VA&6&\=2GJ/33;#P]A.R?$@M'R:Y!PO&P<#7EHU6M6VY!(I'[DDZ
M.BY:24%E#$GUT35-WG_U(JI;O\O^Q(O&[L+?>3FJCUI866&5Z\@517;K")'&
M3O[C'YCC!QJJY<+=OA`L^;&ZVKQ&'BMI8_/^6XT\;3@GC6:66W65P[*\B%"S
MLS*2^?<HZ@C5H+0X_-'=#N(B]*ALAXD_T(#0'#SEZ]0XFS=HT7Y*U73>E&-@
MCR@$;E0MTW;<[1\3TT!CP'/\5S_%0\IQ<W>JS`XR"KHZG#QR(>J.AZ,IZ@Z`
M6^=>.W.?X9*5859<3J\]2\A>O8A*M')$^T,R^V3<K`'#`:`^?;J2=O"^+AG*
M&2G&]'=&"JL*<C5E;:2V-RQ`GKH!%]UX58<>\W'MR=?MVHUK1+F1)9$4)-NV
MMT3'I^/7KC5:N7^IP+4QPGW^`B\JX)>0Y[@J<T,=KF3QU<<7(LAK+6FB+/)(
MR$>]656*IZX5AC4Z^&.^X:N*]+R9?=,3?^'//B(YG^C?MD?Y?3;C/Z=:>D^[
M3M,W5?;JV'G252[#G4MK&[=M[E*)=[*U<QM!-:$TZ*BN'VNT1;8.GJ=>XOPP
MMJEQ/%_NMVS-'+-<N1?Q)8+"<I+:*U*EC<D$[Q'O)(M?"QDJSGM(&<;>F/5M
M6H@I80M/B*HN>)KY3D+G"VZ\M.X'CMQHR0688(HF^D01N>Y&PV[]I,;)G.5P
MV[KJ:*56IJ[;B5JJ=+D[(8T6YB_5:PM:O=2\MBW6K+`RP5Y20TE<3DB:%FCL
M$Y#+Z+\V\'7.KE3A="6W6=*>9K:61_=^2I5L>1+';/(VI+D<5ZTJ.2]K;(\L
MH)VD0D]`70'=GKU&L/\`(Q:IE"6[S-O003JG$NC7E'I!H!7X_P#S=[]^L_Z0
MZT]3?3\M/`Q=%=7\]7$::S&TIGS1?)G^Z4)KR7X>,$]-&[<4KU]N%=I-R>WY
MORRI_'.H^I2G#W8]D>!/TVU&#[_4W?WJO^$\O[_4_E'4A'C5_D;]1T)/97/K
M%)X+X%',FZ,T8&4_%9%JQ;&`WQY(_2<?B-._?X<,2+8>)-/N!XQ?YSCU6O:"
MQQ>YZLA5(R0K?F=SMR.K+D>GPU#;P]=X7+CQ?@<?E4$4_P!M:M>&3ZD%:,<,
MM;<=[K)&JM'M5F]1TPNIFM5MJXD)VM$<>`(8_#.)0QM$4@"]MR2PP2,,3@Y_
M'.D02#0!H`T`:`-`&@%GC/\`9[COW>/^2-:.K^[5M9C_`(_[%'RH9ZSFP0^4
M?_&>/?\`WT3_`.U;&NV5=5\OBCCFWT_-X,AGGSS\9!<LEZMNUY+R5>MQJA&D
M6%((63>%)VS3]&"ID`L0-:NG]YI32I4[:#-GRBY/F<K:2'<;RG&7[=*+R.G9
MCCK)-:I\FMB.:A-9EA$<D44=D396$PC:I+>]2SZU54-)\C6S'=I,]-2<.;TW
MDNDY[C7XV6E6Y6.+ZA%K0V5JNZ_1Q'I.SP?2J)6[F\*.F!@`^NLRRW&+6_'>
M:'F*$$]V&XRGY'BK?'+P\;0BR99Z_*V80C31.!MB,RKW(]\O<Z-)\K$84GIH
MJ6GS=P=2:Y>\G'AW*0\CX]5E0R&2%>Q8$[.THEB]K[VD"NQ)&<D=1UUCSZ.6
MIFK)JC2AUKD=0T`:`-`&@#0!H`T`:`-`&@#0!H`T`:`-`&@$7D8X\S55-;ZO
MEG/]"A5BA(5@Q,C+\L*L`7S^CU.!KME1G.%-MYRS(2TVW">C86QR$D0;ZQK4
M4SVK!4#Z[M+L,,)?VQ5T+X!S[C\?F8]:E!:(;O4Y4N+T^/H?!62>$FI2_H4T
M@DK4)&*M.QSMLVR<LE>/;^6N/@.GRC2,+W/3X+6(1N4K3>H)*-2I/"8;GU_*
M)"L]CD++!Z\"@>VU)UZX7I"A;\3_`)3:*IM706CP\PZ4L8O3X^1KJS*%EE[C
MUN+@(EM-85^[:$ZE3+(0%WRR=!%%^SD-C.U1+7?PMBR$^[C;`U6XX36:K)!-
M'(L1%2E`#(]0S^U))B&7?:G9OBWMR3Z;F,ISC9^B(:E"R]6;>Z%WLX-)Z2"K
M9L1LLBUEZ**U$1JH,\_3)VY7./\`)&HAVQWZWJ1,>R&[4M;#ZBG)5'TD$E7B
MY4CK-4BV]ZU,A9OIH77J5RY[TN[\<'YCI!QG-\-?DA%0E=QU>9MD`F"P6:<'
M(V%?L5(ZQVPPR)AGJ/A1^3&H5G8YW'(P.BZA2FG"U^TEZU&UVPTS;IJ=VPLQ
MFC=6^INX`:X\?3M0*6793B)]Y#=1GK\S&5)I66W60YINS]#56BQ4BKB+ZA+!
M:6K6*]I[A4]+5L#/;@B7&Q1T/3`'M42W.-EJ6LA*4+/6]1UQ*[]IK%^.S<JU
M4GJS3H>W!%@'ZFT1ZRX9NVK'X>I.6U5ZE)NR19:W.%FS54M(U6S+5O)3J5V!
MLR2J)+SF48-IL@D32?)$GP!]/1!+4U%1>[9LTV9"<G!P6_;Y$I\?A,/%1)])
M]"O4I7+;G"DY!E/_`+QO5^IZ_$ZS9CC5?$T9:@KH%7?<1N/'EEX1))+=[(S`
M[5UC,GT<FZ?\T%ML5;<1GV[\?'5.6.OLCV7K:=$X:NW?=V$P\I^G_P##5?I@
MXK]JCV1)\X3O0[=WZ<:$"F__`-<2_P#>^I_V;%H"4^=UN0M>+VZU"NEB>;8N
M)76)8U#!FEW-@;DV[E_3C3LB2ML#C\:6QPOV_#W'1)JL%B9Y1(DH/N=U=Y,[
M&9A@L?3.I2=S5MA#J5\96M<0E^.Y_P`WX+C9;4_'\/)2O!FLQ;HG)&"86C(#
M+(W0G;)@ZB#_`**?&W:B>9?UU6[YVD2KQ[EN8G\_Y;C[D\3P55<PQF%(YMC%
M"AW#+%`"0#GKI*^"VV?@1/2[=GB'!\+S-/[B\I<9ZPXNU#(_8B?\WN,Z;7>,
MDG.U>IP!I!_AEI$5IGH)OH`T`'TT!6%GC8+-^#[D_;^5YI267G^$B;MKR$:^
MV56B<8BN1$?$`MC:?QT))7SC<OSO!"SXAS<=.R`Y5^U'8CD)C($<@/NC=6(/
M0]"/<".FA!L\"N<5;\3X^3C!(M=$:.2.P%$ZSHY6<3A>G=[H8O\`B>N@([]U
MI;\%O@9ZLMN!$F(EFJ1]W'Y]9QO4@]`$9L?$`K\=2JX8I;8^!#ICAP\13]PJ
MTT_F'CD[ENVT4(-A3%'-G,N2$D9<-EU&,>C-\=$WA'LYH;F3!8[^7Q1,/N@9
M%^WW/-&N^057*(3@%AC`SD>I_3KOTGW:=IPZK[=6P\U6*\LG!4N+NVXI;4]=
MN2XFI=6!%B=I"9%BLL)R4_(93$[)NZ8SKWD_>;2U.'EVWGBP]U)O6K=@]\?D
MXWRCBV'$BIQTJ55/)%I)Y[N5`-AW[C/FJF!VH%R'9L=.NN.8GEOWHN<M&KMT
MLZT-5J4%;AJ(K;\8KF#C9+%A;$=I9*M6LA)F9X)%::0)&/9F)ORLA\J!D?*-
M:*<V;A:V)GJRI*-K87C_`(OF>?JP*T=N6[3C@@IT^/:-$GLQ%D=0[F,]M1#T
M7W%LKD'"D#C712W=!WQT':FNI+26/]I^<IMY7SL/']E*5BQ6C5F&Z=V6&8,'
MDVPJ'_)R8\,P_P"C@C#UF6^2F-\'X&SI:US.%Q<FO+/2#0"OQ_\`F[W[]9_T
MAUIZF^GY:>!BZ*ZOYZN(TUF-I0OW`Y7E8?NHU&K=*TY+%![<)?;M'Y0(0;QN
M.,'Y?CJZKJ2@5=-,8CK^]5_PGE_?ZG\HZH71XU?Y&_4="3V=S%^O6\"\-63C
MQ>)XJ#)=I(U5&K1!AN0KG?C&T_KT@L=SAX,K/VJ(W^YB\;3\?H<)!*ZR";N)
M`S2-NB[<H/<DWH=FX_%NOIJ8M3COF):-TAMR]F&K]NZLICCNI'!3`5W*!CF,
M91DZ[_BN/5M(0TK9(1C:(W\0E@F\9XZ6O6%.!X@8ZJY.Q23@=>N?QU$L`XXC
MC0!H`T`:`-`&@%GC/]GN._=X_P"2-:.K^[5M9C_C_L4?*AGK.;"+^?7;M2IQ
M;4!$;TMX0U.\G<3O25YQ%GH2OYFW+#'3/7&=:.GI3;C=#Q1PZBII*%\?!E7^
M;<3RO#>8\5&+=>6C'#6B;BY)&BFY#OR2&PT(9NVCM,Q.P$*>F[VC7H9%:JH<
MISGHT&'.H=-:GV:=(E7A_/.1K\E)XU'-3LI9EAJ7Q,O;5`\<30K,B!I;-AMK
M/.0!M7:#C77GRZ6N><KK8+0<E16X\LK<7I)I=O>4\/:2U<KV^2CBBH53&R$L
M;,,4,L`4PF'W-9GDW'W!MH0XUEIIHJ4%!7]WL-+==+BYW6[S6MJM<D?E[?%B
M7CH(6EA\BKJ:TZR2[9I9E@!1['R=QUV#`&/=EM3!KW4Y_AO]A$8S:EIM>=?A
MWD-OB.7KQ<IR->QQ]^-(%Y&NIF%RTF%B+&(E(YNW(BOC=NP,;0NJ9^6JJ9)Q
M6&A>1;)S'35-R>\M?7G'H!H`T`:`-`&@#0!H`T`:`-`&@#0!H`T`:`-`(/*6
M_F(Y#N@GS&:D/_Q-ISU$`;]B+XR-GT_1G/;)MH1QS;:Q6)58?3OV^2Y(S*:M
M2%W2O`]<>Y2``JP0';ENN]AZ9`4=(8W*V]G..%[MN1Q2S&<3"-EM12J9[UF:
M05S=BBR)"C-D)5B]`H^;/7VEBUTH:O#U*MQM?Z&Q3"B01I$.U,XEI5;1V&=\
M@"[>/3;&&QVX\>N`!G`6+>B\2;>K"*-X7RTT)LP)WS8PAK5(B#BW*$]CSR*3
MVE_97_TF8W&U^K9I"4+7:]N@WP6S'0L"%Y^,J1N#8GD4M9L+8`(<$IDV9",*
M`?:K>F["B'3/2]WL)3EH5MYSS//6[:052ER`*M6E$O=6@LW16;U62W+GU8X7
MU)QDO*@[W+CZ$.*N4^'J9*JU^\[2")XB8KMNL.D+2MDTJ*@#=-(Q_,D`]?PZ
M!5]M[U"ZVY:S8UNG/2B2I3-;CI52M]+"1WKLJ9/T\;@X[*$MW)<X;KUQDF.5
MIS<^&O;J)BFI*7'5L,[52RTE868(N0F;*TT@*K65D.'KRD)D00%`W5O<PZCT
M4$U.$N.W:PTY1G;@CDEE,F&PUFC;?/(\DQ6,VHXB.XPR<I4A#=%7YO\`H[BU
MDN]7+1ZE6^YWO3Z&Q%41Q105S)')FQ3I3='L%/\`[.O'`VQKC\N/]73T"QMM
MJ1-O5FS*!Q*7KR\B%%N7DF0*E:%HQBQ953VWFQGM)\!\<98QPNAIU+5I)XZ=
M&W7H)+XZL0XN,Q0RQ([,X-@YFDW'/=D^(:3YL'T_`>FN&;>=\NXA'W,XCRB?
MDH;,!KMP<YAJ688!'%R,BR/[XEFE5@=_[*J5ZZXRC\/^J_=[3JKK^RY=Z]"0
M^>J%\'L*`R@?2@*WS#%B+H?TZL5(_?\`^N)?^]]3_LV+0#_[G7HJ?AEYI8S*
M)C'"H#;0&>10K$_@IZX^/IJ4!;P/&TW^TGT<86S#]'8*F90%9U9V!97]O1QG
M\-5A'63&#T%9Q<3-R/C?$<9!]4]<SV++/5A#(K=Y0T,DC]=P`'4C=^!TJKA>
MTG;1(M31S3@WVV9-J4/(5_O#8FJQ1S+,C+.G<SVX&,>9<@GW%A\K#ICIZZLY
M7IV[+NTHH.YJW;X&_P`/!;[F\W/#;$M>=)G:'"]"'C4!<J)05(.\%MO48U$'
M&=NVT!*WD65H`T!C#-%-$LL+K)$X#)(A#*P/H01T.@(=Y!X]RG#<I-Y7XI#W
M+<N#SG"`A(^0C48[B9]J6D7Y7_;'M;X$`1FEPUOC_+AS_AEM*-+RV(6WXNXC
M_1RW$(:=9%0[J]AD+$L/V@04.#H26)XYPAXJK8[C*UJ_9DNW.V,1":;&Y8P>
MNT;1U/4^OQQH0*_-_&K/+""S$]9HZL<ZRP75=H0)5'YR[.O<CV]/_J:B+LX$
MJ&SLB0SRU(H98(4NB2.3BJ4<CRH'EOH)<`5&8,4DVDDX_$?KU+UPBMVM306J
M,..V3)WY[7JS^%<M!:CFEJ/6*SQ0#?*T?3<J@D==OZ==NG;68H7G#/2Y'$\[
M_<3P6.E0B@GNM:-&[#QU"Q*P4PT'"R)7P3V\+]4KJY<].AQC7N=-U$7%*]1>
MW3N/'ZC(@K[G#LLR-5*_D-KS`5V@K\=:J<DL%F\S)`L1/Y;12S9=7#+'D[MY
M]3\3GNW2J(WR."53KA=,E=KR5^3X%HJ%&O3XB6\*5*,NGU]@&X\DM>DAWQ!5
MCFCP2J@,%.>@QG65RU3<:H1U77LT/,YJ9*4>V_`3<CS_`"-SCIVI[DXB98JD
M#UX8TO/<02(4E"R,?SS(W>8'#9]HSG76G+2<_BOU0],#G56VI7;XEC_9U^-7
MC^/J5*\<,]7G$2[)%N"F4T++&/:W_N<[-VYMV,[CK#UL8MO\/BC9TD()?W>#
M+UUXYZH:`5^/_P`W>_?K/^D.M/4WT_+3P,7175_/5Q&FLQM*:\N3N?>*G&QM
M_1X@:<110,.\I4QA"0TA7'SY]/@=0TM7^WQM`LF[5>$?:;?[U7_">7]_J?RC
MJ2$>-7^1OU'0D]E<IQT'^Y/B5^?D$K+_``F"-4LRN(D8U8_>B)')D]/=N_1Z
M:0;EA_I\2L4MO^KP8_\`N59_B_C'&M1D9:E^QL,RJRS`]J0KA"I/S*1C&0<'
M1R\_8%._P\T8<GXOP7%_;^E_$I)66B\,Z6.RKR(\LD98"$;`<D`>F?\`#J%%
MXP[X<2:FM'"/!DI\-/')P%6I0L26(JB",O,C1R9(W^Y6`(Z-J>V)'9`=Z`-`
M&@#0!H`T`L\9_L]QW[O'_)&M'5_=JVLQ_P`?]BCY4,]9S81+[@V&B_@"Q7(J
M<YY-'[LNW(ACKS-.R*WJPCS@D$`XSTUIZ9?%*/N^*,_4/X9PGX,KSG/X?S7F
M_CK]OD+T$4\3U+->=IK%69YPPDLPNK1P(F[#93W!=N<J=;LN-.75<O'9I,=<
M*LRF]VQ&?(^8T/'_`+B1\=P]JJ:RTEC>@XFRYEE,H:.<&5&5"TC.2%V#.<]`
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M^N1T#0!H`T`:`C/DWFM+C>(EM<>&Y.?<D4,5+9.S3/,(4BP'&&9]PZ^FT_AK
M1E9#JJ@Y;3AF9R2BIB"U]UI@\M=>/-:W!%]3-"769S%NVCM@%`6,BM"R,05;
MJ?;DZ[+I,8RM[3D^JU6M(Z_#O,>2N7QQ_(1N`RM)#*Y$QDB:0B.6.>&-(I4Z
MB-L*-I`.65@VJY^0DHHG)SFW!DWAGAF4O#(LB!F0LA##<A*L,CXJP(.LC4#4
MG$SU!(:`-`&@#0!H`T`FYG>O(TORXTBL%JTUO.)ML@)[49#(RYV[BP.1CH/P
MZT7,Y5WH37Y(9XX60):K6XUC`K#9-R4D98%#\4KIU9VR0P/J0?=UI4.S\OJ<
MZI]N_P!#+N-;GH"V#-'(%GK\9M"+$%P'GFR$Q!'MS$K=2?7KC:A!.'?;'2(Q
MA'NM@+KA[]9I8(5MKE[5ODK\:"O814*=TE^BQKN98HU]?7.WJUZ9.<M2PMB4
MJFO%V[C;:GC@C:6.J8XDWW:O'N'8@`Y-ZZ.KG&/RHSU_PCV0E''5'P7C:,MP
MPUP\7X&%*>PT"/)((IJ:%N]*(^S1A?KWRL>8Y+$P;*`>@/X9+S4EW[]6Q$4M
M]V[U9E&G84S(MKCXPKQ6K$@/U$BSR!XXXE.YFM3=-S@]/C[@-L.>AVX!2TJW
M$PO@1P&-XFAF@588:U<1R04EG]B0.9`4::</[W/RC]!]\TWVGZ*VI5;5ZLWL
M)CW/Z3&DPQ3GOKE8T?Y5H4M@W#W#\V11GU]",)'9KAXOPM&?9Z+Q-<+0O1B2
M.MMJV52-JT!(;D)HT`,<75ME1.I9AT;K\#[COOGP]0KK3]#89)IK$<4\-?D+
M+QI)47MO`L14[V[H8(WTL65*[@=S?\[HJ$%*5N(O>FW`^-`]NI.T3M/'9!<S
M';W^1D4A=X1B,5(MPPHZ,/Q!]Z,':7J(15I^AE`;;)4@D1[DB`2TJ$H*NZ(Q
MQ<N^NT#&(H_Q^&>B'";NU^"\;1*,L;7NWI*^(AGBJ'O,[O([R`RL6DPYW`/Z
M!2,XVKT'PUFK<S30I%9?=+GN1K^2U>+KW[_'+,(Y4LK%6F@#J<CZ>*1#))+G
M_G8&H3>$'MIJXK@2X8[JH/NBH;29>>[O]R+.XLS?T7+.,,3]1%U8#T.JDD?O
M_P#7$O\`WOJ?]FQ:`EOFMR>EXQ>M5VC6Q$J=HRJ'7<9%4`*01N.<+GXXT@G>
MHB.N`MJ\E;N_;I[.89+<L$L+BZ8XHA(7:(K-M"H-IZ$#UU*IC)*.I$1Q;AK9
M$5M\AXEXOQD''W$"SVK$MZ2N\=EV4;6=^X0R[4S[_P!KTU*55-Z@]<>$0W2[
MG+5#R'_B\7BU/S[EZO'5I*?)2(TEE5D#UYU+J_<`.2K[G.0O^'553C%]MHP)
M=4<%OX7'!XG3[7W6YQUE"((YOZ.J($;?)&VX,N,L/VL]?Q]=0E;'S);++U)`
M:`BOBUG^&\[RGB<B&.&J%O\`#$Y*M2G.'C4X"CZ>?<@4?*A30$JT!4_W&\.3
MAKMOROCTMV8+\L#\E0AV2K!:B.*_)Q),RJC0MC?AL%<Y!!;0DL_BY[=CC*D]
MR'Z:Y+#&]FOD-VY&0%TR.AVMTT(*^^]]6Q9X>G'!<DJG,YDCBWJ\J!`67NH?
MR\#U)4_X-2JJE<^/AXD<M+O4>[QGW'+YEY5<\?GX2M5[U6K]'4%!.W%+&)GD
M[?;GDD5F^0*!L(.H7+<X-Z[^*AW$P;NW>QQ[R7_<:Y#5\-Y-Y)`I[657<%9M
MA#L%R1GVJ==^FICF(X=35"AE">?>0&]R?)2<-9:2MS,D@X^:VRR++$A03K'`
MH;\L/$Z;I$)PJA3M&O9Z?+@ES+X;SR<^N+?*[R+\'Q=OR+DA!Q=,.L(1[-E`
MQJW!2D0!Q1PIE8AEWJ&_:W':-:,RM4*+?FHZSCETNMP2]8:CIY2MQ,/%\9S7
M*SE/(;*/+WI6%NG,B3%'1T4LZ3K$RC8",``Y#:K0ZFW33\/<_834J>55/XMP
MNY`T(*ESD^`M1F.7MJ7CA*68YJY21IS&5)@2220]MXRH4*%/4ZZ4Q;2J7EZE
M*H)-TNUM!;'V"6_RG'&Y:KN)8.3K2F2-0@:./CY8$E<,1D$$+E!U..GJ=>;_
M`",*7!?A?$]#H(U*+T^#+XUXYZH:`5^/_P`W>_?K/^D.M/4WT_+3P,7175_/
M5Q&FLQM*G\['&OYW2JVU[$MJQ5-:>#C3)9=HBK82V'^7IACM]HTUQ2[:N%Q.
MKWGJ]V'F<_\`>J_X3R_O]3^4=`CQJ_R-^HZ$GL3R2O';\%\'J30B6)^-A($F
MU8V<UH@J=QB-K?@/CI?);KR(PF2G[F\=7K>*T*=.IOK17$(IQ;1E5BE;&'(4
M@'W,&^&=%:]\)D-VE[#DY=$?P_C1R=6Q4HS.LL\5-J\U?)>-HGD-C(1&?JJC
MH/CHVW+BFWN9*34U#OAX$N\+DJR>+<;)5[IKM".V9RAE*Y(&XQ^S_DZ:;R-P
MZT`:`-`&@#0!H!9XS_9[COW>/^2-:.K^[5M9C_C_`+%'RH9ZSFPKG[S>,7.6
MJ<'R-6T:K\/R$,G<4`N#/+'"KC=D':6SCXZW=#FJEU)KXD8^LRW4DU@R"0\/
MQUI8?->!BJ\7S,L7U7*\;<,TG8KPJ6:<*4=BTAPWP+_L,#N.MCK:_P#.J+IP
M:M;$R*A/WZ8)XJUM!V^/A2E'FYN!AXZ]Q](4N.X6W7LI]''',T\UGZFT-OL3
MT89]Q4$C.J9F-/-%-Q;4)ZH(MEX50@TH)3EKF9>2_<M^)XD7HN.2O;Y&0UXJ
M<\H1D>J6E-MV$;1++8>5'BDV8<$$]!IE=+S50C)>.'9B3F=1RJ,+[1-]_P`/
MH<E4XCF:D%/DK%YZSV)G^G[]U995>W,V]4S[B(P$(^&T@=#%.<Z6Z7%0CIEH
M%62JDJE!QWZ30O&Q7+5^G5XCDGY(R3RSDRJZ"&RIJ[(K;SL*^P(RM'[B=OX8
MU/-!)MJ%G="9'+%M).-E?&1,J_*6>'\AJQ"RIX:T88Z_O4HT9C4&5<O(SH)&
M(W@(J94=1C65T*JER]ZUL32JN6I?A+`!!&1U'XZQ&P-`&@#0"7R6Q5EHV**O
M')=[?>6N7.X*K`"5HU#,Z(^,C:0?0ZZY2:<<#EFM0AB4]<I>5R_PN7AK$EU:
M$IM6K=]@5J7P)J\CS1R,)&[<@++L&UL^U->I350H\THZ,5)GG.FN4)PTX,PX
M3AN"X?P\>8))'S$O!O.)KL#2,6D-A<R213=J2%E625NVA`&1G=ZZ5UU55\GP
M\WEO%%%--'/?R^9GXG)R7(K%=XCFOXEX[3OV)H..DK@\M%]1('>*19FVN@B+
M2;@&;_)&<89R5,JE"II3_I&5%S3C2GVD_P#MY<Y^^URY=YEK7%-;L3<,DL"0
MS3T2`JR2#"-L5S[6V@GU/J-8NIII4$E.$]IKZ>JIQ;<HRV$\UC-8:`-`&@#0
M!H`T!'?*XHY9*D<RB=6+B&C&/Z18D(QV]Y_FX=O\Z?PZ'IT/?)=]H>N@XYJN
MM9:1/(EVP)OIYHOJ)2*T]TOV8V*]32IGU6*,`F1E]QP<'=U3JH*^VMG)Q=UM
M2`&.2M#"D?U5611%!$B+%)R1B'0L%'LIQ9^/J.G4'#L=?#U&%I^AM/U+BLA8
MS.5^JJ\=8+".`DY:Q:+>X0QD9A1NO^$>R)3X^"UZ29RX>+\#F+VG63LOLXZ9
M&FO\M;C#"PI&PS,K@C8/2")?T$^W`:TNW!+"V+*S[--MR-/(2""K'&`8"&66
MI2F!>3\QL&W;P59IY3TA0'(;](RDTS=NY:M)%3@K=[UZ#NEGN-*9;4RPVJD8
M$LS'N1<=$R@=/F$MN4'].,_A\]$EA<]_H7;>.&[U/L,L"<3)#$S5(UE%>])7
M:25K+[G/;K%B"9Y&/YC8W+G!.5]II\VGPVZM`3E:>S6<![5NY7IRIC:WTRT:
MZG95V.-U8*P7N;XP3.X(PN.NT@->Y1L]?D4O<++5YC&`69;+O!;A2<DPR\BX
M"PEX\LM&HI_]DNW\UAU.#\?EYN$+NSQ?@748W]O@CF`1XR%C$]2TRBO!"G:?
MD#$@4#&6[=./&?P(/I@X>W%;O4CAQ]#ZE:U+:AY+?'R+6(TEJSC<E:)XR2QF
M!`V15_5$]6;J1NZJBH0NXV8@XQOMX&#R6"F(ITCHVUDFM\E;"%[*(H5[#1MU
M[2[P(8U&/0_+T:8+M6"PU>9$7V/'3K\B8<*=U!9/IFK=QF?;(%$KY/\`.R!0
MH#O\Q&LN9?>::+BJ_NC=O</SG(..!_C$'-P15HK,B(\E=PA3;63<9)/FW[5`
M.[XZYMT7U877RW<#JE7=2U.]:;:Y$T\QA>#[>-"[N[Q)21GDZ.2LT0);]/XZ
MF,2L!+?_`.N)?^]]3_LV+0$K\XMM6\7ONA4,R;=SQ]U`"?=N7#`#;GJ1@'03
MMZB/B)8O_"7N<G]--":,W<"KVX"I+!!A%&/AU5?TZ-1DU"VLE-X.._@0WA+G
M)Q^$T$K4:-^U/R4[A;PB&[ME`'"DHBG;ZE?3`Z'KJ$D_Z8[/2VD55.G^KEVQ
M\1SXC3OP?=OF>\ZVHQ%-_23@NH=XW5,H`@P#M(QN_'2.F^V$?`0E*W;#Q-G`
M-R7_`(L\L4KQ[$[BSHTFT+"YC*31QA2`SD>_K[O\&I[&1V\/:6=H`T!&?,8[
M-.SQ?D5=]B<9,5Y-0NXO1G&R7.,'$;[).O0;23H"3*RLH92"I&01U!!T`E\R
MLQP^-<@C"!I+,$E:NEL$UWFE1ECCF."`CM[?=TZX]3H!']K^;CGX.EQ7>-B.
M&C7L\=:9T=I:<@VJKF/V[X&7LM^)7.@.7[L7X>-CX^XK2"Y*)Z<4<30[Y(YE
M7N(L<X*DG'S=-OQZ:E4Q]D?%>)#JA[8;X,6>8\)R?UOC-GC^/LM5IP5XCR"S
M=\5E+J&S73.]]GK(-5JJ2DX]RAVR;B7I49J&^/9-*!(ONV)6\!YA%C:5'JS"
M6-0"6!0X7=G*[C@`@']6M?1_<6TR=7]MGFB#Q^.S4L2<M5Y:+F:KI6GCD@C5
M(?K9U6`M*[12-(5D)7=^'^3Z>\\R#]UT\OD>*LN*FGS>8VAM<=2K0"HE=:EJ
MQ]#)3-J:-*MI85,EN.,'O0LQ_*E]VQ^J[@.HYM-N=ZG=>M'D7327J<'&I/)X
MG!<MW4/'4',%.G957K0RI(\DMCMY+>WN*JJ/YQB`254ZO7\<$INT+7%:/@BW
M)6MI-G`78_(DN1\QS26^2Y)45..:!HXUC65IG(E0=FN<IN=A$0`3\2=1F4\D
M.502QM>,MJN/,YNW86-_=YAGY*SSDMNP9(ZEZ"Y608+;FKO$FZ2/\G:(9`.V
MORD?#TUA_DGRJF&*AO-O\>HQCIB7OKQSU0T`K\?_`)N]^_6?](=:>IOI^6G@
M8NBNK^>KB--9C:0SF_"1<\YXWG(H7*[&%ZV+<T3Q]K:84CB4[65R#O&H;>E[
MH+=B3!:*?&R(E_>J_P"$\O[_`%/Y1U(1XU?Y&_4="3V;S#HGA?@#,H#K1@:"
M4QB0)**L6SH4D_Y,#/XC2$=9$86]43KSR/CFX0-?N14HHY-ZR3QB9&81N`NQ
MB`3@DK^D#3E;NAVD<T-/8*?+Y99/MC&]:.=Y'CIB&-_;,Q[D87>(^YU;X@`Z
M2M9$PMZDB\0`'C/&X<OF%2S%MQW'JW4JGQ_YHT(&^@#0!H`T`:`-`+/&?[/<
M=^[Q_P`D:T=7]VK:S'_'_8H^5#/6<V$5^Y]WZ'PJY=V"3Z::G+VV=8@VRW$<
M&1O:H/XGTUHZ2F.8EMX,S]55"AO9Q*=XWF?$*O`?P+A^+DY2&>TKQD322/&T
MBC>4.U;*1RLC_+'[HU.?FUZE5%;JYJG"5M7J>=370J>6E1G;7Z$O7SR!^.L0
MI+R%:Q$5>9[EA/J)9V?MQUU,$<Z@!`V](X]X(.[:1DYOV\\.SB:/KRQM@0N;
MS+Q,TXO')Z56+CN5CK12XF>U(9A;)9Y+042$Q#:8HF]N#DGX:U+(KCSQ<5'5
MAHXLS?6HARPD^W$E%3[B>/\`'<(*<7%WJZVY_HX>/0;&(Q'WYY.P851DQD&)
ME5@V?7=C/5TU5548J4XV\3NNHIIIA!Z(6\!6MZ/DN0%7D.*6/CY)I8>-XN"W
M`J.LAG?M$AS6>0O789RK9)5MP'7IR\JBG/%PV=N)SYN9P:EHCM[!A<YZYSU:
MC07D89:EA9DNR)*%A=*B*T2F92I60%QO7$3]PC!*KJE.6J&W"?G;7(N\QU)*
M-K;)EG^"RR2^*\>[3/.O:5(Y)(/IF98E$>_M_P"2Y0NI_`C7G]0H5LW9#]Q#
M[7$[!H#"?O&&3LD";:>T6^7=CVY_1G4HAE#^0Q>2*;=7G[O\-X^W/V!1>&4U
M7BD0=^1Y4PS%I@[G,F2J#;G.->QENB3I46N\\K,YKJG!#'B/).%\?I_3<?>[
M'`""-Y%C>,LKUD*R(M8.9P;#,-[*23M)&&.[7.O*JK<6O>MC=(O1FTT*"?NV
MPUB3E.1\=YZX]E[T=7Q,PU(;W'1;HC%-3LJSRI`Z;Y@T>"K]LL5]I'3&NU%-
M5"A"-<Y[5IP.555-3C'W)2V'6?-^+JT^77QKD)WLF-U6O,[5J\K=M0;;/.@F
M+;(PJQQMG)V@`+NU7Z#;7.O'L+?723Y7;2,*K>+2\0E7QF>S0O\`T]FM%3K3
MAJ\M@D*Q^GGEL;HG8LR+VQD`EF4==<WSJJ-<&I6C(NN2$*8IVVEI>*6;5GA8
M);DC/?VHMY<`1I86-5FCBQ[2BN#\I89SUUY^<DJI7&_*;=,[S1Y7YC1\<%86
M()9Y+980I%M&2I48)<J/5Q_@R?AJE*6)=QP&_&WHN0X^M>B#+%:B29%<88!U
M#`$?X=5).C0!H`T`:`0>4'88G=A!!(IBEEB_^,FR<BK!Z%=^,LV>@'P^8=LJ
MVC:<<VVG81>WY!PD5^3C.15(C'$D=;AIUCA4;P`$AF)0B#\MNXQ&&'P(P&[T
MT-_#?B[8Z#C54E\5VBV!V0_6W)%N\?8268$2OR_O6M)VNG8A905%:(.2V[YS
MZ=<LL."D^ZV/`E1<UWVP-]2K'<#!G6>O8S.$L,(Y>4D3`$DG0[:RD@(F,'I^
MS\T5.%OA]24HV^+T"=N3:T4MR"6S$[V*E><J(:T88XMVMGMP@'Y*9_3G.2I0
MA+VZEXAQC/V:WX'*)ZL\$T<(7L(S2W^6NQI(QWJH6<*PZ2NN5ABQ\A!(`VJU
MH-/@EP\V5BGYNW<C;&Z1-$!6D8P@V*G'K^=)#NR?K+7S=RQ(W5$)Z=3\&98<
M\>WP6HE;+:7K!H)9W$,TD56:`)#)-$1'!QR.1B&$KM5K,O3<1T'ZL!D8:_'T
M$(VN]3(1T(JDH@+1(DSTY9X`7FM(9'9:]9\C\QCCO.!ZYRV02L1<9[=FM^!,
MH;MNI>(=F/Y+E."],X^BI\=7E_+K[5#&N%5<``;>](3U7IC&%*.APQCIU^0A
MI4<(>'F:);\L5F-Q8_.N2&"7E1&7A=XP6%:!?V*L9'YC>K=?^<RV5,5LP\=I
M5U3VX^&PVXK.D:15NY3L;3%4B78_(M$H7NNON[52,`;5]#TZ8(5HGIGP]29:
M)<?0ZI(I)BEN)XN3DL$2TK,L6Q*XC+.7L,-OMBW^R(]=PSZY9:IPE=X[/,M"
M,[[8^0]\>,;<7&\;SRK(S/\`46>CRY.>Z%S[4?U48'3X:XYMYVR[B%>8U?%6
M\HGY":CRMKD:%9?K[O'2LB58&!89'<CZE5+$("<:YO#WVM"A%;?A<#HKG[J>
MF<([YC[SMXI/!IY(6+Q/](T;G))4V(B"<]?30A""_P#]<2_][ZG_`&;%H"0?
M<RL9_#+V&=>V8I/8Q3Y95ZM@,2J_-C]&C<"4A;XI%/%]IB+9_-:I<DE>.1<G
M>\K;ED^4'KZ_#4*8=K7D(XSC?#O+/`>/BYVQ]&*_(68Z7:C;+R(R!G$.TMGI
MZD=,_IU-5+<TX;7XMBFI4N#7=Z(F7CU2T?N5RER*["])HY$EJ(KH_<S&%<@C
M8_1<%@=.;"7?X"$HS[I=Y\\4H<@?,Y^0L4IX))(K7UJO&8X(I6G7887.>[W8
MU!;J0,?#5552W+U[?`EIPG;?X%@:L5#0&F[3K7J5BE:3N5K4;PSQG(#1R*59
M>G7J#H!#X-?7^'S\#+-W>0\=D''VF9BSNBHK5YF+>X]V%E))_:W`>F@.#[J\
M1:Y?QPTZ]C",_P#3J!5)!9JN"DHV$%\Q9$H*>X;?;UQH#C^T8XL\.*\?$IQ/
M(<,G\/,4+/)"]1F,]>:"0^UXYE?N`@GUQ^C0"S[]U*=KAN.AF!EF>61:U,/&
MHF<J/:RN,E?Q(90/CJ'3'V1\8]Q*JA[8>G><WFIN_551#>'&0U.-IO:HQL`K
MAFEA*5_<-^U92>GQ5=7I=27NW<"K5+OOX[AY]Y3`WC*QSQ[J\PLK._HZ1FI*
M6*,2JJQ'3+=-:^A^.6KB9>L^&V@J;F_(O*.3OB&I6FDX7D'F@A4&G;J+(R+7
MJ(\Z95F';'<!E'1@OH.OI495%*F_>6U/2Y>AY]>954Y?"]G9,36_'+]SE9Z4
M%^SQDD4LOU4J3M-6CLA(WW6!F.42L#LF(3VL/3X#K3FI4Q@GY:O`Y/+;<(PM
M:)$['$4:TZ6`&FX2&;,_)3!0]EXPV]8(W:)C%(5Z`C</CZ8UH5;:_NT:#@Z$
MOETG1P_C<\(XJXEJ6N>5LA4DB;M1?2HRO*S.&655B(]SE=N5."<9U%>;&*A<
MMXHRH0>DMO\`NZ_PQ?*?)(.,DEDJ5JM2%7G[.XNKRE_=!['&XG#Y)8=<Z\S^
M2CR4MWQ9Z7\?#FJ@7UKQSU0T`K\?_F[W[]9_TAUIZF^GY:>!BZ*ZOYZN(TUF
M-I7/E/E"U_.:L@K.\/!M#7M,+79+MR95$*5L?G!.G7/3KC7H9.5'*<_BU2]W
M2\#S\[-AFJ2]W2YST(2_WJO^$\O[_4_E'7GGHH\:O\C?J.A)[#\L(C^W?A4[
M6#7CCXN-7*[,N'J0@1^]6Z,>A*]1I:TT0HX>/@.?N"_,4_$N,EFLM3ACE(G:
MV(+-A).W,0[-(T<3X'H!U'K\-(QP3VI\$%3#%KY?.\:>5M'_`.&-1UD*QB/C
MV$K+D!0\1W.JACC'S!>OX:E1(EB.?`KT=GQFFBQ21-718W#Q&$$XSE`50%<'
MU`U$A,D.@#0!H`T`:`-`+/&?[/<=^[Q_R1K1U?W:MK,?\?\`8H^5#/6<V$-^
M\%/ZW[=\K3W%?J36BW!&E(WVHA_-K[F_4/76KHJH9J>W@9NK4<MK9Q//U>X[
M1<;%0`Y:6:5(JUBU`ZQP6U7NM">\H`K*S1*/SO:JDD`'K[3IOC+R\[\#R%5&
M$)VX'4L=RW6BA4Q3SE;%VS:M"14EBVND,D-E6C:9%[3AB!N*'_V@'2LD]UE;
ML+39M\DL4ZG$5H+3I+R=^="G%6%:U)##,(Q)&[A1N.R1@K)ZKU#9Z:C*3=4K
MEC<3F-)3O>!Q<CQZ#R3@XN8L6;EM[4L%VO(7@A*U-[5R$(CE5FADB*MM!ZDY
M+$XM35[E7+!*'&_Q*U4^\HV@,K\L-#BZ]WC9*]1GLTI8.+Y!'L5XTLQ3N\<4
MK1R!\L[LTC>T=2&^`I2HN#G)S6J!>IP45JD^T^IYEP5/F(..XU>[Q;I/29JE
M4,SR$(L<3]V'?L,^Y@X9W[>T%<Z?0J=,7??-^NC>/K4IP5VRWL/0GAGU9\8H
M/:*&>1#(S12-*K!V+*V]B>K*03UP#T'37B9\.=P/7R8\BB.M<CJ&@#0%6^2^
M3TELV;L"6H^/Y*O7EO<B7P:IBGDKP)'&I9LSR1E.GM7YFZ9UZ.5E."4HK#3*
M.XP9N:HQP>[VF"<_Y;?\;X2GX_4@AEO3E:%RQ)(T02NHL'W-F1R%22,,4*N1
MN^7U/+H5=3J=U_`+,K=*5*ON.5J7F5V[QLU'D8EAOJ/X'9$DIBCFJ!Y09(61
M7:-XFE5P[$D[?PU;FRTG%77]I6%;:@[[NP1>-R?<VAXT.5AY%YI+-GZ&O661
M)]]F"Q+$#ATDVQ='>0*[,YP%QT&NV:LIU\L,(]D#EEO-5,8ZC;0\J@YWC!1\
M@6]2YKDA`M^@\[UFGJ6)$B>Q#W%`$<CLNQ(QN"J0QP>L59+H<:8.E7/7H)IS
M>90JCS/@7LJA5"CT48'^#7CGJE8_?:_:H\3QEBK*8I5GD]R$"0KLPPC[@:')
M'_O!J5;'=ZH=MN_P>P=P?<7BJEOCN$L1S?Q&PE5%5PBL3.L(RP&,$=_J`/V6
MU*5,(Q(<8W$TU4D-`&@#0$<\J6E)/%5EH-<LW()88"DNQQDJ2JCW;1G!=R,!
M1@YSM/?)C",80.&;"Z$8E1?<=>`3F!9Y7AY?);-^-838,:0U&DKDYKUK+[5C
MB7)[C=2?A\<171E\T:K\$HQVLO37F<L*;L7+N18E*Y)?X3B*WT214S6A6EPL
M3>RPT:+EG<YVTXCZ$_/T]<@->BE4K1X:OF.==3J>GQU[#MH7::V'_F^2N6=L
MMSD&.V*%8'/O`=2J0Q$?E88[FS^#,)JI<-"T6QTD4U*.EZ;8:#@:Q0B@668M
M8IR2=_MRMMEO2(1FU:Z'MP)T[<>.O08.54W@^WAJ6LI%=G'6]1O;/>7MQ)5:
M'=:K59C^735R6:]=)/NF;J40GI_RL*[_`!U+46MLUL4\=46&Q+:K69*M>JT@
M:VR*H2.95`?M[=QM2_LI^RNWH!A#UJ<5!J,;=UM9SI4'%.WF-):E(4&6R36:
M#:G'</&Q:PK3DG?)M.YK,R[NN?9DG/JVN:J<9=KM@B[2A/L5L69`2BRHW+6D
MC*5)+$*EX..CDP%K08&TS-T#R$87IZ>U3&&_;KV$XVEJVGQ;#O4,4IVP2R-#
M<EI9#791(Y$%1?:`,,>[)T^/NZ,P0GYX:WX$1EY8[/$W3P\A!R':L(DRY>+C
M.+18PLD>S9@C#]JLB$=PGJS?#Y5,)IJ7:[8EFFG/L5L#G=;%F"<UV>::TP%O
MFR>W69(<F1%/K'6B^&U@7.0/VG%I)SPPQ]I6;N[[8!%+/'+5:M'+:CGF^I6,
MN8[-QD&3<FPI*P(0H1,#(QZ^U2:OC+@M6T)W0]NO82WAV62A',MI[BSEI5F<
M;3AR3MVX&T+Z8UFKON@::+KXE1?=5>.'ELM:O-4/)WX(Q8KSV;=5!$%V;[$D
M4B1!=OH`I8_AJ*>971G@FN#4ML27RN^$L73:)/\`S>-8_`I8UV[4%15V$E<"
M>(>TGX:J2(K_`/UQ+_WOJ?\`9L6@'_W.>^GA=YJ:*Y';-A3OSV=XWE=GX>IS
MTQG.D8#EB+/#6C'VB0NIB5:5K>+`$H&#)G*CHR_H'ZM+_47:MA7@"U/%^'GX
MWZ3EIVM65@LUY&)0,5P,D*[F+H9!L&<@9U%TVNYJ'&$R8QDGWTS[H,L;Q$>,
M\7Y-9X"E-=EY.%)Y96F9C7(DF[L@1<[5*M)@>T?HU:<)U1U67B0X1E3#79^`
MM\.Y3D.1^Y_.2&^QX^))H8:#E]VZ*1%WX_FU5<D#`W?CHZJKOZ;:O$A4TWXV
MU^!9>H)#0!H"$<SRO#\+]QJ,[2-%:Y2JM*ZCB1(V3N'Z:56($+%)6*-[MPWC
MIUT!R_>/Q*_S'"P<EQ*`\IQ;[B(XP;,E63"V(X90T;QMM]XVMDE<?'0(U?9'
MD.4GX+D*5Z_!>3C[C0U-FY9XX2H*K-&550#\T;)[64Y&/E`EG?\`<OCVNOQ2
M-PL_,5ED?OBN</$&>)6;YES^7O(_2!JM3IQ;79'P9-,<.,/%$:^Y/,V*/D_B
M_&45L)O2`I%"L$MA091&%$<RG9^#/N_5UU/NXP?^F/BGN@B)X1_W-;YK?$D'
MWIFY%?!>1AK1EZ\]:TEU@I;:@KR,AR/3,@4?^36WH4OJ*.KB9.L;Y'`J6KY9
M3X/QI'HT):_)5&#\PM\.CU([T2JQJ.BG9')9CC*[?<<ME0!G7I/)==<W)W0Q
MAI[#SEFJFF2FKXX1T=HG^L1[]ZM$DO(3-91>.GY&!E&_$0G+L)$=@Y57F+(P
MVKDK[NG7EDG=*<+=QSYIM7SQMWD>DM\N./XC@.Z-EF0V(9E6N\"I.91(D.]$
MW.WJ!W/7V^HZ=H4Q=7F<8N"I&?\`#$@Y"]QT%5JM7?):J(T<?M>J[AI)CW)5
M[:K`S+[7'SJ@)]VJ<T4FW9E^6#:A9%C_`-WBW2M>3>2R5JQH1)!56K0*+E*[
MM)*A:1=N\_F=,K\N.NL'\DFJ*8N-YN_CVG55!0+UUY!Z@:`5^/\`\W>_?K/^
MD.M/4WT_+3P,7175_/5Q&FLQM*N\\DXVMY?5Y$\O5/)UYZD5?BC5ADLA99$4
M[96RW4,6_1\->AT]-3H:Y?=G.+X1,.?72JU[U7-*4%QAXG!_>J_X3R_O]3^4
M=>>;T>-7^1OU'0D]C7?+DI^,>(<;#'%)VN-HMR(LPQ31=F2LC#`=T.?9GI_Y
M=3RIJ:CW^"*1<;X=Q*/N<_(_[K48IR@GL6Q!86$@*RR0S+M7NLGS=,]=0X/`
MFX[N;I_6>`4XHK,50]NB\5F9@J*R-&R'/N&21T'QTY6Y)1$4KW`Z_`.'M<5X
MQ4KV[?U=IE#3NL@EB5_1EA(5<)D?AI%XB6!(]`&@#0!H`T`:`6>,_P!GN._=
MX_Y(UHZO[M6UF/\`C_L4?*AGK.;"'?=Z;L?;SE)^TT_::L_93YGVVHCM7H>I
M]/36KHE'-7;P,W5_;?9Q/.E7G)H;K6K+NU.9^U9K-EAVK0$840M@GVHI`*)'
MNB(]VO<>6FH*_P`K:W,\=5N,7=:W8.SP$U:R;/)QP7[D;1N#WS#7G%B%OIA,
M=O<,6Y795`4LA]P5`">/U(J"DK1MXG3D:<YLYJMR%;_'6N6BL6K*6&E6M*)G
MK11JAV2!I0DV4["+D9&U6!7XFSIDU3#Q*JJ:;/EH<?=^KMS\@/I6M)4H7%IQ
M59)>2B$4V`XD`B@R<'>V=@7:2=%%04)PG.,O,EP<7&6S$P\=YUK<C\CS&8TI
MWX&$3P+.`(:5AQ'&N8AL)SM9FZ+\=3FY<)4XKQ1&7F1F]/@R=TTXFQP_%P.M
MOBKLMAN16!F67NM'`KV9G8RDBJJQQ8+E>A^.<C'5S*IW-0AY=MYJ23I5Z<8V
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M"#Q;BJ7*L$LP<K;BC=XQ[[$-F8#>=TBB1\$[MW4ZGJ'&MM?A7!#(^!)Z7Q9`
M_P"(32_<OR2SV#=FBGK0QWMD?]&5;\$6S$ZQ/[5Z9C#?-D'U.MG+_P"5*NO[
M9,R<S^K4[_":+ZUXQZQ&?.N&K\K0B@EX5>7<=PPGNI`\#%<;T=B#U].FJU4I
MW\W9[46IJ:NAV^QD$L1-%]QO'H[MI+O*]FFMF@#,\BN(ES,SKB+"&.1QUZY.
MK7S?%1[N5O>1==PEW\RX%PZ$!H`T`:`C_E/3LK(=D$P,3K!_\99).16B]-JO
MZNV[T_`===LFVA:SCFVTO44O]S?)^<H<^U"IR%-P888;'$_P^2[%4C]S!8W0
M;2BNB"7X_H/RZO56E)\L/[G![?*S%&4ZII5-K\/#S)]P"&]XW4:K8%GZVI&H
MMLO9:_)'#N6K7C)C[59,>[J,]1GU.K)PA'#=KVG-J,;1U;!E#QMD1.AIEHGG
MWQ\:Y`[LO4![+[5(J0[,1[E]P`Z?*NCJ6GM\M;(5+T=GGJ1KKK#'9LRQ2P7;
M<ICN'D71!7AVJP:TY#'VJ25BC.,XS^+ZEW+!70\/.R"OTN^/CY'Q9(4EJQ&O
M-9KSL;,,,A`DMR*RCZJY^T$_]R@0YP!C.U=--H:EXB-UHZWX&:1F&0[`*S0&
M2U#!8;?%Q\<K%VLV3G#3MD]N//M_Y6TC&U^I:A=:[6]9K18H);)@E:"&L\D<
M_*/LEF'>"!NVR@LUF<KT7J54C.#M34WPX6P5M)%T>-L690Q5(9VD?-9H,5!P
M409I72:-F1,[@K32[RTDG[/7W="QAMM;XVP)27I;$ZE=Y66(RP5)8#]+-?B`
M$=19"JK1JGIOEZ`,^.G_`"`5WZM.MEMWAJ1KLR06'DE&Z6*XRPSS1$]V_*@Q
M]-4W$E*ZD$NV<>O7&3J4FNS=K>LAN/;OU+4<;3=RR@N9>:5C!#Q1*PUC)7?:
MD9!;<M>(>XED&\X]?:FK0E+OMB4C.?=;`[(%DDD:RC,VXO/)Y`X94,T`]0-R
M`54!*!23OSTZ`L:O1NMB76G?;`D?CHB_A4;1"<H[,_>L_P`[+N;/=(ST#^H&
M!@?`:X9OQ';+N(C]P?#_`"KF.1BL4[45CB!V_J>&!%6695.9%%D!B=Z]`#C'
MXZX/Y5M23JW^9V36GL;?+N]1SYZ@3P>P@3MA?I0(R<[<6(NF?T:N01^__P!<
M2_\`>^I_V;%H02;[AD#PWDLAF!1!A7[9ZRH,EL'H/C^(Z:1$!9XZT\_VK/UL
M$=>1J5I9(6]L87,@&=GH"OKC26`N(#4^W_DMO@^-O<85GY<\@[SV7LI(@J#;
MZE6:,.X'7:K:KS.G#LMYEX*J45MAZ$T\3X_F!Y_S7(7XXFW]R))A*AE6(,G9
M3MJS,%V@GW#5IN<'X<2DE*-NY&WQ2[R4?F7*<5;CC=4[TB6DK)!(09%*]PKZ
M@AO:V?=@GIJ%RX))ZO;X%FJH7U<NOV>).M25#0!H!?S_``'%\_Q4_%\G#WJL
MX&<$JZ.IRDD;CJCHW56'4'0$*X?R;S?C>=GX;FZ+R4^.B1*EL?F-R,*@[K$<
MGM+644`RP;>ON*_`$22/AO&N%3G9/)^*M2]KD*X1JL4G]#<E]_>[8_\`:?#/
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MDDDD8HH!&Z0G:&`.S;T&LO\`(J%%.UFGH'[U1>>O(/4#0"OQ_P#F[W[]9_TA
MUIZF^GY:>!BZ*ZOYZN(TUF-I3OW#JRCS^B'OQLUFW2>C$DS=^NR85P:R*Q=7
M'4$D#\?37J=,_P#R;Y;DYP4'VL\W/^ZDJHMM2G%>'>9?WJO^$\O[_4_E'7EG
MIH\:O\C?J.A)[9N^2#Q[[:^,V(ZL$DEOBZL;SRA24V5H]IP0=_S8`/Q(U')0
MW&I)]PYJ[J6]_@,_NY1,G"):#VIB"8QQ\+823$4DA;;E3N7;G(.>F-2W"^ZV
M,&0M]L(HW>0<?9O>!<90::"K4G@J);FLNT+@_E[%1D!VLS=,YZ'TTF[E&VQB
M[&'9'Q1(/#JT=7Q?C:\<T5A(H0@G@),;8)ZJ3U/ZSI/$@<:`-`&@#0!H`T`L
M\9_L]QW[O'_)&M'5_=JVLQ_Q_P!BCY4,]9S80;[W2O%]KN=EC8H\:0,KKT92
M+,1!&,=1K7T"CG4VP,O6_:=L3S=R\UBFT-KCXF:*A*EQ9K"]^)GY!=QD,:QA
M8V5NH7<<=/F/77NT).3QEW'BU-J:P\20\/SDA2L\!0V)7:F(9N[)]5<>&6M(
M\:V%14PDJA]ROC;^I3QKR].W8K\#M36[8NXRBK6K=VOP?)\J\_#Q""3O(8J[
MO'*BL+98@3",B)Y"K%,`!B_NQJ&TES)>]:6@)-OE;]VTS78M\`C5$Y"&J)8'
M^GI\FNRT(5"]YIY:"B&*17#`-(7W1L,DXVZE*J<([+M]HB*QAMOW&KABM60V
M>]::"#D*TD@H%3>:..C81D6.(LJ2MZ]MB1CU)U-<Y2N=]UZ(RY:;U=?<S>GB
MOD,?%<9>DO\`)\HHFFN1T:\BLQKE%_,BD4OD-(C1.@/X'`]#'U:8M0I6%N)/
MTZH)Q;/0_@W(-/PR4VABC/'*E=7@E@DBD51A'5(68QY4#V.`1Z:\3J*851TG
ML9%4:8:"0L,J1C.1Z:X'8I/P>'R,^>43R7(P6>!BFN1\#37D&D,3QJRS`#MK
M]0R;MH#'VC\<:LZZW)IR^7\TXVF1R4J::GJJ_+&2M`N3DU+<;;4$`F&09)P!
ME3ZG2B]$57,KAN3M0Q>+<(G')7H$4'-T%<RS5;56/\M4/6(K+N5SZ_HUNY$^
M:J,Y[TS%S-<M,)2W-'?P,H%?P:+:Q+3W6W!3M&VO8&"WH"=W0?KU3,4Z^SBB
M^6_@[?$YO#"S<=X6Y1XU>UR#11.S-LC,5C8JEP&V!?E]>GQ.K9]]>Q>!7)NH
MVOQ)7XOQ4_&<!3K6*,:66F>>>O`=T<,D\CRLRF5W)VE_@?U#6;-KYJFTS1E4
M<M*4"J/([W__`%7E..XY9%C@^A/)@&)5_-N5I@?S7=W4LWN[84@_B->EE4_^
M*;UP[F>?F/\`]6EJCWHO;7CGK%=?>07$J<59JW8Z<B3B,AY5BWB26$C`*MD*
MR`O^"YU*;5UOS4B"=]ORU$<Y+A;L7W`\4D?WT*T5",3I,D6^2-`H.9<]]?T1
M*IU$]?='T7?43%:;<>])%T:$!H`T`:`0>3_EM'/TJIL:*7DE]TZHY'Y%9![N
M[*?0XZ?KUVRM&[Q9QS;/R*TYZMY58YJS+XF*]#C+-.I4BBLQ2/+:DB:1I*T#
MQMMV`M^:^[!Z]<9.K-U*JY58S<$M9'+0Z;W2KI0;]A(J\=N::"G<V<ARX@2.
M5Z;O5AAL0XS'`RD[:\1]TC8^8+ZG"#K3*F/PKOMJ.3FX7[K:SJEW64ECCE^H
M>\LK&TRE1R$M==W8C]R]NJG_`$AOZ]?4L4NS=ZAS[=_H;Y)6N31R"L`+`26I
MQ;,1$YA4+]58R%*5H\>Q2,MT.,X452ACV^"UEFX^7B]1PTC8?D+5UV29A^=!
MRT^1`J+E7N,K``XZI73./7'3+M>J$$MWAYV12F,6]_CY69TR15A3W22B"M&1
M:BJ6B_U-HLX0VI]H+]QB?R%VG!QT]`M4W&T%J\RS2A:>OR"&'Z3"+BLU,--&
MD[=V+C8I26,TY.1)9?=[$Z[?U9+&X]OYO0)0[-WJ:Z:6*M>>.U&*DD,LBS\D
MA,LP2?:1%`V`TEB?`8MZ@$>APBS5!N4]5L$0I*<M=L6?;?%0(U66Q%L#DUHN
M(J,K.@5-R0$[_P"=D#GNR`=%Z;@,LQ5N<.^VX.BZ/=;>;F^I:20PN%LDBI->
MB#"O6ST2E595;8-P"RS;>GZ\!8EX[=;\$3.V&I>9$ON;W[OCR6HW$,LUQ6>S
M!&UR6]+'#*@BJ0.R,8,-U_#)(Z`L:5OE5ZEIPVPQ.F6N9W.>C'OP-GVUMWK?
MCJTN0N3<CR%:P$AX:S7^B2`00HJM80ECV$;+AL^\GTW8`BBJ,:HIK\2C'?B*
MZ80I@T]#M<BT/'Y5FXU95LR7-[N6M2*5$AW')C4^D?\`D8Z8_'7/,4'=`Z9;
ME?$J[[DW8H?)^22XM:Q(U6(<4\MV:M)3?8V9%2.-QDR'=G/PU55/34H:'2N^
M-2+\NK\M3X)DW\T[G_A_)W7[DNRGOD]=S=^++?X=5"$=_P#ZXE_[WU/^S8M`
M23S^QPT?!QU^5CGFAO6H*T$%9NW)).[9C3?E0`2O7)QIVP"C@HGWCG7C?$;,
M=:@W'?P^&8QUK[!DR`TF6D0R!D)/4@Z*#_NW<27'9L('5B\A\GX2ES=*&&'D
M*UFQ5DCK/],BQ[E9$DC+JG1L[R/=_DZGF=/PII:$0X/XFGKJ7H..$X&[<^X]
MWFK].)%&_P"GG6Q&\J+$56,*(VWX?WEU<8]-&JEA4EW+R?<$UII?'AXF?C7,
M>1G[H<KQ-OEEN\3'!*]>KL13&PE0`;PH+%02&_#1MXI>)54TIQ3>\L34%@T`
M:`-`*?*/&Z7D/%&C9DDKR(ZST[D#;)J]B/K'-$WP93_@(R#T.@('P%OR7Q_G
M[D$DG\490+'DG%Q*4,>\-LY+CD8G=',(_P`Z`'(DR5_`B3D\XY:?GN"I7K$%
MNFIN3M2C6L1*_'IVR]B2.8JZD1;F'3_!H[7^`5KO$E7(<+,]GCN<I\U+4BXZ
MG`\M18A-W8T250S(#GW+,W0?$#\-.:I:.77'S(A2],=4/(Z_N4:<OV\YQK+%
M*CTG,C;2Q"$9ZJ"K?KP<ZT=+'ZM,-)PZG[;CH*`K7*O.<8G&\E5:"QQT4EB'
METOI721(%WXAC%9^]WER$+[B0#_DZ]IIT.*=^$/4\A/F4&KL8^AGR$TMF>%K
M7:-7D8Y%2*K,B;>W-E!,[&:)"`?E[BMG.0>@,4J%UZ%46YXCZG?YJ:"6#D99
M)WX]8)6XJ9DAKR2S((Y(UV[G*H8WB.%&P@^J$J.-5-*FL<;=^L[*JK'#`U^2
M<A0$4UEHYN[/$L$"<1'!)1G6-=T[6J\RA4FKHCAF`42+D+MZXG*I=W&_L>A[
MB,RI7\+NU:B1_8B]1N<[SLE7<\*HJ5[#$;Y(UE<%I0I=&<OGW(^W;CH.FN'\
MA2U33$[=#4G547/KRCTPT`K\?_F[W[]9_P!(=:>IOI^6G@8NBNK^>KB--9C:
M53SW`6[WW'FO&/CZSU+%)J5][)K6RH0=Q0J!NZ/50'_4->CEUPRI*MWQE&G?
MX'GYE,<R=5"NA'XNR'B<O]ZK_A/+^_U/Y1UYQZ*/&K_(WZCH2>Q_)I*\7V\\
M*FLR".NG&1"3W`,0]2),`%)0?F_#H<8TMAYHB&J/?X$S^Y!X23C:<'(W!7D%
M@25XQ'WI';LRK[8PRGY2QW?HU94U7KQ\"L5<_#Q-7FL:#[<1Q12'9LI*DKJ"
MY'<C`.TD#<1\,ZK.WL9*M:*&W@"R+X9Q"R8WBNH./3IG'X_#0#_0!H`T`:`-
M`&@%GC/]GN._=X_Y(UHZO[M6UF/^/^Q1\J&>LYL(3]Z:UBU]LN:JUD,MB=8(
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ME*#4*=>KC@<'-.>JTC.S2X8QUJ'%1W88$OP112\G9KI.\[QW`'60!XB-SX4=
M-Q'J/FU"JJFZH78)Z@Z5=3&_'M&W"<%#8EX=.0JFM84O7EX[OK6>1V"@6%D"
MH^$?<S5CO7TQ[=<\S,A&#[?#U.E%$8179;@7GX50%/QZLA2%92&#M7K_`$L9
M"NP0+'@-M5<!2W4CK\=>1GU1J?G$]7)IA39#QRH1BWRX.?U:XG4HCPA;A\C\
M?FM?4_[E2W;)\2B:2LS)8*S',RH!-MV]S;DG'3=IJT8\L(]L?"8BK\7AS.79
M#V%U<Y,8N*LX7>70QA05!S(-HQN(SZ^@ZGX:OEKWD4S'(J'CK'D4G,<)%RJ-
M'5J3UZ_&HZJI[2S<<3@K@]&.TA_=D'K\!Z=2IY:N6]W_`)CSJ75S4Q[/RDJX
MA9FXGPU8'$<S3W1%(1N"L:MK#%>F<'X:S9E]>Q<4:,NZC:^#(5]O>#^Y5CBN
M%:M>2I7JW+K0/-5[BHDR2,)@Q?W))O*J/V3^K5,WJ*FZHJF,L:CIEY-,*6G5
M#LD63X!>FA\7@2]9%R47[=-+$0_+;9:E1-@R<(%3`&>@U3-I;JFH.">XME5*
M$KHM;RJ9N.OT_NYY!-VN_P`=-)4>Q9J/7C+!KT17N*XF;V2,(W[>UCMS\3KU
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M;#&W')$^9+$\Q`>_)$N_!7<NRI&OH-P#?C@^^T&L/3U(BGCZ^AT,PD:&*"#\
MDEK-"A.6`/NR;UTMU6-3_-H?_/C;7;VOP1:WJSGXZ6E86>_',Z7X4$TU^\%:
M--WM:T%3*[RAQ`C'&T>WH3NM4FI8:%P\RM+3GCKX^1D+'TI5)8;%7CF7N+&X
M)EG$S[&FE;<KO9<X*(,E>AQNP%B$=;MN)C#9;>==/O/RM2N(XUN0!5@J.VZ*
MA`%R0<'\RU)'^!]H_1U>M7PMX<?0LKTL>'J:9Q!#/:=++R*C_3V>24$R@9"K
M2J=69YWV@229)S\<XVRHM*79XO5H(<%&?;X+6<K1S06S6L4;%:*T%A3C:^Q8
MIDB7,==7W9/S$S28QCIG;\UHQ44[L?'R*P@X-=GAYBKS8<6W#R6.2MS4Y(;$
M,:>04>BTK*-^7#40CW11`-W3TW?]+HM'&$FJ<?>\=N!>F^YU;/#9B</BMCQ^
MW2O6&YJ;R&,6MMWF'58Y+T\<(&R'.(TJ5XY/=UP3D'I\S+52;BUS:KJ?4G-A
M!2:IWOT+5X&>>?BH'F5@V-JN\8A,B+T63M@G9O'7;_Y!Z:X9BA4=<MQ17GW`
MAY#DO+J_&5>8[T9$1F\=;N5HY0`9&C-N,'WRQJ<(_P`-<W'0NR'-O\&BZ2U]
ML>6W8R5>?*$\(LJ$[84U1V\YVXL1=,_HU((_?_ZXE_[WU/\`LV+0$C^XTT,/
MAW(/)(8B%7MR+C<&#@Y'Z,9W8Z[<XTUC5;Q.'QVRE_[7]U%619*=E1ARB/@R
M+E9),D*WP9OAJ6XZ]_GQ"4-5MBX%93Q6K/@G&P)`JR1<C8"112B/?$70*S+[
M,[F&=Y'3'Z=0JH71W>19J+G!]_GXDS\7KJGW:Y@5ZPBJQ0R;L$#$KF(NV<;G
M[F`<>B_X=0FK@XC7A>/*?<KE+AY*E,[P%31B0+95-RE3(<==OH?=^&IY7?!0
M*\RNBX[B<:`-`&@#0!H!+Y/Q'(7*@M\-)%7YZI[Z%B8,8VZ@O#*%()CE`VG\
M.C#J!H!>.,?ROC:?(78;OC_*1I+7GA#()%5R%FCW$.CQL5!5Q\.O34..'")*
MABN*X$5\YKQ<;Y/PU:C2CF5:M>N9+$=DPUX()FPQEA8>\YZ*5/ID]-2JX2B_
M]T/"`=,9P7<GXDH^[`4_;;R(,P132E!<@D*".IP.O36GH_NT[3/U7VZMAYUY
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M7"%M[;!"I(48.X=3T."=V=9?Y!OZ="=\S3T*7/4U<7=KR3TPT`K\?_F[W[]9
M_P!(=:>IOI^6G@8NBNK^>KB8T;?)/=GKR/798YG)0N>\L)8[#M`QZ:9E%"I3
M4;NR)&3F9CK=+=,FY8PP*R\XX7R"S]V.+M)Q=2U21X6JB41*[E-IFF_G$DD:
M(?+D$#\-:LC,H62U[T<81[,"F?EUO.3C3#!.':9_WJO^$\O[_4_E'7F'I(\:
MO\C?J.A)['Y#EN>XGPGQZRLP'&R<116&+MQRG>L$>_(:"7`)*^K:.JFYI=O_
M`.EP(Y7A'L]A)?N\]>KQ%._*T-9%G[4UUT$CHKQN%7;VYLH23GITZ'4<J;$8
M*WFCL\G/CL/A-&GS7("G5*5"LZ;2Q[+1L&"R`Y4$#=[>@U;E;M["(ZHCGPUZ
M#^+\:_'RO/1:%37FD4(SI\&*J`!G40'9`<Z`-`&@#0!H`T`L\9_L]QW[O'_)
M&M'5_=JVLQ_Q_P!BCY4,]9S81'[L31P^!<C-+VS'&]5W$X#18%N(GN`E<K^/
M4=-:>C4<Q=O`S]7]M]G$I#G':6P8^/JJ/(C$EHPATW6/K:;P'Z.-^PJ5XH]B
M1]6R/120<^MERO?N^3QUGF5SN^+S6!V,U6Q='(KPPN\/:2.\_*O:>"9F6)MO
MTW9$:0B">20R.5"N<]-5FE",*KH0XZ8HF3<815\3'ROPZI9Y3C>3FNV;'CXL
M(PJR3JK58RT9D**`WRQ!6DV^@.[H05TR<YI-07-Q&;DIM./NBNOQMWFZ0GXX
MUHQR?(%N+N2%ML-J!MW=GFD"M9)!D0,Z$(2FW;NUT=:H<'&2GL\#FJ74I8N5
ML1S]QN-@CLUZ0K4WLQ_P\\AWG*UA(*=I]_<A:N[+&FT*WS=/CKGTU3A&>,--
MZVG3J*9PEAP8JK<CY.]GCN:,W'5JG&WYJL(AJV"N^2-2[*I.]9$CEVY!5@0-
MQ)ZZZ.FB#IG%K2BBJKBJI2>@]"^"PV8/%*%>T%%J%7CL[(C`IE21E<A"3T+`
MG=^U\WQUXG4-.MM7'L9":H28]?.QL>N#C]>N)U**^U-..OY30EN3<#_%;!MM
M)"IE;DNCR!BN"8%?(]VT=5SJW(VH\KA\TO\`83SJ[F_+_P!BU_+SQ$L-2GR$
M#2RS222\?(`=L=JK"\Z,74C:=J,1^.NF3S3:[=C.&="296'%+QXY#Q@UN"FX
MB0K5,MJ6-(Q<)M429E*LQ/N)SNZ_'7H5QA5&KFO[)5&&F$:8*%W;.DD?%R<]
M%P/!M_#9(^0XJYRD:5V!.XQ5[2PN<#H)/;C]?KK-FNE.IQBFEX&C*I;Y5K?B
M0/Q2YPAX7QZ;DO.+G'\@3,T]6"PO:IDQNVPI(N4_R<>[_)_3J*_JU<S3I@]2
MMP+T\BY4Z7WNW<6)]JKM>'P3CO?$T,O)6H:\LJ&#N;K4I#)$JG8YZX7IKE75
M56VW?#"UQ>FFFA05T2">+5N9F^]GD%J3C\SF;\N>2LLT;Q16=@DB=6A2+;"`
MI;WG<.ON.O2S72NGI4=^H\_+53SVX;M9?VO&/6*X^\D\4$'$R348[\8E?V.2
M'4AHF+J%93T16.?@<9TBE?%;'#Q$&[H<?!BP^-\I;\HX7EY.,DFEB3C"+40B
M:J5"1FP\CE]Y9-OL*].@]=0ZYX[/>\X;8EE3+#\O"$2VM25#0!H`T`@\G/;:
M*8XK1%3%-=CZVF5R,5JRCW;Y3^T/3]?4=LJVC:SCFVT[$4I]Q/$/(.5\NB^D
MK++''##%6X:AR$=::%RCH$9=LI++')F23`&#C])55.+AS:8P3XP[":4H3Y8W
M0GW2WEB>/U;J\?0XYGDGO1UX*G+78V7=$B*%>O`V1MCC*GNRK\S=![B-G1/W
M4W+5Y^".;7O07?Y:CIF`FI)!5`FBF005RL:JW)21#"^Q2NVG$/7+>X?$CY[*
M3B_9ZE7-2]OH9?0S26EO$1V[QRMBM*I@C@EB<B)Y%/4U80C;?\IAGJ2-KFE"
MY6WL<LXWNVXT72\U0B.S&M>V7DEOV_:;9B3<UAT`)^FCZ+''Z,2,^WY[4R=U
MV"PU;2*IK;O]#HFLN6B8UE2>4B>EQS@`=UO_`+-MJ-F69A^5%T)/_.^2J6OM
M\%XNSEOV>+\#[)*8IU26\QY""$3S36RC?P])`#*^T%E>=V?"!1A00`,?.2BK
MI:L?01USX>IIIWXUE$D$LE"I3D(6#8TD\K.<298AEEM3/A64GV`_Y6=DU4]K
M=NY$*KL2MWGR[(59*:UT:\X->"C"%>.E%(N3#&#['L.AR[GVHO4^WYU*QPX^
M@J>&/#U-@$42S.TFT;C#>N5P1N=F+&AQXZ'JV>Y(.N<GH?DB^V]V]9MZ(BWW
M`DXFUX_2EN0R\;QUB5((XN.G2*2RT<4H';:4K&L$49(>3:2_HOMP36JAN2JG
M&]J,"U-:4X2T1O-?VSAX&+C9:?$6!STT<RM'/9FRD2K&LB%E55V5HV=F*OU9
MP"!GY8HI=*>%.R_9K9-52J=RYNW?'!%K^/RQR\8DB3RV@[,3:F!4RDL<NBGY
M8S^P!TQKEF*>@ZY;D0GS&KX/#Y6LWD$M[B[5G9+3O0V)8X)I(8ROM6$DK)&A
MQU7TUS5+=U4.Z'>UXEVUC3S=\>Y$A\^V?[DV=C%DS5VL222/J(L$DZ`CU_\`
MZXE_[WU/^S8M`2+[DU18\,O@IO:+MRK\WMV2*2_L*GVKD^N@M:(M\5X:7D_M
M5%Q=J:,/<K3IWXRW;_,D=D;H02.HSUZZ./:)=G9[""^3>+\U0\-XRG!R\%YQ
M9M2);S]2J[E4QA<NA`B(/OSA/CZZ5/,IO4'V^&.YA<CN<K;?,;^%6.2;[N\I
M#R"R&Q'5DCDL=!'(4:+!P"2`5.5'P_$Z<\?*S)Y(3AVV2.GP:FW_`(I>069$
MW21I+"TYE=_=W48[8^VL:YS\&SI;#R'=OCQ?`M+0@-`&@#0!H`T`:`J;[K_V
MHJ?TTUD2M"]BOO"M.K230A85*MN?;*^<D?#3F:N?#_)<&.5/"W^UDT^Y<M&+
MP+G);\#6:*5':S7C?ML\8ZLH?!P2-=^E3^I3"^)QZB'(XE,_<KPZBO*5[/$)
M`T47#))=DY&=5DR8F@IDN0&!(79[&`+;<X]3ZO2Y[A"K\6&\\SJ<E1BOPX[B
M,</X_P"2R<QQ*1,L7'\?*W)\;#,B-=DB1R)X9)D3+R_D]OMLWK@#7>O,HY7I
M<GH.-&75S+0IZS#A).!FY0VK2V:7&BE+R7'O#$TEJ2:O.NY9>XVV1P8V<(NY
M$WMGH-3F<R4%-Q@]%O(BCE;G)7GVIS5._P"/6AQO)+2NTVF_H^5;?Q>5#B%9
MV4=U69I(^@<+TW'`T=#52BHI\;=@5:=+@X-<+=I:OV&L]RWS-0SM/)12")Y$
ME=J\ID+R]^*.3+KW`^YF+=2?E&O._D%)/2;^A<VM!;^O,/1#0"OQ_P#F[W[]
M9_TAUIZF^GY:>!BZ*ZOYZN(HH5K\7D$EEW8PR6)D1(VB#*C/G\Q67>58J""&
MUIS*Z7E0A."T[C!DT54Y[;=]54HTRGBH1:>IQ&')2\*/)>)CLT&GY-DG^ANB
M$NL"A5[@:3]C>,?KUCIH;H;C!:(W]F)Z]5?OI0CKT>TKK^]5_P`)Y?W^I_*.
MN)V1XU?Y&_4="3VU+_O$_@_A\7$1SNHXJN]@0@!6_H\00%^N,'KC3FA[(^#*
M\L?;#Q1)/N/)!'PU22>G5O1I;1V@NE5CPL<C$@NRINP.F[3E3DTWLM,E-J:<
M#E\UDAL?;ZO?F"5W"TIUF1<]DF2-B4!*]!^&1^G3EBY>9$87^7L'OAJN/%N,
M#NLC=A29%8.&SUR&4L#G]!T`YT`:`-`&@#0!H!9XS_9[COW>/^2-:.K^[5M9
MC_C_`+%'RH9ZSFPA?WC@2?[<<O!),M=)361IV!*H&M1#<0.O36KHG#-3V\#-
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MA>BGIT&->5GT<M3T'IY-4:4.W`*D-\I!S^K7$ZE+^&<?]K:_F5&AQ_-VK'+Q
MV))ZE&>%XR5@BD6./<8T]D(DD(.?<3UU"RW?S4O9"-M)9UX<E2VV[BV^9@@D
MXZ=Y(U=X(I7A9@"48Q,A93\#M8C]1UTH<SE6I%?01\\W'^.2WU"T(VXM./,)
M]A#68/Y\$_/L5=O_`*6MK=,:H7^]'N9C7-"F-WN\4.:-VY#XSQ<GCLSVX8C=
M#+-&R/,T44Y1,$'_`-NJ]<]?QUPS9.IU*<O#P.^7-4JER]I4G@U+PE>`H6.;
M\H>AS4DMB2>&M.BI7+.\@':>-B23C(_'5<_*==3J3I=U]-);)KY:52TUL=5N
MXL+PUWN>'<)-)9$O_P!WYI%M3#M-./J9SN[8'M=B?EU:FMMN*_IPN]A6JA*$
M/Q8WD$\H2U5\S\CY?D:$W)>.P65KPRUZ2RRB6)HK<T;,Y#QICV&5LC;T'0Z]
M/*:>732G"J&GLLCSLQ0KJJ:C3'1VGHB-@T:LORL`1^HC7AL]DK3[X7):=/B9
M:MV2C>>2>""5,A-LB#N=U@00N`/0$G4J.%ORU"5O_P!4G#!RGD7%>5\>M2Y'
M)X_5CX^G>K2,5D+V888U:&$G<P&T$=/BWKJ4W"$):=&XAJF,8P>C3O+;U4D-
M`&@#0"3RHL*\(6B+C2EX,@`R()HRGY>58`MZ9;V@9S^&NV3??`Y9MUT2B?/>
M-\C;RQY..-VWL@JUY[/&1U99!.H>-*\,EAEF<)GW-D]1N)!'MM7FM.4L;JM\
M)=A%%%+4X/"^'=YEA>/UK<G!<0G*@7+4585%I)A+$TO0R59D`58HXL`S-M&[
MH.J_/T5<9J49^OD<G3"5\)>GF,8W>SRXK.4O=Y0MZPBE5C[+$_T:0,G;@KM^
MUZLXP,MG;-U,;K8ZV1?5"^V&I&RQ+-:2(1(MU++(J*X$4G*-&1NEDV#VUHE/
M3/1NF<C&Z$H:O^OJ2W'7X^AA"_(S3,;;=^^LCR0U9LI!!VCM:W.IZ)$FW\E!
M\V-W5NJG!776EMTA1=]]I^1K#AK8LT;A[$2=^]R-J-2R2,&3Z@EESN>)@((U
M^&#@+T:<(-=GAYD8Q3[?'R.B*:G6<M8@,!J*EGC>.F#.\C32%>].5W,]F1@2
MJ'T]?7)6&F[L;W;`E-*_"Y6Q.>-)..K[<LDM(8ED!$J\=#,WRH/E>W)O_9&%
M'11MP&E^\]N_T(^%;-WJ858IH7N*T\B\;'9DBCD@9S*^[*_308.))I3UED]5
MZ^[=G9+<8:86>S1:,)0CHC9;3ILF[!-!3>-N[*@1>'BC5JHCQA*HWX5O86,T
MJ_+^.,*U5!SWX[?)%G%2W8;/,B_W*2O/X[)+;IR<L_U"1--6A$J26%5PE6LK
M`A*\7N[DGKD?Y7IRS6DE%P6BT)LZY46W"_3&'=J1C]LH;'&\-*6$'U$]CZAZ
M?&UVIK:L=M6&,@'Z2),$MC#?JPK,NE0P7;'EVS^(9E3C>ZMO]7_R6KP7UO\`
M#D-Q]\S$MN`"J5;JNQ0`54#T#>[\>NN>9",B^7&$R-^76;7&2\IR/'^/O8O?
M1/MYD/#A-D;%>DC;@J'J0!U_3KG[D?>BWLBCI[T)0AM@S=YA+)+]NS+*X>62
M.DSN/1F::(D_X=20A+?_`.N)?^]]3_LV+0$D^XTHB\+Y.0Q--M1/:F=P_-0;
MP/CL^;!Z''7II%*\E)NXCW!\HU/[3W9K=.1UKP65/<*H+`D=OS`8R0@;?[@/
ME^&B:MX!IV\17XU!X=7\"B?F?Z3BU9DA0EHGDE;!DC&P@;#T#?L?CJ%3'&&Q
M[O2\EU-.[=OQ[S;Q%CD__%6:K1L;(U1I+5>4[D[)[>Z-<DMW(V)S\/3'3.K1
M[;6D4@K0\CL\7AY"+[H<NSW8YJ;QS1I$%7>61XF)+!%;<F\*>N-1V%I:7O+(
MT(#0!H`T`:`-`&@*Q^YD-R3R*K)'!69((8W2:4KO!#RMM(+J<$H#T!]H8_#3
ML>_S$%C#=Y,E/W'F,/@O,3F,RF*OW#$G4OM8':OXDXP-=^E4<Q'#J/MLIWG(
M1Y'Y/2\GK59&Y$-9-V'9'(*<-"PN$N!MJ@O7[N`ZDD8"@XW:]3+?)0Z&Y2[8
MK#M/.K7/4JU?/LAI[".GC#=-WE^)JO0XF_>-GB.5BB$O:^BD>1K"U]HDAKX7
M+)&6(V]5^.N_-"%-3BTIK;AK9RY8QJ4E&78*[<WD%;F(ZI[\MRS-WZ3WHH4*
M23PC'=V=$[ZEI'16W/@;T;.NE*I=,<-5L/8<ZN950M;B=$K>37+M%KWT;<I9
MG>_+<5X<3UQ$*@GCB0A-HC))#!1[>JX#:JN1)PC"[Q)?,X1A%^PL3^[Q;BFY
MGG`8$:9JM5TY$%^Y/%W)5W2A@N6=PSY_`A?AK#_)*%-.UR-O\>YLO'7DGIAH
M!7X__-WOWZS_`*0ZT]3?3\M/`Q=%=7\]7$WK3I1W\K47N2!IFL[0<."HQD]<
MG/\`Y-<^>ITWZH'944JN5-\XZRL>;Y^AQGW%Y**;D+T-BQ8H+%3K2QQQ/[(U
M]ZL&)!W?#7J96557D*"I@E5>HGF9V;33GM/FBW3<X+U-7]ZK_A/+^_U/Y1UX
MQ[:/&K_(WZCH2>SN;<)X#X4`&+2\4D0(,X"[J<9W$0=7/MPJ-T).IYH8PW6X
MZ"L(X1[$[6B2C[J]T\!31&<"2ZBR*@)+)VI"<J'B+8QNP&^&HM:\1M:1CYA6
M-O[<U:]BN9UE''K9KG><J9(NX&,>]\`9R5SJ'#&W>$X76X#WPTQ_[K<8(@BQ
MK`JHL6_8%7H`O<]_3'[774P$1SH`T`:`-`&@#0"SQG^SW'?N\?\`)&M'5_=J
MVLQ_Q_V*/E0SUG-A!_O8L3?:_G%F?MQ%8!))M+[5^IBR=H()_5G6OH?O4VP,
MO6_:=L2D>+N<<WCT/,\A/+Q<ZE#%!(H=):J$EXQW0^Y>YL9&/N]/7:''K5TO
MFY5/SM;`\NEKEBY"Z2H>,\F!JU8J')VZSK9K672W%8KVU83%)0)L6$5LE5R3
MZ#KT/1/FHFXI/9=X%8<M6A]]YGXW%;IUX6Y1K%>I+8D2"6I*((YXWA*,[JQ^
MEB;LL2N#O9<JHS[C&:TW*$;=HRE!3NMV#7D:?C'')8DH<I6H<%.L:<A6)2W:
M$U(&6!H:DXBW1#=L;O1[CM."=VN=-5=5Z;JPP4]?D=*E0KG+RU>9&J9E;AJU
M2]9-84.5K,+L!AGV`PVK2RJJGM]"^2A;]'Z-=ZOBBE?2_!'"GX8-W->+)AQ]
MWBJ=3C+5B[>K\Q',EM9*RAG50H0I(8Y0PK-&L.6*JK?,2<KK-534VTDN6V^\
MT4U)).+YK;KB\_":LD/&3.08HI)Y##46Q%9AA4.<I"T:)M4.2NPYVXQKR,]Q
M=D>KD*")`Y`1B?0`GIZZX'8H+[=I>J^<4/(I9YY.,\EM6(*KRVHI[3,B2%18
MC[>](QVST1O:<9U+3;B^Q\JAV:/$)TW*_%1<MNDN_F[E>"B\4KA9;22Q5T()
MWN(7D*]/^9&Q_P`&K9=+;V%*VDBGN&HTZ=SQ45N=EY86(J<_TLDXG^F4V:(`
M'5F&X@_@.G0:]2NIM51IA?VRJ/-HI2=,*HW=DZ2PN#YY/(8^)Y3MQ0*E^[%'
M&"68"%)X?7,8#^W+=&'_`)]8<S+Y(K4O`VT9G/!ZWXD/LWN$@\9X[DZK5N-@
MH<_)7#R.,BJEB17C)9I=^8^N`3^C&J9^2N>Y5-I1DB^3F-40BTHN"F27Q::O
M+PZ6J\\5BM;Y^Y+7>0)(FQK<P7L'*X)QE6ZGJ==<U0<-%"X(Y95T=-3XB6G?
MI>0<GY)QS_1V6')=T<;*KV&@$96C]3.B@JWNA)6$_`@MTUVJI="I<[K]\/4Y
M*I5NI2ONW1]"RN,XZ#CN/@HP%C#70(A<Y.!_Y!^H=!Z#IK!74ZG%FVFGE4$1
M[SV6L(*D$LME9)>Z5BJ5XK#M&BCN,1*"%"`_#KJE5*=_+VIO@=*:FKH]CAQ(
M]'RZQ>0\7QW%\&M^K62E%5YEXM\D=>5(2I,AP5/;>0_HP-&J(SG5V^4`G7"4
MJ>SS++U)4-`&@#0"/R'M0SP7'+0-'A$GAPT\Q9@?I$C/S=S;ZG./T>H[9<Y6
MVG+,E.VPI7SJW'QWFTMFQS4_#3QT8D6OQ6WMU@`P6H6*,HF?<#D8]N>GRZO.
M,%4J8_B2<=+G@B(+EBZ75!_TQ4-4M)._'YIY>$KV+=J6X)XH8;'(JK);N'MC
M;2@4D%#G/>8?'/7.2MY2AZ?,_`Y3G&W]J\1G-#R!9*]^HB@@0T^'@;:E@)[E
M1L95:\&[WO@;OB,85H35Z?;H]6&G<UV6P1K!'(5)3$18OR2+]9;E(A6(02;D
M>/#$K5B,;CV]6;]K.2)^%ZK;Q>M=MQC8>(TII&L*(95:Q"]H'=R$L8![\X`]
MM9>@C3T/0?Y(,J^TM2UD.ZT_0VK)><QF=(DN+FU'`Z"*&#.2_(7%!P'/7MH3
M_P"7)6)876DB9]MILVRR/7EL0)<,B5BLDG+SE)?IDDC!=HS@GZB9I&"H.@7;
M@8P&A3G#LT^B)<L>W1ZLUO52%*TEQ#5I(S-5XK;(\[F0%0Q=2,VY6?/5LH,G
MURP1C&$WIM@(0A&[1;$S-:^J*\0AAL1(8`8Y(Q#QZ':%JPDY'U$NY5+L/_)@
M%%6QU[!!VPU;37^16K35H)YCQ8E:.:9&.^>3)Q3IC/Z^]*#DG<2<Y*S-N+OM
M-^"(N4,+27BR'_=3DN1H^.5KF:=6.22&O2H3.TM:4&%P#`D.#VXQ(/<.K'\%
MP##:7G'EAM?@6I53\DN:.Q>(S^UG,<Q)P,?+6UMWGMN*]CEK\2PNF&VCM(.O
MTL0!;<WJ3U^+:YI\RFUV*'M9=^ZY+5-Q]A8GCS1OQ<<D<LTZNS-]38R&E)/6
M15/RHWJ@&!C5,R\OEW$!^Y>T7[KR<M4B@%4]WBY>1L59I4V'<BQ1MMS(.@Z=
M=0E7"2JY=*Y?&E\27R1G\6Q^#1(?+GC?[<[XXF@C:.D4@?YD!FBPI_2/35-A
M>>(FO_\`7$O_`'OJ?]FQ:$$D\_GC3Q\UY6,5>[-'7L6LD+!&QW&1\`^WV;2/
MCG&D1".$1;X^)XOM@QCM?1R00662YLW1@1R.PD2-@WY1`]JX^72,=#VS5M9,
M(:5LO(!Y'?Y[DO&N%LWFFDGGM6(XZP1!(T68_:6B"^HS\-I'S:1[.QK<0H:8
M[6B<>-VN)/W"Y2-./GJ<M(DAL/))&ZE8S&`P4#>JN""IS@]=(4WION)C5"#4
MMK]AS^*<?RC_`'*Y;EKO]'=X)(6IM)"[[.ZO:;$9W;2B]-PTGH<-D"(JZ,]L
M=Q8N@#0!H`T`:`-`&@*B^Z$,-W[B\'QI$O<L0(S=E))#VT-C<<(RKT&5P?@[
M'X:-PQA;8[0)2>B-MJ)K]T`I^WW/!EW*:CAE)`R.F1DE0/\`EUHZ3[M.TS]5
M]NK8>=J2\]S-4"_Q]SCN,C1IK_D;/)#!6C#K%'8@ABVQ2".LHBPNXMN)SC7M
MU<M#DTW^'3J[YGCTJJI332TVU'4?).*X_EVBJ5Q3M?51K$E>:XRSR-F/NRJ6
M:177W@.5#>X$+C4?2JJIG.6HGZE*JE*>LY+/!5L7A)<F@X>G'3CY>:T4+SLR
M%%D60]QPRR`=D9^09QCJ;+,<I>\XPMQ*NA3G)0C;@:%6O1\KK\?4XT5N/EWO
MQD9`CMR[<H@>R3(>U./>S!2KJ2B`ZF;HBW/'1W:B)*N"4L-):GV5BOU_,O(Z
M_(U%HW5ABEEJ8C,D8FD=E5Y8V828_9S[@/FZDZ\[KFGETM.*-_1IJNJ*@RY=
M>6>D&@%?C_\`-WOWZS_I#K3U-]/RT\#%T5U?SU<1<3S,7D,9L2%*4LKA5[Z#
M?U':VQD;L!<[@#U.N_\`YO*<%[R6COF8VLVGJ%S/W6W_`%WZ/=A@KTKR+\_Q
M-KE?N`T-;F(8WKR5IHZ)5EE#Q*KNNX##+VLMZ^I_1J^56J,F+HC?.5KSOF4\
M^=!5M72G:X6?WJO^$\O[_4_E'7F'IH\:O\C?J.A)[-YF.?\`W(\%GA02&/C8
ME96WXVO5ASCMX);I[5^.G-#VP(A'V1]FW`=_=OZXU>/C*P?0/80I+,RKLL)'
M*PWAP59'3I^O2*)IC>H]D?`[.>FD7Q;B*!XS^*U)Z\1L#W%5[21LA)1<=3IS
M)7Q[/8R$G>K;T.?!?I!XAQ0IPBO5$"B*`,7"*,C&YNIT@1&(]T`:`-`&@#0!
MH!9XS_9[COW>/^2-:.K^[5M9C_C_`+%'RH9ZSFPA?WEJVK?VVYBK47?:G^GC
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MY%;_`"MVXDYZ]=>/GOWG&\];)7NRN'3'"DYQT]=<3J>;OMKY"9OO1]-'-QEX
M6)+(EOTJ:UGZ([%3W<2;LKU,8Z_'4NE:$MC=7HB>9O&KM@O5E\>5CC$H1V[T
MG::L[?1G)`,\\3UD4@`YSWB-=,F,8*V)QS80B[8%8\?:HM?\<H5ZDE)>/6BD
M<0K""!S)8I/-,L@Z2[W(P1CT.=>A4G"IMQC''548:6HTI*$(8;"74*/)V_$+
MW%TG>&PD_)U(O>BJO\ZL84!1N0$C'H1ZDG&L6>X..I&S)45#6R">%P7Q/1NW
MO&I*G">*QWTEIQ1"8O<ED*GMIN_,=57!;'S'X:X5O+J4(R@F^8[4JNEQ4&XN
M$':!)_MPXB\-XY+E:?CR.<G2&J8XVV,;$I$>"6V(#D%NC`^FNM-+7^W<<JJT
M[_Q;SAXYJ=3[X6^-DK0IWVDOU9*Z,90[5HD?O&"3"JYW-F6/U_7K;5%].G'5
MOM<9*8+/:[=Q;FO,/1*Y^[S+OX:,UZMC>T_MMRK``%,1?:[%>ICW#'ZM2HX*
MI_+[4'#%I;?8Q?#!;@\HX-$X:I)&8^.2_P`RN++QR)`-J1HI4Q+T`#X(ZYU$
M8?B7:^7=CM)A'&GN4=^&R9:VA`:`-`&@$'DN4EBL#%41QN)>5;W&&-R`8X(^
MN9I>@4[?^7TUVRM&[SU''-T[[8E-^>1>)0<JT7DL][BW5*[4ZE2XL!E#F9H$
MFBS_`#@/62?=T/Q]3JU66ZW)[I1VP?8A37R4SI\X=_>3[QOOR<-2^@0WITHP
MUUE250M:*2)5C@@E.0TORO-+@]!Z?*NK83EXZWX%'&+A[-2-RR5E#PO8:SO"
MQ6)8F/?NE<JM6IN;<M="I#R;NO7+?,VKP=L-;UE)6QU+481T4EN_4RQP6+4^
M((.-@!1,P84Q3`JI2O7PN_(]YQ\-J:.J"AOMBQRSCNM@C.E;>>T]B"46;<L9
M-J:W&@@B:%]RV@0S`0Q;66)<]6R0?F;2I04'=JX;=(I<7'&T]F@^6^W]$6$P
MCKR9L1K;WB6ZRX#6[&U6*H.G90K@G:,?*NBO\L-2\0[K3U^1MNR725E5%KV:
MX-Q*A1#'6CP6>U:!*K]1+UV*3T/Q^9M12EX;=2U$U1\=FMZS?8KT*DS&I-)'
M)#&#R/+3'N-"TP!;M``AK4X91TSM7:!TVJ83;O[%;!$M)7=KMBS07EK7V@DC
M>'BZZ/#7J1"7^D]X$".)SL[L\F=[R$^WX?MMJ;U''AZ$7/5Q]0D/("793B[G
M(Q[:Q^F`[%)&]*M<XVAL#\V4C"CX9VKI+&[CK?@A/"_AJ\V(/.;!7AVGGL3_
M`$5BPL'+\W3C62SL5'+)QZ-G;%$1M=U!/J>O4ZYYB4,%"Z,TM;UG3+JG<ZHZ
M)1U+4<7VZB>6A.(YK?*\=8F"\3%=1H9;JQJ,&4-_]AU\@;BO7Y>HVJ;+-YL4
MX?U*UY%65RPE"/\`3;`M?@I#)QX=K9NN7<26-NQ"X8AA&,#V*>B^OZSKAF*=
MT#KEN5\2*\UXEY6_ES\UQDM"2NS1R""XLI;<E=H=I*=-N6W_`*QKBX1G3S=W
MDSLG*54.SU0T^X.__<RWW,;]U;?M],_419QG5RA';_\`UQ+_`-[ZG_9L6@)3
MYS%&?'9K+I)*:#QW(XXI6ART+AAO9>I0>K+^T.F@[NTPX+E+'DOA279@..EY
M"O*I9<,(\[D#C?\`JW8;_#J6E@N\A:WW%8>0\36X[QWBN'J\S%?FGOV+<-E"
M@B6+<@/OR1N3&`/0]<ZAJJGXDH[%XP+*I/X8M;7X1)GPE3EX/NAR<LO'2K0L
MP.R\C(-P)4QA45QT"G!(74<R;A.(Y(*,K;S@\*DJW?N;SMX0M#,JSPI'C*@)
M*@9RV>C.>I'_`":149>I+524_'R+-U)4-`&@#0!H`T`:`KWS[D?#J7DM*;EA
M97E8(D>DT$QB!R+&.@89.%=?_2`^.I5#<U4UW$.I*4$QO]UT#_;?R)"P0-2D
M4NV<#(QDX!.!^K6CI/NT[3AU7VZMAYGXWAK=WDZE!C%_';$8AMTYELQJ8D8N
M]BW.2IC22+:2<-N7_)U[U5:2;_I[.Y'B44-M+^JUYW5>8@XJA]/:LM;Y"C'V
MQ1BAF4HP1R\DZ^P21P]P0HS,S`#VX75'1S.*4$[>I95\JUJWH?+O$>/\S7L<
MN'BGF69YN6>M#8)[;,<R"*5H<=QDR@C9BB$Y&E-=5+Y>ZXFJFFJ?>:JGDW$4
MC`U)D66=NU>NI(I[B5T?W1Q6-Q2)(W[:!CN8#H.HQ+RJG?;N(6:E<6'_`'<%
MF3F.:B>=GCAJP1P5V=G6)!(Y#1[SO5)MW<`*+ZZQ?R?PK:;/X[XGL+XUXYZH
M:`5^/_S=[]^L_P"D.M/4WT_+3P,7175_/5Q%EFO4B\BAMTS,UQ[`2S&\4C1[
M64JQ60KA0!^#8UHIKJ>4Z:H<L)34>XR9F733GJJA5<[J][W:H0QG#Q@0OG*1
MC^[B6+7&32PV'A->U7E[;G;$JY"B1"RJX]_3Y==\JJ/3054(:I<"<VF'43I3
MCK4>.!J_O5?\)Y?W^I_*.O'/81XU?Y&_4="3VER7(00>!>'P&I-<EDXJ`2)`
M[QD0FM$'5BBME7QMQHZDKW#M7B0J6[E'LJ?#Q)%]V)5C\?J-M+/]8ABVN(V#
MK%*RE6;VY&/CJ5:T&5<,;;T='*>/^/<KX?QJ<Y.]:I!7@Q*L[1*"R*HW]=C@
MG_*SHN:ZEM,F-*O2?8.?%&IMX[0-*02U.T.Q($2(,@]"$C]@'ZM1"$@W'3VW
MC70!H`T`:`@LWW?\?C^X,'@HI7VYB:0QL_8(A51&9!+O)]T9"_,-7A1"/,HZ
M)E8U1ARR["=:H6%GC/\`9[COW>/^2-:.K^[5M9C_`(_[%'RH9ZSFPA_W<H_7
M_;SEJA)5)1`)9`C2[(Q8C+N43WL%4$D+UUJZ.J&:G:XS=73'+:M>4$M/D9KW
M-\=$]>U?,3;ZU<I*ONBPAB[R'+1Q^Q(L+,!'ZG7L\R2I=RM:-TSR8-Q6-K0O
M-4O)VZ?&)9$\-OA$F^GLO4C[D$\Y(=*S(44JSKLFC7>4C.['7*:E4IN%U5I^
M&ED.II1OIM[33R_%O-9N4>.X."9IV6/CJ<<Q1$2`N7L1PIMW%)(W64S,=N[:
M.AU-%4$FZMOEY0(KIC%)&GBKG)\'X[S=1H5Y7A>0K\?/;[022M&LLQ)KQ/N;
M:RRR,GLSUW=`>HFNE5U4NZI1(HJ=-+5]+@=E6]PW/(MBQ0L67L\K6-VK8G"J
M[FC.1&KRE=D4?55)<>T*?7.:NFJB2?\`2^*+JI53ABN#)'QOAWAD7%UEIO03
MD)+JS-6:VDXF@&'$(9I5'<A[3$JP<;FZ$CY>%6=F<SC&$-%KSK3E40E",=)?
M?CA=>/,!+-%5D:"N7CF1^T@`3<TQ)D;'K(OM;X:\;-OB>MEW#-NJD>O3TUS.
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MU3/YU5_=!<"^3RP<O=BP^WUGD9?#N.?^(H9?XS96S<=@HMI]5,7V=""TA^`_
M#3GYFW4I\HY>5+E<HD5XB'EG^^7-I&\AM,T<BV[,-QA%41AMCB16$>U_>N^3
M"`C*YSKT*W3^WI]+S#0G]=^MQ>&O(/4(#]VXU:A29.83B+6Z5(2T+RF82!5,
M8:-6>/+;>H'4X&H:U4_ZH;HR)3^;_3'?#T%\M/DXO*J5BKX]#+$PH$WYHWD<
M*J(N%E8J4*#?U9?V1_E:A54Z^]^'NL.EO1N\?>+.U8@-`&@#0$:\MDKQSTRR
M6&LG<*KPXQ'(?E:-6!628GVJO^3N)*KDZT9*<':R.&<U%6LRLO->1XZCY1:O
M>1\=+?ENPP44M5*BW(Z[98M3@W+M^H)8$N3T&>GH-4JHRFX506*CCK]"]-69
M"-/;##5VZ21<11*<-PT=OCEA@2$I72FR-*S%0HHQ$,I7Y6,K`8'NZ@98]Z:I
M2??Q\D9ZJ9SMJ\V.IA%]+;P([O**C5I*,`.R&N%"M!5Z>D3,AE958G&-N=H$
M*]8*U_@6=SQ=KO$YY;55N^9K/U0FZVY5(22^R[L0P9/Y=./:VY\XZ'KC<39)
MZ/3U*MJV/H;7'U<,$*08CG4&G2R%:<H`OU5EPJE:\/3M@KUP.GRKJ+K;EK9-
M]M[U'-0D,C"S'9CN6'46);MR/!JF(%/J96#F,I\_90=#T8'YFU:I80ALQU>9
M%.F_PU^1MN4Y)J=2*'NT:=B624W[F&$LGM[=BPN`W<D;^:1\*!CIN"H*TU0;
MQ>A<%XAJ*6"M9&^_>NO<B,^Q>4``I4W9&2KN4[7?<P22U*`1&F[`_'&6,4TJ
M$KN/H6JJ<=?#U,6CKUW?M2_2I7416;"GN)2$F"].F`/=-(YZD+[1@8^4:3>O
MQUO4)*UVI:S.:K*ME:)@%2GV62"*LV&N1;F=*\<K;?>^TM*2P/7];:)RC>^&
MOR#4X8<=7F1_ROF;G'4$M4JK\ESD=LT_X16B6:(UD@<M7@09!A#=L2N/=TZ@
M8"ZK76J%.5+Q\=N@M11S/^[1ALV&KP?G+_.U;?(\V\_&1W)D666>(PV)66(,
M8(,9Q4A;<Q?/7KG'N)4UIRIG##1MNF*J87N_'3Y(L[B9K,U")K)#R@8,R@*D
MH'I*@5GPKCKZZX5I)R.U#;4SLU4L1O[B_P!C[O\`TZW_`-LQZ`C=_P#ZXE_[
MWU/^S8M`2SS3QZ?R#@9.,ALBJTDD3F1@64B-PVT@%<YQJ''`E0Q%QIW$^WM_
MC:$\=Z_7KVJXDEC*1O*-V4925Z==N<_IT4E<NST#OQ6TK'B+5?AO$*3\[P<'
M(<H]Z[VE,K1J(]T9:3!)9@_XX^'Z=32DY^\EJCZ$-O!TO:E;>2_QODV7[M\I
MPZVYWCCKRV!6EE9]I=HB04+%512?RR.O4ZGG;DW'N]I'(KTC/P;S'GN5\OLT
M+LZO52.P45(PL9,<J!2KX!+8;.#^SC26B`AK+)U!(:`-`&@#0!H`T!6OW!2[
M+Y1#4JU_K);E6$1N/GJ=NP6,T:@C?DCJ/T?AJ&E>UNX^ZR54[D]__P!(D/W1
M>.+[=>022F3:E&5BT1"R9"Y!4D$`YUIZ3[M.TS]3]NK8>7[RT./K\9;XVY#'
MR%*81^0,DH<3,LB;9]I7++GK@J>ON&3NV_04Q;::D[CPJH*#3FKQW=Y/C(^$
M6/D*,J3R2RUN(GF0-8I1Q3EZXFGD>-C$ID9E;VYQ\`O7E30^:3VZ])U=2Y9K
M9J-/-\M:XVK0J<\\\]DE)1&(7:I'61"(3"DC=A_4!)!N&1GW`>Z<NA5-NGUC
MQ(KK=*2J.;D/#Z"\LLM&O]/LFE`W,&C2.'N+WV4XWJK0G:PPK%6:0JIP+4YS
MY9NUO0K5E*,D65_=[N//SG*1M$(>QQM$(I`#[6+$;\)&#G&X$9Z,.IU@_DE"
ME;6;OX]^\]B+SUY!Z@:`5^/_`,W>_?K/^D.M/4WT_+3P,7175_/5Q%<]D#GX
M$B5XC)8*FQWI'1@F`Z=L`HN2P'4ZT4T_^3C.5T%QO,5=?_NH*$:OBYJG=>H0
M@A#Y3X[4G\O%B7E./@%V>GD6>MV&2L=ZQU3GV]T>NK9&;6LN5-3@G==/2=\^
MC+^I.I*+45"<KH/`2_WJO^$\O[_4_E'7F'J(\:O\C?J.A)[)Y!+/'^(>(<AQ
M]RS3GN<94BL""0*K[*L>PNK,N%&3N?\`9&I536/?X:]Q7E3PMKU$T^XS4(N,
MJ3WJLER!;';>&*8PMAXG.X=1OQM]/PR=5:3O<%V>)-,<+^W_`*G/YQ%7G\`K
MP*L<524TU!E?<L:[T*'(63?M8+G\1J86N[QC[7Y#CP4$>(\7EM[&'+.!@$EB
M20"%Z?ATT('N@#0!H`T!427.7;[H"UY+>AXCZ.T\7`Q6>/C/>IRJ%,<7(YQN
MD/JN<_HT4*W[JIBOFYML(P>\EQI4W5![.7A'@6[H0+/&?[/<=^[Q_P`D:T=7
M]VK:S'_'_8H^5#/6<V$!^]QY,_;_`)**D4'<1`<,PG[@L0]KL[?^=\W_`)-;
M.@A]51M)F3K8_3<+3102HU.BI2U#R(JQPR5+R1$L9)@%:L'23?W9D'L89<`8
M(CZX]F]W0C:/9W;3R;EIM=;<;)(J7&K")E)\?B)_B`",L`LR*\`D->,S+DHV
MUR3MW(51LYTG5\V'MMK$J?E-O'F>VKP4UCDXF..2.*6:61+43D]])YDF'>DC
MA4E]L?M/J<=<15*;^+=H)IG=<8^.5>(X^OQOF'+Q,W$\@TE"I1K!>VT=:*1(
MOJ8U<SNQFA5F*@X]=V[T9KJJ;HIO4_9@*$E"NJYG`RI;\>*2RK/#-R5)I%F_
M,2K3GK2R]9O8Q,0D8$X]N.A_"]U78^UQ*WT]JX$^EH<=RT?&R?Q&"!YYYX:Z
MO6*0I$$0B)HY+9Q+M(>.RAW>H+;M8U4Z8RW^FXU<JJA/=Z[RX/M]?XJQXY7J
M<?.T_P!!FO,99&EFW*[#=*[>K/C=TR.O0D==>7U--2KB\3T>GJ3I@L"2,`5(
M)P"#DZX'<I3PWB*</.^.I]=2/%UKMX\-R,-.6*[>EC$BO'-8;V$8D8Y'\YMZ
M:A4N+DN;%\U_9QT%FY?U<N"@H(N+E?\`JNY_]8D_D'5Z+T<Z[F517-&*UXG2
M03O=CBI6+-MH46&5Y[-+*]Q=N7B5$]NT]".NO2<85O"?"H\]0C2L9<46)XEV
MVI<A%OFF5.0N1L;+]UCB9L@'`]GP5?@-8<]36Q&W)<GM9#O'_M;XU>3D9'DN
MP5OXE>C;CZ]J6&J42PZJO:0@`8'PU7,YJ8*FII06C1IO+9;5474DW%\1I!5/
MT=*M!QR\12H\\L5*NTJ;)(*^Z,21+A=O<8$[.I)R?CKK32J5!./N'&INJ;4/
M?(XO!&M]VN?Y2W6,LTT-2:N\<H96"V(8580QNCIL0C=W&.3[@,>W6KZD<FE)
MZ>#,_)#.J;6CP+=UYAZ)77W=XV&^W#167M10]R7LO0(-DV0$>!%0^JEDR<?$
M#TTB\'#7>)8J.J,!+;J<\/.O'J]J\D!L159K=,V%R)*XK]U2I!)+-&NWKU]V
MK*NIJ486_N7#$CEI5O\`Y\2W]5)#0!H`T`A\H,J]B7N&I!$'[UY2#(!)A>U!
M&,LTTGHIQT_2<:[97?;@<<WN*Q\OYOR7CN9KT..V4EC6(UXHQ#.:,;AVD!1V
M_,O3@8!/M"EC^+&[J>"C'&#[]BT8E%33_4X=MIZ7@2/@Y\\1!//,(I_IXUNV
M*XZPB7#?14$7/YKL?>R^AZ#X!;Q;PMI95I*YVT(Z(%AGKQM]+VJC/)7K5J[$
MS6@Q!^DC?('90KNED^7.[!VY9I<G?/AKVZ"%-72XZMFDWV*\4L_8?M7^3?=7
MGX\QLM6.)`KA8W]NR&!@N]OVS[<;MH$)PG<M./M9+7:]&'L1]JUJ4T3)/=$=
M"<,+%^0A7NF!"2L88G;5A`]/VOU9+&VKE/1H]0DGC+CZ'W)F^DA6,R"38W'T
M[`"-.R`*MV]@+B-<#MQXR>GQP%BZ._R0OAN\V:42TMQI7M,]B$//9>\FU:,G
M1'LR#<8V9@I$*+TVX(Z;BUI0N[L=7F1.-_?AK\C+ME*\VZN]/CI`DK7K*F2T
MVXD;HU8'-FPV.@&4`7/NVJ(C/2]WL1,):%O]K-\*1I8@3<D%^GM;C^'P'1%8
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MN+_8^[_TZW_VS'H"-W_^N)?^]]3_`+-BT`[^ZG)5J/A=PS320-9>&O!)#GN=
MUY5V!2.JGI\WP]=2HX.!#4<(B:#D.9H_9@V[6>4O+7<3K;<YDC><HX=SCTB8
M]3HG&_=?X!4I24K=I#+DL!\.X>^:KS.O(SI*CC<79BBC+ABV_H-H!P<:JTHS
MX>I=1L_0D_#V[A^ZUR/BYZ[1S%YKU4E0W9]B%P,]P.&'N]N/34P2G".O&VHK
MVP[/3Q,/MKR5F7S3DN.M5((+%6.P[R11A&8/+&,M@#YF#'_DU"Y<./JR7''@
M_(M74D!H`R-"(AH2&@#0!H!!Y!X5Q7/\A4M\D\KI2VM#!&PC'<5MP8NH$G^#
M=C4-.,G#9?WEDU":CMN[M.LX?NW_`,,_)?W";_S:U=']VG:9>J^W5L*&X6WP
M@:#@/,J$:TZE6.Q?Y"I'*]B59X6E@FG['>[P1Y0`6/QRRY'3V,RFKXLMS;DC
MRLNI?#6I0O.3_=SDN'M.EZTU:U2:L(KVUYX+5(QM]-(KJ%4*\*=DHW0G&`&!
MU;ZJJ4E)Q['CYE?INESLL!TO)\[:B-&6S+R,D#]Q7MQ,Z2[]K,E3O2/#*LS.
MKJK`%^BC:,:Y<E*G=;'8=.>IROM@(:D<]US;C>:&KQ:)V4?9(T15%[B*D>P=
M(T_-[(WK[]\;>NNS@I:;>R/><5%]EK0[BR/[OD7)?QWR>>2:&:@_TX@,#QN`
M<NP!50K(VTY92JX8GV@Y&L/\BURTK&9NZ"/-5H+MUY)Z8:`5^/\`\W>_?K/^
MD.M/4WT_+3P,7175_/5Q$HDD/D(B->P$%EF9`K]C=O\`;)G&.J^[UQG6N"^E
M&*^'5'8>>G5^XARU0YM?+?)Z+I[2$>=U&;[G5I%XJ9T9JO>G5I.W,-Z@$[05
M7;C&<CY>NNO2UKZ#7-IT2.O4T5?735.B<]\S;_>J_P"$\O[_`%/Y1UXQ[*/&
MK_(WZCH2>SN92P?!O!GB1Y%3C(S(BJS@K])%T(56RQ_9!Z'4.I*]I6VH*ENY
M-[/8R4^;\W0E\:I74KI<KV;`6**;OQ,3VY?E[:]Q3[3ZCTSJT%I[F5GLVKS@
M<7G95_$^(D[L<,@[!2C@;)"P5?8KX/Y>[XGH/711PNMJ8EC;?`D?@V/]T>*P
MX?\`(7W*NT'J?1?AJ`/=`&@#0!H"@;5+^)_>P(W/VKW&U>24GC9*=N2*"<!7
M>$2#^C;&VCW,.GPZ]=17F.5+=&R,^Z%_:31EKXE35MP[X^!?VI(%GC/]GN._
M=X_Y(UHZO[M6UF/^/^Q1\J&>LYL*N^_M)I_&&FD5Q2B@F2U810_;$LU<+T)7
M).#@9UZ'\=5"N&/M,'7KW8X>PJRI0M4ZC/Y'Q<L$5815ZJ;XDDNE9$[4-6>8
MFQ`)64/)MZ(H)&-V->BZDW[K]-N#,*I:7O+UV8F-?EX+36>(XU:7)+R@KB:I
ML,G'5$#ND2[SV#W8]RQPQH"I]22?0Z(0J<5#O=L0JXR4''N5L#.YX_Y##QKV
MX>;>1X+S-#9B9FA[L(EKLG<F?;D*J0;=P#!3\P]Q4YE+<(8>OJ*LNI*,<;>1
MT^3L_'5;-98*]2Q,#6$ME8V[;PNAC#R2*J1QE+2E'B9=ORMO*@FN5[SC?;TQ
MW$YDI6M/VFCAN!*OQO%T^0HVH)KE%EY&-$LPOLH3I,C@))E8Y(6VAU^'J,YU
M->9?4T[G+M0HR[DFKUP.SQFCS$M!?)J5Z_R)KSO3%:81]U*TYWX`F1=RD[V5
MD<C;\%P1JN;52GR-)8]I.6JH<R;9>WA]9Z]2:-IK-C8YC,UFTMLG8S*,;<=M
MB@5F7:,9Q\->/G.+P[H'JY*@O6(_(!&#U!]=<3L0_B?MAP7&<M!>BM79:]*6
M2?CN+FG+U*TLNX,T4>.GSMC).,]-52JN;DM2XWEHTWI3>,_82V>%)X)(7SLE
M5D;'KAA@ZNG`HU$HWBO!6\4\GJ-8Y"7D;=JU20*YKQM$C74(,ZB5GFD*0(%9
M%Z+Z_H]:OJ/J4."@H/3H/+IR?IUJ+C-<2TO$X1+6Y(%W39S%Q_8Q7.V<G!QZ
M@_$:\_.<U\J-V4I/YF;!'7X>NB-W8Q<Y5F&]\%GLS,_3M!LH2>BM\/FU$74]
ME/`F5*VU"&2@8.1LQP0,D)\FKSA0K;?S*D;RN/T-(S$GTSG79512^3Q.3IG_
M`*_`B]R6*K]YN3N79X[,2+32O2DJ66[0D,*%^\JK'_.,#N/<`/3V^HT4J.0D
MM>*UVP.%4LYMZM.HN77EGI%7??.W%4K\'8DD^G*6OR[/O]C]R)E/L!/M*[__
M`$<?'2-I>*9-L?!H=\;3:SY$DQYN&24QU9!3->)I7$4"-(V^1>XF[>&Z'IG1
MTMSY:=N/%<`JH23J\/'B3;0@-`&@#0"#R4;9X+"KVWKQNYY";K7JIT#2A#[7
MF(Z(/_J=#VRKH;M/H<<W3OT>I0?W2M>/1>26816X,I)7KQO=Y=[#7@6221_:
MH!$C8*N0"0Q'7/I>JEQ3:;V5<J]@RW!-4N'^F-F6EP5/CI_%>.FGBKRW5JTZ
MU/B^/#&*%)464PQN"AS-&&+NS8"G\,[K)M25VEVP.;2<W?HMI&D4;S2SDR=4
M!@NVJP.$1!N-#CU&#T"_F.!G_#\AN%M["4;;D?;+F6""`LMRA-^526#:LU]%
M)*0,P)VP0C^<<XW?J^8KXW/AZA]ZX^@5E6Q'8E:!+_(,\<!CFB>&&LT)+_M$
M8K1;!Z+EF'Q)&#EJ7'U"GK?#T.4026ZUJS%.DO'R/$]KE;156[L!,GU(4$'M
M*,+%'Z'H>BY+VC!I8Z/#S*PBF\-/B;46$!$"$,0UNA1L!WDGE'7ZN[M&XNQ'
MY4?3KTZ'Y(L_)>+)MZOP-UNW;GM-8MND%NM'W&+X:'C8F'\XXZA[4@^5>H7]
M75ZTI)05W_+T);;<7?P]3!I^+BK../:6"HFT7K[@M8[T@]T,`8;C:EW8D;]G
M]>,3!MSOT6P$5"5UMYIDA*F.*Y7EAKR1(O%\?4D&R1)"2U8,N=S,`&FD+#IZ
M>W):8Z.UOCY(B&GL\O,2>6\7!ROT<4W(&G-6MQF?D*CF(QB,&+Z#C<(^2#*H
M<X&3T_0M:J:FO=M_<RU+IC[UO[49^/4.)I4[JT^5M<]Q]FP8VFL3K/:NRP+A
MJZR*!VZL6"7/QZ_#YIIIK7Q.?#U(JJHNI4%Q]"R^,:1N/K-(8BS1J?R%*Q8(
MR`@;KM`]/_J:S5WLT4W'3JI8C?W%_L?=_P"G6_\`MF/0$;O_`/7$O_>^I_V;
M%H"4>?*C>(\AN61L*A40@&3(D7TW`_X3ZXSC4-+'S)3M&`G\?X]HOM0:EFPC
MM]':+6)CE!N,C;F)'HN?PTOM9",+>PKCE;OE</C7"S6VCMK7NVDFD+Q5SDB,
MP0,L431F5EZCIUU"<H0[H);81'+'&.V+\B=^/R<4/NKR\(IJ+YB>1;@,@)4]
ML.C(<J.O[7Q^&K05\;=WB(OLV>,?`T_:VD];E+[S+BW.;#VWQ9R[_4':6>0F
M%B%P/;J.>+OG\T=T)=XY8*Z7RPWQGW%E:D@U6HYY*\B5Y>Q,RD1S;0^T_`[3
MT.@*W^V/+\E<YN:E9DCF/&5I*]K9&D:Q3]Y6*0LKOW4(ZEL=.GZM6J;Q7_+?
M%D*&#CW;H)%FZJ2&@#0!H`T!%ONG#W_MYS\&X)WJCQ[VSM7?A<G&3@9UHZ1P
MS:=IPZG[;V'G6M)5>SQG)V:B2<RF(56K,_'&QVML:*LDG?2P&1DDD78I`8#Y
M00/<:<&D_=[_`&'C4NYPGW>T=WU%R6X;U1>&O31H(9U6.0E8E5L.$PIB$N\L
M4CC13CWE=<J90@^96MB=:IQBH.UL!,UNWPW+<?7_`(V%XYA6EN7AW&CBM"#^
MCK9(42)$\1V-&NTJ.IZC+=(*JEOEG/NU'.+I:492)+Q=.[Y.)K<:S_3"=+!K
MO7CGB$]V-@&D2-ZB#W.2'ZAPRD_M#7"NI9<K2[SK32ZYVGW$U^Q%2C`.>KQ+
MWK''3Q4I.2D4">P`IF+28+8&Z0X4L<?CK)_(-OE>F<#7T*2BM!:^O.-X:`5^
M/_S=[]^L_P"D.M/4WT_+3P,7175_/5Q.(\'/#SB<C-9A,+2OMC97#L9&!0$[
M]I9,;5]NNO[A/+Y$G&'#LQQ,[Z/ESEF.JF$7_3.>OFO5RD)/)_'/%9^>>Y;Y
MDTN5LSTXXU[@R.V=X@VY^68+U!^/4:OD9N<J(4TQI2?M[#IGT9'/&IPK;7IW
MD;_O5?\`">7]_J?RCKSCTD>-7^1OU'0D]B\SRUB/P[PZE2Y'Z:=>*KR2PQ,5
MD/\`1HBI<[D4+\1GU.KIU*ZVYG-JEN=MZ\26_=U@/'::[0TK78^UN`9-RQ2O
M[U*2;EPIZ8U2UIHL:O-*M4_;>E)*=KUHZ7:F(#%"QC0ELF,;2&]WH-1"+UDI
MC_P)0OAW$*'[@%=0')!R.N#E>G_)J2!]H`T`:`-`4AR'(>2\7]Y:GCWCO%6>
M$BY:P]FY=>99^/N0(F^69:[#"2=-K;75O3UT6;2I)MO0UP<8^&HEY=3FTDM*
MCW.4+7EWZ$"SQG^SW'?N\?\`)&M'5_=JVLQ_Q_V*/E0SUG-A"OO-'%+]M>8C
ME?M1.*ZO(<>T&U%D]2!_Y=:^A?\`ZKMX&7K%'*=L2B>7-/EH>*CY'C9XN0HL
MM@U41/Z6)2/RSWI#&H&T@X#%`"7UZ]$:8P<GN/+JA5"*FMYNK<=X_&M_DI*A
MX6C561>!\9-A6FEN,A!LSV)`V'C1A(J]648V_#,.JJ2CS-WU:M$"533-P@L%
MK&_(1<S1^KN---QO#D0R?60LD%L1I6546*:60K*D3L^Y)/<0^[JWR\Z72X*^
MK=>=&JE.Y;[CAY*MR_/WGY.:JECB:-4)3Y6Y#5F@;(??-9WRH(Y5+$+&BE2R
MA>N-6I=-"A&;=RCN*5*JIQP2OEO-ZT[<'*<I'P=]4M/9CBCL5JR4((E2K/`J
M*DQ*E>VH#$')8D9^.HYDTN92AICBB>5IOE?A@QM1>Q<EXGD.-I-7C@2U7AXO
MZJ+M1V)!B/:PV.P7OE^Q)E?=A?:-<ZH**;T3A;O.E+;@TM,K<"X?!DLKXQ4-
MNS'<NOO-NW%"M9991(RLW;4#TQC/J<9.O+ZB'.X*"/2R/A49L?:XG4-`&@*Y
M\\I()85AL_4<I%86]'<>.*9Z4\*#L,44((XI`I[A;U4''XC=T]6J5VTQ9ZT.
M=^PZ^/\`/>`XJ,5IJ=N.W;E$\W9A>2&2>V[>^%V/N21XW*_H&JU=/55.*@O`
MM3GTTR@X^8KXCG.&Y&-VH#D+R/R:\XLD-&1ORWD;9&S&1@>L;*&&.@^772O+
MJIO@O=Y;RE%=-5T7.-QCR'F-25);?%Q\E9MSW:O)4JCUI8TDW0=J&OW,MM68
MP,P;;C/J-*<AJ3A"#5^_L(JSE>HWIW"U%'+>0T.=FXJ:'FW2!9EG9>Y'"OYX
MD1D#)]5)'&%>%(AT^;'M;73X:73'W;;M<2GQ5*J'O6WZBX*\\=B".>(YBE4.
MA(()5AD=#U&O,:@X'HIQ(-]S6*6.-D2>&K*(;BK8N*'JX,:_EE6_]HY`VG]?
MKZ:CN>I^U%E*<^SV,CL'B=V3R+AN9J4[ZSQ0\<*$FY!7^F6.,6/K/1NX`OH/
MP7&H^HT[WOGY6O)Y(J:7EYVN+>U)4-`&@#0$:\ML43/5JW5E6':\RV(2=RRJ
M56-$3#!I'+$)GJ/5>O4:,E.#:.&<U),KGG:OF$GEW+V.(X3B[$B5(Y)7ML?Z
M$9`QDQ[)%EG*@%S\#CH1U;EF<D8.EU]RCWX%Z%5"57)WN'=B2SC&6KP=6H(T
MI]B)*W)V:(8M).WN:G4RS,\F[H\F>G7&#\O=*,X;$\-IR<I1VO3L.F*)$2K:
MGA=;*R"/A^*K,@38H(>$9&1@_P`_*<9]/E^:6[TNUVW(A*Y]RMO/M:)[MF9$
ME60J%BY2Y"RQA8`VTUJ>2-D,>#W)!U."![OE-P7#S>L)1?'R6HXY;7$I!,R-
MWJ#MU5W59;QC7*]P@#M4XD(^&&'Z#[[)5=O#UMLJVNSCZ'0LM^QV?JUCDLM_
M2:]-T$,2JO06[BCJL40&(D8[NG7W?)$$KK:EXDQ;OMK?@<BI1MXN),SR=KO<
MA;O("M9]WML^T[6D9!B"/!`7!&%R&M-2[H8ZO,K)S[XX:_(W6Z\T459YH'J<
M7)W9(!*'EF:=AA)9E1D=[,K-F,;O;C_*QMA.,<7;<2UV*V\[>/AE^H[<=97N
MT828*<>#7I`@$1,Q90UF92<OGVY_#JU*G*^3W^B+TJ>M;O5G/]0\55XI++]F
M$B"S;B)8JP&P4>/S[B^%Q))Z^IZ'Y+0B[K:65C!6[D1C[B5N2O\`C5:BE&U'
M#)*L5&EP[(\TB]IV!C61NV8T1R))>FXGIT'NI74J9QGI:C;4B]";:6&V%M;-
M?VCJ6./J6)X>)L\96KRQUY9)((M_;KQ`M!"$9P4+J>Y,W5FZ>ORTI5,()Q[U
MVN.)>NJJ,7NGV(M7@YH9Z'>AGFLQ222,MB?U<%C[DZ`;/\C`QC5,Q09:AQ1W
MZH7--RG5N5VK6XEG@?!>)QE3M8,,C]!`.@([X_2J6N5\B-F%937YE)X-XSLD
M6A6"NOX$9.@-WW"K5K'B'(+8#&-%5\H0&&&&2,E<]">F>OIH(B_Q'^'<7]LZ
MYIR?Q"I%6E,/U)$?=+.V(VW%PH9SMZDZ0PJF(_AE;40;FK=B?Q7B+=3B8*+Q
M\A.D5.%PZ,K%/<RMG)(]6_9Q^G4/EUPVV["9N^$=C)!XS"U7[M<Q%+7D4SPR
MR5['<62,INA+`Y9I%;+=`1M_#2,;>OAVB#[+:O$Z_!/#O(N)\KYGE>09!0NF
M05H^ZW<&9=PS#&?I\8_:QO\`QU*S*G*<-W=-[^P.BE35]L9=T.TL#0@PF:58
M9&A4/*%)C0G:&8#H">N,G0%0_9V;CY/)KRQ0=F9:Q8HLSSQ(28@RPLT<8*;0
MG[3'&-(+#_KOAXDMO'_MX^!<.A`:`-`&@#0$9^Y;1KX'S;2';&M8EV!`(4$9
M.6Z>GXZT=+]RG:<.I^VSSA;Y2:E&J4XG5>3K_4U@(U-.*\2)(W"(E>.*0P1!
MR1W`P(.->XJ$[\.^&_'8>,ZFNWCN\1QQ+\3)45EM\;%:N01]^KQ]:",R[SWE
M))$:M9906BB*[(NA?)URKC&YRTNTM+Q.M+BKUV6OX'`'45(S5IO?X=XIEYO\
MMS*D-@M(LXEE[R9_]UW-Q!_`EMO3&;A5A;B<\)3IQ,O'TYZ'AOH>.G>1ZP:!
M*I5DALP-(6W.TBB52$:0%4^4J>J,O6,SE=47[":%4E!%N_9[DYKU_P`A<0L:
MW<KF.X[@EE$96&,(-P(2$+^8KD/^@YUYG6TP5)Z'1U-NHLW6`W!H!7X__-WO
MWZS_`*0ZT]3?3\M/`Q=%=7\]7$63V*\ODL-3%C>L^\]^9DBRBE@8H_VQ_P"3
M6BFEK)=4KL%/M>!CKKI?4JF%7Q?U5.'^FFYD$\NCJ2?=N"F4I=RVE>1YI;$B
MNG:9#AT!VJ[A0$_$:T]/']M'WI1T6D1U%2_<I>[.&F.R^$_:9?WJO^$\O[_4
M_E'7BGMH\:O\C?J.A)[/Y>WQ-'[>^(V+\+.DG%0QDQSFN3FK$`KX!+J<X_1H
MJ$WZ+Q',U9^!(_N_*L/BL4W;:22*U&\2(%;+JCG!5E?<".F,>OZ-)8VWKB55
MK09PWK]^U]JH9;$#59E-6)=Z%L1K+&%E:-P-XV]2OH=(JJZ8NOE;:2+[>W19
M\5I`030B&-4#3+M$@QNWQ^F5.?P_1I+`3))H`T`:`-`5=-X#YR_W.3GOK5;C
MDN+8CMFU,&2EV]KT!3QV<,W7N9SJ/JU70X0VZ8D_2IOCN<>^,(%HZD@6>,_V
M>X[]WC_DC6CJ_NU;68_X_P"Q1\J&>LYL(C]UY#'X'R$@#$I)48!"%;I;B/M9
MFC`/X$L/UZT]']Q=O`S]5]M]G$HV9*$5N3ZJ^8..+-]4MI(<2J4>:.J7.]I[
M'?;,K',1W?$#;KUU&$E.T]2A=B>7!1OE;O>XY+?&^,\=9BMV:\D<TL56U?XN
M`ET`$2R$;9F529WZF/U3M80'TU955U*"UP=M'C,JZ:5-C"#@>3X;BDLO=@K)
MPSJ.4@=IA"L\W<-=Y9"ZRQG98QC=G/S#Y=4>8JG"'Q7>/`LLMTJ^Z\X>0L\=
M)2$_,\+:FXGAF^CE-8J!O=#+)$@E:4L8.[WE[O<4^H*#H;TIQA2U&J=MMV':
M5;4)J2E;9VDQ\OJP0^3U9:<9OQH]"S/7M.:X"&I9"IW*ZH6]I3K[LY.[.LN2
MVZ'&5_%:31FI<\IW<&+4FY`P2O=XKCOX92O21)Q5=IH5EG^G!9X=B.I=8Y,!
MEPP``#%L-KHTL&XM7]I11Q2@G<7'X%02K2MN'CEE>=DL2K2>C(\L9(=Y59W[
MA<G=O4`'.O+ZBJ+7G$]+(I@GY0)/K.=PT!JMRRQ599(E#R(I**2%!('Q)('_
M`)=2E,AN15/$V^0Y+R+D(WL)QUWD!VI"JPM:M0UG2NCV`8K*+%()MT(10NT]
M68[B/1K2II4HI=RQE=VF"ENJISA'?Q(I8\0\LM<=R@-).]PL_P!#QVZI2L1D
MY1MXVQ`B-0\F=O7)`QG<-:5G4)J?Q3<WYF=Y-;3E=*Y>1UV^"\>\?Y-N!GF^
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M&N-54-/9'P\3M33&RMW$TXJ)XN+IQ/'VGC@C5HLEMI"`%<DDG'Z]6*G5H`T`
M:`-`(/)<I/#84=@PQN7Y.7W15D)`9HXSD-.WRI[?^7Y3VRM&[3Z''-T[]'J)
MPD8X^*6:)ZG&!G--H)2;IG8["K`%^Y8F]^[XQ]?=NR5ZXZ7N]G$YX:%O]O`Y
M[:V<I!6@<7HBD,,50^R@I]RP1/\`(9Y%&97;VJOKD85K*%[NUX^F@JXX7\/7
M2?8DAKP29E=HQ_1K5R$L9)7R3]#1+'=C=DRRYR3DDYZH<[;WX(*5MR\6;(YJ
MUVC6WU8)0WY''5*+@=Y`<O6E."1!%A#(W0-^&"`T---SVQX[24TU=LAPV'Q)
M+D'-6!$8Y^0>/9<,L*I6"KG+;B0Z05\*%Z>\[O4]503IU;_:Q-5:[;D9I'7E
MA[UN61>'L,[V.0E`66W(D9832`J0(%QB*/&&Z=-O1HBU=\6C1ZZ298_#Q]#H
MA2:W/#`5*SI&)>/IV0SE=@"I;OD=2YQ^6A_\_P`L.4^_R1*GX>;.>:6S7^K=
MA&MV-VMV)21(M'>NT*LC[M]F5<*J_*HV@#`&^4DX:./H5;:CIX>IIJ7[+)R$
MBF2EQEF<=Q4_G]YZ&M`$PIGE<DR,O5/3=GY+.E2Q=I[+;853G@K2VVV=D2+6
MN5(YMU;DHS&M"A%%W*\,+Y#0KZ;G*>Z653[?U=&HYIZ,7;<BZDUIM9LU"&JH
ML25U>.G&!%>MU\MZL`U.CM"[4[A.^3`_7GJLQ>-]ILB"PNM)'5:L,83QWTL<
MO&2'M<72AS&UH#:ZXVL56NB_.YZ,#Z>@:J6,9XZO4LWA"6&OT)#PXF''QF:S
M':D;),D(41#K\D>W]E/E&>OXZXUWW0.U%QV:H6#0"_B^(6A:Y.<2F0\E:^K*
MD8V'L10[1UZ_S.<_IT`I^XSWO]T[<5*D;TTY2,HHW;%+`M+@=?9C(Q\<:AM*
M\E)NXC\/U]/[3_1<51M):0QU41XAWB+%E4DE13C)5)"P8XZC)U"JI2C&)+I;
M</)6[A#Y+P?(\;XOQ!J\3:EGIV9V,"H!TDV#,@BD<^[U&#^.GU$IMON?BR>1
MN26]?XP)1PM65?N=R5@Q6%#Q/N=XR`5_*VYD^5D]>VHZCW9U/-A&UL<2O*X1
M@3S4D!H!9Y/<Y*EX]R%KC(3/R$4+-6B5=Y+_``PO[6/7&D4IL0;DB`_;+B8:
M?DUB6O7Y`PR4<RV.2JBL4F[B_EP[0B[67U&,C:.N-552<N95;(^)>JEK#E[F
M6CJQ0-`&@#0!H"+?<]ZP\$YB*QATFKLO9W;6D'JR+\<E0?36CI(_44#/U37T
MV5+YWXEQW"\-5K7:['BZ%L-!<L3/).O'M$%8*$:*3$"RXCVC&\;2&]6]+I\Y
MU5-J]K?ZGGY^2J4D[D]Q!N(6/D>;C=[<7(\'!RL*%;C/+.45-K2GL=OVS1IM
MVGV_\FME?NTW0JY<#+1.K2N8EODG(\KR_.<E5L<JG!T([25?X57!2PE.NQ:P
MX$4+]N,0S=69MC-[AE2`,V53332FES.%^O#$TYE3JJ:;Y5&[4)?*?,;ENO0Y
M2J9ZL#U)5J33(LUMHZLG;J6-T>U1AV?=*_[3-TR%UURLE)M/3V3O7H<LW-;2
M:T<+BW/L'>W^)S\7(G9M\//]+9KF.5=K8WAE>5W9UDW;QT7&?EUYG\C3[\<*
MCT.@?N0T%FZP&X-`*_'_`.;O?OUG_2'6GJ;Z?EIX&+HKJ_GJXB7ZH3>4I%)O
MPL[F/N//M0QD+@+CM_F9ROPP-:^2&3%:/[?;(\_ZD>I2<?B=_/!0_+[UZP1'
MO(>&OI]U>/O;J4OUFWZ6M8+[VA@C`FPH1DWJS!U8G/PTRLRE].U!RO:A>[M9
MKS<NI9Z:J4]3N5^H7?WJO^$\O[_4_E'7EGIH\:O\C?J.A)[-O\3Y'R'A7B:5
M-EBB>)K@5!F,F3Z6(CNR":+*Y7X#I\<ZAO\`MCO\'`CM7;:8\^ZUZ'M\=0>3
MMMW3,Q(V^WLRJ&CD+QKN4C!7/HVIM::"6JW<QCY+QDO*?;^K1KKWGF6CM#2+
M'N"R1M\S':QZ?+GW>F=':07=:V`[\5HS4/':-2=#'-%'B1"5.&))(]GM^/PU
M"#&NI(#0!H`T!7,GFW@S?=&"(<S=/,HC\,_%H'-)9>X&#RJ%VB1F.Q&)Z^FN
MG+5#XERZ,8E.91^%QTEC:YEQ9XS_`&>X[]WC_DC6CJ_NU;68_P"/^Q1\J&>L
MYL(?]VQ5;[?\F+80U2U43B4LL>SZJ+=O9/>%QZE>NM71Q^JH:^!FZN'TW'5Q
M*+6]RMNT:M>P_)7_`*!^-Y&W8GC_`)MHV,K.HV)(U3?O3,LFY?P^'K\J2BY*
M,5;7L1Y<6Y7N$';5VC&M;Y/B./KVSQ-?^'0\DDMZ_P`9VKB2W=H6)HX$9TKJ
M8V4@X#(P;:<MKFTJG",X7.4O$NFZ5&$HX3GX'!S,5RG'XWS=M'Y#B>.@8W$I
M6'CLR/O?9>5NAD=4"_FGUVX]%)'2AI\U*DWIX>A2M0Y:G-+1Q.GQRGP?(V2W
M\2_@_"W;M>%9(YC)8DDMPL51I$,.TR1,4E[JM@!O=N;5<VJJE7<U27"TH$Y=
M-+=\*6^-L3J\A\BO\M*D4G%0SWJ=F'C5:*-YXRB060LS4W2:2%XSNW*V['KU
M`R:Y>6J<9-1X8ELS,YL)J7'`U>/\E16CQ?%Q]MZUZ>9Y.(:K&T\[QUT-:%MU
M8!Q$Y9N^#NV;3M.[&IS*7%O1C'7/'<,NI02TX0[L-Y??B-B_:X&M;Y",07[&
M7LUUD[JQ.#L[:D$J-H7!`QUST!SKQLY)505QZV2VZ8N\<ZY'0-`&@(#]Q.(X
MSCJ%;EJ_'269N/:6>*K#!'/&1#"TVQE=6:-7,.W\LK[CGJ=;>FK=3=+=YDZB
MA))I7$>XSD>-H^-P"G?:]R=UWLRM``$B>3-JQ-!&.Y3[D3YD4/A^V,=?CVKI
M;KFH)>Q:_4XTU)4R<6_;L&/B%^"A)/9Y3E!>J\G4,Z<E)7CHSR.#)(4/;6+M
MR(`Y(+DCH<J3C5,ZGFDE!IW7E\FJ$VXIJ^X^>,?<FK/3[O*CD*5.Q#'%2Y?E
M88A`\XC`?MQQ`/M]VYW9MA^##3-Z5I^[!O0AE]0H1<=K#P3QRCS+S7+<5*1^
M+MRU1R--5,UIP@/=>P0[-N6;.]&5MPS\<!U&:Z9*,U<\.PC(RU5-PD[]/:67
M!7AKQ"*%!'&"S;5&!EB68_X6))U@;B;DH&S4$AH`T`:`-`&@$_,\?)=O5E_.
M3MH\E:PNQX8K"D%7>)A[FQD+_AQ@]==:*H)G*NF+%[\=SL]N.65!#<E5OZ0F
M&BI0D^Y(`?GL2_%R,#]0PU^:E+5Q]"G+4WKX>II;CN0>%J:5&@XFNHLQB,?T
MMBT9W1*Y;/>D+-W),C&<`Y.X3S*^/O;O81RNZ$M_M-B<7S%0P<C]+'++"HCK
M\="P58(G!3L)N7;C)1I).A..G0`%STN4>TGEJ4X=AIM<3R^;`:%I7D5!R-F$
M!6E1CTK55RNV&,'+]0S>GJ<B573Y>;UD.BKS\D9V>*O2QHDM,V8*"K5AC*QQ
M-;8LO63;TCJHP!V#UQU],-"K6F_=ZDNAZ+M_H:X>/\BF1+%M&L69)]U6";I!
M"X'_`,3-&&.%0+^5$I_23N.5EU4J2MJ\V0J:KW;7Y'5#PD[_`)7TN]6GD6U=
MM;#8=MH'U:'W@=5VQIMP!CT'357F+3;065&JVDUTN-L1R5IYJ+BE`99JU'YY
M1(JEOJ)SG#V)6SC)]N?\KJ)JJ4U&=I;"*:7)PE:>TS;C^<LW(9I$$%N96*S#
M:T="%C[DB!^>S)GJY&!^H8:.:E+5Q]!RU-Z^'J$_$6*_?HTDLKQR)W9Y=^Z6
M0$?_``]7)&TN<F20^XD^N>JE6G-PC:;)=#4E&%I(U5*?,5K+69:)+UH(UX^K
M79!`BR$H:PW#`"^UI']3CI[1@RZJ6H1V^954U)QAL\C;%P?(SW)(K1*B5%'(
MWU]ID3U6I5`ZQPKGW-ZG]9R(>8DI=B\7K+*AMS[?):B2PPQ01)#"BQQ1J%CC
M4855`P``/AK@W$[)0,]02&@#0!H`T`:`-`&@#0!H`T`:`-`&@#0!H"#_`'>Y
M>7C_`!=PNT13K-WI&4NR+#`\X9!E>N8QT^(Z:U]%1S5F7JZH4E,>76*=F?DY
MZ7)25[UKE);T/'O7D1IJAA):S*P99(TRQ[89U&%!VDMD^KDIJ":ERPCKT'FY
MK3BTYQCV:3.?QZAS]'AK=N&&C7NJDL/*,J_56J]5,66=8'BA4[4797`W[`S9
MW9U"S'0VE.&&"C=?Q#RU4DW*..G3[#+SGG>$_AU7E.+A>U=D*VX.7KR3+))4
M5V@CBL1NK1ENQ^2[/N;:O7<#IT^75%IW:->KMF3GUTPBK].JTB)5I.>O1<K<
MY*`5X+92#D*P$E,D"42*P9BD&99_F#@^C%5&T8TM4J"6%V/K<9DZG%O&_"TR
MYOL'QR4>1\H3H7DEJRHY569XY(=PD$B>U8Y"2R1$!E7&1KROY"J*I[;>IZ?0
MTP=787#KS#T0T`K\?_F[W[]9_P!(=:>IOI^6G@8NBNK^>KB:)N$NMSD-\V/J
M:Z2%A7ER.T"I7\O'M/7KU&?TZM3U%/TW3"#TK':4JZ.KZRS.;F4;GA+^G#=V
MA;YMQY+2XRMQYNHRR_77XWCQ2(4-&LJD[QW@?;C\-97!7QB[I&]1=URO*Z_O
M5?\`">7]_J?RCJ"R/&K_`"-^HZ$GLCR,[/`O!I"G<"<;'E`SJQW4XE(!0@]0
M2"/CG2,,86UD0)G]R*%B_P`94K0&%,3&1FGE2)>D;*%(<KN!+_`_#4JENY-[
M"(TXM+;[&:/.(1%]NHH9B.Y&**+L`=#*LL849]WM+#&1\-1-:A)ZT.?!MW^Z
M/%E@%8P`E5&`,DG`S\!I&(A`>Z`-`&@#0'GFS5Y!/[P:5%/$(DEY+K-$8%GD
M0#=LG!'<,R+DH`?4Y]-.7^U]^_XO^I,?[MV[X8;ST-H0+/&?[/<=^[Q_R1K1
MU?W:MK,?\?\`8H^5#/6<V$-^\$\\'VZY6>OM[\1K/%O?MKN6U$1E]R;1GX[A
MC\=:NB4<U1U\#-UCAEOLXE$(5XWCJ4T,",UR=)2902SB;\YN_9_*D64.`L99
M^VY^95QKV/B;U6NLSR;DM=KQ9PO.]JE<XOCXHJM7EK7T_+^.W)`)`[,JQV(G
MD6&)523`*@*R]?A@K>O+FFYM*316BN32N=Z9):]010U..NH89[/TW&]JDL,J
MQ-6BEIR30SLX9&$A`#R-L7>=H9O3@W>UK<]<SLE@]G=(YN;XOB9[]J.A::S8
MGBC9N*A6._)+<JQ@K(/IX2NSZ:5E#8SO'7\1;+KJ245VW2>UZ2M=-+<GV7S[
MM!P_P"'E.,Y&M'#=I3TK7'3VZ]QS'9D$=:7ZD1"14VXC)$2=/A^K5_J<K3DX
MIW77R]2O(JDU-0AP9??/^'\7;XFAQU<R\=Q,$;!*W'Q*EII)`&15?8>SDKEF
M&WW>IUXV7G-5-N=6N[U/6S,E-)*2U7FS[?FY2X:"/D^Y"]ICV$>:"6N#N.%K
M-&%(63JZ(2V%^/PTZF#JE;:.GBJ9VV$OUE-(:`-`:;E*M<@,%A-\>Y6'4J0R
M$,K*RD$$$="-334U<152G>1?S/QZU+'%=XJ-3<@L16X^X&DCCFK]4?9N]BLN
MZ.3M+N(;/7&#HR,Q7576M,X9V6[U>0V/[:\A?I">VJT[=!&-0H\S&L!,+85'
M""9NZ'*$(WL3VCW$ZU/JDG!33WX;#,NF;4\-V)V>%>/<[R_T-KR-FLS5(9J<
M,\?U4!AKL5$BEI>Q,\DRK'AP.GNZ]<"N?F4TQ5&,\"V3EU50=6&TM*...-`D
M:A5'P&O.;-\#+0!H`T`:`-`&@#0!H`T`:`-`&@#0!H`T`:`-`&@#0!H`T`:`
M-`&@#0!H`T`:`-`&@#0!H`T`:`-`&@#0%;??;^R1_P#K=W_[0GUO_C_C[N*,
M76_#W\&4S3\:Y/E?#!8L5'X#QFQ-%,;L-F2Q7>.2;:\DT7<89C`55W*N,>XZ
M]2K-5.9!/FKV'FTY3JHBURT[1Q=M48+E"E5J?PN.G)!1LVYHI'2S]&D!&]Y8
MU._HK5S$-Q]2N&.N5*;3;<8SV1C9Q.C:322A"7="R@(^3M^/TJ)MPV;;S03B
MA3@N[6,%OM#O66L1]U0%Z!`J^B@JIQN':E5-P@M,M&B!RJ=*48O1VZ1?X[>\
M+N'D*=R7E+%[EX8Z\9W(_:1#N:-68YE/Y2A>@+>T#'7-\RG,4&N6"*9=66XI
MQBRT_P"[-2XZO!SL@1HN3FEC+U9"W<AK8)@5]VW=N!+!@OI\?AKSOY2IMTZ/
M$W_QM*4=)>&O)/4#0"OQ_P#F[W[]9_TAUIZF^GY:>!BZ*ZOYZN)KFGH#G8)6
MM$2.#`D`5BI="0<L.@.7`ZZFFFKZ;4)7V[BE5>7]=5<SC\,(2EK[2H/+;U+C
MONOR!FXJU:N7+7&BK.DEJ.$;4C7)$.(W]3\WX:RK,2ESM:DT>B\MN?*GKA$;
M_P!ZK_A/+^_U/Y1T"/&K_(WZCH2>Q/*%1O`/!5D8)'_#HV+$@'*4HW&-WM/R
MYP?CC4IO")6"Q+$\GJ\BT]:?C:%.>PR-%-=N''9C++\G0Y)W,V/T:JTG>G5P
M+)M8\HM\LKU:O@"PS1K#&&JB12`<.9DRPVJZJ2W4':0/7&I5K17$JWI''@SI
M)XCQ3QX[;5U*%05&/A@$#_S:E@>:@!H`T`:`H-;?`S??"7B!7MQ-'RZ7)*SW
M*R5GNK""MI4*=X^S_P!F']?AIR8Q_*H]\8\O8.;4M%]7"'+'M+\T`L\9_L]Q
MW[O'_)&M'5_=JVLQ_P`?]BCY4,]9S80G[U2O%]LN:D3&]!79=RAUR+47JA!#
M#]&-:^A7_M3;`R]:_P#R=L2B^"=^-Y>W<=*UB1%DHVVL31Q1O7;,(@J1*S"`
M%6!46$()#9QM8Z]?,7-2E/3[=/8>70X-OLMZFSFN`X;D>1GJJ+]F+C)H8H8$
M,89%=4[C@68XI/8Y1&23V^[*DX.HHS*J5&4[8$UY=+<)RMB9P<CQ=R!ZG(WF
MBY2:Y`M:1LO'$DSL49*TK!D,8786<9(90FWVZ.EJ:4H6F%52Y-SC:1GQ'*>0
M4K'*\Q':NT;7-WS5K<E&NV7N"-Y(*MBM9,W90@!MP#8!Z,`"-1712TJ8)JE7
M>*:)HJJ3=4YNR'WVU\FCM>*>5<CY?;>-[:5:\UM(XIGDEDDL+'LA19(RS/@#
M<F&/4^N=<>JRH5TJA71\#KTV9&BIUZO$F-JQ]S%XWB;-.H*%FM9C?D9KK54%
MCCU60LMIT)[9A7U*`]3D`#(&5+*BTW&4H1OU;32WFP32AW7:R4>.>6S6(98>
M=IOQEJLQ#V9=@I2E]TB?23;OSE$0SNV_KZZSYN3#X7'CVG;+SH_$H<.PDD4[
M-W3(%1$;V,'#93`(<]!M^/37!H[IFW4$AH`T`:`-`&@#0!H`T`:`-`&@#0!H
M`T`:`-`&@#0!H`T`:`-`&@#0!H`T`:`-`&@#0!H`T`:`-`&@#0!H`T`:`-`&
M@#0!H"MOOO\`V2/_`-;N_P#VA/K?_'_'W<48NM^'OX,HW@N/L79[,_-O+%-8
M`J4>.FL"&*K"JK+W[>]2L=6-7#)^7LW?@<:];,J2AR[8POV:SR\NF,>;V;=1
MT/)7Y._8H6>Y'4C$K2=P&.)IX%4B1TE;+)'^7&6[FYMP8CIG40=*35Y,FVF=
MO(TZ/+SBW//%=JI-/<O+()0\TKO(L,:Q+DCN=B**,>JJS8U2FITR4L+<66J2
MJFYD5:'ZV&U:6G7IUN1F2<3+$3)"J`>U0658P'63:V09&!`7J,:8P@HQA:V@
MX7Q<(1M;26S_`'>+?*V?*O*#R!=V1(FB9P<[)II91AF5'*MNW+N`]?0:\W^2
M25%,#T/X]MUU1+WUXYZH:`5^/_S=[]^L_P"D.M/4WT_+3P,7175_/5Q%9&?)
M5K)"[1+*9Y$29#&C'J)'7;N!8]=N[J>NM'_\,6YPA=N]3'?U/*E*,7"N2>EJ
M%[T1UD#\CXS@^:^[,E&7G;-6]%)5F@H,OY(G@C67>C[QZQ>T#'S$^NL'_I"3
M4.V)[$:$YJ?8;/[U7_">7]_J?RCJI9'C5_D;]1T)/;D]WDZ_@'ART1(V[CJS
MLL<)FRT=:(INQ'+TR?3IG_*&JU.G^KE[?4)/"/8-_NS+57Q^L)Y5C/U(==_N
M!VQ2`Y3#EQ[L>G0X.KI/`HX8V[S=Y1"+'V]K1841R)1#M(1L5-\>YG*]`JCJ
M2-59:F.'F,_!$=/$.*5_F$`_9*#U."%/H/PT0<8S'VI(#0!H`T!4$?B/)V/N
M?-?7@>1BX6+E5N2.]V!*<EI8@!>2`IWFZ'&T-C.J1IC>_P#:N[FC&'87@[_=
M[WPNB6_JY06>,_V>X[]WC_DC6CJ_NU;68_X_[%'RH9ZSFPAOW?K0VOMWRM6>
M0103FM'+*SB,*K6H@6+L&5<#XD=-:NB<,U-:^!FZM1RWV<3SPO#35#3FDIFU
M!+7FF^E/>A*P091PLW;*-[5`S$YC;+EE"Y.O;YXQG:VF9X_+"$B2S<[R5"Y9
MHV(UE:U2<2<,M@U)HX6`#SL';LO+'^:8]A]R%""P'3@LM-16#OO.[S&G#5<<
M5SC^=GN-]0?XH]NO+`O(RQ1]TQ*-[@&%H42->VY20[F5XWVC5J:J4I2AA:TR
MK53>DT<D8IJZ>2)RPY`V+#U>=NU4$,`>EL6*1(Y,N[LI5EE3W$DC'4#5J)/D
MA#1VVN*UW<T8Z>PG_B$$$-+R>I0H6/+>-44DIP\B\,(L02RV&,D4LQ[9B4N=
MAZ?X#K%G-MTMM4.=W8:\E0522YU*_M.V"SRGE'C<]/R/Q>W4KTDM)5DAGF>_
M"L<:HB21Q*K,\P?;@-[EZ[=O75&EEUQHJ3C#873==,*J7*.T[_'_`"".Q_#Z
M/$\M6Y+D^.XV8K06(Q[BHS#%AU!@8)L21F?/Z`3JN9EPBZDTF[[7ELO,C!)Q
M:5MAS^$<;+X[S7D-.W<FN\5=^EMT)+K1S26XIHV3Z:-Y9#O4.X4'`_3ZZG/J
MYZ:6E!J,88:R,FGDJJ3<G#M+5'H.F/T:\XWAH`T`:`-`&@#0!H`T`:`-`&@#
M0!H`T`:`-`&@#0!H`T`:`-`&@#0!H`T`:`-`&@#0!H`T`:`-`&@#0!H`T`:`
M-`&@#0!H"O/O6H?QN-#%W@R75[18H#FA..K#Y0/7.MW0_%W<48^L^'OX,J7D
M^<X+C?&:;K0:/D9IF2W4>W"D4J2CMR,8U"(%$ZD;&&,>X%E&5]&G+JJK<Y;+
M8'GU5TTTW3VG+S0X6*Y'/!MM<K9NST^+:2NR'CY*3I'5$KY4;29>XYV'X8Z#
M&K4<T)W0B]<;R*^5/7'NA<)[=OR*UY+"G(VG'*4&2;D9VMCZ?M`;DB2*PT4:
MJ">W)DD`^N>N>M--*HDI.Z7D<JJJG5.]:_,Z/&L!*L#3-R/UU[Z0PTY8JS0&
M'MLRF53V</L!C<2!GV#]DG49N.$%C/U+96&,7;467]B.1Y*WY=Y(;K2*S5JL
MCPLS=M9&EF,G;5@I`WEAUS@Y&2,:P?R%*5%,-+\#=T-3=542[->2>D&@%?C_
M`/-WOWZS_I#K3U-]/RT\#%T5U?SU<1!$]-O+]JG$KSNW611@Q$*P9=F<MGV#
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MB&QR5XWY[A$_=)<^J@'Y_P`2,]`!^C1U-WVMVCE2N)7J`&@#0!H#SU:\A\OI
M?WAZU6/R-I/'K]_Z=^.25WC0QP8>%U:-E1M\B8`8=3TU?ZE4.5I0_P!/HROT
MZ?B4=_L/0NJ%A9XS_9[COW>/^2-:.K^[5M9C_C_L4?*AGK.;"*?=.".?P>]!
M("T<LM1'4;"2#;B!QW"$_P`[IK3TCAF+MX,S]4HY;[.)4LO)<E+7Y&I8Y.:Q
M#:V6;7UHDB6<R1`1QOO5`(HMD<C,(XU<%QAM>DJ5%-+NMYX&#G;338FH'A>6
MM7H+U&"7CD@->M9<R-)7B4]Q(4&T(2LC,LC2-D.`3A=JGK5S4I-.?$Y4PJ;B
MI'3%XO1_,GL68Q/<AEJIQ57O0PQ5^U(LJQQL"@(1]_S9&X8ZG#5>:[DKL2RR
M\7W')Y5PU^+CZM.E+QS7.'L-S%VM6]D9F#H@S*[J.D:`,H!.[(7(!*VR:TVV
MXPJD4S:&DDH14R8>%\Q6DXKR#DK/'-QLV^C8K\?R%KMUWM36+,D/YK'^:=Y`
MQ7'KG`UFSZ'&E)QOFEA!&G)KE4X0NO[3OL\_]T5X'9QGD/C]R^7DD)C=Y941
M`K+#&6#"4;&#,[A2,]3\=467D\TZ:TB[S,WEE52V1?QJ'[HT)+EFES7%\MR?
M%2".Q"TN+`!V;DE>?Z=&A:/&V3<V/V<Z[YKR7!-5).VN9PR_JJ+33:MB6CQ'
ME_!<SS<W#T8XTY7B)19A2;!$T$ZYEDCD=7:,_FDE>C8V_LMKSZ\FJFGF=U1N
MHS::JH*]$BX/EVLP3I;#PVJAS8,O;*;),O&Z21_ELFWT/0X^8`ZXYE$'+$[4
M5Q4QL2`"2<`=23KD=#&.:*3/;=7Q@G:0?F&1Z?B-2T1$^HZ.H9&#*?1@<C_R
M:@D%='!*L&`)!P<X(Z$:`^=Z+?LWKOSMVY&<@9QC]774P(B86+5>M&)+$BQ(
M65`S'&6<[5`_22=$F[@VE>;&=4&6(49`R3CJ3@?^74$F/>A[9EWKVUSE\C:-
MO0]?T:F!$3EY?E8.+I&Y/'))&KQH5B7<WYCA`<9'0;LG]&K44<S@177RJ)PS
M>5T$BXY@-C<M6>U3:=A%%A%C?9))[MC%9>G0^AU99+GJ91YJEK-@\BBEOFO3
M@>[6C[2S6ZY#HLD[[548Z$(OOD.?:"OKGH^E*+D3]2<%,95;5:U72Q6D6:"0
M9CE0Y5A^((US::<&733FC;J"0T`:`-`&@#0!H`T`:`-`&@#0!H`T`:`-`&@#
M0!H`T`:`-`&@#0!H`T`:`-`&@#0!H"O_`+S-$OC\;2RM!&$O;IHV*LO_`-S[
M'H5#D?AZ:V]#\7=Q1DZSX>_@RH^$X3@+WCEOQ*.OQ_'3LL%.;R(M]2K\@JFR
MV\NT31!E!CC98SUR`Q]#Z6974JU7-X\MTKCSZ**72Z)+7KO(P\=^\[<:DJ_6
M*J1\I6`WAIZD+0&7T_-2>M[E+.`9/4]5SHBE/##M\GN.$&Y6D.*U?F.5I/%R
M:<:W(\-#)42N\<;RST]^R.H,,H1E;'9*/G!_';GDW32Y1A5QT^9T7-4IPBK0
M\CGK<'+9Y'CH6Y62L9:P;MQM$HECG:0V)=_Q0HS*%D1"K,%..IU9YD$Y8^PJ
MJ(M3+0^S%>I4\T\DI4(JT7&5HHUJ&J&`?\^02N1(SR!>X"J!CC`]O37G]<V\
MNEN,3?T:2KJ2N+CUY9Z(:`5^/_S=[]^L_P"D.M/4WT_+3P,7175_/5Q$8EG7
MR1818W0?4,<"*3'NEW8W[MO1O9Z:UP7THPG#2M&C>>=SU+J(<SY>;0].GFTR
MN$'E?!^-S>5VK%CR(48K%GCAR_#F-&EGGA8-4[3L.XH;IG9GT/Z=>7].IS7+
M#3BCW^>E2]Z.Y^P7?WJO^$\O[_4_E'0(\:O\C?J.A)ZXYMJ"^-^)@QRI,W#5
M#8?.Q)4$$>P(V1[@21GT&I2>#X^3*MZ4MWFF37[R/(/&((UVHLE@#O-UVOVW
MV`+M<LS'TQ\>GQU%L/-"UI,Y;_&CC?M5"M^9;/9^GGC8;Q@.RX1&;N%/:Q4-
MZ#/II-[;=XDKKK;![]L^;J<IXI5^F4A:H$))`4-[0P(`.1T;]H`_B-2T"5:@
M!H`T`:`H.>;B#]Z/J5J;:*<W'3EH_6E97Y,PAEOBEMZQ`8R=WPW:<LOZH:90
MC^'\1'-/^GF[8PT_AW%^:$BSQG^SW'?N\?\`)&M'5_=JVLQ_Q_V*/E0SUG-A
M#ON]Q\O)?;WE./ASWKC5H(]N,[I+42C&XJ/4_$C6KHJN7-3T1X&;JZ8Y;6SB
M4C3X[BWL%?J)*_;K)3E[Q>T))@O=GGIQ11,))$E7'J4#'HP=NGK55.';'1WG
MF*E;K0)Z*G`P\2HAJ0\=QG9^H:IRLLS]MN.=Y"6$;-V7./S)`I_#+YPN.-3J
MOB]6NWL-25,)*"UZB'5ZUIA9HM('L\O5C9(NR@S,J-8@F<V&01]AQ'G#=%V!
MBS$[=3:D_P`+],-/F9TG=I1]NQ[[QYE5FY"224K8XZM6$,<TL4/:,TLDT:1R
M,N_:T2GT8NK8.-12Y<MVN-N_L#4^:_4<?B,O`\%X_P"6U>=X<VZ7+2Q/6XVI
MVY#"T<5B0`AI)-C1%#TW,1C5\Y55U4.EP:Q[BN553334JE?ZDD^V_,>(UO'W
MY/A/M_=>Z\9JB&$K<-F!RS=V2239E.[$48[3M]-9^IHK=4*LQ0[H'?IZZ.6-
M-#XD@LW^+X2^M>CX)96G7D=K_,]NNU8K(/Z0TLOYI,?M!D.`PVGID8UQ5+K4
M76HZ)Q.KJ5+@J.T0\'9\LL>?T^5B\5OOQ\EFU--R+;(DGCD605[`[@@*L(61
M,2.05`]N<:[9BH66Z>91@I<4<J'6\Q/E<)DCY#R2]9Y0<=!WYZ$#-Q=OC+59
M#6FB<P]RXLU7='VXHFPJ-CJQ_#;KA3E)*+OOC&>,IG:K,;<%==#QD1KCO,/,
M89+G&O:L\O=Y.O-/1BE[E>..PL:;5C="["N\<K2!W95!P/81K15DT2<$DK=Y
MPISJ[KV[=UI#?@O)O(Z]DTX%N67-:K:G6>`B.*:)GC:NKHZS%6V*#O,F`K;L
M#TY9F52U%PO?MM`Z9>;4G!1PM:)A1YVW0NM!3FY."(2"C)0LPRPUTAFLJ%M4
MW7O*6C<E#N8[ERV"![IJRTU/ET[KF*:VG*.C?>CEX?D/->+DJ<?;EL5[?*\E
M;^JJ@=VO"O::1K*2JWU$H9MLNT.JMOPOIJ:Z<NJ+4()+V:-16BJNF3O;=M)H
MO^3WVN?QUQ-QLE9[K3M"DDDD-N%6KQLT$[0KB6O7QNDW*65EPK:M3E*'+?=W
M7X:V5JS7'FNO[_8=C>3<WR%2+EIZMJ>&TE2Y6:O&S74[<2(G:B4QQ,9))Y=S
M`#:"K>FTZI]*FE\J:E%:K7%_JU-1G@]9HFY7R*W0EB:W)RC1"O._(6(;%5FI
MR6>Z3V%$6R>O+&"B[P2H]6!`%E10G=#5)SAP95UU-0C'7J\T,Z7/\MR/#W:<
M8GY'CTM6*4ILQ%'EK6-CRR;JQ6,F(,Z*"GN;`5CZ'G5ETTU)W.$;1.E.8W2U
M>HPM`U^(\_S;\E:X7G3>OV'2U>BORI)#!7FBK!&@09=9(GCG[@);`+!=H.-3
MG9=,%53!7+>,K,JCRU1=[.+E;5Z"IX]1LW..CXBM6H6*?%!EEL-%%$)+$LL=
ME1#NZC:Q8B/&3T8L+4)-U-)\T7/A=9E*FTJ5*$I>TF/+CB*O'Q7^,CE@ISRM
M0M<?QCUWWFTX83!5WINB<E\AE*J6)SZ:S4<S<'??%QP--<$HJZZ4#GDGMUN2
M%NE=J5O$EKQ5('K2N)HMLBN9;BG(V!V*Y0@X?W$9SJ4DU!I\]_L*MM.*:Y+7
MG1P'G7E$W"P'D.#GDNF:2BUZ#LO`\\3;#.$[D6Z%L@KL)SAA\`3&9T]"JE5*
M_P!-I;+SZ^6:G</^2\J-26NM6O\`Q.,VTH7Y:S?_``TIQO:7(*J%#KT+YZXU
MPIR8WRE%:SK5FPNG.!(-<3L&@#0!H`T`:`-`&@#0!H`T`:`-`&@#0!H`T`:`
M-`&@#0!H`T`:`-`&@#0!H`T!7/WQE,7BW<"JY6.]A74,IS0G'53ZZW=`O?[N
M*,?6_#W\&5%RW%B+DX[7!SQW7Y>5(9N)K55[<([*M9[Q0F.PT,:^QHWW!]Q!
M!&O3HKE"J4,8]VP\ZJF#C2[\(#>86Z=R2MR4\IDKUXIZ0@S/+OC;?$&CF$MJ
M:OF-%*3C"RAO<,#7)0:BK>">S`Z.*<[>,-N)C6\CCM\A%0F:G%:]H2D:<M-I
M8Y8E_+2R\#"`?E!8V?'X-U4/J7E049PVQW1G;8%F1<'#NAOA;>,K/CMJU:O!
M&'$UV2;DH:DDUJQ7M0NK.SUI:S*Z2Q;%22!6.<$K[<#7-9J26.&$ML>)=Y;;
M>&.,]D.`P^PST'\DYMZ(C>NU2`QW(\(;"=UPLC0[4>$=-JHPZ`=/Q-/Y"/)3
M'27Z'XG#079KR3TPT`K\?_F[W[]9_P!(=:>IOI^6G@8NBNK^>KB(H8*[>92K
MOB*H_<5A&5(D)R8]Q.&/[65ULJJ?[=7]^&D\VFBC]V[K_P`..B..U$'\X_A/
M_B4UVS]6GD''S<<G`P)*ZBQ%88+9,2A"-J?M=?QSC.O)E?&Z]>[V:V?0P<+K
M\9^<#I_O5?\`">7]_J?RCJ2$>-7^1OU'0D]C^20K)X!X.&A[J_PZ$LRY+*!5
MBZE1)#E0>I))Q@:AI8VW,)LEWW,XCGN2X^NE#MM!%(LH549K"SJK['0]V)2.
MH&#GUSHWJMLY60MOAO/GEM1H_MU5HS*JSI'11X"Q&3')$&567=\>F?3\>FIA
M%76MA`1G?;=Q'7A$<*>+<<8E`#Q!V(R<L2222P!)S\3J$D@VW;VCS4D!H`T`
M:`KKFO`.>Y7SOC^;EGXF*M0N1VXY(ZCKR3P1`CLO8WX*G=U]NJ0<8JE;8OA"
M!>*A!UU?+!0\RQ=7*"SQG^SW'?N\?\D:T=7]VK:S'_'_`&*/E0SUG-A&ON--
M/#XG/-7C[L\=BDT,6&.YQ=A*KA0S')_`'6CIDG7/0^#.'4N%$M7$HWA.`,,?
MDU2SS5OC[O&Q1SV)H%9W$,K,UF2*"*278L9?``520"IVG./6S,R/*TDT[(\N
MC+^)1@U9C:GRLM;@;TU=97H\>0RW.0[;RW.0.$@BF=@-K.SEVCRPA'S'=\O.
MJB-2C>]&"MWG150I>A:<7;N.JG3V(\;1P6HHZT/8CLO(L^-LDBLTTC(5@>Q(
M<RAAA_;_`#9&*U5<;=L,-&LE4VMA''P(KYS8H<_=NU*-SMW*,\$4-68]Z+D+
M3QE;),91#,\02&-`BG_*QUW:T9"="3:D]RP\3CG/G;2=V_3X&GF_$9.-KR\3
MPCMQLD;T9T@YJ5*K.K5)XK!C$K>]#*QST`SZ#'75LO.YGS53O^&>*@5KRH24
MKK]CB<OAU[S+@K_%BIY%Q3U:8?CY:'UR+''7L3;GW.@Z%Y')5U.X$?JU.?3E
MUIQIJBYW$9+KI:A4M%Y8W)S>$CCY+/%^86_XJ\7:"MR(='C,C1O([F.=4WA6
M?(4-\.F3K#0LR,'0H;#95R0BJG':).-Y^CX_RB0U^3:?B8&%A9AR"5YC`2'#
ME7=^Y%)+[?S/5&]=PSKM5ENM34]ARIK5#DY;3CYOF%Y.]4Y?C[%*APU:U#.M
M>I-2016U=9)R9LR=W.5P&5025],=;9='*G2XNJ&NXK75%IJ2[#FCC@N"O9OK
M5GXOBY;%BW1CY4*29@F])C+O[L`EC8''N4=#C:,VC"*48O\`MM,B^^Y:QMRM
M2=[WU[1BIR,L8AXJJ]ZK-'!1590IK+,SLSRI\Q5>AW;3UP>=#E"]8R=^LO6I
MQQPFKM1ARM5JU*D:7*B_RGU4<E&M9D6K<A2),RF-@9XG4!MFWL[0?<.H.5#B
MW%04-JMVD5*"4'%[[=@FN<[7FJ&NO(\=7,=AY(*[V:TT<*2(XE1MTB=T[Y,>
MY0N$7*_AUIRX.,'W,I55*]&-+E.)6K;KR\G7A!K6(:&SEH<0"U-(TJJ-K=PF
M.0,&<YW97<%.IJI<4X8S]W012U!J.\T^.7U\?IM1?D>.ES`Y@E:>M!.LCHC0
MGO1NEC:6&-PD'L"]#Z:G-IYW&#W^PC+?*H16[VG1!R7'IY'8N25Z$SO%$'HM
MRB=OZBM^9W&KXR&#ICVLH`RVWKMU5TOEA%_[=)*:YHP7>9494?D6L/9AM\B;
M,4UR:.S4^H$L81LDE),%7B9MH5=_[77+:5*4+E#0R5?''L'%#R^*ES-+D4KT
MWL25):%\OR:E]]@1MMBW;^[M"!EW8;:P4D@`ZY59,:6IWQN.E.;!IPPA>*O%
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M+7IQF.XD,D*1M)W=T7Y:-9*Y&5<,1N]>I`QRKR*^6"7-&VHZT9U,;^6W:3M?
MN9X(^[9S$+;#M?`<X;<$P<+T.XA?U]-8_P!KF:#5^YR])E%]R?!I;4M1.8@-
MJ!'EG@.X.B1KO=G4@%0%Z]=0^ES$HP)744:32WW5^WBL5;G:RLHW,I+`A2VW
M)!'INZ?KU/[3-_"1^YR])O\`_$?PGZ@UOXK']2,9@V2=P;@6'LV[NH4D:C]M
MF0C`G]Q1I"Q]Q_":R=RSRL<"=??*DB#H,GJRCT`SHNFS'<A^XHTFN?[H>`U_
M_B.:@A]HD_,WI[&.%;W*/:3T!U*Z7,=R(_<Y>DV-]QO"D=$?E$5Y,=M2DH+9
MZ#:"O7U^&H_;9F@G]Q1I-=K[G^!5#BWS,%<G`Q,'C]<X^91ZX.I72YCN1#ZG
M+6)SS?=?[?%_IX?(J:6MZIVVW,V=P#)L&UMQ&0/TZLNDS;^5P(?59?XD?8?N
MOX%/:9(.<IRPI&7<QN[R`J?<2H4@(!^UG4/H\Q+X6%U67&]&T_=3[>K+V6YV
ML)L%NT2P;"YR=N,X&#J/VF;^$G]SEZ3[_P"*/V_Z?_=NOU;8/F^;)&WY?7*D
M8_0=/VF;^$?N<O2#?=+[?*<-SE=3@'!W#H6V@_+_`)1Q^O3]IF_A'[G+TF^[
M]P_"Z*Q-=Y6*L)T>6+NAT+)&2KMAE'12.NHIZ;,=R)?44*]F,GW'\)B5&EY6
M.-9/YLNDBAOC[<KUT739F@C]Q1I-5O[I?;ZG+VKG.5ZTN-W;FW1M@_':Z@XU
M*Z3-=U(?4Y:O9]D^Z'@,2))+S4$<<B=V-WWJK1Y`WJ2O5>HZ^FBZ3,T#]SEZ
M3+_Q-\"]^>;KAHP"Z$L&`.[KM(W8]C9Z=,:?M<S\(_<Y>DR/W'\)$J0GE8^]
M(S1QQ[9-S.HW,JKMR2H.2-1^US-!/[BC2<[_`'8^W$8)DY^H@#&,EF*@.OS*
M<CYA\1JW[/-_"R/W67I..#[U?;>>N\\/+"18R_=58Y&9$C)!D=0N5C/P8]#D
M:L^AS4X0*+K,N%YSI]]_MO+8[%>]-8("L\D%:>1$5B%R[*I"@$]<ZM__`,_-
MA-;R/WN7I)!)Y_XC&K-)R`14!+,T4P``]224]-<5T]>@Z_N*-)JD^Y'A$:/)
M)RL<<<2J\KLLBJJ-T5F)7`#8Z$Z+I<S01^XHTFH_=3[>!UC/.UA([F-$);<7
M!`*`8ZL"1TU;]IF_A8_=9>DW2_<CPF**2:7E8XX83MFE=9%5#TZ.Q7"GJ/75
M5TN9H'[BC2:%^ZG@$D;/7YB*UA&D"5U>5V5/F*JBDMCXXU;]IF8H?N<O2<U[
M[P>#TX'G:S8GAC)[LD%6Q*J*%#"1RJ85&4Y5CT/PU-/19CE#>BKZNA&F#[T^
M"3V8*T4UIY+`4H13L;06!.&;9A2`ISGTU+Z',2C+O1'[S+(G]S//?"?)N!FH
M<;R\;VH8KNZ+9*YW&O)75<(K'+22C;^.M/2]/F9=46I2XQ,_4Y]%=,$]/`A$
MW$5N6\?XYENP\GRU:&:'C+IDEAM0[(!;[G;23L.D,D@4L@;<K#."-:U6Z:G*
M"QT:-LS+R<U*Q:]HP;C8>0JQ\NEVQR,D]1I^1K69EF6-_P`PPU858(<!MS&9
MSG9ET`]13GY7RP2G+S].PNZ(SC&4_+U,:L?%&KR%2OQEJ:W/8C^IK5D:79'8
M.RP)DRQ`CE=M@CD;IT^;<VI;<4VU"T"$E!J#B;/":-3B)C+QMFU<[L[168>0
MEECKLDC8,<2J2)91'W<*^Q]XZC/MU&?4ZKX+9;83DT\MT]I*/LKQS5/*^;F^
MH6U%;IP203*R',2SRJH*(J;?\K=^WG=T.0,_751HIU,[]%3"M["X]>6>D&@%
M?C_\W>_?K/\`I#K3U-]/RT\#%T5U?SU<1/-.O^]$,"U'KS/.6%H&4]Q%'N]H
M&W:WXYQK533_`.+<8J%TI&"JK_\`TJGDY7S?%[TUW0AVD9^YGCW/#R3BO)).
M6$WC]*Y4$W!.6A`+RK&&22/)<[V#8?\`#7F1JC"$M*OML9[GN:?>T7KN.'^]
M5_PGE_?ZG\HZ$H\:O\C?J.A)[%\GE$?@'@OH2>/B,<9++ETIQMN.U7W*B@LR
MGH0.ND;>':1"-O5$@^Y5SE_X!QT%RJ(;#3B62]6DS%#*B2LHCW/`[,0OQZ?X
M=.9;';4T1R]JMW'9Y'3XN3P7CN0MUY;"TZ]4I&LSUY"C]K<&())^4-MZY(TO
MQMV\2;L%VDA\/EJS>,\=)41XZS1`PI*Q=PF3MW,?4XTWD#C0!H`T`:`K#_?W
M[;R_>0<9(EQ/,8(OX5#*5D-9D?=8*^TE,]#[F&K\DH\W^DISSAR]LBS]4+BS
MQG^SW'?N\?\`)&M'5_=JVLQ_Q_V*/E0SUG-A%ON;-/!X9;F@D2&>*:F\4TBL
MZ(RW(2&94][`>N%ZZT=*HYBCKX,S]2X4/LXGG'CH+3\C+R$H^HD,[?67V>6.
M6Q7"&>O9FF$DBI)*=JE%`;`^'N.O=J:A"VM'C)3B36*M7A\?IU[G,S<A7A-.
M:_0NN"E)9Q%([/(A)<O&W;3&SHS#JQUD;;J;2A?!K$TI0I2;C=V":ZDO)6JW
M$7+=J;CI38CEII<*B6S+(TM2K+DNL-=U0E-J9^!_'76GW4ZDE&6&&+ULHYN#
M;AM[EL&OB?.TJ<_/\1Q]"*/DJ\*O1JO"6<P39CE,<G<C<G':<LS;RHP6(`(Y
MYV6WRU-RMZE\JM+F24[>@N\I;C*GD=>MY*WUT5AZ2H]N*,M),(C&9NU`!.M9
M8BB"-_>&.[YO=J^5%T1HE?=:$2F;!50JG=;8<U/9Q_V]NT(.%>IS=WE2G'QO
M&XB@BN,((0\MA-[!65BJG\03UU:J>:G&-*IGV;"*5#+:A[S9GX=XM-0X#E.8
MY0[+P26M9B>"(AI9>Y%W6MR=QE98V9\1X5AM.?4Z9V=&I4JZV`R<J%+J=]L1
M;XH.)KGC?]Y.4F?B887CA4P[I872003+W9E#5T@>PKA1N4LN?PU?.BX\B]ZW
M?&!3*24.9RMW0,O,.(O\=9:M$UA*<CK6X2Y-*\L/*5:\#CL$PK"<Y8*IVY);
MYMH!TR:U4HXX_P!K&=0Z9+LUH[N<1"G&<ER'%V^1KBBE?E(UFF$$<:Y>>&/!
MB82_EQGIE-Q]Q;<-4RW>DTIR+UJYM1E,X_&N3Y%K?'T`Q%WCXQ7H5:W;:1(I
MBRO)*_;D,AV3;?>R,'W!`#JV;2H-X.UK]97+J<4M!.[?W'Y>&G5DC:A72<RU
M*"S(]R0,DG:6M,B!)UC,*.ZEMK%L`YZYR+IJ6W?P[=!J?4-)7<>S25E?J6X>
M2NMS]V'@IXH.[QU1VD#%6?='3:*-$"Q#8WR[=F[U.M]-2:7*N;3YF&JEQ?,X
M6N/O$SV?&XX)KM9IN/B<&%)8)H8W5096,@L)W-B&8C$;;FQD*>ITK2S+K[:!
M3&B^X>\1XNLDDECF9@D]+;;EGC,KQB.*$10"NS][NS9*)M[8V9]O5<+QKSL*
M<9>W5Q.M&5I.&Q#4AECOR\FZ0<A8EGBHQ00P)`Z!UM%$_.+*$7MR[!ALG=GI
MFZ;<H767H5:2G&\PY+@H)Y./Y+A[URMXW$U>&'G^^TJUI,M'..S&I(WV.H)D
MZ;L_*=*<R$54ES3EILA5EW--\NG19BSAT\YXKD>.Y*S+]5%0O/$M>Q*S1*Y5
M:\S`(ZNQ'\VVWXKCTUTK>74FEBO4YT*NEIO!^@UX\/9Y6G'PLCU_&J<DQX%J
M-AEE#%VLM/.'$C]R/M*&#(HZ+UP-<ZI4OF^)WQ[H'13:A\*NAWEJIYWRM.HD
MK6^-M<E%#)]-6.YYW'MVF68ONC;,ON&W;D8R,Z\[]O2W<TC=]=I7J)4'D/DW
M.\O+/RGD*1S&:*Q,MAC8J1FJ56$5:V'P>XXZ@HV1@EL'IZ>7E4TRIU:'/2SS
M\S,JJG5XKN.&MQM@7?XA)+5@>[]+9G\>((FM1]TBQ%6$BA<_DL&3.>NS)U=U
M*$)RC/1M*TT3CLD2SR*VWDER]R,_%2\1Q#QLW"3<;6B-R[NDD*!`5W,VQV,R
M=SIUZ==9LM?322<:L8N2M@:,Q\[;A!805]L9F7.W"_-<GQ'`\G!QW#O%%-:C
MXVM7[L-=VB^HEG91W%VQO[PCL<J<X!Z1EKW554HU:V^P5N;5+@M20W\DBI<E
MPZ>3^'<C+8XB9UI\D^X1K562'Z:Q);B[;R=MU2)R$``QD*/FUSRFZ:N3,7O7
MK7BH'3-2:YJ'+'A,B?-^0^1^1U>6X.:>62<SPO-QT3Q2VML!EFG2LBA'FB"M
M&RACGV=>NM.7ETT-5;\.TX5UU5ITF[Q*/A;_`"=*M:AL7YZ$OTSM]4\"HK1F
M0S1REX)))(9FS,&8;5.U%/KJ,YU)-J4=5NP923:3G"WM)[QOEEM.;2;^(W;=
M#EH?I^-XVS"UA1)7V'NKEK$KJ\3[INH;#=?E.,562N6Y)J]VAV&NG-<;W!VU
M]IIK<UX7>Y9[4\`Y62[92M:DF:G8EG1H70(JMO*5FDB4%,)VVR<XU9T9BI@I
M06NT>)"KH;BY]UH<#"OYQR_'.:%'D(6F61;D?'O''*M7C][2.(6/;=4A1E1T
MEVE=I*'`QH\BFJ;6J.E^NHA9U5,D_1$9\EE%V_-8Y..&:G)6DCB7+M9M-"NZ
M:9+O=8-$H95][LJ^B*V.NC*DH*^/=V6UG#,FXN[CVBKE;O'Q\URM^25*D]Y;
M8XB::$QE)^092@EKNH:!EAC9>^$ZLVX_CKI12^5*^$(]FO'85J:YF],8=MKS
MY3\<XSA4LV.-B%EHD[-YK<CLIL2E/Z%VJ[)W$BEPLKR$#*^AR%TJS77!/=QG
MN(66J;K:CMXE/):W!<)S,O$(.6D3M\=N98U=*\BRU[=A'P5&69%"_,N[`]Q(
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M+:,KFV>D@J=M8@5>([R&=AL).`1G5J:O>BY+9AK*U4^[!$@\?'DD%*:"G+_#
MF<R'D!R<X")0D5I+#"%I7EV+M*]Q/?\`#H<G7',Y&XN>B&G`ZY:JA!2VZ!)-
MQ"Q7S/5A:*R)C+3*K7NUKPBD1Y)*Y?\`*^H&06C`V[01^@]57*?BFMNHY.B<
MO.)\_AEF?E9.1>"&&.S!8IW\A4C^M5"S!(?F>1LB14888D=<$:<Z2AL?8'2X
MQM$ZQQ<TGD_*U).2GXCFI99:\].9(X)N0+E6J1"JH2M'&Q7W_F%?^4:KS^XG
M"-/#3.\MR/F:C!\=$KBP/`9O+/'D%1)(^59V6.U4KS&9DLSH6:!XY.U"_P#E
M[U/M4;=S#TQ=0J*YW>1KR'71*\C_`"U^I/Q=J'RNE))SUV)PHLWNK<@YQ6DB
MCKO[*[Q'(3:5RBC])[T4M-<C]U:L,;\3C6TU[Z]YZ\?(X>%AYRQR?&B+C8I:
M%:Y'>CO74*VYY)8T>66*29P<V9J3=I<9RWX:M6Z4G.<(2NLHS*T*IM2E&,[[
M.$AOR7CG)^7^0\ARI,TTMJW$_%>-&<PPN(TA:V]C<5DC5-@5QLW99=<Z<U95
M*6J=7`ZU9;S*F]=W$WV+'CWD_*P>+<++<M<WQZSM"*S1UJ0E8[K1WRJSA6+L
M%PH*8!(9AUA*K+IYZH<K[]1+=-;Y*8\R[M9%O(/I8+\/B7(4.13DTDFK+9NV
M'2.P9YG(<%``RG<`K,"OIG`!!T9<6N=-0U*XX9DGR-.)]-*2OY#QL?+\R]"Y
MQ5AX;X#`A(A)(LKQA]\C'WHJ*X8N6.W"C4<T:7RJ*=PY85*+@T=/"(_CW)5^
M+YRFL3RRK37E&@+A4KQ,:G<DA9#&H.PR0K^8P#;SC`U%?OJ-+UPX^VXFGW7"
MKOX$NN6*C<!Q?(UZE(]XPP5KE"H*E=5GP9(TAD=YB'^F5$FVKZ?$9&LM*?,T
MV^UQM?<:*G[J<%V*%KKR,\SQ%KS>W?N))'6E+3+Q%NJ")+2]X(TEV3(5HTA6
M3:R[0JH?;C`UHHK64DN_5L.-=#S6WW:]HUGX5ZW/2V.!MC@.%KUFNT^1W3CO
M00+!_2@%RDJANYVQ*V'+GXG7-9D:85+FJC"'?+V:"[HA5[ONTWQ\37Y1RG=*
M0M9LM#Q\PGDFB8_4NDD0_INX%7G6"=BZA&?`C'4J2=3E4;)]VS5%<2,RO=:-
MM!+/LM0:CY7S,/<>56H59>YW&EB=W=S))&7`=3(^6="/:QZ$@C6;KJHT+:S3
MT=,*GL+CUY9Z(:`5^/\`\W>_?K/^D.M/4WT_+3P,7175_/5Q-8@XF+FY'6:7
M^(2%&>,2L<J<@>S/RC'7IC4\V8\NY<NPIRY-.<X1^HX?U/A&Y;"F_N-X=Y%R
M7W?J6TK;JLDM26BJSPH)?I3&TKM$YWL(^N[`_#67ZE4(>]#MAQ/25*_MCOX#
MS^]5_P`)Y?W^I_*.A"/&K_(WZCH2>T>0CXJ?P?PM;EOLM%QL&(5KO99NY5C!
MR(WC9!MSG)P1G1IPC)+6X$)J-T=Y,?/[_,5>-K+Q*2-9DF]_;B$I[:QL3C*2
MJIW;?4:AU4KXH=MD$JG=$6>9_36."X<<F9H9W$,HE;O]E95:)F69*^T[CUVG
M;[<'TU,=#[+H\1#2NV"<.\DGB$21>,\=&D_U*+$-L^'7<,GKB3W_`.=UTM(@
M;Z`-`&@#0'FQ_'.5D_O/_P`3B>A9JI=C>1%FK-8C459!UB]D@9?CC)_7IRU?
MA<-.&Y\1S4W<RCH]J/2>@%GC/]GN._=X_P"2-:.K^[5M9C_C_L4?*AGK.;"`
M_>&XY\>'#+7DG')E<B!@LV8;-<A8\C;N;?TSK9T5/O<VCR9DZRKW>73YHICA
MI3+S?.<;R%Z7DQ=@LUY*\2AQ)F%["WHHV;:+"3P$+'M7;T^77JUKW:6E"$/*
M&R!YM#]YIN,8^W:++'E1IT[59>-FL3TKE<&6YT^MB@8'M60/9,4?MO&"&Z.>
MA^;719,6G&].[#9H]#F\V"A"Y]_F=\]SF>6L5>,LUK:U>3@%GNSTXI9?XA/+
MMCGL-&N'9NVT<9?KM]IQUU1*FE-J$5KP+MU5-)W/5B2KR=:O!\/4:^;_`"-<
M59XH9ZXBAE1YRB)$)4B:U%))&R])']X/N],:SY4:ZG""G;4=\Q*E*,7;O(]P
MO#V>#Y.#F^=MK?YTE>[7=WLSF"2$+%6D,JGMR+&4>/>F&;"`J1@]JZU6N6E0
MIM/S.5%'*^:IQ9KL_2'EFO5N1Y$;[*VYHX-RUVAAW*)HQ`D6&$69MVT;6RI&
M0VI480:5UO(APC%-G;)Y3R#V*MNS1BI\5QY;^$T9JR(Z$XQ)]*C/&DCGUEFV
M[01CHQU192@TG%N^?CX(O]1WNY72%]$KRLU/D7M3[9U[%EQW)(.Z44O$B-$\
M$8"JP<*_RY'0=-=*O=BH6XG.GWH.(TY(<;43GZ-I`W$UZU.*A6M/VH3<AD40
MR0AV#P`)+^:JK\G[6<ZYTQ?*U?..SQU'2J"YD[I=XHDYRY)3CFL6`3$[5*X9
M<JP>NO<+O$PVPUEC`=EP2,>W9TUT66HR5H\6<G6X7V]!E>;DK(O<KXUP\44%
MRO)!R5V(Q&;ZEG#?4Q-$A+%#MD818578`M@8'.F"A36[G+9H]N!T<7&JE83M
MY".#QB3B?'IFY*G8J/?G2Y%)31UF$4$JI$1AY9,/DRID8W#.?;KL\WFJDXPE
M,Y++=-,Y1'B03+Y#;\B@L&O?J\D/IN(NNCD4!'*B6-E@*D;*K?E!L98$?MC7
M)OW53@U>M.B6\ZI>\ZL8W:C1=Y:A=MI&MV2#F*P6+CZ$*DK;$4S3)WHHUC"D
MRLQDC,?3;\W7K--#2N]W%Z"'4F[YK><L$,D5WCH^059^+H=RVM2:,P*\U?+2
M3-N>2>Q')N9XUC.PY/QW:LW%.%[ML15*:C<CHY[EGCXOE+W`\A;H&],MBQNG
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MN1EO5FB6DLRQ7=\#S2)>G!+OM"GNB-MDV7W95/\`*U2FF*4,?"TB]3@W'#QM
M,Y(N_-P-+G)X!Q_))R"FERM>+M2R))-)79#.F:^\J6RZ1[BQ7ITW:LY5.F]0
MNW[2JBZ55<XWVD)^3\<\RAY;G:7`S#A>/ON6N0*SUJSH5P(4R'DW>YDD4X#'
M`'JHUUHS<MTTNKWFNTYU9=<6J7RIFOQ-^7KT)9N(#4^_%4=;C1I%7=HW$<HE
MC/Y4K1[=W4_$';O.=3G<K?O3OM;@1E12EJ.YZ`K>25W/$'Z%>U)7@L//'&M2
MH&9RX=%[KI(9?G^:,'IUSJBJC1?/Q=EVEW3"JZ1N\@X&;G8J]VC2^G\@S'=B
MC>(QB3Z9"(UCPD/>EM#MDB,%54;B5R=1EYG))OW;K:($UY?--+WK<3OM<ORO
M.WJUOZ.SQ5_B^(4B!:BQ2I/+,TD\FV>-1)#[,;1@'."<Y!HJ%0FHIIU:;3+5
M5.IIW-4Z!76X7E+O-<ERMSA9[O)M9KW*:W8>U7>7D<1JK4F*@Y9"S^[#*I7V
MG&NCK2I23@H-2U:RBH;J;:BX\=0V\EX;FN?X;D>4X^C_``VH\)DM\>=R6393
M=)?$*6#[5.Y7"#;E1N7TZ\\JNFBI)N+TZL+CIF455IM*%IGWQWC^5\@>3E;2
M4^(XM>/;B*T594<A/I_9=F"QJ2&*CM909!]@^)C,J5$E%N,=]WF,NEUSDE"'
MK;L.'F8;-GEFY2:S%/QM]A9NV+L7<BVUH4DFBKF%-TBR")/8I/Q#@E,ZO0TJ
M80FM&O3;84K47%W.UMXEHCCZ=RGRW%SQHE=J]8J\;,+"VU:)Y"F0$5RS,C2;
MCN4Y/0#76J+3I>O<<TDGS(9VQ#Q-"YR`22&8/_2((Q';=C.)H(Y)WM3%<`R,
M4"*/7W9VYU1>\TO31=`NX4IOU./AZJ+Q].A5,YAK6X9(**GO?43;!)*J/V>Y
M&K,@+!=R^T$9)!U:MS;>CNWE:5))#&*E_".=Y`V.+%OEPLDL\56U)+'/&LW<
M#+'#M&#^7_.,!AB3EE.J.KFI4'"G875/+4Y3.SF?&1S?`\35K1O+YGQLI->Z
M):[0"2PQNQUR68M+$JX6!A[?FZ8!U2C-Y*FW\#V[(^9:O+YJ4E\:V;?8*N)\
M+\S\DX%(H.('%\A5E:._/+ODFM$EI`9JTW\U'EW964[&?T7.".E>?ET57Q3W
M=I2C)KKIN@Q7P\W,-P<4@A^IX3QV>Y56;$T,M]K@P8=Q(=>N"8E<;O3&[KKI
M6J>;^ZJ'9"UYSH;Y?[:8]L1Q;CYF&S:Y1JR\7;H5*J06'K1Q1R)$)*LMF(%(
M)4C:+W*F[.\>A]NN2=+248IMX]L#HTTXW-)>0<=R7C\-=I>,HQHDESZ^.RKS
MO!W:TBH[)6[E>(#?86..1CMZ>X`$Z54U-S>$,.,]!--5*N6)U\[2L6[1L4P'
M6HJ):NWHJMJ=HG4[Y_Z6[*P[F.YVQG+8W-[=5RZDE!XZ(K@373%RWP?$@7'8
M7Z_O\?+/D1R\73A<*LLYD(64UT)27Y]K"$^PGY2,C6RK"#V^WS,E&,5L)IY%
MX_4/(-3?CU#!XKJ/*8TDBIK'A:T+NT42-&[N@[@`+1J&SN4:RY>8X1CJ[=-M
M)JS,M1A#V:#YRO&4^>\<K6;$%BE7VV+#3?11QHG>F6.+%E(XDD[?951L&Z0G
MI[=**W14TIW8^%H$54*JE/P&?B`\WY.#D:O,\9(HXV1+/)/8>>M(+$4"JD?=
M@C:4B964".':$51G.>M,[Z=,'2[[K/1K.F4JZHJI76M`3<1P/G?FGDMN_P"1
M<>ZT(4C%ZWVY=ACJC\J.$1.F\.1N+(#\6'7IKK7F9>50E2Y^9RHR\S,J;J4A
MC?Y19.!2261;]"G,WTB%GDS6DF.^)%PP_(2.,QN(50A9$'H=<Z:/>T-VW[=#
M+U5>[I5K7:35RGD4L_U5Y)MLU<QIQ]JI*(TXZ&0+),DEIOJ9(XY&#0JT849`
M'RG;J:<N$%WQQ[);157&<>["UQG%)XW:IBK"KCZE:MY*9/8D2TBR3?3E8461
M(;!]9'D7_*P.FH:K3CM79I[`N5J%K,4R^/\`:YN3_>[!$;R5OK)7D>/?65;#
MUUBF[CMCNJ2T<@^*_CGJLR-/N6PB<WEPJ]\9\VO)-S,R2,T-^G1ACCL12122
M12.D$@1@PBE$FT-'/(R[5C]OH,:YT0Y=3?G9:R]:<=:7E9ZA]QTU3CX5C\@M
M15)K$\ET\=((MRI%%]-#'"HCZ,M=M_<ACW2$A`W37&I.KX5'"._CIN.M+2^)
MZ_#AHO(Y4XR."1*/E%":)1*6XZQ-8B-5=E=5,5D`HM=JR`2=D>OR[6P-=W7&
M=#VZ;\-,=)R5$)5*WIH.^GQLB)-6XBB*LG*0QF3DXTA:C%'*5DB,#DQJ\MAF
M"A"J;5R.W[]4JKQJ=V&-E9EE1"Y7]UG9'"_DTO'<W/0?CI)8JUUI.+XR!%B`
MX^U"V:I68D+#)*,SQ;6$9#8"XU?Z7-3&.$WK6.W0\2OU(50AC):GALTFTQE/
MJFDX>_!Q=]5'(2SUF9HZBQM5KPTPR/M1I!$IZ=W:/Q.HC=-15T\;W&T"8:G!
M\+I6B2S[-17H+-B>6E8AY&2I4BL+&8S&T<5UHU>&1FE$D:0G:[%BV%P.HUFZ
MUIJ^47P._1QC=."XEW:\D]0-`*_'_P";O?OUG_2'6GJ;Z?EIX&+HKJ_GJXB`
M686YY8#9C[GUS2=O8O>RLFP+OW9QC]'RZV\C^E&#^'LNMVGEK,I>?R\RC]2,
M(*-\+XQW7')Y;YMXIQ?F_%\;<I0VN?$2GC)F>-9(S:F6%XU9OD+)E^I&[;@=
M=>6LM.;C;MF?0<]2BE=C:!'?[U7_``GE_?ZG\HZJ61XU?Y&_4="3V=RDEJIX
M3X3;HSFO9;C(HI!&Q1Y$:G&!DA'RJ-@G]'IHI3\O$AP=_CX->I+?N:)3P58+
M+V8S9'>DWR1C9V9?:6B#/[FP,?'TU*J:NXI<2K2=ZCO/O/R55^WU>3DN\\79
MIF7MQ]R4L3'C,3`[LM\RD==1?C;<3=:`V\3EH'A*]>DTQBJHL?\`2$[<@]H8
M97`'HWPT[8V[QV0'&@#0!H`T!YFGE\1;^]$B2U+L?,+?C[<XFA>!G^F?J4E4
M.JG_`)A_5J%2KU5V07%/B2ZG=#>_8>F=20+/&?[/<=^[Q_R1K1U?W:MK,?\`
M'_8H^5#/6<V%9_>RU4J4*EFY"T]:&&PTD2,JL<2UL$%U=.AZX88/H=;^A3;:
M5KS#UK22;M<4_P`G!Q4?#\?%>A:XJS6[Q''D)"S(@5V2(ONRW_M5C.T$9Z+G
M7IT.KF<)7*=NX\^J$%$YL_6>*6.!XV0<IPTB168N3M,5LTI(3O\`I)DV2M&-
MA8*(>A/NSC<!:ZOF<JM&G7[2M]'*IK3HU$NX3RQ>-H\A3Y/BHHTXR)K\56:N
MUPNW<A1;5@/^<9(=Y3HPQ@Y"ZS9F3S--.^6C3);311FP335T_4T/PG*7[-ZU
M/+<MSK`W(/R-%##O)BE?Z1HK$BSUT>-V.YCB1OB>F9^HJ4E+1!\=#\".1U-N
M>F/AI7B+)_)9^3\7MCEY(J7%\9"(^-M/#OEE[:H\%:&410Y%@NKR#&-BCIC+
M'HLKEK7+-N_S[.)S>9S4N,DKO+M&_C$TWD4\<U;AQ+RKP*)S9938F@?\QYI:
MZ!:\:.^[9'M"N#ELDYUSS5R*;E;&_M.F7[[DIG!S%#C*]Z1>9I+9F;+1<'&I
MANRQHPCCB[:HVP.R2MB+X`'(!R;T5-KW7VX6NO*5TI/WEV8VV''9YWE[]Q.<
MO6()>/Y"U:AH-4EEAL5["0-7@>.-&[D@"]"B+M)/7UU99=*7*KTE&..)5UMO
MF=S;.JG%#R//68>!L(9+<3FQQB.L47>[,6)0NZ,9`61DF1"5/4H#JM3=-*YL
M,;<-Y:E)U>[C:S%?BO&\5RG,UK7&O:D>O&DE)+EM&99BX49=3'V75X\$$8*D
M=?QZ9M55-+3AV*T2F72G5%<38W*?P_B&\FI27(>;X>WVN1X>=1(T,MCNM7EB
MF"&/M?F,07C/7`7:#J.3FJY'#EJ4GQ)=4%S*/,G=P/L=^Y1>I")*YY!JAE;F
M*MJ"U,9WC[S&RLP:):JJK(L>S\MAG(SU<J<=$;H0[M?$<T-L+XVEP%G!<OSW
M)UH94:E%3:79>W58386=T16["JBE=R0J1MV@9.[<%8CIF44TO&.TYT5MZ(#B
MG:M<WR<-^M#27NR?25[%N&.H;)=3#%%7^G*-%"@!56W;F&1GV].32H4''C#;
M'$ZI\SBH<!A<4<5RLT?(FQ6HTJPIV9EW1_3[5,Q#0Q,887E+QM%L4[L$A=P+
M:I3[U,KW/;YZRS]USN4A=RUGR&GY!6AI<E%_"J/&U:ST9[`2-QN[GTKK,5F5
M]WI+LW+[6]H(Q>A4NEQ4VW[?0I6ZE5)R27L,^&I<>M@<?3JVI.5JP25TX@J1
ME#(W?D=HT24F&-R4:1<LK]/<=*ZG"+:AI)H2C!*>@04[%2SR>+<S"E?D5).-
MD80N;<722&P_M:.1O:RRJ`KE1N&[T[5)I2O6.K4<E!N=SP)/Y#Y#2,%VY'Y%
M8GC@Y`6*_$669@Z)(J#VD#M!'B5/S%<]6.P_-K/EY;BERX7G;,S%-\V-PXB;
MG>4NP\9<CXR:'G4AM?Q`VV6U9@:7)6DA6%=T6]T;\M.YG)#==<GRTJ*YO=PA
M);;2.JC4X.'O8Z=EIGSA['/O<M<FW,0U^%XQV6_<14D2>=F=(GAJF*,2S!HT
M52J#W;EW-C`FM4P2A[SN]N@BAU1;C[JM<=5^IRW^[=#;:>-YXIH);-A4[A!]
MXFJU,/#$%8`._0]2%.`,5I=/.Y6ULM4GRJW<C@N5JS\=2\<,R06JM:027`\4
MF;#3)+&@A7=&AEG=@8]P'[)#8W"]+<77A&VXHTH*G&WB*?(?):G(RDS(UZ03
MS3O25#'`J*K[Y%#&;?[T<+V5"D]688W:Z9>4Z=5K7G/,S%5?:VHQY=JGD]9;
MG)1SU!9JUFJ)'.B+8,4>[N1/*QSM9)%82#`]=ZX]RB.6X*<V*H5J+E([;"6)
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M76F+MF&2G2C!EI0L(.^1W5GGV-B0[9`6EF/Y:8]GNZ=*US3A>\;;E><Z'RRC
MAA;B=?#T.(_B=+E>7Q3^L:LUVE,\*Q1,F^*64`+)&Z,2P#RCU90S=0QK755!
MTTSA&WL+44TQ3<C3+>JS7^=X^G(+7$%9#R5*&423=F7<4-.TN6-B-6(:)?R6
MW;?4]95+2I;E5AZK1KO(YE%I76N>G<=G)^>R<#2EN<-9IR064KK4YN.O&]HK
MDAXBJE^RQ"AE1P/VFZ]=5IZ?G<*D]D9>I:K/Y)J&W'T.CZ9N5-..2[>XM^-K
MQV.#MU94LQS774H6WP+F58779N9=^WV[?QK'EC).-^PM#FA-J%VT6<IY0G,>
M/4>2YVC)S_+UVE2OVHQ5AE$,JI&SC?)MD[AW%!$K/E>A`QKI1E<M35+Y:>^W
M?(I5F\U*=2YF83'F).;X[BZJ5:$Z4.[RU?ZB2RB44KMOEN2G=O.R0#;&`Q'M
MZ`*=2N7E;<7.4L8X$./,DI2GLUBSA_&H^4ITEYZW#4XV.;$?<K/!.U6U-WHY
M:<<.T;I]I4@AV4;>FWKJ]>;RM\JB]N*T["E&6FES."M=M-DG*<='RT7+\BPL
M&LL52?#A(&1[`E5!+"^6EB0?Y)ZC<V[()<CARK;N',D^9G/9XFNL:W^0AGBE
MOQ.?JZY`3;NCGBEDCD9"O:0IN4)LP"P]G42JW<L+6Q(="O>)L\NX^&ES$E>&
MH.8B"125%$1E67*][;7,6X%(1ND<,Y4AE7:`!B,FJ-,8\ML=HS:4G)1.>/DJ
MK1U)Y(3RW$R1O'<Y&I]498;-B50AM0;S&LKQHB;578?09Q@6Y7/!Z)7:B(K:
MNW>3KSORJ+D>7KT9&FI\/)'!+/9K25_HGO0(&7=8C"2"9,+&5W`KM!QK'T^3
MRTQOJ[8PV:#5GYO,X8;H[3CY+R_E.-N4OX:K<1Y!:[D')?5?3O8=(#$K3!*R
M_/8)8IO#[C\H_:U>C)52<?>I5U_CH["M6:Z6H2JQMK%EKR&[//:%KEZM@3BQ
M8YT2K))2W#\A0((7`D9MHCACR,D=SUZZZ++2A!/5IMI[BCS(QB]NBV@ZXS!+
MXQRLE]HHN*EGK<>U-72.3,L:2-'.%.Y)3+$NX;@B`>T+UU5QYU"^;M:);^EQ
MNDA#?XOAOX?<B1Q3D98(F60K))#VW$LB5Y`TTO:AB<GN=M05&<D>O:FNJ*QM
MB<:J:8#VOR')S)3XCDY6YO;'(\7)QEC++#81$/<<X^KCW1D"0*^Q1[UZ=.+I
M2C4O=U6N.RJ;@G/7:\Y>;KTKU;C>3XV&YR-[BA(T),<VRU`!O,*2O)+()H*P
M$G1C$_NVCUS;+;3:<$GN]&^TK6DTFHN%K8&7!^4<Q8\F$M?DFX*CSD.SQF>!
M$3C`T)ZPS)*LFQ]R]KV_)GI[<#49F52J)KF=/Q:;8ZR:,Q\U_*JKM!\\=J\E
M8?GN;EREJ/L]WD[UB64*3(5B!JJ'6Z[&'Y<CWD+M7&IS6ERT[EYX$9:;YJGW
MVO-/E5;S.ORD7)JL-FM8!7DZ$\MAJBNS]TV[-7*BK'-M67M2-\W[)]-3DO+:
MAW.4=B>,+HD9JK3CWW][6$=!G#6L5_*5XU>6CN<M939Y#RLJQQ04J\B(1$;$
MYE=;&^/KA_;Z(,^D-QHC"%."T]BP)2A5",W>]';I.FFXXWD><AJ->Y*&S`(8
M!$[PS/1CD:%Z]>ALE9OS,^]O0>[=DMJM7O*EN"\]+9*]UM*+\MA,?MO!R?)<
MW;;E.-2@YH<4\%6$R182M;:0?S@.%5@<)@=/;Z8.LW5-4TJ#C.K@:>G3JJ<5
M"5/$N;7E'I!H!7X__-WOWZS_`*0ZT]3?3\M/`Q=%=7\]7$4R1V1SZ-/W$C6S
M^1,4*HV\Y*LP/7H-J]-:4Z?I2A'EG;B8JE6L]<W-#FD\)]O8I%0_<3E_%(?N
MAR''6KG(0W;=WB&L4(GK"O8>$PM`?>C2J%W>BGJ<Z\[DC.*_VS['$]GF4;M[
MAW$H_O5?\)Y?W^I_*.H+(\:O\C?J.A)[)\AKQR^!>#NQ`:+C8F&1&<CZ6'<"
M)>@'_.'4:E)X>/A[-)5U)7N`^^[:V5ITYA:5:J31F2`@EXF428LIL#-TS@]#
MHH]A$:<7.VM#/FN/DY'[>4Z\/;1S#2D7O.$C';,;^YG#_A\1UU$\(LF*5[@-
M/!J]ROXCQ4-SMFTD"B;LE6CW=?E*`*1^H:3Q4!VQ'F@#0!H`T!2;_:GFV^^P
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M;@/=3=5]T[3[3O\`&K_/U+-F6]'6L\A5MB/DK<DMGD%<@[$H5Z8E=Y-OU$;+
M(`57<W4G5,VFEI0NA*Y=K?87RZJDYWQUOL@=W\&X'D_H./CY#C9Z@L\C96&S
M/L*2LD:Q#)#QSOM8=W<2R9(7Y<"G/53%P<8*VK47Y*:H**A.VL3UN*\DXR.D
M:_(R0O';O%FABL623&/Z7_23V\0PQAEA+,V\N3@?#JZZ*HQ6"]):=)S5-5-S
MQ?J+I*',0VQRD=-#OC+FNP%\+(X"@%L6"\TB2AUED4J7<+O&TC5U52U"/AY2
MU:CGRM.,/'S[S=>XLGB*[U>/'%06-T$?(R3J]#OOD200'OGM-%&[;)>ZJN0Z
MD$X`BFOWIN.K'A[)$NGW9*&O`6<SY/1M\R*G*16'CXI>MH/WBLJ[$BE-ETE)
MC4MNR%".I7*%O=KI1E-4Q6-KK0*5YJ=4'@8D<-R7#<GQ-6>[9YCE%@Y+AZ@@
MD,C6CL+DA`@W*BLG=R59<OT;.7O4U*IPY5)[+8#W:DU.+FMHR=)YK%^[:OR#
MF))*:_52&PT%6S7B:&*;?&I9Y>Y(!&I"Q9W>YM4N227NST35NTOBVW[TK6D+
MXYPDTUCDU^I@X[MP\A!=HPW7EL5I'=Z\%BIVX^VJL7=F?IT!#`8U=K!8W0<+
M\8,HFHQ>&J,UK1HIU^-\BY2&Y3CDK4>1NF2VUF:&,CNR!)*XVA9IHBF-Z)OQ
ME>JY.IJ;H4'>E9D)*MQ5S9W<QX]>XF2#ZSF*5>ORUE7GGBDWVX8E1S!&CQ!4
M$4"*'98I!GVC!]N:49BJN3DNRSUEZZ'3>U/O-\$/)R1\D*7(SS\IL2Q(U@_F
MR59HL*94+22;OIXTGFD.]0I[8`W$:AM2BI>/MDN\E)S@YV\)ON%,51*]BNW)
MLM2?M)6\?JP5WFD82.T<CRQ(Z8G,@V2B51OP0`5UT;BI3TVT:('-*%\M%M.T
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M%X1-3CBK//QU9:[U>!A"VN#K2&1(<3@HY<*\1S8.]BJ$-@`(&#=9FJ8WU8VU
M>TJX.J'].%M?L%4<;SV+M&.;$]E8XOHZ=B/C%^KK%%;M+-VG`)VR*AC0/+GJ
M=NNCDD^*C*VV118KTMYBN_S<1X@QBN',*1Q03!8V#&#88W8MN$K@G=VRSG8[
MJ<;1CI3E^]:W`YU5KEM;B;^0Y#BJR<9S7&J%I<'/'6M<?8BB*K+.C[@T$@9B
MNZ-@_P"C&&WC.HIIJ<:7?5B354E"I74C6KOIT/I9N3-3C+7.+R4/&NC5S6J"
M65E>.5^U]-WH5+KM<,X`"KZYYN;C"+Y81TOQ.BDH1ES1[/`U1QKR-R1/&^-^
MOXF.VK_Q`-(`$D)E$5JG-)&C)L7:9Y.A*J2V1H_=7ON#A=Y/P(4&_=45&T5X
M@BS<M)3DDMTW6C/)=J6!&]*O82%]JJ;DF19>$D#<X_+Z^\C)+X8R<Y:8=F'B
M/BA=*>C?B=4_(<S;>O?-V!WLVI76([N*DP%V]^W<ACB[Z25VW]U2%5FZ_,!J
MJII4H8?-W+">!9U-SCCLW[!C2LVN7Y7B[)CCL5>.DGLS6Z<D=B*>P>S,YDD4
M59-IBVK^;M42#W%C@:I4E32UB]/;MW8%Z7S-:O39OQ.F'C.+J)`_+SP1/Y'.
ME[F(E#M/)#!`[30;PN84B*/WO<S$@H3ELZJZV_A_IDK<"RI2^+^J;MQ,K7D]
MV_2O+?BJVOX+5/\`1U[<=2,2JKU5"JT@,8$2-M7VLS*G<_9T64DU"*YGVZ[;
MA5FMIQ_I79JMO(LT7'"P[<?2_B%GD6BCD9;+0Q5B!)V9X)7,'?G<K(?>S@GT
M?J-:(N$W!+5?Y+N.'NX*+=N_O/O'<GP2U9*=)(Z'>5H:UJ55G1'8*-Q^:)A(
MDO;,2!G,;*7<&/(5451BYVM/3=>*:Z;E*UK(5_1K3Y0<71DJ4#V&MUHG9I,7
M#-L5(Y"R.DG[`94*E0,AP`VND8TQ<7Y'.$*H7>8W^JK<+?Y;C%II0XKDK,%B
M"`!4%B-69T)>=@-M=M^6B7/I@@CKR@ZDG&+2MWZSIS*EM7)VW'R_+4B,LE*M
M#?6M.&BXYX5ALI8G8MO_`(A7:-)ZLBN_N4_(HZ``MI2GBX:_1W,-K!1MIQ0Z
MKR<E*_%R<I#7O%9GGEY.E$3%.L38>(65+]P=M&#RM&H``0,J-D\FDHPEJ?EX
M>)U3<HSUG!1X?AZ?$CE_XC-PLOD,J?7/8"6W@B:?"D]Q08IMS!HY=WM3W'5Z
MJZG5RPYN7LML*TTTI1C#F.&C:D=HI"PL58JS"HBSRV8ZU)5D_*F^FB:)9!#(
MS2Y!Z$;L$DB]2[X[(OMW'-/NX+L.2C.UY(Z?'0&YR$SB>["C`RA880_>A*=I
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MY2WQ<:]B'CI"A$%6`H(X6G"`B(O(Z2I*,R+E@DBC_P!YC5TD[[[6V;"C<+KK
M6VC;A[-JG3AX:S>DKWJ]R#^!WQVY(Q<G?MLD67V"M)5=9)J_M"YVG!P#SK2;
MYDI0GL\XW,Z4.'NMXRV^4+T;VX?G5\969>8JP<%QUZ,5J_TX7,RF1;+3P-W`
MD,D1;:F"K#:S;5W-JO/3SW/F:]D])/(^2_W4QMR?(T.PM>VTW!45JB6&>K))
M7Y;>&(>S-50;Y8Y9(L%ED;VA2<=#KG12XQ7O./\`IV1.E52A/W5OVP$<-WBD
MX^JEI[<OT<\LM63D8988Y9(U'=%*&+N2,R+&Z*TY.SI[@0!KJZ:HN$)Z/'T.
M7-3!7RT^'J86>.6KQ241?AOUN7MM8I_2SO\`5S32LP>6S,`=T<*[TDE88V^Y
M/4ZE51<80Y5V=FW0'3!0C&+M$[>2YOBGBM\GR5J6;E^->,<A=*I8D2P>L5:C
M&S(*L,F3A]O[)WX?&J4Y;DDO==WF]+LI%JJTXMWJTM`Y^WU'D#?Y9)*K5>Q+
MQ,4C21QUT[B<DLLB;@$5I-IR<,P;(V=&"ZY=34H*<?B_XG3IZ7%RA\/$OG7C
MGK!H!7X__-WOWZS_`*0ZT]3?3\M/`Q=%=7\]7$Y'L<*>7CW=^:P9V4`N[1)(
MIVY*%L#W'`Z:Z*G,Y,$H=IP=>3]52J=7-I<$[KHPV2*?^Y<'*C[K1S6+5NIQ
M"V>.DKV_H9#62QN1.V]I05*,&/0_MD9]->?&EN'N<WYO^/B>M-*,:H;9=W-'
M</\`^]5_PGE_?ZG\HZN0CQJ_R-^HZ$GLCR2H;/V]\+VP]UH.+CG)+;%58ZD1
M)9MR?'!_^IJ&B$X8P)?]SX.(CX1.0N<?);FC<1I)65.^JLCY`9DEZ$$C&/4C
M2"Q\_%!5U)2XP%W)<E'R'VM2>2I)4BA:M'#!AFD"Q31B,JK+&7;H,+CW'4QI
MTRM>%%7[H[B5>%?V4XO_`.L+\0?_`#=-"(CK0!H`T`:`\W/X]W/[T1L5ZEZ.
MY%.EZ??].L#5C$T1F0AD=EW-Z8)_'3G:_J>R#\[M<"8)X+_<N$-T3TCH0+/&
M?[/<=^[Q_P`D:T=7]VK:S'_'_8H^5#/6<V$&^Z/C_,\Q#23C:[3LBS!G5890
MC%XI(RT4TD"NI,6"-VMG29E-,8VO,G59;JA`@UW[8\\:L5?^'/<NQ55KKRD\
M4,_;+,)',$,MSMH=W7J#[]QZ@ZUT]53&,8*-UD9JNFJA"$==F:KGVOYB>KQ_
M''AGL\9QA45DM0P=Z15[8/?>*\BL2L>SV@=#J:>KI3;C-V_"15TU3@H25OQ!
M)]M_)S9:U7XMJ5E8RE1JT44<==V/YDD<?UV,2(`KQGVGJ<98Z+JJ(0;C;Y1^
MWKC&$+;3!_MCY.]:[$*,]>>Q`L%>]#%7%F%5`RG<-WWH[#]O++^RWII^ZHBI
M\?\`$C]M7.7#S.WA_!_,J-`5+-.2V=L<+2_24$;LI(9,+MM84KN]F/1LMU;5
M:^HRVXIP[7Y%J,BM*$-R\Q/+]H_-9+#2K<Y6NDL9K30P1U%7L(J+`J@W#[AV
ME+MZG&1@ZZKK,N%U._R.?[6O^[=YF4GVM\^GM-:EL7TG[`C#Q0U59YE=Y!+(
M_P!:&SW)Y']I'4CX#4+J\M*$M_\`B3^VS&XSW>9]E^T_E9;CGAAM1-0K)`(Q
M%6$9EA;?%:"K=7\X/U8D'/IHNLHG=-Z^[X;A^UKE)RV=]YKD^U'FDA16J1_2
MQH$2F..IB`=2Q;;]=DNS8)8G/0#TZ:E=9EZ=[_Q#Z6O1N7F<@^R/E"36;:MR
M#\E;B[;WGCJAD+@K-L5+@7:\9V@'Y1Z:M^_HDI06WR*?LJKYQ[/,:#[7>5-P
ME_CY:<OUEV)4_B<=>LLO<W$2RNINE2TT#F-R`,X!]1KG^[HYDXR6$_\`'2=/
MVU<&H7[/,Y(_M#Y>D\0$,ZT(`Z5Z25ZR=E)B#,L4PN]U.X<Y.21DXQG5GUE'
M;V_XE5TM>CAYF,WVA\T[UMZ23T$L1_30+#7K[JU8@AH('-[*HX/O^+?$Z+K,
MN49]\_RA]+7.$K?,-Z?V?\HGK%3,O&HL:IL6K&9!'"C(5@'U4L:/()FVM\/C
M^GG5UM">GM]#I3TE3U6VG?X[]H/*8HUMV>5C69K(N"&U69I=T;+VXI62Q+NC
M`C&,/D#`].FJ9G6T7)80O]"V7TE5\;=YPUOL)SRV5GM>03SPW+$4W)0"/M,9
MZTC%+"LDO0[!A3U;+9/Z+O\`D*82INN\BJZ&J,WM.GD?M%RUV*&FZ[(RD)9X
MXE1$>4D2J@6RIC14++)L!)#87(&JT]92IVX$U=)4Y6XFFK]@I)[5Q[OT:_6P
M[92M4QHK*-B+$JSOV^J!SM_'USG4O^1@E",M?H0NABW&'<:(?LSYM3EAJQ\I
M%.U9XS#RC48W=79=JS[GL[MT"J%R4R01T;'2SZW+<X=D?3$A='6I1[8>H)]I
M?-N+>W7ISUYH,B>)H..KJ!+(@AF:JTEI6BD=#[S@#IE>N-/WF75!OB]\A^UK
MIC#@MTS&Q]N/N%'<7M%)(:L;5ZD:\=3,"0N6;:D;7%'J_4E<MM&[.BZG*AMU
MOR#Z?,CZ+S.%/M-YL]62E:226I:,?UQ%&GWIA&VX%I3=W%MQ+9/Q/X8`O^\R
MXQ5ZNF_\2G[6N$'=L7F9-]K//5[(K-/"B5Q3LK])386H`J($L!KN&`2)!CX'
M)&"=1^[R\=,;W+9(?M<S#9<I[S*;[3^53>,3\,]69I[,L+277@KR,L-9-L$4
M0:\3'L;<>AP=QZ:+K*%7S1XX_P"DG]K7R<L'N\SK'VD\JDL<>?J+/;"NLS3U
M*196=#&R-LLA$K-O)V1+G!.?=C5?WE$'=WOROVEOVM4O3SN%%S[%>0<D;$EL
M6$6+N/1II!62%.\QWA0MLDMN82=2!T/X@:Z4_P`A33=#?Y'.KHJJKX[O,[^/
M^U'F'TT=/DQ/=BKA#3:>G3D"RHWL:?==;N1A2588SCTU2KK*(Q4NU^1:GI:[
MG/L7F==G[;>63B>*Y':N"19JSDPUF1JFZ.2&NA>YO2)9HB_3#;6P,:JNJH5T
M%WWZ;BSZ>O&+[KN\XK/VDYVSPXX^;BYFD[@G,^V((91G![`NB-4&]O8N![CJ
MZZRE51C;_:5?2U-0A;O.F;P#[A6*WT=J'OT%C$,5)J5;LK$J1JD04WR>VIA5
MMH(]W7.JKJ,I.*OVO_$L\C,<G=L7F<S?:/GH;)M4*,\$]B-OK'^GJH.^S%Q)
M`D=U5C[3-^7T)`_5G5OWE+4&^/\`B5_:51BD]WF==;[>^>H6FG>Y-.<1]CZ:
MF*SP,29EE'UID+2`[-P?Y<YR3G57U.7JW_XEED5Z]WF?.(^UWD%:.R+4?(1M
M+-WX%H5N.BCC?+/E1):D*^]@=JD+[5R,C2OJZ7"$.UU>0HZ:I:>R'F<D7VG\
MH>DO'\A3GM\>)%G^F$-:$),BA%EBVW/RSL'O4='/5NNK/K*(Q3@^WR*KI:X0
M:EV>9D?LYR/9L1&G?8RPB%)6BI=S<>ZKN66V-HV3>R-,)D#((Z:?O5I6_P`@
M^D>A[O,%^T7.QUJT%:G8IM6>4BW7JT5G*NV8R6:VWO56=?PZY]0-/WE,7%Q[
M7Y#]I5@N'F91?:SRR2Q,;T%F:I(9I881!69H)IDV[H'DODH-W4@?B?T8A]71
M"4(]O^(72UXQW?Y'3)]O/,8XX8^/IO6$4_>8FK59)4"%>Q)`+HC[1)WL@]I;
MW8SJO[G+Q>]_XEOV]:N6Y>9P1_:KS1>97EC7(L)%V42*I7B156-$BP%O_P#L
MNVK(/3/KG5_W>7R\L=[_`,2G[6OFC#A_D83?:K[B6:L]:]/8O+:_^(>S4JR.
MYVA`2QO>JA!@C\-2NKRDXJ"[7_B'TN8U.+[O,/\`PE\R"L(JQ@+R+(RPU*T<
M>%18PHC6_@>U2I(ZLK$-G.G[S+T[W_B/VM>CAYFR]]I?+.0K0I=CNSS*R_4'
M9`D<H1BXDV+>`2;<[?F#]DX&HIZRBERAO_QN)?2UM3CN\S:_VM\J[<;K0,G(
M*ZRM>L4ZDI+`J[KVFNF+:SQAB<;CELYW:C]W1IEM?^(_:U:)[%YG/:^R_DAX
MIZ<)M9LABUGZ>H;0RP5H9)/JU"PE%]L<73T_YPU9==1S1EWN'"\A]'5RPGN\
MS'AOM+YQQDE4E9;D-7HL%BK6(8+_`#89EO!ORB3LZ],E?E.-*^LRZHX1UO\`
MQ%'2UTZ^[S&<OVV\IG='D@N5FV2]TTX:D66F0QR1HIN$+!*JQAT'H%VJ0-<U
MU5"T=L?*\N^GK>#W>9S2_;G[C2QUPY=I8<"1VH4765(QBO&\;7"FR#)V*H`_
M$$C5EU.59OMPQ(?3YEDO/`Y$^T_W!@F[_'R3<;.TC3234J5.%GD9]X9L73\F
M<*%P`-6_>93OGM;_`,2O[7,5TNQ>9NG^TOE%NP\MRI*Z/VI-B5JV/J88PGU#
M`WO?)*5'<)^&<=3G4+K*$I/CW?"2^EK=ZX>9E6^T/GX#W$O25[>\.[+4@CFE
MD7=MD9XK@&0;#MG(_3\!H^MR[H2V^FH+I,R^-N\D'*_:GR#D.31+/(2V*DD$
M\=MGJUDB>:=!!O"QS)[$]LH4H3[<YW8UPHZRFE24]K\NP[5]+4W-[D<]3[-\
MH>;DY4SR&O3LK'Q'&6HU1*\?3-B(U;"[&#*K;AAB`<J3JSZU<L-*F_":(72.
M,>Y>QFWQ_P"U7E4-7DH(;R<5-;MF6S+)1@=)H7^81[;$S;LKD,^,9Z#J=1F=
M70VI1@M/H,OI:ISA/1ZG=)]I/(HI$>ERU2C7JYD@%6D)+C,%P5-FS+(_YG4D
M*5ZGIC5%UE+O3?;+N1?]I4KFEV3WFBO]J>?E6&=KB5X51?XC6>I$\UM1&&[6
MSO/6C4/GHH&YLEB<Y-GU=.C9.[=$JNEJLK_`36?LSS=]8;$EWD:=>!8C+2@6
M!)V,$$4`$!%DPIO,>\[OP_1KJNNI4H)]^W0<WT=3G.W:=]K[/\]6@K<A4Y&2
M2]ADD*4ZQME)`^P3[YDKR&+?L/K[20OPQ1=;2VTU+:X<(EWTE244]R\X$AX?
M[77.+LW;$=J&4W)Z4I3:Z]*MQ;#L22X'L7:J*-J^@P-<*^K522A='>H'6CI7
M2VXWPW,L;6$VAH!7X_\`S=[]^L_Z0ZT]3?3\M/`Q=%=7\]7$65K$<7-O7L=M
M9[%IVC5JTF]U0DH1*!L]J^A^&M%=,<N*N5/XEP,F77RYW+5?54_Z'/1[VK25
MYY[Y%X/#]RHZ'(\/R')<I#8HO*/JI4IJCE1%8$&[M/VY"@QMZM^K7GN#4'6T
MOPGL**<513\V)U?WJO\`A/+^_P!3^4=02CQJ_P`C?J.A)[.Y/FTJ^$>&5H!4
MM6QQM>1Z=F..4A?I$VR9?Y-C$-_SO35N64U'O\-Y3G@X)PMM0]^[4MAJ%*N*
MS-761IFM$1]M9%BD"I[Y$ZXW'J"/3XZK'#'M\F3=,ZN?EKS>"\;5DLUZUFS#
M3>`69!`"8S&[;3UP5_1\=65-3N42'4E>X#3P/C*U'QJIV9(IGG42SSP.TD4C
M^FY"Q],#X8&JP>),5AP@2'0!H`T`:`\^16(3][9I*_BLXY`\P(;'.1&X8FA0
MJ`9"K=GHA)P>@_#57F4)_$^;1'P@65%;7PKETP/0>K%19XS_`&>X[]WC_DC6
MCJ_NU;68_P"/^Q1\J&>LYL#0!H`T`:`-`&@#0!H`T`:`-`&@#0!H`T`:`-`&
M@#0!H`T`:`-`&@#0!H`T`:`-`&@#0!H`T`:`-`&@#0!H`T`:`-`&@#0!H`T`
M:`-`&@#0!H`T`:`-`&@#0!H`T`:`-`&@#0"OQ_\`F[W[]9_TAUIZF^GY:>!B
MZ*ZOYZN(J5]GD#VU=MLED56C:8]S(Z=(R,"/XX!Z^NM#4<KE_MC=+OTF).&>
MZD[ZN6',X]WX=7:5O]P.6Y6#[J5^/CY>E6X:U8H_Q"A-?BAMRNK(8EA#1,\:
M$X+1AO?CIC)UYZI;NIC_`'0IEWOPE@>RX?BAJ]Z?=*TQC_>J_P"$\O[_`%/Y
M1U!9'C5_D;]1T)/9G*S4(?"/#P].6S8FXF`2B"00DQ?31`[VV2%A\%`Z@ZJU
M3>X+L3XDT\[E3'?X$F^ZD5Z?B8*ZF""BTFZ6S-*R8=8Y"$*B-QC`R"3ZXU:^
M242D4IMP[/5'SRN,M]M:LZ%OJ88*30SA0TH.Z(^TL,J6Q\V.GKC4-)S:5N\L
MF[E;?XCG[?LK>&<2P``,`.T'."2<C()SCTSJ80*D@T`:`-`&@*BXGP'S;C_N
M3?Y;LL_"WN6>_P!V/E)846)T"^^DJ;)#T^+==%G57>]#_3#_`")>53\7NQV5
M1\BW="!9XS_9[COW>/\`DC6CJ_NU;68_X_[%'RH9ZSFP-`&@#0!H`T`:`-`&
M@#0!H`T`:`-`&@#0!H`T`:`-`&@#0!H`T`:`-`&@#0!H`T`:`-`&@#0!H`T`
M:`-`&@#0!H`T`:`-`&@#0!H`T`:`-`&@#0!H`T`:`-`&@#0!H`T`:`-`*_'_
M`.;O?OUG_2'6GJ;Z?EIX&+HKJ_GJXG/7X[DDYKZJ6O7DCW2@62_YH1V!3IL_
M84;?FU>K-H>7RIN,I8<<3G1D9JS>9JAJ<X^]!OY<+KRL_.?MY]RN6^[7'^2<
M>*4W!\>]?Z>.R8B8UROU$BQM$Q[F`=K;LCX8UY[:C#DCKE_DG(]14RCSPU3]
MDR1??OPWR#R_[?OP_`P+8Y!K=>81O(L0V1L2QW.0-="J/-K?W9?O&5('$P=1
M_P#CE?\`];0F)Z:3QWS]?'>&XZE:AXXT..KUI0LAWM*(%CE5_P`N1<(R^QE.
MG.U<B.1.]\?-#;S_`,>Y+GN,KT::1.%F[LO>DV+[8V505,<P<9?/I\!J*G*Z
M-MJ)IDXQ@8>2\'S=[Q:IPM6&%W*0+<E>0($[)0D(&BE5MVTXR.FG-#!]GM1$
M(Z!IXAQ$O#>,\;Q<P59*<"Q,J-N4;?P;"Y_Y!H@QOJ2`T`:`-`&@#0"SQG^S
MW'?N\?\`)&M'5_=JVLQ_Q_V*/E0SUG-@:`-`&@#0!H`T`:`-`&@#0!H`T`:`
M-`&@#0!H`T`:`-`&@#0!H`T`:`-`&@#0!H`T`:`-`&@#0!H`T`:`-`&@#0!H
M`T`:`-`&@#0!H`T`:`-`&@#0!H`T`:`-`&@#0!H`T`:`5^/_`,W>_?K/^D.M
M/4WT_+3P,7175_/5Q&FLQM#0!H`T`:`-`&@#0!H`T`@O>-\S9N2SP^3\C3BD
M;*588Z!CC&/13+6D?'_28Z`T?[I\_P#_`#ARO_X+C?\`\DT`?[I\_P#_`#AR
MO_X+C?\`\DT!(*<$M>I%!+8>U+&H5[,H0/(1^TPC5$R?^:H&@%U;@;-:O'7@
MY6TD,2A(TVUSA1Z#)BSK55U"J<713%_-YF#+Z*JBE4TYE<%\O^)L_A-_^N+7
M^96_U.J_6I_!3^;S+_MJ_P!2O\G^(?PF_P#UQ:_S*W^IT^M3^"G\WF/VU?ZE
M?Y/\0_A-_P#KBU_F5O\`4Z?6I_!3^;S'[:O]2O\`)_B'\)O_`-<6O\RM_J=/
MK4_@I_-YC]M7^I7^3_$/X3?_`*XM?YE;_4Z?6I_!3^;S'[:O]2O\G^(?PF__
M`%Q:_P`RM_J=/K4_@I_-YC]M7^I7^3_$/X3?_KBU_F5O]3I]:G\%/YO,?MJ_
MU*_R?XA_";_]<6O\RM_J=/K4_@I_-YC]M7^I7^3_`!#^$W_ZXM?YE;_4Z?6I
M_!3^;S'[:O\`4K_)_B'\)O\`]<6O\RM_J=/K4_@I_-YC]M7^I7^3_$/X3?\`
MZXM?YE;_`%.GUJ?P4_F\Q^VK_4K_`"?XA_";_P#7%K_,K?ZG3ZU/X*?S>8_;
M5_J5_D_Q#^$W_P"N+7^96_U.GUJ?P4_F\Q^VK_4K_)_B'\)O_P!<6O\`,K?Z
MG3ZU/X*?S>8_;5_J5_D_Q#^$W_ZXM?YE;_4Z?6I_!3^;S'[:O]2O\G^(?PF_
M_7%K_,K?ZG3ZU/X*?S>8_;5_J5_D_P`0_A-_^N+7^96_U.GUJ?P4_F\Q^VK_
M`%*_R?XA_";_`/7%K_,K?ZG3ZU/X*?S>8_;5_J5_D_Q#^$W_`.N+7^96_P!3
MI]:G\%/YO,?MJ_U*_P`G^(?PF_\`UQ:_S*W^IT^M3^"G\WF/VU?ZE?Y/\0_A
M-_\`KBU_F5O]3I]:G\%/YO,?MJ_U*_R?XA_";_\`7%K_`#*W^IT^M3^"G\WF
M/VU?ZE?Y/\0_A-_^N+7^96_U.GUJ?P4_F\Q^VK_4K_)_B'\)O_UQ:_S*W^IT
M^M3^"G\WF/VU?ZE?Y/\`$/X3?_KBU_F5O]3I]:G\%/YO,?MJ_P!2O\G^(?PF
M_P#UQ:_S*W^IT^M3^"G\WF/VU?ZE?Y/\0_A-_P#KBU_F5O\`4Z?6I_!3^;S'
M[:O]2O\`)_B'\)O_`-<6O\RM_J=/K4_@I_-YC]M7^I7^3_$/X3?_`*XM?YE;
M_4Z?6I_!3^;S'[:O]2O\G^(?PF__`%Q:_P`RM_J=/K4_@I_-YC]M7^I7^3_$
M/X3?_KBU_F5O]3I]:G\%/YO,?MJ_U*_R?XA_";_]<6O\RM_J=/K4_@I_-YC]
MM7^I7^3_`!#^$W_ZXM?YE;_4Z?6I_!3^;S'[:O\`4K_)_B'\)O\`]<6O\RM_
MJ=/K4_@I_-YC]M7^I7^3_$/X3?\`ZXM?YE;_`%.GUJ?P4_F\Q^VK_4K_`"?X
MA_";_P#7%K_,K?ZG3ZU/X*?S>8_;5_J5_D_Q#^$W_P"N+7^96_U.GUJ?P4_F
M\Q^VK_4K_)_B'\)O_P!<6O\`,K?ZG3ZU/X*?S>8_;5_J5_D_Q#^$W_ZXM?YE
M;_4Z?6I_!3^;S'[:O]2O\G^(?PF__7%K_,K?ZG3ZU/X*?S>8_;5_J5_D_P`0
M_A-_^N+7^96_U.GUJ?P4_F\Q^VK_`%*_R?XA_";_`/7%K_,K?ZG3ZU/X*?S>
M8_;5_J5_D_Q#^$W_`.N+7^96_P!3I]:G\%/YO,?MJ_U*_P`G^(?PF_\`UQ:_
MS*W^IT^M3^"G\WF/VU?ZE?Y/\0_A-_\`KBU_F5O]3I]:G\%/YO,?MJ_U*_R?
MXA_";_\`7%K_`#*W^IT^M3^"G\WF/VU?ZE?Y/\0_A-_^N+7^96_U.GUJ?P4_
MF\Q^VK_4K_)_B'\)O_UQ:_S*W^IT^M3^"G\WF/VU?ZE?Y/\`$/X3?_KBU_F5
MO]3I]:G\%/YO,?MJ_P!2O\G^(?PF_P#UQ:_S*W^IT^M3^"G\WF/VU?ZE?Y/\
M0_A-_P#KBU_F5O\`4Z?6I_!3^;S'[:O]2O\`)_B'\)O_`-<6O\RM_J=/K4_@
MI_-YC]M7^I7^3_$/X3?_`*XM?YE;_4Z?6I_!3^;S'[:O]2O\G^(?PF__`%Q:
M_P`RM_J=/K4_@I_-YC]M7^I7^3_$/X3?_KBU_F5O]3I]:G\%/YO,?MJ_U*_R
M?XA_";_]<6O\RM_J=/K4_@I_-YC]M7^I7^3_`!#^$W_ZXM?YE;_4Z?6I_!3^
M;S'[:O\`4K_)_B'\)O\`]<6O\RM_J=/K4_@I_-YC]M7^I7^3_$/X3?\`ZXM?
MYE;_`%.GUJ?P4_F\Q^VK_4K_`"?XA_";_P#7%K_,K?ZG3ZU/X*?S>8_;5_J5
M_D_Q#^$W_P"N+7^96_U.GUJ?P4_F\Q^VK_4K_)_B'\)O_P!<6O\`,K?ZG3ZU
M/X*?S>8_;5_J5_D_Q.GC>/6C`\0E>9I)'FDEDV[B\AW'Y`J_\@USS<SG<80E
M`ZY&1].F$6XMN+U[("FYXUS5BW-/%Y1R-6*1BR5HHZ!2,']E3)5=\#_G,3KF
M=S3_`+I\_P#_`#ARO_X+C?\`\DT`?[I\_P#_`#ARO_X+C?\`\DT!(JT4D->*
M*25K$D:*KSR!0[D#!9@@5<GU.`!H#9H`T`:`-`&@#0!H`T`:`-`(_!>2N\GX
M;PO(WI.[<MTX9K$N`NYW0%CA0`/\&@'F@#0!H`T`:`-`&@#0!H`T`:`-`&@#
M0!H`T`:`-`&@#0!H`T`:`-`&@#0!H`T`:`-`&@#0!H`T`:`-`&@#0!H`T`:`
M-`&@#0!H`T`:`-`&@#0!H`T`:`-`&@#0!H`T`:`-`&@#0"#P_D[W(0<JUN3N
M-6Y6[5A.`-L4,I6->@'H/CH!_H`T`:`-`&@#0!H`T`:`-`&@#0!H`T!&?ME_
MP]\=_P#O?7_T8T!)M`&@#0!H`T`:`-`&@#0!H`T`:`-`&@#0!H`T`:`-`&@#
M0!H`T`:`-`&@#0!H`T`:`-`&@#0!H`T`:`-`&@#0!H`T`:`-`&@#0!H`T`:`
M-`&@#0!H`T`:`-`&@#0!H`T`:`-`&@(M]O\`_P"&YS_[]\E_ISH"4Z`-`&@#
M0!H`T`:`-`&@#0!H`T`:`-`1G[9?\/?'?_O?7_T8T!)M`&@#0!H`T`:`-`&@
M#0!H`T`:`-`&@#0!H`T`:`-`&@#0!H`T`:`-`&@#0!H`T`:`-`&@#0!H`T`:
M`-`&@#0!H`T`:`-`&@#0!H`T`:`-`&@#0!H`T`:`-`&@#0!H`T`:`-`&@(M]
MO_\`X;G/_OWR7^G.@)3H`T`:`-`&@#0!H`T`:`-`&@#0!H`T`O\`'N&BX3@Z
M'$0R-+%0@2NDKX#,(UV@G'30##0!H`T`:`-`&@#0!H`T`:`-`&@#0!H`T`:`
M-`&@#0!H`T`:`-`&@#0!H`T`:`-`&@#0!H`T`:`-`&@#0!H`T`:`-`&@#0!H
M`T`:`-`&@#0!H`T`:`-`&@#0!H`T`:`-`&@#0!H!=PG"0\3'<2*1I!<N6+KE
=L#:UA][*,?`?#0#'0!H`T`:`-`&@#0!H`T!__]D_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>g704250graphic-2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g704250graphic-2.jpg
M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````/```_^X`#D%D
M;V)E`&3``````?_;`(0`!@0$!`4$!@4%!@D&!08)"P@&!@@+#`H*"PH*#!`,
M#`P,#`P0#`X/$`\.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'!P<-#`T8$!`8
M&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?_\``$0@#2`)H`P$1``(1`0,1`?_$`,,``0`!!0$!````````
M```````%`@,$!@<(`0$!`0$!`0$```````````````$$`@,%$``!`P(#`P4(
M#0L$`0(&`04"``$#!`41$@8A$P<Q02(4%5'1,E24U%4687*R(Y.S=#655A<W
M"'&!D4)2DG/3I+1UHM(S)&*A-,%#4X,E-K&"\&-D)Q$!``$"``H'!@<``@,!
M`0$```$1`O`A,4%1@9$2`Q-A<:&QP5($T4)RHK(SX?$B,E,4!6+B@I(CPM+R
M_]H`#`,!``(1`Q$`/P#U2@("`@("`@(""*L-[>ZG=!>'<]G5TM"SYLV?=@!9
M^1L,<_(@E4!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`
M0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!!$:LOSV"PU%U:#K#P%".Y<LF.^F"+
MPL"Y,^/(@ET!`0$!`0$!`0$!`0$&KZ%_YM3?YNI^*A0;0@("`@("`@("`@("
M`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("
M`@("`@(-2XJ__HM?_%I/[R%!MJ`@("`@("`@("`@("#5]"_\VIO\W4_%0H-H
M0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`
M0$!`0$!`0$!`0$!`0$!`0$&I<5?_`-%K_P"+2?WD*#;4!`0$!`0$!`0$!`0$
M$)IBT5ENDO15+"S5URFJX,KX^]2!&(X]Q\0?8@FT!`0$!`0$!`0$!`0$!`0$
M!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$
M!!`ZZLU;>=+U5NHF%ZF8Z<@8WRCA%41R%M]J#H)Y`0$!`0$!`0$$%>KOJFDK
M&BM>G^TZ;(Q/4]<BI^D[OB.0V=]FS:@P/6/7WU/;Z2I_]J!ZQZ^^I[?25/\`
M[4$[9:RZU=%O;G;^S*K,3=6WP5'1;D+.#,VWN(,?MFY2U%3'26UYXJ>5X7E>
M8`Q(69WP%VQ_66KD61$3==2L5R,']KB3==%EE8MFE=Z(?>T;_P"A_P"IC[RG
M*X7G^65Y_'_C^:#M&_\`H?\`J8^\G*X7G^63G\?^/YH.T;_Z'_J8^\G*X7G^
M63G\?^/YH.T;_P"A_P"IC[R<KA>?Y9.?Q_X_F@[1O_H?^IC[R<KA>?Y9.?Q_
MX_F@[1O_`*'_`*F/O)RN%Y_EDY_'_C^:#M&_^A_ZF/O)RN%Y_EDY_'_C^:#M
M&_\`H?\`J8^\G*X7G^63G\?^/YH.T;_Z'_J8^\G*X7G^63G\?^/YH.T;_P"A
M_P"IC[R<KA>?Y9.?Q_X_F@[1O_H?^IC[R<KA>?Y9.?Q_X_F@[1O_`*'_`*F/
MO)RN%Y_EDY_'_C^:#M&_^A_ZF/O)RN%Y_EDY_'_C^:#M&_\`H?\`J8^\G*X7
MG^63G\?^/YH.T;_Z'_J8^\G*X7G^63G\?^/YH.T;_P"A_P"IC[R<KA>?Y9.?
MQ_X_F@[1O_H?^IC[R<KA>?Y9.?Q_X_F@[1O_`*'_`*F/O)RN%Y_EDY_'_C^:
M#M&_^A_ZF/O)RN%Y_EDY_'_C^:#M&_\`H?\`J8^\G*X7G^63G\?^/YH.T;_Z
M'_J8^\G*X7G^63G\?^/YH.T;_P"A_P"IC[R<KA>?Y9.?Q_X_F@[1O_H?^IC[
MR<KA>?Y9.?Q_X_F@[1O_`*'_`*F/O)RN%Y_EDY_'_C^:#M&_^A_ZF/O)RN%Y
M_EDY_'_C^:#M&_\`H?\`J8^\G*X7G^63G\?^/YH.T;_Z'_J8^\G*X7G^63G\
M?^/YH.T;_P"A_P"IC[R<KA>?Y9.?Q_X_F@[1O_H?^IC[R<KA>?Y9.?Q_X_F@
M[1O_`*'_`*F/O)RN%Y_EDY_'_C^:#M&_^A_ZF/O)RN%Y_EDY_'_C^:#M&_\`
MH?\`J8^\G*X7G^63G\?^/YH.T;_Z'_J8^\G*X7G^63G\?^/YH.T;_P"A_P"I
MC[R<KA>?Y9.?Q_X_F@[1O_H?^IC[R<KA>?Y9.?Q_X_F@[1O_`*'_`*F/O)RN
M%Y_EDY_'_C^:#M&_^A_ZF/O)RN%Y_EDY_'_C^:#M&_\`H?\`J8^\G*X7G^63
MG\?^/YH.T;_Z'_J8^\G*X7G^63G\?^/YH.T;_P"A_P"IC[R<KA>?Y9.?Q_X_
MF@[1O_H?^IC[R<KA>?Y9.?Q_X_F@[1O_`*'_`*F/O)RN%Y_EDY_'_C^:#M&_
M^A_ZF/O)RN%Y_EDY_'_C^:#M&_\`H?\`J8^\G*X7G^63G\?^/YH.T;_Z'_J8
M^\G*X7G^63G\?^/YH.T;_P"A_P"IC[R<KA>?Y9.?Q_X_F@[1O_H?^IC[R<KA
M>?Y9.?Q_X_F@[1O_`*'_`*F/O)RN%Y_EDY_'_C^:#M&_^A_ZF/O)RN%Y_EDY
M_'_C^:#M&_\`H?\`J8^\G*X7G^63G\?^/YH.T;_Z'_J8^\G*X7G^63G\?^/Y
MH.T;_P"A_P"IC[R<KA>?Y9.?Q_X_F@[1O_H?^IC[R<KA>?Y9.?Q_X_F@[1O_
M`*'_`*F/O)RN%Y_EDY_'_C^:#M&_^A_ZF/O)RN%Y_EDY_'_C^:#M&_\`H?\`
MJ8^\G*X7G^63G\?^/YH.T;_Z'_J8^\G*X7G^63G\?^/YH.T;_P"A_P"IC[R<
MKA>?Y9.?Q_X_F@[1O_H?^IC[R<KA>?Y9.?Q_X_F@[1O_`*'_`*F/O)RN%Y_E
MDY_'_C^:#M&_^A_ZF/O)RN%Y_EDY_'_C^:#M&_\`H?\`J8^\G*X7G^63G\?^
M/YH6JJ^7:DAW]3:G"`2`3-IXR=F,F''!FV^$NK/3V732+\?5+CB>LXMD;UW#
MI;\4=22N4]9!0S345+UVJ`<8:7>#%O"_9SEBP_G61]%KGK'K[ZGM])4_^U`]
M8]??4]OI*G_VH,FVWS6-170PUVF>I4AN[2U77H9<C8.^.019RV[-B#8T!`0$
M!`0$!`01=C\.Y_+9/<@M/J/=^&/%B]'EO^.>Z$HLS:("`@("`@("`@("`@("
M`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("
M`@((G57S%/[:'XX%I]']R-?=+#_I?9G5]4)99FX0$!`0:`6I;[6<2:G3M-7#
M!24S@<@[J,BR[@)<C8OFVN[XES8LD69YWO#N6;HR8JLG4&HKY!KFWV6DJ&CI
MJH82*-HFD/!RDWA.[MX.`,W+L7-(KE6,C.U56:P@N-(%CB`Z,@?K4AL#Y2>4
M!9VS$..42<G;V%9CIHD71&:NUPGCYQ2XDZ4UK2VFUWPJ:)K;32U`Q0PY#G(I
M&DD%I`D)LV7DQ5(0_![C)Q,OG$NQ6F[7V2JMU7-(-13E%`+&PP2$S8C&)>$+
M<CH.P_B#UAJS2NG[=7Z=N--0325+Q31S[MY)\P^]QPA(SYBS?HYUQ?;$Y9F'
M5ETQDMWFZ</:R^5NB[15WV2.6[S0,=9)$\9`YN3\CQ.X;&P9\JZMB*8IKTN;
MIFN.-WH;"JB+L?AW/Y;)[D%I]1[OPQXL7H\M_P`<]T)19FT0$!`0$!`0$!`0
M$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0
M$!`0$!`01.JOF*?VT/QP+3Z/[D:^Z6'_`$OLSJ^J$LLS<X[/JK7U#Q1MEOEJ
MZXK'<;I/2O#4VZ&&G:$8S,&AJA,C/P6P=Q;%E.3.7'_[6SV1%87FYOT[+J[9
MQ.Q*H("#FL$XT_%^KFED8*<V>)R.1@C&3JL+LS#CTC-GVXMLP;!^9<S-L9:5
M[741,Y*]OY*]4'6EQ&HZ2C8(9JB*F(:LX-Z0[LI]HOW!QVMBW*NJSDKBU>WP
MESTTKM]BKB/2VR:^6AZ^6;&*-BE",('C*/K$3.YO*3.S8^$PL[X*3-L98C7-
M'5N]FKJKX//OXJ9(I.)L$D1"<1VNF*,Q=G%Q<Y79V=N9(FI2C7>`?WP:9_CR
M_P!O*J2].<<J&]W"VVJCL<=*=S.>0XRN$--+2A'''FE.4ZC'=X#R9&Q=_83>
MI[TV=-:?FXF*^[O]%)PAMG#T9!T7:1DCW4C0X&&[BA9BS/C@$'O67N..QVV\
MZ5KGKKKVK3HIV=[84$78_#N?RV3W(+3ZCW?ACQ8O1Y;_`(Y[H2BS-H@("`@(
M"`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(
M"`@("`@("`@("`@B=5?,4_MH?C@6GT?W(U]TL/\`I?9G5]4)99FYYWM%ML\?
M'*,"O=;VZ]TJZI[;)3UK0E`Y3/T2)]UERF+,6&7H[$W+8G%9-=-+?;59ONF,
M=\3&BL^RCT0B"`@YW;KM%=>($@;BF*@,B>)Y:1PG(XJ<"Z1R1,682VMTO!P7
M47WQBK='0DVV3FB9TY6+K*"6;B'14\4QP2504@#+&0,8N)SN[MMSMT7?;EP7
M-(EU2<J0U_:FJ[[9!.JI&A%Q$J*KE8"J&:>,GPQ9WZ.7'9RE@RL33/3;AM28
MKFKL>=_Q5@$?$^$`%A`+73"(BV#,S'*S,S,I,U6V*0US@']\&F?X\O\`;RHL
MO4'&FU:4N,%EBOU16@76)&IZ*W0%4S54;BQ3Q;L!(F'*#9B;D;\JL74G]LW3
ML[W$QB_=%L=+:=`6^VV[1UKHK8-2%!!$XTX5H%%4,.<GPD`V%QVOL;#D2<N3
M=Z".O>Z6P**B['X=S^6R>Y!:?4>[\,>+%Z/+?\<]T)19FT0$!`0$!`0$!`0$
M!`0$!`0$!!%4.I[-77ZX6*FG8[E:PBDK(OV1F9W#!^?DV]Q<Q=CHZFW%5*KI
MR(++5M(]8]$TP];&-IB@Q;.T;DXL>'<Q;!2JT7E4$!!K=ZUS0VJ^PV0Z"NJJ
MZ>`ZJ)J6(9!**-V8W;IL_1<FQ;!3]5<4=L.HB*5F:;?"%%#Q#L%?<;/1T.]J
M!O05!TM2(81B5*WOL<F9V(9!?8XN*D73.8FV(SMG73D0$!`0$!`06:.MI*R'
M?4DP3Q9B#.#L39@)Q)L6YV)L'4B5F*+RJ(>'4]%+JNHTTT4HUM/2!7/*0LT1
M12&\;92QQ=V)MNQ3'7H6D4RIA5$+?-5T5FN5KH*BGJ)9;O-U>D.$!(-XPN64
MW<AR]$7=2:YH6(C2FE4$!`0$!`0$!`0$!`0$!`0$!`0$!!$ZJ^8I_;0_'`M/
MH_N1K[I8?]+[,ZOJA++,W/-FG[RY_B;JHJD[@%:]35T@2[T`@DIXASQQ&!1Q
MN8-FZ.UWY,%>7,1^W76[\O`WHF<5VJEOMJ])J`@(.>PM`W%Z4B=]Z49"#[''
M931N[96?8_/G=L7\%3%K[?R6DT_/\NUA5M+8K)Q$ZY<+I41RF0U#BY`%,`S%
M*X,>:3,^UB9W8<,&9)FV,V'53'M6VRZ[\O',N\2:QHM3V(6J"CBJQ",FC%WS
MCUN$]IL[='8VQ)DB.AP7\5_WI1_XRG^,E52&M<`_O@TS_'E_MY467H[\093#
M0V+<4KR5!U$T5-5A.=+)!+)&PB6^C,'&-\7>3V&P7-TQ2ETVT_Y4PQ%L37%O
M5Z/REN7"XJPM`61ZP2&JZO[ZQS/4$Y,9-B\I.3ECR[7V<BMM*8J4Z,B75KCK
MKRMI51%V/P[G\MD]R"T^H]WX8\6+T>6_XY[H2BS-H@("`@("`@("`@("`@("
M`@(([4-ZIK+9ZFY5#ME@#H`[X9Y"V`#>R1.S+FZ:+;%7+YK7J+1MWL.J[L='
MN2F*AU!40N;&87*1B&21S?*[13Y6;#F75\1%N*:TZ-J6S6<E*].S,F+QJBKK
M;=K&JCNAVVKTX<T=)3QN`[(H6,)9!-GSM*[[/87$S;DNRSAB>D5S0A/7W4T>
MF=5U$EQ8:RVV^VUM`1"#$)5-,$DFQ_"8C=U)MB,59Q])%TSCI&)(ZGU)?(+K
MJ,:>X[CJ^F([C2.(QXQSL9XDSNSN[/EYUU,1.>=J1II&Q1!JO4-FJK43ULEY
M[7T]47,J6;)CUJECC-MUD87P/>.SCM3=C%N]Y-WFC9"1HKY=WJ=*3T]RDKH-
M2P2=H1MDPA_Z^^:>'!N@T9]%V?%(B)R9LN&DF9SQU,;1-_O57JI[+=+R4H4#
M3R4%2S`PW:%Y,N\;!L&ZMX!L'*^WD4B(BDUFDY/Q\"9NFN**QEQ=S*U*547%
M_3\5%410516BORO*.=L-[#^JSBZZQ9)FCG'2L15&W32L%JU=HVTTE=+3RU$E
MVJ:FM#(,IS3QM)*XL[.(YB?9@VQ=73"6UA31ZONU99:6AJ+K*]PCN%RMV-*,
M8U-6U%FR29R][BRLS$?=YEYTCKZYQ:YR]3TK.6G9W0Q;7J35>H6T+#VY);RO
M=#6%7%3A$Y%+3892;.Q;7YTBRW/7;0FZ<=(C8M5^H=4P4=YKQO\`-O;=J2.U
M11.,6[ZM,449,0Y?";>.XOCL=-RWIVF]=HC8E*34]TCCN]FJ;M-(=#?@MM).
M#1O63Q2P-*T+%T0$F=_^1VY&2D83WSH2LZ(V>&EB:>UQ>;C0V&UW.O.C&XUU
MSHY[JS@,N-$9-!#GP<&D,>4L-N&SE2D1%9_;&&70M:SBC]75X,ZYWW445]I-
M*45T:H(:":>*ZS31P'/4#+E87)@D`MR#CF%F;'E2EN6M+=O;BU)6[16YAUVM
M=64=LUFU7<H&N%IM-)64DD#"\0SG&;R/%F\,",.=2;8C/./5L6)G1DPQI&U5
M5UN'$UQFN\\%,UCH:L:0"!HCDDD-CZ+L^.+\N"ZW;8QSEZTWKJ4CN1FF]772
MNIK!:*^YE21W6INH376)HXC.2CG<8H`?!P`B%W)]FW!2:1CFN[U]\D=$17J\
M%S7.I;M9K551VZ_S5]?9[=UISB&$6SC,0[RJ)^B;$S,&0&QV.Z4MG)7;W:9[
M%B;HRQ&S"D+EWNE6&N[E64E3!3W"32D!TTLQ81M*=2>7%]N#.[\JLTSRYB)T
M-JT/J2&IM=-2W"HDAN\L]5`U%6G&51GI2]]`2#`96CQ\-FVLE:8I]L:B8KCC
M)L[&%Q"DC'4VA1(V%WNY8,[LSO\`]29E9F$B):Q=-0:FI:;6]U"^3.6FKE&U
M%2.T6Z>%PB(HI&RXNS[QVQQV+G<MQY:];O>NQ8HIU)V&^5=_U!>Z4[T=B*RG
M2E201O'A)#+$,Q32M(S[P#=W!L,,,.ZD[L?NSY,=-B1O>[$=.)O-#=;;7E4#
M15,=05+)N:EHR8LDC,Q92PY'P=EU%U4FV8RLI5R("`@("`@("`@("`@("`@(
M"")U5\Q3^VA^.!:?1_<C7W2P_P"E]F=7U0EEF;G$;)Q8U35\<JC1]5;*0[=%
M4UD,%:,1-.,4(`3/G%Y&_6;-CA^;D7,;WF_3HQ+,6>7]6G"';ET@@(-#H[Q=
M1XI5ENE.#J$N'5Q&.)YF8*4#+-(Q[QF<BYPYN5,>F::,V&LI&6F/2B]:-5!Q
M(MLU'&,E2\<(@$F=AEP&H)X'=GR])FQQ<=CLV+LK%<V':3%N>*X=4][(XCU6
MYOUA,P86DW8R#C'B.-5#S$0N>W9@/Y5*SA7#:4B<S@?XK_O2C_QE/\9*BPUK
M@']\&F?X\O\`;RHLO27'6UV6Z3:;H;C;ZFYR2S53TU)3%3QXN$0R&1'4N(-@
M(?EY58OW=&N:1W2XNMB<LSJBLMEX/-;&X:V/LL)H[>\4CTX5.1I6%YC?`MWT
M.7DPYE)FN.E.U:4Z6Y((NQ^'<_ELGN06GU'N_#'BQ>CRW_'/="469M$!`0$!
M`0$!`0$!`0$!`0$!!BW*U6VYT[4]QI8JN!B8VBF%C',/(6#\[+JVZ8R)=;53
M<+/:KE2-1U])%54@NSM!,#&&(^"^5]FQ+;IB:PEUM8I*'U-H:S7:TUE-!1TL
M-?/2E205DD+&\8D.5N3!WR\VU=1?.29Q)N9_'O?;=HFSM:*"EO-%27"MI*2.
MBDJ7A;`PC%A;869\-G([I'$F,DXB;(G*D)M+Z=GD*2:VT\AE$U.1%&+N\+-@
MT;XMX/L*1?,$V1T[951:;L$4M++%;X`EH1<*,VC%GB%^5HWPZ+?D3?G'TKN1
MA,JZ:PV6F>5Z>BABW[$,N0&;$3\)MG,_.RDWS)%L1AA1;ATSIZ$J,H;=3QE;
M\W47&,6>'.^);O!NCCSX*SQ)Q]*19&+HZ97)[#99[E%<YJ*&2XPMA#5D`O*+
M-S"?*RD7S2F99MBM5579K55U<%954D4U52[::<Q8CCQ_8)]K)%TQ%";:S5BM
MI'3##E:UTS#O7GP:(?\`E=L'/DY79]O=5YER<N.G;*L-,:="6GE"VTP24A$5
M,0Q"SQN;XDX8-T<7Y<$GB3.LBR,)E3+I334K5#2VRF-JJ5IZEBB%]Y*SXL9;
M-I,_.G,N-R.G;(>E--&\SE;*9WJ3&6=]V.)R!X)D^'A-S.G,DW(Z=LJI=,:<
MEHI*&2V4Q4<IM+)3O$&1Y&V,>7##-[*<RZM:G+@J=,:=JJ2"CJ+932TM*^:F
MA*('"-^Z#8;$CB71G)L@KM+Z<KB`JRV4TY!'N`<XA?")]F3D\'V$CBW1G)X<
M*RT]8CGIIRH('FHPW=+(X#FC!N01?F9E-^<B[L+):3TP5`5O*UTKT12;XJ=X
MAR;S]O+AX7LKKFW5JG+C"95R:8TY+NMY;*8F@C>&)GB#`8W?'(S8888\RG,N
MTG+@+2^G"EWQ6VF*7<]6SO$+ON6;#=\G@^PD<23<C"96STM:"KK55!",369Y
MBHH@%F$3G#=D6/+X+NIO+NLFX6*S7&>"HKZ*&IGI7S4\LH"11OCCB#OR?F2V
M^8R$VQ*R>E].2=;SVVF)J]V>MQC%]\[/CC)LZ6WNJ\R<70FY&/+CZ9?9M,:<
MGEIIIK932RT8M'2F<0$\8-R"+NW(W,R1Q+HSFY&&&-G04E+`4I00A$4Q;R9P
M%A<S=L,Q8<K[.5<S=,Y746Q&1=440$!`0$!`0$!`0$!`0$!`0$$3JKYBG]M#
M\<"T^C^Y&ONEA_TOLSJ^J$LLS<\S:;'1I?B;JBIY*^.\#75V\B,:>2G*3=CF
MP*-V,1Y?"_/SIO9IMUU\)CN(MG+$]D]]:/3*`@(-%H*6Q4_$(:>GBJ@JZ:(P
M#-/G@83C$W=HB)W%NEAF[NQ*]$8:J%.F>SORJ+Z%5]H]O>.G(A=J9WJ&CD)@
M`7GSMO&)HP9W<6=LKX[%=V:5IBU?GL2L5RQ7##&HXCT];VW:*V.F>HI:4HWJ
M'RY@82J8F=SZ0^"W2;!N93#,N+/X^$//7XK#`^*$)@3$!6NF(29\6=G.7!V=
M'4-;X!_?!IG^/+_;RH2];<4M-Z7O5D!]3UT=#::9SS23,&1IIAW4)YRVB0$6
M+8/MY'V*Q?%N.<-6%'.[,SBRMIM=!!;K;2T%.S-!2Q!#&PBPME`6%L!'8W)S
M),UFJ1%(HRE%1=C\.Y_+9/<@M/J/=^&/%B]'EO\`CGNA*+,VB`@("`@(-3U'
MQ!@L%T.EK+?,=+&U.15<3B?1J"(&=HFZ;Y7!\<%)B[-$3KQ^SM=1NYZ[,7M[
M'R7BAI7J]?/2S'5M;)H8:YHQ?WO?.^!;6VL+"3OAW%*W:)7=B,LH^FXSZ2GN
MS6]M^.>22*.9P?!SB:)SQ'PF9M^VUU-Z[0NY&D#C;H62LEIH9Y9MP&:<@B-W
M`\V7=N&&;-L)W[F#J;UWEDW(TPDGXGZ/;3$^IGJB:SP2-$<[QFSN1`,@X#AB
M[.$@NKO32M)ZL2;F.E47:.->D;B$A,-3"T<%/.^:)RQ>I%B&,<N.)8$/Y<5(
MNN\O;"S9&GLE<J^-&AH+6UQ"IDF@<W`7&(VQRF(R/M;]1C8G]A7>N\LFY%<L
M/C\:-';^B$2G*GKQ(H*EHWROD8W=F;PL6W18[.9-Z[R]QN1I[TC;^)^D*Z^1
MV2"J-KA*YM$!QF`FP.8N0D[8.SO&3-^1-Z:XXF-B;F+%+$OG%[1UGOC6.>66
M2Y#,\51!'&3E&+1%,\K[-H,(\R3-U<5LD6Q2M89=LXH:.N=^.QT-4<]=')N9
M,L9[L3Z>#.>&'2W1X?D2+IK^V:$V4C*PZ_C+P_H*F6FJK@4<T.R0=T;X%B[,
M.+-RNXNIOSY96.'TPN5W%?3%+!6U(O+-2T`4\E1.`/AA4S#"+"S[2<7-L<%:
MW:$W8TK]VXDV2W4=LK'AJ9X+H1!#NXWS"X2A$;&#X%F$C\'#'8K^K-';"1$9
MY[UFGXLZ.J[4-VHJ@JFW[]Z>28`)G$F@*=NB[8OB(X;.=2+KIC]LK-E)I5\M
M_%[0]?4E34U5*4\>;>QO#(S@P/E)RQ;9E+H_E4BZ?+/9[5W.F&)2\:-*54%8
M<,=2\E'(\90O$XD6&7`F<L&Y)!=^XSI%UWE[8-V-/9*0M7%+2=S:W=7EES7-
MQ&G9XCPQ-H\KD^&P7>8&9_95BZ[1/8DV1I7;/Q*TI=[R-HH9Y)*LO!=XC&-\
M0*0>F[8=((R=OR)%TUR3V>TFV(SHZV\9='5=(U14'-0N58]#'%/&68CWLD(D
M.7%G%RA+\B5NSVKN1FEEGQ2TO#<JFW59RTU93E.PQD#OO`ICW9&.7'81[!29
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MZ[1B(LB<ZW1\7=.UY70J&*:HI[;;`N[SLS"TD1%(&01+!V)BB?E2)NT$VQ&=
M(6OB;H^YQ7.2EJR=K/&\MQ$XS$HQ%R8L6=MKLX.VQ(NG1)-E,[&@XMZ+GKHJ
M$*B;?RN0X/!(S"X2#">=\-F60V%_9=(NN\L]GM6;(TQVK%-QET34&^26?=,>
M1IWA+)BS#F=WYF%Y!;:IO7>6>SVFY&GO]B[;^+NC+I'2':Z@ZSKM0%-$P1D.
MV1XVSOF9L!;?!^E6+KO+,=9-E,[*H^)NCZROCH(*LBJ9:P[>`[LV9ZB,1(AQ
MPY,#;:D73HE)LZ4;2<9M'RT-55U'6*1J26:,XI(B<G&`I1*0<N+./_7-_8P3
M>NSV]R[L9I7+CQCT91C1.,LU2]=+N8AAB(G;`I&(N3FW)OA["F]=FMGL-R,\
MLRX<2]/4&H*:SU+3`-50C<8ZY@=X&B,\HL3MM;'\BZF;M&+#,D6QIQK=NXKZ
M*N-#6UU)5G)36^-YJL]T;9(Q(1S/LY,2_P#0NXZD77>62;(C/#'/C/P_'JF%
M<<G7@>6F8(I"<@%S9RV-R-NC_0F]=Y9PUKN=,,NJXIZ*I;!1W^>M<+572'#3
MU&[/!Y(W=B%VPV>"^";UU/VRFYCI6$?#QFTK(`3;JJ&CD)\M243L+1L`R;PF
M?`F'*>/(E;_+VPN[;I[V9:^+.BKG2U=51U4AP4;8RR/$;,[[P8LH8MTGSR".
MSNI%UWEGL]J39T][(H^).F:V^4MEHY))JVJB.<68'81C`!/$W?##%I&P2+IK
MD)MBF5CVKBC8+KINHOE!%/*%,T+RTV1QD=YY-T.7'!B;.SMBW<5B;IS8R8B)
MRXE%DXL:8O-XN]OHWD>*RT<==65;M@#"8YG%A\+$1Y5(NG/&(FR(SEJXOZ'N
MI0#0U<DO6"(8RW,C-C&;1R8OA^H9,Q?E4B^?+/9[5GATSPM-QCT=+*\%*<]1
M/GC!@:$Q;WW([%F)F;#+*!?D=E=Z[R]WM-R-/>O6;BUI"ZP6^2&66.2Y2114
M\1Q&SYIG`1?'##)FD$<W(D779[9[,/%)LC-.&&I)6+75CO5>=OI7E"LCWF>*
M0''#=$S$V;DY"8OR.K$SGA)MBF5L*Z<B`@("`@B=5?,4_MH?C@6GT?W(U]TL
M/^E]F=7U0EEF;GFO3VI[S/\`B8J;7.5%4TL=;7!$;PTSSQ@$08,TF$<F9N3G
M?EY=KI6?---&.G;'B;MN7=BNG\I>E$!`0<WO$]N/7ST]12R13/,+15E.]44[
MD,$9L3"+/#E_5+N-M3'HB=7C4K$9Z:_"GBEK_:[[4ZSH)J>24;8VXWXM,T8=
M`I"+`6D$G+P?U'Q4W;:X]VO;W>*UNIBK1A\0ZBW1WRSM4TK54KN#1L]3)`S9
MZB(6<A$"`]K[,Y-W.=75'_K7\C7.UYX_%8`AQ0B`&80&UTS"+-@S,QRX,S),
MU(:WP#^^#3/\>7^WE19>C_Q#:AN%IL]IAI9'8*V>0)(1BBFWA1B)AF&5B;*.
M#OCW<$BVZ9_36O0D3%,=*=+=>&UQN=RT-9ZZYS=8KZB'//+@PN[N988LS,S.
MS8,Z;N[B[R;JXVRHB+L?AW/Y;)[D%I]1[OPQXL7H\M_QSW0E%F;1`0$!`0:+
MJC4/$*AO-5#;;3'-:L*:.AJL-X9S2R`)LX,8]$1<MKX88)RKIQQ/=XG,MC+'
M?X-5*X\7KL]AN?8-,\,V]:[021AL%@%XGR')F=XY"-AZ38\JL<&Z/>I,=7Y)
M/%LG-EZWVM?BX5OGFH=-45/73$8E2"$6[ER%"\1R$Y['87F'G_\`BKRKY]_'
MAAI2+[(]W%U3AX,VIH-<16:BKZ72MN[7"&<I*!@BW8U#U`-$;%BQ8O$&+X.K
MNWSBW\.Y*V1CIW_FKML?$,QCEN.D;5%425D450\3`3E3FSO/-CCL?-M;EY4W
M;_/4_P#GY9A59]/ZII+'/;(M/4%/22%)4%1R"TL95!20@.QS=LH1Y\'YV%N1
M*75KO;*+6V8I29ZZX88D7UG7%NFMT`Z+ML5;55!1R#3PB0]6B,7?ILXL.`L[
MCCRNS)-G$GWJ[$B>%&;OPQ?DM2TW%F2V4=%ZLT(M-%535SO'">265S<(A%RR
MX/A&SOW&3EW^?N7?X?E[)9]12<0AM%))%I&U'50`+'3'$&QR+IL#L;X,&)/C
M^LF[?Y^[#J[4K9Y9[<.MO-HL%%6T5/5WBT4T-T9A*1FB`7`F?>8"0N6QC=]N
M*;UT129J;MM:QXI6>R6:HJ'J9Z&"6H?8\QQ@1OT7#PG;'P7=OR)'$NB*5)X<
M3-2"QV:"H*IAH8(Z@R8SE",6-R;'!W=FQV9G_2I-\SG(LB)JL2:6TU)+)-):
MZ4I97<I)'A!R)RY7=\-KJ\V[23P[972L%C+>YK?3NT[`TS/$&!M$[.#%LVY7
M;%DWYTFY"[):;7(,0R4D)C`3G"Q`+L!$^+D.S8[OM4WI7=A:BL%CA@ZO%;Z<
M(,V\W0Q`PYLN7-EPPQR[%9XEU:U2.'%*+<>F-.QRO*%LI1D(G-S:(,<SXXOC
MASXIS+M)RX6X-(:9@J*RHCMM.TM>XO5/NQ?/D$1%L,.3`&3F2<N&33V&R4[`
MT%!3Q-&6:/)$`Y2Q9\6P;9M`?T,DWW3G(LB'VFLEGIIGGIJ&"&9RSO($8B6;
M!VQQ9NX3M^=2;YG.L61"AM/6%A86M].PL>]9MT&P\SGFY.7,;O\`G5YEVE.7
M:^S6&R33O/+04\DY"0E(48N3B;NY,[NW.[J;\DV1E?`T[80@DIPMU,,$SB\L
M31`PDX>#BV&&Q7F7:3EPN26:T2C"$E%`8TXN$`E&+L`NV5V'9L;#9L4WY7<A
M;BT]8H@D"*WTX!+&,,@C$#,48;!%V9N1L-BL\2[2D60I]6=.[DX6ME*T,C.T
MD;1!E=G;*[.V'<9.9=I3E6Y"?3.G9RS3VRED+##,4(.^&+ORNW==TCB7:5GA
MVOAZ9T\;QN]MI\T3B\1-&+..3#+@[-LPRLG,DW(55&G;!4333U%NIIIJALL\
MAQ`1&.+/@3NVUNBWZ$CB71DDGAQ*J#3]BIPD""WT\8S1;B5AC%LT38OD+!MH
M])]B3?,D<.(?::Q66E"4*:@@A"<<DPA&(L8MCT29FVMM4F^9SD61"B'3>GH3
MSQ6VEC/#+F&$&?!G8L-C?M"S_E5GB7:3EPI'2^G!C*,;92L!BXF.Z#!Q=V=V
M?9W69.9=I.7"N+3M@AW>ZMU-'N9&EBRQ`V61F9F(<&V/T62>)=.<CAQ!%IZP
MQ3#-%;Z<)0D>89!C%G:0N4V=FY=B<R2.'`^G;`0N)6ZF<2)S(7B!V<G)R=^3
M]HR?\Z<R[2<NUAGHC2A7&EN#VR#K-$!A2X`S`#2.3D[`W1Q?.6WV73F2<N$C
M)9[5+*$TE'"<L<;0@9`+NT;/BP-BW@L[<BD7RLV16JQ1Z;L5&54]-111M6",
M=0#"V4@#-E#+R9>F3X>RZLWRD61"I]/6)SB-[?39H&<87W0=!GQQ8=FSE=.9
M=I.7;H5O9;.]''1/10/21/FCIWC%P$MKXL+MACM=3?FM:FY%**/5ZQ9!#L^F
MR!X([H,&V,.QL.X+,KS+M)RX?8M/V*&$X(K?3A#(SC)&,0,),3L[XMAMQ<6=
M)ONTD<.(?8['98JH:N*A@"J$6`9QC%C81;*PL3-C@S;%)OF8I58LBM5=/9[3
M30O!3T<,,+Y6>,(Q$7R.Y#L9N8GQ9)OF2+(A:IM/6&E>=Z:W4T+U0N%2X1`.
M\%^43P;I-MYU9XETYTCAQ"B#2^FZ<A*"UTL9`[$!#"#.SL^.+/AW=J3Q+M)'
M#MA]'36G@PRVVF'*;2MA$#8&W(7)R[$YEVDY<,>IT9IBHEH)2M\(%;9!FHVC
M%@8##!Q?`</!<6=DWYSD61&1(4]IME/4E4T])#%4&SL<P`(F[$^+XNS8[74F
MZ96+8AE+ET("`@("")U5\Q3^VA^.!:?1_<C7W2P_Z7V9U?5"669N<OMV@^&_
MVQUMSHCK`U;1@]QK(G*3JSM6-N\S.8N+^#X(EL7>_BIN_P#EA/@XW,==[5B=
M07#L0$'/IJFQVWB5-5RU=0U7-[W/!U8BA9BAB&,MZV+"PX;2[KX<R5Z)[.[*
MM.F,.QB:NII)^)-MABEEI#E&F8:T18Q$@ZP3`#%$;,9-CM<L.[S*[M<L8L.G
MP2O3CPPHL<1J:N?5EF>I.*6!Y8>I1B!YW<)X7=YW8V%L"Q(2RX8[.52F&A=[
M#3\OBX=^*_[TH_\`&4_QDJ$-:X!_?!IG^/+_`&\J++U+Q>N]QL9Z>O-JIAK[
MI3U<D,%O()"WH3Q99'8@?H.+"VUTF)F,4TZ<VNOM<_I]['';J;M8ZRNK;12U
M5?1/;:R:-BGH2,9'B)_U<X['2DQEI/48LV1G((NQ^'<_ELGN06GU'N_#'BQ>
MCRW_`!SW0E%F;1`0$!`0$!`06:RLI:.FDJJJ08:>%LTLI;!$6YW25B*HN'6F
ME)C`8KK3$\CB(=-L'(WP%L>3$N9<<R'?+N9)ZDL(34T)5\#258N5,+FW3$>5
MV]C8KOPFY*S!J_2]0!G#=:8QC"20WW@[`BVR$^+\@X[74GB1&4Y=VA+`8F`F
M#L0DS.)-R.S\CKMPI*>`7(2D$7'#,SDS.V;8V/Y5S-T1G6+9T*!K*0C,!FC<
MXR<)!8FQ$F;,[.W,^&U-^-*[DZ'UJNE=G=IHW9L,7S-S\G.IS+=,&Y=H6VN=
MN>,I&J8BC`VB,F-G9C(LC"^#['S;%8OB<Y-DQF76J*=V%VE!V(L@OF;:7<;V
M4WXTF[.A\:KI')A::-R?8S,38N_Z5.9;I@W+M`-72D^`S`3XX;"9]O<Y4CB6
MZ8)LNT*PDCD'-&3&/)B+L[;/R+J)B<B3$QE5*H("`@("`@("`@("#`J;]9:7
M-UFN@AR$\9YS$<#;!W%\7Y>FWZ5Q-\1E=19,Y%D-5:;.J:D"XP'4D;Q-")L1
M9V?*XNS<F#[$CB1*SPYA:DUII2-L3NM,.,KT[>^-B\K,[N#-SO@W,G,@Y=R[
M2:KTY5DXTUQ@D)I`@=F-L=[)CD#;^L65\&5WX)X<E-JO35266GNE-*7)@$HN
M_A[OF?\`;?+^5<QQ;96>%=&9]K-4:=HMYUJXT\+PR[B5BD'$9,K'D)N9\KXK
MK?C(D<.61:[S:[M3E46VJCJX!)P*2)\PYFVNV/YU8FKFZV8RLQ5!`0$!!;J*
MB"F@DJ*B08H(A<Y)#?`1%MKN[NI,T6(JL45VME=2#64E5%-2GX,PDV78^#_^
MJF_&==R="F:]V>&ADN$M;`%#$V,E2\@[L6]DL<%.;;2M5Y=U:4QL@*JFDRY)
M0+/L#`F?'#N*[\:4FR="ZNG(@("`@("`@("`@((G57S%/[:'XX%I]']R-?=+
M#_I?9G5]4)99FYSO3&OK]>]85UL&&T0TM%655+-"]6?:>YII"`97I\F&!8,[
M=+D=<1..DW1U;L]]:=CN8BE8LN^*L4]KHB[<"`@YW#-32\5SC')*$@R9F<2=
MLT=-%F=CVB6&86=N1ORXJ1?HG#;VTZ%FV<^'9XKFIK]?:;7]%;Z(P>*6.!H8
MIG<(BE/?N0$0PREB0Q['QV8>RE.FF&C>@IT5U>+%XERY=2:?$I]Q*;AB.UP-
MFJ87)B%HSS"WLD.&QTFF?#M6(F<C@OXKOO2C_P`93_&2JI#6N`?WP:9_CR_V
M\J++U'QEGL='3V>XZBBFJ-/TTTS5M-$!F!'+'DA(\A#AE-^CBI,TQQ%9U>*6
MZ*[NWP;'PY@J(-$6>*>66:0(&;>5`N,CCF?+F8G)]@X,V+\B1$9LF&@F:]+8
MU41=C\.Y_+9/<@M/J/=^&/%B]'EO^.>Z$HLS:("`@("`@(""U5TXU-+-3F^`
MS`49.W*S$SM_\4A)ARFJT]PWJZHM_J$#IV>`9Z;HL[E1QM&W29L1\'%^XZO,
MMT3AJ=<F_HPUI6/2VE:6T1.VH'>U!2PT%PE=XS>HC<2*'WS!W`B:;'H<JD<2
MS+&3#+I.7?7'2O=U(*\Z%X?W2'M.YZH<B:+J95,3Q0L\`-D:(@!F;9BV;'EY
MU8XMFB9.5Q,U(ZOS=/I+712'27"&IG,`A!H6&4VA,,N`D\3/E?%G[BE(T8^U
M,;5-0\,*"[7FXW":]U%.=;N=Y`)`PQM'L##';R\B5X>>(KJ7_P"F;)K]JB[<
M,+%=KY57%KQ/#-(1C400R"+,909"S,WZV7!]O-[";_#G+$5-WB1DR:V)3\'=
M.Q5]14M>9RI9I-X]&YANAQ8V`6]AB-W%3?X66D=AN\7)[?:O6KAWIJTP7J6.
M^&]+<JJ(YS<XV&*4*EI&'%MF8I.CM3?X>6-9N<3).K+[>YFGP_L-#;Z-GNAP
M4M!*\SF9!E=Y!C`GQ+8)N\;.Q-M9W?#E2;^'EH1;Q,GM1EKX0Z=*0;A#>9JD
MZAPEIIP>-FR@,3-DR^Q%B3\[D[JQ?PYR1!,<2,L]_M4'PDTO;YHJWMN6EC"-
MXCQ.-A+$V+,SOR2,XX,3;<,6YU)XG"SQ"Q;Q9R>/M;?IVAL.FK,T,-<'4B=I
M1DE,6;IB.UMOZW+^=2[B61HA8X=\]*<CJZ61@>.8"WC,X8$V+L39FP;V6VIO
MQI3=G0NKIR("`@("`@("`@(-.O?#.VWBX5$]752/15)/*=#E#+O2W;&69VS8
M$,3-@NXF(S.9JQM+<(;#I^NEJQJ*BL,WE>/?EM#>FY>$.#E@VSI),VYHH4NS
MRQ0X,6DKG0UE7<)ZF*WR@=/2N(`&2*,HP`G!F)\!+:^.W!*VZ$I=T):^\.+9
M=Z&HI2JIZ;?5H7".6%V$XY8H]V&1_8Y5*QGBJQ$QDQ(2U<"].6UZ<H:RI<Z2
M6.6`\19V8)MZX/@W2$^1\?R\JZFZW0D1=I9X<*J6GO$]XHKI4P5U8\A5ID,<
MHR/,>,A,$C$($XL(XCS,I6W13JE9K.6D]<)FVZ9JK+$<=HJ1??&1S=;8Y!VD
MY-NP`P$?"?'NKF:3T+;BS5[/"61NM8;S_P!S;]WCR;B;'+E_B\N93=Z>Q=[_
M`(_-_P!0HM89^C4V_)B.QX)L<-N;_P";^A-WI[#>_P"/S?\`5&]OW.6Y=G4]
MXM)5N!?]=XI7/-&>4N27FP=L%S6-,['<Q=Y?F_ZLBMN%\IBA`[G:X2J).KPC
M)'+B<Q"[@`X3-MV<BF];YBEWE^;_`*LLHM78#EJ:#'%L^,$W)SX>^KO=Z>QQ
MO?\`'YO^K%N=EU%=;9);ZZJHVBG86E.&&5B9Q)BQ'-(3<H\^*L1$9S>Q9/F_
MZM>K>$(US5;U=]JC.L-YI7$(XQ:4LK$0B#-AL!F9E:69XKU_DD3=&2D;?:P'
MX"VGL([.UWJF@)I`$LD?@2.[NY#AE(VS=$WVLK^BN3#8E;Z9>_V_@D;!P@I+
M++%41W6IJZFE=I*4JC!Q&1G9W=V'#PL.DI2S-%%WK\\]_MEM)Q:NZ.2IH&V]
M+&"9]F'-[[W5SN]/8N]_Q^;_`*L.NN5]H2I8*RYVNGJJLQC@&2*46D/%LP@S
MR\NW8N;IB,L]CJ*S&*WYO^JBAN]XKZ,YJ.[6F?(<D3RA'*\;21.[$+^_?J_K
M+F+[?,LVW1[GS?\`5DQU&HRG.E:OMI53#O1B&*7%HW?`2=M[W5U$Q.*J8XBN
M[\W_`%7HXM7[=Y4T#\F&6"9MN'2Y97YUUN]/8YB[_C\W_5EVT+R(EVG+3R%^
MKU:,XVY7Y<YG["4IG*US4UU\(9J`@("`@((G57S%/[:'XX%I]']R-?=+#_I?
M9G5]4)99FYP'3\%I?C($#U8C1T]WN%307!J(HYJJNE$M_1'6.6!A#TLNS;EP
MYDWOBW<T?II$Z?-C(C'BW=[/EK31H[7?D!`0<KTY8[98N)TT02.9FQ")2.PO
MTX`<?!<0<OU<F7']9W5F=!$3GPPZV-<+A5W+BW2QE3!3G1R!%#,^<WPC.;I9
M2R"SF'Y=C['=2DQE\/&),4Y,/F\&=Q:"G*\VII<SXPGF81Q=H]]&YDSX.SEA
ML9GP[JL885@IAA$N!?B>>)^(=$\,I3PO9Z/=S&^8C'-)@3OSN[;5'2"X!_?!
MIG^/+_;RH2];\0JVW4]19HY++V]=))9BMM$9A'&V[BQFD)Y7R8B'@XMS[$W[
MK<E(Z9<[MLQ^JM-$8TKH:LL];I.VU5F@*EMLT;E3TQ<L>)/F#E?P2Q;9L[B5
MF<<K,4SU3J(B['X=S^6R>Y!:?4>[\,>+%Z/+?\<]T)19FT0$!`0$!`0$!!I=
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MA>98YS8V`Q`XYVG\%VREB38/CS)^G1AAUI^K//?[>ZBY3\+*)J:[T5162/!<
M1IXZ=L<SQC3X&Y93;+F.1LQ8-AS)^F)R+.],/M+PHL5OKJ&OBKZF"*V@8M"Q
ML$3L0.#D[,S,+[7=W2Z;,LQ!&_DB4;]AVG)[<-*]SJIWB,2BG(@D("CD(\-K
M.VW/@7=2VZS-$%V_GGO]JN[<"M/W*6"62X5D<D.5W<2%V,@\!R%VPV*Q-GE2
M=[3AM9-+P;M=-J>FOX76M*:F,#&G(V>-\F&Q]G)T?T;%/T>7&M;].+7[:.@K
ME1`0$!`0$!`0$!`0$!`0$!`0$!!I$'#,1@JJ<KE+%!52%++'"(,Y&+X0FYDS
MEB(L.9L<'==3NN<?1XX8514'!.BIXXF"ZU%1(-QAN!R3L+OC&1$;!@W1<L^&
M+<R1N1DBA,WSE\?:Z8N70@("`@(-2UKP_IM55-*534R4\,`[7BV2#(!9X3C)
MV?!Q+:_YEU%,Z37,@*/@/IZCH6I(*^JPCF>>`CR%D)YM\[8.V!"7@ECRLK,V
MZ$C>TX;6Q6#0=)9;M%6P3G+NH9(R*3;(92[MND[-AE`8FRMS8NI-*8H7'G;4
MN5$!`0$!`0$$3JKYBG]M#\<"T^C^Y&ONEA_TOLSJ^J$LLS<\[:9L>J;=^(&N
M>ITX;V.LN-554]RDBE>./"-WCDB,3.,<SRGS-B[OSKTY=T1O8J?^/X2XYML_
MISZWHE>;L0$'+M,%?;IQ'FNE7:Y*.B;/EDRRN!$,`1](S81Z+CAL%MO=;:KN
M3&7#5E[4W[9R8=K+U"TK\4K<4V#T484F1WWF`SD=1@_19PVLV#9G9<S=$9W4
M1,YGWB'3557>*'WBK&,#CIV>*-RAD&6:(B,Y1)F`6',VUL<5U%DSFKL[LNQS
M-T1GIM\'G_\`%8(CQ0B$6P$;93,S=QFDE4=0UO@']\&F?X\O]O*BR]/<>*:&
M?2].Y5-#%/%4"4$%<+8RN[L)-$>\B<'`"<BPY6;!-Z(RS35$QKK$EMLS-8BN
MN8GL;%POK)JS0-FGECAB-X7%@IA8(6&.0@'(+.3,V46YTK7+-7,Q3-1M*"+L
M?AW/Y;)[D%I]1[OPQXL7H\M_QSW0E%F;1`0$!`0$!`0$$3JJU7"[6.IMM#5!
M2'5@4,LL@;QGBD%PD9F9QP?`MCI$1.4K,9$4.@:$-.W*S!NF&X3/,TFZ'`=H
MY6<>?+E75<;FC6ZW@U+53U#C<VI0*6HGI#@`A.(YQ<1;#-DRCFP=L-K)2V<N
M,BZZ,G?^'BWREM%3`=(7:$VZIH0B*E%HVB-P'+F?$7/;R^$N:6Z.V>[(ZK+G
MFL+41ZCN!GK(;:-<\81TKXLT)0"QY2=B9F?!\S8\JXF.%GB=CTMGB9N_\&')
M0TVIK[6C1ZIBIB@K2KSI!S$XP4LL;'*6!`(YRB<7S8[-JL<N<M=B3S(R=ZY0
M6&PT\-_IRU4,W:,%O,JF5S<83B+$28R/!]Z4;OE;:RE>%&:D=1_]9RSCZV/'
MI+J5-6C4:^:2KKQ,J>60WP:`8V.3HY\NT0<W?#G4IP(R0ZKQI_/\/;1:DT;!
M6=0JFUR/7IH3BC(S,7,96C8<`WG1<6'!]GZR4X&2G8F]QL)_!DZCH;/=ZX*:
M/7;QA5T!44]%&^>*66.'=E*^!=$G+(67';@[<Z1/!F<DU)YL9XVIKAI;+#8;
M7472GU!'74#@SU4C$[1B[OFC(F(BREE?!UUO<.E8BFI)CB5I=WU;;Z[:4>&.
M:.Z4\H32C!$\1L>:0\,HLPX_M,N8XD3D)X<QE3:]'`@("`@("`@("`@("`@(
M"`@U_6U3JVFM.]TO3!5U[.;/";BV.,1L#MF<6V2Y<?83<F[%$T-Z+<<Q5IEU
MFXX!3T;4D<,M0#@<Q@T0B3.Q;T39R_4Z.3#EVXIR*^]W>PYT>7LGVI8VXEO8
M+7+5#GO-1%-'<(:5XXPAEE(7B/:^#C&POB[/CM3E9JU.9&6E-2#*'C@-_P"M
M&8G;XZ8,(8MTS/*1NQLP.6!$`[6=TY$9=[#8<_-N]D^WN2EB/C)VC0G=^K/1
MF<;UT,81ME$FCSB),3OT<Q_H3DT]Z9V>PYL3[M-OM0=TMG&>6N"&@FGAC*9R
MK:IYH\CNS'_P@[OEC?H[,$Y$3G]LKSZ9NS#OE)A/QG>FS%$&]@G!A;WEGDA>
M-V-R;'#$7P)MO*G)_P"6&&E.=&CLEB:PI>-M32YK&8Q25%OCCF%I``HZD)7,
MC#;@QF&`/MP9.1$Y;CGT]WLPV)-ZCC%'7NPPP24A!(\381]$A(Q`9"S9G9P8
M2Q9N5.3_`,N[V'-CR]_M;#HN36KE<8]3M&^[E%J&:,1#.&#YG<1=_83<W<]3
M?KFIM\6RH"`@("`@("`@("`@((G57S%/[:'XX%I]']R-?=+#_I?9G5]4)99F
MYR*BU?=ZSB;!1RZBJALHW"JI:2%K:,5+4S0B3'1]::1R(HL'Z3AM=EQ$6UK2
M[_VM^F(K3K=UFE/T[+J[9Q5ZG75VX$!!S^EK)'XKU-+CAM(G+.[D4;4D6`9<
M<!!C+-AAR[5*17,ZK-,]-=/8M:GAHSXF6G?QL;D-.+.^W!V*8F;(SX/B[>$7
M@\W*NHF7$QAA'BD]:4MZFO=J>AW[P8LTC0RF`YFFC)\S"8-X#%M)B[F&U<S;
M;.7=KTTPV.HNF-.&IYM_%?\`>E'_`(RG^,E5(:UP#^^#3/\`'E_MY467JCC)
M=+#3V6EMUYMLEQBN4CC3C#E:1IXB"2,`<F?!Y#P'\F*L3?'[8KM\'$VVS^Z:
M)GAA'11Z#LXT44T%-NB*.&HP:4,TA$0EE9FV$[X>PDUSQ25BF::MH4$78_#N
M?RV3W(+3ZCW?ACQ8O1Y;_CGNA*+,VB`@("`@("`@("`@("#DG$$M$U]54TE4
M%925]'6%)'70BSL4\E.P3,+D0ML@_:_-M5WYSQBZ\*&YHG'U5_-9IKKPPMSQ
M32T-3#+=*:MMCMF<GDI@,S-S9B;!Y"QR\[8I/$N\I'#C+7L8]YNG"RGT_`5=
M0UAVJ\0M5%,QN4IG!))&X&V;'':>+\G_`*)S+\UN&'2<N/-V>%/!;[5X/16R
M&"HM]8\%PCWL<4[D4C11#OHV;$\6$Q;*S=S8Z<R^/=PPV+RHGWNS\/S7+-6<
M+[O>WI0M%527&-Y:,-X;CG"AB9WC/*3X,6Y9W[KMBG,OR3;"3PXRQ=.QD4$7
M#*0ZN[]EU(U`T\,)MF?=F\QQ!DB=R%MDF3$BP5YE],=N'A"<N*XI[/PQRC[-
M<>&=!I-[#!27&KHZ]QQ'%MYNHI!>)L6/`1$I&'#E[JF_=6L6]KK<B(QW=GX*
MK#=>$_4K<=!;:^""CBB>W&3Y=Z+G$X`3Y^<BC=\W<Y4GB7Y[>U(X41DN[/P[
MG3]':UMFJZ$JVWQ310LP$&_%A<P-L1(<'?9L=<Q7/%'5T1FFK8%7(@("`@("
M`@("`@("`@("#6=::JK["]M:BH#KNLU#=>W8D6YHPPWTO1YV<Q9ORINW3D6)
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M;.W+74_PH=]7>@Y=VB5/;MDRL?:%-D+#`M]'@^/)MQYU-Z#E7:)5/>K.VUZZ
MG^%#OJ[T'+NT2->[,3,0U].[/M9VE#!V_2F]!R[M$OC7RRNSNUPIG8<6)]]'
ML=N7':IO0<J[1+ZUZLSLSM7T[L^UG:4.3]*N]!R[M$KE-<K=5&X4U5#.8XYA
MCD$W;#EQ87=(F)2;)C+#(5<B`@("`@B=5?,4_MH?C@6GT?W(U]TL/^E]F=7U
M0EEF;G`K3;[&?&V.[C6U$6>YUL%+(UO&.CJ*H0(9J=IFE)]X&#XGNVS.W*F]
M&B=MO;$1O4T5DIFK'5^KQ_37J=]0$!!SRGIZ5N+L\NSK+B[N^<O!:E`6V9LK
MX;>CDV<N*M<*%$K>:R[O>)"M]3;X*2EW;UE9689XVQ?-'&[-RX,[OF?]9<[T
M9)NF.C2ZBV<UM4#Q.DC]9M/Y<'ED*)XC=MF#5<3O@3&!-BW+@+^RK3HG#4YK
M3.X/^*_[TH_\93_&2HL-:X!_?!IG^/+_`&\J++T]QKMM-6TUGZW>'L]/%-*>
M\#?YC/*.7#<,[[&8N7NINQ.6V;NJ*N=Z8R3$=<Q"<X1U!5'#FRS/.=3FCDRS
MR.3F0M,;"[N6WD;G4B(C)B69F9QMO51%V/P[G\MD]R"T^H]WX8\6+T>6_P".
M>Z$HLS:("`@("`@("`@("`@(+$UOH)F)IJ:*1C?,>8!?%]FU\6]A=1=,9W,V
M1.91):K9(3%)20F3.[LY1B[LY>%RMSIOSI2;+=`5JMAPA"=)"4(-E"-XQ<6%
MWQP9L.ZF_.DW+=#X=HM1N#G1P%D;*&,8O@W)@VQ-^[23P[="H;9;1FWXTL(S
M;??&`6+I-@^W#':F_.E=R-#Z]OH'C*)Z:)XS;*89!RNW<=L$WITFY&A2%JM<
M;8!20BV..R,6V[-O)_XLF_=I3EVZ#LFU[O==3AW>7+DW8Y<NS9AAR;&3?NTG
M+MT+T%+34X,$$01`S,S"`L+8-R-@RDW3.5U%L1D7%%$!`0$!`0$!`0$!`0$!
M`0,&0HI.**0"`P$@)L"%V9V=G[K*U3=AB]C6C*X]2@RECF;=A@^/+S*[TN>7
M;H?6M%J9F9J.%F;8S;L>\F])R[=`-GM(M@-%`S.[OLC'E?EYDWI(X=N@:SVE
MB<FHH,SX,[[L<7PY.9-Z3EVZ![/:7)B>B@<A\%]V.+8_F3>DY=N@:SVEB<FH
MH,SX8ONQQ?#DYDWI.7;H1.I;5"U)3%1T<>+54#5!1QCO&@>1F/+L_)F_\<4K
M,F[;&9SF33G%6DFN!T-)%4A)FZN%5N#%I')RSL)9L!'HL.&S_P`63E:+J:R;
M[<]M=7LIXLZQV[B8+4D5^H:3*STC"<01N12N;;_>Y&PR[O/['@\Z<N8]ZJ[]
ML^[1TWL6T96#J4&4<,!W88-AR<R;TIR[="I[3:WV/1P_!CWDWI.7&A\:T6H6
M86HX&9MC,T8\GZ$WI.7;H?&L]I9G9J*!F)W=VW8;7?EYDWI.7;H?6M%J9F9J
M.!F;8S-&/)^A-Z3EVZ%RGM]#3$Y4]/'"18YBC`1=\>7'!E)F96VR(R+ZCH0$
M!`0$$3JKYBG]M#\<"T^C^Y&ONEA_TOLSJ^J$LLS<\]:9EN8\>JFJ.AM8P35M
M53/CNPF;*YCOJ;WQR,\H"TKY&?,[LF]_RQZL?97%TR4_XS2.F<6JM-D/0J`@
M(.<0.#\8Y&D)L6&3<")=)B:DBS.8N7(XET<&QV.E,,(\2O3AM\&9J6OF'7%!
M;HZ6D,)]P[S20--*SF4F9\<PNS98]CX;%=Z[-,T2EF>(KUL#B=E'4EB/>BSL
M\8M"3NV.:KA9G;HD+=S;^12D2ZB9S8=L."_BO^]*/_&4_P`9*A#6N`?WP:9_
MCR_V\J++VIJ>V7:Y6B2EM-Q[*K2('"MW0S918F<VR'LZ0[%8B)RUIT.)F8R1
M$];.H*"CH*2.DHX0IZ:)G:.*,6$6Q=R?!F[KOBDS,S62(HOJ*B['X=S^6R>Y
M!:?4>[\,>+%Z/+?\<]T)19FT0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`
M0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`01.JOF*?VT/QP+3Z
M/[D:^Z6'_2^S.KZH2RS-SF5KT'P\'BA630TM<^H:!QNK5$N?JD?6BDS!`;ME
MZ1R$1`W.N]Z:?MI&G3VN-V*_NQZ,(=-7#L0$&D-?9Y.)86E]R\(;UPS0#O6<
M*:(BRRL3E_\`-;'$6Q;9S)6=,[8IL6D9:(K7-+356N;?3O&132]5!R9A!\CE
M.W0E=]ACX3-["4PS=WB1,QDG#_V\&9Q`N]UM]WM-+0L,[R`)#`X`<LAA41#M
M(Q)A'*3XOBV#[4I.::%(ICB)PZWG?\4QS'Q+ICFCW4Q6JE>6)GS92<Y<1S-R
MX/SH0U[@']\&F?X\O]O*BR]THY$!!%V/P[G\MD]R"T^H]WX8\6+T>6_XY[H2
MBS-H@("`@("`@("`@("`@("`@(""!UMJH-,V&2Y=7*KFSA%!21XN<A$_2PRL
M3]$&(WV<C*4NG%;E6*9\C5[EQHM,%TZA1TAU+%%O8IW,`$LIB)=%WS;-X.&S
M;S+G]>AWNQT[&+;N.UIFLS7*LM\T..7""-Q,L'&/%\7<6QS3"S"VW#;S)2^,
MV,I;.29V)>#BQ9ZB[4]HAIIAN$[Q9HI69F!Y)1C(7=G?I"QYE?U:$I%*U1%Y
MX[6>CDJ0I**2IZJ4L<F<PBZ<<D0"XYGVB6^_*V"D[^A8MMZ=B2DXQ6(*FEIW
MH:QSJWR1$`"8O)E9W!G%W8GZ8\FQ\=BM+\UO:E+=/8C@X]:=EKZNC@I)Y9(G
M_P"J^#`THM&QXXER8OFP_(I^ORKNVZ67:.-%EN%%3S#0U#RS&X.$;"3-D<AD
M+:[8,+QOR[7;:RL;^A)BW3V,U^+%E>TC<H*.JF`JLZ)H1$6/-&(GF?$F;*[&
MR?KT=I2W3V,:T<:M,70V"GIZIG*:*F'&-G]]G=P`7P?]L7;\RD;_`)2;;8SK
M=QXUZ>H;Y=+8=-/)V0.-3(#,^);W==%L=K,[%BGZ]"Q;;I[&5+Q7M9:?BOE)
M2R2TQU45.0&X1ENYHGE$V=WRXY6\%W9\=G*K^JF1*15<H.+>FJS3DFH`CJ(Z
M"*?<%O`RDS[MY6)\7P9G%OT[$_7$8[2D5Q2C7X[:4ZE05+4]6_:)O'!&X,V#
MYA$<Y.^5LSFW/LY5/U^7M7=MT]F&ID73BNUOI[+.]KDG&ZP/4F,9@Y``B9$P
MX^&[,&*M+\U$_3GJ^%QLTL-'#4/#.SU)0C3QONVSO4/A'TG+*W*SEMZ/.I,W
M:,/P7<C3V8:F;9N)U#<8;K4%1314]NA.ICDZ);Z*,1<LK,^PV<L,.3V58WM"
M3%NEC4W%NVU50%-!05`S/4E2RC*X#D,,[&Y8$7(08-^UCL2E^@I;IG8^MQ8H
MBM%771V^8CI(XC-G<0`WD(1/(3OR`Y\[)2_0?ITJK5Q:L]75V^@JJ.II+A71
M%*43CF`&$'/PVV.Q,+__`!2E^>$I;FE@TW'#3U1*1#2S]3&)S>1LKR,;'(.7
M=XXN+M'CF;DQVJ?KT.IMMT]B_1\:],55QIK<U-5A55$[TQ,\6(`>?)X8NXEC
MBQ-EY1?%6(O\N))BW3ATZ%J[<9K?:JFZ4U502G+0UYV^!HG;"1PCB/,3EAEQ
MWV"3%^:"(MTRZ#2U,=3315$1,02BQ"XNQ-M;NML74.9BBZB"`@("`@("`@("
M`@("`@("`@((G57S%/[:'XX%I]']R-?=+#_I?9G5]4)99FYRRT\4-35?$H].
M26^'J?6ZFE.G".H:KIX8&=XZN:0A:!XIL.BPECM3E7Y<W5BIT75RKOV:^O'_
M`.N:'4T00$',K112TO%62.2>2JD83WE9,\.8_P#K`[190$3Q'-CFY,,&Y4Q9
MOQ_(I.6?P[V-5T%TAXM4DMPJ99:>24>JBS;R,6+?G&/@ME?*SM_XX<NU3=MC
MK[3>F<26U_;Z*;4]FK):P8)Z<&:.)XZB3,)U,..9X2$1%\&;$\6QP5U3V>)A
ME_"7GO\`%=]Z4?\`C*?XR5%AK7`/[X-,_P`>7^WE19>Z4<B`@B['X=S^6R>Y
M!:?4>[\,>+%Z/+?\<]T)19FT0$!`0$!`0$!`0$!`0$!`0$!!24<9NSF+$XOB
M.+8X.[.VS\SJU286'MEM<V-Z2%S;#`MV..SDVX<RZW[M+GEVZ(?>S;<XL/58
M<K%F9MV.&;##'DY5-^[2<NW1"IJ&B:5IFIX]ZW))D'-L]G#%-Z<E5W+:UHME
M:;4;NYT<!.[N3XQ@^U^5^3G5YEVF4GA6Z(7&HJ,=WA!&VZ=GBP$>B[-@SCLV
M;%-Z=*[D:%'9MNS9^JPYF;!BW8XX<F'(F_=I3EVZ(51V^@CQW=-$&/+E`6Y&
MPYF[B3?,YR++8S/HT5&(Y!@C$<SGE8!9LS\K\G*Z;TZ5W(T,<[':#FAF>DB:
M2GD::)Q%APD9G9BV88NS/LQ3?E(LB,BZ5MMQ$9E2PD4G_(3QB[EMQZ3X;=J;
M]VDY=NA4]!0O"\+T\3PN6=XW`<KERYL,,,4WYK6J[EM*4?7H:)X2@>GCW)OF
M*+(.5W?;B[888IO36M3<BE**.S+;NVCZK#NQQ<0W8X-F\+!L.=-^[2G+MT+C
MT=([1L\$;M$V$396Z+.V&`[-FQ-Z=*[D:&)7:?LE=1%155##)3'CC'D9L,VU
MW9QP=G]EE8XEVE.7;H9%-;J"EI@IJ>GCC@`&C&,1;#(S88?^BDW3*Q9"IJ&B
M8B-J>-B-V<R8!Q=VY'?9S)O3I-R-#[U.DR$&XCR$V!#E;!V]EL$WITFY&@:D
MI6(3:$&,&=@+*V+,[8/ALYV4WI-R-"V%KMH.Q!20B[,XL[1BSX%RMR<ZZW[M
M*<NW1"L:&B')EIXVW;L\>`"V5V;!G;9LP;8IOSI7<MT/AT%"99CIXB)R<G=P
M%WS.V#OR<N"1?.DFRV<R['''&#!&+``[!$6P9OR,RYF5B**D40$!`0$!`0$!
M`0$!`0$!`0$!!$ZJ^8I_;0_'`M/H_N1K[I8?]+[,ZOJA++,W.':/];J3B]=+
MG?;MV)'>:EQ#3U5";Q5,4<;!!U>IS/"\@9?U<'?;BR7<*+<<UKIC]O5/XP1Q
M)NQ12G3^Z.J/QEW%`0$'-8ZNF#C)*)N4<F&ZSXNPFYTL;@#MG?'G?P&V_E2D
MTR8NKQIXF+3%5>IJ=I>*=E,@<1#J^$S`Q=-FJ"8,<N9F=L=N;!OSIO9EJHXI
M1RRWZT0#3'.,P.#[O,./_8B?*4@^"/[7L*\O>S5U5\$YF[GIKIXN`_BF@BI^
M)5-3Q"P10VJE",&Q=A$3E9FQ?N*+#7N`?WP:9_CR_P!O*BR]THY$!!%V/P[G
M\MD]R"T^H]WX8\6+T>6_XY[H2BS-H@("`@("`@("`@("`@("`@("`@("`@("
M`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@B=5?,4_MH?
MC@6GT?W(U]TL/^E]F=7U0EEF;G`+1J"FN_&MJ2JIKO4TU#<:CJ<QUF^I:>H]
M\%MY3;IFC`A!WCZ;X-@Z6674WHMBFG]6W+N["Z^/VS=JI;^>UW]`0$'+;H,/
MVGD4]&<\&_B9Q9\7(WIX\IBS/C@'+E_.IG]WY?%<V6?F\$S?K6,_$*UU12TC
M%$T)!#)(`U)9=]B0#E<L&S<F;;M[BN]FKW_D8]#"U\5;;M0V^:EK:@`KI8=]
M"T^`MA/$'O<69G?$=A-AAM=U)LMG-CU_DL771GQ=4?FX#^*_[TH_\93_`!DJ
MJ0UK@']\&F?X\O\`;RHLO=*.1`01=C\.Y_+9/<@M/J/=^&/%B]'EO^.>Z$HL
MS:("`@("`@B=6G6QZ7NQT+FU:-),],\6+GO&!\N7#;CBF[7$5IC<TEIM06O+
M!?ZZX0TTM#O[;)0R5-01W#!FR2%D(F)MF4"Z/*IR(S6[VW%\W:ZYTSGIU[OL
M[,JO3OVB-?J.X74J@`DN4=+6QYS<&`J02)F@R[M@WO*;/L=7D4QY]=>^E-2<
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M8\T5&]432F`G'NF=H\N&[=WPY%?Z]/=[\>O>]B\[I[;<6JE=JX5PKO6BFCCK
MKKZO[MNHR5;5@O)[\S/E>",B)L/!WV#X)R,^YWSXQ3M(XN;>CY8[XQZE=FJ>
M(9TT=OFEKG&MZS="K#$F.(*628'I<7;8\A[HA;]G%/Z].KKSISZZ*^"#M%SN
MY5=$];<KN+/:Y))&IFKS?M!F#=";2PY<SDY;&Z*G]:GN3VQ_^NU>?7WH^2>Z
M.S*[19+]$5KA&ZU`0W.EB@CNC'[V(U1PC(0LY8"_*_(I,Q;E(MF[)#,[?L7I
M&F[G_,'?7/.LTPZY-^B7P=16`L<MRI2P=Q?":-\";E;EY4YMNE>3?HD/46GP
M9G.Y4HL[L+.\T;=)^1N7E3FVZ2.#?HE][?L7I&FV;']^#OIS;-,)R;]$OAZB
MT_&+D=RI1$?"(IHV9ORXNG-MTK'!OG-+[V_8MO\`^1IMG+[\'?3G6:83DWZ)
M?"U#81%R*Y4HB+9B=YHV9F;GY4YMNDY-^B7UM06%V9VN-,[.V+.TT?)W>5.;
M9I.3?HD[?L7I&F[O_,'?3FV:8.3?HE\#45@D$3"Y4I"38B331NSMW6VIS;=*
MSP;XS2/J*P,0B]RI6(\<C;Z/%\.7#:G-MTG)OT2^]OV+9_\`D:;;R>_!WTYM
MFF$Y-^B7PM16`<N:Y4K9GRCC-'M+N-MY4YMNE>3?HE][?L7I&F[G_,'?3G6:
M83DWZ)?#U%8`;$[E2BV+-B\T;;7V,W*G-MTK'!OT2^]OV+;_`/D:;9R^_!WT
MYUFF$Y-^B7P]16`!(CN5*(BV)$\T;,S>SM3FVZ5C@WSFE][?L7I&FV?_`.8.
M^G.LTPG)OT2^>L5@SN':5+G9LSCOH\<'Y\,4YMNE>3?HE][?L7I&F[O_`#!W
MTYMFF$Y-^B7SUBT_F8.TJ7,3.0COH\79N5^7V4YMNE>3?HEJFK;IJZBU*%59
M<:BWQ4$<DE'NRD"<SJ,N4#%\!+(^.*](X>]CAY[\1BE`6[7?$RKI9I6ML>:`
M9IG#<2LY%'%FZLV.7!V+9FVX_E3DW:>["AS;-';AC15BUYQ*GN-R,F8S(P:E
MII:68(2AC@<Y)QE)A$<I-E<>=TG@3&.9F.F:'.MG%BGJG&VFXZXU7ZB4>H:2
ME&*>OJ'.*!XCD(*0F(HF(1Q]\)F;E[J1P[IQ9S?MCJZVLRZYXCW.BEDGH9K>
MT+[R2."*4987P/&$]CYNB+%L3D79\.HCC69FU:TUU>K=:K)6V"`JR.OC:<RW
M$DF<&8'R[&S"3L3OM;'8G+NNR5-^V,M&I7+B?Q%$:N..A<F%SR;JDGS%FQ88
M@=V;IBVU^=.1?TX8=72<ZSHVX89F;0\0M<5%;26FG:,*R8AAF@DII3.F`3$-
M\9XL)YA+,_<Y'7,<.:TK.+J6;XI6D;4MJ776LK79[)/#1/+6U#&5>`T\A"6Z
MD8'9F;,X.0XE@NN5=.**IS+(RTVH^MUKQ$"VCUF-J=JZ`IFJXZ.8GIR<9&"#
M(+DY$;BW2YDY-W3.PYMO1M9M7J#7M)J.W4].YG;YK5#45$<E*<K[V*,CF83'
M+[X;LPX$Z<F<L5[#FQGHAX.(W$ZJH*Z>GHA8[?"=2.>DF?K&T,D8LV7#81<F
M+[$Y%^F8V'-LZ-JBJUKQ(EIK5=H8CRQO40U@M3R-#@Y`PSNW*3#CE'8G(NZ:
MX9CG6]%,,_XMIMNJ];GIVY7BOI`BDIFIMQ1A#(Y97RE/)MZ1=`G=A9MB<JZ,
M5<>HYEL]76UJ^ZZXFU5LJZVU0O2TT573PQ844I3'3RS$QRLQ;>A&+/X/.G(N
MG+7L.=9&C:W+2&I]1W._UE)7PY:6,)"(=Q)$\!A+DB#>'LEWL?3V<B<NZ,<X
M=1OVSD[^]NB(("`@("")U5\Q3^VA^.!:?1_<C7W2P_Z7V9U?5"669N<CM5+>
MJ#7XT&E+55VRS15A!?1DJ*:>BW65R"2.#>%/"4FQVPPV/R),;TU_3$QHG'KM
MI3#*5BV*?JFNFW_]9>]UQ`0$'-AW1\79`:G#?,;FT\CXYQ"DBSB`M^L&<7Q?
MN\JN].2O?[:)2,*>RO:D]11T0:UMU4=T@IY0>GSVZ09,T@YI1$\1?#'$NCBW
M=4U3LJNS;$,+B3)-%?K-,T<Q01X%.\,4L@N+5$3Y9MVQ='G;GS8*Q;,Y(KAV
M]6M-Z(RSAX//7XIJB&IXE4U1`;20S6JEDB-N0A(Y79US$NVO<`_O@TS_`!Y?
M[>54E[I1R(""+L?AW/Y;)[D%I]1[OPQXL7H\M_QSW0E%F;1`0$!`0$!`0$!`
M0$!`0$!`069J&BG%PGIXY1(L[B8"3.6&&;!VY5U%\QDES-D3EAC]A6/T?3=W
M_AC[RZYU_FG:XY-FB-CX.G["..6VTK8OF?"&-L7?G\%7GW^:=IR;-$;`M/V$
MFP*VTI,SL38PQOM;D?P4Y]_FG:<FS1&Q]["L?H^F^!C[RG.O\T[3DV:(V/AZ
M?L)BXG;:4A+E9X8W9_\`2K''O\T[3DV:(V/O85DV_P#X^FV\OO,?>4YU^F=I
MR;-$;`K!8B9Q*W4KL[8.SPQNSL_-R*\Z_P`T[3DV:(V#6&QLS,UNIF9FP9FA
MCY.YR)SK_-.TY-FB-AV%8_1]-\#'WE.=?YIVG)LT1L?`T_80%A"VTHB+8"S0
MQLS-['15GCW^:=IR;-$;!]/V%R$GMM+F''*^YCQ;'EPZ*<^_S3M.39HC8^]A
M6/9_^/IMG)[S'WE.=?YIVG)LT1L?'T_82PS6VE?*^8<88]C]UNBKS[_-.TY-
MFB-C[V%8_1]-W?\`AC[RG.O\T[3DV:(V/A:?L)M@5MI2;%GP>&-]K;6?P5>?
M?YIVG)LT1L?>PK)Z/IMO+[S'WE.=?YIVG)LT1L?#T_83%Q.VTI"38$SPQNSM
M[.Q6./?YIVG)LT1L?>PK'Z/IO@8^\ISK_-.TY-FB-CYZOV',Y=FTN9VRN6YC
MQP;F\%7GW^:=IR;-$;'WL*R>CZ;X&/O*<Z_3.TY-FB-CYZOV',Q=FTN86=F?
M<QXLS\K>"KS[_-.TY-FB-C.$1$6$69A%L&9MC,S+R>KZ@MU--3U5/)3U$8S0
M2BX2Q&S$)"_*SL_*RL30HJCBCBC&*,6",&80`6P9F;8S,S=Q)E**G9G9V=L6
M?8[/SJ*^"(B+"+,(CL9FV,S)5*/J*Q*>SVJFK9Z^GI(8JVJ_]Q4``C))A^T3
M-BZZFZ9BB1;#+7*B`@("`@("`@("`@("")U5\Q3^VA^.!:?1_<C7W2P_Z7V9
MU?5"669N<]L_"/LWB-<=;C?ZTZBXS$<U`S`$!1/&P!%(S-TVCRMD=]K+J8X=
M,GZM-7,3?7+&[HHZ$N70@(-,.JT3;=<S2UY=6U!5D(TDT[.PF)11QY(29W';
M@V..#N_Y$GB9J>/XPL63..OA^>I':CQ+BA:1SB#,U.^7"1G)_P#L/AG9LG(V
M.5^52D9RLX3X,O7@UDM]M,$%X>WQ2"[3TXO(SF.^C;-B`NPXXY&(G9L73=MG
M+'9/A,%9S=\1WQC><OQ511Q<3H(HQ8(X[73"`LV#,S'*S,S,K,D-<X!_?!IG
M^/+_`&\J++W2CD0$$78_#N?RV3W(+3ZCW?ACQ8O1Y;_CGNA*+,VB`@("`@("
M`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("
M`@("`@("`@("")U5\Q3^VA^.!:?1_<C7W2P_Z7V9U?5"669N$!`0$'.YZ"<]
M?W$K;<*..LDFIRJ(.CUE@&"-W%\0<MH`[LS.F]7%6>VGL)C/2)V80Q];%5_:
M!:VHXHRJP>G.F.5SP*06J'W6R06Z8,[8Y'PYW2F&&9:X81E9/$2JJH+S996<
M8P+=C41O(#%TJJ%NB+D+R;7Y,';GY<%)B"*].&G\'G[\5_WI1_XRG^,E5(:U
MP#^^#3/\>7^WE19>Z4<B`@B['X=S^6R>Y!:?4>[\,>+%Z/+?\<]T)19FT0$!
M`0$!`0$$!;==Z:N->U!2U)/5$;QA&4<@9G'-BXN3,SM[V6U<Q=.AU-JS3\1-
M*3R1@-28;ZJ:A@*2*0!.=\W1$B%F=N@^WD4W^CN]J[G2LQ\3M(R5XT$4\TE4
M<KQ``4\Q8NSY7)G8<,N/.F].CN]OXI-L:89EPUYI:WW22UUE:T-;%&4I1.)>
M"`L98/A@[Y2Y$F^F98LK#"I^*&D*BK"D@GFEGD-PC`*>9\<'RYL6'P<>=(NG
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M1R..4LKM@6#[%:SEI-"D:8JP#XJ:,#>?]J4FB8MHP3%F<<,1#`>D72Y&4WYT
M3V>U=SIAF4^O-.3QTIM++'U[#J02PRQG-C(T6$8D+.3YG;\VWD5K.C+U>U-W
MIR,>KXEZ3I)7BFGF9W,HX":"4AG>-\LFX)APDR/X652;IT9>KVXM:Q;TY&Q4
M%=35]%!6TI[RFJ`&2(\';$2;%MC[5U$N9A?500$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`01.JOF*?VT/QP+3Z/[D:^Z6'_2^S.KZH2RS
M-P@("`@YZ`TT7%M]T<`U4[&51&T@'.4;4D;"3@T><!S-@V)[>XE<U>_\BDK6
MJ";[4+(+L)=*G=FRQ.6&%1MQ<FEV%AR#@E,,(\5QTZ%?$@X_6&S1R5#0`V[-
MQ.008\*N%LH`XD\A.[MW&9MO*F&'M-V9S5U//_XK_O2C_P`93_&2H0UK@']\
M&F?X\O\`;RHLO=*.1`01=C\.Y_+9/<@M/J/=^&/%B]'EO^.>Z$HLS:("`@("
M`@LUE4%)1SU4C.04\9RF(MB3L`N3LS=W8@TIN(EU*EDD&V0%.`TDS`-5B&XK
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MVFU5.J+]-0VNJ:?3LLD13C-F:0H6$W`<8-WF=G?!R+.ZZQSFCM]N3HI0R4Q]
MD=RFBU?I*SW&.X16*HIH:>-ZB"I:5F:1B9WIY*@&'84S3.S.^.&QG7,S?,9(
M]F&=8MC3+):LLDKWF^!15`7+<T]SH8Z>H;?99JEXP?$@%MYF-]CYL&?*E9G%
M2)G7LZ.SJ*4QUQ:NYBQ7C2,=DO%110UTE#!*TITG6W#K-5*;M).0Y<6DS,^9
MN1GYE)F:_MBNO#61;3WL75&%.A'6S6&E+7=WO.GK;6QRPTL;US#4%DG.(-].
M$H[N3$Q-W$RV-CW$NFZ<T1AUPL1$3^[%J7YIK%6Q0:M:VSM4UDLLM.`3$>4!
M!YB(F>G+/CCL+I,W[6"ZBZ9Q8JZ__P"L6&)SDG+2-2>N%3;*=YWCCJFM\4QC
M0L%8S2P5;0/6F44+"XY#P=L[N_+L;!<UK.2*Z,=>M<>GLC9TL=HM%T8:="X6
MN2CJ[Q*<AR-*3211L(B!2G+'$;C))EV.V&.+\R[FZZ,T8LO1VRYBVN>>A>MN
MO[4]=9Z([.\?8TV,$AS$[Q#4@44;EC'RDTC[7P%_U2=<;UW1AK]O31WNV]/9
MAJ[T-77O3#RT574V>>OHFJ9(+5;#J&/=S2>^5`QQ/'ERNV+CB6+X;-BL775Q
M1&]/7A";L:9I'5^<MAM_%ZFHK;U:SVMZBV6]@@@EEFDS$+F\8>#$;-X/([XK
MB=[HC#KAU2(TRZA:*V6NME/5RQM%),#$40N3L+OS8D(%^D674.)9BH("`@("
M`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@B=5?,4_MH?C@6GT?W(
MU]TL/^E]F=7U0EEF;A`0$!!SN,*1^,93;E@J]R4.^9MD@-3@;,Y.;XD.;D86
M;!6LX1XT\3%IQZ,/S2-ZMMQ]>[=<!:'JA;B'.<N25LC3$>[!S9G8LPL[97=_
M8P4K&F.HIGI/8MZ\K[O3W>W0T$0F%0+!*6X&:1L9XV9VS`38#CFPQ;DQ5B+I
MR5PU),V9Z5Z?SAYQ_%;C]J,>+XOV938O_P#<E4=0UO@']\&F?X\O]O*BR]TH
MY$!!%V/P[G\MD]R"T^H]WX8\6+T>6_XY[H2BS-H@("`@(->O=RU#V_16BSG2
M1//25%7--5QRR_\`#)#&(B,<D6&.^Q=W?F0?'I^(3M@];:'9_P#_`%*GSE!@
MTNF]4TD4D-+V##%*;22@%!.+$8OBQ.S5',_(NIOF7,6PIJM+ZFJXPCJ1L$P1
MM@`G;YR86QQV8U&S;M2+Y@W(7(M/ZMBA:&,K$$0Q[EHQH)V%H\<V3#K'@X[<
M$WY-V&,^C;Z\)0O!I[=&32&'9TV#FW(3_P#8Y=JO,NTIN1A+(BT]JN(0&)[$
M`Q@$8,-!.V`1/FC%O^QR"^UNXIORL60O06G6M.\[P362)ZDGDJ'"BJ!WANV#
MD>%3TGP[JDW3*Q;$+'JWJG*0?_@<I`,9#V?/@X!AE%_^QR-E;!7?G2FY:I@T
MOJ:`YI(1L$9U#L\Y#;YV<W8L[9O^QMP+;^5)ODW(?#TKJ2249C"P%*#FXF]O
MGQ9Y/#?_`-Q^MCM5YEVE.7:IDTCJ"1F:2'3Q,SN6#VZ9VQ?:[_\`N.=.9=I.
M7:JI=+:DI,W50L$&;',T=OG'',V!<E1SML2;YE8LA5ZLZGZR]5A8>LO'N7EZ
MA/FW>&7+CUCDR[/R*;\FY"]+9M9RL[2RV0V(!B)BH:A\0!\PCMJ>1GVLD73"
MS;$L2/1U^CD&4(=/C(!O()M;YL6-^4L>L*\RYSN0J]4]1=:"KW>G^M18;N;L
M^;,.5L&ROUC9@G,NTFY"W/HJ]3FYS4VG9"?:[E;IGY7Q\8[KXIS+M)RXPE(T
MMMUS24X4]+4V:""-L`BCHJD19O89JE<S-7<+-=<M:VJ>W25T]MJ*6KK8*.6.
M"GGBD89RRYA(IY!Q;V14&VH"`@("`@("`@("`@("`@("`@("`@("`@("`@("
M`@("`@("`@B=5?,4_MH?C@6GT?W(U]TL/^E]F=7U0EEF;A`0$!!H,]HTI5<1
MC*IJJN6[D;2!1D\K4P[NG!VR88`Q8=)WY^1*Q7]NM:W4_=BT,75M)#)Q-LE;
M'3RRU=$T(9\SM3L$Q2MTL(S82;*[L^9L>129CH3;V>WP9>O8+]ZQVNKMS59T
M\$$F]BIMYNS+>QDS29(Y>5A]A)LB[KP_Y6K%\QBKALEYQ_$_/-/Q$HIYX]S/
M+:*0Y87QZ!$4KD/29GV/W65IIP[UA`\`_O@TS_'E_MY4)>Z4<B`@B['X=S^6
MR>Y!:?4>[\,>+%Z/+?\`'/="469M$!`0$!!K]3]X%O\`\36_W-(@V!`0$!`0
M$!`0$!`0$!`0$!`0$&N:W_X;-_F*'XU!L:`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@((G57S%/[:'XX%I]']R-?=+#_I?9G5]4)99FX0$!
M`0<WI2$^,M0)1.QQB3A)ALRO21;7+-ROB[89>9,>'Y>*X88_!EZHH-/5NMJ*
M&X%4'*8TX=7C&-HBQ>;=[R3%I'9^EBPIO1&:NSN2G3W]^1B\12*GU/898II!
MR",.X"26,':2JA'$W`7'FP;,[=Q28C/AVQW2L73&2>[QCV.!?BO^]*/_`!E/
M\9*J0UK@']\&F?X\O]O*BR]THY$!!%V/P[G\MD]R"T^H]WX8\6+T>6_XY[H2
MBS-H@("`@((*]66]37JDNUIK*:GFIZ:>EDCJH#G$AGDBDS-NY879V>'V>5!1
MU;B!Z1M7D-3YV@=6X@>D;5Y#4^=H'5N('I&U>0U/G:!U;B!Z1M7D-3YV@=6X
M@>D;5Y#4^=H'5N('I&U>0U/G:!U;B!Z1M7D-3YV@=6X@>D;5Y#4^=H'5N('I
M&U>0U/G:!U;B!Z1M7D-3YV@=6X@>D;5Y#4^=H'5N('I&U>0U/G:!U;B!Z1M7
MD-3YV@=6X@>D;5Y#4^=H'5N('I&U>0U/G:!U;B!Z1M7D-3YV@=6X@>D;5Y#4
M^=H'5N('I&U>0U/G:#!NVG]<W,*49KI;`:DJH:P,E#4;3@+,(OC5/L?G09W5
MN('I&U>0U/G:!U;B!Z1M7D-3YV@=6X@>D;5Y#4^=H'5N('I&U>0U/G:!U;B!
MZ1M7D-3YV@=6X@>D;5Y#4^=H'5N('I&U>0U/G:!U;B!Z1M7D-3YV@=6X@>D;
M5Y#4^=H'5N('I&U>0U/G:!U;B!Z1M7D-3YV@=6X@>D;5Y#4^=H'5N('I&U>0
MU/G:!U;B!Z1M7D-3YV@=6X@>D;5Y#4^=H'5N('I&U>0U/G:!U;B!Z1M7D-3Y
MV@=6X@>D;5Y#4^=H'5N('I&U>0U/G:!U;B!Z1M7D-3YV@=6X@>D;5Y#4^=H'
M5N('I&U>0U/G:!U;B!Z1M7D-3YV@=6X@>D;5Y#4^=H'5N('I&U>0U/G:!U;B
M!Z1M7D-3YV@=6X@>D;5Y#4^=H'5N('I&U>0U/G:!U;B!Z1M7D-3YV@S+7#J@
M*@GNM70ST^5\H4M-+">?%L'<I)YFPPQV8()1`0$!`0$$3JKYBG]M#\<"T^C^
MY&ONEA_TOLSJ^J$LLS<("`@(-!DN%K#B3+34EMWU]9V.2=ZEA=H2@`7-X\'P
M!AV#_P"6*5NG%BIK]E%Q:9[/;5@:KK8*;B;1RUL\84-/!2RD!1L<C&QSX2`[
M/GPYBP9,>:O5^%/&#"N$I'6>F[I>-6V2MHHW.GI(G.8C)PCR]8B/#9X1NP]%
MEU$:MO@F]3%[/%YW_%=]Z4?^,I_C)5RL-:X!_?!IG^/+_;RHLO=*.1`01=C\
M.Y_+9/<@M/J/=^&/%B]'EO\`CGNA*+,VB`@("`@("`@("`@("`@("`@("`@(
M"`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("")U5\Q3
M^VA^.!:?1_<C7W2P_P"E]F=7U0EEF;A`0$!!SRRZBL%SXCU`4EO9Y@<VANS&
M;-+C31[ULCB+8CE$?S8I^K/&+JQK2-,U[%O4SDW%.S/&&,G_`%\Y-CF8':H%
M\7:1NCMY,CMBE*X?AXI3.KXAT6IZN\6\K=!4QPB;4\E1"3E'NI"!W,Q"2,AR
MOBS]%]G.RD\.V[+3L\86.)-N29[</%YV_$W1/0\0*"B>1YGI;-1PO,7A'D*0
M<SXN_+AW5:1F6)F<J#X!_?!IG^/+_;RH2]THY$!!%V/P[G\MD]R"T^H]WX8\
M6+T>6_XY[H2BS-H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@B=5?,4_MH?C@6GT?W(U]TL/^
ME]F=7U0EEF;A`0$!!S2V4M72<4@AJ:F6I)QE<9CC`(SQI@Y!`!;.W)FQ\'9R
MI2,,OY$8854:LEDIN*%!54\5542M#2A+!"![EPSSNS.;2!'G<O!8QYN5-V9R
M1KQ>.,WHC+.&SQ86O+J7KW;\]1MIBB@BIH-^+COYH")JAQ;)[+%CAS<J;F%/
MQBNQU%TQDR=<=U'%OQ7_`'I1_P",I_C)42&M<`_O@TS_`!Y?[>5%E[I1R(""
M+L?AW/Y;)[D%I]1[OPQXL7H\M_QSW0E%F;1`0$!`0$!`0$!`0$!`0$!`0$!`
M0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!!$ZJ^
M8I_;0_'`M/H_N1K[I8?]+[,ZOJA++,W"`@("#G@2-]L+Q@0;O<F4F+LYO*U/
M&SBW0$FP!Q?#.[;>1DPP_)4A74UN?7\<];)4R5`C3]2&$#&GB=]ZP[XLSB9&
M^?+LV,E.BO3[/%*SDK3QZV!Q)A,[U9G#,)9X^EE9P/\`[,3Y"V/FV;6'%FY^
M9$PPQ^$O/OXK_O2C_P`93_&2HZAK7`/[X-,_QY?[>5%E[I1R(""+L?AW/Y;)
M[D%I]1[OPQXL7H\M_P`<]T)19FT0$!`0$$;>-1V>SO$UQG>'?YMUA'))CEPQ
M_P",3PY>=!'?:)I#QT_)ZG^6@?:)I#QT_)ZG^6@?:)I#QT_)ZG^6@?:)I#QT
M_)ZG^6@?:)I#QT_)ZG^6@?:)I#QT_)ZG^6@?:)I#QT_)ZG^6@?:)I#QT_)ZG
M^6@?:)I#QT_)ZG^6@?:)I#QT_)ZG^6@?:)I#QT_)ZG^6@?:)I#QT_)ZG^6@?
M:)I#QT_)ZG^6@?:)I#QT_)ZG^6@?:)I#QT_)ZG^6@?:)I#QT_)ZG^6@?:)I#
MQT_)ZG^6@?:)I#QT_)ZG^6@?:)I#QT_)ZG^6@?:)I#QT_)ZG^6@?:)I#QT_)
MZG^6@?:)I#QT_)ZG^6@?:)I#QT_)ZG^6@?:)I#QT_)ZG^6@?:)I#QT_)ZG^6
M@?:)I#QT_)ZG^6@?:)I#QT_)ZG^6@?:)I#QT_)ZG^6@?:)I#QT_)ZG^6@?:)
MI#QT_)ZG^6@?:)I#QT_)ZG^6@?:)I#QT_)ZG^6@?:)I#QT_)ZG^6@?:)I#QT
M_)ZG^6@?:)I#QT_)ZG^6@?:)I#QT_)ZG^6@?:)I#QT_)ZG^6@?:)I#QT_)ZG
M^6@?:)I#QT_)ZG^6@?:)I#QT_)ZG^6@?:)I#QT_)ZG^6@?:)I#QT_)ZG^6@?
M:)I#QT_)ZG^6@?:)I#QT_)ZG^6@?:)I#QT_)ZG^6@?:)I#QT_)ZG^6@?:)I#
MQT_)ZG^6@?:)I#QT_)ZG^6@S;3JNPW:I*FM]04LP@\A"\4L?19V;'&0!;G02
MR`@("`@((G57S%/[:'XX%I]']R-?=+#_`*7V9U?5"669N$!`0$'/*YPIM?35
M<=U`*HI@B&D*FJIL`.")BC9Q)HF=\,^+-^5,4XHK7JCVUH9,T;?P8]VJ+F7$
MBV35`TXTYSC3TQQD9D8@\V+"6#`!#_\`-#\BYQ5RUV=N=U6:4QPKXHR/)>;+
M3BPD82!+"_2,AEW\8B^Z8P$FV[<6?#F3>BO3VF2/QQ.!_BNQ^U*/'E[,IL?A
M)5TD-:X!_?!IG^/+_;RHLO=*.1`01=C\.Y_+9/<@M/J/=^&/%B]'EO\`CGNA
M*+,VB`@("`@("`@("`@("`@P;Y=0M5KGKR!Y-TPL$;/AF,R8`;'FQ(FVJ37,
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M>L6%^93=OG)3MQ=:_IC+7V]26J]<U<$I&%L*:B"WQ70I`D9Y=S(^!,,>&TAP
M?GVJ[MV:G:YK;GJACXMU83.$EBECCZQU9J@I1:)CRYLI%ARY=N#*3;?&/%1U
M$VSBBM5D>-4<DLM-#9J@JR!P&4'+`,Q&T)L),SYLDSY'P3<XFA*V:61]K<I@
M,\-I=Z9Z!J\S*86)M@N09<.;.VU-V_H[?8OZ>GL9-XXK4EGM-ON5=0GN*Z,Y
M))(S8@A8)@A;>%AR/O.7F2EU,6,I%:3B85;QMM%';*2NGM]0!5;U(#3NV$@S
M4Y"P1DV&S?`;&/L)-O$T8R-S3B9$'%VC>QA=IZ$@CDJ8J<(8S:0V`]LDQ,S;
M!B#IE["1%W7),1TQ"U%QCIIZ:::*VF!4S"4H3RC%B!1R3,\;NV!N4<3.#-RY
ML$I?GI&TI;FK+.O/%"CH+V5GCI'.?)"\<\QM#"4DK.91/(38,<88$3>RR3%W
M5&DB(G3,Z(1])QC"KMPUD%J,GGW;T\`RB1X'*43M*(L[@6(XLW.R1;?T5UXB
M=V--.]8H^-U/4V^&O[,<*><Q%F*<,PB_A.3*4OZ*ZUI;TMDT]K^EO%IN%?N-
MP="4C=7>02(V`,[88<^56*YW,Q&9`P\9Z6>Z-;`MAPU.ZDJ'.IE"&)XHI7CQ
M&0NBY'AB#<^WN)2_/2(TXUI;.2LRE)^)]NB.*-H,\LAC'NAD#,QO6=4<<O+B
MS>^.W<3]6&&@W8I7'A^*+;C/2@3C-;)"RM%)(=/(,PC%-&4N;$6VN`CTQY62
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MN:.$ZL:6D@;%Y)`S.TDN&'@Q@SF7L,ZN[?HQE;=.)@OQIH=ZXM0.\;3.&\:8
M,-WAB![/V^9E*785]CJEO2O%QAHAJ"B>WR'TA88P,2FP:5HY2>/#'`<7)NZW
MY4I?H2EM,,.M@VWC?%<::FJ:>UY8JN1XX<\PL^S%\2;#9R*4OSTC:M+<U70[
M)=1NEMBK1!XG-R$XW?'*<9.!MCSMF%]JZAQ+.500$!`0$!`0$!`0$!`0$$3J
MKYBG]M#\<"T^C^Y&ONEA_P!+[,ZOJA++,W"`@("#0:2@L\'$6.;M*:>NIXY(
M#BFA'#,4(GTJ@6#,6[(?"Q4F^V,5)C7B[ZK$3.>.K#%LHBKU=;/-Q+H(;;$Q
M7"FGBW^6%HG?$Y0F]]?*Y;1_(^"N],XI\/97M-W#'[:=BK7-JT[0ZSI;Q71R
MRU$F29C:2*&.,0EBC?:0N1OL$N7'!GPY59NI'_\`K_\`/BD16<O=XSW.$?BG
MGAJ.)=/40EGAFM5+)&;<CB1RNS[?84=->X!_?!IG^/+_`&\J$O=*.1`01=C\
M.Y_+9/<@M/J/=^&/%B]'EO\`CGNA*+,VB`@("`@("`@("`@("`@M55+3U5/)
M3U`-)!*+C(!<CLZL31)A2=OH3R9Z>,MTSC'F`7RB[8.S8ML97>E)LC0H:U6M
MH2A:DAW)/B4>['*[X88NV'<?!-^=*<NW0JCMMOC(BCIH@(AR$X@+.X_LO@W(
MDWSI6+(C,K.DI9,7.$#QY<PL_,X\_P#XN[*1=)-L2!2TH89(0'!V=L!9MHME
M%_S#L3>DBV(4C;Z`3DD&GB$Y7S2DP"SD6&&)/AM?!U=Z=)N1H7-Q!AANQPRY
M.1O`;]7\GL*5E:0MRT-%+'NI:>,X\V?(0"[9N[@[<JL72DV1*H:.D%V<8(V=
MGQ9V%N7'-CR=W:IO2;D:%/4*+*X]7CRN.1QR#AE?FY.17>G2;D:'SL^@W&X>
MFBW&#CNL@Y<KOB[8888.Z;TY:FY%*45'0T1OB=/&3XXXN`OM9F;':W<9(NG2
M39&A1';;=&Q-'2Q`Q8YF$!;',V#X[.=MB;\Z2++=#Z5NMYL+%31$PY<K.`OA
MDV#ALYN9-^=*;ENA]GM]#.V$]/%*V.;I@)=)V9L=K<N#)%TQDE9LB<L$=!0Q
M$11T\8$3L1.("SN3<CO@W*DW3.<BR(S+36>T-AA10-@[$V$8<H\C\G,KS+M*
M<NW0K"V6X"8@IHA<7,FR@+;9-AOL;];G4FZ5BR(?3MUODRYZ:(LN#CB`OA@^
M+8;.Z^*;\Z2;+=#XULMK2M*U+"TK$YL>0<V9]CECARIOSI3EVZ'V.W4$381T
MT0-M?`0%MK\O(WLI-\Z5BRV,SX-LMP-((TL0C,V69F`68QPPP+9M;!-^=*19
M;H5PT5'!AN((XLN+#D%APQY>1E)NF5BV(R*#MEMD&43I82&<F.9G`78R;D<M
MFU_RJ[\Z4W+=#X=JMAN3G20DYNSD[QB[N[<F.SF3?G2<NW0^M:[:T,,#4L6Y
MIRS01Y!<0)MN(MAL=-^5FV%UZ:G<6%X@<1QRME;!LS.SX?E9U*RN["P-HM0X
M9:.!L"SMA&.PG;#-R<N"ZYEVESR[="X-OH!F>8::)IGPQD8!S/EY-N',IOSI
M7<C0M=C6CQ&#;R^]!WE>9=I3EVZ%^DI*>DIXZ:FC:*")LH`/(S+F9JZB*+JB
MB`@("`@("`@("`@("`@B=5?,4_MH?C@6GT?W(U]TL/\`I?9G5]4)99FX0$!`
M0:$>EBJN)4EPK:6GJ:+#>Q,[Q;R,P@B`)"#)G+,3$PXELPQ5CB4Q1=CT83X$
MVXLDTTHK4EOHHN)5'#2.=!-6E"4U5!DSN<N_<LF\`L")@VN/)W$KF]L=TP4S
M_CAW,[7]#6U]_M4=%-`80,,=5O90S`>^B,7*,B',6#9A;*N(NLKCF(GKBNJL
M2ZW;J9)IU33OAY^_%:V'%&)NY;*;XR5=)#6^`?WP:9_CR_V\J++W2CD0$$78
M_#N?RV3W(+3ZCW?ACQ8O1Y;_`(Y[H2BS-H@("`@("`@("`@("`@("`@("`@(
M"`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@B=5?,
M4_MH?C@6GT?W(U]TL/\`I?9G5]4)99FX0$!`0<ZI*C__`*[4TV,0X.4O19MZ
M[/1Q"V<MKX<N`_G3;X#)O5WT]:M=O)7493U,D-.?73;>/3CC*([D!C(\,1=S
MZ7.F].2/'&;L3EGMB&#Q&I:3M^T5%.$8SSE"<[Y1$I0:IA9LY%MV;,,.E^97
M>G)7#:D69Z8;'!?Q7_>E'_C*?XR51U#6N`?WP:9_CR_V\J++W2CD0$$78_#N
M?RV3W(+3ZCW?ACQ8O1Y;_CGNA*+,VB`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("")U5\Q3^VA
M^.!:?1_<C7W2P_Z7V9U?5"669N$!`0$'/X(Z8>+$I.$;3DQ$,K@[$_\`U8VR
ML>7:[-M\+##FQ2N9<,/RUHG4%QHJCBS;2I)-]+2O"$T<48O)F$IXRC<R(,`;
M/F?#E=DC'A/L)Q9^U,\1+=43WFT5<,4<Q4CL<8R3QPEGWT>&ZSNW2=MF+-R;
M.=*Q&>(ZS=F<=)FCSE^**H>IXCTE0490O-::21X9&P,'(Y7RDW=9.LA`<`_O
M@TS_`!Y?[>5%E[I1R(""+L?AW/Y;)[D%I]1[OPQXL7H\M_QSW0E%F;1`0$!`
M01UWM$]P>+=7.LMV[S8]4>%L^.'A;V.7DPV88(([U2KOK-=_WZ3S9`]4J[ZS
M7?\`?I/-D#U2KOK-=_WZ3S9`]4J[ZS7?]^D\V0/5*N^LUW_?I/-D#U2KOK-=
M_P!^D\V0/5*N^LUW_?I/-D#U2KOK-=_WZ3S9`]4J[ZS7?]^D\V0/5*N^LUW_
M`'Z3S9`]4J[ZS7?]^D\V0/5*N^LUW_?I/-D#U2KOK-=_WZ3S9`]4J[ZS7?\`
M?I/-D#U2KOK-=_WZ3S9`]4J[ZS7?]^D\V0/5*N^LUW_?I/-D#U2KOK-=_P!^
MD\V0/5*N^LUW_?I/-D#U2KOK-=_WZ3S9`]4J[ZS7?]^D\V0/5*N^LUW_`'Z3
MS9`]4J[ZS7?]^D\V0/5*N^LUW_?I/-D#U2KOK-=_WZ3S9`]4J[ZS7?\`?I/-
MD#U2KOK-=_WZ3S9`]4J[ZS7?]^D\V0/5*N^LUW_?I/-D#U2KOK-=_P!^D\V0
M/5*N^LUW_?I/-D#U2KOK-=_WZ3S9`]4J[ZS7?]^D\V0/5*N^LUW_`'Z3S9`]
M4J[ZS7?]^D\V0/5*N^LUW_?I/-D#U2KOK-=_WZ3S9`]4J[ZS7?\`?I/-D#U2
MKOK-=_WZ3S9`]4J[ZS7?]^D\V0/5*N^LUW_?I/-D#U2KOK-=_P!^D\V0/5*N
M^LUW_?I/-D#U2KOK-=_WZ3S9`]4J[ZS7?]^D\V0/5*N^LUW_`'Z3S9`]4J[Z
MS7?]^D\V0/5*N^LUW_?I/-D&;:K'4T%04TEXKJ\2%QW-44#@SN[/F;=Q1%CL
M[J"50$!`0$!!$ZJ^8I_;0_'`M/H_N1K[I8?]+[,ZOJA++,W"`@("#G44#!Q@
M*>6)WWHR#!)NR%F<*2+%]YNV$\S.[9<^S!6EU.C#I\"L9&+<[7!#Q7HSH*20
MB(H9JVH%GFC!SWSDQ9F?=YG=G;!^5\<$C'DIB*TSY61Q,A.74-GC#>1-*(Q'
M6``R-%FJHG'80EM<FV8<G+R*VQ=FK3H<S,9Z:WG[\4T10\2Z:(I"F*.U4H/+
M)@YF['*V8L&9L7Y]BY=PU[@']\&F?X\O]O*BR]THY$!!%V/P[G\MD]R"T^H]
MWX8\6+T>6_XY[H2BS-H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@B=5?,4_MH?C@6GT?W(U]
MTL/^E]F=7U0EEF;A`0$!!H<MZO(\58Z&:X1=B-$X0T08;UJ@H6+WS9C@^.([
M5-W'7'LFGL7>Q4Q=E>^O8R;O>JZWZ\HJ."+=TE?N1J)A@=Q,GWK,TD[#X3,#
M9&S=U=3;=./'2,,F%$B;=>&&1A<0+R5%J:S0-),)3L+19)"",3>JB',XB+YR
M<7<<"?##V5S-N&$PZB9S8=DO/_XIJ>>IXM4]/3QE+/-;Z4(H@;$B(I)69F;N
MNNHBJ5I#7^"=LN-MXSZ8I[A324L[RR2-'*+@3@5/+@6#\SX*W6S;-)2+HF,3
MW`N00$$78_#N?RV3W(+3ZCW?ACQ8O1Y;_CGNA*+,VB`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("")U5\Q3^VA^.!:?1_<C7W2P_Z7V9U?5"669N$!`0$&@'8JV;B-/74M?#3L
M$C',.\CEGP>FC'=M$XX@Q9,=K^RRGZ-./M6EU,].SO7;U=[I3<1J"D&M-K;4
MA3AU,&C<7D<IG(WQ?.W@LSX)NY\.ZG:;V;%AK\&+Q'&%]2V)Y"(39V:'+SD]
M3%BW@'S=UV;#V4K3#\4W:N-<>:RX4?'^S5%OIQJJP*2CW5.67`W>65LN),XC
MR^$_)RJTF<BUC.^VZ]ZHNOXB-)2:BM@VJK`3R4XY7Q8J:3$G(6Q?D;HOR?G5
MW+K?W37N-ZV?VQ1ZH400$$78_#N?RV3W(+3ZCW?ACQ8O1Y;_`(Y[H2BS-H@(
M"`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(
M"`@("`@("`@("`@("`@B=5?,4_MH?C@6GT?W(U]TL/\`I?9G5]4)99FX0$!`
M0:)1V@PXH5EQBDI<AX-4CO!*HQZJ`@V[9LP^"[[7Y$WK<E<:[LY:3UYN_P`"
M[A8(-?6JF*"4:TCZQ$0U)"!'+O,Q-3/B)LV5W,FPPQ9*]$==/P_,USU835B<
M3*22HU%8O>B*G$X]]*`YB'_M1..5N?:/2[C;4WJ9^VB4AR+C:UR?\0]C:VS#
M3UG5:3)*3L(LV\ES8XD&.(X[,=O(I,1.7$ZCJJR#AU5#^(W2`:AKHJV9A/=%
M!@P"_5Y,_0S$XX]';LQ2+;8R34K,QDH]-JN1`01=C\.Y_+9/<@M/J/=^&/%B
M]'EO^.>Z$HLS:("`@(""+O5NO58\/9MW*UL&;>L,$4^?'##_`)/!P]A!&>KV
ML_K8?D-+WD#U>UG];#\AI>\@>KVL_K8?D-+WD#U>UG];#\AI>\@>KVL_K8?D
M-+WD#U>UG];#\AI>\@>KVL_K8?D-+WD#U>UG];#\AI>\@>KVL_K8?D-+WD#U
M>UG];#\AI>\@>KVL_K8?D-+WD#U>UG];#\AI>\@>KVL_K8?D-+WD#U>UG];#
M\AI>\@>KVL_K8?D-+WD#U>UG];#\AI>\@>KVL_K8?D-+WD#U>UG];#\AI>\@
M>KVL_K8?D-+WD#U>UG];#\AI>\@>KVL_K8?D-+WD#U>UG];#\AI>\@>KVL_K
M8?D-+WD#U>UG];#\AI>\@>KVL_K8?D-+WD#U>UG];#\AI>\@>KVL_K8?D-+W
MD#U>UG];#\AI>\@>KVL_K8?D-+WD#U>UG];#\AI>\@>KVL_K8?D-+WD#U>UG
M];#\AI>\@>KVL_K8?D-+WD#U>UG];#\AI>\@>KVL_K8?D-+WD#U>UG];#\AI
M>\@>KVL_K8?D-+WD#U>UG];#\AI>\@>KVL_K8?D-+WD#U>UG];#\AI>\@>KV
ML_K8?D-+WD#U>UG];#\AI>\@>KVL_K8?D-+WD#U>UG];#\AI>\@>KVL_K8?D
M-+WD#U>UG];#\AI>\@>KVL_K8?D-+WD#U>UG];#\AI>\@S[/:M04E44EQOA7
M*!P<1@*FAAP+%GS9HVQY.9!,("`@("`@B=5?,4_MH?C@6GT?W(U]TL/^E]F=
M7U0EEF;A`0$!!S*G&BI^,-;5R2B#RENR(G<6S=3BR@^+L..#XM^52;HC+AV^
M"Q&&$>*O5T<DW$:WT\)]5EF&F8:YX@DR$/6"88W*,LIDV/ZV'=2D9\G7^/@5
MG,R^(-14C>[/2!;*>X@3!)43S@)2QB%3"V:-W<2;:[/T>3#D5WIC)=3HTF+"
MO@XC^(VQZEN7%<ZNP4L]346JUTE3*5,SE)$V^E89&9NEL+N+JWAS?BAS/$BW
M'+3N"]PNM=QJTU)=)YIZN.62)RJ'=S$1IY<!Z6UL,5QR]W%2CN;][&]O*N1`
M01=C\.Y_+9/<@M/J/=^&/%B]'EO^.>Z$HLS:("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@((G5
M7S%/[:'XX%I]']R-?=+#_I?9G5]4)99FX0$!`0<ZRVZ?BU)!50QS2BSG",C,
M["XTT;YQQ?:7-AEV<JZB;HQQ6F&&@I$KUVJJ637EOAN-I$+@,\?4:R.KDS%$
MSS,)[I@8,&;'.+OSLN:S&+%3J\3%.GL]J/XGQT7KAIZ>HS-(&2.)Q82?&6KA
M;P7VECAMY,&VI6GYT6(G,@]04TS<?ZVZ1G6D]MT_"_4[?&\LT[SRRQLW*PMD
M\)G+9BF[7-6>N([S>F,](VM9>[WBX\;]#E<=+S6!HY*@8:RL8>M5F%/(SG*X
M,(XLNIB^/W3%,U)K36YC<]VM<^*G8](KE1`01=C\.Y_+9/<@M/J/=^&/%B]'
MEO\`CGNA*+,VB`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(
M"`@("`@("`@("`@("`@("`@("`@("`@("")U5\Q3^VA^.!:?1_<C7W2P_P"E
M]F=7U0EEF;A`0$!!SD7DGXM%#+4&\4)'-3PN\HLSC21,3!A[V[>^8ER?E?D4
MQ5Z<.FO8N.F&$[5%ZJXJOB1;6*GDC&GFACWDL3@^<7G87%\CYQ/;E?.S-M5I
MI\/;X8BNB<,-K+XB71Z&]6MVIHJ@LK%%C#%-,YO41#E#>&#CBS\HML=*SDB>
M[V)NQ..8^KP<KXH:XL^D^,XW^ZT=9+4C9Z$J.WPS;D=Z\TKFU2X.XDP#R#M;
M,I=%V:V+I[G=LQGFD=ZW:=04=YXC\,Y;7!7O9=]<9*:ON9"4TTDH2%(`X$71
MB\%L4BV8RQ%O0ET].].FCTLJY$!!%V/P[G\MD]R"T^H]WX8\6+T>6_XY[H2B
MS-H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("##NUWM]IHBK*Z7=0,0@SX.1$9OE$1$6=R(GY&929HL0Q+;J[3E
MR(@I*Z,I`!I#C)\A"+X\HG@^S*^/<7,WQ&*<76ZW)G'&/J2#W"@8&-ZF)@<<
M[$YCADY,V./)MY4YENE-R[0K"IISE>()0*468BC8F<F%^1W;EP=6+HG%5)ME
M<72"`@("`@B=5?,4_MH?C@6GT?W(U]TL/^E]F=7U0EEF;A`0$!!SXJ.W2\2J
MC<U=72W20LXF,,#Q$,=/#O(F,A*3+D<7YFQ?9M3>C)3M\#=G+X3^2C4T1-Q-
MLM4'2.-X(BP=\1CD:=G;#=D&!.S/X;/LV)3/X>)7IU?@^\0Z&-]3VBY'=H+<
MU'$6,4[R#O1>HB(VQ#!FV#AMYTK%,=5B)G)'=XN5<6]0:NI>,6]T;;X[O47&
MRT?0*E:K;=/+*0FPDW1QQY5U;9?=^V9M[-J7766_OB)9E)7:FFXA<+J?4U'3
MT-Y@EKWG@IGA868X3<?>HG?=[.ZN*XZ;T7SUU7%2L6S;#T8J@@((NQ^'<_EL
MGN06GU'N_#'BQ>CRW_'/="469M$!`0$!!'W:>_Q/%V31TU4SX[[K-0=/EY,N
M7)#/FQV]Q!']=U[Z(MOTA-YF@==U[Z(MOTA-YF@==U[Z(MOTA-YF@==U[Z(M
MOTA-YF@==U[Z(MOTA-YF@==U[Z(MOTA-YF@==U[Z(MOTA-YF@==U[Z(MOTA-
MYF@==U[Z(MOTA-YF@==U[Z(MOTA-YF@==U[Z(MOTA-YF@==U[Z(MOTA-YF@=
M=U[Z(MOTA-YF@==U[Z(MOTA-YF@==U[Z(MOTA-YF@==U[Z(MOTA-YF@==U[Z
M(MOTA-YF@==U[Z(MOTA-YF@==U[Z(MOTA-YF@==U[Z(MOTA-YF@==U[Z(MOT
MA-YF@==U[Z(MOTA-YF@==U[Z(MOTA-YF@==U[Z(MOTA-YF@==U[Z(MOTA-YF
M@==U[Z(MOTA-YF@==U[Z(MOTA-YF@==U[Z(MOTA-YF@==U[Z(MOTA-YF@==U
M[Z(MOTA-YF@==U[Z(MOTA-YF@==U[Z(MOTA-YF@==U[Z(MOTA-YF@==U[Z(M
MOTA-YF@==U[Z(MOTA-YF@==U[Z(MOTA-YF@==U[Z(MOTA-YF@==U[Z(MOTA-
MYF@==U[Z(MOTA-YF@==U[Z(MOTA-YF@==U[Z(MOTA-YF@==U[Z(MOTA-YF@=
M=U[Z(MOTA-YF@==U[Z(MOTA-YF@==U[Z(MOTA-YF@P+W:M5Z@MYV^OH;=2PY
M@E$NL353$<9,[`0[FF(6?]L3Q9U8PPSDX9NUK%9P5K*JW3M)<HCNDA4SPU4D
M1%N@@,R*$2<L^0F/+B[X]W%=1%L13'3#"CG>NK7Q_#P(N"M6-HDIY;C%)7-)
M&4$N21@W0&9O"72<LKO)S<[,E+5WKL)_#P36C^&U9I[4/:+UXST[4VX(,IO(
M9.P-B1&18,.39ARJ3%N8WKIRM\7*B`@("`@B=5?,4_MH?C@6GT?W(U]TL/\`
MI?9G5]4)99FX0$!`0<XI!>;C#5$V<&IMCOE+*>\HX_ULK#T?;)AAC\###%XL
MV^C8J+6%LWY5<<KU$<@,U0'5=[4/(S.4,AYO"9]HCSJ8O+'7G6*Z9ZJ>)KR@
MBJ=06>62NC@:)P=Z24#,)!ZQ&[D>429L'9F''#I.RM8C35)BNC:T35M>-%^(
M$R+5$>EXRL]()%*$9C5-OY?>??.@.'+BZXOFR,=U=7B[LB[);$3U^"'JZ>B'
MCWHVII=/#:0J9JDNU(YXYQKL*>3ILT3D`X?EYUW%\W1EMF/^/CD<S%,7ZJ]/
M@]&H@@((NQ^'<_ELGN06GU'N_#'BQ>CRW_'/="469M$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$$3JKYBG]M#\<"T^C^Y&ONEA_TOLSJ^J$LLS<("`@(.>O!I^OXDUE/'45D
M-XII8I3<0BW&(TX%T2<2+P,&+\J5C/&NOA5<=,NJB!O5DN-#Q2BJ(#BKYJD@
MEIZ68RC86,YBZ3D,VP'_`&>;#8E(C)B-Z<]:8=,)_B))9VO=E&OEG@KFRR4Y
M0[IX689XGD>7>.+Y6_\`[VJ3/1770B)S3356K0]?6NV73B[=ZX+=!?[M0:;I
MJJP6F9V*&IE>>1G+#'"3*#YF9=67S$_IF(F<DI=9%/U5I&5#V^WM#Q.X95U=
M;([!J"NZV=RL=.[M%&PQ2-'*T3N6Z<VY629QTF8FZ,LQXK&2L5W<U?!Z5400
M$$78_#N?RV3W(+3ZCW?ACQ8O1Y;_`(Y[H2BS-H@("`@(-.U7=-74VH**GM41
ME2F,3@(PM)'-(4V68)I'VQ"$/29VPQ=.7,X\-9OQ&*<.I"5=OUE2Z;IVAJ*T
MZJ2\5<E6XBQ2%32%,T8NW_T_`PPY$Y49*'-SRC"N?%ZU45NHH0.J%@B<JJ6!
MG/>%&+]7/()]'-FQ-]O_`))R-$S3KC"B\^W/$=OMRX4;=?KMJRGU#20TT4W4
MGIQ,8Z>G&8)I\2WH2R$X[MA%AR[6QQYTY<SC\:;4WXC%[>RC1:;77$YZX:&I
MCGBJ)`DGH8^IB13D+!EB/$0R1L;D)$S;.Z_*IR+NG;D7G6=';[55PN7%2VQ4
M$E'#6M+44&4Z<86FACJ1F,GSN32$)&V5FV/^;E5_KS.3LE.?;G\?:W"GK-6C
M9+[<1AEBN,T%-+11F#FPR/`.\8(WQ\$\<6__`)3EYM)S(RYH:I:K[Q2:FK*F
MM:NC>HG'=EU0)'",(2:/=1X,V6646S8BSMRX-BG]>8_/#(<^V=';[=C)K[GQ
M5K:$LE-(-[@J89'H-TT=''E)\,M0+YI!,=I,^/YDY$YYUXJ:H.=;FV8ZZ\S;
MKQ6ZN.S6F6S#(U9)&4M8,\(,;D$#F,4@^#'GE9A?#DYDY=<60WXCIVM&IM9\
M4.L04DXR=;DB.:C@&D9RG,3`7CFS`&[C;,39F9ORIR)Z>S%UKSK<N+M[,:9N
M5YXJ4T5D:GBWTM4QR5CO`V#2/*S#3DP"601BVYL6Q[J<F9SSV843G6QECO\`
M;E1Y:HXM=FEDI3>9JT@*I*GPZ&[Q",8V!RRN?1)\NS]KG3D3IG;CPUG.LZ,-
M>&A?DJ^*TO9\]24X,=4,M53P0`+1A',X-'BW2(#%V<L>;:G(Z:ZSG1HCM1\V
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MD+641G#'7"\TQ,\I]"4LI.&2+*X,Y,_,^*<F9_X]62,/R.=;GQ^+`NM)Q,G"
MK@DJ:V:>I"(PECB&,86DI"W@Q9=C.TG1P?\`+RIR(PE>?U1M25MK]>6ZY2T9
M0574XI)7HA"G&9JEFS8[V0R'=X,(Y,';'%.3.6.^(IUIS8S^/8B*+4'%Z>0Z
MPZ>I<Z>GJ&IHB@88Y3,8R`I&R!MCZ>7H\NS:G]>=?6<^SHPUM]T+?[Q6T+4E
M\C-KL`E.Q/$4;'3O(X1D^(@S&^')@W=3<FW%C-Z+L<--HM1<6Z^XU%-N9Z.F
M9Y98Z@Z4'(6`"<8>D+#M-A;];VR<B<\SM.=9FIV^U-:1K]:UVICJ+Q%41;ND
MF$Z0HMU31R;P=TP2?_,<PVOCR)RIC'.TYL3BC9GUH".]\2QJIZLAK1WT8C,[
M48DT52`DX4\4;["C(^B4G+ASIR)Z=L;>HY]O1VX5;-?6UOVU;J^B>2%XK?&]
M=2Q@TL,DY3AO(NER8"Y;6VIRZ]9S*8LR,AO/%>JOE92;EJ:DZUNQDW+%NHFD
M+)D(A828XV9W?$L$Y,Y9F3G6Y(C'K]OL0G;?%B>>GK*R.IIRIWJ&!J:ESMOS
MC;+!(!"+/%G9F8]OMD_KSTSKC;U'/MS4[?;E;C:;[JRNU'=[54C&U/;J5IC*
M)F?&:JB$HX&=GQQA(9,>=VRJ;G2LW1H85FEXCO8X6,CIZDJF&`(3A!WCIPA<
MC)R+%WSG@.9^17E9JIS8G'2.U'V>_P#%Z:.,ZBD9^L5`TAL\.5Z<I68BE?$0
MS10N+CSXYN5\$Y$QG[NPYUDYL-JJ?47$IJB07CJ8Z1I"&OFCHP.2F)C-H@IA
M?9.,@L.8GQPQ3D3T[8Q]6@YUO1VXNM'ZCOO$VINIT84U;!;1.%WG@IF>2/=E
M&;F+#F8LXYNBYE^1DY$SCGOA>?;&B)UX=R_2Z@XBTMQIM^!-)>YXZ.`9XQ$A
M%A<AJMUCT<(P?>"VQB)3DTS_`)>TCBQ.;#V2VS4UTU;3:@B@ML<I4O5\],$<
M`RQSS]/.$\KN.Z$68<'9VY>=7ES./QR=>E-^(Q33M[&MTMYXIU,A;EYVI887
MG:66CC"26<<F>G<79L`8G)A)MK]W8G(G/,[8.=;T=OMRL0[KQ.KQ/?A5QC3U
M9L[0P,`G')3RLT3M@)91-@Q?;A^TZ<B<_><ZW-3MPJJMUYXEVJWR124]9533
M22C`)P-)NS=X7C%B_P#IM&Y[7YV3D3F[X.=;GIVK]BNO%*GN%EH)XYIJ5R=J
MV:IAZ4F,\C2YS$7RM''E<'S-C[*<BG5&':<ZV=%<.EDZMU'Q*@U5445DI)2M
M[B$44CTXR`)$POO6+#;^LVTO_P"GG3DS..O:<VV,4TKK]JAZWB'+?**@KGJ>
MK4]=%NYHJ<1"I@&0]Y).8[(\K9=C8,_<3DY\L=>0YT9,43K[%K76L]?6B_5K
M44$L=FB8(VG>G:00<\F$HOATL7<A;$N7]52>#=./&L<6V,6*NOVJ:S5^OXYZ
M"DIFEDK98:B:E@.E%BJFCJ6CA>IV>\"<;OF=L.ZG)GIVY.O2<VW+B[<?5^+'
MFO'%6HJ::2""=R!\LLITPAN)I7$9HQ#8,D<;>"98J\B=/;&V.M.=;T=O;TMI
ML):Q?4M`]UFJ"HQI:N&;WH0BDECJ&W4DC"V`D47)AL=.73'XG,B<6)NZ`@("
M`@((G57S%/[:'XX%I]']R-?=+#_I?9G5]4)99FX0$!`0<T<IX.*]75]6EG$"
M&,(HHP%\)*:(7FSNXE(/ZKMS8?F5FM,VN>[&13\O'%XI.^06XN(5NDEJSCG8
M8':G:`3`C%YMWFF=\PXYBP86YMJE8Z=OAG-V<N98XBT`U-[M1SU5''1Q,+U%
M+5S-$\H-/&1.SN0[`RX\^+[$K$9^R?`IT=S1=16NRW/CN)ST,%5:8;)0R#<.
MMO1!1QE/*(2QD#MGSXL(BSJ77Q$5NW:?\HKA*VVSDC>K_P`?%'SV6VT/&+A]
M6#;"M5WKYZ]ZZGEJ3JI2CBCD"&0C-WV&VUDB8_;&[B\ICG'6Z?B>B54$!!%V
M/P[G\MD]R"T^H]WX8\6+T>6_XY[H2BS-H@("`@("`@(""EXXW-I'%G,6=A/#
M:S/RMBE4HJ11`0$!!3NX\[296WC-E8\-N'+ABE4HJ11`0$!V9V=G;%GV.R"F
M&&*&,8H0&.(&P$`9A%F]AF5F:I$45**("`@("`@("!@V..&U^5T!`0$!`0$%
M$<$,9&4<8@4KYI"%F9R+##$L.5U9F4B%:BB`@(*"AA*4)2`2ECQ:,W9G(<W+
M@_-BK5**U%$!`0$!`0?#C"07$Q8Q?E$FQ;9MYTB4F'S=Q[S>96WC-E8\-N'+
MABE2BI%$!`0$!`0$$3JKYBG]M#\<"T^C^Y&ONEA_TOLSJ^J$LLS<("`@(-(J
M(ZRHXA#!6Q2RVU\7IB.)WA8HX0/`3R8,['B6;/M?8K$3&/Q\*^"5C#"O@Q=3
MQ6JMU[3T)T]7'<VIX2IKI3SN$<3D4S,SQL0XX97)^[R*5S3%M.U:9XF:]6)C
M<18:D]5:?@DBZS1E'EG$AF(2-JB%V)VB9QZ.&+Y]BZBV<L$S&26I:SFH:/C7
M7S7(;8.G::QT1W9[F#F(PA42Y!IHV?;*Y;&V+F>)NX]ZD[:K%F]BI772B$"^
MVB_\:-!7>QR4,MEFDJ@I2IXBAJHW"`\T54)$6T?U7;#8N;;][/-=$YG5UE,V
MNN5Z273@0$$78_#N?RV3W(+3ZCW?ACQ8O1Y;_CGNA*+,VB`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(-7U%Q&T
MUIZ[#;+G))'(]/UEY1!S!FSL`@[M^N6.+-W&Q7%UTQ.**NXMKG5T7$?1E7*<
M,=RC"6.26$PD8@=BA=V/'%MG@OACR\R;^F)7ER^TW$?0]532U-/>()8(&9Y#
M%R?PB<&PV8ETFPV)S(Z=ARYPF$I1:AL==)''1UL4YRN;1B!8N[QL)'A[5C''
M\JMM\3D<S9,94@NG(@("`@((G57S%/[:'XX%I]']R-?=+#_I?9G5]4)99FX0
M$!`0<JTWJ*\WKB9-+"]1#;1Q;JTID4+"T`,>#`V3-G;G?HOLYU(X>>8I.'37
ML6>)FC&DM2#&7$^SYY=C-`XPX='-C/@1$SXB7[#?K;>XKAA&%$PS+G$BIJ8+
MO9=W5]7&6:*)H0J)8I)2>IC<F&,'RDP@SXYA?9L4FV)R]WCF6)G,Y7Q@T=9=
M7\:I[+<+C+;:H[)#-;I@#>1.<,DQ2-,W+ER<F"[MF*XXF>I)WJ8IC6U;07#/
M4&B>,NCWN)PU%%<)ICH*RG)W"46II'QRDPD+X/SLK?;$9)]J6W3.6/8]>+A1
M`01=C\.Y_+9/<@M/J/=^&/%B]'EO^.>Z$HLS:("`@("".NU+?9WB[+N$-"PX
M[W?4SU.;'#+AA+#EPV]U!']F:Y]/T?T:7G2!V9KGT_1_1I>=('9FN?3]']&E
MYT@=F:Y]/T?T:7G2!V9KGT_1_1I>=('9FN?3]']&EYT@=F:Y]/T?T:7G2!V9
MKGT_1_1I>=('9FN?3]']&EYT@=F:Y]/T?T:7G2!V9KGT_1_1I>=('9FN?3]'
M]&EYT@=F:Y]/T?T:7G2!V9KGT_1_1I>=('9FN?3]']&EYT@=F:Y]/T?T:7G2
M!V9KGT_1_1I>=('9FN?3]']&EYT@=F:Y]/T?T:7G2!V9KGT_1_1I>=('9FN?
M3]']&EYT@=F:Y]/T?T:7G2!V9KGT_1_1I>=('9FN?3]']&EYT@=F:Y]/T?T:
M7G2!V9KGT_1_1I>=('9FN?3]']&EYT@=F:Y]/T?T:7G2!V9KGT_1_1I>=('9
MFN?3]']&EYT@=F:Y]/T?T:7G2!V9KGT_1_1I>=('9FN?3]']&EYT@=F:Y]/T
M?T:7G2!V9KGT_1_1I>=('9FN?3]']&EYT@=F:Y]/T?T:7G2!V9KGT_1_1I>=
M('9FN?3]']&EYT@=F:Y]/T?T:7G2!V9KGT_1_1I>=('9FN?3]']&EYT@=F:Y
M]/T?T:7G2!V9KGT_1_1I>=(,^TTE_@.1[I<8*X"9MT,-*],XOSN[O--FQ_,@
MUW4O"?3>H*BHK*PY@N4]1#41U\9,TL30,PA$&+.V3#'%G;G7<712E',Q=FGV
M;%@^$=G.KKICKJHH+E.U764K[K*4P,^[)BR9F87)WPQ3>MT=J4GHV%3P>TY-
M04M(TTP=2<BII,(RP(S<W<A<<I<KMM5WHT%)C)++TIP_IK#?ZRY1Y6@*GAHZ
M&$7=\H1BV\E)L!$3E=AS9=F`LN9F-:Q5N"Y="`@("`@B=5?,4_MH?C@6GT?W
M(U]TL/\`I?9G5]4)99FX0$!`0<UH92?C'6Q%"\<<>R"46<1-RHXR-B?#`G;%
MMF*3;GP]O:M<5*ZL)\'S5U%3U?$FVT]6(%25`TX21C*,<QD/6"%W;.)/&W(^
M#8XOLYTI&>(GKC_KXF/-6-OM\%?%$VBNMBBDK&AIII8X!HLT@',13QMB)`XY
M7C':SJ8M?84F<(\8EJ&LIJX./%12VNZT-HO%;9:2GMU77P/4&YE/*Y#3MR";
MBVUWYE:QDF;HB?*1$Y8B+J:6I6*PWBEXQZ(O-PU2VJ1N=36!%5,QB,94\,@F
M`B>QFS/R,RD6<.W]E=>59NOG%=34]2*N1`01=C\.Y_+9/<@M/J/=^&/%B]'E
MO^.>Z$HLS:("`@(""V=33QS1PG*`S2YGBC<F8BRMB65N?!N5<S=$95H'4TX3
M1PG*`S2L[Q1N3,1,.TLK<KX)O04E7F'NLF_;I*+%7<**CW769ABWT@PQ9G\*
M0_!%O9=)O@B%\I``',B80%G<B=\&9FVNZ;T%&/27.WUA2#2U$<[Q9=YNR8L,
MXYAY.Z+XJ1Q+=*S;,,G%N[R\BZK#E9*LI1J1IBD%IR!Y!CYW$7P=_P`V*F]"
MT?::KIJJ`*BGE&6"3%PD%\6?!\'P_0F]!,4?8*FGJ(AE@E&6(L7$P)B%\'P?
M!V]E(OB<Y,3"F"MI*B6:*&49)*<FCG$7Q<"=F+!_S/BD71),+V+=U-Z-*48K
MW2VM5#2=9CZR1$`PL3.6818B'#NL+XJ;\.MV5RKK:2D@>>IE&&$7$2D-\&9R
M)A%OSN^"LW1E2(F5[%NZKO0BSUVDZWU/>CUK=[[<X]+=YLN;#N9MBF_"TE>Q
M;#''9W5=Z*5S(CSU%8XZ66KDKH0IH)2IY9B-F%I0?`@Q?]9NXN9XD4JZBR:T
M9XF!B)"[.)-B+MSLZL70YHHJ:F"F@.><VCAC;$S?D9E:P,2._P!EEBJ)8JV&
M2.DPZR8$Q,&;DS88KF.)$Y'4VS&5G,0NV+/BRZWH<ON9N[R\BF_&DH9F[J;T
M:2BU-5TL,L,4LHA)4$XP@[[3)FQ=F_,R;T9%HPJ/4M@K;A-;J6OAFK:?'>P"
M72;*^!8<SY7V%AR<Z;\89-JS9*2Q;NIO1I<T,6[JN]`QY;E013#!)41C,3@+
M19FS8R8L&SEZ65\%(OB<BT9&+=U(NB<Z46ZBH@IX))YS:.&(7.0RY!$6Q=W5
MK`L45VME<[M1U4=0[`$K[LF+H2-B!;.8L-BYB^)=3;,$=VMLD%3.%2!0TAG'
M4R,_1`X_#$G_`/'G5WX3=E<HZZCK(!J*689H"=V&0'Q9W9\'VIO03$POXMW5
M=Z$,6[J;T"W45-/3025$\@Q0Q"\DDA/@PB+8N3OW&4FZ(6(J05$,\,<T)L<4
MHL<9MR$)-BSM^97>@HI:MI'K"HFE'K0`TI0X])@)W%BP[F+*;\5H4FE5FKO-
MIHY0AJZR&"4VS"!FPOE;];;S>RI/$M6+9E767.WT4(S5=1'!&;L($9,V9WY&
M'N_F5F^$B)9&8<,<6P3>C2E%MJJG>I.F:1GG`6,X^=A)W9G_`#X*S=$%%J:Z
MVV&MBH9:J,*R?%XJ=R;>$S-CBP\O,N9OB)I+J+9I5E8LNJPY,P]UE-^-)1\(
MQ%G=W9F9L7_(DW1I*+=/54]3`$\$C20R-F`VY';NIO0M%W%L<.=6L(*@@("`
M@("")U5\Q3^VA^.!:?1_<C7W2P_Z7V9U?5"669N$!`0$'.X))&XNRQ;]Y`?.
M30YCPC=J2)GV.^3]#8[5*8\/9XK3%A[?!):FJJRGO,]51V^AJ`MU/#5UM16S
M$$C"#R[MH&9B82%L_2?#EP76/---67#6E(T3*#XFS4<M^T[--+%!N,E6)RY!
M<0ZQ$QOG=V+P2PRC^5]BD5Z<-2TPPGVN?<1*+3MZ_$#:FJ;Q46VIFM]#)8:R
MC`96.=Y92',[[&'+S\Z1=;[T3-=5#=NS3$4ULNK,JOBWPXN0UDTU---<(8:6
M6D&B:,H8Y&E-HFYY#QQ)U;HQX][>_P"4U2*4Q;M/^+T(H"`@B['X=S^6R>Y!
M:?4>[\,>+%Z/+?\`'/="469M$!`0$!!I'$?0UQU)56:KH"@WELED.6*H<Q:6
M*1AS1Y@Q?`\N#^PK$1.7NJ;TQDKJFC!J>&]UGMMGB*HA>KH(:Z$C<I,(AK?!
M&`FZ6$6#"V/,KNVY/`W[LN/:@K7P:U!%7Y*RKIRM&W/21G+E,A&08RRX-_\`
M4;PB=]B;EF7PC\CFWY,>W"5FOX*ZHKJLSDN<(9<IQU#E(<F]$6%B'%FR[&R[
M7+EV8)%EF$8=A/%OPELNE.&M?;XZE[E4C,4U'/2T\6<Y!@ZP3YF'%@'##_Q4
MW;8R=QS+IRUVM?J."EX>VP]5J*>GN$4E+O'B.01DIJ>!HC@=\'V2$V.T79=3
M;;.7N2.)?&2NU.7#AYJ.6@TQ!!7`\]F=NL2RR&[?\@GL9A;/@+9&\%_S;%SN
M680O,NV]+7HN$&M6U!57.:OIIJ:8??;>YRM%4.T[F0R8#B(F+M^T^SE5Y=F6
MN/J.=?DI-.ON3]1PXO\`U+2T%/401G9=E0[')NVQE8RR"[8ET6RMM9_S)NVS
M^1'$NC\T-0\'M3TD$U+%64T(-+++%4Q',QG`;[*(QPP&(N4G;NI-ED_EG(XM
M_3MPQ]*2TYPPU';*R[U778*9KM%41Q4L!2E'1%(#-&<#GMS8["]C##!)LL]N
M+#\3F783WZ5%%PIO._*JJ*B"!P`>I4<,DQ14TP2`3R1N^&TV!W?V74W+-?4<
MV_IIU][+O7"J6Y7NXUKE3M#5RS5$)]-I!FEI6@`GP_8,<S;5?TX0F]=&2NUA
MV;A9J.ETC=;375D5955O5<&EDD.&0J>1CDD/HB3/+A@_*_LI%EL9.Y9XETY>
M]:?A5JPLXA<8:4I7>2GJ(I)G.A#`\:2GQY83S-F=^\IR[,^O%GZ-!S;^G;WZ
M9Z5B;A!JB2<JV&LIJ9WC>,+4!S=6$2?!VSLS'L_Y!_\`/F5W+,^7JQ;#FW].
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MW.CLM?1!6`U1<*-J>HE8I>E,TQ'O'=]O_&678N=RS"%YE_3M06J>#NI[@0T]
MKKX*6@CFWE,#'*!11O,QR1L[,3X$.+=%V_.G+LG+W'.OC)7:S*KA'>8X:F.V
MUT=/'4;W>P,<C#*'6VFAB)R8V81BQ#D_]%=RR?R.;?T[67IKAK?[;?+;65M3
M#6!1/GZT<DAU`"\+Q]6#%F'=B3YF=-VV,G<3Q+IRUVXOS?)^'^JRM]):Q>WG
M;K3*<D.=CWM;&<CD\4YL.,3.S]/+CF=MNQ6D>;JBF+7IZ$BZF;'GFN/5^*#D
MX4:K"^0N,X5!2T>[>Y'+*S49#()!N1QVG'M8-G)RJ<NSHIU8UYMW37K[TM0\
M+=0!,TE360>\B^#,<Q#45`@;!63-B/OCF3.[-W%-RS"(R>TYM_3MPQ(6S<%=
M7TE1=)CN5/!+7O3%!41%(\L&X`Q(1P$&P(CS*\NS"#G7SIVI[3?"Z[T-[DN]
M3)34YM4TLE+34\DQ!#%"#A.(Y\&QF=\2V?E4FRW7U;#F73IITS5:K>$VHZB\
M76I&]OV?6M4M341/)EC8XC&!G]K)/(1?_P!/<3E\/+G.;?DS+FCN$U;9"M<\
MTM/URW#1Q-+"\C9HZ<9!E;;A_P`N=MBLQ;A"1?=T[5B;A3J**LN$=!54T-MN
M585=.V:5B8L)!R,+-E?-G9R=)MMG'X',NC%CVJ[WP^U&=LLEGI!AJ'A:OZQ4
MF<D<4)3L.YEZ'2<P?:/LIN1/5U5(XDQIU2Q#X0:HFHH@"ZA;ZB,H@FZO),03
M!$&)RDY8/O)Y@C(_893E\//W;%YW$S5UR6_@YJ2&I/KEWZU%+@53*\DC%,QD
M!21$+"SY!<2R]+\W*G+X<9.XYW$PE,ZLX;W2]7>I..:`;?41B`$92;R.,('B
M>E$&Z.ZD+IDK%MN6>XW[LF/;AC6M<<-[_>9[8]IK(J,:&E"FSD1LP[M\7R@+
M?K8,V+$WLXJ;ELY>XCB76Y._#Q0MWX2ZSN<U=5S5%$%;7^#4!+4,=*+2[QQA
M++MS#T'Q96.'92DSUXCFW98B=O>HK>"E_KAH'GJ:3&&CJ*2=BWCNPG(4D0,[
M,S$S9NEL;V&5BVV,_8D\2[IVOE7P=UA6T%#35%718VS<!1MGG)LL4AD4FUMA
M93P;\BD661G[%GBW:)VI&#A)?)J@.T*N$Z>,3"81.9^MRN!L-5,SX>^9C;9[
M'Y$W+(_(YM_3M[NAG7?AA=KE?H+E+6QD--:(:&%B*3,-9%(Q[_9[#;'Y5(MM
MP@YE^:NU7J_A;)J#6M+?3>G*FBHCIY&DSM+O<I-&0Y=F#.>*L4I^";UT3BKM
M8UKX>ZIM;7^JGKRKIZNWU,$&60L\LL@>]YF<1PW>&47S.IR[,R\VZ<J*I.$6
MI):"LJ)9H*.JJ1H]Q0Q2RE&`0C_V(S(V)F><L"+`7VLKR[.BO5L.=?TTZV3)
MP9N\E!,,MP"6X%#4!%5222N0F=.$=/M;#9#*+DVS_P!5-RS)3L.;Q.G:P)N#
M>M'.%QND+C'%&-4V\D_[.1F;=OB!9!Q;-MS-[#;5>79A'?\`@<Z_IV]V3#.V
M/2V@M66/4D5Q*LAJJ?<!3U+S22G(8]!GR]%L'!A?#%\']C:I-EL9,6HYMTXI
M[\,,[HZ@("`@("`@B=5?,4_MH?C@6GT?W(U]TL/^E]F=7U0EEF;A`0$!!H$U
MQN=1Q*.UP3T]/''B8S/3`4CBT,12Q#(^!.3XCF?F'!7KFZG7B*1HBK&U),;<
M5;5$^^*&2.G8V9C>%L7GP8L'R8D_,[<RE,],-GB=&'?X,CB!=+K0:EM14TN2
MBZO(53"T02.>$L>QG)GR]'%N7G5W9G'%>WP2ML98ASS4U@M.K..5'UVVUDL+
MV6WU4-123C3]1=Y9":64GYFV"+#MQ5B:5WHMZ=Y::)F-%(57&'>\7^'%SF:X
M15E3+7PE37.03D".GCD`2$1869C\+'#:N=V(Q4B)Z)F>^96M<]8ZJ/0*((""
M+L?AW/Y;)[D%I]1[OPQXL7H\M_QSW0E%F;1`0$!`0$!`0$!`0$!`0$!`0$!`
M0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!!$ZJ^
M8I_;0_'`M/H_N1K[I8?]+[,ZOJA++,W"`@("#FM7%)5<4CIAJJBED9]Y"89V
MCZ-/$1,SN^0G+#I!AR;<<4IIC%K*Z/#\V5J.H*+B3:&<)'CDW`.8YL&)WGPV
MX9&9\.ESOL4Q5_+\UPPPQ/G$2[WBBU#9HZ"J*$3P<PS9(B)YP%ADQ`V]\9\C
M=QW2;8G"?;'B1,YL.SV.<<3;135_$B]7.]G5Q6ZT:<HJVY6FVRNTM2;5$C!%
MG;#$`/;C@NHMB9R1?=FC,1=,9)W8SRB;)2T];Q1X;:MI*BXE27OK01T-UF*>
M:!Z>&0<(S+EC+F4W8MQ;L679XA9NF<^]&EZ>1R(""+L?AW/Y;)[D%I]1[OPQ
MXL7H\M_QSW0E%F;1`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!!$ZJ^8I_;0_'`M/H_N1K[I8?
M]+[,ZOJA++,W"`@("#2J6.CEXDU4C4EP&II\6>K+,]$;24T>QG=LK9,N#-CX
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M("`@(-$XD3S1W:PC+4U]+:2>K>MDMS2N><8<86?=";^'R8M@G+WL>[O4PTPN
M_3%7=V>+1JC7O%4:-Z)Z68*R"$",VI3>3/"X$[.[,XOO@=\?_1/Z]W3ATG/L
MZ&9)KWB+66DPF@>CWK%NJR&EF,RF9A?JK`PLX/TGZ?L)R+L]>S"ASK,U-N+\
M^AT>'7NBQA`9;_;VE$6:1BJH<6)FVL_2Y<417Z_Z&^L%N\JA_P!R!Z_Z&^L%
MN\JA_P!R!Z_Z&^L%N\JA_P!R!Z_Z&^L%N\JA_P!R!Z_Z&^L%N\JA_P!R!Z_Z
M&^L%N\JA_P!R!Z_Z&^L%N\JA_P!R!Z_Z&^L%N\JA_P!R!Z_Z&^L%N\JA_P!R
M!Z_Z&^L%N\JA_P!R!Z_Z&^L%N\JA_P!R!Z_Z&^L%N\JA_P!R!Z_Z&^L%N\JA
M_P!R!Z_Z&^L%N\JA_P!R!Z_Z&^L%N\JA_P!R!Z_Z&^L%N\JA_P!R!Z_Z&^L%
MN\JA_P!R!Z_Z&^L%N\JA_P!R!Z_Z&^L%N\JA_P!R!Z_Z&^L%N\JA_P!R":IZ
MB"I@CJ*>09H)A8XI0=B$A)L6(7;8[.R"X@("`@("`@("`@("`@("`@("`@("
M`@("`@("`@("`@B=5?,4_MH?C@6GT?W(U]TL/^E]F=7U0EEF;A`0$!!S0*AZ
M#B/U0Z^M>W0DS0T0O-+$QG"),/1`B)V(W=\2RL*YW+:UBW'K[LFO51UOS2DS
M]/YL"IBO`\7H*JY!EA,XZ>E/*3"\3'.438QL0/R_K.SYN;D74VX84[I2+ZXF
M=Q0D'UEL,3CM)XR8LQ,3NU7#@P,S.Q.W*^/(R#5-9V*BOO'JKM=QLHW>W36"
M$ZB4B>,J8HY)BC,)6PR.9]'%UU;=-N/%3/5S,1.FN:C7J*AM5NXS:%M]NU)-
M>(H):ERM<\XU96]RICQC:H'PF?DP]A>5L\.?V13J_;J>ET<3W_9.MZ87;@0$
M$78_#N?RV3W(+3ZCW?ACQ8O1Y;_CGNA*+,VB`@("`@("`@IW<?[+?H9`W<?[
M+?H9`W<?[+?H9`W<?[+?H9`W<?[+?H9`W<?[+?H9`W<?[+?H9`W<?[+?H9`W
M<?[+?H9`W<?[+?H9`W<?[+?H9`W<?[+?H9`W<?[+?H9`W<?[+?H9`W<?[+?H
M9`W<?[+?H9`W<?[+?H9`W<?[+?H9`W<?[+?H9`W<?[+?H9`W<?[+?H9!4S8;
M&0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$$3JKYBG]M#\<"T^C^
MY&ONEA_TOLSJ^J$LLS<("`@(-'I+O0R\3*NAW5)UVGPC<FB=JE@*E"7>;W'!
M\<<CMAL;!*SA3ORK3%^,]V1@:D)VXJV5FB<WPA=S'.SB#C4-F(FQ%AS8-E_6
M=V[BNY,XZ8NKQ3>C)5D:^NU90:IL@A4C%2S"X'"\<4AF9U$0ME8S`VP9_P!5
MG4QYIG5/X+%M<T3TS#GW%2.QAQ!U;<;W'55%#;M-T,\E'25)4I39JR0,A$/A
M-TL<'4F8C+%MTYMY;:YIFWJ<YX9W/0]=QBT@^EK-46@0GGZTU14=8WCO3R9<
M-@X8*S?==EBV.I.7%N2Z;NM[&1!`01=C\.Y_+9/<@M/J/=^&/%B]'EO^.>Z$
MHLS:("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@((G57S%/[:'XX%I]']R-?=+#_I?9G5]4)99F
MX0$!`0:#(]BI.(TM6T]6=Q,VC*D@II"C(CIXQQ,QQ$LH8%CS)6N*G;;^93/B
M[6?>)[XVN+?#`54UO)HGD&-BW#X/+O,[M&0_LXYC9^3!-RN/#O\`!=_-AAW(
MOB"UM/5=FAGJ:FGK#A+JAT\(2B)=8BP)W)^B^;!N3DQ357#J<TC3&MQ'CS9N
MT^-MGLU96N`55!10554_0<_?)<SX"Q-F)^1LN&*?IC+D=Q,TQ+>F-#6W1OX@
M-*6VWW!KA#)GE(L<28GIY-KX,S92_5P=^1U9OMN_:YB+HC]3UJH"`@B['X=S
M^6R>Y!:?4>[\,>+%Z/+?\<]T)19FT0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`01.JOF*?VT/
MQP+3Z/[D:^Z6'_2^S.KZH2RS-P@("`@T6".TMQ4EF::<;D4<@.)1!NC$8(7R
M!)X;;MBS>RY8<R5Z.WP6DTR]_P"2+UG6U5/Q%H0&X=0CECIH@G=V+=F3SOB\
M9=!P+!F+'GP7,Q&6?#O=6S=FBNWPDXEPU<FJ]-[H=YDRE)(X.[/A4P\F7%L>
M?DV+K=JXWJ?G1R'C]2VVKX]VBFN<ST]#+248S2MBSX;V79F8@RXOLS8[.5)F
M(RQ5U$3FRK=ALVDK3^(32=/IJN*NI"8BD(B>3!^KRX/O'(L<VWH[,,%(OMN_
M;%";;H_=-7K!5R(""+L?AW/Y;)[D%I]1[OPQXL7H\M_QSW0E%F;1`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!!$ZJ^8I_;0_'`M/H_N1K[I8?]+[,ZOJA++,W"`@("#G=..;B
M[,3DS,+&PAE,7+"DBS/GRY"PS-B..SE2F&'L,,O@MZK"FGXEVNDE`IGGCB:6
M-B+*\+M4";$&[(,NW%^FSJQ-,/Q\";8F/R_-;XFY`U%I^!CW$3%$+RL[X`W6
MH6!L&VOF=LNS_P#A28B<N':L3.;#LEQ[\0-PMMNX\6FNN<._H:>CI#GCV^"T
MLO2P;ER\N'.E9C'!$1.*5G3FI]*:B_$#I.LTU0]2HP8XS;+DQ)J>7HY.1LO=
M;EQ3?NNQW&Y%N*'K-$$!!%V/P[G\MD]R"T^H]WX8\6+T>6_XY[H2BS-H@("`
M@("`@("`@("`@("`@("`@("`@("`@/CALV/S.@Y34\5]14)5FF*J@BDU\U8-
M-:Z4&-J:HIYG<HZS%WQ:,`9]YMV.RYW+J[M<OO='M=;UM-[1FZ74J8:@::(:
MDA.H8!:8P;*+GATG%GQP;%=.5Q`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0
M$!`0$!`0$$3JKYBG]M#\<"T^C^Y&ONEA_P!+[,ZOJA++,W"`@("#G(E3CQ;.
M:0XHQCW@.9;P'SE2PY0S$^0B)GQRLW,W.I6(PPEU$72R[]16&36$G:5?5#6U
M`4HT5/1C*#QL+RL)$8,6.)$6W9@RM8R4JYI.6L0M:_.GCU'81.ABJW%Q?K$K
MRYH6:>(6+H.S.[N[8.7.F/-3#0;=4TVO/?XK_O2C_P`93_&2HL-:X!_?!IG^
M/+_;RHLO=*.1`01=C\.Y_+9/<@M/J/=^&/%B]'EO^.>Z$HLS:("`@("`@("`
M@("`@("`@("`@("`@("`@(/ADX@1,+D[,[L+<KX<S8H..U6A-=U]1/Q#)NKZ
MWIJC-:+0\@O$-NC=Q>C,F?+FG%W(BQV/@NN7%-V9_5IZ?8G,QUB/TZ,_7UNI
M3WVCH;1#<KL_9T9B&]"9V=XS-O`)QS-BS[-BYII7%F1OVC:(]+P?ZN\@?:-H
MCTO!_J[R!]HVB/2\'^KO('VC:(]+P?ZN\@?:-HCTO!_J[R!]HVB/2\'^KO('
MVC:(]+P?ZN\@?:-HCTO!_J[R!]HVB/2\'^KO('VC:(]+P?ZN\@?:-HCTO!_J
M[R!]HVB/2\'^KO('VC:(]+P?ZN\@?:-HCTO!_J[R!]HVB/2\'^KO('VC:(]+
MP?ZN\@?:-HCTO!_J[R!]HVB/2\'^KO('VC:(]+P?ZN\@?:-HCTO!_J[R!]HV
MB/2\'^KO('VC:(]+P?ZN\@?:-HCTO!_J[R!]HVB/2\'^KO('VC:(]+P?ZN\@
M?:-HCTO!_J[R#)MVM-+7*LCHZ&Y13U4N.[B''%\K.3\K=QD$T@("`@("")U5
M\Q3^VA^.!:?1_<C7W2P_Z7V9U?5"669N$!`0$'.Y98:KB=);9*:C,<[3&;P1
MR381TT9,Y&[YVV[!?!7'IFF'_'_]$Q&CO_\`Z\%C5=7'%Q,H'*"2I."&":.G
MA#&0W8IVQ$L6\#]E^7%<S.%:=\K&&%&9K^TC7WRRU)U%-!N<&:&>8H9"WDP,
M3AE=MHMX/_E@DS;&7NKX>PB)G)$[:>/M>=OQ3PC!Q+IX!<B&*U4H"1DY$["<
MK8D3[7?V75(:]P#^^#3/\>7^WE19>Z4<B`@B['X=S^6R>Y!:?4>[\,>+%Z/+
M?\<]T)19FT0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0'=F;%^1N5!C1W2VR4
M15X54140L3E4L8O&S"^!8GCAL=EQS+:5KB=;DUI3&OPS131!+$;'%(S$!B^+
M.+[6=G7435)BBI5!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`01.
MJOF*?VT/QP+3Z/[D:^Z6'_2^S.KZH2RS-P@("`@T:WP4]3Q!.YTU91ST\C$0
M-'-&<K^\!$[9&'/BSCMZ6&'LJ1=$X3^7BLQ,9I\._P`&%J<2/BA9A#+T2II"
M8L.9J@<6Q'EP?9TE=>&WP3##%XL'B5<WEU9:J.$)3:FD@ZTY"0Q"SU,+XOBW
M3QS,S<S/[*8XTQAA4Q:8[W#_`,5_WI1_XRG^,E18:UP#^^#3/\>7^WE19>Z4
M<B`@B['X=S^6R>Y!:?4>[\,>+%Z/+?\`'/="469M$!`0$!`0$!`0$!`0$!`0
M$!`0$!`0$!`0$!!YVOD5M@XAU&D8*J2+AU7W*"2]L`_]>*YR,Y]1:1GP&.<A
M%S;F?8DS$SS*9._3J6*Q&Y7'/=H]CT/''''&,<8L$8,P@`M@S,VQF9F29JD1
M14@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("")U5\Q3^VA^.!:?
M1_<C7W2P_P"E]F=7U0EEF;A`0$!!SFEHABXM.U/[W3@,A%3L(B+$5*#9Q82Q
MV\F9Q9N;E5FZN?'AT>-=1$4C-3##0L:QEJ2UI15]"<=2-.4(!3!+&\CRP%,\
MK-"1B^9A?#P5(I.?'A_QGOA9K&;%IPNCNE?XC5`]OZ>,XV<<P&.;+B!/41-B
MX92<_"PRXLS<O,E9S8=J8G`?Q7_>E'_C*?XR5%AK7`/[X-,_QY?[>5%E[I1R
M(""+L?AW/Y;)[D%I]1[OPQXL7H\M_P`<]T)19FT0$!`0$!`0$!`0$!`0$!`0
M$!`0$!`0$&+67:VT4L4574QP2SM(4(&3,YM$.>3+W<H[77,W1&5U%LSD1L.M
M])SE.T-SAD>GC>65P=R;(.&8F=FZ6&.W+R)%]=.Q9X<PH]>=(34)5(7:%Z=V
MP:0'?%\<!Q!F;$MI-R,F]T3LDY<X40%)9^%AV`]%PRQ5%'<L9Y(MX4DLAU#O
M+OBEVOG=VQ8G?'8NXXVB,4=&)Q/"G/./55+ZCNMJL5MH+;47>IMA2Y(::N`!
MGD?=Y1P,Y8Y@VXMF<F]E<3-,D8NAU;%<LXT1%=:2:J&EAUQ722$TI8A#0..6
M`S"1\S4N&#%$3?F4BZN2)6;*95HK];AI*:K?7%?N:O.].[4]$[DT3X2%@U)C
M@..UTW^B3<ZESMBW;YX/7VKWK3-3.&ZH,6F*3=,'_M>5S?!3F0O+E:*_V\*6
M>JEUO<88*;'?%)3408996A?8])MPD)A5FZ8RQ*1;$Y)@BOUNE:!X]<5[]8<Q
MC_Z]"VV-V8LV-)LPS,F_T2;G4R;77PW2I>EH=:W"6=G=LG5Z%MHCF=MM(VW#
MF5B[HF$FWIA8MMZH[C5C24NM+D4Y2;G`J6C%FDVX`1%1LS$^5\&?E2)G1),1
MIA4%XHRKJB@+6]PCJZ:0(98I*>A!]Y))NA$<U(V;$^XI-U,L2L65BL3$J@NE
M&8UQCKFNR6Z'K-:;P4##'$S8N3OU3F3?Z)-Q:GOUM@.0)-=5V:/=9L(*%_\`
MF;$&;"DVXL^*;_1)N=2J:]6^$B:375<S`!RF>XH<HB`N19GZIL?*..'<3?Z)
M-SJ6#U18Q&<GX@5;M32C3RX14#NTAB1"+84FW%@+D[BYYL=*\J>A=@OUNGSC
M%KBO*6,7,H&IZ%Y,HQE*[Y.J8NV2,G_,NM_'2DU2;.F'V>^6ZGI@J:C75=!'
M)`%5'O(*$2>&23=`;"])C@Y[$F^F6)(LKDH^37VWQ51TKZXN!5$<;2G$%/1$
M3`\8S,^#4C\L9LZ;W1)N],,B:NB@HJ6MFUG<8Z>L!Y83*FHO^(<,TAMU3$`;
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M2+<U8JMT-ZH*_KCTFN:Z:.@"62JE&"@<`&!W&1\W5-N5V4B^N:5FRBDK_:!'
M,^OZK+D>7-NJ##()`#ECU3D8I1;\ZG-A>7+Y'J"V25$T$6NJZ22G<VFRP4+L
M+QN[$V/5.7%L%8OKDB2;*:$MI:NI[C6M)2ZIJ[I'$Q.=++%2`!LSN&.:.GB/
MHEMZ)*Q=7,YFVC;ETY$!`0$!!$ZJ^8I_;0_'`M/H_N1K[I8?]+[,ZOJA++,W
M"`@("#F75:Z;BW6#!.5*[.)G,`QD;Q-31=#I`70(L?UMC[63HG(M>JN'3X)&
M]58Q<1[?3R4%%N7&$H*XXRZRT\I2L;#(+8;1!MCJ[UVG%H2(MT8T=Q4B/U@L
ML\4&]GB%W@?+CC)UB+(/AACTN;\Z%:8?A+@GXICEDXE4TDL;PRG:J4I(G=G<
M"<Y7<<6=V?#V%'4->X!_?!IG^/+_`&\J$O=*.1`01=C\.Y_+9/<@M/J/=^&/
M%B]'EO\`CGNA*+,VB`@("`@("`@("`@("`@("`@("`@("`@UC6VAX-4#!O*A
MZ:2ECG&FF!L3CEF!A&47Q_5[G.RZMIG2:YD7I+AM5V2.ST=17QU-!8(IH[=D
MAW<QO4`X&\Y9B8L&)\,&V\KJS3-,^QS%<\1T]+XW#2JI^P:FAKXQKK!2M34[
MS1.44A8](C$2%]HOLP?8DTG28XS0HI^&MP@O,ER>NIZDIXHHYQFA,1<HP(7P
M"*0(\I.7(XNI,6Z9KJGME<>C9-.RB1UQ5Z0I^QZ34;.3U$IA1`&.5S"-S+%F
M?P<HX?\`HN=_=S5=[E<]$3;*;08V6355+3U%+10/-%/$SN.49IB*7,&.P6*H
M(O8;\B3?,QCC&FY2:1.)K%#>^$5VDI[13!7GN&E8*EB,7QJ1(YHB=B9]HP8.
MV'<4CB3Y%GAXOW8\.AE5-/PU*ZF<M@KG.**:,JK]1\@];WGAX[P!/.!X8LN^
M9?Y8VPFY;YIV3[&8U7PUU#54ECJ*>KBGK9'W4!N8-,TY'4NQ$S](6.'/AS/@
MN8OF)QVK-F+%<O7VEX<VTJB.2"IA*F*H$P@=V%W88-XS,[X8/O0_]59XD^6J
M19_R8EKOFA+=/'?@&X/&$CC/421DXG5B+`09,<S$.](L&;!\>78RDS-/V]N-
M8MBO[L.M,T_J9!:J?5]NIZJHHJBJS-%";N,DSSE"$QQD3"64WZ+]QV3?F8K$
M15-VDTF<75A*.K+_`,-I]0M"5%45%YJI!J3%A?&*2"IP;:[X"^\BVY>5DCB7
M9-U9X<9=YGW6S:"ME][+JZ6>4[C2[R<",BIVIH38B8V=\,I/'TF?E96>),36
M(C%G2+*YVM#+PJFM8W*DIKA/;YAA#?1&>$12NY!"[.6+.0\VW!L.13F3Y(-S
M_EV?AWMBK]-:%AH;?7O059O7=&EM\1FYR'N2=W(7+!R&$'QQ?D9=;\Z(JF[_
M`,IHC-.:*X3ZBN->5MM<X'!(4DLSD8`TDKL3L#9N9\<.YM[JL<69RVPEW#ID
MNE]IJ[AM17DXJBBJX;K13%2QRS8D9O4@5*8B0N[.+"'/R<K+B>)=&+=\7<<.
M)Q[W91GU%IX<ZAL,&I+A03=3M$(T].\KFQ;H/`'*+]+$CV8\ZMO$F(R0YFRL
MXKD0]7P\MUQFFGH+F-;2DT52TI.[M))&T("72P?+'@([>12;Y\L;7461/O3L
M_!GUNI="7.S!45-'7QVVCIVIA)L0WU--&,FY+*68@,1%W9U(NNSVQM@W8S7=
MGX=RBFH.'M]GDMDU!75,A0Q!55503N\$50S'`SR.6(MEAP'#D9=1Q)CW8B.O
M"4NLK[TUZOPHP);SPPW5!6T5#7%2UA2;B2FZ(L[$--()-FQ;_A']./.I/$NG
MW8VT6.'$>]V?@G:ZR</-.V/M&KHIWCN$8EO'S2U`.+M*+AMQ`Q)V=LO.RZGB
M3FAQ%D3EE:JK%PWK]+MJF2*HJH*:9YX[@TAO4G-!,<&\8\<7Q-W_`/12.)^G
M]NI9LFO[L.I'W:X<,*J@HJ&XVVIG.`I1CIR8GF;K;[QYI'S8^^GBXE^UBI'$
MNB?VPZGAQ/O+]/J+AO4UU3"]OJBEDF`I(S!S`YQ(XH@RL[LSD9DS,^Q(ON\I
M-EOF35_DT39ZRU66OI9B8Z2*FIV',8!3P2`X-)MY&(!Q?N<J3?,3BA(LB8RM
M=TU>.%XS%2V.GJSCOL$Y=7''(6^:64PRN_1)]T6',R<RZ9_;25Y<1'[NS\&$
M%-PCJ:.JJNPZQ@,BK:T&9\8HI'8>3/LBD/;D'G;'!7FW>6.S"J<N/-.S\$E#
M9N&5OH;M-1M4T4-HC*:J+,1,ST[MTF8G?,69L?9=)XE?=V$63YDEH.LT4^I9
M:6QE4%,].<H/+THW8GB*1V+%WQP.,</8_*N=^N:B[E,]7154$!`0$!!$ZJ^8
MI_;0_'`M/H_N1K[I8?\`2^S.KZH2RS-P@("`@Y_'+,/$^2*.*4@WSF980C%T
MJ*,7Z3MO2(6;'+CAAS(89_R6-9Q04VMH+N]=2T]53P0-3!4C4%MS38MEB%P+
M/CLVYFP37.JVOC"Q71&V(\)6^)M/+572UD,4LS;EQ,XV]Z`I9HA$CQCER[2_
M*FPK3#\8<!_%+$</$FFBDD>4X[32B<I89B=CE9R?*PMB_L,A#7^`?WP:9_CR
M_P!O*BR]THY$!!%V/P[G\MD]R"T^H]WX8\6+T>6_XY[H2BS-H@("`@("`@("
M`@("`@("`@("`@("`@("`@("#0>)]V>V'2F^G&O\=1%()BP.9@$1!+(W(^'1
M',W==EU$<3W$G<]Y&V6ZW>*UA0/IVG[,K8H2J;="$C$95F<9A<I.B^&3;CS.
MIN\2M:X^JD=Z[UE*8Z==9[D78=24T]-3W&JTQ24C511SW*`89!FI';&)I)^B
MS/G$NCAS/M74\W/.3H[M/@E.'F^K"GBF[1<:RITW=;M<[!`U3#$#TE!%%(TD
MLU53`+1%F[N<8GP[BE+XQ5Q]7XE;)Z(ZV)9[I3S4U%);;%3T=T@KXXYJ:HBE
M>2!W@<#D$L-F0W./''#!*7Y)Q:L1^C+E_P#)%R:PJY:GM>KTU!4[P8^TI`BE
M*0(WG`&9VV])MA<FW!2+>+&2>S\5F[ASE^K%W).ENU=6537:ITS##6]7SU]+
M)'(\PU$4XAD%_`=\N0F)7=XD9\?5XUR)6S5U^"Q;]:W`:FCL,>FX9+)))1.3
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MGCKZJT62MHNS*2&@DKYZ-LP3/3C%$#NQRCTB?>Y1`<NS%28NK6NRWPKC6)MR
M=]WC3$B['6TH5E?-5:2"ECI*:6JHR$)".2>GDCC`'QQS$12\O*K3B1HU1"5L
MG/.N5BDU/6R104;:)".$6<JF`A)F:2CIF>:!G=L&,2P&-WV$V*;O%RUC9ABG
M25X>3'MPR9X2VJ:P*.YP5,MBI:BXR4U.\K9)7.H>=WB..%Q9Q]Y#ES_M<R4O
MG)].W'F(W(Z/_*G5BSHRYWZ-PC#U+$RD.I"1G`A&.H"I>GI`<A;!M\$&9R;8
MV"4XO1AX0?\`STSMIA+X_$.NJZ8HI]-M&%&50%#15$4KR!U:5@CE+9E82;V>
M474BSBQ^7XK-W#G\TA?=3U5JTM;H(--A<K?<8IIJBBI`)@!PFWDO1;D\+,W=
M?%-WB3-8QSTP5X<12<4=;`&],5LADJ]&-UDAMXS@P$1-3.)S3RL38OE@Q=Q%
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M_<2D_><&Q_(I-\SE(MB$BN70@("`@((G57S%/[:'XX%I]']R-?=+#_I?9G5]
M4)99FX0$!`0:C3:5KO7^IU$[C'3M[TPOM.07@C%G;H[&8F?]9=8J8>WP2LY,
MV'1XH755:%-Q+MKO2G4D$$4C#&,9O@SS,^`$^\<]O1<>3;BN:3FP[.^771/C
MAV+NN#LD>IK13U%M>26K(:IJIJAH,LT<L489XR=AD?!^X[[$QY:1X[8(T5NU
M9-CS]^*_[TH_\93_`!DJ$-:X!_?!IG^/+_;RHLO=*.1`01=C\.Y_+9/<@M/J
M/=^&/%B]'EO^.>Z$HLS:("`@("`@("`@("`@("`@("`@("`@("`@("`@("#Y
ME';L;;RI5*0^HI@V..&U$I!E'N-M2I2#!D6@S,W(R)0P;%WPVORH4,&QQPV]
MU"D&#8XX;4*08-W$*096[B%(,K-S)4I`[,[8.V+(4,&1:&#(4,&QQPVLB4,&
M0H96[C)4I!@S<R%#!D6A@W<Y.1$I!@V..&U"D"*("`@("`@("`@B=5?,4_MH
M?C@6GT?W(U]TL/\`I?9G5]4)99FX0$!`0$'.]:265M5;F2GK:B[G31301TE0
M4&,<+RN1]'##)F?V7=V;!,N*D3US^.Q8Q8ZS&J)[X4<0J6:>\6:=CC:"GA:7
MJ]15!3M(83Q&S&TABY8,/Z4UTPZI6(NG)%=6%'GO\4%0]3Q%HZEV$7GM%)(X
M@;2"V8I7P$QV$WLMRH('@']\&F?X\O\`;RH2]THY$!!%V/P[G\MD]R"T^H]W
MX8\6+T>6_P".>Z$HLS:("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(
M"`@("`@("`@("`@("`@("`@("`@("`@("`@("`@((G57S%/[:'XX%I]']R-?
M=+#_`*7V9U?5"669N$!`0$!!S'5\=7-Q,MT=+504\C!3.#E"4DK&76!8V+.`
M8"./1=GQ3%DFO9XXUIG]N':JXF25(:CLXE(74^KFU5D>1C=WGB%G'=NVW:[8
M>RI.&%82D3EP[)<"_%(8'Q(I3C`H@*TTCA&;92%G.7`2'F=NXJL4S-?X!_?!
MIG^/+_;RHLO=*.1`01=C\.Y_+9/<@M/J/=^&/%B]'EO^.>Z$HLS:("`@("#&
MJ;G;J6>&"IJH8)ZE\M/%(8@4C]P!=V<OS+F;HAU%LSD7XY8I08XS$P?D(79V
M?#9RLK5*/IR`#8F3"V+-B[X;7Y$F8@B*OJJ*&FB>5XF,=Z+,1!BV9F?8SNRE
M5HL3W6V4]%UZ>KABHGP=JDY!&/;L;IN^7:I-T4JL6S,T7XIH9H@FB,9(I&8@
MD%V(2%]K.SML=E8F)28HKQ5JBEY(V-@<FSNV+#BV+LW*^"E86BI5%$%1!/&T
ML$@RQN[LQ@[$.(NXDV+=QV=G4B:K,45JH("`@("`@("`@("`@("`@("`@("`
M@("`@("`@("`@("`@("`@("`@("`@("")U5\Q3^VA^.!:?1_<C7W2P_Z7V9U
M?5"669N$!`0$!!SK55-42<4-/SA4.U-`T;5%,P,S9SWN[)Y-C\Q-EV_F2L9*
MX=5?`IT1X]WBL\5&@*]6D9`>21HR>G%G)G&1YHQ`F<3#*^9V;%6*YC%A3Q<!
M_%*,X\2:8:@F.=K32M*0M@SGGES.S.[\_LJ+#7^`?WP:9_CR_P!O*BR]THY$
M!!%V/P[G\MD]R"T^H]WX8\6+T>6_XY[H2BS-H@("`@(-,UIHRZ7J]6^NH9H8
M6@8`E.3%R81F:5\0P()&?+@S/@[/MQ741&><,--8<S,UR8=^QJE1H'6-1JNA
MI9)IBM,,S3U=>-1+&!4^[)GI1`3;ED?-CAC[."YY-F68MV17\G4<6Z,45CN_
M-;NO"375PFH!EO@'3TD,<4N:2H9S>,787=F+:XG@;.K'!X6$03QK]':SKGPT
MUO<Z,GJ+TT54$KR1!#-.(.(Q01,)/C^MN2)]G*2G)X>?'J.=?FK&M<KN'^L)
MJ3J<-Q?K8-0&]R.0QWCTT11F!97S%E-\^#\N*O*LG%F.;=&/.E#T?>JBPT&3
M=A6TE=55D=%._O>2I.3*+NS'E.,9,P['9G5B(KEQZ7,S6,E8:_4<,N(79L-O
MAO,`P1E)))E*:)WW@,&Z%@RBP#E8FV<O,I/"X<Y>YU'&OC)':NR\,=<O5VVM
M&]L]33=5ZR3S5&!-3#$)8#CE]\R%CL_64Y/#PB#G7].U6_"C4T=955,%Y<3G
MMK4D<CR3D83D6:8Q<B?!I<,KX<G,KRN'H[(.;?A*U:>%VO:.2<ZC49U#24SQ
MA&4LN&#R";4[NVU@81<<[=+I*<GA1D[L,70O.XDX88^EN>@-,UFG;-U"JW6=
MB,V*$Y3;WR4Y,OOC[,N\RXMR\KJS$1D[J)%TSEKMJV90$!`0$!`0$!`0$!`0
M$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!!$ZJ^8I_;0_'`M/H_N
M1K[I8?\`2^S.KZH2RS-P@("`@(.9:QBN$G$JUE1-2!41A!N)JB:09'(GGS",
M([##*W3Y^1,629IJPC:N;\OS9NO7MU+<J'K4U?OJB2.;J]*4112%%)&V1QD,
M#P<F9\!+#G=DU=LQMRP8]/95YU_%'515?$>DJHL=U46FEECS-@^4SE=L6YG0
MA`<`_O@TS_'E_MY467NE'(@((NQ^'<_ELGN06GU'N_#'BQ>CRW_'/="469M$
M!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$
M!`0$!`0$!`0$!`0$!`0$$3JKYBG]M#\<"T^C^Y&ONEA_TOLSJ^J$LLS<("`@
M("#5:^*:#4E94T%GAN%;N(#*HGJ&C(79Y&`(V(#RMT<=C\JM9I2L6QK2D5K-
M9V+6KM.W.[72UU%+(=.\&[WS,+'$3--'(02/G`L&8-F#<N"1$9^_"I,O-7XK
MOO2C_P`93_&2J.H:UP#^^#3/\>7^WE19>Z4<B`@B['X=S^6R>Y!:?4>[\,>+
M%Z/+?\<]T)19FT0$!`0$$1=-6V&U7&&WU]3N:B<1(,1)P9C)Q%R-FRCBXORN
MN+KZ3D=1;5)T]535`N5/*$HB^4B`F)F?#'#9^5=1,3D28F,JXJ@@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M((G57S%/[:'XX%I]']R-?=+#_I?9G5]4)99FX0$!`0$&AZNIY)+Y5S#:8KC3
M4]%$=><M45,019I7PB8<<Q.S$_2P;V4_]=<5_):_%JFGYL^^PTE360O54U<]
M(--NX&I"E;>/)E?+[T;-L9L.E^E*=$3L\9CQ3>IDNF,.J7F/\4A.7$FE(HRB
M<K32N\1NSD+N<O1)V=VQ;\J+#7^`?WP:9_CR_P!O*BR]THY$!!%V/P[G\MD]
MR"T^H]WX8\6+T>6_XY[H2BS-H@("`@(-;U!H2T7N[072K<WJ*8!`(^CNRR$Y
MCFV9L,Q;<KMBRZBZCF8EK<D)Z.IZ&QT]ZFH@&GDJJB9J(:B,SWKE-,4AEB.#
MR,V7F;!<W3HC%J=VQ7+./6JLNH:^]76>V6S5I5$U.<D<D@V^'=YHGP+`L^WV
M'9<VW5S=WYNKK:83[**:C4]53UE923:N():(]U-C;8\,_P"R+X[7QV?E4FZF
M8BWI6*'6CULL\,6L7&>E:5ZB&2VQ"8-!$\LF+.7ZHLIS.A9LZ5+:UG>6,&U5
M,\<M&]PCJ.RX]T5.T+SYF+-RY!?9W6P5WIT3V>U-V-,=OL6Y->$%P>W^MDI5
M3$0M&ULBVY'RD[.Y,VQW3>FN3N]J[D:>_P!C-I-35M5<&H(M6'OG<1S/;8F#
MIOE%\V;#`MF#^RRN].CN3=C2^W[4U18JN6CN6L=S4PC"91=GQ.3C.1"&7`MN
MT'4NOI-*%ME8JQYM95$5754C:JFEJ*(2*H".UQD[,`#(7ZVWH&SIO3HGL]IN
MQI[_`&,VY7F[6RCM]77:HD@BN3X4[%;8<S;&?$VS;-A,K,S&;N]J1$3G[_8J
MH[M=JL+E(&JR"&TY^N3';X1$=VY,6'2Q?#(Z5Z#=PQL:/5%6<3R%JPXLI"$@
M26V(2`CF:`6)LVSWPF4W^CN]J[O3WK5NUD5PJJ6GI=8N;UD+SP'V=$P.#1G*
M^+N6Q\D1/M4B_H6;.ECOQ`B>FCGBUB<[2QA-''%;(R,HY(SE8F'-R,,1.7<2
M+YG-)N1&>%V76E7%*4)ZGG&49&B('MD+.TA-CEVGRX+JLZ.V/:D6QI[+O8DK
M1=+S=8ZB2FU1(+4T35!M+;8@<H7<F:0,2Z0XQDVSG96LYX[DF(S2Q+1JFKNT
MT$%'JPRGJ3R01E;8F<G;:6'2PZ`NQ%W&=2)F<TK-L1G?;KJF2U5]50UNM&BJ
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MYI2;(C/"WZ]3-2#5%JBHCAD?+`9VJ,6D=C<"8'<L'R$+L23=,9N[VD6Q.?O]
MCI-HJXZRTT57'-UF.H@BE"HR[O>,8,3'D_5S8XX<RZAS++500$!`0$!`0$!`
M0$!`0$!`0$!`0$!`0$!`0$!!$ZJ^8I_;0_'`M/H_N1K[I8?]+[,ZOJA++,W"
M`@("`@T#5%VKY-;16"CJ8*?K=/`\^^@CEQC,Y6?#,+N3X@W1=\&Y4KCRS"YL
MD3AU^#$UU<Z7UJM5-%4`513[N&8,V1XS.>$F++GCRY@V9F8N7+SI2N;L\:3V
M%:9^W#M<%_%?]Z4?^,I_C)4(:UP#^^#3/\>7^WE19>Z4<B`@B['X=S^6R>Y!
M:?4>[\,>+%Z/+?\`'/="469M$!`0$!`0:#Q%U%16NL'K-E.Z"%+*\A1N6882
M8I)&RMX38P#CSI$7^Z?I]Z6N:8U%2]H/=;388J2IJZB5ZQFGE=L9(2J'+*+/
M'F+*[>QLY$F.).6FR?;WD19&2NV/9W8E%7=+2]\KYKAIZ(WJVC>*7?2N<DDY
M0NP"+[!++,Y]'G%6.9&C8M+)T[8]BS(%@M$[4QZ<HHY9ZFY!UN:>9@=X,HS;
MR0F=W>HW8L(\CJS=Q*98I\,ZLZ1;;/FKUQKS);3TFDM0WB2Q56GRMGO,LT.<
MRC:2,)W'=QY7'8^]DS`W(W-A@E;XG]41^)2V8_3,HN_W;2M-J64)=.L?52J`
MIZF"209SD,RZ#B#X^^319>3G93>XDXL4FY;EK,;/8CHM56*FN%MDBTU6R5,D
MF1B8C)V:FB:62#*[8,\,N`$V&+L&.U-WB^6,,,1^CS2VVT'I+6FHZJ2\VJED
MN5$(M25#2$>]!FVY.1L-F+<^',EE]]N+P]I?9$XXKM0-KJ;,9%64VG`)@>MC
MJ1W\TDI-'!F+#E$C.+H8X^PD<SH_]?Q[R=W/-VV/9W8NO*S[]JVWUU)'%<+3
M3586P'D@(*B1H)Q?*&YIB%O?)&_7%]BYC?S4Q_\`&<(=3%O3TXXQ8=&-A%KN
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MB[`$HG@P\K/BDV\3-$+6S/,]C%L>O+-;K9'6T%A"GF#<5$<92F4D0U4;@8RN
M6W.(1,.5OT)/,R>'X^Q8BSIPU89TQKJ;2%MKXMYIQKE47&FJ):J5L[-GK,!C
MBE+##&<LPAF\'#9@NM[B>[FP_-QNVYYG##$HLVHK1K*\T]NK+,\,%+-56^F%
MY9`J(PACQ(I8VR^]GN\G+RKF(OB<<1L\75T6S&*9Z\7L8E35Z+JIZ!I;8$L=
M-#&-1O*F5YQC*8W>*(6?WQH7BSF+\FQ(FZ,D1LPHLVZ9GLU9F';KMI>Y7JWP
MS:5J*2IJJF&!YGDF!Z::1Y&`G\%Q<H(Q-BYV?!6G$SQ%,[G]&6+IKFR).;5U
MDTU-=+%064^HM.-,Y3R2/%40X.%04>?-CNS?=NPX[5)CB5K$4T8=RQ%M*3-=
MF&&9"VRY:5ZY/)!IX(JAB(I2DJIO?A?"$(P?:QU#!(^5N9NXK^O1'_KV?GL*
M6Z;ML;<F&F5^>XZ0>DJ)_52&>:3<5E-;Z8C>5YP++'3R1B.`2"+$Y@VQ]N*N
M]Q9T5ZL_7GII<[MD9YB.N,G1UZ&25=8:&=IJ:P44=/554U#25I2RQQC#<(!G
ME.5W;H1D&4<K<C\F"DW<2F6*9?VK%MM:8Z]<8^Q'U>K+#13QMZJ/GD(C@*:4
MWI6W48R&4;%T6Q.5]FQR\)/_`*QCBD=-"EDXJS/1A#LMB"D"R6\*.+<T@TT3
M4\.U\D;`V4>EMV-LVJ37.,Y`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!!
M$ZJ^8I_;0_'`M/H_N1K[I8?]+[,ZOJA++,W"`@("`@YUJ=XFXFV=@A%ZDGIL
MTPN[2;MNL;'9I&Z/_P!M_P`JN/4F)>UG:JVLU-01R5]-2TSR12P;XF&67)*!
M'3`PNV+8@QXDS[=BYK;GG##I=1%U,488=&MYZ_%?]Z4?^,I_C)52&M<`_O@T
MS_'E_MY467NE'(@((NQ^'<_ELGN06GU'N_#'BQ>CRW_'/="469M$!`0$!`0:
M5KB?7S7*`--PQO1[@XYY#R.;S3OECD`2Y1@RN1MBV+.F[7WJ884*Q&:NK#*P
M+0?$;M*D*X0;@7J">JCB:%Z;<[^5C(CV'FW#1N&#?E2;<\W5U^&%$B8R1;35
MXX59=_;6IW&XM;@/(T>-J(1@>GPW8MG(B?.TN\<N39EP2(KGR]/AXE8C-D_X
M^/@URF?BGO9H;L\I1QU3BQ4X4Y8TXF^$@YR9LV&#MBV*19$9+OFIJRK-T7>[
M'_K7PPT-ATM3:VGN-LJ]02L)103O5PQM"X#*Y,T>#CB39A=\<$B(CWJZ_`F:
MYJ:O%;O8:TCN]=#9X8X1E,YH:L@B<,#CB`<<78G(9!(B;N)./WJ1UI2,N[6>
MKQ0AS<8SM=04L#P7!WJBH&IAIY!:=YGW+2N3M[SN?UN5W3E9MZO_`)4U_@N_
M;&/=I_XX8^E(4+<2HZ^V27"GB;=UL@5<D`0M&5,P1@TN=WQ%B;.^&'L*S;BQ
MW5UI$VUQ6TU,[53<0X=00AIT(>Q96C.IE)HV*/>$\<KCCRN+82>SR*3;O8][
MM6)BW%N]B,BI.)]/;:EX#CGK!ZR5/'.,+"`O$)1/&P88$YD3-CL[JN['F^:J
M5C/;%/AHG.(,NM(!H9M(4\$\Y[X:O>/&.PP88I,Q?L2/G?NLRG[HIO4UD1%L
MUFVNIJ6^XSQT\,T-(U17X2!*,PP@`-(.6,XSQ?')([&[-RLR<O%2+J:\IS+:
MUFWY?P*-^+[2@53"8QX$\\D<<&=I.8=A>#SXJ\O_`)5_\DWK:_MBOP_AAI?`
M#C'%4"\D03DS`<,@A3N.8H>EFDQQ][)W9FP_(ZG+Q8K\7Q88:%WXK^W'U;,.
M],5$/%&H)H82IZ66:KF>2H`8WC:#.6[+!\3)LK#[+INQ.6_M*Q&2WL\:-@U4
M&KVIZ`+"415.QJN4A#=N[$&9W9WQ9B;/R)2OO4,4>ZCJN36Y:)M_5J6G'4\I
MQ27()'BW8,!.<@N^#L[D([L'PY79*YM_)GJ;MN7=R]#)T1+K:>LK?6B*,:;<
M4\M%AN\S$9S&8FPN_2C%XQ[CX8MRJ1&[[U=:S2[W>Q`2_:W4W&H*)H+=`93U
M-),[1'[T3,T%,;-@Y2,XN[[<.DVU6;(ICO[<_L(NB)Q6X^HI;?Q9IZVEDDEI
MZD6$"EB<(VRE,)L0F^&+X.PYB;F?9BKN:+YVN:QGLC9^&&=9-^+#O4=3*1Z2
M2,9`EJ`IQJ(YX&;>1L(O@03.;Y7QQ;*N>7'FIT;U>WO=;\1[N/3NX:DOIGUU
M.^4X789"H>F\S5(0B.5HV>,@P<CWF^QQ]A6F[G^;P2:79H_]?&D/E^]?PU/5
M#:*<#M[`,E+O!A&)I<GA.3OF=R/8[['9E:5Q[U-?@?IC%NUU>*)M%3Q>BO)R
M34+RV8*D'R3#`%28;F0I";*_ZTK"&W\O(D\*?-JK4W[?+KW6;2TW$TJ0'N&#
MU5-`;55/"T)03R#,)"X,[,_2A)QP?#:*19CQ73,Z:DW1,?MBFC=1$X\9Y)6F
M.)VH9ZNH;J[1PE)'2XYJ=W''ERX"^W'8D<&F/>FO63Q+9Q;L4^'\'6:#?=1I
M]_FWVZ#>YFP+-E;'%FY\5%7T!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$
M$3JKYBG]M#\<"T^C^Y&ONEA_TOLSJ^J$LLS<("`@("#F&KBIIN*-KM\TLKM5
MQ0QRTXN0QO$[5#N^83#IYA;DYE*15U%:8I9?$2JDI-066.*'>-,&[+#*Y.(5
M$4F3I,[ECEV"SMMPVJX\W?3QASBS]U?R>>_Q3RO-Q+IY7`HGDM5*>[D;`QS'
M*^4F;'!VYT6&O<`_O@TS_'E_MY467NE'(@((NQ^'<_ELGN06GU'N_#'BQ>CR
MW_'/="469M$!`0$!`0:=JW1=UO5YI:VEKQIH8Q`)&)C<P87/-NLI,/OC'TL?
MV65W;9RF]=&1K]3PJU35R2337]HB=FBC@B:3=;HXHX)G+,6+DX0"0]PG=.7P
MSF7YN]?J^%5ZEIZ6FBOLD<%&T\$8-G;/!5U!22YW9\<XQY!C=O!VIN</1A^)
MS+\,,R@.$EP"AJ`*YM45\TK2/5R,;$3-4RS.Q92YPD$-G[*N[9DB.R$W[\OC
M+)H^&EUCM-[H)+@,1W4,D55"\F>'&1BZ.9_U6Y%-VW5U+OW:^M%TO"'4T4DT
MU5>HZ^>H)I)))FE%L[FQFS")>"_@X=Q-SAQD[H.9?.7O9M#PTU507"*XP7L)
M)`D_]C(TG5AA$CDBC#`L_1*4FQ=_!9DFRS-EPS',OSY.OQHD)M#ZBJ+=;8:B
MMIY)K:`QE#A-N*D1?8TW2S8<_P"5F2+;?9B\";YT=>/QHC+3PCNU%;ZVBDOL
MDT5;3##E?.[0F]7U@WCS$[Y7#`&9^1-SAYH.9?.5?#A-4TE34RT-UD>.83`8
M*@I#9P<H3$#)G9W%WB(2_P#$MB;MFBF&'6;]^>:X8=3"NG"._5W5Q"[QT\.^
MCEG`&E?=1B;N=/3XELC)G_6YTW+,_=&$=1S+\W?A5>K^%&H:BEIXH-0R4Y4T
M'4PP8W9X7F>=S?;CO6-@9GY,N+)R^'.6,-!S+\.]EV'06J*"W76UU-R&I"Y0
MRC-7DYYWGEQ+>"&/18<[CACR,R;ED9,AS+IRY5)\+*^&,Z.ANIC02"1F\I2%
M*T[TTE/T<'86C]]SX<SLFY9H-^]A4?"2_4-P*HIKP)QQRO-3#+O7?88G'$;,
M6##B/2RIN</"(.9?G[UL>$&I7A)BU-*,LH&QN#&P@8!(-,\>)<C;Y]XQ>%L3
ME\+1A^&8YO$PPSMA^SH"MEUI3F`I[E3TL+38%T3IXA`CY<>D8YMB4MT=D)6[
M"96FX?7`)[CNZN,(JF&HCIY1WK2NT^7+'([%ANX<N`9=J;MN$1A/4N]=A.%.
MMCQ\/]0C36.,ZZGD>S;S`7WK"><A,<W2VY<N";MN$&_=H[?P3=DTU=[??ZJX
M33T\T544I2'A+OW:4V-@Q<LF6+#*&SP4I&;N\<IO3.7O\&H3<'K\`5P4E\P&
MY4PTT[R;S&-]Z4I21Y2;I>".WFQ3<X>CL@YE^$MDAT?>I-14%VKJF`QIJ8::
M6&)Y1;HYVSAB_*[&W*INQA!OSH[?P8-RX7U=?;Z.B.ZG`4%*])-5Q.>_)BDS
MN0DY<N5LK9O95W;,\8C?ORQEZURUZ$U6,-S:Z7\IYKA%NR*(2$7P&1A\)W>-
MA<QPR8>#M4Y=D8=^DYET]&'9VI+1>EKO8:BOZU6A5T]8;2#CO"D8VQVXF3LS
M.SML;N)NVQD-Z9RMJ0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!!$ZJ
M^8I_;0_'`M/H_N1K[I8?]+[,ZOJA++,W"`@("`@T'5UQN%-K*ABH:.CFJIAA
M"":>'/)CC*3BTC2@XMT6;')LQ5K.2M-GYF[;EF,>O\EW5]!55U^MKO-3T30Q
MQ%C4&V$Y/4QD4&`FQ;,N+=%VS8+F9MC+/5A3Q6DSDAYT_%?]Z4?^,I_C)52&
MM<`_O@TS_'E_MY467NE'(@((NQ^'<_ELGN06GU'N_#'BQ>CRW_'/="469M$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$$3JKYBG]M#\<"T^C^Y&ONEA_TOLSJ^J$LLS<("`@(
M"#GNI)G#B9:`"-C<^KL;;>3&?`WPD;P.;H/RJQ;=,8LF'1XF)'\2;?0!JZT5
M-143.4LD3L\A$\5/_P!B$6(!9V\-QRNV'/F4K$8?C!%LSTZO^LN&?BM(2XHQ
M$+LXO;*9V=MK.SR2I5TUO@']\&F?X\O]O*A+W2CD0$$78_#N?RV3W(+3ZCW?
MACQ8O1Y;_CGNA*+,VB`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("")U5\Q3^VA^.!:?1_<C7W2
MP_Z7V9U?5"669N4M-$Y9&,<_[.+8_H7._%:5=;LTK14NG(@("#GNJK_>K5K<
M)(YY3M84L!G0@PX&6>7-@1$.#O@+/L=.7,XXB>VG9;)OQ&*:=E>^&-Q.PEN]
MI?)MFA>,2=WP%Y9H@;%A$G_63##]4&+#\I>?_P`4%(%'Q%HZ0'=PI[121"[[
M7=@*46Q_0DK"!X!_?!IG^/+_`&\J++W2CD0$$78_#N?RV3W(+3ZCW?ACQ8O1
MY;_CGNA*+,VB`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("
M`@("`@("`@("`@("`@("`@("`@("`@("")U5\Q3^VA^.!:?1_<C7W2P_Z7V9
MU?5"669N<LMMMHIM>31U-=%2U,-R*>&G*&2.>8HMY*S1RN>[,7CJ1SBS<C-R
M),QDGNCO@B)G''?/<ZF@("`@YW>-1R/Q)MU'15<YPL<,-3'#+&],SOOVDCDC
M<V+/F$7?`7PPYES2)FM,-CJM(_#Q8=\L.G:OB8U7778()XMR<$#..\WK/'T'
M$Q+9@(NQ#AAF=N==;]L9?'#M*7S&+)AT^#A?XK_O2C_QE/\`&2HD-:X!_?!I
MG^/+_;RHLO=*.1`01=C\.Y_+9/<@M/J/=^&/%B]'EO\`CGNA*+,VB`@("`@(
M"`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(
M"`@("`@("`@("")U5\Q3^VA^.!:?1_<C7W2P_P"E]F=7U0EEF;G/K51G2:B[
M8&**>JN=RGIYZ<P<IX8P(P:892)W9F&-MC-A@[,RD71DB<>>,7Y]JS;.68Q9
MIQ_EV:W054$!`0<UU%!%#Q1LY``A'(<#R1B+LQF35#M(3B[=(2Y-G.^*LS,X
M8?@1&'XX56.(-MI`UM:9H82:LJ6"0JAWB*-BCJ(1P<)6=VSALZ#MR,E<,GYI
M%L=;AGXK_O2C_P`93_&2J.H:UP#^^#3/\>7^WE19>Z4<B`@B['X=S^6R>Y!:
M?4>[\,>+%Z/+?\<]T)19FT0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$
M!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`01.JOF*?VT/QP+3Z/[
MD:^Z6'_2^S.KZH2RS-S4Z+3='%J^IN85=,=SD)I*JA$1Z%.^9HI&''.,CXOF
M/D+D3?MK2OZL,-*;DY:8M>&IMB*("`@YKJ-L.+MF-@(\0A`F!L&%G:H?>$6'
M(W@Y>?,E*ZBL:>WP4\5'+MZQL[^\YXMXS9L?_>0888$(\O=9U,,,2Q#@_P"*
M_P"]*/\`QE/\9*J0UK@']\&F?X\O]O*BR]THY$!!%V/P[G\MD]R"T^H]WX8\
M6+T>6_XY[H2BS-H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@B=5?,4_MH?C@6GT?W(U]TL/^
ME]F=7U0EEF;FE5%YI;=K0Y)+$,=;6RTENDNX&#R213;XH&+9BXB\18MS8JSO
MTIBW=?L2-VN>NJG?X-U440$!!I%YN]70:U&@ML-''/<HX7EJ9A=Y7/WQ@Z+$
MQ&(L'*S='G4F9R5IJ6(BE:5U_A+#UQ0W"LUA:#I8I*EZ&`3JH8A%V89*J)L[
M;PA;HY7?HXNS+N+9PQ>$N9F,].]Y^_%?]Z4?^,I_C)5RZAK7`/[X-,_QY?[>
M5%E[I1R(""+L?AW/Y;)[D%I]1[OPQXL7H\M_QSW0E%F;1`0$!`0$!`0$!`0$
M!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$
M!`0$!!$ZJ^8I_;0_'`M/H_N1K[I8?]+[,ZOJA++,W.>T1T=3KTXZ<Z68::HD
M>ID*JGSC,S/ECCA(W`S''I8#E%2(C+2G_AC_`/;QSDW3DQ_^TTV4['0E00$!
M!H-_M-+-Q-M5P.IC"6".(1B*.4BS.\S,S&WO8.;.^'.^&";T9,?93VF/H\6)
MQ"NM>&J+7!"<\5(3]5G$)*B!S.:6+*8%$0`3"+EX3\JDV5QT6+Z9^[QCN<`_
M%-`$'$NF@!R((K52@)&3F;L)RMB1$[D3^RZJPU[@']\&F?X\O]O*A+W2CD0$
M$78_#N?RV3W(+3ZCW?ACQ8O1Y;_CGNA*+,VB`@("`@("`@("`@("`@("`@("
M`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("")U5
M\Q3^VA^.!:?1_<C7W2P_Z7V9U?5"669N<LML`2:[*:,(XZRFN,HSA)(6:8)3
MF=Y`!C=AW8,#-LZ3N_<5IAN]\[OB5G3\WA7P=34!`0$&AZEJ-/0Z[MT]96'2
MUM,,)9S&GZNT9O*S"1R82"YX/M%]F'LI-\1^?AWNK;+IR>.'4P^)5;$&I=/1
MD[99"$A(G%Q?_L1,V[Q?8>WPOV<6YU*$5PJX'^*_[TH_\93_`!DJJ0UK@']\
M&F?X\O\`;RHLO=*.1`01=C\.Y_+9/<@M/J/=^&/%B]'EO^.>Z$HLS:("`@("
M`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("
M`@("`@("`@("`@((G57S%/[:'XX%I]']R-?=+#_I?9G5]4)99FYSF*]7BFUB
M=1*#O15M?%;WP:/P<U0,1<F.#/&^;;CM97<FE?'\/%(F*Y.S\?!T911`0$'-
M=310CQ3MQ3"<L55%2TY0['CV%4$SDQ"^/Z58FF3*3;7+'8DM8W6V6K4]M.JH
MVK.N1QTS!))&(QL]2#"4<9-F<F-V)WQY&[JE;LWC^12)RO.?XK_O2C_QE/\`
M&2HL-:X!_?!IG^/+_;RHLO=*.1`01=C\.Y_+9/<@M/J/=^&/%B]'EO\`CGNA
M*+,VB`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(
M"`@("`@("`@("`@("`@("`@("")U5\Q3^VA^.!:?1_<C7W2P_P"E]F=7U0EE
MF;FD0V_4DE^B!WK(=S<)*FHG,XRHCI,TCQQ1CX69Q(>;HNW*KN1T=>]-=E:)
MO3^%([Z>+=U%$!`0<DFK+U5<9H6J(@AIXV"&(,&8RCA.9V-MXXEM%V?$&=G;
M9W4I,9^W\_!<4Y([&WZGMUNJK_335MP"EZK2'/'$Y8$^ZGCD.1QY#!A#!V?D
MQQP4FZ(RD1=.3P>9OQ6D)<48B%\1>V4SL_L/)*JL-;X!_?!IG^/+_;RH2]TH
MY$!!%V/P[G\MD]R"T^H]WX8\6+T>6_XY[H2BS-H@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
MB=5?,4_MH?C@6GT?W(U]TL/^E]F=7U0EEF;G+]W15'$UPZU);I&J@<:>4I??
MI::,S,8'8BB<)0J`(V+!VP;!E*6UQVQ7HB._+&&-:S3%,TZY[LG51U!5!`0$
M&BZAN$<7$"TTO9\,Q2'!A6&QL8$XSX978LKN(L6#./.Z?JU=2?ISY>ME:ICI
M"O48UM+0UQ2T[QTE+53A$[CO`<BR&)9L#P;$>[@K%U,]-2[M<=)U/,_XIFF;
MB53-,PC,UII=ZT>.1BSRXL..W#'D46&O<`_O@TS_`!Y?[>5%E[I1R(""+L?A
MW/Y;)[D%I]1[OPQXL7H\M_QSW0E%F;1`0$!`0$!`0$!`0$!`0$!`0$!`0$!`
M0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!!$ZJ^8I_;
M0_'`M/H_N1K[I8?]+[,ZOJA++,W.9:>JGCUG<)*2/&MDN)0W$)8Q'-%(\K"4
M4I^^%NAB''!\O29F9E-^/VUIKC'JCQQKN3EF*ZIQ:_P=-500$!!S/5HO#Q-M
MU?)O7AIHH#8(HY)")V>=BP$`+$MK-R\BE(U]<>,PM9IEQ8=#YQ%F@/5%EG&)
MVJ89(J>,YHB<??9X9'<'<7#P6=L<S8.NMV9S2E8TX=_@X1^*_P"]*/\`QE/\
M9*HL-:X!_?!IG^/+_;RHLO=*.1`01=C\.Y_+9/<@M/J/=^&/%B]'EO\`CGNA
M*+,VB`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(
M"`@("`@("`@("`@("`@("`@("")U5\Q3^VA^.!:?1_<C7W2P_P"E]F=7U0EE
MF;FD'8=(R7JED&NC"XR7!ZR)F$&.26FDF:2/'#'PIB%^[@KS<5,?;AU)RL=<
M3=U%$!`0<RO\]'7<3:"*DJ`DE`J8)MTX;R,H"G<ND[/R8X./LJ1=FPPU.IMF
M(KX8=Z1XAW>Z6^\6EZ6M:"$CBWM,\D8M)FJHHRZ!L[GT3V8.V"3;7'[?RVI$
M]'97Q>=_Q7_>E'_C*?XR54AK7`/[X-,_QY?[>5%E[I1R(""+L?AW/Y;)[D%I
M]1[OPQXL7H\M_P`<]T)19FT0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0
M$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`01.JOF*?VT/QP+3Z/
M[D:^Z6'_`$OLSJ^J$LLS<YK016J+4DM2==#)'->-UU62*;?A4"<VZ8<Q8,.8
MI'8F;*ZE8C3712-JTF=%.N72E4$!`0<UO\%#9=;0U%):6K;A5'&<4\LL[/GD
M>4GC#`"B9F=G<6)_")=3,SBBD:OQ\',6Q6LUG7'=15Q+K)`O%B8LN[E*+/3G
M)E+,]5#AD!MAD//FV8>RN>]WB<#_`!7_`'I1_P",I_C)4(:UP#^^#3/\>7^W
ME19>Z4<B`@B['X=S^6R>Y!:?4>[\,>+%Z/+?\<]T)19FT0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`01.JOF*?VT/QP+3Z/[D:^Z6'_2^S.KZH2RS-SGM5I._RWZ@KY`&>&CN
MS5$$9#&VZ@D.=Y38F=BY"!V_+R+K=C3V_@YWIPAT)<NA`0$'.=3S2!Q0LPCE
M(#ZNQ"[,YMB\^!"6.86;G9FP?G2BX88O%(:[K:REO5I.*/&#,(RR]7>9@SSQ
MATC:*7*SXX89AV[>9=1%U,5=7YXW-8ST><?Q7_>E'_C*?XR5<NH:UP#^^#3/
M\>7^WE19>Z4<B`@B['X=S^6R>Y!:?4>[\,>+%Z/+?\<]T)19FT0$!`0$!`0$
M!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$
M!`0$!`0$!`01.JOF*?VT/QP+3Z/[D:^Z6'_2^S.KZH2RS-S7J6.J@U55551=
M8BH:D6AI;>YMF&7H\@]WH$N?TQCSNJ74R8FPKIR("`@T>\7F[4O$:BHQG$;;
M414X;G=`9O(13.3Y\PF+.P,W@NRFN=N):1HC#5XL?B-=JVAOUD&&:0(9#!I!
M`W'PJF(,S#F%B?`L-K/L=2;8G'AW+%U,7LPV//?XK_O2C_QE/\9*NDAK7`/[
MX-,_QY?[>5%E[I1R(""+L?AW/Y;)[D%I]1[OPQXL7H\M_P`<]T)19FT0$!`0
M$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0
M$!`0$!`0$!`0$!`01.JOF*?VT/QP+3Z/[D:^Z6'_`$OLSJ^J$LLS<T0K?<;?
MJ.@ZV%&3UMQGE@K2`&FW1;PF@=F'%S8,,IX]W%7)DG#V=::NW\<O5V-[440$
M!!H=XI]/T^MZ*28ZJ.>G,)W,IX^JB52\N5MW(3'M<"VBV#)-U,T;9[LBQ;,Y
M^SQ1_$^LJH]36&"GC<VJ&9MZ,02Y/^Q$V?I,?@XX\F'LJ4'!_P`5V+<48V=\
M7[,IMO\`]R54AK7`/[X-,_QY?[>5%E[I1R(""+L?AW/Y;)[D%I]1[OPQXL7H
M\M_QSW0E%F;1`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!!$ZJ^8I_;0_'`M/H_N1K[I8?]+[,
MZOJA++,W-3CN5\J-21TM50!V5#42=6NIPNY$;,[-$(/MCPVMON0N96+;HQUQ
M:/;T=IO6Z\.UMB@("`@YKJD&?B71#*(SPU$-+#U0QBR%C),[]*1G?DYFY<$K
M3KPZ)[RE</\`M'=*KB;!2'?K(U0S[E\(W9L[`S'41#TF`2S,^.&&+=U6)PPD
MPP_!P+\5K,W%&)FY&ME,S?"2J+#6^`?WP:9_CR_V\J++W2CD0$$78_#N?RV3
MW(+3ZCW?ACQ8O1Y;_CGNA*+,VB`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("")U5\Q3^VA^.!:
M?1_<C7W2P_Z7V9U?5"669N:'!J#6P:Q&AJH6&U351Q0E+"T8E&SF_0ESOF<8
MQ`FZ/2=W[BDV4QU[8[LN&-8OB<5._P#)OBJ"`@((.X:1H*[4-+>YI9&GI,CQ
MPCE8'>//E=]F;_YC\ZZB8IDQI-=*WJ#1ENO=TH+C4RRQS6_;$,>3`G:09&S.
M0N_*',Z1,9X)KFEJ7$7@%I?7>H1OESKZVFJ1@"F:.F*)@RQD1,_3C-\>GW5R
MZJP-'?AJT?I74U!J&AN5PFJK>9'%%,4+QDY`4;YLL8OR'W4*NN(@@((NQ^'<
M_ELGN06GU'N_#'BQ>CRW_'/="469M$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`
M0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$$3JKYBG]M#
M\<"T^C^Y&ONEA_TOLSJ^J$LLS<QZFWT55-3S5$(R2TAO+3&7*!NSCF'\SX*Q
M=,),,A11`0$!`0$$?7:AL%OGZO7W.DI)\K%NIYXXCROL9\IDSX;$&/ZYZ/\`
M3MO\J@_WH'KGH_T[;_*H/]Z"0H;C;[A!UB@JHJN#%QWT!C(&9N5LP.[8L@B[
M3<;?3S7..>JBBDZ[(^0Y!%\'`.9W6SC<*ZZ+9B)G],>+YOIN/P[9OBZZ(G?G
M/T0D.V;/X]3_``H=]>'(XGEG8U?VN%Y[=L';-G\>I_A0[Z<CB>6=A_:X7GMV
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M!3T\39I)I28`%NZ1$[,RQ/J(SUST?Z=M_E4'^]`]<]'^G;?Y5!_O07:75&F:
MNH"FI;O15%1(^$<,51$9D^&.`B).[[$$F@("`@(,2JM%JJY=[544%1+AEWDL
M0&6#<V),[H+7J[I_T92?`1_[4#U=T_Z,I/@(_P#:@RZ6DI*2+=4L,=/%B[[N
M(6`<7Y7P%F9!;:"VU)R$T<,Q@3A*6`$[&S-B)<NUEW'$NC),O.>#9,UF(V/O
M9UO\5B^#'O)S;M,IR.'Y8V'9UO\`%8O@Q[R<V[3)R.'Y8V'9UO\`%8O@Q[R<
MV[3)R.'Y8V'9UO\`%8O@Q[R<V[3)R.'Y8V'9UO\`%8O@Q[R<V[3)R.'Y8V'9
MUO\`%8O@Q[R<V[3)R.'Y8V'9UO\`%8O@Q[R<V[3)R.'Y8V'9UO\`%8O@Q[R<
MV[3)R.'Y8V'9UO\`%8O@Q[R<V[3)R.'Y8V'9UO\`%8O@Q[R<V[3)R.'Y8V'9
MUO\`%8O@Q[R<V[3)R.'Y8V'9UO\`%8O@Q[R<V[3)R.'Y8V'9UO\`%8O@Q[R<
MV[3)R.'Y8V'9UO\`%8O@Q[R<V[3)R.'Y8V'9UO\`%8O@Q[R<V[3)R.'Y8V'9
MUO\`%8O@Q[R<V[3)R.'Y8V'9UO\`%8O@Q[R<V[3)R.'Y8V'9UO\`%8O@Q[R<
MV[3)R.'Y8V'9UO\`%8O@Q[R<V[3)R.'Y8V'9UO\`%8O@Q[R<V[3)R.'Y8V'9
MUO\`%8O@Q[R<V[3)R.'Y8V'9UO\`%8O@Q[R<V[3)R.'Y8V'9UO\`%8O@Q[R<
MV[3)R.'Y8V'9UO\`%8O@Q[R<V[3)R.'Y8V'9UO\`%8O@Q[R<V[3)R.'Y8V'9
MUO\`%8O@Q[R<V[3)R.'Y8V'9UO\`%8O@Q[R<V[3)R.'Y8V'9UO\`%8O@Q[R<
MV[3)R.'Y8V'9UO\`%8O@Q[R<V[3)R.'Y8V'9UO\`%8O@Q[R<V[3)R.'Y8V'9
MUO\`%8O@Q[R<V[3)R.'Y8V'9UO\`%8O@Q[R<V[3)R.'Y8V'9UO\`%8O@Q[R<
MV[3)R.'Y8V'9UO\`%8O@Q[R<V[3)R.'Y8V'9UO\`%8O@Q[R<V[3)R.'Y8V'9
MUO\`%8O@Q[R<V[3)R.'Y8V'9UO\`%8O@Q[R<V[3)R.'Y8V'9UO\`%8O@Q[R<
MV[3)R.'Y8V'9UO\`%8O@Q[R<V[3)R.'Y8V'9UO\`%8O@Q[R<V[3)R.'Y8V'9
MUO\`%8O@Q[R<V[3)R.'Y8V'9UO\`%8O@Q[R<V[3)R.'Y8V'9UO\`%8O@Q[R<
MV[3)R.'Y8V'9UO\`%8O@Q[R<V[3)R.'Y8V'9UO\`%8O@Q[R<V[3)R.'Y8V'9
MUO\`%8O@Q[R<V[3)R.'Y8V'9UO\`%8O@Q[R<V[3)R.'Y8V'9UO\`%8O@Q[R<
MV[3)R.'Y8V'9UO\`%8O@Q[R<V[3)R.'Y8V'9UO\`%8O@Q[R<V[3)R.'Y8V'9
MUO\`%8O@Q[R<V[3)R.'Y8V'9UO\`%8O@Q[R<V[3)R.'Y8V'9UO\`%8O@Q[R<
MV[3)R.'Y8V'9UO\`%8O@Q[R<V[3)R.'Y8V'9UO\`%8O@Q[R<V[3)R.'Y8V'9
MUO\`%8O@Q[R<V[3)R.'Y8V'9UO\`%8O@Q[R<V[3)R.'Y8V'9UO\`%8O@Q[R<
MV[3)R.'Y8V'9UO\`%8O@Q[R<V[3)R.'Y8V'9UO\`%8O@Q[R<V[3)R.'Y8V'9
MUO\`%8O@Q[R<V[3)R.'Y8V'9UO\`%8O@Q[R<V[3)R.'Y8V*9::U4P;Z6*"$`
M=O?2$!9G=\&Z3X<[IS+M,D<&R/=C8OSP0SQ%#/&,L1M@<9LQ"[=QV?8ZX>K"
M]7=/^C*3X"/_`&H'J[I_T92?`1_[4%<%DLL$HS04%-%*&T)`AC$F?DV.S8H,
MU`0$!`0$!`0$&KZ%_P";4W^;J?BH4&T("`@("`@("`@("`@("`@("`@("`@(
M"`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("#4N*O\`
M^BU_\6D_O(4&VH"`@("`@("`@("`@(-7T+_S:F_S=3\5"@VA`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0:EQ5__`$6O_BTG]Y"@VU`0$!`0$!`0$!`0$!!J^A?^;4W^;J?B
MH4&T("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("#4N*O_`.BU_P#%I/[R%!MJ`@("`@("`@("
M`@(""U!24M.\KP0A$\YO+,X"PYY"9F<RPY2=F;:@NH"`@("`@("`@("`@("`
M@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`
F@(""U5T=)60%3U<(5$!NSE%*+&#N),0XB^+;"9G9!=0$!`0?_]D_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>14
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0`!@`(````(0`=?[]DX`$``+H6```3``@"6T-O;G1E;G1?5'EP97-=
M+GAM;""B!`(HH``"````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M``````````````````````````````````````#,F-UNVC`8AL\G[1XBGT[$
MV-FZMB+T8#^'&]+8!;CQ!XE(;,MV.[C[.8&B"E$J5*2^)T00^WL?K.B1\D[N
MUEV;/9(/C34E$_F8960JJQNS+-G?^<_1-<M"5$:KUAHJV88"NYM^_#"9;QR%
M+.TVH61UC.Z6\U#5U*F06T<FW5E8WZF8OOHE=ZI:J25Q.1Y?\<J:2":.8C^#
M32??::$>VIC]6*>?MR2>VL"R;]N%?5;)E'-M4ZF82/FCT0<IHUU"GG8.:T+=
MN/`I83!^-*&_\W+`;M_O=#2^T93-E(^_5)<P^+KE_ZQ?W5N[RD\/.4)I%XNF
M(FVKARZ=0!Z<)Z5#312[-A^N>:<:\\1](G]8'/AP$1<&Z?_?,/A,#@G"48!P
M?`;A^`+"<07"\16$XQJ$XP:$0XQ10%",*E"4*E"<*E"D*E"L*E"T*E"\*E#$
M*E#,*E',*E',*E',*E',*E',*E',*E',*E',*E',*E',6J"8M4`Q:X%BU@+%
MK`6*68OW,FM,S2#QX?/MC^DPYI5J*L1-2^'"KY/;H:\EU\J3_A-]ZE`O#O!\
M]BF.U##.O'4A=:V>SC^%IS*UWSUR:1#YV-"^3CU62^X34T][?N!!+TI]$ZQ)
M'\GF0_,\_0\``/__`P!02P,$%``&``@````A`+55,"/U````3`(```L`"`)?
M<F5L<R\N<F5L<R"B!`(HH``"````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M``````````````````````````````````````````````",DL].PS`,QN](
MO$/D^^IN2`BAI;M,2+LA5![`).X?M8VC)$#W]H0#@DICV]'VY\\_6][NYFE4
M'QQB+T[#NBA!L3-B>]=J>*V?5@^@8B)G:13'&HX<85?=WFQ?>*24FV+7^ZBR
MBXL:NI3\(V(T'4\4"_'L<J61,%'*86C1DQFH9=R4Y3V&OQY0+3S5P6H(!WL'
MJC[Z//FRMS1-;W@OYGUBETZ,0)X3.\MVY4-F"ZG/VZB:0LM)@Q7SG-,1R?LB
M8P.>)MI<3_3_MCAQ(DN)T$C@\SS?BG-`Z^N!+I]HJ?B]SCSBIX3A363X8<'%
M#U1?````__\#`%!+`P04``8`"````"$`Z,')Y]\!``"K%0``&@`(`7AL+U]R
M96QS+W=O<FMB;V]K+GAM;"YR96QS(*($`2B@``$`````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````O)C+3L,P$$7W2/Q#Y#UU9P;*0Z1L$!);'A]@)6Y3
MT2:1;1[]>ZP*4BK!91/-)I(=U;FZ,[TGD^N;C\VZ>/,AKKJV-#29FL*W55>O
MVF5IGI_N3BY,$9-K:[?N6E^:K8_F9GY\=/W@UR[E'\5FU<<BG]+&TC0I]5?6
MQJKQ&Q<G7>_;?&?1A8U+>1F6MG?5BUMZR]/IS(:?9YCYP9G%?5V:<%^3F.)I
MV^='_W]XMUBL*G_;5:\;WZ9?GF'?N_`2&^]3/M2%I4^E&;:BW=TAF63-QOXA
M)_NA*^<"R>&9LAR>03FD+8>0'#E5EB.G2,ZYLIIS)(9860TQE*-M#D%W^$S9
M'3Y#[HAV"`H,01DU!&/C@J\?4\C,B=GVKUP^V$;F:#<R[F/M0"8<R)GGJKCB
M*2S5I;:<2R1'FU805MJ-`_N&U*V!WK`VR!F"7+0C1V#FR*CLC&F[SB_Y^QS>
MK='?2)N5$)6DK8:@'-8F-T-R\ZCD'D:G?;<,6U_3%,/Q148-O92G3K^7LEO:
MW16&"VDSDB`C29N1!!DIVB006"QM$$`.:%<*%HJTK2'H#6LSDB$C>51&#BFW
M3YMAZSOXX'PIVIDC,'-$&YH"H:D-*<RH7&/-[X\#O^W!)];Y)P```/__`P!0
M2P,$%``&``@````A`!7Z1Q-L`P``-`L```\```!X;"]W;W)K8F]O:RYX;6R4
MEEU/VS`4AN\G[3]$N1_Y:OD2+1H,-*0)3<#@TC*QTUAU[,YV*/WW.TG5]"0.
M%;MJG/2\><_Q<XYS<?E>R>"-&RNTFH7)41P&7.6:";68A7^>;K^=AH%U5#$J
MM>*S<,-M>#G_^N5BK<WR5>ME``+*SL+2N=5Y%-F\Y!6U1WK%%3PIM*FH@Z59
M1'9E.&6VY-Q5,DKC^#BJJ%#A5N'<?$9#%X7(^0^=UQ57;BMBN*0.[-M2K&PX
MORB$Y,_;C`*Z6MW3"GR_RS"0U+H;)AQGLW`*2[WFO1NF7EW50L+3LRS.PFC>
M)?G;!(P7M);N"=+;J4.]TDF:'C?_;$KQ+/C:[H.:9?#^(A33Z^:O4-I-M\K`
MP+I]]"*8*^%Y',?=O9]<+$JWNPGR$=)O*PCO:7\#U::WJPB!G2(WR@FW(7=J
M6WVA80N;JM]!9DD8F',!%^:.)8UQK'*M%>/*<D;@RFHI&(5BM9K7ND(J*5))
M_T\%#'1F,B33UAN;>>"Y!C#A_8^->1PW07&3X>L'<6"U>Q_4MTM^.HS;)Y\/
MD\]UA66R8Z33[C[V?5@'4N[LG""9DZ&=>^IJPXDN"+22V0*.8C,<?#H,WGNP
M=551LVETK%@H`>U#L0RT=U>2LZ',`V<<NOE5<@(U@<UPHKF&/BZX,5CF#,DD
M\5#GFMJRI2AO+OC?6KQ1"?UKD<0$VJ-SDGAH_M)4D8+F0@+:.*P']`B+5:45
ML4[G2QR%`4X\].ZY(U);2Z#RQ);4<!R+J4T\_&Z%HBH75!*AK#/MG.KEB>%-
M#E`XMG.])L`T)SZ&']6</,&&XGPPS8G'8:_P;2R<`'N&)YC#9`3$??U'@C%]
MB8>?OPTC$I@\&+&#B3:Z&[[*%,.7>O"-]2+YSN`H@6,'MU.*N8+%P,WAML0C
M9HJQ3CU`#S<FIF3:<^31^F%GDL>\Q-2GF#98##+K4]*51FX/(<3+%'?/]NC$
MP[.OTWA@-4P<F%[-$Z238NY@<=#/XWX(7E&U)%@'(Y@>YG>8%CX1I[BM4P]E
M.#Z[.=26=I?62W/2(S\9)A$6@[Q&6@*YPCH8H,PGVIMPV!76P?QD'M$C?M"F
M81`SO/&P&"0VWJBW5!CR3/&XRG"A8?$IG5V-<&(8:/@:`YVH)1&^K'(J<_CD
M:WZ:;Z9V%Z+=!^_\'P```/__`P!02P,$%``&``@````A`,O"H6+.!0``R18`
M`!@```!X;"]W;W)K<VAE971S+W-H965T-"YX;6R46-N.FT@0?5]I_P'Q/H:^
M<;'&$P6C[$;:2*O57IX9C&T48RQ@,LG?;S6-H:N<8?#+>`R'XIRJZCKM?OSP
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M!"L5^H(!W'DNVNY3J4.Z3O[2=G7UGP$Q36H,PH<@`M@/]_G=0>00!#ZO0<*E
M03RCJD]2FG79TV-3OSK0><"[O62ZC]D:`NOL",BQT3+FZZUT@40=Y*..LG%#
MUX''6ZCQMZ=0/'K?H"SY`$EN(0PCME>$3IR.FIH+\'>**L=G/!`PJH#\VBI^
M7MLK60W69*_O2<P%^SU\?$W/9'N+"!6&I+>0*0CB"CVPG*L&0T7L%`3XQ8F!
M0.W&+!%JVW<1Z1P"D8?7+">OP1L7$C,R"T-"WD"BOF58%,:*314VJ;<1*N1Q
M0$*D-D"*,(H9GU*$R,-Z74Y>@PGYB)`WD&#H=QEQRMT&2"ZB@%0FM0',YY))
M]D;7!/=PUV#"/2;<#<1PYP&30A!U6QL1QT$D)F9F>=H`)7WA*RL&2CP,AN6)
MUV#<\I%/R!L(%'YL+)+8[;N(=`Z!R.N-@#4AYV>+!N/,1V3,)09B,O\@(6<^
MS3Q"L$B0MDK1?17[/I^&+:(>WT-=@PEU4O'$0(:FB01-NGV;23FM0M,O]FT1
MJ,C*#&+-P'^69[Q'$]Y3.OHW)P-FKF$&R*`M%C%ECP!,2*6FMV#ZVK:LAKE:
MZGSC,&-V]K",2-V3`6,XQDS$G*SJ[8"8$9JB(!R&#HO?$J(MC0@)H#;O"#%&
MB(201DF8P0QK@$41#,>)A)G[&,.5M(:+Z2>"$+%2EBOCFFB#LZ2\(\'8(9)`
MVB%A!G.5$',_N%&`(:'ODSRD.`@7L;1JC@5HEULN0*/)FB"VF3"#N0H(F!"2
MS-DMP0A)EWR*$0'GL"[&88T5:*];KL`X(RH!&9.)WL6#RD&!Y#P,0H+98@SS
MH=]O-A`8HV2@>/SFFM"FMUR%L4BD@BS9A!G,S)+=O@])!XC)A6#*E_[4L;@.
MVO@L!0O'D[%+6TE,NB5A!C-?#X1YHQX(HT`,5]'4OEB-]L+[U1@'16JH33/D
MLHP)'EE-,<PH@E'A[1:/Q(E4$/B6XV,UVB+O5V.,%:FASLUL\WU@,"I)];88
M(:7PIY0/\Q;'\)D,K+6$A/"[++Q'XW%%4YT,F.NX@CU/3"JVQ1`A`Y]"4@QA
M41R&_I0J+.$G-BYAXLQ;![^U\9C:^(`Q4B@'TU@#9&8HI+-1L!+H#-I5"Y3H
MITA1IM'>TTRXP5Q7/&Q(.&F:[0"953(7!2LA-KYL=O%;.Z>[NV3`F!^B#[+?
M%=U(,7$&#%<J4H*LHA3'"9D"1XRFD8_5:`>^>[5S_12I"V&:#)BX_V7ZP%:<
MVB(&1"M)`"D&L#!>R:GX6`7Q]84UN?7WF'!(]/G:Z.^"P=[(^L4PK!,$\5EH
ML31#"P>)(V4=3!D=YN30'(I517,HML7IU#IY_:)/!3GD<+PZGEA^Y/KTB%Q/
MV!K.L."Z-]Z`@\1+=BB^9,VA/+?.J=A#2'\5`NW&'$6:+UU]Z8_BGNL.CA#[
M?X]P9%S`*9B_`O"^KKOK%_V"\1#ZZ7\```#__P,`4$L#!!0`!@`(````(0#-
MM+0Q20,``-$)```9````>&PO=V]R:W-H965T<R]S:&5E=#,P+GAM;)1676^;
M,!1]G[3_@/Q>OD(@B4*JAJQ;I4V:IGT\.V""5<#(=IKVW^\:$P).FZ9Y2()]
M?'SNN=>^+&^?J])Z(EQ05L?(LUUDD3IE&:UW,?KS^_YFABPA<9WADM4D1B]$
MH-O5YT_+`^./HB!$6L!0BQ@54C8+QQ%I02HL;-:0&F9RQBLLX9'O'-%P@K-V
M454ZONN&3H5IC33#@E_#P?*<IF3#TGU%:JE)."FQ!/VBH(TXLE7I-705YH_[
MYB9E50,46UI2^=*2(JM*%P^[FG&\+2'N9R_`Z9&[?3BCKVC*F6"YM('.T4+/
M8YX[<P>85LN,0@3*=HN3/$9WWF(S0\YJV?KSEY*#&/RW1,$.7SG-OM.:@-F0
M)I6`+6./"OJ0J2%8[)RMOF\3\)-;&<GQOI2_V.$;H;M"0K:G$)"*:Y&];(A(
MP5"@L?VI8DI9"0+@VZJHJ@PP!#^WOP>:R2)&D]">1N[$`[BU)4+>4T6)K'0O
M)*O^:9#746D2OR.9@/INWO\P2="1P&]'XD_LP)]&LRND.#JLUJ4-EGBUY.Q@
M0>6!<-%@5<?>`IB/]NA@>L/>\@N,4B1WBB5&$;+`"@$Y?EH%H;=TGB`Q:8=9
MGV,,1')$J"PHVHT>@.^>-@IZ5@<BZ,,`AX=AO)[=HUH%5FJ/^ZSUP'`?O]^F
M59*<(Z+I&+(YAYQ(1EJA"H9:E>43J.O+FM4BP`VL",(3?RMRK3&0Q=XN0V/R
M+F)S"3&*`K891G%9O0+'"!SJE?F1._9OK3%!U)8/7,BS\7S2S0\X`J.`-B,*
MUYZ=*$;2X>!>+UV!3>F3L;2UQG32C;B2;O*2[C?6CT2''Q&MP*;HT\G1U:(Q
M8%F?DR`T`DM>P9B>OP()3UN-0H#[X7K?%=@,P2CGM<;T)3/UO]P89R+I(,,H
MS0A&++X]#]WAQQMRCL)1;PC&U?G^.5:+S+!"HYPT9MX>A+GM3H=RW&@,3C1X
MUH*-TH.^JC;31('M3T9$9I)T"]7-H2)\1Q)2EL)*V5ZU1Q\VZ$?[SGWGJTO4
M&%]["[C*8=SI)Z"C-GA'?F"^H[6P2I(#I6M'4/A<]V3](%G3MJ0MD]!+V[\%
MO#H1:`:N#>"<,7E\4!OT+V.K_P```/__`P!02P,$%``&``@````A`"G$$P5N
M!0``MAD``!D```!X;"]W;W)K<VAE971S+W-H965T,CDN>&ULG)G;CJ,X$(;O
M5]IW0-P/9T(2)1EUPFFD76FUVL,U39P$=8@CH`_S]EO&0+!)N]+;%R$QGW_,
M[RICJE??/\JS]D:JNJ"7M6X;EJZ12T[WQ>6XUO_^*_XVU[6ZR2[[[$PO9*W_
M)+7^??/K+ZMW6KW4)T(:#10N]5H_-<UU:9IU?B)E5AOT2BYPYD"K,FO@9W4T
MZVM%LGW;J3R;CF7-S#(K+CI76%:/:-##H<A)2//7DEP:+E*1<];`^.M3<:U[
MM3)_1*[,JI?7Z[><EE>0>"[.1?.S%=6U,E_^.%YHE3V?X;X_;"_+>^WVQT2^
M+/**UO30&"!G\H%.[WEA+DQ0VJSV!=P!LUVKR&&M/]G+U)[IYF;5&O1/0=[K
MT7>M/M'WI"KVOQ47`F[#/+$9>*;TA:$_]JP).IN3WG$[`W]4VIX<LM=S\R=]
M3TEQ/#4PW3[<$;NQY?YG2.H<'`49P_&94D[/,`#XU,J"A08XDGVTQ_=BWYS6
MNCLS_,!R;<"U9U(W<<$D=2U_K1M:_LLANY/B(DXG`L=.Q/8-S_&#^5=4W$X%
MCO]_*%XG`L=^*,Z7[P?NO#4%CKU(\&6162<"Q_YV7,/VK-D7C`TZ#<C67L-[
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MVG39H42($A%*Q"B1H$2J(@0WP;FQF^J,9/!:AY@='/*\0'*1,W#]@9%=[`FV
MTDGI&_;G/NT=H43,B5F[DKKP)\=CKW#G^FE_[M[U!=_@833VC46A"WL.M7^L
MD^S?7/*/,RK_4")$B0@E8I1(4"+E!)\)VW-<S[[EG.`F//S&;JI=9+#H8B!-
M\98C*A-1(D2)""5BE$A0(N4$-S'P9TYPVQL('K(7$7DS,D=#DO42S?2\VP7:
M96_+&96;4\+SY=2>,M+"$*%$C!()2J0J0C!T,3443W'62?+3EYZS6\ZH_.R(
MH%W#+,.2'I<AJA"A1(P2"4JD*D+PTH9`E*,3-[/M);LIYWH'J>R\@WB^M!4+
M[T!R@.)(C",)CJ1*1#26;;6EM'_`6+Y!%Y[DOA1D6YM#2F-1),15(AR).V3>
M)H0M)52""Z1*1'24[<E'CJH?1C;?P8M.2G&S[2"/O]R)#_S=</+>GJ-=@$,<
MB7`DQI$$1U(E(AK)-O4C(Q_;(]G\54`T]+9MX$^D#E*&)M=9M)XO#,NWQG_2
MKC7L!'E\24^NJ#O)I3S#<<=*\MH<XV-+<"15(J+-X,+89B1>&2TOJ9(;6YM#
M2GLYTB6D&\SDY2/L1#CA>S.YLA`)`-1S%H$CK>TQ/I`$1U(E(GK)]O]?#UG^
MUB"&K+RO9[5$,%[I*4<Z3[VYOPBDE2[$5:(.4:C$N$J"(ZD2$6UE+P*2K?@[
M.U1[IZ$J[TT[2&GK]$7%FTDY'N(Z$8[$.)+@""MS?QXJW%A>QN;%R))41[(C
MYW.MY?25E:C9R\+0.I3/GUQ62I/:=_82RH+3]IB5V^^T[YPEU(FF?.@LH5PT
M;8^<)52-H-T<+@Q5\VMV)+]GU;&XU-J9'&#(EA%`]%>\[LY_-/3:EEB?:0/U
M\O;K"?X_0J!P:1D`'RAM^A_L`L-_7#;_`0``__\#`%!+`P04``8`"````"$`
M&[6TUG<"``"$!@``&0```'AL+W=O<FMS:&5E=',O<VAE970R."YX;6R4E5UO
MVC`4AN\G[3]8OF^<#T(!$:K2BJW2*DW3/JZ-XQ"+.(YL`^V_W['-9T&,<4%B
M>/WF.>^QG?'#FVS0FFLC5%O@)(HQXBU3I6@7!?[U<W8WP,A8VI:T42TO\#LW
M^&'R^=-XH_32U)Q;!`ZM*7!M;3<BQ+":2VHBU?$6_JF4EM3"4"^(Z32GI9\D
M&Y+&<9](*EH<'$;Z%@]558+Q9\56DK<VF&C>4`O\IA:=V;E)=HN=I'JYZNZ8
MDAU8S$4C[+LWQ4BRT<NB59K.&ZC[+>E1MO/V@S-[*9A61E4V`CL20,]K'I(A
M`:?)N!10@8L=:5X5^#$9/>683,8^G]^";\S1/3*UVGS1HOPF6@YA0YM<`^9*
M+9WTI70_P61R-GOF&_!=HY)7=-78'VKSE8M%;:';.13DZAJ5[\_<,`@4;*+4
M8S#5``!\(RG<RH!`Z)N_;D1IZP)G_2B_C[,$Y&C.C9T)9XD16QFKY)\@2AS4
MWB3=FL!U:Y*D_VV2;4W@>C!)!WF2]_^-0D)9/J5G:NEDK-4&P<H#<--1MXZ3
M$3B[>#((^7(\4)*;\^@F^:F@-M#2]:27W8_)&OK`MIKIN28]53Q=4!Q,"/#M
M(2&W8\CK<$X,16"TATO/X(*F=Z3)/\!=4YRPP8-N9W/B`H/W@2WOGSYY&C3'
M;+WD5/(4)`.??)K'\-D+3MC`Y'8V)_[(=NB';_PT:*ZR!4D_L,59OS<87H:#
M[7,[G!.?PO6RP=XWP`7-5;@@V0:7#B[`A8,D;)&.+O@KU0O1&M3P"GH61_=@
MH<,Q$@96=7XKS)6%[>]O:SCM.>R3.`)QI93=#=Q!M7]_3/X"``#__P,`4$L#
M!!0`!@`(````(0!13/@WL0,``/,,```9````>&PO=V]R:W-H965T<R]S:&5E
M=#(W+GAM;)276X^;.A2%WROU/R#>)V!SR45)J@$T/95ZI*.JEV<"3F(-8&0[
MDYE_?[8QH3%)768>0D@^%FMM[Y@]ZT^O=>6\$"XH:S8NFOFN0YJ"E;0Y;-P?
MWY\>%JXC9-Z4><4:LG'?B'`_;3]^6)\9?Q9'0J0#"HW8N$<IVY7GB>)(ZES,
M6$L:^&;/>)U+..4'3[2<Y&5W45UYV/=CK\YIXVJ%%9^BP?9[6I",%:>:-%*+
M<%+E$OR+(VW%1:TNILC5.7\^M0\%JUN0V-&*RK=.U'7J8O7ET#">[RK(_8K"
MO+AH=R<W\C4M.!-L+V<@YVFCMYF7WM(#I>VZI)!`E=WA9+]Q']$J0]CUMNNN
M0#\I.8NK]XXXLO-G3LNOM"%0;5@GM0([QIX5^J54'\'%WLW53]T*_,>=DNSS
M4R6_L?,_A!Z.$I8[@D0JV*I\RX@HH*(@,\.14BI8!0;@U:FI:@VH2/[:'<^T
ME,>-&\2S:.X'"'!G1X1\HDK2=8J3D*S^I2'42VD1W(O`L1=!T2S$T7SQ'I6@
M5X'C125^OTK8J\#QHC*?&LC3Q>EJG>4RWZXY.SO0P!!?M+GZ.:`5"%^*K$LR
ME/U/58=R*Y%'I;)QYZX#!170*B_;,`C6W@LL;]$SB6;@=6"02:1W"'_$9+?,
M/!QD/`@U)(,ENTYVOVTN`12L`J@V4HD2_<&U6SS<IB/2.\3<1+([R$`87J$Q
MIGM5,#3S52%Q,+ISHAE8T*'8T7!G;?^O1&8C#/=PF^GN%;QQH3*#LS#XO8*Z
M^)I9=(V$\2(.%\N1>TW`ZZ`RRI?9",,];`;3W2O8=(_#D;=$,W'G?KD(1^%2
M_;7-NHTPK,>F=?7C#6"?M;>ZNLB,$`:CXB6:L7A,-:%#XLA7?^82938-(P5L
M&],70,&F>[B[>>=$,[TW%$1HM(FD&K#$RVR$85Y-&U?[I[WT"C;-HW%[))JQ
M>$LUH>,]8!SC:+1\F4W#<+]\CWL%F^YQ-*ILHAGM#=WIBE0#EGB91<+PCJ#3
MIY>^HTWWZ*9Q>LCB+NV1/B&>C]<OLVJ8`=2S;'+O(/WDN]XX<31Z)B4]=.F-
MV+^S__2,)61F1<P,ZA$W/8-^(%YG"(-X].N%F5+UV;6_<-1F:<]8GA!J-+7(
MZ!!Z]M3S4$WX@:2DJH13L).:*Q'LX,.GP\S[V(V\WO`%C)QM?B#_YOQ`&^%4
M9`^7^K,Y;.)<#ZWZ1+*VF[9V3,*PV;T]PC\7!(8-?P;PGC%Y.5%C\?#ORO9_
M````__\#`%!+`P04``8`"````"$`Z$RV+?X%``":(```&0```'AL+W=O<FMS
M:&5E=',O<VAE970R-BYX;6R<FMMNZC@4AN]'FG>(<E^"0SBJL-60LV:DT6@.
MUVDP$)40E*2E^^WW<IQ0[&1[A=V+`N[G/_;Z?5JXS]\^LY/V08LRS<]KG8S&
MND;/2;Y+SX>U_N\_WM-"U\HJ/N_B4WZF:_T[+?5OF]]_>[[FQ5MYI+320.%<
MKO5C55U6AE$F1YK%Y2B_T#/\99\765S!Q^)@E)>"QKNZ4G8RS/%X9F1Q>M:Y
MPJH8HI'O]VE"G3QYS^BYXB(%/<45M+\\II>R5<N2(7)97+R]7YZ2/+N`Q&MZ
M2JOOM:BN9<DJ/)SS(GX]0;\_B14GK7;]H2.?I4F1E_F^&H&<P1O:[?/26!J@
MM'G>I=`#%G:MH/NU_D)6$5GHQN:Y#M!_*;V6=^^U\IA?_2+=_9&>*40;?&(.
MO.;Y&T/#'2N"RD:GME<[\%>A[>@^?C]5?^?7@*:'8P5V3Z%'K&.KW7>'E@E$
M%&1&YI0I)?D)&@"_M2QE0P,B$G_6K]=T5QW7^F0VFL['$P*X]DK+RDN9I*XE
M[V659_]SB#127,1L1."U$2'3D65.YXM'5":-"KRV*K/'5:Q&!5K?J)CST9R,
MEY/Y\`[-&A%X;41^(2KS1@2FVJ^W9-F($#8R'C7(X&;78\>)JWCS7.17#28D
MV%E>8C:]R8HIMZ.&>WP;1S\;1C!^F,H+DUGKT$\8(26,_8^-1<;/Q@>,UZ1A
M;,[`[QM#1&+;0XPEQND^:3*?B#INR[!!SIKG]0B+5?R6:*L$LD8H%T1W50R(
MYBVD,/:%D/9/P#9RC&:1:Q]LMP5?83+%MFY[B+F(.!R!%MYB;1$IDFX?(T72
MZS)28_P>0FI,T$4L8HD-#@<P49?Y:HS@`*P;#SC`:,$!N6`K%SB\0`SO5UOJ
M,><.8+P!C#^`"08PX0`F4C-"C&%U%6+,%HX)+"#JT<YJ";&6"[9R@<,+^#;#
M)K,K%WAR@2\7!')!V!;<SX^I."2C/F9V8X1@P'XB!$,=!$9#L(3)*<T9FS/0
MA-L$EIJW10D')5R4\%#"1XD`)4*4B%2$8`5LU((5P\8EJ[7688&YA=LBBYO7
M]82V.:.R!"4<E'!1PD,)'R4"3BSX3CVN?\3>AJA&I"($2^!8(%BBGAV,EJU8
MBHVS.:.R@A.SNH/FM*>##JKAHAH>JN&C1(`2(4I$*D*P@B5[\G'/@KFEMH35
MDBPQY=,=9U26H(2#$BY*>"CA<X(/#=(W-`)4(T2)2$4(EL"Y7K!$;06C92ND
M@YW-&945*.&@A(L2'DKX*!&@1-@2+.D@X]'T:XNNE^VH_?O7TOZUDPI&L/1'
M<&+8UE%7DRV1#H-V`ZD\P1$'1UP<\7#$QY$`1\(&:68:F<RD[")2:HC>L&3K
M?N%2SQ+"<S-A/S>EI]L-I/2$ZR@0!U=Q<<3#$1]'`AP)<21JD#[;1$]8/O:`
M)SQ]$SV1TD";<$@1\"V..#CBXHC7@\`W6>))Q.^!)"3`D1!'(B4B^L*RN`=\
MX4F?Z(NTB-J$0TI?4,3!55P<\5ID7A_NIB/36M[_+-PG:?7UVQIWQ_N.26CK
M0UPE4B*B21!*P:2!FPVK)F\V<NY(.*0T"T4<7,7%$:]!^&*RF,!!7)Y`:$L"
M_#$ACD1*1/2&)9L/3"">FXH32$X>V3?Q8)S2$Q1Q<!471[P&F?+LSUQT%S6T
M)0'^F!!'(B4B>L*RS7M/V'S!,Q?"DU31&SF;;""E-ZIDMSYG.KB*BR->#V)-
M.G,&;4W0HR,M>2&.1$I$](>EH/?^(`<TGK$*ODSD/(9PB*\=YFR\7%C2>6';
M(`KK'%S%Q54\'/%Q),"1$$<B)2*ZPK+0>U<&[C(\>17=D395&^XRT14-19Q&
MA7\399+)M'--@3_'PQ$?1P(<"7&$7?'^/"S<''Z%RZ_A,EH<Z):>3J66Y._L
M>I8MR[?2V]7QB\5NB*1RAZS@KJM;'I`57%=URVUS9??I;,T5?.\.O'%[`-P,
M7^(#_3,N#NFYU$YT#TT;C]C-:<'OEOF'*K_4EXBO>05WPO7;(_P/`(4OZB$7
MU[5]GE?M!_:`VW\5;'X```#__P,`4$L#!!0`!@`(````(0!JGFD"X`(``&@(
M```9````>&PO=V]R:W-H965T<R]S:&5E=#(U+GAM;)262V_B,!2%]R/-?XB\
M;Q(["2$(J,JC,Y4ZTF@TC[5)'&(UB2/;E/;?SW5,`PD5I1M,X//AGG/]8'K[
M4I7.,Y.*BWJ&L.LCA]6IR'B]G:$_O^]OQLA1FM89+47-9NB5*70[__IENA?R
M216,:0<4:C5#A=;-Q/-46K"**E<TK(9O<B$KJN%1;CW52$:S=E)5>L3W1UY%
M>8VLPD1>HR'RG*=L)=)=Q6IM120KJ8;Z5<$;]:96I=?(550^[9J;5%0-2&QX
MR?5K*XJ<*IT\;&LAZ:8$WR\XI.F;=OMP)E_Q5`HE<NV"G&<+/?><>(D'2O-I
MQL&!B=V1+)^A.SQ91\B;3]M\_G*V5R?O'56(_3?)LT=>,P@;VF0:L!'BR:`/
MF?D()GMGL^_;!OR43L9RNBOU+['_SOBVT-#M"`P97Y/L=<54"H&"C$O:,E)1
M0@'PZE3<K`P(A+ZTXYYGNIBA8.1&L1]@P)T-4_J>&TGDI#NE1?7/0M@4U8F0
M@PB,!Q%,/BT2'$1@/(J0<82CT2=*"0\J,!Y5/NL'G+>AP'@4N;84SR;<-FQ%
M-9U/I=@[L`D@0]50LZ7P!)1-IT(8W^\4I&OFW)E)[52@%:RNYWGH)U/O&99$
M>F`6YPSI$\MWB+B/K,Z1..HCZW,$^T''>&"S\PHKX=3K98\&AG6'G,XC(>-.
MM\UA81GH:L<,JEM^2*P^)-:7B)X_*/9Z?P:>(=#N:B?!,3?KSS)CV^$D"L;C
M..Q'L#Q%8I(0C$=]8F6)"R&M+Q$]@R!RO4$##PT.VK.PS*@U&`1Q$D:#")8]
M(L8AB8?^+`&O79"#7UE?(GK^8.-=[\_``W]DL'\6EK$-C$B"Q\$069XB&,,U
M&22#C;KJ(8F/8Q(-$+A,3#'VA^"N]:/@>!Y8B_:RL&=/0[?L!Y5;7BNG9#D$
MY[LQ2$A[5=@'+9KVC-D(#4=\^[:`&YW!`>2[`.="Z+<'<QEU_Q'F_P$``/__
M`P!02P,$%``&``@````A`,0=($AP$```MH<``!D```!X;"]W;W)K<VAE971S
M+W-H965T,C0N>&ULI-W9<N+(MH#A^QVQW\'!?=M(8,".<NT0@YCGF3O*QF6B
M;>,`JJO[[<\2$H),"?U)G[HHV\FGE9K64DJD\;?__?WQ?O/7:KM;;SZ?4M9M
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MS-9+R2I9ZD5QO#!/*=E1DH<[*3%_?<_D[6]W?TE5>`Y,,<YD5%,Z&J\(>('+
M?H/\'P:VU$4J1W%<Q-4;JGI#36^HZPT-O:&I-[3TAK;>T-$;NGI#[]APMG'I
MM+IY_:,Y;MY`;QCJ#2.]8:PW3/2&J=XPTQOF>L-";W""D\`ONX>S(CCD(L.C
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M]`;7;U`V+:_MI&J<.6W9X:Z@9F#J!J819[2+=]/`M`Q,.\X4U,/:,3!=`].+
M,P]J7WT#,X@Q!>V:,#0P(P,SCC/:C<#$P$P-S"S.:#5X;F`6!L9QXI!^$U0\
MHN--AA.DU]G=5)!?:O9H1]4)<NX<65EMTYR8/#Q'2O60P8A2/9*KAJ>5JJ$W
ME/2&LMY0T1M<O^&T)ZIZ0TUOJ.L-#;VAJ3>T](:VWM#1&[IZ0T]OZ.L-`[UA
MJ#>,](:QWC#1&Z9ZPTQOF.L-"[W!<2(MQ4A+</!.1\()CMY92W#XSEK"XW>Z
M7\[D3^>M<K;)([LKSC9/R\/@\\<+!:U\%WTCZ14^@M`N."449105%"Z**HH:
MBCJ*!HHFBA:*-HH.BBZ*'HH^B@&*(8H1BC&*"8HIBAF*.8H%"L=APEGG<-HY
MG'<.)YZ3F'E*\9''UTKQ\6[&>:#L+?64DL<488')%+1Q7=$W244(13DJ,H53
M%3V,BRM1HQ4[%T4510U%'44#11-%"T4;10=%%T4/11_%`,40Q0C%&,4$Q13%
M#,4<Q0*%XS#AO'-*'"4F\[2L<CCQG,3,4\J0-^_A_"VYY!&WI[7R\Z#=HA5]
MDU1^CL)[Y^[^UDX7[(?3OWSE#^T.HGREKQS]J4AJN]!%44510U%'T4#11-%"
MT4;10=%%T4/11S%`,40Q0C%&,4$Q13%#,4>Q0.$X3#@CG1)'";/P8E8YG'A.
M8N8IA4EF("B%R1L?>3,8D@N4MY1>H+3G.D7?)!4H%&44%10NBBJ*&HHZB@:*
M)HH6BC:*#HHNBAZ*/HH!BB&*$8HQB@F**8H9BCF*!0K'8<)9YY0X2DS>91ZT
MX8+#J><DYIY2ABQY[T*I0\GUY\#5`A2=FN2%E'=>SV[BM/%)*0B30,I,*DS<
M@.3\651I*Y_55J7*06I,ZDP:3)I,6DS:3#I,NDQZ`?%WKI7.Y>_MG#9:[BLF
M$W,`!MS1D,F(R9C)A,F4R8S)G,F"B4P2PU1SB@;&(!]EVACW99"1SC$EXW-?
MK4WRQHM2F[PQDNW-#88BY2VG%JG,@_8F4='R4?QJ'!X`E9B4F528N$RJ3&I,
MZDP:3)I,6DS:3#I,NDQZ3/I,!DR&3$9,QDPF3*9,9DSF3!9,I$QAKDF98A.7
MD)D'??*(04XZ<4F9>="&!E*JDM9)+57>S+KSYTQFC[LM?T+>^?/NG/ZX.S")
MA<H/DT#*'*7"Q&52#8GW]$L;#=2"%_T10_[!2EO:9)0ZBD92!TUM\4S.TM["
M;*%H)W7041;/Y`OYLXE"AZM&%T4O[.#BHX8^DT%(8G;T,'SQ8A>C@/C'(I>S
MY?<GU$DMXS!(3`^3\,6+/4R5'JS[O+Q1K1V-61@EIHMY^.+%+A9J%YEL)FOK
M]<!1C/RF2$9^PTC=4JD^F$$RM9Z-09I)[>$XR8FF5AYO0MUYY8&QD3__3E;A
M]`Z;GH1%RT<)]:3$I,RDPL1E4F528U)GTF#29-)BTF;28=)ETF/29S)@,@S(
MY<H_XB!C)A.MG^@%8,I!9DSF2C]QUX$%!Y&!$2::E"8V!MDH]V\<QR`?95"4
M%$<M35)`E-)D."CR%E-OWW+:=:-H^2:Q0B$I<Y0*$Y=)-20QE[E:^.*I)&O7
MIWI`+F=/(PP2TT,S?/%B#RVMAVC>M,,@,3UTPA<O]M!5>HC+F!X'Z3,9A"1F
M/8?*2EC9>YGUH;U],E)(_+CH>&;%]#!1%K<SN7S6TD8D4X5<&!<E=#%7E\_;
MMFUI`^V%2BZ,BXY]7#QF4GS8E`R,0:;)N(C[2LXUM?AX$RZO&!?Y\S.5<=&#
M=G-2]'ZQFYYL(RESE`H3ETF528U)G4F#29-)BTF;28=)ETF/29_)@,F0R8C)
MF,F$R93)C,F<R8*)#(TPD:0ZL2D9&(.,E.K$?1USTK],ZW>::G7RIGU>49W\
M6:)J=8J,B7`J:<G[;(GD`E8^DOSA+3/MXE@YOGIV^ZB-55PF528U)G4F#29-
M)BTF;28=)ETF/29])@,F0R8C)F,F$R93)C,F<R8+)E*8,(>D,+$QR$6Y9^,X
M!BDI]VQ)<=3"Y$WAO*(P^3,^U<(4>8*-TT)+%I)R0`I^79)'B5E+FQE18>)R
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M=`$.8Y"0\N")XR2GI%*<O(\#O:(X';CZ7EPVK3T4*@8HN#/37BT%KR;5)285
M)BZ3*I,:DSJ3!I,FDQ:3-I,.DRZ3'I,^DP&3(9,1DS&3"9,IDQF3.9,%$_GP
M/IZ`?4S%A&23C^[C.&4#8Y"2\DG827VIA<F;:WD^:C*[M;/]*9KJZ$E[+E0,
M4#!ZRF?DR9'^^:&EP"3LN3*3"A.7295)C4F=28-)DTF+29M)ATF728])G\F`
MR9#)B,F8R83)E,F,R9S)@HF4J:1)TX<ILO(1HVP,$E(^8I3C&*2DE*FD.&J9
MDDKS;\J4MY@^CM)_)<7VD3^.D@]8+^1M[>%1*2")5<J/DD`J',5E4F528U)G
MTF#29-)BTF;28=)ET@M(PI'N<Y0!DR&3$9,QDPF3*9,9DSF3!1.I4I@E4J78
M&"2D5"F.8Y"24J62XJA5RINC>3Z82GX$9?M3.B5\^)`^F]9FK14#=)S<X#V!
MBCR#"DQ"[2DSJ3!QF529U)C4F328-)FTF+29=)ATF?28])D,F`R9C)B,F4R8
M3)G,F,R9+)A(>4J:9'T<1+$I&<0QR$C'("6E/"6MCUJ>I$!<4YX\K@Z>\MK3
M[Z+MFZ`Z^<5),Z7`)%8G/TP"J7`4ETF528U)G4F#29-)BTF;28=)ETDO($F'
MNJ\82SY#(Y=+9[0)<P/N:\ADQ&3,9,)DRF3&9,YDP40*%":*C)_8&.2DC)\X
MCD%62H%*BJ,6*&^RYQ7C)W]NZ/GX*:=/+_`^MD"*V,-A^M+#[>D#X0[?W5?^
MT,[.4K"`K',X*--F3I295)BX3*I,:DSJ3!I,FDQ:3-I,.DRZ3'H!,3[N_6L7
M&/!*#)F,F(R93)A,F<R8S)DLF$@9XUG=10-CD*Q2QK@O@W25,I841RUCWK3/
M*\J8/TOTO(QETUK-*7I_"%#JF'+UU68B!"2Q<B5-2#V,;RL<Q65295)C4F?2
M8-)DTF+29M)ATF728])G,F`R9#)B,F8R83)E,F,R9[)@(M4)LT0&66Q*!J9L
M8`Q24JI3TOJHU<F;]GE%=?)GB:K527L^7K1]9'RU+04+)-:JI.FI0:U"XG)'
M528U)G4F#29-)BTF;28=)ETF/29])@,F0R8C)F,F$R93)C,F<R8+)E*K,`6D
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M^/9MM7Q9;3T@^'6SV1]_\#KXO=G^>=AAW_]/`````/__`P!02P,$%``&``@`
M```A`.AI3/`G`P```@H``!D```!X;"]W;W)K<VAE971S+W-H965T,S$N>&UL
ME);;;YLP%,;?)^U_0'XO]UNBD*I-UZU2)TW3+L\.F&`5,+*=IOWO=XP3;ME8
MTH<0R.>O/W_GP&%U^U:5QBOA@K(Z08YI(X/4*<MHO4O0SQ^/-S$RA,1UADM6
MDP2]$X%NUQ\_K`Z,OXB"$&F`0RT25$C9+"U+I`6IL#!90VKX)6>\PA).^<X2
M#2<X:Q=5I>7:=FA5F-9(.RSY)1XLSVE*'EBZKT@MM0DG)9;`+PK:B)-;E5YB
M5V'^LF]N4E8U8+&E)97OK2DRJG3YM*L9Q]L2]OWF^#@]>;<G9_8533D3+)<F
MV%D:]'S/"VMA@=-ZE5'8@8K=X"1/T)VSW#@VLM:K-J!?E!S$X+LA"G;XS&GV
M3&L":4.=5`6VC+THZ5.F+L%BZVSU8UN!;]S(2([WI?S.#E\(W142RAW`CM3&
MEMG[`Q$I)`HVIALHIY25``"?1D55:T`B^*T]'F@FBP1YH1E$MN>`W-@2(1^I
MLD1&NA>25;^UR#E::1/W:`+'HXD3F+X;1/$U+M[1!8Y7HUAZ6VU*#UCB]8JS
M@P&M!^"BP:J1G248G^+1F^D"^U=>$)0RN5,N"8J0`5$(*/+KV@^#E?4*A4F/
MFGNM@<].XT7>6+,YUSB=P@+B#AN2'&+_O9HG.B56=*JZ"O=>7QBC^-T_:C6;
M<XW;*48HD-H0127H09O.(ZE%H!N$X8=AYZ\IM<8?:":1;N84(T8PN9Y1+4H0
MY-`7+(XGC%HSQWBN\.)%YS*BA!MJ2#F?H!)/Z!9VYZL3U!J_;<C`=.W87?1_
MT:>;OJ*ZYI?K1]SA-=Q*/.;VPVC"K35SJ<XI1FQP3PXSO:P[U:+_=:?6S#'.
M*4:,:M8.GD'S=5?B:7[3KM2:.3:M"'5GQ'[@AGWOC-@6U[`I\92M[W7=DUHS
MQZ85FBUTXRCH'TTC-!B;5^36JB=P4;]I#7<4S=$=)1K/<;RP?X9K.CV*]9"I
M"-^1#2E+8:1LK\:L`Y%W5[M7@#NW'>+=#S"!&[PC7S'?T5H8)<EAJ6U&<(-R
M/</UB61-.\*V3,+L;;\6\*Y%X"%OFR#.&9.G$_66T+V]K?\```#__P,`4$L#
M!!0`!@`(````(0#?M892_P8```DE```9````>&PO=V]R:W-H965T<R]S:&5E
M=#,R+GAM;)R:VW*C.!"&[[=JW\'%_=B(,ZXX4V.;,UNUM;6':V+CA!K;N(!,
M9MY^6PALU'CH9&X26_EHM?J76J*CA\_?3\?9M[RJB_*\4MA<56;Y>5?NB_/S
M2OGG;_^3H\SJ)COOLV-YSE?*C[Q6/C_^_MO#6UE]K5_RO)F!A7.]4EZ:YK)<
M+.K=2W[*ZGEYR<_PET-9G;(&OE;/B_I2Y=F^?>AT7&BJ:BU.67%6A(5E]1X;
MY>%0[/)MN7L]Y>=&&*GR8]:`__5+<:E[:Z?=>\R=LNKKZ^73KCQ=P,13<2R:
M'ZU197;:+:/G<UEE3T<8]W=F9+O>=OME9/Y4[*JR+@_-',PMA*/C,;L+=P&6
M'A_V!8R`AWU6Y8>5\H4M4^8HB\>'-D#_%OE;/?@\JU_*MZ`J]FEQSB':H!-7
MX*DLOW(TVO,F>'@Q>MIO%?BSFNWS0_9Z;/XJW\*\>'YI0&X31L0'MMS_V.;U
M#B(*9N::R2WMRB,X`#]GIX)/#8A(]KW]_5;LFY>5HEMSTU9U!OCL*:\;O^`F
ME=GNM6[*TW\"8ITI843KC!C@??=W[<-&H#OA"?1ULZ(Y)C.M#_C">F?XA]Z.
M_5YO%B(\;;2W69,]/E3EVPRF,#A57S*^(-B26^9QUD$M$95KY'\6>(@XM_*%
MFUDIMC*#QVN8+=\>#9L]++Z!PKN.68\91&QZ@LO)S6YQ@]<WW/IA*K+B]TQO
M)<`-(6Z(<$.,&Q+<D(H&^'D=L6U<![R`Z%Y##%&50GQ_"O>1Y#2/9._]6C0,
M.V*J=NVIC=-FS"!B.R9L4S;BC1'-EA%_C#!5EYG@'G.+3.MO>(]![D3W&$ON
M*[['()^3>XPCVTG'S"U^DI;ZA[3D-"RGP1S1'.3>6C"08:[S"`5B0Q);DO!(
MPB>)@"1"DHA((B:)A"32*4*2$\(N+<T^^TTO4?[42H$Y<Y7,5>4)M1;(E*J"
M<-I<^<G0--NRT:S<2@CD.56ST.SQR'Y\D@A((B2)B"1BDDA((A5$%S/8/U7-
M'*PG25G8=7]!6?X44A;M+FN!6$(WQG3-<5$&W-#(%B&F[5AHV7L28NHF,TQ7
MGF6^A.B.I3(#3<1`1G15AW.L;"64$(U9-MB1D4A"F,[[059B&5%5AYDH+HF$
M&`9CUBW+MOM"*A',,2T+#%U]D02V?DE@_A02&/FP%D@OL&N::*0;"MA*@&'H
M*EZU$L`T`-`&Z<N$Y=AXRP\0H1L."G<H$[9IX.P1R83I6@P)'\N$[MKF38Y6
MLD0B+%B2:"BI!$`6,ZR!'Y*D<'R4UNQT%N8TDA)%8"V07DI5U5PTO@U);"5"
M-RP5V_`DPM9M5T-+V9<(W37<P:1NHQC(A&$.\YHX,DF$9AB:B<82281MV`8*
M1RP`2*+7?0LYFI!$*G7"'-<>SDQ)3?XFCM\L#%C@TZKRIY"J:$*M!3(QC(T@
MA.[8QS::6]*&1Q(^200D$9)$1!(Q220DD0KB?L0D5=U?4I4_A51%4V\MD'ZM
M&J9CX//01D(,W85#TW5O$+(*8F)J>"3ADT1`$B%)1"01DT1"$JD@NJ"BB$FR
M,GCE'ZU67@>87JWM8TA8](ZV[I@)438=TA^&58VY.I969C3(D*:.=F:/[LJG
MD8!&0AJ):"2FD81&T@[I@F<S4],,YW92E&7F58MA4B;D%44.>)VZ[ABZBM,Q
M$]"DOB2RI:UX-.+32$`C(8U$-!+32$(CZ20B:\N+&$-M^<LLO>'RHA_*S;J*
MDW,'36HL[(A<HS/#,1QT0-EV5CI$9;:!^O'H?GP:"6@DI)&(1F(:26@D[9`N
M+*YCVK>#FZPPKVL,%296KRB#R*MWE)T%-*DLB6P9B7@TXM-(0",AC40T$M-(
M0B/I)")K"PI\1%N.RQOOZ#5SS00TJ>T8,4;+EF8\NBN?1@(:"6DDHI&81A(:
M2>\@@^#)\O+*Q@>6KBB$#$N,.GYG7/-_A\$<F)1WC`P\%&?F.V8PX]UA4.KV
M:22@D9!&(AJ):22AD?0.,@B,+"\O<@SE?>?>*VHCLLRWHUNKSYH):%+F88WE
M)WNOA-S=>\E^?-J5@$9"&HEH)*:1A$;2#GG'WLL+'UCA=[P@B7K)4&'#QA5'
M1I9=-AWB=F7GN8;*<%L9<.8&`CRZ$Y]&`AH):22BD9A&$AI).Z0/F^W.!T=.
M>07S"L@OZ"L*)[*^M^-;MX+)^LL&KE+P7-X[>D=?";BG+]F)WW4RD4D"&@EI
M)**1F$82&N$W4(9ANZ>ON&$B[CR<\NHYW^3'8SW;E:_\]H@."^K:>KW9\D7C
M_WY'[6NVA/L(XW:/+>%V`+0OK@_`191+]IS_D57/Q;F>'?,#=*7.;=B-*W&5
M17QIRDM[`^.I;.`*2OOQ!:X<Y7#U09T#?"C+IO_".[A>8GK\'P``__\#`%!+
M`P04``8`"````"$`2MHN>V8#``"H"P``&0```'AL+W=O<FMS:&5E=',O<VAE
M970S,RYX;6R4EMMNHS`0AN]7VG=`W#<<`CDII&I2=;?2KK1:[>':`9-8!8QL
MIVG??F=P0C#INO2F#>;W[V]FC#W+VY>R<)ZID(Q7B1N,?->A5<HS5NT2]_>O
MAYN9ZTA%JHP4O**)^TJE>[OZ_&EYY.))[BE5#CA4,G'W2M4+SY/IGI9$CGA-
M*WB3<U$2!8]BY\E:4)(UD\K""WU_XI6$5:YV6(@A'CS/64KO>7HH::6TB:`%
M4<`O]ZR69[<R'6)7$O%TJ&]27M9@L64%4Z^-J>N4Z>)Q5W%!M@7$_1)$)#U[
M-P]7]B5+!9<\5R.P\S3H=<QS;^Z!TVJ9,8@`T^X(FB?N7;#8!&/76RV;!/UA
M]"@[OQVYY\<O@F7?6$4AVU`GK,"6\R>4/F8X!).]J]D/305^"">C.3D4ZB<_
M?J5LMU=0[A@BPL`6V>L]E2ED%&Q&88Q.*2\``/XZ)<.M`1DA+\W_(\O4/G''
MDU$\]<<!R)TME>J!H:7KI`>I>/E7BX*3E38)3R9CH#^]#X>:>!JHB>^>*+):
M"GYT8-/`DK(FN`6#!1AC8!$@:8PVU/]%"B&BR1VZ).[4=6"ZA/(\KZ)IM/2>
M(:7I2;.^U@2F8G-68"4`KV6$P+N,;R?]C()B1,$B(-M:#X!WRQ;VUKU63.-6
M8I!`AKHDYVS9B7`2%+P#$'7\-:361!W-A:!1;&P*@Q%,/LZ(DQ(7$M$F*9I.
MVAQH1JV9-.6=1$$<]O/8%<3SB3^?78(P$&&#=1'MZ4-Q'VW:0],:6+_%OZRL
MTV=3&&P3DVU8B7'2>R76&ANC36$PPH?6S=\P1IS4SV._Q%IC8]0*O0GB.(QG
MT>4[-QCQZNL<+/8:H[C/-NO56&ML;#:%P38WV8;E#R>]5V.ML3':%`9C`)=4
M-X'#()M9_4SVJWP2G;[DL1_$<S/7&T,1C>,@NIS5)B6>V8/+'.@3WCQF>FNO
M3R);$JT2DP_/]@[?P"SJ&\%^9`=:9.6T24Q./-X_SJDO!5BE/?>NCVWHBW#C
MZFH'P7@R[A=;"]X.1%/JQD@W#B45.[JA12&=E!^PZ0GA2FA'VX;L+L0[N#>^
MQD8-Q[WV!?1)-=G1[T3L6"6=@N9@Z8^F<&(+W6GI!\7KIEW9<@4=4O-S#QTQ
MA3O>'X$XYUR='W"!ML=>_0,``/__`P!02P,$%``&``@````A`"6#8`U/!P``
MS",``!@```!X;"]W;W)K<VAE971S+W-H965T,BYX;6R<FMMNVT80AN\+]!T$
MWMOBGG@P;`>A@K0%6J`H>KBF)<HB(HD"R<3)VW>6L];N+.D5Y5S$5O3OZ.,<
M]E\JO/_P_;!??*O:KFZ.#Q&[C:-%=5PWF_KX_!#]\_?GFRQ:='UYW)3[YE@]
M1#^J+OKP^/-/]R]-^Z7;556_@`C'[B':]?WI;KGLUKOJ4':WS:DZPCO;ICV4
M/;QLGY?=J:W*S;#HL%_R.$Z6A[(^1ACAKIT3H]ENZW7UJ5E_/53''H.TU;[L
M@;_;U:?N-=IA/2?<H6R_?#W=K)O#"4(\U?NZ_S$$C1:']=UOS\>F+9_V<-W?
MF2S7K[&'%Z/PAWK=-EVS[6\AW!)!Q]><+_,E1'J\W]1P!3KMB[;:/D0?V=U*
ML6CY>#\DZ-^Z>NF<WQ?=KGGYI:TWO]?'"K(-==(5>&J:+UKZVT;_$RQ>CE9_
M'BKP9[O85-ORZ[[_JWGYM:J?=SV46\$5Z0N[V_SX5'5KR"B$N>5*1UHW>P"`
MOQ>'6K<&9*3\/OQ\J3?][B$2R:U*8\%`OGBJNOYSK4-&B_77KF\._Z%HN*)S
M$&Z"P$\3A/&K@P@3!'[:(#Q33"67499X64.6/I5]^7C?-B\+:#T`[TZE;F1V
M!Y%U>@0D>3H]D!>]YJ->-"P%=0<U_?;(D_OE-RC#VDB*"0E5K"84Z5FR!+PS
M(Z3-90RS:3%<0[2P;-DY[(!?H$0Z$D45JY""H,'GS$?3XH<(8ENTG'YP@9)L
MR*GB.<L$MTD9Z%>NA#'8343.SU$('%SA?#@MIG`B/H?%O*$DP8*G3,*'4\6*
M*#(>)XZ"H,'LN&CSVDXO\A`9!2A0@HA)HORV7+GO\S27MFT)7D+QPAVGQ1Z6
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M+E2<)&^56>_9#N:%,FLU[4%I`YLLHL9-D;1S:<J,&KP$KF+X<YY_FD7/*2[@
M35B$[1Z#YWH`2_+8:].5/A["-9KTYE+:Y%*TJUR"C6U">BY0&,UK846:Q)YD
M120\X3&+W\*[RBS8V"VD[Q9&8_#B5.6CU+EVP3D3_*VR>G8Q<SC&ON'O;P5#
MC=M]-D&F^5SCR.(8!NB-YO-\8R;EV$"<%C)-Z#H$2_-4CHX$+"0AC<BOLI%!
M[8VPO7[$,QHWB:,1-AHSPK%(9&8W*LIWE9/P"2<9\:$&/SN-I=^')@:^GZFW
M]CY^E8,,:B]QW@<71F-&1"@.!Y=S;V'W$4DJ,QF_=7[G[W*0816]`Y*>RQ9&
MX];7'Y*@A)97[^6.@\R;$JY7>=FT_6/:$#5!3)283A"9RE)N]TS*>965Z'MJ
MX'//"\IN9H8/-4&^D(3B764G?&PGSN'7X*'&-".7*1-2C=H11=/70`$]0YE9
MY[&Q*%L@`^K:QDV2)RSA?-205*227*2Q;6R*ZME+^-3`Q[:B?.\S&LRE4G&>
M<M^^5T1SDX0))ZQ%0J]<(!U;B_(.^`5W?0,.T%.G;*()G[+UMT'^=%\&'5;1
MZ59>00NCF>Z\H3%600FIN/`\9EYS#JOHD(_V2J,)8J(=34LHIN<X,S'QOL2]
M*9#^7BE0,\U@LHF25W,2^H[9AJ&<$]8SH^KCFQ=_ORD$:H*<(0G%A#!^<^J>
M"4^1T*LN51TU0<R0A&)J$[C:(05:1[CJ(7LQ54>)J7J<Z`.'W=THIV=!NCMG
M5'W"BOQSD0BYC.$,22CFNXQ(H']`;YV_`!C/.FJ"50])**9G0C-G?6Q&XUE'
M31`3)5AUD8D83/5\$*68$TXT8X8FG,B:\5#10J`FB!F2$$PYX4.7,8=5%T;=
M:$*800G%?)</2320X*@;31`3PYA19TS!B<\6A7)J+[AZ2Y+H("ZGL@Z"53>:
M(">&F9903&T%UV.B@01'7:)FF@%WI*"$8D*8=V#J5?20-!IUB9H@)DJPZIS%
M.13>WJE0SG<9D;8`C].YHS95OVQ$)LSTI5#,"1^:,>MH(.&JATS&5#TDH9CO
M\B&)!N+.T+CJ(9,QF"@QLPY?%2KX#FEZAY?O,J)A%>U.QT),U2\;D0DSI^J>
M$84/<1*=PZVVT_4&+^0N)HTA":FV\@PHC#>HO>SYM[U&(X?_4&6V>$AV?M>>
M5^P=%"7S/.<"V=AK1G>[\$2&GGC\?^@Q&;X;*BD^CX%/&IS*Y^J/LGVNC]UB
M7VWA]!7?IK!=M/@T!K[HF]/P1,%3T\-3%,.O.WAJIH+'#>);$&^;IG]]H9_W
M.#^'\_@_````__\#`%!+`P04``8`"````"$`M>U:0CD%``"=&@``&````'AL
M+W=O<FMS:&5E=',O<VAE970S+GAM;)Q9:V^K1A#]7JG_`?$]AN5I+-M7UT[3
M7JF5JJJ/SP2O;13#6D#BY-]WEED;=GGC2':</3,Z>V9F#X'UM\_DHGW0+(]9
MNM')PM0UFD;L$*>GC?[/WR]/2UW+BS`]A!>6THW^17/]V_;GG]8WEKWE9TH+
M#3*D^48_%\5U91AY=*9)F"_8E::P<F19$A;P-3L9^36CX:$,2BZ&99J>D81Q
MJF.&538F!SL>XX@^L^@]H6F!23)Z"0O@GY_C:W[/ED1CTB5A]O9^?8I8<H44
MK_$E+K[*I+J61*L?IY1EX>L%]OU)G#"ZYRZ_--(G<92QG!V+!:0SD&ASSX$1
M&)!INS[$L`,NNY;1XT;_3E9[V].-[;H4Z-^8WO+:[UI^9K=?L_CP>YQ24!OJ
MQ"OPRM@;A_XX\#]!L-&(?BDK\&>F'>@Q?+\4?[';;S0^G0LHMPL[XAM;';Z>
M:1Z!HI!F8;D\4\0N0`#>M23FK0&*A)_EYRT^%.>-;GL+US=M`G#ME>;%2\Q3
MZEKTGA<L^0]!1*3"))9(`I\B";$F)[%%$OBLDEA+E[C>,!4#MU6J]!P6X7:=
ML9L&K0?$\VO(&YFL(#.7Q^F4!W3A,=]Y4!D*Z!QJ^K'U[+7Q`66(!&37A%@R
M8M^"\!\0`^@].()LTSGRH(T.[P^.KOM(7VYCAQ"G#I$1^SZ$1!&D4RG:T*OM
M77:7D0?)%#U')K!#R++4V)37]NUK$BW8VW1:/$BAI2J'D+IRGJ>PZX5()*'=
MII/D00K)JGNPO`AQ6K7#-:]<\P-BDHJ^Q,V;PXT'*=R6LCH[A+1SP[5A;GZ3
MV_#H\B"9FUMM'75#2+VX2OGW?0A)/NZBRNDR/!8\2*;8&`N$M(]%^YI$*YA#
MBP<IM!1==@BI*]<8BUZ(1)+`^3%=O#)*H:D.AL"T=Y]8O+>?[9$J7.;78AW#
MQ25X[-?/94\=#H'IX(<)1O#CA[?2?,/S0?#(K_-S*P%P0`2F7F>E$_:]$%G&
M6=9!1GB'P+1/2<>B3(V?X8J"(RK,HY0.5.39$<34%6Q,2C]&)CK+0OAEH$JT
M4>H^$Q$)L!5M?^DOJZ-4YC?+1L@('Q&8CE&I.TDOOQ8K&5'H%B]IC'*?5933
MM"=]$%G&679"1OB)P`3E]4"P".27^\N3TA?["0'R%F99#QGA/0+3T0F8`#O5
M@@L>)W#)XY)$8FC-LITR2AEZ1;.=P+0S%(O(T/.LI5^=&3*_6;9CC;`=@>G@
M5[>=7GXMMC,\2U:+[02/`J'M"$S]T*PTPEGJA<@RSK(=:X3M",SX69H0(&^!
MF\AD>[+0>NH&[RDR[@2FHQ,P`7:JX_(?NTH@,YSE2_R_^2%?$I@.AI@`&1+7
MM_V@FD69X"QCLD88D\!T$*P;4S_!6<YD-9W)4_Y[W@E,[S2-=B9KEC.54<JA
MJ=X`$)@)TX1V-R9`;H59SF2-<":!Z6B%NC,YKA_8OEU=1$@,^2DZ?=[+*$7D
M:AKP9!68=H9B44R3[=B.515))CC+FNP1UB0P'03KUD1Z"<[R)KOI35YU\2`4
M1$S?-(DT[1!91\6;!NZBM7B2:ITV8L8,!1KIA`"9.C>'FB<-4.=HN3=]]9RR
M$8/MYYKXDJ\,]A*&V('E>:9=-;G,4/&D`89-+_(;M9?LQO1\UU)/V[U=Q]@F
M\9T.RX1G`5,$;#J1K]QGWI49-[J8WPYZ=4-JI8</&/#6^34\T3_"[!2GN7:A
M1[C!;"Y\V&"&CQ?P2\&NY2WR5U;`8X'RUS,\!J)P_]Q<`/C(6''_PA]@/!XL
M;?\'``#__P,`4$L#!!0`!@`(````(0"TM,&>>CD``!K"```4````>&PO<VAA
M<F5D4W1R:6YG<RYX;6SLG>MN',F5Y[\OL.^0$&2(`HIL%J_23+L7%$79W)%$
MFJ3L&1CS(5F5%,M=K.+4I=4TYH,?8K\LL`OTL_2C^$GV]S\1D1D9F5DLRCV7
MQ:YAV&)EQNW$N?S/)2*__6\_WHVS'XK9?#2=_/I9?VO[659,!M/A:/+YU\\^
M7;W;?/4LFR_RR3`?3R?%KY\]%/-G_^V[__I?OIW/%QEM)_-?/[M=+.[_[IMO
MYH/;XBZ?;TWOBPE/;J:SNWS!G[//W\SO9T4^G-\6Q>)N_,W.]O;!-W?Y:/(L
M&TR7D\6OG^WN]P^?9<O)Z%^6Q;'[:>_5X;/OOIV/OOMV\=W;Z6!Y5TP6&?/(
M3B:+T>(A.YVX`9CWM]\LOOOV&[WJ7M_-/DPGB]LYKPZ+8?KT0S[;RG;[O6QG
MN[^7/CRZU\/M]H?E-(Y:IY']\>AZOICE@\4_I]V^2'\HN[IZN"_2AR_ZVYN_
M2W\\@@!#(\*[<?XY??KB)A_/&QV5HYP7L]%4I!MF;_-%]WOO1O-!/L[^J<AG
MV3N(/F^,TT:T<AC?W(_6WL'O^FF?5[-<[)9=/MQ=3\?ITQ='O_O'\_1'SP,7
MQ>>1*`YG?,SO&LNBZ:?3CV?_F)W_]NCBP]'QR:>KT^.C]Y>][/3C<4>7Q[#9
M#!*<PCH_9O]0/*3OO=C>AF^V]P[V&LQSO)S-Q*4Q%;M(_F)SL[^SN=L@AE_9
MN]&XF&7'[-7GZ:PYAX_3R68^&!2\Q"M#1N1?Z4Q]5\?3N[OI)+M<3`??][++
MVWQ6S+.SY<*D&KJGS8ZG+'TRIU?^-9^.1T,;0J)'5]>C"4_>Y.-\,BCH#8F>
M9QN?+M]FSU^F/;TM!J6D[:8/`['R^9PN&D_S^:U)^T#_*/YE.?HA'T-;QOHX
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M(Z6)IH\]U7X,IG`T--:_UYW!>LW30;VRB&EST*3-<`@?32>P]'T^&FZ.)MD@
MOQ_!XFEWB,=H,,)N#S#@R[$I$MZ&A[-A\4,QGAJ/"V!\;DB=(Y#-Y'8Z'@)1
M7IA8("$;0]=O8V8-HO8RA',-,O:,YY\VF`P3*GJ2#_/LCQ^*N^MB]L_9OV:7
MZ`$T[%%V\N/@-I]\+FP+STN^\QHXM$A)UM%K]#-*W`WQYI<=PO=Z_+6]HK(F
MTQ^S3Y='K>2(*&"2UTF`E?V\R7Z9?H[_UGYBLUJN-]W,6)R:SYYN9\\QWB#;
M8C$"IKWLLKOKB7X/X9UEF-5E0_36[6#NP$2^7&!\1W]N8NT7GR;CT=T(B)*N
M_HE#C.9SC-'?V,ET%>@QD&0*8`5AXOWL98\NO_7U]J6TOKIRPH%[,`YUE#8(
M*`VUNB@,ML@T"UWD4ML._/#6_:RX!>F-?B@PV?-.&-??6=^A:L"\,S<JP*CX
M$;]PWD0?%\4<=V/@X%YD%=+-_DTQ80%C!TZ&=Z.)0?\%LT_?=%;`KW?%R(:E
M0(N0HL@VPOP:1L5L.:I\]AFU+G!V,YJ`?CO!WND$%`H`]3VGL[L$R&H_.B'>
ML5D-6F<W^<A+J!I@`L&G6G`,RCKAS]&=8-F?;<MMVL6/"^:\',UOQ1/J<0:^
M@(Z0:(CC)QB<U3&.D^_E/;\Z#*(P@5K".@%&V3OI(M]-9\7H\X1-AW#80&.P
M]"6_3X;"']V%C\7"<>EU@>-?A&T#GS59ZM1MJ;`;J'X*=GI(QRZ[TX:VR`+S
M$5H?:AO6@BL"C.AER,/TV""L&(Z3_G:T(JK"MH>_U+,IFW1>]6Y,PV32&.9N
MF6^Q1B=7+-RS\QIO7X#$9G,DBWU]!.X.ET6VF';S@@Q[NJ*3%6S7NKZO&<0#
M/VFQ?+&8C:Z7"X-=-ME*M7L@F4[Q33X?#4Q&AJ/Q4@ZUZ4-4EUA#WK/ME1>U
MPQ8-D;;_`O??JJ,<V@)NZ_U$>KVS3YQO[X:OJ^"=A+9[">+R.KKU$+H+0_17
MQM#Z.RL?6XBMO],118NB`COI3L0A@T9L)'ZXO:+E]NM5#U^M>GBXZN'!JH?[
MJQXV0T7FT;5H4X/&HPE\>Q3AX)@+TW$NBOLEYC.?FU59]>:I@2C33PJK]+()
M.A6AKZ10?-H2OH@:,C7TN7FB[?&&2ZU@\YKI.+V*S3<UF$[[*0HX0@7MOJ)Y
MZ^MHL'063U5.O>R+CT`$B^D\S'J<0=(V*YR[&VO4K]%L!!!EH'W$+9W_4>6*
MGWM7_-BYXIT^R:4,-M,C+I]//#YH=!OYZ\&'[_37VMW@K_-^T7HR1DV4\;A<
MA-AFNI:(>5=S?5<'(>84=EPFM33):V`AN3J>/ZHN;K+G>P<'O8/#79/'R+TW
M._2\WSO8W>WM[A^ZQY$N>.+H-1C(;%/^70,@I%T`7L*"IEV!M707ZFS<1>J8
M#('?"*E\++XH]FQA;`=)P\-TF#;F[AJL6W%VM8A8J:$'N]K$:CS,FB6=EP#:
M%&:GM'KFFX/GBME@A%9-E]Q\HVLJ_VZ08KTP1=MFIXO[.BW21O.TYR=N0.DA
MI?VT2O?3%,17[(NR(C?CZ9=.I[WRN\E'CGYHC?LKBV3Y%0(T=\ZUQ5T:8]='
MA&W-:L__+EUOK`S29^]6.\;O"N]`$PC(Q\1Q4655PJ!,LJ2]_@8?5:_BHJQV
MG..I?:W':W9FM<.K5](Y'C_)9^]N/0E;\F4Z^]XB#,Z:-[8!]@TY*>>X%/?3
M^:B9>3H6IRP%QD3$,AC3S12GECS3T-WOG$>`<[Y6WBUN<;]6HBN$2=9[.^Z_
MH9H;Y!9--CQ17N*?3W\8#:'0]0-$4NIP]>HK+N^F$+;%90R%KTL>[V4WB0BD
M4WNOU%DG!K<@@"&.Z1T(A,QP-B$;VDCHU49G>2M?]H;5>;C"-4T34^E*]]9&
MA0!>&A1J-KF\+P8C$/D/4Z-F[)9TM3!<:A/HH,`$+4:7]\OK,>YZF7&%(*'[
MUEC4:4>[5C*;O,0<407[NG>;>!/U+3A@R)@I5`LJB<OBS/5P.1-C*9J$'%*/
MD6Z^C=W6M)==4^DPL4B=MO^IK0O\D<YVE\O[^[&%B:&M`"JQCR4>@L@:S`P+
M*ZMM&JKH-,0[E0Q,U[12,`W;FO<Y[V`*<^P0S7*S6S?M8[[P,_8:CB!W.A%Z
M4H!3.W!.4<-`.;KN@IW^%A4E:W3J<?DYC'>7#XJE)6;F%)A,*'W05J*2LR^$
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M1',8&/IPS#:A$$J;$3!PPEN>-3?@GO`&:X&#7G:OUIC96E2NOEI@SJCQ*V;P
M]D'_</]5?_?GGUP^_.>?U$;!DH0X2X*:,R.'3YR_6<ZI*")L>^PI"->0/&>#
MH2,!/TNK0XX#D6-[UQC*"3GR"V5_CTV<+N'37O9FAGU`YQY/QTOJE/*>3\YO
MI:J@PMOS)8P*4[$KX@:#O21!\DI7W'M=D?:QL\4X(4+[]=ULY"_;A34=3\*C
M:9EPBF>7DWQ)&0;L@YIX-%+LK9@3^I`4E#JX=PJ";B!FC1\S[?BGK<LM;74V
M1(7E,^<DW!+4QB(5ELP@B>P::W:SH4&4+Z,%Z;R(B&B1P0@K,\\^NRP>+,/S
MXE[S]_)1'YP=H>)QAIXJYY']YNCHW"8CK7*_G"DKLC#%`W%F2W6O)U[>C9'H
M1K)7[_NR(+=C'I&]'WQ,*2<A)>DMK?WRY-A&4SX'3,ED[D+J#SI&%A')L;6S
M+6.T.@,"!5HI/IP*L-%V,%X.V="Q2[HPPZ@[F]3-=+K@598T$X80C34/,<"X
M0(^T=J_5@\>78["L0GRY$1?^^--R@A?(NFQG1)&*>7Q)7V>';A8:7.T>5!H*
MGF`^E73Z:MK=L+!R3V-UKP$`;[/I'&BX6,YM/3*/6*-67*<].#T_<WM`@>.P
MFCU;4V.`"S8_V]O9V[A^*;U!_F%P^_-/7H4VY/]TDMU1MO/90,]?_X(IFMXS
MB>G$]N[KY8F0SIBEV;;FPS\M?0UBMN'V6U+;\*]MLR<JE1[K(3E'O1:U?DF4
M?H""E)I"K=\[>;74,$*D+:EVSEQ`;3-J%\[W9`BUSJ[&B?;+,53G>066;!8E
MVG-;(^9T2%.FVF!$,716/$A#Z*M\;`A#'![F/&*.(S""H@DH#08-;1:W8`7P
M@SA5N<J!5(&X+,]NE@PM1FOLW-7M;+K\C&ZAFSA^'6UZ2#MA."MKQ2`#V<6\
M"XMI9I$]S%R5Z2Y&\1RD#NN#;B!U?=1>Q$;@(S0$50FLPI86CRZYC'O_0GT`
M0D0=NU"HLXE(MN*;".MB-J7*@8A?#HK1O*)UM/;D@.4UFE75=NS;@[FR&`6#
MHRZ_XU.?MM-T/E_2N99$I@:DQ#!^$QUNX^^*K<*6`=@<*3QC!5*;F1?723U=
M&PFLUZWL$K"+^F(BHF#2S$E;Y_AUU@YST%S=2!$V]J,=P3;&FM*2PK!4<I-]
M,LTWSRJK5:@F:2*PUF"P=U[-.<;/;O"=Z5*&2F+%?RNE5T*2A6?*AKAI!5X#
M.C3:R&.)"8H9=)V#!MF5>\JJQ4'\(H.)3HADU!8@X7H@;8=#N`173KU!Q2+,
M2.-/E@4X$OTFO=H8C2$DT[-BT_>*IC%_RL3VNI#F\64#)*X-N5D-A!/Z)U83
M]<3*X++U\M%H8>9KQ:).347*R#.F<:LO(Y4NH?O*.ZJ8-3:D<'&\!\&&_0*;
MVV`<69Y/+@6K`!+N3S,L<P4_L!@04XN01>0%$+$X9DOEW(,S>L)AAG_89H,#
M\UCWP`9W^?>HE#"REW)PJ3&N7"NT;4Z-.N9))&$65`?!:;FO?H=4+I]K3:.R
M9/M;39+0`'H*?I%D=[5S(U$$8WI?752[%*U6*JUK2J$F*XMB)V[JXE6WCVB9
M&+HK$..)I'<J0Q]3!_6K(57\6&X%FJ.>V>[5G[O0ETMX.:#I4VES.#:MM1H6
M;#2Z6&HC[@<!G'XQC"QFA.,+7V2$RF).*F;R_!_HJT"%`.9B:0C!&6]<'C#>
M<*1#!TY)48$)]Y4,T.3/P<N,LJ"4*6<<K](QKK^;WQ.^^/4S9CTO9C\4S[Z[
M@CY!>7DH[R%;65PEVX7W]CG[U@Y@T9?^>\[_C+[A+-:?13_.E&T_XZ_!=.Q4
MZQVC]/7+[!U+=*]<C>[H2UF^BRD;IJ<W^9VP@^M!/WQC'2^^.[H\!MGM<43K
MU$TD6E4T@W^;T=M)%04<!+TXSU(3(ER=>V"OK+F)82G!CNL'4QQ/9UY4X^<Y
M0F4#'8(5U%B%FI86J5(3*44SN$!&&779!$R!C5L90%A3@U*PBW$S2?`[;6"X
M54JU>59.QU`39V,\LXD!;MIG``:[/,[8K,CMTPR)MLN5Q!BE:_#S=2=SF#45
MA!,,>%G$*F7AHAWF_8N"FA8!%:)2F0(PS$VL>X<:("88*AW;Z`J4P*U:#HIA
M+QO=E)`5#^[:`6NG&T5&`Q.,XS"6)RCO696+\,@/^6AL!6>%4@D`!J08)2-K
M72X1+0W613^-1?DM0A=!^Y1:`:+0J@P_CV[HY@:$8/LJJHG8CCC-(3'Z@AFH
M(A6(?E^8>P`%-0EC@#8B?!FQ"WJC-K4@9,0*\QE1$9A)I![@-3.'W'5WMYQ;
MLSOXO82&GK4"/ZM5"S\%0AIML])M66#$P"["=Q6SH?R\R`?"0*6R@WB\N^FP
M&#M[20=?IIOS17%?"9]Q'A92)%0@$/=2M-ITM-H4MVU""?Q--JF2RK!HIY?S
M&F>%6D.9$PRL9SK-[S,0!=&"9\K589=$#BA*(3$JPBROIJ*W:IQE7&#[:"*P
MO_VKL*&\[7!:8*/,<I5X=`8Y,G3/P@7S([)Q-'3*DCQNT!SB]=%E;.Z5R1`P
M0`:<?1$WSQEU\441GWA%K*=MPTSY!5SA1XI430L[S+VY0G]'QWA=)M(D6*,R
M,>)=DEF"N=I$Y&F.=02'@!OY.2HCE\P1KN$91C/&P1(O;\U8HS0IW%9A;'2'
M<_2HE1:T@58T,$61SSGP9(?C2)'A5PP<A`BS,CF*9,B<&S0_S46"V;#2M1Y^
MNGU@+3S1?/&238U+A',%AV`C"4-`!MF&Z06%IUY:GX#K!\#^#>^$\XZV/6Y*
M);)3PL'Y8"@$YL(A1T;4Q`B8821F3F,8IW&*@SP3ZLC>M%D[+ZUB!5'#`OWJ
M1)SNU+'H&-!'`WQ8K'?$:K2/+E`WND,NY)#K)XM*L8&*`FA;R_=#6%W.%R\:
M_>_+RAF'R#Q^I%(^+KIF(;<</I<OY'23HSKH*G:GJ9JLMF=QJZ4Q'09K#**5
M6G)>'I%`;_OY0#'HM3\<:\?=>^I-6SU7_,$YNPR*JB[90D_5G:L>1QR3P1OD
MW!B^Q`]M/0P@8M1/#53B-IIP5GIIIO3;Y,3\%5-H!7L*2+%<^"&N62;6`9JQ
MW0@86-M&2)9?V=5D`>(QN+BJHX8`L<KA3VC@A.5F1H9<]PU(PF7P_(F'UF4X
M4U].H29LZ1B+B"Z]DE6''L'FV9MQ3MWJY8`XB:"3<_AA'3OG89;%&8"[?/8]
MK,]R[5]P`B9>V*ZV[9G<'O(?"H0G>*6^/=K\:)DQ64H&0;3TFNQ7[3@V-'71
MELB;@GUJZBS>6'P/XG#>EB_<D62/QIP75&H'4XSH.6U"NIEBL9+D)0+2!)UF
MQC6O+]&H,W<Q=S;9M*K11[9/^7XI4VTEXB<DY"J/Z,WY.JP^=]G(I32RT\\A
M9CR@&O=!LXRL*3-IS+E]T."WL9\Z)&)4'H]N2G^UT0U+9Y+EQL!C@`B&K@[:
ML*2JR+.A1X0MOGHWS:ZRY\PJ/K;54`]7M3W']!?.SV7CM7<U9PZ>8N&6\M`S
M3&R]LI,H).=:A]YZN;==1"?2)K(#[/]#".=*AI5<7D^(87\S?FPBJI),\2*'
M1`%UF8&SSB7=<9#5T/33AG*V+"@ZMXTV=5DBBW)[[\M9EG+IE8!:])'I8&UJ
MXE@3?N@<:YM'M(#Y:73)'.)Q2B;[]^47:D$"VD<`1T-%'<0^\JB(,9CB<U,S
M::E+>JD67!F16[AN`X`B_+>2C,>EV+=JE]NM3'52]`A+>,P-7Z.*G20BS@IK
M>M4.:;/"(E^*&EI\6/#;+R>J%?"_(,$41PQ4,F`HD^9)O[Q!DL+5.D*>H+/1
M;1(OK\%@YXZ1#>RQVZ7*6>C2"CK5^RW="L3PBB8=FL9*"/ZP`C/,3-<)Q5]>
MYYB/7=)2?K?A0A9@_S9OJ/@1SQWD$/0ANL3')\$H+F!@4=ZRCM$'TD$:1HIV
MLE1Z)]@"G6+IL`.MU'Q;7,M1KIVI$R?Y.PSDG.M0AP?M,&[I-_ONV%H+FWN/
MD*85@T"3:=C$\-XO3OYU.#LQ"[A6%CO+7NT0.GNG@Z6*/Q39ARI0XFNF_J.B
M:*6'6D6:$?%K8P<E<M#-"OI`7\F9?D9FWA,Q&L]__JEO/^[8_\Y=B#T.68>.
M`D3%#U`Y,?\7&(%_JMO*@:Y[FC8.13U!WQB,1C)1.O*NJSA)\2/GDJ4X(M48
M+XCJA'QFZ%;B/M;TM0Y>R3]_UD,+G6@J>CZ:W'-HW6;FC+AY0L7@UJ[*4OS5
M8U&WB]&@WO]GN\6_JK&)'GJ++;X%5,D$HCV_5(4#WDFTV(+HI!GBOKG8)FA>
ME7XF?GY?T(>5%D0A\:Z<1U4&13FX,HC@D?-]#FY2FDM3\+@PCMM9ZH!SV3A+
M`N(%V=@K:,(19E=F8I27MT`]*,X6NC=>XNV(DY<X)(KET;EY@<19_^SQ+Y33
MJCR!C8Y,O)7(QG.FG"F"F7YQ5D$8QW8OE,C7@Q?&+UF?NKS?+2GCL)2>XB@B
MSL!RX8X(/J9>YFI]S!<:!X(J_I_Z:Z[W'7H_=0P2!4S]R&[5TFM3_/^976R$
MWX-#`M`=4E!BNIEQE)YW?R$3R@JC\?ZE-F=Y`W-2IBJ::YW?WR<-6&18G=%>
MLU",T:W\[^4/N@E[ZI<O55,UGQ$VNI;?,YM-KWUU'6&IZ"7/2#`*6Z]9$NL`
M=ZJ<1*P'LU@M06Q)6A?00>!="/QI$HV7SG=.[:S+HS$O+E<B]J:)3RKG4'NM
M+)X3:&$4:!'7FGDH%&D+N%(S7V^B&\7+[`+4_OA-02D/73%&@,+AT`=\*A?@
M\<X<=ZF\+WI?(0*"U!(K+<!W;CD%P'(H:[@K_OQG#AY29*F(Y((05CR3TNX:
M*T:=Q[['?1H"JL%MTUI!K9>'7!7"#S\Z\ZV=*K&)FT4)(QSD]0M9<Q:^V%$)
M2.@(0[B0DTZ6E]$==MO%,$L_RT9J\-^I<_ES1%>11B9">`B_B(ZIBU$A./;*
MN*3LVFV&1RT*/$C55,=#DYN:`GBJ!3K518X0W2@1KRB7=VN`0SF#R4&6%8@.
MA\JT<,&3:E<1.)>K*'Z\S9?.!FJ&P35B#7'+9#ZN5K2^HI(79/);!DTY>N/F
MI57B8=+,`$LAK'D:^:KBUV#AS3%TC@13EPK%!)GS[R*HD+>\W4*Z1Y3!`0*9
MN+L]$/H*JRHJ**[PP<#/V,W%IMFW%L%7+YX?Y<9H=-/+UGL5:"YS>*4CX2/+
M/EGN7)MRXE(\568IF;P17OWWHE2=?@S'85S7@`K217,=L_!'O"OP3IR!VL3I
M@YUP82SM7CW)6*'Q*&#EZ&(RRWC`4A\'EK-F9'*AHHI,36L8;UYP,=SN5:U$
MQ9"[MV[9#)>\UBH?#_YI/Q2?NH>$/RK7(B`&:N`G/(E09E&!.Z+%%"$C,HP;
M6XT2Y$:%";"WE6_$9J%:ARS'GY;#SQYQ7JH<R:&9(,.*"5$4JADQFM9#V60M
MUN%U<!2"E:C+)+O#-`ZG$>5QK>1F6CW>#],Q*\6P(=OE,JW<JV1GX`/"/I.V
M8[51]0V\4FH?E<5>4X(GT*7Y!;NC^#O&,EXX5*94'^,-J/9NN&M33DK6W,T3
M4')/O&[$7GKG/301+;1$X;J&<MWX_#*[+(R@<)L,..HB528?R@I1*L?D`VI8
M4\"&5J)5&''+H*MS(VZG7[30!S96A::VZ&M?ZNY4';?IHE3<)%Q*3UTJ>6SY
MK,H-B--7;GMG^;V=-`GU&-'I".R9S`]<"==074DXS<FL9XS8)I=3YFWIAF*&
M&KN#EF@VR\#D,+U%B3T4N2TH.N&A)JJ"))5X$8W4H60Q)&!,)1N,9&Z]F\&\
M=@:*I2NA]GR_W^OW#WK[KP[@*[7XX"IV0ZEJMA'J[,)-O;O99O:<\_([KWN[
MKZC+3+=KX_8E02'R62S#*:CTC3=VR4OC8A?I,L4NM!2[^@7#/02SF8MF;_.#
M5ARN=-D,5[I4`DY;2VZH+Y9373,6URT%#?K67S&CL$6PY3;KN!?-*&*Y2E/]
M,K.`2:T^F8V3Z=+R[.8;*5T7*[-MC',V`FM@%=@3Y*'8IW=SV3RS!]Z)O%/>
M3:A=6(ON3;&'L^N-3H-&%J]@?605YRYG1^9G.M31*?&+MD$\S3]#X9I3`%]%
M#:RVJN]MRZN<5+2^6%5AD%"X8S9`&B5XR'(Q-@/%FKPX$B8?"$`!6\*I,PS'
MA']SHD4T3+GS=)(=(4-CNY7:+>[=T>6;0,:CRT_V9'/[54\YAW,8C6Z<EF`+
MWI71R$M^=$.8#CCWAVU[V3FUI0NGG4[8RWM-`__F(BC`[*WN`!-TTKZ=P:[6
MNU,E>L8N+(V_.<(TFI.^Q?_6CAXC.6@S.?'\!0PZH1-PO9(=T;P#^.`,2'#@
MRSM27%+'XA1E*90/%X<)E=K*EE6:T0E%8RB]>'+7^)8.V#?:>KWH<PS.!Z6U
M7XLI]J$[HG''Q<9.+A0\>712'AYH-N7J$.$J[AS$3,22*^(0(X>]JB)[2GK#
M&<_H()B[J'S?5FT!5TZA.%6"=#B4[VK_5#"/\%PARV&0X10NG\CQAA(*M!"F
MI8"%_Z.(AUIIIC)@E8[ZOE%2`A:J5Q01;3LX@/:(2G51YBK-UXOB!<NHN_1G
M0T@NUO,SI1D,Q/OZ]1?5Y:_>?TPE2<P-7ND^V[F[A72NY>2F@T.;1X<_FV3O
MBNO9,CG%)Q4;ML5Q!4*69_U-&&&S_WIK![(I$Z?$F>XEG@-LC(;1N8$FBC,;
M^TB9=53O$'<0?!?+XGL-KNYJO]]7CK;9-H<E2A-;Q@_5T)E#TP&^NY(]+7<-
MLA%0D.EHSV*WN@?6LYV#DO9G/E)[=(,VSE5:M=ATE`*/CIJ>`9OAD44XJT#`
M]PZ,0V6NZN,L*!@$0#I$?J,Q;A-#NW,:7QC>>#P^?@*LL2.GCO.9'2`)/]JC
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M\$[B>(;)&X4<?82<@!V*&T`!V1U_)T0["TO@VUXVK5BGJB.-B\XA=&92,7<Z
MVS/VJLGFH>["Q%H9-&$38H:X;^;M@/TC@?#NB]]WAI23NJYPUG8]*)GT0%G,
MK'*8[<Q:?WO[5XW;`VS.L:S6SUJ9Z4U[%R'V>_M[N[W]/BK&Q0IBH:JV9,V8
M9[(A-<J`!"M0'85#JD%6ZAX!F;!K"3MA*P4QG*(5(P[Q$JJ*7295WJ,#`&_>
MX\_E:TC$:XG,CG7=VH?_,52@A7R,PVYZ*!K5+_[#*D7*+[#L\U?;V[V=[8,&
M!FHS3^KXV(-$620M$K-!1,<Y0]X;#:]@2X?97N\5WZSAPR21>-=HZTZ@VDW/
M$.=@]<O693),>MK:TBJQ6\=F*PP)ATVM6C]4T(58FP>9=M;QBY616RX,AN&H
MJ(6NK%9.JP]W?;RTD@[9:!<!?][G\T3;E8./FX;(%]XNZT`WQEN^@.4T'1+V
MO`:T9H)81O/JV26-\_'H\NW1[[+?C*>$J(43O@?R8R(-,7@_S)W-U-MS^SJ-
M?"_)*+Z-&R`D;4EPT1H?;U`4^*VPHXL2)W2T`X7Q(LO\1$F9VBH\XX=SZ<Y_
M"01"]W!9I^3X^3[V$1NI,XDNPK)WV-O=Z_=V#O>>S'7Y$+<<MH-BZ!\[ZBVE
MC,S)M03!R>81]I<WP=BJ4':77\A%EA*N:TQ#1M45\2K,5[K</'J:&_"P2))\
M<0U42I"CL"M4K((M?DM%Q"`$"LR6=]!+*5OP03&4_7V)120:<<R*T??MF3VO
M"8SF437E1>*Y^'9:LS[(HW67T_2(W=Q.8V*`:;A9WS9G&[;E/_V*=<T6T$<:
M]M*P(?(5;A#I[\H>19)MJOVQV1@7^!@,6Q(I^08_'.N6'XULCERELALQ"GOQ
MB!?M'_*S?$!HA;.UQST9Z_;?]F68#T<7Q[\U4G`)2,L'N]Z>')]\>'-R4;VR
MFSJ$&C_][7GZ@TURQ=KM8JZ;?&#!\+2Q5101$_%1B!7DV'>E:]0IM/=T-LG.
M!HLIB0.6R\:S9/XW1@5R?S`\B!U\3OF\:L=4+%=VZ:KN+IDHRE5%/F/"T&_T
M/1J[U.+W;]!=+TU.E_>2E>=[/_]$;G]L,`V>=*[,\YVM_<S_;&Y%J='HM)RB
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MBV:H)O$N>)7">V7`5F;Z>7][:__`%)R/X]H<PH&`?A\/93?28:7WEFI1C:=[
M!#AV0%C.51!7NK\\&+*.*_&XMU*FR4+LV4+,'M:8IR!SUIA\;"G,1L%Y90^D
MJ2BG$8[8V=[9;2C;J]KN*;.$Z)8;9,63<,'^UL[^KTRHX)`!/A=V!VQE)S9!
M%-&&&).X_`S5/1;9EHBH1P3?G1H&E1"R62@'MQ3"4?A;+\D=*!&+!+>8WGB;
M6VJ5DHW$JP3?_1?"6!XRL[@EAJ(D-SU95#O*CRJ\\OS5;FE:J6/0F%YU&+RR
M!8J=37\9+12<7`+ER,%X>%&BL4-$)[H)XX[[NDA/+@F"6]K)YF:XKA(.E=OH
M&@A.@C4V`DWKK>\.(769EKJ>=6>PG$WT4F+&?*=WL/VZ]VIO3PPN&*RC4KQ@
M0[MZNMC:^ML]NH16[&#-13[3LSYC@(8W?];X@R(-:!=_N6.H&E;)BB.?SG$I
MMI.^]GP'\['?ISB2KW=^=I9!+9"ZL"9J[W47JR(4X2<NJ;2^@^]4LJ>!"GE:
M=IS-A_>N95H&A`<[/H_2H/S1A[-/'Z]2&_KFZ/W1Q^,3,A+E'6@N]-VPY[S2
MAA3,Q!DG#00X2GNU&7@.B.`^[-GH<6,'X+RSW[C"_V7S2W75-!LVJ]'MD?<]
M`_W2)>MYF;8/:C,X,.G+%XWM\3O7_2**Q#;'B")FZ9K(1LG4:6?5<A.HFKY8
MPV'IP^C;C)9MAU?CN:6OOX=7W9<<UWG["K;'0"MHWAWS/]!U;57Y0SJBKF&[
M=.ZZ/_A%LBQ]"8U1LF9U/9_$R7R8<,&.C'AL0.]1L7;BTND\P6;4VRF)0)(R
M@A\,9:!!.LC^$NIP>KC\R5*2!(.JA!(TU-!!33JIKMVMI9_,POFMLROT^@#R
M*QY4/:/7]2:Q1\J;P#_2:V(6T"/JI+H?0R_IR[TV172QG4MW/_IY-R9ICDL`
MA18)4,X*JW/-N0V=<:W<ZZCG^O1$/:HB7*V#AG-%05#9J!Z*>JA=M?U3@4ZX
M>"-SAT`M^`KZLHH6_Q;2-IRW/%B2ZG-E7#S%:**#J>`@_E!O%S\Q;6.57S01
MX1S"4DOSS>54J'[&AA1QRS*I'M$*)@OR\RTAN>):@,%F*D-4N<LI/5K>/1Y+
MLTRF+"2$]HA-I(O)'?:,[2>XC*^Q1T&&!_\><#FD`.GC8J:.Z!VKS,=:W<8(
MK7FXCSX]?&T^LVL`-4FB\U2/-9<*U/D>`7RZ><39/4W:Z!Y/V?->*!6763?6
MK7CY&MNDJT1*,:F&U;@"`WXT*H7_!.DU8[>UH11!,)SY^=+!L&TAC-4V'2.V
M*PVP*S:L^1>J8K!!@!F[$<RE6$LFKRJMS7D1/0PW^GP^,FC%1F5ZGV22XVXQ
M$=;;W\/EB_,0QEJE52MY$9@8MS*WQ\@=.,0DEO@*5[/8?6*&^;!<<KC00J5.
M[$NIVV%/NR30X(MD2%^>YHGS-DE!6*):]6"/I;L+!_\9PQFO@%NK$07<=@!N
M8.*]7VD0+;TC8"0"^$^C1-$0K2"VY*$3:1'2A(`F2LJ8"`$=S9OCW%1Z4OA/
M^(HZ[[+$SW-55++#E#29ZZEVC+%+46_@(5T==:GM7>.K.6<E:O7:7.FCI7F.
MMNM<'Q_42S6B"PD&%@Z,#N>'TS"LR!&->>JK([L[04Q$M,AN_KVMJ8S[PHBH
M1K;8O6Z(E6G`%T'9X]^XL&U0+2K*TTS+&*;K@W'T:SP6:,5^PX0U2';%N_7:
MSKH0A[6BW$(AY=/*/2NH7&7G0K%1^4VOJB0RG`&IOD%_]=N+DY.??_IP]O'J
MMY<IDCCY^/;D;?IC0%`96#1]ML$'RT_.KT[//J+%KL[2QR?->LWTE5\UH>S'
MH_2ELA\K@(/KYYUO2$&ASDV6&]]#NQC-OR?F@ALAAS;MXP_IM]%LM]JJH6N;
MFG8C'CCVB9)P_JZMZE=\5>M((B^%.LM5J^:B158^4)W(!$40/K,(@%4:\64%
M.G$EX%ZEF6U7W\'TER=)JRMN]3@MH-:T&YQD%$@+G:4UZA,/;"W5JKX)GT%C
M<\1A=(O4)S#=-"?V<=>G!5YO;>_;;\]QA11BP0;ZG#03(VYA+I["S1$:IF)+
M`2I,LZ\L7VOL9NSCLD/)R?:I.,1[D996!7OH1K2PTGM`,MC1U,GN8>]@?\^M
M8G^/3RCME:\]@2"-Y5NEZW*"W@]EZ\Q`\W)6V$X4FTT#OQIU6M0U(*>:9V_O
MU7[O]2'.M_%*LC-!(4I%!?%%)0/8HAE893^7EGJ)*4M/*ZO:W]H[=!:UH23+
M+ZR5"CH5H1-_E"0[1X5?6B5LMPM%_.7Q'D_MZL)&2J\,M'F!=85(WAJ7E3"V
MOV7.&G:S>@B#5W'D!Y#G\N+N7OW-]%[]8,+]6`Z4BV4C#TU_8N)]F8RWWLA;
M-$Z9DVI]:NS7UH-Z]B.SL0-_,SN_4DGJ>Q(759W"9<I\>8%S=C!TL!$N]<]T
M%>V:Q/7H%_H]5E_F7,%X`N`;?V.D()>/2<"^44FSXV8MDX9)^4>Y>4YF3)GL
M$RS;[^T<A.1T+SL@XG:(!,=#^2!K&#&53E>\K3E9U2UK`XS9,:@(?BB">*U+
MJL#=NF_/:3;^\HG+(+U.>G3?0^?5O@UA:DY`^5X5)ML$`@U-ANJ5:E7MMJXD
ML\QG.*W@JUB=RT/.T!=I"G7Z^U)T^%-7/*D8UFZ6(XC#B#I^"\^$4:577<UP
MQ.(1<YHNUZP4<N",HFE8LI3$A77X@>2'S)O-'1DP+TD'CLHAH2L7Y+'EW$8J
M(Q&-$D\AVY!E)9Q]LXDGJ](H1C++ZL,9QZ&NP=\Z0[?D9-*).BW810X)GE(:
M5EH=WS<OCDPI3$@\L(DJ$Y2^M;6OZMPL:\B/5`@_%H%*>#L[JBY;=$%YQBUS
M_]",HP:E<R<*#4R?!-[N9*T&6UY%VD;1`R(E')(7*>(8%'27BC'[*X\7(\,K
M**1D^L8GIF]A,CQDXKS44L$;M%&R(':,:SI,`_K--9V"+?<T$M<M5<3B_:'`
M`A3V&_]""+&[^*`4)FNZQ:7]+,;6TMS6DD+A!C[#:DP3VI;:-+`IBZD[9IX7
M-/`2'Q,#I`\&,TF;PK6_ZB[NRK8GH5;Y%0&;:MH+@X;#2'2,!)53MFO7TE&Q
M4G$T.+[*S,F'.P?:J"]*VCDA+J,GOD"DK16J5'>=!>@%>R1R2%2!2[,I+Q)'
MH1:2Q[WXF3=>D>F(&M;H&!0\'Y2@JF'A;N56J'&&OE8(*4YXLI]^0<X5U/80
MW6$R$<,YQ5=2=QV&D"&P0(7'4>R5YE*IB*]@`8+Y)B[V"8B:LC"I\K:N`A7V
M:TD-6;:$P)DI;'=6)58>X6X:=@Q"/*(\'/G@/A',1<7\*99*00'M5QQFN:(A
MTD,"/]"=_5RMODJ=6P)/2W0KA*OJT::S'%Q?^\Y+"E(_<F4=;N1TEC[8V.OM
M$(<_.&Q\T7E#E<J4W!TT/N>\P<FS_>T=3IXU'W$F;7>'&MM&'H?N^ON'O5<'
MC0311O]5;Y_/N&YOM\SA=6]_O_&9ZHV]O=[N=MO@RD`>M,R8ZL_>SNO&Q[`W
M=O<8M^7W/DLX[!UN-[ZMO;&W^UH4:Z'C]DZ_]WJW^01"[;/"W>8R#J$C)<5[
MKUJ^M>U*<%MVK.'Y&WM6MY@XSG+7)`XJA2DV"DI$("5=P(F[UUPZBI,"<#."
MK$-\?,I="98*2C4^7>8LHI?-M-OCR)244#A]:=TE/6K:TXX_QO#2B_'C7[8G
M-VH:(>UMH[^UTV315UM[S1_[AZ^W]AJ<_M73\0M/)R2U4H76*F7TMZ*E6.$!
M<%:HO,`?#:8X[B[K3U=Q%OE%-1N8OGBEZ$+Z8W5H+[HH('VIN@67<Q9@L#,T
M^0Q7,%SYNNHK=J\H@2D/!JX8XYVN@[*+**3CJW,X*YIH_\K;,L(U0C0>^-HL
M_LE$`R@T?[^U7Y!\".LKD89]5/(^*L0S@.-N*9*1=!`T#*@@/46(7,M+HJ<L
M8%`VS9V[E*OTX!ZKL2"6#C>&4FZ\*UZ]QP^R(_T!%5>19?F3[M2Z6P]D`@\O
MP;1T]XU!8!RH4+2BHS`V#,]]I:A5[&!^PZ4\/J9=C9"5UQ3Q'8/63ZD:#FCM
M;B>$R-NZ<S-IBSR!N10:B!I5)!`D9M]89[*YJSP/V]T4O927)]YPG[2G6*E%
M;4U^C]@/<\P%TLOK7J,=<D$*E/&]'%/S)1PU=UD^0*3*#(N#G5?E;@/@DP.?
MK517G+BJ\RI'4!&%:*-<76^20O9@G7MB?1)5$4S_4<!Z!C5*&]@FE9<[R,T*
M4S'IJ6;CL1=^5?LZ(C'28J.&%0;S(HG'HXNY+,@@$*I0RQUUC?HA!N(+U8#Y
M-C6<NM[1$+HE"[!I68!0=V+I`)6I^>LER@##PXBK!9!]NB;_/H>7<OZ4+)7O
M4NO%WMI5%!T+<8S201^!Z?+,.W0F]F??Z@KTA@DK)4C=6.P>$%DG6JNK?,6!
MPR+D/NUHN,N#>KEN[2U<V.[+IGAU8%%!26\T**MJGWO#0+VK9DJC^/*,9<ME
M51M>6AI9FC=''_\A>W]V]#$U.7\XNK@X:E9HO3VY./W]T=7I[T_2!N]/C]Z<
MOC^].CUII+K.+T[>G5Q<---=EU=GQ_^0=J12[K<MN;&KLZNC]^G+OC;ILEDR
MMI>^NM&G#NYPIX'LWR+BM7-#D=YQ%<BI6D-""&S9;0!P44"EYLQ5CQK#^P-`
MZ>_1"I+L0/KF52TY$XYXRCRY:_EMCU7)D>TXN=E]4JYFSV1->:*&G@<-^9.[
MZW_E,ML(G]AM,IW.Z4JM0-CR!H-TM9_0<[P2I*F1A;QJ?LAF\1U[F1[5"@:Y
M+F6M."2=@MSYI0J@N,A1=EX[W)+P29L]>JW,^Q`Q-J":-K]XXJT1QP)+4I,I
M:LHVK@1[Y@WZ<\$YWSQQ-SJ6K>T?*DSSYSG2:;VOG2]8IVMK\:[CD,-E]=55
M*]I<^7+-"UMGZ-(C.])Y-.[>.2IO+FHP4HM7L\X0`B-1`/=-&<!]Z^]V:2;6
M4I+&^W`$GP5OA&/&W+G/D0*PY$DM^//HH%J,L==YR.:E@[8Z`YVL8F;F]W9)
M+,)X&7UDJW8GXJF!L'2HCRU?S^8*GZI0"1<&P?(7:7'=CR),#6[]-(F!;W=N
M\JV"U$RRPEPD-=(I?94F>W3*V<:GR[?9\\;4O29()Q&3,=(Q05]F?WROPRNG
M7.$R_^>T+6H/A:^O/`)ZP1WN/(!5D+5\`(;JPF+.->H6E$V[>G$4KKFSPO,0
M-)4'!/CY3_4=FW3J<+=*9R79[+ABV)XFSF!7%_BF#?V5-FAT?^]6^D+]*\%_
M_"`79M;8A8NONSND>7')X^+0Q5O;V0<=OD!#J.8C70;7CVQEH4`Y?8A.,?!I
M^1*O6UT4K&N]E]A5E-&1U%'5]+Q,GE\J)$<4HH-<M8RZ[^O-5_;EFQ]_9?.G
M+3=:H<&[K@66:WIB@V,^+1L*$%;O0,1QZ##E54?Z$-&ZS3_)X0MGKCM7X7;Q
MBD(?7;2-(^;RE='VR3V-LXI=7;DY&D1&0-></'VOM3W'.CDLP?<D6Z$NHWDH
M)NKB!"VW[*0B\@*P'0)7Z]=2I+U$H]M%6IKS&H-[(AC>##G40>ESK-;I_VGO
MD4EI4W&NH6`=<0M>U?HK_/_WT3B]_/_R?30I8[U0A/S_EAM.TLEWBSZE">G+
M9U\FA"%N1_<J/_)X*'T'?-F\^Z21YT];M?C1[LH3;,*CUYVDG7EP@.X;Q-DT
MNV*$\!=U@6F+)A4(%=3*S-,61_Z["5U7<%C=3:@W3QN7QE&>?CA[Y\+XFC&5
M%'@2[N_0!4OAVHVT(\OP-$\$5/=2I`TB)>C"L%X7/J$%!2DN;;-NW^XLT+IO
M1U4,:9,R=-`(/&QFL6MKC]L#%-[EZ\*X]9C#5[MAQ-4`P_Z$;[J*MDL2NE`-
M!Y>WN)W-7<F0=F0/PWT-Z<,_^(M-A9_.PXGX$LHZG/`T1-?:HQ><U5#2X!+2
M>(PP$VD/$9K5;F=Y&#S<6N&"X2W42Y=^%9H2E'2?.Z6F;#;]TM1GY9N<F-$;
MEHW([XD@Z6QR=8&$>;LN[:=75E[[D,XF)EMY]*7,CZSUMI=1*&@(C7-<AIL[
MVT9W"72\HPP'IP#3IR]T>T#Z8T6D6D:E\S4[PLCQ*\H+T:'N.@A`J#_GW51A
MU6[5CN&OZC]_L`#"@J:-_@Q(ZPEU=92%5E,`B]LLS`G%#%"Q]S=>)=`YQ6JY
MG:_T7-D?]53-`_0Z9Y\V3#53K.]JH4S=8FUAK2X=]Z8\`N<_DI`.9>%1(YXI
M4L?WN&;EF?9.C41D0/+1T6]C":LBLH\NPYD^3;/!`C5K_K<I\6U_XBVET=MP
MAC9]\#$^#%>^U1FHX%3ABK!)ZZEM.\_993`43V\>]+:SJEU-#"WY+`.4JPZ?
M'.EJ[,]VK;,*:>/WSKT$'I&C':[4X\XRA*)[?Z0G)=J'KS]BG'9ELS1?74@*
M\7).K?(^S7.^*V.5__&G6[-?X'"K9>>VN7C1\MJKS[:Z=W^YHZU<HV_14B(;
M]](BIAS^S4^V/HD#NOV8?Z*@U/@($U:FV^<N8)5Z%JW<E7+FBW`*.7UP\B/.
ME$YN)RZ':)<(CM"<;IEL'K=-.Z6`U7\(9+WWRP16^-#`TTX'IL.;V+>D+JVT
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MGH1OGC_>V?F:.;RNG7BD(*++<ZP(;)]MX6`4);:KS$Q([+64C+DKL'<K(GPS
MGR^^^S\"````__\#`%!+`P04``8`"````"$`+J8M?"<+``!W7P``#0```'AL
M+W-T>6QE<RYX;6S<7'MOX\81_[]`OP/!:XL$J$\215F28SDXR69[P-4-<BY:
MH"D*BJ)LQGRH%'5G)^AW[\SR-2N)Y-)::H%&R%FDN#._>>S,[(-[_?U+X&M?
MW'CK1>%,'[SOZYH;.M'*"Q]G^M\>K(N)KFT3.US9?A2Z,_W5W>K?W_SV-]?;
MY-5W/S^Y;J(!B7`[TY^29'/5ZVV=)S>PM^^CC1O"+^LH#NP$+N/'WG83N_9J
MBXT"OV?T^Y>]P/9"/:5P%3@B1`([?MYM+IPHV-B)M_1\+WEEM'0M<*X^/H91
M;"]]@/HR,&TGI\TN#L@'GA-'VVB=O`=RO6B]]ASW$.6T-^T!I9OK<!=80;+5
MG&@7)C/=*&YIZ2\?5S/]4M=2D1?1"D#\X3^[*/GN=^F?=W]\]Z[_[V^_^^>/
M[NI?/WUS^-M/W^J]G`VA"3:HI_F^7TL6?DXI]S();J[744@$&8.:4%M7SV'T
M-;3P-W`&$`\?N[G>_J)]L7VX,T!X3N1'L9:`E4$^=B>T`S=]8F'[WC+V\+&U
M'7C^:WK;P!O,,;+G`@_,A#=[*8?S\EDBFERF"<+@9!KB'2I3`"+9>+->)OOG
M(S)QO$;-O$[1'\>+25$OES1>AWYQH,-3>!6V(GSBQ^5,MRR((8-^']5*#=81
ML^FB#_S.QNQR=#;)AM;0&DN5C//%0[LAPZ$E4Y4-#*T/X]NSJ5,^LRKILC!\
MKAZ`'4ZN%CWHNC7]>VSAYQQ^<N:$UHW%&%4NZ+.N5\;&!R]PM]J]^U7[,0KL
M$!5+DQI[FLO)G.-U0YYS`?DL.B9?."_JLD[UDFHC5DMUS^>P+)+I2?*I"YNA
M10]@'6$+/<3S_:+J'YI8%\.=FVL8@"1N'%IPH67?'UXW4!6',%9"=^BESS4\
M_1C;KP.#U89B#;:1[ZT0Q>."U>)9+;2XO+,6=XPO02:*HH*H92W&'1"]FT\7
M\I$NIE/91`T+/I*)?ACA1S)1"_Y;2--IE@U-62`+>EKBX=BY_WX\G4XG@\O)
M9#(UAP/39$I>9A[MA2OWQ<7AM#0U'2(8`8+I<#*]-`!(WYPP5F=%,`0`X]%H
M,AI,#1/^9R&V>P2R=3K255N5(%!D58)`D579\*TG(?)G/05FLA3W58)`D54)
M`D56'4N.P##5I]BJ!($BJQ($BJS*ZE^)?15FB!5;E2!09%6"0)%5I16?602>
M*K<J0:#(J@3!N:V:#ZL6=W<6FX(ZK,RJZV,VDH.QXS**5["\EJ\9#88P;DOO
MW5S[[CJ!46+L/3[AWR3:P+_+*$E@,>KF>N79CU%H^_"UE[?(_]:TA.4Z6)F;
MZ<F3YSP#,VZJ(,6;LNB*0Q&)3*SPS;'9'YLCXS(=1$EB';@K;Q<<2E?P/NHK
MH$;4;;/@1(=AP21SAW)&LH=6R,PGV(*9FEE:L`'X1.X2@BUDR%C.SHO*2%J(
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MYB_3'W`'4N;48`+JU'5X9"*`\76.`(R@`@'NF,IT`.ZI`@&,6W($X*`E`H!3
MXQ6G](,!B6;@`R5+X-\52X@QN90<RPZEK`J_P+]&2HL+OR>IF<1;</12S7!1
M`^`DEE4A5E6((6:'GE:J`"YJ5&!!UI63\@95,5^90DC0!0RE1B`,U&E$GE>2
MF`L\2P#U&IE+K$.(4V`H4@T!X"B!0`PQ4)1_!Q2#H@Q,O4%1"J80N!Q\QCY!
M+<%E2$48`(^27E'6"0,N8YQ1#02"J@A)O,%0%2(I!E4QLC2%H2I$$@BJ(B2U
MA*H023&HBI'$%*I")($`&E$2(:DE5(5(BD%5C"Q-,505(@D$51&26&+8<8CL
MT6G3=!*5SI].WC1_JKVL&R=2!U6#)K![WCP=/:4C1[`%&TN1H32^HV;G<Z?:
M4Q1[O\`@$]]5<V`RU8UU?+<Q\1QZYVML;Q[<%QB*IHL\+^OJN5Y`DL]O[#LC
MC[`24\D?9K)UK0USZ?HY`<OIBFB4G`WJ&R?F]SR#G]QN])!&$#BYHQH#ZCK#
M(-T%)'41[+FJU01)4CD&:BI(F&*QP@+-8?!IB&:-ODJ9HS*R"6^XS14P?*#J
M@#GB$.+=19#$<908]PXDQ[%L.^9UZXK@$>V(270@'(>I8UXSO]VY]U(;#O>'
M@G7<+39YV]B-:<3%31&T)#DH"31\\2&-#N`IO;K2I&O<C>&'I,H66(XG;+YO
MOD&S;/-(R_**=-XW&;ZF+U.%2(G'4KVHPG+U0$4,5QG@*?PWF,J0/5)H=&[,
M*EF!4\D<CL/8JT9Y-YYGBRN-(:(-&NI9;_+:AJ1QPAC!(&&\"VAMU%1M-$AT
M=5&]$Z/!RYW'LRLNE$E!0SM8/O1MHR_T]]-JN#;<!BIK90/#GY"L?'>N#&ZM
M)#\UZ31T7^H'::!M4T?49P!!=5`(X@4/.S!&:<'S_X#[#;F5)A3I]E?D@FUZ
M),U:4N1OQ;PJ,0"2NKQ0&8NH$[\E#YS!&YKG0.E,8&7J/-"0M`)56&]".`]3
MO`A0X3+D5(,KG3^AS+NH&*ERQ%-1\[+`^6=+V.9.!3.N;'$(EH/(YGI^:WVQ
M>*3A(4-P*&+_]]J%]L'!3E2,C[#>6^X\']Y1Q54A7-AS=EMX%6N>WLR68NIH
M%64[EF^4%@PZVM(""FEP-7"QE^""XJPM+6"?TAJ"M(06O'?0FA8D@XP6+L67
MN$P8_K;%!4TR6KSN1X*Z-X_9D6U:*7&AR"*X**W2CJ`Y(N,01&Y+J[0C&([2
M`I';TBKM"`@)+1.8M*55VA&L0&F!N[6E5=C1!,,16B-!W5\>M2/OJ[C"+(*+
MTBKMR/OJ4-!7*:W2CKROHLAM<95V!*I$7R;\T)96:4<^3IB"<8+*6-J1U_U(
M4/?[$97W>$/0XU,JI>W@&]$1IF`1':542JOQ7CX4]/*42FDOWK]-0?].J926
M`GI$(A-^$)>HL-&0UZXIJ-VYO<JC+N\PF&=$8,`1<<[.AV.-(SP4F>V@P$E&
M(A!6'D*4GESG65O`"W$%(;X_8!H5(73WLO'MT$ZB^%7#71,%.=[H(T%R?XJB
M0D<\!9RQ$P'T9SA"&DZGUD`OJ89X'\85\S9DBK[`JP>W4+<A`ZU3-+S_X7"J
M#1EHG9+A@RK63R)D/H:;76$A/I9BZA8A\<D+G]T5[SF\AG'`+$+IWMTEL5WX
M']^E#$'%W.-KE`4-/D2D1T7F[WQF]><]O#69*Q''9Z3O8`TM`ORONX2H$5L1
M(H9@7'KP$GBU/._$'`F$)8+C(8*=3`6)O8@B2./O=AQB;^&Z[IZ/5DA4[@N#
MZG_U4KY2R_2>X"'K[&7;8CP`BEJY:WOG)P_%CS.]_/X7=F@#.%/VU`_>ERAA
M)&9Z^?T3GH8!O1CF+2'<?-K""0OP5]O%WDS_]6X^GM[>6<;%I#^?7)A#=W0Q
M'<UO+T;F8GY[:TW[1G_Q7U`9GDA_!4>:GW#B.SN9'G:&#<RKK0_GPL>9L!GX
MS^6]F4XN4OCL%7B`#6NXN1"];7%B_LW_````__\#`%!+`P04``8`"````"$`
M^V*E;90&``"G&P``$P```'AL+W1H96UE+W1H96UE,2YX;6SL64]OVS84OP_8
M=R!T;VTGMAL'=8K8L9NM31O$;H<>:9F66%.B0-))?1O:XX`!P[IAEP&[[3!L
M*]`"NW2?)EN'K0/Z%?9(2K(8RTO2!AO6U8=$(G]\_]_C(W7UVH.(H4,B).5Q
MVZM=KGJ(Q#X?TSAH>W>&_4L;'I(*QV/,>$S:WIQ([]K6^^]=Q9LJ)!%!L#Z6
MF[CMA4HEFY6*]&$8R\L\(3',3;B(L()7$53&`A\!W8A5UJK59B7"-/90C",@
M>WLRH3Y!0TW2V\J(]QB\QDKJ`9^)@29-G!4&.Y[6-$+.99<)=(A9VP,^8WXT
M)`^4AQB6"B;:7M7\O,K6U0K>3!<QM6)M85W?_-)UZ8+Q=,WP%,$H9UKKUUM7
M=G+Z!L#4,J[7ZW5[M9R>`6#?!TVM+$6:]?Y&K9/1+(#LXS+M;K51K;OX`OWU
M)9E;G4ZGT4IEL40-R#[6E_`;U69]>\W!&Y#%-Y;P]<YVM]MT\`9D\<TE?/]*
MJUEW\084,AI/E]#:H?U^2CV'3#C;+85O`'RCFL(7*(B&/+HTBPF/U:I8B_!]
M+OH`T$"&%8V1FB=D@GV(XBZ.1H)BS0!O$ER8L4.^7!K2O)#T!4U4V_LPP9`1
M"WJOGG__ZOE3].KYD^.'SXX?_G3\Z-'QPQ\M+6?A+HZ#XL*7WW[VY]<?HS^>
M?O/R\1?E>%G$__K#)[_\_'DY$#)H(=&++Y_\]NS)BZ\^_?V[QR7P;8%'1?B0
M1D2B6^0('?`(=#.&<24G(W&^%<,04V<%#H%V">F>"AW@K3EF9;@.<8UW5T#Q
M*`->G]UW9!V$8J9H"><;8>0`]SAG'2Y*#7!#\RI8>#B+@W+F8E;$'6!\6,:[
MBV/'M;U9`E4S"TK']MV0.&+N,QPK')"8**3G^)20$NWN4>K8=8_Z@DL^4>@>
M11U,2TTRI",GD!:+=FD$?IF7Z0RN=FRS=Q=U."O3>H<<NDA(",Q*A!\2YICQ
M.IXI')61'.*(%0U^$ZNP3,C!7/A%7$\J\'1`&$>],9&R;,UM`?H6G'X#0[TJ
M=?L>FT<N4B@Z+:-Y$W->1.[P:3?$45*&'=`X+&(_D%,(48SVN2J#[W$W0_0[
M^`''*]U]EQ+'W:<7@CLT<$1:!(B>F8D27UXGW(G?P9Q-,#%5!DJZ4ZDC&O]=
MV684ZK;E\*YLM[UMV,3*DF?W1+%>A?L/EN@=/(OW"63%\A;UKD*_J]#>6U^A
M5^7RQ=?E12F&*JT;$MMKF\X[6MEX3RAC`S5GY*8TO;>$#6C<AT&]SAPZ27X0
M2T)XU)D,#!Q<(+!9@P17'U$5#D*<0-]>\S210*:D`XD2+N&\:(9+:6L\]/[*
MGC8;^AQB*X?$:H^/[?"Z'LZ.&SD9(U5@SK09HW5-X*S,UJ^D1$&WUV%6TT*=
MF5O-B&:*HL,M5UF;V)S+P>2Y:C"86Q,Z&P3]$%BY"<=^S1K..YB1L;:[]5'F
M%N.%BW21#/&8I#[2>B_[J&:<E,7*DB):#QL,^NQXBM4*W%J:[!MP.XN3BNSJ
M*]AEWGL3+V41O/`24#N9CBPN)B>+T5';:S76&A[R<=+V)G!4AL<H`:]+W4QB
M%L!]DZ^$#?M3D]ED^<*;K4PQ-PEJ</MA[;ZDL%,'$B'5#I:A#0TSE88`BS4G
M*_]:`\QZ40J45*.S2;&^`<'PKTD!=G1=2R83XJNBLPLCVG;V-2VE?*:(&(3C
M(S1B,W&`P?TZ5$&?,95PXV$J@GZ!ZSEM;3/E%N<TZ8J78@9GQS%+0IR66YVB
M629;N"E(N0SFK2`>Z%8JNU'N_*J8E+\@58IA_#]31>\G<`6Q/M8>\.%V6&"D
M,Z7M<:%"#E4H":G?%]`XF-H!T0)7O#`-005WU.:_((?ZO\TY2\.D-9PDU0$-
MD*"P'ZE0$+(/9<E$WRG$:NG>94FRE)")J(*X,K%BC\@A84-=`YMZ;_=0"*%N
MJDE:!@SN9/RY[VD&C0+=Y!3SS:ED^=YK<^"?[GQL,H-2;ATV#4UF_US$O#U8
M[*IVO5F>[;U%1?3$HLVJ9UD!S`I;02M-^]<4X9Q;K:U82QJO-3+AP(O+&L-@
MWA`E<)&$]!_8_ZCPF?W@H3?4(3^`VHK@^X4F!F$#47W)-AY(%T@[.(+&R0[:
M8-*DK&G3UDE;+=NL+[C3S?F>,+:6["S^/J>Q\^;,9>?DXD4:.[6P8VL[MM+4
MX-F3*0I#D^P@8QQCOI05/V;QT7UP]`Y\-I@Q)4TPP:<J@:&''I@\@.2W',W2
MK;\```#__P,`4$L#!!0`!@`(````(0"%B)^V<@(``-0%```9````>&PO=V]R
M:W-H965T<R]S:&5E=#,U+GAM;(R476_:,!2&[R?M/UB^;YR$4"@B5)2J6Z55
MFJ9]7!OG)+&(X\@VI?WW.XXAXV.;N('8?OWD/5^9W[^IAKR"L5*W.4VBF!)H
MA2YD6^7TQ_>GFRDEUO&VX(UN(:?O8.G]XN.'^4Z;C:T!'$%":W-:.]?-&+.B
M!L5MI#MH\:341G&'2U,QVQG@17])-2R-XUNFN&QI(,S,-0Q=EE+`HQ9;!:T+
M$`,-=^C?UK*S!YH2U^`4-YMM=R.TZA"QEHUT[SV4$B5FSU6K#5\W&/=;DG%Q
M8/>+"[R2PFBK2Q<AC@6CES'?L3N&I,6\D!B!3SLQ4.9TF<Q6&66+>9^?GQ)V
M]NB9V%KO/AE9?)$M8+*Q3+X`:ZTW7OI<^"V\S"YN/_4%^&I(`27?-NZ;WGT&
M6=4.JSW&@'Q<L^+]$:S`A"(F2L>>)'2#!O"7*.D[`Q/"W_K_G2Q<G=/1;32>
MQ*,$Y60-UCU)CZ1$;*W3ZE<0)7M4@*1[R`C=[\_3:R$L&.KC>^2.+^9&[PCV
M#+[2=MQW8#)#\"&P8&,(]5^18H@>LO24G$XHP2`L5N=UD4VS.7O%E(J]YN%2
MDYPJ5@>%KP3:&SQBX,<>_Y[T@Q4O]E9\$;RWA["![,%;>O;>2\5D/$A.G&"&
MKG?BQ5CHHQ=GTS_<8"YHLB/-F6+U/\6)-X1<[\V+<XJ!#TG)IK=#S,%;T$S[
M<L:G9SAK_O[Y6?`3IBATF0)3P0J:QA*AMWY"4N0-N\/P+E-?L+/]!QSJ?@38
M<(!#U?$*7KBI9&M)`R4BXVB"4V3"6(:%TUW?VVOM<)SZQQJ_GH`-$4<H+K5V
MAX5OM^%[O/@-``#__P,`4$L#!!0`!@`(````(0#G"2W/HP,``.T,```9````
M>&PO=V]R:W-H965T<R]S:&5E=#,T+GAM;)17VXZC.!!]'VG_`?'>`7/)34E&
MW=OJG9%FI=5J+\\..(G5@)'M=+K_?LHN0KAU8%Z20$X=GSI5+LSFZWN>.6],
M*BZ*K4MFONNP(A$I+XY;]]]_7AZ6KJ,T+5*:B8)MW0^FW*^[W[YL+D*^JA-C
MV@&&0FW=D];EVO-4<F(Y53-1L@+^.0B94PV7\NBI4C*:VJ`\\P+?GWLYY86+
M#&LYA4,<#CQASR(YYZS02")91C7H5R=>JBM;GDRARZE\/9</B<A+H-CSC.L/
M2^HZ>;+^?BR$I/L,\GXG$4VNW/:B1Y_S1`HE#GH&=!X*[>>\\E8>,.TV*8<,
MC.V.9(>M^TC63V3E>KN-->@_SBZJ\=M1)W'Y0_+T!R\8N`UU,A78"_%JH-]3
M<PN"O5[TBZW`7]))V8&>,_VWN'QC_'C24.X8,C*)K=./9Z82<!1H9D%LF!*1
M@0#X=')N6@,<H>_V^\)3?=JZX7P6+_R0`-S9,Z5?N*%TG>2LM,C_1Q"IJ)`D
MJ$C@NR(A\2P*XL5R`HN'BFR"SU33W4:*BP-=`VNJDIH>)&M@-IF%X`_JJ'/]
M+%7(T9`\&I:MNW`="%=0G[==M/0WWAMXFE28)\3`9XTA-<(#-;4DD-&4-&SR
M=64#-BL;TXV4)[S17"887B9L+V,RCSZMZ74Y$P0.-9*(EK<T4`%BH@8F'E8`
MD.F)&O#6A>QJ^Z(PJGEQ9<0L;0&('Y`XF->(EL609W/E:]7O6VV"V@I(W%6`
MF+E5\$!(N`C"807SOH)Q]TU06T$8WC)$#Q!3*5CZ?N#?$"T/H%N;'MS/W8#;
M*T>]E1&#*Q-_$:\6PZF;I\+`EKLOP`1U!"QOC8VI(V9"XZWZ"L;--T%CK8^8
M"0H(S)BF"?>3M^A.]KWFKT#H?Q"0,+A-H%;AB9E$OUP`&]76T&__"C2A_TEG
MRDT;/S:J+:*_`RI0LPK1;4:UK>@,P9$RX&1KSZ#;[L(F)`@:WP;$3*M?+X.)
M:CL0+6\SIM*`H*8#GXQ@\Q3OBAC?"C9J;"]4H"DB.L-PI`K]*=A_$I#F&+PW
M!4EG#$Y[%-BH=A4&-@,.Q*8!G_;AP$R<4(;^4!S8#0BJMN1=*SIC<:0,..M&
M-D-_(/8LP%,G'LIR)H_L=Y9ERDG$V9PH"3Q*Z[OU:?<QL.?5^@\X;);TR/ZD
M\L@+Y63L`*'^;`'=+?&XBA=:E/;(MQ<:CIGVYPE>*Q@<G/P9@`]"Z.N%.1#7
M+RJ[GP```/__`P!02P,$%``&``@````A`+8;>LF4`P``6@P``!@```!X;"]W
M;W)K<VAE971S+W-H965T,2YX;6R4EUUOFS`4AN\G[3\@WQ<P^6JCD*JAZE9I
MDZ9]7CO@)%8!,]MIVG^_8TP(-DE';\+7RWL>'_N8D\7M2Y%[SU1(QLL883]$
M'BU3GK%R&Z-?/Q^NKI$G%2DSDO.2QNB52G2[_/AA<>#B2>XH51XXE#)&.Z6J
M>1#(=$<+(GU>T1*>;+@HB()+L0UD)2C)ZI>*/(C"<!H4A)7(.,S%$`^^V;"4
MWO-T7]!2&1-!<Z*`7^Y8)8]N13K$KB#B:5]=I;RHP&+-<J9>:U/D%>G\<5MR
M0=8YC/L%CTEZ]*XO>O8%2P67?*-\L`L,:'_,-\%-`$[+1<9@!#KMGJ";&-WA
M>8+'*%@NZ@3]9O0@.^>>W/'#)\&R+ZRDD&V8)T76/VA.4T4SF#GDZ1E9<_ZD
M7WV$6R$$D;5`!Y%_CV'N(ATE:,-TSX\A'^II^R:\C&[(/E??^>$S9=N=@D@3
M2(/.QCQ[O:<RA6F`6'XTT:XIS\$"?KV"Z?4$:20OAHYE:A>CT=2?S,(1!KFW
MIE(],&V)O'0O%2_^&!%NK(Q)U)C`\="81/XXFLRNW^,R:ES@V+C@R,?C</I_
MDL",JD[8/5%DN1#\X,%R!6Y9$;WX\1Q\SV<%TJ&U=UH<HQG,6XPD3,WS,EP$
MSY#\M%&LC`)^6P6V%<E1H></&%H02,UP$"W6('JZ--G*W.C&C9RX?<6H55@@
MD(4NB%XO(UBJ;V=&OP2ZSKC'K;LA-(IQ1S&Q%<E;"HL03+J$;Y-I<8Q@].V,
M3.VX*Z/HDLUL1=)7G-@M,JB(X61:;)-=VW%71M$EN[$525]Q@6SZ'C(MMLFP
MN]"-9%(7P1C/(A?,/.^B7P"#:AJ>,BUVP)SZ6AE)-S!V2Z$ON<"F/YR#-P<M
M=MA.%69JP$@L-J=,DK[D`MO->]BTV&$[V1HV(['8G$))^I*3B54&&/:+X8FK
MU0Z=4X&K1F/A.=62G-%<XM.;\.")Q6;+[FXAV%GNJT;3Y8N<DDG.:"[QZ<UZ
M.)_9VKM\D5L5V&@L/K<LSF@N\>FM>CB?V=@M/K<R<'_SC]S2.*.YQ`?C[/(-
M^X9!Z^96270*8*JDT73SZ$AT!ZAMIO76B,/I;!)-3TO!U(GIW$PC4E"QI0G-
M<^FE?*\[,0ROMG?;UK+I^=H'T*159$N_$K%EI?1RNH%70W\&GP1AVCQSH7A5
MMSEKKJ`]JT]WT,-3:!M"'\0;SM7Q0C<E[;^"Y3\```#__P,`4$L#!!0`!@`(
M````(0!<K"X;T0,``),-```9````>&PO=V]R:W-H965T<R]S:&5E=#(S+GAM
M;)2748^C-A#'WROU.R"_7\`0($%)3IO`MB==I:KJ79\).`E:P`@[F]UOWS$&
M@LTM9%]"F/P\S']FL">;KV]%;KR2FF6TW"*\L)!!RH2F67G>HA__/G]9(8/Q
MN$SCG)9DB]X)0U]WO_^VN='ZA5T(X09X*-D673BO`M-DR844,5O0BI3PRXG6
M1<SAMCZ;K*I)G#:+BMRT+<LSBS@KD?00U(_XH*=3EI"0)M>"E%PZJ4D><XB?
M7;**==Z*Y!%W15R_7*LO"2TJ<'',\HR_-TZ1423!MW-)Z_B8@^XWO(R3SG=S
M,W)?9$E-&3WQ!;@S9:!CS6MS;8*GW2;-0(%(NU&3TQ8]X2#"&)F[39.@GQFY
ML<%W@UWH[8\Z2[]G)8%L0YU$!8Z4O@CT6RI,L-@<K7YN*O!W;:3D%%]S_@^]
M_4FR\X5#N5U0)(0%Z7M(6`(9!3<+VQ6>$II#`/!I%)EH#<A(_+9%-CPX2_EE
MBQQOX?J6@P$WCH3QYTRX1$9R99P6_TFH4=0[<5HG<&V=8'MAKUSL>I_PLFR]
MP/7NY;.A0-"-'KC>G3P:BBF3T^0ZC'F\V]3T9D`#@WQ6Q>)UP`%X[I(L4]*G
M_:.L0[J%DR?A98M\9$!"&;3*Z\[QEAOS%<J;M,Q>,O#9,U@E#ATA:BG<AKHA
M&AA,$-"K@!H/5?RZ1;I@!2R"[1ZSEX9A9+866;?D'KOMJT@X1GQ71:(Q@BVG
M9Q1!T&^/"Q*P(D@:AH(<3POFH"\*=4,T,"BQ01</8Q,MX\#;/9UTL0BX0?4=
MS^NU-^7>2P8^^P[1@YXEPEDBFB(4G?`ZZ#I]L$WK%(N:/:?7X'A:J^PE,]3I
M>"LU%X<QH^4BG"6B*4)1ZHV5SE=4+-*5KE45>\DL_69+L!::A$/[\\<%#V>)
M:(I01,+N-"SG=!D%K(GS+4V<9):--GTKZW[[L)7#62*:(A1E8N(9[.'3R@2L
M*K/UO6POF56CS+77>.7HR&&(8`R3D;/6-LU00=86]FU70Z(A`N.5Y3KW#E(D
MKC\C4<"J1,?7"K27S/`=U)MSE@AGB6B*4/1AV$"'-7QL4VU6S>VJ+30E=1X)
MYY%H$E'5BG/\X8Z%(5.OY[AE6ZCM68RQYZZT\^6@,)YGKYW5_?AM)P[YK(ED
MB9E7A/-K1,J4,ZV<LPI2G\F!Y#DS$GH5\ZK8,7IK/TL_.6(@T>P'.X"#>FP/
M[0#.Z[$]L@,XML%N]HY@)*[B,_DKKL]9R8R<G"`$:R%.LEH.U?*&TZJ9!H^4
MPS#<?+W`GQ\"<QALW,@X4<J[&_&`_N_4[G\```#__P,`4$L#!!0`!@`(````
M(0#R0VQ@#`@``-<B```9````>&PO=V]R:W-H965T<R]S:&5E=#(Q+GAM;*R:
M6V_B1A3'WROU.R#>%[`-Q+&25`%\OZBJMNTS`2=8"QAA9[/[[7O&<Y_C$++J
M2P@_G_.?F?]</&-S]\>/PW[PO3PW57V\'UJCR7!0'C?UMCJ^W`___AI\<8>#
MIET?M^M]?2SOAS_+9OC'P^^_W;W5YV_-KBS;`2@<F_OAKFU/WGC<;';E8=V,
MZE-YA"O/]?FP;N'K^67<G,[E>MLE'?9C>S*9CP_KZCBD"M[Y&HWZ^;G:E*MZ
M\WHHCRT5.9?[=0OU;W;5J>%JA\TU<H?U^=OKZ<NF/IQ`XJG:5^W/3G0X.&R\
M^.58G]=/>VCW#VNZWG#M[@N2/U2;<]W4S^T(Y,:THKC-M^/;,2@]W&TK:`&Q
M?7`NG^^'CY976.YP_'#7&?1/5;XURO^#9E>_A>=JFU7'$MR&?B(]\%37WTAH
MO"4(DL<H.^AZX,_S8%L^KU_W[5_U6U16+[L6NGL&+2(-\[8_5V6S`4=!9F3/
MB-*FWD,%X._@4)&A`8ZL?]P/;2BXVK:[^Z$S'\UN)HX%X8.GLFF#BD@.!YO7
MIJT/_](@BTE1$8>)P"<3L4;N;#:=NS?7BTR9"'PR$7MD32=S4H\+9</5K@'P
MR=+<D>W.K-E'B7.6")^\O*L;#+.G*Q0^9>Z%2MZR>/@4E;RB;18,AZX<\H\L
MZ,I>L:!/:;;LW%_H%XOW+OF'5>+F\]UK\?XE_US;EC$=K=W@7ZW;]</=N7X;
MP(H"X[$YK<GZ9'E$D`][V@=B(KPW#V`"$)5'(G,_O!D.8(@W,'F_/SBSV[OQ
M=YAP&Q:SP#&6'K'D$61V$=F5"7P3!"8(31"9(#9!8H+4!)D)<A,4"AB#M<)?
M&#'_A[]$AOC+G5EP(`VW#3-Y!$]9F<`W06""T`21"6(3)"9(39"9(#=!H0#-
M3)@WR$P'9G3_&LW')LF"U5@=F_9$-VO!8D!+#."9'K(4(<)01'Q$`D1"1")$
M8D021%)$,D1R1`J5:-["W$?>DOO?)Q<"(@-K"?2@,-*9FV[3(-)S(LAT6X0(
MMQ'Q$0D0"1&)$(D121!)$<D0R1$I5**Y#<9J;E\>P22Z,Y6;L:#$@55'..C8
MIH<BB*>M$/$1"1`)$8D0B1%)$$D1R1#)$2E4HGD(^PW-0WKK&I&=TF4[2:)N
M)R6.+=;7)2(K1'Q$`D1"1")$8D021%)$,D1R1`J5:-[!G5KS[K)A)%HWC!&Z
M>R6WZB4B*T1\1`)$0D0B1&)$$D121#)$<D0*E6B&D6.>ND^Z;!B)U@VCQ+F5
M(TP0.85MQU@I5S1HJJZ4CCW7[TR^".+S/!#:G(2(1")+EN^8Y<<BB`LE2"A%
M)!-9JK2CUSH705RZ4(4T\V&W_PGS2;1N/B6J^8BL*#&<OM'K[(L@7N<`"86(
M1")+M</8^\8BB$LG2"A%)$-9.2*%FJ792@Y#G_"U"]>-94AU%J,50X:WKN&M
MC.(.!%@KQ"B2B:J_QG8XEE%</L%:*4893LPQ*K1$W65R-+A^Z;#H20)V4+R>
M"X8TEVF4@E8LRG#9.(3Y,HK+!U@^Q"B2B8K+MM&)L8SB\@G62C'*<&*.4:$E
MZBZ3,X/JLK(;:'?5YMNBAIT2N-:S<#MP8&7'6'KRT,RG2'%Z27:WL,(H:,60
M+==W'Z,`)X8813)1==KHR%A&2:=1O5(LG^'$'*-"2]2=)D<(U>D>1^%1D["4
MGCA`C]=S09Y_D!4:UGNY>W6F^GJPY%&P?(DH?(/LCS*T?!9E3[I'$[9M.>8)
M,.`A,$3>+RZ4Q?'61!*IB48-8BY/:^!.)O;$N(TG/.1B#5)9'*]!)M&%&N1<
MGM;`FMC6S-Q)%#SFO2KH`X&<;M2!0*:</1M]N/\FSYF,.S1##EP1[ELSP\0E
M3WRO>NRA$9.7FU.?)4[51,<QSDL!EU<K84^-/4#(HZ1\Q-%4C/&8(0<VE*)!
M]M1H4"(3E2AS$Y;R*%EBAE'.T.4V%CSQO3;J/4S.7F8/P[(W^,2*2H]OVO2G
MR($/88WC&+-A29X]D$'RP?2G4;:TQF>)#BPR0AXY'[`H2%2B3.=#60D^V2*,
M8EXBG+9$B8YCC)NDMT1S=*58/L,HOZK$XJ,2];XF9T6UKS]8UNG14NM7BFPY
M"Y:60-*9GC6<1='7*N0TZ?-$B0*.I'R(4<213(PQ2CB26BE&&4=2*\>HX*C3
MTBTEITG5TE_;D[`SJ7H#I<B&^[TRX(R]V-)BB?`AHGK,9U'Z1#`6*I]IV62K
M]/W!FMS,;HWQ'?#BM)4%SRA1*3FC&-(3C1K$3/ZC!;57RSA5I[RJ\GEZQM%%
M&W(6=<&&@@OIK9$UT$<(.?)>&B%?Z]-[NU9UCT5/SMIDI$B;C`)='`\LJGO5
MVMU0?;)1@Z78EBC@2$Z@$*.((YD88Y1P)+52C#*.I%:.$7E#W%55F8STC2]]
MZ74HSR_ELMSOF\&F?B5O<^TYC&B!Z:OFQ<R#IXXP/DT^]^")&N:)ZR74>R,A
M=3VR`\<9F>N133>^4+CPEKOO`KS^?NSC"_):O$=H87OP&@47L'`\>`>`^>/4
M>P3S\(7%U(/'V)@'KD?.,_A"Z'KD5(,O1*X'SY-Z^*T'3S]ZN#7QR+&][XH%
M5_J:#8<GN-)7^L+U%KT7EJY'3G2XE)7KP:.U'G[KP8.@'@[U]7OK"V=SN-)7
M7S@XPI6N]+$8//"S@M/ZI<S7YY?JV`SVY3,,U$GW8/M,?YA`O[1L<7BJ6_A!
M0;=.[.`')"7<0"=D%_Y<URW_`M4=BY^D//P'``#__P,`4$L#!!0`!@`(````
M(0"HN2.,AP4``),5```9````>&PO=V]R:W-H965T<R]S:&5E=#$Q+GAM;*Q8
M78^C-A1]K]3_@'C?$+X2@I*L)N%;K515V_:9(4Z"!G`$S&3FW_<:8X+M#,VJ
M\[)LSAP?[CV^OC9>?W\O"^4-U4V.JXVJS^:J@JH,'_+JM%'_^A%\<U2E:=/J
MD!:X0AOU`S7J]^VOOZRON'YIS@BU"BA4S48]M^W%U;0F.Z,R;6;X@BKXRQ'7
M9=K"S_JD-9<:I8=N4%EHQGR^T,HTKU2JX-:/:.#C,<^0A[/7$E4M%:E1D;80
M?W/.+PU3*[-'Y,JT?GF]?,MP>0&)Y[S(VX].5%7*S(U/%:[3YP+R?M>M-&/:
MW0])OLRS&C?XV,Y`3J.!RCFOM)4&2MOU(8<,B.U*C8X;]4EW$]U4M>VZ,^CO
M'%V;T?^5YHRO89T??LLK!&[#/)$9>,;XA5#C`X%@L":-#KH9^*-6#NB8OA;M
MG_@:H?QT;F&Z;<B().8>/CS49.`HR,P,FRAEN(``X%^ES$EI@"/I>_>\YH?V
MO%%-:V89]M+1@:\\HZ8-<J*I*MEKT^+R'\K2>RVJ8O0J\.Q5='MF+^?FSXB8
MO0@\F<C,L6UKX2P?C\3J1>#9BQ@SP[%U>T'2F4@!_MH9`4_V=OVQD8M^Y/(V
M\N?CAO78O1Z>0]Q+?;XR2>X38:_Z<?!D89N/A:U#K=&I)T77S^K#@6NTCKJR
M]-(VW:YK?%5@K4.A-)>4=`[=):]@!4ES&$KTLPJ%TB0J3T1FHX*E4'L-+*NW
MK6$LU]H;+(6LY^QDCLXS]HQ!ZI[(>B+@BT`@`J$(1"(0BT`R`C2P9?`&EL=7
M>$-DB#<LJQT#1F8)1C`&&^*)@"\"@0B$(A")0"P"R0C@C(`E_A5&$!EH6%R1
M.'SFNYX#E3A4DLU3]@-E<$="?`D))"24D$A"8@E)Q@AG$K2PKS")R,!BA*D8
M#)"7$B694RX-E,$E"?$E))"04$(B"8DE)!DCG$O0'CF7[F]\K*T0=F<&2V)'
M$1.6[,B>E5`A`XD-\R3$EY!`0D()B20DEI!DC'"YP\[#Y4Y[[8QL&=,VD(&\
M#10QC:&I["7$DQ!?0@()"24DDI!80I(QPN4,6P*7\W2BA,TGVB/T_$+VA+V$
M>!+B2T@@(:&$1!(22T@R1KA$R0E=WDB[R6W/>?:RPU"P4+9W##!APZ3;*!'A
M\^^1V^ZQ'Y#1"C#G_`KP*,F`8\9MF9C"=NL/)+9,@D&;(>&`C(6$MT6#T)AD
M\"'%`XEI)X,V()R7$#;GY1W/X'C(3"-LWK0>`?U1]B8?S[XGP6-$$C+S[I(L
M7LFG)&/>G7NLE6TZSE+@!#V'ZUOBK(5WWR:$%-TE":^+N9"6QLK0]04?=?(?
M$7$30DZ&W(R,6M?CU=VI\#/50P:WW9GBCL\&3KKGW5BLPGPF3U;8V]8TERO+
M%NH@8,-@R_J\$$+&F@PANK%8"+$0PE*WC*4X%6S89R'P<P$A<',QO3IT0A=,
MIY!AW7:/G@70A`D>8]$O4]*-?1D*&'23#V_0A'S$6#?Y6(82!G7RO#/D_/J_
M>S`Y>HF&4<A8C`SK(=@//J\:CVG!6ANQA,7J]ZR^@=C&2G=,\>LI8*3)`@P9
M:S*LZ*&P8J9%^YJNPTV1N1*Z>L)(GX7%3Q`Y/$]-T`]\@5*]NTF.&CY<T$@S
M1"&NI`=H[+W03;U>RW"&J?5E*&#0N*0?D8_8P)M\+$/DQHDD1*.GCM$;)/JI
M7J+ZA/:H*!HEPZ_D=@@:QG8]P/3JRG-<V-&A[PAXY+BP]\HX7'4]=>='@;\C
M5V!W^#O#A0]$66=GNO!1).-/EOL$B<E_V%DN?!_<P6T7SLYW\(4+YTO`M2%2
MN!*[I"?T>UJ?\JI1"G0$4^;=8:NFEVKT1]O7TS-NX2ZL*ZTS7'XBZ%SS&1R[
MCQBW[`=YP7"=NOT7``#__P,`4$L#!!0`!@`(````(0`28]'US`(``,X'```9
M````>&PO=V]R:W-H965T<R]S:&5E=#$P+GAM;)1576^;,!1]G[3_8/F],9"$
M-BBD2E=UJ[1*T[2/9\<8L(HQLIVF_?>[QH%!/KKL!<'E^IQSS[U<EK>OLD(O
M7!NAZA2'DP`C7C.5B;I(\<\?#U<W&!E+ZXQ6JN8I?N,&WZX^?ECNE'XV)><6
M`4)M4EQ:VR2$&%9R2<U$-;R&-[G2DEIXU`4QC>8T:P_)BD1!$!-)18T]0J(O
MP5!Y+AB_5VPK>6T]B.85M:#?E*(Q'9IDE\!)JI^WS153L@&(C:B$?6M!,9(L
M>2QJI>FF@KI?PQEE'7;[<`0O!=/*J-Q.`(YXH<<U+\B"`-)JF0FHP-F.-,]3
MO`Z3NS#`9+5L#?HE^,X,[I$IU>ZS%ME747-P&_KD.K!1ZMFE/F8N!(?)T>F'
MM@/?-,IX3K>5_:YV7[@H2@OMGD-%KK`D>[OGAH&C`#.)Y@Z)J0H$P!5)X48#
M'*&O*8Z`6&2V3/$TGLRO@VD(Z6C#C7T0#A(CMC56R=\^*6Q%>:Q6VCVU=+74
M:H>@WY!M&NJF)TP`N-/D$7J5YT2".@>R=B@IOL8(^`TX^[**HF!)7L`-ML^Y
M\SEP[7/"/H.`FEX2R!A*.FU/Q^R2';.SRTFY\X$A372:9OH_-"X9_!Z(CZ*_
M\CVSSYD-<N:GF2'E\@)=,C0'RNI]._;6)UU`#8,RI';MCF(W;F>FL+/9G6M5
M]#[O(_`5#'2=L3H^9@VCFPMHW<$Q[3XRZF\T/>TSS.-AL;-@,0&(]V?*G1NS
M[B-CUMEI5K>N#[^H!;3O?4YW:LRYCXPYSTS48LSY/I5+'E/M(W&[*8:?(JS#
MXV)BV#K_*J<].";I0N."X@,3_?;T*TIR7?!/O*H,8FKK-F,$NZ6/]EM['3GA
MA_%9LO;;G/1O8)LVM.!/5!>B-JCB.6`&DVLH1_M][!^L:D`[[%1E88^VMR7\
M-SGLE\#5GBMENP=@)OV?>/4'``#__P,`4$L#!!0`!@`(````(0!%Z7S7QP0`
M`$`4```8````>&PO=V]R:W-H965T<R]S:&5E=#DN>&ULE%A=;ZM&$'VOU/^`
M>+^&7?PMVU=)H[17ZI6JJKWWF>"UC0*LQ>(X^?>=&3!AEUU#7R)[/'/.?.P<
MR&Z^ON>9]R9*E<IBZ[-)Z'NB2.0^+8Y;_]]_GK\L?4]5<;&/,UF(K?\AE/]U
M]^LOFZLL7]5)B,H#A$)M_5-5G==!H)*3R&,UD6=1P"\'6>9Q!5_+8Z#.I8CW
M%)1G`0_#>9#':>'7".MR#(8\'-)$/,GDDHNBJD%*D<45Y*].Z5G=T/)D#%P>
MEZ^7\Y=$YF>`>$FSM/H@4-_+D_6W8R'+^"6#NM_9-$YNV/2E!Y^G22F5/%03
M@`OJ1/LUKX)5`$B[S3Z%"K#M7BD.6_^!K1^CA1_L-M2@'ZFXJLYG3YWD]?<R
MW?^9%@*Z#7/"";Q(^8JNW_9H@N"@%_U,$_BK]/;B$%^RZF]Y_4.DQU,%XYY!
M15C8>O_Q)%0"'068"9\A4B(S2`#^>GF*1P,Z$K]O?0[$Z;XZ;?UH/IDMPHB!
MN_<B5/6<(J3O)1=5R?QG[<0HJ1J+4GN*JWBW*>75@WF#MSK'>'K8&H!O.=4(
M;9:N)"$[!'E`E*V_\#W@5]#9MQU;+C;!&W0C:7P>:Q_X^^G3>@2039L2I-%-
MR=Z>&S,Z(S.V"U-YK`U=&FZGB?X/#3I#O[O)+Z<M;LU<^TP[/K/60RL07,87
MB,XP'"CKLV^]WM9.(ZCAH'2I<=Q\CL?-<0IO;<8XRJ+M<V.!+>CDM;07/-=9
M[T\4G76JQJ)W?V6G@C/8*W`*D?<Y,4KG;"S=<\16H9T3!=K<(;X<T54,U&D;
MBT[+[+0K"^T*SLG]4C%*YVPL.J=C:1C,NU?K8C6B5HK4B6\FG3FR5\O`J\M\
MOTKR-M@0`$S:,5I]+K&VHKAO73;2Q>'F4IA!VPB27J1#&3"Y+NU`D>AML#4F
MO<BYHZ6&$&&1TW`U@7T;(&Y%J94#UICT,C^?`7IW+3+$1FT,/B_-DAN3SNQ0
M(F9($<TUY),%@`S4W-<E`H/^Z\P.86(V90+;`&M?F0C(.,?P)N<8L46;^)*-
MV=>^.#&+.O'0H4[,)D]S>&$9++FO4(1E-)J'#HGB%HF*POF($5.DOD\W4W?$
M/'1(%`>O[O;2TY4MADNF0(,8L<`$[6J?KSQTJ!6WJ-6HQSH%&L06O>*A0Z^X
MH5?CUXDB#>9&N_1>.[2+6[1KQL8,N:]=A`6YZ,0.[<)WI>Z0[^\O>1ME(@"8
MNA+-0X=><9M>C5)*BC28&PG3ZW3H%3?T:J#.ODX1`"0PI_\_M!=\BRBM8&L'
M*/J"Q&V"Q!Q2R"V"A#D.L/;5B(#,`3*'#$86-1KWJ*-(?8`WDS9`YM#!"+RZ
M!Y5V<]2K&D4:S`@&)IW9H8.1(4?W.TS>!ENC0=J*,(?X138-&K4B%&DPVS2(
M.=0O,C1HH,Z^\!``)*#7Z5"\R!`>FN?P*RF%&44V"J0/TZ%WD:%``T7VWY((
MH%>D0^_@_J5W:'E$%R(#BTJ11IV-*.EUFGI7W]?4ER*Y*(_B-Y%ERDOD!>]B
M.-QFM-;VGNB!HZB9]NGZH;X_"MI?X/[F'!_%][@\IH7R,G$`S)`>4V5]`U1_
MJ>09<H=;'%G!S0U]/,%-G8`;C1#?'PY25K<OP!RT=W^[_P```/__`P!02P,$
M%``&``@````A``BRNBA^`@``,`8``!@```!X;"]W;W)K<VAE971S+W-H965T
M."YX;6R45,ENVS`4O!?H/Q"\1[3D-8+EP&G@-D`+%$67,TT]241$42#I[>_[
M*#J*8Z>M>Y%$:CCSYBV<W^U53;9@K-1-1N-H0`DT0N>R*3/ZX_OJ9D:)=;S)
M>:T;R.@!++U;O'\WWVGS9"L`1Y"AL1FMG&M3QJRH0'$;Z18:_%-HH[C#I2F9
M;0WPO#ND:I8,!A.FN&QH8$C--1RZ**2`!RTV"AH72`S4W&'\MI*M?693XAHZ
MQ<W3IKT16K5(L9:U=(>.E!(ETL>RT8:O:_2]CT=</'-WBPMZ)8715A<N0CH6
M`KWT?,MN&3(MYKE$!S[MQ$"1T66<WD\H6\R[_/R4L+,GW\16>O?1R/RS;`"3
MC67R!5AK_>2AC[G?PL/LXO2J*\!70W(H^*9VW_3N$\BR<ECM,1KROM+\\`!6
M8$*1)DK&GDGH&@/`)U'2=P8FA.^[]T[FKLIH,HUFX_%H,ILBS1JL6TG/28G8
M6*?5KX"*CUR!)3FRX/O(,IQ$X^E@&*/H/TA8B*@S^,`=7\R-WA%L&I2T+?<M
M&*=(_+8CM.*Q2P_.Z)02C-5B%;:+>#:<LRVF3APQ]P&#SQ=,CV`HVBNCVO7*
M'NR5?6Y]*/=AXU0F>5MF^#\R'IQ1?+X$/QOUO$$Y8$8GF'&/>&40(=<;]&"L
M`=HZD3[/;0!=(8W]<+VT!W?2?7*/.S@G)\'\P>7DM90?C>060_Q[)_E3KS6/
M.Z<5C6>3L\R&"0T-K,"4\`'JVA*A-W[Z$FS)?K>_&):)[YKS_5&Z["X,UO_`
M@6UY"5^X*65C20T%4@XB/Z`FC'Q8.-UBY#APVN&D=I\5WLR`73F($%QH[9X7
M*,SZNW[Q&P``__\#`%!+`P04``8`"````"$`Q\X`]6T(``#<)@``&````'AL
M+W=O<FMS:&5E=',O<VAE970W+GAM;)1:6V_BR!)^7^G\!\0[P7WQ+0I9C=V:
M<U;:E5:K<W:?"3@)&L`(D\G,OS_5KL;N*J!M\I`+_EQ=7]V^MM-/O_[8;2??
MJV.SJ?>+J7B(II-JOZK7F_W;8OJ__WZ=9=-)<UKNU\MMO:\6TY]5,_WU^5^_
M/'W6QV_->U6=)F!AWRRF[Z?3X7$^;U;OU6[9/-2':@]77NOC;GF"/X]O\^9P
MK);K]J;==BZC*)GOEIO]%"T\'L?8J%]?-ZO*U*N/7;4_H9%CM5V>P/_F?7-H
MSM9VJS'F=LOCMX_#;%7O#F#B9;/=G'ZV1J>3W>KQM[=]?5R^;('W#Z&7J[/M
M]H\+\[O-ZE@W]>OI`<S-T=%+SOD\GX.EYZ?U!AC8L$^.U>MB^D4\&IU,Y\]/
M;8#^WE2?C??[I'FO/_]]W*Q_W^PKB#;DR6;@I:Z_6>AO:_L1W#R_N/MKFX$_
MCY-U];K\V)[^JC__4VW>WD^0[A@866*/ZY^F:E8043#S(&-K:55OP0'X/MEM
M;&E`1)8_VI^?F_7I?3%5R4.<1DH`?/)2-:>O&VMR.EE]-*=Z]P^"A#.%1J0S
MHL![=UW>;40[(_#S;"0=:V2.K-H@F>5I^?QTK#\G4'G@=W-8VCH6CV#X'!WD
MTL7K5K@@3M;(%VME,4VG$XA$`SG^_BQT\C3_#GE9.4QQ!4,1Y1EADV#-&OP`
MOG=F4]W=,P<&'0T(L$_C>G+/WEJP]?:\3H$?^.O(;IG6D_(2D<848BXAO1'B
M*Q3!>%\M&$K."X'0*5VY0`QDKPL3\ZT<1)@0@G@/R_C>VX)1T)3AB-N;%E.(
M4.=A'C$2",G:XIEI*=,DS2BD)!`1B4@F+!2&0&(11S+.>@PA`MWK$PD3L&">
M!N9>@1CPH"/)TS"(,"$$\3ZYQWL+IN$7.J?!+1"38/-F4C%V);FNTXQQ,_[U
M1.9:]`DFCL.0&!]V"V:.Q[W=MC4+Q*#C2N2)8IZ5"`CDQ1`32F7IC9*Q>P(V
M+(=KW][$.0@6?,2XX$?VBP)*!(0X!$R0^.>40[CL+9C[WD\UC#]B`JZ5B$!V
M,YFKG$F#(0"A=!RKCC]Q7L"DX1G0T#-A%NU=G$:_`M)PH',#9%HJ!BD)1,::
M]XBA`)7'L:<2E(B5MKM+2:`@^G-4Q+TB.B((<N'.A<HEZ_72V0GDS#C(.6DP
M:T7>QX-RL<KG<1E(!NHDX2!8010"02X9*DTXRY(@8IUX&X,V#(8`A([R5/:5
M2_VWVC?>?U1*W__LPGW$./>C)(Y8PY<BI+>.0,`(]1_R>(?_%LVD+&8CLQ`(
M"A1(.0PQ00BE8'7/2\&X787=QK/QI%B@"X=Q=:RR...CU2$T[CQ$RJX;:B%)
M8MEW'"5A)=`C,=`'*)A^'8GXHI!\59WI6*412U4I?(B(-.=G"&"6R$3*6XUL
M==`C,#(+J)X^$<4&3B%\A9VE,.%5+[%MN9<$HM*,R[@A@"S64O2YIGFP4NC1
M&,@#"J?OOHB9<X7PU76F,IB&"=\@44R6)XGL'70M3<SH+(EDFMVJ)BN*XUF@
MA,+(Z#:?(F8>%@)!P:X>A)B@%9((R=0ZG(@6S56:%Y(#A2@,0XR#G,4MDU'B
M[;@H!R;4`QRN"'3"!DHAB4!KG?3MB*W``,G%?HD"8IU'46^#N@]U/;Z*I$6S
M%"2LB`L'"J8`[6!\XRCSG@6P$9P-)Y"YR$3?<=1_*X*CNT"B9))>3GK5;]<N
M'"CH/]H)0(RSXDI(9`J>>:[O6268\2F,FZKM73P5?9(=%6MZ,75.7*LD'Z`3
M(?IAXQ+A`V9*)4*+7F%H*IA&#W0":C,92`E;O;!OT,!_\*&;6OWBK8/E,,0$
M(90"4^B1J;BBU`GSLY"^#,\DS)/+ASB'"=`UU(R@5B@7)M8#Z;@4:9'PW89$
M4,"_<AAB'.3<&5&:WQ)J>9=0MVC>$?W8<!V!"AND,`@Q;BFDD,HH\T8T3<)=
M(BU17.EXXB+M0$$&PR+MK+@D2'@0O?4D:E]@^.,I7$<MFB>A'WR8!`<*41B&
M&`=!"B!Q(NWKE21!W271+9HQ$'RP.E"0`:IX`&(Z*_:%^$QY;ZZH_U8M1VN<
M0FTE1<2?60H'<L\T.F<:7KKK&%N1YO#%==X03&PWY%KTQ4H9W*72ZHI*I\S#
MPH$"X2T[B`TO&P2&7-2]\%"_P?P=D;=H5CDIWUTH!`7]1HCK3:%DJONXHBP[
M*V>(5B+V=O.4`Y/E<9JF4'EI%5UT`8+0BU@)=473G*$`7^,@-\Q0,DR@!X;1
M%6'F[X$*1819PUXTUXQHZ3!!$L1,K/),97W-4A)W*;.ZHLS>K'83%4$80AVG
M(HNY>I?.$&)$FB7PPHL]>AB*@9<%F8SEK;'*U'ED8:&ZTL+J5W!T$.3H"-@@
MY/QQOU0^!M[*B"3E8]H03"SA.0*:Z?HN7#&E'LGFBF)[_QQP;!#D`@][M@1>
MN79>M)BR7?Z\4X<3`!%4$(48![E>A*3`-)/L<5S:N_CX8H.G<"#D<A%1Y$(P
MP@HS%!$C0S`7=B@;)M\CV:#\DN>+E(6TT(,:70Y#3!!"J5AM'JWDVJ)90OC;
MN\*!,"%*I()Q+!W@>MFT"3,!&]3]NV1<HXR3#'@BA;WA0`'ORF&("4(H!5C)
MS\#(8K)W\4STT]U105"0RB#$:(2XT:<S=6-K8O^KY1,)*V&+9B_U+YZV'2A(
M`!4_`#%!*S07=XDYG`&ZS`$;*X4#X2D!E4?P(ID.GM(A@@QPI:M&D``>)L)S
M,KOJ^%:5U7;;3%;UASTH).$_!=VGW2&F+]*>)V&?%^*Q;$\"S;L+<+;HL'RK
M_E@>WS;[9K*M7L%D])!"Y(]X.@G_.-6']G3.2WV"4T7MK^]PBJR"<S'1`X!?
MZ_IT_@,6GG?GTI[_#P``__\#`%!+`P04``8`"````"$``M4`J?@"``"*"```
M&````'AL+W=O<FMS:&5E=',O<VAE970V+GAM;(R676^;,!2&[R?M/UB^+^8K
MI(E"JB:D6Z5.FJ9]7#M@@E7`R'::]M_O&"<(2);E)@+S^O%YSSFVLWAXKTKT
MQJ3BHHZQY[@8L3H5&:]W,?[U\^GN'B.E:9W14M0LQA],X8?EYT^+@Y"OJF!,
M(R#4*L:%ULV<$)46K*+*$0VKX4LN9$4UO,H=48UD-&LG527Q73<B%>4UMH2Y
MO(4A\IRG+!'IOF*UMA#)2JHA?E7P1IUH57H+KJ+R==_<I:)J`+'E)=<?+12C
M*IT_[VHAZ;8$W^]>2-,3NWTYPU<\E4*)7#N`(S;0<\\S,B-`6BXR#@Y,VI%D
M>8P?O?DFPF2Y://SF[.#ZCTC58C#%\FS%UXS2#:4R11@*\2KD3YG9@@FD[/9
M3VT!ODN4L9SN2_U#'+XROBLT5'L"AHRO>?:1,)5"0@'C^!-#2D4)`<`OJKCI
M#$@(?8]Q``OS3!?P%#F3J1MX($=;IO03-TB,TKW2HOIC1=X192'A$0(SCA`_
M=*:>.PNF_X40&U#K+Z&:+A=2'!#T#"RI&FHZT)L#Y63,AM%9_9=3L&@@CX82
MXRE&8$)!==Z67C!;D#=(:7K4K"YH7&^H69\T)H,&G(P'-KT!`A8Z'_[0Q^7"
MG,(U8A/N:9F5'0!V%[\_'85V+O'<R5"3G&O&F,VYI(\96()FZ9?FNB4C'EBR
M`WU+7N@.XUW?H$DN:?PA9W-=,S`%3=PW9?HM@.UXW9R9-#!G!X;FQKUT@R:Y
MI`E&YJYK!N9@`_7-73=EQ#&&?NAZS@O#X=HKJX$(.LVHY=96<=_N.=^/(G^$
M2/J"Z'[FCWI@T_\^`@R\14-OMQ7.3!I['#E868UU$$91-!T58&T%5Y*0]!%>
M%`3!9+1[X6XP@5QF6)OV[+=G8\7DCJU962J4BKTYUWU(<#?:73F/H3E"1N,K
MN(K:@YMT'^`J:.B.?:-RQVN%2I8#TG7,L2WM96)?M&C:$WDK-%P"[6,!=SZ#
MD]!U0)P+H4\OL##I_D4L_P(``/__`P!02P,$%``&``@````A`)91=;J<%P``
M4;```!@```!X;"]W;W)K<VAE971S+W-H965T-2YX;6R<W=ERV\B2!N#[B9AW
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MOZ=P5VI&U\N<7J57%.G3QR]WM`3+:K]XVGR]OOS#_3#'T>75IX^'%?1_=YM?
MN[-_7^R^;W_53W=?AKO'#:UMVD[+%OB\W?ZYT/;+\A%-?+6:NCIL@?]ZNOBR
M^7KS\W[_W]M?S>;NV_<];>Z0EFA9L`]?_BDVNUM:HQ3FO1<ND6ZW]S0#].?%
MP]V2&K1&;OX^_/WK[LO^^_6E'[T/8\=WB5]\WNSVU=T2\O+B]N=NOWWX?X5<
M'4H%\700^EL'<</W@1?&R6NB^#I*\#N*]^I9H9E6R\.B>$GHAM$KEFA9A2H.
M_>.X3/%+Y^9*K>3#-BMN]C>?/CYM?UW0CD"K<??C9MFMW`_+3RQ;RZ=MKM;M
M:?L]M_EHNRU1_EC"7%_&EQ<T^8YR[J]/:?KQZB]*DUM-,D7HSQ-Q'8>;?!W&
MY:(XBB5OEE\NCQ^<AQ4354=SG*B6'S3R@U9^T,D/>OG!(#\8Y0>3_&!6']"?
MIW42!Z<%OJ)-=-I.E,AL.YGWIN/F6/2R.8X+G*D/SG_(._W.83WF:^$ZPA1K
M(T1I$#'_H6I-7,?GIC:9WROF,,.-R80\3FLR$3>=R8AY[DTFX7$&DQ'[P&@P
MKM@')I,1"3VOS>\-P=*&6C"6-L?=VYX^RU37E_0CI[1TW=\_<%C]F3+)85^/
M8]_WTU"07!%J]DYAQ/8IH"BAJ*"HH6B@:*'HH.BA&*`8H9B@F&V"90]M.I8]
M]JQ9M,P:L6-GREA2(H>B@**$HH*BAJ*!HH6B@Z*'8H!B/(KEN/S.#V6+<_SZ
MV?UTM@F6,=2#>$7&+%IFC&CF,V6B0SL3Q'[@>K%H>7-%:!Z?;6>@*(]B646B
M]:^.WST;OSX*P]3-^7=BSMOS[\2NTEF^Z\^_DP>007VIUUB2!J$X>HS'J9]=
MGNDHEN5)9"]M/GYKFIYE0_2J;%BTS`9QP,B4L6SJ'(H"BA**"HH:B@:*%HH.
MBAZ*00F=+T'BBSUPA!$F*&:;8"E#IQ"O:$`6+5-&].\R9=3B^8GGB[T[/_\^
M30-7?%^H[RTI5YY'\(/4]\0.5S$0NKXG>DKU.7#=Q`M$8]`PX*1>*):R9<!U
MHUA$Z!AP_-`5;5%_#N+$"\6N-YQ_'SI!(J8?U?>6]31!,=L$2Y.E6&0Z;;7W
M4):I9+J(S9TIH]+E7>(GOB-6=<Z$[R>I'XOM63`2>%X<R8-6R4@2>Q1%I@TC
M<>P&;BI6>LV(ZX1.[#C"-,PDH9?&H4B.EA$_#CV*PT]O.D;"($R#2)">$:JZ
M):%L2P9&PL!WY$G#R(2;>K'(PXD#SY6).#-`51;'"Y/?6YFE4?JF-%JFXFF4
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MV;`5F)2<Q'Y,W16>!A4G?AJD\JA5"Q*$YXVXJ@!RX@54WQ>9TG(2!['L675:
M6%9+C\F`R8C)A,FLR7$3)6E\OA_R9%JJA#*98CIYLW>27%5<Y,DD#BJ91I:U
MEFNBYI2.2TD@^T`%(X&?4D>))TJ)?Z?"I,:DP:3%I,.DQV3`9,1DPF361&TB
ML?YY*BTEP_-4`BFD*HPLA3S1%\A<A=2/TT$KC;U`'/YR9M[1,2>.4U?D8L&0
M.5#)S+LHC*B[+9N<BJ/0I:::.L(\(VN._-1?4ELT.PU'U"RY?BA[.BU'U+MW
MPC@0+67'49)Z:9B*6>JYH;5(<809F'&I>R\.#R,#[WQ:=G'LGKB@15KUO)E8
M;0F>4=1TO":C%L[[2JX\S<Y<A:R-$B0%CE)B4F%28])@TF+28=)C,F`R8C)A
M,EL)3Z*E$OF*9DD5+GFS))J<;!D$ITRS)A$D!8Y28E)A4F/28-)BTF'2:Z);
M=)^J]:(U&W"0$9,)D]E*>`XMI<GS''K9$*FK*IHLEU9CI!JI%:(&264#GVMC
MR;<"DQ*3"I,:DP:3%I,.DQZ3`9,1DPF3V4IX-BT5S/-L`ATE5?#D621.5#-7
M(=U+4T-@PN3:6+/(5EP]G%"5IRB&<:SJ]*5IV.<P?7TBAND;]J7H?;3L2]'Q
MZ&Q?]NS+U5C8Z=MG9WK$9,)DMA*>(DM]\A4IHLJ9/$5$23ISSVN>ID$.!DRC
M'!I8$JAD,8SC'%R8!CJ8,(YT<&$:ZN#"--;!A6FP@PG3:`<#IN$.#2PK;,)D
MMA*>-DM!\CQM7GB<4G7,\_21-9W,A=707!/5!KTS)A`,4O(@APP2[4`EB#&%
MU`_I65ER2!8\&Q[%I22*1(/9"F+,(O9#/HTBR+.JGD<Q5JLUL>3)B,F$R6PE
M+)4\6:^V'Z0.7)Y[R;-YC=16<;T@=OU`#E+F&EG61?&2."6.4V%28])@TF+2
M8=)KHE:?YWF^)YKX@0E3@X1_9<)D9C^SWHX\CV2U&N21H4KMB6-]YBED29$<
MDP*3$I,*DQJ3!I,6DPZ3'I,!DQ&3"9/92G@2T:'I#<<U;YE,-$KRTHU,(WVH
M,`[F<V(>S=?&DI,E#V,>SN?&/)[/S3,#^AR91_2Y,0_I<V,>T^?&/*C/C7%4
MGQ/3L+X0AG%]+<R;@>>4+%>_K*_DK<O6J[Z2-N:9.)P%Y9H<.RB.3Y40T9H7
M.$S)PX0T&.?ZHLY<<4-7=B:)O*ZG%L9-@G358>+&<\+$E]=)M=Q0OVLIV//B
M>,=-1%=;R:MG>DTL*W#`9,1DPF2V$IY1-+]O::66R7@KE<J"HZ>,987DFAPS
MRC#$CX.4(HAIC%\0TQB_)(8Q?D%,8_R"F,;X!3&-\7-B&N/7PK)N1TPF3&8K
MX9DD:]8O;)L,M6NYJV?+[62@=JW),95,0_PX2LFC&(?X.3$.\0MB&N+GQ#C$
MSXEIB%\+2Q;TF`R8C)A,F,Q6PG/)5+O&(_R>J78M1E4SC2PK+==$Y9)YA!]'
M*3&I,*DQ:3!I,>DPZ3$9,!DQF3"9K80GT^M*UYZA=+T:X]=(MS817<H5>?)B
MH%P@\R"_0,9(I4#F47Z.GAGEY^B947Z.GAGEY^B947Z.S*/\W%!%*W'D1=X#
M-\OE!*X8@ALYH:L7(G$*/G%!P^RK<7XN5IN5IY4L=R_'NX`.5*!88"A[R^YF
MYBED;:,@*7"4$I,*DQJ3!I,6DPZ3'I,!DQ&3"9/92G@R+279UQ?!/57)/2^"
MKV]HU4BW55Y"=V%$\GK"7"-+QA68E)A4F-28-)BTF'28])@,F(R83)C,5L+2
M:7G0P1O2Z3`9/ZNCITKP4^%,HV-'.XWHUD71Q\JUL643)B4F%28U)@TF+28=
M)CTF`R8C)A,FLY7P;'I=.=PWE,-=45#)-+)D2(Y)@4FIB4I7NI??\3PY-H>C
MU#Q*0G=-^*+RU3`2^'[HR]/8EA'JH,14U^)[5R=(0K=/B1_J&0E2NI-H=76`
M)I:U.V(R83);"4^BMY7#?4,Y7`XA91I9%C?'I,"DU$0G4YS$B=@X%0Y2\R!1
M2A5'G@0-$P$5!^0S9UHFW,!SY.57W5J(7;!G(G0B2B0^'X,6EO4Z8C)A,EL)
M3Z.W5<#]=06<[K?GBYMI9%G<'),"DQ*3"I,:DT:3X[':H5P3A_,61^DPZ3$9
M,!DQF3"9K80G$VWJ53<IHKZ3_13.7R:3W22Q#V<:69-)Q;&0`D<I-=';F&[!
M6MTB7>$H-28-)BTF'28])@,F(R83)K.5\&1Z6_W;7]>_5V-SVE@2)==$94'@
MT&4_8D<O<)"2!?$</PI\D=85(VZTW'<FQGUJ3@(JU<CR6<.)$](OB=EM&:&[
M.APY;M<Q07>A)+(SU3/AT8RL;KG5PK)F1TPF3&8KX7EDJGTOG770**UKWZL1
M.5\9R]+FFJ@\BJ)`G-D5.$3)0@0A#9/QXVS%0.QYJ>A$U1S0S?]B+AH.$C<6
MH&5@&1@6\]`Q$%-!1%SWU3-`@X'REN]!`\O*'#&9,)FMA*>.K'2_;`C.-U6\
MQ1K--+(L;JZ);H/<LV<3'*X?*'"(DH6@`JVL/E02)*O61RV,FHDE@J@"-RP"
MM6#RWKP6SV:'28_)@,F(R83);"4\@TQ%[1<T/H:BMB_VJ,R'%>M<$[7QW"B2
M&Z_`,4H6@Y[?EXA,KG",&I,&DQ:3#I,>DP&3$9,)D]E*>"*9"MIX!-<W%;3%
M!LPTLC9%*HY*I)"NMI8/;"EPD!*3"I,:DP:3%I,.DQZ3`9,1DPF3V4I8+@6R
MFFWO"1VX/#V3C9%&MAS21!])C,,F!0Y3\C!Q$@1TC[;H$7%#1RT_7G6KN7'H
MN.7*QVTUS-`#@MS4D8G?,I/2\2^4IPH=([&?!$XDNF@](Z$7>Y%\5M2@B645
MCYA,F,Q6PC/I=97LP%#)EI<J9AI9%C/71!_63",F!8Y2XB@5)W1?1^2+5*LQ
M:3CQ7&H_Y=D9(_3H`L<5"=(Q06/ZJ7P*6,^$L?ZHA675CIA,F,Q6PC/H;67L
MP%#&EGMXII%E<7-,"DQ*3"I,:DP:3%I,.DQZ3`9,1DPF3&8KX<DDB]G@P&8J
M8HOSGRQ0R)I$D!0X2HE)A4F-28-)BTF'2:^):J;?T3/^UO?YXR@C)A,FLY7P
M)*)-S8K8((D6+GI'\HDH6:"0-8D@*7"4$I,*DQJ3!I,6DPZ3'I,!D_%$EAO.
M34^VAFM_/H4PW2'.,TA6KD$&K2O6='[%>[39<B$<N&(;DP*3$I,*DQJ3!I,6
MDPZ37A/=#-'C)E</3QIPE!&3"9/92G@2R;(U2*)UN9INK)5)A.O5`20%)B4F
M%28U)@TF+28=)CTF`R:C)CH5J9CJR3&%"4>9K80GD2Q@@R0R%*Y75QH%"EF/
M99`4.$J)285)C4F#28M)ATF/R:")RA`ZRUL_E!\'F4[$_%C^T]?X2/:V\G5@
M*%^O+C+2R)I'L,)=X"@E)A4F-28-)BTF'28])H,F*H\B>@ZS*/J..,;$8@0T
M?"`?Y#U;@_"62-:O04MDJEN+HDD6*&3-($@*'*7$I,*DQJ3!I,6DPZ3'9-!$
MMT2&USW@&!,FLY6P%`I?5[8^<'%B)I\SEVED2R%,"DQ*3"I,:DP:3%I,.DQZ
M3`9-5`K1NP+$Q2\C#C%A,EL)SZ#7E:M#0[E:7GJ3:63-(!7'0@H<I<2DPJ3&
MI,&DQ:3#I,=DT$1GD*&"-)Z"+'V=0%YV,K&O5Q>=S*>O85<HE(5J^P'LP&7K
M(Y[*D&ED28P<DP*3$I,*DQJ3!I,6DPZ3'I-!$Y4[IM/^D0G/#_Q(M%`3$\8N
MD'5&>.LCJ],ONYHH-%2IY3T,F4;63,)5:AREQ*3"I,:DP:3%I,.DQV3`9,1D
MPF2V$IY,M*E9E?J%R;1,)IJEU=-H0X74CO,N2.AZP52^YB/7R))Q!28E)A4F
M-28-)BTF'28])@,F(R83)K.5\'22)>L7II.A="TO,<Q"A70Z^2$=A>45JKDV
MUFR"%?`21ZDPJ3%I,&DQZ3#I,1DP&3&9,)FMA&?3ZVK7H:%VO2H[:F3)D!R3
M`I-2$Y6N].X">IRGO"ZHPF%J%H:NFJ4[&,683L.)DP2N?#M1RXCKTQ,4Y&O.
M.D'HXB+YM(>>$7H;0T0/CN!#`X,FEM4[8C)A,EL)SR)9O'YAFV0H8J^*CR&L
M4.>8%)B4FARSB=ZX(5_O4>$H-8M"3R%>/1NEX2)U0WGY6,L$O4:.'OK!<Z!;
M"U%QZYF@)VW196H\QJ"%-8_@NI]PE-E*>![)(C8X<S,4K^6],ED(*],Y)@4F
MI28J?ZB!".3U<A4.4F/28-)BTF'28S)@,F(R83);"<^AUY6O0T/Y6M[ZE6ED
MV55R3`I,2DUT&T2O&!5UB`K'J#%I,&DQZ3#I,1DP&3&9,)FMA*70<A_L&\[8
M#I.),[;5G=8:V5()DP*34A.52O2>K5360RL<I,:DX;_CNO1D!S&`U>(H'28]
M)@,F(R83)K.5\%R2A>RE:[1,;C^T1::"MBAY91I9<PD7M'&44A.=2RY=6NV'
MXA$"%0Y38])@TF+28=)C,F`R8C)A,EL)SR99VGY91SM:7X.]NM-:&VLRJ3`J
M#6+?C>7S9`H<I-1$!?']Y5W.\B#'B$<W>ZQ>;5<S0J_RI3N@Q7TN#2?T;KM4
MOKR@921,?5\^.*]C(J`^72"ZT3T3;DJO%!8S,FAA6;,C)A,FLY7P/'I;@3M:
M%[CEZ6FFC65I<TU4"KA>*E\[7>`8)8M![^%:']W4O*H?H9M]Y%.K:Q:!7L(H
M3[(:#BC91?O;,K#<22W:Q(X!>O*<'%;M&?#I`4WB1&_0P+(V1TPF3&8KX;E#
M,_.6WM$RF>P=B9Y"%BED6=Q<$[5=H]6[I@L<HF0AJ-PC7R!<,>#Y]*)P?NY<
M2R#?F]TPX-(+?46$5@/+DG:8])@,F(R83)C,5L(SZ&TE[,A0PE[=:JV19;WF
MFJ@,HL?BRP:[P#%*%L,+HT0>.2H<I,:DP:3%I,.DQV3`9,1DPF2V$IY)LGR]
M](?PO=:1J8R]:HL4LF:2(OI`1DD0KIX:HG_*$J7$I,*DQJ3!I,6DPZ3'9,!D
MQ&3"9+82GDRRB@U.T4S5:]'WRR)80<TU44ED'L(M<)B2AXD<-W`\D=(5,]3C
MH>*S/##5W-`-&'3[MSAX-<S0:0`]I4_675MF$H>ZSK*LUC%"<TP/W1$#+STC
M`77BZ?%._%@\:&+9PT9,)DQF*^&9]+HZ=F2J8XN3HDPCRV+FFJA,,H[>%CA*
MB:-4C-";S>C!:V*4JL:D883>-1`$\F5\+2/T4)1D-:;&1.@[=/40SX^>">-(
MB!:653MB,F$R6PG/(%G%?N&)_KJ:'8GUD47*6)8VQZ3`I,2DPJ3&I,&DQ:3#
MI,=DP&3$9,)DMA*62_';RMF'R<0)V^H")(V"2\/K@?/3EZ9+-M6#L3`I,:DP
MJ3%I,&DQZ3#I,1DP&3&9,)FMA*>1K&3;NT>QH8(MKZO(-+*U19@4F)285)C4
MF#28M)ATF/2:Z(.]Z599'&3$9,)DMA*>0V^K7\?K^O7ZZ?P:J1424G]S]>R6
M7!-+NA68E)A4F-28-)BTF'28])@,F(R83)C,5L*321:Q08.T+EZ[JVO78H74
M\4P48_/3EY;CV7'Z9TF)HU28U)@TF+28=)CTF`R8C)A,F,Q6PM.'FH$WU+'C
M93+1+9(GR)E&QW-Z*C'*(F.NB;4M4C]E(26.4F%28])@TF+28=)C,F`R8C)A
M,EL)3R99T@9MD:&4+4>PLJ6.29F6'/K6KCB-R_6WEN0HK`%*'*#"I,:DP:3%
MI,.DQV3`9,1DPF369+7Q>-;(\C7(&D/96EYDF,6L)NW05<B>O!D\9\9TOU7!
MA&N,4C)CBE)!44/10-%"T4'10S%H8=G?1DPF3&8V*ZM5K_+G:O=]L]D7-_N;
M3Q\?-D_?-OGF_GYW<;O]^4@#(#ZU&*=/+YXV7Z\O_W`__.%=7JT^S]T/A6OX
MO'0_3(?/KTZ!=I\^_KCYMAEOGK[=/>XN[C=?Z:><]TNB/]U]6^I3ZC_[[8_K
M2SKY^[S=[[</AW]^W]Q\V3PM@/#7[79__`_-T-6O[=.?A\7Y]&\!````__\#
M`%!+`P04``8`"````"$`#MD2M5T"``!/!0``&0```'AL+W=O<FMS:&5E=',O
M<VAE970R,BYX;6R4E-N.FS`0AN\K]1TLWR\.$))-%++*=I5VI:Y453U<.V8`
M*Q@CVSF]?<<X85/M5DIO`,/O;^:?&;-X.*J&[,%8J=N<QM&($FB%+F1;Y?3G
MC_7=/276\;;@C6XAIR>P]&'Y\</BH,W6U@".(*&U.:V=Z^:,65&#XC;2';3X
MI=1&<8=+4S';&>!%OTDU+!F-)DQQV=)`F)M;&+HLI8`G+78*6A<@!AKN,'];
MR\Y>:$K<@E/<;'?=G="J0\1&-M*=>B@E2LR?JU8;OFG0]S$><W%A]XLW>"6%
MT5:7+D(<"XF^]3QC,X:DY:*0Z,"7G1@H<[J*YX]CRI:+OCZ_)!SLU3.QM3Y\
M-K+X*EO`8F.;?`,V6F^]]+GPKW`S>[-[W3?@FR$%E'S7N._Z\`5D53OL=H:&
MO*]Y<7H"*["@B(F2S).$;C`!O!(E_61@0?BQOQ]DX>J<II,HFX[2&.5D`]:M
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M[7"2^\<:?UR`O1E%*"ZU=I>%/W/#KW#Y!P``__\#`%!+`P04``8`"````"$`
M;]@K7U4)``"'*@``&0```'AL+W=O<FMS:&5E=',O<VAE970Q,BYX;6RL6EMO
MXDH2?E]I_P/B?0#;$(*59!2,K]J55D?G\DS`"=8`1MB9S/S[K7)WN[NZ'`.C
M.0_#R>?JSW5S]>?+P]<?A_W@>WZNBO+X.'1&D^$@/V[*;7%\>QS^]6?TY7XX
MJ.KU<;O>E\?\<?@SKX9?G_[]KX>/\ORMVN5Y/0"&8_4XW-7UR1^/J\TN/ZRK
M47G*CW#DM3P?UC7\>7X;5Z=SOMXVBP[[L3N9W(T/Z^(X%`S^^1J.\O6UV.2K
M<O-^R(^U(#GG^W4-_E>[XE0IML/F&KK#^OSM_?1E4QY.0/%2[(OZ9T,Z'!PV
M?OIV+,_KESW$_<.9KC>*N_F#T1^*S;FLRM=Z!'1CX2B/>3%>C('IZ6%;0`28
M]L$Y?WT</CM^YDV'XZ>')D%_%_E'9?S_H-J5'_&YV/ZG..:0;:@35N"E++^A
M:;I%"!:/V>JHJ<#_SH-M_KI^W]=_E!])7KSM:BCW#"+"P/SMSU5>;2"C0#-R
M9\BT*??@`/P[.!38&I"1]8_F]Z/8UKO'H3L=3=W9_-X!^\%+7M51@9S#P>:]
MJLO#/\+*D5R"Q94L\"M9O+O1;#[Q;B'Q),FT)5GTGA3<:UR'WXZ3]GA[)Q?"
MKURX&,V=R<*;`U7/NKE<!]>.6M=K#^XW#L+O;0XZT`:B*M@/(N&=N1B+:C;-
ML5K7ZZ>'<_DQ@"L.RE6=UGC].CZRJ;80T;6-\EF?0(,@RS/2/`XA;NB`"IK[
M^Y/KW3V,OT-#;J3-DMLXU")0%MA]2+NR@=`&(AN(;2"Q@=0&,@,80UK:W$"3
M_H[<(`WF1D6U5("1+"L1RD(M6=E`:`.1#<0VD-A`:@.9`9!$P`7W.Q*!-(]#
M^-=HDCF-?"EMH!-;HQDU"5J3-CL,"1D2,21F2,*0E"&9B9`DP33Z'4E"&K@8
MH11M`OBE)(R\OBRU)FV6&!(R)&)(S)"$(2E#,A,A68+!2;+4O?VHL8+633)4
M$$N!>'#)&NFYMSJD-5++5@P)&1(Q)&9(PI"4(9F)D-AA&R&QXZR]\T9Z,[EZ
MW"(3S8M`/-AQC+PLK+RT1FU>&!(R)&)(S)"$(2E#,A,A>8%M@^7%G8T@CS?N
M0DA$TR(0FI;IQ$I+:]2FA2$A0R*&Q`Q)&)(R)#,1DA94WO;6_$MI02*:%H%8
M:;%WX]:H30M#0H9$#(D9DC`D94AF(B0MH&]86IQ9<Q7U#Q-<2-,@$,]MM^:`
M(2N&A`R)&!(S)&%(RI#,1$C,J,Q(T/V1-N8T5`4).8[B*N#0BD,AAR("43]1
M2MD]*XM3[XK-MV4)XPF,.OSW0#9*,2D$&>R!JO.6CH2TB@HT9(X\Z]I>22L7
M4JL'X]2E$R#45NJ,D:8'B`:),LD,LB,8N"5JHQ&JBD0C(>AQPRF/.A6@!L"&
M):Y[+$!AY4*"-)<WI5RAY/)`O6BKJ64522N+2Y^1I@&5D)D&W,[$?+J0$"&A
M2$*DJ@+98+AG"S]'+J2A:O?D/4-KI6H9RH4NMAC<F<PF^!_-4*3(B0M&MFGL
MJ&_,V"]$+.00B5A`'FQR;<2.79#`D0LOM$!KI2.6]+#GMO3NU+HCBR0]K?=4
M2W(:,^H:,V9QJ]@,WANN;:&.2"H$!`\_M*_.S*I/@,\J\&JX4/S62J="0++X
MCCNWLQPI:M,!]]/2HXPQTW"A]$+UD'@%Y#8/>YJ>#9P6TBDP/9"=+:W$XQF<
MX:%:J*%(00T]K2!*C1M<%\J$N"XA.KAL^>T(*Q=^=/,9^9312*Y%.^5#M7`B
MKE/W_FYZ;VG82-E\U@<T8E01-T0L1`>)6$"D.=VIY53@R(47(I96>@\.Y4+9
MG(M[WIMRS76]B0+BAG#1W)()`B)C">8EG94!;DFP\%*!);U98+E0%MCQ9HZE
M.B/%?55]W=MT46-.`Y80K>_,<BI0"_OKJZR,^DI(#9^NC4>MNJK".*I)A7]I
M"#<L5AZ0&![.P+#4U^S,TDF!7'BA\(K>*+R$/)A@!KVE>")%3VK_V7[DHO"Y
MOMD;<RMF*9V,02RM8#8;?K+1I:STU`TY%"F(#V)H!^KZKU51"AU#)C?$<&%"
M8$::+9D72"N<I-J*!RGI:2HLKE!R>82+33%U1LJEQPH9VIA\4E@[.W^6)RAD
MYTV$H;L;&JO@R(PO+MHM)Y!6^-.7"[GPOET8JH4:BA3447#4(&:O&B'UZP=\
MMV+-:`F9MZT<6G$HY%#$H9A#"8=2#F4$HA5%X6*&?R%FH7/,;=B5D!ZM`8=6
M'`HY%'$HYE#"H91#&8%HS'!%W!(SFEO=*B$S9@'!@QLE;U<XBW%P:RCD4,2A
MF$,)AU(.902B,:-8N:'.4MN8`TQ`GMXZ`K>%>J]0834U'XF[GK6/AY(+K%3^
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M,8@(EG:NBJ75!9&DK`Q5S*%(0;H2L89Z<IPH*TV?<BA3$-=@>"'^AC[EHKLA
M!E5YUX[-0$&P-QL3PNJ:E;*B76-=KZ&TPA_-Q11V-Y=UQEA9]?J52"OKP;/E
M5ZJX>A[69,J&1JB]HJV+(KMO][M.]^.MO#U)I'S7/1=(JTLM+1<:XDHMU%"D
M($T?:\@HFKV1),I*<Z4<PJ_","!PM=4+XBLO\2'/(3^_Y4&^WU>#3?F.7W`U
MTZ2%Q>=ERWL?7JD!@8TO?'CMU(&[,Q\5/3\"^@6.=*V!3]B>&RUGGP,^;6MF
MGHV[0-1QAJ4'G\)UX,]3_QF2P5U:3GWXXJ`#AQBZ0EC>^?`VNL-^[L/K6([#
M6R0?WQ'Q(X$[]U%<\R.@KR&ZKB-+2."R,X&@=?V@\\@*CJ`8X^<!`0L>=!T!
M'>NC-.-K0+OZJ$R[CBS@2+-FW%8+/@,\K=_R_Z[/;\6Q&NSS5VBR2?/@_RP^
M)!1_U/*^_*6LX?N_YA9]!Q]\YO"@>H)O\U_+LE9_P*G'[2>D3_\'``#__P,`
M4$L#!!0`!@`(````(0"3`/)#GA```#!5```9````>&PO=V]R:W-H965T<R]S
M:&5E=#$T+GAM;*R<6W,;NPW'WSO3[^#1^[%UM65-G$XL[?TRG<YI^ZS8<J*)
M;7DDY>2<;U]0)!8D_JN5G.8EBG\+@%R0``EJ5Q_^\>?+\\4?J^UNO7F]ZPTN
M^[V+U>O#YG']^N6N]^_?X]^FO8O=?OGZN'S>O*[N>G^M=KU_?/S[WS[\V&R_
M[;ZN5OL+LO"ZN^M]W>_?9E=7NX>OJY?E[G+SMGJE*T^;[<MR3W]NOUSMWK:K
MY>-!Z>7Y:MCO7U^]+->O/6MAMCW'QN;I:?VP6FP>OK^L7O?6R';UO-Q3_W=?
MUV\[MO;R<(ZYE^7VV_>WWQXV+V]DXO/Z>;W_ZV"T=_'R,,N^O&ZVR\_/=-]_
M#L;+![9]^`/,OZP?MIO=YFE_2>:N;$?QGF^O;J_(TL</CVNZ`^/VB^WJZ:[W
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MA?7_F5T=-,-*_WEGJSRH`QG5LP9DP`-I_O/.-FGL[9WZDZ!K4*[L-#Y$Q6*Y
M7W[\L-W\N*!40_>[>UN:Q#68#<@:QX.=$$V$'`L0B@QCY9,Q<]>C$:<8V%%4
M__%Q>'/[X>H/BL0')W./,H-08LX2)NR,V84&D0:Q!HD&J0:9!KD&A0:E!I4&
MM0>NR+6-?VE2_`K_&C/&O^R9>P:>PY4S68)5%AI$&L0:)!JD&F0:Y!H4&I0:
M5!K4'@B<28'R*YQIS-SUZ%^9K--^Z+U[)T.9I!&:A"+S1J3Q,)`(2`PD`9("
MR8#D0`H@)9`*2.V3P-F4#'Z%LXT92BXTI(TC,358H5&7MQN1QMM`(B`QD`1(
M"B0#D@,I@)1`*B"U3P)OTU(:>+M]/\+IUD@?G,K.N+=D1&E(W#S5^;418K4%
MD`A(#"0!D@+)@.1`"B`ED`I([9/`A[1#"7QHUK+1U.SCW,;H[.7,6`K]:\F(
M]C*>?X<J(S1"C7^!1$!B(`F0%$@&)`=2`"F!5$!JGP3^I>4=_#N<7+[?O<90
MZ%Y+E'M'RKV-4.->(!&0&$@")`62`<F!%$!*(!60VB>!>TV)Z6_%NE.`D0Y]
M:,GXNMDDS($L@$1`8B`)D!1(!B0'4@`I@51`:I\$#J,*(7"8B?<)9<!W[EV-
MF="3EJC9.%:SL1%J9B.0"$@,)`&2`LF`Y$`*("60"DCMD\"YIIH*O-L]'0_B
MH1<=4F[4NRB1:OR(*$(4(TH0I8@R1#FB`E&)J$)4!RATJ2D2_`BWQ=:EJ:-/
M>->6%[2+8B?=FY*5INU(T!S1`E&$*$:4($H198AR1`6B$E&%J`Y0Z$I3(OBN
M/.$_6U$$_G/(GM"8:G-N-JDF$PA:((H0Q8@21"FB#%&.J$!4(JH0U0$*_6>V
M_>_PGZT2R)[,/U<XW#9H;@XRS)2DG"*;I)&JK!9.:NQO]H?7UV%VC42*6XS%
M/*,$42J*7B>T^4RDV%:.M@I$I2AZYJ>J]Y5(L?DZL!6.A2D*WC$6MH8(QL*5
M%?Y8`%J8XQT:'N7X&^WX1HJ['CM%&E=&":+T+/.92+&M'&T5B$I1/)PN]?MJ
M=UB)`%NN`S.ASTT1\0Z?&W&UNEGD.65NSI'M_.<>+!P:#P]G8N/!S5"=BD4B
MP4HQVDD0I:)H'#(>C*[5#B43"3:=HYT"4<F*88BJGE<BQ>;KP%;H<%-5^`[W
MUK[]U_7#M_L-Y0Q:TUH2^8B<YXX9;6T2S'U7KLCDG`\`+1P:BE2$*$;%!%&*
MBAFB'!4+1*5#8W.+9A!A?E0B(5[V[R_TLBDN?"^W>)/*X<:=MA8)W&G1F*:R
MY/"I2A+S@5,\D>D;*>YZ)(J,8D0)HA11ABA'5"`J$56(Z@"%7C85B>]E,Y=M
M(7S"W[:4"?QMT9"V'HV_;]62.1\X/0J/1FB("VNKE$H*D;,U#FQ-I^$J$'.+
MM!A(BV,U#1*6D@U3*LA3'*E.9.V=4`DF9UN=G2A82CI1"NKH1-7:">W[FFT=
MZT0X,TPY]5,SP]9AP<QPB$:U&8);?:(W<$+TT0BUS(Q&BJ,N<HHC2B6BJ,W'
M3FH83!:<!F`^E7YQBUE[B^H(+3^KQ0+-EXBJ]A;5OJ$^U6(PP$-=%9\;^@?%
M<`?A4!CZRA]SU@M&`$)?I-C=D4-AG-^J0(Q9\=CL/BR["4M)B*6(LO865;V?
MLV)GBP5+28LEHJJ]1;49KUGQ6(OA`).C@PCNSN@F,M3&D%$0MVK2S5FH.VY%
M2H;5-JCB5B7FV"F:#XENB%LTGR+*'%(MJ@4C=U+FXWB+!9HO$54.J1;5ZE`[
M*?/1VF(XK*:T_YG$;*)3#[!%8=RJP)JS7M`[C%MG7:9YY!2'=D<XF-[>W/15
M4HC9>#"CM?&$I<1XRFC<5'*90R/:JWEN5+>3BZ(GI5LL6$I:+!%5#G7=8<UJ
MQ^XP'%Q]F'%(RM>'+W[.KRVH/S#2#@6AK!+:G/5.A+(SY14@3C&8YJ.^VOO%
M3NKH-'<9&LRGHLC)(^,62;AKK*VML$4<:VBQ=.9I0>46*V[1WV;`/=;25;]?
MDM3"T:8Y$83RB0QMQ-7":]%0HF!._S=2YD,\H^]YP5+VP3!S9A@ABAF)^011
MRDAL98AR1F*K0%0R$EL5HIK1P5;H4G-P`=GQW0%DCS_\/:SYZM6XE=)<X]9;
MM3[/G9"IMQHAW,.R5)A059Z*G%2PZQGUU:XY9EO!:./RZ.Y'GKI)6;&S$UE[
M)U02S]E69R<*EI).E(PZ.U&U=T+M0VJV=:P3X30QYPYZF@PFA^\O#GGV]\W;
ML3,<:HA/'8;V^"*8)Q;1#.7,,7=29M)VS0JG.&T4(U84%#,2\PFBE)$H9HAR
M1F*K0%0R$EL5HII12T2:HQ/?U2>2G#MI\<[GS6.I%'K!0<ZHK^)E[J3,1Y>7
MG7E)[)%3]')]C"@1\SRN*4IEB')$!=HJ4:I"5`<HG-#FQ,3W\MG5G%%4BXI%
M0:H;]6&SX!1/^-M)R3XJ&CKS=ELX&HRG8_UX3^QDS*GW\<%,6$HR2LI(VLM4
M>_W!S5C=2\Y:G<T5+"7-E8RDN4HU=SN=W$"J<DXYUEPXLN9(PA_9$_'C3C#\
M^'&(6FV<.>K#VF6ES!1KI%K6+F?+CQ]`,1U.'R:52"4.D7F)'Y#*4#%'5*"M
M$J4J1'6``B^;!_;>X>6#>!@U#HW\01WU9>=WV-W.6;';RRPEF3EB\X'B6"7!
M6!0[!C%A*6\L&$F+V5DMYJ+8T6+!4M)BR4A:K,YJL1;%]A;#<:6M13"N)B_Z
M"_U97]:8AQ%5DG1H1#NK)EQ&?766,'=2)X**I22+1&R^L[Z)15$Z`3&;L)0X
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MDNX`P,_=%@6K9(.\,<*MCY.2J1^9Y]1-AA<4,Y(P2A"EC$0Q0Y0S$EL%HI*1
MV*H0U8Q:0M*<#OBN[C[W,(_JZMBSR#31S/'10)W]S)TB2?$<7R"*$,6($D0I
MH@Q1CJA`5"*J$-4!"F:O>5XV<*E7#'=[]Z`99C:'J'!@O\T1+1!%B&)$":(4
M488H1U0@*A%5B.H`A:ZDU!.X\H3_C+CRGT.RIY^;=&FD!"T018AB1`FB%%&&
M*`]0>,_O*Z[I26&X9XMHALJ<:9`$*91@"V?+C$<3ROBDO4BQ^=@AK\5$D&=+
MI]54;'E2\/"]2'&+N9@G%/I/5](GY@R6S/1PK7&I=S=S1`N'E+/4260D4MSU
M&&TEB%)1]#VCS&<BQ>;SP%;H&5,/^KG>2TSG/_8PME6E_VV<0X'#K)2'%DZ*
M^G?DT>5()/AN8C2=($I%\=BC[2+!IO/`3N@H4Y7YCCHQA5P1)SGZWGR+9G),
MN"CJ+P-8*BR\](;42='C%=SUR"%S]""!"L?4HNA)Z1!,SNI$*E+<B8S-]P_C
M.9D,)U/=A9QE*.5*1[TNA&[7E=@)MV/%1>^R&K>K.D`%S=Q)F9?%6CMEST5$
MBN\X8O-V!E_3<P(3=9`6LU:PX_=NV#Y]PU*=/4A%BGN0A3T8CR:#L3H&R%GK
M6`]"EYMMN3_3?RXEN,V]'P`.!0$`!_=C)W4B`!HI]D/D%.E)31/P`WJ7114<
M,4MTNC@YJP.IV.(.9`YU1V`NBNTS+1P+4T_X8W%B^AMQM=FQR*]NQ@UJ[X&;
MZTY*3J\C5A04,Y**)!'483YE*;&5(<H989$R-B5&XQG:G?S<++6%2K!P6:3R
MA?YZZ=`\>9JF85>^<.;]-.W,NWPQ'DR&JCB/V?:Q:'7YPMGN[$'*MJ0'F4/T
MO)R)D\GM=9^.L,-7-W)6.]:%8)+23ZUU#\5Y!]@',^'D=<B?O(*Z',]24EI&
MB&)&WN05U&$^92DQGR'*&7F3U_ZDG/WQK)?5]LMJOGI^WET\;+Z;GXNCE?'C
MAP;;W[*['_=GIAJB+*.OW,SH=R!:^'1&/W?0PF]G]*9^"Q]0"_3">=L5^B$]
M6Q/IMD=DS&[DU!7:=\TRVD:A-=J?S\P&"Z_0[_5].JP3RM:]:;Y%_GXXHY]W
M0COW(^I4"_\TGGVBP6A1&)-OV_B$?D"PC5_/Z)=-T`Z]F$L];;MR3S=]WWK3
M<[HR;[U"-=<LHF(&VZ$"@ZZTW2+MI.E*V[U0(38S6V:T1O78S.R<\0K58#2(
M;3V@&H2NM/6`WGV>F1<6T1J]`CTS[RWB%7H3>F;><VZ[,J8K;7VC%TOI2MOH
MT(N0=*6M'7KM>V9>S,1VZ.WOF7D_$Z_02^`S\XIWVQ6:XJU]H_=IZ4I;W^B%
M3[K2ULX]M7/?>H7>A9^9]U"Q!_3^^\R\W=YVA>9!:]_H-6*ZTM8W>K&5KAS:
MN6HBD'ZO\FWY954MMU_6K[N+Y]43):C^X3'-K?W%2_O'WCVN^7FSIU^LI/1-
M*S'],NF*GFONFU_U>=IL]OP'=?>J^:W3C_\3````__\#`%!+`P04``8`"```
M`"$`2FQZ3Z4/``!93P``&0```'AL+W=O<FMS:&5E=',O<VAE970R,"YX;6RL
MG%MS(CL.@-^W:O\#Q?L)=#<DA$IR:FCZ?JFMK;.[SPPA"35)2`%SYIQ_OW+;
M:ME2IX&I>9G+UY(LRY9M&9J[W_]Z>QW\N=D?MKOW^Z%W-1X.-N_KW>/V_?E^
M^)\_XM]FP\'AN'I_7+WNWC?WP[\WA^'O#__\Q]V/W?[;X66S.0[`POOA?OAR
M/'[,1Z/#^F7SMCI<[3XV[_#D:;=_6QWAO_OGT>%COUD]-DIOKR-_/+X>O:VV
M[T-M8;X_Q\;NZ6F[WBQWZ^]OF_>C-K+?O*Z.X/_A9?MQ0&MOZW/,O:WVW[Y_
M_+;>O7V`B:_;U^WQ[\;H</"VGF?/[[O]ZNLK]/LO;[):H^WF/\+\VW:]WQUV
M3\<K,#?2CLH^WXYN1V#IX>YQ"SU081_L-T_WPR_>O)Y<#T</=TV`_KO=_#A8
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MZA_4;#LG>J+KP030K=HSH<_AD9Z.S>Q>KHZKA[O][L<`E@SH\N%CI18@;Z[,
MXKS6K;<S_;.)#C-<6?FBS-P/8=1A#A\@._]\"*;7=Z,_(:/61F8A93Q7(D0)
ME3[*[)*#B(.8@X2#E(.,@YR#@H.2@XJ#V@(C"&T;7Y@6OR*^RHR*+T9F@8`"
M[K-@H@2J+#F(.(@Y2#A(.<@XR#DH."@YJ#BH+>`$$Q+E5P13F8'UUYJL_FSL
M1F]A9&`Q:6?TU!4)6Y$VPH)$@L2")(*D@F2"Y((4@I2"5(+4-G&"#8O!KPBV
M,@.+"PQI&\A@>N.&<J&%@KYHMR)MM`6)!(D%201)!<D$R04I!"D%J02I;>)$
M&W9F)]K=YPI<;I5T$U0,QD*3`/;;-LRPW[IA#ELA5%L*$@D2"Y((D@J2"9(+
M4@A2"E()4MO$B2&<4IP8ZKWLZ@84^L.I%-UP:A+X[8(;"K(4)!(D%B01)!4D
M$R07I!"D%*02I+:)$SO8NIW8]0=,2;L!,T2?5]7>'0JR%"02)!8D$205)!,D
M%Z00I!2D$J2VB1,P5=C9!Z?^@"EI-V":!+<TPUIBI7#`]J6E%IK8*Z5_S4Y:
M42N$>1ZWMI$D@J2MEM4^-YVU0F@H%X8*0<I6RS(]8UY7K1":KFU#3O"A.K@@
M^$K:#;XF=O`%66K"(LTVKJ@50I]C82@1)&VUK'!<,]-9*X2F<V&H$*1LM=09
M'.X(`G<+J-KG:+6V;3A!5I74!5%NQ-TP&V3'6:*E01._J1LFWHU_ZSH=D01Z
M'4L[B40I*:IP3+S@>N*:SD@"3>?23B%1B8IN)C+/*Y)"\[5CRPVX*B+L-<7:
MP(XOV_6WQ0XV=Q#J6&L"")XIQ70I`B<N;'*A"EO(`&<<!%H:*9^6I$BB6-I*
M)$JE8B91+A4+B4J#)JJ+:A#%_*A(`KM<.W;<**OJPHYR1S3A.J4-IRY&G'!J
M-(%SA7788OD;JB.O6G8@OTA*K.<DA:Y'$L42)1*E$F42Y1(5$I4251+5#G*C
MK.H*.\IJ+OO3JY-G,74;PE9K@WP(:!O)6[8QAJ@'\[H5\F6XC757BBT*D;$U
M<:1F,W?IB+%%.--3BQ,V#1*4HI-12LA2#)@36;<3;(')T5:O$P5*D1,EH1XG
MJDXG>.QKM/69$^[,4#703\T,I<@V&(/@H-`.P:VX53)")Q*QE:)$U"B`0W-K
MW>?F8W5K!F[YSF21TT"83XTB+!#88F80:Y'=[.1GM5A(\Z5$57>+[-10GVK1
M'6!5H/W4`"M%-L`:N:G/XA&J>WBEYXR`3/U6"L,=&44WSV]9(L9H'D:0IH$<
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M(I5;*1IIC9Q4#L;L[!<;\Z=269A/21%;S`P*X*#8-];:EMNB'&O18DF1P!8K
M;!%6FK9%T<>:7"4IW]J%W-&&0#NC?6*%5N)LX]7(IRP(526C#CJ?S3?SD9V1
MTA^"JYO`"!4)Q8C(?")1BH@4,XER1&2KD*A$1+8JB6I$C2TGI#Z_#6E6QTL3
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M/!%O8Y[.49%1-(>FP)O,)C.QK!DU)YEYRB3D`HV):"]C[8V]FPGK2XZ&>ILK
M4,I>P$1S%6ON=C:]$4O5B=ZY(PM.79(_2IQM70;!,<<:3[%W::E3^6-L4;)$
MZJ2A6B042Y08!.9IK(1B)A5SB0IIJY12E42U@]PHJWN!"U8I<XU@U5+JB`YA
M"*!35I19.1L:*544M%+R_A.E:&6.T+RC.&&+8$R*/>83E++'PG2(6LS.:C%'
M6W:W18<*E*(62T348G56BS4I=O?1'5=U,6"/*]_HS_JPQC?7"_9P:Q1`W-J!
M#,;L+B$TBJ>22MN"/11S(S**_?5-C.;AZ-`Z(8*?H!0%/T5$+69GM9B38D^+
M!4I1BR4B:K$ZJ\6:%+M;=(<;TL,9[A.'#27.%DN-8*7`L0C5Z(&46CP^C_(2
MI:ARB22*$9'Y1*(4$=G*),H1D:U"HA(1V:HDJA$UMMR0JNJ89Y!_<45E:FP[
M@S1BQPQV-Q;">;@9(AB#ON`;*9I=D5&$[;CYGFOW,<.H]8YL0B[@E$@147L9
M:Z_SF'%.<P7:MI-'=*]BS74>,TXTYPZSNA#@P^Q-FZ]E-3=/9U9$^E[!OGJ"
M3ZI-^F#X0D*]@VH4J?*(4)%0C(BR()$H142*F40Y(K)52%0B(EN51#4BF5'J
M"Y0BU!=G5&/%7;L0P;BWN1)X[!HN-%(JXULIL6DLT1:,@27%SAN1D7(O_CQ^
MFL<6G6U*7%*@%,W[]"PGLFXG^"4%FN]UHD`I<J(\RXFJVPE^\D?SGSGAI&0`
M4F*>7)Z2C1DV493E9D=K4])(G=CD4(JF?B11C(C2*)$H142V,HER1&2KD*A$
M1+8JB6I$'2FIK@7XZG=Y2IK+!6N3@^^F-I%V:FF/I5%HI$Y4!2CE3![^A83(
M2+GWAC(EC:O.SB=3TDA1-J1G.9%U.R%2\APG"FR1G"@1]4:BZG9"I.0))]R4
M5)4[GR<_D9+F`L">*!K9YTYU^#]][D0IFOJ11#$B2J-$HA01V<HDRA&1K4*B
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M;'_SF!`MB!U5@E9D7[]G5\N1L052./]B,H\H(=338DJV+"GQ_@-)H?F<S`-R
MXZ?JS`OBI\M29\YHY,1/H"4\5E%FP6(WQ!%)H>NQ09;Y1**4%.W(,/,92:'Y
MW+'E1$:YZD3FIVY/&RMN`6(0M(Q>A!(M#?K\*^412:"=6-I))$I)\;-7#D@"
M3>>.'3=0O%3K7W;4X9PMVX@@H=H#2."Q3`I1"F92*R6STDC9]\D&J>,6*8J/
M#TC1DA(?NYWE1$I2&+\,S8^;*[GIU)_.N`LYRKA'>[K#<,.NSN[G9RZ\NR+"
MKI%[">FQI`E1\3.G]'=J2`I['!ED+B&OX?L;4W;!&:.64XG)F!O7>SU(T1;M
M79GKP228>A-V/9.CUF<>N"%718D=\I];$G1I8Z^AD.7-X#@)(#Y00:D3"6!L
MT?(2&47XEHA*>`_>,6*%8(P2O2%.SG(@)5LX%3*#^C,P)\7N#'3'@I=()U:=
MMA)"IQ83C>RJDU"W!V:N&T7Z5"%"14(Q(JH4$T(]YE.4(EN91#DB63RJ[XK\
M@EDJ:Y?&,-R<03JVZVC@L6HR-%(G[G-0BK(U0O/Z0XOKB3?UV:5)C%HP`*T'
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M6Q6+"!R`Y^J(*W6@?IJKDZY\`F747!UXY1,HG>99IP=0.L"3+@]R&-S.$!2S
MN7H)5+92SN;PBG@'OYW#6\T=W!O/U?NW74\\>-+51@R=[WR00-\['Z30]2ZO
M4NAXEU?P2O)<O70LO8)W9N%)EU<+F!2=#T*8$YT/EC`ENKQ:PH3H\@K>P9ZK
MMZRE5_!6,#QIO!JUDPA^V.QC];RI5OOG[?MA\+IY@E5DW'RBN]<_C:;_<S3?
M=?VZ.\)/FD&A!K\O!3]AMX$OA8_5FZ!/N]T1_P--C]H?Q7OX/P```/__`P!0
M2P,$%``&``@````A`/;8Z!R_!P``D"```!D```!X;"]W;W)K<VAE971S+W-H
M965T,3DN>&ULK)I9;^)($,??5]KO@'@?P.:V0E;A,#8^M%KM\>R`$ZP!C&QG
M,O/MM\KNNQR&2#,/`7ZN^G=W51\N>Q[^^'X^=;ZE19GEET77Z@VZG?2RSP_9
MY771_>=O]\NLVRFKY')(3ODE771_I&7WC\???WMXSXNOY3%-JPXH7,I%]UA5
M5Z??+_?'])R4O?R:7N#*2UZ<DPI^%J_]\EJDR:%V.I_Z]F`PZ9^3[-)M%)SB
M'HW\Y27;I^M\_W9.+U4C4J2GI(+^E\?L6G*U\_X>N7-2?'V[?MGGYRM(/&>G
MK/I1BW8[Y[WCOU[R(GD^P;B_6Z-DS[7K'T3^G.V+O,Q?JA[(]9N.TC'/^_,^
M*#T^'#(8`8:]4Z0OB^Z3Y<36I-M_?*@#]&^6OI?*]TYYS-^W178(LTL*T88\
M80:>\_PKFOH'1.#<)]YNG8$_B\XA?4G>3M5?^;N79J_'"M(]AA'AP)S#CW5:
M[B&B(-.SQZBTST_0`?C;.6<X-2`BR?=%UX:&LT-U7'2'D]YX.AA:8-YY3LO*
MS5"RV]F_E55^_J\QLIA4(S)D(O#)1&RI<<-OQ/S@D_G!MQOVT*.ZL_#)[.>]
MD3V>SNK.WG"<,$?XY`WUK-%@@F.\X39E;K!8F)ME]V;C\6@RF][VG#-/^&2>
MXWL:M"#_]0@M"#ASO"^4%B2P\929O!U,BV<-O["VYG>ES>)YPR_,<W1C>/UF
MSM53>)U4R>-#D;]W8%^`09;7!'<9RT$M/GF;E(CI_-%LAFF,*D\HL^A"LF"B
MEK`$OST.QZ.'_C=8-GMFLZ0VEFZQXA:X1E!V;8*-"5P3;$W@F<`WP<X$@0E"
M$T0FB!70A]"*^,)4^!7Q11F,+X_,D@,9<-L()K?@+FL3;$S@FF!K`L\$O@EV
M)@A,$)H@,D&L`"V8L$I^13!1!C999;+:XYD>O26S@<U`S.BQ;K(2)B+"A&P(
M<0G9$N(1XA.R(R0@)"0D(B16B19LV`Q^1;!1!C872*D(Y'!LA'+9&`UO15N8
MB&@3LB'$)61+B$>(3\B.D("0D)"(D%@E6K3A+"/1ML<]<<3=O1.C4!UO'J=E
M0X9P@HH,V!,C`RMAQ-W6A&P(<0G9$N(1XA.R(R0@)"0D(B16B19>N.L@X;7&
M/;R%:+]-XP<;.NKA;,C0%GOQBI`U(1M"7$*VA'B$^(3L"`D("0F)"(E5HL4.
M3G4M=K<#AM9ZP!AI[E?Q6%\1LB9D0XA+R)80CQ"?D!TA`2$A(1$AL4JT@&%A
MI]Y3W0X86NL!:\AP+F>8(,H2'@[T\VC=&(W43=2>3'2CC3#BZ]P5VIQL"?&$
ME]*^*>T+(RZT(T*!((J0.9!0""E&$^.`CH01;RT6VD"T?$`%\(E\H+6>CX:H
M^2!DW1`C^%,C^,*(]]DE0EM"/.&EAL.0]H41E]X1H8"04'CA'3L\-ACJ'8[$
M=:X:JQI:D+%N^D24:W,]S`RI<:9HS=#(KJN,D36UYWJG-]*"]]JE.EN*/.F(
MX1A9PXE1POC2@DOOJ$Y`4<@=]<5I]#R25EP^UK3T@&/)H6XS3>E6GVG5,=M_
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M]1+?<BMY`^91Y,N65"V26Q8!K45S((&45[1,JU!:\>%&LA.86V.X,7?0&E>&
MJZ<62ZU/I!;-C?.((7WA&D?""A^:W;%PA14?ZX8YLH5KW*>Y[*J^;,T0;F7C
M7-:CR)<M*>F8DM0V7;S=8B#E%2VS7Z&TXOV*9"<PM9.>;00R9@8?MJ]G%RN]
M3V2W*0RUA=L@8^&:93$^Q\?L_F3A"BL^W`US9`O7ZHV-<+M<&:)^:^T298\[
MRN7LR\94+:/%'7?46C13%W"KFR,.I14?<20[@0FV>W-C2L?<1VO_P^6+Y:B:
M8+R[:1Z(_.0$;NI8+=4,Z0O9Z-X*7A'=LY!;K8RYO&%:;&W/>X/Q0/UGW+R[
MS/S#J<_V<=$TC[DG^\R1+YN^.1<:K=LM!E)>T3)G3-AN980DDOW"Z3'JV4,U
M(@/#'%_8838^[&"S&S3OY)H7&N>T>$U7Z>E4=O;Y&[YOLZ=P:@K<O`R,9_`R
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M_TOP^#\```#__P,`4$L#!!0`!@`(````(0!OS3X%6@D``"HL```9````>&PO
M=V]R:W-H965T<R]S:&5E=#$S+GAM;*R:77/B.A*&[[=J_P/%_0%LOA(JR:D!
M_/U16UOG[%XSQ$FH`9S"9#+S[T_+LBRI7X<)53,7`WG4:DEO2T(M^^[/'X=]
M[WMQJG;E\;[O#$;]7G'<EH^[X_-]_^^__#]N^KWJO#D^;O;EL;CO_RRJ_I\/
M__[7W7MY^E:]%,6Y1QZ.U7W_Y7Q^70R'U?:E.&RJ0?E:'*GDJ3P=-F?Z\_0\
MK%Y/Q>:QKG38#]W1:#8\;';'OO2P.'W&1_GTM-L6ZW+[=BB.9^GD5.PW9^I_
M];)[K92WP_8S[@Z;T[>WUS^VY>&57'S=[7?GG[73?N^P743/Q_*T^;JG<?]P
M)INM\EW_`>X/N^VIK,JG\X#<#65'<<RWP]LA>7JX>]S1"(3LO5/Q=-__XBQR
M=](?/MS5`OUO5[Q7QO=>]5*^!Z?=8[H[%J0VQ4E$X&M9?A.FT:-`5'D(M?TZ
M`O\Y]1Z+I\W;_OS?\CTL=L\O9PKWE$8D!K9X_+DNJBTI2FX&[E1XVI9[Z@#]
MWSOLQ-0@138_ZL_WW>/YA;[=#B;N='[CD'WO:U&=_9WPV>]MWZIS>?A_8]7X
MDE[<Q@M]-E[&L\%T/AI?XV3<.)FT3FX&<V=T.YY31RXT3J7U$.BS:=R]W-M9
M4X$^U9@G`V<RFHD17VAHWM2CM=,QR@L5;YN*]*D:G&MY+E1T:#[(\&AE/R>*
MH]047SXGBT/"R\9T!)Q+P@SE7*JGYGISWCS<G<KW'JUWDK]ZW8C=PUD(KVI2
MRI&VT_2C64K34WCY(MS<]TEUFG\5+:WO#S/W;OB=5L.V,5FBB6-;K)2%F/K"
MZYH#CP.?@X"#D(.(@YB#A(.4@XR#W`!#4K:5E^;"[Y!7N!'R*F66"FB]F=PK
M9:&JK#GP./`Y"#@(.8@XB#E(.$@YR#C(#6")2<OC=X@IW-SWZ?]VKKK3&WLJ
M+AL;6M.MT=0V6;4FK<)`/"`^D`!(""0"$@-)@*1`,B"Y22RQ:2_X'6(+-[2W
M4$A;(6%GD#;C2V*W)JW80#P@/I``2`@D`A(#28"D0#(@N4DLL>G'S!*[^TB@
M-EMA76NJQ%A*,J9=J%79G=ZR"=L:J6IK(!X0'T@`)`02`8F!)$!2(!F0W"26
MAG1$N$)#86UK*,F$8J0UG(V8AJU1JR$0#X@/)``2`HF`Q$`2("F0#$AN$DM#
M^@&W-!2G`7<Z(,VO/`\(1[:\DHSI0&;(RT\`K5$K+Q`/B`\D`!("B8#$0!(@
M*9`,2&X22UZ1R?'#UI06[97B"C>VN)(P<?F)H#5JQ07B`?&!!$!"(!&0&$@"
M)`62`<E-8HE+)W9+W,M[J+"V-92$K?\Q6_^M4:LA$`^(#R0`$@*)@,1`$B`I
MD`Q(;A)+0Y'$7"%B;6ZKV"`V%2=,1FW5ZHC(0^0C"A"%B")$,:($48HH0Y1;
MR)94I`;FHK\\+QV92="!22FS;!"3E!]'M96JN$;D(?(1!8A"1!&B&%&"*$64
M(<HM9$LJ$@134IFT#L3EPR_4E:F%I:Y$8RWX2IQ6:7,PT!J1A\A'%"`*$46(
M8D0)HA11ABBWD"VE./^;4OY"/YDND#\UR9;BTD+LI$Z+5HC6B#Q$/J(`48@H
M0A0C2A"EB#)$N85L_<21_@K]9`9@Z=<D!;>&?BTRSDIC=A1=B]L:$GYBIDWN
M;&;OM)ZV4A'S&S36+0:(0EW1Z`1W'VDKY3Y&7XE&AB\^H%3[,JQF+#//M)5J
M,=?N"=GA$=G"%>&1R845'HD,L5;BSE9L#UJ_=8-8+.8\%K(B6:FN^^@K0!1^
MRGVDK93[&'TEB%)=45S<T5,!=NK)M('RG%MN;,U%=G&%YC(9L327R!!XY0!:
M-VCBUM>-$V?NLH37TQ:JVS[Z"1"%NJ(09.*,9^P`$VD+Y3I&/PFB5%6T5RWK
M>::ME/O<\F4++O(-4W#CY_#\LMM^6Y:4<M&YHF-O'Y-XS0VNS%JL.#2)C)[H
M*P?0ND&NMO(0^5@Q0!1BQ0A1C!431&F#)F*((H@P/S)MH54VQV>K+!(/4^4.
M->FA1"NGS%,L.1M$'SH%GK-M?>4T5G1&UU9\KUQK*]5UKT'C63U>9\0V3K\I
M%P]<M.,YR\`#=!PBBG1;IB^6<,:=+?*A)-J]X8M;I=I*#3C3G1`!OF'CS3M;
M-\9K1U>D1%=$5V905G0E<NGL:,C+=M*5TU2T@L`'N]96:K!>@R9.'5TV:7Q5
M@8X$1N,0V[9QY394%?7I+=(MF;X@MHTOJT4^D$2[-WQQJU1;J7YENA,BMFRX
MN:I@-?Y1:-WK<MK:W,YI%;(7+OM)6"DK$D;'@(]UK:W46+T&-0N7'>#\IM1>
MMMQM@&Y#1)%NR>CBG(?V4RTFVKWAB_<KU59JN)GNA`CM;.`R(?-?M6\M7*'+
M%0NW-F?1%1[HFM->N#R]5A4O+UQMI8;K-:A9N,Y@RN3V59V/)G/]\QPH*[U0
M0T21;LP("@98CE@<FS^>J8EV?\$JU59JQ)GNA`BP.[AE4SI7=:SV/UR^(ADW
M=V9])WWY%U@$5"2F1JZJD+V06?=6RNH7"[EQ;UNQN>PUOIJU?3L834?F/Y8A
M^(VY$.CCR`2Z@TKS$%&DFS9\X5R0P[C<8J+=&[YPL7]&DDSW2TR/R<`=FXJ,
MF()Y8_YA!^W=@%]GZ,ERY1V[BS<=#;+OX>8LA"MMI8*S1N0A\A$%B$)$$:(8
M48(H190ARBUDJTT+^(.E>:W:PA-;JQ(QM=DA;T7O:]6Y^$V;4J\1>8A\1`&B
M$%&$*$:4($H198C$"VAZ0%)M^4*9?&OG4)R>BU6QWU>];?DF7A8;BYRCQ?)-
MMJ4[4:^R\9*;!3U!H9G)^>V"G@IT<&>T$)?;727TNIR\]>.^')=*ZFV7E[AC
MZM>XPQO=X5"=^@475H?>ROO2Z4LTW^%I28UWVE/372U_F9#_^JT_UO"2>M3)
MIPMZ"-TAR&Q!#U8[^'Q!3P21TT790J2R6$+W90N1T6()W9$MQ`U85\F42KKZ
M15<.5-+5,TJ1J:2K';HC7(B4'=NAJ\*%R-RQA&X,%^(^L*MD2B5=?:.;%BKI
MZAM=!5!)5SM+:F?96;*B$G%#@3V@R]*%N`KM*IE225??Z(*)2KKZ1E<>5%*W
M,VPG#;VI^;IY+K+-Z7EWK'K[XHD6YZA^)G&2[WK*/\[E*VUT]+IF>:97-.NO
M+_1.;D'ONXW$@_:GLCRK/ZB[P_8MWX=_````__\#`%!+`P04``8`"````"$`
M$"H!:;@(``"Q)0``&0```'AL+W=O<FMS:&5E=',O<VAE970Q."YX;6RL6FUO
MXD80_EZI_P'Q_0"_)8!"3L'8O*B5JNK:?G;`)%8`(]NYW/W[SGAGO3N[CB'1
M]<.Y>3SS>-YV=M;X[NN/XZ'W/2W*+#_-^LY@U.^EIVV^RTY/L_X_W^(OXWZO
MK)+3+CGDIW36_YF6_:_WO_]V]Y87+^5SFE8]8#B5L_YS59VGPV&Y?4Z/23G(
MS^D)[NSSXIA4\&?Q-"S/19KL:J7C8>B.1C?#8Y*=^H)A6ES#D>_WV39=Y-O7
M8WJJ!$F1'I(*["^?LW,IV8[;:^B.2?'R>OZRS8]GH'C,#EGULR;M]X[;Z?KI
ME!?)XP'\_N'XR59RUW]8],=L6^1EOJ\&0#<4AMH^3X:3(3#=W^TR\`##WBO2
M_:S_X$PW[J0_O+^K`_1OEKZ5VO_WRN?\;5EDNS^R4PK1ACQA!A[S_`5%USN$
M0'EH:<=U!OXJ>KMTG[P>JK_SMU6:/3U7D.X`/$+'IKN?B[3<0D2!9N`&R+3-
M#V``_-L[9E@:$)'D1WU]RW;5\ZSOC@>./[H!Z=YC6E9QAHS]WO:UK/+C?T+&
M(2;!X1('7(G#NQD$MR//^0")1R1P)1)G,`X"_V9\>[TE/I'`57HS\-W@=EQ;
MTN$"/*(.`USETYTF#!UZ-Z0'5_G`J\-V2[IPE<_\N,>PCFO#X2H-&+CCP`GJ
M!'98/B%%N)+B9'#KC"8>AKM#SX$2%16#M4KE<+7=0U%^=34ODBJYORORMQZT
M"*BP\IQ@PW&F^`A9Q\*2IK+?*VRH:&1Y0)I9'R(*15O":OQ^[P7.W?`[K*`M
MR<QM&4,BE!*X7)!V80*1"<0FL#2!E0FL36"C`4,(2Q,;6%>_(C9(@[&17LTE
MH(+E\E"%4D*J+$P@,H'8!)8FL#*!M0EL-(`%`GK#KP@$TLSZ\&]3)*YWRSV?
MDPQ48B,4<)&P$6FB8R&1A<06LK20E86L+62C(RQ(T/M^19"0!A8CI*()@!<8
M]3$70EY7E!J1)DH6$EE(;"%+"UE9R-I"-CK"H@1-CD6I?;^4;06EZV!()^:$
MB(T0>T1H(0L+B2PDUA%F(.PHS$#1$`?8G:OG;/LRSR$OT#%:#/>@\8EVB"3<
M;D)4%P@;1"7:]4:\UA=""`893<@WJB%JA&24XH8;$.8==&CF78L7,#M(-U":
MNT$(['I-=;J^QXT.28@9;7DFA%R(I&+R?,X4"2$/UIP2\@VAN)5)!9+YC^.W
MN=VYP0"2VQT)U..1$(@'A:Z99K8J4N-.*M/$)M<(R?1%`G&QGK[?N\$(_^.1
MB4F)/5Z+,7,:$L&<[G85I;FK`O%P!<C=W3&S$)(:7!HANYP;H<95XH:"56K^
MC>&L$.*UXJN=@SF+0PSS]E,+N&;A42"(9=P)C+R$4K$[Y4JJ"01!E'3'O34C
M'$NEJW+N@`$L#-U)K\4-?Y$!CB5^,[B$)`60EBVMZFAH(T5Q[,$>'4E%!<42
MJNEY!G$,T1?I!=/%U`([IHSE''=/K&%8)%I5C7E5A23E0O]04K8WQ%6?)6L'
M(ZDX$NO3'=_XXPDGCZ7,>W7`/<:AX@,>BQD$'J$\IK&$9<8WC`H=4KS@,4FI
M/38B12K.R=BN3=)AS]=BR=T%J8^XB^)&;0J(M23HDSP'H2.D+B68Z/4$DR(E
MV(&SC'%4B27W=?G%:>,#^45QPV$!L>;CFB>L$%]`H.*%_)*4GE\!R>;3MN%(
M;@A-ZVKA&<8!1'?X<TV8QAB]S@5D)-X8B$)'2%U*/-'KB2=ZN"@G`V.^B24]
MR_V[^Q&.)WHH+G0S%#=R+R#6B!M(LU-;;M2(24IUW0A+`^AAQI.M(Y902R/&
M(4,W_7-9I%%%SZ*`7&BM6IB-N2[$]GU%-9,4KTN#*R(N#]Q73[2[6"N7:BN\
MQG$JZ8K.M_P,B;PT63HT$^GAH7E'WWD;2+/?3CA)C9OL1D3O*BB6D)UPMWUV
MDN^EKGX;5//41:RL]<QE-">ISE.LDI'UNK"AR(9B&UK:T,J&UC:T81"K`1Q)
M60UT+^Y:G"]N":EF'-K0PH8B&XIM:&E#*QM:V]"&0=QG'(CTNK_@,\U/6GWC
MNL>%K?LL($^5Z8*D-"BRH=B&EC:TLJ&U#6T8Q'W&\>8#/M,TI/LL($]M-B'L
MMA@&@-0JL8],).7K[WI<SQA'(B4EUTFLZ"6T5%#'$U>*2Y,*C*/M6DE)^HVB
M!XC'#P<J/7Z?VDGPW(%UHX=50"RL%K0@1?%[D)CA;2@F2.-:VM!**=:'\Y%C
M3`=K):`"HYO$`X.#EQZ8"XN)1C<]`@3!UJ5VML`X08?X@Q"&[D*M"2E<^XK+
M>BE#7!?>RI"4P:7VTCH-RZOL6K5+&7O\6CZ1IO;ZM0D_$6RD"'=0&<5S@\.@
MGIO/%2U-F7K*!(3M1H4Y4.\SZM"$+BF^9ZN8\:24FA4B@B[,.DI1,\*<*)92
MJM.(E9*2);\F"%J"6":>?4;>2#58'2H.F@D\&SBYZMFXL%+$H,MZ!<V^*E0A
MGA!@6>"2;;6`8DQ2:FB.I**"8@DI^J6".NA74DIQK6UH(Z&6J0VG5CTRGZM3
MFGWU.A40I$FF-80YL@X81*0K8"3%J\98KQ%Q7>HCK5QJR5(?N<:N%3W1Z(*&
M76OI8\?KG8V4X1XJJWCIXEC>E:#K3@KX*X"Y_0D(ZE=EJ($Z,T12:MZ*B!X\
MDURQA!3]4D$=]"LII;C6-H3?9]#J@R>*B(GO+<0OU,>T>$K#]'`H>]O\%;^E
M@,3=WS6P^-`#I@[XTJ.VT+@#GX`\U-5LX'/X-*0>/4W<!2)TWL3A`5X+_N!/
M'\"B%@5_"C^`V?B#.P*+6C7@#AXS;)W%S11^W['QT'6G./S:=V#^!:ZV.W,(
MU;PU5#"+3L/6.PNX$[7>@0$3+&CS$^;,*8Y.MFTP6TYQ<FR[X\.=6F?8Q!\^
MF#DG3^F?2?&4G<K>(=U#$8SJW^(*\<F-^*.BD_9C7L&W,E`G\!T#?!J5PJOG
M$?ZVL\_S2OX!CQXV'UO=_P\``/__`P!02P,$%``&``@````A`&#L)PV>!0``
MAA@``!D```!X;"]W;W)K<VAE971S+W-H965T,38N>&ULE%E=CZLV$'VOU/^`
M>+\!`YL$E.0JV]6V5VJEJNK',TN<!&W`$;!?_[XSM@';0'!>LF$8S_&<&1\[
MWLWWS^+BO-.JSEFY=<G"=QU:9NR0EZ>M^\_?S]_6KE,W:7E(+ZRD6_>+UN[W
MW<\_;3Y8]5J?*6T<B%#66_?<--?$\^KL3(NT7K`K+>'-D55%VL!C=?+J:T73
M`Q]47+S`]Y=>D>:E*R(DE4T,=CSF&7UBV5M!RT8$J>@E;6#^]3F_UFVT(K,)
M5Z35Z]OU6\:**X1XR2]Y\\6#NDZ1)3].):O2EPOD_4FB-&MC\X=!^"+/*E:S
M8[.`<)Z8Z##GV(L]B+3;''+(`&EW*GK<NGN2/$:1Z^TVG*!_<_I1*]^=^LP^
M?JWRP^]Y28%MJ!-6X(6Q5W3]<4`3#/8&HY]Y!?ZLG`,]IF^7YB_V\1O-3^<&
MROT`&6%BR>'KB=89,`IA%L$#1LK8!28`GTZ18VL`(^GGU@T`.#\TYZT;+A</
M*S\DX.Z\T+IYSC&DZV1O=<.*_X03X9,2L?C4GM(FW6TJ]N%`O<&[OJ;8/22!
MP.V<1(1NEE.3A-EAD#U&V;HKUP'\&IA]WX61O_'>@8U,^CP*'_CL?$CGX<%L
MNBG!--0IC=/3(J,S(B-=.)5'85!A@G&8\!X8=`:^U<FOHRZN0!8^D>+ST'EH
M"8*+?8+H#,6!M#K>PJAG3D`+)PMH:!1[:'3FT!VYTJ+S$(]GN=2AL+.""$;>
MKB>.TC&E1:THB?OFTIB%#E33X]T<K'$YS<#B0!U66G38GG<-%A7:7$0Q5.QV
MJCA*QY06'7.B?>,1S%5LD2H.U&&E18<-QZM*0/;47&^GR+TYF-J]?4:B>Z67
M1?L2F.,=Z.BMI\H#@$GKX+A?R5I9<=&I:+R=YNO*AQFP4I5TBB?D`2>GPLY0
MC-X#BOOJ28J%EPW%J"5*,\^@H[>1JS3I%"\GVLD0)*0X\N,%+/H9X*$XX5Z*
M<]%)7DT`C\@3L9(*,I2HUJ0CKR>0QT3*#Q:K69$B0Y5J33KRA"(30Z=F&.[T
M25V[_5*1C26\;!IK1+$"R&AF%D.Y(M*D-A@<9<?9#@R]XMO0FECH)!^IMW9K
M4MD._(E-(0`O=2%Q]5C"B6TN93[0`,981FL'?J^CFFP%([(5^DN+!N,C#>01
MY0K\7EYT9%0913LXV61ED;*0)U#.[J@12!/0U1U\`K]O/QW8$"T.O+0I\E"_
M`FG2BSRAU7BR,#,F5HN9CS2XQF"#*D\H9S`B8`_$ILA#_>*Q!L`3RHEK5DWY
M]OKEWCS-OHQ1KT]"1*23A8@$=TD8]S8XEJJFB\>$5`<CDF6W2?"1!K*4+;VO
M>BJTA@X-V;I-,O?6T5K3DO_Z4W]>A2.Z%`/<#(14(&6%\D"`JB5$)G0X-$1I
M!DVJ#OSI%G\8]6M0M`V/"><%Q:EWT>D<$Z;9O2<<JE)KTMJ'3.P`(2J)(8=V
M[<-'&@4=DR4RL06$8[)D]>N`CS20QV2)3&P!H2%+,W7NM$BM<Z]XLL["RZ;.
M=VE3B-Y&KM*DUW=BUPD-,>([O-49DH\TD*4PZ:MIJI\-89IA62J/OIIZ>9<L
M"R\+EJ.[Q(E[Z[FV)IWEONS:VHU&](K,_PKCPPQ8J6$ZQ3T/.NQ=@A6-"E:_
MK0B*I9<-Q2@]BG3<+C!>JQB-W)ITBOL)Z;FBMBAH_/@4\FO(F6T![DL'R-*D
MLVSN<^*65%Q%%K0ZT5_HY5([&7O#&U"X$=AM.K.\G@V#9`_R!"?$P9LEO%F/
MOHF3/73"R)@(HHG;7C,:2?9\ES/M4;*/QR(1/]F+DZLY@H3PAM]-#MZL`83O
MS>:;8`6YB#O;[A7<`E_3$_TCK4YY63L7>@2.?'[6J\0]LGAHV!6X@[M@UL#]
M+_]ZAOM^"O>B/A["CXPU[0-0XG7_0=C]#P``__\#`%!+`P04``8`"````"$`
M?QX=Q'P)``"Q*P``&0```'AL+W=O<FMS:&5E=',O<VAE970Q-2YX;6RLFMMN
MZ[H1AN\+]!T,W^_8DNS$$9)LK-@Z'U`4N^VUXRB)L6PKL)QU>/L.15$DYU><
MI.A-''^:&9(_CT/KYL]?^]WH1W5LMO7A=NQ<3,>CZK"I'[>'Y]OQO_X*_UB,
M1\UI?7A<[^I#=3O^737C/^_^_K>;G_7Q>_-25:<113@TM^.7T^G5GTR:S4NU
M7S<7]6MUH"=/]7&_/M'7X_.D>3U6Z\?6:;^;N-/IY62_WA[&,H)__$R,^NEI
MNZE6]>9M7QU.,LBQVJU/5/_F9?O:J&C[S6?"[=?'[V^O?VSJ_2N%>-CNMJ??
M;=#Q:+_QD^=#?5P_[*C=OYS9>J-BMU\@_'Z[.=9-_72ZH'`365%L\_7D>D*1
M[FX>M]0"(?OH6#W=CK\Y?NG.QI.[FU:@?V^KGXWQ_ZAYJ7]&Q^UCOCU4I#;U
MD^B!A[K^+DR31X'(>0+>8=L#_SB.'JNG]=ON],_Z9UQMGU].U-US:I%HF/_X
M>U4U&U*4PERX<Q%I4^^H`O1WM-^*H4&*K'_=CETJ>/MX>KD=>Y<7\ZNIYY#Y
MZ*%J3N%6A!R/-F_-J=[_1QHY72@9Q.N"S/H@5Q>+^7QVN;BB(&<<Z6E;.GVJ
MTJF>B[DSOQ3%G_&\[#SIL_-<7,S<^=6BK?<9QZO.D3Y5D4:#SSC2C&GK2I^=
MXR<;>=TYTJ<J\9.-=&@XM&6*?[[63$=UK/A'%?NYACHT%F2I>E!\LJF.&@GB
M'U6J][F.<6CTR&+U,#K?IQ,YEMNIL5J?UG<WQ_KGB-8;:G+SNA:KE^.+L&I2
MR-[MI\E[LX2FAXCR382Y'=-`H0G0T-3^<><YUS>3'S0=-YW-/=HXML5268BY
M)\*N.`@X"#F(.(@Y2#A(.<@XR#DH."@-,"%I>WUI7/P_]!5AA+Y*F7L%M.`N
M$U-9*)<5!P$'(0<1!S$'"0<I!QD'.0<%!Z4!+#%IIH"8'LWWX15<C4WA16NU
M.3;=J2W6?6=#L?H!/+=-EKU)+RB0`$@()`(2`TF`I$`R(#F0`DAI$DM;FON@
MK=@=O[@0B#"TEE`/]D+B2B"-1,_U1ESMWJ17&T@`)`02`8F!)$!2(!F0'$@!
MI#2)I38):ZE]?@0+ZU94)<:])!ZM.KV"GLN7T]Y(N:V`!$!"(!&0&$@")`62
M`<F!%$!*DU@:TGGF"QH*:UM#26;41X:&?!7MC7H-@01`0B`1D!A(`B0%D@')
M@11`2I-8&M*.;6DHMG]W?D&:?W'>BT"VO))X=`8TY/78HMH;]?(""8"$0"(@
M,9`$2`HD`Y(#*8"4)K'D%:FC>;HZ/\V%M:VA)+/+?M]?`ED!"8"$0"(@,9`$
M2`HD`Y(#*8"4)K$$HX._)9@8C]Y"Y&-?'9`BDBVF)&Q`SMB`[(WZ`0DD`!("
MB8#$0!(@*9`,2`ZD`%*:Q-)79$>6P.='9&MNJ]@AMO7P[5M;]3HB"A"%B")$
M,:($48HH0Y0C*A"5%K(E%4=_<Y++%.I"Y/,?J"N3!CHL*9'N10I*P];3:(EH
MA2A`%"**$,6($D0IH@Q1CJA`5%K(EE(<_$TI/]!/Y@F6?AV2ERXBAUR*LZA8
M"31:(0H0A8@B1#&B!%&**$.4(RH0E1:R]1.G^R_H)Y,!BJ?'7Y<?7/=H*>XG
MQ)"D-:7?R%V/)5"KSFIFGND]]])>70-MI4H,=7B%(D2Q=M25\'@E$FVE8J48
M*T.4:T<S/#NL%-I*A2^M6'9?B+/_%_I"I@I67W39@]D7@%;BTH:ZAPE_Q87O
MK535P\Z1^E6A"%$\&-YCF4:BK52L%&-EB')T+!"5EJ.MLL@.OJ"R,&?[F42&
M#$N1]LH1KUJSZA!3><%5EHYDI1Q#C!4AB@?#>RP72;25"I]BK`Q1CHX%HM)R
MM%46^<,75);IAC66);)4!K1R)&(JLWO$0%LI&<(.&>$C1+%V-&:YRSHQT58J
M?(JQ,D0Y.A:(2LO15EFD$:;*QD'B]++=?+^O:0&F`\+`KNC1G6MW$RN3$4O\
M+C_1,WWI`%IUR-56`:(0'2-$L78TE68=F6@KK334*\/P.3H6B$K+T59:Y!^F
MT@.*4LK12RK3%4O2#M%'OREZ'D\FG,[J@ZUST(K%"KI8[K2]77==Q^.7F*$R
MH2'25PIVZDA72JD>:V0ZLAHD*KRLP6(Z=:=L?T^5R=D:9+HX58-<HS,U*%1X
M60-GZCIS?L0HE<U[5;`'@DB4S(&@[S\^&!(RP[*&A$0>[;2]^LZ<B;AT.L?W
MJM?][M%;*86"SG%F.GH>R[M"%=ZLA#MCIX%(6>DC<:Q0^_MK6XFD0QY-R;Y!
M[HPU*-6.AA4_F67*2I>8(RHZ=+Z-I7)\KXU6#]-\P1ZF?6+T^16U#6$?&CKD
MT7[?2^-Y;#8LE:,H3?TL!O-QU5FY6II`A:>3MW;DRH?:T;#BRD>Z$FHHQ8@2
M52)MP'V)GL?&33I8(A]=&8;/$16?*K'\J$2[KVEN6+/Y_!PFQ?EAL$/R+81V
M%BPUTLH,=**,19N&4CE0CAJ%"NE)%B&*%=*.":)4(1TK0Y0KI&,5B$J%VEBV
MI#PC_Y_.)"XFZAT2'\:`8V>QI7*TEB`^Q%?*REP:7;X9!ZI$<53Z<>=,K^;7
M;'R'*I"ULO#B(F6E?XV-%;(=V5*9=%8?+*C#L5B^G2DK78E<H;,R%)V5^[X,
MI0IDMT;7P!XAXGJ`;Z'.O+W^:M?8O^K7]TZMQAF+Z@.342)K,O9(CYJ!R=A9
M+8S)""CL2C3"1XABA72L!%&JD#D9^ZJJ%2%75CI6@:A4:&`R4H=84G^PO@ES
MMF])9-^!>^Q<OB1)VOQ7UW.%*$`4(HH0Q8@21"FB#%&.J$`DWBK3#9*C5[XE
M)E^%V5?'YVI9[7;-:%._B3?`Z/[U[J;'\O4TNIOUQ=TE=2=_XL[4FVO\R=RG
MWR\'/"Y]^DUN@%_Y]&/2`%_X])O)`+_VZ:Y_@#M3JFM[#<%J1!=B?DJ9$?K0
MO9@ODBU\0M=CODBP\`G=?U$Y0T_H9;YO[;TB*_]>B#@0Z=XE"8<X%>`-\&\S
MBM].$5X`]<40IXM&7V2OV`BZ;_1%$HM/Z-K1%Y>*0T]F]&2H'+K+H2=#G4[W
M#_1DJ-LI7Z8G0S6XIQK<#SZA>UE?I/%8-[J+]<5-Z]"3&3T9JC5=<-&3H5K3
MI0P]&:HUW1C0D[8&D[X3Z(7)U_5S5:R/S]M#,]I53S2=INUN<)2O7,HOIVY7
M>*A/]*IDNT&\T*NQ%=W83\7/ST]U?5)?J"&3_F7;N_\"``#__P,`4$L#!!0`
M!@`(````(0!BA5>J)`4``%P3```9````>&PO=V]R:W-H965T<R]S:&5E=#$W
M+GAM;*Q876^C.!1]7VG_`^)]0C"0#Y1DU(00B':EU6IF]ID2)T$-.`+:M/]^
MKC%VL)W2=-6787)Z?'SO\?4U>/;]-3\9+[BL,E+,37LP-`U<I&27%8>Y^?-'
M^&UB&E6=%+OD1`H\-]]P97Y?_/G'[$+*I^J(<6V`0E'-S6-=GWW+JM(CSI-J
M0,ZX@+_L29DG-?PL#U9U+G&R:P;E)PL-AR,K3[+"9`I^>8\&V>^S%`<D?<YQ
M43.1$I^2&N*OCMFYXFIY>H]<GI1/S^=O*<G/(/&8G;+ZK1$UC3SUXT-!RN3Q
M!'F_VFZ2<NWFAR:?9VE)*K*O!R!GL4#UG*?6U`*EQ6R700;4=J/$^[GY8/M;
MVS:MQ:PQZ%>&+U7G_T9U))=-F>W^R@H,;L,ZT15X).2)4N,=A6"PI8T.FQ7X
MIS1V>)\\G^I_R27"V>%8PW)[D!%-S-^]!;A*P5&0&2"/*J7D!`'`OT:>T=(`
M1Y+7YGG)=O5Q;CK>8.)Y[F@R!IE'7-5A1C5-(WVN:I+_QUA-2D(%M2KP;%5L
M;^"-AXX-D]XKXK0B\.0BGX_$;47@V8J@`9IXMC>BD?2D`']MC(`GG]V^;^2H
M'3F^COQ\W+`?F^GA*>(>V\.I0U>A)^QI.PZ>/&SGOK!MJ#6V]+3HVE6].W"+
MU5%3ED%2)XM922X&['4HE.J<T,YA^W0*7I`L!U&B[U4HE"95>:`R<Q,LA=JK
M8%N]+!QW.K->8"ND+6>I<VR9L>(,6O=4-E"!M0J$*K!1@4@%8A78=@`+;!'>
MP/;X"F^H#/6&9[7DP-4LI!C!&7Q(H`)K%0A58*,"D0K$*K#M`)(1L,6_P@@J
M`PVK4R0(3>3,ERT'*E%4DB=35H(BW-&0M8:$&K+1D$A#8@W9=A'))&AA7V$2
ME8'-"$LA#'"\H6S!DI&</I<$1;BD(6L-"35DHR&1AL0:LNTBDDO0'B67;A]\
MO*U0=F,&3V+9(NP\HSUBI2&!AJPU)-20C89$&A)KR+:+2(G",2,ERAKK@)X/
M]3%+GY:$'=,W#'"@@;*V2D7D_%ODVDU6`KD6#'*4@@D8"<&Q(ZH*.4K[70L2
M=SL4VAS9"*0KI,P6":$N2>EQL2!Q[:W0!D3R$LX5R<L;GL'K`C>-LF736@0.
MZT[VCKRG5BU)MDC)++A)<F6E-2.A87,.NE//F4S&"B=L.7#T=$)29MO<G$TA
M13=)RG2Q%-(839%MC^2HMQ]$)"T(_1S1WQH^6=Q41%XGAJ!N[T..VO[;8;W.
M!8+$BVO=:M.]!2\GSGCJ>DH%A.T@Z%T]:R*4>TB1(/'I8WGZL>VBL;H`'TPO
M+0!4J;0`_3N"LF6G&8)<\5*R$DA/7D%+8E\FM/NN-2040CSWC4!ZI"--*-:0
MK1!2&P1]<Y7\^%_=ME&1?6HA-+H:Q2'8+^^72<"U(.0.2]F6:Z[%6H6'IO;$
M06-Y8X:<U%OQ&\[J#2NZ*ZR8:[&P;!ON")RITK^WG/1>6%*]PC=U_P+](&=P
M_L//#"JCK!"#NJ7<3#8W`>IZK_3-@+,F8FG7.A1RZ+I3-E>H1S[BK*M\K$/T
MKH$FQ*)GCK&[`_:1EN/R@%?X=*J,E#S3>X$)]"^!LCN+8.3#T0U;0L&CD0^'
MK([#'<<#NH$OZ=W'+1SY\&6@ZRP=']Z&=?S!]1\@+_T/2]>'%T/`+1$IW&V<
MDP/^.RD/65$9)[R''(?-05*RVQ'VHV[+XY'4<*G15,H1;K$PM*#A`%ZI]H34
M_`>=0-R++7X#``#__P,`4$L#!!0`!@`(````(0"[5_Y_,0$``$`"```1``@!
M9&]C4')O<',O8V]R92YX;6P@H@0!**```0``````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M``````````````"<D4%/PR`8AN\F_H>&>PMLSAC2LD3-3BXQ<<;%&\*WC5@H
M`;3;OY=V79W1DT?ROCP\WT<YWYLZ^P0?=&,K1`N",K"R4=IN*_2\6N0W*`M1
M6"7JQD*%#A#0G%]>E-(QV7AX](T#'S6$+)%L8-)5:!>C8Q@'N0,C0I$:-H6;
MQAL1T]%OL1/R76P!3PBYQ@:B4"(*W`%S-Q+1@%1R1+H/7_<`)3'48,#&@&E!
M\7<W@C?ASPM]<M8T.AY<FFG0/6<K>0S']C[HL=BV;=%.>XWD3_%Z^?#4CYIK
MV^U*`N+=?FH1XC*M<J-!W1[X_LW760B[$O_.2B5[.R8]B`@J2^^QH]TI>9G>
MW:\6B$\(O<K)+*?3%26,SA@EKR4^M8;[?`2:0>#?Q!.`]]X__YQ_`0``__\#
M`%!+`P04``8`"````"$`R5[,.=4"``!F"0``$``(`61O8U!R;W!S+V%P<"YX
M;6P@H@0!**```0``````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M``````````````````````````````````````````````````````"<5M]/
MVS`0?I^T_R'*.Z10F";D!K$"8A)CB!9XM(QS::PZ=F:[%>6OWSE9FP1,U?7-
M/^[.WWW^SF=R_EK*:`G&"JU&\='A((Y`<9T)-1O%C]/K@^]Q9!U3&9-:P2A>
M@8W/TZ]?R+W1%1@GP$880ME17#A7G26)Y064S![BML*=7)N2.9R:6:+S7'"X
MU'Q1@G+)\6#P+8%7!RJ#[*#:!(R;B&=+MV_03'./SSY-5Q4"3LE%54G!F<,L
MTU^"&VUU[J*K5PZ2)-U-@N@FP!=&N%4Z($EW2B:<21ACX#1GT@))V@5R`\R3
M=L^$L2E9NK,E<*=-9,4;TG8<1R_,@H<SBI?,"*8<PO)FS:0>R\HZDSYK,[<%
M@+,D08-FL1YV;;MC<9(.3VL+'/4M?80&"6[T,4Z%DV!_Y_?,N`#DX6D7<XVB
M0=P`6M\B16W0*^60+_I3-;<M=!?Y)H>QQHM6%C**(ZNER)C#B0\PUN4>+D=!
MGP?@&A6-D2>>Q9V,CH.16L#\/6"NRWU\AL%S[IA;&*`ZI[ZF:I7V[C[`H%V4
M)3,K[V/%3`DL+!:,_0`98#V^2*"8!/+BA!]7!G(P)N@R9K:H;X7[`?Q9B"7J
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M0&ZP/1OI@XP+IF:0K6T^;O@?Q5/S;4J/3@X'PP%^%CIK)&D_2.E?````__\#
M`%!+`0(M`!0`!@`(````(0`=?[]DX`$``+H6```3````````````````````
M``!;0V]N=&5N=%]4>7!E<UTN>&UL4$L!`BT`%``&``@````A`+55,"/U````
M3`(```L`````````````````&00``%]R96QS+RYR96QS4$L!`BT`%``&``@`
M```A`.C!R>??`0``JQ4``!H`````````````````/P<``'AL+U]R96QS+W=O
M<FMB;V]K+GAM;"YR96QS4$L!`BT`%``&``@````A`!7Z1Q-L`P``-`L```\`
M````````````````7@H``'AL+W=O<FMB;V]K+GAM;%!+`0(M`!0`!@`(````
M(0#+PJ%BS@4``,D6```8`````````````````/<-``!X;"]W;W)K<VAE971S
M+W-H965T-"YX;6Q02P$"+0`4``8`"````"$`S;2T,4D#``#1"0``&0``````
M``````````#[$P``>&PO=V]R:W-H965T<R]S:&5E=#,P+GAM;%!+`0(M`!0`
M!@`(````(0`IQ!,%;@4``+89```9`````````````````'L7``!X;"]W;W)K
M<VAE971S+W-H965T,CDN>&UL4$L!`BT`%``&``@````A`!NUM-9W`@``A`8`
M`!D`````````````````(!T``'AL+W=O<FMS:&5E=',O<VAE970R."YX;6Q0
M2P$"+0`4``8`"````"$`44SX-[$#``#S#```&0````````````````#.'P``
M>&PO=V]R:W-H965T<R]S:&5E=#(W+GAM;%!+`0(M`!0`!@`(````(0#H3+8M
M_@4``)H@```9`````````````````+8C``!X;"]W;W)K<VAE971S+W-H965T
M,C8N>&UL4$L!`BT`%``&``@````A`&J>:0+@`@``:`@``!D`````````````
M````ZRD``'AL+W=O<FMS:&5E=',O<VAE970R-2YX;6Q02P$"+0`4``8`"```
M`"$`Q!T@2'`0``"VAP``&0`````````````````"+0``>&PO=V]R:W-H965T
M<R]S:&5E=#(T+GAM;%!+`0(M`!0`!@`(````(0#H:4SP)P,```(*```9````
M`````````````*D]``!X;"]W;W)K<VAE971S+W-H965T,S$N>&UL4$L!`BT`
M%``&``@````A`-^UAE+_!@``"24``!D`````````````````!T$``'AL+W=O
M<FMS:&5E=',O<VAE970S,BYX;6Q02P$"+0`4``8`"````"$`2MHN>V8#``"H
M"P``&0`````````````````]2```>&PO=V]R:W-H965T<R]S:&5E=#,S+GAM
M;%!+`0(M`!0`!@`(````(0`E@V`-3P<``,PC```8`````````````````-I+
M``!X;"]W;W)K<VAE971S+W-H965T,BYX;6Q02P$"+0`4``8`"````"$`M>U:
M0CD%``"=&@``&`````````````````!?4P``>&PO=V]R:W-H965T<R]S:&5E
M=#,N>&UL4$L!`BT`%``&``@````A`+2TP9YZ.0``&L(``!0`````````````
M````SE@``'AL+W-H87)E9%-T<FEN9W,N>&UL4$L!`BT`%``&``@````A`"ZF
M+7PG"P``=U\```T`````````````````>I(``'AL+W-T>6QE<RYX;6Q02P$"
M+0`4``8`"````"$`^V*E;90&``"G&P``$P````````````````#,G0``>&PO
M=&AE;64O=&AE;64Q+GAM;%!+`0(M`!0`!@`(````(0"%B)^V<@(``-0%```9
M`````````````````)&D``!X;"]W;W)K<VAE971S+W-H965T,S4N>&UL4$L!
M`BT`%``&``@````A`.<)+<^C`P``[0P``!D`````````````````.J<``'AL
M+W=O<FMS:&5E=',O<VAE970S-"YX;6Q02P$"+0`4``8`"````"$`MAMZR90#
M``!:#```&``````````````````4JP``>&PO=V]R:W-H965T<R]S:&5E=#$N
M>&UL4$L!`BT`%``&``@````A`%RL+AO1`P``DPT``!D`````````````````
MWJX``'AL+W=O<FMS:&5E=',O<VAE970R,RYX;6Q02P$"+0`4``8`"````"$`
M\D-L8`P(``#7(@``&0````````````````#FL@``>&PO=V]R:W-H965T<R]S
M:&5E=#(Q+GAM;%!+`0(M`!0`!@`(````(0"HN2.,AP4``),5```9````````
M`````````"F[``!X;"]W;W)K<VAE971S+W-H965T,3$N>&UL4$L!`BT`%``&
M``@````A`!)CT?7,`@``S@<``!D`````````````````Y\```'AL+W=O<FMS
M:&5E=',O<VAE970Q,"YX;6Q02P$"+0`4``8`"````"$`1>E\U\<$``!`%```
M&`````````````````#JPP``>&PO=V]R:W-H965T<R]S:&5E=#DN>&UL4$L!
M`BT`%``&``@````A``BRNBA^`@``,`8``!@`````````````````Y\@``'AL
M+W=O<FMS:&5E=',O<VAE970X+GAM;%!+`0(M`!0`!@`(````(0#'S@#U;0@`
M`-PF```8`````````````````)O+``!X;"]W;W)K<VAE971S+W-H965T-RYX
M;6Q02P$"+0`4``8`"````"$``M4`J?@"``"*"```&``````````````````^
MU```>&PO=V]R:W-H965T<R]S:&5E=#8N>&UL4$L!`BT`%``&``@````A`)91
M=;J<%P``4;```!@`````````````````;-<``'AL+W=O<FMS:&5E=',O<VAE
M970U+GAM;%!+`0(M`!0`!@`(````(0`.V1*U70(``$\%```9````````````
M`````#[O``!X;"]W;W)K<VAE971S+W-H965T,C(N>&UL4$L!`BT`%``&``@`
M```A`&_8*U]5"0``ARH``!D`````````````````TO$``'AL+W=O<FMS:&5E
M=',O<VAE970Q,BYX;6Q02P$"+0`4``8`"````"$`DP#R0YX0```P50``&0``
M``````````````!>^P``>&PO=V]R:W-H965T<R]S:&5E=#$T+GAM;%!+`0(M
M`!0`!@`(````(0!*;'I/I0\``%E/```9`````````````````#,,`0!X;"]W
M;W)K<VAE971S+W-H965T,C`N>&UL4$L!`BT`%``&``@````A`/;8Z!R_!P``
MD"```!D`````````````````#QP!`'AL+W=O<FMS:&5E=',O<VAE970Q.2YX
M;6Q02P$"+0`4``8`"````"$`;\T^!5H)```J+```&0`````````````````%
M)`$`>&PO=V]R:W-H965T<R]S:&5E=#$S+GAM;%!+`0(M`!0`!@`(````(0`0
M*@%IN`@``+$E```9`````````````````)8M`0!X;"]W;W)K<VAE971S+W-H
M965T,3@N>&UL4$L!`BT`%``&``@````A`&#L)PV>!0``AA@``!D`````````
M````````A38!`'AL+W=O<FMS:&5E=',O<VAE970Q-BYX;6Q02P$"+0`4``8`
M"````"$`?QX=Q'P)``"Q*P``&0````````````````!:/`$`>&PO=V]R:W-H
M965T<R]S:&5E=#$U+GAM;%!+`0(M`!0`!@`(````(0!BA5>J)`4``%P3```9
M``````````````````U&`0!X;"]W;W)K<VAE971S+W-H965T,3<N>&UL4$L!
M`BT`%``&``@````A`+M7_G\Q`0``0`(``!$`````````````````:$L!`&1O
M8U!R;W!S+V-O<F4N>&UL4$L!`BT`%``&``@````A`,E>S#G5`@``9@D``!``
M````````````````T$T!`&1O8U!R;W!S+V%P<"YX;6Q02P4&`````"P`+`#F
)"P``VU$!````
`
end

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0ELKAE">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Net loss per share - Schedule of Antidilutive Securities Excluded from Computation of Basic and Diluted Net Loss Per Share (Detail)<br></strong></div>
        </th>
        <th class="th" colspan="2">3 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2014</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from the computation of basic and diluted net loss per share</a></td>
        <td class="nump">641,522<span></span></td>
        <td class="nump">5,960,985<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Convertible Preferred Stock [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from the computation of basic and diluted net loss per share</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">5,525,844<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Outstanding Stock Options [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from the computation of basic and diluted net loss per share</a></td>
        <td class="nump">630,159<span></span></td>
        <td class="nump">435,141<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Common Stock Warrants [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from the computation of basic and diluted net loss per share</a></td>
        <td class="nump">11,363<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (c)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Antidilution<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6505113<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Diluted Earnings Per Share<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6510752<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Contingent Stock Agreement<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6508534<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	word-wrap: break-word;
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001193125-14-195836-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-14-195836-xbrl.zip
M4$L#!!0````(`*LQK41[O`R@UYL``&[R!@`1`!P`87%X<"TR,#$T,#,S,2YX
M;6Q55`D``T+P<5-"\'%3=7@+``$$)0X```0Y`0``Y%U;;]M(EGY?8/^#U@^+
M76#+KOO%F&1`BA00H#OV.NF9QKX8C,3$Q,B2AY(3>W_]GBK*-G6S2(I%2=AN
M=-(VBU)]W[G5[=3YRU^?[L>]GVD^RZ:3#V?D')_UTLEP.LHF/SZ</<Y0,AMF
MV5EO-D\FHV0\G:0?SI[3V=E?/_[KO_SEWQ#JW=STHNEDDH['Z7/OSV$Z3O-D
MGO8^3>P;PQ0>#A_OT\G\OWK?DEDZZDTGO3_#F]]Z])ST>G?S^</EQ<6O7[_.
M\WST\C'GP^G]10^AEZ_X6]&[RUY/GE/H8>G1S?1Q,KKLB=*O^GF:S*%Y;P3]
MN.Q13#C"`A'ZE:A+2B\9_I]RZ^G#<Y[]N)OW_F/XG]`86L(;K'=S?G->`O;O
MO2_3R0Q:WS\DD^=>,![W;NQ;L]Y-.DOSG^GH?/&A3]_R<0\XG<P^G)7@V5^?
M3_,?%_`5[");L'-6M+RT3\?OM!]GDW]8^E[;VU\LM?_%7&MBC+EP3U^:9K,I
MIT2]UYFBQ>MGS[)-GPQ-R<6?O__V97B7WB=H%0%HRH\D>7A]\WLR^^;>6SRX
ML*PB3!`C+Z^,TK<O<CV:I</S'].?%_!@0_/DGT]O'Y_=I_,\>SI/1S^2'$TG
M@#AU:F/%C=G;6_#U\^>'=+:Q8^[)AJ^RO1G-ESNWX$!<%`^7FF8;F\JB:?;2
M=#9_R#<#MD]L-\AR-X:@W//\>?,[BX<;>C]\S',PX6WO+9[:%^GRB^G3\&[S
M2_;)AF_*)C_3V7SS*\6S#2]-'N\W*^-HGE]8B5Q`BS3/AJ\O@!7N?F<Z02OO
M/<[SK5IO+N#I&=AKK^<L=GPY<WI]DW[O.?.YM)_ZX6R6W3^,K9*[WR7Y,)^.
MTVJ&ZMZXR]/O'\ZLZJ(7S3Q_FHT:V'%U%W%1P%H8WN4U="$%F8^^S*?#?WRY
M2_)T%CS.[Z9Y]K_@CX?3R3Q]FM_8?J;3\>UUK+C!BB-$.,'HOS%\^.V7K]$M
MOBT0$'H+,>)QDA7OS-P'GO5&Z3"[3\9@:)\^#\YZV>C#63:Z99IJHMFM,-%`
M1S%&NF\PX@-F4*@-0Y+%3*B^#JABM^26G7T4V/WSEXMJ_5_&"O[Y?CHY`:#D
M%6@)Z3N]WPKS.LFO\B]S"'6COR7CQ_0ZS=V[>\-=1(7;/[Y$MP]I?MLJ?'KV
M$9\[]&0C_&VHEFGXDHS3J^_%"V#WA\;.PE#1B$;P)9@B'LH0:<4P"K0>1(8K
M*?OLUH91"Y_`.*8D^FU0WC/ETQ0]WR3Z:L!6I&^;WDW'(Q@=QO]\S.;/;0(O
MH\5K6",MJ<$@Y4$_8(B3@"!-!4,J#".B21#%"FP<`OJM.?N(I%9*&6)*XE[K
M>X'-!HK+C0[@<SH_+@^&P8.]^NIW^[TLMJ_I_<,T3_+G`G?1_NIQ[B88,.EH
MAO+64&($?R)4:"WTK6'4:/Q$X*E1HC8'1F`9QE0CJ5B,N)`QTLS:,X])1,-!
M&,?T%M!3&[&8TDK+-^'N0GA(/@CEDGCB0UH^P+4IPR113?E8"X*^N("_L.2U
MJ<`*JRB,#%)42,3M(%H+(E"(2<Q9R!CF`^OEJ8WQ#!/%Q3L1?BL-WK$SI6IC
MK^CVL/T#0IR1C"]YO1V06W+H53&W[>VQ\_94:[`Q078[^X-X`/B/:^G'`:B%
MUD.LPZ2Q0^Q/8>:8S[-OXW33T/_3;/:8COYXF$Z*AG9EJ`6&%'[3$\QQ_;!9
MB2%M&9+K(:,!Y@HZ5+QV6N2`!1%%*25XA_X4X(Y/=9BGZ&H=D!T\KQK72:F.
M5W(4J`X73!O20'5\>-TE[)(S;_%6N7B[.M@X_,"S3``E@OH1/A!@XXY=4A&@
M840TC3S>*8!?>-,!5NB``"]JY&''7.]@;GW,Q6S$X%I@8Q2O/N8Z?*2@2M6?
M?%2S!V+M0:Q/Q$XH5/AF1\-`G4G%"6\2*UHSFC<KP<;G.A2NN0XU2K/+>#*'
MGUN=CG.&&RQ(]<.0#&*A4!`/*.)]0NS2%$>X'T?42!'WC;AU"D^P5()*&#I6
M`[#B$Y+973`9V;\L%S^3<3J9SX)Y/\GS9VCMUB)K8F9VQZ?9&F,P&"@:R0A@
M\P&"4;=!.@@,$CJ6$6&#D.O^K5-F9D<^!J(_%;1D[57@K#`P3F:SJ^]_AQ;)
M9'Z5NRWNSX_WW]+\ZON7=/B89_,LG?63\3@=A<^+=K-%PUE=;@BFS/D`!EH)
M/L`&"_LCUU@_$6RX,?7'3$J$+%(\1/U0$L0E92CHJPB%_=``?[P?1=$M<VL4
M=A6>25:B;#_\%<B,G])\F,U2M\C_^K`K!E<7]A=?7Z:4[D&H7?/!YT+N('0'
M!\LL_I9-H$T?(E4V'R3#;`PF_7ORE-T_WH?3/)_^`DWN)P_PI+87?F-O-UUE
MBI!<XRBDH8XIXRB.1!]Q0\!9!;%&,!D1>#"@H9&J6"$"COCJOE\=C,OL_)Y-
MIJ"3SY\`-]C&_.K7!#SY7?9P#12#N2<_TO#Y&LQFTF#W8,5Q/3SF:2L1F#OC
M8Z`L2UM@-;#LWN#>:Q"_`KS%;1.W^+-C;WMK?-H^9CLNB&(GQ$V#JF`$V@\C
MSF1\G62C3Q-0^&R>C/>&5CG>,HK[E(8*@;6"#7-#4<@E!-T!?*S&H0Y"&#W>
M2JNXE"O">-G3;>G^JC-+OEGKMC'$'</9WRK;AD>DA<>4Q+3LH%;[O8)K.OGQ
M-<WO?YLFD]D@G]Z'R>0?[4)[FF67DVS\X6R>/Z;KFCDP_4"'X'`''#33T!`9
M'"C$(A/0..*<L,B=NE@]'',UOTOS$KS/T\GP2"5#[<HZYJ7YW/;.MS]?:0JN
MT@R%V9URHMV.LE&4T^H3^6#H#L+-KI/G!.:U,."%WX"*C$[!UIPKH5B:TI)5
M#4"K1@C&MWCKZ]1:H!?<K1@B7C/$*,UABC+/?J:G88W$SKFP$J9DCSLP;(T%
M(.-#FFC5P`>104AXS+7>&!HVPEB5<C$6^)H\'5C,(2414R)&`2<<_!*Q$QHS
M0/%`&!ZR6($:%Z=<B#**$UH6\_L@=D]@@GMKXFV.4=LW4;IFHB6P1Z><U!ZI
M8X)2+C?JYOM1_V@#A%W3DM"#[3%_8R@(9K-T?K2HE/4C("@ERV&OW.7-(1[\
MBT-_DPY3\+,0YF:?T[EGE!L/>E;#R<\^2BFH7(_M[R+9H*H%.4<<#8VS/L;Y
MBJ*N=GQM0OL`DZ7XZ2&=S-)C55>P0<&5+D>`C1W?9()'!\;N$:X'\:*S_E?#
M]YE'X,B$&E!%"O[@\4`B+>$;!#=]0Y0:1!$M#I8+:N`%JO9:"?]R-\WG=DK[
MR:6QV`2VXQ,F3!^HLE]=/DB^H>.K8["?Z7CZ8)]\L8MJL5UO>\BS60H#FVR8
MS<%+/=X_CNWQZ^@Q!WY6WS@Z(J1UM4822:DHC]/V!;IN$4>G\'8]V0BF=7GW
MV_9TO>\G9,;VZ"Q3A@NV#*JJ^5[GTX<TGS]?CY/)'$S?ON?$VN@8O6?MU:"\
M"M"6X\OV[I<2!?Z8Y.EP^F-BS]F[A=709MC:'%4(2RX'=A&A.I2OBD(2*X&,
M-`1Q;6(4A@.,*--Q1,D`PL[+"6%[6DO#_)DLT@<JH_%]C,EB;SF?H)HF6%JX
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MO1KO,]`DU[42`](R(&DYT^<@5VNT#[_B.4F;ZFLVP:][JXH?U?<L>%))\)6T
MWU_X],P!/KZ;X^KPX3%D.'Z$:>=JN9;.8S:@I97SU-9/:)O?5B<E^I6C/3:%
M6P=<0_0K@%<!'7)0W2B?N1)TY39&3F=0[9N)TQM4KS#BT4,6#)WBH-JWUC0=
M5/L[)&>3>KE13\"((%L6O=_WG`+K,"210@,<0Z@0@P`%FL'_13PD)F`BBH+7
MI%1!")%BZ4ZJZJ?FW`+I>[F^]HAK<QI<;C.FU)X=Z2([G"XN,EQDAU="MZP7
M@R3+'3^_I\GL,4_MV9V_9_.[/R;3;_:Z>/O&I\D#^*&;%&BQ60'NA(O]\3&W
M1]'"9);-7LYY/^^G1TH8^F1YE)8_(Z5X(D0(09C]41DP,#`S>T-W?273NJ\5
M'W!$P$(1#P5&FD4#1'6?X1`+'"A3K'[Q]809+S0=OR3<I3@ODC",82*K">+]
MQ(ZJHK#7B*WF=GA9'=!,,;!4B06MOZQ*B$V[$0$B>*#`9T4ATC$,=%D8Q8"T
M'S,Z*+R7/?.K^5ZK`6M'S0)KYC^<MH3/;TVNDV?[J^!7DH^N'IR>E#ZXN"GB
MV.F"`9*D6@F^LGC0)@<5;L(X(07CU2X*V:IBQ^6#.G+X[$`.O[V9>R>7,S%[
M.9.=JJ/U`^R[9NP>H(IMYRO:694PQ:K$^O4)OJ%B3FCC8]R"8R4C@L!?4)LJ
M"M,(+0<(QI%*$,X'E`V*R]Y!XQ%XBG)JS4Y@^T7;%UQ;CUP:0WC]>Q<K0L;"
M9D=Q(F6-I>BV1%D9<MN"!M0@:+V4==.1^N[OE*HJ,RZ4F9):RKPO3.'92ME+
M208&$%EW5BH.9Z7,ZJM-^Z.,,ZF[,].ZF-N6-,"V5X.*+LU4=&JF[.5B1T:X
MK*/-^\*4GLU4N/M@BALV<(?!5![.3(4S4UW[%N>V9'D@,RU@VQL!&%>LP['O
M&^Y.3%6X83[@1`*D2PX+M.$@OZI`32%0S#L=.BC//DE9GV3/0"/**0A1=>>6
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M]E'F8-&(O%ZYLEIXSK?)UL3<NK1Q(6TC.1?RP++N)AY9T,K)NN.`M`NROX!D
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MC;B[B4@NN99V'Y%V(?87D9C;,Z)V@X')Y?W0`VAW9Q&I@&VU&\2L=9<[*V_`
M.XE([B!94Z>]+U3J.2*YPV34'I,3=C)(<8V1A8_\SCWP5BH)S%[VCV"NC04K
M72O>J`["?DZ+'BPDOUX@U'E(KHFY;6W'A;932FQZ5(<A>1/N;D*R<!MIN/.0
MO`NQOY`LW)82/D!(KHFY=>UFA78;98C`789DVFE(=@=&&T:M=@LBL[5X54V/
M*U4+9D=1$-DSQ&8%D?>N3[>.JMU+=Z@K%DRE74`I^=PNB@7O`:U2^4-ZZR:U
MS![!*2';U'-/]83]"\^.][4H)^YU5D]X#W"5G*<[JVV+12`II&&U<DA6[GYY
M&1L7)3N#^3S/OCW.BQJ[13'ZHQ.LX.X4E="JO"!3&U=7=98[<%.V4!J#T4)9
MV0]>9]F_#[/#0[%\4>#6SONLQMR!A-WI5P*MCZ,:LW_$MAHS$9(;@C=7O.V^
M&G,'8C9'68YY#^"$#/HF9H`Y,"'B*A8H,`IL6LBXKY@)0LV+%1UA-5RO#$BJ
M@&FKB','(Q(*@8MKC@W=J-(^BCAWH+2VB+/AY64)[T6<_:.RR;F"&LE$::VX
MXR+.E5$VKY5D;T&@RO##%W'V+U*[K*(4-:LS`O]%G#L8$Y]]E,R4S_=5J.'\
M$EFNOL/?X$G[TUGM*L`=C`1L[6VE>/D0W\:>MU"@N@-OB3>-:[HJ4+W/Q+1*
M9=O%M9(8@S+2/3=F]BY0[5^8=MZE*99'7J"Z`QNU!:K7EB*.H$"U?X4'>X:8
M0I=233W7I_8/RM:G5H13M0*JJO6V6)_:O_)JD*#@<BEV5JI/O6,&?I..TGMW
M@61QC>31`;?7L6B,J8U$30!YO6>=[;BWQ6_=8>H*53.E5?G*Z&.X;;TN+WZK
M5=,CJU9]<*U1%;6F0ATT7TOS352G!7]3\`,#!:89-G+[W?Q5E^Y]%N"L2%5S
M'HZU9N\.X)X+-U-7Z5L9)HDZ*;?;<;EO>F3EO@^N-:JBUARAVWU/==H8YCE^
MW%W5TBX]LU/VNWO62J<MUDKWZVA]GAPM*L+8!6XC&2>FO';A]VQ=3<QM'YK`
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M-EPS4;.TY;&!K[H6I8J]PGH)O6O<^'$9GH5.*@A]8S7JU4;^!B">&;"'`)FA
M4N+R/5#OX-M*1%>1=ID0CY'6$23,IDA;`7:W#L)?_KLK8^`<A-`8F^ZNI:V+
MN?4U>N;6Z+FTU3NIV;U&[]:8%H5J9XN"Y:W[`\^"MN-O3@1G9+%FMH;GD+,Q
MJA3WXPR5FZ^ZQ3'[+]LUACR2V9AO0NSBF%!,F1,X`_$.+QZ#1,'3*4['?.L.
MK:H[QS@?VZY`+<S''#_,)@$1;&!*MGUOK_9\S%^F!E#%N%%/P)@@C3:Q!-9A
M2"*%!CAFB(M!@`+-X/\B'A(3,!%%07$F#;N9O&&Z7`B^?N;&IJ3-F_0^R2:V
MO/DTSZ>_;,9.\@#/]AB=@%RU+=]H[U+=S0M:/S02TE#'P"Z*(P%*8XA"01!K
MQ+01>#``59*JN+75V11>232OA7*9(2]5XAL3J82AH%],20(_&2G%$UB'$(39
M'Y4!PP3S9*2)\FG=UXH/.")@V8B'`B/-H@&BNL]PB`4.E%G<^[R>X.Z%IN.7
MA!MLODC",)@IR^X$X5(_7G("_M\*HB.RF26;8'#MM%NVVYLD=G)7F"MUU_"Z
M&S?8`4+247]Z;U-A'5>!G5[]<-2&SV]-KI-G^ZO@5Y*//C_>?TOSJ^][3JXX
M)E2],44(T8+4GTO&@P&G,"E&46!YBF((5A$,>)C`(8D'G`O%[0E'FS#TD7`(
M:VNE;-HD86TYZB%/[^!SLY^@FL/I??HYG5]]_YH\56>+F((NUCBU3</@!3P7
M&O0#&-Z0@"!-!4/J_[B[UAZWC2S[5Q;YSFR]'POL`%)+"@QXW(:3S&(^!7(W
M'7-7EKQZ>./Y]7MO45)3:CV*9+%8-":8Q&ZUQ'MTZ[[KW/%X0@T=`6;T9?,V
MG$C#JT;NAA`7#D\9/9>7%B&E*%9E=E'^]6RUKG=5L:;L%XL-_M)CL4&#@C!]
M?HY\I#J[9;U8K)XPN;JL8OO;YVEJ`2ZF,ZQ:@/63IE)W>E@MOX'AP1MQGTYY
M[]XLMZM*O3)-!,#]:,TYMY+M"T_>`D4$(?RXL!]"Y+!ZQA@PO9+&@*@TM!T#
MY5F^]$>)X?:APS!Y$X&]+&RU;M'.Q`;N^'D"!=FD`-,+;N<DD_27-JX?:M`+
M"H@4.JG6WFD?RCQ^FA7+.43*RS\/K&'X2_`W>4W*DY``-;=+VG$N20V?6DT<
M/*7MRW)'1@A]V[`L=DQ#!!9;2L'=<K'F!KM?)6K<B?2$J5S7E`DCB;5:#%>9
MFG4O_5%"]W_L4[=W_^'3R0!U"L^@FB2>7%:0D#Z78MIHAJVFFNV=>:>I9EU<
MFEL5.XC$,RH>QS14U/9&]^J:[U;;O#0T7Q?%]N5M/R"NU!\<5F+#L)970>/K
M;IU78;AP=XH(^#4ZSB37,A.S"<G&4ZHRP2?B05#Z0":F)%PB/Q/)B+EY+?6V
M.!7].!3NWH'R?/FZ6'W/\TFQSI^VJW4-][*7&DS9B=3'=[I;M02_24;3&7@'
M2D$'Y#@S8D8R8LUL9B:2C,</?U#LKQV\ZZWG#E38+;F+-K^X`9LWR]+X_+)>
M;1H"`VY74BV1%(09R>J7=KU`VI=VX93P\V4H84&X3!%YY>VQ+_%F^5Q\*YYW
M\\5A6NG]NGBJ88C]P&PV3>(/+K9BZ,_DA&"[J>PURAGO\O]S/VJ@?)0U6.G!
MQV/-)FR2H37+Q%@!()J3;&3,;&*%5NH!(CI4M7J%BJ,<'6?@5X3W'Q7QDU\$
MR:\AQGN_7CWE^;-;IW%XV1MXZF*^>+_[N"B>#A2FR4%P$KO5%N<\I'_QYY6X
MO_QK"'OJ>V(G_:N,APEM*?R1"(CT6V;35A(UGC*3*<VGCK`<PGK$2DSIA(UG
MX^G4D8KPTVS:6^1X1@*`H)KHOZQ"8M:.3,;>AJH`1N-#_K4\:IO'3SAGLSD,
MVM07GYD&PT*OCXR>369C,A494QQB-T`C&QMA,S(;"34";.QD=O313(%W$96$
MYZH\IV+_,B^6F[?@@N$%$/)O`:Q=L?E<VIQ)_G$(XN,8#T5?^R+]7;%>48<>
M+4R;+Y]#"$'B3HJ56Y7.)\6N"I1>/'L852"&V+^L94K7KQN9R82.1^-1I@2!
MA,=.=6:E?L`RFI9J!K;3TN-1(1%"6>>Z@D]`@.EJ#&_WDR"'LPB(,WWHR76!
M00>5.ZXDNE79@OY6"J+5A&96"W!8E**Y4K-LHH665(@9X[,_!';`C6M<,BV;
MENK`M._63Y\1L5>UK#1%QN*3/'?0M\3PE[IN]?I4[*M<F]9243^M]D2$2+?J
MPS!FSU?)WI0RDBYX@Q):4P"7EIK2@3%H7\?W/2>DE6D(*;KJV"BHPRQ4!AD,
MD2R-ID5=X1M;`'48A!+&"GF^%[Y^E\+KUY!2'7X3<L%-\9ROR_'=1#4#RP#"
M\+K]FXLB=MO0B0H+#F`084RS'DZ7DTZG,/3A515Z#RR**$;5^17><)-.9[]W
M2>.&AQH6'MFK`?=&PD<VTFU#E9;`#=F$]Q3EE<!U9^`["(,B18#*37*T"HJZ
M]6[M^_.^&F)#^;J0VJ`[]O$&?3R2NF;P8496#T<"4;&W](U-:BF_NYW6VIR>
M7:[&+=0Y*LEOJY=]0NX]1L__O2L7IB6+B,(U9^0&\:2/=%'L1)P3`KY#&R9E
MBTDF;P#?%O""9_<NY4A0OJPS91`5%XD^E5+%+G,@UQ2R1C1<[3K^#A+6#TET
M?Q&PP7B$$9PF/:=%JR6SOQV.#U=H;<,(SF*<PH7F]Q&[+'6TI/0V6@TO*ODB
M1=T";DF49;JSI#2<>V]Y[:TE4IA.60!J6`%`OYAAOL"%(=>99?S#@QY]8_#[
MEC4@E!AR0Q+_HWC.]J22GMAIYS@C^,VNW$#K"RN^2''G!KC5)\-]PW`#]:\_
MM40*J5J-4>95<W0X;B`Z9LX-$!8D2TS%#82X=U<#0EE>*'=S5,'=0`>%J$AE
M28-ER99EJ:C'L!XJ;8HSI)/B3*3<,4HMU[A:+N2*W:>*(;U?^_N*_N@$JGAV
M6]*+J2[#+?!%1:G+<E](;V4[+GY2CM5/X2IX6C*B25)]$V_Q&UN1$@#<1GQ^
MC3/->#D6(B4ML57T.E%S,IV3.(>$EXMAE.;#,:V1S`<Z88[S\B&#?_=&I=D!
MB[.'\G%Y>KD\5430"PLM^!Z/>V)$J^/8WLKY``R!0V0<V27Q+GGU4LBIB5('
M%IB4/HD*I:7';%E"GJE?T-!M94;``PRTE!,&Q>;&BY3F/-/$N$U'<4OZX8]M
MG"(U`L=+XP;9BP=U3F+&+6+%=0\5&C>NK-*>98T$C5MTT)QQTT+)ZYM"AF?<
MHM6I]QBB<9.6<\6'D?I'*E1CW$K:%@*BGL1(E>H],"'3X5Z/7DQM<@P]QFHF
MAI(7QL6GBRPQ9(00J9*/EMD&JL%U6V**5*/>`S+<@E-4G$HS4^*4LD>GI'GM
MR6OK"MNS!61&,JLE3ZF4[R]\X\6<3GQ<AC2$C"(6'IB2:BE4B)2A6QL;YWA(
M[!=;)M5@;&H<7#320"FM"$T]5(N#!T5:,"'8<8E(*B7\@_B!5X?X`4-*ZE<`
MQG9W2SR<L^F@%NT/%,[C<RXY'90_ZA4R9'#1AFH;*LG>;^6>%)LG7`S;$RB-
M[1!QM*:,*77,H,\DZMTK]0@-TO93(KDZDI`'\UG>;Y2&@K4[=7@9C2KP=751
M]-;%-%!JHVO<A8V47M&TBTCT%`NTWR/BB8I;LZPME?K^58/$8H$PK1M_H-R*
M7B.H'&XL$!LRC`6L9E4.B_1B@2#+C;PA&50L$!<:%PM0RJU4/U0L$/O4N5A`
M:U(;Q5YC@;BZAK$`U9+8!K%`!^7D2"N]\0-;%I>CNJ[V[6%_6$(667NUW_$T
M">N-1!H>=,:LTWIC3'2ZJ3Z&#*8#+*7S-+@V3$^GVZ9%@.UKWG`,MX41$R5=
MHJ1"CIYTX<5IQ]T,<62+ID023:K3Y`FTA;W%;VQ"Q($4^3Z%4`JY=RQ`,&91
M7%2W%Z;:&(YS1*0;5F-B.-,VD8#!N2Q..$O_=E<<0!QMCY#2Z-1:P[2WUK!P
M'4\!P"A+/3J>/=:#:X(4WOJ2TAUQ^%C%[Q,:)>24^L7,=8>)J[L,,LL.`V)C
MRT5*4PX/)R1EP6UYM#)I$KJ(=5(&T4+MD=.^.H674(O3*12N`28<+0E\RM!<
M0\0*?(D4N`;0*\'Y(`@ITL#,-0N9U0.]]1L(Q.:N@>]=`QA28GXLUQ!=%YUK
MX)*$&:?IL.04J:`MCILY6A2@HEJR2*VC$IB0=9A>35=$9<**!$66A\%4)&+"
MTTU](F1X%:EY)%SS*$CEM]O*9J2^B#CL!AIHG3,J3+J$*:B)Z<*9\XY+GO9(
M$&@TLUS3I-I'WM(W-B).?DZ'TCZ*!(CC0V"<!,FX#F_P?KUZRO/GS6R]^O*V
M6.:;QT\/X*.*#E%X?2@HG3W8*7_(Q,B.,Z&G,AM933(AU?1!<SL:&U$6@0`"
M,`^$5+='7!4ABCN)8@OP6CH78(-I"P=R2'(>EWA>YF`A'S_M\Y_:K,QQOFWN
MAF\=L>Y="?KSE'&\`45*:DF%O#("F5#\'0<0B*DTUY;)6A&W>^G[^7>TA&`H
M9L42U`B\R<-JL]U,\H^)VCV!IE^+PV#-+0&BE;=Y;YU/ZXP#[B?11IL`^TE.
M->7E_#2NBM7$)GR\L.?]%$J=<)G<$S1R#-DO/KBVQ4K"V#!N"*6`F:/#$U(/
ME>LS$(B-'=>!ZI,1K@0W@ZWZ)Z&+?-\0KGT5.<`EKI<_/KK_'R:"V"'FW-0.
M*<^EOX[@C^)+]8LO]1.SUS`LSI2!=3>SV)Z`5][OG:<1AT7L3MHC1;'BG%<Y
M9%,.Q*(#Y'89@!TW;!`+])(`K20FUIP%VZ-ZJ*1,_\K73\5F7UAJ7!KJS2!A
MKJR5IJ<WML_%"GA+/8PZ-(\I06;<ZF;L<<(PF5OJ_4/CPFW.*>1YP6G6>@VW
MHQL<[A8W<Q%F_C*!<#LZ@D@F(96I3X/N'V^GH6FM;)D\M64^5_TC9A[1@R-=
MB1Z;I!X=-+XC3=;8(SU^\S9XU'`PTA";/;+CA^H&]QH:1-0E;*(1"`1X^HRK
M?<#3K*46,4F--,1F'15\D/F3;J<.(DUGV0,U?NL9A-YM3.<PH8UQ,(4L[@?V
MY0KI&DS76QF)FUS!,H44T@J5S)K;>N(W7['A`&!V`&MNHR+B"C3<:AF"9K`[
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MRM4U70*HX0EL@N0B]7!HW"@JD5#8H8?XBB5?SXRD&GA0)"1H;#`&)1(P$BDH
MX3]%TB0J$0$Q>`4+GL,TZCA'-")]W3Y0KD*)3$Z:,:N&&10'`K&QII'RZ.'&
M/2UX;9*P%,9`T]%%7=ZZ,F&YUOHZRA''^92KQ^%1MDJ0'^DH1QL0+2'$H\S@
M.730NGG_1SFZ+NJ2-E&%V3S682H3:0I..2JWP20VT09.2UQ"ICF]6JZ(NH0!
MOR3&T."6JJN`/RH\[<+_;G/D2$.#RM4DAYLQ1X5)OL"4:`5.,RQ/BHZ'HYB;
MC<*,!B/Q1.8J:XK>N(SOA'?;G4GK,GXG0Q(G0%Q)UBBQE@K6S90$?+I$JCQ!
ME5+W0>IE1J(92.%U"9`*I$L=&)!(742W_[*5.;GHHD:8)/R98]0W_O[RDCUY
MV>C_YNOGV;Q8EP$BX%K:Z\V'8O,_LW4.'[@%.[W9?@`G6`=`85$@0?B9'?JZ
M6^=5L,0KL$:":O@'6=@F-A,:?)+A8IHI;<9&*Z5'A/WAEA&3G\E)-:YS`$[Q
MGL[72]#+#2BF>]M)L=A!I!`"I8IF_?$U7__QVBRQ5[@!.)*`N\Z,GAKPX(QE
M5DYG&9F-Q`,=/2BFQH`;=34X;7\6E;FM*Z)TJ%\8.3W!1_QCM8"W6>`5RHXT
M[#52GAI&4,.J)S$"`*>(_U=>_/D97C/ZEJ_G?^;O=E\^YNO]=U/ZB\?==K.=
M+Y_ARVN4REY%\;7&O39KOAJ'<;4ULCK\UE"RVP<0<"^>4C]^PN/X.4$N'+Z/
M]W7O8QW=^RU??Z$M`&MVKB`F>J_^R?[.].3L;'4BG\>1>OSDWKNB<NX;&"V?
M`]ITGQ.E+)EJ0U@V(U9E@LU$9H1XR,:"39BU;,P?9H@@\SQ1=P4[!0?B"HRH
MWJ]7WXKG_'G\_7<`^\WR$<X`?!UP$)^VQ;=B6^2;!\"C6.[@[_8_!-0#G[S;
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M%$><F6)5^]Y,NDZ*-M'4`V-XB61F;M54[4+-->+X%+]RG+>58!FXJ3!.7!/@
MLIB_K49/_[LKUOFOGU?K+<;D;Y;?\C*A2U)F7('$#"/J9,&)CS2O#C[H`%H&
MW(IR*9(L+<:QX9:#D]VNYZLUF-7Y^ON;;?YE\VZU1(C6J\4"?O50C4KR6)37
M:92$OSLU$%VA<`KWP0P_+G^=+_+'3Q#=PT=LO[]?0)"(O:FOH8HCH9%#=C%<
M7%=!S4^8:W;E[6J^3-:DX&P')=K2BQ;E^.BO4M,711I]FQ>+^<=%_ML*C.Z7
MU=(U"SZO%L_Y>M-%%2A(B(6#/II*QH2Q)ZEH'<%.4?D`GO8`W+O5-M\`COCK
M27[M"HD7I:[>%[[V_->EK+D=)IYT)4?&R4ZL\^<^]PX'MU%^_RF;=OCJN)*F
M&@-<>_P[,0"\#)+/`K[C=,-<W",*+U?,WG#_YX+<B_E'3VY*;W.(@S_D3WGQ
M#94]20S0F2MPY>)6I']#IFNN>9*OX15;%R%OMNN=`Q5L("0-VS2C?0-FBQ)&
M[47O?%N><Z4HC\A[R(Y2_,X=N1S5U%:_\Y='OA9L'#OUN`LNV:C#7;`4G,KJ
MI>9;0M2M:/R^A%.Q*/X5O-`5YCP3MX=<24+KE#1>A#H+QU;+U:%87MK_^H-^
M\1(3K.PIB+MD)?2X*L&-N#/%J))>K$6<//;E@PM?/@0HN_739[#ECY\J\6:*
M^NNF5.6%?/RZ&'<BD9.,"CQ8/QFB[_$%\:5`+NH;(<E5B7QCDWWT#;^*0YR[
M_/EM,?^(LPE%HD$*9))&PEM2GRCEEG1GX4J^!,NPP%<^?RF6!3AVY^(3MG%(
M1$V8@,^O3"_?D<.K^7NL\`VO^>MH3(@PADFF[C9_/06]OKDY^00<F:49<9L/
M[CW_=2FKQA;GN_,O^/K&UQ[B20_!K=2&2U&EV*@K6<QK1G6AN31_ZQE$N.(%
M%4I50HC6[`F7N\\IZH;CGB16GVR^NOCTKZ+@)[`DC^OW\_5V_P?GBS<%OOB\
M1+!WT\]M1JZ:*($G"KC,0`C#Q4F0W$C`L_8>_M;R&?^%NO1MOL"PI1SH.'?7
M*:H'+D.1S,)OL&J[KX947IZVK*@-TM.R<K^3@@>0=QVMIYR7:R<)AV"H)1"A
MGS;'3Y[ZNE<]5![2S\-P!Z<E5*O+3O2B(-?EOM#<2CX50V\!QH#JRPC<$>F^
M#KR!)R_FB_>[CXOBZ?$31!]P+E)$`OD3):?\M.OA+=)YDV>3SR'\PN&J_%N^
M6#FT$C[N8/($U\;2:FYQ4XI3@2?YUS4\A3-V\-\+%UQAJO9EM=X6_THV6'(S
M0!8^_45J'U'.;@U7?C*$,1C()#GG1E?._"T13H4]CA7O]2"NA)[JC',^\"E$
M\DIZ].K)+PVXO-P4'^?+_%.19`>3NL6)5)(3TI<K`E3N<Y]^RZ?)8`/>D6@*
MBR-,W$K'SNTMR"FSP=J-",\7>T?NQCY'V^VZ^+C;OII1."QX#3G6^M>F^(]E
ML?C/G[;K7=ZX/LY^^K=_KRN8$VD_@)Z>1/14HM-O]O!=MJ"BB'8H[6TEO29*
M1?9?OZ+?6?QCM76F]ZB.Y0WA+BY,A/&A!%/MO=`>,O1!,!&M@X6E:R.5(N&9
MI`+RLT2#`XO6QFI'\5.#CZ54);0SAZ#;O?RYV.Z05V#YA$W>Y_%N^VZU_6>>
M[`P"KN?EEG!Q,`GU1*I@,?T+S].NV'Q&:X\EW2_S`B]SG+RC"]<F.^?,EM_R
M]>:">TQ12Q1F'Y:Q`PUR.&DK$!X'V&8YMLW>Y\OY8OL]1;61+]-W-Y[\1#04
M?[YX_'0\7OO6QQ!LA#RW$?[B='#S0M.]U)0UY*HUD%$2#!<>1CP3=$0SPR3/
M]'@\H8:.)M/R(ZB;H84\S')=*=6G00M7$X6+/'#>.&##!@*G$'N?NB+RBJ@5
M]*>_62NJ!;ED>;LBHH)Q%>7,V)!;^P*'51'A4,Y%,$OKAU5]A!(1D3'8_L25
M"J:C8"*^_>V"G=D/3U)RPBDE;`#CW)]M"D\3[HT?WB,3H)A*#H]9.!TMQ$NJ
M@IK:>U(NT@K7>XN7/Y8UM"'"AR&V4JRV[SR7/24WTN.9QOE523D7/Z:+"<0:
M[@DGW_,$VNHP_]!]3!#^>F\`T<=H3C4;('M].FKH5G0*]:/XF-CPX<20X:3V
M'J+!^)BX9]HX;GPE,?+NU,F$KYH%('SW3/?(8&IH038K>*,2L*+6IT.-IT;N
MQ@D$=#KDOM,NRTLQP1ERL2DF3M%*3YU6MP.L7_!T<G:PM>Z8&+$C1N$7,:=#
MLFX)PLNO\$G>'C7R8I1DX!0/DT;!2,^O/75GG,NL)($U/XO*8./P",\C?-OD
MU;?=.0'Y-:F",5NRDGZ<``"5FRDIT(_W<1#$W8.0*/7X&5A!U)WYJ7M`<O`V
MVNXU4LE*:G`?;4^4&MSC5`08&#KX!*L4HW<OK/U8M.!![0YHW13^E]$9FV1"
MR2F`/0/C,Z-R/)-C3D;6.990Q-0_&"EX!*=.[X9PP<U99R3=K+QHZN'!(E-T
M1PAC;#V[?H>@>P3FZQD!*K[EO^9/N[6S:M._GA8[,'PE4>N7K[OM?A+_'./1
MEWH="W]\+A7QA)@9*<8/V509F0GN=&,RR[@!%0&LK!Q3EZS\35I%K*E`%$3.
M"-SFK=V>Y_DI:<`T(16,DB4VCQ8+N&XJ$8:<W`Q+@]8\FF:XQ42$$J::<)HG
MP74=#2MV":O!$EW'@@WO)%I>W=C7A.6Z,R;HUC!X>G*W\%U*(SDY23V:TT"W
MIQ*.I0+8%Q'BY`:N#XUP1W2ZT1P,]LKT3>_B3:4;AG<UEN2.=94S+1J1K@9@
M&8WF$MSV("YX-(K16.:*7O)U'ORB(8DVHQU4\]/?A*IZJ%1)-J,A@O<QD38O
M48;-6.<;N=$8-ZJ"0RUVS6/M"$[."V>XRQH.('W_.Z"Y@]3B<?D!4]7U/G7?
M_+Y<?=SD:^<-WBPA6]W`SR%.A%]R<:7+V"`KV8#S7+U%VAG>&8"7\O,'Q2?:
MZ$DVY@94::)(9L?C<?;``41IV53;0Q6PDG7&!:0?KM-H;A8OC6NC-&/D;CF[
M-=%I6`K06!@A`2@%3;1651?/I$L`&N!D>KIXCFP4G*1$_ME:*R9Z,J93+3.K
M+,V$L=-L/)Z1#(SX=,+H3!A#2Z,DQ?^S]ZS-:2/+?M^J_(>I;'8KJ9*(GH#B
MNZ=*@+CK>Q+;&SM;N_?+J3$:C,X*B2.)V.RO/]TS>O+P`P,&K*J4`T(:=??T
M]/1[FBWCH=C$+CI:[DQ:F-P<49LMM=2K</_[6>Y,4F!KMZ:J/GQ@\&Y;6>Y*
MU^'=!?3*R2^/;&.YL7:..U-OL2NTTE97]"]\4B_'#74PW)G%BOVP-:MLU;U8
M]\*=23YT/[7*`:*GMRY\1C>_74VMCOF/S;9>RN]?T<EO"SWN=C67Z$TV#;V]
MK_WM'HIY;J`7G+;+[G:[P6?+O>UVM0*M^YASUWWM=B9=09EN[753NUWY3'GK
M%;/5WGP'@\W5QNR*%NA`-)K*$TMA]B%1Y5^6UM85\T[5FKII;2EO!<N$N!5J
M:F;;,+::NK(/Q+3P^-OV=FBI(2UY7VX30-D**5WF?;J***957<[&UZ'_5'+D
MS>'FG:B=CMIWS!;(V+XFPP)2Y7;7,F2EZ\#&TC2=KF7^"Q_\A_W;'Q?_\W$!
MD`(^!]!-9E_9#7=)!\D9'3]91CX33!7!_'9Z=OX'N?C5_OK%[CK?KDZ[]N=+
MB9R>=07XR^`LL+!!C7%Y"S^?/J']_0/@*]VVWC4LV>KW0&:I1EMN:VI'[ED*
MK+Z.Y70458`_!%9D`LX*)/-D[GL^B[HT83=A](36B!NA,HC6LS"0Z6#`?%3O
MF4LX.&7R5N`K@.^%`WY6:1]T$>K_"69?'ZX\61U\)IW!4,%!!+PK0%J$^6HV
MV1P_/PY0/!$8!JT"BG`L0B<\9@Z8T&ND`C\33$W04U9T65>KP%;`FF=BW),C
M5%"X&0PWB#Z2^:5-H:%9BMUK:1VY:5@.\+5CRK9A`E9F2P%Q;IAF1Q/4!E'>
MDA4S1^-Q<,[CU07$(^J?!BZ[^R?;]?*$V8`!812C:1AE-.;`*J`6.9BE%;!I
M-GH<X)@/*:M:3OQ58*T2)X+77D*@@$3\35TF3DH@S3NO;]/P->RD%U$8P,<!
M-Z'CB]#W!C/Q]PIPZ/AK*-BK$&HY2K_3,7NRUE)!H=$ZCFRI+07GPVD[/;UM
MJ.E2^-E/3ESO^\\WR0E`CM\F)$YF/OOE[1?[Z_^>GLF=\ZNK\R^?B#))3DC_
M_.Q*OCS]?^<348L+??O+Z><_/Y$K;\QB`DB3K^&8!B<D'>+J_`+N;T^2MZ7W
M7.-G_.#AA_?>!X)I2:`"TIQB9%(A&=[\T<L>^Y@/\'&R`_";!?2G`;$GD><3
MG`&))"-&^O9EAWC<_"3VY3<B!&5;(C_3\>3DQSOXWCT!4R1&[PD7>N$01DJC
MI=0GEW!98$EHX)+,*RP1[A>6\"+<GSN'BV&-DZ]L@@X`(!>W_7F$`,`H!4%P
M1/S-#S'B'<-`X1`O3,(8%!'\@BIJ&/#7PS<:$"%+&L5[>B=EQ&"(B0A7Q.0&
M;4JTE"/F<S4A"3E-7#;T`B]%EE#BEJ!#$#+X.'@1XPDP,0F`_&X!*SYZ'2:C
ME4\+[`9`+.K!BS"]#>]-44M&-"%N2((P(6/&$@0,GKX/M&+H!KD:>0*B'$</
MJ<>&0X8Q&4:&8<1Q1?K18,:_TR"8PHQ.N%"(R36HH`&J_"0,X-G_H_!K-$L)
M:RLGJH1$-3D:'L9"O''^[*V7C`"K9!3&C,Q`-L8($V*0O=`-D6:`'7")-_`F
M*,\I&5,<!X#PX*Y!DLY(\5@QK=9)3(8Y%P+5.%4DF(]XZ@MN*)$:L,-3^F"@
MH1_>`NGA7WHKWID@N08C+'5J+"S,CZF8*<>]GB8=YV1K6I&2.Y\OV8U80.L*
MT=QJ3$=ZR&S4-+6EV2!;S7ZO*1MF1Y<MNZ7)'=ON]TQ'T[I&:E65RP!7@?V8
M$+?PJ]H!QDSA&>!`%`\IM3:V&]J&XVAM6W9LPP:TG*;<UIN6;!AVJV\T.QU-
M:>W9YC'\0`I.XHLP1F^/S*N&@2X%!?=E#[DJ"8VQR$2*N209A#%?2YB"Y`W@
M8L23=1D*!\+NQ.I"%&$0D-,4:P?Q?L9]?W`3F+M3L0X$]F'`Q[U!(UAV43X,
MJ1>1[^@0%#L!_LS'X<*E@&`Z&*7CWWJ^#X(,80EO`N]O'/8[BU*A(J05<:?\
M++G;D0?/Y>`#&V=;Q0(*Z?/\'1*Y$2EO_HP#E,:^T\$;Q`8(N#<GG=2T!3\0
M+42)/)[XX8RE[RN!Z0GL"Q$7%QNM&&@ZX7(9[@*JP"Q,4M'."4;F"!8ORK6M
ML;RVG%N0+BC?!;L4H`E1+>0TAQUQBY&$@LH=G\**N!R,0DQC%W?"S'B8K$7&
MH<O\=+^C$YBO.WP'WC&-N<)`BZI4(-(-Q;*2&Q#^`1=G^&Z/Y\J)'3??S0$K
M*NI>D<0A?/^+D=B#R1EZ`Z1O@0WN?_^>ND(8-LBEA]LMP(=LDFU?N))%%#7C
MV].+<ZF\`U=WM@&/#0AA0&XIWRF18?E1@<AH$06V%`.PM-B6?,^;:)2PYD]G
M"PJ&\`)W"BMM!OP)Z'L!</,X51ILU^6;*+*R!*MF0(&&%2UAQ"&!4<J4`-(G
MZ.4!9,&D&$Q1EZH"!GOZ6,`:P[[NPX-<%1HST`_<_*$,6'BI^YA=>(V=9L^[
MUBQNZ*+DN=C-C?4*GKGQJC1`6WOP+.<-HK^5'CGW'B.RV=8@JNB'H#:T(^B1
M\S!O+5+ID;R%>F)#:6^)LY:C_R(=>58?8??LB*`J.O*H1MMHEY3NC;3D*=?)
MB4BK.!B'\1\N02"O3XDY7'7%``35CFSJP#9&OZ?('4<%&T/O&5U#5;M*KRTX
MIJ(9<+,49`$EJ@P;DJQ:#0WV8@YDN@G&"&:)Q1[&:0M]B78K?(P'A<^2JL<S
MBN>`Y6;:&LDLJ^;6:.G=CME1Y:;5!_,*IQ4$!'Q2;*/5MNQNR]F];TY;8EZI
M#2*H4'4"O*S=9`.3!N$=N8!Y&],!FR:@/?FQ1$!/:0@?"BBAM\#2H-Z%MP&L
MAGAZ'7NN1Z.9M'H`_KQ$WL,DQZ#CN-R1Q3U+X?C:PV&$!EKVYRVHG+V3LE\N
M9HR<A0DK7#T:X14F2,])R1?X`?7K"/TV`]\+$!RT4L!$FE1@Y-HO]_F@M^J[
M.+E;^`5=D5#)G4Q@0A$WFMZ`0@CBS!66`BC0$0/%'!15GX['A=]M@%ZMJ%&U
M,:I*-.C@8R`>&&SH<O?BU+F7IW`*5R;ZG^1\>%1DP8IPIX.D`@>-;A@WZRY_
M/;U04UL1;0[R%YO!*&!:H`X;1L(O-V"^#]\CKBA3G]N#-!G=4C1TB3<>3P/&
M;P*#(9U8&&1^:M]_N[0_"`9!Q=C+@SK".OY"2]XXG;OCE!;<)8Q"X9GE#E/F
MHZ7*)/(-Q!8\RW^!-Y\'BUX]K24)]_`]+%>"2]C$@GD#C*C#C*U$*&7V]V5>
MS-X!0Y;Y\<-]=%DRRF]_7)`NV&PNK8PBH;4^9I&/<]0$5::MZ@6NE0?@NUA*
M"Z2>!BY+O:7\`;1)T4!E<0R,EX?98F(#T\"\]-B`X3Y=(FJ33X[..5=()!:+
MF?H=^#B<PJ*02`<S,.(1C.G#/N]1*7W?HUR2"V)_3@<8C)@[Q;SM9Z9];#SD
MH_<U6V]IAMSO:!W83)R6;#E]5>[WC+[9ZO0=U5%><EM!\3($J1S>XBH>T>\,
M3&/&_4&<8F0()$L]8#G=N/>?:QBIG$N-G8`EQ,>"9I@FX15"5[1PX0@MB-R&
M4]\MWI-*J&S&/JV_=VEXH8RE4MH[<U9=&)^GQV;O>")-.^=?>\Y7N7O^^;-]
M<0D/#8"0=!*#W<&%WX2B$X<KS?A]0ETW^W[KN<GHE[>MYD]O"0C0F^"7MVC/
ML^@MN0XC6)!X5QG,J/S%S9YO&C^]S;?\Q*W>\ST=^#I,DG"<OU-55C^SJ>LO
M]^Z/54I%2Z:V_=#,OKT7%_[>*D,]@/W<$_<_F\*;\E;&[C_R@TX5HDX2PA6A
MMPLD!N8#C@NX2EYEJ8Q27#N\^O6KXQ0P?`$Z_'K)?XW(QQ04YZSG]*H*9>G7
M?"A8;=U?B=B:56-.`7T:36HJ"BKJFZ7B(U;#PX(.1-(-D"4$F?1CM^LX_?Z*
M!9*$D_(ODS7%:BK$/SO]*WB`C4_(E?/'E7P*Y#R#*S)<REXC.L$G'LKP2991
M+$SJ1:UBD_PUSS9!>!O1R2]OQ?]K</?\"!GS1>@AF=O'N!FS)5"WMR2?+0`6
M26)*IF9*;</8+N*;647[LF9*+K74^92&IW:Z8C8Q_4U=D533>FU<;^BF!#;(
M(?#\/N\<E1"D*/0[N!6@JI+>U`]I`;R*G?(QBV=R]P@S8P<L.+_D4I69F]"%
MOGR7ZLM+INNIZV6K+]RR6?'JZ7=<JM!5F%!_/:$/OPS#(%GN7KB?J?"Y[9G)
M2]0D0P4]67N17>*`R&1*5E.1K+99[PU/$34ZB!HWG((%OBOAMOX;]W-W."8*
M5KG[(_>NER\LIKEM/'(SW[/F.BEJ+#8>WK%;W;YB&XZLFYHE&Z:MRU:S:\AM
MRU;47J>OF;WF7B1EFPWR.:0!&=(!SS+BL_%BZ0+G`3D?)&$UBJ@+#ZA$2N%.
MPGVO/&$X"0GEN9;$!T1@D`P57HY!+N$S3"KYG?H^FY$.#?ZJ!E$O?^]4@J<\
MTWDZ$8G*[XP"D+'G^[S8(ARFD?!W6L,DZ64>0,V3OWG2Z0(JNB)0X0%12H;3
MB->_O%-+PV!T/6OY+6`HHYV,HG!Z,UH2;,W<[3Q!NOS,FQ]2L-"QDQ7>T)N(
M,5?F]UY@ET.BP<LFLN\%#).H:5Y1@G$^&`(CW5UX>>`-R/DU)JV+M.N+J0_V
M,N8;P&KB$:HJ=;OG%[TJ>7DJ?,>G+MY[@<!<S@(7WL(^\C3*.($%3GW2G?%/
M<76\SL7EQ]-N9408+D_$2+",IL@NP/BZR%>XF5(TY46FPM*XN77"*ZVN07*F
M@>TB`IZS5\Y<#2PKHVGJ,(;_)Y$78$&/CRD$7M9TG4>^^21GU59Y(KP[Y6D#
MP'Y2!5P1.BU/>EJH!G?F'@E"$V`;I6$V>4PUO<SA2-M6PAC""R`"KCR+Y9)%
MV%BX.^\33_EQ$$:84!]R'R`\7R2+<T`\0#\6K5S(=][+I31T"=X&Z6>!XS<_
MY"'B%7G@!4(1IDZS:.#%G/5Q%0H$8)#B/>44<5[_$)?&8'<3#X8!EM(437^Y
MW/^"73!U'/[+^2%*DU/,AF;^)/*?8A$>3K"8`FL@8(SKV4H6Q1QWEL12&HC'
M2<#!0;8-$E[&EE<B7D\3SHG9;2#_\%?>SPY)'[%PV)@#-V=B43B'IYSP+LY(
M4B![,O)%R0J,E18_YL4'#'YZU]8EU"-PDAAO*UM(02&<$&.<]H(X6/R&>_I,
MU&X`;;Y@VSF\O=7@9$"OG%@(8SK#=/]ID-#(@_=Q^.86*,5%!Q=AOEZ&`<X#
M@4%I!VNGR46553VF+L\AH_$H$PHB->N=)C45"\,7N)Z'4[^"*16-5\*2M[XJ
MIV"$.4F%<\P'X._`?2JMV<4T#JR`Y#S**J<MO^&E1BYH2:4YBV-,]*G>B+>]
MTV![-E45>"S$DB+<=]-:H^*]$Q90'QFSN#1D3(@>T2&\6":W\)_8MW!+<;/"
MRFO<O$&Z13=I`<HP:U_,JZ">4^USD&DBS?;STD3:ZZ2)Z'6JQ@LG&=A?SK^=
M7<UIZG5&P+TNO8[]V3[K.L5>:IRL*.W6UW/\;3"8\&Z=!P\TW+%/3F']?@["
MS8?OK'S+SDT]>;6=MU-.VH2O4Y-,14$5[A`8XR6%S?VLDC:(%9G_H&<='!^\
MU[2FI)EKN[P_O!ZQT*^JH`<WU:HFM?8A4>J08AMUW'9_)/&3U;Z5KM,UMVO_
M<$*9FJ2UFY+1WG)JW'$)>'O..7'T7&(=2N;L_BJ`>4]O'BO:B#9X0`R4>@,/
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MC15//^X`!NWM/RZ:?\Z=O[`5Q!YQ[,+YD(]=:J+&N]3;@;NQ$S\><^I"TU*<
M5EO1Y+YB-65#XT=C&UVY8V@]S;*TCM[M(^FTQYZZ\"!>JQHN+VW:7SQVA<R\
M\;)[M0-_6]V6;#0-^&,9JMRQ.TVYWW?TCJJ8=DOIOG1799<EU/.S0MA5W9/S
MWLDLI2/6^;Y)*V%Y27.<]F>.7UMS9*Q:>TZ4P[PG:K`JTM!ZN2#',;^ZCE]L
MLI]PZ=J+MF`^6$)M.,RQEX1:#`)I36F.*'AHP]RE]Z=G7>?BZO3\K)0E=76^
M0[8[]J!1/D/X@1]Y"AH8'FL11AS]ATY!W;J[]Z7NJR%]QGW'%30ZRPX228]Z
MFD1L!(8>-B+BE[U@,(VBXAS9TK%'J#OC*4T[7S=K>M#>&Y*FM22P>1_U_%/3
M63?%P>MBITJ*JDA:LW64V)FJ9"J:9+:W@]ZQ;X5%^0RVI_&]_TSQ0#)Q`#(V
MKF)XUG#^[66.=G@Z0RU=!:JN26UK[5;=.UD%FT#3;$GMYG;JR?<'S;9D-IN2
MHFQ'9!_75EY=XYE;*Y[B`8>BE/XX5K@EF>;:B4&'P?>&(>G*?F_D&Q!AV,"M
MN25]Y=@W]"MZA\T9054_DGU;`=W56KO"]3!87C=@+SMV)%70OEI22UF[#?XK
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MHMHI.V)N&L,U82A,I@E+"W*"+.\0#]L3-L2;M!9G_U?S,]U/NJ0:;=`4M]S/
M]\46SG/)HZA2R]CRX=`'2QP+3*[6VMEM=52$1T6&0S;@T9!)F+``#T?U9R0[
M$IG$^9G(BX6`>R>+ZOVWQNS@-8O[>W%?\@2(4)21[_6*?,U1O*TNFYJP-6%?
MLSYSOX#LEF(P^=G=M:!\:;:KUW--V,,B[+%%F8XGGZ#.PJBI5N>N;-,OG;6'
MJCW3M6>Z]DP?L&?ZD!248TI+J-,Y:KK5:3!;:,V#BH@HUEF>?(OJ23G]MF1"
M\F#[WJLM:[>\:6@[[>6S]3UX74*T&T9-",X1+:NQOH)69^`>Z%90;Z$UW0Y/
M]3@F12/UGM2JQK'OL+6J4:L:KUGTUUMF3;>]/K)FS0-#YDX=*6WSSG^F7C([
M"Q.VY"2<39TSTM$[':77[\I:#YXR=,N6+;OGR);2ZSI]Q=%[9O/!<T;&-+KQ
M`ADTJ$\J/^4@O2`F\Q/7FG![D&/O;_9)+;X/Z=CS9Y_N4="N\;/>(%^9R]B8
MJT6B1TKBX>?Y;DTT<%<J2]8)>>^RH3?PD@^$<>+RF;S.1?;2DT=*R#4WA]MY
M0/KL.IK2:%9PH=82[>8EWO(9S_ZAP8PPGC6-@32BRL,PDE6KH<$0$6]BQ5+,
MXXGO\=1J&S`+PCOR[=(NXQY7*L930CU`2F+_]L<%Z=*`NG396#`"NQN,\%0B
M<8Z*B/#ADY7KI:'Y'0UB^W[E&!@Z#J=!(AX-^'$],>*2#GCK):.T#S9`[&+S
MO11Z'H>EG#BBC_:U%\"7H1?08.!1'SME)_S(I'1L6$WP*6)O>`NO&(\5<+'M
M%R63,(9)Y%1$[UW<>!1+B(-G-L837V@T&!4,H6H90WCC,7,]P,6?`>!>&*%U
MP`D"@@&["HE3>&"4TXOS*O],@6+1+;8AHL`S871#`^]OWH18(K<C;S""J_'4
M3T2S<8ISXHV!#K!2\M-\/*#?@$Z\A),TF@X2$$8-XE!X.CW_)PW2P>-A<<12
MQG3+V`1YM>`O<DMC>#:):!"GS`(8EI@9@<N&X9U6PX!5>9HW9BL]486O96'G
MRV8%NDL6>0")78'OS0\+#"O!T[K45%O+GNX\]#3G/+W5EEKMI:_O/C#`$DK=
M3Z?2NLPIE8^4X2P!X`A8=[D4R,3HG$B1D%GP0#'O.[`B+.28<Q7RCY0>X\1[
M7$T'HQ(4G"'A];?X1_TO>U?:VSARM+\/X/]`##:`#9!:WD<F&8"Z=OUFUG9L
M3_+1H*2VS0U%ZB7%\2B_/E7=O"G)LJS;1()92R+[J*ZKJZOKX55-X4U+*C!"
M/BB95W2#5R4U^?7L4^%W-F+@,UGF94FL-_"VR;2X?C;B%,+*(RG/XS<9&8OZ
M,J*BXX`*0TJ@EOD13+/*7C7&QB'#PSB&RN-SAL1(%%)KAXH,5L_AV"5<;('I
MR;3)Y5JV,@X>MT/0Q#/Q1MQ@5EY4VFM"NBP]8X'@LA4IM%SB@I1R54U3>!X:
M&)"A,R9HT43Q+USP@DH[B@>1"SHNG-66Z0Y^`HN-.HRJ/3>B]J_<`Q)$XS55
MX35)2X=1%+>,+/3EE?R)RN(4*82KX5,_`GQ7'!FS6P6S!7]5]%-Y5O=47Q=9
MK%AFLJB4&0)$2(;!D^^F_.D'OC!T(I0S9S@,8QQ5L9;E(_<+2(J%PB33QN>V
MPHP&?`W3H+>P/-<9N&`%9Y3YV%*."`,33"Z#S*F3R9CB%Q/+R8KZ8=G.HC%$
M<XDT!7L&AA+L']`#A(%1(7T(O(H1I_*F(O*XR5BPG.>N/_1B"MD!/^GLX=2C
MJ3].&V5=91U-XA"K`$Y38_X84SU!?I)PZ$:T7>"Q`!.H0$]-62U!M@1/F&S.
M1!7?9$8^=*?H.5$+`*SDHYZ&9]%_8M(`KF0(HG#!.>@-@",Q3!A%:L%$\SCD
M@,#B(TFR=E&`1K`/H7X:Y=UTH@,"4H@&B0I9P+CURK[KVO^$!G[S@@&H/%B<
M_Y`I\C)=IF1E:.OT^6@V'@1>(0VW\P4U1OZY^Z5UQF`'G:>G$+J<$IHR-@F#
M(2&C"+AT2&`M:C1^#(-QLK[I]'GZ)LQ[_NQ27W+L1BB)4:+\T[?3FNY`-@U,
M.IAU64\TZ"^JP2NJQ,N&ND0$"NP]^?FE+!#9YTP>\GC3XLWM/.D2=R]<S@B8
MD_KB8*@(T):YY<`DZ(53`XJ*ECJ6E.]`@H)P$H1.5CZ_;)6H=^K$T^<@A`$#
ML[^@VAUZ3A0Q":.BQ:>"AIUE>HGQZ)16T*JJ9G0T"^-&$,I")P$MSDFQ*34-
MA;J@!7@&UN.R'0@TJ(G9$]4-%I>_C((,3/?"X<R?`FKBSFI5A#E8IV<FK2"<
M3HA1D9@)J-BB`0\IEU%J=6DKE;5)0<OH$+H@%3CWVL\*^@,%7948U<H8:R.D
M;$[)`]NFL&A>ZPP_)T:R:GBC'!6Y(M,.&+J;,/CA`E.U9]^!_)?^]01!Q:!K
M&]U1>G&X`\SL^L!"3\F/*+[OQJMUHT"5)>/A^UUW.6BMW>\;<E?O"G9/[0NJ
M*%J":=N6H)D]O2LI_;9J(FJKI'W^*BBF*$NZF1/G?;,L4ZP(!$RFT1_$0?*.
MKOU;O&,=)N"WT7<_`,<J_($.PZ4_B6&Z0*PAF'_:Z.91;<5N6]0U2Y"[<E=0
MS9XB6(8!'_M]637Z1K?=5W>.:FL6D&+3B!/2+Y>^R`6'";46F-^X0#+07T"S
MB#O_ANA<G'*Q2CRI0;(MQGV3]W7Y[4BV^O[@9$^YZP;)]A7<T;9]]0_NV[5]
M1;_)(4/_;=_>VE?WE6]A#)?_LN\O_]6K_/#MTFY??KN\O^S=5=3&5LYO]DRT
MF]M>OW=[6T.MO;N_[ORC\AVBNG;K`+<-)>G$[J_O[6^;G>>I9_2V[6_V50>X
MHY`X\W^.7SY\*4+]'@&JIBQ+O"*O70/V77=B=C7'))ITTG.4:&UC3=[R+(\M
M<^Z5P@LL8NKZW&/)49\3QH3MTLY%^KU7NLXEV)X;\N%B:7Z(2_D[\A?VRPW'
M;_J7:XIN];RCH!>X>#('\*MP!$,/>4I1O?S'G2J51MYV*6_O=#N.`RYPFY,\
MM3S:TRDQL<MLT(9J'YMJQ[;E>'L,8<'!VWJN@7?PEW$DT>`U:VT0GG=Y`6^B
MSEMI,F^TJ]'H:+VJK=+ST'GLU/R34[IWT=Q7:>AVT/=\-IQ:4<[;P`00VQ_A
M?WI99FFTQ?L_?;FOV%W9$&11[0FJK(B"U9/[@MFV;-GL=Z6.W#^(C`RUQ2%5
M6&X>_I%GWK(`[T=,NS#TW:==6/O+?=AZUTWNPRN'SR`@G=]+.Y["[;5TZ[.[
M\_?]$J/;ZV"JPNUB>BB;I<?Q!^N7[[%1P:^W>=[]^;MJ\9IB\J:A[F7_MOL)
M&[QLR;PD-0?5;^3HFJ=R3$?1"J\8%E[8.S8N?__$#4GE9>,`V/V80A&G$[YN
MZ'<(X?^W.BLKKZ-W\.%V3>8MR>05^0@B[ON)%4N\*.J\8LF-COZHX;N&@IO5
MTRL$0%>.459*&R6ED,@(KUT2/Z)Q4!M!LYYHA9;V+'_DQIGA5_:+$XZN&0#A
M;Q1=Z]*_(:$;C%)T"9N!2]`?N\Z49-'9C=[Z>YB0\('=E2Q>`)3KY93:2J<'
M_Q.D/EYPT[6>8-I]6;#ZDM;N:VU%M"T63K5:HE:X&+E;XFQH98JA\)A5"(AZ
M/R>T6E'7Q5N,_N@6K_J^>RTFP%?+*6^KD@'_UP3;ZEJ":A@=P534GJ`;9MLT
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M]@%],\@"%<A''\9LG<N\+K[+=C4WMC_P'N:`=RS'>(GVH\>UCTD5?.A<C96/
MF\NGU*\@6.TGMT*WQ)YABK+0%RU=4.6^*H`Y[`AM5>[*EB6WE0Y>59.ESU\%
MA(W,J?#*=+:9I_);B`"?[Z97G3Z75_UULT\P!V);J2=TOJM@FN6`7C=I`2;Z
MX"76%K\!2SJ<;2H%HFMTM)ZM]H1>QV@#XYBFT.[U9,'H*&;/[DNRI1@'<<<1
M_W"IMT<N5D0\HV+O9OHV/S%?ZQ+D&R>AYW.X+V%L.%'D/KIDM"K,RO39F4(C
M"&Q4>`.+R[LCDD*Y),WGUI$!D?G3,/`X>'-,_OM?!^2<@JI0/FN5AH6%P,(1
M!9JAF%?+1W:60@8YTV*105HR#.O?._Z09#@2#$2`?9G"0R"X604P8^B$X0P/
M4WZD!0M3>)7Z2,[JZ`!('M<?A@0E$6$N)E3DW"'%?V$1&00OF#)TG`RTA?:V
M!(^BQA4_RUR!GTN\*[\-E&+#7%>XF'O)P$:<041\AF0"9'`H!!Q)=#Y#J,@)
MQ'B,<0*R'(.6P^PC_-GQN(GCC@37S^#.$H`5T$,4?HCA6$$C%"@M?D0\0?QA
MX'B,)4('GT&6]K';>!Q[%*`N@1YL<=>^-^.<QRF%OR,_GYTXFJ8(5$DKE*<*
M[U;&Q#,(,(IIDL\LXV\8\;R.Z]['BO@,*ZCJLL:OY!]>4?2-ZT=J1J+K'#*"
MVN%M&,<Y.)>FH8F=KB681L\45%$&JXA9<6+?5CN2W=%EO0TVP/K\59%44S6E
MG"AOFDV9$+02P/6C/:1:`)YAU&+_;A[+T^Q;DM:U!=64P4%25%6PQ+XHM-N]
MMFYKF@%SW[6=TY>:.>>"HR1*D$80CI%Z'X=DU4"4F`%!&8U])P9-P5Q@!D2Y
M&(82&I@/1!F2`O@DB/5WGS9YAX^@[C[/;5SGR_?672O_W/UR`7L+SW-"!E/T
M[/Q`M"9"ZUA.G#`!<1RB*D!-DJ@X^@UC041]@B%-/*#`$_$IM-0,?R>3`MI8
M=4B(738&<S-TZJ/C?K/MF_(0:8RW`FX5QAY)L91"\H3:B<*S)&:PU"-WA\4T
M6)5.;*N7@J1U,EBF*IWN>IWR&!!.B,8'W7%A'5P?OA_3KEMXD@%T`J)X,_Z,
M8@)%9/Z:C0+$#N4HY!>X)(@UEXR[T""J8Q]!^X(I`QH-T0\)$QR_!%UP00?X
M8O0<Q!Z29X!>@4,7`[CKS]BOX'CE3%@%/*5NRQS(TQ3+;09VD6/03(N/BJ&1
M9*(9/\QUOK!7#Q&X*")DS'I!:#47ZZW2P4Q@&PPZ/L/.*BW9Y<UU9<E<CXSR
M:<*2%KD(0\'`0YPJJ^>#"T0:J\2.$OC<M[@Z[_3BY9(O`K\[;,]4IE,P`8(@
M1&$)P;:F.,X^O8)@"];7`T)3[G-&?X+?P+YG2'3(QU2T4O][F`@8XP+@40]_
M9#5JBN]?@!L[)%&$R(N4RHERHGZOQ]#4\O%,@H@5TW6HZ"X(W_&)+#`40_ID
MD",R945<'KW@A;&-PQ"!P9^-<N680KZE8IRVEFM/U*4HF.D,7!BO"^9XR*J`
M)UB/["W<94"W/HH723+U$X1-!-ZCLK$?WKE_#H/XZ;D&T#N'QW/DM2+&*,/3
M1)IS+^"_`1%>P=3DSM&SXY2+%G=3@!,^J\-JYDP-#A8LPYCR)Z5E%>4T:1\:
MR9!,X;6DUC*%^DN**1=V;22!Z*VT=?:ICHK*IC0`FX4.+35;L`G"BQ936&^/
M@9DEWFO2!G1`=WO,MY[C:>#GG+=S_F(D.:N!JZ7DIQXXQ8W.1):A1I>Q2A<W
MP"\?4TGF"CSL9KT6=$?2,X)J4TE)'!8&$NQ0VX$V//<5B.<BHBQ*V%[XO9]8
M(R;P#*(1=!C)T$7KM@DQ%F7P@^$]*BMURF:JIX;M!XS[@WC!A#(QZ-,GRI<D
MI#A^/&.3"6R\<!43[PB8H:"O*.50S<Q@OS\`WX5NM)GW-&5"\X/X,2*;@QE`
M"UCKD>'3PC(+00KHED0*&!KY@.`WJ):H;6!;_3@',BR8@9HN988#VGZ&ERGX
M01!1I,*EZ.YIA".1F*+)2O>,?%53IY:!&C*VPX3^SBI8['.]K4H8)_-(&`^@
MK[P&%\SA`6AIOA-0W^ZNMCU;'AK?/$:>WM<ZO;XFZ(:(&'FR(5C]OBGHG6[/
M,%395OO*040KC18\/J6\EJ-2[G>_=NG/A;T%/Y-?[,76<.VS2&1B"-.08<WF
M92C6S.8*U$#1L%#1ZA8ZYC,<YM1,);]7L;O/JAC;&<;I8HSQ^6T412Z%FJ9#
M<,.T+93$A9#59V6HU/.($"YS'5:D-\:Y8`-`_2V'DP3H4)"LEDS59AB1I+-H
MXF%\[)XAL6>#0(EFH,?,<4PRSJ(2MK>3D;(&XE[S:9@WH?&FJO&RGB.[ZK+)
M&YI:ZDR2>$57*$>P7GDTQ>@[@M[S9BV.Q;#PT5%R.)9&'@MPRL].1%4\P2@=
M>#Y.\GH&C3O'!5[BE.W':-=GZA?%O\B?E1!''"7Q362FET"@&Q1N3*;/P:B\
M1YXX8*_0_%+[&&5!`&"U1QIQ'24W:]&N8U24H]YD@5FJTE7'*7=2M]1+8J6X
M@YT$(8W_3A-8ZS2J3P4_ZQ2M<B(1,\9%A9[*X.`4CAB>%G+,>.JF7:2X[]EI
M";":2]MPV<ZF?#(2X&ZE1!94,*7H"%\.^>1R6*4UG_$FDL$#J^4D$.*+Z)[I
MJY"P8'*&I(Q"69"_7'\L;*K@?OYDP874Z*=B&^?^[V`59CM+P-9/\FRC=**6
M\0B2JK@QZC"FNRLP"]7MN(LO+T1VT(:B`Q:*!KZ0WU$$,)Q%CRT2M1^>?2IA
M0V=#H=P;9=CO*"EQ5`==?P%/-/%*8]H]\G;94VAQWS/T]SJCIJN-C#J=ANX@
M9I?18;!%.4O%SXV*FU,83,+=3%Q@[^E&K!'XE0YC0*8OR(HUS.[%HD8'7&W'
M1?_!&R9'+:`?,C;U"!U]]0V^<&)#X8A@,4>,[9GLLY,LOWX267F3J:GJJ6,-
MSXA/7/VI\S/=7<QYBH*)+]:::((+OR9,4C"3B]1@9JM'N!7&'135`G3_#T8P
MQFW6P'.?DKW,-$BGQ:*.2+",!7.=R91\1NE5&`2-"X8:4"[8IA-6#L>3J\&U
M6*(802XKQ"*-^%*C!6^BZKBQ/M%`)2JRH"`3-F/+C^[$<A69&&*F,IC[Q;U@
M?#E7Q#1&-W4%^CXX)/L*?A$47L?UBB[<4EM0=+%2345W^KC0'NY4_[K^5(ZR
M$O1[`;@UZ>W%,HS]58(^Y:Z;"B&O(2#_?MOKY6/X`^CP.T5^+F)(7]4!I&GQ
M:JZ48#Q8=?7?3;*C)=2&:U@?)*'JE;QEG:\0!<..E:_.+Z\ZO9O[R^NKPN6*
M^^L=LMWQ7_U9?E^@GC-R%8\Q]!V$*^6(;+T^P;Z>:T;ZCN=.ZTY-%H1/<H\J
MYT#9.5*ZJ2H<3=&MI?-$=BXW:U9\/5=Y639XW3!7>G]?X*SKSD[B14GD97WM
M@K\'/3M-XC51YC5S.],[=5.8W[K'6,8*<:/"!8%C*MD#4B`I,F]:VP$\WY''
MNM(T-8,W]>V4H3J<:9J\INN\*&Y'99^6*2_+^(H1WB.4<(O7M+6+(AP'WZLJ
MKXB';<@WH,(PW4K?DK]RZ@;]?NF)S!%*M0B^J[5V89SC8'E%!5MVZI.4P/LR
M>$-<&U?C`YGL6YK"Y+"S*Y#HB3-CEU=K$LV-XN1X$A-"HNP<[]@%_]W<LL/!
M+^]]C18.L(#'H:B1'?'%J;L)O9^8=A"[T7-:`BLD8\?ULZRKZ@ZAIF;./LU)
MZ3@Z-7.N*A9&_P[6]#;*Y52XX=1*()U.-;1-L5]#M89JK]'@M/8I]P'><5DU
M7W(][\`[>,C(<Y4798FWE)VZ$6^BRRZI(?.:9O*:LM-8[,%2PY!X39;?4T'^
M0WD5IU18<9<6LJ%;0[=3#UI@-X-46=$DO2[Q`UIS8).9>SMT./;YW';-93.S
M]9\[K3U"6NF.<UBIN_26'[WAQS8*DWA*D@LY2RYD'KXTOS/\I/"2:H*GN&48
MD+T)SGO)(TJ\H:Z=V73BQ+%@RV6LG=W6G(K04Q%VH1'/-0(LS,K*0:47&0M7
M-.L7`0].%S7VMYG9T7L6RR%\[HJWH0]:(C_R*=Y6Q:8A;$/8C^S/+%>0G7E5
M,QI%N6^V:^2Y(>QQ$?;43IE.)Y^@R<)HJ-;DKFPS+KU"J<"#=JG6,$A-9/J-
MY&DBTT<0F3XF!^64TA*:=(Z&;DT:S!9*\Q0*<LY-OCU;A,6@?J&'[0?OMJQ=
M\J8E[[26S]9M\+J$,%MJ0PC*$8;56M]!:S)PC]04-":TH=OQN1ZGY&@DT9/&
MU3AU"]NX&HVK\9%5?V,R&[KMS]7XE5KD>:/:,L8&0\;`LB%U)*;7<9C./KT.
M,^*&RX%&TO3<CP;.8>CO`^?0U;>#<TCB_B`RMM]W@Y&Q2>B'_`I>X=>LJ;W"
M9IPF%3>,J7'J8?3.8B#CM=R!+65EK='"`2:0;7Y_\=YC:8W79$1K5;<[\=.*
M"%TOPJ+;J<1L8OEU1>0E;>V:',?*]:JB\9*ZY32>T[<<&TNKWR,K,!#J8Q*`
M#V$I3RW&=SKIKPW]FL.Q2NF[]92^=SR)O[I*RY?MQ4H<$9DTWM)%WC*WG`)\
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M"Z/#@&"$`YZ!-]T15H)Y=(?L^(HBQN=@EPFZ/.AQ$D_=840QMES_T7/&8RQ+
M-SO#(ZZ(.!%)L#2QJ'[8XFPO0Z9?/@-X+<1QP&=H>\P@-SLPBY'32@KP.E%$
MIA'W3+P,C_-[ZZ[%,^!.Z!TI`'^,G=#U9MCMT(F>D^'`'^3_8Q?4`4P':4%"
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M[GZY`,OL>4[(-$U^(`\M3IP$K!?''(Y0"4%K+^[TN<0-H0M#FGA`@2?B@P+"
M^E?P.YE,<ZC?ZI!@@>PQ"8&UZJ/C?K/MF_(0<6B3.$1TD2FF$&*38>PQ]0C-
MA>0I]A+-ERC(4H]@K-(R7+2MWL_AL^,_434Z=J,$FZ0TDKM>ISP&IJ3!EKCC
MPCJ`V@8%2[MN(6HBT`F(XLUX:`^&$9'Y:S8*P*.?(B(R9CW`YB!3[(4&SS[1
MP3X&P10>AJ&'J'1Q37`LR$8>V+8%3`$O1L^8_`"M#(!:Q*&+`=SU9^P/J5FB
M*XE]YDS(."UO\NQ3M5$V$AP`OCDC3L@1'Q,W4HU>T_8*&L3_M?>DO8T;R7X/
M,/]!&"3`#"`Z/$4RFQ=`YUN_G8R]8T^R^VE`2[3-'8GTDI2/_/I75=U--BG)
MEFT=;9OYDK$D-KN.KKNK8E[>P?EAJ?K"MTZ!GY+L*ASG<ZX7<QP<'>5L,U=@
M1$9CP-4YT`&8KT*RP^.C&LFB:3@IP022REP$RWT!'FK9IOWA["/.R:II*Y<I
MJT5=M(M"F<.8FQV(^KJ:!X2@F<+*9%8)#EADD:`R.=/P?(HU,LA]P>0_\RQG
MGW]@U`+\TM$:3\%6*(P9P07`HU/\<IX2(:3G/[9B8(4L0R5"6.;"J74>1"G(
M!MQUN9^K)(N8D41'=X7!T.9G`5::3W/ZI6SL"*/D?)K<,+9!F.`'43+)2N%X
MP&6P.,9BM5)ZHBS%@RD@0-,GBB<$.TA&LFG$4V1-@F[$XX7C$\<Y/YE!ZWP.
MK\>SL1_>.;U,D_D%2&G8:Y)>!''T%Z^C6N!QP^0(;G7_^:]C;B,"1.-@AL(^
M:-U<)BC0DYN8;(.S+)I$W#SH@C2*D]O6UY-NZ\-GD`LM,-Q:QX#TE`MIPI:\
M@[;$U`N6N;P#)"E?'Q;!-Y"-B68U2?$Y<+VX4D_V6IJ@3=L*@_$E[:VZ%JPA
M[Y;68B"=@<X"WF9M&\_NN.D^QI."_B$O3^=KP`NR^9A)D[-EE@;^7?)VR5\,
M)8L&L4`_]R8`W\61I?4/6B>`<A#[H1!9*^EW[YXJ9T[BX:AXJR0[^)O1VZ"3
MP@V65IX&<1:0[D`=+A7O32/JJ`TG;"_\/N+:B!UX5D((,BR\$DR_J)O,#N)-
MM^`Y.BNK?96VK+`084'%EP-Y>D%\&:;D-K49FUQ-@QBIR*TC',M8RBO"'(J9
MNQ#]QHMYC.>%64\Y.S3783P/@0B@!E`#+KRQS21<&FI\79#!;.H:\_R8-\JG
MNDYP1["/.9:K')`(E-3`@BQEB@/6OH2'4>QAC66;SW%;6OS"GUI^H</_&VP?
MCUC>KDMJH1E(D<UG9,-=A_1^B1^76ELU1[BP2!@/H*W\!"Y8P@.PTHZ-@/LC
M+V"I?,4YO>>M,,O!.\^Y'Z:(>\/<AB6R4&(X9H8B):/\CIEG:/?#"FCY"RLW
MDU4%'(]9\#TL829.`KMD/F/%)*1!\.BQLE]R$"@P@,P_0U^%&)U'/?#A:12<
M1=/2)V#J:A)E8V#W>4HH1L4"YPAWL.I)]BYD5,Z1*]TT]HZEV^+G%$<FILSL
M*G])/A8Q-2@#V2$'DUZX!/B;$EOPN(2GE`6NKH/IO"`+B'5P?^@D,[C:E>_%
M41:5.K1W4;30QHW#MOZ28UM`=H"7-#P\7*X58*4WC83$\SD10@..93(+<4QM
MF'&A(#"-@05DA2YX`)(*'5,=]R1"PU_4B">9Q!#*'-#Q1QRHK=:I%$*2N^TB
MXE@2H85AS8M6`47WI"_Y0;;>!D6$OW[W0QTX,!`CL(A0+\:,F2IG!-YY!1Y=
M0$93D!>'NV#Q<7(11X(O"P;!`<8K3AP7],CDA=$]S_'`XD.H.,A<`ON=3M8U
M'3YZMWP+@+_XKS5<TH63C!L(;FD1>&_,M#1G1,3BBNV`B7W2;P$RRS@)UW01
M,S%!H==!XMM/,%R,0,![8K#`"L7-M34%,S(!";YX&MS@/E,Z&L0#,Q`7L*0(
M0,NH)I.%D!VA1)G,Q^&DW8K.2T>NC:8QA0I(:+%7W]&;F`&=,XH&H./!?(1E
M\?!?!]&4[CN$UVA6C]%JX0Y6`2A(=A:>F"(Q\.3_L2@]1)`KP76`8N>PT'E.
M#@##'J*=D(2@++P63"B$#,06V#+1]Y"<4,`E;H0X8SDR;B*@"/Y&WF"K?C1:
MX!^G()3#C)DQ:83.9<#1T9J!6XP+S.!@"#^@SO95C[C@-#+C"+F$[])5SD$5
MQA28(PHP-ERR,XZPC!PYL93\[EDR":<\HM?*;Q(MR\.K\L02=C/B:5(*04L.
MMR`Z-89.#=&I`:KD^$OE30(M3-HC=F1^%%>$0XXS]A6:VA=@#\9LGKD4*&#G
M'_`.7)]+/"GS(UL*^8;H3@1W])\$`Q!`S$H6M&W-KV!Y4#>D45K``_F4]K<$
MM<$T2QX09K+0&L,[R+6ZXSJ,":BS,+\)&7P8)^$09LL)S##'C88%^;7"[-A7
M\.HZ9-$@)@7A:$6TZ2F3D'`$,E#T+$>&.CY$NYM+,Q0-:80/`R2RXT/WNY@&
MXY$6`+UT73"S56B&G+L5-)4:*9PE<<#MG7E*%@D[K6QG=-2E8\[#MW?T3L1U
M*@4ON9O)2#XENI(!!RO-V?MF`09UZ=S%DIYM?:`3B>'FC[0J^%-WH#W0(%N"
M,'R<DSLKH@#`NO!D",>"1:NF(*!1TI=,GJ31!4922;V(O3,OMN0]W&7.F3+`
M@\8#XE&AR<+]L`[%;**`G7D6XX]F5VCJL;-`P@HXYHK,_*3X/:G2%`SF@(O(
MVV"%H\HO"$XC.+P3]FNJRB&S\S#F4IH'#ZMQL<L@*[DAOT0<PI:2N'Q-83H3
M4N,DULCK9@FT=,Y-FZO@CG:7,._^+)@21V:780@*E"+_2*XLF(F8#CKPN?QN
M.@H@&+BPJ<&IC#4\^0AN=QI=L_AIW>?"B#!Y"V'%6:2$09:G<Q)ARAO2G,*H
M5*2[#I,P!QU*9!:N$Y(UP10$?)XM\F92!#0+%JH@C/0>'FH\]^=I&$KO*E`L
M!TL*%#(+4&R#AX@*9JJ_)Y?HTB[$P83["*B[>]-@_%T[&5\F>#Z9EXCG9DR.
M*!H53,_/@O0[L_'H7ZCH*4*+JE?F>?*?V^QLUXS9*HMP)WTY1]7E]'V9U%7Q
MKX,JF<$`'9,;378U%DY()CN7'4(:DT("[<*2HHMB1^*"PD0N=`B1K@(J1;+Y
M^*"[6IP!#TB&>:QQB!N.,K%3MB$>VT7S`>,99!WQK&F92AO#=B@)+9E/ETL$
M9C7`(5[+=!.&`1"0ZY`%WZ;1>;AR(4!!E,E<]^Z'BCU9"2N@AR*V+LM7?ME.
M-C,+^V<EO1\?[=Q7WD9F/3`P0Q9)$>&NBM"A:&S&0S!TG"?AC,<Z>=@&HYT3
M?B#DZ*TD&814P406RQ2C8&FM+5DP]A.RGY+:&L,[@JBT]\FZ*2PI.>.3++RL
M>K*7OJX:C&>\E/%$.S%4G>L*%)0K9_S@16D][3'EG$TRJ28('Q!.HNX@J\JG
M1PBE*I-BC40MP:DBDUY=387C"V(GFF#(CJ$+_-W+9"*<W712X(O'!TE.%!H)
MQ8I(U4^3(,Z8_?0HZ<6?6RZO#EJ?V->D^KB#.<%?EV(,\R=<R>$2K(,$(INR
M8.AI,J!@@3+H)0"E`KGI>"X\'!8KD5<F'UZV<:08&9YN+L%7OYU'B0MQB^8$
M'*?%"$*Q,$:F:@]'%98D711_1[Y&7YH996R=(J'T#&VZBG'++#QNC2>](LY'
M@0@#A+?!.*=A>AD7?*4MPN-CE$L":YK>358SY7'`#F,:>REZ2GDB^`H;B0B.
M*KRN>_$Z",_R@KDJF;=Q<!7EW(NLV%A%D*F&8!X22:LZ%;"3[(`4R_B=S.\*
MQ^]'TLC1Z)9GZNW6".7M'R0]?B_#1W(TND@>E8D<`/T,&`*Y`Q/8YQAK)>PB
M1I!3`$^?,,R026EU^M)D950LHU7-#O%%"V,>J)@%4_R?8`I.US**E)&2+B,@
M]$XIURA'Q#"FG#,;H`POAK<L&(>AGE(OR7M*PXN`"M"8-88OX)94<'&!7^:E
MO<#DZ=6<A]C+G$T>CB]C<(ZEN09\9])K*44C!\6`/I3FC3%$7^Z.F1=%'(/.
M->O)<\9]$&8\4^@-,<A"RSR3@'YX$-$6!.U`AI9R,V(U<BUJ83.M5"@4L37N
M>0`-\P@S\7$NE$0M"$DJXP,@F0*UX_`C$U,7&"7`0\XLL@SO&$1@(4Q0FLOZ
M[#*"LP;<<,>@I#!"A(>9H6#.LK8<Y819VOY2Q!-_YI5>22#:0D[3);-$MW`>
MV8TV^Z>5#C$Q<,N0[[[^<Y[DK.IAS*RD@.DP1@2>=RHJ;%B<'4V=5';D=B)M
MUH3.E*$[9+23LC$<!66L.3G+PO0:O7[PG".>D9B`1")-1B%+\5>;U1+!"?EO
M!6N(HRR:17#N128B225S`3#TM]HC45Q@N-@))BX8]O^&[Q79$<Y_2S9,\0=6
MS@9**TW.,);&8M;EC_#,L`,%QR5@>YV?H07/)]\2TV+YFZQ[5X"A$J$MF=!?
M8PDM=8QE\RN>P0?,`"`YH0X6BLLP!^)=&';E@U+V7AQOV>7G0KE`ULY1M4Y`
M+_S8^@*>9C@CW-Q3$Z1BV$Z4LH83<I<?!D*4E=Q0X+=X`N-\(,;NO8PC%27.
MPK_^"F)0C9B:`/L$#4AY6X652`+AH9V5(>:*?TH:5!@?;3)I>9:V9J8F*;=D
M2"6SG13NE!QI6[&3)5[V#:LOPS0+.Q8L>HX-^XH@-7!\Q&V@(E#!3(E'<,5M
ME2OP[YKU6%YE77W+<%M<IU?*M^DL@QA!S`-"`0T!^?DAOX+8KD7Q;Z3DPCMV
MSP(5Z&1"24$LE0932,/8"O,PA`RI)+MP$8S09O-S++FCBVDLKM%&SZI07/!:
M5F]'H1&JSCMH'<5X=0,3ZY1#NPSF6>&/BG@M\I3T;&U/[%H<LZU*R,JT1;+T
MQ:K(MO./K?):&--MR-X:"]>B\P2>DW(WBH04*;+FS$5D$0?48F0B%)9V1,TV
M6;;OG&0!LL,-^`T4=2;Q5(GP58+5%QBOT<A4+F7/NQ\*18_K<)$B=D!&#JU?
M9EF+Y+44R^!I558"QR,LQ?:K]1]5$`2_X3O:TB4D*GL+LTH%'18U4V$W)ZJ(
M';#B:I!+T^0NY.];K!%:6@[$%D+QRQ0X8(7G)]'R)82U:@A3('175@@N9EE$
M_)CV7B1^&)8?3OV(C`16D=Q&O%H7_!U*ATL5FZ6S&K3B.5T&+?VC2K%8M;91
MU(+*YE2U+O0_\\D%]Z)/L`*X++P1B0*Z.B55WQP>'[7O4^65YDT9VM;OQ&4D
MYG86*?:BL.DZ05>?A?<*J.EI<:#(&I^`C$U1889I[3)9(?C15<`;&>A!RN'O
M2]H)"GL)$X!ZO$),C?9Y/#*L;@P-<[97\#*NIF0.D2M,<<PBB,DWBXZJ,@*Z
MN7;>7#O?[;7S/3'ZY<?6ITIC:U6XO$=MN&LS37GO[2@3`U!YH1MH:V1.^C6K
M'T6[EL]0U<0,U5+VRZMEU6(*9A3(AL)!:R"U`1=&]=)=26>15!EWM#>UDS:_
M_<AK`%BA%6LP+MJ02TNB$N%^8,'(E4)+\596"HE;1)N)9\BXF1'>ANDXRL+Z
MPDLK]JD^65R&O$$W`<,P0)3"SF'QC/:CL()&GX07WL"]IBPE*&45%K%(%#Q!
M"6P1$*;>[)K`G3*',<*0QSBL-4%(DQC^/:YG(/9[/('079">4^GFVJA[TA/<
MTSWY2M]HNM>NU%X<5^\+PDJCPM0]J=YA.4Y1WN=@DQR#1Y@+K34$2E]5[RK;
M?RMZ<\!9S=@5#]S&434K-2@S&,R3@`^NDBR84@H+50XHO*+@O37$.Z!WE28&
M,F"D/UC=<QF[%W6:W&6F1$51J,OSS'QW<N:=WSGF5F@,Z)>S+3B5(,DO5S[-
MM2BOB&!1XTD!&BL\9WT`9E@#)6J;5F^M7)K;V+BC`L8(L5>FC84HDB_(!7&,
M&7HA"\["BRB.B]J-_PO@V_1.RH*1CG18Z0Z_,UW($1:>8+=P\*HSBR2]^Z%X
MX20),Q:%CEGF)<<:3K324\K"PJ_&>6F4/W#_0A1'MU?<`:?@=8:59>QJ(=4/
ML)\RXP6U$[F,:_666:M13+6Y3%<:+%'VFQCRP1:C-)GURY$61^?U3E1=EG1^
M:N^9.3`-/<2D\WM@I#%84=/L?]X??AXM]*:Q[9'GV+V^-NQXCF9;(UOS[,%(
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ML_<4YZW!L#_\O3?\TC([[1I6L`-7[:,/AY_[P^/3PZ//TG#KTZ,=\MUK'T@U
M7*Q36#3\5!]'I3]Y?/Q/V][M)N#[W'TJ>"]UUIRW'8*^KC%"Q=$E5S^,)R]O
MD)S>G-M7=6ZW0\\WHX,Q3I:U/E`:]>.+.\R=`_W)]-_=OIN#_33:FLVTXT<<
MZ2]1]IUUM<#+<R_N*!L'SI,']S6J64F2F@=^I]'.3SC*?_)0>!$(7WKW92$R
MO_,S_^/3^,(_T+<\>K(Y\SLFJ7U@;GDX]Z/G+6XV^5=-+&(W$&H&<G1>5*L>
MEA?76%)R4_G"7L?L#`>VIPUUQ]=LSW(US^OIFM/W;<OQ_5%_9"E6S=#T7FQZ
M+S:]%YO>BTWOQ:;W8M-[L>F]V/1>;'HO-KT7F]Z+3>_%IO?BNZ;WXKNF]V+3
M>['IO:@`H5]<[\7%..=:L<A5]R+Z8$EUXPG^;UC>W-C2O0=#[YONP-9\U[8T
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M&NY*R#S]C6I*Z=>$P6?4+ZX3I*L&^`ZI]=-I<+NE!DMV;]`9ZOVA9GL=0[.[
MW8'6T_L]K>_9SM`<#5VGMS*4MZ>2Q/''UBEVPB)DJUQ7*+?MXGG:`HI*[LVU
M]7:+41K7JP(GU2J(M)K<5>V.-<G'8K-*O_MWHBD:S1\H:K)$#ALGB*_HT59.
M0RC:O?-L/8V53V(V17[,:F;"Z[!(#%X&UV'K+`PQ+;8X^."!YIQRXCO%5]$B
M\-Z8=4'BM0,T56/Y=MJ8T6P!,LOY#>_*:C^JL5L`B6]?2@F%<3#.BP0\+S"K
ME@WABZ?!#>XSI69JQ`-R+K*&ZG<_"&13^<9D/L;B@NB\%8>P[RQ(L3O_G91I
M%6-W\$UG`,QYQ,LC@KQ=5A\&UT$TI7AZ2)=X<4"+2!V5K?H3-BZ#E31@WO>/
MQ7YS]>$8YVTVPZ7`'A6(\134XFMQKCQ`-DM2K"'\'E(>"7")&V$]:I<B@V9Y
MX&_D#;;J1T/*H%/Q!*],X^AHS>89+3`+\W)&0XWM5\S=>/>#0"XK[A']86&7
MW\.8%6`B!1@;+MF9:!*,(!5+R>^6>B3!4C>)EN7A57EB*\W#:!&YH!+1J3%T
M:HA.#5!5J9R4WR30PJM1WE5SXT&>I]'97%3F%&->@M9%!">`H"R@+Z;O3*FH
M*)?K:21^+!-C1'<BN*/_)!B``&*3!01M697`?,J*@*32BB6HI6S]_<),%EHX
M-ZIH7H==#YF`$D4$C.T$A-ER`C/,\4J'!?GU;GFCROV4UAS&.)2&E4"A%(2C
M%=&FR_*4C"8W8;X22_M"K&S@T@Q%0QKAPP")/-P!:<DUF*B'CJNUU4FA&:1Y
M4233@BR)`]XA<YY2P04[K6QGY=@>7EK%2'I7#,F1:RSY%)^BN!H'7MU2F2K)
M;)0TP807C`:QI&=;'^A$8E7M1UKU.DSOJ(0U6H:P=S\4Y,8D..D13/,752VX
MN2D(:)3T)9,GX%%%,5<O8N]MWCQ0\!Z5PW&FI%I(/FLH*C39+IO32ZQ#LS2B
M@)WY=(X7`*+9%38'96>!A!4?/H1\)'Y/JC2]2GC9//PT6#;LCO=MC3#[_5\L
MO6$U[>B#4J/2PYA+:=[5$)3V/_]US"=\T-23<M(7%L;CEN0"\G?%Y#I$:IS$
M&K^^0;/"YMRTN0KN6$E$C`/CJI<5VBTQ9:F5!3.<2I9%5*_*93=_MSQ6#81-
M#<YU\OFK;/=5*7RL2=Q6PMYS![K3T7IN!Q/V'5WS^UU7LX<F6/O#KME=??'H
MA2?L.T_HGG=/Q[U-?;Z_=]>#,]5M7=*%5=A'9S7:I-^4F5][0[]O*@J:BH+G
M5A14,"#U>BL>:RH-'IN7/;E,TERCFD#JLLZ4(MT]P'L;3PKC/37HN"PPO5Y$
MO/;@8H0<'Y7J"#>YPQ=6O6`Z>EO?=D^>UU6[\"F)+Q0^(L];X4V<E6?W26GK
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MV,[R=FG9/0W32IE1>[28/5CV7)O'U&(!?TQTP]XF,Q!6K#E)G*<!FR`I7_LN
M&\X5':K@&4P'RMVH:@P!"T?9=XTZ0U5:Q&#*/ZR/'6C=1>%TTN8)^58&BP43
M)J/"Q>DBY27K.CB,LBOP1"PHYOSE"8%R/L7\]C)6$$WN1!D"[)*WMJ.)U"&6
MFA!56(D?_27DSM+U1!%,6>10U`)490U5C2V#8"?](E:;$%75+%^#GR^Y:/^!
M7\C_N`DE_29'OCWEEOD]>>Y-??X67]VDHQ_(P/:ZG__1^G34_4R?E+G6/[M?
MOG0_G]8^A3T<_M$]/?QC6/OBTV&W=_CI\/1P>%(3&]M.8.\#:<=?AJ/AER\+
ML]U.3H_Z_ZA]AOGMP>(8N`:3!-CIT6GWTV;A?.VI_%[W4_=S'[A#B@/_7Q#/
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ME`U8908"^C+#VHUPLK+<BV;$Z(:U5G/^]<I+:S6I21H"@?O4H6!\=UJ.-_G?
M((H_)5G6"\_A-Z>LD]&3ZE+G<<0>BK+$-@WWV]>3P7LL4XEFP32CLH1:Z6K'
MUX>NIYO:2/<[FFV.;,VS[;[6L\V!Z?MFS^J/OAG?#/W];YKA@UML26A8'Z*%
M1F94*3/@]3.'\3&6*4:3`0\X#=F`JVX\.<+:QBYK$;0[K'1'(]<<=`9:=VB/
M-%O7?<WK=GW-\8:=@6&->K;71ZQ8[W^S'<O5G4JCAR?`5L5/7Q[MQ#I'?`[S
MHW,U6<,&UK!-T^VX7HF&>T"HPLJ']V;%G(OXHD_SL92CMH74]@S=MZ4SL&K[
MRSKWX8D8I<FL#Y!%,<X6/2KZZ;"34G0)";/A+8B[!`=`!>G=81[.LL])3,5Y
MR70*CQ;#X-1C"',90VP1!55<`YN5[^J*]F2G29^BU30?^C*98A.X7I!%XQWB
MK^>YCMX?`'>Y0P_XS#0UWQF.-'W4M?M&M]\Q.SW`GXOHTTW#M]P2?8^$JHJ2
M+T4-^-'Y)YSJ=73>9S66NP/>,$9]?VCU-;OK]S3;'3I:UW=US78ZP[YK^=V>
M9W]S==WXYK__S>SH/K!6"?Y*"%8#2E/]E!,BID70X7_+H<-MUX6'J'=G'*#N
MR>\`;)Y548;+M_Z0.=#E%Q6$DOQ2W&A04"^@O+,\Q]/O,P+N@:B*#.1NP=RC
M8$RESF*Y+KNIL0<&6/_T`@]4C^XC`*IB0AB11W$Y=5XRN$$B@F65JV@2>8`#
MP_)-O\3"NL#43P9#S#$.3E2.\2V0U);A&K[,^.6&'^O^?(V+WI#*@<K\'[WC
MZ,9C_)\2I)J-DL2\E2):,2@9N5>@'B\;!D+>,2S+E@3<2@#NL<74L[2,989J
M9<_+?973I#NF9J3'*6(AOSN>!G$.HAT;>;/VF>IQ,`@EV^XL<5T>AF9==7W,
MKA7"HURP?Y*[LBJ'$71<70L=^'4T]WW`U107ZSB-OYS,HC@"*4_R7MDS#@8,
MX,$S):W]``PUV2Z&5<+9*=4;138$DN[XC.?)40RF#TA,$!SHJ63R>$XVDQ6^
M!S</'B*W\%0$_4"U)!3OL[:&P,//HP44]CO6P/7<@=:S/&"F`;;+[/5Z6M\"
M)#J^.71]G]WMUI=,[]P-0A:$+@X5..8-O'MW7S,TL8KX1)<--`6V7>:%JW=.
M+1NC;*[A.9U.14P_`\J:7$^3<1A.*#(!OA@?`WYT_J6XY'@L2N%.\N?T#=B>
M6^FC*O,EX^2Q,%4Q<AK.\/9J>H<Z(+_KBNZWIPD^SZZO$H-WZ2KE5E7>LE.Y
MIH('9]OP'4<ZF4\`K-:B%Z_2]K#K/H8X01:RB\>[XXB!.^@90]?1_(YO:+;G
M#[5>;Z1KIN4-!Z8QLCV/-YLP++?C2#)]^=9KH>>E4TF.Z?9K73>J=PPL!T2%
MX1N&+T<A'@/36J*4A35>H"@UR>*M6('/`W&YNZJLH>-0OL;3O46/=:EA(PO1
MPRR;8^/P0ZR8#J;'\[-I-#["%N_BVKQ2I+;`J',LPZI&&M<&J!Y794,#X!0-
MRAD!RI(9N-SP7-\Q*A'D>T"H0CL(KU+8!'$X_'M*"@(MX1FV\OQKUP)_78(C
MT*`$2I#7@:,*N?R-^@DY&\-/?D<6]?<!4`7U2(0O.`OL$KXUV9A2!89MR31=
MV#:#*OCO+>5<12YHB\VNG.'`'W1M7W/[(S"]?-W0NKU>5^OVG=ZP[[K^")[?
M<;,K?4FCBLY!JR]=4*%*CF<VH-ADBZL/P<<6<R9$&YDI[PNL0%.KH[BU<`O8
M=%FE#!MNDDD91[P\U`7#*DYN6U]/NJQ-TC5UE`I8<0TSMG&L&8ZAN0Y;&&)J
M?2CK/_O4KIX^+C\<_.TC:^6"W\%B]!`VGIJ%K1#TU)B62EBWE0EVS>&]:N#U
M-+)D7K8(.CP^PIXSM>J?#@.I?`M[1\2F2V7S,4[D8E.D^/`O9@,%\C`I4]<[
M]-Q!JTMSLO+*8FS#\&RQY386,YW/4YHS=L&ZZHB9.#3,AAK:U-<^I=8]Y;IB
MWE0!(JU$35DDMLK:[$^DQ56I#O@0%FS\D^5I1*UU^"B5FR"=+/L"Q1RNPK\'
M.00OGK%1*I4GY6^H<YGX@J&0C5?#7["9<8PUV&^H!=+L:IK<A=B";!+!AO,D
M+9[%&5GS:1[L;=82S78+;J/9?%8V=6+ME5C7-_E*'!NO%=PA72,PMM@HF7<_
M5.@K\9S1MDVK;1O`E:R+%'\#:^VTT$AJQ5L!H=BZ*6E]B*2K2*[3:9NNWXH!
M1O8@$&HZQZ9<'R+YA[BK!<AP:%1Z+>9`<;NQQJ;B@`8Y*[Z+9N'B24@0S])!
M*+<@[P%[*_$W9_.S__#A0Q6VQH9+C),*]F8<1*<`FW8MGB%&D)MD/IVP\82T
MP$U$#9S8V"\V(Z_R5!OEP"4V*J-+D=39Z?8JXJ./$NQ6AWVRP-000B&0#T0Y
MAXX[5"`E)A.Z=(E3H]J<)1YDI@=(4!$-)$R">9Y@I[HQOJ9L3I4L$>T&'<1@
M?`FKW(&5S#JSB9Y7\-W\"@$P=/H6..<LO(AB:A>V=+DVVXW#6G?%$_Y#_*ML
M4[:\S81IT_1#^Z>R6UF>X&RRI0@*KB+\+IGG&0@%\1[PY;$172I7>:+@$<H!
MON;-%:>P.0`7H6JW"&:<\`6OJ;_M'?9=8V1F@^5PI;,$Z8N7ZX6<VJ%0NG\N
MZADW+C0V'W(LQ7L4LC&6:^,VL-\\%>3"J5Y")92(III@6$2<=B$5@$M%J!-'
MF!'GP$*6U;8L<^%HO>/SP_[&3W68CD$84$,_N6\>5[!96"AK$`8_&L:!KB.G
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M+Z]%W),;/S;G]@W1\\WH8`Q:9:T/%+C[^.(.<^=@VV-'FX.]/]J:]G9A?EVZ
M^4N4?6_1*`V<H/'BCK)QX)B-:GY5)]@\\)_<)O%-:^<_>2B\"(13R%VC&H9[
M(O,[/_-/;%7E'^A.H[75//-/)*E]\/0VRT]1UOMJ-U1,'`M8)6&8+1_%5:]&
MB&D^&-Z20I1ITR@.6V=XG:>57/,ZA.#J:AJ-*>F48M5+%L%IQZ0^SS9&R03S
MS'Q]433#YXEEK0MV(VO*<L^\F(`_QPJ8EB386$W00W*ER/CQ3.>['UCOI,=U
M3F)]FG[$PT^?_4C9T32D4JSH.IS>'=0:.BW?Q-,Z."UIW+0+EEF59:>)950<
M?1FD%ZRL)*)KI46]%A;\(<%9-MERVQV'(?-'QVYW7+OXX5JT>/=#E1KM.N8I
M%SZ/>=/OO^K['2<9EG=1Y<=TRDBS#"[:-=]SV_:<MN\:;)+BNX7R.L$B$A<7
M@]P`'V=A2]H-G1,\1(*--<'$91V*<6"[K`;EOC9=:Q3#2E6SU9+AZJ4H?!(O
M?ZI7^^QBM;=GFY;%X5T'#`GJKQ(CR+>!>%FQ,%"ZC`3LKLRF*HC7O,%DOO_M
MV/BW\[OA#SB,3]FT!#/=]<&J_V#*N8/J0;IYGD9G\WRAH<Z?8N3ALZG/"D_>
MMVZSZ)<XFH+)F<[#)]]:-]^W?GXL6`30T=6&[B5M%AZC"L\@S,9I=,49.4PQ
MY0?DQ*N+V$N!<_AI<-L#C7@>Y5^O`.0PSZ?ALZXAUC:O.X...1@,-'?DPN8M
M2]=Z6*AO8=\3SW:=D<'O_79;,W:5EU[?"CC>0U[_R;[#XLT+$,5Q"SN67"49
M&[O`BX:FJ".RG,^0)1,`?@4"D@#,V$I8B@2'G-:-6X[^4VL:?0?9CC\78R5Y
M_PRJ5)Q/^2Q1,#($=@[X27H>CE=*3R%HCN*]79A=\VZ%?[_\7`7(\ML67WAM
MYBA)Q:4J"<&;XLB>V?-=O]/3=+\/8G,T&FE>IV-K0WT`8A,\7,L<<8ZL%)BV
MEI;T/K*^5*HN7;.\M%54E3Y04WI?46F+61!K59*VB@+22@7IT^M'6Y8AUGA:
MU>A]-:-2T>BBQ7(_0TE,6#VZQ3B7+8C'XB1>@323CZ#Y5-%IO/]-/\"[V4^#
M1,+"9\+[T?F_D9&8]EN"P3^!;<5UWQV?23)E]']S4!^_70E6XH^%2]SBAX>Q
MQ$5BI1*UNZ#^FB@AZNLV1\FSH)*PL_;U_D\1_&!";V$2/J3K*JIU*`+&,0S+
M]'RAIIX'H*RXQ9-'Y]S.W8.SLWY;.?!W3,-R#$.HZY7;EV`<WF*,9!YEER@P
M9*U>0^,N"6\:`\MUAEK7-FS--HR!UNO[(VTX<GR[9PW=?M?[9N+Q\'3=U#L<
MWK5!J3H&K)4J]X_V:)6MR>XVL#M`[0LJ/P2!+!=1C@K90#\'&P@-;U@#&[1-
M>O/\<Y+_.U2TF9Z-MYE]W;(=(1(?!=`]7/\EG`41VE65%>E*]&!.'J^8W%:/
M&ZC'()WWO]F6;YKNBF/Q=%@E!!;M6$<AMOLZ#L&0WJF,6%\L>G1@J,7#/5NO
MP(;P!].C\^)L\<9FZDL'!WTVWW5ULX!V76#J_=61"_)HH0G2*1;+')V77/)$
M)'SS3<-W[%O#=#S/Q3]MUS?@3]VVS$63R7?T3F]H>EK'M89$9<VSP(+R[*$Q
M,'NCWG`(&@'IC7THN^!].6W'MMH..$;"09%]F-+#28MN3WQ`(P&],-FQ=H%;
M_):%:<'E"XNV.0\[DM6U#N26\.MB???4XN3I&([W1/)82!Z@SA`=7DX46+2M
M&YT*;4[``0:L=5OA[9AF]08U@O#+N:YOM3N&N^S9WOW/LD$8KM=VO:6O[M_[
M.-'OG_\Z;O6#.)@$[%X;;SF7,H:0626*B]7(PT_BL%Q'P-J&+>.F^H]@PGK^
MHHL1-/AH/LW;TJ4RNILK=D"7:45^R6C;CM7V?$-BU')#9MOJN&TPP1:_97LU
MVJYIMDU#7_S!8\#8"/\7OD_Y$VH5N!E^_^9;IN_IM[ZE=VQKT9MW=7?0`^'L
MFDX'A+-A:AX('JVG&T/;ZH%W;X^8<*IQOZ4##FVGPH)<4E08L,3O,_EN73&T
M"IT/-^(>%A>_!T$>&L_`OZ=[MSA*PO<7,>YT7=OH]UUMA#K1[G1=S>^-+*W;
M[_>Z/:.GFSV/81S<0UC6U71+LXS[6V[7MKY.TW'6&.L+_'Q`*=EG98$6@%X9
M4K"?@1"=H@J.Z3S4?WPY;`]C982I>^SV#/8CL[30S&+_HG.\=YZPWO^&Q0`8
M>&Q-$VH4$L7CZ"J88OX59]&0A80GB%+*%+V%`SJ=4C?@%FO?<DNI`_CN1\]J
MXS4M/%PA-5-J'8WS!&T`W/W]>'X06P\CG!$F&O.GC@M@-LV&:UNKZY,"G7BK
MTG_M,1#*N89ID&5%I.,H_8*)SO)$8R!Q2WSG.CUKX-H]K=_K&`"LB7!B-]Q^
MSP<WUNX/!@,$UJ)N5;HIXE1K['A%#^'?RV3:GU%^^5`[W&KSW**[[D8[5@*2
M7,<W;WW3<CL&_.5W.LZM83B.8UCXI^N#^@0E:AE/82C/ZWNN/;(UPX6=V#U'
M!_MR,-),KV_I/=W1NZ[_S>'R7C,,RS6M);V&MXFX2GJ6?71T/@1/8#())V6'
M8ZDE]BA)2RN'-'Q?.!78N%C2POLCROWIZ_7)8A4)[!?%S>"*.IY`G`^&G-'9
M)=[,;V8]\:\89ST909LX[29*U$H,>./XJ35_C/-H$DWGN-P)\B&M-KREYE,3
M-K5K!BS+4^3#(,5`&_;1I;=T9\]('@!:05,"DD$;^=Z22I/[VT';]LAS[%Y?
M&W8\1[,M2OH#3BW/LVW?&?I.#X0G5\D=H*,CS2S9"-PJHM+O&/9V4&EQ902Z
M2.XEO`5,*BY(=R0+K$;S[PGO.Y+!'!&TSR<C@I:"Q;#')@_ZT]]XD3N/SB-L
M:#6^!#;YG_>7>7[UR\\_W]S<'&3A^.`BN?ZY?_@/<)YU7-SNX`"O\K%RJ2R\
MH-J+7V_/TNDD^B6\Q9KV*/^=%<Q,HAE._$SB_WF_P*2]N^*??X<UL5+XCL97
M=&^C[/UO"[]GG,L&7+#E?_UYZ5M_^_5GL2V.@)\K&/CUJO3M&1!YD.88!<'@
MB:WIAH93G<I/BQ^&\43Z&8NQB,_$JZ3%?_V9D_&9-)7%MY(T?::<[]TM7Z#*
M"-QU?).D)R/H[9)^R/O]247+;XL-UG4_E&2190,.\>YRG<9U];ELJOH#9%=*
M"ZV]F1,X'62LL8H=/#!)C-!6]U!-$KW%`[!&9.<%G@"R(T71VH+Q>/>66;X7
MQ-\_)4%\=#:-+MB$F;?%]Y58O)*\O2R#(?'U"7PPIA+4:7B'Y'QC]%N=5U>2
MFL6YY/D:4C75,RGYJAN7!B?C,`Z`"#(#D;=\6F;^T:;LPC>L+N`TX5G]KUGP
M=EE+<69JR+J9.D&EJ#P)HU\^A1?!=$B[D6B[-NDVPDFK2W@KEW??$!=MG4]>
M)G:L)JJRQZB*M1X;6+MF`]"@EN-O_\RHQP>2]%Q2A+I-1TLU7E!+8"J`'=?@
MZL0P\:0(OP6LDHZ:!V4-OZ6\!(_WHP[C/KOLK8A=8)@[):2I^R^7D./Q?#:?
MXA2:07B.R[&276F,ZPE>`WY3E*WY#26A'<5,G+VX#:N92<F@^LY9!M-*!<M8
MKOMR6$8$#';(,BM-IC?$/6I93`I@QX+/577!"6K-[.S3!;=<$PLN;<-DSE=C
MB6Q$,*Q)6MW&G^V(M$OUBJ'[OF&_H!#F#A4+:P(4WNPD6JD>Q[Q$6;E=]'0Z
MJ$K,!5G9N-^/L0K,]:P"<Q^4;+3>:R-MXX`K[H"KS3.-!ZZX!ZX<^RAE-JF#
M'MUKS*9G^0?>6I2$G^V!DHW9]-I(VYA-:IM-BO-,8S:I;3:IQSY*F4UJH,>A
M4IC&;-I-3=,>*-F83:^-M(W9I+;9I#C/-&:3VF:3>NRCE-FD$'J,QFQZ%J,;
MZU'2V`<E&[/IM9&V,9L4-YO4YIG&;%+<;%*.?=0RF]1!C]Z83<]B='T]2NK[
MH&1C-KTVTC9FD^)FD]H\TYA-BIM-RK&/6F:3,NC1_<9L>E8VVE\OW>KO@Y*-
MV?3:2-N836J;38KS3&,VJ6TVJ<<^2IE-"J'';<RF9S&ZNQXEW7U0LC&;7AMI
M&[-)<;/IY?",>HV6%>.9W;0<4)MA&CM;<3O[I;!/T^-$E1XGRG&,6IZ9.NCI
M-)[9LQB]LQXE._N@9..9O3;2-EI/::VG',>HI?7408_3R,K-<KZS'FF='9*V
MD95*RTKE.$8M6:D`>DS63M<PW5)2&H;A.89B8>!U>9O^/HS'^*[K\'@:Q*<W
MR>EE,L^">#)*YFD>AEN?:[M6%V#XF;L+FNJ>[M_ZOMEQ%24I$NES,`LE*K*!
ME:O(>!+=O@$*6H9NZ<U\RL>2S](`E::_QJU57;/T;1Y`R_0:\CWA]%ETK!X\
M??`S;ZODX]-<#%=W;_T.^"R*4N]D?I9%DRA([TZ":;BH$K_&DS"]2:,\3+<\
MV!<.U5[G`U0I=]^4QR9[J>HHVKX*DR958F2E?!:5D*-WZ)0[ANN`>@5MZRCF
M\PMV/XURE,N'\22ZCB;S8"K[XDDL1D0.HC0<Y\GVA;3NK$4^O;-U\BG(VTH@
MQT3?33GDK#G>QMR66V3(PW^:;.:SU)NUSSE%JPC9!.A?&66;*E.UJTQ?#LLT
M;IH*1:9J\TM38ZIVC:ERW*.<A;UO[.A-.O#9'!_%0#_XM9PC$I]MFE1-%^J-
MTJMH9;IU>IF^ZP.]@&J6H2:]1D&4_A%,YV'OKOCGWV'-(!U?WGU"BE2)5_SH
M,+Z:YQG]PGH-E'(=W^0^"]*MTW'@+TLW.B^!B@-`QW6`LN\0$)7.\?$O458[
M>$-X?#+!4R=^/8KB(!Y'P;1\[*&PI%*<]7BQQ$H.P(J^2F*$=G<.V3[9&LSD
MCB'8VC`<QS&LE\_7I/K_#-(44%C^\E,4G%%J^RTS,J;O/R5!?'0VC2X"C#QN
M.-VP'VYN:BQ4I(IE^RZ($<,Q5`_0_V^87*3!U64T%MFY<3*/\_3NEZ\G+YL&
M*R*PKFNK11+%PFDG0(@PZ[T^O=]$Y)6+R*O$"$V<?5]Q=J6XP+:<A@L>5`_=
M-R,5;'W[P?*7SP_]U\P/4G;-TVW52FX4R:XQ7XX)AQUEV!3BBR;KJDC651V>
M,`S3[A@OR)C8C[#HO3W&T"W#=QO&>(`Q^J^7,?9>?;%+F,TF4[])'C5W1J\F
M8*9TP&SOC-`$S!0(F.V%"QK'1VG'9U<\H9(9LW68F_G-&^518V?T:LP8I<V8
MO3-"8\8H8,;LA0L:,T9I,V97/*&2&;-UF)MYRAOE47UG]&K,&*7-F+TS0F/&
M*&#&[(4+&C-&:3-F5SRADAFS;9B;^<8;Y=%R2.;6Z=68,2J;,?MGA,:,V;\9
MLQ\N:,P8E<V8G?&$0F;,]F'V&C-FDSSJ[8Q>C1FCM!FS=T9HS!@%S)B]<$%C
MQBAMQNR*)U0R8[8.L[M@QC2-B=<GC[M[\C16YHN@5V-E*FUE[IT1&BM3`2MS
M+US06)E*6YF[X@F5K,RMP[PX`KZQ,M<G3V?WY&FLS!=!KV:4M&JCI/?`!BII
MDJW#[#2B:I,\ZNR,7HVH4EA4[8H-5!)56X?9;D35)GG4WAF]&E&EL*C:%1NH
M)*JV#7,SGO*Y$W.L'9.GT20O@E[JSZ10>V+.#BGE6:X%2KZC.Z9B76.+*1CS
M+(K#+`,M>Q;%-`;C)+P*4CA(T[LOX3BYB*._PLEI&L19,*8I&9)Z_A(FZ44`
MOZ`'7P/%FAE'S8RC7=T1W3E;-S..WA@C[W+&T0ZYV7)]`]2J:7J>\2)&'G&[
ME3/I4?HENKC,%[DW.TV.Y\!.01:N[_6NO0EEYB[MDE.:N4M[IT$S=^D%S%W:
M.S\TM6O[KUU3@`N:<3OK2(5=C=M1@!^:<3MK\,.NQNWLA1^:<3O*C]O9,U\T
MHU54':VR;\9H1JLH.EIE5XRA4,9]^S!;AFY:S13PQU'%T@"1IK4+JK"XI8G9
MI9=!I,?'+9E`&3]5H#3LL\@^Z@DR:_O"V[9TM6`&X6UKEKY5A66833W.1@T,
MP]P!O9H`]XL)<.^5'YI;^O?SPYMA!,-Y017?>V"$+^$D#&<!V(Y[\DOWR1U-
M'DR5/-A>N:#)@RF7!]LO/S1Y,-7R8+OFAR8/]C+R8'ODBZ;WCW*]?Q3@"3`I
M&YY8CR=>K7'9),M?2+)\CXS1),M53I;O@#$4R[<\%N9Y'#&`L\L@#;,"FED8
M9/,T_(U]_.O/XF^V!#Y5>S[*$MLTW&]?3P;?X'7?:NM-HFN`K-PU/O=Y/@O3
M($]*)I=>S-?[!=:KOIU!M/QY6G80QLD,[V4N7W@91.6:BP__^K.T]X=`7\#?
M2C#60B+/%2N(13F5O4E<7L$R"TC$#]?`WB!*PS&\;)&+:;?%UVLL=<+$SO*%
M^)<KEF&R#/[Q_U!+`P04````"`"K,:U$`B3-'6$/``![VP``%0`<`&%Q>'`M
M,C`Q-#`S,S%?8V%L+GAM;%54"0`#0O!Q4T+P<5-U>`L``00E#@``!#D!``#M
M75EOZS86?B_0_Z!Q@<$,,(ZS=)D;W+1PML)`)@ELW[:8EX*1Z(13671)*3?N
MKY]#+99DBQ)E2Z;HFY<L-I?S'9)GXR'Y\:>WN6N]8L8)]2YZ)T?'/0M[-G6(
M]WS1^S3I#R=7HU'OIQ^__NKCW_I]:SRVKJGG8=?%2^LW&[N8(1];4_1&/3I?
M6E?(M0,7^=":=4>\/YX0Q_^RQ$_'@H]^NQS?6:=')Y;UXON+\\'@\^?/1XPY
M29-'-IT/K'X_Z>Z7B+!SZ_NC4Z`M\\V8!IYS;GV7^>B*X:AC!T@ZMTZ/3[[M
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M_C[Q8=Z)/AYFM\2#@2+(?:2<B"ZN7,0YF1'L;(U`L?E]8GE$#&\_)#7Z\%^P
M3VSD-H]N!,)NCH>NCYD'D^$5-P%GL]'&Z9Z\`%]>J.N`A+SY,X`)/?2<!^`3
M$Z(*OL(>AXXC2IK`5*]#O7@;FY?U>VUOIEXA_G+KTL]\Y#F$8=MO`N!FHSO3
M?4VX[5(>,'R/?/CY,'M8""L!5C4?.DZXO)';B$ROW5.#X*ZHY\#H8V<2S.>(
M+6&RD&</1):-/']HVV"?^&!$/5*7V`2WAKP1,AIDRQ@[&*R,)U=0!G:E3^#/
M1ZB&&0,B?6K_`4LH_!VO*P<#L<2/EU=+;&J%K"9G$ZQ#($#\$CV^(A>6)Q=V
MGQ.X.%JGF]\W,7^VZ[A!Z'<4>;?()FZ+PU_=1TN`4D9F/VT8D:23MB`E@N82
M>7^TB4K:3Z-2?#ZG7K3^6Y/0%5VT`R>=%+]BX;!B9PAR#SWC(>?!?!$JR6;1
M*?78I'F!_3O*^2-FH9G6FFVATDU[L#*B&$S.P`_[$XN"$QL$\S5Q`^#T#6(>
MJ/E5K>9Q;TG'/A@S!!/'$?V#*3[!=L!@@#"_>;/=P,'.+:/S,I+7FFV3<\T2
MVB!K5_[WR.,^"P,E_!81]@MR`YPS*3]Y]$G$O80I-?*`UB:$R$[=M\R&ML2*
M>E_->)+WU,=\2E?=KIQ`OND\;0VO5B=MXRIUA*;XS;]T06NU@%6QXV[@3S[0
MQH<5`:WS(^/=16Z=*)NNR%:GA'+?;7.AV*';#Q?4^^X,%Z9"T[2Q..I2T#9'
MKO&3OY]9(.M)$\+61KB\O]9G>.J8[6EQEW>H%V][RUBEV[:QKWM=;0ZSO"]M
M*%L;W*H>VT9<Y"/L9S&K]MP1#K0V`^KU'W/#3I-@1`Y,CBM0`WN.2`.(/A7]
M-YK+$)$P6*-A/X0IIBB$Q``YP+D<":Y(3:$L/V5B"L+\DQGB3V$22L#[SP@M
M!B)C9X!=GR>?A#D\_>.3.!?EF_CCWV/_@R?;MV-L8Q)&$?@]]J\")K9NDXY=
M](3=BUZ]N@.-J![14I`#!,(G+,#.'4%/(E8.;I4:-I46M"#D'(L04S'QT9?Z
MZ*K@;:Z,#BJ+?8RA?X486X)B"^-K$NK5ZNI`=1WOVC[,X#=0<D6Y=(H4E]5)
M]12]9=;6/?7LTDE464T/%@830D2QZT$IKU4/R:8I(3ZIZD3D`41;40^+*)";
M(W6K)G2,0(8R";>S)313N)99$<6_JLDNKJ892[G([XC6%+OEB4J?4K%_7D&V
MM+P>ZKWG*6;SD"JQ*28(DE)>5%8'U:%I&*G\2DE87%8;U<K36U:Z"Y2K,;T[
M.O21X04BSLW;0J3OE?.]N*P>JND",W_YZ(I-'?`_02@OA,<'GI"4^)(J.C!,
M7BCSA=`8>:^8^_,HDZZ0]L*B6FA6U9\=T9A3,)$H0VP9T9`X#<.Y\#:'OL_(
M4^!'ZB9*FY;`J=_."FTFV#%D>>"(V4E_\&<NTK%YUB4N,>`B'TVTUB<^GB?U
M9Z!S-CS2I#,J<P8MRF"`PO-6/QP?]ZS/8<)4^#_\MV"$,D![T3OM60$'XN@B
M2@OH*KIRL9""_?<A@)5H^A3E!]-0KFF?+%C%$$(*_O2`P!=KBA3KV0%A58R0
MIN"_/2#P$F,L!?O=`8&5Q,]2L-^;`[8@#I*%6N39K'">&+1\*W!6!N12T`8M
M6PGH[>)\*0<,6LN5PUX54TY1']"B+HX/I5`-,JDKH)8%.5*\!EG5JE%AB1#/
MHC;(RMX&]18>](HW0.!!\Z:H5`K>3+6N8)HK;?.G"\3,25#"AY)MC13UR:&A
MEH;H4\S;^-R=3A'*7Z70$7HW;_5H8L,:!#KSR5_QD2^16R;6^H.7/YQ>M$^M
M6%-+XLGF[1CW&%@(AJHLW:2D1B.)`3=OXO1)0/A+-)IC/$=$9'>&F9TCS@-Q
MM5+H"U\'(%ZB>P)XR-OJL6BP=1WC=4L92`\O$BWV<LI`T");3*R?`88X=7B)
M9U!&/GYU6M"!,*'BP4L]QTQ.)\PU&`9?"D^YNEYL$R2.F>:B\:M0?"6RTLI:
M<&$/,^0*>\>9PVH"=H>,C\-T,D`5M70@B02:8'-TR%><A`M`.J2G(:/5$96#
M-2).!0/=H.)!2;+E"'10Z/Q!35!+0-_SR`,]A+EL6-OL41\'@<YX&"]AE&>D
M'/UFZ48TR7KC*KJZLHX>GD8#6KZ>UDOIH339?XD863GY)<5UT`ZZ(5V,PU=$
MW,A_R9P<BEW9\+R_!%+=5K0@!;LY$B]"6`ABRV>6O+R6A**$E)@(64[(9CD=
MU(K;1\'7%'NSU_@5NS14T^7\+J_3B&P<8V'6(C?QED#BQ0Z[BI2L4;L#22TB
M"(.%*IW2=+LAW`\?.O\+(OFCEM:BU%(CXZ/<\1V!`DYH*42<Q^+BV8(QV[%%
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M475"EZ1>=^X1>@03@SHP0QE&'%_CZ+<LOZM.$U]:REI3M_(`.38)IP_\[89A
M&"'V,]-*`D6I:C<3TSYY,&=<\E<JUVIGIF6:>$]->T]-4TQ'RHFLD5=R?E:>
MI%2CC6ZA+#N*4!MN:6/=P!T?$$X.W,6V<S).I;<4;MF8IE0EH:!AG;T2,!0O
MEY\X!NV\LI&&(#9?HT,(!9MV\LRE71KM$!^B&%O#?%!MM$-\6+F=3?)!M5$M
MMQZA970;,`61O`B8_0+K.'P(*0G?2[`J5-2)1]%CDA;72[LX#J9&=EI2+\7A
MB.>V:RI)+ZBB$\.4#FTPO$1NAH^\9_&*9JGRJZ[7"332^XM48<D;Z`2^&E>>
MJ=75=/><C;$3)@TE*V+D@:9`[F/PY!([N=!$ADRY?E?0*:F8RGJZT82WZ\<V
MO@*(7''=M&>U=OJ&<&DF\];-Z,9:X&2KB,(:+3248KZ(1-0M%C[3(_:0NW$=
M8EE)/>GZBY5*%^\"23/TUXKIIE5A[4J+Z[G;$S%\">O,$=%9<*O+HIZ2PHW,
MTLE"Q%/=7Z@?6LLK:2Q$-':*+MY7KJ8WXWN+K8!<,NZ.+J61R:DM,4TY'F'D
M54$M,4TYF+5BVIE9N>$-1/#R>1/KFDMR!5/7<V8:YTQA)$)R!].7QQRI`Y!R
MR*!,FW;7E8Q!)AV&:G<*23QB(R_]:D\2E<6G4U89E0/=ZJQ2\^Y3SIF40-T8
MX]3=F911)N57MV@7%,7[4R;]\+X.U:*Y*<L,<E_:G%?KNW8I@P[`(J^YRU[$
MH8I]#V//:K;-KI+8K[$G-IOF69V`N9&W;^]AGFUN'DN.=9HYO6KFQ]0_F&_2
M&97F>:26YVSDBS3-,ZO\@(213]DTQZ32_41##PTW/H/JGZX]``MAV\FD=O3'
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M+UY8VZ1UOV(,<`L%!AJ:^*L1#]]`?`A\[B//D1_X4:NK0SB7O&17C$1:7@_U
MA0^P2B@O*JOYV;T:4ZKN^X,F:9<=&%'^`J^92B63UM1EG9(A,U4IOX:\QLX0
M'!OT++95@^CJ9=X1JN^Q+^)OCYB%,<PN,WB-U(P;1>>+P(]C^^%-O>(R0>(&
MP/@;Q,2%O*M:C;P->:!O%G;W72TY92R\]0ZY\>H3'.+Y5Y@SZ_)7,+;1YA'K
MW=K:'Y*PWX=%+G)7&T*N$>WO;DFLDWP9[51V]'6P][>>WM]Z:O2MISV.XYIA
M=!_,GS"+=78DMC*V;N58;MM:9Y#'%\]FR2R3*_7:T+U!M>M3)FL:PTB?KC/O
MX.1]P.[O;NI]!\>H][OV^`Z.:;EW^W\'QZA7/;KX#LZQ24\M[6C.9`563?O`
MR`=#&F#7MFZSD2EY>^578<!DMP=(NAL[''H^<00CR2N>8#M@83;3S9OM!M!Y
M]`ZF/+JXUFQ'`J7Q:0(1PUTE[=XBPD(S)Y<I],FC3QRS,(5PY`',KH2EBR!T
M+S8=W@\QI2MB5Z]P\,ULLHX26IHV-H6^+UVAEDTF/OF@JR`RYE7DHXBRZ5+H
M^B`4Y\(<(/W3*-&ZFRC$%5#F\%Q";:<YG#&+S&%T.=&=YO?ZSFW762VEM]-<
M+C*TS)G>BM17C<#'@:#M"7$,__P?4$L#!!0````(`*LQK41J]FTQBQX``'<.
M`@`5`!P`87%X<"TR,#$T,#,S,5]D968N>&UL550)``-"\'%30O!Q4W5X"P`!
M!"4.```$.0$``.U=6V_K.))^'V#^@S<#+&:!37*2=,]L'_29@7/K-9".`\?I
M[MV7`T9B'&[+DIN2$GM^_9*2;,D629$2%9(^?LG%YJ6^XJVJ6%7\\9_+>3!X
M@SA&4?CEZ.SDT]$`AE[DHW#VY>CI\7CX>#4:'?WS'W_^TX__=GP\F$P&UU$8
MPB"`J\%O'@P@!@D<3,$R"J/Y:G`-7U"($M+8X`Z%OS^#&/[G@/[T!^2CWRXG
M=X/SD[/!X#5)%I]/3]_?WT\P]M<MGGC1_'1P?+SN[9><KL^#OYV<$](JWTRB
M-/0_#[ZO?'2%(<@Z]@E%GP?GG\Z^._[T_?'9^?3L[Y_/SS]?G/UOM72T6&$T
M>TT&?_7^@Q0F)4F-B\'D9')2@?CO@\<HC$GI^0*$J\$P"`836BL>3&`,\1OT
M3XI&@P+N@#`TC+\<51`NGW%P$N'9*>GFXG1=\.C/?QKDA3\O8[15X?UB7?SL
M]+>?[QZ]5S@'QRB,$Q!Z6Q5I8ZRJ9S_\\,-I]FVU-*'#3S;%JV1]?YI_F9>.
MT><XZ_,N\C*>2L`9<$O0_X[7Q8[I1V10CB_.3I:Q?_0/VN&/.`K@!+X,,HH_
M)ZL%_'(4H_DB@$?%9Z\8OGPY`G\L%W2<OOMTD=?_RW7DI7,8$L;X-V&"DM4H
M?(GP/*/Z:$#;?9J,-N2C.4PP6IY`?P;P<122IF$VZ9)B`I_2&J?"1D^[DCPA
M-;\^)F26TC[&+[<H),.*0/`0Q=G2N0I`'*,7!/W6""2;_T@L#P##]D.BT$?R
M"A/D@4`_NA'9&>=P&"00AV0RO$$=<.J-:J?[\97PY34*?+*?WOR1D@D]#/TQ
MX1.F&QOY"H8QZ3BG1`<FM0[-XM4V+]5[[6^F7H'X]3:(WN-1Z",,O40'P'JC
MG>F^1K$71'&*X3U(R,_QRWA!10JRJN.A[V?+&P1:]G3EGC2"NXI"GXP^]!_3
M^1S@%9DL:!:2+<L#83+T/"+-)$3B>H@"Y"'8&W(M9&ADRP3ZD$@9SP&EC`BA
M"2)_/I!J$&-"9!)YOY,EE/TNUI5/Y$L/)<7RZHE-O9"E<S:1=4@(H+]HCV\@
M(,LSIE*BGP8P7Z?U[W7,GW8=:X1^%X'P%G@HZ''XF_OH"5#)R.JGFA%Q.ND+
MTGJCN03A[WVBXO:C=1>?SZ,P7_^][=`-7?0#IYP4OT*JWD)_2/8],(/#.$[G
MB^R0U(M.JD>=X@5,[J(X?H`X$]-ZDRUDNND/5F4K)B)GFF3]T441(X]LS-<H
M2`FG;P`.R3&_J:4?=TLZ/H(Q0R+B^+1_(HH_0B_%9(!@?+/T@M2'_BV.YB*2
M=YKMDW-Z"=7(VHW^/0KC!&>&DO@6(/P+"%*X)5(^A=$SM9)146H4$EIU;"*=
MNN^9#7UM*_)]Z=$D[Z,$QM-HT^U&"8SKRE-K>$J=](U+J`A-X3*Y#,BIU0-6
MR8[MP+_^P!@?-@3TSH^*=I>K=;1LN2)[G1+2???-!;9"]S%<D._;&BY,Z4G3
MQ^)0I:!OCES#Y^1C9@&O)T,(>QMA<7^]S_!2,?N@Q2WNT"S>_I:Q3+=]8]_5
MNOH<9GY?QE#V-KA-/?:-F*4C?,QBENW9$@[T-@/4^B^X`;`GRQ".A\7:=X.Z
M5GR?\0D$P=&@:+B*<%,+A<FIC^:G19E36J%'>DA7].XS"H]]^`+2(%&CKE[]
M8VB-Y@"%K4G-:_=):=;#\1S.GR%6)'.K:H\TOI(FL)<^P^,-9]0H9350T.MO
M?,VHJ]D6S62IP="G_C/YI[0IK4Y`.06GVR1\"%F2GCT9+80:LN%LD1!0CZX(
M,X<S&X07$#]G(Y'&QS,`%J?4+>X4!DF\_B1SE#O^=%:X</VE^/AKH;;':Z^'
M"?0@RHQO\3U,KE),/1[6'0?@&09?CM3JGAI$]0!6E!Q"(/D$I]"_0^"97C$A
M&,MADVG!",*-(?$!('\47H$%2D#`0\,IK49Y_6RGGWP=$N4VC)9/,?BYV-6V
M:&"7T=3S<G$%0N`+>]XI8V2TXAA2.SI[</(OS=$U?":2#_"X2V&[D#DZ&U;L
M5AGC5$HQ=;>L":K99JIA<@4P7A'=*+NBX:"0JVL$%3U5QR^YVE[(A&P(]8)&
MZ"VM#,R]C%_.,+7W*:6B<*0DQV5^I;<6"4I-JFF7Z=2D81X(E\AN,1.T7A=N
M<.,7\INLRZLHYAY'[+(FJ9Z"947JNH]"3W@0-%8S@P63[9&Z!:A!$=?2(D4U
M=$(=*W/?GO$BOQFO"UFJ39@9@3<81`NJA1%U;`:)?@CQ`J,87N>.H$3`3^=I
M0#0U_SJE,W^W!G>0.C?<GA\Q]$YFT1M1:E'."O+'+@?(1U]S;9AY$M:^[I^:
M.S@#0=[G<(EV=R)6"1,SIC*7.4-?+6&8PH;CE572-,7;[MCYI;D$^<QJAK&(
M51-+;`9U,N0GC0V:"G417AMDIA%U&FY@.[>\&>K#V13B>485]02D!'$I9Y4U
M074F<N?*:J.TPBYKC&KIY<DK;0/E<DRW1\Y]P'`!D'^S7-"8)3'?V67-4!TM
M($Y6#P'U9`M]>JADXMD]Y!,OJ*)%+G\D0C4Y[KCA3'R;IV1-$YPN2)-`(E-#
M(Y\O6_.YL:8Y/E\J\YE=0R.?KUKSN;&F.3Y?*?.97<,(@M<()U38&!'NQLD\
M#SMDD\XJ:H3F]7UJU7K+T"2;RQNE_@Z%<$3^;"2[+&B4WLP)IHG6O)`9.B6U
M24OTQSH9#?J8H((=].NZ#-#1L@F.3.%\$6&`5U+#R2MM`>7K"[SAG'I!#),$
MH^<TR17I/`N&'":)=C9H2Q^<(=[&#;"W[JYP,5+UEBIJOQ!5FGNQO>XR:KJE
M'4283$R:>.OBAT^?C@8+C"),P'XY.C\:I#$A+EKDWA96@Q,K/1N,WWUR&"/'
M?%&".W,8W-JKI$1S;CD:CMFQ"DK2'6&#^7P/,+-%\!+BA?L0)?T,2\S?N8^9
M8PLK,7[O/D:.9T&)\6_N8]SQ/BNQ_=U:;'SW)PI,R;Q8POTO1^%*V1Y+F/;*
M=-*CVFS,+$58>\4[E5'E6#I+F/8*>M*CVFPZ+>':*Q6IC"K'KEK"M%<RDH/)
M</LLP=DK`NGP_^2P85>^O[!72-+-!6Y,1\D,>Z4IW<S0X:Y7\LT^28WGE+?9
M\^O!+1LXG^P[S"3@[$8)E7!,'5:UJ-%=1!P_10JJ#KC$8Z]()7`8K"X^D:?8
M!N:9O3NS),Q&I^P2J[T;;P/6=B[>)7#[=D[E06Z*(BC!VJOARBY<MI-AB=!>
MY582H<A!KM3A]VD'KN*R[^"7=RYFF8.E`K3+@]5>=4\-OL"3N01KK_JG!I;K
MC%M"=4*2D!E7(4I3,H10S)5VJ=K2UQG&#>/B;Y9`1PCM;M??:LOBM./EM,;S
MZ5.!*$^3\IDJK]#_<I3@+.:S^#`BZNDRN0FR%KX<Q7`VST;?RDDMQY#="^AR
M@.V5">60,<_@$IZ]4J`</*X74@G17C%0=K'R7>=*8==>*5!]GK*#Y4JLAB1#
M9JXH(>(M)]*U):5F:#%^FF@`)G&T%C#/;;89-;NIBE=F"W-P.:WMO<=28TLW
M\WC)#WLUH*[3I(K27M6GP<-7<`S+N-26%Q9R,HC%R>RVW\H[Y!EKZ/D;S7K4
MGMZOYZ:S_KB5IXFLQS'.EJZ?G3?E:SA-]'-K&D:4GY_#-'DEF^2_RCV-CZ16
MPPH$HSA.Y:DO2EM!^3A-Z.O6]-UQ6?*K5;ZUK#<*U'3:W6S)PG.(:S_$M??#
MYT-<^R&N_1`CSBMXB!&7CG-5E(IE:UN`3%(Z;JJE98=LZ.0I#-`<)34:U>I:
MPW.A/"^J80V"9KF^L9JMCO?M0I\L-D/K#'VRV+K<1^B3Q69FG:%/%OOI]A'Z
M9+&KKL[0)XL=<[N'/EGHB'N(U[`I7F/](MDN),<"-G0&H'P]MPL1:XCVQ]GP
M0YPJK1C2@UMEK]YY?`N$"V[O8LB*RK\+KN^MQKANBW'!];T#U+4)Q+SO>Z\P
MM^PD^^,>+>4UL#_NTD*7@OUQF>;Z'>R/O[380>'@*VTQL!Y\I4T[1XY"\C4<
M!@G$819[;<<#Q-G*V/;3+5R/R?)9D*_H`+[!G'I#3Q)O$GODJ3[8^3V$M]&*
MC9BX>N&D>Q'#$M8Q@B+(&H=^-J\N`5'BZ#PBDRA[=+M(?LB#(U=9DQ/OP7UX
MW]R'77/&W=U>[R'9D*=@R:>;6T/+S,QO5>AY/7[9OF\8A4E481MKRLI7_EA:
M<]&O$\5%$V9FB8H;F6PMJYQ;]<R'FV5"SO,4Q:^Y7#.!M&WR439X5+D!H0>S
M?+37*9Q&_,%G316-K6M!FZ]^LO"+,W$<-F-HK+.W+L;W\+WI;."7,['J%9:Z
M/0Z6DKY".AW_#^Z@!W?0;_[)H-QPE^NS#Q"C*%>?XNH9]!0B_C->:HU8AS/_
M_#;"])&(-ABW&[`7'\UM1B@D0Q(C,O%`@FK/KVMHT"+\V1U#QVG,:<,VE!TF
M,:.^M>A8,Z[-@#8T:`S_!"Y2[+U2RU5]W8EPBBO:AJ?(RJT,)Z]G@6,[32\(
MZ5R91F6VTSSQAO]_:?[F#@=?FY;Z")O@=WR'2`$_6PJY=@");LK2=SJV^+&H
MZEEI.P"J-?:Q6'X%&(,PH<E=:/:/3E!VV^H#2=FE`LF,2GW0IL[+7CA6-!K?
M+"'V4,R.7JH7ZJ=OOLV35]1^]W#I=XGL];>1@[JO[RX)3''NO[8D$\;@_-M*
M#5?4[K^NU-;GP.:'E@Z1*C9%JNS'RR*'%-*'6(>V:7KES7Q[$O&@X%6Q/R$/
M$M:C_0EZ4+V&<3\.HIT+SO[$1,@8>_<G)$+AXF)_`B14[AS=CYG@V;",1TE\
M["3FW$^YD/FES?C6MBJ+4[[H7+7LFW07,L&H1]C6[.,N9()1A\FZHG`A"8SD
MXSN2814NY(.1#M[CN\?;G!FF_116OM%UX1W'=F\425W/N_"^H\Y9P-_)+7X(
M4B<#!`_3GCLMF#6[\Y=`7970M$=IE"QQ55P3N1V7Z%R5T@2!`24X0X+9(?;^
MFXJ]5PIR/SQ5=(@UWKM8XT,4:7=J^HY>U!0["%9;K[&%L_5CH5OB%6?,96L?
MHB+;T-SH1RM=[1`SV9KZFK#ZK<9,BKV)10[57`]J2_WYY+V'+;Z1U^(];/'-
M>W<'6PLOV@_>EP?ORX/WY<'[TK3AE7]WX*QSI;R(O3]NE=+*G7'GRH.%]9NR
ML%(_N-L@>H]'H8\P]!*#V4WIPB>;>HKA/4C(S_'+>+'VY2I#F$;A2X3GN>N/
M#;02'<6G=W_^8SJ?`[PBTP'-0O2"/+)O#[UL*Z/^3%&`//IX%Q_(!]L6R<B3
M38C^HJ;U-Q"0"1$/DRMRXJP(P:)<`7)UM6BUUS#V,,HOCU\>R`HF/8$9I%>0
M($#_`OD74["\A"$9\N1I0;0,F"2Y!,!2@CNV:,*F<)_2`VBS'L+98R[7\$PA
M_/):QF2;:5XTRQ>:VC"H-V+$FI,S[B<8S3!8O-*K)>$U![^\T]0K/V3.>V19
MM#7R#'PJ-?NGDF76DZUEU!Y9'549ZV^M?/>;FHPK>)437_RS2W?Q\=>GQQT"
M*U\8%/>;5A25$ZL0C`OT-76\Q4(LGW&46!E[J+!W85E7`<9FLV(7OK00(LR;
M)+6S0D+"L]GBTQ&UI`YBW`[4:#M0%!N8QH3Z^6S<9J+Z#B1/Q-A^%Y=[@MJ$
M5\9$WPENFU<A#9LZJ(T6SNE$YE[,KLV:A=.>GV=A*7SWNIL^#HYZWXRC7H4,
MGF(H+FO8O;!T@;\$,5?;$E0XN$<J4,M_X;")?FY-PXCJCQ@V(:G5L`)!\\L"
MPBH]/SHSC:1>F%!KP)RK<$YAA97%00W],R[SF^H9=GR6WY($5:QRWJX&M5,5
MMQR"9FC2+5F%>`KQG!S0[8'6&S"![[H@:0J6=P@\HX"(LS"F20E2C/F9IQNK
MN>R0+_FLT]JI8QSN1(VR=EOYRH?@@7R*_4Q4&ZHYCL($DATA&;^'9)V\HD5I
M9;M<Y0%2G$FJTH*FQYV2!QQY$/KQ+5&OUWXP(ZK)@N`A?0Z0-WXA*Z<N.*C7
M/P1T]!<<H2AZ2U8VCTM2`&^H9`N.]3/ATAB*"K;0WZQ&--4R@43"8B84:N7K
M&[E:!@$LM(9[,"=_3C$(8^!E7IQ"/X/FBGN&1]F!0CNB!XR\IKV96]P([43L
M`!A%3V&\@!YZ0=`7#P*WO-/4FYHYWBOTT\UTN%QE1E9A3)N@AAZW'"++D;-5
M;2=5J6G&12LC3>%,$-70R.?+UGQNK&F.SY?*?&;7T,CGJ]9\;JQICL]7RGQF
MU]##YTP4S([DO`>J+Y:7<M-(YOI0O9%#J'=KZM>'H0SE6V7-4+V;!>H^2F"N
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MMRW.A*,`5=Y-T'CXK$[@S9JX:_D,VXVSR`'6M8R'Z@.^-A[9G/ZPY5@+W<]=
M>&)0&J^2PZ4+SPQ*(V]V@G;A[<%&N*I>S"X\-:@F=$I<BKCP_J`\:*ZOE`L/
M#,I-:#6G:Q=>')0>7O44C!:_/B@WVOPK0Q?>&VRO.E5]MEUX<K`-4K[7O0NO
M"\JOV@:7?!?>$FP)5F*$+7X_L-,(UU0DBY\)[`24\[J:?=)4EWSXIAZ+ZRD?
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M?V[H?R!@QJ'(5+-F3-8IQ1^AE^+LDOX*!`'T+U==AD>A51.<^(DLV?@NBF,8
MC\/:]3U\YH4G-M<S@8;:D\GYBR$YV3;''/\@X1:WA?9RJ5P3T9H7"2M3TQ9$
MMQC^D<+06XU?B@MF(BD5?V7NC`H8F]NR!?7:ZVE"QJ+J(*(`EMN$+1COJ)B*
MA6)#8[4]PF(H#0V3K(9TX.(ZMJ#X&2S1/)U?1AA'[V3Z7X$%^::6$+-5$[9@
MS)<T\HI-C(ATH8<6(%#`R&W"%HP32)<'X7Z7D10T8@M.4>HG?GDSZ0-+#S=*
M6;PFC4,]O[R9E(&+?*H3,F2HYY?7DW:"#*87A;]0(7]U"4)15B).42UTK+6+
M:?208N\5Q(V)P:6K]41?'J'IM4COU+HMLQ;D1KL7XPZ$;:1QQ'2L"[`=UP32
MKDXBP]KNP_4MUH-#7L<M.2%R4K#?Z;BKE:GTXV@TB3H4#M<W5[9-DPY%R>E@
M3#M;A$,!=GTSB:^(.125US>3:M9)A^+V^N:-A)W3H;`_G=P2Z&L.Q03JY(C$
M'8SYP$$YE89[HR*Y;+8-K^9E?"FU1B=H5U0;6:MYY25TCEW$>+`H-PV1E"V]
M:7#W/QF1%C;QK?LN9"=29H'`Y.I".B(M0RZZ"'`A59$R$]IY`KF0RD@/*U2D
M*.-YCJ1=^P6'@MPZ<2U*10FPP"2L&J-BD6MMZ0M<_=0Z#^#'=#X'F*BH5!ZS
MCM**U=<V5V5&$D[=K\)S7V;>,&4"8XC?H'\;X75&CFL8>QAERX+ICBE=V<1%
M[CI1$J%R0?87D&]<9%N896+PKRAY'84^>D-^"H*M8Y,S!AT:U#)6>:JC44CS
M6Z$W^!"`</H>35^C-`:A_XB6_!M-V:I:Z+R/PIOY(HA6$%XC##U23Y!;7E!:
M#S6%%,#JATF/J+Q6BNA50IQ'$S.6SZ\H(+N3AR&(F<[I+5HQX@Q"IAH-U1&X
MS6X5,4FC<`?>*>0(G>9?KZ,S\Y+,/MZV&5^NRC)KV_8[P+[D6W<=VS?"'2;-
M/*CLPO;07>$UC]4UW4T*HU+#3O%CHYG*/7&LOQ]][[KI).L>OC/]VOKHQZGY
M,LZDZ/BGS&@Q"O/;Y)]P%&M?4(*>W.?8KY!:`Z`_?(,8S&#V);UJO@4(9RF^
M/H2;S51\2R\7BEY;J[%\+<F.PHKJN19UR\R_S$VD4X/Z,/%TL-LHQ0F$H<"]
M5Z&ZD7?.4$(%LE(%%LP>=EDKJ*9J_`0&V?2@":6G$2M161.>AE:^&:2ZPK>?
M0J*"1[.0'M_5!7RSI'_"G3V5&0W7OAWM"-@'2D%#$]GBRL8]682/?JGL@,8O
M\B5]5%@6CJV[V1VMW?C-BYP7BAHL5_Q,V":4,N&\K(G5N`-5FU1@>DPQ:HG#
M'+A@[)5#V\O(R3QY^IG"$16-Y]?CNF[ILWQQGIOKRN,]]@?KB?=]V&)<\"VS
MC)U\4Z@+CFMZF=FC5=4%![@>F*G@WN""7UP?TZV;H<VXWYP9KK6YPG<AF+*?
MPZ&+)XX+D98]3C"VUXH+D966R1EM+X1<B,_\2%:[$979PXI4L-^Z$(G9,X?D
M;?3F@S0/">:K0(77>$(C3M-]DDT<$(QT7PQPQ43>\IZP%%T$[K^JN67L"1DH
M;74[^]B0"/OS7+BP(LSA'B8T]GO]6ITUH0Z7:4P#$V/"TV<49F0\P@7`9%L-
M5I/-P5%)Z!\+'`C:MF;BXKT%K<(K^/;M?=/H#;E",R/2MMX=9,)LK&8$R^Y+
MKQ(X1%6T.%9,(,$"R*!G<X'O/\4LI\>Q:W,VW`!,(Y`WNV]-6-YRZ)*HUC-]
M+!][J2HN.H-69EYN7NG)W;/>CQF'3K+D7J.`"%QQ[M9P'R4P7XB+`"7E*WX3
MBH^7#%ZY&3NP3B"EJD*G-+QZ3;/Z6$>YJ:JP=#B*S2LN4KJ;#<QR1<_K+)AM
M-#[V"6S\OJ/FS:%Z6)>79$T'Z!ZZ7[1AEM)^;+.SA%[P30>OS9X.73@A5A=L
M=DGH-/[ZQ52;?1,Z39!&W=BX?T&CPZ2*AM51OFCG6&N7/;+RK"59'6F2`:<9
M8V+D#4/_&@5I`OU=+MIH62V1#,,$^91P]`;+9%,W2R](_?QY>!'6G69-V&85
M`>R.SG`>I2%/P]+3M@FMLB/EERMV`P*K=I\].LA!GO5,>_/V\*8QO4=CM3W"
MHNWM5]Z3%X*T1(UU3/!Y?:^:$9*+BTP$S>7-)H7IN'#E,L-HZ<0$GPIQ6#BR
MVV7,6B@_X)RL"L[-FXUYZYN4L=(ROEEAM^1&8.D6)=AQ6'HVICVT!G[$,&C2
M0FPVEJ@*3)5`EB81QF9S:AO8$C*/S7;3+I!W!`#CAM(60<,Z)3R->X3XS'3,
MLG:+0A!ZB'KVQ>1(R<*$-Y$+XY='-`O1"_+(3'H*HV<:G42Y.@H)>V(C'H!%
M5NCQ<X!FN3>I4,;EE]>B%5[#/#*+S!+2J$^&Y1IB]`;HS+A#X)EFKB93XS;"
MY8Z;W6(4>S'T1V$25>XX6&JD_D[,I%)>TTS(2C#PDBGI4JC;"ZOL`09#WH0E
M2>6BGZ!8E*E-6,6,%6-W);!VL@;#AD(31C!F%[_T+(I"0HIPFK'+.DFUH56Q
M.?6&<0R3>!CZE;WU9[+_DM/2'X<3>M[3%RI)@?N(1BOE_](+F5AD5-+7OE'N
M7*XV?_XW@IB(=Z^K._@&19GZ)"L;Q96+-!DQ%\)M0U3#*`+Q=,KF3TV&HW?$
M(7U?`Q2RIO"NI)>NC/*LH'Y;[-U,3>'>I=;&-X'2],Y=H9'&F]4UENTYN#UA
MUW.Z>&=WG7-A+7PK\$=_WRYQ->9`$R5'[J<O(\\K;!G6A`<)LZC1M,T[XIC(
MRT!<1XMN75BPZKKNBG_CVEC'G!%/1G?<F&J;L;N0OD,6<CNESGQ6#;FK31EU
M>SO3C8AKQF_7Y.XE=8*VXE)18KH+-=\MMTV^$=.%ZPAIG.S#T)VK".TF`?:,
M9ZT0X_/=#B;)FAW<R8G;*[L:)#GCN7$E3TPU8Q-SOLBIO,97F=QA^D'\L.*<
MY3KO]&GG8K*L^P+=8Q^>#Q\-O58(%_Q[;&>QHOG,>!26!2SORV?`>)BT"F]5
MK-',><JZJC'ON28GVDC9VK9L(FQER_@YK9CQL!/<-H*)A7Y5@C1J1JBE(>7Q
M--J0NAFL^!XD!,/X94R4FOPXM9+,BG?:T/.HYR[9G!^B`'ED_YR2OB\#NCVZ
M2_KZ`SLA,',4E$O`[@&X`O$K$=WI+TK\&PCHIWM'?::)V#E_KN%SX@J_.;1:
MS-V*?.@*D\4D6\SKFN>YU6SF4FLQAUGBE"O36I+V!N[_>$I)>R9Z(_GG_P%0
M2P,$%`````@`JS&M1`IN%!<M6@``>^($`!4`'`!A<7AP+3(P,30P,S,Q7VQA
M8BYX;6Q55`D``T+P<5-"\'%3=7@+``$$)0X```0Y`0``W;UM<^0VLB;Z?2/V
M/^!Z-W8]$=WN(NO=<>9L2.KNN8KMZ=*1U.,YUW'#056A)*ZKR#+)4DO^]8L7
MOA,`01($H/EBJR4RD4\RGT3B+?%O_^OE>`#/,(K],/CK#\Y/DQ\`#+;AS@\>
M__K#M[OW%W=7U]<__*]__Z__Y=_^G_?OP>TM^!@&`3P<X"OXYQ8>8.0E$-Q[
M+V$0'E_!%^\!'F+PQ0]^?_!B^`[@_^Y`&(!_7MY^`>Y/#@!/27+Z^<.'[]^_
M_Q1%NTS:3]OP^`&\?Y^U]`^JT\]@\9.+U"K]Y38\![N?P;STJZL(>@EZ&NR0
M-C\#=^+,WD_F[QWWWEG^[+H_3R?_7_GI\/0:^8]/"?AQ^Q?T,'H2O3$%MS_=
M_E2"]S_`71C$Z.GCR0M>P<7A`&[Q6S&XA3&,GN'NIU3H(84+D#&#^*\_E!"^
M/$2'G\+H\0-J9OHA>_"'__I?`'WXYY?8K[SP?9H][GSXY]^_W&V?X-%[[P=Q
MX@7;RHM8&.M59[U>?R!_I4_'_L\QD?(EW!(K22@(N$_@?[W/'GN/?X7,_'[J
M_/02[W[X=]S@OT7A`=["/2`Z_)R\GN!??XC]X^D`?TA_]Q3!/5N+0Q1]P.]_
M".`C^I8[W,(:M^`L<`O_+?TU\;,?`'[RV^TU%]"Z(HN^]$&;DO?(A6$O34MO
MINH>\#\PK2H*PY<$!CNXRU3&,@1?ES1!'(,(Q6+#;47@`;M(&#%-0&3MO?B!
M"#S'[Q\][_0!,^<#/"1Q]AO"I?<3)_6)_Y;^^K>+[181-T&!Y28\^%L?QA</
M<1)YVR1KC6#\ZP\2+WS(]<>O5!!$,`[/T19V,@G]1AVU^.WP@%\Z'M`K.%K"
MX/VWNQ^`O_OK#_[NM^G*73FKZ6]K=[5>KGYS?G-^^/="%LB$@5\S<?__OU$]
MU$)+2CXX)CZW'[Z+J.I_7K3-]$0_M@!,G_BP#5%D/"7O*Y]Q'X5'*5_*V@^E
M;?+!''OBBV"W29Y@=`NWT'_V'@XP_@J3JW,4P:"%2"WOZN>46"%)]YLNIXM9
MA5XQ0'(!$0Q*D@$2#5+91JFF$+9;@>TAV"&![1WI;Z*\!0O()^>[#!Y*&,PD
M)6^\5ZP24A+])CJC/,/W'OR#GZ"X(4=,&0D&Z"FAEJRWSMWULD;25#HA:RH?
ME!JP@ZJJ35`E["DU`2:NEYK@4#1@`V<[.#>+N;+VZ\9?[X\7PLK99)IR$O\&
M-QI!/,#9['_QHL@+DH]^3/2H?>6VIQ5S;1=NST>$E`R^NJDBYUR.NW`6D\5O
MT]2[J#"PV8-4',CDC<(F5BQ1BLLQ@XL;)92"<ZO@PCWXGH+;"<"-'0<D"84Y
M+V,-0_WS^7@^X/'T1[A':7SR\1RAG/XC?(:'\(09>9=XC_#O\/@`(WY'T$6(
MWEZZ@V:RO93K3M8YWS+Y(&T`T!9`J0E`V@"_TE;,C6'',H7+,X4(L<9.NH>'
MU_KIKI8S0N7=SL?!Q3O<>/[N.KCR3G[B<=V!\[1.<K)5D'6]Z=*=IBS,!0$L
M"5P'()5EB&H*@+DU8"<DZ;T?@"T?F#9&B1VM0AV!)2SBB+AW$[YCGB\=`_9\
MM6ACC>F>2AG..HEN4A+)X#3,)D%WU&H>,\SZ/^<XP7UA_!6!]N*GZP0>X_OP
M%F(C^`?X%2;7P38\PB]AC'Y_A1ZYB<)G?P=WEZ_?8HB@;$YXJ11UK1?;Q'\F
M`^"V]8^QF]7*[W&QR*Y5+*=S-PL1N48@50D0G<!]"'*MR*0QU0M@Q?`?L6H@
MTPU<O@*L'0XQN7Z@4-#\^HY-EB=!"ZGQGIC;)^;&DU\1W!Z\./91!DHF2>*?
MS88M/7RO1CX-G\E(\#P0X7!W]^1%\!)O!\$[*F`0DR_]Z07_"'G.*_>RSD`F
MI9$D*683=S5)PU$F%Q#!@$@&9=$@E6THC*C'38+!71)N?W]/=PEM2P*-\K^3
MRU98+&^E_ER,X?:GQ_#YPP[ZE(;HASK[T*]^NT#19(<CRN>#]UC[K,V_:^!0
MHU'9OL-9S[+5H^QU@-_72X5AZKMRZH_MXUS'P&[,1JAF;>881HG_IT>GB+.Y
MX4UP@UZ"4808@P,!<YY=[DWM:S92:DDN!3AH2#=WTO6;DF"\U)&)!IL`Y,(!
MD:YY-6<$Q(Y1Q*SM@;J`SQK(<2(,7W#Z=O;C)Q(EPCU*C8^>'^!!1;8<A'?3
MGG*SQ+BGB<'YA'Z+>)]NY<5OUI\QMXS4B?O%DI*\V8TDMA7U/ON!A]+TX/$J
MC).8ET2)7M&9Q`KTD)V$6J\74S9]<WF`"#24KZJ"2/KM`M*6!TE;<BKA=I64
MM,T0(W3O588*-V'(O&>V:V<K)1GM41\SG\[8'7NM:S.U1T,Y6&90T`JV9>.&
M<L2NJKZ<F$;<E?.R(`,]N9CFG'Y<8&\CO7B0^#O_<$[\9W@'M^>(S)I]>MD>
MSCNX^XR@XP'\.4FU_^1%^/O%-S`B0_R+(R.RJ96M,R]0H;!L[^HL%MFQB%*S
MH&@79`T#W#(H-8T#2M8X0*VG<V:T?4/YAG;3N0W3Q87I8&8Z3%Z0/$$RN9:9
M#T64!R_VMR1,D=?1DP%,P`$O<9R00<F(P6B:HY*7E7Q(V8=Z@^'J\I4MX.+%
MYXY91FSQ[80V$0SI<U+3R5QMP+M\!3Q1OV+-3"TY6F+K9H24,M`;"7$R7%88
M^%J_RAL,AU_\`))EUG$<N1#_=@)=KK,LTZ:SE:LVJOV*=:![,=YF`.MG0V&T
M^E3)YZZJN5P/&[Z1&-<@J,*`5OU*]D2OK]X1?@SQ1$$G[RR]9CS:%+I([PZ:
MK6;B*()E@E^I5*O"0D^P(KJ_:T=KEL!-'VTG9LU.:J:=_SC[0?CR+?:8VYS9
MSVB?3JXI('L\;+Y:+2?IU#$5`;[=78R[@9D_33P(A%,!$7N&=F$K0.)V^1QZ
MYF0Y'"CF7UF`%='OY73E!=Y.2+_:,_KI5U6@P_>>KU+Z_<<_;P"5`:@0W>0;
M`B$EW\LI@V"4?$.0N/6/80'YV`PHD8\!V$BR&<>0OS&!_E%GXDA:E)WP1O_+
M3O:0]\;QW##Q#L+\K[O."ZSS/18,/*[FVG*YB@M4,K8"F3G?;#L.4WU(NZ]V
M+HLUFT_*/FO^)$A_&*Z8>GH=6'B,HHG1G$.W%/^I/*/=G;N6FW)JWCQJ>1ZY
M2-P'0BD@;^GKU@1F43F=!E[C7BT5K>O/FO+RKD%OX<SF+&^W)(8/045"^96=
MKM\>V5G(35#AT@M^_Q)ZP>;AX#_2(XO"@_;\YS52@JN$]#K%<I%NV<>B`)8%
M2L(,GZU7`\^MPK/A&'VKLY5Y(K:"&:[$?KS9UXJJOM+_WL.7Y/+0//K3\66M
M+)+12#8IF4P6DXQ22"Y>$JU7T7W-_O<KE@Z(>&,44X[=+;#3C:YQ-IEGEG)=
M?+;*/VD3&2'C.?8#&,=7X?'!#XB=[^#)PU7\#Z_XK/ECX/\)=_>1%\2H@\7A
M0[`YK*\TG73MIZ+\1J-E>@PF:PB46@)%4Z!H"Y0;,[I32X=Q7)YQW@VSCK90
M,(PQE=@PP-QO)%@(=R[TEV=WP.BT_#]U9]/YP)!A=!N$'@,-#!L6;)T8S)Z!
MH:/W9@LUP0,7J.%X$/F31DKC]J1+D\RR"E'X+3,,ZZRO*])7E[^7/WC9=7,T
MIKSP(MCA_WWZX^P_>P=<8JEE\K+E)<V>R]=$.J!.YO/"ITG%??)#2:3QF4V%
M2',VD/--'9'J9$N[8]9YU&(ABQB67'E1](K&O__P#F=>?2^Y=\WSK:J0]`X`
M=S5MH]U%`C+9@`@?A7TG&/GA[E/`K'$R'O99A8BDYA\L)+\#$%]8LP=4NQ&!
MWR5>E.B%/F^!_@`?_8`<!1_7`'WC[@#HKA"ZF05C]2@7^E$^P^@AU/TU'?'G
M!#]^#1,(9G^QL"]E=T$272K#7/;TK+ADPB&,SQ%L6SN1?]]X#\M02GZ2L3VY
M+<1;L(@RC@6Z1UVS[!2X<3M#><:RAZ4WI$N_#K81]&+X$=+_=_((C@CC7&7K
M)=VI+":3-KK2%D#6!,C:L"EW4&`%DD+D(,D%&+Q>=D<OWL&%//C)HEE"BSV^
MG=,"@YJB=:_QK#T#V<$9X&RR6*]*9-4_<)7J3!7A+'I0BSK.[OFLI8GLYT/X
M/:ML'SS#F)2I#W9Y0<*B9'W1N4M,TPX2JYF/0W25S07G\\FLQ%C<9'&]1=8H
MZ76+FI:EVRK*B;(%$\+:+%:[F"(W%.Z,][FAO+PYH_=3J*)3/7(,MK:1V((O
M#MGL:35!T>8#QH,Z^=]HO<-M3QFCL0R\0Y"6T#2["V`@(+<`%,H`TL8MKCM5
MV,(&;]K_O[34,V(_:X@%7[I6R9DO)APB?#%=,&@X+B8?6G"9X$3#Q7BT^&*\
MO$ZJ37H=\2:Z]1^?$L%F5O[S^AG25$+^$,/:J;$DNRQ[$P$BSNB64S4`JW3)
M`(;M`#5SAN]\#-YP;&(-=V32*^8;IOG3K3S3:IT=R1`PR(;<:S#(-A;9DX^)
M'+&52:JK3C$;^?0"HZT?>P^'^N2@W#NZR^*T*21;`7\V72_FM$P.GRXEN7HK
MYZA%V1(4QD8I+JVC%BH)#:DL7$Y<B$Q+J1U9UN6E=Z0,8DWGFBH&;R)_"_,_
MQNE?.^6L;:),=\<M^DG/(ZSG]?$@CY(0D+9*C\3Y,X8N*!K=,E4&)R$X(0Q/
M>*71B@+_0TC0VN/+V'',5.#D1Z3C_4_H,8OBR;QF24)0UDG2_Q:SZ7S1GA)D
MD@$6;45:T!MK:Q0:'VNOY*`WX')P0=D!DF-=8L#B8%MNT+"'->G!US.NX;#9
M%_5TK[S#`5_]/213Z"#5=-(@KZKTO.MDM6QC+FV53#47I:AIP_CV#:N3B9$L
MQL\KTJM(PSV]I>R=P7M'%7.I->'H:&MKPLKFG,2)%^S\H'Y#N/1KI@-#21=9
M/U[/G%;FE\1:Q.F^8*ND#<78C)*3X9&M[*M;Q0B]PN,Q#,C2UU5^=R,I!L/[
MOOP7=%**JX6L?\V*Z7(B*UV\+*0!(LX0B=3`<TOPZ"6=:5]77-/Y#NQ@O(W\
MD^G21>V.6.&3V$!J!LE%&^V'5V3>T#XT%JHCZ4FK^7J=3927B:+S;`I_0*P.
M83,46''Z1C7,1D@P-_Z5HE<Q]&VW@>'^4UA)L_F<F=ZR4VG)Z60QFS*88;9@
MYC`T;B<T!GH_?HU,-G##7I\/(4EF<>-%9,_^1;#;)$\P*JC:6KQDB$@S7.JL
MI_1"R'+)RDU+LSHTC4--TD,L9&<\:;74:UE0'$67K9J)+CW?O3![OEL!2SC\
M[V=.PZ$"J;F)[E"^"G=$W>Q*PW;OX;YIAO@\=:0O0E_.'`:_,9TW$:""4V+G
M=V,:9[`2T`VBO@,GA/J9=Q+/`%7;O)3#2*%Y5(]';V$,HV>X^QQ&UW%\]A"^
MC\4POF4(T?*RP5&J6#/)G4`.2O2R&]`J],JD`R0>9/+!1_'TAY:QJTK<S;!B
M!K?TB%8E>!)>[O+UG&TY(X@R,^R1&?S,#(9GO_H1FS4HEC"CX>Z??I>+<_(4
M1KCH9WN7TWC#3'=?5T-^O+E<,/B8^F<ASWC7/@@@HTM/9YD](4(#73O/`SE=
M.M,L5I`(,UR>0.G3)LE#59!>L%\N6--.*7&H+$M(TP,8GS`^%YDQLE0]34B4
MDBFL((G$)@'1*R;ITF.]?#I?L9*_E#/FMP6H@MB<ZFG9%C`8FTS]0F4?D!\<
M;-G]($$S89BP;->#L"Y2_3$S,:%3]<OY8L5:S#19ZV@($BO6*]O<AN/OAJL7
MA<=3!)]@$/O/\#I`8V'X%2:;_;WWPO]0W#?T>CY/#5G7F4Y+ZY:%,$"E`20.
MKZ(@@<88H00A+?^#P!S".*85^"IPR:_]@-P8N\.5^G;P&1["$YZ/0VSR'DV5
M)E2$?]$5/RY$J,<&<DF#&C_O[`;29M`86-MB52W&"BVG:+H]VU>VV=^@!R&V
M'HGKUT$2EL(\>WY3]F7]T^V2FLD>K)FXSBR;;<_W3J+HF@M/,Q`L'I1S$MW3
M[6/@=FS!W3;=/@9XMP:>7H29@J=C,Q^#O_CC[`?A"_AV=U&9DC<XX=Z1VJ4)
M]RZ&U!N'Z/!JT.=/15@;DZA^LB4!YHNI.^D5FM)I$TLC5!\K]`E48UI!4;SJ
M8XJA8>N=P"YVA:]J1.@>Q$K6'3F4W9>;96ZD[2'`GC#&T$[29]W);.JZ,D'L
MOD;>43?I]@AB@VT@$<*TVJ!O"!ML"$8`NX4["(^X/$QZ@BGQ\<]U^]0#O,FM
MS_TC@D0@X]G8S$1<H64IK*;?">X<[OQ`VWM:)^5:E)%=YD!#AQ6+RI7EJEPL
M<$S-T*F$VW(.+S&]YBOIG]4I&!D#F:,;B7_RAW,$KV@G&5L/^:M$%Y5I"=H1
M6-`K*@=)6/7I9?N$'H5>)Y1ZJ27VQ2:K!+8Q3*AJ)RO+*>9;9FC%4D7:Z:;+
M99-9]13+&G(-AMKD5PDK[;\LXYC(/3DTXUK)*J:5-UA].X5!T?MV]0.!)!L8
MR5=/^IB)F]^K*&!I92LAP"V5*C]81EU%-G'K-JE->EG)X7;'E^)UBPD53FXQ
M&H_;YK,$[YB9PN(K)#M1L9C.UY6I=R8-Q1W(V)-4JE"V!9N14<I,0ZF"VH@A
M7;(?C1-*[2RLS2&U&,BJ9.`>1L=XL^^?`S0%V-#U-[22WCCKSIWV'I^(QQ--
MUO;SPPQ`J%F`MKG04U>_ENKBV=;K3]P8;G]Z#)\_[*!/.8M^J%,5_>JW*[RK
M*D@^^_'6.^`"K)^"W4<OJ6\I%CZJ@7ZB]F7]#+6032U128"*(M6!`1(&L#2]
MK%*&R^V#:VS.R#@89D>K%4QT8!_A0R)]*2KG88T=$UL#Z8MI\I(.6(Y-%Y(J
MP.5VQZ6K-Q$[6;GG$-C!/#MX907;GC;&CZ[5Y]SY>C;A$,18<3V5T`A'OH1>
M`/;>UC_XR:L]M&!6U9,!KV1BY"/<1M"+X6;_"0VH=CNX^P@C_]E+_&?XQ?<>
ML+%\&'\.HR*CJRXF2FRX5M^([JD7Y0ADA_;3^13]?TJI277`XZ1,"U"H`4IZ
MD&HBC06!8N'>\'9OP]9TWI8UU]2:`7S$]8NXDTFFC3JC5HW@-GP,_"3=^W0H
MF?&,9_+KNSF+03#>`%4I"K,53@9HF;$:+3SF4USC?#8S21-5#Q\`@D%,8ND%
M+JG^"'%L_<5/GJZ#G?_L[\[>H7*;$K?G[RU0:^K55TOI%:)YD9VEW"DW!DJM
M`=P<*-JK759F*H/38J%T23S%>R*7L^77DN%8%)+IM1@\XC+_R(@HW@1A\!X>
M3X?P%4*P\U'P0N0P>KO(<!95\\=!IC<91C9[]'\_>+P*8^X%1.QG#9"_HH"L
MUR[7CE/C=28'$$%FZ=H?DUO!%&:8MCQ,NKG%="T6;9HF,,F(>^^EE!%\#>FA
MX8`_:]?RF@&>\'21+CNQFJQJE$$B*\EZ(=0L?91`)4RZV&XCO!,F04A/WBO9
M[=7,I$V=E%?[:3L`3LM(3XV6D9;E)BNZ""UF)M`@$V]]DB6@GP^0I`O![N(8
M1HG_)VMVI-.K6@-.NSZRGKE&G5H6=`JI(!=+"KR7!9L*/(HA4RZVX-)'-'G?
MK))-TBIF")<-]=%HGBQYW*,F/X9'S^<33?"*5H+Q]9!>OYHZ>6^>3[QEX@"6
M!WZE$HVM/2@"Z?)`BO#IHU:[%U8IU6(5LU2Z#N(D(M/YMW[\^\4+][8\X2M&
MJ-340_I&QL5BWJ!2(0Y@>>!7+-$XE0:"K%.I!)*/3S^5^%[(IA+'*F:IU&VX
M*7[+"*&&C4@6DVF#4W8--=7AK-R^7EZUH:.LE>%1EI1'LIFE:HS%74$7-H0/
M_Q_)Q/.&>_]'5Q'Z5[\[Z2>];=U=N<ML;;N%8*!H!&P,7`@RJ@GD8HPF$XB/
M+(QJ!Q*#2BC#]']V3?T,87UIV;>['16%JWRC^69_`Y%S!+C`Y&9_"[U#.AXF
MQ1HO80#W?H)/9-W!)#F0!2.V2PR2J#^8#5%7]LH;9^(N9EELRQLD97'R)O&_
M2HVF56]!VBX]^%BTK#O>Z;.28[N5VD*B/E.1"(GA/U!9,8A((R@PDMTUYT/B
M'ST4&N.\`>-G2Q2&G5+X'&QS,R.KO*[O'=;W4X!<ZQ3Y,?R(M-SZR<461:_S
M`6_T^GC&*X_U-[@C@<&"M8[/AFHK/8_MS!99?"E**A,1H&@5I,V"4KN`-@P:
M[^G>W&?*:.E^/FH8KV08&VM4JR-6=0RIQ.1&(DV^:1P?NRLV_]Q"HBW9T$#V
M$3YX,=S=>*]8Y;9KH`<*U1EA!FDJ?\6:DPW>BA,3Y!1K:7=>VB3=T0.*1D'6
MJOE#2/J,Y=:,%8J,E=9R?=_)7-HBCA*"5:+-\,^@9H2(]`C/0;()LKLJ-_MT
M8I!9P%KXO/;1G4`9V<F(V7+I.NG8+16'YR#RVUF1TV8B-0_*E(%S*N`V)7";
ML<#)'F-0AW%6GM+>I7+-C8`D:%6,;]JLH(;I*9LN@AU*;?SD]3K8A]&1[A)F
MIP+R[VEGOH12DGW5W'$GV<1T*I7L\:%R04GPV'TW/Q2H1NM8@+9EGD4U9'<X
M9#V1HP--BP@B:ZWQJW!DJM#J!S<P\L/=9_2[>C8A?E93'0ZN`O(%*YQUC4UI
MQ0HJ#!!I^@MQJ`'F]@&FHQ)'JY-EI3C$=M#-!EP+1(X+Q9-&F)`W+^LNSGHY
M8_.`5&ZQ@@7]0#$Y(`:EGP$-QV+[?]4"^KR?\HY?CHG]G&;/KS0N[R*K>OQ/
MXZ.Y(DS#`;E=`>GT>*8SU?V]B5V?M^/]L8+/0OZLV;=QFQT\H![*\>OF_+BS
M\JZ4\CI]MNP2=5?-X9E8.?CD18$?/,:(+V2VL65-@/NXQME^G@[2^XI73KIY
M.I.$(QR=?38^.Z\$G-L+G*ZY]#:7*\^2"\UA`U\NO=C?2GY+^JQ!IA`%I$MI
M+;*98X8G$4EV,*0[J.HES471""])(O_AG)`3J+7R-$_A88<TPZM3;."FV%-Q
M0!%U"CM9PYL+E)[YAW,"=UV^=>DMTUPJ5)&.S^ZTA55D:C*5:A'#>D(E7*.X
M\&WH.RJB8%ZE!!3=Y[LT>OA`TE%;F5:SEPV<Z\8U"SC6T>%FT_62RRVK&-4'
MV)!>:\<';XI7'?AD&X]NPH._?6VK$]OVED%>U521KKNU$O"+RK2@@JQ*L&DE
MV3+?;.(0QQ%%7&)9PP9.=663%3SJ[%23Q8R?_=E'G7[X.!V53<3I1!D+R-*H
M%?K9#[Q@ZWN'XB`Y^VZK7B)T4JJ#7K)>.)TXZ3$`5JG?7'ZIEH"I>Z%&MX++
MLT+YT*D-5T?V<?$*:;M:T`R/:>U14KF7'O5L(2WO>:T,Y2@A/7I9K5<9'=/:
MJ_0>*"K,./54P",\VYR3./&"'3Y(5$9H"\-:G*]*)Y%5QE]*I9O8KB`N.(0(
MO(,O_QN^,I8(V<]I6EQE-BZ_4)D/IN@VQ%0.(((`DJ1_P74X(+<K(!V+L$)G
MRE9C^=BU>7M1U9W6?"_%$_['$KVDEP<"3>0W'<[<*BG*U\BG5S&4Y!JCB"JL
M+@?K.TFP&NDCX9TU+K4921>QF!46&W_62I9N106=]7)2H869.HF#U'<EU=?G
MT<V2ATR`NKSTLW^`T967P,<PXJ<ZU:>T^FRE:?EOG]T!GWY[(@5D8DPY<'\L
M;B<L^KR9Z3Y5IVZ"UN7;U\$VC$YA1.OR(@TV^\JON-^I]46M#&C3ID.JO*B0
MHB*%;++%)S,KOS7%%*68Z<9,#"_<`[\-GC[RR/IGE4]2IM%%L5OXZ..]<4'R
MU3NRMA\S']-*GVK;\HXSK0Z4"S$`RS%%C`%HW&YH]/&`[415KV?@-C*7^L<9
M*=.V7;GZD,Y9TTK+LG/V[G21^3IYW_QVY/XP7&D8VF9`F2Y3F?9LPC7GV[@J
M2!C`(!'>$,!^5KNGUQ20#8?+J3NO.'PNQ_!=`,-1N9U1Z>4!Q[V:=&`904E!
M"BH>I4Q(MO\,;Y!1[[^']T_A.?:"W9W_PEP<Z_2J[K(4DGI).M+:72Q7M#)%
MZDBY9(!%`R0;9,(!DC[N6AHK"HR&VK$%M;A,Q1C073YTI-;"Z&IB'^+F52JZ
M&$M-A'E)_.#Q[,=/F+6;?5%HYQX>\3`M>J4Z,3^M],O:HXRL9ET*<J_30%.1
MC<?I#_X>(2"%VJ*B6O<>>DE:TZU4KIO,\_^D.?J,8PV'88W-'I3+:.7R`6W`
M1/P9!WS]VI7LBHA7L`^CLAMPB[:;"TY=.5^$ITZV'"5`W4*<8J%?D16SK!H8
M*0;X\0SOPZO\DO3-OK@A/&GNFU4MW72(ZZ^ZO..OI^P82$J2I\VG>W7S`GJT
MSB=2`=R'H%""%#7/"7$WVHV=TD%1E_TX4=-6^W4+KKJ,Z+([XB@W(CWYXV=&
MW-+ZJ=]KQ0_?,0(U3IFCM.QJ^<+5W3D]/)1_@6K'KOX+2%:(-.;(LSX?H;<=
MC72-PWL;;M\Y\#.9F'7[[/G1/[S#&5[$,4SBBV!7VB3]=^CA6KV[37`+\:TM
M"!EZX&L81-D_\:G/^!Z3B3.EI$Z^QMD]94I+SQT[T_0:-MPT(&T#VC@Y&5W>
MN)ZUCW/Q7`/R5%D'<JPZ!K\2-0Q-)YHQHULS8]H0V0K_KF0QKVXQ@:UT35(J
M9V-Y8E/MY[`@6#%T)DI^"\*'&$;/6-?KX'1.T)^1[1%2DGFWG;I3W8JYP#54
M=>G[?]T9-WRQPQ6-3F4]`%$$5#6QX'B@29/60QG*JN[\Q\#?^UN<\C;-9Z0P
MX\CL%(0P)1_#:""[?,U__']]&"%K/[U^P1>L".YTEGS91-@1:B1=0F6YGC2B
MR>4K*/TK%PZ(=*.W/H\`OL;[=R6\YN]_[N:[3/:V6\HH*8M;2MIN"Q*^8H*`
M##VDC[&O)JL&[4KRC&_+40:RWJW*@]3.,8$K,IG%,XU1/M'4A!!\*CSZ*WK#
M!)N::LA7I,PJGI7\C(I+NZRIX2/`JD#2:C$2D+1SA^]V3.IP[&"4.>(!NDRN
M^\4/X'4"CZW)I,JF3'!5H?[2=36=];Q!\O:I.NFQ+U8($(U,QPA3QFTDPDSK
MA@WKOE-@7NWQ:@2R,P.=ZH]I-$*69W>;@PKA)N)N,DS$-!G%I#/?Z;J9WI<;
M8(^OS6Y('L\2]3&`'&+M,:&+>S/)+FTX6UC\BY\\-<)/7(T_U6"5Q;-7>OW%
M=;"-D#CX$=+_=W`M]6T;CAK*`4D7DIRO9Z)H`[!FK`GL>B]=3YMR_;(+6C(-
M0::B/9'*K/5)A+MZ0@]"?)_Y'G^'YVP98=?<Y8C2`=M"WFBQH"U4CO/EWE*(
MC3GPB"S%'!"W]09"J!"`+&EG\T5SRJA'R(P%,9,('25`GK*KI\8(DNKL2_>W
MT6IU#]X!;\\:T1QWB1<E=AMD3JXJ@(]^$+38Q/:.0"IBJ0C\[<8W&NB_PJ0X
MPT#6R7,-I8?[-<3WD1?$>Y0"70=)2&=(VQQ:DQ8F.@<]T&19O)POF^-Z7(BZ
M=)"%*%GJ!KK-2S9R\EQ;@-7-UC,,Y]T6?A62@1?&>H#)=P@#:J\8..]<L@>1
M:3CMP59OU&"&88U?T&B`WNQ959KI'05M7BY\UT0P%"DD/5Q=3YLA;+/G%"VG
ML@U'&V6P>6<.\0('C@[58?L^MXA?M&I%_)!Q:B;K6RUIA*L,E8JM%:T;B"7?
MULE7.96D-]JOG/34&YNCA6@;=O".@-VM8K>%C=W<ML+'#D8RPL@P@OYC<(4Z
M?QAL7TG'[FUQ'_\WSP_P;467<(^>N?=>>&[008).9LJK)7\)QC*;?*?"028=
ME,0#+!^0>YYH"P`U88BA(]G`+=L`OFSI9#B^H<<H2[N[<H6I'8UE)UN_!1'T
M#OZ?W)L9.XFPBJ^%7K+..I_.)YT(6S2A^WCR^&:8O5'2-CVZ&VMK]C)!VTR5
M35",2$KY`!J@WT0PX?:PTJ]KI*NL3M(^ZBS2RQH*-FZ"\F1;.0_&\W!4OIF.
M=13T/1:6TTN.5\Q+CG6$JW'<8/:VEMB[TKL<OSH9T&SLNO,.$-=7"$\P2EYQ
MO;4$5S`Z845;W4/XLI&X)=)(.AN>9P=T*U$+BZ9%9ZAP4FXO`;EXTT%+&702
ML@A:1$PX#KP^P4C=MYWE'Q=?@RV#5'_4D2$F.^:TVLE4Q(FQ?A!IV"BC!A]$
MP4;\GN8X(U1&>C?!<KHH0DP,J$P<91CE!)%<<[%%'5RZP`>C(QJ>>,$[>O=O
MB$<M]0)*.PYBG224\M4Z_]J-981Z,("1=[@(=A>[HQ^0TOPX(_GT<H(!=\MO
MVULZ:2=617J9>9:=V4T%DCI`59$@E6F(<`J!NF6@>'',JX@TRB\YAZRP2\(R
M)KB%;W,Y0DS[SPCB51@@WI\1]3>H[Z7[G^C\(GWNWGN!,8H-D1=&.S_PHE=R
M,.@K,AEZ$YD/Z?=X'2`_@3&O0QRS18V<'A&&?"Z8K:331FBFC]4!A3Z@4"B;
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M[I(GZ$?@X/]Q]G?T\<A_?$IT7[2AUE"\N+$)QJW\+EEW7#%8$DDNMMOHC`;L
MX;Y2>UWN\@Q5B.^%)>\5PUZ1:4&$%:9?UZ*+0F2#5U[C7,HV1O,.NE>X;5,N
M]W$3F4=-!^FMI_/EHA%"J"P+]MDJ0>>FW+%A\,SW+6:^P8)MB!B5L^?7`0K!
M^&H,7/)[@[K5Z!9NH4\.S?#*@G63H9="\HI)+^:LEM.<5]5J$N`Z`%D+9'*=
MM`%*C1C,]<>R1-9O4]0X&0L):N](?Q/E@@V3M+N?UYC;T8)VT?F&IE)X!0'G
M6+!<S[^STPB%64%PD8:R_KU83Z28GK9%E]-H:^7:<\8ZV+%-XU:8G^7J9*TM
MM8(E>]F&L4(N"K1:U8YPD$ZQ!X]7WLE/O$/[/+6L`*.TYVDE.^<[R_>\,:F>
MBP>I?!OFN,<P06V[;A`&[[=>_`2^A]'O&/Z6RO[9+C:W.;68P4+#V<%:-(H^
M>?[N8SJ63D?76>)![[>0=A0I84;9+*.A].*KZRP$S$Z;`EE;^21;D;[3]NS)
MW-5;AZ3P1.PK/8J`^_`=/(6Q;_:,ZC`FB&DO;495ZP"T:)!WN`J/QS`@M_[%
M%TD2^0_G!*<.^,H_\A<\4_8+O:FRSNIAL@RL&_125'(*=3);S-<3NIY0:@I0
MB?0>530.+[5&KU"E?\4-@JQ%[<L$&NSBV&H7\96R>HQ#$QT*F4RR9W?#&HEW
M2D)$>1:^OP7U13O2]H9<NML_S%6$6!G?RAI*^J@S<1;.M&M@H\Q-6[(PH/4W
M1,=(-KXA%$2P_M:@YY,(QI"/T9Z0Q>)YMUC5L)6941G=82@^-E!_2NLXJM*T
M[!!@M79SAE$!XQP"Z#+D&0"$C&4NO>!WL$6>])A5QJ(5:_`,!KY@V^R8ANE'
MU<%*TP`F7?X&C9-:OA5YQ("SXW:ESV&[\W7-T_'KIB;P>@)P*P!.'`"ZO;GL
M(BQ7SF&:\>-GI`+N9>CZ>^L1$\[C6OV;K8/TVNQLEH\`,TG9R8UQ#V2T.[X"
M9%42T&,49FD@]K`J)00&,$N/^.)P(--?Y5^UK1!)O6R$.B*-I._6GA3SQ[D0
M@`2GL\/EWYI?%%*.W*TA?]<+NGX:RG@RFY2MINM/T1AN?WH,GS_LH$_9B7ZH
MDQ+]ZK<O*$<^?`H2/WEE7.W->D(#O1C-RGJ2LYZG-0:)`$`E&+F(>R@*MP.*
ML;U>X"K8M7E0370Q[9N-#.T@ZK/WQ<G.](R^R:?M<&M?[<EAU'LLW98M.BW[
M;FS83%/2H24G8CUIQJ>[]OGSZ6+6\&WC><U00*X$60TXNB@?X4$V[?@!/<CQ
M%!YVZ*OANDH)[QZ"UM<,48*EB_0,S#*[0*7,#[Q7I"P34*'&^X3A4-D=Q3L0
MP1V$1[+@@GS^&4:)7SN;A]M]1^9>XY(*_Y.4&4-9TX\[N/>W?L(L\FB"BR+'
MYA&3:U[#+*6%8R5ZI^Q!,TQ,6Y>>^$'`F]Q+A1CG6A\P)79MZ>L6IF,U9^)P
MH0S?#N^7S]'J+QAE0]<$9[U<+;FLL"ES&X*/[M:QG2*2^1S+$&8H$\#-_@KU
MUG[RV=N2N[,NR*&MS3F)$X]<?,G]KC+O:B62A$+2J<^J&`4%I.@M%0PRR8"*
M!B79YBY*50_=LHM/U0.4O\A41PZA&ETY:0\],]N#>@69:L"4-8LUL;,Y5=_Z
MN.D(V6'Z>[::K,1!T<1\OE)TZ>1^@$9SX*MWA`;G]F4=K94R9F?]FPI]>CGY
MM*+/1R^!3H?/67_3,'=JZDA/2"ZS\@$\&A6"`98,''L8-01SO?[UT4O.$<:[
M0Z)LHQC'2]O8QK*/+<3[',$_SO@ZH<W^AI[SN@AVZ4_XLW3IN]IE&29GJX+2
M]Z[.IHZ8KGE3Y'(,V@29$<Y^)NW9PV&UIJFS.CU""!(>:).LEJ9`&\_E;&@+
M\[.SCVEA@I;=CUTD&&8Y1RWY>YD<5\SM_,AP5M;#[-;)L6R0%?(@$'T!1)/D
M;?'B-LJ*[&0/4:E2MRAY^'C&%]??D!F23N[`$6&<JFR]9/UT,G/6;5Q-=P/C
M)@!M`]!&;&*K`C-4^]R<L""R,)%N<^EVV@H,9@MOZ93!Q_#H^?5SHM*O&>9G
M61?I.9.%.Q%S,IU+^97*M6AJJ#=<-X<;-N"^D\%KDHPL/VTC8,-2UI`._8Y<
M!-'EL^?OF*9;IHCT8&L];<E5?R5_($)M(EHOH"*6M0(URK"Z4[;2JV(?6[CU
M=^_%/YZ/EV$4A=]I92ST%\%.OPXB##./IY?T@&GBMLS?IBV`O`F0M6$/+958
MH9:'[C,#D'+^=^AG1"+P#^]P@*\`G\BVC:QM7M[&7:$1;:$R39?];3H[=8-2
MZ*U_\KHX"U>$82KS])(N&."LEV(J9RWD<[EY&_9068D5&M.X&?!3)@X4Y>%L
MXW&;B[?Q6&A!6WA\"W$&CJ+,D$Y9(,0PE_F:27=)TUG+#%'>AM5=LR)+U#KG
MAQSQ-I7V#GC/GG\@>_C/)WQC#JE?3F;-GO"<MPN2\/3^@(VY\Q(/7]!S/MC'
M_G9BM/&_Q>*V1(![_*DZ.!)]WC"OB1+2)\ZGTY8.^5<BSZ+Q;7=\XK$M'Y])
MCE5<KXU.A4F,,`?O>$R+L=^'>-C1<AJ&^[Q.YO"4D`[Y\V4V/81%Y5<2W(=D
MY#7N*9E6WBA!5SD#<`HCLD$*4>@!XR-]W(]?PP2".?-(V6"4SS!Z"'7@=&A]
MOR>$\#W>1<'$:C1`M#&L$B"$-C$3(()'G!<1S?#]PU@I[A=E/:LU,#`4Z%`I
M:9$%!935D620A@=RR3=O2D9'0!B*RLVK_%G"_,&?R<V^DZVD%["F2GB>*4R0
M_>]^$$:E9>3-]P`YYY-_0F/^+:XZ^@@O7V\\07[018+&P-!!+>E=NK/EG(:+
M3'BQIR(7#PKYX/(5T!;,1)&Q3$"86``^Y=),\J^'(Y=9V=56)KCZ%6\(1Z.)
M]#Z69E5PP8,:F==L7=J[%ME>8BH##W`+*69(-!"-6T*#NJI0B$875_B.5*8$
M![D1SX?)E1<_W43AL[^#N\O7;S'>H?@Y*UI\L4W\9YG"0ST$Z61.9^WDM^9,
MTIU(J`V`&P%9*[B7PNW@RW[RED#1E/$C\B-;A3"T`.[ETHPRM+?#5QC<SW)V
M,_PJ#!(_.*/?M?>#PX1:R7R6IK(#J>5JL>P;!8IV1^^2VPZ$:S06.2E.#'7*
M#/7P6BJ6_]:BA8@\_2('U\0611%:J%9!GB`29#Y:"+23[A%G[EPB0N0MO8$\
M09552H6>K6>^A,-+L+W-<G8S?'B>("O42N8/Z?I6*Z=W%+`_3QC#6$6>\.,Y
M)F<$_U+)&/PW&S<&9@Q=C&U1/,FO/!Z:,8@$F8\;`NVD#]RM)VN)6%%<$&Y_
MQJ#**G2>/`=N-?,E'%Z"[6V6LYOAPS,&6:%6,G]`)^@NW;7;-PK8GS&,8:PB
M8T@3AFQMX`U&BH$Y0A?S&HH@]"*J+V$L"`BE9_3RNVA8>A_58KHHZ)K>>H8%
M&.N'>V)P,PP']"8IIH[$G"+X!(/8?X;TUWY`BD<3DB5/$.S@,SR$)W)>)3:]
M;LUTKAII:L8QSH'V5)CQK"E.=+[5*[\:OL8-&]+5@;`H7<Y''%+#R!JW;\DT
M.:#-TR`['E*Y+#Z][.#2B_VMU(=LEV*,.JVJR0;KZ=)=LDF5MX&W8F?7EI>O
M"B'M&$L'1S-&I08Q[KO*=[0G(>['L"G*=X/8PU=IQ^<S6<Z:W3B.+TS'S)U-
MIBEOR17JJ&&4<FXAW)']EM=Q?,;5K*\#E&IZAYOSP\'?;O9[&#7+N7=_7S%7
M=^'V3&Y_QRGP4.7D'-29N"MW[?PVS>AZ2N4#[!+`3UM`V11I`IQ(&R!,&_EI
M%*ZR8M;(^/-PE<FGN\*S%D#:!*!M@*P1O;G!R#:@A>\>'R-R*3T(RMY`CT.B
MM)JX12B`/W:0ZLUR')[Z6=!,\O']8KO%%=YQE:\H#-"/6TA.G-^$2,%7^M][
M^))<(C5X9S8ZB]&:?G3333;[G<[=?'[J.RB:`-4V`!6?_>]7W`X@#1E+^4>T
M!R'W+<3;FX%7F.14:<9LTM'/X:M91P\+*DH[OI=2F[_#XP.,V-&;\9S^-**I
MA&Q7L5X[,S=+%[Y7DGCP*Q4U#GT$2<%0-(Y^-&U]_%!(;AW2DQ?A13@!)DT=
M-Y\GI0Z:`U\-5<,`3TS+[R>7?4L[C5M5DO49QYTYRY34R%G(2H6)[>%\CBN&
MZAB'VA(`%..U:M][1Q8684'.**J"Q!:U);^95/8M`T&B12593T)9I#O)@P06
M:F1KJ"A&*$7JF$;:&B*4PK5JRVM'#I9#A(Q1C`SHJ6J;Z,:+DO0?%]L_SG[L
M8^Y>(PX'C_C>Z(LXADE,_A3!'>].J-[B=`[P>^HHO1MSGA4YRVBZB?`A[`1D
M_RZU!HKF`&T/9`V:NE1*BWT(KV^0[J2,6;C'%?(S.WC4#OLP`C$=(.`)7\B\
M(D#;/,!`GE3F`X886%4>\>EX.H2O$'Y$HK?HO5@P.\!_VD#>P%%%MEN9NJNY
M6PPJ,FD@%V=JOD`1,L<4LM:\0`D\-X7W'G:#IRLU:*%5.240V<-0*I#O_Z.K
MI)]>3C"(>?4,^<_K[<S92LCOX7(7.6F*_8_I_H!4F*&U?R782JO\8?($([P7
M#4/[$5)A,;,BD\9^5>QTM8Y38!"K.-.V/ZWU/1LXU'6#UW*V;N>2^3UL2N'2
M$Q9OB%C"G6Y2IE&3@IYQ9[?9LSI"9@(A>EY[&BI01C*?<1;HQW6:B!)QN-00
M.W'3G(DJ`^<8`]>2C"I#Z)80HD%L4$Y,=R*$>O)1"8X5&6F;48STKZE2^?F,
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M[&=U4H2E@'1MR/EZEM*#3#ZFFP<*08:(,1A3,:%JE`<B1ZIP@`O8F/]_\;T'
M?,L3+F+1S@#&T[HYT%1!UF,6[GI59D%)DMG[E%3@LH@)?)=J<($#V@8VR'4)
M[!<,<J)[()W-%U,>+:SH(8:CLY,<$GT%'[H)BJ3WZ6[VQ?[U8$<.N&0#_ZLP
MYDZWR[ZMD3R2*DEOH5AF4_'9]=*;??ED1K!+SV7E$V9$O!EJC8&=7NE7G@`C
M\V+%&?SM:'@E+O4:Y6L3R-^"'8R^1SX9F>W\F)S?S.L['1%\7!",_#L[=\XW
MA:YPU)'-Y=C4Q9(&`U7\.8QNX2G=.+S9ET[DB5U$]*+^\"301CI%=);32F2*
MR<1](97<S5LZ.JJ6HVN*-2!5&782'%4&>4;/C.<P:Q/T%O!/PDD9U&LSD$G6
ME<*"1#[0?-P`P^HZ2)=&FLY7-5Y5NOP1^O?N7!H&;D8/53%KYUC3B7%]CD4=
MICV4K,/S6O@('YB'+87/ZUY;%RDCNTRZ<%?S]!1V3HBP00B`1>I=*U<'KHWM
MXX$3KWVK0U@[:6V,X]*4RE>G6VU@MEO$5^C*]8C%DT8ZP[QYZ:YBOIPTF8'%
MV-(%]H0TH[<X(QP6=74-/V+W<E7(9EV_ZRP1^Q4C9!@P0S"=,/J+\:>`^O!C
M*$I"E+M\MD<PU:.?+YTF-?BV,,F@^S`]V5L_\-OR8?GO&>`25QGIR?S5HC[<
MN@^S,_#-T_&F6:4([ZSU^+L--&OU4!;7Q!:R@G`W$=Z/EKS>H$^57`2[3^BW
MI!:_[,?G"S!)0:Y6TO-K<V?&YV(F'A#Y9.DC;\$:6BJR08.?IPP\GO"'(MC&
M2-KJU4*VB@UG!6WOGL(HN8?1D1;2$9T#DGO7)%E9"DF/8V:K^M"LQ%,B&6#1
MH"3;&H8.!]X@9XQ%OD\P8E^,V!@Y1;XKY"777&IF-V&$:^]ZCW"SOX7;\#$@
M)6@V^WOOY1(&<.\GWTYA<`>3Y``9/61/(=KG0;MJ*'L*=#U?.&DUF:(-/"(L
MM8+_B=H!:4,`MP2*IC1/FHYK"<<Z2[3,L(YK#K=F#A2K$H3_(<5_QOAC(7X]
M$[)]HT`Q2]O+CD:R"O3=OGI'>/'B<Y.'\B,Z<X12N]*W?*ZR4Q+X;8!?![]B
M`88.1O3&X,IBT-:%,QRETE/7D9KTYH_AT?/K71_G(0,>35N6]0=GNEHT?)J*
M,.S5/7#4_5J`0[=G5YV&Y=LEO$:\&\F"^-I$_O4%PD=U>CJC?5D_<=U\QTDF
MQ6BQ?V68W*Z8M#%`X%@5'O`L8)X--UZTB>X2//S^AW<X0Y2!D:4:J6_)?=D8
M8W@:2?O;/"L]5O<W)!D7X*6R`1$.D'1:]<`&8BF!7J,:V0GY#IP0]F<LTQZR
MM?DMGWY".YDGY"W<P>,)CWH^IKO%I;X^XS5C)&SJ(CTQMY@MV?0K9(),J`VD
M&P@UO;<JAY8=$`#HY_QD!%DVR!E)"FO8PT.^N_(9R#&:>>[1JB47Y^0IC/P_
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M'FP$U\CK(-88\%W1B<_2`6H+)BDZNG25G5UL9PMCI8H8M+YGF*&]SO.OUNN9
MD)FC5C`8PLC^<)OU5&P8<TEZ91O9+"E:4-+LBQ^@C'5_A5)8GY\@\IXW1*J*
M$M)Q?NE,660BP@B3B#CS'.J/CG#GT@M^!P=R?!/?I1G!+?1Q.>[W8+--0ES8
M?#IY![!K&"M*I.93$K1D&S=&^PYX1[+"\!!&4?C=GH#!9!@O4#3-83I`?`T3
M&-]XK][#@;]VSGG<4'@HZR`]Y%KG=0XJT8'(`JDP\[&A-S2:X%96WD)<I"N,
M7D&`A=I"%Y:_\=C2L(9ILI3+$^'%0'C$JE4GB22^LI080^22T4TZX7-F3-)5
M:W05K8#:3*EY/BJW!FN>%/P8Y0O+?[$L'>[B\3P:2QO1-+WOO`-2L?/IV`X2
M#)&Z12WIO&PRF[/XC,5C)NL[(=N'RRJ-0&A,8-MY-K:[4_/(*V,U0[QE:_05
M"HC*?T4O,[EZ2%\PLUHX.16YI`-(HC'BJ<'H5C#:Q+!6]ZM12FP/$QPJ.N.K
M,$`#^\1O],O"0P?R[VMDE[12TKM&G'FZD%_*5$NRZUFKX5,+X^!W%>'7Q<_.
MKETF:S<3*CF(?@L?SP?\]"LM%L.YXDK\K.YCY3Q%I.\07LR="3T]7HC*;O(9
M^8HK5@A1",HQ`DI\V%L-,K</,BW'N-LXE)_6%AI"$9V1]E[@_TFXP^Q$^<_I
MIW%3"4F?F"PF<S>G<%G,N+V@@+U#L3BZL;21=B@@MR,@35SE$Z3$4PYV11Q-
MMUY]AA!EY#<P\`[)*_L;,)_4SU.6&M*%D*=SU\V8F@H"2!(94Z6R='-U.!ZG
MB>=B9#QM?!T.BE:KAI!>KW*B(O#1JH=\[3??-ZA[D5?=EW.KGVZ?NN*)_^DT
M12916"C%)JX)S`SELWVDFSVC-#_W,:T#\VK;TA5#W>6DQG.RGT-]47KYJF[#
ML,RJGA_N"V*_PSR(31.AS:NJ@V6&*4Q3X(O$MB?^\X9(\:7/7IGI>C9CL>.+
M#=N>U*"K;@0:J^OK1_X!WTP0!0C__0#9%\9&I[E;.<6+!$V[F`X)$AN=N(\;
M"@A]=@--ERN'%0]&W.C4CSG]P36)8]-FIS:?XS'&BLU.MS"&".L3RF@_PF=X
M",D:57K<A_M11>]HI8Y`$>GE_5EVWBP31P:4)8'9`3137:HJD&X%).YQ=H5`
MLPR2<,(JC=ILHFC""(V+8^^PV5\'V_`([[V7E*^;0+@'L.O;^B>69%63'^*O
MUO-LLHD*QW'ZR@N\G8_R&UP%]KN?X.WK\0EN$Y"$Q1^W870*(SI1B1XDZXWU
M0C+$7Y,GZ$?@X/]Q]G?T\<A_?$+]'2DLNR5K=_B:VEHE&@SD)]U37>-8V*E8
M&'7S5#RI,IPV`#:!V7V5HQK`K;L8]JQ3BAQ]^=IG![LSQ+XF]`V#4T]=`TQI
M.JJ3?4WD%G0G&=$!U];<[.\C+XB]+:FG)*K?*O&BQBRC71OI^JCS=3JQE6V@
MI/LG2*%47"J\$&RX_JMBS)7=DW>T5`0!'<J#UI6,R'MM.2.1-)AA&MY$_K:M
M<";W<3.4J^@@O8-IXJQ91"/"3!?#5`*N>:J6I$FH9\,(3PAAS$-H@$A,O^/0
MIVD3(Z39PL"+_/!;@--5?^_#G;C+XCZODS8\)>0+TZ_3N:1,%"C),MTG*4'G
MEM&]DX:GC31M?E=AC=`B9FCS!'=GS.6+(/%W_N&<^,_P#F[/D9_X,/[TLCV<
M=W"'#QJ@Z'4ZTS'J9O_)BP(_>(PSXM\+9FT5-Z*5H"HUEZW7M7*S74Y9^[A'
M+&L`"A5`I@,]Z5/2`K^4Z5'TH>!7HHNQF&#,H&[%H*&$0?=U@X9=#:HO"HU!
MXVKH4O[AWG:\@R_)Y8%_FGB$AMYDW,NTEZ7J?#EQQHQ]2!]`%'KS`;"79=4$
MP4LO]K=D@O<C?A4]]14FX$L8Q^*QVML+AW66CQ,2*Y_2;%B\\F*\2H/_AT_`
M/:-Q'K[L$0=M^9`G)<1(.)/13/X&F6Q^OQRJL&BR($E^*#4"2"M6A2#EUFB$
M%V($CV$-.\)#%V]G4U_:A&9IC??]=20QXQ4CE&WJ(>V2JZS@6)F@6)Z%7!P(
MDS+O?#QZT2OMHH/?48_L!>"SM_4/OMEMJC*.R.87QRQFV53OP$D^A/<VT&RH
M(]&Z23/"P4XJRB:D2\>=->G)R-IINGE12C?MH^]X%FKVJ6W)>-.$=G"_%VW8
M8:&[N95L,.(K\,4/X'4"C_4K>Z5?T[VE2$(G23==3-?3-=U*U$+D7[%H0&1K
M/G6J&JU,V!H=K7A#CVK(K@+(6C;I="!IOCM'UE@C1Q'6*HK4*_9$CPX3\\X$
MSTHMY4+'B*L6/:)&#Y12(</$VHQZJ%*APMRJ21<22D0(6U8T<*3*#O2D@SX?
MQO+CD+;WC8P\6I22OJ'/63"F`DAOE9_``X5\JX86*DW0&$Q8.$4@Z<?L@8&,
ML<S2-!NOP!T>R,$@)IWL112AKP?)4:/+U^*9&WK\Z.*[%^WD]E@,E6^$Y@.5
MEMY1-%^NFF$@GV5`8^=R\Z#</KA\K3R8Z@"($K9LJM!IQD8H(8+?/[28\>&U
M\J"T&?7'(45$9<<I%5_*ECA6UHYL"=V02MDQO@2=PHKC,ZV>W74E44DCAB-:
M?\VE]^ROUBUAK4HSNKDZ50/D>H"2(A9.L6JW:"/"_0+QZ35DSHMG&'F/L&PP
MVV+6<%*V!:Z!7\%P],(*7[Y>';PXELRK&F^8B2MU-:3S?W:0(*$`Y39$H#5Y
MS""0S<R$@'R0`&F`L3Q'Y-"/:1DC7(*/F/Y_@^%CY)V>_*UW$)^XX#ZODT<\
M):1WT<VF&8NH*%"69?K$A1)TA#[2J+0QILW=*GP1&L(@6V[A*8P2/WB\"0_^
M]I7^MS4=EGI7/XO$"LF?\EG.JXS*Y0(J,ON?!<FH<N!N&7B4R;6`:'*>RB"=
MA''4K*+!R(?Q1;>+$;J\J7U-34HM2>]:36:K1;JR1N2""W-7(O`7V-1#=NR`
MW++:IAZW6\']Z67[A&>2ZI>VT=(LQHM+=^-NL08G;S8S?3Q1K\/]+*(WM/;G
M7#6D.[/9=%[CGAU\4XW1[8U17P?>ZH;5;EML&(6=]67OSKKU33.==9M:LA=W
MN+.%,Z_TUI?6]M9J,3MV8);IKM4")W'DXC_^>4/+JGGO0&Z%-]%YRW*YUGE+
M&=%<YWW9N?-FOZ&]\V:J(7V"9+F<U9AH!_M48W1[8]3;>0O=L-EY\PVCL/.^
MZMUYM[YIIO-N4TMVS^/462^KG?>5M9VW6LR.'9AE.F^UP-T*\#?17\O2M]9?
M2]G-7']]U;F_9K^AO;]FJB$_$)U,:N2S@W"J,;J],>KMKX5NV.RO^88QPB3F
M5C3>EV4_K),_3`UDW6HU6V;U93B[/@TQ9C@J2A;L4.G>RNW8J`2WD*G\6D)@
M`/*+_6L+`D(&5?C/-X<]U"_M0N5M0OWL^1'>YP5+>[QP.?]M`G<?_6=_!X/=
MK9=P=U6-WJ[Q@*00C'29N\5L)8YMY:W8X@WM6#>R,[2RR1%DZH%,/X`5M"ED
MFK(["5*Y>7:I&+/;0G6QNSW"J?XJQH+E0SNRAR[(\*UICLC!QVE0=W@<!84L
M/Q?393DNBD^HY&&1=3ZE+2J2._`<@^'0O)VK<1!I?8S!CZ_0B^*_&(^%HY*W
M$03'^Q;_,JGB/\(#$H./GNI.%FLMO_5TL0I'>KOO9-$R&%:7,!8:_JNEC`-L
M7PV6S[D@XY%2#]%'SQL9G^;-Q\Y;/_[]<P3A=7K[K*[(R6SWK<9-%AA9YLZ<
MO)K+6%$3JP>P?B!3\%\E:`XV/+U/#MMGC^T3<<SR)J.EB-JCQ4KN%WE3D?(+
MI_Z>0L%O(=9]Z5C:S5W,ULKF#,T5O#-D-S>W6TO9BY:J%RUVLSZ6-<BG)%A]
M&5!YSW`T^GK&*[KI8?GXXIP\A9'_)]RI=EMN.V\A5O&4ES[K/9U.5(4NJDM>
M-2,&A3IO+)(IL2H);'_W7OSC^0@":IMPG]WLC'[:EF\R3)Z\!!R]5_``@8\2
M"[;-K(]B;:15$M2$GT?-;DW5JGV%WYG[ZL9H1_M.T!%`2-^/[:[FLW3?Z)@!
M#""=-.\U-6[5\;N%T:S:LIO5N&D;-]F^R_N%<Q(G7K`S=(!]].A7;(T=ZR.\
MJ20W+??T-_1@$E\'-S#RP]W?HC!6/@87M/06$EV^^M))V7RR4!73LK)O5!UP
M'0"J$"`:O;%L5Y%IBQV&($S-\XA%OM%,MIV92G+9%N.__6"6U?M+R_V1/W[T
M$IA/HVIQYW8MWFP0;(4FO05O.E>V)L,-D(WRC^0)@!4N+>3\*T10M=^%1-?<
M>%YJ/!)@P0X;;X^-]TQ6P?`L@VP<-K=_W0Z[.@+#OF\S[+].QR8=I<?K].2^
MZUOL$#?%F(X.7D;B2;.=-]2I-927IK'C*N^V2LJD\Q=OLT<:9E02&C.3&)Z8
M&)V+*@,;V^SVA"ZJYD6PNT;V#O"-VS?('6):9K"3*XHE&0\_0O5DN3!=SZ8M
M`8:V0Z[7S%L"I*FT[J9-X4.=46C]G>TV/`>DU.@^C&B")'EXTFS0D&)!>UAH
M-Z>Z):GK.#Y[J!F\-Q.%E^2,W`8U>\;'H"_/R=<P^4^8W'A^?9&\CP0CRTC2
MZG68;Y^YY06BK`50;@)D;8"'<P)0*^`5)@"W8V#19R0;.-(VN$QM\)]CVD!B
MB68D0V11*SHCK.%^CT8?*'9MPS@Q,J`;P.[J8DHW<QG+1LK9D:C?JCRG.Y,H
M-R[=)2[=\@)#910Q"H5.9-S\*=BUY@"]X<S(X0HZ$+KT#MB]WJ7KN,8[=)8C
M-;KK!G)UG7%\C\8#,:U!\AFI=X'^0NL0WH<7?YS]('SY%GN"PEZ=A1CIDKMH
M*!V(G?FJW"O'H-0(P*V`4EE'<!^"M"7P[>["5/&O<8WA"(V!FF$9(_:,5@4;
MUR(NQR+[NGLD\NZAKS/O$QVJ_7EGRYKITL,HP:=JKX-G&"<XG/"W+C`>U=JQ
M-]N7+J(S+2B*I-!#ZB4YIL;W`Q&Y.:+W^)0Y\,6(]'7O?*>J]O`<_&HZ>?\Q
M\/?^U@N28HZ##.M]&'_AG)7I\J;V[EQ*+4D'6CC+R2KMP@NYH#0;E$D>_TP+
MO\]6C]BQ`G%+QZP>MJL"MI[>MQ-MBRY7WF;C1Q?6;8JR;UD553I</.A,)LXJ
MK^#?YFDCWK'8+YKT0"H72DS<)CD*7+D08NY>R8ZTE(L<AN^7%*K6=F6>W,LZ
M,W@IC:3O)YZLUK(<-'YIGGKDZ1F$8(<K?^Y`?#X>O>B5['$JF<,KS'%*FS,Z
M,NCDT)6Q@KP%%?7O2'08_,,['.#KI1>(*OQS'M7?DS/UD(WRZ]EZ/<VZ;R()
M4%$`RS(U:Z<"DV,$4UOOK`"8VP>8IGY82)]2Y\LW@QH>G^#6]P[_"'&\H$>V
MR"&':W)(E[6#7?HU[?QNUTEVAG:^=I;9!#Z5"JA8D)YJHP=!J.01]W3S>:\:
MJV,<:TL\4`W8+0-^IH`K1];-'5/O2LPB6D@:R4BNCHA+-A>2>^G36^HO7GSN
M=#KW>9T9.4\)Z2NEUJNL`$4F"A!9Y,`PO:("RS.5=RO!1U-M@BIL1Z4MEVYS
MN$KZ+#2$4;Y\^N/L)Z]X2UX8X!4`&<XPWS'!&Y8BLCLTEO.U6^<.E0<*@7;0
M9S!,6N6S`SCM+!*Y(9-)7)L89=/?8/@8>:<G-%(^R#"I\;P)%M65D-[C-%LO
MZPPJR[*#/(/0$>)(8M+.&9ZS,?G"-(-1KO`6@04/FF!'UQ4_=S%?-I(R"PH3
M#L/C=L.CG0O,I<D6[$:]?[._\N*GSX?P>WSQ$">1MTW:OASK%1.,8.@A?P?N
M?%'G!AJJ8'F`"$3Q-15IFB=#4=88$W9`J9T]`F=D\HAG&\.,^NP'7H"G*&["
MV"?GBJ29Q7_5#,.X^DB7JE[D4^]EIN5R02;8)L:I0=UD7F?4!AC8ZKP<)HIM
M9IB19*+C*3SLD!/0$9L\)07OFN$D7R'I5,K-%\W+I"P+SN8@+&*E(MQ-6I8%
M_T\YX`:(V>[#'&:VV,TH->^V,/`B/Y29I*@\:X)Z906D>X+EVJE3+9-CQ\1$
M;U242.U8M'.%Y51,;C2@&^4":[\HYR$3WM]ALR"*M,MEP^V-;()4`*,^YV!N
M<Z/899@NWG?K(F\C!>Y+&M43KH-M!-$OKX/:<BP^:GH#(UQ2P7MD;[$8)%#[
MYHLAVDJOW#L+)]N60589&;5*LB9Q4;[&!@92%:!H5_.>#7TF<NPV4<M6#WUV
M*I_!K%]9@'X'HV=\(#.,R&808IF3T#)Z=H:HB#3%GI'!UC:3&M0S=V[OUGA0
M:XI0;UUVAG*V6)5I7!U[&BRW,`P0H]Z"J:1G$`X2-^[#Q#O08)$/D2$=(O^X
M@WM_ZR=F[S/F<J2:#S$M80>I6^>B[)B`&CK[,G=6"R[9+9AH4H+/K>.SG2WB
M220+9X[J*GT-$_C1C[>',#Y'L/4\E/3[1KG%44IZMU513I5!-2P<%-)M.!DU
MB@'H#:EP!^$1CX)1XAL\PRCQ\<\GY).T$@G-@[U@5^OD<KZF!+:+MBU>+V:Q
MR+CVD+KX<C?9QRKV>8O+G/:69YST$DK*7^BQ$/2W)`B4R)$W5SX)8;;PJ18#
M=0@2]D6`#A1ICPBREK4G0I#?WIT.?G)%OEJ,QO2W>&3O='(I@1CC\8"OF_0Y
MX:4[;PD#E/&D%5`T`T@[P+&)_8K,D1V;SI!&!&FX!Q'$OX)I4A#CANQC?;O;
MMY.]Q9"6<+QR2]R-EU[9'NPVR1.,B@RF?>OB<,EF(T%7=:47<IV5:*!0O_41
MM4S/1I(JZ:3QTD#"AEV3>BU7S*R#K7?R$^]@6;3H2Z"6`-++J';$E%L:X8OX
M)^U*S3>-QH2&.M+S5%-WQN=\*K:<$]C"Y6&(ZWW^@Q?[,5GVLK[3Y_JLF*9L
M>ZG;!U"Y*^'^>WC_%)YC+]A]1LZ00!@(BJ5T>-W(&K^<;I++L(ZSFCNK\HI^
M]7X1@!H`60L@:\)4K96QX#LVP9=8FQ_#!N4#L#4C8(Y94+&E.Z^K:^P=K&8L
M'Z"%(CZ>\941]-HZFL@4G<-F_RWP^360NPG1G25(:R8]9%[-YA7ZTB(IM(7L
M3M!TA%#J8-&P@31C,'T8QQ2EK#^"2"TO\/\DW8D5MRKT\O!&(M'-<M91F?[^
M<QCA`V)]/*0JP!8*5[22'JE.*^L`0OJF?T,MD&."%E*WOPD(;5.`..W?(@'O
M0`#)&9"8T)E40Z*W"%G/9::+2_.X:49[.?P560IIB4)/[*/1#2MS5R#0.HZS
MM)0>\1:7A77A?-HDJ+1I<Q`8;*-Z4/#1R#!X)*M_7AS#MQ0'1#3I'A>XEK4N
M3GR%W\F?>J7KQ<NV\#_72/J8_VHYE>4Z$D[_;F-6W@^Y:'=['!YVB-+@^F9C
M+7\;[BO-U:J]+.(E60X8.)KFR##/4K9BTANK2P?CN&2E2VRV#Z45&(([DK:0
MK6*GEB"MP%ZV<7?`\)GQOB6<[3-RG,ZGB_:Y+\I7F\?.`PW0;>AL*WG[CI@Y
MQK.6M*S4O4_OVR+0-EHSM91V\V51PEB>Y\SQLH6]M$(;M0Z8K6>_D!Z=PP'?
MHL;BPRT\(>]ZPJ==FX,&D?>(7]3-=Z$VT@LV\^K@N"24.4)6R]TUA1K`1R^!
M[4=.%2*>T6WMF;SZR-B:62TI7VV0LMU0MI&/=<>(_'N64*_#!13KZ6H^=>68
M-\)M&VJ(UP-O"^]LY5OCIHUNYE&WIXQ2^.*</(61_R?<?87U#9KB9XWL%F,H
M(GU+^G2UGI6WAJ4SF84P@*09V`(V&)-C`I/$OJ[!P$IE$0*Z03X;!,?`R\6:
MW<(EH%%UOQ;/&D;ZS_,#RJ%]+WJ]\PY0XO(<[O,Z^TN>$O('DB;9$8Q<%,"R
M++D\1PD^MXKO'05HTSTZ;;Y7Z12%-C%#G=/I0`J^>8>L)O9U@,;G1T^F`+7D
MVUII):62K!-.9K-LV:4DN"B%#DJRS9]B&@&[V\"^*PI`X"056V*/+>$7+?UL
MEI&=7+K*3WD#FF#K/3R>P@B%#ZGZ/[RG-;*1HX)T%["8IHLHN2!;ROZH0-:E
MSLB/Y,#UU&@1H!;W*S-)9!X;F+/=1A!3^C[$]C^>\,_T,.+N_YSC!(<`R0\O
M(\D@XR34DYZHF,VF'#;FS8#[$!0-96=^\Z9,3=:,;A4R?5-8`2]P%,N;I#0F
M6>$$Z&\6%0<9P`H1V66MJV3V1[KQ+SYZ8$<Z<EJG!`;;^LRJ"HFZ9Y*&J2L]
MA>$XJ,>:-MW\4$A-71N+Q8Z>Y%&"%L+Z2>]LE$Z[](F*I69!T:[N"*G?5(Q0
MR?<A"X*EPBB33Z$I,+C>X%G\<W,:'(@:PJP-F75-.[CZ,IV=[Q@52K^@35H:
M-(=9ID^\U&,9\4*`)O.0@>'%,41C0;JME9:8RO&'Z?_>8'SD!9+NH9%I8KU1
M\1<OBKP@P85KPG-CQ#A,EK4QL:9H%\^>]@J):8,@:]'2B#C(+GT"XKAV49TZ
M#C//C!41OZ<&V*4RWV1`Y,20[O&096`+IMJND%JO?O"(/A[2ZB))(O_AG.#Y
MSOOPQHND)]HDY)B;9FM73OYXRXH7#;)&`&T%E)O!`8(V9,5TN&)[O)%:N[T]
M7S"9)FE)"XB.M-E$Y/XPNL'K!D9DDXB<QW#?-D=JGDJRY\17[IQ'95P/<Q,!
M*CSMSI%XNN')"@8K`=^!M^_`"=GDF;>CTQ"%VWQ:0%RA`<<8IA3I0(?Q".,E
MPP./ID;2J:*[FDWH".-C*2/,5V!0QEAR.KKO#L\^$J?#?WWP]P@=H61IL+V'
M7G*.H-G9ZZ%688>ATI#"ID'$8+"S+.ZDX(H!PA[\]]EB\6ZQG))/?_$?_[Q!
M>57@[3QRD\=_=]XMIM-WT_F2_AFI$X0OX-O=19LGV3+0X$<!WHB"8VT+,HKZ
M'E.YGJOQEKD,HJZ*;.<Y72_6',HVMD1;D2T,`MHI2[!BOW1'?Q5D"4S#C9$=
MU!OZ%AS\HY\T2-7M7<.Y`E<QZ7M.U\YDP9F4;!X^R,4;3044@98,+R.#[K3<
MH@CYVXLWO0C-Z^_%5K2FVZ<'I;MT/^D;IKM[JH;\J=O94LQ%*L^B;KX'P#Z4
M\[FXC7;O5;]L[=I+QK*&6IMS$B<>N6>XRW<OOV::9"5=I,LVSEU7S+224(OH
MUA=J'\Z%8@L8)1[#:UO95[?=&)EU]TT`EBWU]UV9=5?3Y9#IMG3Y-C8[LS8(
M/3N<V+@P/PPFF5#[A;'<_A:FQ#JNL-NSCIY>K]MZS*O^G-;.N=:X=%KH3O+>
M.+M$VH)#74/0N)W0Z.M+.6Y4[3Q9P(UXO9_@D]'7J,]^]G=G[R`XQ\]^5J?W
MLQ203M*<979P`(O!I_8+04:/[@^'Y1:P0DE8VO@@<K`*)[A6L((7O_C)TRT\
MT+IQ3_[I/OP4)*C[^A@>/9]WS4%7*2:Y)%9-_@J_M8!EN`U0;@3OHZ+-@%]I
M0[9P4*$YTI%A"74BA=H81>5\74A>"?/UIW4,MS\]AL\?=M"GC$8_U(F,?O7;
M?>3AH>C=Z_$AK'_XYM\UD*_1J*P?.6LW&_W0UP%]7R]9AJGORJD_MM=S'0/[
M,QNADFF,;P'>ZO)(%P$X8PS!@[HG+9A:2'[OF3-=IU,5%3%C#SBX<Q##P3C:
MP8B7ZH8C<KLBTC*7(&1)/H7`1Z^(JCL8?8]\_`GXE^,RGM)/TKH*DBZPF$P6
MTXRAA0Q#=]D.A.'HA=%&S$%8W$Y8-%&2QX82'YF@%9$Q@MOP,<!4OPJ/)QC$
MA`^?7O"/\!?H/SXE*`H\P\A[A+3B*?O#])"CG]#=E92<6YZX<]==99POF@'E
M=D#:$,A:`FE3:0U@W7%A;&LX]EFC+;R,;1*W81*R9OG^@52$WI;-@VOLO`/?
MTS;?>ZEQ3K1<="'!8.CJ'SM*P:VGR96'/[+(>HF_`T./-F\1OVPRT`DUDW7>
MZ6RRGC*B&[VUBDAG<MM<1%,(NQG&C,"6#UT*L7>,5U;$(BDB,P-0N^&&3ZN1
M==CHE4ZMI?^H3Z^EO_X-?YC*IR[]0<.$6M&:]%34W$DWXWX#=WI9T%/9U,'Q
MEE%Z@M'LF*#YY;&CUK"96++Y%L/-_E.<^$=L(\X\?^TAC0LNU9:E5[I7\W0]
M!;V/5U-R"6;620:@<#,4X1Y`$0I=ZQYLARDO:S#0*DGJLCTO*%=\1@'\&7[Q
MO0?_X">O_.FFUG=TIW!M"DEVX\Y\/G?2S"W?R97+!+E00W-3:E$Z9E&*$S2U
M4-T6J+[A?JP3$?-<3,I&2F.$8)^KZ8VM_38Y.FMG[<YJA#=2:VJ0_HXV_>58
MVPN$R]IH:IR-O)VCMFP53?5@]M7L9S3FF96&90<:ZX53\V@S_=!P$,2CK^A5
M;O32FE26V=Y&Z#KEE+.)7&5O$G]Z@='6C]GGD)L/&>I1"@UDP]G,6<^=2I\2
M@UR(D5ZE+P9'(P:IGJ4O$+<"!(J`Z.Q=FA2H]R\UP./PCWG+K_!1XUSL<K^M
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M_8ZT*9"VQ2C@,MJE@UFDP/>X"V<,-=AF4;%-MMTQK;5QQJ-`%#[PCB/4*-BE
MM@I@`@YA'.-MD?B/.%^*>76GM4U##J-.9<)R@.'?4-1HJ0HQ5*K]4:3C(2-W
M.5\M%$03XT4J=)J+Y"*?]GNX);633V&")/G>X?!*PPE>/X_A]AR1Y7.CUWXK
MHI&"2&*\A@93[\V>J%S2^-*+_>U%L$L1=7&W=F&FXT>KAM(\<"8S<=C8[-/=
MS>6`05H#J+DLJE@4+-3:AL0("A>74,_2C._UM"1+-<@HI51H+KW:?&GT:O-A
ME&D-&G(6MRU65,);CW1#),:2^,#23=;[%_/52BXR5',)*Q,(5?8@T>`C#,*C
M'V"?M974(M^6I3/76#83F02>@9Y!95A(8:*8]/:<Y:(7?TDC=E.WNQW<+E,)
M#Z2W?SL3"6TTZ$/XPL24!RGH+T@>^C?Z%_H!'_E"__B_4$L#!!0````(`*LQ
MK43*(>Q$OBX``$-[`P`5`!P`87%X<"TR,#$T,#,S,5]P<F4N>&UL550)``-"
M\'%30O!Q4W5X"P`!!"4.```$.0$``.U=67/CN'9^3U7^@].I2B55Z>YI]]PD
MTS63E+Q-7/%8+EL]<V]>IF`2EI"A2%V2<EOWUP?@(I`B=H("!>FE%QL`S_FP
MG7-PEA__ZVT9G;W"-$-)_-.[3Q^^>W<&XR`)43S_Z=W7I_>3I\O;VW?_]9]_
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MC_@SGS_6#=_]_=^=E8V_O&6HU>';Y[KYIX]__N7N*5C`)7B/XBP'<=#J2`9C
M=?WTPP\_?"Q^6[;.T)>L&.4N"0J4%`@\X[8@_WM?-WM/?H1A?O_YTX>W+'SW
MG^2#/Z9)!!_ARUE!PY=\LX(_O<O0<A7!=]7/%BE\^>D=^.O;BB#__7>?R_[_
M>)4$ZR5917%X'><HW]S&+TFZ+*A^=T;&_?IXNR4?+6&>HK</,)R#]'T2XZ%A
ML8SR:E%^)#T^"@?]V)?D1]SS]R>\[B'YQO3E!L5XHA"('I(,D4]<1B#+T`N"
MH3$'BL/ODY<'D$+S*='X1KZ`.0I`9)^[6WS:+>$DRF$:X\7P"FVPTQW4.MU/
M"XS+(HE"?$)>_W6-%_0D#J<8IY0<5?A7,,[PATM*;/"D]T&W_%I;E_I?'6ZE
M7H)L<1,EW[+;.$0I#'(;#'8'[4WW%<J"*,G6*;P'.?YS^C)=$3$![^IL$H;%
M]@:1E3-=^TL6F;M,XA#//@R?ULLE2#=XL:!YC(^L`,3Y)`BP?))C*>HAB5"`
MX&"<6R'#(BR/,(18RGB."&58L,P1_B<6"U]@FF(B\R3X`V^AXN]J7X40$XOR
M:GL-!-,@9-E<37@?8@+(7^2+KR#"VS,C<E^XCF"Y3[N_M[%^S#YLD?6[!,0W
M($#1@-,O_\9`#%$@FS^US!'G(T.Q5!\T%R#^8TBNN-^Q>HHOETE<[O_!3FC)
M)X9AARZ*WR!16&$XP><>F,-)EJV7J^*2M,N=TA=MBA<POTNR[`&FA9@VF&RA
M\IGAV&H<Q5CD7)>V%;(I,A3@@_D*16N,]#5(8WS-;WO9Y]N0CGT`,\$B3DB^
MCT7Q)QBL4SQ!,+M^"Z)U",.;-%F*2-X9=DCD[!)J$=JM_GT;9WE:&$JR&X#2
M7T&TABV1\FN</!.[%Q&E;F-,JXU#I-?G!X9AJ&-%_5MV-,G[)(?9+-E^=JL$
M9EWER9@]K8\,S9=0$9K!M_PBPK?6`+PJ?G@<_-<_<(;#EH#!\6AH=Z5:1]K2
M'3GHDE#^]M`HL!6Z_:"@_NW1H#`C-\T0FT.7@J$1N8+/^7Y6`>]+CC@<;(;%
MWQM\A5/%;$^;6_Q!M_P.MXU5/CLT[[M:UY#3S/^6,RX'FUS9%X?FF*4C[&<S
MJWYY)`@,M@+TOE^AL6IXP1`GF!8LN`N,0^('4/Z4$&#5F:&@`5.!Z6I]."*.
M'TG:GI#JNX5W1P:##_/D]6,(T4?B"D/^4?C$O/_N4^7;\8_X1[]/\*=#\OF;
M",SKX2+P#*.?WG5__W%P>B[7*7EXO<'3`J*_0)!>Q^$5GD`&:=RF>E1VES'Y
MR>_UM$P8TS)YQNL'D$?;%E'J_8;'L2:C1`>?>2@);_#/,@:0_+;[II/,HAJ5
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M1>K[$U(2R9-B]:<35HQ[B>+S;R=\^%(%A>G?3S`)1&Z*TW^<<!(;%RA4/YR@
MXNH:6Y2P<'E"25&7I*`-+9+_^''76+DG$Z9B-).QFO<"LN<"F'7V?@[`JM3U
M8)1G]4]VE;[JQ[]7K@I9'>GQ"`.("H>C[![FU7FPHQ#J]3577OMS]0`VA!Q,
M(/Y)NL9K"H%GXE:+8*;&F\H(3CC<.D\]`!3>QI=@A7*PJ[K+6ELQ!$_^ND9Q
M\O8U`[_`Y3-,=VA@M['TY;?5)8A!*/SR3ALGLY5E,-^UV>[\TAU='&L]IY$[
M.B4[MM7&.95*H.ZV=4$UVS5GDE^"--W@"[IP2^5PH=;7"5?D5IV^E*X*R1*@
MF,="MZ$3>JF(Q#S+^.T<4WN_)E14P:/XNBS=F&N1@+X>RTZ97D,ZQD"X17:;
MN:#UJA*IIR_X;[PO+Y.,>QVQV[JD>@;>&E+7?1('PHM`VLT-+RD^'DDHA!XK
MXEYV'O+%'R'!I&4\TW151@,PWO0UAW`S`Z\P2E9$"\/JV!QBU12F6&7,X%49
M_(H%_/5R'6%-+;Q:DY6_VX,[2;T'WM?S(_,F[/QZ>&KNX!Q$Y3<G;XCES+#;
MPL6*::QESM0W6SBF4'*]LEJZIK@=@EX&"BB0S^SFF!>Q:C(2FT&7#/5%,P9-
MA81%UP:964("I26P<]N[H3Z>SV"Z+*@BT8^$("[EK+8NJ"Y$[E)9E4HK[+;.
MJ%;>GKS68Z!<#?3QR+D/*5P!%%Z_K4B>%C'N[+9NJ$Y6,,TW#Q$HWS?PI5*(
M9_>03[R@BQ6Y_`D+U?BZXZ9PX=L\%7NZ0+HB38$3E1X6<;XPQEG:TQW.%]HX
MLWM8Q/G2&&=I3W<X7VKCS.[AA(-%DN9$V+C%Z&9Y$?3!(YW5U`G-]7MJTWK+
MT"3E[9U2?X=B>(O_*26;-G1*+^/U6J)!*'5URE,1S"2COFSDADY%#7DD.G&7
M#.D*X788!_VV'CALC.P"D1E<KI(4I!NEZ>2U'@'E]:/D9$D\.R9YGJ+G=5X:
M!\ILIFH\*8SCPD>KII;]ID\<LMHM.B:@K1_69[]<_-2!$:N!6WR^]\NY3QT?
MCC&(`N-73(WNCFHB81(]D^0@.@0D.,;C)B"*3B5;O,X-\,*ZX'-R&&M'`3&V
M&D8!\BO,2!L>13]5BI=?P4;:>''LL!0?OP*,M/'A>,10?/P*,-+?;VV/2XJ+
M2431^"\VOKL@`47+'$^A\BNH2`TJ)3L_A<A/34-Y-<D?':A2YJ?2H;.:.*\9
M%"(_U0_EU21_6J%0^17=;[*:.&\V%"(_)6XUB!CNZ!08/T5K&S[M'`AWM=W/
M?@K?MA'DQKA1(/V4TFT#:</UF6*NHP'\4&(>PSD9>YRH\]RCM[=K-\S0URQ"
M"E#LQGKZFC!(X*;>#FZOD:)`^"FI"WS-FV>-R,F81OK[>0$J0B2-!:(X^7F_
M27`RBTJBH/F5]$9[<<F"YBA0!@:J@WAT43VJV![Y%!\_K5.*Z(@\T:D![W37
MU0%B%!,3F7#\)G)Y]!#KO4XI`XNOR13-H!.$.?F:2]$,*&Z4CZ]I%`W7DQ`A
M$PES_(>5U$&\9:ECF$1]U^;X/NC=5V"&`N=98DD]5)C2@:^Y)/6@X3H+^YH_
M4@\>D7>\K[DCS?<6.S]`OW21!W1U*43;M-=6.Z+E:&ZP5@1/;9OMF&YK.+X[
M/CP4A*(:G2-<+:+S:;MH/%XULG@M\?UE\#Y)#W"_7HS,(.WWUDNQ]--RTG=Y
M-A'RTV0B"<\3".<J\7#TU7]HK6;DN;E+0!8P1P$F^90V6?)E.P&<IR2N>Z(6
MK^YI6FR$L+ASZA*P<OJY/1US5-ZADW6^P,?.W^@)P>>DTV,4'-QFV5J=^JKU
M*"CGUPM4ZG)*B;E+4+^4F*<D4Z<D4\/@?$HR=4HR=4K8Q&MX2MAT7`F;=I1L
M3<E:M?<(.%.4L&6]K)SZDH]\Q;K_$N4=&O7ZC@9SH4X@ZC$:#N2Z@;3;>&/H
MS*+%/36&VXP6]]3&/42TN*?&;IO1XI[&H`P1+>YI&(K-:'%/@T[Z1XN;!)F,
M&)A3L*@.%*=@T2,-%CWY7P_A3LLW)O@>02.&2],&X'L4C=':ZIIS?(^BZ0%3
M;8'I%T;C-40M$\\I;D39X>(41R+UY#C%D@A=14Z!)')_E%Y!)`>1`^$41C)H
M&,GQP:$>17)^`L=5$,D8O*AO8_QK.(DPX7&1P,>.N_0R27/TMX*#Z0L)AB!>
MZ].X;9=ENC*K]73D-(EG9@'C#,-4XG8/,80S\,;WF>3V<,'!-4AC?*-FM0![
M`3(43.+P"D7K[H.[:B\K3@'7;SG^QAIEBW)=/D)B6L(_*CY)I"5\*\(B\?O5
M&LZ2\CTD*U:)?%59'-W%O-TD*43SN$P($6QF*8@S+!%@\G[&;-PE678!7W`;
M_DK4&<$%AS45TYBF$KN-L>"S+FIKX%V#IR'GLJ?<W2UO3R""9$$U"A=MJQ9)
M.1-V=L(7C&$*(I(M*%SBW43$5`)\5<:"QY"DEPM.RJ.9P$P2B^'-CT^+-3X=
MIACJXB:J=D?9#N\1F.$3)0586,#2>KHI9`>2<@OWQ!<LIF]^2[*VPHPWK4-^
MT1V"6[E"XK?(:^V.<HQPM0`O\/I\06+*NZVMW(&[@ZO(2](^;C`MEZ+X)-AM
MY8;2NGY3":1TVW*:NZ`=WVKT&)F\`A25X:`-8TH57EM(;!R6=$=QPBG67<J#
MD1QSA%CQRN*W'Q7UDE-2WL\%-].:I(H8GG=]M]THJ)5@SF_O@OI'F$&0!J0X
M7R/'NWCMB_M8N:<>(5&.0%1;#_#M4V5`5+FQ-'J/P`6:),*$1"";)32+<9GJ
M(?R_=7D7J'E%*XTTA(,]_\-W"#<("WFS1![KAKOKRL:(+N;Q-ZSO+G(83O!J
M`W/82M?1>%U0,X$8#N;2_"F1R%NI.?F'I.\/G!HH*5SCOK]U:J`UJ$K=[]%T
M_%GEM'%FJ*]FCZ:'4`+&`"6AZ;Y?5(\7J\F*V&`6^N/IBC,2(\TB@CQ#4-$4
M9A8:U,9JYL65JZV3^1XJI(J9S3='L]@BS[:NL66R7P"2%U>P\AN][Q5O-+`R
MU?%]KXBC;'%N:Q([CS9FH7"'=*09XL1[,O(U8*X77*K>#[X'1?4$3^86XWN8
ME!9\6CZ(9I%3WA]S6CYGOH=6&2$H>+7N%V(U?GE7^NS:Q$GRRMFO5-_XUY86
M5E*?.XJ6GS*(%EH,7P6*CXF8H;/SQN#=7VA"[8S\58$"AD5<S_/?SBMMLY9]
M6=V>7=)>F#]3<Q`7K]&3,$3EZG@`*+R-+\$*X;4D9DO8QPD743$X%ITJRP0,
MR3K"BZA8S6+'%,7.EI+FG]+U2^;RE*[?UU@ASLKD6Z]OX[QIFF4M6?7.^Z6U
MC!;N17$UA)M5HI/X6K77(2?C/Z[HL,.(`QAY481[^$UV-_#;N=CU&EO=\O[N
MD=!;,1.PS=(@IP3V!Y?`7EX!CL>"L.\IA;V(SFX9/0ZMG8;.Z"VSWY1:^@-,
M45(JA5GS9OT:HYR_\K4&&1V?Y<]ODO029`L3'ML#C)<_XL&+*<13DJ&P\OSM
MQ2]SP!'Q7_CT]5S&G#'&QF6/1<SH/UKN6"O.9$(E`SKC_Q&NUFFP(/:X[KX3
M\2GN.#9^BCDP8*?L=XI$,]+-#CP2K2]7]+_3%>/FZSG8?GGY#:0IB//:CZ(7
M*[MC#<$)_:0&R8Q.0]"FC^4@B%6#9M=O,`U0QJZXU&TTS+?YEEQ>TT,HM:!:
MM./<SU2[:C#)L/$S]%2A]@O;M$F!\=,!O'\9D\]^NG6K`2-Q-:`@^>E.I0B2
MIM\)1<TOMZI3A1P=*$X5<DX5<DX5<H0`==ZLV@F7M6RFOH>$*-3)T7#:\3T"
M1&.)B4V`_@=\]-J-W)<XWX,\;&['VIIQJJ6C^LY@EFGJ:'8EZ\7-]W13%HXQ
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M"[`I#[T;%&/-!0N8^*S;OG-L=1G.G*OV/F7H,*%9&OVDW.V4O\.8^HYV=LK?
MX5/^#G%DFRBXCQO--]IX"?5(-D^=`ZU$LGGJ!-@_8,NSZI*GJ!H=*$Y1-:>H
MFE-4C>&C$O\]]RB#9M2UH5.XC)8.;Q8T<X!PG5Z-!GDU.CXXU!^-SD_@'/.;
M$0E-N8F2;]EM'*(4XF/&28&*VJ,NJYS0B]D@#E`!_C^*8*NHYRPA5#^DR2O"
M0%QLOF8PO(VW]58F08Y>48ZZY5EV##"#?]9)F8Q6Y;'MS2JRA@N[V'F@:WVA
M+1^);%5*_9P\->&5@(45\A>YI5]!1%;1)+_$$O$&8R=*^*?6UTNN?C\?$5]E
M$`S>WRD$&;R"Y=]:['&&<,4C.<CKDZPH%%J*U%2\WAY19/-$2;9..T7D&'SW
M&O;8"J#8X>`*8G("5!Q\^-]1X1!,"J\U#D0.*TI=7?`D+^KX-<;[)T)_ZR0#
M-!K"!8_J-5.9_"EW=\N;N)BNA#-A9Q=\[1[?M_$D*"2+K':?PO(@Q+.!U0B>
M"*4WQKBX?``;0A8Y(H(@76--!X%G%!4'NC:[PL'&P?=68J^2TTEN0(T!QL$?
M/B)6`)'4<H6P7!>+K=;A),L@5Q,P',P-WV7E<Y)GD,M-HXD+&O%YS5(9&8*3
M9`T:##1N?B^3&&^@-?Y9M9GX:>U[#CHB'*CPW'/>10.-F]_^\ZXZZ(APT+=,
M&0PT;G[[S[OJH';*NB5QH?@J']2JO6Q1U];%5:F3]7*RADJRIND#2//J/Y,`
M*P19D4@8W^$@GA/7KU+6*'Z%!9%/O-5C.IQ#)^8,J[4T0=GTA5\.5:.C2WX4
M[<[<YFYIOTM`K$8V;>F68EV_=W87ESS,DFHG[FY0"2/\?J/@IF7EP$J3S$JB
M,<`H^'M:)&D^@^FRO%6*7ZJRQNSK)G@A"2`,LYLT6=8[XC;&UP6('M;/$0JF
M+UCYY9<=5>\_%NZ4KAAI/]?<W"<YK.U-"DRTFKNFO7EK$P<QN`0=[W8%GI2&
M<<TKP^"K<A1JC&!%JL98ED?4#23VK0<8@ZA3SU34T@7.6U+PE7X%GWE@=IJY
MIE5A[W*;.PGH869JXU#.:6QEE;;2M136V!#E:Y+&,0[(JUAXL<9J3_X7R#*,
MFHQ@A^H5>9&,?DT*JSF]0\K<DRRW`N5NCH/6MOY3ZK%JW2Y.>%BO5E%!$8AJ
MBF[CER1=EDYZ$G84>[MT`-R75UG3I5#MW=YW-WD7R(O]WGQWN-\GXD)IR7=7
M?1=+6]7QPBP,]I`2W>U]F:LYKOH>8^MVT<L\J?POWN$"?Y[&XWO=#Q=8ZWE&
MFM41.:3UKN^SU413TY_/_ZSTMN%4<S`SRUY_S+BJ.63ZGO*^'ZI]75+,LN'7
MZ":8NG&C:^Z2V$2Y:W;V/Q&^'>28;@;^I\&W!![W]<_W1/CVMRT//U]SY-M?
M@9S7=-^SX]L]!T6N;V;9](][4:HY%O1*Q>_]&E5_LJ0X^FGXLRWS")/[G/MJ
MOAONZN&XJ5%(_;31V5Z6W-?"SR=EQD#95H[WHCB;Y)T\%F5;+WL%Q=1$$SIN
M3#N93BB8!HX:9<FBIQRD^0E2F@"F`:J!@G0@=:#,(T!9-Y3$W]ZLA+H'UU5?
M.`4^R69%U8\04QU';]^KL0^T3+LQ469%V8]O=?8-3#>K['[PPI2F^X):A6Z3
MA.JO,'U.QKKK-2/%J65)TX5_B^#W?KE4:L:RM_:U<=`X!=-/Z[Q*:(+9>SD=
MA0KP?BU(4PR'=QFCB/MIK]=%7,='A&+GIXW>THX7GL`40S]]CBQA*)0"*(9^
M&N5U,50.0*-7MN>)ZA6!ZY_IER+J5[TG7425)5`*F)_N1;J`254>"IB?EA[-
MZ-FV[-),7+F_TFO.JDW0$^@>$#UW^D)-+),P1"65#?3,2U#H55PF(GFZ2DI2
MKO`.F+ZT?E1_IXI]UNAH)6C^*SZ7<CC'L_HW&(HRN[$;.E/IA72WB\W)9^"H
M]L=E@L>*L2CYM%XN0;J9OCRA>8Q>4$!,Z65T`#YP'Y((!>2XM;MY1EPWPLZ&
MNH)9D*)5%<L)TX!,Z[QPE".Q5560YPR\7<`8OJ#\ZRJ)GV">EP<]:^?U'-%)
MOL4U*72Y/8/C^1.<B_)V\=M;F9,V:$$RCY'^-.@/8BECT'P=D=:;RLPH.*.Y
M;9WD_BBG\&>8S%.P6N#C)6H72-W-]L%M;R<[C.B0N^/4,=?I.3R5K#K?JKV<
M9K!ISJE*D?M.>W/J:V&M0"7=E,17_]FEN_KQ[U^?=@AL_,*9P",[!^C+C\(2
M\KYFH>SL(6@UI]O7C"(&1]]V(?659'PM^-T'4P-)Q-=BX88P*HB8OF:^ZHF8
MKCNJ9UFL-.4K9@W7KB"S+>7JVU5J`)?6^MQG#5S']FZ>^-M:8GR)97_"V@BL
M4S2<\#*)7V&:HTYD85V_O2I@'N)+,T!Y5<>\O[6*5UT6CQ\G;U\S\`LD-P]+
M#^NTL5/7%O]Q"6(0"K^\T\9)1<Q&^6^AJL]HZ)I>G@5`W-91W=$Z3+3<(AE>
MXA<@XZK5@@Z.Z6>N9WX[Q]0^@'2:%H=Z&9F+9?G"RU)./[>G8XX*(K+).E^4
M[RAR3CH]1L'!=)UG.8A#?OD$81<KIS3=6KLI'&>);,D;#.`&=TIA`\KJHN:7
M2Y+W<\=-(5^H'TF"+HYY:"^9$N$RC0`Q*-`ID+.F/-*H."8!:QG)[6'*:'<`
M-S6Y2Y)FX*V1D(VX#Q5Y&WFITJ7=^EO0U=P=F')?Y]<ND*T4!''*^9U&5FZ&
MZS>B`J]1MBB=G^J4OM-X!I?$"2'=E)]EW0KJG8>?X3LX!U$YCXQ7'%8+%_/\
M"U;!TL+MHW2!FGZ+\7Y>H!6UO5YL'H!@,^F,8*?6(LDS;%8?2K^_PYI>C208
MM1*O45!.VMM-#:+F':*I(BAV=L^7HJ(@Z306/DIA1H.'JL-8Z)>K.[)>;BHS
M22U[0N%;O;\37X<B++V@XAXL\3\;^;7%;B_RCH[Y>4A1(#O)N,V=T(XO:9"B
MY&N<D?QJ+PB&XBG@MG=#_0*&ZRV<%YO"],CR_5'I8<<K"4L.^"37V[<Z/=WX
MIQ6D:9Q`HAX6<;XPQEG:TQW.%]HXLWM8Q/G2&&=I3W<X7VKCS.YAKXY@5EQH
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MWQ.GZ4#$L8;XGNE,#2*-!QG?TYL)/8';D2`*:KBO@6\6T)(9:'P-=M.&3N3E
M[6M\6Q^0&,IUKT"V42<%-@!*W6O2UU!H;=#DYAL*E?]RA-GZ$ODA4_2.7*@0
M6CHI2OY;9136F##Z@&+E9_939:RT?&!I_0$_XW"549/[WIL5P?$(*EV'=K,*
M-QX!IOO:Z7OU&G7`N`Z(9G5I/(+((&:@7XT9#S#3CD2@B!G(]GYHCQ+O!XK0
MD<OOPHAJBM+1R^\*D?04K2.7X&7Q-_2Q_LB%=M4`+`K8D8KN*A%1%*0C%]>E
M85<4*;_D=%XD]U8>Z&8CHE#X9055@&+7>YU"X>?UQ8ZA;ZEMHN@E7]/."H+C
MVZ4(]I_2S5'J.^5HR.UF8OFCTNWDIX8A#51LE_/4BZ2AX/EI)E$'3S,U$W5V
M\71SR@-,F<E/V[%!WB8^-86)'VQ10^7O<:\&%?.:K,$Y/W)P%`():Z@^GZ`2
M:7-'E%F8%VS*0^EHY$]1/&M;7>$*$=YC)(L.Y+S&<07ZH\I3S4ZF3P\P]N]=
MU4VKQ]V)-"Q^Y22+([L4@3@WGZ33B/AP5I/.'E=&[*CPX<+JJ[3:=DME'($?
MOQ$N:K5#/'T_,$),J^B*R7-"DH/H@.[.NP3$-R`@_G4V"C98.O1*,?DW/"\@
MSJ?I(YHO<D&R!'Y[AZ4,VM2HU&!@]K"3$)WU@>LWF`8HXQ4RE/89#;854;#P
M3=O^,JM^J[5H9$,-.1LK5-9`_@L$[*3T"MU&,R=U2;`G&*S3PG?W$D01#"\V
M?:9'8U0W"<.?<WJT2D1H3F,7=/^,#YKL+LDRF$WCCD<QII/#@KR?"VZ(^0DK
M??C&1OGV:N-?'MSF8Z&=;G%2,)V7.4NEYU@XNDGA7]<P#C;3E\H'%(MEU;^*
M*#@-'N5CC87K.@#D$<]%T^]<@UGN$&/A\8Z(IJE0V)%V&PTODC)4XCYCX>(7
M\(:6Z^5%DJ;)-[Q@+L$*_Z93X,!HB+'P6&X"%%3;'@MO<8!66,U2YY$[Q%AX
M?(1D<V#T^\RD8)"Q\"E*KLQO[R8=/`WY()1E-6D<ZOGMW:2`7Y5+'9.A0CV_
MO9W$CG@R@R3^E8CSFPL0B_+^<II:H:/6(V;)PSH-%B"3%J12[C80?65VG<`@
M@;+Q6"-P&^;;AACOK6Q3C.^/B@IVJ*U;EOFR.I)H-D,412YM)L%LAPJ8OCF(
M>@Q*;9='DOIC:$3;]L<CR0AB`U0SI?](DHD,#3!?]SN2#"1#`]PQ/QY)CI*A
M<54P@AY)BA.;2`O4VB/)?V(3386'(=^3I(C?]&2;W/-@.]4G-QE,[6>#8T2+
M]7!"(\YXQC'?T^\H/<O(%A?_!<1WIT)M^`0F[5[NA`>1@\?*8A,]T_B>*U@;
M0#-OKEZYA(\&1AW!S_<TP])W1MFN/I(P6RV<!`\QW@?9]EY0C?V\SQ#)D3F<
MTQ"MYD_U/,XY[Z23($AA7J09J%9HG1F5]1(J:'T<?J0<%&DVV3HC([V063@*
MVX_%PV2R+$B4UOY3Z^LE5[^?CX:OVQAO39!!LD77,*S?4[2<)MDC6-DA#UMK
MXS:):9&TE.$U+6]_3%Y,'#RW]ML;"(D]'.++J^/B)FKIB2_5P5DZ&>=/+_/*
MJLS)G8,T'[<LV`\V[O'F>_BF.FQ*1BD_+2IRD*3"KN_6$D6(Q)*LF0'DAQ*D
M&,Y)CELO8.)=O[U<K`["^JL(D%C>\]UI2OW05GF'UW)\\FNSZ6IC_9R92EGJ
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M08X:SJ&<76QHFSJ`Y!M(0U$"!7OC.T&'23./57;C\=#=P)H']9TD`XV%@0\*
MCZU/8Z<$GUUXN-^QD^K"-EGW\!OK_ACD.P>U7J:%C)[]7+SRW,9EJ.C/:9)9
MWU""+QT^8K]!XMH)P\DK3,$<%K\DL:`W`*6B--3[IL()TK+R#[N8<-O;.5N*
M6AV[D-?RX6W<4&QK`1*C2Y0&#"GS$.DUH#V>>)K-3;).<PAC0;H@C>XN5M`,
MY40@HPJV8/6PVXZ":F(D*'1ELG,7:#5+KAGU&F7\2$:QLIZ^QEC92^8QN=*:
MB_KZC?P3[IPSS!R-YN-8YX!]R%8TR,@6=QY!,#/#?MBNAJYZ+O@>*6G')L:I
M'MI7%_4]H)=E`FEYL.V8'XX%#\[&539S^IY;P+JY1[-XG;>!;(,"V][MWL>Z
M#8HE1_@]ID*4`^Q\"_;&(RC<:,TJ:P5[D:W*]SP5(YL*OIG9]Z`,NQ,QH+7;
M]\"/`29"PR'&]YB1(99Y/\.K[QDX!D#<Q,G"]TS!PURD??S-?(^(&7!AL_V9
M?$\;/#)9T/1!U/?DP_N<IIXIAP_"`WZ`<T3CE<CW1,,#HZO^BNA[#F*I.P0C
M@UCKC<_WIQ'A:[_0,BI[8#\ZY-0\#JA8)7!:WU\1FW&%"U$S],YY-<'JT[(4
M?9S$V!Y\A(=C/[ZM)-J82'(S!9C1*[)_\'HB)4EL>^XI?]<9FL]RKIYUN"+Q
MFKR:O`-^T)O5^&M"3O`B=?*>U^/.EP\>T4>4_7&30M@L.;0//)G?/2@T_?!Z
M]L/K;!]GC._OJ0<R+6U!Q/>WU8$F92!YQO<'UI%O$?9=[ON[[(@FI;_=W\"2
MH&FI'H$MX1[FI#P8AJ>`<33I1R[6&4DZE^%9?T9Q0<83Q`L03U:T>=P:;F=X
M!C.\=,A4"\)N3$=S(00;T"H,T3$?SP7WS*(4\OQFTFY.>&G8Z0KW!@4^1%U<
M\'`-4E(,B1X08A,=M[FEW.*8!X"7:[&*^1&#S'9V0AFW]M9=3CL/3:T01H5N
M`]/'RBJAU.40#0&-75,Z8PRDZG>_XR:$&1\7BR3"@DM6AN;<)SDL#Y$55IHO
MDQ@+)AF1PPA_7&.G[C#CX/41$JH:="JSU^WI4G;N*?$TA>8>(H3OCY"]I:M&
MIFW69>2[@Z),'J#^M+*;R->5IBLGM$/^%$XW7XV?=H&378&^6BO[H"A66'RU
M*/9:=_8%55]MA+T6IM0JX&O\A8Y6UU,$]#RT7!=)]?5Z9`5`=TS&%")R!*Y+
M$DBEAPP%DSB\0M$ZA^$N?"YLRFYL6</07L"K2'C9=@Q45XM!D>ZZM9W4S&\Y
M'GN-L@6Y@Z<OVSKOQ:?J:+.R%-`:SA(J,4Y?'NK]7(A&+".:Q=&M<'L;XQV,
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M19.!CGBS3-;<5P\[8[NPAO>D_&+#'D`0:SKD%P\0P3M)"5QKPX\'&VFA:FDW
M*Z^_I:4J1UAP:1NJ!*7>I7W&X$5V4'Y[5<;"AFS.1%_>WFTY\Y[;5*VFN96/
M.'ES+74!X<RVV[B4,?=P)S;%4?DAZ6LHV%!7J!Q=;;'/UZ@3W9NZ46U%=GOZ
M[C>@`YG"=>=KP%T?N';N#5\C[$Q,ZK9%#]_OF&%$-8LWC5AL\#;L[&#FY^YH
M`]IN4`SB`)&<9_@\6A<YZ;89X:8O3V@>HQ<4X(/Z:YP\DPI59`IN8XRED^3J
M%R#^XRX!\?0Y0O,R>[Y0\^"WMV)GN()E=2Z\I/"@(9Z6*YBB5T#6X1T"SR1O
M*UZ(-TE*!:G"%%V)6#"\C?/FRPK+,&'_(R[T1$HS)JNX^F;XDT);D;"+6Q[H
M=B'9+@4F46$7-U:9W37$.@,DAAJ-(9SP6+B=DB,_B3$IPD7&;NN"ZF8N59AG
MDSAL[.Y?\`F`S^MP&C^2^RTE[V!Q>)^02C[E?\FS3"8R-MD;WRDZ%YOM/_\;
MP12+(8O-'7R%D6`7*G9VRA>]E&4!?,(N3GDH!8,"T,_"(T34PRD'XBU1[(&.
M)$1R2N#3+T*UQ"9\]1GD4TXQJZAO"X_;[24\??7&&`N7I'I35QYNSTU[(NNY
MWI3)F.NJKK5HIX&._6\?$JH9AS5148MAOG5"S>!;OY\[P:UMQ19>3,RF;K)]
M5M4(=P14D?^%N(\5C;<RVW8UT`W_95W:QVG>?@6]=/LR(N?>]U`$5;C,U$W?
M8P]4#`CMZN4BM'VWZPO5^%;&-[Y5T/>G-V6,V'>@[\]NUFTJ[-W)VLW>/^L,
MBJVJN:=&V=M#<%"4)4)F#>[Y"=P^2]BJ36F?#Y2.)T7)TLM$7,TBY;O\I&):
M9L+7?S<<#;0#V(ME*]J"Q:>7R^.J,"/BJR/-3Y.T1Q.Q[WE+AIZNH3PV_$]]
M,O:-)+,Y]TNO4IYWU_&A3)+.<QP3?=8KKN\>WTKF]I9ADVUXV9_@,U+OP=&4
M4?7*L>(>-AX="O&\\?*@>!#O')I%_0N\.#-RH96;70;+GJ@8Q2FJJS/M:X;V
M=Q`[.V!(_:ILEFQ/E^W9G-V#O"BP/<5W<GGS.TDW$`0D<@Q/XT,2H0!)SQ5!
M!R=IU[LHLNEF-'0:9B3%O95VB<'E46^>AC-_%\D9_O9%1/29TX;2]]500Y;C
MM*'6^7`VGBH:I\TH!:G^P6E3FH0*81%K^K)#U:;\4[8I%3N/(26(&D.R7DZU
MF^D+2Y,L293I),*^+KBB":B5)H;;W$U!GF^-)9_BDVP=!["!J!I/VL,XN;3A
MO'#8@*LDU3T>U/HZX8I9E;5,1S")R:L"IAMKJ`\1UBV%.\QD)#>.LJSZQZ30
M`%R"3@H+DM4<BODV'L\%]U^+IXPL1TLL6?#TN)U&AR-*JM[AOENG]5#;71.^
M^T#JH<._GWUWAM3#25$Z\SY[DI[N:WX9^?Z\KPFDB1QC]A+O+81J`FZ_TB.^
M@2;5KGT/\-$TLFLKC/L+\1FCU8]Y/="G1J=6^*I8FR3#;+O1>!0^%H@Z"AZK
MO_O`'GU9@XG#49O:+T&VP"(#^8O`]`HB\M.1;#HV<9)-*.GD8E.J@ZS#TM@V
MI=IL-3>I!BZG3:J"4Q%@X.1!S)>M2M,QLHDK$)9>HGJ#'-:FU47HJ'?N%7S.
M1W*9MDF1[$Q.8S=Y!=D0JA`^CCTF1KX=-,WA];2)QG39'>I6HD<W(4KS*F-T
M<<L#7H7D$L*[`.4W(*A";]09DO4_C"-#`P_?'P)-0&-MA/T]"8[PL&U$[_46
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M@>TUY/C(^/$C8?$99!#_Y_\!4$L#!!0````(`*LQK40<U^5[LPX``.F5```1
M`!P`87%X<"TR,#$T,#,S,2YX<V155`D``T+P<5-"\'%3=7@+``$$)0X```0Y
M`0``[1U=;^,V\KU`_P//#W=;H([CI+OM!IL6SM?!0)H$CM./>REHB;:)RJ27
MI!*[O_Z&E&3)DDQ+EKTK`WK9E<7YY`PYPR'%?/IE,?/0*Q&2<G;9ZIZ<MA!A
M#G<IFURV7I[;O>?K?K_UR\_??O/I7^TV&@S0#6>,>!Y9HC\<XA&!%4%#O.",
MSY;HV9F2&?X>C;`D+N(,_7$UN$=G)UV$IDK-+SJ=M[>W$R'<B,B)PV<=U&Y'
M#'X+1+E`'T[.0)I$RX#[S+U`[Q.OK@7!"J"1"T)<H+/3[@_MT_?M[MFP^^/%
MV=G%^>G_DM!\OA1T,E7HG?,=``,D8)RCP<G@)*'5O]$S9Q*@9W/,EJCG>6B@
ML20:$$G$*W%/0J+2*(N@!YF\;"7T>SL_X6+2`1;=SA^_W@>=TOKV&Q3`7BQ&
MPJ-K&/I-A'/>H4PJS!R20/$H^]N"H9MUGR>99%!"L;H?/W[LF-8$M"_;$XSG
M*_@QEB,#'39T=%>U3[OM\^XZEEK.B<Q%,RWY>/CS(F9%9T0)NC@A[@2+-F<@
M&3%NH>UY>KZ&R,!,_BR_(UPE.IIG!X#:`$4$=9*HV_$R.!K&52NT9)^_[P2-
M"6@'/%2)Y3JX),[)A+]VPL;\_G!\(6#8;4(-6S7N60;7)30?#1KRN9&%,\U'
MT2WY.)2]$JGRL8*V?#RIYB(?2[=HG&X"1V$Q(>H!SXB<8X>4=!&8C6:$J3LN
M9C=DC'T/Y/WL8X^.*7%;""N@,?(560/P60SRLZ;R"3/&E9E7S&_]9CZG;,S#
MG_!"#YX+P3TR!+]!^N%ET-\NK0JGR8[&Z-QPQ]?R8N;>,D75L@\\Q,QP;B'J
M7K:L$"MI(GE<,J:,&KF[IUW41A%Z\A%(H8`62A#[U$E32!/W83Y_9#^;9P=[
MCN\9Q'OX'2*'$#;$N8`9E*D=,&/)-N.%;R.S[-E:SR"V<:_'\1UE,#M3[#UQ
M:62Z]K"4H9=INPT`X:^""'8SGH/M5H20CF',)4S'5GB2W*,Z\KG&JA"P1B"Z
MBZZPIX,'>IX2HF1CVCV9]@G#)*RF1%'HI-)V-MA;C/U#96.C=VM2?M<8OXSQ
M^Y#XSDC/4T0PT.65Y%LY"V8WZ_N-9G729G4BL\H(7B(^1GRNTVRJT](0"GI\
M"C2`.?*X;`9Y*3L_3V&03+GGPEKC]K,/L;#'W$<8-.(ZV;.!G?-]H!P)NW]\
MJ.P?``=+.$5''D'`?$P@7]0PW/G;H)FG4-K_(,W<H:KQF8/Y3(%049[>%B_Z
M\>MX41-QJGC5-9;3.X^_R3YSJ2".RG>6+)C=%WZJ[@O`$8TUR\:@6PWZP!61
M0[[*_E9=+Q^P\@5Y'#^N`GC"P*70[`;_J)=X5#J0"P`B_`@HK.<.C24K6/*9
M3A@D\@YFJN>86@YEDR<82@X%#+)05Q[,CH6L6Y"4U>+=T[3%XS$N_=D,BZ4V
MOHQ9(;SBA>8AL\8CJGA$(AP&$5S#QC8IZ12%J=G]HIOVBP%Q"9EA'=3+!?AW
M883_#A$C3^,L%9Q%1W!(\/1_VKJOV--O=W66XM3LSG*6F41TV#=I@7X@,>W&
M^!6,?T-&:E=3;\*U&_8\;=A[CAD:8X=ZS4BN.)+Y;,:9F:YW'KYV$G;3_I`-
M_)I:,'DWEJU@V5LL&&1'\HD(LSHO9]3-V'9[OL^D[D29FAZ"Q!U)3:JQ:@6K
MKE[UF53"GU6)NT5IV2W^(6WQ%5E$8[J-T0^^6HM>[''5MB)I=X$?][%Z0^\B
M;DW5[8ODYD.]BBKF+65IVMWEI\)Y.GH7$&P\X@`)>PG[VRG8K9TIYJTE[XV%
M#Y_%EQGH10A9[7V64\J+,_K&W`=-[4M8>AL-NY$S=;ELFM^8^@OF^R4,7XZB
MW0TR%;?<W+_QA!*G*%>]F=TUZ[FND4V;+GVTLC2:W;"9BEO>#AR\CFDGSU^B
M=S=$8=ILGY<R^&K1]!RLF1['UD5:(6_8"TV[J^14\'98_#6NM$]7BG?)KN--
MLJ=HC\RD=["<2V[2A;MCX=F=(JYU$!YV5\L4%_>V&]CXWWZGLMQZ@?YPR/4]
M$IP`RK9G)J_=J-A]*%.NW%Q\:*.(U^H,47Z1HG&1\BZBJP!W81&@T'RS'<%N
M^$R1<KT.T4P`A[)N/&"3;VWFW8!AMV^FJIBV;W(PF[:[50VJ,7%%$T?9Y15F
M?Q>V\D8DNZ&W%!3!T'':J4DWQM['VF15%RRX[M@";S7QN;V&V$S5!S)M/._^
M3O0WXL3M04Z-)Z0G82DW-XM^BZ4+H=L-GZDKI@R?G,,C)BCD@A)L&E?8J>1$
MU#V7JY)PL7I3$1R[T3-5Q)QB<C/F#VCHQ)**S^9^H)V.RY(ZL,"ZH9X/XRR]
M8[#%$W8D:G>5;%TRSU62LT2">9`0`'NSC`L%0)$$"$1`S\'.1>-3>_2I'E/4
MU9U-7\DS<7P!`A-YNW`\WR7NG>`SFX.DR!9VNOURM7MEI@2ZU2N3TJ%8/!3)
MA\8@X';?U7RTG(WO5O/=O#VQ.TS%;]CSR5K-_(7QD;XV1]<<^PRLDTF(*M&R
M^UFF_IF_W0;O@1\R#+7?)%BB)$\4,&U<9E\N4RAA*HYH=X9BYRZ;Q`E>ZW_T
M=5(#,D;FIJ@+?4'294O2V=R#D!*\P\+1^/8[ICISH3=`]63=B<A&!#+8ZY=:
M&0=*]5\H541A*LCXLJ6ODVI'5P']!1@GBYD7@2BJ-)?KF`[2A.3W"'M>JU-?
MS=?-6$!Q0,A1_&9%YDCT]O"(>`55!M@<E>\UA2/1-CW,"R@-*#E*/R4(Y>G^
MJ9.\Q@I^K5]S]0E4YT(AEKE\RW(_'0JNP+OGCB%D0=&_VA%>6[]J=\_:Y]V3
MA71#$<M($/=T.0DBO+(2Y-[\5I1WA*"9OB_$SGJ-WB:VAF7NO7T=XBFYHM6.
M:97O_<QE>84Z(8VE>^*C[O[NARHB).[Y*RD&9P^[26*[%[&"8?2;LG;9=KV@
M59P\O.A'-4%R+BLL)DD2<?6K'9,I+TOJ!L1"8D0X^J%21Z3O4BS$?85DGBKQ
MS][*6$B"!%KX7$F*]"V/A618(9FG=HR>Y!_>]F@$N&SU'$>0H#+Q.Q8"5FXZ
MU=?^'"PG=`3]RP84)`#F9M:+&6>0ZHME7Y&9SHY;"(]@@8`===D:8\\$>`,(
M@9]R=VA075^$RY>@;13<S';9`IZPGF@A1CU/KR(O6[#6T)'+!Z)4^1KIOX+[
M\X@]!;8;M)Q!E]-_PA),)/PC6S]%E-2X(,+AM'?)Z"#*KVN09^Q"X$>A^&>?
M,KYXD?A7,AL1D50RTQ0H%-R3>^'R&:8L3Y]`&)LZ>Q%\,;_&#+MY@J>;ZB2X
MN;=Q-4D\"G,!].V""(=*33JAR';0I(N9TJ8LY6!!TKP?3]H@[)P&??<GP6*[
M:NO02>TF^M6.HV<?VA7X-#]0;`O@FBNJZ'TM%(ON(+_CHB^EKZ>:&R(=0>=Q
MZ2RMXS:<-0=5@K+)UU25A;?1I^?L/E,\H=2:JH5QCB+*%];';&#(77HBPJPX
M-WTATP^3HF="24F\6L6930?!Y08M;:!U4NR&P'C`DCR.;T$XUR7N#;!ZQ7K[
M[I[BD3Y91HF$&2E6QKA?J"9Q-P_W`]`^ABPP5\D'SH*5LM(G^X.S/(_I4%`:
MLW)WK'*6PTV2B0@&PQ[2+5W[G(!3#`CV5FG_$"^N""-CJE[F8&VB5$!DK7>J
M$:I3](P7>%&@7Z5OR3!A!SN*&!G]08->SI]&Z(4B)C4N!%[,E%]D`@V^^>DS
M[8TP<)^@!X=O?#CEOL3,?::+3(`HC%&G.'&[T%^U^51.@YMN8\\<$EU?`M<+
M]$HJ6ASG*%PYK<^`:)/`*Q.UHA%ZS:62-S[1.<VF?,?2256('D-T#"[*AED:
MUJ?Z6TI+36P[Z)$H+,QO[(6IC,EQ>N$?N='4U]+?G#"P.XDZ+1L*:6'D?TP>
MR"[>`^NX=5+]@:@GP1U"7*G/YT6CNJ^W^['WY(\\ZCR.P;5AW">T+H=V#(/A
M@;S95HCYS76*@Y"-FTO>@Q-);-)S((:;/#TGF2D"7*-41J\T0-R^V4PJH-M6
MX'KI=CN;>WQ)R(VYF9^+[-+=!E0K)_2U3(_C/'F3ZEC!DL:A3)$)^8H5X4A4
M79>6P=R>4PS]'1B92&`.E&3T+(.<U#[2Y.NI_X27YDSCZB]3L4F0\9%1<LS9
MP8XBAUY?MSM\$IQX*U0`V`$W'+4P9.<!\M>S\8!,]+%&+I8]*8G*FU,W@]1H
M)AT0+B:8A067S!R:WURGV7-`YL$XNB.DQ]PGPK"WMF[=!'`4`VQ`]/(0>]&?
M/X.Q`=.&)FI9:95!.HI>B+^627^&=4\9T>(F`V4AZ!H-P<WR#E.;WELAO[!6
MKKJ8+O54[(],OV[0#UA`'KEQ)R4SZ11%J-,T%,A\55;)[0CU4_*ZK)+;$6JE
MI!Y/5_H/J>O/V@B30;5:UV`F!NYJ&8.$.5SO#0LW2ES#8H:OIES0?_0W>F_)
M+CD(^3J51]9*G:;8!W'`UR(%6U_NE:\>N/J3J"=,W737E$`\AA))8*TA6%<&
M?J]+/_$IK"&WG#+;`;=6`\EV@U]NX"Z(4*?8;;V>/AV^"P#7,X)3D)&SW[#G
MD:6^JB;KJIL@:N60<Z(_._R-*[/47E4F]91#7/,9:E*E(M!',05IJ3,1)RJ>
M]%E*-\T^7ILG.Z0:G1HMWL.C6?E;MG?<%XJ0[%JX%%:M_#X^>I9,&U1:MUR0
MBIG%/H_1IO:95Y\5#'E\EL:,RWL*`*[IP"#?).:KN96V50D=PZ@OK*/E!%,%
M&D=15RBLW^9O6W8G<81.%*NTO2?R8(]0Y?2<^,(\.@-L=[/F%I2*A]8..)D6
M]O"C].,7YF!%)H$]<DKU&]IKM-!X82X1;P(`<G8Z\QKKE("\,!%L\/RSGCN&
M)X%2M_`]&3'6U-L%O5Y[@DD=\DM`H38;]-Z"4WD0;CHZO+\Q&$T<F5/1RXP_
M;P>MDW=OGCH/.5?N3W`9?C:W%M-RVFJT$LA(E_DD9R-$G2JED9!#_N0+9PJC
MVW:<JA!T#0=&0N!@/\`IOH&P.XFOV!&?.L'7]O#X?U!+`0(>`Q0````(`*LQ
MK41[O`R@UYL``&[R!@`1`!@```````$```"D@0````!A<7AP+3(P,30P,S,Q
M+GAM;%54!0`#0O!Q4W5X"P`!!"4.```$.0$``%!+`0(>`Q0````(`*LQK40"
M),T=80\``'O;```5`!@```````$```"D@2*<``!A<7AP+3(P,30P,S,Q7V-A
M;"YX;6Q55`4``T+P<5-U>`L``00E#@``!#D!``!02P$"'@,4````"`"K,:U$
M:O9M,8L>``!W#@(`%0`8```````!````I('2JP``87%X<"TR,#$T,#,S,5]D
M968N>&UL550%``-"\'%3=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`JS&M
M1`IN%!<M6@``>^($`!4`&````````0```*2!K,H``&%Q>'`M,C`Q-#`S,S%?
M;&%B+GAM;%54!0`#0O!Q4W5X"P`!!"4.```$.0$``%!+`0(>`Q0````(`*LQ
MK43*(>Q$OBX``$-[`P`5`!@```````$```"D@2@E`0!A<7AP+3(P,30P,S,Q
M7W!R92YX;6Q55`4``T+P<5-U>`L``00E#@``!#D!``!02P$"'@,4````"`"K
M,:U$'-?E>[,.``#IE0``$0`8```````!````I($U5`$`87%X<"TR,#$T,#,S
M,2YX<V155`4``T+P<5-U>`L``00E#@``!#D!``!02P4&``````8`!@`:`@``
&,V,!````
`
end

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0E2JAC">
      <tr>
        <th class="tl" colspan="1" rowspan="1">
          <div style="width: 200px;"><strong>Cash and cash equivalents - Schedule of cash and cash equivalents (Detail) (USD $)<br></strong></div>
        </th>
        <th class="th">
          <div>Mar. 31, 2014</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAbstract', window );"><strong>Cash And Cash Equivalents [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash</a></td>
        <td class="nump">$ 49,538,874<span></span></td>
        <td class="nump">$ 7,292,116<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Cash equivalents</a></td>
        <td class="nump">3,379,453<span></span></td>
        <td class="nump">3,714,276<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
        <td class="nump">$ 52,918,327<span></span></td>
        <td class="nump">$ 11,006,392<span></span></td>
        <td class="nump">$ 19,017,252<span></span></td>
        <td class="nump">$ 2,000,539<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Cash<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 1<br><br> -Article 5<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_Cash</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CashAndCashEquivalentsAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Cash<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Cash Equivalents<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 1<br><br> -Article 5<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 1<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3044-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CashAndCashEquivalentsAtCarryingValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashEquivalentsAtCarryingValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Cash Equivalents<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 1<br><br> -Article 5<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CashEquivalentsAtCarryingValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Condensed summary of significant accounting policies<br></strong></div>
        </th>
        <th class="th" colspan="1">3 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Condensed summary of significant accounting policies</a></td>
        <td class="text"><div>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt">
 <b>2. Condensed summary of significant accounting policies</b></p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt">
 <b><i>(a) Basis of presentation</i></b></p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt">
 The accompanying unaudited condensed consolidated and combined
 financial statements are presented in United States
 (&#x201C;U.S.&#x201D;) dollars and have been prepared in accordance
 with accounting principles generally accepted in the United States
 of America (&#x201C;U.S. GAAP&#x201D;) and pursuant to the rules and
 regulations of the United States Securities and Exchange Commission
 (&#x201C;SEC&#x201D;) for interim financial information. Accordingly,
 these financial statements do not include all of the information
 and footnotes required for complete financial statements and should
 be read in conjunction with the audited combined financial
 statements and notes for the year ended December&#xA0;31, 2013
 included in the Company&#x2019;s final prospectus for its initial
 public offering (&#x201C;IPO&#x201D;) filed with the SEC pursuant to
 Rule 424(b) on March&#xA0;7, 2014.</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt">
 In management&#x2019;s opinion, the condensed consolidated and
 combined financial statements reflect all adjustments (including
 reclassifications and normal recurring adjustments) necessary to
 present fairly the financial position as of March&#xA0;31, 2014,
 and results of operations and cash flows for all periods presented.
 The interim results presented are not necessarily indicative of
 results that can be expected for a full year.</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt">
 Through a reorganization on March&#xA0;12, 2014, AQXP Canada became
 a wholly owned subsidiary of Aquinox USA (Note 3). Prior to the
 reorganization, management determined that AQXP Canada and Aquinox
 USA were entities under common control as each of AQXP Canada and
 Aquinox USA were owned beneficially by identical shareholders and
 as such the basis of presentation of financial results prior to
 March&#xA0;12, 2014 was on a combined basis. Subsequent to
 March&#xA0;12, 2014, the basis of presentation of the financial
 results is on a consolidated basis. All intercompany transactions
 have been eliminated.</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt">
 For the period from inception on December&#xA0;26, 2003 through
 March&#xA0;31, 2014, the Company is a development stage enterprise,
 as planned principal operations have not yet begun to generate
 revenues. In its development stage, all pre-operating costs are
 being expensed as incurred. The statements of operations and
 comprehensive loss, convertible preferred stock and
 stockholders&#x2019; deficit, and cash flows present the cumulative
 consolidated financial information of the Company for the period
 from inception on December&#xA0;26, 2003 through March&#xA0;31,
 2014.</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt">
 <b><i>(b) Use of estimates</i></b></p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt">
 The preparation of financial statements in conformity with U.S.
 GAAP requires management to make estimates and assumptions that
 affect the reported amounts of assets and liabilities and the
 disclosure of contingent assets and liabilities at the date of the
 financial statements and the reported amounts of expenses during
 the reporting period. Significant areas requiring management
 estimates are the valuation of intangible assets, valuation of
 stock options and warrants, amortization and depreciation,
 valuation allowance for deferred income taxes, and contingencies.
 Actual results could differ from those estimates.</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt">
 <b><i>(c) Taxes</i></b></p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt">
 The Company accounts for income taxes using <i>ASC&#xA0;740, Income
 Taxes</i> which is an asset and liability approach that requires
 the recognition of deferred tax assets and liabilities for the
 expected future tax consequences of events that have been
 recognized in the Company&#x2019;s financial statements or tax
 returns. In estimating future tax consequences, ASC 740 generally
 considers all expected future events other than enactments of and
 changes in the tax law or rates. The measurement of deferred tax
 assets is reduced, if necessary, by the amount of any tax benefits
 that, based on available evidence, are not expected to be realized.
 Valuation allowances are provided if, after considering other
 available evidence it is more likely than not that deferred tax
 assets will not be realized. ASC&#xA0;740 clarifies the criteria
 that must be met prior to recognition of the financial statement
 benefit of a position taken in a tax return. ASC&#xA0;740 provides
 a benefit recognition model with a two-step approach consisting of
 a &#x201C;more-likely-than-not&#x201D; recognition criteria, and a
 measurement attribute that measures a given tax position as the
 largest amount of tax benefits that are more than 50% likely of
 being realized upon ultimate settlement. ASC&#xA0;740 also requires
 the recognition of liabilities created by differences between tax
 positions taken in a tax return and amounts recognized in the
 financial statements.</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt">
 Investment tax credits relating to scientific research and
 experimental development are accounted for in operations. To the
 extent there is reasonable assurance the credits will be realized,
 they are recorded in the period the related expenditure is made as
 an income tax (provision) recovery. If investment tax credit
 amounts subsequently received are less or more than originally
 recorded, the difference is treated as a change in estimate.</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt">
 Canadian tax rules impose a tax with respect to Canadian
 corporation taxable preferred stock and their liquidation rights.
 In prior periods, AQXP Canada has recorded this tax on preferred
 stock as a non-current accrued tax payable on its balance sheet, on
 the same basis as it recorded the accretion of preferred stock.</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt">
 <b><i>(d) Derivative liabilities and fair value of financial
 instruments</i></b></p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt">
 The Company accounts for currently outstanding detachable warrants
 to purchase preferred stock or common stock as liabilities as they
 are freestanding derivative financial instruments. The warrants are
 recorded as liabilities at fair value, estimated using a
 Black-Scholes option pricing model, and marked to market at each
 balance sheet date, with changes in the fair value of the
 derivative liabilities recorded in the consolidated and combined
 statements of operations. The Company allocates the total
 consideration received for issuing preferred stock and warrants
 based on the relative fair value of each security at the date of
 issuance. This allocation results in a discount to the initial
 carrying amount of the preferred stock at the date of issuance
 amortized over the life of the preferred stock and is recorded as
 &#x201C;amortization of discount on preferred stock&#x201D; in the
 consolidated and combined statements of operations and
 comprehensive loss.</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt">
 The Company also evaluates and accounts for conversion and
 redemption options embedded in convertible instruments as they can
 be free standing derivative financial instruments depending on
 certain criteria. If they are determined to be free standing
 derivative financial instruments, the Company records these as
 preferred stock embedded derivatives on their consolidated balance
 sheets at fair value with changes in the fair values of these
 derivatives recorded in the consolidated and combined statements of
 operations and comprehensive loss.</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt">
 The Company applies the residual value method to record the fair
 value of warrants issued with loans as a discount to the initial
 carrying amount of loans at the date of issuance. Loans are
 measured at amortized cost using the effective interest method
 which is a method of calculating the amortized cost of a financial
 liability and allocating the effective interest expense over the
 term of the financial liability. Interest expense is recorded in
 bank charges and financing costs in the consolidated and combined
 statements of operations and comprehensive loss. The interest rate
 is the rate that exactly discounts estimated future cash payments
 throughout the term of the financial instrument to the net carrying
 amount of the financial liability. Debt issuance costs are
 capitalized, recorded as deferred financing costs, and are
 amortized into financing costs in the consolidated and combined
 statements of operations and comprehensive loss using the effective
 interest method.</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt">
 <i>ASC 820, Fair Value Measurements</i> requires disclosures about
 transfers into and out of Levels&#xA0;1 and 2 and separate
 disclosures about purchases, sales, issuances, and settlements
 relating to Level&#xA0;3 measurements. It also clarifies existing
 fair value disclosures regarding the level of disaggregation and
 the inputs and valuation techniques used to measure fair value.
 ASC&#xA0;820 defines fair value as the amounts that would be
 received upon sale of an asset or paid to transfer a liability in
 an orderly transaction between market participants at the
 measurement date (exit price). The guidance also established a fair
 value hierarchy that prioritizes the use of inputs used in
 valuation techniques into the following three levels:</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 4%; MARGIN-TOP: 6pt">
 Level 1&#x2014;Quoted prices in active markets for identical assets
 or liabilities.</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 4%; MARGIN-TOP: 6pt">
 Level 2&#x2014;Inputs other than Level 1 that are observable, either
 directly or indirectly, such as quoted prices for similar assets or
 liabilities; quoted prices in markets that are not active; or other
 inputs that are observable or can be corroborated by observable
 market data for substantially the full term of the assets or
 liabilities.</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 4%; MARGIN-TOP: 6pt">
 Level 3&#x2014;Unobservable inputs that are supported by little or
 no market activity and that are significant to the fair value of
 the assets or liabilities.</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt">
 <b><i>(e) Redeemable convertible preferred stock</i></b></p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt">
 The Company classified redeemable convertible preferred stock that
 was redeemable outside of the Company&#x2019;s control as mezzanine
 equity. The Company recorded such redeemable convertible preferred
 stock at fair value upon issuance, net of any issuance costs or
 discounts. The carrying value of the redeemable convertible
 preferred stock was increased by periodic accretion to its
 redemption value.</p>
 <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 1px; MARGIN-TOP: 12px">
 &#xA0;</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt">
 In the absence of retained earnings, the accretion was recorded
 within additional paid-in capital to the extent there was a
 sufficient balance, rather than accumulated deficit. Only after
 exhausting the balance of accumulated paid-in capital, was the
 accretion recorded to accumulated deficit.</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt">
 <b><i>(f) Accounting for stock-based compensation</i></b></p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt">
 The Company measures the cost of services received in exchange for
 an award of equity instruments based on the grant-date fair value
 of the award. The cost of such award will be recognized over the
 period during which services are provided in exchange for the
 award, generally the vesting period. All share-based payments to
 employees are recognized in the financial statements based upon
 their respective grant date fair values.</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt">
 The Company estimates the fair value of options granted using the
 Black-Scholes option pricing model. This approximation uses
 assumptions regarding a number of inputs that requires management
 to make significant estimates and judgments. Since prior to the
 completion of the IPO, the Company&#x2019;s common stock was not
 publicly traded, the expected volatility assumption was based on
 industry peer information. Additionally, because the Company has no
 significant history to calculate the expected term, the simplified
 method calculation was used.</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt">
 <b><i>(g) Segment reporting</i></b></p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt">
 Management has determined that the Company&#x2019;s operation, and
 how they manage the business, was one segment being the
 identification and development of therapeutics for inflammatory
 diseases and cancer. All of the Company&#x2019;s operations are
 performed in Canada. Total assets held in the U.S., comprised
 primarily of cash and cash equivalents, were $51,116,586 as of
 March&#xA0;31, 2014 (December 31, 2013 - $6,629,383).</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt">
 <b><i>(h) Loss per share</i></b></p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt">
 Basic loss per common share is computed by dividing loss by the
 weighted-average number of common shares outstanding during the
 period. Diluted net earnings per common share is determined using
 the weighted-average number of common shares outstanding during the
 period, adjusted for the dilutive effect of common stock
 equivalents, consisting of shares that might be issued upon
 exercise of common stock options and warrants. In periods where
 losses are reported, the weighted-average number of common shares
 outstanding excludes common stock equivalents because their
 inclusion would be anti-dilutive.</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt">
 <b><i>(i) Recent accounting pronouncements</i></b></p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt">
 In April 2014, the FASB issued ASU 2014-08, &#x201C;Presentation of
 Financial Statements and Property, Plant, and
 Equipment&#x2014;Reporting Discontinued Operations and Disclosures
 of Disposals of Components of an Entity.&#x201D; ASU 2014-08
 provides guidance related to the definition of a discontinued
 operation and requires new disclosures of both discontinued
 operations and certain other disposals that do not meet the
 definition of a discontinued operation. This new guidance is
 effective for the Company for annual periods beginning on
 January&#xA0;1, 2015 and interim periods within those years. The
 Company does not anticipate a material impact to the
 Company&#x2019;s financial position, results of operations or cash
 flows as a result of this change.</p>
 </div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccountingPoliciesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for all significant accounting policies of the reporting entity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-107790<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18726-107790<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18861-107790<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18743-107790<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 5<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18854-107790<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SignificantAccountingPoliciesTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>20
<FILENAME>Financial_Report.xls
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xls
M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O
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M<B!E9&ET;W(@9&]E<VXG="!S=7!P;W)T(%=E8B!!<F-H:79E(&9I;&5S+B`@
M4&QE87-E(&1O=VYL;V%D(&$@8G)O=W-E<B!T:&%T('-U<'!O<G1S(%=E8B!!
M<F-H:79E+"!S=6-H(&%S($UI8W)O<V]F="!);G1E<FYE="!%>'!L;W)E<BX-
M"@T*+2TM+2TM/5].97AT4&%R=%\U-S%F,S(V,5\Q,#%E7S0V,#E?83AC95]B
M-F9E-V$P8C1E-#D-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-3<Q
M9C,R-C%?,3`Q95\T-C`Y7V$X8V5?8C9F93=A,&(T930Y+U=O<FMB;V]K+FAT
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M;V9T+6-O;3IO9F9I8V4Z97AC96PB('AM;&YS/3-$(FAT='`Z+R]W=W<N=S,N
M;W)G+U12+U)%0RUH=&UL-#`B/@T*/&AE860^#0H\;65T82!N86UE/3-$(D5X
M8V5L(%=O<FMB;V]K($9R86UE<V5T(CX-"@T*/&UE=&$@;F%M93TS1%!R;V=)
M9"!C;VYT96YT/3-$17AC96PN4VAE970^#0H\;&EN:R!R96P],T1&:6QE+4QI
M<W0@:')E9CTS1")7;W)K<VAE971S+V9I;&5L:7-T+GAM;"(^#0H-"CPA+2U;
M:68@9W1E(&US;R`Y73X\>&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX
M.D5X8V5L5V]R:W-H965T<SX-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@
M(#QX.DYA;64^1&]C=6UE;G1?86YD7T5N=&ET>5]);F9O<FUA=&EO/"]X.DYA
M;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H965T
M<R]3:&5E=#`Q+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@
M(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^0V]N9&5N<V5D7T-O
M;G-O;&ED871E9%]A;F1?0V]M/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T
M4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#`R+FAT;6PB+SX-"B`@
M(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*
M("`@(#QX.DYA;64^0V]N9&5N<V5D7T-O;G-O;&ED871E9%]A;F1?0V]M,3PO
M>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS
M:&5E=',O4VAE970P,RYH=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE970^
M#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE/D-O;F1E;G-E
M9%]C;VYS;VQI9&%T961?86YD7V-O;3PO>#I.86UE/@T*("`@(#QX.E=O<FMS
M:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE970P-"YH=&UL(B\^
M#0H@("`\+W@Z17AC96Q7;W)K<VAE970^#0H@("`\>#I%>&-E;%=O<FMS:&5E
M=#X-"B`@("`\>#I.86UE/D-O;F1E;G-E9%]C;VYS;VQI9&%T961?86YD7V-O
M;3$\+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS1")7
M;W)K<VAE971S+U-H965T,#4N:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H
M965T/@T*("`@/'@Z17AC96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M93Y#;VYD
M96YS961?8V]N<V]L:61A=&5D7V%N9%]C;VTR/"]X.DYA;64^#0H@("`@/'@Z
M5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#`V+FAT
M;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R
M:W-H965T/@T*("`@(#QX.DYA;64^0V]N9&5N<V5D7V-O;G-O;&ED871E9%]A
M;F1?8V]M,SPO>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F
M/3-$(E=O<FMS:&5E=',O4VAE970P-RYH=&UL(B\^#0H@("`\+W@Z17AC96Q7
M;W)K<VAE970^#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE
M/DYA='5R95]O9E]O<&5R871I;VYS/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H
M965T4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#`X+FAT;6PB+SX-
M"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T
M/@T*("`@(#QX.DYA;64^0V]N9&5N<V5D7W-U;6UA<GE?;V9?<VEG;FEF:6-A
M/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R
M:W-H965T<R]3:&5E=#`Y+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E
M=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^4F5D965M
M86)L95]C;VYV97)T:6)L95]P<F5F97)R/"]X.DYA;64^#0H@("`@/'@Z5V]R
M:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#$P+FAT;6PB
M+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H
M965T/@T*("`@(#QX.DYA;64^0V%S:%]A;F1?8V%S:%]E<75I=F%L96YT<SPO
M>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS
M:&5E=',O4VAE970Q,2YH=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE970^
M#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE/DQO86Y?9F%C
M:6QI='D\+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS
M1")7;W)K<VAE971S+U-H965T,3(N:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R
M:W-H965T/@T*("`@/'@Z17AC96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M93Y#
M;VUM;VY?<W1O8VL\+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE9713;W5R8V4@
M2%)E9CTS1")7;W)K<VAE971S+U-H965T,3,N:'1M;"(O/@T*("`@/"]X.D5X
M8V5L5V]R:W-H965T/@T*("`@/'@Z17AC96Q7;W)K<VAE970^#0H@("`@/'@Z
M3F%M93Y.971?;&]S<U]P97)?<VAA<F4\+W@Z3F%M93X-"B`@("`\>#I7;W)K
M<VAE9713;W5R8V4@2%)E9CTS1")7;W)K<VAE971S+U-H965T,30N:'1M;"(O
M/@T*("`@/"]X.D5X8V5L5V]R:W-H965T/@T*("`@/'@Z17AC96Q7;W)K<VAE
M970^#0H@("`@/'@Z3F%M93Y&:6YA;F-I86Q?:6YS=')U;65N=',\+W@Z3F%M
M93X-"B`@("`\>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS1")7;W)K<VAE971S
M+U-H965T,34N:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H965T/@T*("`@
M/'@Z17AC96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M93Y#;VYD96YS961?<W5M
M;6%R>5]O9E]S:6=N:69I8V$Q/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T
M4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#$V+FAT;6PB+SX-"B`@
M(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*
M("`@(#QX.DYA;64^0V%S:%]A;F1?8V%S:%]E<75I=F%L96YT<U]486)L/"]X
M.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H
M965T<R]3:&5E=#$W+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-
M"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^3&]A;E]F86-I
M;&ET>5]486)L97,\+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE9713;W5R8V4@
M2%)E9CTS1")7;W)K<VAE971S+U-H965T,3@N:'1M;"(O/@T*("`@/"]X.D5X
M8V5L5V]R:W-H965T/@T*("`@/'@Z17AC96Q7;W)K<VAE970^#0H@("`@/'@Z
M3F%M93Y#;VUM;VY?<W1O8VM?5&%B;&5S/"]X.DYA;64^#0H@("`@/'@Z5V]R
M:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#$Y+FAT;6PB
M+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H
M965T/@T*("`@(#QX.DYA;64^3F5T7VQO<W-?<&5R7W-H87)E7U1A8FQE<SPO
M>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS
M:&5E=',O4VAE970R,"YH=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE970^
M#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE/D9I;F%N8VEA
M;%]I;G-T<G5M96YT<U]486)L97,\+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE
M9713;W5R8V4@2%)E9CTS1")7;W)K<VAE971S+U-H965T,C$N:'1M;"(O/@T*
M("`@/"]X.D5X8V5L5V]R:W-H965T/@T*("`@/'@Z17AC96Q7;W)K<VAE970^
M#0H@("`@/'@Z3F%M93Y.871U<F5?;V9?;W!E<F%T:6]N<U]!9&1I=&EO;F$\
M+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS1")7;W)K
M<VAE971S+U-H965T,C(N:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H965T
M/@T*("`@/'@Z17AC96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M93Y#;VYD96YS
M961?<W5M;6%R>5]O9E]S:6=N:69I8V$R/"]X.DYA;64^#0H@("`@/'@Z5V]R
M:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#(S+FAT;6PB
M+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H
M965T/@T*("`@(#QX.DYA;64^4F5D965M86)L95]C;VYV97)T:6)L95]P<F5F
M97)R,3PO>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$
M(E=O<FMS:&5E=',O4VAE970R-"YH=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K
M<VAE970^#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE/D-A
M<VA?86YD7V-A<VA?97%U:79A;&5N='-?4V-H93PO>#I.86UE/@T*("`@(#QX
M.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE970R-2YH
M=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE970^#0H@("`\>#I%>&-E;%=O
M<FMS:&5E=#X-"B`@("`\>#I.86UE/DQO86Y?9F%C:6QI='E?061D:71I;VYA
M;%]);F9O<CPO>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F
M/3-$(E=O<FMS:&5E=',O4VAE970R-BYH=&UL(B\^#0H@("`\+W@Z17AC96Q7
M;W)K<VAE970^#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE
M/DQO86Y?9F%C:6QI='E?4V-H961U;&5?;V9?3&]A;CPO>#I.86UE/@T*("`@
M(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE970R
M-RYH=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE970^#0H@("`\>#I%>&-E
M;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE/DQO86Y?9F%C:6QI='E?4W5M;6%R
M>5]O9E]"86YK7SPO>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(
M4F5F/3-$(E=O<FMS:&5E=',O4VAE970R."YH=&UL(B\^#0H@("`\+W@Z17AC
M96Q7;W)K<VAE970^#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.
M86UE/D-O;6UO;E]S=&]C:U]!9&1I=&EO;F%L7TEN9F]R;3PO>#I.86UE/@T*
M("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE
M970R.2YH=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE970^#0H@("`\>#I%
M>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE/D-O;6UO;E]S=&]C:U]38VAE
M9'5L95]O9E]796EG:#PO>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C
M92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE970S,"YH=&UL(B\^#0H@("`\+W@Z
M17AC96Q7;W)K<VAE970^#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\
M>#I.86UE/DYE=%]L;W-S7W!E<E]S:&%R95]!9&1I=&EO;F%L7SPO>#I.86UE
M/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O
M4VAE970S,2YH=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE970^#0H@("`\
M>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE/DYE=%]L;W-S7W!E<E]S
M:&%R95]38VAE9'5L95]O9CPO>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O
M=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE970S,BYH=&UL(B\^#0H@("`\
M+W@Z17AC96Q7;W)K<VAE970^#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@
M("`\>#I.86UE/DYE=%]L;W-S7W!E<E]S:&%R95]38VAE9'5L95]O9C$\+W@Z
M3F%M93X-"B`@("`\>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS1")7;W)K<VAE
M971S+U-H965T,S,N:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H965T/@T*
M("`@/'@Z17AC96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M93Y&:6YA;F-I86Q?
M:6YS=')U;65N='-?1F%I<E]686P\+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE
M9713;W5R8V4@2%)E9CTS1")7;W)K<VAE971S+U-H965T,S0N:'1M;"(O/@T*
M("`@/"]X.D5X8V5L5V]R:W-H965T/@T*("`@/'@Z17AC96Q7;W)K<VAE970^
M#0H@("`@/'@Z3F%M93Y&:6YA;F-I86Q?:6YS=')U;65N='-?061D:71I;VX\
M+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS1")7;W)K
M<VAE971S+U-H965T,S4N:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H965T
M/@T*("`\+W@Z17AC96Q7;W)K<VAE971S/@T*("`\>#I3='EL97-H965T($A2
M968],T0B5V]R:W-H965T<R]R97!O<G0N8W-S(B\^#0H@(#QX.D%C=&EV95-H
M965T/C`\+W@Z06-T:79E4VAE970^#0H@(#QX.E!R;W1E8W13=')U8W1U<F4^
M1F%L<V4\+W@Z4')O=&5C=%-T<G5C='5R93X-"B`@/'@Z4')O=&5C=%=I;F1O
M=W,^1F%L<V4\+W@Z4')O=&5C=%=I;F1O=W,^#0H@/"]X.D5X8V5L5V]R:V)O
M;VL^#0H\+WAM;#X\(5ME;F1I9ETM+3X-"CPO:&5A9#X-"B`@/&)O9'D^#0H@
M("`\<#Y4:&ES('!A9V4@<VAO=6QD(&)E(&]P96YE9"!W:71H($UI8W)O<V]F
M="!%>&-E;"!84"!O<B!N97=E<BX\+W`^#0H@(#PO8F]D>3X-"CPO:'1M;#X-
M"@T*+2TM+2TM/5].97AT4&%R=%\U-S%F,S(V,5\Q,#%E7S0V,#E?83AC95]B
M-F9E-V$P8C1E-#D-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-3<Q
M9C,R-C%?,3`Q95\T-C`Y7V$X8V5?8C9F93=A,&(T930Y+U=O<FMS:&5E=',O
M4VAE970P,2YH=&UL#0I#;VYT96YT+51R86YS9F5R+45N8V]D:6YG.B!Q=6]T
M960M<')I;G1A8FQE#0I#;VYT96YT+51Y<&4Z('1E>'0O:'1M;#L@8VAA<G-E
M=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\345402!H
M='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL
M.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I
M<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N
M="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L
M87-S/3-$<F5P;W)T(&ED/3-$240P13%#044^#0H@("`@("`\='(^#0H@("`@
M("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O=W-P86X],T0R/CQS
M=')O;F<^1&]C=6UE;G0@86YD($5N=&ET>2!);F9O<FUA=&EO;CQB<CX\+W-T
M<F]N9SX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$
M,3XS($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H
M(&-O;'-P86X],T0Q/CPO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T:#Y-87(N(#,Q+"`R,#$T/&)R/CPO=&@^
M#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D%P<BX@,S`L(#(P,30\8G(^/"]T
M:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^1&]C=6UE
M;G0@06YD($5N=&ET>2!);F9O<FUA=&EO;B!;06)S=')A8W1=/"]S=')O;F<^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^1&]C=6UE;G0@
M5'EP93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)S$P+5$\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y!
M;65N9&UE;G0@1FQA9SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)V9A;'-E/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^1&]C=6UE;G0@4&5R:6]D($5N9"!$871E/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#Y-87(@,S$L#0H)"3(P,30\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y$;V-U;65N
M="!&:7-C86P@665A<B!&;V-U<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)S(P,30\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y$;V-U;65N="!&:7-C86P@4&5R:6]D($9O8W5S/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG43$\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y4<F%D:6YG(%-Y
M;6)O;#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)T%16%`\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y%
M;G1I='D@4F5G:7-T<F%N="!.86UE/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG05%524Y/6"!02$%234%#155424-!3%,L($E.0SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D5N=&ET
M>2!#96YT<F%L($EN9&5X($ME>3PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)S`P,#$T,#0V-#0\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y#=7)R96YT($9I<V-A;"!996%R($5N9"!$
M871E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG+2TQ,BTS,3QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/D5N=&ET>2!&:6QE<B!#871E9V]R>3PO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)TYO;BUA8V-E;&5R871E9"!&:6QE<CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D5N=&ET>2!#;VUM
M;VX@4W1O8VLL(%-H87)E<R!/=71S=&%N9&EN9SPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C$P+#8W-2PR-C`\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL
M/@T*#0HM+2TM+2T]7TYE>'1087)T7S4W,68S,C8Q7S$P,65?-#8P.5]A.&-E
M7V(V9F4W83!B-&4T.0T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B\U
M-S%F,S(V,5\Q,#%E7S0V,#E?83AC95]B-F9E-V$P8C1E-#DO5V]R:W-H965T
M<R]3:&5E=#`R+FAT;6P-"D-O;G1E;G0M5')A;G-F97(M16YC;V1I;F<Z('%U
M;W1E9"UP<FEN=&%B;&4-"D-O;G1E;G0M5'EP93H@=&5X="]H=&UL.R!C:&%R
M<V5T/2)U<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!
M(&AT='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT
M;6P[(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C
M<FEP="!S<F,],T13:&]W+FIS/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM
M96YT("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@
M8VQA<W,],T1R97!O<G0@:60],T1)1#!%5T9!23X-"B`@("`@(#QT<CX-"B`@
M("`@("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#$^
M/'-T<F]N9SY#;VYD96YS960@0V]N<V]L:61A=&5D(&%N9"!#;VUB:6YE9"!"
M86QA;F-E(%-H965T<R`H55-$("0I/&)R/CPO<W1R;VYG/CPO=&@^#0H@("`@
M("`@(#QT:"!C;&%S<STS1'1H/DUA<BX@,S$L(#(P,30\8G(^/"]T:#X-"B`@
M("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q,SQB<CX\+W1H/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY#=7)R96YT(&%S
M<V5T<SPO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/D-A<V@@86YD(&-A<V@@97%U:79A;&5N=',@*$YO=&4@-"D\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@-3(L.3$X+#,R-SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,3$L,#`V
M+#,Y,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^4VAO<G0M=&5R;2!I;G9E<W1M96YT<SPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^,BPW,30L,3`P/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,BPX,C`L-C`P/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y!8V-O=6YT<R!A
M;F0@;W1H97(@86UO=6YT<R!R96-E:79A8FQE/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XV-BPU,C8\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XR-RPY-#8\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E!R97!A>6UE;G1S/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XU-#<L.#$R/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-C,L.3<U/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y$969E
M<G)E9"!O9F9E<FEN9R!C;W-T<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C$L,S<W+#0S.#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')E=3X-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/E1O=&%L(&-U<G)E;G0@87-S971S/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XU-BPR-#8L-S8U/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,34L,CDV+#,U
M,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^4')O<&5R='D@86YD(&5Q=6EP;65N=#PO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^-C<L,S<Y/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^-S4L-#8U/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y/=&AE<CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^,3,U+#,T-#QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(W-RPR.3`\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;W4^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y4;W1A;"!A<W-E
M=',\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C4V+#0T.2PT.#@\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ
M-2PV-#DL,3`V/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#X\<W1R;VYG/D-U<G)E;G0@;&EA8FEL:71I97,\+W-T<F]N
M9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y!8V-O=6YT
M<R!P87EA8FQE(&%N9"!A8V-R=65D(&QI86)I;&ET:65S/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XQ+#(R,"PV.34\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR+#,U,"PV-C`\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D-U<G)E
M;G0@<&]R=&EO;B!O9B!B86YK(&QO86X@*$YO=&4@-2D\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<F;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR-3`L,#`P/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y/=&AE
M<CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,38L.3`W/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3DL-#0U
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F5U/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^5&]T86P@8W5R<F5N="!L:6%B:6QI=&EE<SPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^,2PR,S<L-C`R/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,BPV,C`L,3`U/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y787)R86YT(&QI
M86)I;&ET:65S("A.;W1E(#@I/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XQ,#<L-3DW/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^,C(Q+#,R,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^4F5D96UP=&EO;B!O<'1I;VX@;VX@<')E
M9F5R<F5D('-T;V-K("A.;W1E(#,I/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^.#`P+#(P-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^06-C<G5E9"!T87@@<&%Y86)L92!O;B!P<F5F
M97)R960@<W1O8VL@*$YO=&4@,RD\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C$L-SDW+#0Q,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C$L-SDW+#0Q,CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0F%N:R!L;V%N("A.;W1E(#4I
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG)FYB<W`[)FYB<W`[
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M,BPP,S8L-#@Y/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y/=&AE<CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^-RPP-#<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XX+#4V,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')E=3X-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/E1O=&%L(&QI86)I;&ET:65S/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XQ+#,U,BPR-#8\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XW+#0X-"PP.3(\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O
M;F<^4F5D965M86)L92!C;VYV97)T:6)L92!P<F5F97)R960@<W1O8VL@*$YO
M=&4@,RD\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y2961E96UA8FQE(&-O;G9E<G1I8FQE('!R969E<G)E9"!S=&]C:SPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C<S+#@U."PW,C(\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS
M=')O;F<^0V]M;6]N('-T;V-K("A.;W1E(#8I/"]S=')O;F<^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^061D:71I;VYA;"!P86ED+6EN
M(&-A<&ET86P\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$R-"PW
M,3,L-#4V/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^1&5F:6-I="!A8V-U;75L871E9"!I;B!T:&4@9&5V96QO<&UE
M;G0@<W1A9V4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#8Y+#8Q
M-BPR,C4I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;3XH-C4L-CDS+#<P."D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/E1O=&%L('-T;V-K:&]L9&5R<R<@97%U:71Y
M("AD969I8VET*3PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-34L
M,#DW+#(T,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6T^*#8U+#8Y,RPW,#@I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F]U/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^5&]T86P@;&EA8FEL:71I97,L(')E9&5E
M;6%B;&4@8V]N=F5R=&EB;&4@<')E9F5R<F5D('-T;V-K+"!A;F0@<W1O8VMH
M;VQD97)S)R!E<75I='D@*&1E9FEC:70I/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XU-BPT-#DL-#@X/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^,34L-C0Y+#$P-CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')H/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^05%84"!#86YA9&$@
M6TUE;6)E<ET@?"!397)I97,@02!%>&-H86YG96%B;&4@4')E9F5R<F5D(%-H
M87)E<R!;365M8F5R73PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/CQS=')O;F<^4F5D965M86)L92!C;VYV97)T:6)L92!P<F5F97)R960@
M<W1O8VL@*$YO=&4@,RD\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y2961E96UA8FQE(&-O;G9E<G1I8FQE('!R969E<G)E
M9"!S=&]C:SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$S+#,R
M.2PV,SD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R:#X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/D%16%`@0V%N861A(%M-96UB97)=('P@05%84"!#86YA9&$L(%-E
M<FEE<R!"($5X8VAA;F=E86)L92!0<F5F97)R960@4VAA<F5S(%M-96UB97)=
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY2
M961E96UA8FQE(&-O;G9E<G1I8FQE('!R969E<G)E9"!S=&]C:R`H3F]T92`S
M*3PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/E)E9&5E;6%B;&4@8V]N=F5R=&EB;&4@<')E9F5R<F5D('-T;V-K/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3`L-C@T+#`Y,SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')H
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^05%84"!#
M86YA9&$@6TUE;6)E<ET@?"!397)I97,@0R!%>&-H86YG96%B;&4@4')E9F5R
M<F5D(%-H87)E<R!;365M8F5R73PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/CQS=')O;F<^4F5D965M86)L92!C;VYV97)T:6)L92!P<F5F
M97)R960@<W1O8VL@*$YO=&4@,RD\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y2961E96UA8FQE(&-O;G9E<G1I8FQE('!R
M969E<G)E9"!S=&]C:SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C,L.#,P+#DV,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')H/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^07%U:6YO>"!54T$@6TUE;6)E<ET@?"!397)I97,@02!0
M<F5F97)R960@4W1O8VL@6TUE;6)E<ET\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#X\<W1R;VYG/E)E9&5E;6%B;&4@8V]N=F5R=&EB;&4@
M<')E9F5R<F5D('-T;V-K("A.;W1E(#,I/"]S=')O;F<^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4F5D965M86)L92!C;VYV97)T:6)L
M92!P<F5F97)R960@<W1O8VL\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XQ,2PQ-3<L,3,X/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F@^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y!<75I;F]X(%5302!;365M8F5R72!\(%-E<FEE
M<R!"(%!R969E<G)E9"!3=&]C:R!;365M8F5R73PO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^4F5D965M86)L92!C;VYV97)T
M:6)L92!P<F5F97)R960@<W1O8VL@*$YO=&4@,RD\+W-T<F]N9SX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y2961E96UA8FQE(&-O;G9E
M<G1I8FQE('!R969E<G)E9"!S=&]C:SPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C(Q+#`Y,2PQ-3`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R:#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/D%Q=6EN;W@@55-!(%M-96UB97)=('P@
M4V5R:65S($,@4')E9F5R<F5D(%-T;V-K(%M-96UB97)=/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY2961E96UA8FQE(&-O
M;G9E<G1I8FQE('!R969E<G)E9"!S=&]C:R`H3F]T92`S*3PO<W1R;VYG/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E)E9&5E;6%B;&4@
M8V]N=F5R=&EB;&4@<')E9F5R<F5D('-T;V-K/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^,3,L-S8U+#<T,3QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')H/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^07%U:6YO>"!54T$@6TUE;6)E
M<ET@?"!#;VUM;VX@4W1O8VL@6TUE;6)E<ET\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/D-O;6UO;B!S=&]C:R`H3F]T92`V
M*3PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/D-O;6UO;B!S=&]C:SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M,3$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y4;W1A;"!S=&]C:VAO;&1E<G,G(&5Q=6ET>2`H9&5F:6-I="D\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,3$\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-
M"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\U-S%F,S(V,5\Q,#%E7S0V
M,#E?83AC95]B-F9E-V$P8C1E-#D-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z
M+R\O0SHO-3<Q9C,R-C%?,3`Q95\T-C`Y7V$X8V5?8C9F93=A,&(T930Y+U=O
M<FMS:&5E=',O4VAE970P,RYH=&UL#0I#;VYT96YT+51R86YS9F5R+45N8V]D
M:6YG.B!Q=6]T960M<')I;G1A8FQE#0I#;VYT96YT+51Y<&4Z('1E>'0O:'1M
M;#L@8VAA<G-E=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@
M("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G
M=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT
M+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H
M:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@
M/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P14=30D<^#0H@("`@("`\
M='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O=W-P
M86X],T0Q/CQS=')O;F<^0V]N9&5N<V5D($-O;G-O;&ED871E9"!A;F0@0V]M
M8FEN960@0F%L86YC92!3:&5E=',@*%!A<F5N=&AE=&EC86PI("A54T0@)"D\
M8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^36%R
M+B`S,2P@,C`Q-#QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$
M96,N(#,Q+"`R,#$S/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F@^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y!45A0($-A;F%D82!;365M8F5R72!\(%-E<FEE<R!!($5X8VAA;F=E
M86)L92!0<F5F97)R960@4VAA<F5S(%M-96UB97)=/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^4F5D965M86)L92!C;VYV97)T:6)L92!P
M<F5F97)R960@<W1O8VLL('!A<B!V86QU93PO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^)"`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^)"`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y2961E96UA8FQE(&-O;G9E<G1I8FQE('!R
M969E<G)E9"!S=&]C:RP@<VAA<F5S(&%U=&AO<FEZ960\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B=5;FQI;6ET960\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG56YL:6UI=&5D/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y2961E
M96UA8FQE(&-O;G9E<G1I8FQE('!R969E<G)E9"!S=&]C:RP@<VAA<F5S(&ES
M<W5E9#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,#QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C<Y,2PP,38\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/E)E9&5E;6%B;&4@8V]N=F5R=&EB;&4@<')E9F5R<F5D('-T;V-K+"!S:&%R
M97,@;W5T<W1A;F1I;F<\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XW.3$L,#$V/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F@^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y!45A0($-A;F%D82!;365M8F5R72!\($%16%`@0V%N861A
M+"!397)I97,@0B!%>&-H86YG96%B;&4@4')E9F5R<F5D(%-H87)E<R!;365M
M8F5R73PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E)E9&5E
M;6%B;&4@8V]N=F5R=&EB;&4@<')E9F5R<F5D('-T;V-K+"!P87(@=F%L=64\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,#QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,#QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4F5D965M
M86)L92!C;VYV97)T:6)L92!P<F5F97)R960@<W1O8VLL('-H87)E<R!A=71H
M;W)I>F5D/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG56YL:6UI
M=&5D/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)U5N;&EM:71E9#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^4F5D965M86)L92!C;VYV97)T:6)L92!P<F5F97)R
M960@<W1O8VLL('-H87)E<R!I<W-U960\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XW.3,L-C$W/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y2961E96UA8FQE(&-O;G9E<G1I8FQE('!R
M969E<G)E9"!S=&]C:RP@<VAA<F5S(&]U='-T86YD:6YG/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XP/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^-SDS+#8Q-SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')H/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^05%84"!#86YA9&$@6TUE
M;6)E<ET@?"!397)I97,@0R!%>&-H86YG96%B;&4@4')E9F5R<F5D(%-H87)E
M<R!;365M8F5R73PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/E)E9&5E;6%B;&4@8V]N=F5R=&EB;&4@<')E9F5R<F5D('-T;V-K+"!P87(@
M=F%L=64\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,#QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,#QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M4F5D965M86)L92!C;VYV97)T:6)L92!P<F5F97)R960@<W1O8VLL('-H87)E
M<R!A=71H;W)I>F5D/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M56YL:6UI=&5D/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)U5N;&EM:71E9#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^4F5D965M86)L92!C;VYV97)T:6)L92!P
M<F5F97)R960@<W1O8VLL('-H87)E<R!I<W-U960\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XS-S@L-S@V/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y2961E96UA8FQE(&-O;G9E<G1I
M8FQE('!R969E<G)E9"!S=&]C:RP@<VAA<F5S(&]U='-T86YD:6YG/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XP/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,S<X+#<X-CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')H/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^07%U:6YO>"!5
M4T$@6TUE;6)E<ET@?"!397)I97,@02!0<F5F97)R960@4W1O8VL@6TUE;6)E
M<ET\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y2961E96UA
M8FQE(&-O;G9E<G1I8FQE('!R969E<G)E9"!S=&]C:RP@<&%R('9A;'5E/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#`N,#`P,#`Q/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`P+C`P
M,#`P,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^4F5D965M86)L92!C;VYV97)T:6)L92!P<F5F97)R960@<W1O8VLL
M('-H87)E<R!A=71H;W)I>F5D/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XP/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^,C<L.3$T+#DU,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^4F5D965M86)L92!C;VYV97)T:6)L92!P<F5F
M97)R960@<W1O8VLL('-H87)E<R!I<W-U960\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XV-C(L.#<U/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y2961E96UA8FQE(&-O;G9E<G1I8FQE
M('!R969E<G)E9"!S=&]C:RP@<VAA<F5S(&]U='-T86YD:6YG/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XP/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-C8R+#@W-3QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')H/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^07%U:6YO>"!54T$@
M6TUE;6)E<ET@?"!397)I97,@0B!0<F5F97)R960@4W1O8VL@6TUE;6)E<ET\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y2961E96UA8FQE
M(&-O;G9E<G1I8FQE('!R969E<G)E9"!S=&]C:RP@<&%R('9A;'5E/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#`N,#`P,#`Q/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`P+C`P,#`P
M,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^4F5D965M86)L92!C;VYV97)T:6)L92!P<F5F97)R960@<W1O8VLL('-H
M87)E<R!A=71H;W)I>F5D/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XP/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^-#4L-#4T+#4S-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^4F5D965M86)L92!C;VYV97)T:6)L92!P<F5F97)R
M960@<W1O8VLL('-H87)E<R!I<W-U960\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XQ+#4W,RPW.3<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/E)E9&5E;6%B;&4@8V]N=F5R=&EB;&4@
M<')E9F5R<F5D('-T;V-K+"!S:&%R97,@;W5T<W1A;F1I;F<\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C`\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+#4W,RPW.3<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R:#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D%Q=6EN;W@@55-!
M(%M-96UB97)=('P@4V5R:65S($,@4')E9F5R<F5D(%-T;V-K(%M-96UB97)=
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4F5D965M86)L
M92!C;VYV97)T:6)L92!P<F5F97)R960@<W1O8VLL('!A<B!V86QU93PO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`P+C`P,#`P,3QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,"XP,#`P
M,#$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/E)E9&5E;6%B;&4@8V]N=F5R=&EB;&4@<')E9F5R<F5D('-T;V-K+"!S
M:&%R97,@875T:&]R:7IE9#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C0U+#<Y,RPW,S@\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/E)E9&5E;6%B;&4@8V]N=F5R=&EB;&4@<')E9F5R
M<F5D('-T;V-K+"!S:&%R97,@:7-S=65D/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XP/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^,2PS-#,L-#(T/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y2961E96UA8FQE(&-O;G9E<G1I8FQE
M('!R969E<G)E9"!S=&]C:RP@<VAA<F5S(&]U='-T86YD:6YG/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XP/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,2PS-#,L-#(T/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F@^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y!<75I;F]X(%53
M02!;365M8F5R72!\($-O;6UO;B!3=&]C:R!;365M8F5R73PO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D-O;6UO;B!S=&]C:RP@<&%R('9A
M;'5E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#`N,#`P,#`Q
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M)"`P+C`P,#`P,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^0V]M;6]N('-T;V-K+"!S:&%R97,@875T:&]R:7IE9#PO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-3`L,#`P+#`P,#QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$S.2PR
M-C8L,#,W/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#Y#;VUM;VX@<W1O8VLL('-H87)E<R!I<W-U960\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C$P+#8W-2PR-C`\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS,#$L-S0U/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#;VUM
M;VX@<W1O8VLL('-H87)E<R!O=71S=&%N9&EN9SPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^,3`L-C<U+#(V,#QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,P,2PW-#4\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*
M/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'1087)T7S4W,68S,C8Q7S$P,65?-#8P
M.5]A.&-E7V(V9F4W83!B-&4T.0T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO
M+R]#.B\U-S%F,S(V,5\Q,#%E7S0V,#E?83AC95]B-F9E-V$P8C1E-#DO5V]R
M:W-H965T<R]3:&5E=#`T+FAT;6P-"D-O;G1E;G0M5')A;G-F97(M16YC;V1I
M;F<Z('%U;W1E9"UP<FEN=&%B;&4-"D-O;G1E;G0M5'EP93H@=&5X="]H=&UL
M.R!C:&%R<V5T/2)U<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@
M(#Q-151!(&AT='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T
M97AT+VAT;6P[(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O
M:F%V87-C<FEP="!S<F,],T13:&]W+FIS/B\J($1O($YO="!296UO=F4@5&AI
M<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@("`\
M=&%B;&4@8VQA<W,],T1R97!O<G0@:60],T1)1#!%,5!!1SX-"B`@("`@(#QT
M<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A
M;CTS1#(^/'-T<F]N9SY#;VYD96YS960@8V]N<V]L:61A=&5D(&%N9"!C;VUB
M:6YE9"!S=&%T96UE;G1S(&]F(&]P97)A=&EO;G,@86YD(&-O;7!R96AE;G-I
M=F4@;&]S<R`H55-$("0I/&)R/CPO<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT
M:"!C;&%S<STS1'1H(&-O;'-P86X],T0R/C,@36]N=&AS($5N9&5D/"]T:#X-
M"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^,3(S($UO;G1H
M<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*("`@("`@
M("`\=&@@8VQA<W,],T1T:#Y-87(N(#,Q+"`R,#$T/&)R/CPO=&@^#0H@("`@
M("`@(#QT:"!C;&%S<STS1'1H/DUA<BX@,S$L(#(P,3,\8G(^/"]T:#X-"B`@
M("`@("`@/'1H(&-L87-S/3-$=&@^36%R+B`S,2P@,C`Q-#QB<CX\+W1H/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY/<&5R871I;F<@
M97AP96YS97,\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^4F5S96%R8V@@86YD(&1E=F5L;W!M96YT/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XD(#$L.#<Y+#4Q-#QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@-3<R+#DV-SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@-#,L
M-S@Y+#$R-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^1V5N97)A;"!A;F0@861M:6YI<W1R871I=F4\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C<S-"PX,C0\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XT,C,L.#8U/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3`L,C0Q+#0Q
M,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')O=3X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/E1O=&%L(&]P97)A=&EN9R!E>'!E;G-E<SPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^,BPV,30L,S,X/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^.3DV+#@S,CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C4T+#`S,"PU,S@\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS
M=')O;F<^3W1H97(@:6YC;VUE("AE>'!E;G-E<RD\+W-T<F]N9SX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0F%N:R!C:&%R9V5S(&%N
M9"!F:6YA;F-I;F<@8V]S=',\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6T^*#0U,RPX,#@I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;3XH,2PX,S0I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;3XH-3DP+#`R,RD\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DEN=&5R97-T(&EN8V]M93PO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,BPX,S4\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+#0T-CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,V-2PX
M.#$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/E-A;&4@;V8@97%U:7!M96YT/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^,CDL,SDV/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^,3,T+#4U,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0VAA;F=E(&EN(&9A:7(@=F%L=64@
M;V8@9&5R:79A=&EV92!L:6%B:6QI=&EE<R`H3F]T92`X*3PO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^.3$S+#DR.3QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR+#$P,BPQ.3,\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D%M;W)T
M:7IA=&EO;B!A;F0@97AT:6YG=6ES:&UE;G0@;V8@<F5M86EN:6YG(&1I<V-O
M=6YT(&]N('!R969E<G)E9"!S:&%R97,@=7!O;B!C;VYV97)S:6]N(&]F('!R
M969E<G)E9"!S:&%R97,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^
M*#$L.#@T+#(S,RD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M/B@R-2PT,S@I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;3XH,BPS.34L-3<U*3QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^1F]R96EG;B!E>&-H86YG
M92!L;W-S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@Q.3(L,#8S
M*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^
M*#$W+#`P-2D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M/B@R,SDL-#@T*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')O=3X-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/E1O=&%L(&]T:&5R(&EN8V]M92`H97AP96YS
M97,I/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@Q+#8Q,RPS-#`I
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH
M,3,L-#,U*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6T^*#8R,BPT-34I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F5U/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^3F5T(&QO<W,@8F5F;W)E(&EN8V]M92!T87AE
M<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH-"PR,C<L-C<X*3QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#$L
M,#$P+#(V-RD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M/B@U-"PV-3(L.3DS*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^26YC;VUE('1A>"!R96-O=F5R>3PO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS+#$U,"PT,#8\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M974^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y.970@
M;&]S<R!A;F0@8V]M<')E:&5N<VEV92!L;W-S(&EN8W5R<F5D(&EN('1H92!D
M979E;&]P;65N="!S=&%G93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;3XH-"PR,C<L-C<X*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6T^*#$L,#$P+#(V-RD\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M/B@U,2PU,#(L-3@W*3QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^06-C<F5T:6]N
M(&9O<B!L:7%U:61A=&EO;B!P<F5F97)E;F-E(&]N('!R969E<G)E9"!S=&]C
M:SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,2PQ,S(L.#DS*3QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#$L
M,34W+#@V-2D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M/B@Q."PU-C8L,#`X*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^06-C<F5T:6]N(&9O<B!S:&%R92!I<W-U
M86YC92!C;W-T<R!O;B!P<F5F97)R960@<W1O8VL\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6T^*#$Y+#4U,"D\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M/B@T-"PS,#<I/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,2PP,30L-C8W*3QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^5&%X
M(&5X<&5N<V4@;VX@<')E9F5R<F5D('-T;V-K/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M/B@Q,#`L,CDQ*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6T^*#,T-BPP.3$I/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,2PX.3<L-S`R*3QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4F5V
M97)S86P@;V8@=&%X('!A>6%B;&4@;VX@<')E9F5R<F5D('-T;V-K(&1U92!T
M;R!C;VYV97)S:6]N(&]F('!R969E<G)E9"!S=&]C:SPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^,2PX.3<L-S`R/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$L.#DW+#<P,CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^17AT:6YG
M=6ES:&UE;G0@;V8@<F5M86EN:6YG('-H87)E(&ES<W5A;F-E(&-O<W1S(&1U
M92!T;R!C;VYV97)S:6]N(&]F('!R969E<G)E9"!S=&]C:SPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;3XH-#,Y+#(R-RD\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH-#,Y+#(R-RD\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M974^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y4;W1A
M;"!L;W-S(&%T=')I8G5T86)L92!T;R!C;VUM;VX@<W1O8VMH;VQD97)S/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B0@*#0L,#(Q+#DS-RD\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B0@*#(L
M-34X+#4S,"D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M/B0@*#<Q+#4R,BPT.#DI/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y"87-I8R!A;F0@9&EL=71E9"!L;W-S
M('!E<B!C;VUM;VX@<W1O8VL@*$YO=&4@-RD\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6T^)"`H,2XR."D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M/B0@*#@N-#@I/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XD("@Q-SDN-#4I/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y"87-I8R!A
M;F0@9&EL=71E9"!W96EG:'1E9"!A=F5R86=E(&-O;6UO;B!S=&]C:R!O=71S
M=&%N9&EN9R`H3F]T92`W*3PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^,RPQ-#@L-#@Q/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^,S`Q+#<T-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C,Y."PU-S,\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL
M/@T*#0HM+2TM+2T]7TYE>'1087)T7S4W,68S,C8Q7S$P,65?-#8P.5]A.&-E
M7V(V9F4W83!B-&4T.0T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B\U
M-S%F,S(V,5\Q,#%E7S0V,#E?83AC95]B-F9E-V$P8C1E-#DO5V]R:W-H965T
M<R]3:&5E=#`U+FAT;6P-"D-O;G1E;G0M5')A;G-F97(M16YC;V1I;F<Z('%U
M;W1E9"UP<FEN=&%B;&4-"D-O;G1E;G0M5'EP93H@=&5X="]H=&UL.R!C:&%R
M<V5T/2)U<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!
M(&AT='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT
M;6P[(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C
M<FEP="!S<F,],T13:&]W+FIS/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM
M96YT("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@
M8VQA<W,],T1R97!O<G0@:60],T1)1#!%2DI&33X-"B`@("`@(#QT<CX-"B`@
M("`@("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^
M/'-T<F]N9SY#;VYD96YS960@8V]N<V]L:61A=&5D(&%N9"!C;VUB:6YE9"!S
M=&%T96UE;G1S(&]F(&-O;G9E<G1I8FQE('!R969E<G)E9"!S=&]C:R!A;F0@
M<W1O8VMH;VQD97)S)R!D969I8VET("A54T0@)"D\8G(^/"]S=')O;F<^/"]T
M:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^,2!-;VYT
M:',@16YD960\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N
M/3-$,CXS($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS
M1'1H(&-O;'-P86X],T0Q,#XQ,B!-;VYT:',@16YD960\+W1H/@T*("`@("`@
M("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XQ,C,@36]N=&AS($5N9&5D
M/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C
M;&%S<STS1'1H/DUA<BX@,S$L(#(P,30\8G(^/"]T:#X-"B`@("`@("`@/'1H
M(&-L87-S/3-$=&@^36%R+B`Q,BP@,C`Q-#QB<CX\+W1H/@T*("`@("`@("`\
M=&@@8VQA<W,],T1T:#Y-87(N(#,Q+"`R,#$T/&)R/CPO=&@^#0H@("`@("`@
M(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3,\8G(^/"]T:#X-"B`@("`@
M("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q,CQB<CX\+W1H/@T*("`@
M("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$Q/&)R/CPO=&@^#0H@
M("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3`\8G(^/"]T:#X-
M"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`P.3QB<CX\+W1H
M/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#`X/&)R/CPO
M=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,#<\8G(^
M/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`P-CQB
M<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#`U
M/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P
M,#0\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^36%R+B`S,2P@
M,C`Q-#QB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0V]N
M=F5R<VEO;B!O9B!P<F5F97)R960@<W1O8VL@:6YT;R!!<75I;F]X(%5302!C
M;VUM;VX@<W1O8VL\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@
M-S<L,S,S+#DU,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E)E<'5R8VAA<V4@;V8@8V]M;6]N
M('-T;V-K/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6T^*#,U,"D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^27-S=65D(&9O<B!C87-H+"!N970@;V8@<VAA<F4@:7-S
M=64@8V]S=',\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C0W+#,T
M,2PR-S@\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^-SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C@\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XS/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C$P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^-#@Y+#0U,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XX,#`\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y)<W-U960@9F]R(&EN=&%N
M9VEB;&4@87-S971S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^-#0L.#,T/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y3=&]C:RUB87-E9"!C;VUP96YS871I;VX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,X+#(S-SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/CDY+#0Q-SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS
M-#DL,S(Q/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^,S4Q+#,R,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C$Q."PR-#,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XQ,#DL,C4V/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3$Q+#8W,SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$P,RPU,3@\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XW."PR
M-34\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XU,"PT.#@\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/DYE="!L;W-S(&%N9"!C;VUP<F5H96YS:79E(&QO<W,@
M:6YC=7)R960@:6X@9&5V96QO<&UE;G0@<W1A9V4\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6T^*#@S."PS,#8I/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,RPS.#DL,S<R*3QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#0L,C(W+#8W."D\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@X
M+#<R.2PS-S$I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;3XH-RPW,30L,3DX*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6T^*#$P+#4P-RPP,#@I/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH."PU,CDL-S4S*3QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#,L-S4R
M+#`W,"D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M/B@U+#0U.2PT-C`I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;3XH,BPP,#@L-3,T*3QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#4T,RPP-3(I/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,3DL,C<U*3QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#$R+#$X
M."D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M/B@U,2PU,#(L-3@W*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^06-C<F5T:6]N(&9O<B!L:7%U:61A=&EO;B!P<F5F
M97)E;F-E(&]N('!R969E<G)E9"!S=&]C:SPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6T^*#$L,3,R+#@Y,RD\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M/B@Q+#$S,BPX.3,I/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH-2PS-3$L-#4Y*3QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#,L
M.#8P+#$T,"D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M/B@S+#,P,RPR,#`I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;3XH,BPQ-C<L-C`Q*3QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#$L,S`Q+#0P,"D\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@Q+#`P."PQ
M-3,I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;3XH-#0Q+#$V,BD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M/B@Q."PU-C8L,#`X*3QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^06-C<F5T:6]N(&9O<B!S:&%R
M92!I<W-U86YC92!C;W-T<R!O;B!P<F5F97)R960@<W1O8VL\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M/B@Q.2PU-3`I/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,3DL-34P*3QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#$R,RPP-S0I
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH
M,38X+#<P,BD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M/B@Q-C,L-#@S*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6T^*#$W-2PT-C<I/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,34Y+#8Q,2D\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@Q,SDL-S4X*3QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#8U+#`R
M-"D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M/B@Q+#`Q-"PV-C<I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y!8V-R=6%L(&]F('1A>"!P87EA8FQE(&]N('!R
M969E<G)E9"!S=&]C:SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^
M*#$P,"PR.3$I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;3XH,3`P+#(Y,2D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M/B@W,S<L.3(U*3QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#,Y-"PY,#@I/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,S0U+#4X-RD\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@R-#0L
M,C4Q*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6T^*#<T+#<T,RD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6T^*#$L.#DW+#<P,BD\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D5X=&EN9W5I<VAM96YT(&]F
M(')E;6%I;FEN9R!S:&%R92!I<W-U86YC92!C;W-T<RP@=V%R<F%N="!D:7-C
M;W5N="P@<F5D96UP=&EO;B!O<'1I;VX@86YD(')E;&%T960@=&%X('!A>6%B
M;&4@9'5E('1O(&-O;G9E<G-I;VX@;V8@<')E9F5R<F5D('-T;V-K/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,2PT-3@L-#<X/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-#,Y+#(R-SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XT,SDL,C(W/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y%;F1I;F<@0F%L86YC93PO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^-34L,#DW+#(T,CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#8X+#<W-RPY,3DI/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-34L,#DW
M+#(T,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6T^*#8U+#8Y,RPW,#@I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;3XH-3$L,3`Q+#(P-RD\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@S.2PS,30L-3@Q*3QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#(U+#$Q,RPU
M-3,I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;3XH,30L,3`U+#<T-2D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M/B@X+#DR.2PU.3<I/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,BPT,C4L-S0W*3QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$P+#<P.#QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#,Q+#`Q
M,RD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M/B@Q,2PS.#@I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^-34L,#DW+#(T,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')H/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^061D:71I;VYA;"!086ED+6EN($-A<&ET
M86P@6TUE;6)E<ET\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y3:&%R92!R96]R9V%N:7IA=&EO;CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-3,T+#<S-3QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D-O
M;G9E<G-I;VX@;V8@<')E9F5R<F5D('-T;V-K(&EN=&\@07%U:6YO>"!54T$@
M8V]M;6]N('-T;V-K/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XW
M-RPS,S,L.30U/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^27-S=65D(&9O<B!C87-H+"!N970@
M;V8@<VAA<F4@:7-S=64@8V]S=',\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C0W+#,T,2PR-S0\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^-SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C@\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XS/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$P/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4W1O8VLM8F%S960@
M8V]M<&5N<V%T:6]N/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS
M."PR,S<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XY.2PT,3<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^,S0Y+#,R,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C,U,2PS,C(\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,3@L,C0S/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3`Y+#(U-CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$Q,2PV
M-S,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XQ,#,L-3$X/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^-S@L,C4U/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^-3`L-#@X/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y!8V-R971I;VX@9F]R(&QI<75I
M9&%T:6]N('!R969E<F5N8V4@;VX@<')E9F5R<F5D('-T;V-K/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;3XH.3DL-#$W*3QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@S-#DL,S(X*3QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#,U,2PS
M,C(I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;3XH,3$X+#(U,"D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M/B@Q,#DL,C8T*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6T^*#$Q,2PV-S,I/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,S(U+#@T-RD\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@T-#$L,38R*3QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/D5N9&EN9R!"86QA;F-E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XQ,C0L-S$S+#0U-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XQ,C0L-S$S+#0U-CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(R,BPS,C8\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XU,"PT
M.#@\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C$R-"PW,3,L-#4V/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F@^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y!8V-U;75L871E9"!$969I8VET(%M-96UB97)=
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^3F5T(&QO<W,@86YD(&-O;7!R96AE;G-I=F4@;&]S<R!I;F-U<G)E9"!I
M;B!D979E;&]P;65N="!S=&%G93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;3XH.#,X+#,P-BD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M/B@S+#,X.2PS-S(I/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#@L-S(Y+#,W,2D\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@W+#<Q-"PQ.3@I
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH
M,3`L-3`W+#`P."D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M/B@X+#4R.2PW-3,I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;3XH,RPW-3(L,#<P*3QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#4L-#4Y+#0V,"D\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@R+#`P
M."PU,S0I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;3XH-30S+#`U,BD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M/B@Q.2PR-S4I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;3XH,3(L,3@X*3QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D%C8W)E=&EO;B!F;W(@
M;&EQ=6ED871I;VX@<')E9F5R96YC92!O;B!P<F5F97)R960@<W1O8VL\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@Q+#`S,RPT-S8I/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#4L,#`R
M+#$S,2D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M/B@S+#4P."PX,3@I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;3XH,RPQ.#0L.34P*3QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#(L,#4X+#,S-RD\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@Q+#$X.2PW,C0I
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH
M-C@R+#,P-BD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^06-C<F5T:6]N(&9O<B!S:&%R92!I<W-U86YC92!C
M;W-T<R!O;B!P<F5F97)R960@<W1O8VL\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M/B@Q.2PU-3`I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6T^*#$R,RPP-S0I/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,38X+#<P,BD\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@Q-C,L-#@S*3QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#$W
M-2PT-C<I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;3XH,34Y+#8Q,2D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M/B@Q,SDL-S4X*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6T^*#8U+#`R-"D\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y!8V-R=6%L(&]F
M('1A>"!P87EA8FQE(&]N('!R969E<G)E9"!S=&]C:SPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6T^*#$P,"PR.3$I/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#<S-RPY,C4I/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,SDT+#DP."D\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@S
M-#4L-3@W*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6T^*#(T-"PR-3$I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;3XH-S0L-S0S*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^17AT:6YG=6ES:&UE;G0@
M;V8@<F5M86EN:6YG('-H87)E(&ES<W5A;F-E(&-O<W1S+"!W87)R86YT(&1I
M<V-O=6YT+"!R961E;7!T:6]N(&]P=&EO;B!A;F0@<F5L871E9"!T87@@<&%Y
M86)L92!D=64@=&\@8V]N=F5R<VEO;B!O9B!P<F5F97)R960@<W1O8VL\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+#0U."PT-S@\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/D5N9&EN9R!"86QA;F-E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M/B@V.2PV,38L,C(U*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6T^*#8X+#<W-RPY,3DI/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH-CDL-C$V+#(R-2D\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@V-2PV
M.3,L-S`X*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6T^*#4Q+#$P,2PR,#<I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;3XH,SDL,S$T+#4X,2D\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@R-2PQ,3,L-34S*3QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#$T+#$P
M-2PW-#4I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;3XH."PY,CDL-3DW*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6T^*#(L-C0X+#`W,RD\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@U-S0L-3$U*3QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#,Q+#0V,RD\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@Q,BPQ
M.#@I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;3XH-CDL-C$V+#(R-2D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R:#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/D%16%`@0V%N861A(%M-96UB97)=('P@17AC:&%N
M9V5A8FQE(%!R969E<G)E9"!3:&%R97,@6TUE;6)E<ET\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#;VYV97)S:6]N
M(&]F('!R969E<G)E9"!S=&]C:R!I;G1O($%Q=6EN;W@@55-!(&-O;6UO;B!S
M=&]C:SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,C@L.#(T+#8U
M,2D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y#;VYV97)S:6]N(&]F('!R969E<G)E9"!S=&]C
M:R!I;G1O($%Q=6EN;W@@55-!(&-O;6UO;B!S=&]C:RP@4VAA<F5S/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@Q+#DV,RPT,3DI/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^27-S=65D(&9O<B!C87-H+"!N970@;V8@<VAA<F4@:7-S=64@8V]S
M=',\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,L.34P+#(R
M.#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XS+#@X-2PV,S8\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XT+#,S-2PS,3@\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XQ+#0V-RPU,#@\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+#0X,BPY,S8\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XT+#DY,BPW
M,3`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#Y)<W-U960@9F]R(&-A<V@L(&YE="!O9B!S:&%R92!I<W-U92!C
M;W-T<RP@4VAA<F5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XS-S@L-S@V/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C,V.2PQ,3@\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XT,C0L-#DY/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,30R+#`T-3QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$T,BPP-#0\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XU,#8L.3(W
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^5V%R<F%N="!D:7-C;W5N="!O;B!I<W-U86YC92!O9B!P<F5F97)R
M960@<VAA<F5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M/B@Q,#DL,3$U*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/E)E9&5M<'1I;VX@9&ES8V]U;G0@;V8@)#0V
M-BPV-S,@9F]R($%16%`@0V%N861A(&%N9"`D,2PV,S,L,S4W(&9O<B!!<75I
M;F]X(%5302!O;B!I<W-U86YC92!O9B!P<F5F97)R960@<VAA<F5S/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@T-C8L-C<S*3QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/D%C8W)E=&EO;B!F;W(@;&EQ=6ED871I;VX@<')E9F5R96YC92!O;B!P
M<F5F97)R960@<W1O8VL\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XT,#$L,38U/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C(L,#,V+#0S.#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C$L-C0W+#0S,CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$L-#0U+#$R,#QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$L,#4S+#8T
M-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C<P."PP,S<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XU-3,L.#`X/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^,C0U+#$V,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D%C8W)E=&EO;B!F;W(@<VAA
M<F4@:7-S=6%N8V4@8V]S=',@;VX@<')E9F5R<F5D('-T;V-K/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-BPV-#D\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-#4L-S4T/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-S(L,CDV/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-S`L
M-3`Y/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^-S@L,3<Y/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^.#0L.34T/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^-S0L-C4P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^,S0L.#`P/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^06UO<G1I>F%T:6]N
M(&]F('=A<G)A;G0@9&ES8V]U;G0@;VX@<')E9F5R<F5D('-T;V-K/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-"PQ.#<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,C$L.#(U/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,C$L.#@R
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M,C$L.#(S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^,38L-#0R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^06UO<G1I>F%T:6]N(&]F(')E9&5M<'1I
M;VX@;W!T:6]N(&]N('!R969E<G)E9"!S=&]C:SPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C$V+#8R,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XW,RPS.#D\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y%>'1I
M;F=U:7-H;65N="!O9B!R96UA:6YI;F<@<VAA<F4@:7-S=6%N8V4@8V]S=',L
M('=A<G)A;G0@9&ES8V]U;G0L(')E9&5M<'1I;VX@;W!T:6]N(&%N9"!R96QA
M=&5D('1A>"!P87EA8FQE(&1U92!T;R!C;VYV97)S:6]N(&]F('!R969E<G)E
M9"!S=&]C:SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C4U,2PS
M,S0\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/D5N9&EN9R!"86QA;F-E/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^,C@L.#(T+#8U,3QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR-RPX-#0L-CDS/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,C(L,3@S
M+#<S,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C(P+#0T,BPQ,C(\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XQ-2PP,3DL,#,T/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^.2PV-#0L-38U/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-RPS.#0L,#8V/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-2PR
M-S(L-C<R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^16YD:6YG($)A;&%N8V4L(%-H87)E<SPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C$L.38S+#0Q.3QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+#DV,RPT,3D\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+#4X
M-"PV,S,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XQ+#4X-"PV,S,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XQ+#(Q-2PU,34\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XW.3$L,#$V/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-C0X+#DW,3QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C4P-BPY,C<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F@^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y!45A0($-A;F%D82!;365M8F5R72!\($YE=R!#;VUM;VX@4VAA<F5S
M(%M-96UB97)=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^4VAA<F4@<F5O<F=A;FEZ871I;VX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#4S-"PW,S4I/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4F5P
M=7)C:&%S92!O9B!C;VUM;VX@<W1O8VL\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;3XH,S4P*3QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y3:&%R92!R96]R9V%N:7IA
M=&EO;BP@4VAA<F5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M/B@S,#$L-S0U*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/E)E<'5R8VAA<V4@;V8@8V]M;6]N('-T
M;V-K+"!3:&%R97,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;3XH,3@R+#(Y,BD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^27-S=65D(&9O<B!C87-H+"!N970@;V8@
M<VAA<F4@:7-S=64@8V]S=',\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XT.#DL-#4Q/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C@P,#QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DES<W5E9"!F;W(@8V%S:"P@
M;F5T(&]F('-H87)E(&ES<W5E(&-O<W1S+"!3:&%R97,\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XV,BPQ-CD\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-#$V+#8V,#QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/DES<W5E9"!F;W(@:6YT86YG:6)L92!A<W-E=',\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XT-"PX,S0\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DES<W5E9"!F
M;W(@:6YT86YG:6)L92!A<W-E=',L(%-H87)E<SPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C4L,C`X/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y%;F1I;F<@0F%L
M86YC93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C4S-"PW,S4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XT-3`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XX,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y%;F1I;F<@0F%L86YC92P@4VAA<F5S/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,S`Q+#<T-3QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(S
M-"PS-C@\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XT,38L-C8P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')H/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^07%U:6YO>"!54T$@6TUE;6)E<ET@?"!0<F5F97)R
M960@4W1O8VL@6TUE;6)E<ET\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y#;VYV97)S:6]N(&]F('!R969E<G)E9"!S
M=&]C:R!I;G1O($%Q=6EN;W@@55-!(&-O;6UO;B!S=&]C:SPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;3XH-#@L-3`Y+#DW-"D\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#Y#;VYV97)S:6]N(&]F('!R969E<G)E9"!S=&]C:R!I;G1O($%Q=6EN;W@@
M55-!(&-O;6UO;B!S=&]C:RP@4VAA<F5S/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M/B@S+#4X,"PP.38I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^27-S=65D(&9O
M<B!C87-H+"!N970@;V8@<VAA<F4@:7-S=64@8V]S=',\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C$S+#@R-2PX,C(\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^."PR,S0L,S,S/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^."PP
M.#0L,34X/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^,2PS-CDL-C<U/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^,2PS.#0L,#<S/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,RPX.#8L.#DR/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^27-S=65D
M(&9O<B!C87-H+"!N970@;V8@<VAA<F4@:7-S=64@8V]S=',L(%-H87)E<SPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,2PS,C4L-S4S/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C<X
M,BPR,C4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XW.3$L-3<R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^,3,R+#4W-#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C$S,BPU-S4\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS.3<L-S(V/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^5V%R<F%N
M=',@97AE<F-I<V5D/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XT,34L-#,Q/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^5V%R<F%N=',@97AE<F-I<V5D+"!3:&%R
M97,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$W+#8W,3QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/E=A<G)A;G0@9&ES8V]U;G0@;VX@:7-S=6%N8V4@;V8@<')E
M9F5R<F5D('-H87)E<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;3XH-C@L.3(P*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;3XH,3$W+#4P.2D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y2961E;7!T:6]N(&1I<V-O
M=6YT(&]F("0T-C8L-C<S(&9O<B!!45A0($-A;F%D82!A;F0@)#$L-C,S+#,U
M-R!F;W(@07%U:6YO>"!54T$@;VX@:7-S=6%N8V4@;V8@<')E9F5R<F5D('-H
M87)E<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,2PV,S,L
M,S4W*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/D%C8W)E=&EO;B!F;W(@;&EQ=6ED871I;VX@<')E
M9F5R96YC92!O;B!P<F5F97)R960@<W1O8VL\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XW,S$L-S(X/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C,L,S$U+#`R,3QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(L,C$R+#<P.#QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$L.#4X
M+#`X,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C$L,3$S+#DU-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C4Y,RPS-C,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XT-30L,S0V/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3DV+#`P,#QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D%C8W)E
M=&EO;B!F;W(@<VAA<F4@:7-S=6%N8V4@8V]S=',@;VX@<')E9F5R<F5D('-T
M;V-K/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3(L.3`Q/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C<W
M+#,R,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/CDV+#0P-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/CDR+#DW-#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/CDW+#(X.#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C<T+#8U-SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C8U+#$P.#QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,P+#(R-#QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/D%M;W)T:7IA=&EO;B!O9B!W87)R86YT(&1I<V-O=6YT(&]N('!R969E<G)E
M9"!S=&]C:SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C8L-#8W
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C,T+#,T,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C(S+#4V-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C(S+#4P,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C$W+#<P-CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D%M;W)T:7IA=&EO
M;B!O9B!R961E;7!T:6]N(&]P=&EO;B!O;B!P<F5F97)R960@<W1O8VL\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XU."PS,#`\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,C4V+#@V,SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/D5X=&EN9W5I<VAM96YT(&]F(')E;6%I;FEN9R!S:&%R92!I
M<W-U86YC92!C;W-T<RP@=V%R<F%N="!D:7-C;W5N="P@<F5D96UP=&EO;B!O
M<'1I;VX@86YD(')E;&%T960@=&%X('!A>6%B;&4@9'5E('1O(&-O;G9E<G-I
M;VX@;V8@<')E9F5R<F5D('-T;V-K/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^,2PV.#8L-30Y/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y%;F1I;F<@0F%L86YC
M93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C0X+#4P.2PY-S0\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M-#8L,#$T+#`R.3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C(Y+#<Y,2PU,#8\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XR-RPT-3@L.#(V/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3<L,C0Y+#DS-SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C@L,#4T
M+#,S.#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C8L,#$V+#8T,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C0L,3$S+#$Q-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D5N9&EN9R!"86QA;F-E+"!3
M:&%R97,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS+#4X,"PP
M.38\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^,RPU.#`L,#DV/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^,BPR,S8L-C<R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^,BPR,S8L-C<R/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,2PT-30L-#0W/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-C8R+#@W
M-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C4S,"PS,#$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XS.3<L-S(V/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')H/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^07%U:6YO>"!54T$@6TUE;6)E<ET@?"!#
M;VUM;VX@4W1O8VL@6TUE;6)E<ET\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#;VYV97)S:6]N(&]F('!R969E<G)E
M9"!S=&]C:R!I;G1O($%Q=6EN;W@@55-!(&-O;6UO;B!S=&]C:SPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E-H87)E
M(')E;W)G86YI>F%T:6]N+"!3:&%R97,\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C,P,2PW-#4\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#;VYV97)S:6]N(&]F
M('!R969E<G)E9"!S=&]C:R!I;G1O($%Q=6EN;W@@55-!(&-O;6UO;B!S=&]C
M:RP@4VAA<F5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XU+#4T
M,RPU,34\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y)<W-U960@9F]R(&-A<V@L(&YE="!O9B!S
M:&%R92!I<W-U92!C;W-T<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^-#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/DES<W5E9"!F;W(@8V%S:"P@;F5T(&]F('-H
M87)E(&ES<W5E(&-O<W1S+"!3:&%R97,\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C0L.#,P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D5N9&EN9R!"86QA
M;F-E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#$Q/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,3$\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^)"`Q,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^16YD:6YG($)A;&%N8V4L(%-H87)E<SPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3`L-C<U+#(V,#QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,P,2PW-#4\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,"PV
M-S4L,C8P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^,S`Q+#<T-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C,P,2PW-#4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XS,#$L-S0U/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,S`Q+#<T-3QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,P,2PW-#4\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS,#$L
M-S0U/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^,S`Q+#<T-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C$P+#8W-2PR-C`\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*
M#0HM+2TM+2T]7TYE>'1087)T7S4W,68S,C8Q7S$P,65?-#8P.5]A.&-E7V(V
M9F4W83!B-&4T.0T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B\U-S%F
M,S(V,5\Q,#%E7S0V,#E?83AC95]B-F9E-V$P8C1E-#DO5V]R:W-H965T<R]3
M:&5E=#`V+FAT;6P-"D-O;G1E;G0M5')A;G-F97(M16YC;V1I;F<Z('%U;W1E
M9"UP<FEN=&%B;&4-"D-O;G1E;G0M5'EP93H@=&5X="]H=&UL.R!C:&%R<V5T
M/2)U<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT
M='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[
M(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP
M="!S<F,],T13:&]W+FIS/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT
M("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA
M<W,],T1R97!O<G0@:60],T1)1#!%5TQ!0SX-"B`@("`@(#QT<CX-"B`@("`@
M("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T
M<F]N9SY#;VYD96YS960@8V]N<V]L:61A=&5D(&%N9"!C;VUB:6YE9"!S=&%T
M96UE;G1S(&]F(&-O;G9E<G1I8FQE('!R969E<G)E9"!S=&]C:R!A;F0@<W1O
M8VMH;VQD97)S)R!D969I8VET("A087)E;G1H971I8V%L*2`H55-$("0I/&)R
M/CPO<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P
M86X],T0T/C$R($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$S
M/&)R/D%16%`@0V%N861A(%M-96UB97)=/&)R/D5X8VAA;F=E86)L92!0<F5F
M97)R960@4VAA<F5S(%M-96UB97)=/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C
M;&%S<STS1'1H/D1E8RX@,S$L(#(P,3`\8G(^05%84"!#86YA9&$@6TUE;6)E
M<ET\8G(^17AC:&%N9V5A8FQE(%!R969E<G)E9"!3:&%R97,@6TUE;6)E<ET\
M8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q
M,SQB<CY!<75I;F]X(%5302!;365M8F5R73QB<CY0<F5F97)R960@4W1O8VL@
M6TUE;6)E<ET\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C
M+B`S,2P@,C`Q,#QB<CY!<75I;F]X(%5302!;365M8F5R73QB<CY0<F5F97)R
M960@4W1O8VL@6TUE;6)E<ET\8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/E=A<G)A;G0@9&ES8V]U;G0\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XD(#(R-BPV,C0\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#8X+#DR,#QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,C(V+#8R-#QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4F5D
M96UP=&EO;B!D:7-C;W5N="!O;B!I<W-U86YC92!O9B!P<F5F97)R960@<VAA
M<F5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#0V-BPV-S,\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M)"`Q+#8S,RPS-3<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].
M97AT4&%R=%\U-S%F,S(V,5\Q,#%E7S0V,#E?83AC95]B-F9E-V$P8C1E-#D-
M"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-3<Q9C,R-C%?,3`Q95\T
M-C`Y7V$X8V5?8C9F93=A,&(T930Y+U=O<FMS:&5E=',O4VAE970P-RYH=&UL
M#0I#;VYT96YT+51R86YS9F5R+45N8V]D:6YG.B!Q=6]T960M<')I;G1A8FQE
M#0I#;VYT96YT+51Y<&4Z('1E>'0O:'1M;#L@8VAA<G-E=#TB=7,M87-C:6DB
M#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\345402!H='1P+65Q=6EV/3-$
M0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T/75T
M9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO
M=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T
M/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T
M(&ED/3-$240P15<R0D<^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S
M<STS1'1L(&-O;'-P86X],T0Q(')O=W-P86X],T0R/CQS=')O;F<^0V]N9&5N
M<V5D(&-O;G-O;&ED871E9"!A;F0@8V]M8FEN960@<W1A=&5M96YT<R!O9B!C
M87-H(&9L;W=S("A54T0@)"D\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@("`@
M/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#(^,R!-;VYT:',@16YD960\+W1H
M/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XQ,C,@36]N
M=&AS($5N9&5D/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(^#0H@("`@
M("`@(#QT:"!C;&%S<STS1'1H/DUA<BX@,S$L(#(P,30\8G(^/"]T:#X-"B`@
M("`@("`@/'1H(&-L87-S/3-$=&@^36%R+B`S,2P@,C`Q,SQB<CX\+W1H/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T:#Y-87(N(#,Q+"`R,#$T/&)R/CPO=&@^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/D]P97)A=&EN
M9R!A8W1I=FET:65S/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/DYE="!L;W-S(&%N9"!C;VUP<F5H96YS:79E(&QO<W,@
M:6YC=7)R960@:6X@=&AE(&1E=F5L;W!M96YT('-T86=E/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M/B0@*#0L,C(W+#8W."D\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B0@*#$L,#$P+#(V-RD\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B0@
M*#4Q+#4P,BPU.#<I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#X\<W1R;VYG/DYO;BUC87-H(&ET96US(&%N9"!R96-L
M87-S:69I8V%T:6]N<SH\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^06UO<G1I>F%T:6]N/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XQ."PR,S@\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XQ-"PW.#4\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XV,CDL-#$P/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y&:6YA;F-I;F<@
M8V]S=',\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,Q.2PV,S4\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M,S,S+#@W-SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^1F5E<R!A;F0@<&5N86QT>2!O;B!B86YK(&QO86X@<F5P87EM
M96YT/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,#`L,#`P/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$P
M,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/D=A:6X@;VX@<V%L92!O9B!E<75I<&UE;G0\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M/B@R.2PS.38I/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,3,T+#4U,RD\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D%M;W)T:7IA
M=&EO;B!A;F0@97AT:6YG=6ES:&UE;G0@;V8@<F5M86EN:6YG(&1I<V-O=6YT
M(&]N('!R969E<G)E9"!S=&]C:R!U<&]N(&-O;G9E<G-I;VX@;V8@<')E9F5R
M<F5D('-T;V-K/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+#@X
M-"PR,S,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XR-2PT,S@\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XR+#,Y-2PU-S4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/D-H86YG92!I;B!F86ER('9A;'5E(&]F
M(&1E<FEV871I=F4@;&EA8FEL:71I97,\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6T^*#DQ,RPY,CDI/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6T^*#(L,3`R+#$Y,RD\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E-T;V-K+6)A<V5D(&-O
M;7!E;G-A=&EO;CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3,W
M+#8U-#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C4T+#8W-#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C$L-#`Y+#<R,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^1F]R96EG;B!E>&-H86YG92!L;W-S/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,#8L-3`Q/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$P-BPU,#$\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/CQS=')O;F<^0VAA;F=E(&EN(&YO;BUC87-H('=O<FMI;F<@8V%P:71A;#H\
M+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M06-C;W5N=',@86YD(&]T:&5R(&%M;W5N=',@<F5C96EV86)L93PO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,S@L-3@P*3QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#$W,"D\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@V-BPU,C0I/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y0
M<F5P87EM96YT<R!A;F0@9&5P;W-I=',\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6T^*#0U,RPW,#4I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^,3`L-#@P/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;3XH-C(V+#(R,RD\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D%C8V]U;G1S('!A
M>6%B;&4@86YD(&%C8W)U960@;&EA8FEL:71I97,\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6T^*#<S-"PU,S<I/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,S<L.#,U/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^.#4T+#(Q,3QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O
M=3X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D-A<V@@
M=7-E9"!I;B!O<&5R871I;F<@86-T:79I=&EE<SPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;3XH,RPX,#(L,38X*3QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#@Y-BPV,C$I/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH-#@L-C`R+#<X-"D\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/CQS=')O;F<^26YV97-T:6YG(&%C=&EV:71I97,\+W-T<F]N9SX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4'5R8VAA<V4@;V8@<VAO
M<G0M=&5R;2!I;G9E<W1M96YT<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M/B@R+#@R,"PV,#`I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y0=7)C:&%S92!O9B!P<F]P97)T>2!A;F0@
M97%U:7!M96YT/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@T+#0V
M,RD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M/B@T+#8Y-BD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M/B@U-#DL,#`S*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^4V%L92!O9B!P<F]P97)T>2!A;F0@97%U:7!M
M96YT/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-3`L.#$P/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3DQ
M+#@Q-SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^4'5R8VAA<V4@;V8@:6YT86YG:6)L92!A<W-E=',\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,3@S+#8R.2D\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;W4^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#87-H("AU<V5D
M(&EN*2!P<F]V:61E9"!B>2!I;G9E<W1I;F<@86-T:79I=&EE<SPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;3XH-"PT-C,I/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-#8L,3$T/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,RPS-C$L-#$U
M*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^/'-T<F]N9SY&:6YA;F-I;F<@86-T:79I=&EE<SPO<W1R;VYG/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y297!A>6UE;G0@;V8@
M8F%N:R!L;V%N+"!F965S(&%N9"!P96YA;'1Y/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M/B@R+#8P,"PP,#`I/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#$P,"PP,#`I/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y,;V%N(&-O<W1S
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#$P-RPY,3$I/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y)
M<W-U86YC92!O9B!P<F]M:7-S;W)Y(&YO=&5S/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C<R,"PX-C,\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E)E<&%Y;65N="!O9B!P<F]M:7-S
M;W)Y(&YO=&5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#(U
M-2PW-S4I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#Y#;VUM;VX@<W1O8VL@:7-S=65D/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C0Y,"PQ-S8\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E)E<'5R8VAA<V4@;V8@8V]M;6]N
M('-T;V-K/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#,U,"D\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/E!R969E<G)E9"!S=&]C:R`H<F5D96UP=&EO;BD@:7-S=65D/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M/B@T.3$I/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3<L.3DY+#DV,3QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C4W+#@S-2PT
M,3@\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/E-P96-I86P@=F]T:6YG(&-O;6UO;B!S=&]C:R!I<W-U960\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XW/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-#0\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E-H87)E(&ES<W5E(&-O
M<W1S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,3,R+#<T."D\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@Q
M+#0S,2PU-3@I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y);FET:6%L('!U8FQI8R!O9F9E<FEN9R!O9B!C;VUM;VX@
M<VAA<F5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XU,RPQ,S`L
M,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C4S+#$S,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/DEN:71I86P@<'5B;&EC(&]F9F5R:6YG(&-O<W1S
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@T+#@Q,"PY-#,I/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#4L
M,SDX+#,X,2D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R974^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y#87-H('!R;W9I9&5D(&)Y(&9I;F%N8VEN9R!A8W1I=FET
M:65S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XT-2PW,3@L-38V
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M,3<L.#8W+#(R,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C$P-"PX.#(L-3(V/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F]U/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^26YC<F5A<V4@:6X@8V%S:"!A;F0@
M8V%S:"!E<75I=F%L96YT<R!D=7)I;F<@=&AE('!E<FEO9#PO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^-#$L.3$Q+#DS-3QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$W+#`Q-BPW,3,\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XU,BPY
M,3@L,S(W/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#Y#87-H(&%N9"!C87-H(&5Q=6EV86QE;G1S+"!B96=I;FYI;F<@
M;V8@<&5R:6]D/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,2PP
M,#8L,SDR/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^,BPP,#`L-3,Y/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^0V%S:"!A;F0@8V%S:"!E<75I=F%L96YT<RP@
M96YD(&]F('!E<FEO9#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M-3(L.3$X+#,R-SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C$Y+#`Q-RPR-3(\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XU,BPY,3@L,S(W/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/E-U<'!L
M96UE;G1A;"!D:7-C;&]S=7)E(&]F(&-A<V@@9FQO=R!I;F9O<FUA=&EO;CH\
M+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M26YT97)E<W0@<&%I9#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M,S$L-S$Y/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C,Q+#<Q.3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^/'-T<F]N9SY);G9E<W1I;F<@86-T:79I=&EE<SPO
M<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y0
M=7)C:&%S92!O9B!I;G1A;F=I8FQE(&%S<V5T<R!F;W(@<VAA<F5S(&ES<W5E
M9#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XT-"PX,S0\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS
M=')O;F<^1FEN86YC:6YG(&%C=&EV:71I97,\+W-T<F]N9SX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^06-C<G5E9"!O9F9E<FEN9R!C
M;W-T<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`S.3`L,S0U
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/B0@,SDP+#,T-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X
M=%!A<G1?-3<Q9C,R-C%?,3`Q95\T-C`Y7V$X8V5?8C9F93=A,&(T930Y#0I#
M;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+S4W,68S,C8Q7S$P,65?-#8P
M.5]A.&-E7V(V9F4W83!B-&4T.2]7;W)K<VAE971S+U-H965T,#@N:'1M;`T*
M0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*
M0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*
M#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O
M;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M
M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N
M:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\
M+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I
M9#TS1$E$,$5-13X-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$
M=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T<F]N9SY.871U<F4@;V8@
M;W!E<F%T:6]N<SQB<CX\+W-T<F]N9SX\+W1H/@T*("`@("`@("`\=&@@8VQA
M<W,],T1T:"!C;VQS<&%N/3-$,3XS($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y-
M87(N(#,Q+"`R,#$T/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#X\<W1R;VYG/D%C8V]U;G1I;F<@4&]L:6-I97,@6T%B<W1R86-T73PO
M<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3F%T
M=7)E(&]F(&]P97)A=&EO;G,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\9&EV/@T*(#QP('-T>6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P=#L@
M1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N
M.R!-05)'24XM5$]0.B`Q,G!T)SX-"B`\8CXQ+B!.871U<F4@;V8@;W!E<F%T
M:6]N<SPO8CX\+W`^#0H@/'`@<W1Y;&4],T0G34%21TE.+4)/5%1/33H@,'!T
M.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M
M86X[($U!4D=)3BU43U`Z(#9P="<^#0H@07%U:6YO>"!0:&%R;6%C975T:6-A
M;',L($EN8RX@86YD(&ET<R!W:&]L;'D@;W=N960@<W5B<VED:6%R>2P-"B!!
M<75I;F]X(%!H87)M86-E=71I8V%L<R!);F,N+"`H8V]N<V]L:61A=&5D(&%N
M9"!C;VUB:6YE9"!T:&4-"B`F(W@R,#%#.T-O;7!A;GDF(W@R,#%$.R8C>#(P
M,30[<V5E($YO=&4F(WA!,#LR($)A<VES(&]F('!R97-E;G1A=&EO;BD-"B!A
M<F4@82!C;&EN:6-A;"!S=&%G92!P:&%R;6%C975T:6-A;"!C;VUP86YY(&1I
M<V-O=F5R:6YG(&%N9`T*(&1E=F5L;W!I;F<@;W)A;"!D<G5G(&-A;F1I9&%T
M97,@=&\@=')E870@:6YF;&%M;6%T:6]N(&%N9"!C86YC97(N#0H@5&AE($-O
M;7!A;GDF(W@R,#$Y.W,@<')I;6%R>2!F;V-U<R!I<R!T:&4@9&5V96QO<&UE
M;G0@;V8-"B!A;G1I+6EN9FQA;6UA=&]R>2!P<F]D=6-T(&-A;F1I9&%T97,@
M=&%R9V5T:6YG(%-(25`Q('=H:6-H(&ES(&$@:V5Y#0H@<F5G=6QA=&]R(&]F
M(&$@8V5L;'5L87(@<VEG;F%L:6YG('!A=&AW87D@:6X@:6UM=6YE(&-E;&QS
M+B!!<75I;F]X#0H@4&AA<FUA8V5U=&EC86QS("A54T$I($EN8RX@=V%S(&EN
M8V]R<&]R871E9"!O;B!-87DF(WA!,#LS,2P@,C`P-R!I;@T*('1H92!3=&%T
M92!O9B!$96QA=V%R92P@56YI=&5D(%-T871E<RX@3VX@2F%N=6%R>28C>$$P
M.S(W+"`R,#$T+`T*($%Q=6EN;W@@4&AA<FUA8V5U=&EC86QS("A54T$I($EN
M8RX@8VAA;F=E9"!I=',@;F%M92!T;R!!<75I;F]X#0H@4&AA<FUA8V5U=&EC
M86QS+"!);F,N("@F(W@R,#%#.T%Q=6EN;W@@55-!)B-X,C`Q1#LI+B!!<75I
M;F]X#0H@4&AA<FUA8V5U=&EC86QS($EN8RX@*"8C>#(P,4,[05%84"!#86YA
M9&$F(W@R,#%$.RDL(&9O<FUE<FQY#0H@-C$W-3@Q,R8C>$$P.T-A;F%D828C
M>$$P.TEN8RXL('=A<R!I;F-O<G!O<F%T960@=6YD97(@=&AE($-A;F%D80T*
M($)U<VEN97-S($-O<G!O<F%T:6]N<R!!8W0@;VX@1&5C96UB97(F(WA!,#LR
M-BP@,C`P,R!A;F0@;W!E<F%T97,@:6X-"B!686YC;W5V97(L($)R:71I<V@@
M0V]L=6UB:6$L($-A;F%D82X\+W`^#0H@/"]D:78^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO
M:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\U-S%F,S(V,5\Q,#%E7S0V,#E?
M83AC95]B-F9E-V$P8C1E-#D-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O
M0SHO-3<Q9C,R-C%?,3`Q95\T-C`Y7V$X8V5?8C9F93=A,&(T930Y+U=O<FMS
M:&5E=',O4VAE970P.2YH=&UL#0I#;VYT96YT+51R86YS9F5R+45N8V]D:6YG
M.B!Q=6]T960M<')I;G1A8FQE#0I#;VYT96YT+51Y<&4Z('1E>'0O:'1M;#L@
M8VAA<G-E=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\
M345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X
M="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA
M=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@
M0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A
M8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P14U%/@T*("`@("`@/'1R/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$
M,CX\<W1R;VYG/D-O;F1E;G-E9"!S=6UM87)Y(&]F('-I9VYI9FEC86YT(&%C
M8V]U;G1I;F<@<&]L:6-I97,\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@("`@
M/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^,R!-;VYT:',@16YD960\+W1H
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S
M/3-$=&@^36%R+B`S,2P@,C`Q-#QB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^/'-T<F]N9SY!8V-O=6YT:6YG(%!O;&EC:65S(%M!8G-T
M<F%C=%T\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/D-O;F1E;G-E9"!S=6UM87)Y(&]F('-I9VYI9FEC86YT(&%C8V]U;G1I
M;F<@<&]L:6-I97,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M9&EV/@T*(#QP('-T>6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P=#L@1D].5"U3
M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!-05)'
M24XM5$]0.B`Q.'!T)SX-"B`\8CXR+B!#;VYD96YS960@<W5M;6%R>2!O9B!S
M:6=N:69I8V%N="!A8V-O=6YT:6YG('!O;&EC:65S/"]B/CPO<#X-"B`\<"!S
M='EL93TS1"=-05)'24XM0D]45$]-.B`P<'0[($9/3E0M4TE:13H@,3!P=#L@
M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@34%21TE.+51/4#H@-G!T
M)SX-"B`\8CX\:3XH82D@0F%S:7,@;V8@<')E<V5N=&%T:6]N/"]I/CPO8CX\
M+W`^#0H@/'`@<W1Y;&4],T0G34%21TE.+4)/5%1/33H@,'!T.R!&3TY4+5-)
M6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86X[($U!4D=)
M3BU43U`Z(#9P="<^#0H@5&AE(&%C8V]M<&%N>6EN9R!U;F%U9&ET960@8V]N
M9&5N<V5D(&-O;G-O;&ED871E9"!A;F0@8V]M8FEN960-"B!F:6YA;F-I86P@
M<W1A=&5M96YT<R!A<F4@<')E<V5N=&5D(&EN(%5N:71E9"!3=&%T97,-"B`H
M)B-X,C`Q0SM5+E,N)B-X,C`Q1#LI(&1O;&QA<G,@86YD(&AA=F4@8F5E;B!P
M<F5P87)E9"!I;B!A8V-O<F1A;F-E#0H@=VET:"!A8V-O=6YT:6YG('!R:6YC
M:7!L97,@9V5N97)A;&QY(&%C8V5P=&5D(&EN('1H92!5;FET960@4W1A=&5S
M#0H@;V8@06UE<FEC82`H)B-X,C`Q0SM5+E,N($=!05`F(W@R,#%$.RD@86YD
M('!U<G-U86YT('1O('1H92!R=6QE<R!A;F0-"B!R96=U;&%T:6]N<R!O9B!T
M:&4@56YI=&5D(%-T871E<R!396-U<FET:65S(&%N9"!%>&-H86YG92!#;VUM
M:7-S:6]N#0H@*"8C>#(P,4,[4T5#)B-X,C`Q1#LI(&9O<B!I;G1E<FEM(&9I
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M9&5D($1E8V5M8F5R)B-X03`[,S$L(#(P,3,-"B!I;F-L=61E9"!I;B!T:&4@
M0V]M<&%N>28C>#(P,3D[<R!F:6YA;"!P<F]S<&5C='5S(&9O<B!I=',@:6YI
M=&EA;`T*('!U8FQI8R!O9F9E<FEN9R`H)B-X,C`Q0SM)4$\F(W@R,#%$.RD@
M9FEL960@=VET:"!T:&4@4T5#('!U<G-U86YT('1O#0H@4G5L92`T,C0H8BD@
M;VX@36%R8V@F(WA!,#LW+"`R,#$T+CPO<#X-"B`\<"!S='EL93TS1"=-05)'
M24XM0D]45$]-.B`P<'0[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ
M(%1I;65S($YE=R!2;VUA;CL@34%21TE.+51/4#H@,3)P="<^#0H@26X@;6%N
M86=E;65N="8C>#(P,3D[<R!O<&EN:6]N+"!T:&4@8V]N9&5N<V5D(&-O;G-O
M;&ED871E9"!A;F0-"B!C;VUB:6YE9"!F:6YA;F-I86P@<W1A=&5M96YT<R!R
M969L96-T(&%L;"!A9&IU<W1M96YT<R`H:6YC;'5D:6YG#0H@<F5C;&%S<VEF
M:6-A=&EO;G,@86YD(&YO<FUA;"!R96-U<G)I;F<@861J=7-T;65N=',I(&YE
M8V5S<V%R>2!T;PT*('!R97-E;G0@9F%I<FQY('1H92!F:6YA;F-I86P@<&]S
M:71I;VX@87,@;V8@36%R8V@F(WA!,#LS,2P@,C`Q-"P-"B!A;F0@<F5S=6QT
M<R!O9B!O<&5R871I;VYS(&%N9"!C87-H(&9L;W=S(&9O<B!A;&P@<&5R:6]D
M<R!P<F5S96YT960N#0H@5&AE(&EN=&5R:6T@<F5S=6QT<R!P<F5S96YT960@
M87)E(&YO="!N96-E<W-A<FEL>2!I;F1I8V%T:79E(&]F#0H@<F5S=6QT<R!T
M:&%T(&-A;B!B92!E>'!E8W1E9"!F;W(@82!F=6QL('EE87(N/"]P/@T*(#QP
M('-T>6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P=#L@1D].5"U325I%.B`Q,'!T
M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!-05)'24XM5$]0.B`Q
M,G!T)SX-"B!4:')O=6=H(&$@<F5O<F=A;FEZ871I;VX@;VX@36%R8V@F(WA!
M,#LQ,BP@,C`Q-"P@05%84"!#86YA9&$@8F5C86UE#0H@82!W:&]L;'D@;W=N
M960@<W5B<VED:6%R>2!O9B!!<75I;F]X(%5302`H3F]T92`S*2X@4')I;W(@
M=&\@=&AE#0H@<F5O<F=A;FEZ871I;VXL(&UA;F%G96UE;G0@9&5T97)M:6YE
M9"!T:&%T($%16%`@0V%N861A(&%N9"!!<75I;F]X#0H@55-!('=E<F4@96YT
M:71I97,@=6YD97(@8V]M;6]N(&-O;G1R;VP@87,@96%C:"!O9B!!45A0($-A
M;F%D82!A;F0-"B!!<75I;F]X(%5302!W97)E(&]W;F5D(&)E;F5F:6-I86QL
M>2!B>2!I9&5N=&EC86P@<VAA<F5H;VQD97)S(&%N9`T*(&%S('-U8V@@=&AE
M(&)A<VES(&]F('!R97-E;G1A=&EO;B!O9B!F:6YA;F-I86P@<F5S=6QT<R!P
M<FEO<B!T;PT*($UA<F-H)B-X03`[,3(L(#(P,30@=V%S(&]N(&$@8V]M8FEN
M960@8F%S:7,N(%-U8G-E<75E;G0@=&\-"B!-87)C:"8C>$$P.S$R+"`R,#$T
M+"!T:&4@8F%S:7,@;V8@<')E<V5N=&%T:6]N(&]F('1H92!F:6YA;F-I86P-
M"B!R97-U;'1S(&ES(&]N(&$@8V]N<V]L:61A=&5D(&)A<VES+B!!;&P@:6YT
M97)C;VUP86YY('1R86YS86-T:6]N<PT*(&AA=F4@8F5E;B!E;&EM:6YA=&5D
M+CPO<#X-"B`\<"!S='EL93TS1"=-05)'24XM0D]45$]-.B`P<'0[($9/3E0M
M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@34%2
M1TE.+51/4#H@,3)P="<^#0H@1F]R('1H92!P97)I;V0@9G)O;2!I;F-E<'1I
M;VX@;VX@1&5C96UB97(F(WA!,#LR-BP@,C`P,R!T:')O=6=H#0H@36%R8V@F
M(WA!,#LS,2P@,C`Q-"P@=&AE($-O;7!A;GD@:7,@82!D979E;&]P;65N="!S
M=&%G92!E;G1E<G!R:7-E+`T*(&%S('!L86YN960@<')I;F-I<&%L(&]P97)A
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M8VMH;VQD97)S)B-X,C`Q.3L@9&5F:6-I="P@86YD(&-A<V@@9FQO=W,@<')E
M<V5N="!T:&4@8W5M=6QA=&EV90T*(&-O;G-O;&ED871E9"!F:6YA;F-I86P@
M:6YF;W)M871I;VX@;V8@=&AE($-O;7!A;GD@9F]R('1H92!P97)I;V0-"B!F
M<F]M(&EN8V5P=&EO;B!O;B!$96-E;6)E<B8C>$$P.S(V+"`R,#`S('1H<F]U
M9V@@36%R8V@F(WA!,#LS,2P-"B`R,#$T+CPO<#X-"B`\<"!S='EL93TS1"=-
M05)'24XM0D]45$]-.B`P<'0[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)
M3%DZ(%1I;65S($YE=R!2;VUA;CL@34%21TE.+51/4#H@,3AP="<^#0H@/&(^
M/&D^*&(I(%5S92!O9B!E<W1I;6%T97,\+VD^/"]B/CPO<#X-"B`\<"!S='EL
M93TS1"=-05)'24XM0D]45$]-.B`P<'0[($9/3E0M4TE:13H@,3!P=#L@1D].
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M:69I8V%N="!A<F5A<R!R97%U:7)I;F<@;6%N86=E;65N=`T*(&5S=&EM871E
M<R!A<F4@=&AE('9A;'5A=&EO;B!O9B!I;G1A;F=I8FQE(&%S<V5T<RP@=F%L
M=6%T:6]N(&]F#0H@<W1O8VL@;W!T:6]N<R!A;F0@=V%R<F%N=',L(&%M;W)T
M:7IA=&EO;B!A;F0@9&5P<F5C:6%T:6]N+`T*('9A;'5A=&EO;B!A;&QO=V%N
M8V4@9F]R(&1E9F5R<F5D(&EN8V]M92!T87AE<RP@86YD(&-O;G1I;F=E;F-I
M97,N#0H@06-T=6%L(')E<W5L=',@8V]U;&0@9&EF9F5R(&9R;VT@=&AO<V4@
M97-T:6UA=&5S+CPO<#X-"B`\<"!S='EL93TS1"=-05)'24XM0D]45$]-.B`P
M<'0[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2
M;VUA;CL@34%21TE.+51/4#H@,3AP="<^#0H@/&(^/&D^*&,I(%1A>&5S/"]I
M/CPO8CX\+W`^#0H@/'`@<W1Y;&4],T0G34%21TE.+4)/5%1/33H@,'!T.R!&
M3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86X[
M($U!4D=)3BU43U`Z(#9P="<^#0H@5&AE($-O;7!A;GD@86-C;W5N=',@9F]R
M(&EN8V]M92!T87AE<R!U<VEN9R`\:3Y!4T,F(WA!,#LW-#`L($EN8V]M90T*
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M=',@;W1H97(@=&AA;B!E;F%C=&UE;G1S(&]F(&%N9`T*(&-H86YG97,@:6X@
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M<F5D('1A>`T*(&%S<V5T<R!W:6QL(&YO="!B92!R96%L:7IE9"X@05-#)B-X
M03`[-S0P(&-L87)I9FEE<R!T:&4@8W)I=&5R:6$-"B!T:&%T(&UU<W0@8F4@
M;65T('!R:6]R('1O(')E8V]G;FET:6]N(&]F('1H92!F:6YA;F-I86P@<W1A
M=&5M96YT#0H@8F5N969I="!O9B!A('!O<VET:6]N('1A:V5N(&EN(&$@=&%X
M(')E='5R;BX@05-#)B-X03`[-S0P('!R;W9I9&5S#0H@82!B96YE9FET(')E
M8V]G;FET:6]N(&UO9&5L('=I=&@@82!T=V\M<W1E<"!A<'!R;V%C:"!C;VYS
M:7-T:6YG(&]F#0H@82`F(W@R,#%#.VUO<F4M;&EK96QY+71H86XM;F]T)B-X
M,C`Q1#L@<F5C;V=N:71I;VX@8W)I=&5R:6$L(&%N9"!A#0H@;65A<W5R96UE
M;G0@871T<FEB=71E('1H870@;65A<W5R97,@82!G:79E;B!T87@@<&]S:71I
M;VX@87,@=&AE#0H@;&%R9V5S="!A;6]U;G0@;V8@=&%X(&)E;F5F:71S('1H
M870@87)E(&UO<F4@=&AA;B`U,"4@;&EK96QY(&]F#0H@8F5I;F<@<F5A;&EZ
M960@=7!O;B!U;'1I;6%T92!S971T;&5M96YT+B!!4T,F(WA!,#LW-#`@86QS
M;R!R97%U:7)E<PT*('1H92!R96-O9VYI=&EO;B!O9B!L:6%B:6QI=&EE<R!C
M<F5A=&5D(&)Y(&1I9F9E<F5N8V5S(&)E='=E96X@=&%X#0H@<&]S:71I;VYS
M('1A:V5N(&EN(&$@=&%X(')E='5R;B!A;F0@86UO=6YT<R!R96-O9VYI>F5D
M(&EN('1H90T*(&9I;F%N8VEA;"!S=&%T96UE;G1S+CPO<#X-"B`\<"!S='EL
M93TS1"=-05)'24XM0D]45$]-.B`P<'0[($9/3E0M4TE:13H@,3!P=#L@1D].
M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@34%21TE.+51/4#H@,3)P="<^
M#0H@26YV97-T;65N="!T87@@8W)E9&ET<R!R96QA=&EN9R!T;R!S8VEE;G1I
M9FEC(')E<V5A<F-H(&%N9`T*(&5X<&5R:6UE;G1A;"!D979E;&]P;65N="!A
M<F4@86-C;W5N=&5D(&9O<B!I;B!O<&5R871I;VYS+B!4;R!T:&4-"B!E>'1E
M;G0@=&AE<F4@:7,@<F5A<V]N86)L92!A<W-U<F%N8V4@=&AE(&-R961I=',@
M=VEL;"!B92!R96%L:7IE9"P-"B!T:&5Y(&%R92!R96-O<F1E9"!I;B!T:&4@
M<&5R:6]D('1H92!R96QA=&5D(&5X<&5N9&ET=7)E(&ES(&UA9&4@87,-"B!A
M;B!I;F-O;64@=&%X("AP<F]V:7-I;VXI(')E8V]V97)Y+B!)9B!I;G9E<W1M
M96YT('1A>"!C<F5D:70-"B!A;6]U;G1S('-U8G-E<75E;G1L>2!R96-E:79E
M9"!A<F4@;&5S<R!O<B!M;W)E('1H86X@;W)I9VEN86QL>0T*(')E8V]R9&5D
M+"!T:&4@9&EF9F5R96YC92!I<R!T<F5A=&5D(&%S(&$@8VAA;F=E(&EN(&5S
M=&EM871E+CPO<#X-"B`\<"!S='EL93TS1"=-05)'24XM0D]45$]-.B`P<'0[
M($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA
M;CL@34%21TE.+51/4#H@,3)P="<^#0H@0V%N861I86X@=&%X(')U;&5S(&EM
M<&]S92!A('1A>"!W:71H(')E<W!E8W0@=&\@0V%N861I86X-"B!C;W)P;W)A
M=&EO;B!T87AA8FQE('!R969E<G)E9"!S=&]C:R!A;F0@=&AE:7(@;&EQ=6ED
M871I;VX@<FEG:'1S+@T*($EN('!R:6]R('!E<FEO9',L($%16%`@0V%N861A
M(&AA<R!R96-O<F1E9"!T:&ES('1A>"!O;B!P<F5F97)R960-"B!S=&]C:R!A
M<R!A(&YO;BUC=7)R96YT(&%C8W)U960@=&%X('!A>6%B;&4@;VX@:71S(&)A
M;&%N8V4@<VAE970L(&]N#0H@=&AE('-A;64@8F%S:7,@87,@:70@<F5C;W)D
M960@=&AE(&%C8W)E=&EO;B!O9B!P<F5F97)R960@<W1O8VLN/"]P/@T*(#QP
M('-T>6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P=#L@1D].5"U325I%.B`Q,'!T
M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!-05)'24XM5$]0.B`Q
M.'!T)SX-"B`\8CX\:3XH9"D@1&5R:79A=&EV92!L:6%B:6QI=&EE<R!A;F0@
M9F%I<B!V86QU92!O9B!F:6YA;F-I86P-"B!I;G-T<G5M96YT<SPO:3X\+V(^
M/"]P/@T*(#QP('-T>6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P=#L@1D].5"U3
M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!-05)'
M24XM5$]0.B`V<'0G/@T*(%1H92!#;VUP86YY(&%C8V]U;G1S(&9O<B!C=7)R
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M9`T*(&-O;7!R96AE;G-I=F4@;&]S<RX\+W`^#0H@/'`@<W1Y;&4],T0G34%2
M1TE.+4)/5%1/33H@,'!T.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9
M.B!4:6UE<R!.97<@4F]M86X[($U!4D=)3BU43U`Z(#$R<'0G/@T*(%1H92!#
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M3TTZ(#!P=#L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@
M3F5W(%)O;6%N.R!-05)'24XM5$]0.B`Q,G!T)SX-"B!4:&4@0V]M<&%N>2!A
M<'!L:65S('1H92!R97-I9'5A;"!V86QU92!M971H;V0@=&\@<F5C;W)D('1H
M92!F86ER#0H@=F%L=64@;V8@=V%R<F%N=',@:7-S=65D('=I=&@@;&]A;G,@
M87,@82!D:7-C;W5N="!T;R!T:&4@:6YI=&EA;`T*(&-A<G)Y:6YG(&%M;W5N
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M<W0@;65T:&]D+CPO<#X-"B`\<"!S='EL93TS1"=-05)'24XM0D]45$]-.B`P
M<'0[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2
M;VUA;CL@34%21TE.+51/4#H@,3)P="<^#0H@/&D^05-#(#@R,"P@1F%I<B!6
M86QU92!-96%S=7)E;65N=',\+VD^(')E<75I<F5S(&1I<V-L;W-U<F5S(&%B
M;W5T#0H@=')A;G-F97)S(&EN=&\@86YD(&]U="!O9B!,979E;',F(WA!,#LQ
M(&%N9"`R(&%N9"!S97!A<F%T90T*(&1I<V-L;W-U<F5S(&%B;W5T('!U<F-H
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M=7)E(&9A:7(@=F%L=64N#0H@05-#)B-X03`[.#(P(&1E9FEN97,@9F%I<B!V
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M>6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P=#L@1D].5"U325I%.B`Q,'!T.R!&
M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!-05)'24XM3$5&5#H@-"4[
M($U!4D=)3BU43U`Z(#9P="<^#0H@3&5V96P@,28C>#(P,30[475O=&5D('!R
M:6-E<R!I;B!A8W1I=F4@;6%R:V5T<R!F;W(@:61E;G1I8V%L(&%S<V5T<PT*
M(&]R(&QI86)I;&ET:65S+CPO<#X-"B`\<"!S='EL93TS1"=-05)'24XM0D]4
M5$]-.B`P<'0[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S
M($YE=R!2;VUA;CL@34%21TE.+4Q%1E0Z(#0E.R!-05)'24XM5$]0.B`V<'0G
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M9G5L;"!T97)M(&]F('1H92!A<W-E=',@;W(-"B!L:6%B:6QI=&EE<RX\+W`^
M#0H@/'`@<W1Y;&4],T0G34%21TE.+4)/5%1/33H@,'!T.R!&3TY4+5-)6D4Z
M(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86X[($U!4D=)3BU,
M1494.B`T)3L@34%21TE.+51/4#H@-G!T)SX-"B!,979E;"`S)B-X,C`Q-#M5
M;F]B<V5R=F%B;&4@:6YP=71S('1H870@87)E('-U<'!O<G1E9"!B>2!L:71T
M;&4@;W(-"B!N;R!M87)K970@86-T:79I='D@86YD('1H870@87)E('-I9VYI
M9FEC86YT('1O('1H92!F86ER('9A;'5E(&]F#0H@=&AE(&%S<V5T<R!O<B!L
M:6%B:6QI=&EE<RX\+W`^#0H@/'`@<W1Y;&4],T0G34%21TE.+4)/5%1/33H@
M,'!T.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@
M4F]M86X[($U!4D=)3BU43U`Z(#$X<'0G/@T*(#QB/CQI/BAE*2!2961E96UA
M8FQE(&-O;G9E<G1I8FQE('!R969E<G)E9"!S=&]C:SPO:3X\+V(^/"]P/@T*
M(#QP('-T>6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P=#L@1D].5"U325I%.B`Q
M,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!-05)'24XM5$]0
M.B`V<'0G/@T*(%1H92!#;VUP86YY(&-L87-S:69I960@<F5D965M86)L92!C
M;VYV97)T:6)L92!P<F5F97)R960@<W1O8VL@=&AA=`T*('=A<R!R961E96UA
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M"B!R961E;7!T:6]N('9A;'5E+CPO<#X-"B`\<"!S='EL93TS1"=-05)'24XM
M0D]45$]-.B`P<'@[($9/3E0M4TE:13H@,7!X.R!-05)'24XM5$]0.B`Q,G!X
M)SX-"B`F(WA!,#L\+W`^#0H@/'`@<W1Y;&4],T0G34%21TE.+4)/5%1/33H@
M,'!T.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@
M4F]M86X[($U!4D=)3BU43U`Z(#!P="<^#0H@26X@=&AE(&%B<V5N8V4@;V8@
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M871E9"!D969I8VET+CPO<#X-"B`\<"!S='EL93TS1"=-05)'24XM0D]45$]-
M.B`P<'0[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE
M=R!2;VUA;CL@34%21TE.+51/4#H@,3AP="<^#0H@/&(^/&D^*&8I($%C8V]U
M;G1I;F<@9F]R('-T;V-K+6)A<V5D(&-O;7!E;G-A=&EO;CPO:3X\+V(^/"]P
M/@T*(#QP('-T>6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P=#L@1D].5"U325I%
M.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!-05)'24XM
M5$]0.B`V<'0G/@T*(%1H92!#;VUP86YY(&UE87-U<F5S('1H92!C;W-T(&]F
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M=65S+CPO<#X-"B`\<"!S='EL93TS1"=-05)'24XM0D]45$]-.B`P<'0[($9/
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M<&%N>28C>#(P,3D[<R!C;VUM;VX@<W1O8VL@=V%S(&YO=`T*('!U8FQI8VQY
M('1R861E9"P@=&AE(&5X<&5C=&5D('9O;&%T:6QI='D@87-S=6UP=&EO;B!W
M87,@8F%S960@;VX-"B!I;F1U<W1R>2!P965R(&EN9F]R;6%T:6]N+B!!9&1I
M=&EO;F%L;'DL(&)E8V%U<V4@=&AE($-O;7!A;GD@:&%S(&YO#0H@<VEG;FEF
M:6-A;G0@:&ES=&]R>2!T;R!C86QC=6QA=&4@=&AE(&5X<&5C=&5D('1E<FTL
M('1H92!S:6UP;&EF:65D#0H@;65T:&]D(&-A;&-U;&%T:6]N('=A<R!U<V5D
M+CPO<#X-"B`\<"!S='EL93TS1"=-05)'24XM0D]45$]-.B`P<'0[($9/3E0M
M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@34%2
M1TE.+51/4#H@,3AP="<^#0H@/&(^/&D^*&<I(%-E9VUE;G0@<F5P;W)T:6YG
M/"]I/CPO8CX\+W`^#0H@/'`@<W1Y;&4],T0G34%21TE.+4)/5%1/33H@,'!T
M.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M
M86X[($U!4D=)3BU43U`Z(#9P="<^#0H@36%N86=E;65N="!H87,@9&5T97)M
M:6YE9"!T:&%T('1H92!#;VUP86YY)B-X,C`Q.3MS(&]P97)A=&EO;BP@86YD
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M8V%S:"!A;F0@8V%S:"!E<75I=F%L96YT<RP@=V5R92`D-3$L,3$V+#4X-B!A
M<R!O9@T*($UA<F-H)B-X03`[,S$L(#(P,30@*$1E8V5M8F5R(#,Q+"`R,#$S
M("T@)#8L-C(Y+#,X,RDN/"]P/@T*(#QP('-T>6QE/3-$)TU!4D=)3BU"3U14
M3TTZ(#!P=#L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@
M3F5W(%)O;6%N.R!-05)'24XM5$]0.B`Q.'!T)SX-"B`\8CX\:3XH:"D@3&]S
M<R!P97(@<VAA<F4\+VD^/"]B/CPO<#X-"B`\<"!S='EL93TS1"=-05)'24XM
M0D]45$]-.B`P<'0[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I
M;65S($YE=R!2;VUA;CL@34%21TE.+51/4#H@-G!T)SX-"B!"87-I8R!L;W-S
M('!E<B!C;VUM;VX@<VAA<F4@:7,@8V]M<'5T960@8GD@9&EV:61I;F<@;&]S
M<R!B>2!T:&4-"B!W96EG:'1E9"UA=F5R86=E(&YU;6)E<B!O9B!C;VUM;VX@
M<VAA<F5S(&]U='-T86YD:6YG(&1U<FEN9R!T:&4-"B!P97)I;V0N($1I;'5T
M960@;F5T(&5A<FYI;F=S('!E<B!C;VUM;VX@<VAA<F4@:7,@9&5T97)M:6YE
M9"!U<VEN9PT*('1H92!W96EG:'1E9"UA=F5R86=E(&YU;6)E<B!O9B!C;VUM
M;VX@<VAA<F5S(&]U='-T86YD:6YG(&1U<FEN9R!T:&4-"B!P97)I;V0L(&%D
M:G5S=&5D(&9O<B!T:&4@9&EL=71I=F4@969F96-T(&]F(&-O;6UO;B!S=&]C
M:PT*(&5Q=6EV86QE;G1S+"!C;VYS:7-T:6YG(&]F('-H87)E<R!T:&%T(&UI
M9VAT(&)E(&ES<W5E9"!U<&]N#0H@97AE<F-I<V4@;V8@8V]M;6]N('-T;V-K
M(&]P=&EO;G,@86YD('=A<G)A;G1S+B!);B!P97)I;V1S('=H97)E#0H@;&]S
M<V5S(&%R92!R97!O<G1E9"P@=&AE('=E:6=H=&5D+6%V97)A9V4@;G5M8F5R
M(&]F(&-O;6UO;B!S:&%R97,-"B!O=71S=&%N9&EN9R!E>&-L=61E<R!C;VUM
M;VX@<W1O8VL@97%U:79A;&5N=',@8F5C875S92!T:&5I<@T*(&EN8VQU<VEO
M;B!W;W5L9"!B92!A;G1I+61I;'5T:79E+CPO<#X-"B`\<"!S='EL93TS1"=-
M05)'24XM0D]45$]-.B`P<'0[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)
M3%DZ(%1I;65S($YE=R!2;VUA;CL@34%21TE.+51/4#H@,3AP="<^#0H@/&(^
M/&D^*&DI(%)E8V5N="!A8V-O=6YT:6YG('!R;VYO=6YC96UE;G1S/"]I/CPO
M8CX\+W`^#0H@/'`@<W1Y;&4],T0G34%21TE.+4)/5%1/33H@,'!T.R!&3TY4
M+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86X[($U!
M4D=)3BU43U`Z(#9P="<^#0H@26X@07!R:6P@,C`Q-"P@=&AE($9!4T(@:7-S
M=65D($%352`R,#$T+3`X+"`F(W@R,#%#.U!R97-E;G1A=&EO;B!O9@T*($9I
M;F%N8VEA;"!3=&%T96UE;G1S(&%N9"!0<F]P97)T>2P@4&QA;G0L(&%N9`T*
M($5Q=6EP;65N="8C>#(P,30[4F5P;W)T:6YG($1I<V-O;G1I;G5E9"!/<&5R
M871I;VYS(&%N9"!$:7-C;&]S=7)E<PT*(&]F($1I<W!O<V%L<R!O9B!#;VUP
M;VYE;G1S(&]F(&%N($5N=&ET>2XF(W@R,#%$.R!!4U4@,C`Q-"TP.`T*('!R
M;W9I9&5S(&=U:61A;F-E(')E;&%T960@=&\@=&AE(&1E9FEN:71I;VX@;V8@
M82!D:7-C;VYT:6YU960-"B!O<&5R871I;VX@86YD(')E<75I<F5S(&YE=R!D
M:7-C;&]S=7)E<R!O9B!B;W1H(&1I<V-O;G1I;G5E9`T*(&]P97)A=&EO;G,@
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M(&UA=&5R:6%L(&EM<&%C="!T;R!T:&4-"B!#;VUP86YY)B-X,C`Q.3MS(&9I
M;F%N8VEA;"!P;W-I=&EO;BP@<F5S=6QT<R!O9B!O<&5R871I;VYS(&]R(&-A
M<V@-"B!F;&]W<R!A<R!A(')E<W5L="!O9B!T:&ES(&-H86YG92X\+W`^#0H@
M/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO
M=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R
M=%\U-S%F,S(V,5\Q,#%E7S0V,#E?83AC95]B-F9E-V$P8C1E-#D-"D-O;G1E
M;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-3<Q9C,R-C%?,3`Q95\T-C`Y7V$X
M8V5?8C9F93=A,&(T930Y+U=O<FMS:&5E=',O4VAE970Q,"YH=&UL#0I#;VYT
M96YT+51R86YS9F5R+45N8V]D:6YG.B!Q=6]T960M<')I;G1A8FQE#0I#;VYT
M96YT+51Y<&4Z('1E>'0O:'1M;#L@8VAA<G-E=#TB=7,M87-C:6DB#0H-"CQH
M=&UL/@T*("`\:&5A9#X-"B`@("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N
M="U4>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\
M<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO
M*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A
M9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$
M240P14U%/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C
M;VQS<&%N/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG/E)E9&5E;6%B;&4@8V]N
M=F5R=&EB;&4@<')E9F5R<F5D('-T;V-K(&%N9"!S=&]C:VAO;&1E<G,G("AD
M969I8VET*2!E<75I='D\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H
M(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^,R!-;VYT:',@16YD960\+W1H/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$
M=&@^36%R+B`S,2P@,C`Q-#QB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^/'-T<F]N9SY%<75I='D@6T%B<W1R86-T73PO<W1R;VYG/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4F5D965M86)L92!C
M;VYV97)T:6)L92!P<F5F97)R960@<W1O8VL@86YD('-T;V-K:&]L9&5R<R<@
M*&1E9FEC:70I(&5Q=6ET>3PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQD:78^#0H@/'`@<W1Y;&4],T0G;6%R9VEN+71O<#HQ.'!T.R!M87)G
M:6XM8F]T=&]M.C!P=#L@9F]N="US:7IE.C$P<'0[(&9O;G0M9F%M:6QY.E1I
M;65S($YE=R!2;VUA;B<^#0H@/&(^,RX@4F5D965M86)L92!C;VYV97)T:6)L
M92!P<F5F97)R960@<W1O8VL@86YD#0H@<W1O8VMH;VQD97)S)B-X,C`Q.3L@
M*&1E9FEC:70I(&5Q=6ET>3PO8CX\+W`^#0H@/'`@<W1Y;&4],T0G;6%R9VEN
M+71O<#HV<'0[(&UA<F=I;BUB;W1T;VTZ,'!T.R!F;VYT+7-I>F4Z,3!P=#L@
M9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N)SX-"B!/;B!&96)R=6%R>28C
M>$$P.S(W+"`R,#$T+"!T:&4@0V]M<&%N>2!E9F9E8W1E9"!A(#$M9F]R+3$Y
M+C(-"B!R979E<G-E('-T;V-K('-P;&ET(&]F($%Q=6EN;W@@55-!)B-X,C`Q
M.3MS(&-O;6UO;B!S=&]C:R!A;F0-"B!C;VYV97)T:6)L92!P<F5F97)R960@
M<W1O8VL@86YD($%16%`@0V%N861A)B-X,C`Q.3MS(&-O;6UO;@T*(&5X8VAA
M;F=E86)L92!S:&%R97,@86YD(&5X8VAA;F=E86)L92!P<F5F97)R960@<VAA
M<F5S+B!!;&P@<&5R#0H@<VAA<F4@86UO=6YT<R!A;F0@;G5M8F5R<R!O9B!S
M:&%R97,@=VET:&EN('1H92!C;VYD96YS960-"B!C;VYS;VQI9&%T960@86YD
M(&-O;6)I;F5D(&9I;F%N8VEA;"!S=&%T96UE;G1S(&%N9"!N;W1E<R!A<F4-
M"B!P<F5S96YT960@;VX@82!P;W-T+7-P;&ET(&)A<VES+CPO<#X-"B`\<"!S
M='EL93TS1"=M87)G:6XM=&]P.C$R<'0[(&UA<F=I;BUB;W1T;VTZ,'!T.R!F
M;VYT+7-I>F4Z,3!P=#L@9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N)SX-
M"B!/;B!-87)C:"8C>$$P.S$R+"`R,#$T+"!I;6UE9&EA=&5L>2!P<FEO<B!T
M;R!T:&4@8VQO<VEN9R!O9B!T:&4-"B!)4$\L('1H92!#;VUP86YY('5N9&5R
M=V5N="!A(')E;W)G86YI>F%T:6]N+"!W:&EC:"!R97-U;'1E9"!I;B!A#0H@
M<VEM<&QI9FEC871I;VX@;V8@:71S(&-A<&ET86P@<W1R=6-T=7)E+B!%86-H
M(&]F('1H92`S,#$L-S0U#0H@;W5T<W1A;F1I;F<@8V]M;6]N(&5X8VAA;F=E
M86)L92!S:&%R97,@;V8@05%84"!#86YA9&$@=V%S#0H@=')A;G-F97)R960@
M=&\@07%U:6YO>"!54T$@:6X@97AC:&%N9V4@9F]R(&]N92!C;VUM;VX@<W1O
M8VL@;V8-"B!!<75I;F]X(%5302X@16%C:"!O9B!T:&4@-SDQ+#`Q-B!O=71S
M=&%N9&EN9R!397)I97,@02!E>&-H86YG96%B;&4-"B!P<F5F97)R960@<VAA
M<F5S+"`W.3,L-C$W(&]U='-T86YD:6YG(%-E<FEE<R!"(&5X8VAA;F=E86)L
M90T*('!R969E<G)E9"!S:&%R97,@86YD(#,W."PW.#8@;W5T<W1A;F1I;F<@
M4V5R:65S($,@97AC:&%N9V5A8FQE#0H@<')E9F5R<F5D('-H87)E(&]F($%1
M6%`@0V%N861A('=A<R!T<F%N<V9E<G)E9"!T;R!!<75I;F]X(%5302!I;@T*
M(&5X8VAA;F=E(&9O<B!O;F4@<VAA<F4@;V8@4V5R:65S($$L($(@86YD($,@
M8V]N=F5R=&EB;&4@<')E9F5R<F5D#0H@<W1O8VL@;V8@07%U:6YO>"!54T$L
M(')E<W!E8W1I=F5L>2X@07,@82!R97-U;'0L(&9O;&QO=VEN9R!S=6-H#0H@
M97AC:&%N9V4L('1H97)E('=E<F4@,2PT-3,L.#DQ('-H87)E<R!O9B!397)I
M97,@02P@,BPS-C<L-#$T('-H87)E<PT*(&]F(%-E<FEE<R!"(&%N9"`Q+#<R
M,BPR,3`@<VAA<F5S(&]F(%-E<FEE<R!#(&-O;G9E<G1I8FQE('!R969E<G)E
M9`T*('-T;V-K(&]F($%Q=6EN;W@@55-!+B!&;VQL;W=I;F<@=&AE(&-O;7!L
M971I;VX@;V8@=&AE(&5X8VAA;F=E(&%N9`T*(&-O;G9E<G-I;VXL(&%L;"!S
M<&5C:6%L('9O=&EN9R!S:&%R97,@;V8@05%84"!#86YA9&$@86YD(&%L;`T*
M('-P96-I86P@=F]T:6YG('-T;V-K(&]F($%Q=6EN;W@@55-!('=E<F4@<F5D
M965M960@9F]R(&$@;F]M:6YA;`T*(&%M;W5N="!A;F0@86QL(&5X8VAA;F=E
M86)L92!P<F5F97)R960@<VAA<F5S(&]F($%16%`@0V%N861A+"!N;W<-"B!H
M96QD(&)Y($%Q=6EN;W@@55-!+"!W97)E(&-O;G9E<G1E9"!T;R!C;VUM;VX@
M97AC:&%N9V5A8FQE('-H87)E<PT*(&]F($%16%`@0V%N861A+B!!<R!A(')E
M<W5L="!O9B!T:&4@<F5O<F=A;FEZ871I;VXL($%16%`@0V%N861A#0H@8F5C
M86UE(&$@,3`P)2!O=VYE9"!S=6)S:61I87)Y(&]F($%Q=6EN;W@@55-!+B!3
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M)VUA<F=I;BUT;W`Z,3)P=#L@;6%R9VEN+6)O='1O;3HP<'0[(&9O;G0M<VEZ
M93HQ,'!T.R!F;VYT+69A;6EL>3I4:6UE<R!.97<@4F]M86XG/@T*($]N($UA
M<F-H)B-X03`[,3(L(#(P,30L('1H92!#;VUP86YY(&-L;W-E9"!I=',@25!/
M('=H97)E8GD@=&AE#0H@0V]M<&%N>2!S;VQD(#0L.#,P+#`P,"!S:&%R97,@
M;V8@8V]M;6]N('-T;V-K("AI;F-L=7-I=F4@;V8@-C,P+#`P,`T*('-H87)E
M<R!O9B!C;VUM;VX@<W1O8VL@<V]L9"!B>2!T:&4@0V]M<&%N>2!P=7)S=6%N
M="!T;R!T:&4@9G5L;`T*(&5X97)C:7-E(&]F(&%N(&]V97)A;&QO=&UE;G0@
M;W!T:6]N(&=R86YT960@=&\@=&AE('5N9&5R=W)I=&5R<R!I;@T*(&-O;FYE
M8W1I;VX@=VET:"!T:&4@;V9F97)I;F<I(&%T(&$@<')I8V4@;V8@)#$Q+C`P
M('!E<B!S:&%R92!B969O<F4-"B!U;F1E<G=R:71I;F<@9&ES8V]U;G1S+B!4
M:&4@<VAA<F5S(&)E9V%N('1R861I;F<@;VX@=&AE($Y!4T1!40T*($=L;V)A
M;"!-87)K970@:6X@36%R8V@@,C`Q-"P@=6YD97(@=&AE('-Y;6)O;"`F(W@R
M,#%#.T%16%`F(W@R,#%$.RX-"B!4:&4@86=G<F5G871E(&YE="!P<F]C965D
M<R!R96-E:79E9"!B>2!T:&4@0V]M<&%N>2!F<F]M('1H90T*(&]F9F5R:6YG
M+"!N970@;V8@=6YD97)W<FET:6YG(&1I<V-O=6YT<R!A;F0@8V]M;6ES<VEO
M;G,@86YD#0H@;V9F97)I;F<@8V]S=',@;V8@)#4L-S@X+#<R-BP@=V5R92`D
M-#<L,S0Q+#(W-"X\+W`^#0H@/'`@<W1Y;&4],T1F;VYT+7-I>F4Z,7!X.VUA
M<F=I;BUT;W`Z,3)P>#MM87)G:6XM8F]T=&]M.C!P>#X-"B`F(WA!,#L\+W`^
M#0H@/'`@<W1Y;&4],T0G;6%R9VEN+71O<#HP<'0[(&UA<F=I;BUB;W1T;VTZ
M,'!T.R!F;VYT+7-I>F4Z,3!P=#L@9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O
M;6%N)SX-"B!/;B!-87)C:"8C>$$P.S$R+"`R,#$T+"!T:&4@0V]M<&%N>2!A
M9&]P=&5D(&%N(&%M96YD960@86YD(')E<W1A=&5D#0H@8V5R=&EF:6-A=&4@
M;V8@:6YC;W)P;W)A=&EO;B!F;W(@07%U:6YO>"!54T$L('=H:6-H(&%U=&AO
M<FEZ960@='=O#0H@8VQA<W-E<R!O9B!S=&]C:RP@8V]M;6]N(&%N9"!P<F5F
M97)R960N(%1H92!T;W1A;"!N=6UB97(@;V8@<VAA<F5S#0H@=&AE($-O;7!A
M;GD@:7,@875T:&]R:7IE9"!T;R!I<W-U92!I<R`U-2PP,#`L,#`P('-H87)E
M<RP@8V]M<')I<V5D#0H@;V8@-3`L,#`P+#`P,"!C;VUM;VX@<W1O8VL@86YD
M(#4L,#`P+#`P,"!O9B!A(&YE=R!C871E9V]R>2!O9@T*('!R969E<G)E9"!S
M=&]C:R!B;W1H('=I=&@@82!P87(@=F%L=64@;V8@)#`N,#`P,#`Q('!E<B!S
M:&%R92X@07,@;V8-"B!-87)C:"8C>$$P.S,Q+"`R,#$T(&%N9"!$96-E;6)E
M<B8C>$$P.S,Q+"`R,#$S+"!N;R!S:&%R97,@;V8@=&AI<PT*(&YE=R!C871E
M9V]R>2!O9B!P<F5F97)R960@<W1O8VL@=V5R92!I<W-U960@;W(@;W5T<W1A
M;F1I;F<N/"]P/@T*(#PO9&EV/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM
M+2TM+3U?3F5X=%!A<G1?-3<Q9C,R-C%?,3`Q95\T-C`Y7V$X8V5?8C9F93=A
M,&(T930Y#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+S4W,68S,C8Q
M7S$P,65?-#8P.5]A.&-E7V(V9F4W83!B-&4T.2]7;W)K<VAE971S+U-H965T
M,3$N:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R
M:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S
M+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE
M<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA
M<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R
M8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\
M+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS
M1')E<&]R="!I9#TS1$E$,$5-13X-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H
M(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T<F]N9SY#
M87-H(&%N9"!C87-H(&5Q=6EV86QE;G1S/&)R/CPO<W1R;VYG/CPO=&@^#0H@
M("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/C,@36]N=&AS($5N
M9&5D/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(^#0H@("`@("`@(#QT
M:"!C;&%S<STS1'1H/DUA<BX@,S$L(#(P,30\8G(^/"]T:#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^0V%S:"!!;F0@0V%S:"!%<75I
M=F%L96YT<R!;06)S=')A8W1=/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y#87-H(&%N9"!C87-H(&5Q=6EV86QE;G1S/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/&1I=CX-"B`\<"!S='EL
M93TS1"=-05)'24XM0D]45$]-.B`P<'0[($9/3E0M4TE:13H@,3!P=#L@1D].
M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@34%21TE.+51/4#H@,3AP="<^
M#0H@/&(^-"X@0V%S:"!A;F0@8V%S:"!E<75I=F%L96YT<SPO8CX\+W`^#0H@
M/'`@<W1Y;&4],T0G34%21TE.+4)/5%1/33H@,'!T.R!&3TY4+5-)6D4Z(#$R
M<'0[($U!4D=)3BU43U`Z(#!P="<^#0H@)B-X03`[/"]P/@T*(#QT86)L92!S
M='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.
M97<@4F]M86X[($)/4D1%4BU#3TQ,05!313H@8V]L;&%P<V4G(&-E;&QS<&%C
M:6YG/3-$,"!C96QL<&%D9&EN9STS1#`@=VED=&@],T0W-B4@86QI9VX],T1C
M96YT97(@8F]R9&5R/3-$,#X-"B`\='(^#0H@/'1D('=I9'1H/3-$-C(E/CPO
M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE/CPO=&0^#0H@
M/'1D/CPO=&0^#0H@/'1D/CPO=&0^#0H@/'1D/CPO=&0^#0H@/'1D('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#DE/CPO=&0^#0H@/'1D/CPO=&0^#0H@/'1D
M/CPO=&0^#0H@/'1D/CPO=&0^#0H@/"]T<CX-"B`\='(@<W1Y;&4],T0G1D].
M5"U325I%.B`X<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XG/@T*
M(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N
M/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('-T>6QE/3-$)T)/
M4D1%4BU"3U143TTZ(",P,#`P,#`@,7!T('-O;&ED)R!V86QI9VX],T1B;W1T
M;VT@8V]L<W!A;CTS1#(@86QI9VX],T1C96YT97(^/&(^34%20T@F(WA!,#LS
M,2PF(WA!,#LR,#$T/"]B/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF
M(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[
M/"]T9#X-"B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q
M<'0@<V]L:60G('9A;&EG;CTS1&)O='1O;2!C;VQS<&%N/3-$,B!A;&EG;CTS
M1&-E;G1E<CX\8CY$14-%34)%4B8C>$$P.S,Q+"8C>$$P.S(P,3,\+V(^/"]T
M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@/"]T<CX-
M"B`\='(@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@
M5&EM97,@3F5W(%)O;6%N)R!B9V-O;&]R/3-$(T-#145&1CX-"B`\=&0@=F%L
M:6=N/3-$=&]P/@T*(#QP('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].
M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@34%21TE.+4Q%1E0Z(#%E;3L@
M5$585"U)3D1%3E0Z("TQ96TG/@T*($-A<V@\+W`^#0H@/"]T9#X-"B`\=&0@
M=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG
M;CTS1&)O='1O;3XD/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N
M/3-$<FEG:'0^-#DL-3,X+#@W-#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O
M;2!N;W=R87`],T1N;W=R87`^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L
M:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS
M1&)O='1O;3XD/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$
M<FEG:'0^-RPR.3(L,3$V/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO
M=W)A<#TS1&YO=W)A<#XF(WA!,#LF(WA!,#L\+W1D/@T*(#PO='(^#0H@/'1R
M('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S
M($YE=R!2;VUA;B<^#0H@/'1D('9A;&EG;CTS1'1O<#X-"B`\<"!S='EL93TS
M1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M
M86X[($U!4D=)3BU,1494.B`Q96T[(%1%6%0M24Y$14Y4.B`M,65M)SX-"B!#
M87-H(&5Q=6EV86QE;G1S/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O
M='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^
M)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$<FEG
M:'0^,RPS-SDL-#4S/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A
M<#TS1&YO=W)A<#XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B
M;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M
M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I
M9VAT/C,L-S$T+#(W-CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R
M87`],T1N;W=R87`^)B-X03`[)B-X03`[/"]T9#X-"B`\+W1R/@T*(#QT<B!S
M='EL93TS1"=&3TY4+5-)6D4Z(#%P>"<^#0H@/'1D('9A;&EG;CTS1&)O='1O
M;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T
M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%
M4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X-
M"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU4
M3U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\
M=&0^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C
M>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS
M1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*
M(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="
M3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO
M=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/"]T<CX-"B`\='(@<W1Y;&4],T0G
M1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N
M)R!B9V-O;&]R/3-$(T-#145&1CX-"B`\=&0@=F%L:6=N/3-$=&]P/CPO=&0^
M#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=&3TY4+5-)
M6D4Z(#AP="<^)B-X03`[)B-X03`[/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG
M;CTS1&)O='1O;3XD/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N
M/3-$<FEG:'0^-3(L.3$X+#,R-SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O
M;2!N;W=R87`],T1N;W=R87`^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L
M:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@.'!T)SXF
M(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M
M/B0\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XQ
M,2PP,#8L,SDR/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS
M1&YO=W)A<#XF(WA!,#LF(WA!,#L\+W1D/@T*(#PO='(^#0H@/'1R('-T>6QE
M/3-$)T9/3E0M4TE:13H@,7!X)SX-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO
M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*
M(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@<W1Y;&4],T0G0D]21$52+51/
M4#H@(S`P,#`P,"`S<'@@9&]U8FQE)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\
M=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z
M(",P,#`P,#`@,W!X(&1O=6)L92<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D
M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!
M,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@<W1Y;&4],T0G
M0D]21$52+51/4#H@(S`P,#`P,"`S<'@@9&]U8FQE)SXF(WA!,#L\+W`^#0H@
M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/
M4D1%4BU43U`Z(",P,#`P,#`@,W!X(&1O=6)L92<^)B-X03`[/"]P/@T*(#PO
M=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/"]T<CX-"B`\+W1A8FQE/@T*(#PO
M9&EV/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A
M8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?
M-3<Q9C,R-C%?,3`Q95\T-C`Y7V$X8V5?8C9F93=A,&(T930Y#0I#;VYT96YT
M+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+S4W,68S,C8Q7S$P,65?-#8P.5]A.&-E
M7V(V9F4W83!B-&4T.2]7;W)K<VAE971S+U-H965T,3(N:'1M;`T*0V]N=&5N
M="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N
M="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M
M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M
M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C
M<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@
M1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^
M#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$
M,$5-13X-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&P@8V]L
M<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T<F]N9SY,;V%N(&9A8VEL:71Y/&)R
M/CPO<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P
M86X],T0Q/C,@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DUA<BX@,S$L(#(P,30\
M8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^
M1&5B="!$:7-C;&]S=7)E(%M!8G-T<F%C=%T\+W-T<F]N9SX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DQO86X@9F%C:6QI='D\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\9&EV/@T*(#QP('-T>6QE/3-$
M)TU!4D=)3BU"3U143TTZ(#!P=#L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!
M34E,63H@5&EM97,@3F5W(%)O;6%N.R!-05)'24XM5$]0.B`Q.'!T)SX-"B`\
M8CXU+B!,;V%N(&9A8VEL:71Y/"]B/CPO<#X-"B`\<"!S='EL93TS1"=-05)'
M24XM0D]45$]-.B`P<'0[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ
M(%1I;65S($YE=R!2;VUA;CL@34%21TE.+51/4#H@-G!T)SX-"B!/;B!/8W1O
M8F5R)B-X03`[,C,L(#(P,3,L($%16%`@0V%N861A(&5N=&5R960@:6YT;R!A
M('1E<FT@;&]A;@T*(&9A8VEL:71Y('=I=&@@4VEL:6-O;B!686QL97D@0F%N
M:R`H)B-X,C`Q0SM35D(F(W@R,#%$.RD@9F]R('5P('1O#0H@)#0F(WA!,#MM
M:6QL:6]N+"!O9B!W:&EC:"`D,BXU(&UI;&QI;VX@=V%S(')E8V5I=F5D(&]N
M#0H@3V-T;V)E<B8C>$$P.S,P+"`R,#$S(&%N9"!A(&9U<G1H97(@)#$N-2!M
M:6QL:6]N(&ES(&%V86EL86)L92!T;PT*($%16%`@0V%N861A('1H<F]U9V@@
M1&5C96UB97(F(WA!,#LS,2P@,C`Q-"!U<&]N($%16%`@0V%N861A#0H@<F5C
M96EV:6YG(&-E<G1A:6X@86=R965D+75P;VX@4&AA<V4@,B!T;W`M;&EN92!D
M871A(')E<W5L=',@9G)O;0T*(&ET<R!#:')O;FEC($]B<W1R=6-T:79E(%!U
M;&UO;F%R>2!$:7-O<F1E<B`H)B-X,C`Q0SM#3U!$)B-X,C`Q1#LI(&]R#0H@
M0FQA9&1E<B!086EN(%-Y;F1R;VUE+TEN=&5R<W1I=&EA;"!#>7-T:71I<R`H
M)B-X,C`Q0SM"4%,O24,F(W@R,#%$.RD-"B!C;&EN:6-A;"!T<FEA;',N($%Q
M=6EN;W@@55-!(&ES(&$@9W5A<F%N=&]R(&]F($%16%`@0V%N861A)B-X,C`Q
M.3MS#0H@;V)L:6=A=&EO;G,@=6YD97(@=&AE('1E<FT@;&]A;B!F86-I;&ET
M>2X@26X@861D:71I;VX@=&\@<')I;F-I<&%L+`T*(&EN=&5R97-T(&%N9"!O
M=&AE<B!R96QA=&5D('!A>6UE;G1S(&1U92!T;R!35D(L($%Q=6EN;W@@55-!
M(&%N9`T*($%16%`@0V%N861A(&ES<W5E9"!35D(@=V%R<F%N=',@870@)#$P
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M(&5X<&ER92!I;B`R,#(S+CPO<#X-"B`\<"!S='EL93TS1"=-05)'24XM0D]4
M5$]-.B`P<'0[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S
M($YE=R!2;VUA;CL@34%21TE.+51/4#H@,3)P="<^#0H@5&AE('1E<FT@;&]A
M;B!H87,@86X@:6YT97)E<W0@<F%T92!O9B`U+C(U)2!A;F0@:7,@8V]L;&%T
M97)A;&EZ960-"B!B>2!!45A0($-A;F%D828C>#(P,3D[<R!A<W-E=',L(&5X
M8VQU9&EN9R!I;G1E;&QE8W1U86P@<')O<&5R='DL(&)U=`T*(&EN8VQU9&EN
M9R!A;&P@<')O8V5E9',@=&AE<F5O9BX@5&AE('1E<FT@;&]A;B!P<FEN8VEP
M86P@:7,-"B!R97!A>6%B;&4@:6X@;6]N=&AL>2!I;G-T86QL;65N=',@87!P
M<F]X:6UA=&5L>2`D.#,L,#`P(&-O;6UE;F-I;F<-"B!/8W1O8F5R(#(P,30@
M86YD('1H92!L;V%N(&AA<R!A(&UA='5R:71Y(&1A=&4@;V8@36%R8V@@,C`Q
M-RX@05%84`T*($-A;F%D82!M87D@=F]L=6YT87)I;'D@<F5P87D@=&AE('1E
M<FT@;&]A;B!A="!A;GD@=&EM92X\+W`^#0H@/'`@<W1Y;&4],T0G34%21TE.
M+4)/5%1/33H@,'!T.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4
M:6UE<R!.97<@4F]M86X[($U!4D=)3BU43U`Z(#$R<'0G/@T*($]N($UA<F-H
M)B-X03`[,C@L(#(P,30L($%16%`@0V%N861A(&UA9&4@82!C87-H('!A>6UE
M;G0@;V8-"B`D,BPV,#DL.#0T('1O(&9U;&QY(')E<&%Y('1H92!A;6]U;G0@
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M9R!C;W-T<RX\+W`^#0H@/'`@<W1Y;&4],T0G34%21TE.+4)/5%1/33H@,'!T
M.R!&3TY4+5-)6D4Z(#$R<'0[($U!4D=)3BU43U`Z(#!P="<^#0H@)B-X03`[
M/"]P/@T*(#QT86)L92!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M
M1D%-24Q9.B!4:6UE<R!.97<@4F]M86X[($)/4D1%4BU#3TQ,05!313H@8V]L
M;&%P<V4G(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`@=VED=&@]
M,T0V."4@86QI9VX],T1C96YT97(@8F]R9&5R/3-$,#X-"B`\='(^#0H@/'1D
M('=I9'1H/3-$.#0E/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#$S)3X\+W1D/@T*(#QT9#X\+W1D/@T*(#QT9#X\+W1D/@T*(#QT9#X\
M+W1D/@T*(#PO='(^#0H@/'1R('-T>6QE/3-$)T9/3E0M4TE:13H@.'!T.R!&
M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)SX-"B`\=&0@=F%L:6=N/3-$
M8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!
M,#LF(WA!,#L\+W1D/@T*(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C
M,#`P,#`P(#%P="!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R
M(&%L:6=N/3-$8V5N=&5R/CQB/D%-3U5.5#PO8CX\+W1D/@T*(#QT9"!V86QI
M9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\+W1R/@T*(#QT<B!S='EL93TS
M1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M
M86XG(&)G8V]L;W(],T0C0T-%149&/@T*(#QT9"!V86QI9VX],T1T;W`^#0H@
M/'`@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM
M97,@3F5W(%)O;6%N.R!-05)'24XM3$5&5#H@,65M.R!415A4+4E.1$5.5#H@
M+3%E;2<^#0H@0D%,04Y#128C>#(P,30[2F%N=6%R>28C>$$P.S$L(#(P,3,\
M+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P
M.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^
M)#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`@
M86QI9VX],T1R:6=H=#X-"B`F(W@R,#$T.R8C>$$P.R8C>$$P.SPO=&0^#0H@
M/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^)B-X03`[)B-X
M03`[/"]T9#X-"B`\+W1R/@T*(#QT<B!S='EL93TS1"=&3TY4+5-)6D4Z(#$P
M<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XG/@T*(#QT9"!V86QI
M9VX],T1T;W`^#0H@/'`@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4
M+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!-05)'24XM3$5&5#H@,V5M.R!4
M15A4+4E.1$5.5#H@+3%E;2<^#0H@0F%N:R!L;V%N(&-A<V@@<F5C96EV960@
M+2!/8W1O8F5R)B-X03`[,S`L(#(P,3,\+W`^#0H@/"]T9#X-"B`\=&0@=F%L
M:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS
M1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI
M9VX],T1R:6=H=#XR+#4P,"PP,#`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T
M;VT@;F]W<F%P/3-$;F]W<F%P/B8C>$$P.R8C>$$P.SPO=&0^#0H@/"]T<CX-
M"B`\='(@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@
M5&EM97,@3F5W(%)O;6%N)R!B9V-O;&]R/3-$(T-#145&1CX-"B`\=&0@=F%L
M:6=N/3-$=&]P/@T*(#QP('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].
M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@34%21TE.+4Q%1E0Z(#-E;3L@
M5$585"U)3D1%3E0Z("TQ96TG/@T*(%=A<G)A;G0@9&ES8V]U;G0\+W`^#0H@
M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^
M#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI
M9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XH,C(V+#(U-3PO=&0^#0H@/'1D
M('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^*28C>$$P.SPO=&0^
M#0H@/"]T<CX-"B`\='(@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4
M+49!34E,63H@5&EM97,@3F5W(%)O;6%N)SX-"B`\=&0@=F%L:6=N/3-$=&]P
M/@T*(#QP('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ
M(%1I;65S($YE=R!2;VUA;CL@34%21TE.+4Q%1E0Z(#-E;3L@5$585"U)3D1%
M3E0Z("TQ96TG/@T*($9I;F%N8VEN9R!C;W-T<SPO<#X-"B`\+W1D/@T*(#QT
M9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L
M:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O
M;2!A;&EG;CTS1')I9VAT/C$R+#<T-#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O
M='1O;2!N;W=R87`],T1N;W=R87`^)B-X03`[)B-X03`[/"]T9#X-"B`\+W1R
M/@T*(#QT<B!S='EL93TS1"=&3TY4+5-)6D4Z(#%P>"<^#0H@/'1D('9A;&EG
M;CTS1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[
M)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE
M/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^
M#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$
M)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@
M/"]T9#X-"B`\=&0^)B-X03`[/"]T9#X-"B`\+W1R/@T*(#QT<B!S='EL93TS
M1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M
M86XG(&)G8V]L;W(],T0C0T-%149&/@T*(#QT9"!V86QI9VX],T1T;W`^#0H@
M/'`@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM
M97,@3F5W(%)O;6%N.R!-05)'24XM3$5&5#H@,65M.R!415A4+4E.1$5.5#H@
M+3%E;2<^#0H@0D%,04Y#128C>#(P,30[1&5C96UB97(F(WA!,#LS,2P@,C`Q
M,SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y
M;&4],T0G1D].5"U325I%.B`X<'0G/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D
M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L
M:6=N/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^,BPR.#8L-#@Y/"]T9#X-"B`\
M=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XF(WA!,#LF(WA!
M,#L\+W1D/@T*(#PO='(^#0H@/'1R('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P
M=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;B<^#0H@/'1D('9A;&EG
M;CTS1'1O<#X-"B`\<"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M
M1D%-24Q9.B!4:6UE<R!.97<@4F]M86X[($U!4D=)3BU,1494.B`S96T[(%1%
M6%0M24Y$14Y4.B`M,65M)SX-"B!!8V-R=65D(&EN=&5R97-T/"]P/@T*(#PO
M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=&3TY4
M+5-)6D4Z(#AP="<^)B-X03`[)B-X03`[/"]F;VYT/CPO=&0^#0H@/'1D('9A
M;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T
M;VT@86QI9VX],T1R:6=H=#XY+#@T-#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O
M='1O;2!N;W=R87`],T1N;W=R87`^)B-X03`[)B-X03`[/"]T9#X-"B`\+W1R
M/@T*(#QT<B!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9
M.B!4:6UE<R!.97<@4F]M86XG(&)G8V]L;W(],T0C0T-%149&/@T*(#QT9"!V
M86QI9VX],T1T;W`^#0H@/'`@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&
M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!-05)'24XM3$5&5#H@,V5M
M.R!415A4+4E.1$5.5#H@+3%E;2<^#0H@06-C<F5T:6]N(&]F('=A<G)A;G0@
M9&ES8V]U;G0\+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF
M;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@.'!T)SXF(WA!,#LF(WA!,#L\+V9O
M;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@
M/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/C(Q,RPU,3$\+W1D
M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W<F%P/3-$;F]W<F%P/B8C>$$P
M.R8C>$$P.SPO=&0^#0H@/"]T<CX-"B`\='(@<W1Y;&4],T0G1D].5"U325I%
M.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)SX-"B`\=&0@
M=F%L:6=N/3-$=&]P/@T*(#QP('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@
M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@34%21TE.+4Q%1E0Z(#-E
M;3L@5$585"U)3D1%3E0Z("TQ96TG/@T*(%)E<&%Y;65N="!F964@86YD('!E
M;F%L='D\+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT
M('-T>6QE/3-$)T9/3E0M4TE:13H@.'!T)SXF(WA!,#LF(WA!,#L\+V9O;G0^
M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D
M('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/C$P,"PP,#`\+W1D/@T*
M(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W<F%P/3-$;F]W<F%P/B8C>$$P.R8C
M>$$P.SPO=&0^#0H@/"]T<CX-"B`\='(@<W1Y;&4],T0G1D].5"U325I%.B`Q
M,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!B9V-O;&]R/3-$
M(T-#145&1CX-"B`\=&0@=F%L:6=N/3-$=&]P/@T*(#QP('-T>6QE/3-$)T9/
M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@
M34%21TE.+4Q%1E0Z(#-E;3L@5$585"U)3D1%3E0Z("TQ96TG/@T*(%)E<&%Y
M;65N="!O9B!B86YK(&QO86X@86YD(&EN=&5R97-T/"]P/@T*(#PO=&0^#0H@
M/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z
M(#AP="<^)B-X03`[)B-X03`[/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS
M1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI
M9VX],T1R:6=H=#XH,BPV,#DL.#0T/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T
M=&]M(&YO=W)A<#TS1&YO=W)A<#XI)B-X03`[/"]T9#X-"B`\+W1R/@T*(#QT
M<B!S='EL93TS1"=&3TY4+5-)6D4Z(#%P>"<^#0H@/'1D('9A;&EG;CTS1&)O
M='1O;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[
M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/
M4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T
M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%
M4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X-
M"B`\=&0^)B-X03`[/"]T9#X-"B`\+W1R/@T*(#QT<B!S='EL93TS1"=&3TY4
M+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XG/@T*
M(#QT9"!V86QI9VX],T1T;W`^#0H@/'`@<W1Y;&4],T0G1D].5"U325I%.B`Q
M,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!-05)'24XM3$5&
M5#H@,65M.R!415A4+4E.1$5.5#H@+3%E;2<^#0H@0D%,04Y#128C>#(P,30[
M36%R8V@F(WA!,#LS,2P@,C`Q-#PO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX]
M,T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`X<'0G/B8C>$$P
M.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W
M<F%P/3-$;F]W<F%P/B0\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W
M<F%P/3-$;F]W<F%P(&%L:6=N/3-$<FEG:'0^#0H@)B-X,C`Q-#LF(WA!,#LF
M(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W<F%P/3-$;F]W
M<F%P/B8C>$$P.R8C>$$P.SPO=&0^#0H@/"]T<CX-"B`\='(@<W1Y;&4],T0G
M1D].5"U325I%.B`Q<'@G/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-
M"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D
M('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C
M,#`P,#`P(#-P>"!D;W5B;&4G/B8C>$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V
M86QI9VX],T1B;W1T;VT^#0H@/'`@<W1Y;&4],T0G0D]21$52+51/4#H@(S`P
M,#`P,"`S<'@@9&]U8FQE)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0^)B-X
M03`[/"]T9#X-"B`\+W1R/@T*(#PO=&%B;&4^#0H@/'`@<W1Y;&4],T0G34%2
M1TE.+4)/5%1/33H@,'!T.R!&3TY4+5-)6D4Z(#$R<'0[($U!4D=)3BU43U`Z
M(#!P="<^#0H@)B-X03`[/"]P/@T*(#QT86)L92!S='EL93TS1"=&3TY4+5-)
M6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86X[($)/4D1%
M4BU#3TQ,05!313H@8V]L;&%P<V4G(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D
M9&EN9STS1#`@=VED=&@],T0W-B4@86QI9VX],T1C96YT97(@8F]R9&5R/3-$
M,#X-"B`\='(^#0H@/'1D('=I9'1H/3-$-C8E/CPO=&0^#0H@/'1D('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$Q)3X\+W1D/@T*(#QT9#X\+W1D/@T*(#QT
M9#X\+W1D/@T*(#QT9#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Q,24^/"]T9#X-"B`\=&0^/"]T9#X-"B`\=&0^/"]T9#X-"B`\=&0^
M/"]T9#X-"B`\+W1R/@T*(#QT<CX-"B`\=&0^/"]T9#X-"B`\=&0@8V]L<W!A
M;CTS1#0^/"]T9#X-"B`\=&0@8V]L<W!A;CTS1#0^/"]T9#X-"B`\+W1R/@T*
M(#QT<B!S='EL93TS1"=&3TY4+5-)6D4Z(#AP=#L@1D].5"U&04U)3%DZ(%1I
M;65S($YE=R!2;VUA;B<^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\
M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-
M"B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'0@<V]L
M:60G('9A;&EG;CTS1&)O='1O;2!C;VQS<&%N/3-$,B!A;&EG;CTS1&-E;G1E
M<CX\8CY-05)#2"8C>$$P.S,Q+"8C>$$P.S(P,30\+V(^/"]T9#X-"B`\=&0@
M=F%L:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O
M='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!S='EL93TS1"="3U)$15(M
M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M(&-O
M;'-P86X],T0R(&%L:6=N/3-$8V5N=&5R/CQB/D1%0T5-0D52)B-X03`[,S$L
M/"]B/CQB<B`O/@T*(#QB/C(P,3,\+V(^/"]T9#X-"B`\=&0@=F%L:6=N/3-$
M8F]T=&]M/B8C>$$P.SPO=&0^#0H@/"]T<CX-"B`\='(@<W1Y;&4],T0G1D].
M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!B
M9V-O;&]R/3-$(T-#145&1CX-"B`\=&0@=F%L:6=N/3-$=&]P/@T*(#QP('-T
M>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE
M=R!2;VUA;CL@34%21TE.+4Q%1E0Z(#%E;3L@5$585"U)3D1%3E0Z("TQ96TG
M/@T*(%-H;W)T+71E<FT@<&]R=&EO;B!O9B!B86YK(&QO86X\+W`^#0H@/"]T
M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@
M/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^)#PO=&0^#0H@
M/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`@86QI9VX],T1R
M:6=H=#X-"B`F(W@R,#$T.R8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG
M;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^)B-X03`[)B-X03`[/"]T9#X-
M"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D
M('9A;&EG;CTS1&)O='1O;3XD/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M
M(&%L:6=N/3-$<FEG:'0^,C4P+#`P,#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O
M='1O;2!N;W=R87`],T1N;W=R87`^)B-X03`[)B-X03`[/"]T9#X-"B`\+W1R
M/@T*(#QT<B!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9
M.B!4:6UE<R!.97<@4F]M86XG/@T*(#QT9"!V86QI9VX],T1T;W`^#0H@/'`@
M<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@
M3F5W(%)O;6%N.R!-05)'24XM3$5&5#H@,65M.R!415A4+4E.1$5.5#H@+3%E
M;2<^#0H@3&]N9RUT97)M('!O<G1I;VX@;V8@8F%N:R!L;V%N/"]P/@T*(#PO
M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*
M(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W<F%P/3-$;F]W<F%P/B8C>$$P.SPO
M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`@86QI
M9VX],T1R:6=H=#X-"B`F(W@R,#$T.R8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D
M('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^)B-X03`[)B-X03`[
M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^
M#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI
M9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XR+#`S-BPT.#D\+W1D/@T*(#QT
M9"!V86QI9VX],T1B;W1T;VT@;F]W<F%P/3-$;F]W<F%P/B8C>$$P.R8C>$$P
M.SPO=&0^#0H@/"]T<CX-"B`\='(@<W1Y;&4],T0G1D].5"U325I%.B`Q<'@G
M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\=&0@=F%L:6=N/3-$
M8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O
M;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI
M9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-
M"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^
M)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/'1D('9A
M;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX]
M,T1B;W1T;VT^#0H@/'`@<W1Y;&4],T0G0D]21$52+51/4#H@(S`P,#`P,"`Q
M<'@@<V]L:60G/B8C>$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B
M;W1T;VT^#0H@/'`@<W1Y;&4],T0G0D]21$52+51/4#H@(S`P,#`P,"`Q<'@@
M<V]L:60G/B8C>$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*
M(#PO='(^#0H@/'1R('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&
M04U)3%DZ(%1I;65S($YE=R!2;VUA;B<@8F=C;VQO<CTS1"-#0T5%1D8^#0H@
M/'1D('9A;&EG;CTS1'1O<#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^
M/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`X<'0G/B8C>$$P.R8C>$$P.SPO
M9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W<F%P/3-$;F]W
M<F%P/B0\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W<F%P/3-$;F]W
M<F%P(&%L:6=N/3-$<FEG:'0^#0H@)B-X,C`Q-#LF(WA!,#LF(WA!,#L\+W1D
M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W<F%P/3-$;F]W<F%P/B8C>$$P
M.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL
M93TS1"=&3TY4+5-)6D4Z(#AP="<^)B-X03`[)B-X03`[/"]F;VYT/CPO=&0^
M#0H@/'1D('9A;&EG;CTS1&)O='1O;3XD/"]T9#X-"B`\=&0@=F%L:6=N/3-$
M8F]T=&]M(&%L:6=N/3-$<FEG:'0^,BPR.#8L-#@Y/"]T9#X-"B`\=&0@=F%L
M:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XF(WA!,#LF(WA!,#L\+W1D
M/@T*(#PO='(^#0H@/'1R('-T>6QE/3-$)T9/3E0M4TE:13H@,7!X)SX-"B`\
M=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O
M;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@
M/'`@<W1Y;&4],T0G0D]21$52+51/4#H@(S`P,#`P,"`S<'@@9&]U8FQE)SXF
M(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP
M('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,W!X(&1O=6)L92<^)B-X
M03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG
M;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B
M;W1T;VT^#0H@/'`@<W1Y;&4],T0G0D]21$52+51/4#H@(S`P,#`P,"`S<'@@
M9&]U8FQE)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T
M=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,W!X(&1O
M=6)L92<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@
M/"]T<CX-"B`\+W1A8FQE/@T*(#PO9&EV/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^
M#0H-"BTM+2TM+3U?3F5X=%!A<G1?-3<Q9C,R-C%?,3`Q95\T-C`Y7V$X8V5?
M8C9F93=A,&(T930Y#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+S4W
M,68S,C8Q7S$P,65?-#8P.5]A.&-E7V(V9F4W83!B-&4T.2]7;W)K<VAE971S
M+U-H965T,3,N:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O
M=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S
M970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@
M:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M
M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R
M:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE
M;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C
M;&%S<STS1')E<&]R="!I9#TS1$E$,$5-13X-"B`@("`@(#QT<CX-"B`@("`@
M("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T
M<F]N9SY#;VUM;VX@<W1O8VL\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@("`@
M/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^,R!-;VYT:',@16YD960\+W1H
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S
M/3-$=&@^36%R+B`S,2P@,C`Q-#QB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^/'-T<F]N9SY497AT($)L;V-K(%M!8G-T<F%C=%T\+W-T
M<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D-O;6UO
M;B!S=&]C:SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQD:78^
M#0H@/'`@<W1Y;&4],T0G34%21TE.+4)/5%1/33H@,'!T.R!&3TY4+5-)6D4Z
M(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86X[($U!4D=)3BU4
M3U`Z(#!P="<^#0H@/&(^-BX@0V]M;6]N('-T;V-K/"]B/CPO<#X-"B`\<"!S
M='EL93TS1"=-05)'24XM0D]45$]-.B`P<'0[($9/3E0M4TE:13H@,3!P=#L@
M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@34%21TE.+51/4#H@-G!T
M)SX-"B`\8CX\:3XH82D@4W1O8VL@;W!T:6]N('!L86X\+VD^/"]B/CPO<#X-
M"B`\<"!S='EL93TS1"=-05)'24XM0D]45$]-.B`P<'0[($9/3E0M4TE:13H@
M,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@34%21TE.+51/
M4#H@-G!T)SX-"B!/;B!*86YU87)Y)B-X03`[,C<L(#(P,30L('1H92!S=&]C
M:VAO;&1E<G,@;V8@07%U:6YO>"!54T$@87!P<F]V960-"B!A(#(P,30@17%U
M:71Y($EN8V5N=&EV92!0;&%N("@F(W@R,#%#.S(P,30@4&QA;B8C>#(P,40[
M*2X@5&AE(#(P,30-"B!0;&%N(&)E8V%M92!E9F9E8W1I=F4@;VX@=&AE(&1A
M=&4@;V8@=&AE('!R;W-P96-T=7,@9F]R('1H92!)4$\L#0H@36%R8V@F(WA!
M,#LV+"`R,#$T+B!4:&4@,C`Q-"!0;&%N(&ES('1H92!S=6-C97-S;W(@=&\@
M86YD#0H@8V]N=&EN=6%T:6]N(&]F('1H92`R,#`V(%!L86XN($%F=&5R('1H
M92`R,#$T(%!L86X@8F5C86UE#0H@969F96-T:79E+"!N;R!F=7)T:&5R(&=R
M86YT<R!W:6QL(&)E(&UA9&4@=6YD97(@=&AE(#(P,#8@4&QA;BX@5&AE#0H@
M,C`Q-"!0;&%N('!R;W9I9&5S(&9O<B!T:&4@9W)A;G0@;V8@<W1O8VL@;W!T
M:6]N<RP@<W1O8VL-"B!A<'!R96-I871I;VX@<FEG:'1S+"!R97-T<FEC=&5D
M('-T;V-K(&%W87)D<RP@<F5S=')I8W1E9"!S=&]C:R!U;FET#0H@87=A<F1S
M+"!P97)F;W)M86YC92!S=&]C:R!A=V%R9',L('!E<F9O<FUA;F-E(&-A<V@@
M87=A<F1S+"!A;F0-"B!O=&AE<B!F;W)M<R!O9B!E<75I='D@87=A<F1S('1O
M(&5M<&QO>65E<RP@9&ER96-T;W)S+"!A;F0-"B!C;VYS=6QT86YT<RX\+W`^
M#0H@/'`@<W1Y;&4],T0G34%21TE.+4)/5%1/33H@,'!T.R!&3TY4+5-)6D4Z
M(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86X[($U!4D=)3BU4
M3U`Z(#$R<'0G/@T*(%1H92!M87AI;75M(&YU;6)E<B!O9B!S:&%R97,@;V8@
M8V]M;6]N('-T;V-K('1H870@;6%Y(&)E(&ES<W5E9"!T:&4-"B!U;F1E<B!T
M:&4@,C`Q-"!0;&%N(&ES(#$L-#(S+#0Q-BP@=VAI8V@@;G5M8F5R(&EN8VQU
M9&5S(&$@;G5M8F5R(&]F#0H@<VAA<F5S(&]F(&-O;6UO;B!S=&]C:R!E<75A
M;"!T;R`H:2DF(WA!,#LW-38L,C<Y(&YE=R!S:&%R97,L('!L=7,-"B`H:6DI
M)B-X03`[=&AE(&YU;6)E<B!O9B!S:&%R97,@<F5S97)V960@9F]R(&ES<W5A
M;F-E('5N9&5R('1H92`R,#`V#0H@4&QA;B!A="!T:&4@=&EM92!T:&4@,C`Q
M-"!0;&%N(&)E8V]M97,@969F96-T:79E+"!P;'5S#0H@*&EI:2DF(WA!,#MA
M;GD@<VAA<F5S('-U8FIE8W0@=&\@<W1O8VL@;W!T:6]N<R!O<B!O=&AE<B!S
M=&]C:PT*(&%W87)D<R!G<F%N=&5D('5N9&5R('1H92`R,#`V(%!L86X@=&AA
M="!W;W5L9"!H879E(&]T:&5R=VES90T*(')E='5R;F5D('1O('1H92`R,#`V
M(%!L86XL('-U8V@@87,@=7!O;B!T:&4@97AP:7)A=&EO;B!O<@T*('1E<FUI
M;F%T:6]N(&]F(&$@<W1O8VL@87=A<F0@<')I;W(@=&\@=F5S=&EN9RX@061D
M:71I;VYA;&QY+"!T:&4-"B!N=6UB97(@;V8@<VAA<F5S(&]F(&-O;6UO;B!S
M=&]C:R!R97-E<G9E9"!F;W(@:7-S=6%N8V4@=6YD97(@=&AE#0H@,C`Q-"!0
M;&%N('=I;&P@875T;VUA=&EC86QL>2!I;F-R96%S92!O;B!*86YU87)Y)B-X
M03`[,2!O9B!E86-H#0H@>65A<B!F;W(@82!P97)I;V0@;V8@=7`@=&\@,3`@
M>65A<G,L(&)E9VEN;FEN9R!O;B!*86YU87)Y)B-X03`[,2P-"B`R,#$U(&%N
M9"!E;F1I;F<@;VX@86YD(&EN8VQU9&EN9R!*86YU87)Y)B-X03`[,2P@,C`R
M-"P@8GD@-"4@;V8@=&AE#0H@=&]T86P@;G5M8F5R(&]F('-H87)E<R!O9B!C
M87!I=&%L(&]U='-T86YD:6YG(&]N($1E8V5M8F5R)B-X03`[,S$-"B!O9B!T
M:&4@<')E8V5D:6YG(&-A;&5N9&%R('EE87(L(&]R(&$@;&5S<V5R(&YU;6)E
M<B!O9B!S:&%R97,-"B!D971E<FUI;F5D(&)Y('1H92!B;V%R9"!O9B!D:7)E
M8W1O<G,N/"]P/@T*(#QP('-T>6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P=#L@
M1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N
M.R!-05)'24XM5$]0.B`Q.'!T)SX-"B`\8CX\:3XH8BD@4W1O8VLM8F%S960@
M8V]M<&5N<V%T:6]N/"]I/CPO8CX\+W`^#0H@/'`@<W1Y;&4],T0G34%21TE.
M+4)/5%1/33H@,'!T.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4
M:6UE<R!.97<@4F]M86X[($U!4D=)3BU43U`Z(#9P="<^#0H@3VX@36%R8V@F
M(WA!,#LV+"`R,#$T+"!F;W5R(&]F('1H92!N;VXM96UP;&]Y964@9&ER96-T
M;W)S('=E<F4-"B!G<F%N=&5D(&]P=&EO;G,@=&\@<'5R8VAA<V4@82!T;W1A
M;"!O9B`S,RPS,S(@<VAA<F5S(&]F(&-O;6UO;@T*('-T;V-K.R!T:&4@97AE
M<F-I<V4@<')I8V4@<&5R('-H87)E(&9O<B!T:&5S92!G<F%N=',@=V%S("0Q
M,2XP,"P-"B!W:&EC:"!W87,@=&AE(&]F9F5R:6YG('!R:6-E(&]F('1H92!C
M;VUM;VX@<W1O8VL@:6X@=&AE($E03RX\+W`^#0H@/'`@<W1Y;&4],T0G34%2
M1TE.+4)/5%1/33H@,'!T.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9
M.B!4:6UE<R!.97<@4F]M86X[($U!4D=)3BU43U`Z(#$R<'0G/@T*(%1H92!F
M86ER('9A;'5E(&]F('-T;V-K(&]P=&EO;G,@9W)A;G1E9"!I<R!E<W1I;6%T
M960@=7-I;F<@=&AE#0H@0FQA8VLM4V-H;VQE<R!O<'1I;VX@<')I8VEN9R!M
M;V1E;"!W:71H('1H92!F;VQL;W=I;F<@=V5I9VAT960-"B!A=F5R86=E(&%S
M<W5M<'1I;VYS.CPO<#X-"B`\<"!S='EL93TS1"=-05)'24XM0D]45$]-.B`P
M<'0[($9/3E0M4TE:13H@,3)P=#L@34%21TE.+51/4#H@,'!T)SX-"B`F(WA!
M,#L\+W`^#0H@/'1A8FQE('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].
M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D]21$52+4-/3$Q!4%-%.B!C
M;VQL87!S92<@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!W:61T
M:#TS1#@T)2!A;&EG;CTS1&-E;G1E<B!B;W)D97(],T0P/@T*(#QT<CX-"B`\
M=&0@=VED=&@],T0U,24^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,30E/CPO=&0^#0H@/'1D/CPO=&0^#0H@/'1D/CPO=&0^#0H@/'1D
M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$T)3X\+W1D
M/@T*(#QT9#X\+W1D/@T*(#QT9#X\+W1D/@T*(#QT9#X\+W1D/@T*(#QT9"!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q-"4^/"]T9#X-"B`\=&0^/"]T9#X-
M"B`\=&0^/"]T9#X-"B`\=&0^/"]T9#X-"B`\+W1R/@T*(#QT<B!S='EL93TS
M1"=&3TY4+5-)6D4Z(#AP=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA
M;B<^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V
M86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@<W1Y;&4]
M,T0G0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'0@<V]L:60G('9A;&EG;CTS
M1&)O='1O;2!C;VQS<&%N/3-$,B!A;&EG;CTS1&-E;G1E<CX\8CY42%)%128C
M>$$P.TU/3E1(4SQB<B`O/@T*($5.1$5$/&)R("\^#0H@34%20T@@,S$L(#(P
M,30\+V(^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^
M#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!S='EL
M93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI9"<@=F%L:6=N
M/3-$8F]T=&]M(&-O;'-P86X],T0R(&%L:6=N/3-$8V5N=&5R/CQB/E1(4D5%
M)B-X03`[34].5$A3/&)R("\^#0H@14Y$140\8G(@+SX-"B!-05)#2"`S,2P@
M,C`Q,SPO8CX\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T
M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@
M/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!T('-O;&ED
M)R!V86QI9VX],T1B;W1T;VT@8V]L<W!A;CTS1#(@86QI9VX],T1C96YT97(^
M/&(^1$5#14U"15(@,C8L/&)R("\^#0H@,C`P,SQB<B`O/@T*("A)3D-%4%1)
M3TXI)B-X03`[5$\\8G(@+SX-"B!-05)#2"`S,2P@,C`Q-#PO8CX\+W1D/@T*
M(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\+W1R/@T*(#QT
M<B!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE
M<R!.97<@4F]M86XG(&)G8V]L;W(],T0C0T-%149&/@T*(#QT9"!V86QI9VX]
M,T1T;W`^#0H@/'`@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!
M34E,63H@5&EM97,@3F5W(%)O;6%N.R!-05)'24XM3$5&5#H@,65M.R!415A4
M+4E.1$5.5#H@+3%E;2<^#0H@17AP96-T960@=F]L871I;&ET>3PO<#X-"B`\
M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-
M"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG
M;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/C$P.#PO=&0^#0H@/'1D('9A;&EG
M;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^)28C>$$P.SPO=&0^#0H@/'1D
M('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B
M;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N
M/3-$<FEG:'0^3D$\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W<F%P
M/3-$;F]W<F%P/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O
M='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^
M)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$<FEG
M:'0^.#@\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W<F%P/3-$;F]W
M<F%P/B4F(WA!,#L\+W1D/@T*(#PO='(^#0H@/'1R('-T>6QE/3-$)T9/3E0M
M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;B<^#0H@
M/'1D('9A;&EG;CTS1'1O<#X-"B`\<"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P
M<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86X[($U!4D=)3BU,1494
M.B`Q96T[(%1%6%0M24Y$14Y4.B`M,65M)SX-"B!%>'!E8W1E9"!D:79I9&5N
M9',\+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C
M>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*
M(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XP/"]T9#X-"B`\
M=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XE)B-X03`[/"]T
M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A
M;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T
M;VT@86QI9VX],T1R:6=H=#Y.03PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O
M;2!N;W=R87`],T1N;W=R87`^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L
M:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS
M1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI
M9VX],T1R:6=H=#XP/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A
M<#TS1&YO=W)A<#XE)B-X03`[/"]T9#X-"B`\+W1R/@T*(#QT<B!S='EL93TS
M1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M
M86XG(&)G8V]L;W(],T0C0T-%149&/@T*(#QT9"!V86QI9VX],T1T;W`^#0H@
M/'`@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM
M97,@3F5W(%)O;6%N.R!-05)'24XM3$5&5#H@,65M.R!415A4+4E.1$5.5#H@
M+3%E;2<^#0H@17AP96-T960@=&5R;7,@*'EE87)S*3PO<#X-"B`\+W1D/@T*
M(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@
M=F%L:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O
M='1O;2!A;&EG;CTS1')I9VAT/C8N,#`\+W1D/@T*(#QT9"!V86QI9VX],T1B
M;W1T;VT@;F]W<F%P/3-$;F]W<F%P/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D
M('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B
M;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N
M/3-$<FEG:'0^3D$\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W<F%P
M/3-$;F]W<F%P/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O
M='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^
M)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$<FEG
M:'0^-BXR-#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N
M;W=R87`^)B-X03`[)B-X03`[/"]T9#X-"B`\+W1R/@T*(#QT<B!S='EL93TS
M1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M
M86XG/@T*(#QT9"!V86QI9VX],T1T;W`^#0H@/'`@<W1Y;&4],T0G1D].5"U3
M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!-05)'
M24XM3$5&5#H@,65M.R!415A4+4E.1$5.5#H@+3%E;2<^#0H@4FES:R!F<F5E
M(')A=&4\+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P
M.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D
M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XQ+C4R/"]T
M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XE)B-X
M03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@
M/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX]
M,T1B;W1T;VT@86QI9VX],T1R:6=H=#Y.03PO=&0^#0H@/'1D('9A;&EG;CTS
M1&)O='1O;2!N;W=R87`],T1N;W=R87`^)B-X03`[)B-X03`[/"]T9#X-"B`\
M=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A
M;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T
M;VT@86QI9VX],T1R:6=H=#XR+CDV/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T
M=&]M(&YO=W)A<#TS1&YO=W)A<#XE)B-X03`[/"]T9#X-"B`\+W1R/@T*(#QT
M<B!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE
M<R!.97<@4F]M86XG(&)G8V]L;W(],T0C0T-%149&/@T*(#QT9"!V86QI9VX]
M,T1T;W`^#0H@/'`@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!
M34E,63H@5&EM97,@3F5W(%)O;6%N.R!-05)'24XM3$5&5#H@,65M.R!415A4
M+4E.1$5.5#H@+3%E;2<^#0H@5V5I9VAT960@879E<F%G92!G<F%N="UD871E
M(&9A:7(@=F%L=64@;V8@<W1O8VL@;W!T:6]N<SPO<#X-"B`\+W1D/@T*(#QT
M9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L
M:6=N/3-$8F]T=&]M/B0\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI
M9VX],T1R:6=H=#XY+C`U/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO
M=W)A<#TS1&YO=W)A<#XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX]
M,T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C
M>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT
M/DY!/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A
M<#XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X
M03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B0\+W1D/@T*
M(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XT+C(S/"]T9#X-
M"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XF(WA!,#LF
M(WA!,#L\+W1D/@T*(#PO='(^#0H@/"]T86)L93X-"B`\<"!S='EL93TS1"=-
M05)'24XM0D]45$]-.B`P<'0[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)
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M;V0N(%1H92!W96EG:'1E9`T*(&%V97)A9V4@9W)A;G0@9&%T92!F86ER('9A
M;'5E(&]F('-T;V-K(&]P=&EO;G,@9W)A;G1E9"!F;W(@=&AE#0H@=&AR964@
M;6]N=&AS(&5N9&5D($UA<F-H)B-X03`[,S$L(#(P,30@86YD(#(P,3,@=V5R
M92`D.2XP-2!A;F0@)#`L#0H@<F5S<&5C=&EV96QY+B!4:&5R92!W97)E(&YO
M('-T;V-K(&]P=&EO;G,@9W)A;G1E9"!D=7)I;F<@=&AE('1H<F5E#0H@;6]N
M=&AS(&5N9&5D($UA<F-H)B-X03`[,S$L(#(P,3,N/"]P/@T*(#QP('-T>6QE
M/3-$)TU!4D=)3BU"3U143TTZ(#!P=#L@1D].5"U325I%.B`Q,'!T.R!&3TY4
M+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!-05)'24XM5$]0.B`Q,G!T)SX-
M"B!3=&]C:RUB87-E9"!C;VUP96YS871I;VX@97AP96YS92!C:&%R9V5D('1O
M(&EN8V]M92!F;W(@=&AE('!L86YS#0H@=V%S("0Q,S<L-C4T(&%N9"`D-30L
M-C<T(&9O<B!T:&4@=&AR964@;6]N=&AS(&5N9&5D($UA<F-H)B-X03`[,S$L
M#0H@,C`Q-"!A;F0@,C`Q,RP@<F5S<&5C=&EV96QY+B!4;W1A;"!U;G)E8V]G
M;FEZ960@8V]M<&5N<V%T:6]N(&-O<W0-"B!F;W(@86QL('-T;V-K+6)A<V5D
M(&-O;7!E;G-A=&EO;B!P;&%N<R!W87,@)#$L-#@U+#DW,2!A<R!O9@T*($UA
M<F-H)B-X03`[,S$L(#(P,30L('=H:6-H(&ES(&5X<&5C=&5D('1O(&)E(')E
M8V]G;FEZ960@;W9E<B!A#0H@=V5I9VAT960M879E<F%G92!P97)I;V0@;V8@
M,2XT-R!Y96%R<RX\+W`^#0H@/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-
M"@T*+2TM+2TM/5].97AT4&%R=%\U-S%F,S(V,5\Q,#%E7S0V,#E?83AC95]B
M-F9E-V$P8C1E-#D-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-3<Q
M9C,R-C%?,3`Q95\T-C`Y7V$X8V5?8C9F93=A,&(T930Y+U=O<FMS:&5E=',O
M4VAE970Q-"YH=&UL#0I#;VYT96YT+51R86YS9F5R+45N8V]D:6YG.B!Q=6]T
M960M<')I;G1A8FQE#0I#;VYT96YT+51Y<&4Z('1E>'0O:'1M;#L@8VAA<G-E
M=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\345402!H
M='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL
M.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I
M<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N
M="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L
M87-S/3-$<F5P;W)T(&ED/3-$240P14U%/@T*("`@("`@/'1R/@T*("`@("`@
M("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$,CX\<W1R
M;VYG/DYE="!L;W-S('!E<B!S:&%R93QB<CX\+W-T<F]N9SX\+W1H/@T*("`@
M("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XS($UO;G1H<R!%;F1E
M9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@
M8VQA<W,],T1T:#Y-87(N(#,Q+"`R,#$T/&)R/CPO=&@^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/D5A<FYI;F=S(%!E<B!3:&%R92!;
M06)S=')A8W1=/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#Y.970@;&]S<R!P97(@<VAA<F4\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\9&EV/@T*(#QP('-T>6QE/3-$)TU!4D=)3BU"3U14
M3TTZ(#!P=#L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@
M3F5W(%)O;6%N.R!-05)'24XM5$]0.B`Q.'!T)SX-"B`\8CXW+B!.970@;&]S
M<R!P97(@<VAA<F4\+V(^/"]P/@T*(#QP('-T>6QE/3-$)TU!4D=)3BU"3U14
M3TTZ(#!P=#L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@
M3F5W(%)O;6%N.R!-05)'24XM5$]0.B`V<'0G/@T*($EN(&-O;FYE8W1I;VX@
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M1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N
M.R!-05)'24XM5$]0.B`Q,G!T)SX-"B!"87-I8R!A;F0@9&EL=71E9"!N970@
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M3TTZ(#!P>#L@1D].5"U325I%.B`Q<'@[($U!4D=)3BU43U`Z(#$R<'@G/@T*
M("8C>$$P.SPO<#X-"B`\<"!S='EL93TS1"=-05)'24XM0D]45$]-.B`P<'0[
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M<G)E9`T*('-T;V-K+"!A8V-R971I;VX@;V8@<VAA<F4@:7-S=6%N8V4@8V]S
M=',@;VX@<')E9F5R<F5D('-T;V-K+"!A;F0-"B!T87@@97AP96YS92!O;B!P
M<F5F97)R960@<W1O8VLN($%S(&AO;&1E<G,@;V8@<')E9F5R<F5D('-T;V-K
M+`T*(&AO;&1E<G,@;V8@<W1O8VL@;W!T:6]N<R!A;F0@:&]L9&5R<R!O9B!C
M;VUM;VX@<W1O8VL@=V%R<F%N=',@9&\-"B!N;W0@:&%V92!C;VYT<F%C='5A
M;"!O8FQI9V%T:6]N<R!T;R!S:&%R92!I;B!T:&4@;&]S<V5S(&]F('1H90T*
M($-O;7!A;GDL('1H92!N970@;&]S<R!A='1R:6)U=&%B;&4@=&\@8V]M;6]N
M('-T;V-K:&]L9&5R<R!F;W(@96%C:`T*('!E<FEO9"!I<R!N;W0@86QL;V-A
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M9F9E8W0@=V]U;&0@:&%V92!B965N#0H@86YT:2UD:6QU=&EV92X\+W`^#0H@
M/'`@<W1Y;&4],T0G34%21TE.+4)/5%1/33H@,'!T.R!&3TY4+5-)6D4Z(#$P
M<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86X[($U!4D=)3BU43U`Z
M(#$R<'0G/@T*(%1H92!D971A:6P@;V8@=&AE(&-O;7!U=&%T:6]N(&]F(&)A
M<VEC(&%N9"!D:6QU=&5D(&5A<FYI;F=S('!E<@T*('-H87)E(&ES(&%S(&9O
M;&QO=W,Z/"]P/@T*(#QP('-T>6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P=#L@
M1D].5"U325I%.B`Q,G!T.R!-05)'24XM5$]0.B`P<'0G/@T*("8C>$$P.SPO
M<#X-"B`\=&%B;&4@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!
M34E,63H@5&EM97,@3F5W(%)O;6%N.R!"3U)$15(M0T],3$%04T4Z(&-O;&QA
M<'-E)R!C96QL<W!A8VEN9STS1#`@8V5L;'!A9&1I;F<],T0P('=I9'1H/3-$
M.#0E(&%L:6=N/3-$8V5N=&5R(&)O<F1E<CTS1#`^#0H@/'1R/@T*(#QT9"!W
M:61T:#TS1#4Q)3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0W)3X\+W1D/@T*(#QT9#X\+W1D/@T*(#QT9#X\+W1D/@T*(#QT9#X\+W1D
M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)3X\+W1D/@T*(#QT
M9#X\+W1D/@T*(#QT9#X\+W1D/@T*(#QT9#X\+W1D/@T*(#QT9"!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0W)3X\+W1D/@T*(#QT9#X\+W1D/@T*(#QT9#X\
M+W1D/@T*(#QT9#X\+W1D/@T*(#PO='(^#0H@/'1R('-T>6QE/3-$)T9/3E0M
M4TE:13H@.'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)SX-"B`\
M=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS
M1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!S='EL93TS1"="3U)$
M15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M
M(&-O;'-P86X],T0R(&%L:6=N/3-$8V5N=&5R/CQB/E1(4D5%)B-X03`[34].
M5$A3/&)R("\^#0H@14Y$140\8G(@+SX-"B!-05)#2"`S,2P@,C`Q-#PO8CX\
M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@
M=F%L:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D('-T>6QE/3-$)T)/
M4D1%4BU"3U143TTZ(",P,#`P,#`@,7!T('-O;&ED)R!V86QI9VX],T1B;W1T
M;VT@8V]L<W!A;CTS1#(@86QI9VX],T1C96YT97(^/&(^5$A2144F(WA!,#M-
M3TY42%,\8G(@+SX-"B!%3D1%1#QB<B`O/@T*($U!4D-((#,Q+"`R,#$S/"]B
M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT
M9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@<W1Y;&4],T0G
M0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'0@<V]L:60G('9A;&EG;CTS1&)O
M='1O;2!C;VQS<&%N/3-$,B!A;&EG;CTS1&-E;G1E<CX\8CY$14-%34)%4B8C
M>$$P.S(V+#QB<B`O/@T*(#(P,#,\8G(@+SX-"B`H24Y#15!424].*28C>$$P
M.U1//&)R("\^#0H@34%20T@@,S$L(#(P,30\+V(^/"]T9#X-"B`\=&0@=F%L
M:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@/"]T<CX-"B`\='(@<W1Y;&4]
M,T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O
M;6%N)R!B9V-O;&]R/3-$(T-#145&1CX-"B`\=&0@=F%L:6=N/3-$=&]P/@T*
M(#QP('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I
M;65S($YE=R!2;VUA;CL@34%21TE.+4Q%1E0Z(#%E;3L@5$585"U)3D1%3E0Z
M("TQ96TG/@T*(#QB/CQI/DYU;65R871O<CPO:3X\+V(^/"]P/@T*(#PO=&0^
M#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT
M9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M
M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI
M9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M
M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI
M9VX],T1B;W1T;VT^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P
M.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI
M9VX],T1B;W1T;VT^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^
M#0H@/"]T<CX-"B`\='(@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4
M+49!34E,63H@5&EM97,@3F5W(%)O;6%N)SX-"B`\=&0@=F%L:6=N/3-$=&]P
M/@T*(#QP('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ
M(%1I;65S($YE=R!2;VUA;CL@34%21TE.+4Q%1E0Z(#%E;3L@5$585"U)3D1%
M3E0Z("TQ96TG/@T*($YE="!L;W-S(&%N9"!C;VUP<F5H96YS:79E(&QO<W,@
M:6YC=7)R960@:6X@=&AE(&1E=F5L;W!M96YT#0H@<W1A9V4\+W`^#0H@/"]T
M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@
M/'1D('9A;&EG;CTS1&)O='1O;3XD/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T
M=&]M(&%L:6=N/3-$<FEG:'0^*#0L,C(W+#8W.#PO=&0^#0H@/'1D('9A;&EG
M;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^*28C>$$P.SPO=&0^#0H@/'1D
M('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B
M;W1T;VT^)#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I
M9VAT/B@Q+#`Q,"PR-C<\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W
M<F%P/3-$;F]W<F%P/BDF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T
M;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B0\+W1D/@T*
M(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XH-3$L-3`R+#4X
M-SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^
M*28C>$$P.SPO=&0^#0H@/"]T<CX-"B`\='(@<W1Y;&4],T0G1D].5"U325I%
M.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!B9V-O;&]R
M/3-$(T-#145&1CX-"B`\=&0@=F%L:6=N/3-$=&]P/@T*(#QP('-T>6QE/3-$
M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA
M;CL@34%21TE.+4Q%1E0Z(#%E;3L@5$585"U)3D1%3E0Z("TQ96TG/@T*($%C
M8W)E=&EO;B!F;W(@;&EQ=6ED871I;VX@<')E9F5R96YC92!O;B!P<F5F97)R
M960@<W1O8VL\+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C
M>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\
M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XH,2PQ
M,S(L.#DS/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO
M=W)A<#XI)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P
M.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT
M9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XH,2PQ-3<L.#8U/"]T
M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XI)B-X
M03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@
M/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX]
M,T1B;W1T;VT@86QI9VX],T1R:6=H=#XH,3@L-38V+#`P.#PO=&0^#0H@/'1D
M('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^*28C>$$P.SPO=&0^
M#0H@/"]T<CX-"B`\='(@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4
M+49!34E,63H@5&EM97,@3F5W(%)O;6%N)SX-"B`\=&0@=F%L:6=N/3-$=&]P
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M;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N
M/3-$<FEG:'0^*#$Y+#4U,#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N
M;W=R87`],T1N;W=R87`^*28C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O
M='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[
M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^*#0T
M+#,P-SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R
M87`^*28C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\
M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@
M=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^*#$L,#$T+#8V-SPO=&0^
M#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^*28C>$$P
M.SPO=&0^#0H@/"]T<CX-"B`\='(@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T
M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!B9V-O;&]R/3-$(T-#
M145&1CX-"B`\=&0@=F%L:6=N/3-$=&]P/@T*(#QP('-T>6QE/3-$)T9/3E0M
M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@34%2
M1TE.+4Q%1E0Z(#%E;3L@5$585"U)3D1%3E0Z("TQ96TG/@T*(%1A>"!E>'!E
M;G-E(&]N('!R969E<G)E9"!S=&]C:SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI
M9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$
M8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG
M;CTS1')I9VAT/B@Q,#`L,CDQ/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M
M(&YO=W)A<#TS1&YO=W)A<#XI)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$
M8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!
M,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XH
M,S0V+#`Y,3PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N
M;W=R87`^*28C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!
M,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\
M=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^*#$L.#DW+#<P,CPO
M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^*28C
M>$$P.SPO=&0^#0H@/"]T<CX-"B`\='(@<W1Y;&4],T0G1D].5"U325I%.B`Q
M,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)SX-"B`\=&0@=F%L
M:6=N/3-$=&]P/@T*(#QP('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].
M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@34%21TE.+4Q%1E0Z(#%E;3L@
M5$585"U)3D1%3E0Z("TQ96TG/@T*(%)E=F5R<V%L(&]F('1A>"!P87EA8FQE
M(&]N('!R969E<G)E9"!S=&]C:R!D=64@=&\@8V]N=F5R<VEO;B!O9@T*('!R
M969E<G)E9"!S=&]C:SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T
M;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C
M>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT
M/C$L.#DW+#<P,CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`]
M,T1N;W=R87`^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T
M=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`]
M,T1N;W=R87`^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO
M=W)A<#TS1&YO=W)A<"!A;&EG;CTS1')I9VAT/@T*("8C>#(P,30[)B-X03`[
M)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO
M=W)A<#XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^
M)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^
M#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/C$L.#DW+#<P
M,CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^
M)B-X03`[)B-X03`[/"]T9#X-"B`\+W1R/@T*(#QT<B!S='EL93TS1"=&3TY4
M+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XG(&)G
M8V]L;W(],T0C0T-%149&/@T*(#QT9"!V86QI9VX],T1T;W`^#0H@/'`@<W1Y
M;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W
M(%)O;6%N.R!-05)'24XM3$5&5#H@,65M.R!415A4+4E.1$5.5#H@+3%E;2<^
M#0H@17AT:6YG=6ES:&UE;G0@;V8@<F5M86EN:6YG('-H87)E(&ES<W5A;F-E
M(&-O<W1S(&1U92!T;R!C;VYV97)S:6]N#0H@;V8@<')E9F5R<F5D('-T;V-K
M/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!
M,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\
M=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^*#0S.2PR,C<\+W1D
M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W<F%P/3-$;F]W<F%P/BDF(WA!
M,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\
M=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XF(WA!,#L\+W1D
M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W<F%P/3-$;F]W<F%P(&%L:6=N
M/3-$<FEG:'0^#0H@)B-X,C`Q-#LF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V
M86QI9VX],T1B;W1T;VT@;F]W<F%P/3-$;F]W<F%P/B8C>$$P.R8C>$$P.SPO
M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V
M86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T
M=&]M(&%L:6=N/3-$<FEG:'0^*#0S.2PR,C<\+W1D/@T*(#QT9"!V86QI9VX]
M,T1B;W1T;VT@;F]W<F%P/3-$;F]W<F%P/BDF(WA!,#L\+W1D/@T*(#PO='(^
M#0H@/'1R('-T>6QE/3-$)T9/3E0M4TE:13H@,7!X)SX-"B`\=&0@=F%L:6=N
M/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF
M(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@<W1Y;&4]
M,T0G0D]21$52+51/4#H@(S`P,#`P,"`Q<'@@<V]L:60G/B8C>$$P.SPO<#X-
M"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@<W1Y;&4],T0G
M0D]21$52+51/4#H@(S`P,#`P,"`Q<'@@<V]L:60G/B8C>$$P.SPO<#X-"B`\
M+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^
M)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE
M/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^
M#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$
M)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@
M/"]T9#X-"B`\=&0^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M
M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL
M93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P
M/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS
M1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*
M(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/"]T<CX-"B`\='(@<W1Y;&4]
M,T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O
M;6%N)SX-"B`\=&0@=F%L:6=N/3-$=&]P/@T*(#QP('-T>6QE/3-$)T9/3E0M
M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@34%2
M1TE.+4Q%1E0Z(#%E;3L@5$585"U)3D1%3E0Z("TQ96TG/@T*(%1O=&%L(&QO
M<W,@871T<FEB=71A8FQE('1O(&-O;6UO;B!S=&]C:VAO;&1E<G,\+W`^#0H@
M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)T9/
M3E0M4TE:13H@.'!T)SXF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@
M=F%L:6=N/3-$8F]T=&]M/B0\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@
M86QI9VX],T1R:6=H=#XH-"PP,C$L.3,W/"]T9#X-"B`\=&0@=F%L:6=N/3-$
M8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XI)B-X03`[/"]T9#X-"B`\=&0@=F%L
M:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@.'!T)SXF
M(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B0\+W1D
M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XH,BPU-3@L
M-3,P/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A
M<#XI)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T
M>6QE/3-$)T9/3E0M4TE:13H@.'!T)SXF(WA!,#L\+V9O;G0^/"]T9#X-"B`\
M=&0@=F%L:6=N/3-$8F]T=&]M/B0\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T
M;VT@86QI9VX],T1R:6=H=#XH-S$L-3(R+#0X.3PO=&0^#0H@/'1D('9A;&EG
M;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^*28C>$$P.SPO=&0^#0H@/"]T
M<CX-"B`\='(@<W1Y;&4],T0G1D].5"U325I%.B`Q<'@G/@T*(#QT9"!V86QI
M9VX],T1B;W1T;VT^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P
M.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL
M93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#-P>"!D;W5B;&4G/B8C>$$P.SPO
M<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@<W1Y;&4]
M,T0G0D]21$52+51/4#H@(S`P,#`P,"`S<'@@9&]U8FQE)SXF(WA!,#L\+W`^
M#0H@/"]T9#X-"B`\=&0^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T
M=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S
M='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#-P>"!D;W5B;&4G/B8C>$$P
M.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@<W1Y
M;&4],T0G0D]21$52+51/4#H@(S`P,#`P,"`S<'@@9&]U8FQE)SXF(WA!,#L\
M+W`^#0H@/"]T9#X-"B`\=&0^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$
M8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\
M<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#-P>"!D;W5B;&4G/B8C
M>$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@
M<W1Y;&4],T0G0D]21$52+51/4#H@(S`P,#`P,"`S<'@@9&]U8FQE)SXF(WA!
M,#L\+W`^#0H@/"]T9#X-"B`\=&0^)B-X03`[/"]T9#X-"B`\+W1R/@T*(#QT
M<B!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE
M<R!.97<@4F]M86XG(&)G8V]L;W(],T0C0T-%149&/@T*(#QT9"!V86QI9VX]
M,T1T;W`^#0H@/'`@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!
M34E,63H@5&EM97,@3F5W(%)O;6%N.R!-05)'24XM3$5&5#H@,65M.R!415A4
M+4E.1$5.5#H@+3%E;2<^#0H@/&(^/&D^1&5N;VUI;F%T;W(\+VD^/"]B/CPO
M<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4]
M,T0G1D].5"U325I%.B`X<'0G/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*
M(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T
M=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D/@T*(#QT9"!V
M86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`X<'0G
M/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T
M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS
M1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y
M;&4],T0G1D].5"U325I%.B`X<'0G/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT
M9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M
M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D/@T*(#PO='(^#0H@
M/'1R('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I
M;65S($YE=R!2;VUA;B<^#0H@/'1D('9A;&EG;CTS1'1O<#X-"B`\<"!S='EL
M93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@
M4F]M86X[($U!4D=)3BU,1494.B`Q96T[(%1%6%0M24Y$14Y4.B`M,65M)SX-
M"B!796EG:'1E9"!A=F5R86=E('-H87)E<R!U<V5D('1O(&-O;7!U=&4@8F%S
M:6,@;F5T(&QO<W,@<&5R(&-O;6UO;@T*('-H87)E/"]P/@T*(#PO=&0^#0H@
M/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z
M(#AP="<^)B-X03`[)B-X03`[/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS
M1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI
M9VX],T1R:6=H=#XS+#$T."PT.#$\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T
M;VT@;F]W<F%P/3-$;F]W<F%P/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A
M;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#AP="<^
M)B-X03`[/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!
M,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XS
M,#$L-S0U/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO
M=W)A<#XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^
M/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`X<'0G/B8C>$$P.SPO9F]N=#X\
M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@
M=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^,SDX+#4W,SPO=&0^#0H@
M/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^)B-X03`[)B-X
M03`[/"]T9#X-"B`\+W1R/@T*(#QT<B!S='EL93TS1"=&3TY4+5-)6D4Z(#$P
M<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XG(&)G8V]L;W(],T0C
M0T-%149&/@T*(#QT9"!V86QI9VX],T1T;W`^#0H@/'`@<W1Y;&4],T0G1D].
M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!-
M05)'24XM3$5&5#H@,65M.R!415A4+4E.1$5.5#H@+3%E;2<^#0H@169F96-T
M(&]F('!O=&5N=&EA;&QY(&1I;'5T:79E('-E8W5R:71I97,Z/"]P/@T*(#PO
M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=&3TY4
M+5-)6D4Z(#AP="<^)B-X03`[)B-X03`[/"]F;VYT/CPO=&0^#0H@/'1D('9A
M;&EG;CTS1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T
M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS
M1&)O='1O;3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#AP="<^)B-X03`[
M/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D/@T*(#QT
M9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M
M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=&
M3TY4+5-)6D4Z(#AP="<^)B-X03`[/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG
M;CTS1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-
M"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/"]T<CX-"B`\='(@<W1Y
M;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W
M(%)O;6%N)SX-"B`\=&0@=F%L:6=N/3-$=&]P/@T*(#QP('-T>6QE/3-$)T9/
M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@
M34%21TE.+4Q%1E0Z(#-E;3L@5$585"U)3D1%3E0Z("TQ96TG/@T*(%-T;V-K
M(&]P=&EO;G,\+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF
M;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@.'!T)SXF(WA!,#LF(WA!,#L\+V9O
M;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A
M<#XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W<F%P/3-$
M;F]W<F%P(&%L:6=N/3-$<FEG:'0^#0H@)B-X,C`Q-#LF(WA!,#LF(WA!,#L\
M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W<F%P/3-$;F]W<F%P/B8C
M>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S
M='EL93TS1"=&3TY4+5-)6D4Z(#AP="<^)B-X03`[/"]F;VYT/CPO=&0^#0H@
M/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^)B-X03`[/"]T
M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<"!A;&EG
M;CTS1')I9VAT/@T*("8C>#(P,30[)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@
M=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XF(WA!,#LF(WA!,#L\
M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G1D].
M5"U325I%.B`X<'0G/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX]
M,T1B;W1T;VT@;F]W<F%P/3-$;F]W<F%P/B8C>$$P.SPO=&0^#0H@/'1D('9A
M;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`@86QI9VX],T1R:6=H=#X-
M"B`F(W@R,#$T.R8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O
M='1O;2!N;W=R87`],T1N;W=R87`^)B-X03`[)B-X03`[/"]T9#X-"B`\+W1R
M/@T*(#QT<B!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9
M.B!4:6UE<R!.97<@4F]M86XG(&)G8V]L;W(],T0C0T-%149&/@T*(#QT9"!V
M86QI9VX],T1T;W`^#0H@/'`@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&
M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!-05)'24XM3$5&5#H@,V5M
M.R!415A4+4E.1$5.5#H@+3%E;2<^#0H@0V]M;6]N('-T;V-K('=A<G)A;G1S
M/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL
M93TS1"=&3TY4+5-)6D4Z(#AP="<^)B-X03`[)B-X03`[/"]F;VYT/CPO=&0^
M#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^)B-X03`[
M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<"!A
M;&EG;CTS1')I9VAT/@T*("8C>#(P,30[)B-X03`[)B-X03`[/"]T9#X-"B`\
M=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XF(WA!,#LF(WA!
M,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G
M1D].5"U325I%.B`X<'0G/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI
M9VX],T1B;W1T;VT@;F]W<F%P/3-$;F]W<F%P/B8C>$$P.SPO=&0^#0H@/'1D
M('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`@86QI9VX],T1R:6=H
M=#X-"B`F(W@R,#$T.R8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS
M1&)O='1O;2!N;W=R87`],T1N;W=R87`^)B-X03`[)B-X03`[/"]T9#X-"B`\
M=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@
M.'!T)SXF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M
M(&YO=W)A<#TS1&YO=W)A<#XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B
M;W1T;VT@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$<FEG:'0^#0H@)B-X,C`Q
M-#LF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W
M<F%P/3-$;F]W<F%P/B8C>$$P.R8C>$$P.SPO=&0^#0H@/"]T<CX-"B`\='(@
M<W1Y;&4],T0G1D].5"U325I%.B`Q<'@G/@T*(#QT9"!V86QI9VX],T1B;W1T
M;VT^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO
M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$
M15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^
M#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M
M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@
M/'1D/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\
M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@<W1Y;&4],T0G0D]2
M1$52+51/4#H@(S`P,#`P,"`Q<'@@<V]L:60G/B8C>$$P.SPO<#X-"B`\+W1D
M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@<W1Y;&4],T0G0D]21$52
M+51/4#H@(S`P,#`P,"`Q<'@@<V]L:60G/B8C>$$P.SPO<#X-"B`\+W1D/@T*
M(#QT9#XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[
M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/
M4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T
M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%
M4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X-
M"B`\=&0^)B-X03`[/"]T9#X-"B`\+W1R/@T*(#QT<B!S='EL93TS1"=&3TY4
M+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XG/@T*
M(#QT9"!V86QI9VX],T1T;W`^#0H@/'`@<W1Y;&4],T0G1D].5"U325I%.B`Q
M,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!-05)'24XM3$5&
M5#H@,65M.R!415A4+4E.1$5.5#H@+3%E;2<^#0H@5V5I9VAT960@879E<F%G
M92!S:&%R97,@=7-E9"!T;R!C;VUP=71E(&1I;'5T960@;F5T(&QO<W,@<&5R
M(&-O;6UO;@T*('-H87)E/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O
M='1O;3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#AP="<^)B-X03`[)B-X
M03`[/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\
M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XS+#$T
M."PT.#$\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W<F%P/3-$;F]W
M<F%P/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\
M9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#AP="<^)B-X03`[/"]F;VYT/CPO
M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V
M86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XS,#$L-S0U/"]T9#X-"B`\
M=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XF(WA!,#LF(WA!
M,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G
M1D].5"U325I%.B`X<'0G/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI
M9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M
M(&%L:6=N/3-$<FEG:'0^,SDX+#4W,SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O
M='1O;2!N;W=R87`],T1N;W=R87`^)B-X03`[)B-X03`[/"]T9#X-"B`\+W1R
M/@T*(#QT<B!S='EL93TS1"=&3TY4+5-)6D4Z(#%P>"<^#0H@/'1D('9A;&EG
M;CTS1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[
M)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE
M/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,W!X(&1O=6)L92<^)B-X03`[/"]P
M/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS
M1"="3U)$15(M5$]0.B`C,#`P,#`P(#-P>"!D;W5B;&4G/B8C>$$P.SPO<#X-
M"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T
M;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T
M>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,W!X(&1O=6)L92<^)B-X03`[
M/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL
M93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#-P>"!D;W5B;&4G/B8C>$$P.SPO
M<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B
M;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP
M('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,W!X(&1O=6)L92<^)B-X
M03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S
M='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#-P>"!D;W5B;&4G/B8C>$$P
M.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#PO='(^#0H@/'1R
M('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S
M($YE=R!2;VUA;B<@8F=C;VQO<CTS1"-#0T5%1D8^#0H@/'1D('9A;&EG;CTS
M1'1O<#X-"B`\<"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-
M24Q9.B!4:6UE<R!.97<@4F]M86X[($U!4D=)3BU,1494.B`Q96T[(%1%6%0M
M24Y$14Y4.B`M,65M)SX-"B!.970@;&]S<R!P97(@<VAA<F4@871T<FEB=71A
M8FQE('1O(&-O;6UO;@T*('-T;V-K:&]L9&5R<R8C>#(P,30[8F%S:6,\+W`^
M#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$
M)T9/3E0M4TE:13H@.'!T)SXF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\
M=&0@=F%L:6=N/3-$8F]T=&]M/B0\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T
M;VT@86QI9VX],T1R:6=H=#XH,2XR.#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O
M='1O;2!N;W=R87`],T1N;W=R87`^*28C>$$P.SPO=&0^#0H@/'1D('9A;&EG
M;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#AP="<^)B-X
M03`[/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XD/"]T9#X-
M"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^*#@N-#@\+W1D
M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W<F%P/3-$;F]W<F%P/BDF(WA!
M,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G
M1D].5"U325I%.B`X<'0G/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI
M9VX],T1B;W1T;VT^)#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG
M;CTS1')I9VAT/B@Q-SDN-#4\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@
M;F]W<F%P/3-$;F]W<F%P/BDF(WA!,#L\+W1D/@T*(#PO='(^#0H@/'1R('-T
M>6QE/3-$)T9/3E0M4TE:13H@,7!X)SX-"B`\=&0@=F%L:6=N/3-$8F]T=&]M
M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D
M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@<W1Y;&4],T0G0D]21$52
M+51/4#H@(S`P,#`P,"`S<'@@9&]U8FQE)SXF(WA!,#L\+W`^#0H@/"]T9#X-
M"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU4
M3U`Z(",P,#`P,#`@,W!X(&1O=6)L92<^)B-X03`[/"]P/@T*(#PO=&0^#0H@
M/'1D/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\
M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@<W1Y;&4],T0G0D]2
M1$52+51/4#H@(S`P,#`P,"`S<'@@9&]U8FQE)SXF(WA!,#L\+W`^#0H@/"]T
M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%
M4BU43U`Z(",P,#`P,#`@,W!X(&1O=6)L92<^)B-X03`[/"]P/@T*(#PO=&0^
M#0H@/'1D/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!
M,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@<W1Y;&4],T0G
M0D]21$52+51/4#H@(S`P,#`P,"`S<'@@9&]U8FQE)SXF(WA!,#L\+W`^#0H@
M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/
M4D1%4BU43U`Z(",P,#`P,#`@,W!X(&1O=6)L92<^)B-X03`[/"]P/@T*(#PO
M=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/"]T<CX-"B`\='(@<W1Y;&4],T0G
M1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N
M)SX-"B`\=&0@=F%L:6=N/3-$=&]P/@T*(#QP('-T>6QE/3-$)T9/3E0M4TE:
M13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@34%21TE.
M+4Q%1E0Z(#%E;3L@5$585"U)3D1%3E0Z("TQ96TG/@T*($YE="!L;W-S('!E
M<B!S:&%R92!A='1R:6)U=&%B;&4@=&\@8V]M;6]N#0H@<W1O8VMH;VQD97)S
M)B-X,C`Q-#MD:6QU=&5D/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O
M='1O;3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#AP="<^)B-X03`[)B-X
M03`[/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XD/"]T9#X-
M"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^*#$N,C@\+W1D
M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W<F%P/3-$;F]W<F%P/BDF(WA!
M,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G
M1D].5"U325I%.B`X<'0G/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI
M9VX],T1B;W1T;VT^)#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG
M;CTS1')I9VAT/B@X+C0X/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO
M=W)A<#TS1&YO=W)A<#XI)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T
M=&]M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@.'!T)SXF(WA!,#L\+V9O
M;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B0\+W1D/@T*(#QT9"!V
M86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XH,3<Y+C0U/"]T9#X-"B`\
M=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XI)B-X03`[/"]T
M9#X-"B`\+W1R/@T*(#QT<B!S='EL93TS1"=&3TY4+5-)6D4Z(#%P>"<^#0H@
M/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T
M;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*
M(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,W!X(&1O=6)L92<^
M)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\
M<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#-P>"!D;W5B;&4G/B8C
M>$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#QT9"!V86QI
M9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M
M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,W!X(&1O=6)L
M92<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-
M"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#-P>"!D;W5B;&4G
M/B8C>$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#QT9"!V
M86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T
M=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,W!X(&1O
M=6)L92<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O
M;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#-P>"!D;W5B
M;&4G/B8C>$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#PO
M='(^#0H@/"]T86)L93X-"B`\<"!S='EL93TS1"=-05)'24XM0D]45$]-.B`P
M<'0[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2
M;VUA;CL@34%21TE.+51/4#H@,3)P="<^#0H@5&AE(&9O;&QO=VEN9R!H879E
M(&)E96X@97AC;'5D960@9G)O;2!T:&4@8V]M<'5T871I;VX@;V8@8F%S:6,@
M86YD#0H@9&EL=71E9"!N970@;&]S<R!P97(@<VAA<F4@87,@=&AE:7(@969F
M96-T('=O=6QD(&AA=F4@8F5E;@T*(&%N=&ED:6QU=&EV93H\+W`^#0H@/'`@
M<W1Y;&4],T0G34%21TE.+4)/5%1/33H@,'!T.R!&3TY4+5-)6D4Z(#$R<'0[
M($U!4D=)3BU43U`Z(#!P="<^#0H@)B-X03`[/"]P/@T*(#QT86)L92!S='EL
M93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@
M4F]M86X[($)/4D1%4BU#3TQ,05!313H@8V]L;&%P<V4G(&-E;&QS<&%C:6YG
M/3-$,"!C96QL<&%D9&EN9STS1#`@=VED=&@],T0W-B4@86QI9VX],T1C96YT
M97(@8F]R9&5R/3-$,#X-"B`\='(^#0H@/'1D('=I9'1H/3-$-C0E/CPO=&0^
M#0H@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$P)3X\+W1D/@T*(#QT
M9#X\+W1D/@T*(#QT9#X\+W1D/@T*(#QT9#X\+W1D/@T*(#QT9"!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Q,"4^/"]T9#X-"B`\=&0^/"]T9#X-"B`\=&0^
M/"]T9#X-"B`\=&0^/"]T9#X-"B`\+W1R/@T*(#QT<B!S='EL93TS1"=&3TY4
M+5-)6D4Z(#AP=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;B<^#0H@
M/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX]
M,T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@<W1Y;&4],T0G0D]2
M1$52+4)/5%1/33H@(S`P,#`P,"`Q<'0@<V]L:60G('9A;&EG;CTS1&)O='1O
M;2!C;VQS<&%N/3-$,B!A;&EG;CTS1&-E;G1E<CX\8CY42%)%128C>$$P.TU/
M3E1(4SQB<B`O/@T*($5.1$5$/"]B/CQB<B`O/@T*(#QB/DU!4D-((#,Q+"`R
M,#$T/"]B/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D
M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\
M=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'0@<V]L:60G
M('9A;&EG;CTS1&)O='1O;2!C;VQS<&%N/3-$,B!A;&EG;CTS1&-E;G1E<CX\
M8CY42%)%128C>$$P.TU/3E1(4SQB<B`O/@T*($5.1$5$/"]B/CQB<B`O/@T*
M(#QB/DU!4D-((#,Q+"`R,#$S/"]B/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O
M='1O;3XF(WA!,#L\+W1D/@T*(#PO='(^#0H@/'1R('-T>6QE/3-$)T9/3E0M
M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;B<@8F=C
M;VQO<CTS1"-#0T5%1D8^#0H@/'1D('9A;&EG;CTS1'1O<#X-"B`\<"!S='EL
M93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@
M4F]M86X[($U!4D=)3BU,1494.B`Q96T[(%1%6%0M24Y$14Y4.B`M,65M)SX-
M"B!#;VYV97)T:6)L92!P<F5F97)R960@<W1O8VL\+W`^#0H@/"]T9#X-"B`\
M=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A
M;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^)B-X03`[/"]T9#X-"B`\
M=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1')I
M9VAT/@T*("8C>#(P,30[)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N
M/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XF(WA!,#LF(WA!,#L\+W1D/@T*
M(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@
M=F%L:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O
M='1O;2!A;&EG;CTS1')I9VAT/C4L-3(U+#@T-#PO=&0^#0H@/'1D('9A;&EG
M;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^)B-X03`[)B-X03`[/"]T9#X-
M"B`\+W1R/@T*(#QT<B!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M
M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XG/@T*(#QT9"!V86QI9VX],T1T;W`^
M#0H@/'`@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@
M5&EM97,@3F5W(%)O;6%N.R!-05)'24XM3$5&5#H@,65M.R!415A4+4E.1$5.
M5#H@+3%E;2<^#0H@3W5T<W1A;F1I;F<@<W1O8VL@;W!T:6]N<SPO<#X-"B`\
M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-
M"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG
M;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/C8S,"PQ-3D\+W1D/@T*(#QT9"!V
M86QI9VX],T1B;W1T;VT@;F]W<F%P/3-$;F]W<F%P/B8C>$$P.R8C>$$P.SPO
M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*
M(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N
M/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^-#,U+#$T,3PO=&0^#0H@/'1D('9A
M;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^)B-X03`[)B-X03`[/"]T
M9#X-"B`\+W1R/@T*(#QT<B!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/
M3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XG(&)G8V]L;W(],T0C0T-%149&
M/@T*(#QT9"!V86QI9VX],T1T;W`^#0H@/'`@<W1Y;&4],T0G1D].5"U325I%
M.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!-05)'24XM
M3$5&5#H@,65M.R!415A4+4E.1$5.5#H@+3%E;2<^#0H@0V]M;6]N('-T;V-K
M('=A<G)A;G1S/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF
M(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[
M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^,3$L
M,S8S/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A
M<#XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X
M03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS
M1&YO=W)A<#XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W
M<F%P/3-$;F]W<F%P(&%L:6=N/3-$<FEG:'0^#0H@)B-X,C`Q-#LF(WA!,#LF
M(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W<F%P/3-$;F]W
M<F%P/B8C>$$P.R8C>$$P.SPO=&0^#0H@/"]T<CX-"B`\='(@<W1Y;&4],T0G
M1D].5"U325I%.B`Q<'@G/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-
M"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D
M('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C
M,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A
M;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P
M,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P
M.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D
M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@<W1Y;&4],T0G0D]21$52
M+51/4#H@(S`P,#`P,"`Q<'@@<V]L:60G/B8C>$$P.SPO<#X-"B`\+W1D/@T*
M(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@<W1Y;&4],T0G0D]21$52+51/
M4#H@(S`P,#`P,"`Q<'@@<V]L:60G/B8C>$$P.SPO<#X-"B`\+W1D/@T*(#QT
M9#XF(WA!,#L\+W1D/@T*(#PO='(^#0H@/'1R('-T>6QE/3-$)T9/3E0M4TE:
M13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;B<^#0H@/'1D
M('9A;&EG;CTS1'1O<#X-"B`\<"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[
M($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86X[($U!4D=)3BU,1494.B`Q
M96T[(%1%6%0M24Y$14Y4.B`M,65M)SX-"B!4;W1A;#PO<#X-"B`\+W1D/@T*
M(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%
M.B`X<'0G/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX]
M,T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L
M:6=N/3-$<FEG:'0^-C0Q+#4R,CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O
M;2!N;W=R87`],T1N;W=R87`^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L
M:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@.'!T)SXF
M(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M
M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I
M9VAT/C4L.38P+#DX-3PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R
M87`],T1N;W=R87`^)B-X03`[)B-X03`[/"]T9#X-"B`\+W1R/@T*(#QT<B!S
M='EL93TS1"=&3TY4+5-)6D4Z(#%P>"<^#0H@/'1D('9A;&EG;CTS1&)O='1O
M;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T
M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%
M4BU43U`Z(",P,#`P,#`@,W!X(&1O=6)L92<^)B-X03`[/"]P/@T*(#PO=&0^
M#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M
M5$]0.B`C,#`P,#`P(#-P>"!D;W5B;&4G/B8C>$$P.SPO<#X-"B`\+W1D/@T*
M(#QT9#XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[
M)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE
M/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,W!X(&1O=6)L92<^)B-X03`[/"]P
M/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS
M1"="3U)$15(M5$]0.B`C,#`P,#`P(#-P>"!D;W5B;&4G/B8C>$$P.SPO<#X-
M"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#PO='(^#0H@/"]T86)L93X-
M"B`\+V1I=CX\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'10
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M/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT
M96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G
M/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS
M/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H
M96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60]
M,T1)1#!%344^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L
M(&-O;'-P86X],T0Q(')O=W-P86X],T0R/CQS=')O;F<^1FEN86YC:6%L(&EN
M<W1R=6UE;G1S/&)R/CPO<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S
M<STS1'1H(&-O;'-P86X],T0Q/C,@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DUA
M<BX@,S$L(#(P,30\8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/CQS=')O;F<^26YV97-T;65N=',@06QL($]T:&5R($EN=F5S=&UE;G1S
M(%M!8G-T<F%C=%T\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/D9I;F%N8VEA;"!I;G-T<G5M96YT<SPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQD:78^#0H@/'`@<W1Y;&4],T0G34%21TE.
M+4)/5%1/33H@,'!T.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4
M:6UE<R!.97<@4F]M86X[($U!4D=)3BU43U`Z(#$X<'0G/@T*(#QB/C@N($9I
M;F%N8VEA;"!I;G-T<G5M96YT<SPO8CX\+W`^#0H@/'`@<W1Y;&4],T0G34%2
M1TE.+4)/5%1/33H@,'!T.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9
M.B!4:6UE<R!.97<@4F]M86X[($U!4D=)3BU43U`Z(#9P="<^#0H@/&(^/&D^
M1F%I<B!V86QU92!O9B!F:6YA;F-I86P@:6YS=')U;65N=',\+VD^/"]B/CPO
M<#X-"B`\<"!S='EL93TS1"=-05)'24XM0D]45$]-.B`P<'0[($9/3E0M4TE:
M13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@34%21TE.
M+51/4#H@-G!T)SX-"B!4:&4@8V%R<GEI;F<@86UO=6YT<R!O9B!C97)T86EN
M(&]F('1H92!#;VUP86YY)B-X,C`Q.3MS(&9I;F%N8VEA;`T*(&EN<W1R=6UE
M;G1S(&EN8VQU9&EN9R!C87-H+"!C87-H(&5Q=6EV86QE;G1S+"!A8V-O=6YT
M<R!A;F0@;W1H97(-"B!A;6]U;G1S(')E8V5I=F%B;&4L('!R97!A>6UE;G1S
M+"!A8V-O=6YT<R!P87EA8FQE+"!A;F0@86-C<G5E9`T*(&QI86)I;&ET:65S
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M;F0@87,@;V8@36%R8V@F(WA!,#LS,2P@,C`Q-"!H860@80T*(&9A:7(@=F%L
M=64@87!P<F]X:6UA=&EN9R!T:&5I<B!C87)R>6EN9R!A;6]U;G0N/"]P/@T*
M(#QP('-T>6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P>#L@1D].5"U325I%.B`Q
M<'@[($U!4D=)3BU43U`Z(#$R<'@G/@T*("8C>$$P.SPO<#X-"B`\<"!S='EL
M93TS1"=-05)'24XM0D]45$]-.B`P<'0[($9/3E0M4TE:13H@,3!P=#L@1D].
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M86-T=6%L('1E<FT@;V8@=&AE('=A<G)A;G1S(&%N9`T*(')E9&5E;6%B;&4@
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M:6QI=&EE<SH\+W`^#0H@/'`@<W1Y;&4],T0G34%21TE.+4)/5%1/33H@,'!T
M.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M
M86X[($U!4D=)3BU43U`Z(#$X<'0G/@T*(#QB/D9A:7(@=F%L=64@;V8@<VEG
M;FEF:6-A;G0@=6YO8G-E<G9A8FQE(&EN<'5T<R`H3&5V96P@,RD\+V(^/"]P
M/@T*(#QP('-T>6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P=#L@1D].5"U325I%
M.B`Q,G!T.R!-05)'24XM5$]0.B`P<'0G/@T*("8C>$$P.SPO<#X-"B`\=&%B
M;&4@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM
M97,@3F5W(%)O;6%N.R!"3U)$15(M0T],3$%04T4Z(&-O;&QA<'-E)R!C96QL
M<W!A8VEN9STS1#`@8V5L;'!A9&1I;F<],T0P('=I9'1H/3-$.#0E(&%L:6=N
M/3-$8V5N=&5R(&)O<F1E<CTS1#`^#0H@/'1R/@T*(#QT9"!W:61T:#TS1#8R
M)3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0V)3X\+W1D
M/@T*(#QT9#X\+W1D/@T*(#QT9#X\+W1D/@T*(#QT9#X\+W1D/@T*(#QT9"!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0V)3X\+W1D/@T*(#QT9#X\+W1D/@T*
M(#QT9#X\+W1D/@T*(#QT9#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0V)3X\+W1D/@T*(#QT9#X\+W1D/@T*(#QT9#X\+W1D/@T*(#QT
M9#X\+W1D/@T*(#PO='(^#0H@/'1R('-T>6QE/3-$)T9/3E0M4TE:13H@.'!T
M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)SX-"B`\=&0@=F%L:6=N
M/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF
M(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-
M.B`C,#`P,#`P(#%P="!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X]
M,T0R(&%L:6=N/3-$8V5N=&5R/CQB/D)!3DL@3$]!3CQB<B`O/@T*(%=!4E)!
M3E0\8G(@+SX-"B!$15))5D%4259%/&)R("\^#0H@3$E!0DE,251)15,\+V(^
M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D
M('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!S='EL93TS1"="
M3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI9"<@=F%L:6=N/3-$8F]T
M=&]M(&-O;'-P86X],T0R(&%L:6=N/3-$8V5N=&5R/CQB/E!2149%4E)%1#QB
M<B`O/@T*(%-43T-+/&)R("\^#0H@14U"141$140\8G(@+SX-"B!$15))5D%4
M259%/&)R("\^#0H@3$E!0DE,251)15,\+V(^/"]T9#X-"B`\=&0@=F%L:6=N
M/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF
M(WA!,#L\+W1D/@T*(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P
M,#`P(#%P="!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R(&%L
M:6=N/3-$8V5N=&5R/CQB/E1/5$%,/"]B/CPO=&0^#0H@/'1D('9A;&EG;CTS
M1&)O='1O;3XF(WA!,#L\+W1D/@T*(#PO='(^#0H@/'1R('-T>6QE/3-$)T9/
M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;B<@
M8F=C;VQO<CTS1"-#0T5%1D8^#0H@/'1D('9A;&EG;CTS1'1O<#X-"B`\<"!S
M='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.
M97<@4F]M86X[($U!4D=)3BU,1494.B`Q96T[(%1%6%0M24Y$14Y4.B`M,65M
M)SX-"B!"04Q!3D-%4R8C>#(P,30[2F%N=6%R>28C>$$P.S$L(#(P,30\+W`^
M#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO
M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XD/"]T9#X-"B`\=&0@=F%L:6=N
M/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^,C(Q+#,R,#PO=&0^#0H@/'1D('9A
M;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^)B-X03`[)B-X03`[/"]T
M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A
M;&EG;CTS1&)O='1O;3XD/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L
M:6=N/3-$<FEG:'0^.#`P+#(P-CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O
M;2!N;W=R87`],T1N;W=R87`^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L
M:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O
M;3XD/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^
M,2PP,C$L-3(V/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS
M1&YO=W)A<#XF(WA!,#LF(WA!,#L\+W1D/@T*(#PO='(^#0H@/'1R('-T>6QE
M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2
M;VUA;B<^#0H@/'1D('9A;&EG;CTS1'1O<#X-"B`\<"!S='EL93TS1"=&3TY4
M+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86X[($U!
M4D=)3BU,1494.B`S96T[(%1%6%0M24Y$14Y4.B`M,65M)SX-"B!#:&%N9V4@
M:6X@9F%I<B!V86QU92!O9B!D97)I=F%T:79E(&QI86)I;&ET:65S/"]P/@T*
M(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D
M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L
M:6=N/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^*#$Q,RPW,C,\+W1D/@T*(#QT
M9"!V86QI9VX],T1B;W1T;VT@;F]W<F%P/3-$;F]W<F%P/BDF(WA!,#L\+W1D
M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L
M:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XF(WA!,#L\+W1D/@T*(#QT
M9"!V86QI9VX],T1B;W1T;VT@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$<FEG
M:'0^#0H@)B-X,C`Q-#LF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX]
M,T1B;W1T;VT@;F]W<F%P/3-$;F]W<F%P/B8C>$$P.R8C>$$P.SPO=&0^#0H@
M/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX]
M,T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L
M:6=N/3-$<FEG:'0^*#$Q,RPW,C,\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T
M;VT@;F]W<F%P/3-$;F]W<F%P/BDF(WA!,#L\+W1D/@T*(#PO='(^#0H@/'1R
M('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S
M($YE=R!2;VUA;B<@8F=C;VQO<CTS1"-#0T5%1D8^#0H@/'1D('9A;&EG;CTS
M1'1O<#X-"B`\<"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-
M24Q9.B!4:6UE<R!.97<@4F]M86X[($U!4D=)3BU,1494.B`S96T[(%1%6%0M
M24Y$14Y4.B`M,65M)SX-"B!$97)E8V]G;FET:6]N(&]F(&QI86)I;&ET:65S
M('5P;VX@<')E9F5R<F5D('-T;V-K(&-O;G9E<G-I;VX@=&\-"B!C;VUM;VX@
M<W1O8VL@8V]N=F5R<VEO;CPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B
M;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M
M(&YO=W)A<#TS1&YO=W)A<#XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B
M;W1T;VT@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$<FEG:'0^#0H@)B-X,C`Q
M-#LF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W
M<F%P/3-$;F]W<F%P/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS
M1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X
M03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^
M*#@P,"PR,#8\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W<F%P/3-$
M;F]W<F%P/BDF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X
M03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@
M/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/B@X,#`L,C`V/"]T
M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XI)B-X
M03`[/"]T9#X-"B`\+W1R/@T*(#QT<B!S='EL93TS1"=&3TY4+5-)6D4Z(#%P
M>"<^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI9VX]
M,T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T
M=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O
M;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M
M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED
M)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0^)B-X03`[/"]T9#X-"B`\=&0@
M=F%L:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O
M='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S
M;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O
M;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI
M9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/'1D
M('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B
M;W1T;VT^#0H@/'`@<W1Y;&4],T0G0D]21$52+51/4#H@(S`P,#`P,"`Q<'@@
M<V]L:60G/B8C>$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T
M;VT^#0H@/'`@<W1Y;&4],T0G0D]21$52+51/4#H@(S`P,#`P,"`Q<'@@<V]L
M:60G/B8C>$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#PO
M='(^#0H@/'1R('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)
M3%DZ(%1I;65S($YE=R!2;VUA;B<^#0H@/'1D('9A;&EG;CTS1'1O<#X-"B`\
M<"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE
M<R!.97<@4F]M86X[($U!4D=)3BU,1494.B`Q96T[(%1%6%0M24Y$14Y4.B`M
M,65M)SX-"B!"04Q!3D-%4R8C>#(P,30[36%R8V@F(WA!,#LS,2P@,C`Q-#PO
M<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4]
M,T0G1D].5"U325I%.B`X<'0G/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*
M(#QT9"!V86QI9VX],T1B;W1T;VT^)#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O
M='1O;2!A;&EG;CTS1')I9VAT/C$P-RPU.3<\+W1D/@T*(#QT9"!V86QI9VX]
M,T1B;W1T;VT@;F]W<F%P/3-$;F]W<F%P/B8C>$$P.R8C>$$P.SPO=&0^#0H@
M/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z
M(#AP="<^)B-X03`[/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O
M;2!N;W=R87`],T1N;W=R87`^)#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O
M;2!N;W=R87`],T1N;W=R87`@86QI9VX],T1R:6=H=#X-"B`F(W@R,#$T.R8C
M>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`]
M,T1N;W=R87`^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T
M=&]M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@.'!T)SXF(WA!,#L\+V9O
M;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B0\+W1D/@T*(#QT9"!V
M86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XQ,#<L-3DW/"]T9#X-"B`\
M=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XF(WA!,#LF(WA!
M,#L\+W1D/@T*(#PO='(^#0H@/'1R('-T>6QE/3-$)T9/3E0M4TE:13H@,7!X
M)SX-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS
M1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T
M;VT^#0H@/'`@<W1Y;&4],T0G0D]21$52+51/4#H@(S`P,#`P,"`S<'@@9&]U
M8FQE)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M
M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,W!X(&1O=6)L
M92<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/'1D
M('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B
M;W1T;VT^#0H@/'`@<W1Y;&4],T0G0D]21$52+51/4#H@(S`P,#`P,"`S<'@@
M9&]U8FQE)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T
M=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,W!X(&1O
M=6)L92<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@
M/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX]
M,T1B;W1T;VT^#0H@/'`@<W1Y;&4],T0G0D]21$52+51/4#H@(S`P,#`P,"`S
M<'@@9&]U8FQE)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$
M8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,W!X
M(&1O=6)L92<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^
M#0H@/"]T<CX-"B`\+W1A8FQE/@T*(#QP('-T>6QE/3-$)TU!4D=)3BU"3U14
M3TTZ(#!P=#L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@
M3F5W(%)O;6%N.R!-05)'24XM5$]0.B`Q,G!T)SX-"B!4:&5R92!W97)E(&YO
M('1R86YS9F5R<R!B971W965N($QE=F5L<R`Q+"`R+"!A;F0@,R!D=7)I;F<@
M=&AE('1H<F5E#0H@;6]N=&AS(&5N9&5D($UA<F-H)B-X03`[,S$L(#(P,30@
M86YD(#(P,3,N/"]P/@T*(#PO9&EV/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-
M"BTM+2TM+3U?3F5X=%!A<G1?-3<Q9C,R-C%?,3`Q95\T-C`Y7V$X8V5?8C9F
M93=A,&(T930Y#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+S4W,68S
M,C8Q7S$P,65?-#8P.5]A.&-E7V(V9F4W83!B-&4T.2]7;W)K<VAE971S+U-H
M965T,38N:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D
M+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970]
M(G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T
M<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@
M8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T
M('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@
M*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S
M<STS1')E<&]R="!I9#TS1$E$,$5&24%#/@T*("`@("`@/'1R/@T*("`@("`@
M("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$,CX\<W1R
M;VYG/D-O;F1E;G-E9"!S=6UM87)Y(&]F('-I9VYI9FEC86YT(&%C8V]U;G1I
M;F<@<&]L:6-I97,@*%!O;&EC:65S*3QB<CX\+W-T<F]N9SX\+W1H/@T*("`@
M("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XS($UO;G1H<R!%;F1E
M9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@
M8VQA<W,],T1T:#Y-87(N(#,Q+"`R,#$T/&)R/CPO=&@^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/D%C8V]U;G1I;F<@4&]L:6-I97,@
M6T%B<W1R86-T73PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^0F%S:7,@;V8@<')E<V5N=&%T:6]N/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/&1I=CX-"B`\<"!S='EL93TS1"=-05)'24XM
M0D]45$]-.B`P<'0[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I
M;65S($YE=R!2;VUA;CL@34%21TE.+51/4#H@-G!T)SX-"B`\8CX\:3XH82D@
M0F%S:7,@;V8@<')E<V5N=&%T:6]N/"]I/CPO8CX\+W`^#0H@/'`@<W1Y;&4]
M,T0G34%21TE.+4)/5%1/33H@,'!T.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M
M1D%-24Q9.B!4:6UE<R!.97<@4F]M86X[($U!4D=)3BU43U`Z(#9P="<^#0H@
M5&AE(&%C8V]M<&%N>6EN9R!U;F%U9&ET960@8V]N9&5N<V5D(&-O;G-O;&ED
M871E9"!A;F0@8V]M8FEN960-"B!F:6YA;F-I86P@<W1A=&5M96YT<R!A<F4@
M<')E<V5N=&5D(&EN(%5N:71E9"!3=&%T97,-"B`H)B-X,C`Q0SM5+E,N)B-X
M,C`Q1#LI(&1O;&QA<G,@86YD(&AA=F4@8F5E;B!P<F5P87)E9"!I;B!A8V-O
M<F1A;F-E#0H@=VET:"!A8V-O=6YT:6YG('!R:6YC:7!L97,@9V5N97)A;&QY
M(&%C8V5P=&5D(&EN('1H92!5;FET960@4W1A=&5S#0H@;V8@06UE<FEC82`H
M)B-X,C`Q0SM5+E,N($=!05`F(W@R,#%$.RD@86YD('!U<G-U86YT('1O('1H
M92!R=6QE<R!A;F0-"B!R96=U;&%T:6]N<R!O9B!T:&4@56YI=&5D(%-T871E
M<R!396-U<FET:65S(&%N9"!%>&-H86YG92!#;VUM:7-S:6]N#0H@*"8C>#(P
M,4,[4T5#)B-X,C`Q1#LI(&9O<B!I;G1E<FEM(&9I;F%N8VEA;"!I;F9O<FUA
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M03`[,S$L(#(P,3,-"B!I;F-L=61E9"!I;B!T:&4@0V]M<&%N>28C>#(P,3D[
M<R!F:6YA;"!P<F]S<&5C='5S(&9O<B!I=',@:6YI=&EA;`T*('!U8FQI8R!O
M9F9E<FEN9R`H)B-X,C`Q0SM)4$\F(W@R,#%$.RD@9FEL960@=VET:"!T:&4@
M4T5#('!U<G-U86YT('1O#0H@4G5L92`T,C0H8BD@;VX@36%R8V@F(WA!,#LW
M+"`R,#$T+CPO<#X-"B`\<"!S='EL93TS1"=-05)'24XM0D]45$]-.B`P<'0[
M($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA
M;CL@34%21TE.+51/4#H@,3)P="<^#0H@26X@;6%N86=E;65N="8C>#(P,3D[
M<R!O<&EN:6]N+"!T:&4@8V]N9&5N<V5D(&-O;G-O;&ED871E9"!A;F0-"B!C
M;VUB:6YE9"!F:6YA;F-I86P@<W1A=&5M96YT<R!R969L96-T(&%L;"!A9&IU
M<W1M96YT<R`H:6YC;'5D:6YG#0H@<F5C;&%S<VEF:6-A=&EO;G,@86YD(&YO
M<FUA;"!R96-U<G)I;F<@861J=7-T;65N=',I(&YE8V5S<V%R>2!T;PT*('!R
M97-E;G0@9F%I<FQY('1H92!F:6YA;F-I86P@<&]S:71I;VX@87,@;V8@36%R
M8V@F(WA!,#LS,2P@,C`Q-"P-"B!A;F0@<F5S=6QT<R!O9B!O<&5R871I;VYS
M(&%N9"!C87-H(&9L;W=S(&9O<B!A;&P@<&5R:6]D<R!P<F5S96YT960N#0H@
M5&AE(&EN=&5R:6T@<F5S=6QT<R!P<F5S96YT960@87)E(&YO="!N96-E<W-A
M<FEL>2!I;F1I8V%T:79E(&]F#0H@<F5S=6QT<R!T:&%T(&-A;B!B92!E>'!E
M8W1E9"!F;W(@82!F=6QL('EE87(N/"]P/@T*(#QP('-T>6QE/3-$)TU!4D=)
M3BU"3U143TTZ(#!P=#L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@
M5&EM97,@3F5W(%)O;6%N.R!-05)'24XM5$]0.B`Q,G!T)SX-"B!4:')O=6=H
M(&$@<F5O<F=A;FEZ871I;VX@;VX@36%R8V@F(WA!,#LQ,BP@,C`Q-"P@05%8
M4"!#86YA9&$@8F5C86UE#0H@82!W:&]L;'D@;W=N960@<W5B<VED:6%R>2!O
M9B!!<75I;F]X(%5302`H3F]T92`S*2X@4')I;W(@=&\@=&AE#0H@<F5O<F=A
M;FEZ871I;VXL(&UA;F%G96UE;G0@9&5T97)M:6YE9"!T:&%T($%16%`@0V%N
M861A(&%N9"!!<75I;F]X#0H@55-!('=E<F4@96YT:71I97,@=6YD97(@8V]M
M;6]N(&-O;G1R;VP@87,@96%C:"!O9B!!45A0($-A;F%D82!A;F0-"B!!<75I
M;F]X(%5302!W97)E(&]W;F5D(&)E;F5F:6-I86QL>2!B>2!I9&5N=&EC86P@
M<VAA<F5H;VQD97)S(&%N9`T*(&%S('-U8V@@=&AE(&)A<VES(&]F('!R97-E
M;G1A=&EO;B!O9B!F:6YA;F-I86P@<F5S=6QT<R!P<FEO<B!T;PT*($UA<F-H
M)B-X03`[,3(L(#(P,30@=V%S(&]N(&$@8V]M8FEN960@8F%S:7,N(%-U8G-E
M<75E;G0@=&\-"B!-87)C:"8C>$$P.S$R+"`R,#$T+"!T:&4@8F%S:7,@;V8@
M<')E<V5N=&%T:6]N(&]F('1H92!F:6YA;F-I86P-"B!R97-U;'1S(&ES(&]N
M(&$@8V]N<V]L:61A=&5D(&)A<VES+B!!;&P@:6YT97)C;VUP86YY('1R86YS
M86-T:6]N<PT*(&AA=F4@8F5E;B!E;&EM:6YA=&5D+CPO<#X-"B`\<"!S='EL
M93TS1"=-05)'24XM0D]45$]-.B`P<'0[($9/3E0M4TE:13H@,3!P=#L@1D].
M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@34%21TE.+51/4#H@,3)P="<^
M#0H@1F]R('1H92!P97)I;V0@9G)O;2!I;F-E<'1I;VX@;VX@1&5C96UB97(F
M(WA!,#LR-BP@,C`P,R!T:')O=6=H#0H@36%R8V@F(WA!,#LS,2P@,C`Q-"P@
M=&AE($-O;7!A;GD@:7,@82!D979E;&]P;65N="!S=&%G92!E;G1E<G!R:7-E
M+`T*(&%S('!L86YN960@<')I;F-I<&%L(&]P97)A=&EO;G,@:&%V92!N;W0@
M>65T(&)E9W5N('1O(&=E;F5R871E#0H@<F5V96YU97,N($EN(&ET<R!D979E
M;&]P;65N="!S=&%G92P@86QL('!R92UO<&5R871I;F<@8V]S=',@87)E#0H@
M8F5I;F<@97AP96YS960@87,@:6YC=7)R960N(%1H92!S=&%T96UE;G1S(&]F
M(&]P97)A=&EO;G,@86YD#0H@8V]M<')E:&5N<VEV92!L;W-S+"!C;VYV97)T
M:6)L92!P<F5F97)R960@<W1O8VL@86YD#0H@<W1O8VMH;VQD97)S)B-X,C`Q
M.3L@9&5F:6-I="P@86YD(&-A<V@@9FQO=W,@<')E<V5N="!T:&4@8W5M=6QA
M=&EV90T*(&-O;G-O;&ED871E9"!F:6YA;F-I86P@:6YF;W)M871I;VX@;V8@
M=&AE($-O;7!A;GD@9F]R('1H92!P97)I;V0-"B!F<F]M(&EN8V5P=&EO;B!O
M;B!$96-E;6)E<B8C>$$P.S(V+"`R,#`S('1H<F]U9V@@36%R8V@F(WA!,#LS
M,2P-"B`R,#$T+CPO<#X-"B`\+V1I=CX\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E5S92!O9B!E<W1I;6%T97,\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\9&EV/@T*(#QP('-T>6QE
M/3-$)TU!4D=)3BU"3U143TTZ(#!P=#L@1D].5"U325I%.B`Q,'!T.R!&3TY4
M+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!-05)'24XM5$]0.B`Q.'!T)SX-
M"B`\8CX\:3XH8BD@57-E(&]F(&5S=&EM871E<SPO:3X\+V(^/"]P/@T*(#QP
M('-T>6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P=#L@1D].5"U325I%.B`Q,'!T
M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!-05)'24XM5$]0.B`V
M<'0G/@T*(%1H92!P<F5P87)A=&EO;B!O9B!F:6YA;F-I86P@<W1A=&5M96YT
M<R!I;B!C;VYF;W)M:71Y('=I=&@@52Y3+@T*($=!05`@<F5Q=6ER97,@;6%N
M86=E;65N="!T;R!M86ME(&5S=&EM871E<R!A;F0@87-S=6UP=&EO;G,@=&AA
M=`T*(&%F9F5C="!T:&4@<F5P;W)T960@86UO=6YT<R!O9B!A<W-E=',@86YD
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M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^5&%X97,\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\9&EV/@T*(#QP('-T>6QE/3-$)TU!
M4D=)3BU"3U143TTZ(#!P=#L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,
M63H@5&EM97,@3F5W(%)O;6%N.R!-05)'24XM5$]0.B`Q.'!T)SX-"B`\8CX\
M:3XH8RD@5&%X97,\+VD^/"]B/CPO<#X-"B`\<"!S='EL93TS1"=-05)'24XM
M0D]45$]-.B`P<'0[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I
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M<F5M96YT(&]F(&1E9F5R<F5D('1A>`T*(&%S<V5T<R!I<R!R961U8V5D+"!I
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M86QI>F5D+B!!4T,F(WA!,#LW-#`@8VQA<FEF:65S('1H92!C<FET97)I80T*
M('1H870@;75S="!B92!M970@<')I;W(@=&\@<F5C;V=N:71I;VX@;V8@=&AE
M(&9I;F%N8VEA;"!S=&%T96UE;G0-"B!B96YE9FET(&]F(&$@<&]S:71I;VX@
M=&%K96X@:6X@82!T87@@<F5T=7)N+B!!4T,F(WA!,#LW-#`@<')O=FED97,-
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M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!-05)'
M24XM5$]0.B`Q,G!T)SX-"B!);G9E<W1M96YT('1A>"!C<F5D:71S(')E;&%T
M:6YG('1O('-C:65N=&EF:6,@<F5S96%R8V@@86YD#0H@97AP97)I;65N=&%L
M(&1E=F5L;W!M96YT(&%R92!A8V-O=6YT960@9F]R(&EN(&]P97)A=&EO;G,N
M(%1O('1H90T*(&5X=&5N="!T:&5R92!I<R!R96%S;VYA8FQE(&%S<W5R86YC
M92!T:&4@8W)E9&ET<R!W:6QL(&)E(')E86QI>F5D+`T*('1H97D@87)E(')E
M8V]R9&5D(&EN('1H92!P97)I;V0@=&AE(')E;&%T960@97AP96YD:71U<F4@
M:7,@;6%D92!A<PT*(&%N(&EN8V]M92!T87@@*'!R;W9I<VEO;BD@<F5C;W9E
M<GDN($EF(&EN=F5S=&UE;G0@=&%X(&-R961I=`T*(&%M;W5N=',@<W5B<V5Q
M=65N=&QY(')E8V5I=F5D(&%R92!L97-S(&]R(&UO<F4@=&AA;B!O<FEG:6YA
M;&QY#0H@<F5C;W)D960L('1H92!D:69F97)E;F-E(&ES('1R96%T960@87,@
M82!C:&%N9V4@:6X@97-T:6UA=&4N/"]P/@T*(#QP('-T>6QE/3-$)TU!4D=)
M3BU"3U143TTZ(#!P=#L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@
M5&EM97,@3F5W(%)O;6%N.R!-05)'24XM5$]0.B`Q,G!T)SX-"B!#86YA9&EA
M;B!T87@@<G5L97,@:6UP;W-E(&$@=&%X('=I=&@@<F5S<&5C="!T;R!#86YA
M9&EA;@T*(&-O<G!O<F%T:6]N('1A>&%B;&4@<')E9F5R<F5D('-T;V-K(&%N
M9"!T:&5I<B!L:7%U:61A=&EO;B!R:6=H=',N#0H@26X@<')I;W(@<&5R:6]D
M<RP@05%84"!#86YA9&$@:&%S(')E8V]R9&5D('1H:7,@=&%X(&]N('!R969E
M<G)E9`T*('-T;V-K(&%S(&$@;F]N+6-U<G)E;G0@86-C<G5E9"!T87@@<&%Y
M86)L92!O;B!I=',@8F%L86YC92!S:&5E="P@;VX-"B!T:&4@<V%M92!B87-I
M<R!A<R!I="!R96-O<F1E9"!T:&4@86-C<F5T:6]N(&]F('!R969E<G)E9"!S
M=&]C:RX\+W`^#0H@/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y$97)I=F%T:79E(&QI86)I;&ET:65S(&%N
M9"!F86ER('9A;'5E(&]F(&9I;F%N8VEA;"!I;G-T<G5M96YT<SPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQD:78^#0H@/'`@<W1Y;&4],T0G
M34%21TE.+4)/5%1/33H@,'!T.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-
M24Q9.B!4:6UE<R!.97<@4F]M86X[($U!4D=)3BU43U`Z(#$X<'0G/@T*(#QB
M/CQI/BAD*2!$97)I=F%T:79E(&QI86)I;&ET:65S(&%N9"!F86ER('9A;'5E
M(&]F(&9I;F%N8VEA;`T*(&EN<W1R=6UE;G1S/"]I/CPO8CX\+W`^#0H@/'`@
M<W1Y;&4],T0G34%21TE.+4)/5%1/33H@,'!T.R!&3TY4+5-)6D4Z(#$P<'0[
M($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86X[($U!4D=)3BU43U`Z(#9P
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M<FME9"!T;R!M87)K970@870@96%C:`T*(&)A;&%N8V4@<VAE970@9&%T92P@
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M#0H@)B-X,C`Q0SMA;6]R=&EZ871I;VX@;V8@9&ES8V]U;G0@;VX@<')E9F5R
M<F5D('-T;V-K)B-X,C`Q1#L@:6X@=&AE#0H@8V]N<V]L:61A=&5D(&%N9"!C
M;VUB:6YE9"!S=&%T96UE;G1S(&]F(&]P97)A=&EO;G,@86YD#0H@8V]M<')E
M:&5N<VEV92!L;W-S+CPO<#X-"B`\<"!S='EL93TS1"=-05)'24XM0D]45$]-
M.B`P<'0[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE
M=R!2;VUA;CL@34%21TE.+51/4#H@,3)P="<^#0H@5&AE($-O;7!A;GD@86QS
M;R!E=F%L=6%T97,@86YD(&%C8V]U;G1S(&9O<B!C;VYV97)S:6]N(&%N9`T*
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M;&]S<RX\+W`^#0H@/'`@<W1Y;&4],T0G34%21TE.+4)/5%1/33H@,'!T.R!&
M3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86X[
M($U!4D=)3BU43U`Z(#$R<'0G/@T*(%1H92!#;VUP86YY(&%P<&QI97,@=&AE
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M97-T(&UE=&AO9`T*('=H:6-H(&ES(&$@;65T:&]D(&]F(&-A;&-U;&%T:6YG
M('1H92!A;6]R=&EZ960@8V]S="!O9B!A(&9I;F%N8VEA;`T*(&QI86)I;&ET
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M9`T*('-T871E;65N=',@;V8@;W!E<F%T:6]N<R!A;F0@8V]M<')E:&5N<VEV
M92!L;W-S('5S:6YG('1H92!E9F9E8W1I=F4-"B!I;G1E<F5S="!M971H;V0N
M/"]P/@T*(#QP('-T>6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P=#L@1D].5"U3
M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!-05)'
M24XM5$]0.B`Q,G!T)SX-"B`\:3Y!4T,@.#(P+"!&86ER(%9A;'5E($UE87-U
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M86QU92X-"B!!4T,F(WA!,#LX,C`@9&5F:6YE<R!F86ER('9A;'5E(&%S('1H
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M9F]L;&]W:6YG('1H<F5E(&QE=F5L<SH\+W`^#0H@/'`@<W1Y;&4],T0G34%2
M1TE.+4)/5%1/33H@,'!T.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9
M.B!4:6UE<R!.97<@4F]M86X[($U!4D=)3BU,1494.B`T)3L@34%21TE.+51/
M4#H@-G!T)SX-"B!,979E;"`Q)B-X,C`Q-#M1=6]T960@<')I8V5S(&EN(&%C
M=&EV92!M87)K971S(&9O<B!I9&5N=&EC86P@87-S971S#0H@;W(@;&EA8FEL
M:71I97,N/"]P/@T*(#QP('-T>6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P=#L@
M1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N
M.R!-05)'24XM3$5&5#H@-"4[($U!4D=)3BU43U`Z(#9P="<^#0H@3&5V96P@
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M;V8@=&AE(&%S<V5T<R!O<@T*(&QI86)I;&ET:65S+CPO<#X-"B`\<"!S='EL
M93TS1"=-05)'24XM0D]45$]-.B`P<'0[($9/3E0M4TE:13H@,3!P=#L@1D].
M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@34%21TE.+4Q%1E0Z(#0E.R!-
M05)'24XM5$]0.B`V<'0G/@T*($QE=F5L(#,F(W@R,#$T.U5N;V)S97)V86)L
M92!I;G!U=',@=&AA="!A<F4@<W5P<&]R=&5D(&)Y(&QI='1L92!O<@T*(&YO
M(&UA<FME="!A8W1I=FET>2!A;F0@=&AA="!A<F4@<VEG;FEF:6-A;G0@=&\@
M=&AE(&9A:7(@=F%L=64@;V8-"B!T:&4@87-S971S(&]R(&QI86)I;&ET:65S
M+CPO<#X-"B`\+V1I=CX\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/E)E9&5E;6%B;&4@8V]N=F5R=&EB;&4@<')E9F5R
M<F5D('-T;V-K/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/&1I
M=CX-"B`\<"!S='EL93TS1"=-05)'24XM0D]45$]-.B`P<'0[($9/3E0M4TE:
M13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@34%21TE.
M+51/4#H@,3AP="<^#0H@/&(^/&D^*&4I(%)E9&5E;6%B;&4@8V]N=F5R=&EB
M;&4@<')E9F5R<F5D('-T;V-K/"]I/CPO8CX\+W`^#0H@/'`@<W1Y;&4],T0G
M34%21TE.+4)/5%1/33H@,'!T.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-
M24Q9.B!4:6UE<R!.97<@4F]M86X[($U!4D=)3BU43U`Z(#9P="<^#0H@5&AE
M($-O;7!A;GD@8VQA<W-I9FEE9"!R961E96UA8FQE(&-O;G9E<G1I8FQE('!R
M969E<G)E9"!S=&]C:R!T:&%T#0H@=V%S(')E9&5E;6%B;&4@;W5T<VED92!O
M9B!T:&4@0V]M<&%N>28C>#(P,3D[<R!C;VYT<F]L(&%S(&UE>GIA;FEN90T*
M(&5Q=6ET>2X@5&AE($-O;7!A;GD@<F5C;W)D960@<W5C:"!R961E96UA8FQE
M(&-O;G9E<G1I8FQE('!R969E<G)E9`T*('-T;V-K(&%T(&9A:7(@=F%L=64@
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M1D].5"U325I%.B`Q<'@[($U!4D=)3BU43U`Z(#$R<'@G/@T*("8C>$$P.SPO
M<#X-"B`\<"!S='EL93TS1"=-05)'24XM0D]45$]-.B`P<'0[($9/3E0M4TE:
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M/"]P/@T*(#PO9&EV/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^06-C;W5N=&EN9R!F;W(@<W1O8VLM8F%S960@8V]M
M<&5N<V%T:6]N/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/&1I
M=CX-"B`\<"!S='EL93TS1"=-05)'24XM0D]45$]-.B`P<'0[($9/3E0M4TE:
M13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@34%21TE.
M+51/4#H@,3AP="<^#0H@/&(^/&D^*&8I($%C8V]U;G1I;F<@9F]R('-T;V-K
M+6)A<V5D(&-O;7!E;G-A=&EO;CPO:3X\+V(^/"]P/@T*(#QP('-T>6QE/3-$
M)TU!4D=)3BU"3U143TTZ(#!P=#L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!
M34E,63H@5&EM97,@3F5W(%)O;6%N.R!-05)'24XM5$]0.B`V<'0G/@T*(%1H
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M<F5S<&5C=&EV92!G<F%N="!D871E(&9A:7(@=F%L=65S+CPO<#X-"B`\<"!S
M='EL93TS1"=-05)'24XM0D]45$]-.B`P<'0[($9/3E0M4TE:13H@,3!P=#L@
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M;VUM;VX@<W1O8VL@=V%S(&YO=`T*('!U8FQI8VQY('1R861E9"P@=&AE(&5X
M<&5C=&5D('9O;&%T:6QI='D@87-S=6UP=&EO;B!W87,@8F%S960@;VX-"B!I
M;F1U<W1R>2!P965R(&EN9F]R;6%T:6]N+B!!9&1I=&EO;F%L;'DL(&)E8V%U
M<V4@=&AE($-O;7!A;GD@:&%S(&YO#0H@<VEG;FEF:6-A;G0@:&ES=&]R>2!T
M;R!C86QC=6QA=&4@=&AE(&5X<&5C=&5D('1E<FTL('1H92!S:6UP;&EF:65D
M#0H@;65T:&]D(&-A;&-U;&%T:6]N('=A<R!U<V5D+CPO<#X-"B`\+V1I=CX\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/E-E9VUE;G0@<F5P;W)T:6YG/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/&1I=CX-"B`\<"!S='EL93TS1"=-05)'24XM0D]45$]-.B`P<'0[
M($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA
M;CL@34%21TE.+51/4#H@,3AP="<^#0H@/&(^/&D^*&<I(%-E9VUE;G0@<F5P
M;W)T:6YG/"]I/CPO8CX\+W`^#0H@/'`@<W1Y;&4],T0G34%21TE.+4)/5%1/
M33H@,'!T.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.
M97<@4F]M86X[($U!4D=)3BU43U`Z(#9P="<^#0H@36%N86=E;65N="!H87,@
M9&5T97)M:6YE9"!T:&%T('1H92!#;VUP86YY)B-X,C`Q.3MS(&]P97)A=&EO
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M;'D@;V8@8V%S:"!A;F0@8V%S:"!E<75I=F%L96YT<RP@=V5R92`D-3$L,3$V
M+#4X-B!A<R!O9@T*($UA<F-H)B-X03`[,S$L(#(P,30@*$1E8V5M8F5R(#,Q
M+"`R,#$S("T@)#8L-C(Y+#,X,RDN/"]P/@T*(#PO9&EV/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3&]S<R!P97(@
M<VAA<F4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\9&EV/@T*
M(#QP('-T>6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P=#L@1D].5"U325I%.B`Q
M,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!-05)'24XM5$]0
M.B`Q.'!T)SX-"B`\8CX\:3XH:"D@3&]S<R!P97(@<VAA<F4\+VD^/"]B/CPO
M<#X-"B`\<"!S='EL93TS1"=-05)'24XM0D]45$]-.B`P<'0[($9/3E0M4TE:
M13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@34%21TE.
M+51/4#H@-G!T)SX-"B!"87-I8R!L;W-S('!E<B!C;VUM;VX@<VAA<F4@:7,@
M8V]M<'5T960@8GD@9&EV:61I;F<@;&]S<R!B>2!T:&4-"B!W96EG:'1E9"UA
M=F5R86=E(&YU;6)E<B!O9B!C;VUM;VX@<VAA<F5S(&]U='-T86YD:6YG(&1U
M<FEN9R!T:&4-"B!P97)I;V0N($1I;'5T960@;F5T(&5A<FYI;F=S('!E<B!C
M;VUM;VX@<VAA<F4@:7,@9&5T97)M:6YE9"!U<VEN9PT*('1H92!W96EG:'1E
M9"UA=F5R86=E(&YU;6)E<B!O9B!C;VUM;VX@<VAA<F5S(&]U='-T86YD:6YG
M(&1U<FEN9R!T:&4-"B!P97)I;V0L(&%D:G5S=&5D(&9O<B!T:&4@9&EL=71I
M=F4@969F96-T(&]F(&-O;6UO;B!S=&]C:PT*(&5Q=6EV86QE;G1S+"!C;VYS
M:7-T:6YG(&]F('-H87)E<R!T:&%T(&UI9VAT(&)E(&ES<W5E9"!U<&]N#0H@
M97AE<F-I<V4@;V8@8V]M;6]N('-T;V-K(&]P=&EO;G,@86YD('=A<G)A;G1S
M+B!);B!P97)I;V1S('=H97)E#0H@;&]S<V5S(&%R92!R97!O<G1E9"P@=&AE
M('=E:6=H=&5D+6%V97)A9V4@;G5M8F5R(&]F(&-O;6UO;B!S:&%R97,-"B!O
M=71S=&%N9&EN9R!E>&-L=61E<R!C;VUM;VX@<W1O8VL@97%U:79A;&5N=',@
M8F5C875S92!T:&5I<@T*(&EN8VQU<VEO;B!W;W5L9"!B92!A;G1I+61I;'5T
M:79E+CPO<#X-"B`\+V1I=CX\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/E)E8V5N="!A8V-O=6YT:6YG('!R;VYO=6YC
M96UE;G1S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/&1I=CX-
M"B`\<"!S='EL93TS1"=-05)'24XM0D]45$]-.B`P<'0[($9/3E0M4TE:13H@
M,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@34%21TE.+51/
M4#H@,3AP="<^#0H@/&(^/&D^*&DI(%)E8V5N="!A8V-O=6YT:6YG('!R;VYO
M=6YC96UE;G1S/"]I/CPO8CX\+W`^#0H@/'`@<W1Y;&4],T0G34%21TE.+4)/
M5%1/33H@,'!T.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE
M<R!.97<@4F]M86X[($U!4D=)3BU43U`Z(#9P="<^#0H@26X@07!R:6P@,C`Q
M-"P@=&AE($9!4T(@:7-S=65D($%352`R,#$T+3`X+"`F(W@R,#%#.U!R97-E
M;G1A=&EO;B!O9@T*($9I;F%N8VEA;"!3=&%T96UE;G1S(&%N9"!0<F]P97)T
M>2P@4&QA;G0L(&%N9`T*($5Q=6EP;65N="8C>#(P,30[4F5P;W)T:6YG($1I
M<V-O;G1I;G5E9"!/<&5R871I;VYS(&%N9"!$:7-C;&]S=7)E<PT*(&]F($1I
M<W!O<V%L<R!O9B!#;VUP;VYE;G1S(&]F(&%N($5N=&ET>2XF(W@R,#%$.R!!
M4U4@,C`Q-"TP.`T*('!R;W9I9&5S(&=U:61A;F-E(')E;&%T960@=&\@=&AE
M(&1E9FEN:71I;VX@;V8@82!D:7-C;VYT:6YU960-"B!O<&5R871I;VX@86YD
M(')E<75I<F5S(&YE=R!D:7-C;&]S=7)E<R!O9B!B;W1H(&1I<V-O;G1I;G5E
M9`T*(&]P97)A=&EO;G,@86YD(&-E<G1A:6X@;W1H97(@9&ES<&]S86QS('1H
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M86YY)B-X,C`Q.3MS(&9I;F%N8VEA;"!P;W-I=&EO;BP@<F5S=6QT<R!O9B!O
M<&5R871I;VYS(&]R(&-A<V@-"B!F;&]W<R!A<R!A(')E<W5L="!O9B!T:&ES
M(&-H86YG92X\+W`^#0H@/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*
M+2TM+2TM/5].97AT4&%R=%\U-S%F,S(V,5\Q,#%E7S0V,#E?83AC95]B-F9E
M-V$P8C1E-#D-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-3<Q9C,R
M-C%?,3`Q95\T-C`Y7V$X8V5?8C9F93=A,&(T930Y+U=O<FMS:&5E=',O4VAE
M970Q-RYH=&UL#0I#;VYT96YT+51R86YS9F5R+45N8V]D:6YG.B!Q=6]T960M
M<')I;G1A8FQE#0I#;VYT96YT+51Y<&4Z('1E>'0O:'1M;#L@8VAA<G-E=#TB
M=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\345402!H='1P
M+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C
M:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@
M<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J
M+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S
M/3-$<F5P;W)T(&ED/3-$240P14U%/@T*("`@("`@/'1R/@T*("`@("`@("`\
M=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG
M/D-A<V@@86YD(&-A<V@@97%U:79A;&5N=',@*%1A8FQE<RD\8G(^/"]S=')O
M;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^
M,R!-;VYT:',@16YD960\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<CX-
M"B`@("`@("`@/'1H(&-L87-S/3-$=&@^36%R+B`S,2P@,C`Q-#QB<CX\+W1H
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY#87-H($%N
M9"!#87-H($5Q=6EV86QE;G1S(%M!8G-T<F%C=%T\+W-T<F]N9SX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E-C:&5D=6QE(&]F($-A<V@@
M86YD($-A<V@@17%U:79A;&5N=',\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\9&EV/@T*(#QT86)L92!S='EL93TS1"=&3TY4+5-)6D4Z(#$P
M<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86X[($)/4D1%4BU#3TQ,
M05!313H@8V]L;&%P<V4G(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS
M1#`@=VED=&@],T0W-B4@86QI9VX],T1C96YT97(@8F]R9&5R/3-$,#X-"B`\
M='(^#0H@/'1D('=I9'1H/3-$-C(E/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#DE/CPO=&0^#0H@/'1D/CPO=&0^#0H@/'1D/CPO=&0^
M#0H@/'1D/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE
M/CPO=&0^#0H@/'1D/CPO=&0^#0H@/'1D/CPO=&0^#0H@/'1D/CPO=&0^#0H@
M/"]T<CX-"B`\='(@<W1Y;&4],T0G1D].5"U325I%.B`X<'0[($9/3E0M1D%-
M24Q9.B!4:6UE<R!.97<@4F]M86XG/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^
M)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P
M.SPO=&0^#0H@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@
M,7!T('-O;&ED)R!V86QI9VX],T1B;W1T;VT@8V]L<W!A;CTS1#(@86QI9VX]
M,T1C96YT97(^/&(^34%20T@F(WA!,#LS,2PF(WA!,#LR,#$T/"]B/CPO=&0^
M#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI
M9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@<W1Y;&4],T0G
M0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'0@<V]L:60G('9A;&EG;CTS1&)O
M='1O;2!C;VQS<&%N/3-$,B!A;&EG;CTS1&-E;G1E<CX\8CY$14-%34)%4B8C
M>$$P.S,Q+"8C>$$P.S(P,3,\+V(^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T
M=&]M/B8C>$$P.SPO=&0^#0H@/"]T<CX-"B`\='(@<W1Y;&4],T0G1D].5"U3
M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!B9V-O
M;&]R/3-$(T-#145&1CX-"B`\=&0@=F%L:6=N/3-$=&]P/@T*(#QP('-T>6QE
M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2
M;VUA;CL@34%21TE.+4Q%1E0Z(#%E;3L@5$585"U)3D1%3E0Z("TQ96TG/@T*
M($-A<V@\+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P
M.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XD/"]T9#X-"B`\
M=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^-#DL-3,X+#@W-#PO
M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^)B-X
M03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C
M>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XD/"]T9#X-"B`\=&0@
M=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^-RPR.3(L,3$V/"]T9#X-
M"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XF(WA!,#LF
M(WA!,#L\+W1D/@T*(#PO='(^#0H@/'1R('-T>6QE/3-$)T9/3E0M4TE:13H@
M,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;B<^#0H@/'1D('9A
M;&EG;CTS1'1O<#X-"B`\<"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/
M3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86X[($U!4D=)3BU,1494.B`Q96T[
M(%1%6%0M24Y$14Y4.B`M,65M)SX-"B!#87-H(&5Q=6EV86QE;G1S/"]P/@T*
M(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D
M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L
M:6=N/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^,RPS-SDL-#4S/"]T9#X-"B`\
M=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XF(WA!,#LF(WA!
M,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T
M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A
M;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/C,L-S$T+#(W-CPO=&0^#0H@
M/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^)B-X03`[)B-X
M03`[/"]T9#X-"B`\+W1R/@T*(#QT<B!S='EL93TS1"=&3TY4+5-)6D4Z(#%P
M>"<^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI9VX]
M,T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T
M=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O
M;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M
M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED
M)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0^)B-X03`[/"]T9#X-"B`\=&0@
M=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG
M;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P
M(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS
M1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P
M>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^
M#0H@/"]T<CX-"B`\='(@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4
M+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!B9V-O;&]R/3-$(T-#145&1CX-
M"B`\=&0@=F%L:6=N/3-$=&]P/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O
M;3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#AP="<^)B-X03`[)B-X03`[
M/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XD/"]T9#X-"B`\
M=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^-3(L.3$X+#,R-SPO
M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^)B-X
M03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T
M>6QE/3-$)T9/3E0M4TE:13H@.'!T)SXF(WA!,#LF(WA!,#L\+V9O;G0^/"]T
M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B0\+W1D/@T*(#QT9"!V86QI9VX]
M,T1B;W1T;VT@86QI9VX],T1R:6=H=#XQ,2PP,#8L,SDR/"]T9#X-"B`\=&0@
M=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XF(WA!,#LF(WA!,#L\
M+W1D/@T*(#PO='(^#0H@/'1R('-T>6QE/3-$)T9/3E0M4TE:13H@,7!X)SX-
M"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O
M='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^
M#0H@/'`@<W1Y;&4],T0G0D]21$52+51/4#H@(S`P,#`P,"`S<'@@9&]U8FQE
M)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*
M(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,W!X(&1O=6)L92<^
M)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/'1D('9A
M;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX]
M,T1B;W1T;VT^#0H@/'`@<W1Y;&4],T0G0D]21$52+51/4#H@(S`P,#`P,"`S
M<'@@9&]U8FQE)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$
M8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,W!X
M(&1O=6)L92<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^
M#0H@/"]T<CX-"B`\+W1A8FQE/@T*(#PO9&EV/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT
M;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?-3<Q9C,R-C%?,3`Q95\T-C`Y7V$X
M8V5?8C9F93=A,&(T930Y#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z
M+S4W,68S,C8Q7S$P,65?-#8P.5]A.&-E7V(V9F4W83!B-&4T.2]7;W)K<VAE
M971S+U-H965T,3@N:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@
M<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H
M87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%
M5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O
M:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A
M<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O
M;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L
M92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$4R1CX-"B`@("`@(#QT<CX-"B`@
M("`@("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^
M/'-T<F]N9SY,;V%N(&9A8VEL:71Y("A486)L97,I/&)R/CPO<W1R;VYG/CPO
M=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/C,@36]N
M=&AS($5N9&5D/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(^#0H@("`@
M("`@(#QT:"!C;&%S<STS1'1H/DUA<BX@,S$L(#(P,30\8G(^/"]T:#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^1&5B="!$:7-C;&]S
M=7)E(%M!8G-T<F%C=%T\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/E-C:&5D=6QE(&]F($QO86X@1F%C:6QI='D\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\9&EV/@T*(#QT86)L92!S='EL
M93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@
M4F]M86X[($)/4D1%4BU#3TQ,05!313H@8V]L;&%P<V4G(&-E;&QS<&%C:6YG
M/3-$,"!C96QL<&%D9&EN9STS1#`@=VED=&@],T0V."4@86QI9VX],T1C96YT
M97(@8F]R9&5R/3-$,#X-"B`\='(^#0H@/'1D('=I9'1H/3-$.#0E/CPO=&0^
M#0H@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$S)3X\+W1D/@T*(#QT
M9#X\+W1D/@T*(#QT9#X\+W1D/@T*(#QT9#X\+W1D/@T*(#PO='(^#0H@/'1R
M('-T>6QE/3-$)T9/3E0M4TE:13H@.'!T.R!&3TY4+49!34E,63H@5&EM97,@
M3F5W(%)O;6%N)SX-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^
M#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT
M9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI9"<@
M=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R(&%L:6=N/3-$8V5N=&5R/CQB
M/D%-3U5.5#PO8CX\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[
M/"]T9#X-"B`\+W1R/@T*(#QT<B!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[
M($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XG(&)G8V]L;W(],T0C0T-%
M149&/@T*(#QT9"!V86QI9VX],T1T;W`^#0H@/'`@<W1Y;&4],T0G1D].5"U3
M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!-05)'
M24XM3$5&5#H@,65M.R!415A4+4E.1$5.5#H@+3%E;2<^#0H@0D%,04Y#128C
M>#(P,30[2F%N=6%R>28C>$$P.S$L(#(P,3,\+W`^#0H@/"]T9#X-"B`\=&0@
M=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG
M;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^)#PO=&0^#0H@/'1D('9A;&EG
M;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`@86QI9VX],T1R:6=H=#X-"B`F
M(W@R,#$T.R8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O
M;2!N;W=R87`],T1N;W=R87`^)B-X03`[)B-X03`[/"]T9#X-"B`\+W1R/@T*
M(#QT<B!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4
M:6UE<R!.97<@4F]M86XG/@T*(#QT9"!V86QI9VX],T1T;W`^#0H@/'`@<W1Y
M;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W
M(%)O;6%N.R!-05)'24XM3$5&5#H@,V5M.R!415A4+4E.1$5.5#H@+3%E;2<^
M#0H@0F%N:R!L;V%N(&-A<V@@<F5C96EV960@+2!/8W1O8F5R)B-X03`[,S`L
M(#(P,3,\+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P
M.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D
M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XR+#4P,"PP
M,#`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W<F%P/3-$;F]W<F%P
M/B8C>$$P.R8C>$$P.SPO=&0^#0H@/"]T<CX-"B`\='(@<W1Y;&4],T0G1D].
M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!B
M9V-O;&]R/3-$(T-#145&1CX-"B`\=&0@=F%L:6=N/3-$=&]P/@T*(#QP('-T
M>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE
M=R!2;VUA;CL@34%21TE.+4Q%1E0Z(#-E;3L@5$585"U)3D1%3E0Z("TQ96TG
M/@T*(%=A<G)A;G0@9&ES8V]U;G0\+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N
M/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O
M='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX]
M,T1R:6=H=#XH,C(V+#(U-3PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N
M;W=R87`],T1N;W=R87`^*28C>$$P.SPO=&0^#0H@/"]T<CX-"B`\='(@<W1Y
M;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W
M(%)O;6%N)SX-"B`\=&0@=F%L:6=N/3-$=&]P/@T*(#QP('-T>6QE/3-$)T9/
M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@
M34%21TE.+4Q%1E0Z(#-E;3L@5$585"U)3D1%3E0Z("TQ96TG/@T*($9I;F%N
M8VEN9R!C;W-T<SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^
M)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P
M.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/C$R
M+#<T-#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R
M87`^)B-X03`[)B-X03`[/"]T9#X-"B`\+W1R/@T*(#QT<B!S='EL93TS1"=&
M3TY4+5-)6D4Z(#%P>"<^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D/@T*
M(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@
M=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P
M,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0@=F%L
M:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P
M,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0^)B-X03`[
M/"]T9#X-"B`\+W1R/@T*(#QT<B!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[
M($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XG(&)G8V]L;W(],T0C0T-%
M149&/@T*(#QT9"!V86QI9VX],T1T;W`^#0H@/'`@<W1Y;&4],T0G1D].5"U3
M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!-05)'
M24XM3$5&5#H@,65M.R!415A4+4E.1$5.5#H@+3%E;2<^#0H@0D%,04Y#128C
M>#(P,30[1&5C96UB97(F(WA!,#LS,2P@,C`Q,SPO<#X-"B`\+W1D/@T*(#QT
M9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`X
M<'0G/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B
M;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N
M/3-$<FEG:'0^,BPR.#8L-#@Y/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M
M(&YO=W)A<#TS1&YO=W)A<#XF(WA!,#LF(WA!,#L\+W1D/@T*(#PO='(^#0H@
M/'1R('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I
M;65S($YE=R!2;VUA;B<^#0H@/'1D('9A;&EG;CTS1'1O<#X-"B`\<"!S='EL
M93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@
M4F]M86X[($U!4D=)3BU,1494.B`S96T[(%1%6%0M24Y$14Y4.B`M,65M)SX-
M"B!!8V-R=65D(&EN=&5R97-T/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS
M1&)O='1O;3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#AP="<^)B-X03`[
M)B-X03`[/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!
M,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XY
M+#@T-#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R
M87`^)B-X03`[)B-X03`[/"]T9#X-"B`\+W1R/@T*(#QT<B!S='EL93TS1"=&
M3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XG
M(&)G8V]L;W(],T0C0T-%149&/@T*(#QT9"!V86QI9VX],T1T;W`^#0H@/'`@
M<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@
M3F5W(%)O;6%N.R!-05)'24XM3$5&5#H@,V5M.R!415A4+4E.1$5.5#H@+3%E
M;2<^#0H@06-C<F5T:6]N(&]F('=A<G)A;G0@9&ES8V]U;G0\+W`^#0H@/"]T
M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)T9/3E0M
M4TE:13H@.'!T)SXF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L
M:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O
M;2!A;&EG;CTS1')I9VAT/C(Q,RPU,3$\+W1D/@T*(#QT9"!V86QI9VX],T1B
M;W1T;VT@;F]W<F%P/3-$;F]W<F%P/B8C>$$P.R8C>$$P.SPO=&0^#0H@/"]T
M<CX-"B`\='(@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,
M63H@5&EM97,@3F5W(%)O;6%N)SX-"B`\=&0@=F%L:6=N/3-$=&]P/@T*(#QP
M('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S
M($YE=R!2;VUA;CL@34%21TE.+4Q%1E0Z(#-E;3L@5$585"U)3D1%3E0Z("TQ
M96TG/@T*(%)E<&%Y;65N="!F964@86YD('!E;F%L='D\+W`^#0H@/"]T9#X-
M"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:
M13H@.'!T)SXF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N
M/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A
M;&EG;CTS1')I9VAT/C$P,"PP,#`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T
M;VT@;F]W<F%P/3-$;F]W<F%P/B8C>$$P.R8C>$$P.SPO=&0^#0H@/"]T<CX-
M"B`\='(@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@
M5&EM97,@3F5W(%)O;6%N)R!B9V-O;&]R/3-$(T-#145&1CX-"B`\=&0@=F%L
M:6=N/3-$=&]P/@T*(#QP('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].
M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@34%21TE.+4Q%1E0Z(#-E;3L@
M5$585"U)3D1%3E0Z("TQ96TG/@T*(%)E<&%Y;65N="!O9B!B86YK(&QO86X@
M86YD(&EN=&5R97-T/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O
M;3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#AP="<^)B-X03`[)B-X03`[
M/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D
M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XH,BPV,#DL
M.#0T/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A
M<#XI)B-X03`[/"]T9#X-"B`\+W1R/@T*(#QT<B!S='EL93TS1"=&3TY4+5-)
M6D4Z(#%P>"<^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D/@T*(#QT9"!V
M86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N
M/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@
M,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$
M8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X
M('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0^)B-X03`[/"]T9#X-
M"B`\+W1R/@T*(#QT<B!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M
M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XG/@T*(#QT9"!V86QI9VX],T1T;W`^
M#0H@/'`@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@
M5&EM97,@3F5W(%)O;6%N.R!-05)'24XM3$5&5#H@,65M.R!415A4+4E.1$5.
M5#H@+3%E;2<^#0H@0D%,04Y#128C>#(P,30[36%R8V@F(WA!,#LS,2P@,C`Q
M-#PO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y
M;&4],T0G1D].5"U325I%.B`X<'0G/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D
M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W<F%P/3-$;F]W<F%P/B0\+W1D
M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W<F%P/3-$;F]W<F%P(&%L:6=N
M/3-$<FEG:'0^#0H@)B-X,C`Q-#LF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V
M86QI9VX],T1B;W1T;VT@;F]W<F%P/3-$;F]W<F%P/B8C>$$P.R8C>$$P.SPO
M=&0^#0H@/"]T<CX-"B`\='(@<W1Y;&4],T0G1D].5"U325I%.B`Q<'@G/@T*
M(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T
M=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-
M"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#-P>"!D;W5B;&4G
M/B8C>$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@
M/'`@<W1Y;&4],T0G0D]21$52+51/4#H@(S`P,#`P,"`S<'@@9&]U8FQE)SXF
M(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0^)B-X03`[/"]T9#X-"B`\+W1R/@T*
M(#PO=&%B;&4^#0H@/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y3=6UM87)Y(&]F($)A;FL@3&]A;B!&86-I
M;&ET>3PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQD:78^#0H@
M/'1A8FQE('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ
M(%1I;65S($YE=R!2;VUA;CL@0D]21$52+4-/3$Q!4%-%.B!C;VQL87!S92<@
M8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!W:61T:#TS1#<V)2!A
M;&EG;CTS1&-E;G1E<B!B;W)D97(],T0P/@T*(#QT<CX-"B`\=&0@=VED=&@]
M,T0V-B4^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3$E
M/CPO=&0^#0H@/'1D/CPO=&0^#0H@/'1D/CPO=&0^#0H@/'1D/CPO=&0^#0H@
M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$Q)3X\+W1D/@T*(#QT9#X\
M+W1D/@T*(#QT9#X\+W1D/@T*(#QT9#X\+W1D/@T*(#PO='(^#0H@/'1R/@T*
M(#QT9#X\+W1D/@T*(#QT9"!C;VQS<&%N/3-$-#X\+W1D/@T*(#QT9"!C;VQS
M<&%N/3-$-#X\+W1D/@T*(#PO='(^#0H@/'1R('-T>6QE/3-$)T9/3E0M4TE:
M13H@.'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)SX-"B`\=&0@
M=F%L:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O
M='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!S='EL93TS1"="3U)$15(M
M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M(&-O
M;'-P86X],T0R(&%L:6=N/3-$8V5N=&5R/CQB/DU!4D-()B-X03`[,S$L)B-X
M03`[,C`Q-#PO8CX\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[
M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^
M#0H@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!T('-O
M;&ED)R!V86QI9VX],T1B;W1T;VT@8V]L<W!A;CTS1#(@86QI9VX],T1C96YT
M97(^/&(^1$5#14U"15(F(WA!,#LS,2P\+V(^/&)R("\^#0H@/&(^,C`Q,SPO
M8CX\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\
M+W1R/@T*(#QT<B!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-
M24Q9.B!4:6UE<R!.97<@4F]M86XG(&)G8V]L;W(],T0C0T-%149&/@T*(#QT
M9"!V86QI9VX],T1T;W`^#0H@/'`@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T
M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!-05)'24XM3$5&5#H@
M,65M.R!415A4+4E.1$5.5#H@+3%E;2<^#0H@4VAO<G0M=&5R;2!P;W)T:6]N
M(&]F(&)A;FL@;&]A;CPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T
M;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO
M=W)A<#TS1&YO=W)A<#XD/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO
M=W)A<#TS1&YO=W)A<"!A;&EG;CTS1')I9VAT/@T*("8C>#(P,30[)B-X03`[
M)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO
M=W)A<#XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^
M)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B0\+W1D
M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XR-3`L,#`P
M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XF
M(WA!,#LF(WA!,#L\+W1D/@T*(#PO='(^#0H@/'1R('-T>6QE/3-$)T9/3E0M
M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;B<^#0H@
M/'1D('9A;&EG;CTS1'1O<#X-"B`\<"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P
M<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86X[($U!4D=)3BU,1494
M.B`Q96T[(%1%6%0M24Y$14Y4.B`M,65M)SX-"B!,;VYG+71E<FT@<&]R=&EO
M;B!O9B!B86YK(&QO86X\+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T
M=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N
M;W=R87`],T1N;W=R87`^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T
M=&]M(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1')I9VAT/@T*("8C>#(P,30[
M)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A
M<#TS1&YO=W)A<#XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B
M;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M
M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I
M9VAT/C(L,#,V+#0X.3PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R
M87`],T1N;W=R87`^)B-X03`[)B-X03`[/"]T9#X-"B`\+W1R/@T*(#QT<B!S
M='EL93TS1"=&3TY4+5-)6D4Z(#%P>"<^#0H@/'1D('9A;&EG;CTS1&)O='1O
M;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T
M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%
M4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X-
M"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU4
M3U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\
M=&0^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C
M>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS
M1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*
M(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="
M3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO
M=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/"]T<CX-"B`\='(@<W1Y;&4],T0G
M1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N
M)R!B9V-O;&]R/3-$(T-#145&1CX-"B`\=&0@=F%L:6=N/3-$=&]P/CPO=&0^
M#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=&3TY4+5-)
M6D4Z(#AP="<^)B-X03`[)B-X03`[/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG
M;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^)#PO=&0^#0H@/'1D('9A;&EG
M;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`@86QI9VX],T1R:6=H=#X-"B`F
M(W@R,#$T.R8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O
M;2!N;W=R87`],T1N;W=R87`^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L
M:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@.'!T)SXF
M(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M
M/B0\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XR
M+#(X-BPT.#D\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W<F%P/3-$
M;F]W<F%P/B8C>$$P.R8C>$$P.SPO=&0^#0H@/"]T<CX-"B`\='(@<W1Y;&4]
M,T0G1D].5"U325I%.B`Q<'@G/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T
M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@
M/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0
M.B`C,#`P,#`P(#-P>"!D;W5B;&4G/B8C>$$P.SPO<#X-"B`\+W1D/@T*(#QT
M9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@<W1Y;&4],T0G0D]21$52+51/4#H@
M(S`P,#`P,"`S<'@@9&]U8FQE)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0^
M)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P
M.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="
M3U)$15(M5$]0.B`C,#`P,#`P(#-P>"!D;W5B;&4G/B8C>$$P.SPO<#X-"B`\
M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@<W1Y;&4],T0G0D]2
M1$52+51/4#H@(S`P,#`P,"`S<'@@9&]U8FQE)SXF(WA!,#L\+W`^#0H@/"]T
M9#X-"B`\=&0^)B-X03`[/"]T9#X-"B`\+W1R/@T*(#PO=&%B;&4^#0H@/"]D
M:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B
M;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\U
M-S%F,S(V,5\Q,#%E7S0V,#E?83AC95]B-F9E-V$P8C1E-#D-"D-O;G1E;G0M
M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-3<Q9C,R-C%?,3`Q95\T-C`Y7V$X8V5?
M8C9F93=A,&(T930Y+U=O<FMS:&5E=',O4VAE970Q.2YH=&UL#0I#;VYT96YT
M+51R86YS9F5R+45N8V]D:6YG.B!Q=6]T960M<')I;G1A8FQE#0I#;VYT96YT
M+51Y<&4Z('1E>'0O:'1M;#L@8VAA<G-E=#TB=7,M87-C:6DB#0H-"CQH=&UL
M/@T*("`\:&5A9#X-"B`@("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4
M>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R
M:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$
M;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-
M"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P
M14U%/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS
M<&%N/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG/D-O;6UO;B!S=&]C:R`H5&%B
M;&5S*3QB<CX\+W-T<F]N9SX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T
M:"!C;VQS<&%N/3-$,3XS($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y-87(N(#,Q
M+"`R,#$T/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\
M<W1R;VYG/E1E>'0@0FQO8VL@6T%B<W1R86-T73PO<W1R;VYG/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4V-H961U;&4@;V8@5V5I9VAT
M960@079E<F%G92!!<W-U;7!T:6]N<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQD:78^#0H@/'`@<W1Y;&4],T0G34%21TE.+4)/5%1/33H@
M,'!T.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@
M4F]M86X[($U!4D=)3BU43U`Z(#$R<'0G/@T*(%1H92!F86ER('9A;'5E(&]F
M('-T;V-K(&]P=&EO;G,@9W)A;G1E9"!I<R!E<W1I;6%T960@=7-I;F<@=&AE
M#0H@0FQA8VLM4V-H;VQE<R!O<'1I;VX@<')I8VEN9R!M;V1E;"!W:71H('1H
M92!F;VQL;W=I;F<@=V5I9VAT960-"B!A=F5R86=E(&%S<W5M<'1I;VYS.CPO
M<#X-"B`\<"!S='EL93TS1"=-05)'24XM0D]45$]-.B`P<'0[($9/3E0M4TE:
M13H@,3)P=#L@34%21TE.+51/4#H@,'!T)SX-"B`F(WA!,#L\+W`^#0H@/'1A
M8FQE('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I
M;65S($YE=R!2;VUA;CL@0D]21$52+4-/3$Q!4%-%.B!C;VQL87!S92<@8V5L
M;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!W:61T:#TS1#@T)2!A;&EG
M;CTS1&-E;G1E<B!B;W)D97(],T0P/@T*(#QT<CX-"B`\=&0@=VED=&@],T0U
M,24^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,30E/CPO
M=&0^#0H@/'1D/CPO=&0^#0H@/'1D/CPO=&0^#0H@/'1D/CPO=&0^#0H@/'1D
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$T)3X\+W1D/@T*(#QT9#X\+W1D
M/@T*(#QT9#X\+W1D/@T*(#QT9#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Q-"4^/"]T9#X-"B`\=&0^/"]T9#X-"B`\=&0^/"]T9#X-
M"B`\=&0^/"]T9#X-"B`\+W1R/@T*(#QT<B!S='EL93TS1"=&3TY4+5-)6D4Z
M(#AP=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;B<^#0H@/'1D('9A
M;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T
M;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@<W1Y;&4],T0G0D]21$52+4)/
M5%1/33H@(S`P,#`P,"`Q<'0@<V]L:60G('9A;&EG;CTS1&)O='1O;2!C;VQS
M<&%N/3-$,B!A;&EG;CTS1&-E;G1E<CX\8CY42%)%128C>$$P.TU/3E1(4SQB
M<B`O/@T*($5.1$5$/&)R("\^#0H@34%20T@@,S$L(#(P,30\+V(^/"]T9#X-
M"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG
M;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!S='EL93TS1"="3U)$15(M
M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M(&-O
M;'-P86X],T0R(&%L:6=N/3-$8V5N=&5R/CQB/E1(4D5%)B-X03`[34].5$A3
M/&)R("\^#0H@14Y$140\8G(@+SX-"B!-05)#2"`S,2P@,C`Q,SPO8CX\+W1D
M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L
M:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('-T>6QE/3-$
M)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!T('-O;&ED)R!V86QI9VX],T1B
M;W1T;VT@8V]L<W!A;CTS1#(@86QI9VX],T1C96YT97(^/&(^1$5#14U"15(@
M,C8L/&)R("\^#0H@,C`P,SQB<B`O/@T*("A)3D-%4%1)3TXI)B-X03`[5$\\
M8G(@+SX-"B!-05)#2"`S,2P@,C`Q-#PO8CX\+W1D/@T*(#QT9"!V86QI9VX]
M,T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\+W1R/@T*(#QT<B!S='EL93TS1"=&
M3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XG
M(&)G8V]L;W(],T0C0T-%149&/@T*(#QT9"!V86QI9VX],T1T;W`^#0H@/'`@
M<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@
M3F5W(%)O;6%N.R!-05)'24XM3$5&5#H@,65M.R!415A4+4E.1$5.5#H@+3%E
M;2<^#0H@17AP96-T960@=F]L871I;&ET>3PO<#X-"B`\+W1D/@T*(#QT9"!V
M86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N
M/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A
M;&EG;CTS1')I9VAT/C$P.#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N
M;W=R87`],T1N;W=R87`^)28C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O
M='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[
M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^3D$\
M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W<F%P/3-$;F]W<F%P/B8C
M>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF
M(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-
M"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^.#@\+W1D/@T*
M(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W<F%P/3-$;F]W<F%P/B4F(WA!,#L\
M+W1D/@T*(#PO='(^#0H@/'1R('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@
M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;B<^#0H@/'1D('9A;&EG;CTS
M1'1O<#X-"B`\<"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-
M24Q9.B!4:6UE<R!.97<@4F]M86X[($U!4D=)3BU,1494.B`Q96T[(%1%6%0M
M24Y$14Y4.B`M,65M)SX-"B!%>'!E8W1E9"!D:79I9&5N9',\+W`^#0H@/"]T
M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@
M/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX]
M,T1B;W1T;VT@86QI9VX],T1R:6=H=#XP/"]T9#X-"B`\=&0@=F%L:6=N/3-$
M8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XE)B-X03`[/"]T9#X-"B`\=&0@=F%L
M:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O
M;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R
M:6=H=#Y.03PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N
M;W=R87`^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M
M/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!
M,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XP
M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XE
M)B-X03`[/"]T9#X-"B`\+W1R/@T*(#QT<B!S='EL93TS1"=&3TY4+5-)6D4Z
M(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XG(&)G8V]L;W(]
M,T0C0T-%149&/@T*(#QT9"!V86QI9VX],T1T;W`^#0H@/'`@<W1Y;&4],T0G
M1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N
M.R!-05)'24XM3$5&5#H@,65M.R!415A4+4E.1$5.5#H@+3%E;2<^#0H@17AP
M96-T960@=&5R;7,@*'EE87)S*3PO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX]
M,T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T
M=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS
M1')I9VAT/C8N,#`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W<F%P
M/3-$;F]W<F%P/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O
M='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[
M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^3D$\
M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W<F%P/3-$;F]W<F%P/B8C
M>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF
M(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-
M"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^-BXR-#PO=&0^
M#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^)B-X03`[
M)B-X03`[/"]T9#X-"B`\+W1R/@T*(#QT<B!S='EL93TS1"=&3TY4+5-)6D4Z
M(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XG/@T*(#QT9"!V
M86QI9VX],T1T;W`^#0H@/'`@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&
M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!-05)'24XM3$5&5#H@,65M
M.R!415A4+4E.1$5.5#H@+3%E;2<^#0H@4FES:R!F<F5E(')A=&4\+W`^#0H@
M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^
M#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI
M9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XQ+C4R/"]T9#X-"B`\=&0@=F%L
M:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XE)B-X03`[/"]T9#X-"B`\
M=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS
M1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI
M9VX],T1R:6=H=#Y.03PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R
M87`],T1N;W=R87`^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$
M8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O
M;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R
M:6=H=#XR+CDV/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS
M1&YO=W)A<#XE)B-X03`[/"]T9#X-"B`\+W1R/@T*(#QT<B!S='EL93TS1"=&
M3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XG
M(&)G8V]L;W(],T0C0T-%149&/@T*(#QT9"!V86QI9VX],T1T;W`^#0H@/'`@
M<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@
M3F5W(%)O;6%N.R!-05)'24XM3$5&5#H@,65M.R!415A4+4E.1$5.5#H@+3%E
M;2<^#0H@5V5I9VAT960@879E<F%G92!G<F%N="UD871E(&9A:7(@=F%L=64@
M;V8@<W1O8VL@;W!T:6]N<SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B
M;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M
M/B0\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XY
M+C`U/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A
M<#XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X
M03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@
M/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/DY!/"]T9#X-"B`\
M=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XF(WA!,#LF(WA!
M,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T
M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B0\+W1D/@T*(#QT9"!V86QI9VX]
M,T1B;W1T;VT@86QI9VX],T1R:6=H=#XT+C(S/"]T9#X-"B`\=&0@=F%L:6=N
M/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XF(WA!,#LF(WA!,#L\+W1D/@T*
M(#PO='(^#0H@/"]T86)L93X-"B`\+V1I=CX\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL
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M<V5T/2)U<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!
M(&AT='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT
M;6P[(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C
M<FEP="!S<F,],T13:&]W+FIS/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM
M96YT("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@
M8VQA<W,],T1R97!O<G0@:60],T1)1#!%,D8^#0H@("`@("`\='(^#0H@("`@
M("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O=W-P86X],T0R/CQS
M=')O;F<^3F5T(&QO<W,@<&5R('-H87)E("A486)L97,I/&)R/CPO<W1R;VYG
M/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/C,@
M36]N=&AS($5N9&5D/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(^#0H@
M("`@("`@(#QT:"!C;&%S<STS1'1H/DUA<BX@,S$L(#(P,30\8G(^/"]T:#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^16%R;FEN9W,@
M4&5R(%-H87)E(%M!8G-T<F%C=%T\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/E-C:&5D=6QE(&]F($-O;7!U=&%T:6]N(&]F
M($)A<VEC(&%N9"!$:6QU=&5D($5A<FYI;F=S(%!E<B!3:&%R93PO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQD:78^#0H@/'`@<W1Y;&4],T0G
M34%21TE.+4)/5%1/33H@,'!T.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-
M24Q9.B!4:6UE<R!.97<@4F]M86X[($U!4D=)3BU43U`Z(#$R<'0G/@T*(%1H
M92!D971A:6P@;V8@=&AE(&-O;7!U=&%T:6]N(&]F(&)A<VEC(&%N9"!D:6QU
M=&5D(&5A<FYI;F=S('!E<@T*('-H87)E(&ES(&%S(&9O;&QO=W,Z/"]P/@T*
M(#QP('-T>6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P=#L@1D].5"U325I%.B`Q
M,G!T.R!-05)'24XM5$]0.B`P<'0G/@T*("8C>$$P.SPO<#X-"B`\=&%B;&4@
M<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@
M3F5W(%)O;6%N.R!"3U)$15(M0T],3$%04T4Z(&-O;&QA<'-E)R!C96QL<W!A
M8VEN9STS1#`@8V5L;'!A9&1I;F<],T0P('=I9'1H/3-$.#0E(&%L:6=N/3-$
M8V5N=&5R(&)O<F1E<CTS1#`^#0H@/'1R/@T*(#QT9"!W:61T:#TS1#4Q)3X\
M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)3X\+W1D/@T*
M(#QT9#X\+W1D/@T*(#QT9#X\+W1D/@T*(#QT9#X\+W1D/@T*(#QT9"!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0W)3X\+W1D/@T*(#QT9#X\+W1D/@T*(#QT
M9#X\+W1D/@T*(#QT9#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0W)3X\+W1D/@T*(#QT9#X\+W1D/@T*(#QT9#X\+W1D/@T*(#QT9#X\
M+W1D/@T*(#PO='(^#0H@/'1R('-T>6QE/3-$)T9/3E0M4TE:13H@.'!T.R!&
M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)SX-"B`\=&0@=F%L:6=N/3-$
M8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!
M,#LF(WA!,#L\+W1D/@T*(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C
M,#`P,#`P(#%P="!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R
M(&%L:6=N/3-$8V5N=&5R/CQB/E1(4D5%)B-X03`[34].5$A3/&)R("\^#0H@
M14Y$140\8G(@+SX-"B!-05)#2"`S,2P@,C`Q-#PO8CX\+W1D/@T*(#QT9"!V
M86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T
M=&]M/B8C>$$P.SPO=&0^#0H@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ
M(",P,#`P,#`@,7!T('-O;&ED)R!V86QI9VX],T1B;W1T;VT@8V]L<W!A;CTS
M1#(@86QI9VX],T1C96YT97(^/&(^5$A2144F(WA!,#M-3TY42%,\8G(@+SX-
M"B!%3D1%1#QB<B`O/@T*($U!4D-((#,Q+"`R,#$S/"]B/CPO=&0^#0H@/'1D
M('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B
M;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/
M33H@(S`P,#`P,"`Q<'0@<V]L:60G('9A;&EG;CTS1&)O='1O;2!C;VQS<&%N
M/3-$,B!A;&EG;CTS1&-E;G1E<CX\8CY$14-%34)%4B8C>$$P.S(V+#QB<B`O
M/@T*(#(P,#,\8G(@+SX-"B`H24Y#15!424].*28C>$$P.U1//&)R("\^#0H@
M34%20T@@,S$L(#(P,30\+V(^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M
M/B8C>$$P.SPO=&0^#0H@/"]T<CX-"B`\='(@<W1Y;&4],T0G1D].5"U325I%
M.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!B9V-O;&]R
M/3-$(T-#145&1CX-"B`\=&0@=F%L:6=N/3-$=&]P/@T*(#QP('-T>6QE/3-$
M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA
M;CL@34%21TE.+4Q%1E0Z(#%E;3L@5$585"U)3D1%3E0Z("TQ96TG/@T*(#QB
M/CQI/DYU;65R871O<CPO:3X\+V(^/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG
M;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B
M;W1T;VT^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D
M('9A;&EG;CTS1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^
M)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D
M('9A;&EG;CTS1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^
M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D
M('9A;&EG;CTS1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^
M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/"]T<CX-"B`\
M='(@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM
M97,@3F5W(%)O;6%N)SX-"B`\=&0@=F%L:6=N/3-$=&]P/@T*(#QP('-T>6QE
M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2
M;VUA;CL@34%21TE.+4Q%1E0Z(#%E;3L@5$585"U)3D1%3E0Z("TQ96TG/@T*
M($YE="!L;W-S(&%N9"!C;VUP<F5H96YS:79E(&QO<W,@:6YC=7)R960@:6X@
M=&AE(&1E=F5L;W!M96YT#0H@<W1A9V4\+W`^#0H@/"]T9#X-"B`\=&0@=F%L
M:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS
M1&)O='1O;3XD/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$
M<FEG:'0^*#0L,C(W+#8W.#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N
M;W=R87`],T1N;W=R87`^*28C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O
M='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)#PO=&0^
M#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/B@Q+#`Q,"PR
M-C<\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W<F%P/3-$;F]W<F%P
M/BDF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T
M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B0\+W1D/@T*(#QT9"!V86QI9VX]
M,T1B;W1T;VT@86QI9VX],T1R:6=H=#XH-3$L-3`R+#4X-SPO=&0^#0H@/'1D
M('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^*28C>$$P.SPO=&0^
M#0H@/"]T<CX-"B`\='(@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4
M+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!B9V-O;&]R/3-$(T-#145&1CX-
M"B`\=&0@=F%L:6=N/3-$=&]P/@T*(#QP('-T>6QE/3-$)T9/3E0M4TE:13H@
M,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@34%21TE.+4Q%
M1E0Z(#%E;3L@5$585"U)3D1%3E0Z("TQ96TG/@T*($%C8W)E=&EO;B!F;W(@
M;&EQ=6ED871I;VX@<')E9F5R96YC92!O;B!P<F5F97)R960@<W1O8VL\+W`^
M#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO
M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V
M86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XH,2PQ,S(L.#DS/"]T9#X-
M"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XI)B-X03`[
M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D
M('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B
M;W1T;VT@86QI9VX],T1R:6=H=#XH,2PQ-3<L.#8U/"]T9#X-"B`\=&0@=F%L
M:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XI)B-X03`[/"]T9#X-"B`\
M=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS
M1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI
M9VX],T1R:6=H=#XH,3@L-38V+#`P.#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O
M='1O;2!N;W=R87`],T1N;W=R87`^*28C>$$P.SPO=&0^#0H@/"]T<CX-"B`\
M='(@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM
M97,@3F5W(%)O;6%N)SX-"B`\=&0@=F%L:6=N/3-$=&]P/@T*(#QP('-T>6QE
M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2
M;VUA;CL@34%21TE.+4Q%1E0Z(#%E;3L@5$585"U)3D1%3E0Z("TQ96TG/@T*
M($%C8W)E=&EO;B!F;W(@<VAA<F4@:7-S=6%N8V4@8V]S=',@;VX@<')E9F5R
M<F5D('-T;V-K/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF
M(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[
M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^*#$Y
M+#4U,#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R
M87`^*28C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\
M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@
M=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^*#0T+#,P-SPO=&0^#0H@
M/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^*28C>$$P.SPO
M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V
M86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T
M=&]M(&%L:6=N/3-$<FEG:'0^*#$L,#$T+#8V-SPO=&0^#0H@/'1D('9A;&EG
M;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^*28C>$$P.SPO=&0^#0H@/"]T
M<CX-"B`\='(@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,
M63H@5&EM97,@3F5W(%)O;6%N)R!B9V-O;&]R/3-$(T-#145&1CX-"B`\=&0@
M=F%L:6=N/3-$=&]P/@T*(#QP('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@
M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@34%21TE.+4Q%1E0Z(#%E
M;3L@5$585"U)3D1%3E0Z("TQ96TG/@T*(%1A>"!E>'!E;G-E(&]N('!R969E
M<G)E9"!S=&]C:SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^
M)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P
M.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/B@Q
M,#`L,CDQ/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO
M=W)A<#XI)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P
M.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT
M9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XH,S0V+#`Y,3PO=&0^
M#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^*28C>$$P
M.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT
M9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$
M8F]T=&]M(&%L:6=N/3-$<FEG:'0^*#$L.#DW+#<P,CPO=&0^#0H@/'1D('9A
M;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^*28C>$$P.SPO=&0^#0H@
M/"]T<CX-"B`\='(@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!
M34E,63H@5&EM97,@3F5W(%)O;6%N)SX-"B`\=&0@=F%L:6=N/3-$=&]P/@T*
M(#QP('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I
M;65S($YE=R!2;VUA;CL@34%21TE.+4Q%1E0Z(#%E;3L@5$585"U)3D1%3E0Z
M("TQ96TG/@T*(%)E=F5R<V%L(&]F('1A>"!P87EA8FQE(&]N('!R969E<G)E
M9"!S=&]C:R!D=64@=&\@8V]N=F5R<VEO;B!O9@T*('!R969E<G)E9"!S=&]C
M:SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X
M03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@
M/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/C$L.#DW+#<P,CPO
M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^)B-X
M03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.SPO
M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^)B-X
M03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A
M<"!A;&EG;CTS1')I9VAT/@T*("8C>#(P,30[)B-X03`[)B-X03`[/"]T9#X-
M"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XF(WA!,#LF
M(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-
M"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG
M;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/C$L.#DW+#<P,CPO=&0^#0H@/'1D
M('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^)B-X03`[)B-X03`[
M/"]T9#X-"B`\+W1R/@T*(#QT<B!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[
M($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XG(&)G8V]L;W(],T0C0T-%
M149&/@T*(#QT9"!V86QI9VX],T1T;W`^#0H@/'`@<W1Y;&4],T0G1D].5"U3
M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!-05)'
M24XM3$5&5#H@,65M.R!415A4+4E.1$5.5#H@+3%E;2<^#0H@17AT:6YG=6ES
M:&UE;G0@;V8@<F5M86EN:6YG('-H87)E(&ES<W5A;F-E(&-O<W1S(&1U92!T
M;R!C;VYV97)S:6]N#0H@;V8@<')E9F5R<F5D('-T;V-K/"]P/@T*(#PO=&0^
M#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT
M9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$
M8F]T=&]M(&%L:6=N/3-$<FEG:'0^*#0S.2PR,C<\+W1D/@T*(#QT9"!V86QI
M9VX],T1B;W1T;VT@;F]W<F%P/3-$;F]W<F%P/BDF(WA!,#L\+W1D/@T*(#QT
M9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$
M8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XF(WA!,#L\+W1D/@T*(#QT9"!V86QI
M9VX],T1B;W1T;VT@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$<FEG:'0^#0H@
M)B-X,C`Q-#LF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T
M;VT@;F]W<F%P/3-$;F]W<F%P/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A
M;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T
M;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$
M<FEG:'0^*#0S.2PR,C<\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W
M<F%P/3-$;F]W<F%P/BDF(WA!,#L\+W1D/@T*(#PO='(^#0H@/'1R('-T>6QE
M/3-$)T9/3E0M4TE:13H@,7!X)SX-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO
M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*
M(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@<W1Y;&4],T0G0D]21$52+51/
M4#H@(S`P,#`P,"`Q<'@@<V]L:60G/B8C>$$P.SPO<#X-"B`\+W1D/@T*(#QT
M9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@<W1Y;&4],T0G0D]21$52+51/4#H@
M(S`P,#`P,"`Q<'@@<V]L:60G/B8C>$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF
M(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-
M"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU4
M3U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\
M=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z
M(",P,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0^
M)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^
M#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M
M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@
M/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0
M.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D
M/B8C>$$P.SPO=&0^#0H@/"]T<CX-"B`\='(@<W1Y;&4],T0G1D].5"U325I%
M.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)SX-"B`\=&0@
M=F%L:6=N/3-$=&]P/@T*(#QP('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@
M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@34%21TE.+4Q%1E0Z(#%E
M;3L@5$585"U)3D1%3E0Z("TQ96TG/@T*(%1O=&%L(&QO<W,@871T<FEB=71A
M8FQE('1O(&-O;6UO;B!S=&]C:VAO;&1E<G,\+W`^#0H@/"]T9#X-"B`\=&0@
M=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@.'!T
M)SXF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T
M=&]M/B0\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H
M=#XH-"PP,C$L.3,W/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A
M<#TS1&YO=W)A<#XI)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M
M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@.'!T)SXF(WA!,#L\+V9O;G0^
M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B0\+W1D/@T*(#QT9"!V86QI
M9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XH,BPU-3@L-3,P/"]T9#X-"B`\
M=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XI)B-X03`[/"]T
M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)T9/3E0M
M4TE:13H@.'!T)SXF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$
M8F]T=&]M/B0\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R
M:6=H=#XH-S$L-3(R+#0X.3PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N
M;W=R87`],T1N;W=R87`^*28C>$$P.SPO=&0^#0H@/"]T<CX-"B`\='(@<W1Y
M;&4],T0G1D].5"U325I%.B`Q<'@G/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^
M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^
M#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M
M5$]0.B`C,#`P,#`P(#-P>"!D;W5B;&4G/B8C>$$P.SPO<#X-"B`\+W1D/@T*
M(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@<W1Y;&4],T0G0D]21$52+51/
M4#H@(S`P,#`P,"`S<'@@9&]U8FQE)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\
M=&0^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.SPO
M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$
M15(M5$]0.B`C,#`P,#`P(#-P>"!D;W5B;&4G/B8C>$$P.SPO<#X-"B`\+W1D
M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@<W1Y;&4],T0G0D]21$52
M+51/4#H@(S`P,#`P,"`S<'@@9&]U8FQE)SXF(WA!,#L\+W`^#0H@/"]T9#X-
M"B`\=&0^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P
M.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="
M3U)$15(M5$]0.B`C,#`P,#`P(#-P>"!D;W5B;&4G/B8C>$$P.SPO<#X-"B`\
M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@<W1Y;&4],T0G0D]2
M1$52+51/4#H@(S`P,#`P,"`S<'@@9&]U8FQE)SXF(WA!,#L\+W`^#0H@/"]T
M9#X-"B`\=&0^)B-X03`[/"]T9#X-"B`\+W1R/@T*(#QT<B!S='EL93TS1"=&
M3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XG
M(&)G8V]L;W(],T0C0T-%149&/@T*(#QT9"!V86QI9VX],T1T;W`^#0H@/'`@
M<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@
M3F5W(%)O;6%N.R!-05)'24XM3$5&5#H@,65M.R!415A4+4E.1$5.5#H@+3%E
M;2<^#0H@/&(^/&D^1&5N;VUI;F%T;W(\+VD^/"]B/CPO<#X-"B`\+W1D/@T*
M(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%
M.B`X<'0G/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX]
M,T1B;W1T;VT^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@
M/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T
M;VT^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`X<'0G/B8C>$$P.SPO9F]N
M=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\=&0@=F%L
M:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D
M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G1D].5"U3
M25I%.B`X<'0G/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B
M;W1T;VT^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D
M('9A;&EG;CTS1&)O='1O;3X\+W1D/@T*(#PO='(^#0H@/'1R('-T>6QE/3-$
M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA
M;B<^#0H@/'1D('9A;&EG;CTS1'1O<#X-"B`\<"!S='EL93TS1"=&3TY4+5-)
M6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86X[($U!4D=)
M3BU,1494.B`Q96T[(%1%6%0M24Y$14Y4.B`M,65M)SX-"B!796EG:'1E9"!A
M=F5R86=E('-H87)E<R!U<V5D('1O(&-O;7!U=&4@8F%S:6,@;F5T(&QO<W,@
M<&5R(&-O;6UO;@T*('-H87)E/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS
M1&)O='1O;3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#AP="<^)B-X03`[
M)B-X03`[/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!
M,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XS
M+#$T."PT.#$\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W<F%P/3-$
M;F]W<F%P/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O
M;3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#AP="<^)B-X03`[/"]F;VYT
M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT
M9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XS,#$L-S0U/"]T9#X-
M"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XF(WA!,#LF
M(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4]
M,T0G1D].5"U325I%.B`X<'0G/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V
M86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T
M=&]M(&%L:6=N/3-$<FEG:'0^,SDX+#4W,SPO=&0^#0H@/'1D('9A;&EG;CTS
M1&)O='1O;2!N;W=R87`],T1N;W=R87`^)B-X03`[)B-X03`[/"]T9#X-"B`\
M+W1R/@T*(#QT<B!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-
M24Q9.B!4:6UE<R!.97<@4F]M86XG(&)G8V]L;W(],T0C0T-%149&/@T*(#QT
M9"!V86QI9VX],T1T;W`^#0H@/'`@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T
M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!-05)'24XM3$5&5#H@
M,65M.R!415A4+4E.1$5.5#H@+3%E;2<^#0H@169F96-T(&]F('!O=&5N=&EA
M;&QY(&1I;'5T:79E('-E8W5R:71I97,Z/"]P/@T*(#PO=&0^#0H@/'1D('9A
M;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#AP="<^
M)B-X03`[)B-X03`[/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O
M;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\=&0@=F%L
M:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N
M="!S='EL93TS1"=&3TY4+5-)6D4Z(#AP="<^)B-X03`[/"]F;VYT/CPO=&0^
M#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B
M;W1T;VT^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D
M('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#AP
M="<^)B-X03`[/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\
M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\=&0@=F%L:6=N
M/3-$8F]T=&]M/CPO=&0^#0H@/"]T<CX-"B`\='(@<W1Y;&4],T0G1D].5"U3
M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)SX-"B`\
M=&0@=F%L:6=N/3-$=&]P/@T*(#QP('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P
M=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@34%21TE.+4Q%1E0Z
M(#-E;3L@5$585"U)3D1%3E0Z("TQ96TG/@T*(%-T;V-K(&]P=&EO;G,\+W`^
M#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$
M)T9/3E0M4TE:13H@.'!T)SXF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\
M=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XF(WA!,#L\+W1D
M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W<F%P/3-$;F]W<F%P(&%L:6=N
M/3-$<FEG:'0^#0H@)B-X,C`Q-#LF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V
M86QI9VX],T1B;W1T;VT@;F]W<F%P/3-$;F]W<F%P/B8C>$$P.R8C>$$P.SPO
M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=&3TY4
M+5-)6D4Z(#AP="<^)B-X03`[/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS
M1&)O='1O;2!N;W=R87`],T1N;W=R87`^)B-X03`[/"]T9#X-"B`\=&0@=F%L
M:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1')I9VAT/@T*
M("8C>#(P,30[)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T
M=&]M(&YO=W)A<#TS1&YO=W)A<#XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V
M86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`X<'0G
M/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W
M<F%P/3-$;F]W<F%P/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O
M;2!N;W=R87`],T1N;W=R87`@86QI9VX],T1R:6=H=#X-"B`F(W@R,#$T.R8C
M>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`]
M,T1N;W=R87`^)B-X03`[)B-X03`[/"]T9#X-"B`\+W1R/@T*(#QT<B!S='EL
M93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@
M4F]M86XG(&)G8V]L;W(],T0C0T-%149&/@T*(#QT9"!V86QI9VX],T1T;W`^
M#0H@/'`@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@
M5&EM97,@3F5W(%)O;6%N.R!-05)'24XM3$5&5#H@,V5M.R!415A4+4E.1$5.
M5#H@+3%E;2<^#0H@0V]M;6]N('-T;V-K('=A<G)A;G1S/"]P/@T*(#PO=&0^
M#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=&3TY4+5-)
M6D4Z(#AP="<^)B-X03`[)B-X03`[/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG
M;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^)B-X03`[/"]T9#X-"B`\=&0@
M=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1')I9VAT
M/@T*("8C>#(P,30[)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$
M8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT
M9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`X
M<'0G/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@
M;F]W<F%P/3-$;F]W<F%P/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O
M='1O;2!N;W=R87`],T1N;W=R87`@86QI9VX],T1R:6=H=#X-"B`F(W@R,#$T
M.R8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R
M87`],T1N;W=R87`^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$
M8F]T=&]M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@.'!T)SXF(WA!,#L\
M+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO
M=W)A<#XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W<F%P
M/3-$;F]W<F%P(&%L:6=N/3-$<FEG:'0^#0H@)B-X,C`Q-#LF(WA!,#LF(WA!
M,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W<F%P/3-$;F]W<F%P
M/B8C>$$P.R8C>$$P.SPO=&0^#0H@/"]T<CX-"B`\='(@<W1Y;&4],T0G1D].
M5"U325I%.B`Q<'@G/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\
M=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A
M;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P
M,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG
M;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P
M(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO
M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V
M86QI9VX],T1B;W1T;VT^#0H@/'`@<W1Y;&4],T0G0D]21$52+51/4#H@(S`P
M,#`P,"`Q<'@@<V]L:60G/B8C>$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI
M9VX],T1B;W1T;VT^#0H@/'`@<W1Y;&4],T0G0D]21$52+51/4#H@(S`P,#`P
M,"`Q<'@@<V]L:60G/B8C>$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\
M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@
M=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P
M,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0@=F%L
M:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P
M,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0^)B-X03`[
M/"]T9#X-"B`\+W1R/@T*(#QT<B!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[
M($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XG/@T*(#QT9"!V86QI9VX]
M,T1T;W`^#0H@/'`@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!
M34E,63H@5&EM97,@3F5W(%)O;6%N.R!-05)'24XM3$5&5#H@,65M.R!415A4
M+4E.1$5.5#H@+3%E;2<^#0H@5V5I9VAT960@879E<F%G92!S:&%R97,@=7-E
M9"!T;R!C;VUP=71E(&1I;'5T960@;F5T(&QO<W,@<&5R(&-O;6UO;@T*('-H
M87)E/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S
M='EL93TS1"=&3TY4+5-)6D4Z(#AP="<^)B-X03`[)B-X03`[/"]F;VYT/CPO
M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V
M86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XS+#$T."PT.#$\+W1D/@T*
M(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W<F%P/3-$;F]W<F%P/B8C>$$P.R8C
M>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS
M1"=&3TY4+5-)6D4Z(#AP="<^)B-X03`[/"]F;VYT/CPO=&0^#0H@/'1D('9A
M;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T
M;VT@86QI9VX],T1R:6=H=#XS,#$L-S0U/"]T9#X-"B`\=&0@=F%L:6=N/3-$
M8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT
M9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`X
M<'0G/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^
M)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$<FEG
M:'0^,SDX+#4W,SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`]
M,T1N;W=R87`^)B-X03`[)B-X03`[/"]T9#X-"B`\+W1R/@T*(#QT<B!S='EL
M93TS1"=&3TY4+5-)6D4Z(#%P>"<^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\
M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-
M"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU4
M3U`Z(",P,#`P,#`@,W!X(&1O=6)L92<^)B-X03`[/"]P/@T*(#PO=&0^#0H@
M/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0
M.B`C,#`P,#`P(#-P>"!D;W5B;&4G/B8C>$$P.SPO<#X-"B`\+W1D/@T*(#QT
M9#XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T
M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%
M4BU43U`Z(",P,#`P,#`@,W!X(&1O=6)L92<^)B-X03`[/"]P/@T*(#PO=&0^
M#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M
M5$]0.B`C,#`P,#`P(#-P>"!D;W5B;&4G/B8C>$$P.SPO<#X-"B`\+W1D/@T*
M(#QT9#XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[
M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/
M4D1%4BU43U`Z(",P,#`P,#`@,W!X(&1O=6)L92<^)B-X03`[/"]P/@T*(#PO
M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$
M15(M5$]0.B`C,#`P,#`P(#-P>"!D;W5B;&4G/B8C>$$P.SPO<#X-"B`\+W1D
M/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#PO='(^#0H@/'1R('-T>6QE/3-$)T9/
M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;B<@
M8F=C;VQO<CTS1"-#0T5%1D8^#0H@/'1D('9A;&EG;CTS1'1O<#X-"B`\<"!S
M='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.
M97<@4F]M86X[($U!4D=)3BU,1494.B`Q96T[(%1%6%0M24Y$14Y4.B`M,65M
M)SX-"B!.970@;&]S<R!P97(@<VAA<F4@871T<FEB=71A8FQE('1O(&-O;6UO
M;@T*('-T;V-K:&]L9&5R<R8C>#(P,30[8F%S:6,\+W`^#0H@/"]T9#X-"B`\
M=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@
M.'!T)SXF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$
M8F]T=&]M/B0\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R
M:6=H=#XH,2XR.#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`]
M,T1N;W=R87`^*28C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\
M9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#AP="<^)B-X03`[/"]F;VYT/CPO
M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XD/"]T9#X-"B`\=&0@=F%L:6=N
M/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^*#@N-#@\+W1D/@T*(#QT9"!V86QI
M9VX],T1B;W1T;VT@;F]W<F%P/3-$;F]W<F%P/BDF(WA!,#L\+W1D/@T*(#QT
M9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`X
M<'0G/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^
M)#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/B@Q
M-SDN-#4\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W<F%P/3-$;F]W
M<F%P/BDF(WA!,#L\+W1D/@T*(#PO='(^#0H@/'1R('-T>6QE/3-$)T9/3E0M
M4TE:13H@,7!X)SX-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D
M('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI
M9VX],T1B;W1T;VT^#0H@/'`@<W1Y;&4],T0G0D]21$52+51/4#H@(S`P,#`P
M,"`S<'@@9&]U8FQE)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N
M/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@
M,W!X(&1O=6)L92<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO
M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V
M86QI9VX],T1B;W1T;VT^#0H@/'`@<W1Y;&4],T0G0D]21$52+51/4#H@(S`P
M,#`P,"`S<'@@9&]U8FQE)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0@=F%L
M:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P
M,#`@,W!X(&1O=6)L92<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P
M.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT
M9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@<W1Y;&4],T0G0D]21$52+51/4#H@
M(S`P,#`P,"`S<'@@9&]U8FQE)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0@
M=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P
M,#`P,#`@,W!X(&1O=6)L92<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C
M>$$P.SPO=&0^#0H@/"]T<CX-"B`\='(@<W1Y;&4],T0G1D].5"U325I%.B`Q
M,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)SX-"B`\=&0@=F%L
M:6=N/3-$=&]P/@T*(#QP('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].
M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@34%21TE.+4Q%1E0Z(#%E;3L@
M5$585"U)3D1%3E0Z("TQ96TG/@T*($YE="!L;W-S('!E<B!S:&%R92!A='1R
M:6)U=&%B;&4@=&\@8V]M;6]N#0H@<W1O8VMH;VQD97)S)B-X,C`Q-#MD:6QU
M=&5D/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S
M='EL93TS1"=&3TY4+5-)6D4Z(#AP="<^)B-X03`[)B-X03`[/"]F;VYT/CPO
M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XD/"]T9#X-"B`\=&0@=F%L:6=N
M/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^*#$N,C@\+W1D/@T*(#QT9"!V86QI
M9VX],T1B;W1T;VT@;F]W<F%P/3-$;F]W<F%P/BDF(WA!,#L\+W1D/@T*(#QT
M9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`X
M<'0G/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^
M)#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/B@X
M+C0X/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A
M<#XI)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T
M>6QE/3-$)T9/3E0M4TE:13H@.'!T)SXF(WA!,#L\+V9O;G0^/"]T9#X-"B`\
M=&0@=F%L:6=N/3-$8F]T=&]M/B0\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T
M;VT@86QI9VX],T1R:6=H=#XH,3<Y+C0U/"]T9#X-"B`\=&0@=F%L:6=N/3-$
M8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XI)B-X03`[/"]T9#X-"B`\+W1R/@T*
M(#QT<B!S='EL93TS1"=&3TY4+5-)6D4Z(#%P>"<^#0H@/'1D('9A;&EG;CTS
M1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X
M03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$
M)T)/4D1%4BU43U`Z(",P,#`P,#`@,W!X(&1O=6)L92<^)B-X03`[/"]P/@T*
M(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="
M3U)$15(M5$]0.B`C,#`P,#`P(#-P>"!D;W5B;&4G/B8C>$$P.SPO<#X-"B`\
M+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^
M)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE
M/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,W!X(&1O=6)L92<^)B-X03`[/"]P
M/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS
M1"="3U)$15(M5$]0.B`C,#`P,#`P(#-P>"!D;W5B;&4G/B8C>$$P.SPO<#X-
M"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T
M;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T
M>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,W!X(&1O=6)L92<^)B-X03`[
M/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL
M93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#-P>"!D;W5B;&4G/B8C>$$P.SPO
M<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#PO='(^#0H@/"]T86)L
M93X-"B`\+V1I=CX\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/E-C:&5D=6QE(&]F($%N=&ED:6QU=&EV92!396-U<FET
M:65S($5X8VQU9&5D(&9R;VT@0V]M<'5T871I;VX@;V8@0F%S:6,@86YD($1I
M;'5T960@3F5T($QO<W,@4&5R(%-H87)E/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/&1I=CX-"B`\<"!S='EL93TS1"=-05)'24XM0D]45$]-
M.B`P<'0[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE
M=R!2;VUA;CL@34%21TE.+51/4#H@,3)P="<^#0H@5&AE(&9O;&QO=VEN9R!H
M879E(&)E96X@97AC;'5D960@9G)O;2!T:&4@8V]M<'5T871I;VX@;V8@8F%S
M:6,@86YD#0H@9&EL=71E9"!N970@;&]S<R!P97(@<VAA<F4@87,@=&AE:7(@
M969F96-T('=O=6QD(&AA=F4@8F5E;@T*(&%N=&ED:6QU=&EV93H\+W`^#0H@
M/'`@<W1Y;&4],T0G34%21TE.+4)/5%1/33H@,'!T.R!&3TY4+5-)6D4Z(#$R
M<'0[($U!4D=)3BU43U`Z(#!P="<^#0H@)B-X03`[/"]P/@T*(#QT86)L92!S
M='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.
M97<@4F]M86X[($)/4D1%4BU#3TQ,05!313H@8V]L;&%P<V4G(&-E;&QS<&%C
M:6YG/3-$,"!C96QL<&%D9&EN9STS1#`@=VED=&@],T0W-B4@86QI9VX],T1C
M96YT97(@8F]R9&5R/3-$,#X-"B`\='(^#0H@/'1D('=I9'1H/3-$-C0E/CPO
M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$P)3X\+W1D/@T*
M(#QT9#X\+W1D/@T*(#QT9#X\+W1D/@T*(#QT9#X\+W1D/@T*(#QT9"!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Q,"4^/"]T9#X-"B`\=&0^/"]T9#X-"B`\
M=&0^/"]T9#X-"B`\=&0^/"]T9#X-"B`\+W1R/@T*(#QT<B!S='EL93TS1"=&
M3TY4+5-)6D4Z(#AP=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;B<^
M#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI
M9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@<W1Y;&4],T0G
M0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'0@<V]L:60G('9A;&EG;CTS1&)O
M='1O;2!C;VQS<&%N/3-$,B!A;&EG;CTS1&-E;G1E<CX\8CY42%)%128C>$$P
M.TU/3E1(4SQB<B`O/@T*($5.1$5$/"]B/CQB<B`O/@T*(#QB/DU!4D-((#,Q
M+"`R,#$T/"]B/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\
M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-
M"B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'0@<V]L
M:60G('9A;&EG;CTS1&)O='1O;2!C;VQS<&%N/3-$,B!A;&EG;CTS1&-E;G1E
M<CX\8CY42%)%128C>$$P.TU/3E1(4SQB<B`O/@T*($5.1$5$/"]B/CQB<B`O
M/@T*(#QB/DU!4D-((#,Q+"`R,#$S/"]B/CPO=&0^#0H@/'1D('9A;&EG;CTS
M1&)O='1O;3XF(WA!,#L\+W1D/@T*(#PO='(^#0H@/'1R('-T>6QE/3-$)T9/
M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;B<@
M8F=C;VQO<CTS1"-#0T5%1D8^#0H@/'1D('9A;&EG;CTS1'1O<#X-"B`\<"!S
M='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.
M97<@4F]M86X[($U!4D=)3BU,1494.B`Q96T[(%1%6%0M24Y$14Y4.B`M,65M
M)SX-"B!#;VYV97)T:6)L92!P<F5F97)R960@<W1O8VL\+W`^#0H@/"]T9#X-
M"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D
M('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^)B-X03`[/"]T9#X-
M"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS
M1')I9VAT/@T*("8C>#(P,30[)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L
M:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XF(WA!,#LF(WA!,#L\+W1D
M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\
M=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS
M1&)O='1O;2!A;&EG;CTS1')I9VAT/C4L-3(U+#@T-#PO=&0^#0H@/'1D('9A
M;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^)B-X03`[)B-X03`[/"]T
M9#X-"B`\+W1R/@T*(#QT<B!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/
M3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XG/@T*(#QT9"!V86QI9VX],T1T
M;W`^#0H@/'`@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,
M63H@5&EM97,@3F5W(%)O;6%N.R!-05)'24XM3$5&5#H@,65M.R!415A4+4E.
M1$5.5#H@+3%E;2<^#0H@3W5T<W1A;F1I;F<@<W1O8VL@;W!T:6]N<SPO<#X-
M"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T
M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A
M;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/C8S,"PQ-3D\+W1D/@T*(#QT
M9"!V86QI9VX],T1B;W1T;VT@;F]W<F%P/3-$;F]W<F%P/B8C>$$P.R8C>$$P
M.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D
M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L
M:6=N/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^-#,U+#$T,3PO=&0^#0H@/'1D
M('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^)B-X03`[)B-X03`[
M/"]T9#X-"B`\+W1R/@T*(#QT<B!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[
M($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86XG(&)G8V]L;W(],T0C0T-%
M149&/@T*(#QT9"!V86QI9VX],T1T;W`^#0H@/'`@<W1Y;&4],T0G1D].5"U3
M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!-05)'
M24XM3$5&5#H@,65M.R!415A4+4E.1$5.5#H@+3%E;2<^#0H@0V]M;6]N('-T
M;V-K('=A<G)A;G1S/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O
M;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X
M03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^
M,3$L,S8S/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO
M=W)A<#XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^
M)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A
M<#TS1&YO=W)A<#XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@
M;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$<FEG:'0^#0H@)B-X,C`Q-#LF(WA!
M,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W<F%P/3-$
M;F]W<F%P/B8C>$$P.R8C>$$P.SPO=&0^#0H@/"]T<CX-"B`\='(@<W1Y;&4]
M,T0G1D].5"U325I%.B`Q<'@G/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T
M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@
M/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0
M.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D
M('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C
M,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C
M>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\
M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@<W1Y;&4],T0G0D]2
M1$52+51/4#H@(S`P,#`P,"`Q<'@@<V]L:60G/B8C>$$P.SPO<#X-"B`\+W1D
M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@<W1Y;&4],T0G0D]21$52
M+51/4#H@(S`P,#`P,"`Q<'@@<V]L:60G/B8C>$$P.SPO<#X-"B`\+W1D/@T*
M(#QT9#XF(WA!,#L\+W1D/@T*(#PO='(^#0H@/'1R('-T>6QE/3-$)T9/3E0M
M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;B<^#0H@
M/'1D('9A;&EG;CTS1'1O<#X-"B`\<"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P
M<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86X[($U!4D=)3BU,1494
M.B`Q96T[(%1%6%0M24Y$14Y4.B`M,65M)SX-"B!4;W1A;#PO<#X-"B`\+W1D
M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G1D].5"U3
M25I%.B`X<'0G/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI
M9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M
M(&%L:6=N/3-$<FEG:'0^-C0Q+#4R,CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O
M='1O;2!N;W=R87`],T1N;W=R87`^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@
M=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@.'!T
M)SXF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T
M=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS
M1')I9VAT/C4L.38P+#DX-3PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N
M;W=R87`],T1N;W=R87`^)B-X03`[)B-X03`[/"]T9#X-"B`\+W1R/@T*(#QT
M<B!S='EL93TS1"=&3TY4+5-)6D4Z(#%P>"<^#0H@/'1D('9A;&EG;CTS1&)O
M='1O;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[
M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/
M4D1%4BU43U`Z(",P,#`P,#`@,W!X(&1O=6)L92<^)B-X03`[/"]P/@T*(#PO
M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$
M15(M5$]0.B`C,#`P,#`P(#-P>"!D;W5B;&4G/B8C>$$P.SPO<#X-"B`\+W1D
M/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X
M03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T
M>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,W!X(&1O=6)L92<^)B-X03`[
M/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL
M93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#-P>"!D;W5B;&4G/B8C>$$P.SPO
M<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#PO='(^#0H@/"]T86)L
M93X-"B`\+V1I=CX\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE
M>'1087)T7S4W,68S,C8Q7S$P,65?-#8P.5]A.&-E7V(V9F4W83!B-&4T.0T*
M0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B\U-S%F,S(V,5\Q,#%E7S0V
M,#E?83AC95]B-F9E-V$P8C1E-#DO5V]R:W-H965T<R]3:&5E=#(Q+FAT;6P-
M"D-O;G1E;G0M5')A;G-F97(M16YC;V1I;F<Z('%U;W1E9"UP<FEN=&%B;&4-
M"D-O;G1E;G0M5'EP93H@=&5X="]H=&UL.R!C:&%R<V5T/2)U<RUA<V-I:2(-
M"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#
M;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F
M+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W
M+FIS/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^
M/"]H96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@
M:60],T1)1#!%344^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS
M1'1L(&-O;'-P86X],T0Q(')O=W-P86X],T0R/CQS=')O;F<^1FEN86YC:6%L
M(&EN<W1R=6UE;G1S("A486)L97,I/&)R/CPO<W1R;VYG/CPO=&@^#0H@("`@
M("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/C,@36]N=&AS($5N9&5D
M/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C
M;&%S<STS1'1H/DUA<BX@,S$L(#(P,30\8G(^/"]T:#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^26YV97-T;65N=',@06QL($]T:&5R
M($EN=F5S=&UE;G1S(%M!8G-T<F%C=%T\+W-T<F]N9SX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/D9A:7(@5F%L=64@;V8@4VEG;FEF:6-A
M;G0@56YO8G-E<G9A8FQE($EN<'5T<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQD:78^#0H@/'`@<W1Y;&4],T0G34%21TE.+4)/5%1/33H@
M,'!T.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@
M4F]M86X[($U!4D=)3BU43U`Z(#$X<'0G/@T*(#QB/D9A:7(@=F%L=64@;V8@
M<VEG;FEF:6-A;G0@=6YO8G-E<G9A8FQE(&EN<'5T<R`H3&5V96P@,RD\+V(^
M/"]P/@T*(#QP('-T>6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P=#L@1D].5"U3
M25I%.B`Q,G!T.R!-05)'24XM5$]0.B`P<'0G/@T*("8C>$$P.SPO<#X-"B`\
M=&%B;&4@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@
M5&EM97,@3F5W(%)O;6%N.R!"3U)$15(M0T],3$%04T4Z(&-O;&QA<'-E)R!C
M96QL<W!A8VEN9STS1#`@8V5L;'!A9&1I;F<],T0P('=I9'1H/3-$.#0E(&%L
M:6=N/3-$8V5N=&5R(&)O<F1E<CTS1#`^#0H@/'1R/@T*(#QT9"!W:61T:#TS
M1#8R)3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0V)3X\
M+W1D/@T*(#QT9#X\+W1D/@T*(#QT9#X\+W1D/@T*(#QT9#X\+W1D/@T*(#QT
M9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0V)3X\+W1D/@T*(#QT9#X\+W1D
M/@T*(#QT9#X\+W1D/@T*(#QT9#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0V)3X\+W1D/@T*(#QT9#X\+W1D/@T*(#QT9#X\+W1D/@T*
M(#QT9#X\+W1D/@T*(#PO='(^#0H@/'1R('-T>6QE/3-$)T9/3E0M4TE:13H@
M.'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)SX-"B`\=&0@=F%L
M:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O
M;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!S='EL93TS1"="3U)$15(M0D]4
M5$]-.B`C,#`P,#`P(#%P="!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P
M86X],T0R(&%L:6=N/3-$8V5N=&5R/CQB/D)!3DL@3$]!3CQB<B`O/@T*(%=!
M4E)!3E0\8G(@+SX-"B!$15))5D%4259%/&)R("\^#0H@3$E!0DE,251)15,\
M+V(^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@
M/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!S='EL93TS
M1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI9"<@=F%L:6=N/3-$
M8F]T=&]M(&-O;'-P86X],T0R(&%L:6=N/3-$8V5N=&5R/CQB/E!2149%4E)%
M1#QB<B`O/@T*(%-43T-+/&)R("\^#0H@14U"141$140\8G(@+SX-"B!$15))
M5D%4259%/&)R("\^#0H@3$E!0DE,251)15,\+V(^/"]T9#X-"B`\=&0@=F%L
M:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O
M;3XF(WA!,#L\+W1D/@T*(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C
M,#`P,#`P(#%P="!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R
M(&%L:6=N/3-$8V5N=&5R/CQB/E1/5$%,/"]B/CPO=&0^#0H@/'1D('9A;&EG
M;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#PO='(^#0H@/'1R('-T>6QE/3-$
M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA
M;B<@8F=C;VQO<CTS1"-#0T5%1D8^#0H@/'1D('9A;&EG;CTS1'1O<#X-"B`\
M<"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE
M<R!.97<@4F]M86X[($U!4D=)3BU,1494.B`Q96T[(%1%6%0M24Y$14Y4.B`M
M,65M)SX-"B!"04Q!3D-%4R8C>#(P,30[2F%N=6%R>28C>$$P.S$L(#(P,30\
M+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P
M.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XD/"]T9#X-"B`\=&0@=F%L
M:6=N/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^,C(Q+#,R,#PO=&0^#0H@/'1D
M('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^)B-X03`[)B-X03`[
M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D
M('9A;&EG;CTS1&)O='1O;3XD/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M
M(&%L:6=N/3-$<FEG:'0^.#`P+#(P-CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O
M='1O;2!N;W=R87`],T1N;W=R87`^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@
M=F%L:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O
M='1O;3XD/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$<FEG
M:'0^,2PP,C$L-3(V/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A
M<#TS1&YO=W)A<#XF(WA!,#LF(WA!,#L\+W1D/@T*(#PO='(^#0H@/'1R('-T
M>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE
M=R!2;VUA;B<^#0H@/'1D('9A;&EG;CTS1'1O<#X-"B`\<"!S='EL93TS1"=&
M3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86X[
M($U!4D=)3BU,1494.B`S96T[(%1%6%0M24Y$14Y4.B`M,65M)SX-"B!#:&%N
M9V4@:6X@9F%I<B!V86QU92!O9B!D97)I=F%T:79E(&QI86)I;&ET:65S/"]P
M/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\
M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@
M=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$<FEG:'0^*#$Q,RPW,C,\+W1D/@T*
M(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W<F%P/3-$;F]W<F%P/BDF(WA!,#L\
M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@
M=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XF(WA!,#L\+W1D/@T*
M(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$
M<FEG:'0^#0H@)B-X,C`Q-#LF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI
M9VX],T1B;W1T;VT@;F]W<F%P/3-$;F]W<F%P/B8C>$$P.R8C>$$P.SPO=&0^
M#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI
M9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M
M(&%L:6=N/3-$<FEG:'0^*#$Q,RPW,C,\+W1D/@T*(#QT9"!V86QI9VX],T1B
M;W1T;VT@;F]W<F%P/3-$;F]W<F%P/BDF(WA!,#L\+W1D/@T*(#PO='(^#0H@
M/'1R('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I
M;65S($YE=R!2;VUA;B<@8F=C;VQO<CTS1"-#0T5%1D8^#0H@/'1D('9A;&EG
M;CTS1'1O<#X-"B`\<"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M
M1D%-24Q9.B!4:6UE<R!.97<@4F]M86X[($U!4D=)3BU,1494.B`S96T[(%1%
M6%0M24Y$14Y4.B`M,65M)SX-"B!$97)E8V]G;FET:6]N(&]F(&QI86)I;&ET
M:65S('5P;VX@<')E9F5R<F5D('-T;V-K(&-O;G9E<G-I;VX@=&\-"B!C;VUM
M;VX@<W1O8VL@8V]N=F5R<VEO;CPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX]
M,T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T
M=&]M(&YO=W)A<#TS1&YO=W)A<#XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX]
M,T1B;W1T;VT@;F]W<F%P/3-$;F]W<F%P(&%L:6=N/3-$<FEG:'0^#0H@)B-X
M,C`Q-#LF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@
M;F]W<F%P/3-$;F]W<F%P/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG
M;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^
M)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$<FEG
M:'0^*#@P,"PR,#8\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W<F%P
M/3-$;F]W<F%P/BDF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^
M)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^
M#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/B@X,#`L,C`V
M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XI
M)B-X03`[/"]T9#X-"B`\+W1R/@T*(#QT<B!S='EL93TS1"=&3TY4+5-)6D4Z
M(#%P>"<^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI
M9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$
M8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X
M('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T
M=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O
M;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0^)B-X03`[/"]T9#X-"B`\
M=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS
M1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P
M>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O
M='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S
M;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@
M/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX]
M,T1B;W1T;VT^#0H@/'`@<W1Y;&4],T0G0D]21$52+51/4#H@(S`P,#`P,"`Q
M<'@@<V]L:60G/B8C>$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B
M;W1T;VT^#0H@/'`@<W1Y;&4],T0G0D]21$52+51/4#H@(S`P,#`P,"`Q<'@@
M<V]L:60G/B8C>$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*
M(#PO='(^#0H@/'1R('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&
M04U)3%DZ(%1I;65S($YE=R!2;VUA;B<^#0H@/'1D('9A;&EG;CTS1'1O<#X-
M"B`\<"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4
M:6UE<R!.97<@4F]M86X[($U!4D=)3BU,1494.B`Q96T[(%1%6%0M24Y$14Y4
M.B`M,65M)SX-"B!"04Q!3D-%4R8C>#(P,30[36%R8V@F(WA!,#LS,2P@,C`Q
M-#PO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y
M;&4],T0G1D].5"U325I%.B`X<'0G/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D
M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)#PO=&0^#0H@/'1D('9A;&EG;CTS
M1&)O='1O;2!A;&EG;CTS1')I9VAT/C$P-RPU.3<\+W1D/@T*(#QT9"!V86QI
M9VX],T1B;W1T;VT@;F]W<F%P/3-$;F]W<F%P/B8C>$$P.R8C>$$P.SPO=&0^
M#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=&3TY4+5-)
M6D4Z(#AP="<^)B-X03`[/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O
M='1O;2!N;W=R87`],T1N;W=R87`^)#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O
M='1O;2!N;W=R87`],T1N;W=R87`@86QI9VX],T1R:6=H=#X-"B`F(W@R,#$T
M.R8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R
M87`],T1N;W=R87`^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$
M8F]T=&]M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@.'!T)SXF(WA!,#L\
M+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B0\+W1D/@T*(#QT
M9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XQ,#<L-3DW/"]T9#X-
M"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XF(WA!,#LF
M(WA!,#L\+W1D/@T*(#PO='(^#0H@/'1R('-T>6QE/3-$)T9/3E0M4TE:13H@
M,7!X)SX-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG
M;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B
M;W1T;VT^#0H@/'`@<W1Y;&4],T0G0D]21$52+51/4#H@(S`P,#`P,"`S<'@@
M9&]U8FQE)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T
M=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,W!X(&1O
M=6)L92<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@
M/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX]
M,T1B;W1T;VT^#0H@/'`@<W1Y;&4],T0G0D]21$52+51/4#H@(S`P,#`P,"`S
M<'@@9&]U8FQE)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$
M8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,W!X
M(&1O=6)L92<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^
M#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI
M9VX],T1B;W1T;VT^#0H@/'`@<W1Y;&4],T0G0D]21$52+51/4#H@(S`P,#`P
M,"`S<'@@9&]U8FQE)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N
M/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@
M,W!X(&1O=6)L92<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO
M=&0^#0H@/"]T<CX-"B`\+W1A8FQE/@T*(#PO9&EV/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\
M+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?-3<Q9C,R-C%?,3`Q95\T-C`Y
M7V$X8V5?8C9F93=A,&(T930Y#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O
M+T,Z+S4W,68S,C8Q7S$P,65?-#8P.5]A.&-E7V(V9F4W83!B-&4T.2]7;W)K
M<VAE971S+U-H965T,C(N:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN
M9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[
M(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@
M/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E
M>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J
M879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES
M($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT
M86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$5-13X-"B`@("`@(#QT<CX-
M"B`@("`@("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS
M1#(^/'-T<F]N9SY.871U<F4@;V8@;W!E<F%T:6]N<R`M($%D9&ET:6]N86P@
M26YF;W)M871I;VX@*$1E=&%I;"D\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@
M("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^,R!-;VYT:',@16YD960\
M+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L
M87-S/3-$=&@^36%R+B`S,2P@,C`Q-#QB<CX\+W1H/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^/'-T<F]N9SY5;F-A=&5G;W)I>F5D(%M!8G-T<F%C
M=%T\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/D1A=&4@;V8@:6YC;W)P;W)A=&EO;CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^36%Y(#,Q+`T*"0DR,#`W/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-
M"@T*+2TM+2TM/5].97AT4&%R=%\U-S%F,S(V,5\Q,#%E7S0V,#E?83AC95]B
M-F9E-V$P8C1E-#D-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-3<Q
M9C,R-C%?,3`Q95\T-C`Y7V$X8V5?8C9F93=A,&(T930Y+U=O<FMS:&5E=',O
M4VAE970R,RYH=&UL#0I#;VYT96YT+51R86YS9F5R+45N8V]D:6YG.B!Q=6]T
M960M<')I;G1A8FQE#0I#;VYT96YT+51Y<&4Z('1E>'0O:'1M;#L@8VAA<G-E
M=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\345402!H
M='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL
M.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I
M<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N
M="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L
M87-S/3-$<F5P;W)T(&ED/3-$240P14A/044^#0H@("`@("`\='(^#0H@("`@
M("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O=W-P86X],T0R/CQS
M=')O;F<^0V]N9&5N<V5D('-U;6UA<GD@;V8@<VEG;FEF:6-A;G0@86-C;W5N
M=&EN9R!P;VQI8VEE<R`M($%D9&ET:6]N86P@26YF;W)M871I;VX@*$1E=&%I
M;"D@*%531"`D*3QB<CX\+W-T<F]N9SX\+W1H/@T*("`@("`@("`\=&@@8VQA
M<W,],T1T:"!C;VQS<&%N/3-$,3XS($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@
M("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/CPO=&@^#0H@("`@("`@
M(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/CPO=&@^#0H@("`@("`@(#QT
M:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/CPO=&@^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y-87(N(#,Q+"`R
M,#$T/&)R/E-E9VUE;G0\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$
M=&@^1&5C+B`S,2P@,C`Q,SQB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,]
M,T1T:#Y-87(N(#,Q+"`R,#$S/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S
M<STS1'1H/D1E8RX@,S$L(#(P,3(\8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/CQS=')O;F<^4VEG;FEF:6-A;G0@06-C;W5N=&EN9R!0
M;VQI8VEE<R!;3&EN92!)=&5M<UT\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/E1A>"!B96YE9FET<R!R96%L:7IE9"!U
M<&]N('5L=&EM871E('-E='1L96UE;G0L(&1E<V-R:7!T:6]N/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG02!M96%S=7)E;65N="`@871T<FEB
M=71E('1H870@;65A<W5R97,@82!G:79E;B!T87@@<&]S:71I;VX@87,@=&AE
M(&QA<F=E<W0@86UO=6YT(&]F('1A>"`@8F5N969I=',@=&AA="!A<F4@;6]R
M92!T:&%N(#4P)2!L:6ME;'D@;V8@8F5I;F<@<F5A;&EZ960@=7!O;B!U;'1I
M;6%T92`@<V5T=&QE;65N="X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/E!E<F-E;G1A9V4@;V8@=&%X(&)E;F5F
M:70@=7!O;B!S971T;&5M96YT/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XU,"XP,"4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/D]P97)A=&EN9R!S96=M96YT/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XQ/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#87-H(&%N9"!C87-H(&5Q=6EV
M86QE;G1S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#4R+#DQ
M."PS,C<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XD(#$Q+#`P-BPS.3(\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XD(#$Y+#`Q-RPR-3(\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#(L,#`P+#4S.3QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')H/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^56YI
M=&5D(%-T871E<R!;365M8F5R73PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^/'-T<F]N9SY3:6=N:69I8V%N="!!8V-O=6YT:6YG(%!O
M;&EC:65S(%M,:6YE($ET96US73PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^0V%S:"!A;F0@8V%S:"!E<75I=F%L96YT
M<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`U,2PQ,38L-3@V
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M)"`V+#8R.2PS.#,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?
M3F5X=%!A<G1?-3<Q9C,R-C%?,3`Q95\T-C`Y7V$X8V5?8C9F93=A,&(T930Y
M#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+S4W,68S,C8Q7S$P,65?
M-#8P.5]A.&-E7V(V9F4W83!B-&4T.2]7;W)K<VAE971S+U-H965T,C0N:'1M
M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L
M90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI
M(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS
M1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU
M=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H
M;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP
M=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R
M="!I9#TS1$E$,$5,4TA+/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA
M<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG/E)E9&5E
M;6%B;&4@8V]N=F5R=&EB;&4@<')E9F5R<F5D('-T;V-K(&%N9"!S=&]C:VAO
M;&1E<G,G("AD969I8VET*2!E<75I='D@+2!!9&1I=&EO;F%L($EN9F]R;6%T
M:6]N("A$971A:6PI("A54T0@)"D\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@
M("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#(^,"!-;VYT:',@16YD960\
M+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XS($UO
M;G1H<R!%;F1E9#PO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P
M86X],T0Q/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X]
M,T0Q/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q
M/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/CPO
M=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/CPO=&@^
M#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/CPO=&@^#0H@
M("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/CPO=&@^#0H@("`@
M("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/CPO=&@^#0H@("`@("`@
M(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/CPO=&@^#0H@("`@("`@(#QT
M:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/CPO=&@^#0H@("`@("`@(#QT:"!C
M;&%S<STS1'1H(&-O;'-P86X],T0Q/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S
M<STS1'1H(&-O;'-P86X],T0Q/C$@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@
M("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^/"]T:#X-"B`@("`@("`@
M/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^/"]T:#X-"B`@("`@("`@/'1H
M(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^/"]T:#X-"B`@("`@("`@/'1H(&-L
M87-S/3-$=&@@8V]L<W!A;CTS1#$^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S
M/3-$=&@@8V]L<W!A;CTS1#$^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$
M=&@@8V]L<W!A;CTS1#$^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@
M8V]L<W!A;CTS1#$^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L
M<W!A;CTS1#$^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A
M;CTS1#$^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS
M1#$^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^
M/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^,"!-
M;VYT:',@16YD960\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS
M<&%N/3-$,SXS($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`@(#QT:"!C;&%S
M<STS1'1H(&-O;'-P86X],T0Q/C`@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DUA
M<BX@,3(L(#(P,30\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^
M1F5B+B`R-RP@,C`Q-#QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T
M:#Y-87(N(#,Q+"`R,#$T/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS
M1'1H/D1E8RX@,S$L(#(P,3,\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S
M/3-$=&@^36%R+B`Q,BP@,C`Q-#QB<CY!45A0($-A;F%D82!;365M8F5R73QB
M<CY%>&-H86YG96%B;&4@0V]M;6]N(%-T;V-K(%M-96UB97)=/&)R/CPO=&@^
M#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DUA<BX@,S$L(#(P,30\8G(^05%8
M4"!#86YA9&$@6TUE;6)E<ET\8G(^4V5R:65S($$@17AC:&%N9V5A8FQE(%!R
M969E<G)E9"!3:&%R97,@6TUE;6)E<ET\8G(^/"]T:#X-"B`@("`@("`@/'1H
M(&-L87-S/3-$=&@^36%R+B`Q,BP@,C`Q-#QB<CY!45A0($-A;F%D82!;365M
M8F5R73QB<CY397)I97,@02!%>&-H86YG96%B;&4@4')E9F5R<F5D(%-H87)E
M<R!;365M8F5R73QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$
M96,N(#,Q+"`R,#$S/&)R/D%16%`@0V%N861A(%M-96UB97)=/&)R/E-E<FEE
M<R!!($5X8VAA;F=E86)L92!0<F5F97)R960@4VAA<F5S(%M-96UB97)=/&)R
M/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DUA<BX@,S$L(#(P,30\
M8G(^05%84"!#86YA9&$@6TUE;6)E<ET\8G(^05%84"!#86YA9&$L(%-E<FEE
M<R!"($5X8VAA;F=E86)L92!0<F5F97)R960@4VAA<F5S(%M-96UB97)=/&)R
M/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DUA<BX@,3(L(#(P,30\
M8G(^05%84"!#86YA9&$@6TUE;6)E<ET\8G(^05%84"!#86YA9&$L(%-E<FEE
M<R!"($5X8VAA;F=E86)L92!0<F5F97)R960@4VAA<F5S(%M-96UB97)=/&)R
M/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3,\
M8G(^05%84"!#86YA9&$@6TUE;6)E<ET\8G(^05%84"!#86YA9&$L(%-E<FEE
M<R!"($5X8VAA;F=E86)L92!0<F5F97)R960@4VAA<F5S(%M-96UB97)=/&)R
M/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DUA<BX@,S$L(#(P,30\
M8G(^05%84"!#86YA9&$@6TUE;6)E<ET\8G(^4V5R:65S($,@17AC:&%N9V5A
M8FQE(%!R969E<G)E9"!3:&%R97,@6TUE;6)E<ET\8G(^/"]T:#X-"B`@("`@
M("`@/'1H(&-L87-S/3-$=&@^36%R+B`Q,BP@,C`Q-#QB<CY!45A0($-A;F%D
M82!;365M8F5R73QB<CY397)I97,@0R!%>&-H86YG96%B;&4@4')E9F5R<F5D
M(%-H87)E<R!;365M8F5R73QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,]
M,T1T:#Y$96,N(#,Q+"`R,#$S/&)R/D%16%`@0V%N861A(%M-96UB97)=/&)R
M/E-E<FEE<R!#($5X8VAA;F=E86)L92!0<F5F97)R960@4VAA<F5S(%M-96UB
M97)=/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DUA<BX@,S$L
M(#(P,30\8G(^07%U:6YO>"!54T$@6TUE;6)E<ET\8G(^0V]M;6]N(%-T;V-K
M(%M-96UB97)=/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E
M8RX@,S$L(#(P,3,\8G(^07%U:6YO>"!54T$@6TUE;6)E<ET\8G(^0V]M;6]N
M(%-T;V-K(%M-96UB97)=/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS
M1'1H/DUA<BX@,S$L(#(P,30\8G(^07%U:6YO>"!54T$@6TUE;6)E<ET\8G(^
M4V5R:65S($$@4')E9F5R<F5D(%-T;V-K(%M-96UB97)=/&)R/CPO=&@^#0H@
M("`@("`@(#QT:"!C;&%S<STS1'1H/DUA<BX@,3(L(#(P,30\8G(^07%U:6YO
M>"!54T$@6TUE;6)E<ET\8G(^4V5R:65S($$@4')E9F5R<F5D(%-T;V-K(%M-
M96UB97)=/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@
M,S$L(#(P,3,\8G(^07%U:6YO>"!54T$@6TUE;6)E<ET\8G(^4V5R:65S($$@
M4')E9F5R<F5D(%-T;V-K(%M-96UB97)=/&)R/CPO=&@^#0H@("`@("`@(#QT
M:"!C;&%S<STS1'1H/DUA<BX@,S$L(#(P,30\8G(^07%U:6YO>"!54T$@6TUE
M;6)E<ET\8G(^4V5R:65S($(@4')E9F5R<F5D(%-T;V-K(%M-96UB97)=/&)R
M/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DUA<BX@,3(L(#(P,30\
M8G(^07%U:6YO>"!54T$@6TUE;6)E<ET\8G(^4V5R:65S($(@4')E9F5R<F5D
M(%-T;V-K(%M-96UB97)=/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS
M1'1H/D1E8RX@,S$L(#(P,3,\8G(^07%U:6YO>"!54T$@6TUE;6)E<ET\8G(^
M4V5R:65S($(@4')E9F5R<F5D(%-T;V-K(%M-96UB97)=/&)R/CPO=&@^#0H@
M("`@("`@(#QT:"!C;&%S<STS1'1H/DUA<BX@,S$L(#(P,30\8G(^07%U:6YO
M>"!54T$@6TUE;6)E<ET\8G(^4V5R:65S($,@4')E9F5R<F5D(%-T;V-K(%M-
M96UB97)=/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DUA<BX@
M,3(L(#(P,30\8G(^07%U:6YO>"!54T$@6TUE;6)E<ET\8G(^4V5R:65S($,@
M4')E9F5R<F5D(%-T;V-K(%M-96UB97)=/&)R/CPO=&@^#0H@("`@("`@(#QT
M:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3,\8G(^07%U:6YO>"!54T$@6TUE
M;6)E<ET\8G(^4V5R:65S($,@4')E9F5R<F5D(%-T;V-K(%M-96UB97)=/&)R
M/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DUA<BX@,3(L(#(P,30\
M8G(^07%U:6YO>"!54T$@6TUE;6)E<ET\8G(^4F5D965M86)L92!#;VYV97)T
M:6)L92!0<F5F97)R960@4W1O8VL@6TUE;6)E<ET\8G(^/"]T:#X-"B`@("`@
M("`@/'1H(&-L87-S/3-$=&@^36%R+B`Q,BP@,C`Q-#QB<CY5;F1E<G=R:71E
M<G,@6TUE;6)E<ET\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^
M36%R+B`S,2P@,C`Q-#QB<CY3:&%R97,@5')A;G-F97)R960@9G)O;2!!45A0
M($-A;F%D82!T;R!!<75I;F]X(%5302!;365M8F5R73QB<CX\+W1H/@T*("`@
M("`@("`\=&@@8VQA<W,],T1T:#Y-87(N(#,Q+"`R,#$T/&)R/E-H87)E<R!4
M<F%N<V9E<G)E9"!F<F]M($%16%`@0V%N861A('1O($%Q=6EN;W@@55-!(%M-
M96UB97)=/&)R/D-O;6UO;B!3=&]C:R!;365M8F5R73QB<CX\+W1H/@T*("`@
M("`@("`\=&@@8VQA<W,],T1T:#Y-87(N(#,Q+"`R,#$T/&)R/D-O;G9E<G-I
M;VX@;V8@4F5D965M86)L92!#;VYV97)T:6)L92!0<F5F97)R960@4W1O8VL@
M=&\@0V]M;6]N(%-T;V-K(%M-96UB97)=/&)R/D%Q=6EN;W@@55-!(%M-96UB
M97)=/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DUA<BX@,3(L
M(#(P,30\8G(^0V]N=F5R<VEO;B!O9B!2961E96UA8FQE($-O;G9E<G1I8FQE
M(%!R969E<G)E9"!3=&]C:R!T;R!#;VUM;VX@4W1O8VL@6TUE;6)E<ET\8G(^
M07%U:6YO>"!54T$@6TUE;6)E<ET\8G(^0V]M;6]N(%-T;V-K(%M-96UB97)=
M/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG
M/D-L87-S(&]F(%-T;V-K(%M,:6YE($ET96US73PO<W1R;VYG/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^0V]N=F5R<VEO;B!B87-I<R!F;W(@<F5V97)S92!S=&]C
M:R!S<&QI=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG5&AE
M($-O;7!A;GD@969F96-T960@82`Q+69O<BTQ.2XR(')E=F5R<V4@<W1O8VL@
M<W!L:70\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#;VYV97)S:6]N
M(')A=&EO(&]F(')E=F5R<V4@<W1O8VL@<W!L:70\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XP+C`U,C`X,SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C`N,#4R,#@S/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^0V]M;6]N('-T;V-K('-H87)E<R!C;VYV97)S
M:6]N+"!D97-C<FEP=&EO;CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B=%86-H(&]F('1H92`S
M,#$L-S0U(&]U='-T86YD:6YG(&-O;6UO;B!E>&-H86YG96%B;&4@<VAA<F5S
M(&]F($%16%`@0V%N861A('=A<R!T<F%N<V9E<G)E9"!T;R!!<75I;F]X(%53
M02!I;B!E>&-H86YG92!F;W(@;VYE(&-O;6UO;B!S=&]C:R!O9B!!<75I;F]X
M(%5302X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^0V]M;6]N('-T;V-K+"!S:&%R97,@;W5T<W1A;F1I;F<\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS,#$L-S0U/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^,3`L-C<U+#(V,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C,P,2PW-#4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E!R969E<G)E
M9"!S:&%R97,@8V]N=F5R<VEO;BP@9&5S8W)I<'1I;VX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B=%86-H(&]F('1H92`W.3$L,#$V(&]U='-T86YD:6YG(%-E<FEE<R!!(&5X
M8VAA;F=E86)L92!P<F5F97)R960@<VAA<F5S+"`W.3,L-C$W(&]U='-T86YD
M:6YG(%-E<FEE<R!"(&5X8VAA;F=E86)L92!P<F5F97)R960@<VAA<F5S(&%N
M9"`S-S@L-S@V(&]U='-T86YD:6YG(%-E<FEE<R!#(&5X8VAA;F=E86)L92!P
M<F5F97)R960@<VAA<F4@;V8@05%84"!#86YA9&$@=V%S('1R86YS9F5R<F5D
M('1O($%Q=6EN;W@@55-!(&EN(&5X8VAA;F=E(&9O<B!O;F4@<VAA<F4@;V8@
M4V5R:65S($$L($(@86YD($,@8V]N=F5R=&EB;&4@<')E9F5R<F5D('-T;V-K
M(&]F($%Q=6EN;W@@55-!+"!R97-P96-T:79E;'DN($%S(&$@<F5S=6QT+"!F
M;VQL;W=I;F<@<W5C:"!E>&-H86YG92P@=&AE<F4@=V5R92`Q+#0U,RPX.3$@
M<VAA<F5S(&]F(%-E<FEE<R!!+"`R+#,V-RPT,30@<VAA<F5S(&]F(%-E<FEE
M<R!"(&%N9"`Q+#<R,BPR,3`@<VAA<F5S(&]F(%-E<FEE<R!#(&-O;G9E<G1I
M8FQE('!R969E<G)E9"!S=&]C:R!O9B!!<75I;F]X(%5302X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)T%L;"`U+#4T
M,RPU,34@;V8@=&AE("!O=71S=&%N9&EN9R!S:&%R97,@;V8@<F5D965M86)L
M92!C;VYV97)T:6)L92!P<F5F97)R960@<W1O8VL@;V8@07%U:6YO>"!54T$@
M(&-O;G9E<G1E9"!T;R!A;B!E<75I=F%L96YT(&YU;6)E<B!O9B!S:&%R97,@
M;V8@8V]M;6]N('-T;V-K(&]F($%Q=6EN;W@@55-!+CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E)E9&5E;6%B;&4@
M8V]N=F5R=&EB;&4@<')E9F5R<F5D('-T;V-K+"!S:&%R97,@;W5T<W1A;F1I
M;F<\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,#QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C<Y,2PP
M,38\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XW.3$L,#$V/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C<Y,RPV,3<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XW.3,L-C$W/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,#QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,W."PW.#8\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS-S@L-S@V/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XP/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C8V
M,BPX-S4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XP/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C$L-3<S+#<Y-SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^,2PS-#,L-#(T/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-2PU-#,L-3$U/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D-O
M;G9E<G1I8FQE('!R969E<G)E9"!S=&]C:SPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XW.3$L,#$V/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XW.3,L-C$W
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XS-S@L-S@V/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^4F5D965M86)L92!C;VYV97)T:6)L92!P<F5F
M97)R960@<W1O8VLL('-H87)E<R!I<W-U960\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XW.3$L,#$V/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,#QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XW.3,L-C$W/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,#QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS-S@L-S@V
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XP/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^,2PT-3,L.#DQ/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^-C8R+#@W-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XR+#,V-RPT,30\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+#4W,RPW.3<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XP/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,2PW,C(L
M,C$P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^,2PS-#,L-#(T/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y#;VUM;VX@<W1O8VL@<VAA<F5S(&-O;G9E
M<G1E9#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^-2PU-#,L-3$U/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y/=VYE<G-H:7`@<&5R
M8V5N=&%G93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,#`N
M,#`E/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^06-C<G5E9"!T87@@
M<&%Y86)L92!O;B!P<F5F97)R960@<W1O8VL\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^)"`Q+#<Y-RPT,3(\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#$L-SDW+#0Q,CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^1&5R:79A=&EV92!L:6%B:6QI='D@9F]R
M(')E9&5M<'1I;VX@;W!T:6]N(&]N('!R969E<G)E9"!S=&]C:SPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XX,#`L,C`V/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^4VAA<F5S(&]F(&-O;6UO;B!S=&]C:R!S;VQD
M(&EN($E03SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-"PX,S`L
M,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C8S,"PP,#`\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#;VUM
M;VX@<W1O8VL@<VAA<F4@<')I8V4@<&5R('-H87)E/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XD(#$Q/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#Y!9V=R96=A=&4@;F5T('!R;V-E961S(')E8V5I=F5D(&9R;VT@
M;V9F97)I;F<\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C0W+#,T
M,2PR-S0\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E5N9&5R=W)I
M=&EN9R!D:7-C;W5N=',@86YD(&-O;6UI<W-I;VYS(&%N9"!O9F9E<FEN9R!C
M;W-T<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`U+#<X."PW
M,C8\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^)"`U+#<X."PW,C8\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y4
M;W1A;"!N=6UB97(@;V8@<VAA<F5S(&%U=&AO<FEZ960\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C4U+#`P,"PP,#`\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/D-O;6UO;B!S=&]C:RP@<VAA<F5S(&%U=&AO<FEZ
M960\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C4P+#`P,"PP,#`\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^-3`L,#`P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C$S.2PR-C8L,#,W/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y#;VUM;VX@<W1O8VLL('!A<B!V86QU93PO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^)"`P+C`P,#`P,3QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#`N,#`P
M,#`Q/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^)"`P+C`P,#`P,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4')E9F5R<F5D('-T;V-K
M+"!S:&%R97,@875T:&]R:7IE9#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^-2PP,#`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#Y0<F5F97)R960@<W1O8VLL('!A<B!V86QU93PO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^)"`P+C`P,#`P,3QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^4')E9F5R<F5D('-T;V-K+"!S:&%R97,@:7-S=65D/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C`\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XP/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y0<F5F97)R960@<W1O8VLL('-H87)E<R!O=71S
M=&%N9&EN9SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XP/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,#QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^
M#0H-"BTM+2TM+3U?3F5X=%!A<G1?-3<Q9C,R-C%?,3`Q95\T-C`Y7V$X8V5?
M8C9F93=A,&(T930Y#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+S4W
M,68S,C8Q7S$P,65?-#8P.5]A.&-E7V(V9F4W83!B-&4T.2]7;W)K<VAE971S
M+U-H965T,C4N:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O
M=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S
M970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@
M:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M
M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R
M:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE
M;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C
M;&%S<STS1')E<&]R="!I9#TS1$E$,$4R2D%#/@T*("`@("`@/'1R/@T*("`@
M("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$,3X\
M<W1R;VYG/D-A<V@@86YD(&-A<V@@97%U:79A;&5N=',@+2!38VAE9'5L92!O
M9B!C87-H(&%N9"!C87-H(&5Q=6EV86QE;G1S("A$971A:6PI("A54T0@)"D\
M8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^36%R
M+B`S,2P@,C`Q-#QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$
M96,N(#,Q+"`R,#$S/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H
M/DUA<BX@,S$L(#(P,3,\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$
M=&@^1&5C+B`S,2P@,C`Q,CQB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^/'-T<F]N9SY#87-H($%N9"!#87-H($5Q=6EV86QE;G1S(%M!
M8G-T<F%C=%T\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/D-A<V@\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/B0@-#DL-3,X+#@W-#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/B0@-RPR.3(L,3$V/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D-A<V@@97%U:79A;&5N=',\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,L,S<Y+#0U,SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,L-S$T
M+#(W-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F]U/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^0V%S:"!A;F0@8V%S:"!E<75I=F%L96YT<SPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^)"`U,BPY,3@L,S(W/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`Q,2PP,#8L,SDR
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M)"`Q.2PP,3<L,C4R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^)"`R+#`P,"PU,SD\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*
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M/2)U<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT
M='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[
M(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP
M="!S<F,],T13:&]W+FIS/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT
M("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA
M<W,],T1R97!O<G0@:60],T1)1#!%4DM"1SX-"B`@("`@(#QT<CX-"B`@("`@
M("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T
M<F]N9SY,;V%N(&9A8VEL:71Y("T@061D:71I;VYA;"!);F9O<FUA=&EO;B`H
M1&5T86EL*2`H55-$("0I/&)R/CPO<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT
M:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/C,@36]N=&AS($5N9&5D/"]T:#X-
M"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^,3(@36]N=&AS
M($5N9&5D/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS
M1#(^,"!-;VYT:',@16YD960\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T
M:"!C;VQS<&%N/3-$,3XS($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`@(#QT
M:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/CPO=&@^#0H@("`@("`@(#QT:"!C
M;&%S<STS1'1H(&-O;'-P86X],T0R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S
M<STS1'1H(&-O;'-P86X],T0Q/CPO=&@^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y-87(N(#,Q+"`R,#$T/&)R
M/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3,\
M8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^36%R+B`R."P@,C`Q
M-#QB<CY3:6QI8V]N(%9A;&QE>2!"86YK(%M-96UB97)=/&)R/CPO=&@^#0H@
M("`@("`@(#QT:"!C;&%S<STS1'1H/D]C="X@,S`L(#(P,3,\8G(^4VEL:6-O
M;B!686QL97D@0F%N:R!;365M8F5R73QB<CX\+W1H/@T*("`@("`@("`\=&@@
M8VQA<W,],T1T:#Y-87(N(#,Q+"`R,#$T/&)R/E-I;&EC;VX@5F%L;&5Y($)A
M;FL@6TUE;6)E<ET\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^
M1&5C+B`S,2P@,C`Q,SQB<CY3:6QI8V]N(%9A;&QE>2!"86YK(%M-96UB97)=
M/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D]C="X@,C,L(#(P
M,3,\8G(^4VEL:6-O;B!686QL97D@0F%N:R!;365M8F5R73QB<CX\+W1H/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T:#Y/8W0N(#(S+"`R,#$S/&)R/E-I;&EC
M;VX@5F%L;&5Y($)A;FL@6TUE;6)E<ET\8G(^5V%R<F%N=',@=&\@4'5R8VAA
M<V4@4V5R:65S($,@0V]N=F5R=&EB;&4@4')E9F5R<F5D(%-T;V-K(%M-96UB
M97)=/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DUA<BX@,S$L
M(#(P,30\8G(^4VEL:6-O;B!686QL97D@0F%N:R!;365M8F5R73QB<CY787)R
M86YT<R!T;R!0=7)C:&%S92!#;VUM;VX@4W1O8VL@6TUE;6)E<ET\8G(^/"]T
M:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^3&EN92!O
M9B!#<F5D:70@1F%C:6QI='D@6TQI;F4@271E;7-=/"]S=')O;F<^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E1E<FT@;&]A
M;B!F86-I;&ET>2!W:71H(%-I;&EC;VX@5F%L;&5Y($)A;FL\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@-"PP,#`L,#`P/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E1E
M<FT@;&]A;BP@86UO=6YT(&)O<G)O=V5D/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^,BPU,#`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C(L-3`P+#`P,#QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y497)M(&QO
M86X@8F]R<F]W:6YG(&-A<&%C:71Y+"!A=F%I;&%B;&4@=7!O;B!R96-E:79I
M;F<@4&AA<V4@,B!T;W`M;&EN92!D871A(')E<W5L=',\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,2PU,#`L,#`P/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y787)R86YT
M<R!T;R!P=7)C:&%S92!P97(@<VAA<F4\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XQ,"XU-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E=A<G)A;G1S('1O('!U<F-H87-E
M('-H87)E<R!O9B!S=&]C:RP@<VAA<F5S/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^,3$L,S8S/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^5V%R<F%N=',@97AE<F-I<V%B
M;&4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3$L
M,S8S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y787)R86YT(&5X<&ER93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<R,#(S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^5&5R;2!L;V%N(&EN=&5R97-T(')A=&4\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XU+C(U)3QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/E1E<FT@;&]A;BP@<&5R:6]D:6,@<')I;F-I<&%L(')E<&%Y;65N=',\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XX,RPP,#`\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y4
M97)M(&QO86XL(&UA='5R:71Y(&1A=&4\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#Y-87(@,S$L#0H)"3(P,3<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y497)M(&QO86XL
M('!A>6UE;G0@=&5R;7,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG5&AE('1E<FT@;&]A;B!P<FEN8VEP86P@:7,@<F5P87EA8FQE(&EN
M(&UO;G1H;'D@:6YS=&%L;&UE;G1S("!A<'!R;WAI;6%T96QY("0X,RPP,#`@
M8V]M;65N8VEN9R!/8W1O8F5R(#(P,30\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y497)M(&QO86X@<F5P87EM
M96YT/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR+#8P.2PX-#0\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M,BPV,#DL.#0T/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y497)M(&QO86XL(&QO<W,@;VX@97AT:6YG=6ES
M:&UE;G0@;V8@9&5B=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XD(#(Q,RPU,3$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM
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M<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M97%U
M:78],T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S
M970]=71F+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S<F,]
M,T13:&]W+FIS/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO/"]S
M8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R
M97!O<G0@:60],T1)1#!%04=!13X-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H
M(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T<F]N9SY,
M;V%N(&9A8VEL:71Y("T@4V-H961U;&4@;V8@3&]A;B!&86-I;&ET>2`H1&5T
M86EL*2`H55-$("0I/&)R/CPO<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C
M;&%S<STS1'1H(&-O;'-P86X],T0Q/C,@36]N=&AS($5N9&5D/"]T:#X-"B`@
M("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^,3(@36]N=&AS($5N
M9&5D/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^
M,3(S($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y-87(N(#,Q+"`R,#$T/&)R/CPO
M=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3,\8G(^
M/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^36%R+B`S,2P@,C`Q-#QB
M<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY$
M96)T($1I<V-L;W-U<F4@6T%B<W1R86-T73PO<W1R;VYG/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y"96=I;FYI;F<@8F%L86YC93PO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`R+#(X-BPT.#D\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M06-C<G5E9"!I;G1E<F5S=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^.2PX-#0\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^0F%N:R!L;V%N(&-A<V@@<F5C96EV960@+2!/8W1O8F5R
M(#,P+"`R,#$S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,BPU
M,#`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^06-C<F5T:6]N(&]F('=A<G)A;G0@9&ES8V]U;G0\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(Q,RPU,3$\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^5V%R<F%N="!D
M:7-C;W5N=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#(R-BPR
M-34I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^4F5P87EM96YT(&9E92!A;F0@<&5N86QT>3PO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^,3`P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,#`L,#`P/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y&:6YA;F-I;F<@
M8V]S=',\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,BPW-#0\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#Y297!A>6UE;G0@;V8@8F%N:R!L;V%N(&%N9"!I;G1E<F5S=#PO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,BPV,#DL.#0T*3QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y%;F1I;F<@
M8F%L86YC93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)R9N8G-P
M.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/B0@,BPR.#8L-#@Y/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\
M+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?-3<Q9C,R-C%?,3`Q95\T-C`Y
M7V$X8V5?8C9F93=A,&(T930Y#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O
M+T,Z+S4W,68S,C8Q7S$P,65?-#8P.5]A.&-E7V(V9F4W83!B-&4T.2]7;W)K
M<VAE971S+U-H965T,C@N:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN
M9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[
M(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@
M/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E
M>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J
M879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES
M($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT
M86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$4V0T%#/@T*("`@("`@/'1R
M/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N
M/3-$,3X\<W1R;VYG/DQO86X@9F%C:6QI='D@+2!3=6UM87)Y(&]F($)A;FL@
M3&]A;B!&86-I;&ET>2`H1&5T86EL*2`H55-$("0I/&)R/CPO<W1R;VYG/CPO
M=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DUA<BX@,S$L(#(P,30\8G(^
M/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q,SQB
M<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY$
M96)T($1I<V-L;W-U<F4@6T%B<W1R86-T73PO<W1R;VYG/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E-H;W)T+71E<FT@<&]R=&EO;B!O
M9B!B86YK(&QO86X\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<F
M;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XD(#(U,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/DQO;F<M=&5R;2!P;W)T:6]N(&]F(&)A
M;FL@;&]A;CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)R9N8G-P
M.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C(L,#,V+#0X.3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')O=3X-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/E1O=&%L(&QO86YS/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`R+#(X-BPT.#D\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@
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M96%D/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N
M=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP
M93TS1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS/B\J($1O($YO="!2
M96UO=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D
M>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60],T1)1#!%351!1SX-
M"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS
M1#$@<F]W<W!A;CTS1#(^/'-T<F]N9SY#;VUM;VX@<W1O8VL@+2!!9&1I=&EO
M;F%L($EN9F]R;6%T:6]N("A$971A:6PI("A54T0@)"D\8G(^/"]S=')O;F<^
M/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^,"!-
M;VYT:',@16YD960\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS
M<&%N/3-$,CXS($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`@(#QT:"!C;&%S
M<STS1'1H(&-O;'-P86X],T0Q/C$R,R!-;VYT:',@16YD960\+W1H/@T*("`@
M("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,SXP($UO;G1H<R!%;F1E
M9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@
M8VQA<W,],T1T:#Y-87(N(#`V+"`R,#$T/&)R/D1I<F5C=&]R<SQB<CX\+W1H
M/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y-87(N(#,Q+"`R,#$T/&)R/CPO
M=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DUA<BX@,S$L(#(P,3,\8G(^
M/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^36%R+B`S,2P@,C`Q-#QB
M<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y-87(N(#`V+"`R,#$T
M/&)R/DYO;BUE;7!L;WEE92!$:7)E8W1O<G,@6TUE;6)E<ET\8G(^/"]T:#X-
M"B`@("`@("`@/'1H(&-L87-S/3-$=&@^2F%N+B`R-RP@,C`Q-#QB<CY%<75I
M='D@26YC96YT:79E(%!L86X@,C`P-B!;365M8F5R73QB<CX\+W1H/@T*("`@
M("`@("`\=&@@8VQA<W,],T1T:#Y*86XN(#(W+"`R,#$T/&)R/D5Q=6ET>2!)
M;F-E;G1I=F4@4&QA;B`R,#$T(%M-96UB97)=/&)R/CPO=&@^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/E-H87)E+6)A<V5D($-O;7!E
M;G-A=&EO;B!!<G)A;F=E;65N="!B>2!3:&%R92UB87-E9"!087EM96YT($%W
M87)D(%M,:6YE($ET96US73PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^4W1O8VL@;W!T:6]N<R!G<F%N=&5D/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,#QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,S,L,S,R/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,#QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DUA
M>&EM=6T@;G5M8F5R(&]F('-H87)E<R!O9B!C;VUM;VX@<W1O8VL@=&AA="!M
M87D@8F4@:7-S=65D/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XQ+#0R,RPT,38\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/D-O;6UO;B!S=&]C:RP@<VAA<F5S(&]U='-T86YD
M:6YG/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XW-38L
M,C<Y/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y3:&%R97,@;V8@8V]M;6]N('-T;V-K(')E<V5R=F5D(&9O<B!I<W-U
M86YC92!D97-C<FEP=&EO;CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B=!9&1I=&EO;F%L;'DL("!T:&4@;G5M8F5R(&]F('-H87)E<R!O9B!C
M;VUM;VX@<W1O8VL@<F5S97)V960@9F]R(&ES<W5A;F-E('5N9&5R('1H92`R
M,#$T(%!L86X@('=I;&P@875T;VUA=&EC86QL>2!I;F-R96%S92!O;B!*86YU
M87)Y(#$@;V8@96%C:"!Y96%R(&9O<B!A('!E<FEO9"!O9B!U<"!T;R`Q,"`@
M>65A<G,L(&)E9VEN;FEN9R!O;B!*86YU87)Y(#$L(#(P,34@86YD(&5N9&EN
M9R!O;B!A;F0@:6YC;'5D:6YG($IA;G5A<GD@,2P@,C`R-"P@(&)Y(#0E(&]F
M('1H92!T;W1A;"!N=6UB97(@;V8@<VAA<F5S(&]F(&-A<&ET86P@;W5T<W1A
M;F1I;F<@;VX@1&5C96UB97(@,S$@;V8@=&AE("!P<F5C961I;F<@8V%L96YD
M87(@>65A<BP@;W(@82!L97-S97(@;G5M8F5R(&]F('-H87)E<R!D971E<FUI
M;F5D(&)Y('1H92!B;V%R9"!O9B`@9&ER96-T;W)S+CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y3:&%R97,@
M;V8@8V]M;6]N('-T;V-K(')E<V5R=F5D(&9O<B!I<W-U86YC92!P97)C96YT
M86=E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-"XP,"4\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^665A<G,@;V8@:6YC<F5A<V4@:6X@<VAA<F5S(&]F(&-O;6UO;B!S=&]C
M:R!R97-E<G9E9"!F;W(@:7-S=6%N8V4\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG,3`@>65A<G,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^17AE<F-I<V4@<')I8V4@<&5R
M('-H87)E(&]F(&]P=&EO;G,@9W)A;G1E9"!T;R!N;VXM96UP;&]Y964@9&ER
M96-T;W)S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`Q
M,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y.=6UB97(@;V8@;F]N+65M<&QO>65E(&1I<F5C=&]R<SPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-#QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^5V5I9VAT960@879E
M<F%G92!G<F%N="!D871E(&9A:7(@=F%L=64@;V8@<W1O8VL@;W!T:6]N<R!G
M<F%N=&5D/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`Y+C`U
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M)"`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^)"`T+C(S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y3=&]C:RUB87-E9"!C;VUP96YS871I;VX@97AP96YS
M93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,3,W+#8U-#QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@
M-30L-C<T/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^)"`Q+#0P.2PW,C(\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/E5N<F5C;V=N:7IE9"!S=&]C:RUB87-E
M9"!C;VUP96YS871I;VX@8V]S=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/B0@,2PT.#4L.3<Q/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/B0@,2PT.#4L.3<Q/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y5;G)E8V]G;FEZ
M960@<W1O8VLM8F%S960@8V]M<&5N<V%T:6]N(&-O<W0L('=E:6=H=&5D+6%V
M97)A9V4@<&5R:6]D(')E8V]G;FEZ960\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG,2!Y96%R(#4@;6]N=&AS(#$Y(&1A>7,\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\
M+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?-3<Q9C,R-C%?
M,3`Q95\T-C`Y7V$X8V5?8C9F93=A,&(T930Y#0I#;VYT96YT+4QO8V%T:6]N
M.B!F:6QE.B\O+T,Z+S4W,68S,C8Q7S$P,65?-#8P.5]A.&-E7V(V9F4W83!B
M-&4T.2]7;W)K<VAE971S+U-H965T,S`N:'1M;`T*0V]N=&5N="U4<F%N<V9E
M<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T
M97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE
M860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT
M96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E
M/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E
M;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y
M/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$5,3D%#/@T*
M("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$
M,2!R;W=S<&%N/3-$,CX\<W1R;VYG/D-O;6UO;B!S=&]C:R`M(%-C:&5D=6QE
M(&]F(%=E:6=H=&5D($%V97)A9V4@07-S=6UP=&EO;G,@*$1E=&%I;"D@*%53
M1"`D*3QB<CX\+W-T<F]N9SX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T
M:"!C;VQS<&%N/3-$,CXS($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`@(#QT
M:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/C$R,R!-;VYT:',@16YD960\+W1H
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S
M/3-$=&@^36%R+B`S,2P@,C`Q-#QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA
M<W,],T1T:#Y-87(N(#,Q+"`R,#$S/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C
M;&%S<STS1'1H/DUA<BX@,S$L(#(P,30\8G(^/"]T:#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^1&ES8VQO<W5R92!/9B!#;VUP96YS
M871I;VX@4F5L871E9"!#;W-T<R!3:&%R96)A<V5D(%!A>6UE;G1S(%M!8G-T
M<F%C=%T\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^17AP96-T960@=F]L871I;&ET>3PO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^,3`X+C`P)3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<F;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XX."XP,"4\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D5X<&5C
M=&5D(&1I=FED96YD<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M,"XP,"4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^,"XP,"4\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D5X<&5C=&5D('1E<FUS("AY96%R
M<RD\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<V('EE87)S/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)R9N
M8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<V('EE87)S(#(@;6]N=&AS(#(W(&1A>7,\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E)I<VL@9G)E
M92!R871E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+C4R)3QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<F
M;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XR+CDV)3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^5V5I9VAT960@879E<F%G92!G<F%N="UD871E
M(&9A:7(@=F%L=64@;V8@<W1O8VL@;W!T:6]N<SPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^)"`Y+C`U/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^)"`P/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`T+C(S/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO
M:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\U-S%F,S(V,5\Q,#%E7S0V,#E?
M83AC95]B-F9E-V$P8C1E-#D-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O
M0SHO-3<Q9C,R-C%?,3`Q95\T-C`Y7V$X8V5?8C9F93=A,&(T930Y+U=O<FMS
M:&5E=',O4VAE970S,2YH=&UL#0I#;VYT96YT+51R86YS9F5R+45N8V]D:6YG
M.B!Q=6]T960M<')I;G1A8FQE#0I#;VYT96YT+51Y<&4Z('1E>'0O:'1M;#L@
M8VAA<G-E=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\
M345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X
M="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA
M=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@
M0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A
M8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P14M004,^#0H@("`@("`\='(^
M#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O=W-P86X]
M,T0R/CQS=')O;F<^3F5T(&QO<W,@<&5R('-H87)E("T@061D:71I;VYA;"!)
M;F9O<FUA=&EO;B`H1&5T86EL*3QB<CX\+W-T<F]N9SX\+W1H/@T*("`@("`@
M("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XP($UO;G1H<R!%;F1E9#PO
M=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/C,@36]N
M=&AS($5N9&5D/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(^#0H@("`@
M("`@(#QT:"!C;&%S<STS1'1H/D9E8BX@,C<L(#(P,30\8G(^/"]T:#X-"B`@
M("`@("`@/'1H(&-L87-S/3-$=&@^36%R+B`S,2P@,C`Q-#QB<CX\+W1H/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY38VAE9'5L92!/
M9B!%87)N:6YG<R!097(@4VAA<F4@6TQI;F4@271E;7-=/"]S=')O;F<^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0V]N=F5R<VEO;B!B
M87-I<R!F;W(@<F5V97)S92!S=&]C:R!S<&QI=#PO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B=4:&4@0V]M<&%N>2!E9F9E8W1E9"!A(#$M9F]R
M+3$Y+C(@<F5V97)S92!S=&]C:R!S<&QI=#QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0V]N=F5R<VEO;B!R871I;R!O
M9B!R979E<G-E('-T;V-K('-P;&ET/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XP+C`U,C`X,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C`N,#4R,#@S/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F@^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y296]R9V%N:7IA=&EO;B!;365M
M8F5R73PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O
M;F<^4V-H961U;&4@3V8@16%R;FEN9W,@4&5R(%-H87)E(%M,:6YE($ET96US
M73PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/D-O;6UO;B!S=&]C:R!O=71S=&%N9&EN9SPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C4L.#0U+#(V,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3W!T:6]N<R!O=71S=&%N9&EN9SPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C8R."PW-30\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E=A<G)A
M;G1S(&]U='-T86YD:6YG/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^,3$L,S8S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT
M4&%R=%\U-S%F,S(V,5\Q,#%E7S0V,#E?83AC95]B-F9E-V$P8C1E-#D-"D-O
M;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-3<Q9C,R-C%?,3`Q95\T-C`Y
M7V$X8V5?8C9F93=A,&(T930Y+U=O<FMS:&5E=',O4VAE970S,BYH=&UL#0I#
M;VYT96YT+51R86YS9F5R+45N8V]D:6YG.B!Q=6]T960M<')I;G1A8FQE#0I#
M;VYT96YT+51Y<&4Z('1E>'0O:'1M;#L@8VAA<G-E=#TB=7,M87-C:6DB#0H-
M"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\345402!H='1P+65Q=6EV/3-$0V]N
M=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX
M)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ
M<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO
M:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED
M/3-$240P141(04D^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS
M1'1L(&-O;'-P86X],T0Q(')O=W-P86X],T0R/CQS=')O;F<^3F5T(&QO<W,@
M<&5R('-H87)E("T@4V-H961U;&4@;V8@0V]M<'5T871I;VX@;V8@0F%S:6,@
M86YD($1I;'5T960@16%R;FEN9W,@4&5R(%-H87)E("A$971A:6PI("A54T0@
M)"D\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@
M8V]L<W!A;CTS1#,^,R!-;VYT:',@16YD960\+W1H/@T*("`@("`@("`\=&@@
M8VQA<W,],T1T:"!C;VQS<&%N/3-$-SXQ,B!-;VYT:',@16YD960\+W1H/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XQ,C,@36]N=&AS
M($5N9&5D/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(^#0H@("`@("`@
M(#QT:"!C;&%S<STS1'1H/DUA<BX@,3(L(#(P,30\8G(^/"]T:#X-"B`@("`@
M("`@/'1H(&-L87-S/3-$=&@^36%R+B`S,2P@,C`Q-#QB<CX\+W1H/@T*("`@
M("`@("`\=&@@8VQA<W,],T1T:#Y-87(N(#,Q+"`R,#$S/&)R/CPO=&@^#0H@
M("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3,\8G(^/"]T:#X-
M"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q,CQB<CX\+W1H
M/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#$Q/&)R/CPO
M=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3`\8G(^
M/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`P.3QB
M<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y$96,N(#,Q+"`R,#`X
M/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P
M,#<\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^36%R+B`S,2P@
M,C`Q-#QB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T
M<F]N9SY.=6UE<F%T;W(\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y.970@;&]S<R!A;F0@8V]M<')E:&5N
M<VEV92!L;W-S(&EN8W5R<F5D(&EN('1H92!D979E;&]P;65N="!S=&%G93PO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^)"`H-"PR,C<L-C<X*3QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^)"`H
M,2PP,3`L,C8W*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M/B0@*#4Q+#4P,BPU.#<I/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y!8V-R971I;VX@9F]R
M(&QI<75I9&%T:6]N('!R969E<F5N8V4@;VX@<')E9F5R<F5D('-T;V-K/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@Q+#$S,BPX.3,I/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,2PQ,S(L
M.#DS*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6T^*#$L,34W+#@V-2D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M/B@U+#,U,2PT-3DI/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,RPX-C`L,30P*3QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#,L,S`S+#(P,"D\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@R
M+#$V-RPV,#$I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;3XH,2PS,#$L-#`P*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6T^*#$L,#`X+#$U,RD\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@T-#$L,38R*3QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#$X+#4V-BPP
M,#@I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y!8V-R971I;VX@9F]R('-H87)E(&ES<W5A;F-E(&-O<W1S(&]N('!R
M969E<G)E9"!S=&]C:SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH
M,3DL-34P*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6T^*#$Y+#4U,"D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M/B@T-"PS,#<I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;3XH,3(S+#`W-"D\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@Q-C@L-S`R*3QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#$V,RPT.#,I
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH
M,3<U+#0V-RD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M/B@Q-3DL-C$Q*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6T^*#$S.2PW-3@I/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;3XH-C4L,#(T*3QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#$L,#$T+#8V-RD\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E1A
M>"!E>'!E;G-E(&]N('!R969E<G)E9"!S=&]C:SPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;3XH,3`P+#(Y,2D\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M/B@Q,#`L,CDQ*3QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#,T-BPP.3$I/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH-S,W+#DR
M-2D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M/B@S.30L.3`X*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6T^*#,T-2PU.#<I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;3XH,C0T+#(U,2D\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@W-"PW-#,I/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@Q+#@Y-RPW,#(I
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#Y2979E<G-A;"!O9B!T87@@<&%Y86)L92!O;B!P<F5F97)R960@<W1O8VL@
M9'5E('1O(&-O;G9E<G-I;VX@;V8@<')E9F5R<F5D('-T;V-K/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,2PX.3<L-S`R/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+#@Y
M-RPW,#(\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/D5X=&EN9W5I<VAM96YT(&]F(')E;6%I;FEN9R!S:&%R92!I<W-U
M86YC92!C;W-T<R!D=64@=&\@8V]N=F5R<VEO;B!O9B!P<F5F97)R960@<W1O
M8VL\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#$L-#4X+#0W."D\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@T
M,SDL,C(W*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;3XH-#,Y+#(R-RD\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;W4^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y4;W1A;"!L;W-S(&%T=')I8G5T
M86)L92!T;R!C;VUM;VX@<W1O8VMH;VQD97)S/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;3XD("@T+#`R,2PY,S<I/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XD("@R+#4U."PU,S`I/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^
M)"`H-S$L-3(R+#0X.2D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^1&5N;VUI;F%T;W(\+W-T<F]N9SX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y7
M96EG:'1E9"!A=F5R86=E('-H87)E<R!U<V5D('1O(&-O;7!U=&4@8F%S:6,@
M;F5T(&QO<W,@<&5R(&-O;6UO;B!S:&%R93PO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C,L,30X+#0X,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C,P,2PW-#4\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,SDX+#4W,SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M/'-T<F]N9SY%9F9E8W0@;V8@<&]T96YT:6%L;'D@9&EL=71I=F4@<V5C=7)I
M=&EE<SH\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y3=&]C:R!O<'1I;VYS/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<F;F)S<#LF;F)S<#L\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^0V]M;6]N('-T;V-K('=A<G)A;G1S/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)R9N8G-P.R9N8G-P.SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<F;F)S
M<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O=3X-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E=E:6=H=&5D(&%V97)A
M9V4@<VAA<F5S('5S960@=&\@8V]M<'5T92!D:6QU=&5D(&YE="!L;W-S('!E
M<B!C;VUM;VX@<VAA<F4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XS+#$T."PT.#$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XS,#$L-S0U/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,Y."PU-S,\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DYE="!L;W-S('!E
M<B!S:&%R92!A='1R:6)U=&%B;&4@=&\@8V]M;6]N('-T;V-K:&]L9&5R<RUB
M87-I8SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^)"`H,2XR."D\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B0@
M*#@N-#@I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6T^)"`H,3<Y+C0U*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3F5T(&QO<W,@<&5R('-H87)E(&%T
M=')I8G5T86)L92!T;R!C;VUM;VX@<W1O8VMH;VQD97)S+61I;'5T960\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B0@*#$N,C@I/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XD("@X+C0X*3QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M/B0@*#$W.2XT-2D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]
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M:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M97%U:78]
M,T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S970]
M=71F+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S<F,],T13
M:&]W+FIS/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I
M<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R97!O
M<G0@:60],T1)1#!%3$M!13X-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L
M87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T<F]N9SY.970@
M;&]S<R!P97(@<VAA<F4@+2!38VAE9'5L92!O9B!!;G1I9&EL=71I=F4@4V5C
M=7)I=&EE<R!%>&-L=61E9"!F<F]M($-O;7!U=&%T:6]N(&]F($)A<VEC(&%N
M9"!$:6QU=&5D($YE="!,;W-S(%!E<B!3:&%R92`H1&5T86EL*3QB<CX\+W-T
M<F]N9SX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$
M,CXS($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y-87(N(#,Q+"`R,#$T/&)R/CPO
M=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DUA<BX@,S$L(#(P,3,\8G(^
M/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^06YT
M:61I;'5T:79E(%-E8W5R:71I97,@17AC;'5D960@9G)O;2!#;VUP=71A=&EO
M;B!O9B!%87)N:6YG<R!097(@4VAA<F4@6TQI;F4@271E;7-=/"]S=')O;F<^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^06YT:61I;'5T
M:79E('-E8W5R:71I97,@97AC;'5D960@9G)O;2!T:&4@8V]M<'5T871I;VX@
M;V8@8F%S:6,@86YD(&1I;'5T960@;F5T(&QO<W,@<&5R('-H87)E/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XV-#$L-3(R/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-2PY-C`L.3@U/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F@^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#
M;VYV97)T:6)L92!0<F5F97)R960@4W1O8VL@6TUE;6)E<ET\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/D%N=&ED:6QU=&EV
M92!396-U<FET:65S($5X8VQU9&5D(&9R;VT@0V]M<'5T871I;VX@;V8@16%R
M;FEN9W,@4&5R(%-H87)E(%M,:6YE($ET96US73PO<W1R;VYG/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D%N=&ED:6QU=&EV92!S96-U
M<FET:65S(&5X8VQU9&5D(&9R;VT@=&AE(&-O;7!U=&%T:6]N(&]F(&)A<VEC
M(&%N9"!D:6QU=&5D(&YE="!L;W-S('!E<B!S:&%R93PO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C4L-3(U+#@T-#QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')H/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3W5T<W1A;F1I;F<@4W1O
M8VL@3W!T:6]N<R!;365M8F5R73PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/CQS=')O;F<^06YT:61I;'5T:79E(%-E8W5R:71I97,@17AC
M;'5D960@9G)O;2!#;VUP=71A=&EO;B!O9B!%87)N:6YG<R!097(@4VAA<F4@
M6TQI;F4@271E;7-=/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^06YT:61I;'5T:79E('-E8W5R:71I97,@97AC;'5D960@
M9G)O;2!T:&4@8V]M<'5T871I;VX@;V8@8F%S:6,@86YD(&1I;'5T960@;F5T
M(&QO<W,@<&5R('-H87)E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XV,S`L,34Y/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^-#,U+#$T,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')H/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^0V]M;6]N(%-T;V-K(%=A<G)A;G1S(%M-96UB
M97)=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N
M9SY!;G1I9&EL=71I=F4@4V5C=7)I=&EE<R!%>&-L=61E9"!F<F]M($-O;7!U
M=&%T:6]N(&]F($5A<FYI;F=S(%!E<B!3:&%R92!;3&EN92!)=&5M<UT\+W-T
M<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y!;G1I
M9&EL=71I=F4@<V5C=7)I=&EE<R!E>&-L=61E9"!F<F]M('1H92!C;VUP=71A
M=&EO;B!O9B!B87-I8R!A;F0@9&EL=71E9"!N970@;&]S<R!P97(@<VAA<F4\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$Q+#,V,SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@/"]B
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M/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N=&5N
M=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP93TS
M1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS/B\J($1O($YO="!296UO
M=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-
M"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60],T1)1#!%4$M!13X-"B`@
M("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@
M<F]W<W!A;CTS1#(^/'-T<F]N9SY&:6YA;F-I86P@:6YS=')U;65N=',@+2!&
M86ER(%9A;'5E(&]F(%-I9VYI9FEC86YT(%5N;V)S97)V86)L92!);G!U=',@
M*$1E=&%I;"D@*$QE=F5L(#,@6TUE;6)E<ETL(%531"`D*3QB<CX\+W-T<F]N
M9SX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XS
M($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T:#Y-87(N(#,Q+"`R,#$T/&)R/CPO=&@^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/D9A:7(@5F%L
M=64L($QI86)I;&ET:65S($UE87-U<F5D(&]N(%)E8W5R<FEN9R!"87-I<RP@
M56YO8G-E<G9A8FQE($EN<'5T(%)E8V]N8VEL:6%T:6]N(%M,:6YE($ET96US
M73PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M0F5G:6YN:6YG(&)A;&%N8V4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/B0@,2PP,C$L-3(V/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y#:&%N9V4@:6X@9F%I<B!V86QU92!O9B!D97)I
M=F%T:79E(&QI86)I;&ET:65S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M/B@Q,3,L-S(S*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^1&5R96-O9VYI=&EO;B!O9B!L:6%B:6QI=&EE<R!U
M<&]N('!R969E<G)E9"!S=&]C:R!C;VYV97)S:6]N('1O(&-O;6UO;B!S=&]C
M:R!C;VYV97)S:6]N/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@X
M,#`L,C`V*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^16YD:6YG(&)A;&%N8V4\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C$P-RPU.3<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R:#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/E=A<G)A;G0@1&5R:79A=&EV92!,:6%B:6QI
M=&EE<R!;365M8F5R72!\($)A;FL@3&]A;B!;365M8F5R73PO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY&86ER(%9A;'5E+"!,
M:6%B:6QI=&EE<R!-96%S=7)E9"!O;B!296-U<G)I;F<@0F%S:7,L(%5N;V)S
M97)V86)L92!);G!U="!296-O;F-I;&EA=&EO;B!;3&EN92!)=&5M<UT\+W-T
M<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D)E9VEN
M;FEN9R!B86QA;F-E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR
M,C$L,S(P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#Y#:&%N9V4@:6X@9F%I<B!V86QU92!O9B!D97)I=F%T:79E(&QI
M86)I;&ET:65S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@Q,3,L
M-S(S*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^1&5R96-O9VYI=&EO;B!O9B!L:6%B:6QI=&EE<R!U<&]N('!R969E
M<G)E9"!S=&]C:R!C;VYV97)S:6]N('1O(&-O;6UO;B!S=&]C:R!C;VYV97)S
M:6]N/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG)FYB<W`[)FYB
M<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y%;F1I;F<@8F%L86YC93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^,3`W+#4Y-SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')H/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^16UB961D960@1&5R:79A=&EV92!,:6%B:6QI=&EE
M<R!;365M8F5R72!\(%!R969E<G)E9"!3=&]C:R!;365M8F5R73PO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY&86ER(%9A;'5E
M+"!,:6%B:6QI=&EE<R!-96%S=7)E9"!O;B!296-U<G)I;F<@0F%S:7,L(%5N
M;V)S97)V86)L92!);G!U="!296-O;F-I;&EA=&EO;B!;3&EN92!)=&5M<UT\
M+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D)E
M9VEN;FEN9R!B86QA;F-E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XX,#`L,C`V/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y#:&%N9V4@:6X@9F%I<B!V86QU92!O9B!D97)I=F%T:79E
M(&QI86)I;&ET:65S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y$97)E8V]G;FET:6]N(&]F(&QI86)I;&ET:65S('5P
M;VX@<')E9F5R<F5D('-T;V-K(&-O;G9E<G-I;VX@=&\@8V]M;6]N('-T;V-K
M(&-O;G9E<G-I;VX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#@P
M,"PR,#8I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#Y%;F1I;F<@8F%L86YC93PO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-
M"BTM+2TM+3U?3F5X=%!A<G1?-3<Q9C,R-C%?,3`Q95\T-C`Y7V$X8V5?8C9F
M93=A,&(T930Y#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+S4W,68S
M,C8Q7S$P,65?-#8P.5]A.&-E7V(V9F4W83!B-&4T.2]7;W)K<VAE971S+U-H
M965T,S4N:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D
M+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970]
M(G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T
M<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@
M8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T
M('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@
M*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S
M<STS1')E<&]R="!I9#TS1$E$,$5'2#X-"B`@("`@(#QT<CX-"B`@("`@("`@
M/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T<F]N
M9SY&:6YA;F-I86P@:6YS=')U;65N=',@+2!!9&1I=&EO;F%L($EN9F]R;6%T
M:6]N("A$971A:6PI("A54T0@)"D\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@
M("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#(^,R!-;VYT:',@16YD960\
M+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L
M87-S/3-$=&@^36%R+B`S,2P@,C`Q-#QB<CX\+W1H/@T*("`@("`@("`\=&@@
M8VQA<W,],T1T:#Y-87(N(#,Q+"`R,#$S/&)R/CPO=&@^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/D9A:7(@5F%L=64@1&ES8VQO<W5R
M97,@6T%B<W1R86-T73PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/E1R86YS9F5R<R!B971W965N($QE=F5L<R`Q+#(@86YD
M(#,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,#QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,#QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\
M+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?-3<Q9C,R-C%?
M,3`Q95\T-C`Y7V$X8V5?8C9F93=A,&(T930Y#0I#;VYT96YT+4QO8V%T:6]N
M.B!F:6QE.B\O+T,Z+S4W,68S,C8Q7S$P,65?-#8P.5]A.&-E7V(V9F4W83!B
M-&4T.2]7;W)K<VAE971S+V9I;&5L:7-T+GAM;`T*0V]N=&5N="U4<F%N<V9E
M<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T
M97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\>&UL('AM;&YS.F\]
M,T0B=7)N.G-C:&5M87,M;6EC<F]S;V9T+6-O;3IO9F9I8V4Z;V9F:6-E(CX-
M"B`\;SI-86EN1FEL92!(4F5F/3-$(BXN+U=O<FMB;V]K+FAT;6PB+SX-"B`\
M;SI&:6QE($A2968],T0B4VAE970P,2YH=&UL(B\^#0H@/&\Z1FEL92!(4F5F
M/3-$(E-H965T,#(N:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E=#`S
M+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE970P-"YH=&UL(B\^#0H@
M/&\Z1FEL92!(4F5F/3-$(E-H965T,#4N:'1M;"(O/@T*(#QO.D9I;&4@2%)E
M9CTS1")3:&5E=#`V+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE970P
M-RYH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T,#@N:'1M;"(O/@T*
M(#QO.D9I;&4@2%)E9CTS1")3:&5E=#`Y+FAT;6PB+SX-"B`\;SI&:6QE($A2
M968],T0B4VAE970Q,"YH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T
M,3$N:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E=#$R+FAT;6PB+SX-
M"B`\;SI&:6QE($A2968],T0B4VAE970Q,RYH=&UL(B\^#0H@/&\Z1FEL92!(
M4F5F/3-$(E-H965T,30N:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E
M=#$U+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE970Q-BYH=&UL(B\^
M#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T,3<N:'1M;"(O/@T*(#QO.D9I;&4@
M2%)E9CTS1")3:&5E=#$X+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE
M970Q.2YH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T,C`N:'1M;"(O
M/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E=#(Q+FAT;6PB+SX-"B`\;SI&:6QE
M($A2968],T0B4VAE970R,BYH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H
M965T,C,N:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E=#(T+FAT;6PB
M+SX-"B`\;SI&:6QE($A2968],T0B4VAE970R-2YH=&UL(B\^#0H@/&\Z1FEL
M92!(4F5F/3-$(E-H965T,C8N:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3
M:&5E=#(W+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE970R."YH=&UL
M(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T,CDN:'1M;"(O/@T*(#QO.D9I
M;&4@2%)E9CTS1")3:&5E=#,P+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B
M4VAE970S,2YH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T,S(N:'1M
M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E=#,S+FAT;6PB+SX-"B`\;SI&
M:6QE($A2968],T0B4VAE970S-"YH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$
M(E-H965T,S4N:'1M;"(O/@T*/"]X;6P^#0HM+2TM+2T]7TYE>'1087)T7S4W
F,68S,C8Q7S$P,65?-#8P.5]A.&-E7V(V9F4W83!B-&4T.2TM#0H`
`
end

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EMTAG">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Common stock - Additional Information (Detail) (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="1">0 Months Ended</th>
        <th class="th" colspan="2">3 Months Ended</th>
        <th class="th" colspan="1">123 Months Ended</th>
        <th class="th" colspan="3">0 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 06, 2014

</div>
          <div>Directors</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2014</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2013</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2014</div>
        </th>
        <th class="th">
          <div>Mar. 06, 2014

</div>
          <div>Non-employee Directors [Member]</div>
        </th>
        <th class="th">
          <div>Jan. 27, 2014

</div>
          <div>Equity Incentive Plan 2006 [Member]</div>
        </th>
        <th class="th">
          <div>Jan. 27, 2014

</div>
          <div>Equity Incentive Plan 2014 [Member]</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Stock options granted</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">0<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">33,332<span></span></td>
        <td class="nump">0<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Maximum number of shares of common stock that may be issued</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,423,416<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqxp_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedNew', window );">Common stock, shares outstanding</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">756,279<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqxp_CommonStockReservedForIssuanceDescription', window );">Shares of common stock reserved for issuance description</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">Additionally,  the number of shares of common stock reserved for issuance under the 2014 Plan  will automatically increase on January 1 of each year for a period of up to 10  years, beginning on January 1, 2015 and ending on and including January 1, 2024,  by 4% of the total number of shares of capital outstanding on December 31 of the  preceding calendar year, or a lesser number of shares determined by the board of  directors.<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqxp_StockBasedCompensationIncreaseInCommonStockIssuancePercentage', window );">Shares of common stock reserved for issuance percentage</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">4.00%<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqxp_NumberOfYearsSharesReservedForIssuanceWillIncrease', window );">Years of increase in shares of common stock reserved for issuance</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">10 years<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualExercisePrice', window );">Exercise price per share of options granted to non-employee directors</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 11.00<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqxp_NumberOfNonEmployeeDirectors', window );">Number of non-employee directors</a></td>
        <td class="nump">4<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value of stock options granted</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 9.05<span></span></td>
        <td class="nump">$ 0.00<span></span></td>
        <td class="nump">$ 4.23<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 137,654<span></span></td>
        <td class="nump">$ 54,674<span></span></td>
        <td class="nump">$ 1,409,722<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqxp_UnrecognizedShareBasedCompensationExpense', window );">Unrecognized stock-based compensation cost</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 1,485,971<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 1,485,971<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqxp_UnrecognizedCompensationExpenseWeightedAveragePeriod', window );">Unrecognized stock-based compensation cost, weighted-average period recognized</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">1 year 5 months 19 days<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqxp_CommonStockReservedForIssuanceDescription">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Common Stock Reserved For Issuance Description</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>aqxp_CommonStockReservedForIssuanceDescription</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>aqxp_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqxp_NumberOfNonEmployeeDirectors">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number Of Non Employee Directors</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>aqxp_NumberOfNonEmployeeDirectors</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>aqxp_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:integerItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqxp_NumberOfYearsSharesReservedForIssuanceWillIncrease">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number Of Years Shares Reserved For Issuance Will Increase</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>aqxp_NumberOfYearsSharesReservedForIssuanceWillIncrease</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>aqxp_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqxp_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedNew">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized New</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>aqxp_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedNew</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>aqxp_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqxp_StockBasedCompensationIncreaseInCommonStockIssuancePercentage">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Stock Based Compensation Increase In Common Stock Issuance Percentage</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>aqxp_StockBasedCompensationIncreaseInCommonStockIssuancePercentage</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>aqxp_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqxp_UnrecognizedCompensationExpenseWeightedAveragePeriod">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Unrecognized Compensation Expense Weighted Average Period</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>aqxp_UnrecognizedCompensationExpenseWeightedAveragePeriod</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>aqxp_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqxp_UnrecognizedShareBasedCompensationExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Unrecognized Share Based Compensation Expense</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>aqxp_UnrecognizedShareBasedCompensationExpense</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>aqxp_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationArrangementWithIndividualExercisePrice">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The per share price that the individual must pay to acquire shares under the deferred compensation arrangement.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DeferredCompensationArrangementWithIndividualExercisePrice</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensation</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The maximum number of shares (or other type of equity) originally approved (usually by shareholders and board of directors), net of any subsequent amendments and adjustments, for awards under the equity-based compensation plan. As stock or unit options and equity instruments other than options are awarded to participants, the shares or units remain authorized and become reserved for issuance under outstanding awards (not necessarily vested).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (a)(3)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Gross number of share options (or share units) granted during the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (d)(1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0E6CAC">
      <tr>
        <th class="tl" colspan="1" rowspan="1">
          <div style="width: 200px;"><strong>Loan facility - Summary of Bank Loan Facility (Detail) (USD $)<br></strong></div>
        </th>
        <th class="th">
          <div>Mar. 31, 2014</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LoansPayableToBankCurrent', window );">Short-term portion of bank loan</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">$ 250,000<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermLoansFromBank', window );">Long-term portion of bank loan</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">2,036,489<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityAmountOutstanding', window );">Total loans</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">$ 2,286,489<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DebtDisclosureAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityAmountOutstanding">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount borrowed under the credit facility as of the balance sheet date.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 19, 22<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_LineOfCreditFacilityAmountOutstanding</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LoansPayableToBankCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Carrying value as of the balance sheet date of current portion of long-term loans payable to bank due within one year or the operating cycle if longer.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.20)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 19, 20<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_LoansPayableToBankCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermLoansFromBank">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Carrying value as of the balance sheet date of loans from a bank with maturities initially due after one year or beyond the operating cycle if longer, excluding current portion.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.22)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 19, 22<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_LongTermLoansFromBank</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0ELNAC">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Common stock - Schedule of Weighted Average Assumptions (Detail) (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="2">3 Months Ended</th>
        <th class="th" colspan="1">123 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2014</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2013</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
        <td class="nump">108.00%<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">88.00%<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividends</a></td>
        <td class="nump">0.00%<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">0.00%<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected terms (years)</a></td>
        <td class="text">6 years<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">6 years 2 months 27 days<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk free rate</a></td>
        <td class="nump">1.52%<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">2.96%<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average grant-date fair value of stock options</a></td>
        <td class="nump">$ 9.05<span></span></td>
        <td class="nump">$ 0.00<span></span></td>
        <td class="nump">$ 4.23<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (f)(2)(iii)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Expected term of share-based compensation awards, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SAB TOPIC 14.D.2)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27013229&amp;loc=d3e301413-122809<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (f)(2)(i)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 14<br><br> -Section D<br><br> -Subsection 2<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (f)(2)(ii)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (f)(2)(iv)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (d)(1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EKPAC">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Net loss per share - Additional Information (Detail)<br></strong></div>
        </th>
        <th class="th" colspan="1">0 Months Ended</th>
        <th class="th" colspan="1">3 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Feb. 27, 2014</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqxp_ScheduleOfEarningsPerShareLineItems', window );"><strong>Schedule Of Earnings Per Share [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityReverseStockSplit', window );">Conversion basis for reverse stock split</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">The Company effected a 1-for-19.2 reverse stock split<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1', window );">Conversion ratio of reverse stock split</a></td>
        <td class="nump">0.052083<span></span></td>
        <td class="nump">0.052083<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Reorganization [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqxp_ScheduleOfEarningsPerShareLineItems', window );"><strong>Schedule Of Earnings Per Share [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock outstanding</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">5,845,260<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">628,754<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">11,363<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqxp_ScheduleOfEarningsPerShareLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>aqxp_ScheduleOfEarningsPerShareLineItems</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>aqxp_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of warrants or rights outstanding.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.4-08.(i))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> -Paragraph i<br><br> -Article 4<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ClassOfWarrantOrRightOutstanding</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 30<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommonStockSharesOutstanding</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of options outstanding, including both vested and non-vested options.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(1)(i)-(ii)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Stock Split<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6525746<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 4<br><br> -Subparagraph (SAB TOPIC 4.C)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187143-122770<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockholdersEquityNoteStockSplitConversionRatio1</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:pureItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityReverseStockSplit">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 4<br><br> -Subparagraph (SAB TOPIC 4.C)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187143-122770<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 4<br><br> -Section C<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockholdersEquityReverseStockSplit</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Nature of operations<br></strong></div>
        </th>
        <th class="th" colspan="1">3 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NatureOfOperations', window );">Nature of operations</a></td>
        <td class="text"><div>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt">
 <b>1. Nature of operations</b></p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt">
 Aquinox Pharmaceuticals, Inc. and its wholly owned subsidiary,
 Aquinox Pharmaceuticals Inc., (consolidated and combined the
 &#x201C;Company&#x201D;&#x2014;see Note&#xA0;2 Basis of presentation)
 are a clinical stage pharmaceutical company discovering and
 developing oral drug candidates to treat inflammation and cancer.
 The Company&#x2019;s primary focus is the development of
 anti-inflammatory product candidates targeting SHIP1 which is a key
 regulator of a cellular signaling pathway in immune cells. Aquinox
 Pharmaceuticals (USA) Inc. was incorporated on May&#xA0;31, 2007 in
 the State of Delaware, United States. On January&#xA0;27, 2014,
 Aquinox Pharmaceuticals (USA) Inc. changed its name to Aquinox
 Pharmaceuticals, Inc. (&#x201C;Aquinox USA&#x201D;). Aquinox
 Pharmaceuticals Inc. (&#x201C;AQXP Canada&#x201D;), formerly
 6175813&#xA0;Canada&#xA0;Inc., was incorporated under the Canada
 Business Corporations Act on December&#xA0;26, 2003 and operates in
 Vancouver, British Columbia, Canada.</p>
 </div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccountingPoliciesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfOperations">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for the nature of an entity's business, the major products or services it sells or provides and its principal markets, including the locations of those markets. If the entity operates in more than one business, the disclosure also indicates the relative importance of its operations in each business and the basis for the determination (for example, assets, revenues, or earnings).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 275<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6927468&amp;loc=d3e6003-108592<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NatureOfOperations</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EDHAI">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Net loss per share - Schedule of Computation of Basic and Diluted Earnings Per Share (Detail) (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="3">3 Months Ended</th>
        <th class="th" colspan="7">12 Months Ended</th>
        <th class="th" colspan="1">123 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 12, 2014</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2014</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2010</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2009</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2008</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2007</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAbstract', window );"><strong>Numerator</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss and comprehensive loss incurred in the development stage</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">$ (4,227,678)<span></span></td>
        <td class="num">$ (1,010,267)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">$ (51,502,587)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqxp_TemporaryEquityAccretionToRedemptionValueLiquidationPreference', window );">Accretion for liquidation preference on preferred stock</a></td>
        <td class="num">(1,132,893)<span></span></td>
        <td class="num">(1,132,893)<span></span></td>
        <td class="num">(1,157,865)<span></span></td>
        <td class="num">(5,351,459)<span></span></td>
        <td class="num">(3,860,140)<span></span></td>
        <td class="num">(3,303,200)<span></span></td>
        <td class="num">(2,167,601)<span></span></td>
        <td class="num">(1,301,400)<span></span></td>
        <td class="num">(1,008,153)<span></span></td>
        <td class="num">(441,162)<span></span></td>
        <td class="num">(18,566,008)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment', window );">Accretion for share issuance costs on preferred stock</a></td>
        <td class="num">(19,550)<span></span></td>
        <td class="num">(19,550)<span></span></td>
        <td class="num">(44,307)<span></span></td>
        <td class="num">(123,074)<span></span></td>
        <td class="num">(168,702)<span></span></td>
        <td class="num">(163,483)<span></span></td>
        <td class="num">(175,467)<span></span></td>
        <td class="num">(159,611)<span></span></td>
        <td class="num">(139,758)<span></span></td>
        <td class="num">(65,024)<span></span></td>
        <td class="num">(1,014,667)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqxp_IncomeTaxExpenseOnPreferredStock', window );">Tax expense on preferred stock</a></td>
        <td class="num">(100,291)<span></span></td>
        <td class="num">(100,291)<span></span></td>
        <td class="num">(346,091)<span></span></td>
        <td class="num">(737,925)<span></span></td>
        <td class="num">(394,908)<span></span></td>
        <td class="num">(345,587)<span></span></td>
        <td class="num">(244,251)<span></span></td>
        <td class="num">(74,743)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(1,897,702)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqxp_ReversalOfIncomeTaxPayableOnPreferredStock', window );">Reversal of tax payable on preferred stock due to conversion of preferred stock</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,897,702<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,897,702<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqxp_ExtinguishmentOfRemainingShareIssuanceCostsDueToConversionOfPreferredStock', window );">Extinguishment of remaining share issuance costs due to conversion of preferred stock</a></td>
        <td class="num">(1,458,478)<span></span></td>
        <td class="num">(439,227)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(439,227)<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Total loss attributable to common stockholders</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">$ (4,021,937)<span></span></td>
        <td class="num">$ (2,558,530)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">$ (71,522,489)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Denominator</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average shares used to compute basic net loss per common share</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">3,148,481<span></span></td>
        <td class="nump">301,745<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">398,573<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract', window );"><strong>Effect of potentially dilutive securities:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqxp_IncrementalCommonSharesAttributableToStockOptions', window );">Stock options</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqxp_IncrementalCommonSharesAttributableToCommonStockWarrants', window );">Common stock warrants</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment', window );">Weighted average shares used to compute diluted net loss per common share</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">3,148,481<span></span></td>
        <td class="nump">301,745<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">398,573<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per share attributable to common stockholders-basic</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">$ (1.28)<span></span></td>
        <td class="num">$ (8.48)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">$ (179.45)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per share attributable to common stockholders-diluted</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">$ (1.28)<span></span></td>
        <td class="num">$ (8.48)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">$ (179.45)<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqxp_ExtinguishmentOfRemainingShareIssuanceCostsDueToConversionOfPreferredStock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Extinguishment Of Remaining Share Issuance Costs Due To Conversion Of Preferred Stock</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>aqxp_ExtinguishmentOfRemainingShareIssuanceCostsDueToConversionOfPreferredStock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>aqxp_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqxp_IncomeTaxExpenseOnPreferredStock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Canadian tax with respect to Canadian corporation taxable preferred shares and their liquidation rights.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>aqxp_IncomeTaxExpenseOnPreferredStock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>aqxp_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqxp_IncrementalCommonSharesAttributableToCommonStockWarrants">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Incremental Common Shares Attributable To Common Stock Warrants</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>aqxp_IncrementalCommonSharesAttributableToCommonStockWarrants</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>aqxp_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqxp_IncrementalCommonSharesAttributableToStockOptions">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Incremental Common Shares Attributable To Stock Options</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>aqxp_IncrementalCommonSharesAttributableToStockOptions</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>aqxp_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqxp_ReversalOfIncomeTaxPayableOnPreferredStock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Reversal of Canadian tax with respect to Canadian corporation taxable preferred shares and their liquidation rights upon conversion of preferred stock.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>aqxp_ReversalOfIncomeTaxPayableOnPreferredStock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>aqxp_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqxp_TemporaryEquityAccretionToRedemptionValueLiquidationPreference">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Accretion for liquidation preference on temporary equity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>aqxp_TemporaryEquityAccretionToRedemptionValueLiquidationPreference</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>aqxp_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7655603&amp;loc=d3e1252-109256<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 55<br><br> -Paragraph 52<br><br> -URI http://asc.fasb.org/extlink&amp;oid=32703322&amp;loc=d3e4984-109258<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.21)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 944<br><br> -SubTopic 225<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.7-04.19)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 942<br><br> -SubTopic 225<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.9-04.23)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Paragraph 18<br><br> -Article 7<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> -Paragraph 20<br><br> -Article 5<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Paragraph 21<br><br> -Article 9<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EarningsPerShareBasic</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7655603&amp;loc=d3e1252-109256<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.21)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Paragraph 18<br><br> -Article 7<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> -Paragraph 20<br><br> -Article 5<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Paragraph 21<br><br> -Article 9<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EarningsPerShareDiluted</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Paragraph 20<br><br> -Article 9<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Other Comprehensive Income<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6519514<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Net Income<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6518256<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 944<br><br> -SubTopic 225<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.7-04.19)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.18)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 944<br><br> -SubTopic 225<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.7-04.22)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 220<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358780&amp;loc=d3e565-108580<br><br><br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> -Paragraph 19<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetIncomeLoss</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetIncomeLossAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Net income after adjustments for dividends on preferred stock (declared in the period) and/or cumulative preferred stock (accumulated for the period).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 11<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7655603&amp;loc=d3e1377-109256<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of decrease to net income for accretion of temporary equity to its redemption value to derive net income apportioned to common stockholders.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 10<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7655603&amp;loc=d3e1448-109256<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Weighted-Average Number of Common Shares Outstanding<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6528421<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EWFAI">
      <tr>
        <th class="tl" colspan="1" rowspan="1">
          <div style="width: 200px;"><strong>Condensed Consolidated and Combined Balance Sheets (USD $)<br></strong></div>
        </th>
        <th class="th">
          <div>Mar. 31, 2014</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents (Note 4)</a></td>
        <td class="nump">$ 52,918,327<span></span></td>
        <td class="nump">$ 11,006,392<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Short-term investments</a></td>
        <td class="nump">2,714,100<span></span></td>
        <td class="nump">2,820,600<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsAndOtherReceivablesNetCurrent', window );">Accounts and other amounts receivable</a></td>
        <td class="nump">66,526<span></span></td>
        <td class="nump">27,946<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrent', window );">Prepayments</a></td>
        <td class="nump">547,812<span></span></td>
        <td class="nump">63,975<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredOfferingCosts', window );">Deferred offering costs</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,377,438<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
        <td class="nump">56,246,765<span></span></td>
        <td class="nump">15,296,351<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment</a></td>
        <td class="nump">67,379<span></span></td>
        <td class="nump">75,465<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other</a></td>
        <td class="nump">135,344<span></span></td>
        <td class="nump">277,290<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
        <td class="nump">56,449,488<span></span></td>
        <td class="nump">15,649,106<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Accounts payable and accrued liabilities</a></td>
        <td class="nump">1,220,695<span></span></td>
        <td class="nump">2,350,660<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LoansPayableToBankCurrent', window );">Current portion of bank loan (Note 5)</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">250,000<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other</a></td>
        <td class="nump">16,907<span></span></td>
        <td class="nump">19,445<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
        <td class="nump">1,237,602<span></span></td>
        <td class="nump">2,620,105<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesNoncurrent', window );">Warrant liabilities (Note 8)</a></td>
        <td class="nump">107,597<span></span></td>
        <td class="nump">221,320<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqxp_DerivativeLiabilitiesNoncurrentRedemptionOption', window );">Redemption option on preferred stock (Note 3)</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">800,206<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesNoncurrent', window );">Accrued tax payable on preferred stock (Note 3)</a></td>
        <td class="nump">1,797,412<span></span></td>
        <td class="nump">1,797,412<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermLoansFromBank', window );">Bank loan (Note 5)</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">2,036,489<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other</a></td>
        <td class="nump">7,047<span></span></td>
        <td class="nump">8,560<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
        <td class="nump">1,352,246<span></span></td>
        <td class="nump">7,484,092<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityAbstract', window );"><strong>Redeemable convertible preferred stock (Note 3)</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Redeemable convertible preferred stock</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">73,858,722<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract', window );"><strong>Common stock (Note 6)</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
        <td class="nump">124,713,456<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage', window );">Deficit accumulated in the development stage</a></td>
        <td class="num">(69,616,225)<span></span></td>
        <td class="num">(65,693,708)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders' equity (deficit)</a></td>
        <td class="nump">55,097,242<span></span></td>
        <td class="num">(65,693,708)<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities, redeemable convertible preferred stock, and stockholders' equity (deficit)</a></td>
        <td class="nump">56,449,488<span></span></td>
        <td class="nump">15,649,106<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">AQXP Canada [Member] | Series A Exchangeable Preferred Shares [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityAbstract', window );"><strong>Redeemable convertible preferred stock (Note 3)</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Redeemable convertible preferred stock</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">13,329,639<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">AQXP Canada [Member] | AQXP Canada, Series B Exchangeable Preferred Shares [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityAbstract', window );"><strong>Redeemable convertible preferred stock (Note 3)</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Redeemable convertible preferred stock</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">10,684,093<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">AQXP Canada [Member] | Series C Exchangeable Preferred Shares [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityAbstract', window );"><strong>Redeemable convertible preferred stock (Note 3)</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Redeemable convertible preferred stock</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">3,830,961<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Aquinox USA [Member] | Series A Preferred Stock [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityAbstract', window );"><strong>Redeemable convertible preferred stock (Note 3)</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Redeemable convertible preferred stock</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">11,157,138<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Aquinox USA [Member] | Series B Preferred Stock [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityAbstract', window );"><strong>Redeemable convertible preferred stock (Note 3)</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Redeemable convertible preferred stock</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">21,091,150<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Aquinox USA [Member] | Series C Preferred Stock [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityAbstract', window );"><strong>Redeemable convertible preferred stock (Note 3)</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Redeemable convertible preferred stock</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">13,765,741<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Aquinox USA [Member] | Common Stock [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract', window );"><strong>Common stock (Note 6)</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock</a></td>
        <td class="nump">11<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders' equity (deficit)</a></td>
        <td class="nump">$ 11<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqxp_DerivativeLiabilitiesNoncurrentRedemptionOption">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Derivative Liabilities Noncurrent Redemption Option</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>aqxp_DerivativeLiabilitiesNoncurrentRedemptionOption</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>aqxp_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsAndOtherReceivablesNetCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount due from customers, clients, or other third-parties, or arising from transactions not separately disclosed, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccountsAndOtherReceivablesNetCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.19,20)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 20<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 19<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 31<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.30(a)(1))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AdditionalPaidInCapital</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.18)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 12<br><br><br><br> -Article 7<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 18<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_Assets</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.9)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 3<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6801-107765<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 9<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AssetsCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AssetsCurrentAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Cash<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Cash Equivalents<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 1<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.1)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br><br><br><br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 4<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3044-108585<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CashAndCashEquivalentsAtCarryingValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.29)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 30<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommonStockValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredOfferingCosts">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.8)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 340<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27011391&amp;loc=d3e105025-122735<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Staff Accounting Bulletin (SAB)<br><br><br><br> -Number Topic 5<br><br><br><br> -Section A<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DeferredOfferingCosts</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesNoncurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of deferred tax liability attributable to taxable temporary differences, net of deferred tax asset attributable to deductible temporary differences and carryforwards net of valuation allowances expected to be realized or consumed after one year (or the normal operating cycle, if longer).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 740<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 4<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=21917399&amp;loc=d3e31917-109318<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 740<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 6<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=21917399&amp;loc=d3e31931-109318<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 740<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 9<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=21917399&amp;loc=d3e31958-109318<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DeferredTaxLiabilitiesNoncurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilitiesNoncurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 825<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 10<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28364263&amp;loc=d3e13433-108611<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 815<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 5<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6945355&amp;loc=d3e41228-113958<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 825<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 15<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28364263&amp;loc=d3e13495-108611<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 3<br><br><br><br> -Subparagraph (c)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=20225523&amp;loc=SL20225862-175312<br><br><br><br><br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 815<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 6<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6945355&amp;loc=d3e41271-113958<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DerivativeLiabilitiesNoncurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Cumulative net losses reported during the development stage.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 915<br><br><br><br> -SubTopic 210<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6472335&amp;loc=d3e37729-110921<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.19-26)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_Liabilities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.32)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 25<br><br><br><br> -Article 7<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 32<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_LiabilitiesAndStockholdersEquity</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.21)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 21<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_LiabilitiesCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_LiabilitiesCurrentAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LoansPayableToBankCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Carrying value as of the balance sheet date of current portion of long-term loans payable to bank due within one year or the operating cycle if longer.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.20)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 19, 20<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_LoansPayableToBankCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermLoansFromBank">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Carrying value as of the balance sheet date of loans from a bank with maturities initially due after one year or beyond the operating cycle if longer, excluding current portion.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.22)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 19, 22<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_LongTermLoansFromBank</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Aggregate carrying amount, as of the balance sheet date, of noncurrent assets not separately disclosed in the balance sheet. Noncurrent assets are expected to be realized or consumed after one year (or the normal operating cycle, if longer).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.17)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 17<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherAssetsNoncurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Aggregate carrying amount of current liabilities (due within one year or within the normal operating cycle if longer) not separately disclosed in the balance sheet. Includes costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered and of liabilities not separately disclosed.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 20<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.20)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 6<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6911-107765<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 5<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6904-107765<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherLiabilitiesCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Aggregate carrying amount, as of the balance sheet date, of noncurrent obligations not separately disclosed in the balance sheet. Noncurrent liabilities are expected to be paid after one year (or the normal operating cycle, if longer).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.24)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 24<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherLiabilitiesNoncurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Current Assets<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6509628<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (g)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6787-107765<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 340<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 05<br><br><br><br> -Paragraph 5<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6386993&amp;loc=d3e5879-108316<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PrepaidExpenseCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 360<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.13)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 13<br><br><br><br> -Subparagraph a<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 8<br><br><br><br> -Article 7<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PropertyPlantAndEquipmentNet</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Investments which are intended to be sold in the short term (usually less than one year or the normal operating cycle, whichever is longer) including trading securities, available-for-sale securities, held-to-maturity securities, and other short-term investments not otherwise listed in the existing taxonomy.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.2)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph g<br><br><br><br> -Article 7<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShortTermInvestments</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 310<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SAB TOPIC 4.E)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Staff Accounting Bulletin (SAB)<br><br><br><br> -Number Topic 4<br><br><br><br> -Section E<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.29-31)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 29, 30, 31<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockholdersEquity</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_TemporaryEquityAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_TemporaryEquityCarryingAmountAttributableToParent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EWLAC">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Condensed consolidated and combined statements of convertible preferred stock and stockholders' deficit (Parenthetical) (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="4">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Dec. 31, 2013

</div>
          <div>AQXP Canada [Member]

</div>
          <div>Exchangeable Preferred Shares [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2010

</div>
          <div>AQXP Canada [Member]

</div>
          <div>Exchangeable Preferred Shares [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013

</div>
          <div>Aquinox USA [Member]

</div>
          <div>Preferred Stock [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2010

</div>
          <div>Aquinox USA [Member]

</div>
          <div>Preferred Stock [Member]</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqxp_WarrantDiscount', window );">Warrant discount</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 226,624<span></span></td>
        <td class="nump">$ 68,920<span></span></td>
        <td class="nump">$ 226,624<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockRedemptionDiscount', window );">Redemption discount on issuance of preferred shares</a></td>
        <td class="nump">$ 466,673<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 1,633,357<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqxp_WarrantDiscount">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Warrant Discount</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>aqxp_WarrantDiscount</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>aqxp_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockRedemptionDiscount">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The excess of (1) the carrying amount of the preferred stock in the registrant's balance sheet over (2) the fair value of the consideration transferred to the holders of the preferred stock, during the accounting period, which will be added to net earnings to arrive at net earnings available to common shareholders in the calculation of earnings per share.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 260<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27010884&amp;loc=d3e42851-122695<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PreferredStockRedemptionDiscount</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EGH">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Financial instruments - Additional Information (Detail) (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="2">3 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2014</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationTransfersIntoLevel3', window );">Transfers between Levels 1,2 and 3</a></td>
        <td class="nump">$ 0<span></span></td>
        <td class="nump">$ 0<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_FairValueDisclosuresAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationTransfersIntoLevel3">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of transfers of financial instrument classified as a derivative asset (liability) after deduction of derivative liability (asset) into level 3 of the fair value hierarchy.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 820<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=25499696&amp;loc=d3e19279-110258<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 820<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(3)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=25499696&amp;loc=d3e19207-110258<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationTransfersIntoLevel3</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Nature of operations - Additional Information (Detail)<br></strong></div>
        </th>
        <th class="th" colspan="1">3 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqxp_UncategorizedAbstract', window );"><strong>Uncategorized [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationDateOfIncorporation', window );">Date of incorporation</a></td>
        <td class="text">May 31,
				 2007<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqxp_UncategorizedAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>aqxp_UncategorizedAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>aqxp_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationDateOfIncorporation">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Date when an entity was incorporated</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityIncorporationDateOfIncorporation</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:dateItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0ELSHK">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Redeemable convertible preferred stock and stockholders' (deficit) equity - Additional Information (Detail) (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="2">0 Months Ended</th>
        <th class="th" colspan="1">3 Months Ended</th>
        <th class="th" colspan="1"></th>
        <th class="th" colspan="1"></th>
        <th class="th" colspan="1"></th>
        <th class="th" colspan="1"></th>
        <th class="th" colspan="1"></th>
        <th class="th" colspan="1"></th>
        <th class="th" colspan="1"></th>
        <th class="th" colspan="1"></th>
        <th class="th" colspan="1"></th>
        <th class="th" colspan="1"></th>
        <th class="th" colspan="1"></th>
        <th class="th" colspan="1">1 Months Ended</th>
        <th class="th" colspan="1"></th>
        <th class="th" colspan="1"></th>
        <th class="th" colspan="1"></th>
        <th class="th" colspan="1"></th>
        <th class="th" colspan="1"></th>
        <th class="th" colspan="1"></th>
        <th class="th" colspan="1"></th>
        <th class="th" colspan="1"></th>
        <th class="th" colspan="1"></th>
        <th class="th" colspan="1"></th>
        <th class="th" colspan="1"></th>
        <th class="th" colspan="1">0 Months Ended</th>
        <th class="th" colspan="3">3 Months Ended</th>
        <th class="th" colspan="1">0 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 12, 2014</div>
        </th>
        <th class="th">
          <div>Feb. 27, 2014</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2014</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
        <th class="th">
          <div>Mar. 12, 2014

</div>
          <div>AQXP Canada [Member]

</div>
          <div>Exchangeable Common Stock [Member]</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2014

</div>
          <div>AQXP Canada [Member]

</div>
          <div>Series A Exchangeable Preferred Shares [Member]</div>
        </th>
        <th class="th">
          <div>Mar. 12, 2014

</div>
          <div>AQXP Canada [Member]

</div>
          <div>Series A Exchangeable Preferred Shares [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013

</div>
          <div>AQXP Canada [Member]

</div>
          <div>Series A Exchangeable Preferred Shares [Member]</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2014

</div>
          <div>AQXP Canada [Member]

</div>
          <div>AQXP Canada, Series B Exchangeable Preferred Shares [Member]</div>
        </th>
        <th class="th">
          <div>Mar. 12, 2014

</div>
          <div>AQXP Canada [Member]

</div>
          <div>AQXP Canada, Series B Exchangeable Preferred Shares [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013

</div>
          <div>AQXP Canada [Member]

</div>
          <div>AQXP Canada, Series B Exchangeable Preferred Shares [Member]</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2014

</div>
          <div>AQXP Canada [Member]

</div>
          <div>Series C Exchangeable Preferred Shares [Member]</div>
        </th>
        <th class="th">
          <div>Mar. 12, 2014

</div>
          <div>AQXP Canada [Member]

</div>
          <div>Series C Exchangeable Preferred Shares [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013

</div>
          <div>AQXP Canada [Member]

</div>
          <div>Series C Exchangeable Preferred Shares [Member]</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2014

</div>
          <div>Aquinox USA [Member]

</div>
          <div>Common Stock [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013

</div>
          <div>Aquinox USA [Member]

</div>
          <div>Common Stock [Member]</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2014

</div>
          <div>Aquinox USA [Member]

</div>
          <div>Series A Preferred Stock [Member]</div>
        </th>
        <th class="th">
          <div>Mar. 12, 2014

</div>
          <div>Aquinox USA [Member]

</div>
          <div>Series A Preferred Stock [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013

</div>
          <div>Aquinox USA [Member]

</div>
          <div>Series A Preferred Stock [Member]</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2014

</div>
          <div>Aquinox USA [Member]

</div>
          <div>Series B Preferred Stock [Member]</div>
        </th>
        <th class="th">
          <div>Mar. 12, 2014

</div>
          <div>Aquinox USA [Member]

</div>
          <div>Series B Preferred Stock [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013

</div>
          <div>Aquinox USA [Member]

</div>
          <div>Series B Preferred Stock [Member]</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2014

</div>
          <div>Aquinox USA [Member]

</div>
          <div>Series C Preferred Stock [Member]</div>
        </th>
        <th class="th">
          <div>Mar. 12, 2014

</div>
          <div>Aquinox USA [Member]

</div>
          <div>Series C Preferred Stock [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013

</div>
          <div>Aquinox USA [Member]

</div>
          <div>Series C Preferred Stock [Member]</div>
        </th>
        <th class="th">
          <div>Mar. 12, 2014

</div>
          <div>Aquinox USA [Member]

</div>
          <div>Redeemable Convertible Preferred Stock [Member]</div>
        </th>
        <th class="th">
          <div>Mar. 12, 2014

</div>
          <div>Underwriters [Member]</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2014

</div>
          <div>Shares Transferred from AQXP Canada to Aquinox USA [Member]</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2014

</div>
          <div>Shares Transferred from AQXP Canada to Aquinox USA [Member]

</div>
          <div>Common Stock [Member]</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2014

</div>
          <div>Conversion of Redeemable Convertible Preferred Stock to Common Stock [Member]

</div>
          <div>Aquinox USA [Member]</div>
        </th>
        <th class="th">
          <div>Mar. 12, 2014

</div>
          <div>Conversion of Redeemable Convertible Preferred Stock to Common Stock [Member]

</div>
          <div>Aquinox USA [Member]

</div>
          <div>Common Stock [Member]</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityReverseStockSplit', window );">Conversion basis for reverse stock split</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">The Company effected a 1-for-19.2 reverse stock split<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1', window );">Conversion ratio of reverse stock split</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">0.052083<span></span></td>
        <td class="nump">0.052083<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockConversionBasis', window );">Common stock shares conversion, description</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">Each of the 301,745 outstanding common exchangeable shares of AQXP Canada was transferred to Aquinox USA in exchange for one common stock of Aquinox USA.<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">301,745<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">10,675,260<span></span></td>
        <td class="nump">301,745<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertiblePreferredStockTermsOfConversion', window );">Preferred shares conversion, description</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">Each of the 791,016 outstanding Series A exchangeable preferred shares, 793,617 outstanding Series B exchangeable preferred shares and 378,786 outstanding Series C exchangeable preferred share of AQXP Canada was transferred to Aquinox USA in exchange for one share of Series A, B and C convertible preferred stock of Aquinox USA, respectively. As a result, following such exchange, there were 1,453,891 shares of Series A, 2,367,414 shares of Series B and 1,722,210 shares of Series C convertible preferred stock of Aquinox USA.<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">All 5,543,515 of the  outstanding shares of redeemable convertible preferred stock of Aquinox USA  converted to an equivalent number of shares of common stock of Aquinox USA.<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Redeemable convertible preferred stock, shares outstanding</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">0<span></span></td>
        <td class="nump">791,016<span></span></td>
        <td class="nump">791,016<span></span></td>
        <td class="nump">0<span></span></td>
        <td class="nump">793,617<span></span></td>
        <td class="nump">793,617<span></span></td>
        <td class="nump">0<span></span></td>
        <td class="nump">378,786<span></span></td>
        <td class="nump">378,786<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">0<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">662,875<span></span></td>
        <td class="nump">0<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,573,797<span></span></td>
        <td class="nump">0<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,343,424<span></span></td>
        <td class="nump">5,543,515<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion', window );">Convertible preferred stock</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">791,016<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">793,617<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">378,786<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Redeemable convertible preferred stock, shares issued</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">0<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">791,016<span></span></td>
        <td class="nump">0<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">793,617<span></span></td>
        <td class="nump">0<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">378,786<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">0<span></span></td>
        <td class="nump">1,453,891<span></span></td>
        <td class="nump">662,875<span></span></td>
        <td class="nump">0<span></span></td>
        <td class="nump">2,367,414<span></span></td>
        <td class="nump">1,573,797<span></span></td>
        <td class="nump">0<span></span></td>
        <td class="nump">1,722,210<span></span></td>
        <td class="nump">1,343,424<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesConverted1', window );">Common stock shares converted</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">5,543,515<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByParent', window );">Ownership percentage</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">100.00%<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesNoncurrent', window );">Accrued tax payable on preferred stock</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 1,797,412<span></span></td>
        <td class="nump">$ 1,797,412<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqxp_ExtinguishmentOfDiscountOnTemporaryEquity', window );">Derivative liability for redemption option on preferred stock</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">800,206<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares of common stock sold in IPO</a></td>
        <td class="nump">4,830,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">630,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Common stock share price per share</a></td>
        <td class="nump">$ 11.00<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqxp_NetProceedsFromIssuanceInitialPublicOffering', window );">Aggregate net proceeds received from offering</a></td>
        <td class="nump">47,341,274<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentOfFinancingAndStockIssuanceCosts', window );">Underwriting discounts and commissions and offering costs</a></td>
        <td class="nump">$ 5,788,726<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 5,788,726<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqxp_StockSharesAuthorizedNet', window );">Total number of shares authorized</a></td>
        <td class="nump">55,000,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
        <td class="nump">50,000,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">50,000,000<span></span></td>
        <td class="nump">139,266,037<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
        <td class="nump">$ 0.000001<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 0.000001<span></span></td>
        <td class="nump">$ 0.000001<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
        <td class="nump">5,000,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
        <td class="nump">$ 0.000001<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">0<span></span></td>
        <td class="nump">0<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">0<span></span></td>
        <td class="nump">0<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqxp_ExtinguishmentOfDiscountOnTemporaryEquity">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Extinguishment of bifurcated redemption feature of preferred shares.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>aqxp_ExtinguishmentOfDiscountOnTemporaryEquity</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>aqxp_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqxp_NetProceedsFromIssuanceInitialPublicOffering">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Net proceeds from issuance initial public offering.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>aqxp_NetProceedsFromIssuanceInitialPublicOffering</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>aqxp_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqxp_StockSharesAuthorizedNet">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Stock Shares Authorized Net</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>aqxp_StockSharesAuthorizedNet</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>aqxp_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ClassOfStockLineItems</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockConversionBasis">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Describe the conversion features of common stock if such stock is convertible. That is, shares of common stock into which another convertible security was converted, or shares of common stock into which another class of common stock was converted.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 30<br><br> -Article 5<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21506-112644<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommonStockConversionBasis</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Face amount or stated value per share of common stock.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 30<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommonStockParOrStatedValuePerShare</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 30<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommonStockSharesAuthorized</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 30<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommonStockSharesOutstanding</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockSharesConverted1">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 5<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4332-108586<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4313-108586<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4304-108586<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ConversionOfStockSharesConverted1</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of shares issued for each share of convertible preferred stock that is converted.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21475-112644<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29<br><br> -Article 5<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 6<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21506-112644<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertiblePreferredStockTermsOfConversion">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Specific terms relevant to convertibility. Includes class of preferred stock and number of shares convertible into, exercise (or conversion) price or rates, dates relevant to conversion timing and events relevant to conversion. Describe also any beneficial conversion features. where convertible preferred stock with a nondetachable conversion feature is in-the-money at commitment date. For contingently convertible preferred stock, discuss the circumstances of the contingency, including the events or changes in circumstance that would cause the contingency to be met and any of the significant features necessary to understand the conversion rights and the timing of those rights. Include also an events or changes in circumstance, if any, that could adjust or change the contingency, conversion price, or number of shares, including significant terms of those changes.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21475-112644<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29<br><br> -Article 5<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21506-112644<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 7<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21521-112644<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Contingently Convertible Instruments<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6508575<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 8<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21538-112644<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ConvertiblePreferredStockTermsOfConversion</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesNoncurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of deferred tax liability attributable to taxable temporary differences, net of deferred tax asset attributable to deductible temporary differences and carryforwards net of valuation allowances expected to be realized or consumed after one year (or the normal operating cycle, if longer).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=21917399&amp;loc=d3e31917-109318<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=21917399&amp;loc=d3e31931-109318<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 9<br><br> -URI http://asc.fasb.org/extlink&amp;oid=21917399&amp;loc=d3e31958-109318<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DeferredTaxLiabilitiesNoncurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestOwnershipPercentageByParent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The parent entity's interest in net assets of the subsidiary, expressed as a percentage.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_MinorityInterestOwnershipPercentageByParent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentOfFinancingAndStockIssuanceCosts">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The total of the cash outflow during the period which has been paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt and the cost incurred directly for the issuance of equity securities.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Financing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 15<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3291-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PaymentOfFinancingAndStockIssuanceCosts</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.28)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PreferredStockParOrStatedValuePerShare</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.28)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PreferredStockSharesAuthorized</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.28)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PreferredStockSharesIssued</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.28)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PreferredStockSharesOutstanding</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SaleOfStockPricePerShare</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Stock Split<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6525746<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 4<br><br> -Subparagraph (SAB TOPIC 4.C)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187143-122770<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockholdersEquityNoteStockSplitConversionRatio1</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:pureItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityReverseStockSplit">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 4<br><br> -Subparagraph (SAB TOPIC 4.C)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187143-122770<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 4<br><br> -Section C<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockholdersEquityReverseStockSplit</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of new stock issued during the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodSharesNewIssues</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesIssued">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.27(b))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 28<br><br> -Subparagraph b<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_TemporaryEquitySharesIssued</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.27(b))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 28<br><br> -Subparagraph b<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_TemporaryEquitySharesOutstanding</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/**
 * Rivet Software Inc.
 *
 * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved.
 * Version 2.4.0.3
 *
 */

var Show = {};
Show.LastAR = null,

Show.hideAR = function(){
	Show.LastAR.style.display = 'none';
};

Show.showAR = function ( link, id, win ){
	if( Show.LastAR ){
		Show.hideAR();
	}

	var ref = link;
	do {
		ref = ref.nextSibling;
	} while (ref && ref.nodeName != 'TABLE');

	if (!ref || ref.nodeName != 'TABLE') {
		var tmp = win ?
			win.document.getElementById(id) :
			document.getElementById(id);

		if( tmp ){
			ref = tmp.cloneNode(true);
			ref.id = '';
			link.parentNode.appendChild(ref);
		}
	}

	if( ref ){
		ref.style.display = 'block';
		Show.LastAR = ref;
	}
};

Show.toggleNext = function( link ){
	var ref = link;

	do{
		ref = ref.nextSibling;
	}while( ref.nodeName != 'DIV' );

	if( ref.style &&
		ref.style.display &&
		ref.style.display == 'none' ){
		ref.style.display = 'block';

		if( link.textContent ){
			link.textContent = link.textContent.replace( '+', '-' );
		}else{
			link.innerText = link.innerText.replace( '+', '-' );
		}
	}else{
		ref.style.display = 'none';

		if( link.textContent ){
			link.textContent = link.textContent.replace( '-', '+' );
		}else{
			link.innerText = link.innerText.replace( '-', '+' );
		}
	}
};
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EW2BG">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Condensed consolidated and combined statements of cash flows (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="2">3 Months Ended</th>
        <th class="th" colspan="1">123 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2014</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2013</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Operating activities</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Net loss and comprehensive loss incurred in the development stage</a></td>
        <td class="num">$ (4,227,678)<span></span></td>
        <td class="num">$ (1,010,267)<span></span></td>
        <td class="num">$ (51,502,587)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Non-cash items and reclassifications:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Amortization</a></td>
        <td class="nump">18,238<span></span></td>
        <td class="nump">14,785<span></span></td>
        <td class="nump">629,410<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Financing costs</a></td>
        <td class="nump">319,635<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">333,877<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqxp_RepaymentFeeAndPenalty', window );">Fees and penalty on bank loan repayment</a></td>
        <td class="nump">100,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">100,000<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment', window );">Gain on sale of equipment</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(29,396)<span></span></td>
        <td class="num">(134,553)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqxp_AmortizationOfPreferredStockDiscount', window );">Amortization and extinguishment of remaining discount on preferred stock upon conversion of preferred stock</a></td>
        <td class="nump">1,884,233<span></span></td>
        <td class="nump">25,438<span></span></td>
        <td class="nump">2,395,575<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnDerivativeInstrumentsNetPretax', window );">Change in fair value of derivative liabilities</a></td>
        <td class="num">(913,929)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(2,102,193)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
        <td class="nump">137,654<span></span></td>
        <td class="nump">54,674<span></span></td>
        <td class="nump">1,409,722<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossUnrealized', window );">Foreign exchange loss</a></td>
        <td class="nump">106,501<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">106,501<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Change in non-cash working capital:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables', window );">Accounts and other amounts receivable</a></td>
        <td class="num">(38,580)<span></span></td>
        <td class="num">(170)<span></span></td>
        <td class="num">(66,524)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepayments and deposits</a></td>
        <td class="num">(453,705)<span></span></td>
        <td class="nump">10,480<span></span></td>
        <td class="num">(626,223)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued liabilities</a></td>
        <td class="num">(734,537)<span></span></td>
        <td class="nump">37,835<span></span></td>
        <td class="nump">854,211<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations', window );">Cash used in operating activities</a></td>
        <td class="num">(3,802,168)<span></span></td>
        <td class="num">(896,621)<span></span></td>
        <td class="num">(48,602,784)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Investing activities</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireShortTermInvestments', window );">Purchase of short-term investments</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(2,820,600)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of property and equipment</a></td>
        <td class="num">(4,463)<span></span></td>
        <td class="num">(4,696)<span></span></td>
        <td class="num">(549,003)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment', window );">Sale of property and equipment</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">50,810<span></span></td>
        <td class="nump">191,817<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireIntangibleAssets', window );">Purchase of intangible assets</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(183,629)<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations', window );">Cash (used in) provided by investing activities</a></td>
        <td class="num">(4,463)<span></span></td>
        <td class="nump">46,114<span></span></td>
        <td class="num">(3,361,415)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Financing activities</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayment of bank loan, fees and penalty</a></td>
        <td class="num">(2,600,000)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(100,000)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfLoanCosts', window );">Loan costs</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(107,911)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromNotesPayable', window );">Issuance of promissory notes</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">720,863<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfNotesPayable', window );">Repayment of promissory notes</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(255,775)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Common stock issued</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">490,176<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Repurchase of common stock</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(350)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRepurchaseOfRedeemablePreferredStock', window );">Preferred stock (redemption) issued</a></td>
        <td class="num">(491)<span></span></td>
        <td class="nump">17,999,961<span></span></td>
        <td class="nump">57,835,418<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqxp_SpecialVotingCommonStockIssuedValue', window );">Special voting common stock issued</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">7<span></span></td>
        <td class="nump">44<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Share issue costs</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(132,748)<span></span></td>
        <td class="num">(1,431,558)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Initial public offering of common shares</a></td>
        <td class="nump">53,130,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">53,130,000<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfFinancingCosts', window );">Initial public offering costs</a></td>
        <td class="num">(4,810,943)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(5,398,381)<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations', window );">Cash provided by financing activities</a></td>
        <td class="nump">45,718,566<span></span></td>
        <td class="nump">17,867,220<span></span></td>
        <td class="nump">104,882,526<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease', window );">Increase in cash and cash equivalents during the period</a></td>
        <td class="nump">41,911,935<span></span></td>
        <td class="nump">17,016,713<span></span></td>
        <td class="nump">52,918,327<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents, beginning of period</a></td>
        <td class="nump">11,006,392<span></span></td>
        <td class="nump">2,000,539<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents, end of period</a></td>
        <td class="nump">52,918,327<span></span></td>
        <td class="nump">19,017,252<span></span></td>
        <td class="nump">52,918,327<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosure of cash flow information:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaid', window );">Interest paid</a></td>
        <td class="nump">31,719<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">31,719<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqxp_NoncashInvestingActivitiesAbstract', window );"><strong>Investing activities</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1', window );">Purchase of intangible assets for shares issued</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">44,834<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqxp_NonCashFinancingActivitiesAbstract', window );"><strong>Financing activities</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqxp_ShareIssuanceExpendituresIncurredButNotYetPaid', window );">Accrued offering costs</a></td>
        <td class="nump">$ 390,345<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 390,345<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqxp_AmortizationOfPreferredStockDiscount">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amortization Of Preferred Stock Discount</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>aqxp_AmortizationOfPreferredStockDiscount</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>aqxp_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqxp_NonCashFinancingActivitiesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>aqxp_NonCashFinancingActivitiesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>aqxp_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqxp_NoncashInvestingActivitiesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>aqxp_NoncashInvestingActivitiesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>aqxp_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqxp_RepaymentFeeAndPenalty">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Repayment Fee and Penalty</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>aqxp_RepaymentFeeAndPenalty</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>aqxp_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqxp_ShareIssuanceExpendituresIncurredButNotYetPaid">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Share Issuance Expenditures Incurred but Not yet Paid</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>aqxp_ShareIssuanceExpendituresIncurredButNotYetPaid</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>aqxp_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqxp_SpecialVotingCommonStockIssuedValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Special Voting Common Stock Issued Value</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>aqxp_SpecialVotingCommonStockIssuedValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>aqxp_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of noncash expense included in interest expense to issue debt and obtain financing associated with the related debt instruments. Alternate captions include noncash interest expense.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.8)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> -Paragraph 8<br><br> -Article 5<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Paragraph 8<br><br> -Article 9<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AmortizationOfFinancingCosts</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Cash<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Cash Equivalents<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 1<br><br> -Article 5<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 1<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3044-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CashAndCashEquivalentsAtCarryingValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 24<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3521-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 830<br><br> -SubTopic 230<br><br> -Section 45<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6450594&amp;loc=d3e33268-110906<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Other Comprehensive Income<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6519514<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Comprehensive Income<br><br> -URI http://asc.fasb.org/extlink&amp;oid=16317811<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 220<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 5<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358780&amp;loc=d3e557-108580<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Net Income<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6518256<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ComprehensiveIncomeNetOfTax</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DepreciationDepletionAndAmortization</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossUnrealized">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount before tax of foreign currency transaction unrealized gain (loss) recognized in the income statement.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 830<br><br> -SubTopic 20<br><br> -Section 45<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6450189&amp;loc=d3e30690-110894<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 830<br><br> -SubTopic 20<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6450222&amp;loc=d3e30840-110895<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 830<br><br> -SubTopic 20<br><br> -Section 45<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6450189&amp;loc=d3e30700-110894<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ForeignCurrencyTransactionGainLossUnrealized</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDerivativeInstrumentsNetPretax">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Aggregate net gain (loss) on all derivative instruments recognized in earnings during the period, before tax effects.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 815<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 4A<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7476318&amp;loc=SL5618551-113959<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_GainLossOnDerivativeInstrumentsNetPretax</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_GainLossOnSaleOfPropertyPlantEquipment</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The increase (decrease) during the reporting period in the amount due from customers for the credit sale of goods and services; includes accounts receivable and other types of receivables.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The increase (decrease) during the reporting period in the value of prepaid expenses and other assets not separately disclosed in the statement of cash flows, for example, deferred expenses, intangible assets, or income taxes.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaid">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount of cash paid for interest during the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4297-108586<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 25<br><br> -Subparagraph (e)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3536-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_InterestPaid</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of cash inflow (outflow) of financing activities, excluding discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 24<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3521-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 26<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3574-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of cash inflow (outflow) of investing activities, excluding discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 24<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3521-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 26<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3574-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 24<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3521-108585<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 25<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3536-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount of intangibles that an Entity acquires in a noncash (or part noncash) acquisition. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 5<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4332-108586<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4313-108586<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4304-108586<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash outflow to reacquire common stock during the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Financing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 15<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3291-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PaymentsForRepurchaseOfCommonStock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfFinancingCosts">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash outflow for loan and debt issuance costs.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Financing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 15<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3291-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PaymentsOfFinancingCosts</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfLoanCosts">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash outflow for loan origination associated cost which is usually collected through escrow.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 15<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3291-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PaymentsOfLoanCosts</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash outflow for cost incurred directly with the issuance of an equity security.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Financing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 15<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3291-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PaymentsOfStockIssuanceCosts</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireIntangibleAssets">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Investing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 13<br><br> -Subparagraph (c)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3213-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PaymentsToAcquireIntangibleAssets</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Investing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 13<br><br> -Subparagraph (c)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3213-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireShortTermInvestments">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Investing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 13<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3213-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PaymentsToAcquireShortTermInvestments</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash inflow associated with the amount received from entity's first offering of stock to the public.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Financing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 14<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3255-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ProceedsFromIssuanceInitialPublicOffering</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash inflow from the additional capital contribution to the entity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Financing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 14<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3255-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ProceedsFromIssuanceOfCommonStock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromNotesPayable">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash inflow from a borrowing supported by a written promise to pay an obligation.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Financing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 14<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3255-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ProceedsFromNotesPayable</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepurchaseOfRedeemablePreferredStock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Cash inflows (outflows) from issuing and redeeming redeemable preferred stock; includes convertible and nonconvertible redeemable preferred stock.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 15<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3291-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ProceedsFromRepurchaseOfRedeemablePreferredStock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Investing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 12<br><br> -Subparagraph (c)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3179-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfDebt">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_RepaymentsOfDebt</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfNotesPayable">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash outflow for a borrowing supported by a written promise to pay an obligation.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 15<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3291-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Financing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_RepaymentsOfNotesPayable</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensation</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SupplementalCashFlowInformationAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EGSBG">
      <tr>
        <th class="tl" colspan="1" rowspan="1">
          <div style="width: 200px;"><strong>Condensed Consolidated and Combined Balance Sheets (Parenthetical) (USD $)<br></strong></div>
        </th>
        <th class="th">
          <div>Mar. 31, 2014</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">AQXP Canada [Member] | Series A Exchangeable Preferred Shares [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityParOrStatedValuePerShare', window );">Redeemable convertible preferred stock, par value</a></td>
        <td class="nump">$ 0<span></span></td>
        <td class="nump">$ 0<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqxp_TemporaryEquitySharesAuthorizedUnlimited', window );">Redeemable convertible preferred stock, shares authorized</a></td>
        <td class="text">Unlimited<span></span></td>
        <td class="text">Unlimited<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Redeemable convertible preferred stock, shares issued</a></td>
        <td class="nump">0<span></span></td>
        <td class="nump">791,016<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Redeemable convertible preferred stock, shares outstanding</a></td>
        <td class="nump">0<span></span></td>
        <td class="nump">791,016<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">AQXP Canada [Member] | AQXP Canada, Series B Exchangeable Preferred Shares [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityParOrStatedValuePerShare', window );">Redeemable convertible preferred stock, par value</a></td>
        <td class="nump">$ 0<span></span></td>
        <td class="nump">$ 0<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqxp_TemporaryEquitySharesAuthorizedUnlimited', window );">Redeemable convertible preferred stock, shares authorized</a></td>
        <td class="text">Unlimited<span></span></td>
        <td class="text">Unlimited<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Redeemable convertible preferred stock, shares issued</a></td>
        <td class="nump">0<span></span></td>
        <td class="nump">793,617<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Redeemable convertible preferred stock, shares outstanding</a></td>
        <td class="nump">0<span></span></td>
        <td class="nump">793,617<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">AQXP Canada [Member] | Series C Exchangeable Preferred Shares [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityParOrStatedValuePerShare', window );">Redeemable convertible preferred stock, par value</a></td>
        <td class="nump">$ 0<span></span></td>
        <td class="nump">$ 0<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqxp_TemporaryEquitySharesAuthorizedUnlimited', window );">Redeemable convertible preferred stock, shares authorized</a></td>
        <td class="text">Unlimited<span></span></td>
        <td class="text">Unlimited<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Redeemable convertible preferred stock, shares issued</a></td>
        <td class="nump">0<span></span></td>
        <td class="nump">378,786<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Redeemable convertible preferred stock, shares outstanding</a></td>
        <td class="nump">0<span></span></td>
        <td class="nump">378,786<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Aquinox USA [Member] | Series A Preferred Stock [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityParOrStatedValuePerShare', window );">Redeemable convertible preferred stock, par value</a></td>
        <td class="nump">$ 0.000001<span></span></td>
        <td class="nump">$ 0.000001<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Redeemable convertible preferred stock, shares authorized</a></td>
        <td class="nump">0<span></span></td>
        <td class="nump">27,914,951<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Redeemable convertible preferred stock, shares issued</a></td>
        <td class="nump">0<span></span></td>
        <td class="nump">662,875<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Redeemable convertible preferred stock, shares outstanding</a></td>
        <td class="nump">0<span></span></td>
        <td class="nump">662,875<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Aquinox USA [Member] | Series B Preferred Stock [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityParOrStatedValuePerShare', window );">Redeemable convertible preferred stock, par value</a></td>
        <td class="nump">$ 0.000001<span></span></td>
        <td class="nump">$ 0.000001<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Redeemable convertible preferred stock, shares authorized</a></td>
        <td class="nump">0<span></span></td>
        <td class="nump">45,454,535<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Redeemable convertible preferred stock, shares issued</a></td>
        <td class="nump">0<span></span></td>
        <td class="nump">1,573,797<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Redeemable convertible preferred stock, shares outstanding</a></td>
        <td class="nump">0<span></span></td>
        <td class="nump">1,573,797<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Aquinox USA [Member] | Series C Preferred Stock [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityParOrStatedValuePerShare', window );">Redeemable convertible preferred stock, par value</a></td>
        <td class="nump">$ 0.000001<span></span></td>
        <td class="nump">$ 0.000001<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Redeemable convertible preferred stock, shares authorized</a></td>
        <td class="nump">0<span></span></td>
        <td class="nump">45,793,738<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Redeemable convertible preferred stock, shares issued</a></td>
        <td class="nump">0<span></span></td>
        <td class="nump">1,343,424<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Redeemable convertible preferred stock, shares outstanding</a></td>
        <td class="nump">0<span></span></td>
        <td class="nump">1,343,424<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Aquinox USA [Member] | Common Stock [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
        <td class="nump">$ 0.000001<span></span></td>
        <td class="nump">$ 0.000001<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
        <td class="nump">50,000,000<span></span></td>
        <td class="nump">139,266,037<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
        <td class="nump">10,675,260<span></span></td>
        <td class="nump">301,745<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
        <td class="nump">10,675,260<span></span></td>
        <td class="nump">301,745<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqxp_TemporaryEquitySharesAuthorizedUnlimited">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Temporary Equity Shares Authorized Unlimited</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>aqxp_TemporaryEquitySharesAuthorizedUnlimited</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>aqxp_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Face amount or stated value per share of common stock.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.29)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 30<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommonStockParOrStatedValuePerShare</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.29)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 30<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommonStockSharesAuthorized</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.29)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 30<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommonStockSharesIssued</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 04<br><br><br><br> -Article 3<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.3-04)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.29)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 30<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommonStockSharesOutstanding</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityParOrStatedValuePerShare">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 28<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_TemporaryEquityParOrStatedValuePerShare</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesAuthorized">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.27(b))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 28<br><br><br><br> -Subparagraph b<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_TemporaryEquitySharesAuthorized</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesIssued">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.27(b))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 28<br><br><br><br> -Subparagraph b<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_TemporaryEquitySharesIssued</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.27(b))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 28<br><br><br><br> -Subparagraph b<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_TemporaryEquitySharesOutstanding</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Cash and cash equivalents (Tables)<br></strong></div>
        </th>
        <th class="th" colspan="1">3 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAbstract', window );"><strong>Cash And Cash Equivalents [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock', window );">Schedule of Cash and Cash Equivalents</a></td>
        <td class="text"><div>
 <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="76%" align="center" border="0">
 <tr>
 <td width="62%"></td>
 <td valign="bottom" width="9%"></td>
 <td></td>
 <td></td>
 <td></td>
 <td valign="bottom" width="9%"></td>
 <td></td>
 <td></td>
 <td></td>
 </tr>
 <tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>MARCH&#xA0;31,&#xA0;2014</b></td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>DECEMBER&#xA0;31,&#xA0;2013</b></td>
 <td valign="bottom">&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF">
 <td valign="top">
 <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em">
 Cash</p>
 </td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">$</td>
 <td valign="bottom" align="right">49,538,874</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">$</td>
 <td valign="bottom" align="right">7,292,116</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
 <td valign="top">
 <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em">
 Cash equivalents</p>
 </td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" align="right">3,379,453</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" align="right">3,714,276</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF">
 <td valign="top"></td>
 <td valign="bottom"><font style="FONT-SIZE: 8pt">&#xA0;&#xA0;</font></td>
 <td valign="bottom">$</td>
 <td valign="bottom" align="right">52,918,327</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 <td valign="bottom"><font style="FONT-SIZE: 8pt">&#xA0;&#xA0;</font></td>
 <td valign="bottom">$</td>
 <td valign="bottom" align="right">11,006,392</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 </table>
 </div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CashAndCashEquivalentsAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of the components of cash and cash equivalents.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0E1CAE">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Document and Entity Information<br></strong></div>
        </th>
        <th class="th" colspan="1">3 Months Ended</th>
        <th class="th" colspan="1"></th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2014</div>
        </th>
        <th class="th">
          <div>Apr. 30, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqxp_DocumentAndEntityInformationAbstract', window );"><strong>Document And Entity Information [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
        <td class="text">10-Q<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
        <td class="text">false<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
        <td class="text">Mar. 31,
				 2014<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
        <td class="text">2014<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
        <td class="text">Q1<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
        <td class="text">AQXP<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
        <td class="text">AQUINOX PHARMACEUTICALS, INC<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
        <td class="text">0001404644<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
        <td class="text">--12-31<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
        <td class="text">Non-accelerated Filer<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">10,675,260<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqxp_DocumentAndEntityInformationAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>aqxp_DocumentAndEntityInformationAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>aqxp_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>If the value is true, then the document is an amendment to previously-filed/accepted document.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_AmendmentFlag</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:booleanItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>End date of current fiscal year in the format --MM-DD.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_CurrentFiscalYearEndDate</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:gMonthDayItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>This is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_DocumentFiscalPeriodFocus</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:fiscalPeriodItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_DocumentFiscalYearFocus</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:gYearItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_DocumentPeriodEndDate</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:dateItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word "Other".</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_DocumentType</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:submissionTypeItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation 12B<br><br> -Number 240<br><br> -Section 12b<br><br> -Subsection 1<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityCentralIndexKey</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:centralIndexKeyItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityCommonStockSharesOutstanding</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, (4) Smaller Reporting Company (Non-accelerated) or (5) Smaller Reporting Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityFilerCategory</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:filerCategoryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation 12B<br><br> -Number 240<br><br> -Section 12b<br><br> -Subsection 1<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityRegistrantName</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:normalizedStringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Trading symbol of an instrument as listed on an exchange.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_TradingSymbol</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:normalizedStringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0E2F">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Loan facility (Tables)<br></strong></div>
        </th>
        <th class="th" colspan="1">3 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock', window );">Schedule of Loan Facility</a></td>
        <td class="text"><div>
 <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="68%" align="center" border="0">
 <tr>
 <td width="84%"></td>
 <td valign="bottom" width="13%"></td>
 <td></td>
 <td></td>
 <td></td>
 </tr>
 <tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>AMOUNT</b></td>
 <td valign="bottom">&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF">
 <td valign="top">
 <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em">
 BALANCE&#x2014;January&#xA0;1, 2013</p>
 </td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom" nowrap="nowrap">$</td>
 <td valign="bottom" nowrap="nowrap" align="right">
 &#x2014;&#xA0;&#xA0;</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
 <td valign="top">
 <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em">
 Bank loan cash received - October&#xA0;30, 2013</p>
 </td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" align="right">2,500,000</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF">
 <td valign="top">
 <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em">
 Warrant discount</p>
 </td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" align="right">(226,255</td>
 <td valign="bottom" nowrap="nowrap">)&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
 <td valign="top">
 <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em">
 Financing costs</p>
 </td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" align="right">12,744</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF">
 <td valign="top">
 <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em">
 BALANCE&#x2014;December&#xA0;31, 2013</p>
 </td>
 <td valign="bottom"><font style="FONT-SIZE: 8pt">&#xA0;&#xA0;</font></td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" align="right">2,286,489</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
 <td valign="top">
 <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em">
 Accrued interest</p>
 </td>
 <td valign="bottom"><font style="FONT-SIZE: 8pt">&#xA0;&#xA0;</font></td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" align="right">9,844</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF">
 <td valign="top">
 <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em">
 Accretion of warrant discount</p>
 </td>
 <td valign="bottom"><font style="FONT-SIZE: 8pt">&#xA0;&#xA0;</font></td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" align="right">213,511</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
 <td valign="top">
 <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em">
 Repayment fee and penalty</p>
 </td>
 <td valign="bottom"><font style="FONT-SIZE: 8pt">&#xA0;&#xA0;</font></td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" align="right">100,000</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF">
 <td valign="top">
 <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em">
 Repayment of bank loan and interest</p>
 </td>
 <td valign="bottom"><font style="FONT-SIZE: 8pt">&#xA0;&#xA0;</font></td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" align="right">(2,609,844</td>
 <td valign="bottom" nowrap="nowrap">)&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
 <td valign="top">
 <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em">
 BALANCE&#x2014;March&#xA0;31, 2014</p>
 </td>
 <td valign="bottom"><font style="FONT-SIZE: 8pt">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap">$</td>
 <td valign="bottom" nowrap="nowrap" align="right">
 &#x2014;&#xA0;&#xA0;</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 </table>
 </div><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Summary of Bank Loan Facility</a></td>
        <td class="text"><div>
 <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="76%" align="center" border="0">
 <tr>
 <td width="66%"></td>
 <td valign="bottom" width="11%"></td>
 <td></td>
 <td></td>
 <td></td>
 <td valign="bottom" width="11%"></td>
 <td></td>
 <td></td>
 <td></td>
 </tr>
 <tr>
 <td height="16"></td>
 <td height="16" colspan="4"></td>
 <td height="16" colspan="4"></td>
 </tr>
 <tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>MARCH&#xA0;31,&#xA0;2014</b></td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>DECEMBER&#xA0;31,</b><br />
 <b>2013</b></td>
 <td valign="bottom">&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF">
 <td valign="top">
 <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em">
 Short-term portion of bank loan</p>
 </td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom" nowrap="nowrap">$</td>
 <td valign="bottom" nowrap="nowrap" align="right">
 &#x2014;&#xA0;&#xA0;</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">$</td>
 <td valign="bottom" align="right">250,000</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
 <td valign="top">
 <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em">
 Long-term portion of bank loan</p>
 </td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;</td>
 <td valign="bottom" nowrap="nowrap" align="right">
 &#x2014;&#xA0;&#xA0;</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" align="right">2,036,489</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF">
 <td valign="top"></td>
 <td valign="bottom"><font style="FONT-SIZE: 8pt">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap">$</td>
 <td valign="bottom" nowrap="nowrap" align="right">
 &#x2014;&#xA0;&#xA0;</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 <td valign="bottom"><font style="FONT-SIZE: 8pt">&#xA0;&#xA0;</font></td>
 <td valign="bottom">$</td>
 <td valign="bottom" align="right">2,286,489</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 </table>
 </div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DebtDisclosureAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ScheduleOfDebtTableTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.4-08.(e),(f))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> -Paragraph f<br><br> -Article 4<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.19(b),22(b))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 19, 22<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0E1PAG">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Condensed consolidated and combined statements of operations and comprehensive loss (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="2">3 Months Ended</th>
        <th class="th" colspan="1">123 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2014</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2013</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
        <td class="nump">$ 1,879,514<span></span></td>
        <td class="nump">$ 572,967<span></span></td>
        <td class="nump">$ 43,789,126<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
        <td class="nump">734,824<span></span></td>
        <td class="nump">423,865<span></span></td>
        <td class="nump">10,241,412<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
        <td class="nump">2,614,338<span></span></td>
        <td class="nump">996,832<span></span></td>
        <td class="nump">54,030,538<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other income (expenses)</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Bank charges and financing costs</a></td>
        <td class="num">(453,808)<span></span></td>
        <td class="num">(1,834)<span></span></td>
        <td class="num">(590,023)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
        <td class="nump">2,835<span></span></td>
        <td class="nump">1,446<span></span></td>
        <td class="nump">365,881<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment', window );">Sale of equipment</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">29,396<span></span></td>
        <td class="nump">134,553<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnDerivativeInstrumentsNetPretax', window );">Change in fair value of derivative liabilities (Note 8)</a></td>
        <td class="nump">913,929<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">2,102,193<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqxp_AmortizationOfDiscountOnPreferredStock', window );">Amortization and extinguishment of remaining discount on preferred shares upon conversion of preferred shares</a></td>
        <td class="num">(1,884,233)<span></span></td>
        <td class="num">(25,438)<span></span></td>
        <td class="num">(2,395,575)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax', window );">Foreign exchange loss</a></td>
        <td class="num">(192,063)<span></span></td>
        <td class="num">(17,005)<span></span></td>
        <td class="num">(239,484)<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other income (expenses)</a></td>
        <td class="num">(1,613,340)<span></span></td>
        <td class="num">(13,435)<span></span></td>
        <td class="num">(622,455)<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Net loss before income taxes</a></td>
        <td class="num">(4,227,678)<span></span></td>
        <td class="num">(1,010,267)<span></span></td>
        <td class="num">(54,652,993)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax recovery</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">3,150,406<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Net loss and comprehensive loss incurred in the development stage</a></td>
        <td class="num">(4,227,678)<span></span></td>
        <td class="num">(1,010,267)<span></span></td>
        <td class="num">(51,502,587)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqxp_TemporaryEquityAccretionToRedemptionValueLiquidationPreference', window );">Accretion for liquidation preference on preferred stock</a></td>
        <td class="num">(1,132,893)<span></span></td>
        <td class="num">(1,157,865)<span></span></td>
        <td class="num">(18,566,008)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment', window );">Accretion for share issuance costs on preferred stock</a></td>
        <td class="num">(19,550)<span></span></td>
        <td class="num">(44,307)<span></span></td>
        <td class="num">(1,014,667)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqxp_IncomeTaxExpenseOnPreferredStock', window );">Tax expense on preferred stock</a></td>
        <td class="num">(100,291)<span></span></td>
        <td class="num">(346,091)<span></span></td>
        <td class="num">(1,897,702)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqxp_ReversalOfIncomeTaxPayableOnPreferredStock', window );">Reversal of tax payable on preferred stock due to conversion of preferred stock</a></td>
        <td class="nump">1,897,702<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,897,702<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqxp_ExtinguishmentOfRemainingShareIssuanceCostsDueToConversionOfPreferredStock', window );">Extinguishment of remaining share issuance costs due to conversion of preferred stock</a></td>
        <td class="num">(439,227)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(439,227)<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Total loss attributable to common stockholders</a></td>
        <td class="num">$ (4,021,937)<span></span></td>
        <td class="num">$ (2,558,530)<span></span></td>
        <td class="num">$ (71,522,489)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Basic and diluted loss per common stock (Note 7)</a></td>
        <td class="num">$ (1.28)<span></span></td>
        <td class="num">$ (8.48)<span></span></td>
        <td class="num">$ (179.45)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Basic and diluted weighted average common stock outstanding (Note 7)</a></td>
        <td class="nump">3,148,481<span></span></td>
        <td class="nump">301,745<span></span></td>
        <td class="nump">398,573<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqxp_AmortizationOfDiscountOnPreferredStock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amortization Of Discount On Preferred Stock</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>aqxp_AmortizationOfDiscountOnPreferredStock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>aqxp_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqxp_ExtinguishmentOfRemainingShareIssuanceCostsDueToConversionOfPreferredStock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Extinguishment Of Remaining Share Issuance Costs Due To Conversion Of Preferred Stock</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>aqxp_ExtinguishmentOfRemainingShareIssuanceCostsDueToConversionOfPreferredStock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>aqxp_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqxp_IncomeTaxExpenseOnPreferredStock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Canadian tax with respect to Canadian corporation taxable preferred shares and their liquidation rights.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>aqxp_IncomeTaxExpenseOnPreferredStock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>aqxp_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqxp_ReversalOfIncomeTaxPayableOnPreferredStock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Reversal of Canadian tax with respect to Canadian corporation taxable preferred shares and their liquidation rights upon conversion of preferred stock.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>aqxp_ReversalOfIncomeTaxPayableOnPreferredStock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>aqxp_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqxp_TemporaryEquityAccretionToRedemptionValueLiquidationPreference">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Accretion for liquidation preference on temporary equity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>aqxp_TemporaryEquityAccretionToRedemptionValueLiquidationPreference</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>aqxp_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Other Comprehensive Income<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6519514<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Comprehensive Income<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=16317811<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 220<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 5<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358780&amp;loc=d3e557-108580<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Net Income<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6518256<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ComprehensiveIncomeNetOfTax</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EarningsPerShareBasicAndDiluted</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 830<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6450189&amp;loc=d3e30690-110894<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 830<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6450222&amp;loc=d3e30840-110895<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 830<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6450189&amp;loc=d3e30700-110894<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ForeignCurrencyTransactionGainLossBeforeTax</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDerivativeInstrumentsNetPretax">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Aggregate net gain (loss) on all derivative instruments recognized in earnings during the period, before tax effects.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 815<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 4A<br><br><br><br> -Subparagraph (b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=7476318&amp;loc=SL5618551-113959<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_GainLossOnDerivativeInstrumentsNetPretax</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 28<br><br><br><br> -Subparagraph (b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_GainLossOnSaleOfPropertyPlantEquipment</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 225<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SX 210.5-03.4)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_GeneralAndAdministrativeExpense</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>This element represents the income or loss from continuing operations attributable to the economic entity which may also be defined as revenue less expenses from ongoing operations, after income or loss from equity method investments, but before income taxes, extraordinary items, and noncontrolling interest.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 10<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 235<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.4-08.(h))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 08<br><br><br><br> -Paragraph h<br><br><br><br> -Article 4<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Income Tax Expense (or Benefit)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6515339<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 740<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 9<br><br><br><br> -Subparagraph (a),(b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32639-109319<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncomeTaxExpenseBenefit</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of the cost of borrowed funds accounted for as interest expense.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 835<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 942<br><br><br><br> -SubTopic 225<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.9-04.9)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 04<br><br><br><br> -Paragraph 9<br><br><br><br> -Article 9<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_InterestExpense</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 7<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 225<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SX 210.5-03.7(b))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_InvestmentIncomeInterest</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Net income after adjustments for dividends on preferred stock (declared in the period) and/or cumulative preferred stock (accumulated for the period).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 260<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 11<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=7655603&amp;loc=d3e1377-109256<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 225<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SX 210.5-03.7)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 7<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NonoperatingIncomeExpense</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NonoperatingIncomeExpenseAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OperatingExpenses</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OperatingExpensesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 985<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 730<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ResearchAndDevelopmentExpense</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of decrease to net income for accretion of temporary equity to its redemption value to derive net income apportioned to common stockholders.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Loan facility<br></strong></div>
        </th>
        <th class="th" colspan="1">3 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Loan facility</a></td>
        <td class="text"><div>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt">
 <b>5. Loan facility</b></p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt">
 On October&#xA0;23, 2013, AQXP Canada entered into a term loan
 facility with Silicon Valley Bank (&#x201C;SVB&#x201D;) for up to
 $4&#xA0;million, of which $2.5 million was received on
 October&#xA0;30, 2013 and a further $1.5 million is available to
 AQXP Canada through December&#xA0;31, 2014 upon AQXP Canada
 receiving certain agreed-upon Phase 2 top-line data results from
 its Chronic Obstructive Pulmonary Disorder (&#x201C;COPD&#x201D;) or
 Bladder Pain Syndrome/Interstitial Cystitis (&#x201C;BPS/IC&#x201D;)
 clinical trials. Aquinox USA is a guarantor of AQXP Canada&#x2019;s
 obligations under the term loan facility. In addition to principal,
 interest and other related payments due to SVB, Aquinox USA and
 AQXP Canada issued SVB warrants at $10.56 per warrant to purchase
 11,363 shares of Series C preferred stock and a corresponding
 number of Canadian special voting shares of AQXP Canada. Following
 the completion of the IPO, the warrants are exercisable for 11,363
 shares of common stock. These warrants expire in 2023.</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt">
 The term loan has an interest rate of 5.25% and is collateralized
 by AQXP Canada&#x2019;s assets, excluding intellectual property, but
 including all proceeds thereof. The term loan principal is
 repayable in monthly installments approximately $83,000 commencing
 October 2014 and the loan has a maturity date of March 2017. AQXP
 Canada may voluntarily repay the term loan at any time.</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt">
 On March&#xA0;28, 2014, AQXP Canada made a cash payment of
 $2,609,844 to fully repay the amount outstanding under the term
 loan facility. The repayment was accounted for as an extinguishment
 of debt and the loss on extinguishment of $213,511 along with the
 prepayment penalty, repayment fee and accrued interest were
 recorded within bank charges and financing costs.</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; MARGIN-TOP: 0pt">
 &#xA0;</p>
 <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="68%" align="center" border="0">
 <tr>
 <td width="84%"></td>
 <td valign="bottom" width="13%"></td>
 <td></td>
 <td></td>
 <td></td>
 </tr>
 <tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>AMOUNT</b></td>
 <td valign="bottom">&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF">
 <td valign="top">
 <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em">
 BALANCE&#x2014;January&#xA0;1, 2013</p>
 </td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom" nowrap="nowrap">$</td>
 <td valign="bottom" nowrap="nowrap" align="right">
 &#x2014;&#xA0;&#xA0;</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
 <td valign="top">
 <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em">
 Bank loan cash received - October&#xA0;30, 2013</p>
 </td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" align="right">2,500,000</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF">
 <td valign="top">
 <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em">
 Warrant discount</p>
 </td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" align="right">(226,255</td>
 <td valign="bottom" nowrap="nowrap">)&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
 <td valign="top">
 <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em">
 Financing costs</p>
 </td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" align="right">12,744</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF">
 <td valign="top">
 <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em">
 BALANCE&#x2014;December&#xA0;31, 2013</p>
 </td>
 <td valign="bottom"><font style="FONT-SIZE: 8pt">&#xA0;&#xA0;</font></td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" align="right">2,286,489</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
 <td valign="top">
 <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em">
 Accrued interest</p>
 </td>
 <td valign="bottom"><font style="FONT-SIZE: 8pt">&#xA0;&#xA0;</font></td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" align="right">9,844</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF">
 <td valign="top">
 <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em">
 Accretion of warrant discount</p>
 </td>
 <td valign="bottom"><font style="FONT-SIZE: 8pt">&#xA0;&#xA0;</font></td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" align="right">213,511</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
 <td valign="top">
 <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em">
 Repayment fee and penalty</p>
 </td>
 <td valign="bottom"><font style="FONT-SIZE: 8pt">&#xA0;&#xA0;</font></td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" align="right">100,000</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF">
 <td valign="top">
 <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em">
 Repayment of bank loan and interest</p>
 </td>
 <td valign="bottom"><font style="FONT-SIZE: 8pt">&#xA0;&#xA0;</font></td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" align="right">(2,609,844</td>
 <td valign="bottom" nowrap="nowrap">)&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
 <td valign="top">
 <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em">
 BALANCE&#x2014;March&#xA0;31, 2014</p>
 </td>
 <td valign="bottom"><font style="FONT-SIZE: 8pt">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap">$</td>
 <td valign="bottom" nowrap="nowrap" align="right">
 &#x2014;&#xA0;&#xA0;</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 </table>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; MARGIN-TOP: 0pt">
 &#xA0;</p>
 <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="76%" align="center" border="0">
 <tr>
 <td width="66%"></td>
 <td valign="bottom" width="11%"></td>
 <td></td>
 <td></td>
 <td></td>
 <td valign="bottom" width="11%"></td>
 <td></td>
 <td></td>
 <td></td>
 </tr>
 <tr>
 <td height="16"></td>
 <td height="16" colspan="4"></td>
 <td height="16" colspan="4"></td>
 </tr>
 <tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>MARCH&#xA0;31,&#xA0;2014</b></td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>DECEMBER&#xA0;31,</b><br />
 <b>2013</b></td>
 <td valign="bottom">&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF">
 <td valign="top">
 <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em">
 Short-term portion of bank loan</p>
 </td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom" nowrap="nowrap">$</td>
 <td valign="bottom" nowrap="nowrap" align="right">
 &#x2014;&#xA0;&#xA0;</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">$</td>
 <td valign="bottom" align="right">250,000</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
 <td valign="top">
 <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em">
 Long-term portion of bank loan</p>
 </td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;</td>
 <td valign="bottom" nowrap="nowrap" align="right">
 &#x2014;&#xA0;&#xA0;</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" align="right">2,036,489</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF">
 <td valign="top"></td>
 <td valign="bottom"><font style="FONT-SIZE: 8pt">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap">$</td>
 <td valign="bottom" nowrap="nowrap" align="right">
 &#x2014;&#xA0;&#xA0;</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 <td valign="bottom"><font style="FONT-SIZE: 8pt">&#xA0;&#xA0;</font></td>
 <td valign="bottom">$</td>
 <td valign="bottom" align="right">2,286,489</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 </table>
 </div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DebtDisclosureAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21475-112644<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 19, 20, 22<br><br> -Article 5<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.19,20,22)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DebtDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Cash and cash equivalents<br></strong></div>
        </th>
        <th class="th" colspan="1">3 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAbstract', window );"><strong>Cash And Cash Equivalents [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsDisclosureTextBlock', window );">Cash and cash equivalents</a></td>
        <td class="text"><div>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt">
 <b>4. Cash and cash equivalents</b></p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; MARGIN-TOP: 0pt">
 &#xA0;</p>
 <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="76%" align="center" border="0">
 <tr>
 <td width="62%"></td>
 <td valign="bottom" width="9%"></td>
 <td></td>
 <td></td>
 <td></td>
 <td valign="bottom" width="9%"></td>
 <td></td>
 <td></td>
 <td></td>
 </tr>
 <tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>MARCH&#xA0;31,&#xA0;2014</b></td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>DECEMBER&#xA0;31,&#xA0;2013</b></td>
 <td valign="bottom">&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF">
 <td valign="top">
 <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em">
 Cash</p>
 </td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">$</td>
 <td valign="bottom" align="right">49,538,874</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">$</td>
 <td valign="bottom" align="right">7,292,116</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
 <td valign="top">
 <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em">
 Cash equivalents</p>
 </td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" align="right">3,379,453</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" align="right">3,714,276</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF">
 <td valign="top"></td>
 <td valign="bottom"><font style="FONT-SIZE: 8pt">&#xA0;&#xA0;</font></td>
 <td valign="bottom">$</td>
 <td valign="bottom" align="right">52,918,327</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 <td valign="bottom"><font style="FONT-SIZE: 8pt">&#xA0;&#xA0;</font></td>
 <td valign="bottom">$</td>
 <td valign="bottom" align="right">11,006,392</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 </table>
 </div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CashAndCashEquivalentsAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for cash and cash equivalent footnotes,  which may include the types of deposits and money market instruments, applicable carrying amounts, restricted amounts and compensating balance arrangements. Cash and equivalents include: (1) currency on hand (2) demand deposits with banks or financial institutions (3) other kinds of accounts that have the general characteristics of demand deposits (4) short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Generally, only investments maturing within three months from the date of acquisition qualify.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Cash<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Cash Equivalents<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 1<br><br> -Article 5<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4273-108586<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SAB TOPIC 6.H.3)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13728-122682<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 6<br><br> -Section H<br><br> -Subsection 3<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CashAndCashEquivalentsDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EHOAE">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Condensed summary of significant accounting policies - Additional Information (Detail) (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="1">3 Months Ended</th>
        <th class="th" colspan="1"></th>
        <th class="th" colspan="1"></th>
        <th class="th" colspan="1"></th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2014

</div>
          <div>Segment</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqxp_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqxp_DescriptionOfPercentageOfRealizationOfTaxBenefitUponSettlement', window );">Tax benefits realized upon ultimate settlement, description</a></td>
        <td class="text">A measurement  attribute that measures a given tax position as the largest amount of tax  benefits that are more than 50% likely of being realized upon ultimate  settlement.<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqxp_PercentageOfRecognitionOfTaxBenefitUponSettlement', window );">Percentage of tax benefit upon settlement</a></td>
        <td class="nump">50.00%<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Operating segment</a></td>
        <td class="nump">1<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
        <td class="nump">$ 52,918,327<span></span></td>
        <td class="nump">$ 11,006,392<span></span></td>
        <td class="nump">$ 19,017,252<span></span></td>
        <td class="nump">$ 2,000,539<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">United States [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqxp_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
        <td class="nump">$ 51,116,586<span></span></td>
        <td class="nump">$ 6,629,383<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqxp_DescriptionOfPercentageOfRealizationOfTaxBenefitUponSettlement">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Description Of Percentage Of Realization Of Tax Benefit Upon Settlement</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>aqxp_DescriptionOfPercentageOfRealizationOfTaxBenefitUponSettlement</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>aqxp_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqxp_PercentageOfRecognitionOfTaxBenefitUponSettlement">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Percentage Of Recognition Of Tax Benefit Upon Settlement</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>aqxp_PercentageOfRecognitionOfTaxBenefitUponSettlement</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>aqxp_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqxp_SignificantAccountingPoliciesLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>aqxp_SignificantAccountingPoliciesLineItems</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>aqxp_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Cash<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Cash Equivalents<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 1<br><br> -Article 5<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 1<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3044-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CashAndCashEquivalentsAtCarryingValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NumberOfOperatingSegments</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:integerItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Common stock (Tables)<br></strong></div>
        </th>
        <th class="th" colspan="1">3 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TextBlockAbstract', window );"><strong>Text Block [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of Weighted Average Assumptions</a></td>
        <td class="text"><div>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt">
 The fair value of stock options granted is estimated using the
 Black-Scholes option pricing model with the following weighted
 average assumptions:</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; MARGIN-TOP: 0pt">
 &#xA0;</p>
 <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="84%" align="center" border="0">
 <tr>
 <td width="51%"></td>
 <td valign="bottom" width="14%"></td>
 <td></td>
 <td></td>
 <td></td>
 <td valign="bottom" width="14%"></td>
 <td></td>
 <td></td>
 <td></td>
 <td valign="bottom" width="14%"></td>
 <td></td>
 <td></td>
 <td></td>
 </tr>
 <tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>THREE&#xA0;MONTHS<br />
 ENDED<br />
 MARCH 31, 2014</b></td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>THREE&#xA0;MONTHS<br />
 ENDED<br />
 MARCH 31, 2013</b></td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>DECEMBER 26,<br />
 2003<br />
 (INCEPTION)&#xA0;TO<br />
 MARCH 31, 2014</b></td>
 <td valign="bottom">&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF">
 <td valign="top">
 <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em">
 Expected volatility</p>
 </td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" align="right">108</td>
 <td valign="bottom" nowrap="nowrap">%&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" align="right">NA</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" align="right">88</td>
 <td valign="bottom" nowrap="nowrap">%&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
 <td valign="top">
 <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em">
 Expected dividends</p>
 </td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" align="right">0</td>
 <td valign="bottom" nowrap="nowrap">%&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" align="right">NA</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" align="right">0</td>
 <td valign="bottom" nowrap="nowrap">%&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF">
 <td valign="top">
 <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em">
 Expected terms (years)</p>
 </td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" align="right">6.00</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" align="right">NA</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" align="right">6.24</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
 <td valign="top">
 <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em">
 Risk free rate</p>
 </td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" align="right">1.52</td>
 <td valign="bottom" nowrap="nowrap">%&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" align="right">NA</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" align="right">2.96</td>
 <td valign="bottom" nowrap="nowrap">%&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF">
 <td valign="top">
 <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em">
 Weighted average grant-date fair value of stock options</p>
 </td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">$</td>
 <td valign="bottom" align="right">9.05</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" align="right">NA</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">$</td>
 <td valign="bottom" align="right">4.23</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 </tr>
 </table>
 </div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (f)(2)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TextBlockAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_TextBlockAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Financial instruments<br></strong></div>
        </th>
        <th class="th" colspan="1">3 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsAllOtherInvestmentsAbstract', window );"><strong>Investments All Other Investments [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsDisclosureTextBlock', window );">Financial instruments</a></td>
        <td class="text"><div>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt">
 <b>8. Financial instruments</b></p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt">
 <b><i>Fair value of financial instruments</i></b></p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt">
 The carrying amounts of certain of the Company&#x2019;s financial
 instruments including cash, cash equivalents, accounts and other
 amounts receivable, prepayments, accounts payable, and accrued
 liabilities, approximate their fair values because of their nature
 and/or short maturities and are categorized as Level 1 in the fair
 value hierarchy. Short-term investments are categorized as Level 2
 in the fair value hierarchy and as of March&#xA0;31, 2014 had a
 fair value approximating their carrying amount.</p>
 <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 1px; MARGIN-TOP: 12px">
 &#xA0;</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt">
 The Company&#x2019;s preferred stock embedded feature and warrants
 are accounted for as derivative liabilities. The Company used Level
 3 inputs for the valuation methodology of the derivative
 liabilities. The estimated fair values were computed using a
 Black-Scholes option pricing model which incorporates a number of
 assumptions and judgments to estimate the fair value of these
 derivative liabilities including the fair value per share of the
 underlying stock, remaining contractual term of the warrants and
 redeemable convertible preferred stock, risk-free interest rate,
 expected dividend yield, credit spread, and expected volatility of
 the underlying stock. The derivative liabilities are adjusted to
 reflect estimated fair value at each period end, with any decrease
 or increase in the estimated fair value being recorded in change in
 fair value of derivative liabilities:</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt">
 <b>Fair value of significant unobservable inputs (Level 3)</b></p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; MARGIN-TOP: 0pt">
 &#xA0;</p>
 <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="84%" align="center" border="0">
 <tr>
 <td width="62%"></td>
 <td valign="bottom" width="6%"></td>
 <td></td>
 <td></td>
 <td></td>
 <td valign="bottom" width="6%"></td>
 <td></td>
 <td></td>
 <td></td>
 <td valign="bottom" width="6%"></td>
 <td></td>
 <td></td>
 <td></td>
 </tr>
 <tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>BANK LOAN<br />
 WARRANT<br />
 DERIVATIVE<br />
 LIABILITIES</b></td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>PREFERRED<br />
 STOCK<br />
 EMBEDDED<br />
 DERIVATIVE<br />
 LIABILITIES</b></td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>TOTAL</b></td>
 <td valign="bottom">&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF">
 <td valign="top">
 <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em">
 BALANCES&#x2014;January&#xA0;1, 2014</p>
 </td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">$</td>
 <td valign="bottom" align="right">221,320</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">$</td>
 <td valign="bottom" align="right">800,206</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">$</td>
 <td valign="bottom" align="right">1,021,526</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
 <td valign="top">
 <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em">
 Change in fair value of derivative liabilities</p>
 </td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" align="right">(113,723</td>
 <td valign="bottom" nowrap="nowrap">)&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;</td>
 <td valign="bottom" nowrap="nowrap" align="right">
 &#x2014;&#xA0;&#xA0;</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" align="right">(113,723</td>
 <td valign="bottom" nowrap="nowrap">)&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF">
 <td valign="top">
 <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em">
 Derecognition of liabilities upon preferred stock conversion to
 common stock conversion</p>
 </td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;</td>
 <td valign="bottom" nowrap="nowrap" align="right">
 &#x2014;&#xA0;&#xA0;</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" align="right">(800,206</td>
 <td valign="bottom" nowrap="nowrap">)&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" align="right">(800,206</td>
 <td valign="bottom" nowrap="nowrap">)&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
 <td valign="top">
 <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em">
 BALANCES&#x2014;March&#xA0;31, 2014</p>
 </td>
 <td valign="bottom"><font style="FONT-SIZE: 8pt">&#xA0;&#xA0;</font></td>
 <td valign="bottom">$</td>
 <td valign="bottom" align="right">107,597</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 <td valign="bottom"><font style="FONT-SIZE: 8pt">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap">$</td>
 <td valign="bottom" nowrap="nowrap" align="right">
 &#x2014;&#xA0;&#xA0;</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 <td valign="bottom"><font style="FONT-SIZE: 8pt">&#xA0;</font></td>
 <td valign="bottom">$</td>
 <td valign="bottom" align="right">107,597</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 </table>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt">
 There were no transfers between Levels 1, 2, and 3 during the three
 months ended March&#xA0;31, 2014 and 2013.</p>
 </div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentsDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for financial instruments. This disclosure includes, but is not limited to, fair value measurements of short and long term marketable securities, international currencies forward contracts, and auction rate securities. Financial instruments may include hedging and non-hedging currency exchange instruments, derivatives, securitizations and securities available for sale at fair value. Also included are investment results, realized and unrealized gains and losses as well as impairments and risk management disclosures.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_FinancialInstrumentsDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsAllOtherInvestmentsAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_InvestmentsAllOtherInvestmentsAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Common stock<br></strong></div>
        </th>
        <th class="th" colspan="1">3 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TextBlockAbstract', window );"><strong>Text Block [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqxp_CommonStockDisclosureTextBlock', window );">Common stock</a></td>
        <td class="text"><div>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt">
 <b>6. Common stock</b></p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt">
 <b><i>(a) Stock option plan</i></b></p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt">
 On January&#xA0;27, 2014, the stockholders of Aquinox USA approved
 a 2014 Equity Incentive Plan (&#x201C;2014 Plan&#x201D;). The 2014
 Plan became effective on the date of the prospectus for the IPO,
 March&#xA0;6, 2014. The 2014 Plan is the successor to and
 continuation of the 2006 Plan. After the 2014 Plan became
 effective, no further grants will be made under the 2006 Plan. The
 2014 Plan provides for the grant of stock options, stock
 appreciation rights, restricted stock awards, restricted stock unit
 awards, performance stock awards, performance cash awards, and
 other forms of equity awards to employees, directors, and
 consultants.</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt">
 The maximum number of shares of common stock that may be issued the
 under the 2014 Plan is 1,423,416, which number includes a number of
 shares of common stock equal to (i)&#xA0;756,279 new shares, plus
 (ii)&#xA0;the number of shares reserved for issuance under the 2006
 Plan at the time the 2014 Plan becomes effective, plus
 (iii)&#xA0;any shares subject to stock options or other stock
 awards granted under the 2006 Plan that would have otherwise
 returned to the 2006 Plan, such as upon the expiration or
 termination of a stock award prior to vesting. Additionally, the
 number of shares of common stock reserved for issuance under the
 2014 Plan will automatically increase on January&#xA0;1 of each
 year for a period of up to 10 years, beginning on January&#xA0;1,
 2015 and ending on and including January&#xA0;1, 2024, by 4% of the
 total number of shares of capital outstanding on December&#xA0;31
 of the preceding calendar year, or a lesser number of shares
 determined by the board of directors.</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt">
 <b><i>(b) Stock-based compensation</i></b></p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt">
 On March&#xA0;6, 2014, four of the non-employee directors were
 granted options to purchase a total of 33,332 shares of common
 stock; the exercise price per share for these grants was $11.00,
 which was the offering price of the common stock in the IPO.</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt">
 The fair value of stock options granted is estimated using the
 Black-Scholes option pricing model with the following weighted
 average assumptions:</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; MARGIN-TOP: 0pt">
 &#xA0;</p>
 <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="84%" align="center" border="0">
 <tr>
 <td width="51%"></td>
 <td valign="bottom" width="14%"></td>
 <td></td>
 <td></td>
 <td></td>
 <td valign="bottom" width="14%"></td>
 <td></td>
 <td></td>
 <td></td>
 <td valign="bottom" width="14%"></td>
 <td></td>
 <td></td>
 <td></td>
 </tr>
 <tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>THREE&#xA0;MONTHS<br />
 ENDED<br />
 MARCH 31, 2014</b></td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>THREE&#xA0;MONTHS<br />
 ENDED<br />
 MARCH 31, 2013</b></td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>DECEMBER 26,<br />
 2003<br />
 (INCEPTION)&#xA0;TO<br />
 MARCH 31, 2014</b></td>
 <td valign="bottom">&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF">
 <td valign="top">
 <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em">
 Expected volatility</p>
 </td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" align="right">108</td>
 <td valign="bottom" nowrap="nowrap">%&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" align="right">NA</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" align="right">88</td>
 <td valign="bottom" nowrap="nowrap">%&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
 <td valign="top">
 <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em">
 Expected dividends</p>
 </td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" align="right">0</td>
 <td valign="bottom" nowrap="nowrap">%&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" align="right">NA</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" align="right">0</td>
 <td valign="bottom" nowrap="nowrap">%&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF">
 <td valign="top">
 <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em">
 Expected terms (years)</p>
 </td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" align="right">6.00</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" align="right">NA</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" align="right">6.24</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
 <td valign="top">
 <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em">
 Risk free rate</p>
 </td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" align="right">1.52</td>
 <td valign="bottom" nowrap="nowrap">%&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" align="right">NA</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" align="right">2.96</td>
 <td valign="bottom" nowrap="nowrap">%&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF">
 <td valign="top">
 <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em">
 Weighted average grant-date fair value of stock options</p>
 </td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">$</td>
 <td valign="bottom" align="right">9.05</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" align="right">NA</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">$</td>
 <td valign="bottom" align="right">4.23</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 </tr>
 </table>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt">
 The Company amortizes the fair value of the stock options on a
 straight-line basis over the applicable requisite service periods
 of the awards, which is generally the vesting period. The weighted
 average grant date fair value of stock options granted for the
 three months ended March&#xA0;31, 2014 and 2013 were $9.05 and $0,
 respectively. There were no stock options granted during the three
 months ended March&#xA0;31, 2013.</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt">
 Stock-based compensation expense charged to income for the plans
 was $137,654 and $54,674 for the three months ended March&#xA0;31,
 2014 and 2013, respectively. Total unrecognized compensation cost
 for all stock-based compensation plans was $1,485,971 as of
 March&#xA0;31, 2014, which is expected to be recognized over a
 weighted-average period of 1.47 years.</p>
 </div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqxp_CommonStockDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Common Stock Disclosure [Text Block]</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>aqxp_CommonStockDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>aqxp_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TextBlockAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_TextBlockAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Net loss per share<br></strong></div>
        </th>
        <th class="th" colspan="1">3 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Net loss per share</a></td>
        <td class="text"><div>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt">
 <b>7. Net loss per share</b></p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt">
 In connection with the IPO, the Company&#x2019;s capital structure
 was reorganized such that AQXP Canada became a wholly-owned
 subsidiary of the Company, and the holders of the preferred shares
 of AQXP Canada, common shares of AQXP Canada and preferred shares
 of the Company exchanged their shares for shares of common stock of
 the Company (see Note 3). In connection with the IPO, the Company
 effected a 1-for-19.2 reverse stock split. The common stock,
 options and warrants outstanding as of the completion of the
 reorganization were 5,845,260 shares, 628,754 options and 11,363
 warrants, respectively. Basic and diluted earnings per share has
 been retroactively restated for all periods prior to the
 reorganization.</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt">
 Basic and diluted net loss per common share are presented using the
 two-class method required for participating securities. If a
 dividend is paid on common stock, the holders of preferred stock
 are entitled to a proportionate share of any such dividend as if
 they were holders of common stock (on an if-converted basis). The
 Company considers its preferred stock to be participating
 securities and, in accordance with the two-class method, earnings
 allocated to participating securities and the related number of
 outstanding shares of participating securities have been excluded
 from the computation of basic and diluted net loss per common
 share.</p>
 <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 1px; MARGIN-TOP: 12px">
 &#xA0;</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt">
 The Company considers the Aquinox USA Common Stock to be their
 participating stock that is subordinate to all other stock or
 shares of the Company. These shares are used by the Company when
 computing its loss per share. Under the two-class method, net loss
 attributable to common stockholders is determined by allocating
 undistributed loss between common stock and participating
 securities. Undistributed loss is calculated as net loss less
 distributed loss, accretion of liquidation preference on preferred
 stock, accretion of share issuance costs on preferred stock, and
 tax expense on preferred stock. As holders of preferred stock,
 holders of stock options and holders of common stock warrants do
 not have contractual obligations to share in the losses of the
 Company, the net loss attributable to common stockholders for each
 period is not allocated between common stock and participating
 securities. Accordingly, outstanding stock options, common stock
 warrants and preferred stock are excluded from the calculation of
 basic and diluted net loss per share as the effect would have been
 anti-dilutive.</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt">
 The detail of the computation of basic and diluted earnings per
 share is as follows:</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; MARGIN-TOP: 0pt">
 &#xA0;</p>
 <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="84%" align="center" border="0">
 <tr>
 <td width="51%"></td>
 <td valign="bottom" width="7%"></td>
 <td></td>
 <td></td>
 <td></td>
 <td valign="bottom" width="7%"></td>
 <td></td>
 <td></td>
 <td></td>
 <td valign="bottom" width="7%"></td>
 <td></td>
 <td></td>
 <td></td>
 </tr>
 <tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>THREE&#xA0;MONTHS<br />
 ENDED<br />
 MARCH 31, 2014</b></td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>THREE&#xA0;MONTHS<br />
 ENDED<br />
 MARCH 31, 2013</b></td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>DECEMBER&#xA0;26,<br />
 2003<br />
 (INCEPTION)&#xA0;TO<br />
 MARCH 31, 2014</b></td>
 <td valign="bottom">&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF">
 <td valign="top">
 <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em">
 <b><i>Numerator</i></b></p>
 </td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 </tr>
 <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
 <td valign="top">
 <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em">
 Net loss and comprehensive loss incurred in the development
 stage</p>
 </td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">$</td>
 <td valign="bottom" align="right">(4,227,678</td>
 <td valign="bottom" nowrap="nowrap">)&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">$</td>
 <td valign="bottom" align="right">(1,010,267</td>
 <td valign="bottom" nowrap="nowrap">)&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">$</td>
 <td valign="bottom" align="right">(51,502,587</td>
 <td valign="bottom" nowrap="nowrap">)&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF">
 <td valign="top">
 <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em">
 Accretion for liquidation preference on preferred stock</p>
 </td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" align="right">(1,132,893</td>
 <td valign="bottom" nowrap="nowrap">)&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" align="right">(1,157,865</td>
 <td valign="bottom" nowrap="nowrap">)&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" align="right">(18,566,008</td>
 <td valign="bottom" nowrap="nowrap">)&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
 <td valign="top">
 <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em">
 Accretion for share issuance costs on preferred stock</p>
 </td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" align="right">(19,550</td>
 <td valign="bottom" nowrap="nowrap">)&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" align="right">(44,307</td>
 <td valign="bottom" nowrap="nowrap">)&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" align="right">(1,014,667</td>
 <td valign="bottom" nowrap="nowrap">)&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF">
 <td valign="top">
 <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em">
 Tax expense on preferred stock</p>
 </td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" align="right">(100,291</td>
 <td valign="bottom" nowrap="nowrap">)&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" align="right">(346,091</td>
 <td valign="bottom" nowrap="nowrap">)&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" align="right">(1,897,702</td>
 <td valign="bottom" nowrap="nowrap">)&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
 <td valign="top">
 <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em">
 Reversal of tax payable on preferred stock due to conversion of
 preferred stock</p>
 </td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" align="right">1,897,702</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;</td>
 <td valign="bottom" nowrap="nowrap" align="right">
 &#x2014;&#xA0;&#xA0;</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" align="right">1,897,702</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF">
 <td valign="top">
 <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em">
 Extinguishment of remaining share issuance costs due to conversion
 of preferred stock</p>
 </td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" align="right">(439,227</td>
 <td valign="bottom" nowrap="nowrap">)&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;</td>
 <td valign="bottom" nowrap="nowrap" align="right">
 &#x2014;&#xA0;&#xA0;</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" align="right">(439,227</td>
 <td valign="bottom" nowrap="nowrap">)&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
 <td valign="top">
 <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em">
 Total loss attributable to common stockholders</p>
 </td>
 <td valign="bottom"><font style="FONT-SIZE: 8pt">&#xA0;&#xA0;</font></td>
 <td valign="bottom">$</td>
 <td valign="bottom" align="right">(4,021,937</td>
 <td valign="bottom" nowrap="nowrap">)&#xA0;</td>
 <td valign="bottom"><font style="FONT-SIZE: 8pt">&#xA0;</font></td>
 <td valign="bottom">$</td>
 <td valign="bottom" align="right">(2,558,530</td>
 <td valign="bottom" nowrap="nowrap">)&#xA0;</td>
 <td valign="bottom"><font style="FONT-SIZE: 8pt">&#xA0;</font></td>
 <td valign="bottom">$</td>
 <td valign="bottom" align="right">(71,522,489</td>
 <td valign="bottom" nowrap="nowrap">)&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF">
 <td valign="top">
 <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em">
 <b><i>Denominator</i></b></p>
 </td>
 <td valign="bottom"><font style="FONT-SIZE: 8pt">&#xA0;&#xA0;</font></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"><font style="FONT-SIZE: 8pt">&#xA0;</font></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"><font style="FONT-SIZE: 8pt">&#xA0;</font></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 </tr>
 <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
 <td valign="top">
 <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em">
 Weighted average shares used to compute basic net loss per common
 share</p>
 </td>
 <td valign="bottom"><font style="FONT-SIZE: 8pt">&#xA0;&#xA0;</font></td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" align="right">3,148,481</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 <td valign="bottom"><font style="FONT-SIZE: 8pt">&#xA0;</font></td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" align="right">301,745</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 <td valign="bottom"><font style="FONT-SIZE: 8pt">&#xA0;</font></td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" align="right">398,573</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF">
 <td valign="top">
 <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em">
 Effect of potentially dilutive securities:</p>
 </td>
 <td valign="bottom"><font style="FONT-SIZE: 8pt">&#xA0;&#xA0;</font></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"><font style="FONT-SIZE: 8pt">&#xA0;</font></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"><font style="FONT-SIZE: 8pt">&#xA0;</font></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 </tr>
 <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
 <td valign="top">
 <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em">
 Stock options</p>
 </td>
 <td valign="bottom"><font style="FONT-SIZE: 8pt">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap">&#xA0;</td>
 <td valign="bottom" nowrap="nowrap" align="right">
 &#x2014;&#xA0;&#xA0;</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 <td valign="bottom"><font style="FONT-SIZE: 8pt">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap">&#xA0;</td>
 <td valign="bottom" nowrap="nowrap" align="right">
 &#x2014;&#xA0;&#xA0;</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 <td valign="bottom"><font style="FONT-SIZE: 8pt">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap">&#xA0;</td>
 <td valign="bottom" nowrap="nowrap" align="right">
 &#x2014;&#xA0;&#xA0;</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF">
 <td valign="top">
 <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em">
 Common stock warrants</p>
 </td>
 <td valign="bottom"><font style="FONT-SIZE: 8pt">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap">&#xA0;</td>
 <td valign="bottom" nowrap="nowrap" align="right">
 &#x2014;&#xA0;&#xA0;</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 <td valign="bottom"><font style="FONT-SIZE: 8pt">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap">&#xA0;</td>
 <td valign="bottom" nowrap="nowrap" align="right">
 &#x2014;&#xA0;&#xA0;</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 <td valign="bottom"><font style="FONT-SIZE: 8pt">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap">&#xA0;</td>
 <td valign="bottom" nowrap="nowrap" align="right">
 &#x2014;&#xA0;&#xA0;</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
 <td valign="top">
 <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em">
 Weighted average shares used to compute diluted net loss per common
 share</p>
 </td>
 <td valign="bottom"><font style="FONT-SIZE: 8pt">&#xA0;&#xA0;</font></td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" align="right">3,148,481</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 <td valign="bottom"><font style="FONT-SIZE: 8pt">&#xA0;</font></td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" align="right">301,745</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 <td valign="bottom"><font style="FONT-SIZE: 8pt">&#xA0;</font></td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" align="right">398,573</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF">
 <td valign="top">
 <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em">
 Net loss per share attributable to common
 stockholders&#x2014;basic</p>
 </td>
 <td valign="bottom"><font style="FONT-SIZE: 8pt">&#xA0;&#xA0;</font></td>
 <td valign="bottom">$</td>
 <td valign="bottom" align="right">(1.28</td>
 <td valign="bottom" nowrap="nowrap">)&#xA0;</td>
 <td valign="bottom"><font style="FONT-SIZE: 8pt">&#xA0;</font></td>
 <td valign="bottom">$</td>
 <td valign="bottom" align="right">(8.48</td>
 <td valign="bottom" nowrap="nowrap">)&#xA0;</td>
 <td valign="bottom"><font style="FONT-SIZE: 8pt">&#xA0;</font></td>
 <td valign="bottom">$</td>
 <td valign="bottom" align="right">(179.45</td>
 <td valign="bottom" nowrap="nowrap">)&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
 <td valign="top">
 <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em">
 Net loss per share attributable to common
 stockholders&#x2014;diluted</p>
 </td>
 <td valign="bottom"><font style="FONT-SIZE: 8pt">&#xA0;&#xA0;</font></td>
 <td valign="bottom">$</td>
 <td valign="bottom" align="right">(1.28</td>
 <td valign="bottom" nowrap="nowrap">)&#xA0;</td>
 <td valign="bottom"><font style="FONT-SIZE: 8pt">&#xA0;</font></td>
 <td valign="bottom">$</td>
 <td valign="bottom" align="right">(8.48</td>
 <td valign="bottom" nowrap="nowrap">)&#xA0;</td>
 <td valign="bottom"><font style="FONT-SIZE: 8pt">&#xA0;</font></td>
 <td valign="bottom">$</td>
 <td valign="bottom" align="right">(179.45</td>
 <td valign="bottom" nowrap="nowrap">)&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 </table>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt">
 The following have been excluded from the computation of basic and
 diluted net loss per share as their effect would have been
 antidilutive:</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; MARGIN-TOP: 0pt">
 &#xA0;</p>
 <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="76%" align="center" border="0">
 <tr>
 <td width="64%"></td>
 <td valign="bottom" width="10%"></td>
 <td></td>
 <td></td>
 <td></td>
 <td valign="bottom" width="10%"></td>
 <td></td>
 <td></td>
 <td></td>
 </tr>
 <tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>THREE&#xA0;MONTHS<br />
 ENDED</b><br />
 <b>MARCH 31, 2014</b></td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>THREE&#xA0;MONTHS<br />
 ENDED</b><br />
 <b>MARCH 31, 2013</b></td>
 <td valign="bottom">&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF">
 <td valign="top">
 <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em">
 Convertible preferred stock</p>
 </td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;</td>
 <td valign="bottom" nowrap="nowrap" align="right">
 &#x2014;&#xA0;&#xA0;</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" align="right">5,525,844</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
 <td valign="top">
 <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em">
 Outstanding stock options</p>
 </td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" align="right">630,159</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" align="right">435,141</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF">
 <td valign="top">
 <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em">
 Common stock warrants</p>
 </td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" align="right">11,363</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;</td>
 <td valign="bottom" nowrap="nowrap" align="right">
 &#x2014;&#xA0;&#xA0;</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
 <td valign="top">
 <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em">
 Total</p>
 </td>
 <td valign="bottom"><font style="FONT-SIZE: 8pt">&#xA0;&#xA0;</font></td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" align="right">641,522</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 <td valign="bottom"><font style="FONT-SIZE: 8pt">&#xA0;&#xA0;</font></td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" align="right">5,960,985</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 </table>
 </div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EarningsPerShareAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for earnings per share.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7655603&amp;loc=d3e1278-109256<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7655603&amp;loc=d3e1252-109256<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 55<br><br> -Paragraph 52<br><br> -URI http://asc.fasb.org/extlink&amp;oid=32703322&amp;loc=d3e4984-109258<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.21)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EarningsPerShareTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EFIAC">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Condensed summary of significant accounting policies (Policies)<br></strong></div>
        </th>
        <th class="th" colspan="1">3 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of presentation</a></td>
        <td class="text"><div>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt">
 <b><i>(a) Basis of presentation</i></b></p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt">
 The accompanying unaudited condensed consolidated and combined
 financial statements are presented in United States
 (&#x201C;U.S.&#x201D;) dollars and have been prepared in accordance
 with accounting principles generally accepted in the United States
 of America (&#x201C;U.S. GAAP&#x201D;) and pursuant to the rules and
 regulations of the United States Securities and Exchange Commission
 (&#x201C;SEC&#x201D;) for interim financial information. Accordingly,
 these financial statements do not include all of the information
 and footnotes required for complete financial statements and should
 be read in conjunction with the audited combined financial
 statements and notes for the year ended December&#xA0;31, 2013
 included in the Company&#x2019;s final prospectus for its initial
 public offering (&#x201C;IPO&#x201D;) filed with the SEC pursuant to
 Rule 424(b) on March&#xA0;7, 2014.</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt">
 In management&#x2019;s opinion, the condensed consolidated and
 combined financial statements reflect all adjustments (including
 reclassifications and normal recurring adjustments) necessary to
 present fairly the financial position as of March&#xA0;31, 2014,
 and results of operations and cash flows for all periods presented.
 The interim results presented are not necessarily indicative of
 results that can be expected for a full year.</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt">
 Through a reorganization on March&#xA0;12, 2014, AQXP Canada became
 a wholly owned subsidiary of Aquinox USA (Note 3). Prior to the
 reorganization, management determined that AQXP Canada and Aquinox
 USA were entities under common control as each of AQXP Canada and
 Aquinox USA were owned beneficially by identical shareholders and
 as such the basis of presentation of financial results prior to
 March&#xA0;12, 2014 was on a combined basis. Subsequent to
 March&#xA0;12, 2014, the basis of presentation of the financial
 results is on a consolidated basis. All intercompany transactions
 have been eliminated.</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt">
 For the period from inception on December&#xA0;26, 2003 through
 March&#xA0;31, 2014, the Company is a development stage enterprise,
 as planned principal operations have not yet begun to generate
 revenues. In its development stage, all pre-operating costs are
 being expensed as incurred. The statements of operations and
 comprehensive loss, convertible preferred stock and
 stockholders&#x2019; deficit, and cash flows present the cumulative
 consolidated financial information of the Company for the period
 from inception on December&#xA0;26, 2003 through March&#xA0;31,
 2014.</p>
 </div><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of estimates</a></td>
        <td class="text"><div>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt">
 <b><i>(b) Use of estimates</i></b></p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt">
 The preparation of financial statements in conformity with U.S.
 GAAP requires management to make estimates and assumptions that
 affect the reported amounts of assets and liabilities and the
 disclosure of contingent assets and liabilities at the date of the
 financial statements and the reported amounts of expenses during
 the reporting period. Significant areas requiring management
 estimates are the valuation of intangible assets, valuation of
 stock options and warrants, amortization and depreciation,
 valuation allowance for deferred income taxes, and contingencies.
 Actual results could differ from those estimates.</p>
 </div><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Taxes</a></td>
        <td class="text"><div>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt">
 <b><i>(c) Taxes</i></b></p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt">
 The Company accounts for income taxes using <i>ASC&#xA0;740, Income
 Taxes</i> which is an asset and liability approach that requires
 the recognition of deferred tax assets and liabilities for the
 expected future tax consequences of events that have been
 recognized in the Company&#x2019;s financial statements or tax
 returns. In estimating future tax consequences, ASC 740 generally
 considers all expected future events other than enactments of and
 changes in the tax law or rates. The measurement of deferred tax
 assets is reduced, if necessary, by the amount of any tax benefits
 that, based on available evidence, are not expected to be realized.
 Valuation allowances are provided if, after considering other
 available evidence it is more likely than not that deferred tax
 assets will not be realized. ASC&#xA0;740 clarifies the criteria
 that must be met prior to recognition of the financial statement
 benefit of a position taken in a tax return. ASC&#xA0;740 provides
 a benefit recognition model with a two-step approach consisting of
 a &#x201C;more-likely-than-not&#x201D; recognition criteria, and a
 measurement attribute that measures a given tax position as the
 largest amount of tax benefits that are more than 50% likely of
 being realized upon ultimate settlement. ASC&#xA0;740 also requires
 the recognition of liabilities created by differences between tax
 positions taken in a tax return and amounts recognized in the
 financial statements.</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt">
 Investment tax credits relating to scientific research and
 experimental development are accounted for in operations. To the
 extent there is reasonable assurance the credits will be realized,
 they are recorded in the period the related expenditure is made as
 an income tax (provision) recovery. If investment tax credit
 amounts subsequently received are less or more than originally
 recorded, the difference is treated as a change in estimate.</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt">
 Canadian tax rules impose a tax with respect to Canadian
 corporation taxable preferred stock and their liquidation rights.
 In prior periods, AQXP Canada has recorded this tax on preferred
 stock as a non-current accrued tax payable on its balance sheet, on
 the same basis as it recorded the accretion of preferred stock.</p>
 </div><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Derivative liabilities and fair value of financial instruments</a></td>
        <td class="text"><div>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt">
 <b><i>(d) Derivative liabilities and fair value of financial
 instruments</i></b></p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt">
 The Company accounts for currently outstanding detachable warrants
 to purchase preferred stock or common stock as liabilities as they
 are freestanding derivative financial instruments. The warrants are
 recorded as liabilities at fair value, estimated using a
 Black-Scholes option pricing model, and marked to market at each
 balance sheet date, with changes in the fair value of the
 derivative liabilities recorded in the consolidated and combined
 statements of operations. The Company allocates the total
 consideration received for issuing preferred stock and warrants
 based on the relative fair value of each security at the date of
 issuance. This allocation results in a discount to the initial
 carrying amount of the preferred stock at the date of issuance
 amortized over the life of the preferred stock and is recorded as
 &#x201C;amortization of discount on preferred stock&#x201D; in the
 consolidated and combined statements of operations and
 comprehensive loss.</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt">
 The Company also evaluates and accounts for conversion and
 redemption options embedded in convertible instruments as they can
 be free standing derivative financial instruments depending on
 certain criteria. If they are determined to be free standing
 derivative financial instruments, the Company records these as
 preferred stock embedded derivatives on their consolidated balance
 sheets at fair value with changes in the fair values of these
 derivatives recorded in the consolidated and combined statements of
 operations and comprehensive loss.</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt">
 The Company applies the residual value method to record the fair
 value of warrants issued with loans as a discount to the initial
 carrying amount of loans at the date of issuance. Loans are
 measured at amortized cost using the effective interest method
 which is a method of calculating the amortized cost of a financial
 liability and allocating the effective interest expense over the
 term of the financial liability. Interest expense is recorded in
 bank charges and financing costs in the consolidated and combined
 statements of operations and comprehensive loss. The interest rate
 is the rate that exactly discounts estimated future cash payments
 throughout the term of the financial instrument to the net carrying
 amount of the financial liability. Debt issuance costs are
 capitalized, recorded as deferred financing costs, and are
 amortized into financing costs in the consolidated and combined
 statements of operations and comprehensive loss using the effective
 interest method.</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt">
 <i>ASC 820, Fair Value Measurements</i> requires disclosures about
 transfers into and out of Levels&#xA0;1 and 2 and separate
 disclosures about purchases, sales, issuances, and settlements
 relating to Level&#xA0;3 measurements. It also clarifies existing
 fair value disclosures regarding the level of disaggregation and
 the inputs and valuation techniques used to measure fair value.
 ASC&#xA0;820 defines fair value as the amounts that would be
 received upon sale of an asset or paid to transfer a liability in
 an orderly transaction between market participants at the
 measurement date (exit price). The guidance also established a fair
 value hierarchy that prioritizes the use of inputs used in
 valuation techniques into the following three levels:</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 4%; MARGIN-TOP: 6pt">
 Level 1&#x2014;Quoted prices in active markets for identical assets
 or liabilities.</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 4%; MARGIN-TOP: 6pt">
 Level 2&#x2014;Inputs other than Level 1 that are observable, either
 directly or indirectly, such as quoted prices for similar assets or
 liabilities; quoted prices in markets that are not active; or other
 inputs that are observable or can be corroborated by observable
 market data for substantially the full term of the assets or
 liabilities.</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 4%; MARGIN-TOP: 6pt">
 Level 3&#x2014;Unobservable inputs that are supported by little or
 no market activity and that are significant to the fair value of
 the assets or liabilities.</p>
 </div><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteRedeemablePreferredStockIssuePolicy', window );">Redeemable convertible preferred stock</a></td>
        <td class="text"><div>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt">
 <b><i>(e) Redeemable convertible preferred stock</i></b></p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt">
 The Company classified redeemable convertible preferred stock that
 was redeemable outside of the Company&#x2019;s control as mezzanine
 equity. The Company recorded such redeemable convertible preferred
 stock at fair value upon issuance, net of any issuance costs or
 discounts. The carrying value of the redeemable convertible
 preferred stock was increased by periodic accretion to its
 redemption value.</p>
 <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 1px; MARGIN-TOP: 12px">
 &#xA0;</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt">
 In the absence of retained earnings, the accretion was recorded
 within additional paid-in capital to the extent there was a
 sufficient balance, rather than accumulated deficit. Only after
 exhausting the balance of accumulated paid-in capital, was the
 accretion recorded to accumulated deficit.</p>
 </div><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Accounting for stock-based compensation</a></td>
        <td class="text"><div>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt">
 <b><i>(f) Accounting for stock-based compensation</i></b></p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt">
 The Company measures the cost of services received in exchange for
 an award of equity instruments based on the grant-date fair value
 of the award. The cost of such award will be recognized over the
 period during which services are provided in exchange for the
 award, generally the vesting period. All share-based payments to
 employees are recognized in the financial statements based upon
 their respective grant date fair values.</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt">
 The Company estimates the fair value of options granted using the
 Black-Scholes option pricing model. This approximation uses
 assumptions regarding a number of inputs that requires management
 to make significant estimates and judgments. Since prior to the
 completion of the IPO, the Company&#x2019;s common stock was not
 publicly traded, the expected volatility assumption was based on
 industry peer information. Additionally, because the Company has no
 significant history to calculate the expected term, the simplified
 method calculation was used.</p>
 </div><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Segment reporting</a></td>
        <td class="text"><div>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt">
 <b><i>(g) Segment reporting</i></b></p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt">
 Management has determined that the Company&#x2019;s operation, and
 how they manage the business, was one segment being the
 identification and development of therapeutics for inflammatory
 diseases and cancer. All of the Company&#x2019;s operations are
 performed in Canada. Total assets held in the U.S., comprised
 primarily of cash and cash equivalents, were $51,116,586 as of
 March&#xA0;31, 2014 (December 31, 2013 - $6,629,383).</p>
 </div><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Loss per share</a></td>
        <td class="text"><div>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt">
 <b><i>(h) Loss per share</i></b></p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt">
 Basic loss per common share is computed by dividing loss by the
 weighted-average number of common shares outstanding during the
 period. Diluted net earnings per common share is determined using
 the weighted-average number of common shares outstanding during the
 period, adjusted for the dilutive effect of common stock
 equivalents, consisting of shares that might be issued upon
 exercise of common stock options and warrants. In periods where
 losses are reported, the weighted-average number of common shares
 outstanding excludes common stock equivalents because their
 inclusion would be anti-dilutive.</p>
 </div><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent accounting pronouncements</a></td>
        <td class="text"><div>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt">
 <b><i>(i) Recent accounting pronouncements</i></b></p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt">
 In April 2014, the FASB issued ASU 2014-08, &#x201C;Presentation of
 Financial Statements and Property, Plant, and
 Equipment&#x2014;Reporting Discontinued Operations and Disclosures
 of Disposals of Components of an Entity.&#x201D; ASU 2014-08
 provides guidance related to the definition of a discontinued
 operation and requires new disclosures of both discontinued
 operations and certain other disposals that do not meet the
 definition of a discontinued operation. This new guidance is
 effective for the Company for annual periods beginning on
 January&#xA0;1, 2015 and interim periods within those years. The
 Company does not anticipate a material impact to the
 Company&#x2019;s financial position, results of operations or cash
 flows as a result of this change.</p>
 </div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccountingPoliciesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_BasisOfAccountingPolicyPolicyTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-107790<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (c)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -URI http://asc.fasb.org/subtopic&amp;trid=2144384<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EarningsPerSharePolicyTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for determining the fair value of financial instruments.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-107790<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 820<br><br> -SubTopic 10<br><br> -URI http://asc.fasb.org/subtopic&amp;trid=2155942<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_FairValueOfFinancialInstrumentsPolicy</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-107790<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -URI http://asc.fasb.org/subtopic&amp;trid=2144681<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 30<br><br> -URI http://asc.fasb.org/subtopic&amp;trid=2144749<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 19<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32840-109319<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 954<br><br> -SubTopic 740<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6491622&amp;loc=d3e9504-115650<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 17<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32809-109319<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 25<br><br> -URI http://asc.fasb.org/extlink&amp;oid=21917399&amp;loc=d3e32247-109318<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -URI http://asc.fasb.org/extlink&amp;oid=21917399&amp;loc=d3e32280-109318<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncomeTaxPolicyTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for segment reporting.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-107790<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SegmentReportingPolicyPolicyTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for stock option and stock incentive plans. This disclosure may include (1) the types of stock option or incentive plans sponsored by the entity (2) the groups that participate in (or are covered by) each plan (3) significant plan provisions and (4) how stock compensation is measured, and the methodologies and significant assumptions used to determine that measurement.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-107790<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (b),(f)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -URI http://asc.fasb.org/subtopic&amp;trid=2228939<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteRedeemablePreferredStockIssuePolicy">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for redeemable preferred stock issued. This disclosure may include the accounting treatment for the difference, if there is any, between the carrying value and redemption amount. For example, describe whether the issuer accretes changes in the redemption value.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-107790<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.27(b),(c))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -URI http://asc.fasb.org/subtopic&amp;trid=2208763<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 28<br><br> -Subparagraph b<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockholdersEquityNoteRedeemablePreferredStockIssuePolicy</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 275<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 9<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6927468&amp;loc=d3e6143-108592<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 275<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 8<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6927468&amp;loc=d3e6132-108592<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 275<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6927468&amp;loc=d3e6061-108592<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_UseOfEstimates</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EPKAE">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Financial instruments - Fair Value of Significant Unobservable Inputs (Detail) (Level 3 [Member], USD $)<br></strong></div>
        </th>
        <th class="th" colspan="1">3 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Beginning balance</a></td>
        <td class="nump">$ 1,021,526<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease', window );">Change in fair value of derivative liabilities</a></td>
        <td class="num">(113,723)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqxp_DecreaseOfEmbeddedDerivativeLiabilitiesForPreferredSharesConvertedIntoCommonStock', window );">Derecognition of liabilities upon preferred stock conversion to common stock conversion</a></td>
        <td class="num">(800,206)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Ending balance</a></td>
        <td class="nump">107,597<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Warrant Derivative Liabilities [Member] | Bank Loan [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Beginning balance</a></td>
        <td class="nump">221,320<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease', window );">Change in fair value of derivative liabilities</a></td>
        <td class="num">(113,723)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqxp_DecreaseOfEmbeddedDerivativeLiabilitiesForPreferredSharesConvertedIntoCommonStock', window );">Derecognition of liabilities upon preferred stock conversion to common stock conversion</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Ending balance</a></td>
        <td class="nump">107,597<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Embedded Derivative Liabilities [Member] | Preferred Stock [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Beginning balance</a></td>
        <td class="nump">800,206<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease', window );">Change in fair value of derivative liabilities</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqxp_DecreaseOfEmbeddedDerivativeLiabilitiesForPreferredSharesConvertedIntoCommonStock', window );">Derecognition of liabilities upon preferred stock conversion to common stock conversion</a></td>
        <td class="num">(800,206)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Ending balance</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqxp_DecreaseOfEmbeddedDerivativeLiabilitiesForPreferredSharesConvertedIntoCommonStock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Decrease Of Embedded Derivative Liabilities For Preferred Shares Converted Into Common Stock</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>aqxp_DecreaseOfEmbeddedDerivativeLiabilitiesForPreferredSharesConvertedIntoCommonStock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>aqxp_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of increase (decrease) of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 820<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=25499696&amp;loc=d3e19207-110258<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 820<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=25499696&amp;loc=d3e19207-110258<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Financial instruments (Tables)<br></strong></div>
        </th>
        <th class="th" colspan="1">3 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsAllOtherInvestmentsAbstract', window );"><strong>Investments All Other Investments [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Fair Value of Significant Unobservable Inputs</a></td>
        <td class="text"><div>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt">
 <b>Fair value of significant unobservable inputs (Level 3)</b></p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; MARGIN-TOP: 0pt">
 &#xA0;</p>
 <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="84%" align="center" border="0">
 <tr>
 <td width="62%"></td>
 <td valign="bottom" width="6%"></td>
 <td></td>
 <td></td>
 <td></td>
 <td valign="bottom" width="6%"></td>
 <td></td>
 <td></td>
 <td></td>
 <td valign="bottom" width="6%"></td>
 <td></td>
 <td></td>
 <td></td>
 </tr>
 <tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>BANK LOAN<br />
 WARRANT<br />
 DERIVATIVE<br />
 LIABILITIES</b></td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>PREFERRED<br />
 STOCK<br />
 EMBEDDED<br />
 DERIVATIVE<br />
 LIABILITIES</b></td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>TOTAL</b></td>
 <td valign="bottom">&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF">
 <td valign="top">
 <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em">
 BALANCES&#x2014;January&#xA0;1, 2014</p>
 </td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">$</td>
 <td valign="bottom" align="right">221,320</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">$</td>
 <td valign="bottom" align="right">800,206</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">$</td>
 <td valign="bottom" align="right">1,021,526</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
 <td valign="top">
 <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em">
 Change in fair value of derivative liabilities</p>
 </td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" align="right">(113,723</td>
 <td valign="bottom" nowrap="nowrap">)&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;</td>
 <td valign="bottom" nowrap="nowrap" align="right">
 &#x2014;&#xA0;&#xA0;</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" align="right">(113,723</td>
 <td valign="bottom" nowrap="nowrap">)&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF">
 <td valign="top">
 <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em">
 Derecognition of liabilities upon preferred stock conversion to
 common stock conversion</p>
 </td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;</td>
 <td valign="bottom" nowrap="nowrap" align="right">
 &#x2014;&#xA0;&#xA0;</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" align="right">(800,206</td>
 <td valign="bottom" nowrap="nowrap">)&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" align="right">(800,206</td>
 <td valign="bottom" nowrap="nowrap">)&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
 <td valign="top">
 <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em">
 BALANCES&#x2014;March&#xA0;31, 2014</p>
 </td>
 <td valign="bottom"><font style="FONT-SIZE: 8pt">&#xA0;&#xA0;</font></td>
 <td valign="bottom">$</td>
 <td valign="bottom" align="right">107,597</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 <td valign="bottom"><font style="FONT-SIZE: 8pt">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap">$</td>
 <td valign="bottom" nowrap="nowrap" align="right">
 &#x2014;&#xA0;&#xA0;</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 <td valign="bottom"><font style="FONT-SIZE: 8pt">&#xA0;</font></td>
 <td valign="bottom">$</td>
 <td valign="bottom" align="right">107,597</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 </table>
 </div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of the fair value measurement of assets using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income (loss), and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 820<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=25499696&amp;loc=d3e19279-110258<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 820<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=25499696&amp;loc=d3e19207-110258<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsAllOtherInvestmentsAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_InvestmentsAllOtherInvestmentsAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0ERKBG">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Loan facility - Additional Information (Detail) (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="1">3 Months Ended</th>
        <th class="th" colspan="1">12 Months Ended</th>
        <th class="th" colspan="2">0 Months Ended</th>
        <th class="th" colspan="1">3 Months Ended</th>
        <th class="th" colspan="1"></th>
        <th class="th" colspan="2"></th>
        <th class="th" colspan="1"></th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2014</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
        <th class="th">
          <div>Mar. 28, 2014

</div>
          <div>Silicon Valley Bank [Member]</div>
        </th>
        <th class="th">
          <div>Oct. 30, 2013

</div>
          <div>Silicon Valley Bank [Member]</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2014

</div>
          <div>Silicon Valley Bank [Member]</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013

</div>
          <div>Silicon Valley Bank [Member]</div>
        </th>
        <th class="th">
          <div>Oct. 23, 2013

</div>
          <div>Silicon Valley Bank [Member]</div>
        </th>
        <th class="th">
          <div>Oct. 23, 2013

</div>
          <div>Silicon Valley Bank [Member]

</div>
          <div>Warrants to Purchase Series C Convertible Preferred Stock [Member]</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2014

</div>
          <div>Silicon Valley Bank [Member]

</div>
          <div>Warrants to Purchase Common Stock [Member]</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Term loan facility with Silicon Valley Bank</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 4,000,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromLinesOfCredit', window );">Term loan, amount borrowed</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">2,500,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">2,500,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity', window );">Term loan borrowing capacity, available upon receiving Phase 2 top-line data results</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,500,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights', window );">Warrants to purchase per share</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">10.56<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants to purchase shares of stock, shares</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">11,363<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqxp_ClassOfWarrantOrRightExercisable', window );">Warrants exercisable</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">11,363<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqxp_ClassOfWarrantOrRightExpirationYear', window );">Warrant expire</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">2023<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod', window );">Term loan interest rate</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">5.25%<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityPeriodicPaymentPrincipal', window );">Term loan, periodic principal repayments</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">83,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityExpirationDate1', window );">Term loan, maturity date</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">Mar. 31,
				 2017<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityFrequencyOfPaymentAndPaymentTerms', window );">Term loan, payment terms</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">The term loan principal is repayable in monthly installments  approximately $83,000 commencing October 2014<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLinesOfCredit', window );">Term loan repayment</a></td>
        <td class="nump">2,609,844<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">2,609,844<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Term loan, loss on extinguishment of debt</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 213,511<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqxp_ClassOfWarrantOrRightExercisable">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Class Of Warrant Or Right Exercisable</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>aqxp_ClassOfWarrantOrRightExercisable</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>aqxp_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqxp_ClassOfWarrantOrRightExpirationYear">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Class Of Warrant Or Right Expiration Year</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>aqxp_ClassOfWarrantOrRightExpirationYear</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>aqxp_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:gYearItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Exercise price per share or per unit of warrants or rights outstanding.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.4-08.(i)(4))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> -Paragraph i<br><br> -Subparagraph 4<br><br> -Article 4<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>us-types:perUnitItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.4-08.(i)(2))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> -Paragraph i<br><br> -Subparagraph 2<br><br> -Article 4<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 470<br><br> -SubTopic 50<br><br> -Section 40<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6850294&amp;loc=d3e12317-112629<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 470<br><br> -SubTopic 50<br><br> -Section 40<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6850294&amp;loc=d3e12355-112629<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_GainsLossesOnExtinguishmentOfDebt</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityExpirationDate1">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Date the credit facility terminates, in CCYY-MM-DD format.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.19(b),22(b))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 19, 22<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_LineOfCreditFacilityExpirationDate1</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:dateItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityFrequencyOfPaymentAndPaymentTerms">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Description of the frequency of the required periodic payments of interest, principal, or both, and the amount, if set, or a description of a formula upon which payment is based.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.19(b),22(b))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 19, 22<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_LineOfCreditFacilityFrequencyOfPaymentAndPaymentTerms</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The effective interest rate during the reporting period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.19(b),22(b))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 19, 22<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_LineOfCreditFacilityInterestRateDuringPeriod</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_LineOfCreditFacilityLineItems</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.19(b),22(b))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 19, 22<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityPeriodicPaymentPrincipal">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of the required periodic payment applied to principal.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.19(b),22(b))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 19, 22<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_LineOfCreditFacilityPeriodicPaymentPrincipal</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.19(b),22(b))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 19, 22<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLinesOfCredit">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.4-08.(f))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> -Paragraph f<br><br> -Article 4<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Financing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 14<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3255-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ProceedsFromLinesOfCredit</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLinesOfCredit">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.4-08.(f))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> -Paragraph f<br><br> -Article 4<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 15<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3291-108585<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Financing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_RepaymentsOfLinesOfCredit</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EJJFM">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Condensed consolidated and combined statements of convertible preferred stock and stockholders' deficit (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="1">1 Months Ended</th>
        <th class="th" colspan="2">3 Months Ended</th>
        <th class="th" colspan="10">12 Months Ended</th>
        <th class="th" colspan="1">123 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2014</div>
        </th>
        <th class="th">
          <div>Mar. 12, 2014</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2014</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2011</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2010</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2009</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2008</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2007</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2006</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2005</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2004</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqxp_ConversionOfPreferredStockIntoCommonStock', window );">Conversion of preferred stock into Aquinox USA common stock</a></td>
        <td class="nump">$ 77,333,952<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Repurchase of common stock</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(350)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForCash', window );">Issued for cash, net of share issue costs</a></td>
        <td class="nump">47,341,278<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">7<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">7<span></span></td>
        <td class="nump">8<span></span></td>
        <td class="nump">3<span></span></td>
        <td class="nump">3<span></span></td>
        <td class="nump">10<span></span></td>
        <td class="nump">489,451<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">800<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForNoncashConsiderations', window );">Issued for intangible assets</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">44,834<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation</a></td>
        <td class="nump">38,237<span></span></td>
        <td class="nump">99,417<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">349,321<span></span></td>
        <td class="nump">351,322<span></span></td>
        <td class="nump">118,243<span></span></td>
        <td class="nump">109,256<span></span></td>
        <td class="nump">111,673<span></span></td>
        <td class="nump">103,518<span></span></td>
        <td class="nump">78,255<span></span></td>
        <td class="nump">50,488<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Net loss and comprehensive loss incurred in development stage</a></td>
        <td class="num">(838,306)<span></span></td>
        <td class="num">(3,389,372)<span></span></td>
        <td class="num">(4,227,678)<span></span></td>
        <td class="num">(8,729,371)<span></span></td>
        <td class="num">(7,714,198)<span></span></td>
        <td class="num">(10,507,008)<span></span></td>
        <td class="num">(8,529,753)<span></span></td>
        <td class="num">(3,752,070)<span></span></td>
        <td class="num">(5,459,460)<span></span></td>
        <td class="num">(2,008,534)<span></span></td>
        <td class="num">(543,052)<span></span></td>
        <td class="num">(19,275)<span></span></td>
        <td class="num">(12,188)<span></span></td>
        <td class="num">(51,502,587)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqxp_TemporaryEquityAccretionToRedemptionValueLiquidationPreference', window );">Accretion for liquidation preference on preferred stock</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(1,132,893)<span></span></td>
        <td class="num">(1,132,893)<span></span></td>
        <td class="num">(5,351,459)<span></span></td>
        <td class="num">(3,860,140)<span></span></td>
        <td class="num">(3,303,200)<span></span></td>
        <td class="num">(2,167,601)<span></span></td>
        <td class="num">(1,301,400)<span></span></td>
        <td class="num">(1,008,153)<span></span></td>
        <td class="num">(441,162)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(18,566,008)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment', window );">Accretion for share issuance costs on preferred stock</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(19,550)<span></span></td>
        <td class="num">(19,550)<span></span></td>
        <td class="num">(123,074)<span></span></td>
        <td class="num">(168,702)<span></span></td>
        <td class="num">(163,483)<span></span></td>
        <td class="num">(175,467)<span></span></td>
        <td class="num">(159,611)<span></span></td>
        <td class="num">(139,758)<span></span></td>
        <td class="num">(65,024)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(1,014,667)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqxp_IncomeTaxExpenseOnPreferredStock', window );">Accrual of tax payable on preferred stock</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(100,291)<span></span></td>
        <td class="num">(100,291)<span></span></td>
        <td class="num">(737,925)<span></span></td>
        <td class="num">(394,908)<span></span></td>
        <td class="num">(345,587)<span></span></td>
        <td class="num">(244,251)<span></span></td>
        <td class="num">(74,743)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(1,897,702)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqxp_ExtinguishmentOfRemainingShareIssuanceCostsDueToConversionOfPreferredStock', window );">Extinguishment of remaining share issuance costs, warrant discount, redemption option and related tax payable due to conversion of preferred stock</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,458,478<span></span></td>
        <td class="nump">439,227<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">439,227<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending Balance</a></td>
        <td class="nump">55,097,242<span></span></td>
        <td class="num">(68,777,919)<span></span></td>
        <td class="nump">55,097,242<span></span></td>
        <td class="num">(65,693,708)<span></span></td>
        <td class="num">(51,101,207)<span></span></td>
        <td class="num">(39,314,581)<span></span></td>
        <td class="num">(25,113,553)<span></span></td>
        <td class="num">(14,105,745)<span></span></td>
        <td class="num">(8,929,597)<span></span></td>
        <td class="num">(2,425,747)<span></span></td>
        <td class="nump">10,708<span></span></td>
        <td class="num">(31,013)<span></span></td>
        <td class="num">(11,388)<span></span></td>
        <td class="nump">55,097,242<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Additional Paid-in Capital [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfUnits', window );">Share reorganization</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">534,735<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqxp_ConversionOfPreferredStockIntoCommonStock', window );">Conversion of preferred stock into Aquinox USA common stock</a></td>
        <td class="nump">77,333,945<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForCash', window );">Issued for cash, net of share issue costs</a></td>
        <td class="nump">47,341,274<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">7<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">7<span></span></td>
        <td class="nump">8<span></span></td>
        <td class="nump">3<span></span></td>
        <td class="nump">3<span></span></td>
        <td class="nump">10<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation</a></td>
        <td class="nump">38,237<span></span></td>
        <td class="nump">99,417<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">349,321<span></span></td>
        <td class="nump">351,322<span></span></td>
        <td class="nump">118,243<span></span></td>
        <td class="nump">109,256<span></span></td>
        <td class="nump">111,673<span></span></td>
        <td class="nump">103,518<span></span></td>
        <td class="nump">78,255<span></span></td>
        <td class="nump">50,488<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqxp_TemporaryEquityAccretionToRedemptionValueLiquidationPreference', window );">Accretion for liquidation preference on preferred stock</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(99,417)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(349,328)<span></span></td>
        <td class="num">(351,322)<span></span></td>
        <td class="num">(118,250)<span></span></td>
        <td class="num">(109,264)<span></span></td>
        <td class="num">(111,673)<span></span></td>
        <td class="num">(325,847)<span></span></td>
        <td class="num">(441,162)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending Balance</a></td>
        <td class="nump">124,713,456<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">124,713,456<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">222,326<span></span></td>
        <td class="nump">50,488<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">124,713,456<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Accumulated Deficit [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Net loss and comprehensive loss incurred in development stage</a></td>
        <td class="num">(838,306)<span></span></td>
        <td class="num">(3,389,372)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(8,729,371)<span></span></td>
        <td class="num">(7,714,198)<span></span></td>
        <td class="num">(10,507,008)<span></span></td>
        <td class="num">(8,529,753)<span></span></td>
        <td class="num">(3,752,070)<span></span></td>
        <td class="num">(5,459,460)<span></span></td>
        <td class="num">(2,008,534)<span></span></td>
        <td class="num">(543,052)<span></span></td>
        <td class="num">(19,275)<span></span></td>
        <td class="num">(12,188)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqxp_TemporaryEquityAccretionToRedemptionValueLiquidationPreference', window );">Accretion for liquidation preference on preferred stock</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(1,033,476)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(5,002,131)<span></span></td>
        <td class="num">(3,508,818)<span></span></td>
        <td class="num">(3,184,950)<span></span></td>
        <td class="num">(2,058,337)<span></span></td>
        <td class="num">(1,189,724)<span></span></td>
        <td class="num">(682,306)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment', window );">Accretion for share issuance costs on preferred stock</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(19,550)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(123,074)<span></span></td>
        <td class="num">(168,702)<span></span></td>
        <td class="num">(163,483)<span></span></td>
        <td class="num">(175,467)<span></span></td>
        <td class="num">(159,611)<span></span></td>
        <td class="num">(139,758)<span></span></td>
        <td class="num">(65,024)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqxp_IncomeTaxExpenseOnPreferredStock', window );">Accrual of tax payable on preferred stock</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(100,291)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(737,925)<span></span></td>
        <td class="num">(394,908)<span></span></td>
        <td class="num">(345,587)<span></span></td>
        <td class="num">(244,251)<span></span></td>
        <td class="num">(74,743)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqxp_ExtinguishmentOfRemainingShareIssuanceCostsDueToConversionOfPreferredStock', window );">Extinguishment of remaining share issuance costs, warrant discount, redemption option and related tax payable due to conversion of preferred stock</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,458,478<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending Balance</a></td>
        <td class="num">(69,616,225)<span></span></td>
        <td class="num">(68,777,919)<span></span></td>
        <td class="num">(69,616,225)<span></span></td>
        <td class="num">(65,693,708)<span></span></td>
        <td class="num">(51,101,207)<span></span></td>
        <td class="num">(39,314,581)<span></span></td>
        <td class="num">(25,113,553)<span></span></td>
        <td class="num">(14,105,745)<span></span></td>
        <td class="num">(8,929,597)<span></span></td>
        <td class="num">(2,648,073)<span></span></td>
        <td class="num">(574,515)<span></span></td>
        <td class="num">(31,463)<span></span></td>
        <td class="num">(12,188)<span></span></td>
        <td class="num">(69,616,225)<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">AQXP Canada [Member] | Exchangeable Preferred Shares [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqxp_ConversionOfPreferredStockIntoCommonStock', window );">Conversion of preferred stock into Aquinox USA common stock</a></td>
        <td class="num">(28,824,651)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqxp_ConversionOfPreferredStockIntoCommonStockShares', window );">Conversion of preferred stock into Aquinox USA common stock, Shares</a></td>
        <td class="num">(1,963,419)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForCash', window );">Issued for cash, net of share issue costs</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">3,950,228<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">3,885,636<span></span></td>
        <td class="nump">4,335,318<span></span></td>
        <td class="nump">1,467,508<span></span></td>
        <td class="nump">1,482,936<span></span></td>
        <td class="nump">4,992,710<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForCash', window );">Issued for cash, net of share issue costs, Shares</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">378,786<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">369,118<span></span></td>
        <td class="nump">424,499<span></span></td>
        <td class="nump">142,045<span></span></td>
        <td class="nump">142,044<span></span></td>
        <td class="nump">506,927<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqxp_TemporaryEquityWarrantDiscount', window );">Warrant discount on issuance of preferred shares</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(109,115)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqxp_TemporaryEquityRedemptionDiscount', window );">Redemption discount of $466,673 for AQXP Canada and $1,633,357 for Aquinox USA on issuance of preferred shares</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(466,673)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqxp_TemporaryEquityAccretionToRedemptionValueLiquidationPreference', window );">Accretion for liquidation preference on preferred stock</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">401,165<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">2,036,438<span></span></td>
        <td class="nump">1,647,432<span></span></td>
        <td class="nump">1,445,120<span></span></td>
        <td class="nump">1,053,645<span></span></td>
        <td class="nump">708,037<span></span></td>
        <td class="nump">553,808<span></span></td>
        <td class="nump">245,162<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment', window );">Accretion for share issuance costs on preferred stock</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">6,649<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">45,754<span></span></td>
        <td class="nump">72,296<span></span></td>
        <td class="nump">70,509<span></span></td>
        <td class="nump">78,179<span></span></td>
        <td class="nump">84,954<span></span></td>
        <td class="nump">74,650<span></span></td>
        <td class="nump">34,800<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqxp_TemporaryEquityAccretionToRedemptionValueWarrantDiscount', window );">Amortization of warrant discount on preferred stock</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">4,187<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">21,825<span></span></td>
        <td class="nump">21,882<span></span></td>
        <td class="nump">21,823<span></span></td>
        <td class="nump">16,442<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqxp_TemporaryEquityAccretionToRedemptionValueRedemptionOption', window );">Amortization of redemption option on preferred stock</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">16,623<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">73,389<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqxp_ExtinguishmentOfRemainingShareIssuanceCostsDueToConversionOfPreferredStock', window );">Extinguishment of remaining share issuance costs, warrant discount, redemption option and related tax payable due to conversion of preferred stock</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">551,334<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending Balance</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">28,824,651<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">27,844,693<span></span></td>
        <td class="nump">22,183,732<span></span></td>
        <td class="nump">20,442,122<span></span></td>
        <td class="nump">15,019,034<span></span></td>
        <td class="nump">9,644,565<span></span></td>
        <td class="nump">7,384,066<span></span></td>
        <td class="nump">5,272,672<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending Balance, Shares</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,963,419<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,963,419<span></span></td>
        <td class="nump">1,584,633<span></span></td>
        <td class="nump">1,584,633<span></span></td>
        <td class="nump">1,215,515<span></span></td>
        <td class="nump">791,016<span></span></td>
        <td class="nump">648,971<span></span></td>
        <td class="nump">506,927<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">AQXP Canada [Member] | New Common Shares [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfUnits', window );">Share reorganization</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(534,735)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Repurchase of common stock</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(350)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits', window );">Share reorganization, Shares</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(301,745)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchase of common stock, Shares</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(182,292)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForCash', window );">Issued for cash, net of share issue costs</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">489,451<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">800<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForCash', window );">Issued for cash, net of share issue costs, Shares</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">62,169<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">416,660<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForNoncashConsiderations', window );">Issued for intangible assets</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">44,834<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForNoncashConsideration', window );">Issued for intangible assets, Shares</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">5,208<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending Balance</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">534,735<span></span></td>
        <td class="nump">450<span></span></td>
        <td class="nump">800<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending Balance, Shares</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">301,745<span></span></td>
        <td class="nump">234,368<span></span></td>
        <td class="nump">416,660<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Aquinox USA [Member] | Preferred Stock [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqxp_ConversionOfPreferredStockIntoCommonStock', window );">Conversion of preferred stock into Aquinox USA common stock</a></td>
        <td class="num">(48,509,974)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqxp_ConversionOfPreferredStockIntoCommonStockShares', window );">Conversion of preferred stock into Aquinox USA common stock, Shares</a></td>
        <td class="num">(3,580,096)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForCash', window );">Issued for cash, net of share issue costs</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">13,825,822<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">8,234,333<span></span></td>
        <td class="nump">8,084,158<span></span></td>
        <td class="nump">1,369,675<span></span></td>
        <td class="nump">1,384,073<span></span></td>
        <td class="nump">3,886,892<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForCash', window );">Issued for cash, net of share issue costs, Shares</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,325,753<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">782,225<span></span></td>
        <td class="nump">791,572<span></span></td>
        <td class="nump">132,574<span></span></td>
        <td class="nump">132,575<span></span></td>
        <td class="nump">397,726<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqxp_WarrantsExercised', window );">Warrants exercised</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">415,431<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqxp_WarrantsExercisedShares', window );">Warrants exercised, Shares</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">17,671<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqxp_TemporaryEquityWarrantDiscount', window );">Warrant discount on issuance of preferred shares</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(68,920)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(117,509)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqxp_TemporaryEquityRedemptionDiscount', window );">Redemption discount of $466,673 for AQXP Canada and $1,633,357 for Aquinox USA on issuance of preferred shares</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(1,633,357)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqxp_TemporaryEquityAccretionToRedemptionValueLiquidationPreference', window );">Accretion for liquidation preference on preferred stock</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">731,728<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">3,315,021<span></span></td>
        <td class="nump">2,212,708<span></span></td>
        <td class="nump">1,858,080<span></span></td>
        <td class="nump">1,113,956<span></span></td>
        <td class="nump">593,363<span></span></td>
        <td class="nump">454,346<span></span></td>
        <td class="nump">196,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment', window );">Accretion for share issuance costs on preferred stock</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">12,901<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">77,320<span></span></td>
        <td class="nump">96,406<span></span></td>
        <td class="nump">92,974<span></span></td>
        <td class="nump">97,288<span></span></td>
        <td class="nump">74,657<span></span></td>
        <td class="nump">65,108<span></span></td>
        <td class="nump">30,224<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqxp_TemporaryEquityAccretionToRedemptionValueWarrantDiscount', window );">Amortization of warrant discount on preferred stock</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">6,467<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">34,343<span></span></td>
        <td class="nump">23,566<span></span></td>
        <td class="nump">23,502<span></span></td>
        <td class="nump">17,706<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqxp_TemporaryEquityAccretionToRedemptionValueRedemptionOption', window );">Amortization of redemption option on preferred stock</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">58,300<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">256,863<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqxp_ExtinguishmentOfRemainingShareIssuanceCostsDueToConversionOfPreferredStock', window );">Extinguishment of remaining share issuance costs, warrant discount, redemption option and related tax payable due to conversion of preferred stock</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,686,549<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending Balance</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">48,509,974<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">46,014,029<span></span></td>
        <td class="nump">29,791,506<span></span></td>
        <td class="nump">27,458,826<span></span></td>
        <td class="nump">17,249,937<span></span></td>
        <td class="nump">8,054,338<span></span></td>
        <td class="nump">6,016,643<span></span></td>
        <td class="nump">4,113,116<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending Balance, Shares</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">3,580,096<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">3,580,096<span></span></td>
        <td class="nump">2,236,672<span></span></td>
        <td class="nump">2,236,672<span></span></td>
        <td class="nump">1,454,447<span></span></td>
        <td class="nump">662,875<span></span></td>
        <td class="nump">530,301<span></span></td>
        <td class="nump">397,726<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Aquinox USA [Member] | Common Stock [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqxp_ConversionOfPreferredStockIntoCommonStock', window );">Conversion of preferred stock into Aquinox USA common stock</a></td>
        <td class="nump">7<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits', window );">Share reorganization, Shares</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">301,745<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqxp_ConversionOfPreferredStockIntoCommonStockShares', window );">Conversion of preferred stock into Aquinox USA common stock, Shares</a></td>
        <td class="nump">5,543,515<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForCash', window );">Issued for cash, net of share issue costs</a></td>
        <td class="nump">4<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForCash', window );">Issued for cash, net of share issue costs, Shares</a></td>
        <td class="nump">4,830,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending Balance</a></td>
        <td class="nump">$ 11<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 11<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 11<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending Balance, Shares</a></td>
        <td class="nump">10,675,260<span></span></td>
        <td class="nump">301,745<span></span></td>
        <td class="nump">10,675,260<span></span></td>
        <td class="nump">301,745<span></span></td>
        <td class="nump">301,745<span></span></td>
        <td class="nump">301,745<span></span></td>
        <td class="nump">301,745<span></span></td>
        <td class="nump">301,745<span></span></td>
        <td class="nump">301,745<span></span></td>
        <td class="nump">301,745<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">10,675,260<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqxp_ConversionOfPreferredStockIntoCommonStock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Conversion Of Preferred Stock Into Common Stock</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>aqxp_ConversionOfPreferredStockIntoCommonStock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>aqxp_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqxp_ConversionOfPreferredStockIntoCommonStockShares">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Conversion Of Preferred Stock Into Common Stock Shares</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>aqxp_ConversionOfPreferredStockIntoCommonStockShares</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>aqxp_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqxp_ExtinguishmentOfRemainingShareIssuanceCostsDueToConversionOfPreferredStock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Extinguishment Of Remaining Share Issuance Costs Due To Conversion Of Preferred Stock</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>aqxp_ExtinguishmentOfRemainingShareIssuanceCostsDueToConversionOfPreferredStock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>aqxp_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqxp_IncomeTaxExpenseOnPreferredStock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Canadian tax with respect to Canadian corporation taxable preferred shares and their liquidation rights.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>aqxp_IncomeTaxExpenseOnPreferredStock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>aqxp_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqxp_TemporaryEquityAccretionToRedemptionValueLiquidationPreference">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Accretion for liquidation preference on temporary equity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>aqxp_TemporaryEquityAccretionToRedemptionValueLiquidationPreference</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>aqxp_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqxp_TemporaryEquityAccretionToRedemptionValueRedemptionOption">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Temporary Equity Accretion To Redemption Value Redemption Option</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>aqxp_TemporaryEquityAccretionToRedemptionValueRedemptionOption</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>aqxp_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqxp_TemporaryEquityAccretionToRedemptionValueWarrantDiscount">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Temporary Equity Accretion To Redemption Value Warrant Discount</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>aqxp_TemporaryEquityAccretionToRedemptionValueWarrantDiscount</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>aqxp_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqxp_TemporaryEquityRedemptionDiscount">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Discount on issuance of preferred shares for value of bifurcated redemption feature.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>aqxp_TemporaryEquityRedemptionDiscount</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>aqxp_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqxp_TemporaryEquityWarrantDiscount">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Discount on issuance of preferred shares for value of warrants.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>aqxp_TemporaryEquityWarrantDiscount</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>aqxp_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqxp_WarrantsExercised">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Warrants Exercised</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>aqxp_WarrantsExercised</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>aqxp_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqxp_WarrantsExercisedShares">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Warrants Exercised Shares</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>aqxp_WarrantsExercisedShares</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>aqxp_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Represents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 718<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5047-113901<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 718<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SAB TOPIC 14.F)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27013229&amp;loc=d3e301413-122809<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 718<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (h)(1)(i)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Staff Accounting Bulletin (SAB)<br><br><br><br> -Number Topic 14<br><br><br><br> -Section F<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AllocatedShareBasedCompensationExpense</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Other Comprehensive Income<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6519514<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Comprehensive Income<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=16317811<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 220<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 5<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358780&amp;loc=d3e557-108580<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Net Income<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6518256<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ComprehensiveIncomeNetOfTax</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of shares issued which are neither cancelled nor held in the treasury.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SharesOutstanding</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 310<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SAB TOPIC 4.E)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Staff Accounting Bulletin (SAB)<br><br><br><br> -Number Topic 4<br><br><br><br> -Section E<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.29-31)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 29, 30, 31<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockholdersEquity</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The number of shares issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 04<br><br><br><br> -Article 3<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.3-04)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 3<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21475-112644<br><br><br><br><br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.28,29)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 29, 30, 31<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForCash">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of shares issued as consideration for cash for development stage entities.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 915<br><br><br><br> -SubTopic 215<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6472370&amp;loc=d3e38297-110927<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodSharesIssuedForCash</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForNoncashConsideration">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of shares issued for noncash consideration for development stage entities.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 915<br><br><br><br> -SubTopic 215<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6472370&amp;loc=d3e38297-110927<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodSharesIssuedForNoncashConsideration</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfUnits">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Value of stock issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 04<br><br><br><br> -Article 3<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.3-04)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.29-31)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 29, 30, 31<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodValueConversionOfUnits</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueIssuedForCash">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Value of shares issued as consideration for cash for development stage entities.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 915<br><br><br><br> -SubTopic 215<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6472370&amp;loc=d3e38297-110927<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodValueIssuedForCash</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueIssuedForNoncashConsiderations">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Value of shares issued for noncash consideration for development stage entities.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 915<br><br><br><br> -SubTopic 215<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6472370&amp;loc=d3e38297-110927<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodValueIssuedForNoncashConsiderations</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 04<br><br><br><br> -Article 3<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 29, 30<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockRepurchasedDuringPeriodShares</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 04<br><br><br><br> -Article 3<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 505<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 29, 30, 31<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockRepurchasedDuringPeriodValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of decrease to net income for accretion of temporary equity to its redemption value to derive net income apportioned to common stockholders.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Redeemable convertible preferred stock and stockholders' (deficit) equity<br></strong></div>
        </th>
        <th class="th" colspan="1">3 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Redeemable convertible preferred stock and stockholders' (deficit) equity</a></td>
        <td class="text"><div>
 <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
 <b>3. Redeemable convertible preferred stock and
 stockholders&#x2019; (deficit) equity</b></p>
 <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
 On February&#xA0;27, 2014, the Company effected a 1-for-19.2
 reverse stock split of Aquinox USA&#x2019;s common stock and
 convertible preferred stock and AQXP Canada&#x2019;s common
 exchangeable shares and exchangeable preferred shares. All per
 share amounts and numbers of shares within the condensed
 consolidated and combined financial statements and notes are
 presented on a post-split basis.</p>
 <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
 On March&#xA0;12, 2014, immediately prior to the closing of the
 IPO, the Company underwent a reorganization, which resulted in a
 simplification of its capital structure. Each of the 301,745
 outstanding common exchangeable shares of AQXP Canada was
 transferred to Aquinox USA in exchange for one common stock of
 Aquinox USA. Each of the 791,016 outstanding Series A exchangeable
 preferred shares, 793,617 outstanding Series B exchangeable
 preferred shares and 378,786 outstanding Series C exchangeable
 preferred share of AQXP Canada was transferred to Aquinox USA in
 exchange for one share of Series A, B and C convertible preferred
 stock of Aquinox USA, respectively. As a result, following such
 exchange, there were 1,453,891 shares of Series A, 2,367,414 shares
 of Series B and 1,722,210 shares of Series C convertible preferred
 stock of Aquinox USA. Following the completion of the exchange and
 conversion, all special voting shares of AQXP Canada and all
 special voting stock of Aquinox USA were redeemed for a nominal
 amount and all exchangeable preferred shares of AQXP Canada, now
 held by Aquinox USA, were converted to common exchangeable shares
 of AQXP Canada. As a result of the reorganization, AQXP Canada
 became a 100% owned subsidiary of Aquinox USA. Subsequent to this
 reorganization, all 5,543,515 of the outstanding shares of
 redeemable convertible preferred stock of Aquinox USA converted to
 an equivalent number of shares of common stock of Aquinox USA. The
 exchange and conversion resulted in the derecognition of non-cash
 accrued tax payable of $1,797,412 and the derecognition of the
 derivative liability for the redemption option on preferred stock
 of $800,206.</p>
 <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
 On March&#xA0;12, 2014, the Company closed its IPO whereby the
 Company sold 4,830,000 shares of common stock (inclusive of 630,000
 shares of common stock sold by the Company pursuant to the full
 exercise of an overallotment option granted to the underwriters in
 connection with the offering) at a price of $11.00 per share before
 underwriting discounts. The shares began trading on the NASDAQ
 Global Market in March 2014, under the symbol &#x201C;AQXP&#x201D;.
 The aggregate net proceeds received by the Company from the
 offering, net of underwriting discounts and commissions and
 offering costs of $5,788,726, were $47,341,274.</p>
 <p style="font-size:1px;margin-top:12px;margin-bottom:0px">
 &#xA0;</p>
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
 On March&#xA0;12, 2014, the Company adopted an amended and restated
 certificate of incorporation for Aquinox USA, which authorized two
 classes of stock, common and preferred. The total number of shares
 the Company is authorized to issue is 55,000,000 shares, comprised
 of 50,000,000 common stock and 5,000,000 of a new category of
 preferred stock both with a par value of $0.000001 per share. As of
 March&#xA0;31, 2014 and December&#xA0;31, 2013, no shares of this
 new category of preferred stock were issued or outstanding.</p>
 </div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EquityAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.4-08.(d),(e))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 4<br><br> -Subparagraph (SAB TOPIC 4.C)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187143-122770<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29-31)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 310<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SAB TOPIC 4.E)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 4<br><br> -Section C<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 4<br><br> -Section E<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> -Article 4<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21506-112644<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Preferred Stock<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6521494<br><br><br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30, 31<br><br> -Article 5<br><br><br><br>Reference 11: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 12: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 13: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 14: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21475-112644<br><br><br><br>Reference 15: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 11<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21564-112644<br><br><br><br>Reference 16: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 5<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21488-112644<br><br><br><br>Reference 17: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21484-112644<br><br><br><br>Reference 18: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> -Paragraph d<br><br> -Article 4<br><br><br><br>Reference 19: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 30<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23285-112656<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockholdersEquityNoteDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EAGAE">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Loan facility - Schedule of Loan Facility (Detail) (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="1">3 Months Ended</th>
        <th class="th" colspan="1">12 Months Ended</th>
        <th class="th" colspan="1">123 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2014</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityAmountOutstanding', window );">Beginning balance</a></td>
        <td class="nump">$ 2,286,489<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityIncreaseAccruedInterest', window );">Accrued interest</a></td>
        <td class="nump">9,844<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromLinesOfCredit', window );">Bank loan cash received - October 30, 2013</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">2,500,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqxp_AccretionOfWarrantDiscount', window );">Accretion of warrant discount</a></td>
        <td class="nump">213,511<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqxp_DiscountOnIssuanceOfWarrants', window );">Warrant discount</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(226,255)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqxp_RepaymentFeeAndPenalty', window );">Repayment fee and penalty</a></td>
        <td class="nump">100,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">100,000<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_aqxp_PaymentsOfFinancingCostsDebt', window );">Financing costs</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">12,744<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLinesOfCredit', window );">Repayment of bank loan and interest</a></td>
        <td class="num">(2,609,844)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityAmountOutstanding', window );">Ending balance</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">$ 2,286,489<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqxp_AccretionOfWarrantDiscount">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Accretion Of Warrant Discount</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>aqxp_AccretionOfWarrantDiscount</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>aqxp_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqxp_DiscountOnIssuanceOfWarrants">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Discount on Issuance of Warrants</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>aqxp_DiscountOnIssuanceOfWarrants</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>aqxp_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqxp_PaymentsOfFinancingCostsDebt">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Payments of Financing Costs Debt</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>aqxp_PaymentsOfFinancingCostsDebt</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>aqxp_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqxp_RepaymentFeeAndPenalty">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Repayment Fee and Penalty</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>aqxp_RepaymentFeeAndPenalty</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>aqxp_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DebtDisclosureAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityAmountOutstanding">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount borrowed under the credit facility as of the balance sheet date.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 19, 22<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_LineOfCreditFacilityAmountOutstanding</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityIncreaseAccruedInterest">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Increase for accrued, but unpaid interest on the credit facility for the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.4-08.(f))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> -Paragraph f<br><br> -Article 4<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_LineOfCreditFacilityIncreaseAccruedInterest</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLinesOfCredit">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.4-08.(f))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> -Paragraph f<br><br> -Article 4<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Financing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 14<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3255-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ProceedsFromLinesOfCredit</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLinesOfCredit">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.4-08.(f))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> -Paragraph f<br><br> -Article 4<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 15<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3291-108585<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Financing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_RepaymentsOfLinesOfCredit</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<FilingSummary xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <Version>2.4.0.8</Version>
  <ProcessingTime />
  <ReportFormat>Html</ReportFormat>
  <ContextCount>173</ContextCount>
  <ElementCount>211</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>35</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>7</UnitCount>
  <MyReports>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>101 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imetrix.edgar-online.com/taxonomy/role/DocumentandEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
    </Report>
    <Report>
      <IsDefault>true</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>103 - Statement - Condensed Consolidated and Combined Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imetrix.edgar-online.com/taxonomy/role/StatementOfFinancialPositionClassified</Role>
      <ShortName>Condensed Consolidated and Combined Balance Sheets</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>104 - Statement - Condensed Consolidated and Combined Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imetrix.edgar-online.com/taxonomy/role/StatementOfFinancialPositionClassifiedParenthetical</Role>
      <ShortName>Condensed Consolidated and Combined Balance Sheets (Parenthetical)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>105 - Statement - Condensed consolidated and combined statements of operations and comprehensive loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imetrix.edgar-online.com/taxonomy/role/StatementOfIncomeAlternative</Role>
      <ShortName>Condensed consolidated and combined statements of operations and comprehensive loss</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>106 - Statement - Condensed consolidated and combined statements of convertible preferred stock and stockholders' deficit</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imetrix.edgar-online.com/taxonomy/role/StatementOfShareholdersEquityAndOtherComprehensiveIncome</Role>
      <ShortName>Condensed consolidated and combined statements of convertible preferred stock and stockholders' deficit</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>107 - Statement - Condensed consolidated and combined statements of convertible preferred stock and stockholders' deficit (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imetrix.edgar-online.com/taxonomy/role/StatementOfShareholdersEquityAndOtherComprehensiveIncomeParenthetical</Role>
      <ShortName>Condensed consolidated and combined statements of convertible preferred stock and stockholders' deficit (Parenthetical)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>108 - Statement - Condensed consolidated and combined statements of cash flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imetrix.edgar-online.com/taxonomy/role/StatementOfCashFlowsIndirect</Role>
      <ShortName>Condensed consolidated and combined statements of cash flows</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>109 - Disclosure - Nature of operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsNatureOfOperations</Role>
      <ShortName>Nature of operations</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>110 - Disclosure - Condensed summary of significant accounting policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsSignificantAccountingPoliciesTextBlock</Role>
      <ShortName>Condensed summary of significant accounting policies</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>111 - Disclosure - Redeemable convertible preferred stock and stockholders' (deficit) equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsStockholdersEquityNoteDisclosureTextBlock</Role>
      <ShortName>Redeemable convertible preferred stock and stockholders' (deficit) equity</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>112 - Disclosure - Cash and cash equivalents</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsCashAndCashEquivalentsDisclosureTextBlock</Role>
      <ShortName>Cash and cash equivalents</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>113 - Disclosure - Loan facility</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsDebtDisclosureTextBlock</Role>
      <ShortName>Loan facility</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>114 - Disclosure - Common stock</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsCommonStockDisclosureTextBlock</Role>
      <ShortName>Common stock</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>115 - Disclosure - Net loss per share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsEarningsPerShareTextBlock</Role>
      <ShortName>Net loss per share</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>116 - Disclosure - Financial instruments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsFinancialInstrumentsDisclosureTextBlock</Role>
      <ShortName>Financial instruments</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>117 - Disclosure - Condensed summary of significant accounting policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsSignificantAccountingPoliciesTextBlockPolicies</Role>
      <ShortName>Condensed summary of significant accounting policies (Policies)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>118 - Disclosure - Cash and cash equivalents (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsCashAndCashEquivalentsDisclosureTextBlockTables</Role>
      <ShortName>Cash and cash equivalents (Tables)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>119 - Disclosure - Loan facility (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsDebtDisclosureTextBlockTables</Role>
      <ShortName>Loan facility (Tables)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>120 - Disclosure - Common stock (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsCommonStockDisclosureTextBlockTables</Role>
      <ShortName>Common stock (Tables)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>121 - Disclosure - Net loss per share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsEarningsPerShareTextBlockTables</Role>
      <ShortName>Net loss per share (Tables)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>122 - Disclosure - Financial instruments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsFinancialInstrumentsDisclosureTextBlockTables</Role>
      <ShortName>Financial instruments (Tables)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>123 - Disclosure - Nature of operations - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imetrix.edgar-online.com/taxonomy/role/DisclosureNatureOfOperationsAdditionalInformation</Role>
      <ShortName>Nature of operations - Additional Information (Detail)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>124 - Disclosure - Condensed summary of significant accounting policies - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imetrix.edgar-online.com/taxonomy/role/DisclosureCondensedSummaryOfSignificantAccountingPoliciesAdditionalInformation</Role>
      <ShortName>Condensed summary of significant accounting policies - Additional Information (Detail)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>125 - Disclosure - Redeemable convertible preferred stock and stockholders' (deficit) equity - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imetrix.edgar-online.com/taxonomy/role/DisclosureRedeemableConvertiblePreferredStockAndStockholdersdeficitEquityAdditionalInformation</Role>
      <ShortName>Redeemable convertible preferred stock and stockholders' (deficit) equity - Additional Information (Detail)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>126 - Disclosure - Cash and cash equivalents - Schedule of cash and cash equivalents (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imetrix.edgar-online.com/taxonomy/role/DisclosureCashAndCashEquivalentsScheduleOfCashAndCashEquivalents</Role>
      <ShortName>Cash and cash equivalents - Schedule of cash and cash equivalents (Detail)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>127 - Disclosure - Loan facility - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imetrix.edgar-online.com/taxonomy/role/DisclosureLoanFacilityAdditionalInformation</Role>
      <ShortName>Loan facility - Additional Information (Detail)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>128 - Disclosure - Loan facility - Schedule of Loan Facility (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imetrix.edgar-online.com/taxonomy/role/DisclosureLoanFacilityScheduleOfLoanFacility</Role>
      <ShortName>Loan facility - Schedule of Loan Facility (Detail)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>129 - Disclosure - Loan facility - Summary of Bank Loan Facility (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imetrix.edgar-online.com/taxonomy/role/DisclosureLoanFacilitySummaryOfBankLoanFacility</Role>
      <ShortName>Loan facility - Summary of Bank Loan Facility (Detail)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>130 - Disclosure - Common stock - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imetrix.edgar-online.com/taxonomy/role/DisclosureCommonStockAdditionalInformation</Role>
      <ShortName>Common stock - Additional Information (Detail)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>131 - Disclosure - Common stock - Schedule of Weighted Average Assumptions (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imetrix.edgar-online.com/taxonomy/role/DisclosureCommonStockScheduleOfWeightedAverageAssumptions</Role>
      <ShortName>Common stock - Schedule of Weighted Average Assumptions (Detail)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>132 - Disclosure - Net loss per share - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imetrix.edgar-online.com/taxonomy/role/DisclosureNetLossPerShareAdditionalInformation</Role>
      <ShortName>Net loss per share - Additional Information (Detail)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>133 - Disclosure - Net loss per share - Schedule of Computation of Basic and Diluted Earnings Per Share (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imetrix.edgar-online.com/taxonomy/role/DisclosureNetLossPerShareScheduleOfComputationOfBasicAndDilutedEarningsPerShare</Role>
      <ShortName>Net loss per share - Schedule of Computation of Basic and Diluted Earnings Per Share (Detail)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>134 - Disclosure - Net loss per share - Schedule of Antidilutive Securities Excluded from Computation of Basic and Diluted Net Loss Per Share (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imetrix.edgar-online.com/taxonomy/role/DisclosureNetLossPerShareScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfBasicAndDilutedNetLossPerShare</Role>
      <ShortName>Net loss per share - Schedule of Antidilutive Securities Excluded from Computation of Basic and Diluted Net Loss Per Share (Detail)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>135 - Disclosure - Financial instruments - Fair Value of Significant Unobservable Inputs (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imetrix.edgar-online.com/taxonomy/role/DisclosureFinancialInstrumentsFairValueOfSignificantUnobservableInputs</Role>
      <ShortName>Financial instruments - Fair Value of Significant Unobservable Inputs (Detail)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>136 - Disclosure - Financial instruments - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imetrix.edgar-online.com/taxonomy/role/DisclosureFinancialInstrumentsAdditionalInformation</Role>
      <ShortName>Financial instruments - Additional Information (Detail)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Info">Element us-gaap_ProceedsFromLinesOfCredit had a mix of decimals attribute values: -5 0.</Log>
    <Log type="Warning">Warning: The equity rendering routine was not applied to 106 - Statement - Condensed consolidated and combined statements of convertible preferred stock and stockholders' deficit.
None of the elements feature the 'periodStartLabel' preferred label role.</Log>
    <Log type="Info">'Monetary' elements on report '127 - Disclosure - Loan facility - Additional Information (Detail)' had a mix of different decimal attribute values.</Log>
    <Log type="Info">Process Flow-Through: 103 - Statement - Condensed Consolidated and Combined Balance Sheets</Log>
    <Log type="Info">	Process Flow-Through: Removing column 'Mar. 12, 2014'</Log>
    <Log type="Info">	Process Flow-Through: Removing column 'Mar. 31, 2013'</Log>
    <Log type="Info">	Process Flow-Through: Removing column 'Dec. 31, 2012'</Log>
    <Log type="Info">	Process Flow-Through: Removing column 'Dec. 31, 2011'</Log>
    <Log type="Info">	Process Flow-Through: Removing column 'Dec. 31, 2010'</Log>
    <Log type="Info">	Process Flow-Through: Removing column 'Dec. 31, 2009'</Log>
    <Log type="Info">	Process Flow-Through: Removing column 'Dec. 31, 2008'</Log>
    <Log type="Info">	Process Flow-Through: Removing column 'Dec. 31, 2007'</Log>
    <Log type="Info">	Process Flow-Through: Removing column 'Dec. 31, 2006'</Log>
    <Log type="Info">	Process Flow-Through: Removing column 'Dec. 31, 2005'</Log>
    <Log type="Info">	Process Flow-Through: Removing column 'Dec. 31, 2004'</Log>
    <Log type="Info">Process Flow-Through: 104 - Statement - Condensed Consolidated and Combined Balance Sheets (Parenthetical)</Log>
    <Log type="Info">	Process Flow-Through: Removing column 'Mar. 12, 2014'</Log>
    <Log type="Info">Process Flow-Through: 105 - Statement - Condensed consolidated and combined statements of operations and comprehensive loss</Log>
    <Log type="Info">	Process Flow-Through: Removing column '1 Months Ended
Mar. 31, 2014'</Log>
    <Log type="Info">	Process Flow-Through: Removing column '3 Months Ended
Mar. 12, 2014'</Log>
    <Log type="Info">	Process Flow-Through: Removing column '12 Months Ended
Dec. 31, 2013'</Log>
    <Log type="Info">	Process Flow-Through: Removing column '12 Months Ended
Dec. 31, 2012'</Log>
    <Log type="Info">	Process Flow-Through: Removing column '12 Months Ended
Dec. 31, 2011'</Log>
    <Log type="Info">	Process Flow-Through: Removing column '12 Months Ended
Dec. 31, 2010'</Log>
    <Log type="Info">	Process Flow-Through: Removing column '12 Months Ended
Dec. 31, 2009'</Log>
    <Log type="Info">	Process Flow-Through: Removing column '12 Months Ended
Dec. 31, 2008'</Log>
    <Log type="Info">	Process Flow-Through: Removing column '12 Months Ended
Dec. 31, 2007'</Log>
    <Log type="Info">	Process Flow-Through: Removing column '12 Months Ended
Dec. 31, 2006'</Log>
    <Log type="Info">	Process Flow-Through: Removing column '12 Months Ended
Dec. 31, 2005'</Log>
    <Log type="Info">	Process Flow-Through: Removing column '12 Months Ended
Dec. 31, 2004'</Log>
    <Log type="Info">Process Flow-Through: 106 - Statement - Condensed consolidated and combined statements of convertible preferred stock and stockholders' deficit</Log>
    <Log type="Info">	Process Flow-Through: Removing column '3 Months Ended
Mar. 31, 2013'</Log>
    <Log type="Info">Process Flow-Through: 107 - Statement - Condensed consolidated and combined statements of convertible preferred stock and stockholders' deficit (Parenthetical)</Log>
    <Log type="Info">	Process Flow-Through: Removing column '0 Months Ended
Mar. 12, 2014'</Log>
    <Log type="Info">	Process Flow-Through: Removing column '1 Months Ended
Mar. 31, 2014
Aquinox USA [Member]
Common Stock [Member]'</Log>
    <Log type="Info">Process Flow-Through: 108 - Statement - Condensed consolidated and combined statements of cash flows</Log>
  </Logs>
  <InputFiles>
    <File>aqxp-20140331.xml</File>
    <File>aqxp-20140331.xsd</File>
    <File>aqxp-20140331_cal.xml</File>
    <File>aqxp-20140331_def.xml</File>
    <File>aqxp-20140331_lab.xml</File>
    <File>aqxp-20140331_pre.xml</File>
  </InputFiles>
  <SupplementalFiles />
  <BaseTaxonomies />
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0E2F">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Net loss per share (Tables)<br></strong></div>
        </th>
        <th class="th" colspan="1">3 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Mar. 31, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Computation of Basic and Diluted Earnings Per Share</a></td>
        <td class="text"><div>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt">
 The detail of the computation of basic and diluted earnings per
 share is as follows:</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; MARGIN-TOP: 0pt">
 &#xA0;</p>
 <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="84%" align="center" border="0">
 <tr>
 <td width="51%"></td>
 <td valign="bottom" width="7%"></td>
 <td></td>
 <td></td>
 <td></td>
 <td valign="bottom" width="7%"></td>
 <td></td>
 <td></td>
 <td></td>
 <td valign="bottom" width="7%"></td>
 <td></td>
 <td></td>
 <td></td>
 </tr>
 <tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>THREE&#xA0;MONTHS<br />
 ENDED<br />
 MARCH 31, 2014</b></td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>THREE&#xA0;MONTHS<br />
 ENDED<br />
 MARCH 31, 2013</b></td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>DECEMBER&#xA0;26,<br />
 2003<br />
 (INCEPTION)&#xA0;TO<br />
 MARCH 31, 2014</b></td>
 <td valign="bottom">&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF">
 <td valign="top">
 <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em">
 <b><i>Numerator</i></b></p>
 </td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 </tr>
 <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
 <td valign="top">
 <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em">
 Net loss and comprehensive loss incurred in the development
 stage</p>
 </td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">$</td>
 <td valign="bottom" align="right">(4,227,678</td>
 <td valign="bottom" nowrap="nowrap">)&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">$</td>
 <td valign="bottom" align="right">(1,010,267</td>
 <td valign="bottom" nowrap="nowrap">)&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">$</td>
 <td valign="bottom" align="right">(51,502,587</td>
 <td valign="bottom" nowrap="nowrap">)&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF">
 <td valign="top">
 <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em">
 Accretion for liquidation preference on preferred stock</p>
 </td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" align="right">(1,132,893</td>
 <td valign="bottom" nowrap="nowrap">)&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" align="right">(1,157,865</td>
 <td valign="bottom" nowrap="nowrap">)&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" align="right">(18,566,008</td>
 <td valign="bottom" nowrap="nowrap">)&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
 <td valign="top">
 <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em">
 Accretion for share issuance costs on preferred stock</p>
 </td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" align="right">(19,550</td>
 <td valign="bottom" nowrap="nowrap">)&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" align="right">(44,307</td>
 <td valign="bottom" nowrap="nowrap">)&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" align="right">(1,014,667</td>
 <td valign="bottom" nowrap="nowrap">)&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF">
 <td valign="top">
 <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em">
 Tax expense on preferred stock</p>
 </td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" align="right">(100,291</td>
 <td valign="bottom" nowrap="nowrap">)&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" align="right">(346,091</td>
 <td valign="bottom" nowrap="nowrap">)&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" align="right">(1,897,702</td>
 <td valign="bottom" nowrap="nowrap">)&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
 <td valign="top">
 <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em">
 Reversal of tax payable on preferred stock due to conversion of
 preferred stock</p>
 </td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" align="right">1,897,702</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;</td>
 <td valign="bottom" nowrap="nowrap" align="right">
 &#x2014;&#xA0;&#xA0;</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" align="right">1,897,702</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF">
 <td valign="top">
 <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em">
 Extinguishment of remaining share issuance costs due to conversion
 of preferred stock</p>
 </td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" align="right">(439,227</td>
 <td valign="bottom" nowrap="nowrap">)&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;</td>
 <td valign="bottom" nowrap="nowrap" align="right">
 &#x2014;&#xA0;&#xA0;</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" align="right">(439,227</td>
 <td valign="bottom" nowrap="nowrap">)&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
 <td valign="top">
 <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em">
 Total loss attributable to common stockholders</p>
 </td>
 <td valign="bottom"><font style="FONT-SIZE: 8pt">&#xA0;&#xA0;</font></td>
 <td valign="bottom">$</td>
 <td valign="bottom" align="right">(4,021,937</td>
 <td valign="bottom" nowrap="nowrap">)&#xA0;</td>
 <td valign="bottom"><font style="FONT-SIZE: 8pt">&#xA0;</font></td>
 <td valign="bottom">$</td>
 <td valign="bottom" align="right">(2,558,530</td>
 <td valign="bottom" nowrap="nowrap">)&#xA0;</td>
 <td valign="bottom"><font style="FONT-SIZE: 8pt">&#xA0;</font></td>
 <td valign="bottom">$</td>
 <td valign="bottom" align="right">(71,522,489</td>
 <td valign="bottom" nowrap="nowrap">)&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF">
 <td valign="top">
 <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em">
 <b><i>Denominator</i></b></p>
 </td>
 <td valign="bottom"><font style="FONT-SIZE: 8pt">&#xA0;&#xA0;</font></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"><font style="FONT-SIZE: 8pt">&#xA0;</font></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"><font style="FONT-SIZE: 8pt">&#xA0;</font></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 </tr>
 <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
 <td valign="top">
 <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em">
 Weighted average shares used to compute basic net loss per common
 share</p>
 </td>
 <td valign="bottom"><font style="FONT-SIZE: 8pt">&#xA0;&#xA0;</font></td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" align="right">3,148,481</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 <td valign="bottom"><font style="FONT-SIZE: 8pt">&#xA0;</font></td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" align="right">301,745</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 <td valign="bottom"><font style="FONT-SIZE: 8pt">&#xA0;</font></td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" align="right">398,573</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF">
 <td valign="top">
 <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em">
 Effect of potentially dilutive securities:</p>
 </td>
 <td valign="bottom"><font style="FONT-SIZE: 8pt">&#xA0;&#xA0;</font></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"><font style="FONT-SIZE: 8pt">&#xA0;</font></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"><font style="FONT-SIZE: 8pt">&#xA0;</font></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 <td valign="bottom"></td>
 </tr>
 <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
 <td valign="top">
 <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em">
 Stock options</p>
 </td>
 <td valign="bottom"><font style="FONT-SIZE: 8pt">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap">&#xA0;</td>
 <td valign="bottom" nowrap="nowrap" align="right">
 &#x2014;&#xA0;&#xA0;</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 <td valign="bottom"><font style="FONT-SIZE: 8pt">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap">&#xA0;</td>
 <td valign="bottom" nowrap="nowrap" align="right">
 &#x2014;&#xA0;&#xA0;</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 <td valign="bottom"><font style="FONT-SIZE: 8pt">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap">&#xA0;</td>
 <td valign="bottom" nowrap="nowrap" align="right">
 &#x2014;&#xA0;&#xA0;</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF">
 <td valign="top">
 <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em">
 Common stock warrants</p>
 </td>
 <td valign="bottom"><font style="FONT-SIZE: 8pt">&#xA0;&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap">&#xA0;</td>
 <td valign="bottom" nowrap="nowrap" align="right">
 &#x2014;&#xA0;&#xA0;</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 <td valign="bottom"><font style="FONT-SIZE: 8pt">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap">&#xA0;</td>
 <td valign="bottom" nowrap="nowrap" align="right">
 &#x2014;&#xA0;&#xA0;</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 <td valign="bottom"><font style="FONT-SIZE: 8pt">&#xA0;</font></td>
 <td valign="bottom" nowrap="nowrap">&#xA0;</td>
 <td valign="bottom" nowrap="nowrap" align="right">
 &#x2014;&#xA0;&#xA0;</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
 <td valign="top">
 <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em">
 Weighted average shares used to compute diluted net loss per common
 share</p>
 </td>
 <td valign="bottom"><font style="FONT-SIZE: 8pt">&#xA0;&#xA0;</font></td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" align="right">3,148,481</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 <td valign="bottom"><font style="FONT-SIZE: 8pt">&#xA0;</font></td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" align="right">301,745</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 <td valign="bottom"><font style="FONT-SIZE: 8pt">&#xA0;</font></td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" align="right">398,573</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF">
 <td valign="top">
 <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em">
 Net loss per share attributable to common
 stockholders&#x2014;basic</p>
 </td>
 <td valign="bottom"><font style="FONT-SIZE: 8pt">&#xA0;&#xA0;</font></td>
 <td valign="bottom">$</td>
 <td valign="bottom" align="right">(1.28</td>
 <td valign="bottom" nowrap="nowrap">)&#xA0;</td>
 <td valign="bottom"><font style="FONT-SIZE: 8pt">&#xA0;</font></td>
 <td valign="bottom">$</td>
 <td valign="bottom" align="right">(8.48</td>
 <td valign="bottom" nowrap="nowrap">)&#xA0;</td>
 <td valign="bottom"><font style="FONT-SIZE: 8pt">&#xA0;</font></td>
 <td valign="bottom">$</td>
 <td valign="bottom" align="right">(179.45</td>
 <td valign="bottom" nowrap="nowrap">)&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
 <td valign="top">
 <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em">
 Net loss per share attributable to common
 stockholders&#x2014;diluted</p>
 </td>
 <td valign="bottom"><font style="FONT-SIZE: 8pt">&#xA0;&#xA0;</font></td>
 <td valign="bottom">$</td>
 <td valign="bottom" align="right">(1.28</td>
 <td valign="bottom" nowrap="nowrap">)&#xA0;</td>
 <td valign="bottom"><font style="FONT-SIZE: 8pt">&#xA0;</font></td>
 <td valign="bottom">$</td>
 <td valign="bottom" align="right">(8.48</td>
 <td valign="bottom" nowrap="nowrap">)&#xA0;</td>
 <td valign="bottom"><font style="FONT-SIZE: 8pt">&#xA0;</font></td>
 <td valign="bottom">$</td>
 <td valign="bottom" align="right">(179.45</td>
 <td valign="bottom" nowrap="nowrap">)&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 </table>
 </div><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of Antidilutive Securities Excluded from Computation of Basic and Diluted Net Loss Per Share</a></td>
        <td class="text"><div>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt">
 The following have been excluded from the computation of basic and
 diluted net loss per share as their effect would have been
 antidilutive:</p>
 <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; MARGIN-TOP: 0pt">
 &#xA0;</p>
 <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="76%" align="center" border="0">
 <tr>
 <td width="64%"></td>
 <td valign="bottom" width="10%"></td>
 <td></td>
 <td></td>
 <td></td>
 <td valign="bottom" width="10%"></td>
 <td></td>
 <td></td>
 <td></td>
 </tr>
 <tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>THREE&#xA0;MONTHS<br />
 ENDED</b><br />
 <b>MARCH 31, 2014</b></td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>THREE&#xA0;MONTHS<br />
 ENDED</b><br />
 <b>MARCH 31, 2013</b></td>
 <td valign="bottom">&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF">
 <td valign="top">
 <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em">
 Convertible preferred stock</p>
 </td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;</td>
 <td valign="bottom" nowrap="nowrap" align="right">
 &#x2014;&#xA0;&#xA0;</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" align="right">5,525,844</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
 <td valign="top">
 <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em">
 Outstanding stock options</p>
 </td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" align="right">630,159</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" align="right">435,141</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF">
 <td valign="top">
 <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em">
 Common stock warrants</p>
 </td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" align="right">11,363</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;</td>
 <td valign="bottom" nowrap="nowrap" align="right">
 &#x2014;&#xA0;&#xA0;</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
 <td valign="top">
 <p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em">
 Total</p>
 </td>
 <td valign="bottom"><font style="FONT-SIZE: 8pt">&#xA0;&#xA0;</font></td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" align="right">641,522</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 <td valign="bottom"><font style="FONT-SIZE: 8pt">&#xA0;&#xA0;</font></td>
 <td valign="bottom">&#xA0;</td>
 <td valign="bottom" align="right">5,960,985</td>
 <td valign="bottom" nowrap="nowrap">&#xA0;&#xA0;</td>
 </tr>
 <tr style="FONT-SIZE: 1px">
 <td valign="bottom"></td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 <td valign="bottom">&#xA0;&#xA0;</td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td valign="bottom">
 <p style="BORDER-TOP: #000000 3px double">&#xA0;</p>
 </td>
 <td>&#xA0;</td>
 </tr>
 </table>
 </div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EarningsPerShareAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (c)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
